identification	B-UNK
of	O
apc2	B-UNK
,	O
a	O
homologue	B-UNK
of	O
the	O
adenomatous	B-DISEASE
polyposis	I-DISEASE
coli	I-DISEASE
tumour	B-UNK
suppressor	I-UNK
.	O

 	O
the	O
adenomatous	B-DISEASE
polyposis	I-DISEASE
coli	I-DISEASE
(	O
apc	B-UNK
)	O
tumour	B-UNK
-	O
suppressor	B-UNK
protein	B-UNK
controls	B-UNK
the	O
wnt	B-UNK
signalling	B-UNK
pathway	B-UNK
by	O
forming	O
a	O
complex	B-UNK
with	O
glycogen	O
synthase	O
kinase	B-UNK
3beta	O
(	O
gsk	O
-	O
3beta	O
)	O
,	O
axin	O
/	O
conductin	O
and	O
betacatenin	O
.	O

 	O
complex	B-UNK
formation	B-UNK
induces	B-UNK
the	O
rapid	B-UNK
degradation	B-UNK
of	O
betacatenin	O
.	O

 	O
in	O
colon	O
carcinoma	B-DISEASE
cells	B-UNK
,	O
loss	B-UNK
of	O
apc	B-UNK
leads	B-UNK
to	O
the	O
accumulation	B-UNK
of	O
betacatenin	O
in	O
the	O
nucleus	O
,	O
where	O
it	O
binds	O
to	O
and	O
activates	O
the	O
tcf	B-UNK
-	O
4	O
transcription	B-UNK
factor	B-UNK
(	O
reviewed	O
in	O
[	O
1	O
]	O
[	O
2	O
]	O
)	O
.	O

 	O
here	O
,	O
we	O
report	B-UNK
the	O
identification	B-UNK
and	O
genomic	B-UNK
structure	B-UNK
of	O
apc	B-UNK
homologues	B-UNK
.	O

 	O
mammalian	B-UNK
apc2	B-UNK
,	O
which	O
closely	B-UNK
resembles	O
apc	B-UNK
in	O
overall	B-UNK
domain	B-UNK
structure	B-UNK
,	O
was	O
functionally	B-UNK
analyzed	B-UNK
and	O
shown	B-UNK
to	O
contain	B-UNK
two	O
samp	O
domains	B-UNK
,	O
both	O
of	O
which	O
are	O
required	B-UNK
for	O
binding	B-UNK
to	O
conductin	O
.	O

 	O
like	B-UNK
apc	B-UNK
,	O
apc2	B-UNK
regulates	B-UNK
the	O
formation	B-UNK
of	O
active	B-UNK
betacatenin	O
-	O
tcf	B-UNK
complexes	B-UNK
,	O
as	O
demonstrated	B-UNK
using	O
transient	O
transcriptional	B-UNK
activation	I-UNK
assays	B-UNK
in	O
apc	B-UNK
-	O
/	O
-	O
colon	O
carcinoma	B-DISEASE
cells	B-UNK
.	O

 	B-UNK
human	I-UNK
apc2	B-UNK
maps	B-UNK
to	O
chromosome	B-UNK
19p13	O
.	O

 	O
3	O
.	O

 	O
apc	B-UNK
and	O
apc2	B-UNK
may	O
therefore	O
have	O
comparable	B-UNK
functions	B-UNK
in	O
development	B-UNK
and	O
cancer	B-DISEASE
.	O

 	O
a	O
common	B-UNK
msh2	B-UNK
mutation	B-UNK
in	O
english	O
and	O
north	B-UNK
american	I-UNK
hnpcc	B-UNK
families	B-UNK
:	O
origin	B-UNK
,	O
phenotypic	B-UNK
expression	B-UNK
,	O
and	O
sex	B-UNK
specific	B-UNK
differences	B-UNK
in	O
colorectal	B-DISEASE
cancer	I-DISEASE
.	O

 	O
the	O
frequency	B-UNK
,	O
origin	B-UNK
,	O
and	O
phenotypic	B-UNK
expression	B-UNK
of	O
a	O
germline	B-UNK
msh2	B-UNK
gene	B-UNK
mutation	B-UNK
previously	B-UNK
identified	I-UNK
in	O
seven	B-UNK
kindreds	B-UNK
with	O
hereditary	B-UNK
non	B-UNK
-	O
polyposis	B-DISEASE
cancer	B-DISEASE
syndrome	B-DISEASE
(	O
hnpcc	B-UNK
)	O
was	O
investigated	B-UNK
.	O

 	O
the	O
mutation	B-UNK
(	O
a	O
-	O
-	O
>	O
t	B-UNK
at	B-DISEASE
nt943	O
+	O
3	O
)	O
disrupts	O
the	O
3	O
splice	B-UNK
site	I-UNK
of	O
exon	B-UNK
5	O
leading	B-UNK
to	O
the	O
deletion	B-UNK
of	O
this	O
exon	B-UNK
from	O
msh2	B-UNK
mrna	B-UNK
and	O
represents	B-UNK
the	O
only	O
frequent	B-UNK
msh2	B-UNK
mutation	B-UNK
so	O
far	B-UNK
reported	B-UNK
.	O

 	O
although	O
this	O
mutation	B-UNK
was	O
initially	B-UNK
detected	B-UNK
in	O
four	O
of	O
33	O
colorectal	B-DISEASE
cancer	I-DISEASE
families	B-UNK
analysed	B-UNK
from	O
eastern	B-UNK
england	O
,	O
more	O
extensive	B-UNK
analysis	B-UNK
has	O
reduced	B-UNK
the	O
frequency	B-UNK
to	O
four	O
of	O
52	O
(	O
8	O
%	O
)	O
english	O
hnpcc	B-UNK
kindreds	B-UNK
analysed	B-UNK
.	O

 	O
in	O
contrast	B-UNK
,	O
the	O
msh2	B-UNK
mutation	B-UNK
was	O
identified	B-UNK
in	O
10	O
of	O
20	O
(	O
50	O
%	O
)	O
separately	B-UNK
identified	B-UNK
colorectal	B-UNK
families	B-UNK
from	O
newfoundland	B-UNK
.	O

 	O
to	O
investigate	O
the	O
origin	B-UNK
of	O
this	O
mutation	B-UNK
in	O
colorectal	B-DISEASE
cancer	I-DISEASE
families	B-UNK
from	O
england	O
(	O
n	B-UNK
=	O
4	O
)	O
,	O
newfoundland	B-UNK
(	O
n	B-UNK
=	O
10	O
)	O
,	O
and	O
the	O
united	B-UNK
states	B-UNK
(	O
n	B-UNK
=	O
3	O
)	O
,	O
haplotype	B-UNK
analysis	B-UNK
using	O
microsatellite	B-UNK
markers	I-UNK
linked	B-UNK
to	O
msh2	B-UNK
was	O
performed	B-UNK
.	O

 	O
within	O
the	O
english	O
and	O
us	O
families	B-UNK
there	O
was	O
little	B-UNK
evidence	B-UNK
for	O
a	O
recent	B-UNK
common	B-UNK
origin	B-UNK
of	O
the	O
msh2	B-UNK
splice	B-UNK
site	I-UNK
mutation	I-UNK
in	O
most	O
families	B-UNK
.	O

 	O
in	O
contrast	B-UNK
,	O
a	O
common	B-UNK
haplotype	B-UNK
was	O
identified	B-UNK
at	B-DISEASE
the	O
two	O
flanking	B-UNK
markers	B-UNK
(	O
ca5	O
and	O
d2s288	O
)	O
in	O
eight	O
of	O
the	O
newfoundland	B-UNK
families	B-UNK
.	O

 	O
these	O
findings	B-UNK
suggested	B-UNK
a	O
founder	B-UNK
effect	B-UNK
within	O
newfoundland	B-UNK
similar	B-UNK
to	O
that	O
reported	B-UNK
by	O
others	O
for	O
two	O
mlh1	O
mutations	B-UNK
in	O
finnish	B-UNK
hnpcc	B-UNK
families	B-UNK
.	O

 	O
we	O
calculated	O
age	B-UNK
related	B-UNK
risks	O
of	O
all	O
,	O
colorectal	B-UNK
,	O
endometrial	O
,	O
and	O
ovarian	B-UNK
cancers	B-DISEASE
in	O
nt943	O
+	O
3	O
a	O
-	O
-	O
>	O
t	B-UNK
msh2	B-UNK
mutation	B-UNK
carriers	B-UNK
(	O
n	B-UNK
=	O
76	O
)	O
for	O
all	O
patients	B-UNK
and	O
for	O
men	B-UNK
and	O
women	B-UNK
separately	B-UNK
.	O

 	O
for	O
both	O
sexes	O
combined	B-UNK
,	O
the	O
penetrances	O
at	B-DISEASE
age	B-UNK
60	O
years	B-UNK
for	O
all	O
cancers	B-DISEASE
and	O
for	O
colorectal	B-DISEASE
cancer	I-DISEASE
were	O
0	O
.	O

 	O
86	O
and	O
0	O
.	O

 	O
57	O
,	O
respectively	B-UNK
.	O

 	O
the	O
risk	B-UNK
of	O
colorectal	B-DISEASE
cancer	I-DISEASE
was	O
significantly	B-UNK
higher	B-UNK
(	O
p	B-UNK
<	O
0	O
.	O
01	O
)	O
in	O
males	B-UNK
than	O
females	B-UNK
(	O
0	O
.	O
63	O
v	O
0	O
.	O
30	O
and	O
0	O
.	O
84	O
v	O
0	O
.	O
44	O
at	B-DISEASE
ages	O
50	O
and	O
60	O
years	B-UNK
,	O
respectively	B-UNK
)	O
.	O

 	O
for	O
females	B-UNK
there	O
was	O
a	O
high	B-UNK
risk	B-UNK
of	O
endometrial	B-DISEASE
cancer	I-DISEASE
(	O
0	O
.	O
5	O
at	B-DISEASE
age	B-UNK
60	O
years	B-UNK
)	O
and	O
premenopausal	O
ovarian	B-DISEASE
cancer	I-DISEASE
(	O
0	O
.	O
2	O
at	B-DISEASE
50	O
years	B-UNK
)	O
.	O

 	O
these	O
intersex	O
differences	B-UNK
in	O
colorectal	B-DISEASE
cancer	I-DISEASE
risks	O
have	O
implications	B-UNK
for	O
screening	B-UNK
programmes	O
and	O
for	O
attempts	O
to	O
identify	B-UNK
colorectal	B-DISEASE
cancer	I-DISEASE
susceptibility	B-UNK
modifiers	O
.	O

 	O
age	B-UNK
of	O
onset	B-UNK
in	O
huntington	B-DISEASE
disease	I-DISEASE
:	O
sex	B-UNK
specific	B-UNK
influence	O
of	O
apolipoprotein	B-DISEASE
e	I-DISEASE
genotype	B-UNK
and	O
normal	B-UNK
cag	B-UNK
repeat	I-UNK
length	O
.	O

 	O
age	B-UNK
of	O
onset	B-UNK
(	O
ao	B-UNK
)	O
of	O
huntington	B-DISEASE
disease	I-DISEASE
(	O
hd	B-UNK
)	O
is	O
known	B-UNK
to	O
be	O
correlated	B-UNK
with	O
the	O
length	O
of	O
an	O
expanded	B-UNK
cag	I-UNK
repeat	B-UNK
in	O
the	O
hd	B-UNK
gene	B-UNK
.	O

 	O
apolipoprotein	B-DISEASE
e	I-DISEASE
(	O
apoe	B-UNK
)	O
genotype	B-UNK
,	O
in	O
turn	O
,	O
is	O
known	B-UNK
to	O
influence	O
ao	B-UNK
in	O
alzheimer	B-DISEASE
disease	I-DISEASE
,	O
rendering	O
the	O
apoe	B-UNK
gene	B-UNK
a	O
likely	B-UNK
candidate	B-UNK
to	O
affect	B-UNK
ao	B-UNK
in	O
other	O
neurological	B-UNK
diseases	B-DISEASE
too	O
.	O

 	O
we	O
therefore	O
determined	B-UNK
apoe	B-UNK
genotype	B-UNK
and	O
normal	B-UNK
cag	B-UNK
repeat	I-UNK
length	O
in	O
the	O
hd	B-UNK
gene	B-UNK
for	O
138	O
hd	B-UNK
patients	B-UNK
who	O
were	O
previously	B-UNK
analysed	B-UNK
with	O
respect	O
to	O
cag	B-UNK
repeat	I-UNK
length	O
.	O

 	O
genotyping	B-UNK
for	O
apoe	B-UNK
was	O
performed	B-UNK
blind	B-UNK
to	O
clinical	B-UNK
information	B-UNK
.	O

 	O
in	O
addition	B-UNK
to	O
highlighting	O
the	O
effect	B-UNK
of	O
the	O
normal	B-UNK
repeat	B-UNK
length	O
upon	O
ao	B-UNK
in	O
maternally	B-UNK
inherited	B-UNK
hd	B-UNK
and	O
in	O
male	B-UNK
patients	I-UNK
,	O
we	O
show	O
that	O
the	O
apoe	B-UNK
epsilon2epsilon3	O
genotype	B-UNK
is	O
associated	B-UNK
with	O
significantly	B-UNK
earlier	B-UNK
ao	B-UNK
in	O
males	B-UNK
than	O
in	O
females	B-UNK
.	O

 	O
such	O
a	O
sex	B-UNK
difference	B-UNK
in	O
ao	B-UNK
was	O
not	O
apparent	B-UNK
for	O
any	O
of	O
the	O
other	O
apoe	B-UNK
genotypes	O
.	O

 	O
our	O
findings	B-UNK
suggest	B-UNK
that	O
subtle	O
differences	B-UNK
in	O
the	O
course	B-UNK
of	O
the	O
neurodegeneration	O
in	O
hd	B-UNK
may	O
allow	B-UNK
interacting	O
genes	B-UNK
to	O
exert	O
gender	O
specific	B-UNK
effects	B-UNK
upon	O
ao	B-UNK
.	O

 	B-UNK
familial	I-UNK
deficiency	B-UNK
of	O
the	O
seventh	B-UNK
component	B-UNK
of	O
complement	B-UNK
associated	B-UNK
with	O
recurrent	B-UNK
bacteremic	O
infections	B-DISEASE
due	O
to	O
neisseria	O
.	O

 	O
the	O
serum	B-UNK
of	O
a	O
29	O
-	O
year	B-UNK
old	I-UNK
woman	B-UNK
with	O
a	O
recent	B-UNK
episode	O
of	O
disseminated	B-UNK
gonococcal	B-UNK
infection	B-DISEASE
and	O
a	O
history	B-UNK
of	O
meningococcal	B-UNK
meningitis	B-DISEASE
and	O
arthritis	B-DISEASE
as	O
a	O
child	B-UNK
was	O
found	B-UNK
to	O
lack	B-UNK
serum	B-UNK
hemolytic	B-UNK
complement	I-UNK
activity	B-UNK
.	O

 	O
the	O
seventh	B-UNK
component	B-UNK
of	O
complement	B-UNK
(	O
c7	B-UNK
)	O
was	O
not	O
detected	B-UNK
by	O
functional	B-UNK
or	O
immunochemical	B-UNK
assays	B-UNK
,	O
whereas	O
other	O
components	B-UNK
were	O
normal	B-UNK
by	O
hemolytic	B-UNK
and	O
immunochemical	B-UNK
assessment	B-UNK
.	O

 	O
her	O
fresh	B-UNK
serum	B-UNK
lacked	B-UNK
complement	B-UNK
-	O
mediated	B-UNK
bactericidal	B-UNK
activity	I-UNK
against	O
neisseria	O
gonorrhoeae	O
,	O
but	O
the	O
addition	B-UNK
of	O
fresh	B-UNK
normal	B-UNK
serum	I-UNK
or	O
purified	B-UNK
c7	B-UNK
restored	B-UNK
bactericidal	B-UNK
activity	I-UNK
as	O
well	O
as	O
hemolytic	B-UNK
activity	B-UNK
.	O

 	O
the	O
absence	B-UNK
of	O
functional	B-UNK
c7	B-UNK
activity	B-UNK
could	O
not	O
be	O
accounted	B-UNK
for	O
on	O
the	O
basis	B-UNK
of	O
an	O
inhibitor	B-UNK
.	O

 	O
opsonization	O
and	O
generation	B-UNK
of	O
chemotactic	B-UNK
activity	B-UNK
functioned	O
normally	B-UNK
.	O

 	O
complete	B-UNK
absence	B-UNK
of	O
c7	B-UNK
was	O
also	O
found	B-UNK
in	O
one	O
sibling	B-UNK
who	O
had	O
the	O
clinical	B-UNK
syndrome	B-DISEASE
of	O
meningococcal	B-UNK
meningitis	B-DISEASE
and	O
arthritis	B-DISEASE
as	O
a	O
child	B-UNK
and	O
in	O
this	O
siblings	B-UNK
clinically	B-UNK
well	O
eight	O
-	O
year	B-UNK
-	O
old	B-UNK
son	O
.	O

 	O
hla	B-UNK
histocompatibility	O
typing	B-UNK
of	O
the	O
family	B-UNK
members	I-UNK
did	O
not	O
demonstrate	B-UNK
evidence	B-UNK
for	O
genetic	B-UNK
linkage	B-UNK
of	O
c7	B-UNK
deficiency	I-UNK
with	O
the	O
major	B-UNK
histocompatibility	I-UNK
loci	B-UNK
.	O

 	O
this	O
report	B-UNK
represents	B-UNK
the	O
first	O
cases	B-UNK
of	O
c7	B-UNK
deficiency	I-UNK
associated	B-UNK
with	O
infectious	B-UNK
complications	O
and	O
suggests	B-UNK
that	O
bactericidal	B-UNK
activity	I-UNK
may	O
be	O
important	B-UNK
in	O
host	O
defense	O
against	O
bacteremic	O
neisseria	O
infections	B-DISEASE
.	O

 	B-UNK
increased	I-UNK
incidence	O
of	O
cancer	B-DISEASE
in	O
patients	B-UNK
with	O
cartilage	B-DISEASE
-	I-DISEASE
hair	I-DISEASE
hypoplasia	I-DISEASE
.	O

 	O
objective	B-UNK
previous	B-UNK
reports	B-UNK
have	O
suggested	B-UNK
an	O
increased	B-UNK
risk	B-UNK
of	O
cancer	B-DISEASE
among	O
patients	B-UNK
with	O
cartilage	B-DISEASE
-	I-DISEASE
hair	I-DISEASE
hypoplasia	I-DISEASE
(	O
chh	O
)	O
.	O

 	O
this	O
study	B-UNK
was	O
carried	B-UNK
out	O
to	O
further	O
evaluate	O
this	O
risk	B-UNK
among	O
patients	B-UNK
with	O
chh	O
and	O
their	O
first	O
-	O
degree	B-UNK
relatives	B-UNK
.	O

 	O
study	B-UNK
design	B-UNK
one	O
hundred	O
twenty	O
-	O
two	O
patients	B-UNK
with	O
chh	O
were	O
identified	B-UNK
through	O
2	O
countrywide	O
epidemiologic	B-UNK
surveys	O
in	O
1974	O
and	O
in	O
1986	O
.	O

 	O
their	O
parents	B-UNK
and	O
nonaffected	O
siblings	B-UNK
were	O
identified	B-UNK
through	O
the	O
population	B-UNK
register	O
center	B-UNK
.	O

 	O
this	O
cohort	B-UNK
underwent	B-UNK
follow	B-UNK
-	O
up	O
for	O
cancer	B-DISEASE
incidence	O
through	O
the	O
finnish	B-UNK
cancer	B-DISEASE
registry	O
to	O
the	O
end	B-UNK
of	O
1995	O
.	O

 	B-UNK
results	I-UNK
a	O
statistically	O
significant	B-UNK
excess	B-UNK
risk	B-UNK
of	O
cancer	B-DISEASE
was	O
seen	B-UNK
among	O
the	O
patients	B-UNK
with	O
chh	O
(	O
standardized	B-UNK
incidence	I-UNK
ratio	B-UNK
6	O
.	O
9	O
,	O
95	O
%	O
confidence	B-UNK
interval	B-UNK
2	O
.	O
3	O
to	O
16	O
)	O
,	O
which	O
was	O
mainly	B-UNK
attributable	O
to	O
non	B-UNK
-	O
hodgkins	O
lymphoma	B-DISEASE
(	O
standardized	B-UNK
incidence	I-UNK
ratio	B-UNK
90	O
,	O
95	O
%	O
confidence	B-UNK
interval	B-UNK
18	O
to	O
264	O
)	O
.	O

 	O
in	O
addition	B-UNK
,	O
a	O
significant	B-UNK
excess	B-UNK
risk	B-UNK
of	O
basal	B-DISEASE
cell	I-DISEASE
carcinoma	I-DISEASE
was	O
seen	B-UNK
(	O
standardized	B-UNK
incidence	I-UNK
ratio	B-UNK
35	O
,	O
95	O
%	O
confidence	B-UNK
interval	B-UNK
7	O
.	O
2	O
to	O
102	O
)	O
.	O

 	O
the	O
cancer	B-DISEASE
incidence	O
among	O
the	O
siblings	B-UNK
or	O
the	O
parents	B-UNK
did	O
not	O
differ	B-UNK
from	O
the	O
average	B-UNK
cancer	B-DISEASE
incidence	O
in	O
the	O
finnish	B-UNK
population	B-UNK
.	O

 	O
conclusions	B-UNK
this	O
study	B-UNK
confirms	B-UNK
an	O
increased	B-UNK
risk	B-UNK
of	O
cancer	B-DISEASE
,	O
especially	B-UNK
non	B-UNK
-	O
hodgkins	O
lymphoma	B-DISEASE
,	O
probably	B-UNK
attributable	O
to	O
defective	B-UNK
immunity	B-UNK
,	O
among	O
patients	B-UNK
with	O
chh	O
.	O

 	O
genotype	B-UNK
and	O
phenotype	B-UNK
in	O
patients	B-UNK
with	O
dihydropyrimidine	B-DISEASE
dehydrogenase	I-DISEASE
deficiency	I-DISEASE
.	O

 	O
dihydropyrimidine	O
dehydrogenase	B-UNK
(	O
dpd	B-UNK
)	O
deficiency	B-UNK
is	O
an	O
autosomal	O
recessive	O
disease	B-DISEASE
characterised	B-UNK
by	O
thymine	O
-	O
uraciluria	O
in	O
homozygous	B-UNK
deficient	B-UNK
patients	I-UNK
and	O
has	O
been	O
associated	B-UNK
with	O
a	O
variable	B-UNK
clinical	I-UNK
phenotype	B-UNK
.	O

 	O
in	O
order	B-UNK
to	O
understand	O
the	O
genetic	B-UNK
and	O
phenotypic	B-UNK
basis	B-UNK
for	O
dpd	B-UNK
deficiency	B-UNK
,	O
we	O
have	O
reviewed	O
17	O
families	B-UNK
presenting	B-UNK
22	O
patients	B-UNK
with	O
complete	B-UNK
deficiency	B-UNK
of	O
dpd	B-UNK
.	O

 	O
in	O
this	O
group	B-UNK
of	O
patients	B-UNK
,	O
7	O
different	B-UNK
mutations	B-UNK
have	O
been	O
identified	B-UNK
,	O
including	B-UNK
2	O
deletions	B-UNK
[	O
295	O
-	O
298deltcat	O
,	O
1897delc	O
]	O
,	O
1	O
splice	O
-	O
site	B-UNK
mutation	B-UNK
[	O
ivs14	O
+	O
1	O
g	B-UNK
>	I-UNK
a	O
)	O
]	O
and	O
4	O
missense	B-UNK
mutations	I-UNK
(	O
85	O
t	B-UNK
>	O
c	B-UNK
,	O
703c	O
>	O
t	B-UNK
,	O
2658	O
g	B-UNK
>	I-UNK
a	O
,	O
2983	O
g	B-UNK
>	I-UNK
t	B-UNK
)	O
.	O

 	O
analysis	B-UNK
of	O
the	O
prevalence	B-UNK
of	O
the	O
various	O
mutations	B-UNK
among	O
dpd	B-UNK
patients	B-UNK
has	O
shown	B-UNK
that	O
the	O
g	B-UNK
-	O
-	O
>	O
a	O
point	B-UNK
mutation	I-UNK
in	O
the	O
invariant	O
splice	B-UNK
donor	I-UNK
site	I-UNK
is	O
by	O
far	B-UNK
the	O
most	O
common	B-UNK
(	O
52	O
%	O
)	O
,	O
whereas	O
the	O
other	O
six	O
mutations	B-UNK
are	O
less	O
frequently	B-UNK
observed	B-UNK
.	O

 	O
a	O
large	B-UNK
phenotypic	B-UNK
variability	I-UNK
has	O
been	O
observed	B-UNK
,	O
with	O
convulsive	B-DISEASE
disorders	B-UNK
,	O
motor	B-UNK
retardation	O
and	O
mental	B-DISEASE
retardation	I-DISEASE
being	O
the	O
most	O
abundant	O
manifestations	B-UNK
.	O

 	O
a	O
clear	B-UNK
correlation	B-UNK
between	O
the	O
genotype	B-UNK
and	O
phenotype	B-UNK
has	O
not	O
been	O
established	B-UNK
.	O

 	O
an	O
altered	B-UNK
beta	B-UNK
-	O
alanine	O
,	O
uracil	O
and	O
thymine	O
homeostasis	B-UNK
might	O
underlie	O
the	O
various	O
clinical	B-UNK
abnormalities	B-DISEASE
encountered	O
in	O
patients	B-UNK
with	O
dpd	B-UNK
deficiency	B-UNK
.	O

 	O
fibroblast	B-UNK
growth	B-UNK
factor	B-UNK
homologous	B-UNK
factor	B-UNK
2	O
(	O
fhf2	O
)	O
:	O
gene	B-UNK
structure	B-UNK
,	O
expression	B-UNK
and	O
mapping	B-UNK
to	O
the	O
borjeson	B-DISEASE
-	I-DISEASE
forssman	I-DISEASE
-	I-DISEASE
lehmann	I-DISEASE
syndrome	I-DISEASE
region	B-UNK
in	O
xq26	O
delineated	O
by	O
a	O
duplication	B-UNK
breakpoint	B-UNK
in	O
a	O
bfls	O
-	O
like	B-UNK
patient	B-UNK
.	O

 	O
borjeson	B-DISEASE
-	I-DISEASE
forssman	I-DISEASE
-	I-DISEASE
lehmann	I-DISEASE
syndrome	I-DISEASE
(	O
bfls	O
)	O
is	O
a	O
syndromal	O
x	B-UNK
-	O
linked	B-UNK
mental	B-DISEASE
retardation	I-DISEASE
,	O
which	O
maps	B-UNK
by	O
linkage	B-UNK
to	O
the	O
q26	O
region	B-UNK
of	O
the	O
human	B-UNK
x	B-DISEASE
chromosome	I-DISEASE
.	O

 	O
we	O
have	O
identified	B-UNK
a	O
male	B-UNK
patient	B-UNK
with	O
bfls	O
-	O
like	B-UNK
features	B-UNK
and	O
a	O
duplication	B-UNK
,	O
46	O
,	O
y	O
,	O
dup	O
(	O
x	B-UNK
)	O
(	O
q26q28	O
)	O
,	O
inherited	B-UNK
from	O
his	O
phenotypically	B-UNK
normal	I-UNK
mother	B-UNK
.	O

 	O
fluorescence	B-UNK
in	O
situ	B-UNK
hybridisation	B-UNK
using	O
yeast	B-UNK
artificial	I-UNK
chromosome	B-UNK
clones	B-UNK
from	O
xq26	O
localised	B-UNK
the	O
duplication	B-UNK
breakpoint	B-UNK
to	O
an	O
approximately	B-UNK
400	O
-	O
kb	B-UNK
interval	B-UNK
in	O
the	O
xq26	O
.	O

 	O
3	O
region	B-UNK
between	O
dxs155	O
and	O
dxs294	O
/	O
dxs730	O
.	O

 	O
database	B-UNK
searches	O
and	O
analysis	B-UNK
of	O
available	B-UNK
genomic	B-UNK
dna	I-UNK
sequence	B-UNK
from	O
the	O
region	B-UNK
revealed	B-UNK
the	O
presence	B-UNK
of	O
the	O
fibroblast	B-UNK
growth	B-UNK
factor	B-UNK
homologous	B-UNK
factor	B-UNK
gene	B-UNK
,	O
fhf2	O
,	O
within	O
the	O
duplication	B-UNK
breakpoint	B-UNK
interval	B-UNK
.	O

 	O
the	O
gene	B-UNK
structure	B-UNK
of	O
fhf2	O
was	O
determined	B-UNK
and	O
two	O
new	B-UNK
exons	B-UNK
were	O
identified	B-UNK
,	O
including	B-UNK
a	O
new	B-UNK
5	O
end	B-UNK
exon	B-UNK
,	O
1b	O
.	O

 	O
fhf2	O
is	O
a	O
large	B-UNK
gene	B-UNK
extending	B-UNK
over	O
approximately	B-UNK
200	O
kb	B-UNK
in	O
xq26	O
.	O

 	O
3	O
and	O
is	O
composed	O
of	O
at	B-DISEASE
least	O
seven	B-UNK
exons	B-UNK
.	O

 	O
it	O
shows	B-UNK
tissue	B-UNK
-	O
specific	B-UNK
alternative	B-UNK
splicing	I-UNK
and	O
alternative	B-UNK
transcription	B-UNK
starts	O
.	O

 	O
northern	B-UNK
blot	O
hybridisation	B-UNK
showed	B-UNK
highest	B-UNK
expression	B-UNK
in	O
brain	B-UNK
and	O
skeletal	B-UNK
muscle	I-UNK
.	O

 	O
the	O
fhf2	O
gene	B-UNK
localisation	B-UNK
and	O
tissue	B-UNK
-	O
specific	B-UNK
expression	B-UNK
pattern	B-UNK
suggest	B-UNK
it	O
to	O
be	O
a	O
candidate	B-UNK
gene	B-UNK
for	O
familial	B-UNK
cases	B-UNK
of	O
the	O
bfls	O
syndrome	B-DISEASE
and	O
other	O
syndromal	O
and	O
non	B-UNK
-	O
specific	B-UNK
forms	B-UNK
of	O
x	B-UNK
-	O
linked	B-UNK
mental	B-DISEASE
retardation	I-DISEASE
mapping	B-UNK
to	O
the	O
region	B-UNK
.	O

 	B-UNK
germline	I-UNK
e	B-UNK
-	O
cadherin	B-UNK
gene	B-UNK
(	O
cdh1	O
)	O
mutations	B-UNK
predispose	B-UNK
to	O
familial	B-UNK
gastric	B-DISEASE
cancer	I-DISEASE
and	O
colorectal	B-DISEASE
cancer	I-DISEASE
.	O

 	B-UNK
inherited	I-UNK
mutations	B-UNK
in	O
the	O
e	B-UNK
-	O
cadherin	B-UNK
gene	B-UNK
(	O
cdh1	O
)	O
were	O
described	B-UNK
recently	B-UNK
in	O
three	O
maori	B-UNK
kindreds	B-UNK
with	O
familial	B-UNK
gastric	B-DISEASE
cancer	I-DISEASE
.	O

 	B-UNK
familial	I-UNK
gastric	B-DISEASE
cancer	I-DISEASE
is	O
genetically	B-UNK
heterogeneous	B-UNK
and	O
it	O
is	O
not	O
clear	B-UNK
what	O
proportion	B-UNK
of	O
gastric	B-DISEASE
cancer	I-DISEASE
susceptibility	B-UNK
in	O
non	B-UNK
-	O
maori	B-UNK
populations	B-UNK
is	O
due	O
to	O
germline	B-UNK
cdh1	O
mutations	B-UNK
.	O

 	O
therefore	O
,	O
we	O
screened	O
eight	O
familial	B-UNK
gastric	B-DISEASE
cancer	I-DISEASE
kindreds	B-UNK
of	O
british	B-UNK
and	O
irish	B-UNK
origin	B-UNK
for	O
germline	B-UNK
cdh1	O
mutations	B-UNK
,	O
by	O
sscp	B-UNK
analysis	B-UNK
of	O
all	O
16	O
exons	B-UNK
and	O
flanking	B-UNK
sequences	B-UNK
.	O

 	O
each	O
family	B-UNK
contained	B-UNK
(	O
i	O
)	O
two	O
cases	B-UNK
of	O
gastric	B-DISEASE
cancer	I-DISEASE
in	O
first	O
degree	B-UNK
relatives	B-UNK
with	O
one	O
affected	B-UNK
before	O
age	B-UNK
50	O
years	B-UNK
;	O
or	O
(	O
ii	B-UNK
)	O
three	O
or	O
more	O
cases	B-UNK
of	O
gastric	B-DISEASE
cancer	I-DISEASE
.	O

 	B-UNK
novel	I-UNK
germline	B-UNK
cdh1	O
mutations	B-UNK
(	O
a	O
nonsense	B-UNK
and	O
a	O
splice	B-UNK
site	I-UNK
)	O
were	O
detected	B-UNK
in	O
two	O
families	B-UNK
(	O
25	O
%	O
)	O
.	O

 	O
both	O
mutations	B-UNK
were	O
predicted	B-UNK
to	O
truncate	O
the	O
e	B-UNK
-	O
cadherin	B-UNK
protein	B-UNK
in	O
the	O
signal	B-UNK
peptide	I-UNK
domain	B-UNK
.	O

 	O
in	O
one	O
family	B-UNK
there	O
was	O
evidence	B-UNK
of	O
non	B-UNK
-	O
penetrance	B-UNK
and	O
susceptibility	B-UNK
to	O
both	O
gastric	O
and	O
colorectal	B-DISEASE
cancer	I-DISEASE
;	O
thus	O
,	O
in	O
addition	B-UNK
to	O
six	O
cases	B-UNK
of	O
gastric	B-DISEASE
cancer	I-DISEASE
,	O
a	O
cdh1	O
mutation	B-UNK
carrier	B-UNK
developed	B-UNK
colorectal	B-DISEASE
cancer	I-DISEASE
at	B-DISEASE
age	B-UNK
30	O
years	B-UNK
.	O

 	O
we	O
have	O
confirmed	B-UNK
that	O
germline	B-UNK
mutations	I-UNK
in	O
the	O
cdh1	O
gene	B-UNK
cause	B-UNK
familial	B-UNK
gastric	B-DISEASE
cancer	I-DISEASE
in	O
non	B-UNK
-	O
maori	B-UNK
populations	B-UNK
.	O

 	O
however	O
,	O
only	O
a	O
minority	O
of	O
familial	B-UNK
gastric	O
cancers	B-DISEASE
can	O
be	O
accounted	B-UNK
for	O
by	O
cdh1	O
mutations	B-UNK
.	O

 	O
loss	B-UNK
of	O
e	B-UNK
-	O
cadherin	B-UNK
function	B-UNK
has	O
been	O
implicated	O
in	O
the	O
pathogenesis	O
of	O
sporadic	B-UNK
colorectal	B-UNK
and	O
other	O
cancers	B-DISEASE
,	O
and	O
our	O
findings	B-UNK
provide	I-UNK
evidence	B-UNK
that	O
germline	B-UNK
cdh1	O
mutations	B-UNK
predispose	B-UNK
to	O
early	B-UNK
onset	I-UNK
colorectal	B-DISEASE
cancer	I-DISEASE
.	O

 	O
thus	O
,	O
cdh1	O
should	O
be	O
investigated	B-UNK
as	O
a	O
cause	B-UNK
of	O
inherited	B-UNK
susceptibility	B-UNK
to	O
both	O
gastric	O
and	O
colorectal	B-UNK
cancers	B-DISEASE
.	O

 	O
a	O
zinc	B-DISEASE
finger	B-UNK
truncation	O
of	O
murine	B-UNK
wt1	B-UNK
results	B-UNK
in	O
the	O
characteristic	B-UNK
urogenital	B-DISEASE
abnormalities	I-DISEASE
of	O
denys	B-DISEASE
-	I-DISEASE
drash	I-DISEASE
syndrome	I-DISEASE
.	O

 	O
the	O
wilms	B-DISEASE
tumor	I-DISEASE
-	O
suppressor	B-UNK
gene	B-UNK
,	O
wt1	B-UNK
,	O
plays	O
a	O
key	B-UNK
role	B-UNK
in	O
urogenital	B-UNK
development	B-UNK
,	O
and	O
wt1	B-UNK
dysfunction	B-UNK
is	O
implicated	O
in	O
both	O
neoplastic	O
(	O
wilms	B-DISEASE
tumor	I-DISEASE
,	O
mesothelioma	B-DISEASE
,	O
leukemias	O
,	O
and	O
breast	B-DISEASE
cancer	I-DISEASE
)	O
and	O
nonneoplastic	O
(	O
glomerulosclerosis	B-DISEASE
)	O
disease	B-DISEASE
.	O

 	O
the	O
analysis	B-UNK
of	O
diseases	B-DISEASE
linked	B-UNK
specifically	B-UNK
with	O
wt1	B-UNK
mutations	B-UNK
,	O
such	O
as	O
denys	B-DISEASE
-	I-DISEASE
drash	I-DISEASE
syndrome	I-DISEASE
(	O
dds	O
)	O
,	O
can	O
provide	B-UNK
valuable	B-UNK
insight	B-UNK
concerning	B-UNK
the	O
role	B-UNK
of	O
wt1	B-UNK
in	O
development	B-UNK
and	O
disease	B-DISEASE
.	O

 	O
dds	O
is	O
a	O
rare	B-UNK
childhood	B-UNK
disease	B-DISEASE
characterized	B-UNK
by	O
a	O
nephropathy	B-DISEASE
involving	B-UNK
mesangial	B-DISEASE
sclerosis	I-DISEASE
,	O
xy	O
pseudohermaphroditism	B-DISEASE
,	O
and	O
/	O
or	O
wilms	B-DISEASE
tumor	I-DISEASE
(	O
wt	O
)	O
.	O

 	O
dds	O
patients	B-UNK
are	O
constitutionally	O
heterozygous	B-UNK
for	O
exonic	B-UNK
point	B-UNK
mutations	I-UNK
in	O
wt1	B-UNK
,	O
which	O
include	B-UNK
mutations	B-UNK
predicted	B-UNK
to	O
truncate	O
the	O
protein	B-UNK
within	O
the	O
c	B-UNK
-	O
terminal	B-UNK
zinc	B-DISEASE
finger	B-UNK
(	O
zf	O
)	O
region	B-UNK
.	O

 	O
we	O
report	B-UNK
that	O
heterozygosity	B-UNK
for	O
a	O
targeted	B-UNK
murine	B-UNK
wt1	B-UNK
allele	B-UNK
,	O
wt1	B-UNK
(	O
tmt396	O
)	O
,	O
which	O
truncates	O
zf3	O
at	B-DISEASE
codon	B-UNK
396	O
,	O
induces	B-UNK
mesangial	B-DISEASE
sclerosis	I-DISEASE
characteristic	B-UNK
of	O
dds	O
in	O
adult	B-UNK
heterozygous	B-UNK
and	O
chimeric	B-UNK
mice	B-UNK
.	O

 	O
male	B-UNK
genital	O
defects	B-UNK
also	O
were	O
evident	O
and	O
there	O
was	O
a	O
single	B-UNK
case	B-UNK
of	O
wilms	B-DISEASE
tumor	I-DISEASE
in	O
which	O
the	O
transcript	B-UNK
of	O
the	O
nontargeted	O
allele	B-UNK
showed	I-UNK
an	O
exon	B-UNK
9	O
skipping	B-UNK
event	B-UNK
,	O
implying	O
a	O
causal	B-UNK
link	B-UNK
between	O
wt1	B-UNK
dysfunction	B-UNK
and	O
wilms	B-UNK
tumorigenesis	B-UNK
in	O
mice	B-UNK
.	O

 	O
however	O
,	O
the	O
mutant	B-UNK
wt1	B-UNK
(	O
tmt396	O
)	O
protein	B-UNK
accounted	B-UNK
for	O
only	O
5	O
%	O
of	O
wt1	B-UNK
in	O
both	O
heterozygous	B-UNK
embryonic	O
stem	O
cells	B-UNK
and	O
the	O
wt	O
.	O

 	O
this	O
has	O
implications	B-UNK
regarding	O
the	O
mechanism	B-UNK
by	O
which	O
the	O
mutant	B-UNK
allele	I-UNK
exerts	O
its	O
effect	B-UNK
.	O

 	O
mechanism	B-UNK
of	O
increased	B-UNK
iron	B-UNK
absorption	I-UNK
in	O
murine	B-UNK
model	B-UNK
of	O
hereditary	B-DISEASE
hemochromatosis	I-DISEASE
:	O
increased	B-UNK
duodenal	B-UNK
expression	I-UNK
of	O
the	O
iron	B-UNK
transporter	B-UNK
dmt1	B-UNK
.	O

 	B-UNK
hereditary	I-UNK
hemochromatosis	B-DISEASE
(	O
hh	B-UNK
)	O
is	O
a	O
common	B-UNK
autosomal	B-UNK
recessive	I-UNK
disorder	I-UNK
characterized	I-UNK
by	O
tissue	B-UNK
iron	B-UNK
deposition	O
secondary	B-UNK
to	O
excessive	B-UNK
dietary	B-UNK
iron	B-UNK
absorption	I-UNK
.	O

 	O
we	O
recently	B-UNK
reported	B-UNK
that	O
hfe	B-UNK
,	O
the	O
protein	B-UNK
defective	B-UNK
in	O
hh	B-UNK
,	O
was	O
physically	O
associated	B-UNK
with	O
the	O
transferrin	O
receptor	B-UNK
(	O
tfr	O
)	O
in	O
duodenal	B-UNK
crypt	B-UNK
cells	B-UNK
and	O
proposed	B-UNK
that	O
mutations	B-UNK
in	O
hfe	B-UNK
attenuate	O
the	O
uptake	B-UNK
of	O
transferrin	O
-	O
bound	O
iron	B-UNK
from	O
plasma	B-UNK
by	O
duodenal	B-UNK
crypt	B-UNK
cells	B-UNK
,	O
leading	B-UNK
to	O
up	O
-	O
regulation	B-UNK
of	O
transporters	B-UNK
for	O
dietary	B-UNK
iron	B-UNK
.	O

 	O
here	O
,	O
we	O
tested	B-UNK
the	O
hypothesis	O
that	O
hfe	B-UNK
-	O
/	O
-	O
mice	B-UNK
have	O
increased	B-UNK
duodenal	B-UNK
expression	I-UNK
of	O
the	O
divalent	O
metal	O
transporter	B-UNK
(	O
dmt1	B-UNK
)	O
.	O

 	O
by	O
4	O
weeks	O
of	O
age	B-UNK
,	O
the	O
hfe	B-UNK
-	O
/	O
-	O
mice	B-UNK
demonstrated	B-UNK
iron	B-UNK
loading	O
when	O
compared	B-UNK
with	O
hfe	B-UNK
+	O
/	O
+	O
littermates	O
,	O
with	O
elevated	B-UNK
transferrin	I-UNK
saturations	O
(	O
68	O
.	O
4	O
%	O
vs	B-UNK
.	O
49	O
.	O
8	O
%	O
)	O
and	O
elevated	B-UNK
liver	B-DISEASE
iron	B-UNK
concentrations	B-UNK
(	O
985	O
micrograms	O
vs	B-UNK
.	O
381	O
micrograms	O
)	O
.	O

 	O
by	O
using	O
northern	B-UNK
blot	O
analyses	B-UNK
,	O
we	O
quantitated	O
duodenal	B-UNK
expression	I-UNK
of	O
both	O
classes	O
of	O
dmt1	B-UNK
transcripts	B-UNK
one	O
containing	B-UNK
an	O
iron	B-UNK
responsive	O
element	B-UNK
(	O
ire	O
)	O
,	O
called	B-UNK
dmt1	B-UNK
(	O
ire	O
)	O
,	O
and	O
one	O
containing	B-UNK
no	O
ire	O
,	O
called	B-UNK
dmt1	B-UNK
(	O
non	B-UNK
-	O
ire	O
)	O
.	O

 	O
the	O
positive	B-UNK
control	B-UNK
for	O
dmt1	B-UNK
up	O
-	O
regulation	B-UNK
was	O
a	O
murine	B-UNK
model	B-UNK
of	O
dietary	B-UNK
iron	B-UNK
deficiency	B-UNK
that	O
demonstrated	B-UNK
greatly	B-UNK
increased	I-UNK
levels	B-UNK
of	O
duodenal	B-UNK
dmt1	B-UNK
(	O
ire	O
)	O
mrna	B-UNK
.	O

 	O
hfe	B-UNK
-	O
/	O
-	O
mice	B-UNK
also	O
demonstrated	B-UNK
an	O
increase	B-UNK
in	O
duodenal	B-UNK
dmt1	B-UNK
(	O
ire	O
)	O
mrna	B-UNK
(	O
average	B-UNK
7	O
.	O
7	O
-	O
fold	B-UNK
)	O
,	O
despite	B-UNK
their	O
elevated	B-UNK
transferrin	I-UNK
saturation	O
and	O
hepatic	B-UNK
iron	B-UNK
content	I-UNK
.	O

 	O
duodenal	B-UNK
expression	I-UNK
of	O
dmt1	B-UNK
(	O
non	B-UNK
-	O
ire	O
)	O
was	O
not	O
increased	B-UNK
,	O
nor	O
was	O
hepatic	B-UNK
expression	B-UNK
of	O
dmt1	B-UNK
increased	B-UNK
.	O

 	O
these	O
data	B-UNK
support	B-UNK
the	O
model	B-UNK
for	O
hh	B-UNK
in	O
which	O
hfe	B-UNK
mutations	B-UNK
lead	B-UNK
to	O
inappropriately	O
low	B-UNK
crypt	B-UNK
cell	B-UNK
iron	B-UNK
,	O
with	O
resultant	B-UNK
stabilization	O
of	O
dmt1	B-UNK
(	O
ire	O
)	O
mrna	B-UNK
,	O
up	O
-	O
regulation	B-UNK
of	O
dmt1	B-UNK
,	O
and	O
increased	B-UNK
absorption	B-UNK
of	O
dietary	B-UNK
iron	B-UNK
.	O

 	O
neurophysiologic	B-UNK
follow	B-UNK
-	O
up	O
of	O
long	B-UNK
-	O
term	B-UNK
dietary	B-UNK
treatment	B-UNK
in	O
adult	B-UNK
-	O
onset	B-UNK
adrenoleukodystrophy	B-DISEASE
.	O

 	O
objective	B-UNK
to	O
monitor	O
the	O
effects	B-UNK
of	O
dietary	B-UNK
treatment	B-UNK
in	O
adult	B-UNK
-	O
onset	B-UNK
adrenoleukodystrophy	B-DISEASE
(	O
ald	B-UNK
)	O
by	O
means	O
of	O
somatosensory	O
evoked	O
potentials	B-UNK
(	O
seps	O
)	O
and	O
motor	B-UNK
evoked	O
potentials	B-UNK
(	O
meps	O
)	O
.	O

 	B-UNK
background	I-UNK
seps	O
and	O
meps	O
have	O
proved	O
useful	B-UNK
in	O
revealing	O
signs	B-UNK
of	O
progressively	B-UNK
severe	B-UNK
,	O
central	B-UNK
dying	B-UNK
-	O
back	O
axonopathy	O
in	O
early	B-UNK
stages	O
of	O
adult	B-UNK
-	O
onset	B-UNK
ald	B-UNK
.	O

 	O
methods	B-UNK
eight	O
patients	B-UNK
with	O
adult	B-UNK
-	O
onset	B-UNK
ald	B-UNK
underwent	B-UNK
clinical	B-UNK
examination	B-UNK
,	O
brain	B-UNK
and	O
spine	O
mri	B-UNK
,	O
and	O
sep	O
and	O
mep	O
studies	B-UNK
before	O
and	O
after	O
3	O
years	B-UNK
of	O
lorenzos	O
oil	O
dietary	B-UNK
therapy	B-UNK
.	O

 	B-UNK
results	I-UNK
before	O
treatment	B-UNK
,	O
brain	B-UNK
mri	B-UNK
was	O
normal	B-UNK
in	O
five	O
patients	B-UNK
.	O

 	O
three	O
of	O
these	O
patients	B-UNK
had	O
pure	O
spinal	B-UNK
sep	O
abnormalities	B-DISEASE
and	O
in	O
the	O
remaining	B-UNK
two	O
patients	B-UNK
seps	O
showed	B-UNK
signs	B-UNK
of	O
involvement	B-UNK
of	O
both	O
the	O
spinal	B-UNK
and	O
cerebral	O
somatosensory	O
tracts	O
.	O

 	O
after	O
treatment	B-UNK
,	O
the	O
three	O
patients	B-UNK
with	O
pure	O
spinal	B-UNK
abnormalities	B-DISEASE
showed	B-UNK
clinical	B-UNK
and	O
neurophysiologic	B-UNK
worsening	O
,	O
whereas	O
the	O
two	O
patients	B-UNK
with	O
a	O
more	O
advanced	B-UNK
stage	B-UNK
of	O
disease	B-DISEASE
(	O
exhibited	B-UNK
by	O
seps	O
)	O
showed	B-UNK
substantially	B-UNK
unchanged	O
clinical	B-UNK
and	O
neurophysiologic	B-UNK
features	B-UNK
.	O

 	O
the	O
patients	B-UNK
with	O
abnormal	B-UNK
brain	B-UNK
mri	B-UNK
at	B-DISEASE
the	O
onset	B-UNK
of	O
treatment	B-UNK
showed	B-UNK
clinical	B-UNK
and	O
neurophysiologic	B-UNK
worsening	O
.	O

 	O
conclusions	B-UNK
lorenzos	O
oil	O
therapy	B-UNK
had	O
no	O
effect	B-UNK
on	O
patients	B-UNK
with	O
evidence	B-UNK
of	O
inflammatory	B-UNK
brain	B-UNK
lesions	B-UNK
.	O

 	O
moreover	O
,	O
in	O
patients	B-UNK
without	O
clear	B-UNK
signs	B-UNK
of	O
inflammatory	B-UNK
damage	B-UNK
,	O
this	O
treatment	B-UNK
does	O
not	O
modify	B-UNK
significantly	B-UNK
the	O
natural	B-UNK
course	B-UNK
of	O
the	O
disease	B-DISEASE
.	O

 	O
however	O
,	O
because	O
effective	B-UNK
treatments	B-UNK
should	O
begin	O
before	O
the	O
onset	B-UNK
of	O
severe	B-UNK
neurologic	B-DISEASE
symptoms	B-UNK
,	O
seps	O
and	O
meps	O
should	O
be	O
considered	B-UNK
to	O
evaluate	O
the	O
effectiveness	O
of	O
other	O
experimental	B-UNK
treatments	B-UNK
in	O
the	O
patient	B-UNK
with	O
a	O
negative	B-UNK
brain	B-UNK
mri	B-UNK
.	O

 	O
gch1	B-UNK
mutation	B-UNK
in	O
a	O
patient	B-UNK
with	O
adult	B-UNK
-	O
onset	B-UNK
oromandibular	O
dystonia	B-DISEASE
.	O

 	O
the	O
authors	B-UNK
report	B-UNK
a	O
mutation	B-UNK
in	O
exon	B-UNK
5	O
of	O
gch1	B-UNK
in	O
a	O
patient	B-UNK
with	O
adult	B-UNK
-	O
onset	B-UNK
oromandibular	O
dystonia	B-DISEASE
and	O
no	O
obvious	B-UNK
family	B-UNK
history	B-UNK
of	O
dystonia	B-DISEASE
.	O

 	O
the	O
patient	B-UNK
responded	O
positively	O
to	O
treatment	B-UNK
with	O
l	B-UNK
-	O
dopa	O
.	O

 	O
these	O
findings	B-UNK
demonstrate	B-UNK
that	O
gch1	B-UNK
mutations	B-UNK
must	O
be	O
considered	B-UNK
even	O
in	O
patients	B-UNK
with	O
dystonic	O
symptoms	B-UNK
not	O
typical	B-UNK
of	O
dopa	O
-	O
responsive	O
dystonia	B-DISEASE
.	O

 	B-UNK
germline	I-UNK
mutations	B-UNK
of	O
the	O
apc	B-UNK
gene	B-UNK
in	O
korean	O
familial	B-DISEASE
adenomatous	I-DISEASE
polyposis	I-DISEASE
patients	B-UNK
.	O

 	O
we	O
extensively	O
analyzed	B-UNK
genomic	B-UNK
dna	I-UNK
and	O
messenger	B-UNK
rna	I-UNK
(	O
mrna	B-UNK
)	O
from	O
62	O
unrelated	B-UNK
korean	O
patients	B-UNK
with	O
familial	B-DISEASE
adenomatous	I-DISEASE
polyposis	I-DISEASE
(	O
fap	B-DISEASE
)	O
for	O
identification	B-UNK
of	O
germline	B-UNK
adenomatous	B-DISEASE
polyposis	I-DISEASE
coli	I-DISEASE
(	O
apc	B-UNK
)	O
gene	B-UNK
mutations	B-UNK
.	O

 	O
we	O
adopted	O
both	O
single	B-UNK
-	O
strand	B-UNK
conformation	I-UNK
polymorphism	I-UNK
(	O
sscp	B-UNK
)	O
analysis	B-UNK
and	O
a	O
method	B-UNK
of	O
analysis	B-UNK
involving	B-UNK
the	O
reverse	B-UNK
transcription	B-UNK
-	O
polymerase	B-UNK
chain	I-UNK
reaction	I-UNK
(	O
rt	O
-	O
pcr	B-UNK
)	O
followed	B-UNK
by	O
a	O
protein	B-UNK
truncation	B-UNK
test	I-UNK
(	O
ptt	O
)	O
.	O

 	B-UNK
dna	I-UNK
sequencing	B-UNK
confirmed	B-UNK
all	O
alterations	B-UNK
represented	B-UNK
by	O
aberrant	B-UNK
bands	B-UNK
.	O

 	B-UNK
germline	I-UNK
mutations	B-UNK
were	O
identified	B-UNK
in	O
38	O
patients	B-UNK
(	O
61	O
%	O
)	O
.	O

 	O
nineteen	O
of	O
the	O
detected	B-UNK
mutations	B-UNK
were	O
presumed	B-UNK
to	O
be	O
novel	B-UNK
,	O
thus	O
emphasizing	O
the	O
heterogeneity	B-UNK
of	O
the	O
mutational	B-UNK
spectrum	B-UNK
in	O
korean	O
fap	B-DISEASE
patients	B-UNK
.	O

 	O
in	O
the	O
initial	B-UNK
48	O
patients	B-UNK
,	O
sscp	B-UNK
analysis	B-UNK
was	O
followed	B-UNK
by	O
ptt	O
for	O
those	O
patients	B-UNK
for	O
whom	O
no	O
detectable	B-UNK
mutations	B-UNK
were	O
found	B-UNK
by	O
sscp	B-UNK
.	O

 	O
using	O
this	O
combined	B-UNK
approach	B-UNK
,	O
we	O
identified	B-UNK
germline	B-UNK
apc	B-UNK
gene	B-UNK
mutations	B-UNK
in	O
29	O
of	O
the	O
48	O
fap	B-DISEASE
patients	B-UNK
(	O
60	O
%	O
)	O
,	O
including	B-UNK
6	O
patients	B-UNK
in	O
whom	O
sscp	B-UNK
analysis	B-UNK
failed	B-UNK
to	O
distinguish	O
the	O
mutant	B-UNK
allele	I-UNK
.	O

 	O
in	O
the	O
14	O
later	B-UNK
patients	B-UNK
,	O
we	O
identified	B-UNK
truncating	B-UNK
mutations	B-UNK
in	O
9	O
patients	B-UNK
(	O
64	O
%	O
)	O
using	O
ptt	O
only	O
.	O

 	O
our	O
results	B-UNK
confirm	B-UNK
that	O
the	O
mutation	B-UNK
detection	B-UNK
rate	B-UNK
with	O
ptt	O
was	O
superior	O
to	O
that	O
with	O
sscp	B-UNK
,	O
and	O
suggest	B-UNK
that	O
ptt	O
would	O
be	O
a	O
more	O
practical	B-UNK
screening	B-UNK
method	I-UNK
to	O
detect	B-UNK
germline	B-UNK
mutations	I-UNK
of	O
the	O
apc	B-UNK
gene	B-UNK
in	O
fap	B-DISEASE
patients	B-UNK
.	O

 	B-UNK
molecular	I-UNK
epidemiology	O
of	O
c9	B-DISEASE
deficiency	I-DISEASE
heterozygotes	B-UNK
with	O
an	O
arg95stop	B-UNK
mutation	B-UNK
of	O
the	O
c9	B-UNK
gene	B-UNK
in	O
japan	O
.	O

 	O
deficiency	B-UNK
of	O
the	O
ninth	B-UNK
component	B-UNK
of	O
human	B-UNK
complement	B-UNK
(	O
c9	B-UNK
)	O
is	O
the	O
most	O
common	B-UNK
complement	B-UNK
deficiency	I-UNK
in	O
japan	O
,	O
with	O
an	O
incidence	O
of	O
approximately	B-UNK
one	O
homozygote	O
in	O
1000	O
,	O
but	O
is	O
very	O
rare	B-UNK
in	O
other	O
countries	B-UNK
.	O

 	B-UNK
genetic	I-UNK
analyses	B-UNK
of	O
japanese	B-UNK
c9	B-DISEASE
deficiency	I-DISEASE
have	O
shown	B-UNK
that	O
a	O
c	B-UNK
-	O
to	O
-	O
t	B-UNK
transition	I-UNK
leading	B-UNK
to	O
tga	B-DISEASE
stop	B-UNK
codon	B-UNK
for	O
arg95	O
in	O
exon	B-UNK
4	O
of	O
the	O
c9	B-UNK
gene	B-UNK
(	O
arg95stop	B-UNK
)	O
is	O
common	B-UNK
in	O
japanese	B-UNK
c9	B-DISEASE
deficiency	I-DISEASE
.	O

 	O
to	O
determine	O
the	O
prevalence	B-UNK
of	O
heterozygous	B-UNK
carriers	B-UNK
of	O
the	O
arg95stop	B-UNK
mutation	B-UNK
in	O
a	O
japanese	B-UNK
population	B-UNK
,	O
we	O
collected	B-UNK
dna	B-UNK
samples	I-UNK
from	O
300	O
individuals	B-UNK
in	O
two	O
of	O
the	O
four	O
main	B-UNK
islands	O
of	O
japan	O
.	O

 	O
heterozygote	B-UNK
detection	B-UNK
was	O
performed	B-UNK
with	O
an	O
allele	B-UNK
-	O
specific	B-UNK
polymerase	B-UNK
chain	I-UNK
reaction	I-UNK
(	O
pcr	B-UNK
)	O
system	B-UNK
designed	O
to	O
detect	B-UNK
exclusively	B-UNK
only	O
one	O
of	O
the	O
normal	B-UNK
and	O
mutant	B-UNK
alleles	I-UNK
,	O
followed	B-UNK
by	O
confirmation	O
with	O
pcr	B-UNK
/	O
single	B-UNK
-	O
strand	B-UNK
conformation	I-UNK
polymorphism	I-UNK
(	O
sscp	B-UNK
)	O
analysis	B-UNK
and	O
direct	B-UNK
sequencing	I-UNK
.	O

 	O
twenty	O
individuals	B-UNK
were	O
heterozygous	B-UNK
for	O
the	O
arg95stop	B-UNK
mutation	B-UNK
.	O

 	O
none	O
was	O
homozygous	B-UNK
.	O

 	O
the	O
prevalence	B-UNK
of	O
carriers	B-UNK
of	O
the	O
arg95stop	B-UNK
mutation	B-UNK
was	O
6	O
.	O

 	O
7	O
%	O
(	O
20	O
/	O
300	O
)	O
.	O

 	O
an	O
estimated	B-UNK
frequency	B-UNK
(	O
0	O
.	O
12	O
%	O
)	O
of	O
complete	B-UNK
c9	B-DISEASE
deficiency	I-DISEASE
due	O
to	O
homozygous	B-UNK
arg95stop	B-UNK
mutation	B-UNK
was	O
consistent	B-UNK
with	O
frequencies	B-UNK
determined	B-UNK
by	O
serological	O
studies	B-UNK

 	O
the	O
hereditary	B-DISEASE
hemochromatosis	I-DISEASE
protein	B-UNK
,	O
hfe	B-UNK
,	O
specifically	B-UNK
regulates	B-UNK
transferrin	O
-	O
mediated	B-UNK
iron	B-UNK
uptake	I-UNK
in	O
hela	B-UNK
cells	B-UNK
.	O

 	O
hfe	B-UNK
is	O
the	O
protein	B-UNK
product	B-UNK
of	O
the	O
gene	B-UNK
mutated	B-UNK
in	O
the	O
autosomal	O
recessive	O
disease	B-DISEASE
hereditary	B-DISEASE
hemochromatosis	I-DISEASE
(	O
feder	O
,	O
j	B-UNK
.	O

 	O
n	B-UNK
.	O
,	O
gnirke	O
,	O
a	O
.	O
,	O
thomas	O
,	O
w	O
.	O
,	O
tsuchihashi	O
,	O
z	B-UNK
.	O
,	O
ruddy	O
,	O
d	B-UNK
.	O

 	O
a	O
.	O
,	O
basava	O
,	O
a	O
.	O
,	O
dormishian	O
,	O
f	B-UNK
.	O
,	O
domingo	O
,	O
r	B-UNK
.	O

 	O
j	B-UNK
.	O
,	O
ellis	O
,	O
m	B-UNK
.	O

 	O
c	B-UNK
.	O
,	O
fullan	O
,	O
a	O
.	O
,	O
hinton	O
,	O
l	B-UNK
.	O

 	O
m	B-UNK
.	O
,	O
jones	O
,	O
n	B-UNK
.	O

 	O
l	B-UNK
.	O
,	O
kimmel	O
,	O
b	B-UNK
.	O

 	O
e	B-UNK
.	O
,	O
kronmal	O
,	O
g	B-UNK
.	O

 	O
s	O
.	O
,	O
lauer	O
,	O
p	B-UNK
.	O
,	O
lee	O
,	O
v	O
.	O

 	O
k	B-UNK
.	O
,	O
loeb	O
,	O
d	B-UNK
.	O

 	O
b	B-UNK
.	O
,	O
mapa	O
,	O
f	B-UNK
.	O

 	O
a	O
.	O
,	O
mcclelland	O
,	O
e	B-UNK
.	O
,	O
meyer	O
,	O
n	B-UNK
.	O

 	O
c	B-UNK
.	O
,	O
mintier	O
,	O
g	B-UNK
.	O

 	O
a	O
.	O
,	O
moeller	O
,	O
n	B-UNK
.	O
,	O
moore	O
,	O
t	B-UNK
.	O
,	O
morikang	O
,	O
e	B-UNK
.	O
,	O
prasss	O
,	O
c	B-UNK
.	O

 	O
e	B-UNK
.	O
,	O
quintana	O
,	O
l	B-UNK
.	O
,	O
starnes	O
,	O
s	O
.	O

 	O
m	B-UNK
.	O
,	O
schatzman	O
,	O
r	B-UNK
.	O

 	O
c	B-UNK
.	O
,	O
brunke	O
,	O
k	B-UNK
.	O

 	O
j	B-UNK
.	O
,	O
drayna	O
,	O
d	B-UNK
.	O

 	O
t	B-UNK
.	O
,	O
risch	O
,	O
n	B-UNK
.	O

 	O
j	B-UNK
.	O
,	O
bacon	O
,	O
b	B-UNK
.	O

 	O
r	B-UNK
.	O
,	O
and	O
wolff	O
,	O
r	B-UNK
.	O

 	O
r	B-UNK
.	O

 	O
(	O
1996	O
)	O
nat	O
.	O

 	O
genet	B-UNK
.	O

 	O
13	O
,	O
399	O
-	O
408	O
)	O
.	O

 	O
at	B-DISEASE
the	O
cell	B-UNK
surface	B-UNK
,	O
hfe	B-UNK
complexes	B-UNK
with	O
transferrin	O
receptor	B-UNK
(	O
tfr	O
)	O
,	O
increasing	B-UNK
the	O
dissociation	O
constant	B-UNK
of	O
transferrin	O
(	O
tf	B-UNK
)	O
for	O
its	O
receptor	B-UNK
10	O
-	O
fold	B-UNK
(	O
gross	O
,	O
c	B-UNK
.	O

 	O
n	B-UNK
.	O
,	O
irrinki	O
,	O
a	O
.	O
,	O
feder	O
,	O
j	B-UNK
.	O
n	B-UNK
.	O
,	O
and	O
enns	O
,	O
c	B-UNK
.	O
a	O
.	O
(	O
1998	O
)	O
j	B-UNK
.	O
biol	O
.	O
chem	O
.	O
273	O
,	O
22068	O
-	O
22074	O
;	O
feder	O
,	O
j	B-UNK
.	O
n	B-UNK
.	O
,	O
penny	O
,	O
d	B-UNK
.	O
m	B-UNK
.	O
,	O
irrinki	O
,	O
a	O
.	O
,	O
lee	O
,	O
v	O
.	O
k	B-UNK
.	O
,	O
lebron	O
,	O
j	B-UNK
.	O
a	O
.	O
,	O
watson	O
,	O
n	B-UNK
.	O
,	O
tsuchihashi	O
,	O
z	B-UNK
.	O
,	O
sigal	O
,	O
e	B-UNK
.	O
,	O
bjorkman	O
,	O
p	B-UNK
.	O
j	B-UNK
.	O
,	O
and	O
schatzman	O
,	O
r	B-UNK
.	O
c	B-UNK
.	O
(	O
1998	O
)	O
proc	O
.	O
natl	O
.	O

 	O
acad	O
.	O

 	O
sci	B-DISEASE
.	O

 	O
u	B-UNK
s	O
a	O
95	O
,	O
1472	O
-	O
1477	O
)	O
.	O

 	O
hfe	B-UNK
does	O
not	O
remain	O
at	B-DISEASE
the	O
cell	B-UNK
surface	B-UNK
,	O
but	O
traffics	O
with	O
tfr	O
to	O
tf	B-UNK
-	O
positive	B-UNK
internal	B-UNK
compartments	O
(	O
gross	O
et	O
al	O
.	O
,	O
1998	O
)	O
.	O

 	O
using	O
a	O
hela	B-UNK
cell	B-UNK
line	B-UNK
in	O
which	O
the	O
expression	B-UNK
of	O
hfe	B-UNK
is	O
controlled	O
by	O
tetracycline	O
,	O
we	O
show	O
that	O
the	O
expression	B-UNK
of	O
hfe	B-UNK
reduces	B-UNK
55fe	O
uptake	B-UNK
from	O
tf	B-UNK
by	O
33	O
%	O
but	O
does	O
not	O
affect	B-UNK
the	O
endocytic	O
or	O
exocytic	O
rates	B-UNK
of	O
tfr	O
cycling	O
.	O

 	O
therefore	O
,	O
hfe	B-UNK
appears	B-UNK
to	O
reduce	B-UNK
cellular	B-UNK
acquisition	O
of	O
iron	B-UNK
from	O
tf	B-UNK
within	O
endocytic	O
compartments	O
.	O

 	O
hfe	B-UNK
specifically	B-UNK
reduces	B-UNK
iron	B-UNK
uptake	I-UNK
from	O
tf	B-UNK
,	O
as	O
non	B-UNK
-	O
tf	B-UNK
-	O
mediated	B-UNK
iron	B-UNK
uptake	I-UNK
from	O
fe	O
-	O
nitrilotriacetic	O
acid	O
is	O
not	O
altered	B-UNK
.	O

 	O
these	O
results	B-UNK
explain	O
the	O
decreased	B-UNK
ferritin	B-UNK
levels	I-UNK
seen	B-UNK
in	O
our	O
hela	B-UNK
cell	B-UNK
system	B-UNK
and	O
demonstrate	B-UNK
the	O
specific	B-UNK
control	B-UNK
of	O
hfe	B-UNK
over	O
the	O
tf	B-UNK
-	O
mediated	B-UNK
pathway	B-UNK
of	O
iron	B-UNK
uptake	I-UNK
.	O

 	O
these	O
results	B-UNK
also	O
have	O
implications	B-UNK
for	O
the	O
understanding	B-UNK
of	O
cellular	B-UNK
iron	B-UNK
homeostasis	I-UNK
in	O
organs	O
such	O
as	O
the	O
liver	B-DISEASE
,	O
pancreas	O
,	O
heart	B-UNK
,	O
and	O
spleen	O
that	O
are	O
iron	B-UNK
loaded	B-UNK
in	O
hereditary	B-UNK
hemochromatotic	O
individuals	B-UNK
lacking	B-UNK
functional	B-UNK
hfe	B-UNK
.	O

 	O
mutation	B-UNK
and	O
haplotype	B-UNK
studies	B-UNK
of	O
familial	B-DISEASE
mediterranean	I-DISEASE
fever	I-DISEASE
reveal	B-UNK
new	B-UNK
ancestral	B-UNK
relationships	B-UNK
and	O
evidence	B-UNK
for	O
a	O
high	B-UNK
carrier	B-UNK
frequency	I-UNK
with	O
reduced	B-UNK
penetrance	B-UNK
in	O
the	O
ashkenazi	B-UNK
jewish	I-UNK
population	B-UNK
.	O

 	O
familial	B-DISEASE
mediterranean	I-DISEASE
fever	I-DISEASE
(	O
fmf	B-UNK
)	O
is	O
a	O
recessive	O
disorder	O
characterized	B-UNK
by	O
episodes	O
of	O
fever	B-DISEASE
with	O
serositis	B-DISEASE
or	O
synovitis	B-DISEASE
.	O

 	O
the	O
fmf	B-UNK
gene	B-UNK
(	O
mefv	B-UNK
)	O
was	O
cloned	B-UNK
recently	B-UNK
,	O
and	O
four	O
missense	B-UNK
mutations	I-UNK
were	O
identified	B-UNK
.	O

 	O
here	O
we	O
present	B-UNK
data	B-UNK
from	O
non	B-UNK
-	O
ashkenazi	B-UNK
jewish	I-UNK
and	O
arab	O
patients	B-UNK
in	O
whom	O
we	O
had	O
not	O
originally	B-UNK
found	B-UNK
mutations	B-UNK
and	O
from	O
a	O
new	B-UNK
,	O
more	O
ethnically	O
diverse	B-UNK
panel	O
.	O

 	O
among	O
90	O
symptomatic	B-UNK
mutation	B-UNK
-	O
positive	B-UNK
individuals	B-UNK
,	O
11	O
mutations	B-UNK
accounted	B-UNK
for	O
79	O
%	O
of	O
carrier	B-UNK
chromosomes	B-UNK
.	O

 	O
of	O
the	O
two	O
mutations	B-UNK
that	O
are	O
novel	B-UNK
,	O
one	O
alters	O
the	O
same	O
residue	B-UNK
(	O
680	O
)	O
as	O
a	O
previously	B-UNK
known	B-UNK
mutation	B-UNK
,	O
and	O
the	O
other	O
(	O
p369s	O
)	O
is	O
located	B-UNK
in	O
exon	B-UNK
3	O
.	O

 	O
consistent	B-UNK
with	O
another	O
recent	B-UNK
report	B-UNK
,	O
the	O
e148q	O
mutation	B-UNK
was	O
observed	B-UNK
in	O
patients	B-UNK
of	O
several	O
ethnicities	O
and	O
on	O
multiple	B-UNK
microsatellite	O
haplotypes	B-UNK
,	O
but	O
haplotype	B-UNK
data	I-UNK
indicate	B-UNK
an	O
ancestral	B-UNK
relationships	B-UNK
between	O
non	B-UNK
-	O
jewish	B-UNK
italian	B-UNK
and	O
ashkenazi	B-UNK
jewish	I-UNK
patients	B-UNK
with	O
fmf	B-UNK
and	O
other	O
affected	B-UNK
populations	B-UNK
.	O

 	O
among	O
approximately	B-UNK
200	O
anonymous	B-UNK
ashkenazi	B-UNK
jewish	I-UNK
dna	B-UNK
samples	I-UNK
,	O
the	O
mefv	B-UNK
carrier	B-UNK
frequency	I-UNK
was	O
21	O
%	O
,	O
with	O
e148q	O
the	O
most	O
common	B-UNK
mutation	B-UNK
.	O

 	O
several	O
lines	B-UNK
of	O
evidence	B-UNK
indicate	B-UNK
reduced	B-UNK
penetrance	B-UNK
among	O
ashkenazi	B-UNK
jews	B-UNK
,	O
especially	B-UNK
for	O
e148q	O
,	O
p369s	O
,	O
and	O
k695r	O
.	O

 	O
nevertheless	O
,	O
e148q	O
helps	O
account	B-UNK
for	O
recessive	O
inheritance	B-UNK
in	O
an	O
ashkenazi	B-UNK
family	B-UNK
previously	I-UNK
reported	B-UNK
as	O
an	O
unusual	B-UNK
case	B-UNK
of	O
dominantly	B-UNK
inherited	I-UNK
fmf	B-UNK
.	O

 	O
the	O
presence	B-UNK
of	O
three	O
frequent	B-UNK
mefv	B-UNK
mutations	B-UNK
in	O
multiple	B-UNK
mediterranean	B-UNK
populations	B-UNK
strongly	B-UNK
suggests	B-UNK
a	O
heterozygote	B-UNK
advantage	B-UNK
in	O
this	O
geographic	B-UNK
region	B-UNK
.	O

 	O
autoimmune	B-DISEASE
lymphoproliferative	I-DISEASE
syndrome	I-DISEASE
with	O
defective	B-UNK
fas	B-UNK
:	O
genotype	B-UNK
influences	B-UNK
penetrance	B-UNK
.	O

 	O
autoimmune	B-DISEASE
lymphoproliferative	I-DISEASE
syndrome	I-DISEASE
(	O
alps	B-UNK
)	O
is	O
a	O
disorder	O
of	O
lymphocyte	B-UNK
homeostasis	B-UNK
and	O
immunological	B-UNK
tolerance	O
.	O

 	O
most	O
patients	B-UNK
have	O
a	O
heterozygous	B-UNK
mutation	B-UNK
in	O
the	O
apt1	B-UNK
gene	B-UNK
,	O
which	O
encodes	B-UNK
fas	B-UNK
(	O
cd95	B-UNK
,	O
apo	O
-	O
1	O
)	O
,	O
mediator	O
of	O
an	O
apoptotic	B-UNK
pathway	B-UNK
crucial	B-UNK
to	O
lymphocyte	B-UNK
homeostasis	B-UNK
.	O

 	O
of	O
17	O
unique	B-UNK
apt1	B-UNK
mutations	B-UNK
in	O
unrelated	B-UNK
alps	B-UNK
probands	B-UNK
,	O
12	O
(	O
71	O
%	O
)	O
occurred	B-UNK
in	O
exons	B-UNK
7	O
-	O
9	O
,	O
which	O
encode	O
the	O
intracellular	B-UNK
portion	B-UNK
of	O
fas	B-UNK
.	O

 	O
in	O
vitro	B-UNK
,	O
activated	B-UNK
lymphocytes	B-UNK
from	O
all	O
17	O
patients	B-UNK
showed	I-UNK
apoptotic	B-UNK
defects	B-UNK
when	O
exposed	O
to	O
an	O
anti	O
-	O
fas	B-UNK
agonist	O
monoclonal	B-UNK
antibody	I-UNK
.	O

 	O
similar	B-UNK
defects	B-UNK
were	O
found	B-UNK
in	O
a	O
fas	B-UNK
-	O
negative	B-UNK
cell	B-UNK
line	B-UNK
transfected	B-UNK
with	O
cdnas	B-UNK
bearing	B-UNK
each	O
of	O
the	O
mutations	B-UNK
.	O

 	O
in	O
cotransfection	O
experiments	B-UNK
,	O
fas	B-UNK
constructs	O
with	O
either	O
intra	O
-	O
or	O
extracellular	B-UNK
mutations	B-UNK
caused	B-UNK
dominant	B-UNK
inhibition	B-UNK
of	O
apoptosis	B-UNK
mediated	B-UNK
by	O
wild	B-UNK
-	O
type	B-UNK
fas	B-UNK
.	O

 	O
two	O
missense	B-UNK
fas	B-UNK
variants	B-UNK
,	O
not	O
restricted	O
to	O
patients	B-UNK
with	O
alps	B-UNK
,	O
were	O
identified	B-UNK
.	O

 	O
variant	B-UNK
a	O
(	O
-	O
1	O
)	O
t	B-UNK
at	B-DISEASE
the	O
fas	B-UNK
signal	B-UNK
-	O
sequence	B-UNK
cleavage	B-UNK
site	B-UNK
,	O
which	O
mediates	O
apoptosis	B-UNK
less	O
well	O
than	O
wild	B-UNK
-	O
type	B-UNK
fas	B-UNK
and	O
is	O
partially	B-UNK
inhibitory	B-UNK
,	O
was	O
present	B-UNK
in	O
13	O
%	O
of	O
african	B-UNK
american	B-UNK
alleles	B-UNK
.	O

 	O
among	O
the	O
alps	B-UNK
-	O
associated	B-UNK
fas	B-UNK
mutants	B-UNK
,	O
dominant	B-UNK
inhibition	B-UNK
of	O
apoptosis	B-UNK
was	O
much	O
more	O
pronounced	O
in	O
mutants	B-UNK
affecting	B-UNK
the	O
intracellular	B-UNK
,	O
versus	O
extracellular	B-UNK
,	O
portion	B-UNK
of	O
the	O
fas	B-UNK
receptor	B-UNK
.	O

 	O
mutations	B-UNK
causing	B-UNK
disruption	B-UNK
of	O
the	O
intracellular	B-UNK
fas	B-UNK
death	B-DISEASE
domain	B-UNK
also	O
showed	B-UNK
a	O
higher	B-UNK
penetrance	B-UNK
of	O
alps	B-UNK
phenotype	B-UNK
features	B-UNK
in	O
mutation	B-UNK
-	O
bearing	B-UNK
relatives	B-UNK
.	O

 	B-UNK
significant	I-UNK
alps	B-UNK
-	O
related	B-UNK
morbidity	O
occurred	B-UNK
in	O
44	O
%	O
of	O
relatives	B-UNK
with	O
intracellular	B-UNK
mutations	B-UNK
,	O
versus	O
0	O
%	O
of	O
relatives	B-UNK
with	O
extracellular	B-UNK
mutations	B-UNK
.	O

 	O
thus	O
,	O
the	O
location	B-UNK
of	O
mutations	B-UNK
within	O
apt1	B-UNK
strongly	B-UNK
influences	B-UNK
the	O
development	B-UNK
and	O
the	O
severity	B-UNK
of	O
alps	B-UNK
.	O

 	O
multicentric	O
origin	B-UNK
of	O
hemochromatosis	B-DISEASE
gene	B-UNK
(	O
hfe	B-UNK
)	O
mutations	B-UNK
.	O

 	B-UNK
genetic	I-UNK
hemochromatosis	B-DISEASE
(	O
gh	B-UNK
)	O
is	O
believed	O
to	O
be	O
a	O
disease	B-DISEASE
restricted	O
to	O
those	O
of	O
european	B-UNK
ancestry	B-UNK
.	O

 	O
in	O
northwestern	O
europe	B-UNK
,	O
>	O
80	O
%	O
of	O
gh	B-UNK
patients	B-UNK
are	O
homozygous	B-UNK
for	O
one	O
mutation	B-UNK
,	O
the	O
substitution	B-UNK
of	O
tyrosine	O
for	O
cysteine	O
at	B-DISEASE
position	B-UNK
282	O
(	O
c282y	B-UNK
)	O
in	O
the	O
unprocessed	O
protein	B-UNK
.	O

 	O
in	O
a	O
proportion	B-UNK
of	O
gh	B-UNK
patients	B-UNK
,	O
two	O
mutations	B-UNK
are	O
present	B-UNK
,	O
c282y	B-UNK
and	O
h63d	B-UNK
.	O

 	O
the	O
clinical	B-UNK
significance	B-UNK
of	O
this	O
second	B-UNK
mutation	B-UNK
is	O
such	O
that	O
it	O
appears	B-UNK
to	O
predispose	B-UNK
1	O
%	O
-	O
2	O
%	O
of	O
compound	B-UNK
heterozygotes	B-UNK
to	O
expression	B-UNK
of	O
the	O
disease	B-DISEASE
.	O

 	O
the	O
distribution	B-UNK
of	O
the	O
two	O
mutations	B-UNK
differ	B-UNK
,	O
c282y	B-UNK
being	O
limited	B-UNK
to	O
those	O
of	O
northwestern	O
european	B-UNK
ancestry	B-UNK
and	O
h63d	B-UNK
being	O
found	B-UNK
at	B-DISEASE
allele	B-UNK
frequencies	I-UNK
>	O
5	O
%	O
,	O
in	O
europe	B-UNK
,	O
in	O
countries	B-UNK
bordering	O
the	O
mediterranean	B-UNK
,	O
in	O
the	O
middle	B-UNK
east	O
,	O
and	O
in	O
the	O
indian	B-UNK
subcontinent	O
.	O

 	O
the	O
c282y	B-UNK
mutation	B-UNK
occurs	B-UNK
on	O
a	O
haplotype	B-UNK
that	O
extends	O
<	O
/	O
=	O
6	O
mb	B-UNK
,	O
suggesting	B-UNK
that	O
this	O
mutation	B-UNK
has	O
arisen	O
during	O
the	O
past	O
2	O
,	O
000	O
years	B-UNK
.	O

 	O
the	O
h63d	B-UNK
mutation	B-UNK
is	O
older	B-UNK
and	O
does	O
not	O
occur	B-UNK
on	O
such	O
a	O
large	B-UNK
extended	B-UNK
haplotype	B-UNK
,	O
the	O
haplotype	B-UNK
in	O
this	O
case	B-UNK
extending	B-UNK
<	O
/	O
=	O
700	O
kb	B-UNK
.	O

 	O
here	O
we	O
report	B-UNK
the	O
finding	B-UNK
of	O
the	O
h63d	B-UNK
and	O
c282y	B-UNK
mutations	B-UNK
on	O
new	B-UNK
haplotypes	B-UNK
.	O

 	O
in	O
sri	O
lanka	O
we	O
have	O
found	B-UNK
h63d	B-UNK
on	O
three	O
new	B-UNK
haplotypes	B-UNK
and	O
have	O
found	B-UNK
c282y	B-UNK
on	O
one	O
new	B-UNK
haplotype	B-UNK
,	O
demonstrating	B-UNK
that	O
these	O
mutations	B-UNK
have	O
arisen	O
independently	B-UNK
on	O
this	O
island	B-UNK
.	O

 	O
these	O
results	B-UNK
suggest	B-UNK
that	O
the	O
hfe	B-UNK
gene	B-UNK
has	O
been	O
the	O
subject	B-UNK
of	O
selection	B-UNK
pressure	B-UNK
.	O

 	O
these	O
selection	B-UNK
pressures	O
could	O
be	O
due	O
to	O
infectious	B-DISEASE
diseases	I-DISEASE
,	O
environmental	B-UNK
conditions	B-UNK
,	O
or	O
other	O
genetic	B-UNK
disorders	B-UNK
such	O
as	O
anemia	B-DISEASE
.	O

 	O
a	O
retrospective	B-UNK
anonymous	B-UNK
pilot	O
study	B-UNK
in	O
screening	B-UNK
newborns	O
for	O
hfe	B-UNK
mutations	B-UNK
in	O
scandinavian	O
populations	B-UNK
.	O

 	O
we	O
have	O
retrospectively	O
analyzed	B-UNK
837	O
random	B-UNK
anonymized	O
dried	O
blood	B-UNK
spot	B-UNK
(	O
dbs	O
)	O
samples	B-UNK
from	O
neonatal	B-UNK
screening	B-UNK
programs	B-UNK
in	O
scandinavia	O
for	O
mutations	B-UNK
in	O
hfe	B-UNK
,	O
the	O
candidate	B-UNK
gene	B-UNK
for	O
hemochromatosis	B-DISEASE
.	O

 	O
we	O
have	O
found	B-UNK
c282y	B-UNK
allele	B-UNK
frequencies	I-UNK
of	O
2	O
.	O

 	O
3	O
%	O
(	O
+	O
2	O
.	O
0	O
%	O
)	O
(	O
-	O
1	O
.	O
3	O
%	O
)	O
in	O
greenland	O
,	O
4	O
.	O

 	O
5	O
%	O
+	O
/	O
-	O
1	O
.	O

 	O
9	O
%	O
in	O
iceland	O
,	O
5	O
.	O

 	O
1	O
%	O
+	O
/	O
-	O
2	O
.	O

 	O
3	O
%	O
in	O
the	O
faeroe	O
islands	O
,	O
and	O
8	O
.	O

 	O
2	O
%	O
+	O
/	O
-	O
2	O
.	O

 	O
7	O
%	O
in	O
denmark	O
.	O

 	O
the	O
high	B-UNK
prevalence	B-UNK
of	O
hfe	B-UNK
mutations	B-UNK
in	O
denmark	O
suggests	B-UNK
that	O
population	B-UNK
screening	B-UNK
for	O
the	O
c282y	B-UNK
mutation	B-UNK
could	O
be	O
highly	B-UNK
advantageous	O
in	O
terms	O
of	O
preventive	O
health	B-UNK
care	O
.	O

 	O
long	B-UNK
-	O
term	B-UNK
follow	B-UNK
-	O
up	O
evaluation	B-UNK
of	O
c282y	B-UNK
homozygotes	B-UNK
and	O
h63d	B-UNK
/	O
c282y	B-UNK
compound	B-UNK
heterozygotes	B-UNK
will	O
give	O
an	O
indication	O
of	O
the	O
penetrance	B-UNK
of	O
the	O
mutations	B-UNK
.	O

 	O
identification	B-UNK
of	O
the	O
mutation	B-UNK
in	O
the	O
alkaptonuria	B-DISEASE
mouse	B-UNK
model	I-UNK
.	O

 	O
alkaptonuria	B-DISEASE
(	O
aku	B-UNK
)	O
,	O
an	O
inborn	B-DISEASE
error	I-DISEASE
of	I-DISEASE
metabolism	I-DISEASE
caused	B-UNK
by	O
the	O
loss	B-UNK
of	O
homogentisate	O
1	O
,	O
2	O
-	O
dioxygenase	B-UNK
(	O
hgd	O
)	O
,	O
has	O
been	O
described	B-UNK
in	O
a	O
mouse	B-UNK
model	I-UNK
created	B-UNK
by	O
ethylnitrosourea	O
mutagenesis	B-UNK
but	O
the	O
mutation	B-UNK
in	O
these	O
mice	B-UNK
has	O
not	O
previously	B-UNK
been	O
identified	B-UNK
.	O

 	O
we	O
used	O
rt	O
-	O
pcr	B-UNK
to	O
amplify	O
the	O
hgd	O
cdna	B-UNK
from	O
hgd	O
(	O
aku	B-UNK
)	O
/	O
hgd	O
(	O
aku	B-UNK
)	O
mice	B-UNK
.	O

 	O
two	O
products	B-UNK
shorter	B-UNK
than	O
the	O
wild	B-UNK
-	O
type	B-UNK
product	B-UNK
were	O
amplified	B-UNK
.	O

 	O
restriction	O
mapping	B-UNK
and	O
dna	B-UNK
sequencing	I-UNK
were	O
then	O
used	O
to	O
identify	B-UNK
the	O
hgd	O
(	O
aku	B-UNK
)	O
mouse	B-UNK
mutation	B-UNK
,	O
found	B-UNK
to	O
be	O
a	O
single	B-UNK
base	B-UNK
change	I-UNK
in	O
a	O
splice	B-UNK
donor	I-UNK
consensus	B-UNK
sequence	B-UNK
,	O
causing	B-UNK
exon	B-UNK
skipping	B-UNK
and	O
frame	B-UNK
-	O
shifted	O
products	B-UNK
.	O

 	O
this	O
base	B-UNK
change	I-UNK
allowed	B-UNK
us	O
to	O
create	O
a	O
non	B-UNK
-	O
radioactive	O
genotyping	B-UNK
assay	B-UNK
for	O
this	O
allele	B-UNK
.	O

 	O
non	B-UNK
-	O
syndromic	O
hearing	B-DISEASE
loss	I-DISEASE
associated	B-UNK
with	O
enlarged	O
vestibular	B-UNK
aqueduct	I-UNK
is	O
caused	B-UNK
by	O
pds	B-UNK
mutations	B-UNK
.	O

 	O
enlarged	O
vestibular	B-UNK
aqueduct	I-UNK
(	O
eva	O
)	O
,	O
known	B-UNK
as	O
the	O
most	O
common	B-UNK
form	B-UNK
of	O
inner	B-UNK
ear	B-UNK
abnormality	B-UNK
,	O
has	O
recently	B-UNK
been	O
of	O
particular	B-UNK
genetic	B-UNK
interest	O
because	O
this	O
anomaly	B-UNK
is	O
inherited	B-UNK
in	O
a	O
recessive	O
manner	B-UNK
.	O

 	O
the	O
locus	B-UNK
for	O
non	B-UNK
-	O
syndromic	O
sensorineural	B-DISEASE
hearing	I-DISEASE
loss	I-DISEASE
with	O
eva	O
has	O
been	O
mapped	B-UNK
to	O
the	O
same	O
chromosomal	B-UNK
region	B-UNK
,	O
7q31	O
,	O
as	O
the	O
pendred	B-DISEASE
syndrome	I-DISEASE
locus	B-UNK
.	O

 	O
in	O
the	O
present	B-UNK
study	I-UNK
,	O
seven	B-UNK
mutations	B-UNK
in	O
the	O
pds	B-UNK
gene	B-UNK
(	O
pds	B-UNK
)	O
,	O
the	O
gene	B-UNK
responsible	B-UNK
for	O
pendred	B-DISEASE
syndrome	I-DISEASE
,	O
have	O
been	O
found	B-UNK
in	O
families	B-UNK
of	O
non	B-UNK
-	O
syndromic	O
sensorineural	B-DISEASE
hearing	I-DISEASE
loss	I-DISEASE
with	O
eva	O
.	O

 	O
one	O
family	B-UNK
is	O
homozygous	B-UNK
,	O
three	O
families	B-UNK
are	O
compound	B-UNK
heterozygotes	B-UNK
,	O
and	O
two	O
families	B-UNK
are	O
heterozygous	B-UNK
but	O
with	O
no	O
other	O
mutation	B-UNK
detected	B-UNK
.	O

 	O
the	O
present	B-UNK
results	B-UNK
provide	I-UNK
evidence	B-UNK
that	O
mutations	B-UNK
in	O
pds	B-UNK
cause	B-UNK
both	O
syndromic	O
and	O
non	B-UNK
-	O
syndromic	O
hearing	B-DISEASE
loss	I-DISEASE
.	O
.	O

 	B-UNK
mutational	I-UNK
analysis	B-UNK
and	O
genotype	B-UNK
-	O
phenotype	B-UNK
correlation	B-UNK
of	O
29	O
unrelated	B-UNK
japanese	I-UNK
patients	B-UNK
with	O
x	B-UNK
-	O
linked	B-UNK
adrenoleukodystrophy	B-DISEASE
.	O

 	B-UNK
background	I-UNK
x	B-UNK
-	O
linked	B-UNK
adrenoleukodystrophy	B-DISEASE
(	O
ald	B-UNK
)	O
is	O
an	O
inherited	B-UNK
disease	B-DISEASE
characterized	B-UNK
by	O
progressive	B-UNK
neurologic	B-DISEASE
dysfunction	B-UNK
,	O
occasionally	B-UNK
associated	B-UNK
with	O
adrenal	B-DISEASE
insufficiency	I-DISEASE
.	O

 	O
the	O
classic	B-UNK
form	B-UNK
of	O
ald	B-UNK
usually	B-UNK
has	O
onset	B-UNK
in	O
childhood	B-UNK
(	O
childhood	B-UNK
cerebral	I-UNK
ald	B-UNK
)	O
,	O
with	O
rapid	B-UNK
neurologic	B-DISEASE
deterioration	B-UNK
leading	B-UNK
to	O
a	O
vegetative	O
state	B-UNK
.	O

 	O
adult	B-UNK
-	O
onset	B-UNK
cerebral	I-UNK
ald	B-UNK
also	O
presents	O
with	O
rapidly	B-UNK
progressive	B-UNK
neurologic	B-DISEASE
dysfunction	B-UNK
.	O

 	O
milder	B-UNK
phenotypes	B-UNK
such	O
as	O
adrenomyeloneuropathy	B-UNK
and	O
addison	B-DISEASE
disease	I-DISEASE
only	O
also	O
have	O
been	O
recognized	B-UNK
.	O

 	O
despite	B-UNK
discovery	B-UNK
of	O
the	O
causative	B-UNK
gene	B-UNK
,	O
a	O
molecular	B-UNK
basis	I-UNK
for	O
the	O
diverse	B-UNK
clinical	B-UNK
presentations	B-UNK
remains	B-UNK
to	O
be	O
elucidated	O
.	O

 	O
objectives	B-UNK
to	O
conduct	O
mutational	B-UNK
analyses	B-UNK
in	O
29	O
japanese	B-UNK
patients	I-UNK
with	O
ald	B-UNK
from	O
29	O
unrelated	B-UNK
families	I-UNK
,	O
to	O
obtain	O
knowledge	B-UNK
of	O
the	O
spectrum	B-UNK
of	O
mutations	B-UNK
in	O
this	O
gene	B-UNK
,	O
and	O
to	O
study	B-UNK
genotype	B-UNK
-	O
phenotype	B-UNK
correlations	B-UNK
in	O
japanese	B-UNK
patients	I-UNK
.	O

 	O
methods	B-UNK
the	O
29	O
patients	B-UNK
comprised	O
13	O
patients	B-UNK
with	O
childhood	B-UNK
cerebral	I-UNK
ald	B-UNK
,	O
11	O
patients	B-UNK
with	O
adult	B-UNK
-	O
onset	B-UNK
cerebral	I-UNK
ald	B-UNK
,	O
and	O
5	O
patients	B-UNK
with	O
adrenomyeloneuropathy	B-UNK
.	O

 	O
we	O
conducted	O
detailed	B-UNK
mutational	B-UNK
analyses	B-UNK
of	O
29	O
unrelated	B-UNK
japanese	I-UNK
patients	B-UNK
with	O
ald	B-UNK
by	O
genomic	B-UNK
southern	B-UNK
blot	I-UNK
analysis	I-UNK
and	O
direct	B-UNK
nucleotide	B-UNK
sequence	I-UNK
analysis	I-UNK
of	O
reverse	B-UNK
transcriptase	B-UNK
-	O
polymerase	B-UNK
chain	I-UNK
reaction	I-UNK
products	B-UNK
derived	B-UNK
from	O
total	B-UNK
rna	B-UNK
that	O
was	O
extracted	O
from	O
cultured	B-UNK
skin	B-DISEASE
fibroblasts	B-UNK
,	O
lymphoblastoid	B-UNK
cells	B-UNK
,	O
or	O
peripheral	B-UNK
blood	I-UNK
leukocytes	B-UNK
.	O

 	B-UNK
results	I-UNK
three	O
patients	B-UNK
with	O
adult	B-UNK
-	O
onset	B-UNK
cerebral	I-UNK
ald	B-UNK
were	O
identified	B-UNK
as	O
having	B-UNK
large	B-UNK
genomic	B-UNK
rearrangements	I-UNK
.	O

 	O
the	O
remaining	B-UNK
26	O
patients	B-UNK
were	O
identified	B-UNK
as	O
having	B-UNK
21	O
independent	B-UNK
mutations	B-UNK
,	O
including	B-UNK
12	O
novel	B-UNK
mutations	B-UNK
resulting	B-UNK
in	O
small	B-UNK
nucleotide	B-UNK
alterations	B-UNK
in	O
the	O
ald	B-UNK
gene	B-UNK
.	O

 	O
eighteen	O
(	O
69	O
%	O
)	O
of	O
26	O
mutations	B-UNK
were	O
missense	B-UNK
mutations	I-UNK
.	O

 	O
most	O
missense	B-UNK
mutations	I-UNK
involved	B-UNK
amino	O
acids	O
conserved	B-UNK
in	O
homologous	B-UNK
gene	B-UNK
products	B-UNK
,	O
including	B-UNK
pmp70	B-UNK
,	O
maldrp	O
,	O
and	O
pxa1p	O
.	O

 	O
the	O
ag	B-UNK
dinucleotide	B-UNK
deletion	B-UNK
at	B-DISEASE
position	B-UNK
1081	O
-	O
1082	O
,	O
which	O
has	O
been	O
reported	B-UNK
previously	B-UNK
to	O
be	O
the	O
most	O
common	B-UNK
mutation	B-UNK
in	O
white	B-UNK
patients	B-UNK
(	O
12	O
%	O
-	O
17	O
%	O
)	O
,	O
was	O
also	O
identified	B-UNK
as	O
the	O
most	O
common	B-UNK
mutation	B-UNK
in	O
japanese	B-UNK
patients	I-UNK
(	O
12	O
%	O
)	O
.	O

 	O
all	O
phenotypes	B-UNK
were	O
associated	B-UNK
with	O
mutations	B-UNK
resulting	B-UNK
in	O
protein	B-UNK
truncation	O
or	O
subtle	O
amino	B-UNK
acid	I-UNK
changes	B-UNK
.	O

 	O
there	O
were	O
no	O
differences	B-UNK
in	O
phenotypic	B-UNK
expressions	B-UNK
between	O
missense	B-UNK
mutations	I-UNK
involving	B-UNK
conserved	B-UNK
amino	O
acids	O
and	O
those	O
involving	B-UNK
nonconserved	O
amino	O
acids	O
.	O

 	O
conclusions	B-UNK
there	O
are	O
no	O
obvious	B-UNK
correlations	B-UNK
between	O
the	O
phenotypes	B-UNK
of	O
patients	B-UNK
with	O
ald	B-UNK
and	O
their	O
genotypes	O
,	O
suggesting	B-UNK
that	O
other	O
genetic	B-UNK
or	O
environmental	B-UNK
factors	B-UNK
modify	B-UNK
the	O
phenotypic	B-UNK
expressions	B-UNK
of	O
ald	B-UNK
.	O
.	O

 	O
a	O
common	B-UNK
human	B-UNK
skin	B-DISEASE
tumour	B-UNK
is	O
caused	B-UNK
by	O
activating	B-UNK
mutations	B-UNK
in	O
beta	B-UNK
-	O
catenin	B-UNK
.	O

 	O
wnt	B-UNK
signalling	B-UNK
orchestrates	O
a	O
number	B-UNK
of	O
developmental	B-UNK
programs	B-UNK
.	O

 	O
in	O
response	B-UNK
to	O
this	O
stimulus	O
,	O
cytoplasmic	B-UNK
beta	B-UNK
-	O
catenin	B-UNK
(	O
encoded	B-UNK
by	O
ctnnb1	O
)	O
is	O
stabilized	O
,	O
enabling	O
downstream	B-UNK
transcriptional	B-UNK
activation	I-UNK
by	O
members	B-UNK
of	O
the	O
lef	O
/	O
tcf	B-UNK
family	B-UNK
.	O

 	O
one	O
of	O
the	O
target	B-UNK
genes	B-UNK
for	O
beta	B-UNK
-	O
catenin	B-UNK
/	O
tcf	B-UNK
encodes	B-UNK
c	B-UNK
-	O
myc	O
,	O
explaining	O
why	O
constitutive	O
activation	B-UNK
of	O
the	O
wnt	B-UNK
pathway	B-UNK
can	O
lead	B-UNK
to	O
cancer	B-DISEASE
,	O
particularly	B-UNK
in	O
the	O
colon	O
.	O

 	O
most	O
colon	O
cancers	B-DISEASE
arise	O
from	O
mutations	B-UNK
in	O
the	O
gene	B-UNK
encoding	B-UNK
adenomatous	B-DISEASE
polyposis	I-DISEASE
coli	I-DISEASE
(	O
apc	B-UNK
)	O
,	O
a	O
protein	B-UNK
required	B-UNK
for	O
ubiquitin	O
-	O
mediated	B-UNK
degradation	B-UNK
of	O
beta	B-UNK
-	O
catenin	B-UNK
,	O
but	O
a	O
small	B-UNK
percentage	B-UNK
of	O
colon	O
and	O
some	O
other	O
cancers	B-DISEASE
harbour	O
beta	B-UNK
-	O
catenin	B-UNK
-	O
stabilizing	O
mutations	B-UNK
.	O

 	O
recently	B-UNK
,	O
we	O
discovered	O
that	O
transgenic	B-UNK
mice	I-UNK
expressing	B-UNK
an	O
activated	B-UNK
beta	B-UNK
-	O
catenin	B-UNK
are	O
predisposed	O
to	O
developing	B-UNK
skin	B-DISEASE
tumours	B-UNK
resembling	B-UNK
pilomatricomas	O
.	O

 	O
given	B-UNK
that	O
the	O
skin	B-DISEASE
of	O
these	O
adult	B-UNK
mice	B-UNK
also	O
exhibits	O
signs	B-UNK
of	O
de	B-UNK
novo	I-UNK
hair	B-UNK
-	O
follicle	O
morphogenesis	O
,	O
we	O
wondered	O
whether	O
human	B-UNK
pilomatricomas	O
might	O
originate	O
from	O
hair	B-UNK
matrix	I-UNK
cells	B-UNK
and	O
whether	O
they	O
might	O
possess	O
beta	B-UNK
-	O
catenin	B-UNK
-	O
stabilizing	O
mutations	B-UNK
.	O

 	O
here	O
,	O
we	O
explore	O
the	O
cell	B-UNK
origin	B-UNK
and	O
aetiology	O
of	O
this	O
common	B-UNK
human	B-UNK
skin	B-DISEASE
tumour	B-UNK
.	O

 	O
we	O
found	B-UNK
nuclear	B-UNK
lef	O
-	O
1	O
in	O
the	O
dividing	O
tumour	B-UNK
cells	B-UNK
,	O
providing	O
biochemical	B-UNK
evidence	B-UNK
that	O
pilomatricomas	O
are	O
derived	B-UNK
from	O
hair	B-UNK
matrix	I-UNK
cells	B-UNK
.	O

 	O
at	B-DISEASE
least	O
75	O
%	O
of	O
these	O
tumours	B-UNK
possess	O
mutations	B-UNK
affecting	B-UNK
the	O
amino	O
-	O
terminal	B-UNK
segment	B-UNK
,	O
normally	B-UNK
involved	B-UNK
in	O
phosphorylation	B-UNK
-	O
dependent	B-UNK
,	O
ubiquitin	O
-	O
mediated	B-UNK
degradation	B-UNK
of	O
the	O
protein	B-UNK
.	O

 	O
this	O
percentage	B-UNK
of	O
ctnnb1	O
mutations	B-UNK
is	O
greater	B-UNK
than	O
in	O
all	O
other	O
human	B-UNK
tumours	B-UNK
examined	B-UNK
thus	O
far	B-UNK
,	O
and	O
directly	B-UNK
implicates	O
beta	B-UNK
-	O
catenin	B-UNK
/	O
lef	O
misregulation	O
as	O
the	O
major	B-UNK
cause	B-UNK
of	O
hair	B-UNK
matrix	I-UNK
cell	B-UNK
tumorigenesis	B-UNK
in	O
humans	B-UNK
.	O
.	O

 	O
the	O
pendred	B-DISEASE
syndrome	I-DISEASE
gene	B-UNK
encodes	B-UNK
a	O
chloride	B-UNK
-	O
iodide	B-UNK
transport	I-UNK
protein	B-UNK
.	O

 	O
pendred	B-DISEASE
syndrome	I-DISEASE
is	O
the	O
most	O
common	B-UNK
form	B-UNK
of	O
syndromic	O
deafness	B-DISEASE
and	O
characterized	B-UNK
by	O
congenital	B-DISEASE
sensorineural	B-DISEASE
hearing	I-DISEASE
loss	I-DISEASE
and	O
goitre	O
.	O

 	O
this	O
disorder	O
was	O
mapped	B-UNK
to	O
chromosome	B-DISEASE
7	I-DISEASE
and	O
the	O
gene	B-UNK
causing	B-UNK
pendred	B-DISEASE
syndrome	I-DISEASE
(	O
pds	B-UNK
)	O
was	O
subsequently	B-UNK
identified	B-UNK
by	O
positional	B-UNK
cloning	I-UNK
.	O

 	O
pds	B-UNK
encodes	B-UNK
a	O
putative	B-UNK
transmembrane	B-UNK
protein	B-UNK
designated	B-UNK
pendrin	B-UNK
.	O

 	O
pendrin	B-UNK
is	O
closely	B-UNK
related	B-UNK
to	O
a	O
family	B-UNK
of	O
sulfate	B-UNK
transport	I-UNK
proteins	B-UNK
that	O
includes	B-UNK
the	O
rat	B-UNK
sulfate	B-UNK
-	O
anion	B-UNK
transporter	B-UNK
(	O
encoded	B-UNK
by	O
sat	O
-	O
1	O
;	O
29	O
%	O
amino	B-UNK
acid	I-UNK
sequence	I-UNK
identity	O
)	O
,	O
the	O
human	B-UNK
diastrophic	B-DISEASE
dysplasia	I-DISEASE
sulfate	B-UNK
transporter	B-UNK
(	O
encoded	B-UNK
by	O
dtd	O
;	O
32	O
%	O
)	O
and	O
the	O
human	B-UNK
sulfate	B-UNK
transporter	B-UNK
downregulated	O
in	O
adenoma	B-DISEASE
(	O
encoded	B-UNK
by	O
dra	O
;	O
45	O
%	O
)	O
.	O

 	O
on	O
the	O
basis	B-UNK
of	O
this	O
homology	B-UNK
and	O
the	O
presence	B-UNK
of	O
a	O
slightly	B-UNK
modified	B-UNK
sulfate	B-UNK
-	O
transporter	B-UNK
signature	O
sequence	B-UNK
comprising	B-UNK
its	O
putative	B-UNK
second	B-UNK
transmembrane	B-UNK
domain	B-UNK
,	O
pendrin	B-UNK
has	O
been	O
proposed	B-UNK
to	O
function	B-UNK
as	O
a	O
sulfate	B-UNK
transporter	B-UNK
.	O

 	O
we	O
were	O
unable	O
to	O
detect	B-UNK
evidence	B-UNK
of	O
sulfate	B-UNK
transport	I-UNK
following	B-UNK
the	O
expression	B-UNK
of	O
pendrin	B-UNK
in	O
xenopus	B-UNK
laevis	O
oocytes	B-UNK
by	O
microinjection	O
of	O
pds	B-UNK
crna	O
or	O
in	O
sf9	B-UNK
cells	B-UNK
following	B-UNK
infection	B-DISEASE
with	O
pds	B-UNK
-	O
recombinant	B-UNK
baculovirus	O
.	O

 	O
the	O
rates	B-UNK
of	O
transport	B-UNK
for	O
iodide	B-UNK
and	O
chloride	B-UNK
were	O
significantly	B-UNK
increased	B-UNK
following	B-UNK
the	O
expression	B-UNK
of	O
pendrin	B-UNK
in	O
both	O
cell	B-UNK
systems	B-UNK
.	O

 	O
our	O
results	B-UNK
demonstrate	B-UNK
that	O
pendrin	B-UNK
functions	B-UNK
as	O
a	O
transporter	B-UNK
of	O
chloride	B-UNK
and	O
iodide	B-UNK
,	O
but	O
not	O
sulfate	B-UNK
,	O
and	O
may	O
provide	B-UNK
insight	B-UNK
into	O
thyroid	B-DISEASE
physiology	O
and	O
the	O
pathophysiology	O
of	O
pendred	B-DISEASE
syndrome	I-DISEASE
.	O
.	O

 	O
hfe	B-UNK
mutations	B-UNK
analysis	B-UNK
in	O
711	O
hemochromatosis	B-DISEASE
probands	B-UNK
:	O
evidence	B-UNK
for	O
s65c	B-UNK
implication	O
in	O
mild	B-UNK
form	B-UNK
of	O
hemochromatosis	B-DISEASE
.	O

 	B-UNK
hereditary	I-UNK
hemochromatosis	B-DISEASE
(	O
hh	B-UNK
)	O
is	O
a	O
common	B-UNK
autosomal	B-UNK
recessive	I-UNK
genetic	I-UNK
disorder	I-UNK
of	O
iron	B-UNK
metabolism	B-DISEASE
.	O

 	O
the	O
hfe	B-UNK
candidate	B-UNK
gene	B-UNK
encoding	B-UNK
an	O
hla	B-UNK
class	B-UNK
i	O
-	O
like	B-UNK
protein	B-UNK
involved	B-UNK
in	O
hh	B-UNK
was	O
identified	B-UNK
in	O
1996	O
.	O

 	O
two	O
missense	B-UNK
mutations	I-UNK
have	O
been	O
described	B-UNK
c282y	B-UNK
,	O
accounting	O
for	O
80	O
%	O
to	O
90	O
%	O
of	O
hh	B-UNK
chromosomes	B-UNK
,	O
and	O
h63d	B-UNK
,	O
which	O
is	O
associated	B-UNK
with	O
a	O
milder	B-UNK
form	B-UNK
of	O
the	O
disease	B-DISEASE
representing	B-UNK
40	O
%	O
to	O
70	O
%	O
of	O
non	B-UNK
-	O
c282y	B-UNK
hh	B-UNK
chromosomes	B-UNK
.	O

 	O
we	O
report	B-UNK
here	O
on	O
the	O
analysis	B-UNK
of	O
c282y	B-UNK
,	O
h63d	B-UNK
,	O
and	O
the	O
193a	O
-	O
-	O
>	O
t	B-UNK
substitution	B-UNK
leading	B-UNK
to	O
the	O
s65c	B-UNK
missense	B-UNK
substitution	B-UNK
in	O
a	O
large	B-UNK
series	B-UNK
of	O
probands	B-UNK
and	O
controls	B-UNK
.	O

 	O
the	O
results	B-UNK
confirm	B-UNK
that	O
the	O
c282y	B-UNK
substitution	B-UNK
was	O
the	O
main	B-UNK
mutation	B-UNK
involved	B-UNK
in	O
hemochromatosis	B-DISEASE
,	O
accounting	O
for	O
85	O
%	O
of	O
carrier	B-UNK
chromosomes	B-UNK
,	O
whereas	O
the	O
h63d	B-UNK
substitution	B-UNK
represented	B-UNK
39	O
%	O
of	O
the	O
hh	B-UNK
chromosomes	B-UNK
that	O
did	O
not	O
carry	B-UNK
the	O
c282y	B-UNK
mutation	B-UNK
.	O

 	O
in	O
addition	B-UNK
,	O
our	O
screening	B-UNK
showed	B-UNK
that	O
the	O
s65c	B-UNK
substitution	B-UNK
was	O
significantly	B-UNK
enriched	O
in	O
probands	B-UNK
with	O
at	B-DISEASE
least	O
one	O
chromosome	B-UNK
without	O
an	O
assigned	B-UNK
mutation	B-UNK
.	O

 	O
this	O
substitution	B-UNK
accounted	B-UNK
for	O
7	O
.	O

 	O
8	O
%	O
of	O
hh	B-UNK
chromosomes	B-UNK
that	O
were	O
neither	O
c282y	B-UNK
nor	O
h63d	B-UNK
.	O

 	O
this	O
enrichment	O
of	O
s65c	B-UNK
among	O
hh	B-UNK
chromosomes	B-UNK
suggests	B-UNK
that	O
the	O
s65c	B-UNK
substitution	B-UNK
is	O
associated	B-UNK
with	O
the	O
mild	B-UNK
form	B-UNK
of	O
hemochromatosis	B-DISEASE
.	O

 	B-UNK
germline	I-UNK
brca1	B-UNK
alterations	B-UNK
in	O
a	O
population	B-UNK
-	O
based	B-UNK
series	B-UNK
of	O
ovarian	B-DISEASE
cancer	I-DISEASE
cases	B-UNK
.	O

 	O
the	O
objective	B-UNK
of	O
this	O
study	B-UNK
was	O
to	O
provide	B-UNK
more	O
accurate	B-UNK
frequency	B-UNK
estimates	B-UNK
of	O
breast	B-DISEASE
cancer	I-DISEASE
susceptibility	B-UNK
gene	B-UNK
1	O
(	O
brca1	B-UNK
)	O
germline	B-UNK
alterations	B-UNK
in	O
the	O
ovarian	B-DISEASE
cancer	I-DISEASE
population	B-UNK
.	O

 	O
to	O
achieve	O
this	O
,	O
we	O
determined	B-UNK
the	O
prevalence	B-UNK
of	O
brca1	B-UNK
alterations	B-UNK
in	O
a	O
population	B-UNK
-	O
based	B-UNK
series	B-UNK
of	O
consecutive	B-UNK
ovarian	B-DISEASE
cancer	I-DISEASE
cases	B-UNK
.	O

 	O
this	O
is	O
the	O
first	O
population	B-UNK
-	O
based	B-UNK
ovarian	B-DISEASE
cancer	I-DISEASE
study	B-UNK
reporting	O
brca1	B-UNK
alterations	B-UNK
derived	B-UNK
from	O
a	O
comprehensive	B-UNK
screen	B-UNK
of	O
the	O
entire	B-UNK
coding	I-UNK
region	B-UNK
.	O

 	O
one	O
hundred	O
and	O
seven	B-UNK
ovarian	B-DISEASE
cancer	I-DISEASE
cases	B-UNK
were	O
analyzed	B-UNK
for	O
brca1	B-UNK
alterations	B-UNK
using	O
the	O
rnase	O
mismatch	O
cleavage	B-UNK
assay	B-UNK
followed	B-UNK
by	O
direct	B-UNK
sequencing	I-UNK
.	O

 	O
two	O
truncating	B-UNK
mutations	B-UNK
,	O
962del4	O
and	O
3600del11	O
,	O
were	O
identified	B-UNK
.	O

 	O
both	O
patients	B-UNK
had	O
a	O
family	B-UNK
history	B-UNK
of	O
breast	B-UNK
or	O
ovarian	B-DISEASE
cancer	I-DISEASE
.	O

 	O
several	O
novel	B-UNK
as	O
well	O
as	O
previously	B-UNK
reported	I-UNK
uncharacterized	B-UNK
variants	B-UNK
were	O
also	O
identified	B-UNK
,	O
some	O
of	O
which	O
were	O
associated	B-UNK
with	O
a	O
family	B-UNK
history	B-UNK
of	O
cancer	B-DISEASE
.	O

 	O
the	O
frequency	B-UNK
distribution	B-UNK
of	O
common	B-UNK
polymorphisms	B-UNK
was	O
determined	B-UNK
in	O
the	O
91	O
caucasian	B-UNK
cancer	B-DISEASE
cases	B-UNK
in	O
this	O
series	B-UNK
and	O
24	O
sister	O
controls	B-UNK
using	O
allele	B-UNK
-	O
specific	B-UNK
amplification	B-UNK
.	O

 	O
the	O
rare	B-UNK
form	B-UNK
of	O
the	O
q356r	O
polymorphism	O
was	O
significantly	B-UNK
(	O
p	B-UNK
=	O
0	O
.	O
03	O
)	O
associated	B-UNK
with	O
a	O
family	B-UNK
history	B-UNK
of	O
ovarian	B-DISEASE
cancer	I-DISEASE
,	O
suggesting	B-UNK
that	O
this	O
polymorphism	O
may	O
influence	O
ovarian	B-DISEASE
cancer	I-DISEASE
risk	B-UNK
.	O

 	O
in	O
summary	O
,	O
our	O
data	B-UNK
suggest	B-UNK
a	O
role	B-UNK
for	O
some	O
uncharacterized	B-UNK
variants	B-UNK
and	O
rare	B-UNK
forms	B-UNK
of	O
polymorphisms	B-UNK
in	O
determining	O
ovarian	B-DISEASE
cancer	I-DISEASE
risk	B-UNK
,	O
and	O
highlight	O
the	O
necessity	O
to	O
screen	B-UNK
for	O
missense	B-UNK
alterations	B-UNK
as	O
well	O
as	O
truncating	B-UNK
mutations	B-UNK
in	O
this	O
population	B-UNK
.	O

 	O
adrenoleukodystrophy	B-DISEASE
-	O
related	B-UNK
protein	B-UNK
can	O
compensate	O
functionally	B-UNK
for	O
adrenoleukodystrophy	B-DISEASE
protein	B-DISEASE
deficiency	I-DISEASE
(	O
x	B-UNK
-	O
ald	B-UNK
)	O
:	O
implications	B-UNK
for	O
therapy	B-UNK
.	O

 	B-UNK
inherited	I-UNK
defects	B-UNK
in	O
the	O
peroxisomal	B-UNK
atp	B-UNK
-	O
binding	B-UNK
cassette	O
(	O
abc	O
)	O
transporter	B-UNK
adrenoleukodystrophy	B-DISEASE
protein	B-UNK
(	O
aldp	O
)	O
lead	B-UNK
to	O
the	O
lethal	B-UNK
peroxisomal	B-UNK
disorder	O
x	B-UNK
-	O
linked	B-UNK
adrenoleukodystrophy	B-DISEASE
(	O
x	B-UNK
-	O
ald	B-UNK
)	O
,	O
for	O
which	O
no	O
efficient	O
treatment	B-UNK
has	O
been	O
established	B-UNK
so	O
far	B-UNK
.	O

 	O
three	O
other	O
peroxisomal	B-UNK
abc	O
transporters	B-UNK
currently	B-UNK
are	O
known	B-UNK
adrenoleukodystrophy	B-DISEASE
-	O
related	B-UNK
protein	B-UNK
(	O
aldrp	O
)	O
,	O
70	O
kda	B-UNK
peroxisomal	B-UNK
membrane	I-UNK
protein	B-UNK
(	O
pmp70	B-UNK
)	O
and	O
pmp70	B-UNK
-	O
related	B-UNK
protein	B-UNK
.	O

 	O
by	O
using	O
transient	O
and	O
stable	B-UNK
overexpression	B-UNK
of	O
human	B-UNK
cdnas	B-UNK
encoding	B-UNK
aldp	O
and	O
its	O
closest	O
relative	B-UNK
aldrp	O
,	O
we	O
could	O
restore	O
the	O
impaired	B-UNK
peroxisomal	B-UNK
beta	B-UNK
-	O
oxidation	B-UNK
in	O
fibroblasts	B-UNK
of	O
x	B-UNK
-	O
ald	B-UNK
patients	I-UNK
.	O

 	O
the	O
pathognomonic	O
accumulation	B-UNK
of	O
very	O
long	B-UNK
chain	I-UNK
fatty	I-UNK
acids	O
could	O
also	O
be	O
prevented	O
by	O
overexpression	B-UNK
of	O
aldrp	O
in	O
immortalized	O
x	B-UNK
-	O
ald	B-UNK
cells	B-UNK
.	O

 	O
immunofluorescence	O
analysis	B-UNK
demonstrated	B-UNK
that	O
the	O
functional	B-UNK
replacement	O
of	O
aldp	O
by	O
aldrp	O
was	O
not	O
due	O
to	O
stabilization	O
of	O
the	O
mutated	B-UNK
aldp	O
itself	O
.	O

 	O
moreover	O
,	O
we	O
were	O
able	O
to	O
restore	O
the	O
peroxisomal	B-UNK
beta	B-UNK
-	O
oxidation	B-UNK
defect	B-UNK
in	O
the	O
liver	B-DISEASE
of	O
aldp	O
-	O
deficient	B-UNK
mice	B-UNK
by	O
stimulation	B-UNK
of	O
aldrp	O
and	O
pmp70	B-UNK
gene	B-UNK
expression	B-UNK
through	O
a	O
dietary	B-UNK
treatment	B-UNK
with	O
the	O
peroxisome	B-UNK
proliferator	O
fenofibrate	O
.	O

 	O
these	O
results	B-UNK
suggest	B-UNK
that	O
a	O
correction	O
of	O
the	O
biochemical	B-UNK
defect	B-UNK
in	O
x	B-UNK
-	O
ald	B-UNK
could	O
be	O
possible	B-UNK
by	O
drug	O
-	O
induced	B-UNK
overexpression	B-UNK
or	O
ectopic	B-UNK
expression	B-UNK
of	O
aldrp	O
.	O
.	O

 	O
centrosome	O
amplification	B-UNK
and	O
a	O
defective	B-UNK
g2	O
-	O
m	B-UNK
cell	B-UNK
cycle	B-UNK
checkpoint	B-UNK
induce	O
genetic	B-UNK
instability	B-UNK
in	O
brca1	B-UNK
exon	B-UNK
11	O
isoform	B-UNK
-	O
deficient	B-UNK
cells	B-UNK
.	O

 	B-UNK
germline	I-UNK
mutations	B-UNK
of	O
the	O
brca1	B-UNK
tumor	B-DISEASE
suppressor	B-UNK
gene	B-UNK
predispose	B-UNK
women	B-UNK
to	O
breast	B-UNK
and	O
ovarian	B-UNK
cancers	B-DISEASE
.	O

 	O
to	O
study	B-UNK
mechanisms	B-UNK
underlying	I-UNK
brca1	B-UNK
-	O
related	B-UNK
tumorigenesis	B-UNK
,	O
we	O
derived	B-UNK
mouse	B-UNK
embryonic	O
fibroblast	B-UNK
cells	B-UNK
carrying	B-UNK
a	O
targeted	B-UNK
deletion	B-UNK
of	O
exon	B-UNK
11	O
of	O
the	O
brca1	B-UNK
gene	B-UNK
.	O

 	O
we	O
show	O
that	O
the	O
mutant	B-UNK
cells	B-UNK
maintain	O
an	O
intact	B-UNK
g1	O
-	O
s	O
cell	B-UNK
cycle	B-UNK
checkpoint	B-UNK
and	O
proliferate	O
poorly	B-UNK
.	O

 	O
however	O
,	O
a	O
defective	B-UNK
g2	O
-	O
m	B-UNK
checkpoint	B-UNK
in	O
these	O
cells	B-UNK
is	O
accompanied	O
by	O
extensive	B-UNK
chromosomal	B-UNK
abnormalities	B-DISEASE
.	O

 	B-UNK
mutant	I-UNK
fibroblasts	B-UNK
contain	B-UNK
multiple	B-UNK
,	O
functional	B-UNK
centrosomes	O
,	O
which	O
lead	B-UNK
to	O
unequal	B-UNK
chromosome	B-UNK
segregation	B-UNK
,	O
abnormal	B-UNK
nuclear	B-UNK
division	O
,	O
and	O
aneuploidy	B-DISEASE
.	O

 	O
these	O
data	B-UNK
uncover	O
an	O
essential	B-UNK
role	B-UNK
of	O
brca1	B-UNK
in	O
maintaining	O
genetic	B-UNK
stability	B-UNK
through	O
the	O
regulation	B-UNK
of	O
centrosome	O
duplication	B-UNK
and	O
the	O
g2	O
-	O
m	B-UNK
checkpoint	B-UNK
and	O
provide	B-UNK
a	O
molecular	B-UNK
basis	I-UNK
for	O
the	O
role	B-UNK
of	O
brca1	B-UNK
in	O
tumorigenesis	B-UNK
.	O
.	O

 	B-UNK
defective	I-UNK
cd95	B-UNK
/	O
apo	O
-	O
1	O
/	O
fas	B-UNK
signal	B-UNK
complex	B-UNK
formation	B-UNK
in	O
the	O
human	B-UNK
autoimmune	B-DISEASE
lymphoproliferative	I-DISEASE
syndrome	I-DISEASE
,	O
type	B-UNK
ia	O
.	O

 	B-UNK
heterozygous	I-UNK
mutations	B-UNK
in	O
the	O
cd95	B-UNK
(	O
apo	O
-	O
1	O
/	O
fas	B-UNK
)	O
receptor	B-UNK
occur	B-UNK
in	O
most	O
individuals	B-UNK
with	O
autoimmune	B-DISEASE
lymphoproliferative	I-DISEASE
syndrome	I-DISEASE
(	O
alps	B-UNK
)	O
and	O
dominantly	B-UNK
interfere	O
with	O
apoptosis	B-UNK
by	O
an	O
unknown	B-UNK
mechanism	B-UNK
.	O

 	O
we	O
show	O
that	O
local	O
or	O
global	O
alterations	B-UNK
in	O
the	O
structure	B-UNK
of	O
the	O
cytoplasmic	B-UNK
death	B-DISEASE
domain	B-UNK
from	O
nine	O
independent	B-UNK
alps	B-UNK
cd95	B-UNK
death	B-DISEASE
-	O
domain	B-UNK
mutations	B-UNK
result	B-UNK
in	O
a	O
failure	O
to	O
bind	B-UNK
the	O
fadd	O
/	O
mort1	O
signaling	B-UNK
protein	B-UNK
.	O

 	O
despite	B-UNK
heterozygosity	B-UNK
for	O
the	O
abnormal	B-UNK
allele	B-UNK
,	O
lymphocytes	B-UNK
from	O
alps	B-UNK
patients	B-UNK
showed	I-UNK
markedly	B-UNK
decreased	B-UNK
fadd	O
association	B-UNK
and	O
a	O
loss	B-UNK
of	O
caspase	O
recruitment	O
and	O
activation	B-UNK
after	O
cd95	B-UNK
crosslinking	O
.	O

 	O
these	O
data	B-UNK
suggest	B-UNK
that	O
intracytoplasmic	O
cd95	B-UNK
mutations	B-UNK
in	O
alps	B-UNK
impair	O
apoptosis	B-UNK
chiefly	O
by	O
disrupting	O
death	B-DISEASE
-	O
domain	B-UNK
interactions	B-UNK
with	O
the	O
signaling	B-UNK
protein	B-UNK
fadd	O
/	O
mort1	O
.	O
.	O

 	O
analysis	B-UNK
of	O
alkaptonuria	B-DISEASE
(	O
aku	B-UNK
)	O
mutations	B-UNK
and	O
polymorphisms	B-UNK
reveals	B-UNK
that	O
the	O
ccc	O
sequence	B-UNK
motif	B-UNK
is	O
a	O
mutational	B-UNK
hot	I-UNK
spot	B-UNK
in	O
the	O
homogentisate	O
1	O
,	O
2	O
dioxygenase	B-UNK
gene	B-UNK
(	O
hgo	B-UNK
)	O
.	O

 	O
we	O
recently	B-UNK
showed	B-UNK
that	O
alkaptonuria	B-DISEASE
(	O
aku	B-UNK
)	O
is	O
caused	B-UNK
by	O
loss	B-UNK
-	O
of	O
-	O
function	B-UNK
mutations	B-UNK
in	O
the	O
homogentisate	O
1	O
,	O
2	O
dioxygenase	B-UNK
gene	B-UNK
(	O
hgo	B-UNK
)	O
.	O

 	O
herein	O
we	O
describe	B-UNK
haplotype	B-UNK
and	O
mutational	B-UNK
analyses	B-UNK
of	O
hgo	B-UNK
in	O
seven	B-UNK
new	I-UNK
aku	B-UNK
pedigrees	B-UNK
.	O

 	O
these	O
analyses	B-UNK
identified	B-UNK
two	O
novel	B-UNK
single	B-UNK
-	O
nucleotide	B-UNK
polymorphisms	B-UNK
(	O
inv4	O
+	O
31a	O
-	O
-	O
>	O
g	B-UNK
and	O
inv11	O
+	O
18a	O
-	O
-	O
>	O
g	B-UNK
)	O
and	O
six	O
novel	B-UNK
aku	B-UNK
mutations	B-UNK
(	O
inv1	O
-	O
1	O
g	B-UNK
-	O
-	O
>	O
a	O
,	O
w60	O
g	B-UNK
,	O
y62c	O
,	O
a122d	O
,	O
p230	O
t	B-UNK
,	O
and	O
d291e	O
)	O
,	O
which	O
further	O
illustrates	B-UNK
the	O
remarkable	O
allelic	B-UNK
heterogeneity	I-UNK
found	B-UNK
in	O
aku	B-UNK
.	O

 	O
reexamination	O
of	O
all	O
29	O
mutations	B-UNK
and	O
polymorphisms	B-UNK
thus	O
far	B-UNK
described	B-UNK
in	O
hgo	B-UNK
shows	B-UNK
that	O
these	O
nucleotide	B-UNK
changes	B-UNK
are	O
not	O
randomly	B-UNK
distributed	B-UNK
;	O
the	O
ccc	O
sequence	B-UNK
motif	B-UNK
and	O
its	O
inverted	B-UNK
complement	B-UNK
,	O
ggg	O
,	O
are	O
preferentially	B-UNK
mutated	B-UNK
.	O

 	O
these	O
analyses	B-UNK
also	O
demonstrated	B-UNK
that	O
the	O
nucleotide	B-UNK
substitutions	B-UNK
in	O
hgo	B-UNK
do	O
not	O
involve	B-UNK
cpg	B-UNK
dinucleotides	O
,	O
which	O
illustrates	B-UNK
important	B-UNK
differences	B-UNK
between	O
hgo	B-UNK
and	O
other	O
genes	B-UNK
for	O
the	O
occurrence	B-UNK
of	O
mutation	B-UNK
at	B-DISEASE
specific	B-UNK
short	B-UNK
-	O
sequence	B-UNK
motifs	B-UNK
.	O

 	O
because	O
the	O
ccc	O
sequence	B-UNK
motifs	B-UNK
comprise	O
a	O
significant	B-UNK
proportion	B-UNK
(	O
34	O
.	O
5	O
%	O
)	O
of	O
all	O
mutated	B-UNK
bases	B-UNK
that	O
have	O
been	O
observed	B-UNK
in	O
hgo	B-UNK
,	O
we	O
conclude	O
that	O
the	O
ccc	O
triplet	B-UNK
is	O
a	O
mutational	B-UNK
hot	I-UNK
spot	B-UNK
in	O
hgo	B-UNK
.	O

 	O
fabry	B-DISEASE
disease	I-DISEASE
:	O
identification	B-UNK
of	O
novel	B-UNK
alpha	B-UNK
-	O
galactosidase	B-UNK
a	O
mutations	B-UNK
and	O
molecular	B-UNK
carrier	B-UNK
detection	I-UNK
by	O
use	B-UNK
of	O
fluorescent	B-UNK
chemical	B-UNK
cleavage	B-UNK
of	O
mismatches	O
.	O

 	O
fabry	B-DISEASE
disease	I-DISEASE
(	O
fd	O
)	O
(	O
angiokeratoma	B-DISEASE
corporis	O
diffusum	O
)	O
is	O
an	O
x	B-UNK
-	O
linked	B-UNK
inborn	B-UNK
error	B-UNK
of	O
glycosphingolipid	O
metabolism	B-DISEASE
caused	B-UNK
by	O
defects	B-UNK
in	O
the	O
lysosomal	B-UNK
alpha	B-UNK
-	O
galactosidase	B-UNK
a	O
gene	B-UNK
(	O
gla	O
)	O
.	O

 	O
the	O
enzymatic	B-UNK
defect	B-UNK
leads	B-UNK
to	O
the	O
systemic	O
accumulation	B-UNK
of	O
neutral	O
glycosphingolipids	O
with	O
terminal	B-UNK
alpha	B-UNK
-	O
galactosyl	O
moieties	O
.	O

 	O
clinically	B-UNK
,	O
affected	B-UNK
hemizygous	B-UNK
males	B-UNK
have	O
angiokeratoma	B-DISEASE
,	O
severe	B-UNK
acroparesthesia	O
,	O
renal	B-DISEASE
failure	I-DISEASE
,	O
and	O
vasculopathy	B-DISEASE
of	O
the	O
heart	B-UNK
and	O
brain	B-UNK
.	O

 	O
while	O
demonstration	O
of	O
alpha	B-UNK
-	O
galactosidase	B-UNK
deficiency	B-UNK
in	O
leukocytes	B-UNK
is	O
diagnostic	B-UNK
in	O
affected	B-UNK
males	B-UNK
,	O
enzymatic	B-UNK
detection	B-UNK
of	O
female	B-UNK
carriers	B-UNK
is	O
often	O
inconclusive	O
,	O
due	O
to	O
random	B-UNK
x	B-UNK
-	O
chromosomal	B-UNK
inactivation	B-UNK
,	O
underlining	O
the	O
need	O
of	O
molecular	B-UNK
investigations	O
for	O
accurate	B-UNK
genetic	B-UNK
counseling	B-UNK
.	O

 	O
by	O
use	B-UNK
of	O
chemical	B-UNK
cleavage	B-UNK
of	O
mismatches	O
adapted	O
to	O
fluorescence	B-UNK
-	O
based	B-UNK
detection	B-UNK
systems	B-UNK
,	O
we	O
have	O
characterized	B-UNK
the	O
mutations	B-UNK
underlying	B-UNK
alpha	B-UNK
-	O
gal	O
a	O
deficiency	B-UNK
in	O
16	O
individuals	B-UNK
from	O
six	O
unrelated	B-UNK
families	I-UNK
with	O
fd	O
.	O

 	O
the	O
mutational	B-UNK
spectrum	B-UNK
included	B-UNK
five	O
missense	B-UNK
mutations	I-UNK
(	O
c202w	O
,	O
c223	O
g	B-UNK
,	O
n224d	O
,	O
r301q	O
,	O
and	O
q327k	O
)	O
and	O
one	O
splice	O
-	O
site	B-UNK
mutation	B-UNK
[	O
ivs3	O
g	B-UNK
(	O
-	O
1	O
)	O
-	O
-	O
>	O
c	B-UNK
]	O
.	O

 	O
studies	B-UNK
at	B-DISEASE
the	O
mrna	B-UNK
level	B-UNK
showed	B-UNK
that	O
the	O
latter	O
led	B-UNK
to	O
altered	B-UNK
pre	O
-	O
mrna	B-UNK
splicing	B-UNK
with	O
consequent	O
alteration	B-UNK
of	O
the	O
mrna	B-UNK
translational	B-UNK
reading	I-UNK
frame	B-UNK
and	O
generation	B-UNK
of	O
a	O
premature	B-UNK
termination	I-UNK
codon	B-UNK
of	O
translation	B-UNK
.	O

 	O
by	O
use	B-UNK
of	O
this	O
strategy	O
,	O
carrier	B-UNK
status	B-UNK
was	O
accurately	O
assessed	B-UNK
in	O
all	O
seven	B-UNK
at	B-DISEASE
-	O
risk	B-UNK
females	B-UNK
tested	B-UNK
,	O
whereas	O
enzymatic	B-UNK
dosages	O
failed	B-UNK
to	O
diagnose	O
or	O
exclude	O
heterozygosity	B-UNK
.	O
.	O

 	O
prenatal	B-UNK
diagnosis	I-UNK
by	O
fish	B-UNK
in	O
a	O
family	B-UNK
with	O
pelizaeus	B-DISEASE
-	I-DISEASE
merzbacher	I-DISEASE
disease	I-DISEASE
caused	B-UNK
by	O
duplication	B-UNK
of	O
plp	B-UNK
gene	B-UNK
.	O

 	O
a	O
diagnosis	B-UNK
of	O
pelizaeus	B-DISEASE
-	I-DISEASE
merzbacher	I-DISEASE
disease	I-DISEASE
(	O
mim	O
312080	O
)	O
was	O
made	O
in	O
a	O
young	B-UNK
boy	B-UNK
.	O

 	O
no	O
mutation	B-UNK
in	O
the	O
coding	B-UNK
region	I-UNK
of	O
the	O
proteolipid	B-UNK
protein	B-UNK
(	O
plp	B-UNK
)	O
gene	B-UNK
had	O
been	O
found	B-UNK
.	O

 	O
the	O
boys	B-UNK
maternal	B-UNK
aunt	B-UNK
came	O
for	O
prenatal	B-UNK
diagnosis	I-UNK
when	O
16	O
+	O
weeks	O
pregnant	O
and	O
carrying	B-UNK
a	O
male	B-UNK
fetus	B-UNK
.	O

 	O
samples	B-UNK
were	O
tested	B-UNK
for	O
duplication	B-UNK
of	O
the	O
plp	B-UNK
gene	B-UNK
,	O
by	O
interphase	O
fish	B-UNK
,	O
in	O
lymphocyte	B-UNK
preparations	O
from	O
the	O
proband	B-UNK
,	O
his	O
aunt	B-UNK
and	O
an	O
amniotic	B-UNK
fluid	B-UNK
cell	B-UNK
preparation	O
from	O
the	O
fetus	B-UNK
.	O

 	O
the	O
proband	B-UNK
was	O
found	B-UNK
to	O
carry	B-UNK
the	O
duplication	B-UNK
,	O
thus	O
confirming	O
the	O
diagnosis	B-UNK
of	O
pelizaeus	O
merzbacher	O
disease	B-DISEASE
,	O
but	O
neither	O
the	O
aunt	B-UNK
nor	O
the	O
fetus	B-UNK
carried	B-UNK
a	O
duplication	B-UNK
.	O
.	O

 	O
dominant	B-UNK
negative	I-UNK
effect	B-UNK
of	O
the	O
apc1309	O
mutation	B-UNK
:	O
a	O
possible	B-UNK
explanation	B-UNK
for	O
genotype	B-UNK
-	O
phenotype	B-UNK
correlations	B-UNK
in	O
familial	B-DISEASE
adenomatous	I-DISEASE
polyposis	I-DISEASE
.	O

 	O
inactivation	B-UNK
of	O
the	O
adenomatous	B-DISEASE
polyposis	I-DISEASE
coli	I-DISEASE
(	O
apc	B-UNK
)	O
gene	B-UNK
product	B-UNK
initiates	O
colorectal	B-UNK
tumorigenesis	B-UNK
.	O

 	B-UNK
patients	I-UNK
with	O
familial	B-UNK
apc	B-UNK
(	O
fap	B-DISEASE
)	O
carry	B-UNK
germ	O
-	O
line	B-UNK
mutations	B-UNK
in	O
the	O
apc	B-UNK
gene	B-UNK
and	O
develop	B-UNK
multiple	B-UNK
colorectal	B-UNK
adenomas	B-UNK
and	O
subsequent	B-UNK
carcinomas	B-UNK
early	B-UNK
in	O
life	B-UNK
.	O

 	O
the	O
severity	B-UNK
of	O
the	O
disease	B-DISEASE
correlates	B-UNK
with	O
the	O
position	B-UNK
of	O
the	O
inherited	B-UNK
apc	B-UNK
mutation	B-UNK
(	O
genotype	B-UNK
-	O
phenotype	B-UNK
correlation	B-UNK
)	O
.	O

 	O
together	O
with	O
the	O
fact	O
that	O
both	O
germ	O
-	O
line	B-UNK
and	O
sporadic	B-UNK
apc	B-UNK
mutations	B-UNK
cluster	O
in	O
the	O
central	B-UNK
region	B-UNK
of	O
the	O
apc	B-UNK
gene	B-UNK
,	O
this	O
points	O
to	O
a	O
dominant	B-UNK
negative	I-UNK
effect	B-UNK
of	O
certain	B-UNK
apc	B-UNK
mutants	B-UNK
.	O

 	O
loss	B-UNK
of	O
apc	B-UNK
function	B-UNK
was	O
recently	B-UNK
shown	B-UNK
to	O
result	B-UNK
in	O
enhanced	B-UNK
beta	B-UNK
-	O
catenin	B-UNK
-	O
/	O
tcf	B-UNK
-	O
mediated	B-UNK
transcription	B-UNK
in	O
colon	O
epithelial	B-UNK
cells	I-UNK
.	O

 	O
here	O
,	O
we	O
provide	B-UNK
experimental	B-UNK
evidence	B-UNK
for	O
a	O
dominant	B-UNK
negative	I-UNK
effect	B-UNK
of	O
apc	B-UNK
gene	B-UNK
products	B-UNK
associated	B-UNK
with	O
severe	B-UNK
polyposis	B-DISEASE
.	O

 	O
wild	B-UNK
-	O
type	B-UNK
apc	B-UNK
activity	B-UNK
in	O
beta	B-UNK
-	O
catenin	B-UNK
-	O
/	O
tcf	B-UNK
-	O
mediated	B-UNK
transcription	B-UNK
was	O
strongly	B-UNK
inhibited	B-UNK
by	O
a	O
mutant	B-UNK
apc	B-UNK
that	O
is	O
truncated	B-UNK
at	B-DISEASE
codon	B-UNK
1309	O
.	O

 	O
in	O
contrast	B-UNK
,	O
mutant	B-UNK
apc	B-UNK
gene	B-UNK
products	B-UNK
that	O
are	O
associated	B-UNK
with	O
attenuated	O
polyposis	B-DISEASE
(	O
codon	B-UNK
386	O
or	O
1465	O
)	O
interfered	O
only	O
weakly	O
with	O
wild	B-UNK
-	O
type	B-UNK
apc	B-UNK
activity	B-UNK
.	O

 	O
these	O
results	B-UNK
suggest	B-UNK
a	O
molecular	B-UNK
explanation	B-UNK
for	O
the	O
genotype	B-UNK
-	O
phenotype	B-UNK
correlation	B-UNK
in	O
fap	B-DISEASE
patients	B-UNK
and	O
support	B-UNK
the	O
idea	O
that	O
colorectal	B-UNK
tumor	B-DISEASE
growth	B-UNK
might	O
be	O
,	O
in	O
part	O
,	O
driven	O
by	O
selection	B-UNK
for	O
a	O
mutation	B-UNK
in	O
the	O
mutation	B-UNK
cluster	B-UNK
region	I-UNK
.	O
.	O

 	B-UNK
brca1	I-UNK
interacts	B-UNK
with	O
components	B-UNK
of	O
the	O
histone	B-UNK
deacetylase	O
complex	B-UNK
.	O

 	O
germ	O
-	O
line	B-UNK
mutations	B-UNK
in	O
the	O
brca1	B-UNK
tumor	B-DISEASE
-	O
suppressor	B-UNK
gene	B-UNK
are	O
associated	B-UNK
with	O
an	O
increased	B-UNK
susceptibility	B-UNK
to	O
breast	B-UNK
and	O
ovarian	B-DISEASE
cancer	I-DISEASE
.	O

 	B-UNK
brca1	I-UNK
contains	B-UNK
a	O
carboxyl	B-UNK
-	O
terminal	B-UNK
domain	B-UNK
(	O
brct	B-UNK
)	O
that	O
is	O
shared	B-UNK
with	O
several	O
other	O
proteins	B-UNK
involved	B-UNK
in	O
maintaining	O
genome	B-UNK
integrity	O
.	O

 	O
in	O
an	O
effort	O
to	O
understand	O
the	O
function	B-UNK
of	O
brca1	B-UNK
,	O
we	O
sought	O
to	O
isolate	B-UNK
proteins	B-UNK
that	O
interact	B-UNK
with	O
the	O
brct	B-UNK
domain	B-UNK
.	O

 	O
purified	B-UNK
brct	B-UNK
polypeptide	B-UNK
was	O
used	O
as	O
a	O
probe	B-UNK
to	O
screen	B-UNK
a	O
human	B-UNK
placenta	B-DISEASE
cdna	B-UNK
expression	B-UNK
library	B-UNK
by	O
far	B-UNK
western	B-UNK
analysis	B-UNK
.	O

 	O
here	O
we	O
report	B-UNK
that	O
brca1	B-UNK
interacts	B-UNK
in	O
vivo	B-UNK
and	O
in	O
vitro	B-UNK
with	O
the	O
rb	O
-	O
binding	B-UNK
proteins	B-UNK
,	O
rbap46	O
and	O
rbap48	O
,	O
as	O
well	O
as	O
with	O
rb	O
.	O

 	O
moreover	O
,	O
the	O
brct	B-UNK
domain	B-UNK
associates	O
with	O
the	O
histone	B-UNK
deacetylases	O
hdac1	O
and	O
hdac2	O
.	O

 	O
these	O
results	B-UNK
demonstrate	B-UNK
that	O
brca1	B-UNK
interacts	B-UNK
with	O
components	B-UNK
of	O
the	O
histone	B-UNK
deacetylase	O
complex	B-UNK
,	O
and	O
therefore	O
may	O
explain	O
the	O
involvement	B-UNK
of	O
brca1	B-UNK
in	O
multiple	B-UNK
processes	B-UNK
such	O
as	O
transcription	B-UNK
,	O
dna	B-UNK
repair	B-UNK
,	O
and	O
recombination	B-UNK
.	O
.	O

 	B-UNK
combined	I-UNK
genetic	B-UNK
deficiency	B-UNK
of	O
c6	B-UNK
and	O
c7	B-UNK
in	O
man	B-UNK
.	O

 	O
by	O
routine	B-UNK
screening	B-UNK
of	O
sera	O
,	O
a	O
subject	B-UNK
was	O
discovered	O
who	O
showed	B-UNK
a	O
sub	O
-	O
total	B-UNK
deficiency	B-UNK
of	O
c6	B-UNK
and	O
c7	B-UNK
.	O

 	O
no	O
clinical	B-UNK
disease	B-DISEASE
was	O
associated	B-UNK
with	O
this	O
deficiency	B-UNK
which	O
was	O
transmitted	B-UNK
through	O
the	O
subjects	B-UNK
family	B-UNK
as	O
a	O
single	B-UNK
genetic	B-UNK
characteristic	B-UNK
,	O
the	O
c6	B-DISEASE
deficiency	I-DISEASE
being	O
associated	B-UNK
with	O
a	O
silent	B-UNK
allele	B-UNK
at	B-DISEASE
the	O
structural	B-UNK
locus	B-UNK
.	O

 	O
the	O
propositus	O
was	O
found	B-UNK
to	O
have	O
low	B-UNK
quantities	B-UNK
of	O
an	O
abnormal	B-UNK
c6	B-UNK
which	O
was	O
both	O
antigenically	O
deficient	B-UNK
and	O
smaller	B-UNK
in	O
size	B-UNK
than	O
normal	B-UNK
c6	B-UNK
(	O
110	O
,	O
000	O
daltons	O
compared	B-UNK
with	O
140	O
,	O
000	O
daltons	O
)	O
and	O
small	B-UNK
quantities	B-UNK
of	O
apparently	B-UNK
normal	I-UNK
c7	B-UNK
.	O

 	O
it	O
is	O
concluded	O
that	O
the	O
most	O
likely	B-UNK
explanation	B-UNK
for	O
this	O
defect	B-UNK
is	O
that	O
the	O
subject	B-UNK
has	O
a	O
structural	B-UNK
mutation	B-UNK
in	O
his	O
c6	B-UNK
gene	B-UNK
which	O
produces	B-UNK
hyopsynthesis	O
not	O
only	O
of	O
c6	B-UNK
but	O
also	O
of	O
the	O
closely	B-UNK
linked	I-UNK
gene	B-UNK
for	O
c7	B-UNK
.	O

 	O
these	O
findings	B-UNK
suggest	B-UNK
the	O
possibility	O
that	O
c6	B-UNK
and	O
c7	B-UNK
may	O
function	B-UNK
as	O
a	O
single	B-UNK
genetic	B-UNK
unit	O
and	O
that	O
the	O
primary	B-UNK
transcript	B-UNK
copied	O
from	O
the	O
genome	B-UNK
includes	B-UNK
information	B-UNK
for	O
both	O
proteins	B-UNK
.	O
.	O

 	O
changes	B-UNK
at	B-DISEASE
p183	O
of	O
emerin	B-UNK
weaken	O
its	O
protein	B-UNK
-	O
protein	B-UNK
interactions	B-UNK
resulting	B-UNK
in	O
x	B-DISEASE
-	I-DISEASE
linked	I-DISEASE
emery	I-DISEASE
-	I-DISEASE
dreifuss	I-DISEASE
muscular	I-DISEASE
dystrophy	I-DISEASE
.	O

 	O
emery	B-DISEASE
-	I-DISEASE
dreifuss	I-DISEASE
muscular	I-DISEASE
dystrophy	I-DISEASE
(	O
edmd	B-UNK
)	O
is	O
an	O
x	B-UNK
-	O
linked	B-UNK
recessive	O
muscular	B-DISEASE
dystrophy	I-DISEASE
characterized	B-UNK
by	O
early	B-UNK
contractures	B-DISEASE
of	O
the	O
elbows	O
,	O
achilles	B-UNK
tendons	B-UNK
and	O
spine	O
,	O
slowly	B-UNK
progressive	B-UNK
muscle	B-UNK
wasting	I-UNK
and	O
weakness	B-DISEASE
,	O
and	O
cardiomyopathy	B-DISEASE
associated	B-UNK
with	O
cardiac	B-UNK
conduction	I-UNK
defects	B-UNK
.	O

 	O
the	O
emerin	B-UNK
gene	B-UNK
has	O
been	O
mapped	B-UNK
to	O
xq28	B-UNK
and	O
encodes	B-UNK
a	O
34	O
-	O
kda	B-UNK
serine	B-UNK
-	O
rich	B-UNK
protein	B-UNK
,	O
emerin	B-UNK
,	O
which	O
has	O
been	O
localized	B-UNK
to	O
the	O
nuclear	B-UNK
envelope	O
in	O
a	O
wide	B-UNK
variety	B-UNK
of	O
tissues	B-UNK
,	O
including	B-UNK
skeletal	B-UNK
and	O
cardiac	B-UNK
muscle	B-UNK
.	O

 	O
mutations	B-UNK
spanning	B-UNK
the	O
emerin	B-UNK
gene	B-UNK
have	O
been	O
identified	B-UNK
in	O
patients	B-UNK
with	O
edmd	B-UNK
.	O

 	O
we	O
present	B-UNK
here	O
the	O
effect	B-UNK
,	O
on	O
emerin	B-UNK
protein	B-UNK
expression	B-UNK
,	O
of	O
two	O
missense	B-UNK
mutations	I-UNK
identified	B-UNK
in	O
unrelated	B-UNK
edmd	B-UNK
patients	B-UNK
.	O

 	O
these	O
alterations	B-UNK
predict	O
the	O
replacement	O
of	O
a	O
proline	O
residue	B-UNK
at	B-DISEASE
position	B-UNK
183	O
with	O
either	O
a	O
histidine	B-UNK
or	O
a	O
threonine	B-UNK
.	O

 	B-UNK
biochemical	I-UNK
analysis	B-UNK
has	O
demonstrated	B-UNK
that	O
the	O
mobility	B-UNK
and	O
expression	B-UNK
levels	B-UNK
of	O
the	O
mutant	B-UNK
forms	B-UNK
of	O
emerin	B-UNK
are	O
indistinguishable	O
from	O
that	O
of	O
wild	B-UNK
-	O
type	B-UNK
emerin	B-UNK
,	O
but	O
that	O
they	O
have	O
weakened	O
interactions	B-UNK
with	O
nuclear	B-UNK
lamina	B-UNK
components	B-UNK
.	O

 	O
in	O
comparison	B-UNK
with	O
the	O
usual	O
edmd	B-UNK
phenotype	B-UNK
,	O
patients	B-UNK
with	O
p183	O
missense	B-UNK
mutations	I-UNK
have	O
a	O
later	B-UNK
age	B-UNK
at	B-DISEASE
onset	B-UNK
of	O
first	O
symptoms	B-UNK
,	O
elbow	O
contractures	B-DISEASE
,	O
ankle	O
contractures	B-DISEASE
,	O
upper	O
limb	B-UNK
weakness	B-DISEASE
and	O
lower	B-UNK
limb	B-UNK
weakness	B-DISEASE
,	O
but	O
there	O
is	O
no	O
difference	B-UNK
for	O
the	O
age	B-UNK
at	B-DISEASE
onset	B-UNK
of	O
cardiac	B-UNK
involvement	B-UNK
.	O

 	O
this	O
is	O
the	O
first	O
report	B-UNK
of	O
protein	B-UNK
studies	B-UNK
on	O
patients	B-UNK
with	O
missense	B-UNK
mutations	I-UNK
resulting	B-UNK
in	O
the	O
clinical	B-UNK
features	I-UNK
of	O
edmd	B-UNK
.	O

 	O
these	O
studies	B-UNK
demonstrate	B-UNK
the	O
importance	O
of	O
proline	O
183	O
for	O
the	O
proper	O
structure	B-UNK
/	O
function	B-UNK
of	O
emerin	B-UNK
.	O
.	O

 	O
microdeletions	O
at	B-DISEASE
chromosome	B-UNK
bands	B-UNK
1q32	B-UNK
-	O
q41	O
as	O
a	O
cause	B-UNK
of	O
van	B-DISEASE
der	I-DISEASE
woude	I-DISEASE
syndrome	I-DISEASE
.	O

 	O
van	B-DISEASE
der	I-DISEASE
woude	I-DISEASE
syndrome	I-DISEASE
(	O
vws	B-UNK
)	O
is	O
an	O
autosomal	O
dominant	B-UNK
disorder	O
comprising	B-UNK
cleft	B-DISEASE
lip	I-DISEASE
and	O
/	O
or	O
cleft	B-DISEASE
palate	I-DISEASE
and	O
lip	B-DISEASE
pits	O
.	O

 	O
we	O
reported	B-UNK
previously	B-UNK
a	O
family	B-UNK
whose	O
underlying	B-UNK
mutation	B-UNK
is	O
a	O
500	O
-	O
800	O
kb	B-UNK
deletion	B-UNK
localized	B-UNK
to	O
chromosome	B-UNK
bands	B-UNK
1q32	B-UNK
-	O
q41	O
[	O
sander	O
et	O
al	O
.	O
,	O
1994	O
hum	B-UNK
mol	O
genet	B-UNK
3	O
576	O
-	O
578	O
]	O
.	O

 	O
along	O
with	O
cleft	B-DISEASE
lip	I-DISEASE
/	O
palate	O
and	O
lip	B-DISEASE
pits	O
,	O
affected	B-UNK
relatives	B-UNK
exhibit	B-UNK
developmental	B-UNK
delays	O
,	O
suggesting	B-UNK
that	O
the	O
function	B-UNK
of	O
a	O
gene	B-UNK
nearby	B-UNK
may	O
also	O
be	O
disrupted	B-UNK
.	O

 	O
to	O
further	O
localize	B-UNK
the	O
vws	B-UNK
gene	B-UNK
we	O
searched	O
for	O
other	O
deletions	B-UNK
that	O
cause	B-UNK
vws	B-UNK
.	O

 	O
an	O
allele	B-UNK
loss	B-UNK
assay	B-UNK
was	O
performed	B-UNK
using	O
a	O
novel	B-UNK
highly	B-UNK
polymorphic	I-UNK
marker	B-UNK
,	O
d1s3753	O
.	O

 	O
from	O
a	O
panel	O
of	O
37	O
unrelated	B-UNK
individuals	B-UNK
,	O
we	O
detected	B-UNK
an	O
allele	B-UNK
loss	B-UNK
in	O
one	O
family	B-UNK
,	O
indicating	B-UNK
the	O
presence	B-UNK
of	O
a	O
deletion	B-UNK
.	O

 	O
in	O
this	O
family	B-UNK
,	O
the	O
phenotype	B-UNK
in	O
three	O
generations	B-UNK
of	O
affected	B-UNK
individuals	I-UNK
was	O
confined	O
to	O
the	O
cardinal	B-UNK
signs	B-UNK
of	O
vws	B-UNK
.	O

 	O
surprisingly	B-UNK
,	O
mapping	B-UNK
of	O
the	O
new	B-UNK
deletion	B-UNK
showed	B-UNK
that	O
it	O
extended	B-UNK
0	O
.	O

 	O
2	O
-	O
1	O
mb	B-UNK
beyond	O
the	O
proximal	B-UNK
breakpoint	B-UNK
for	O
the	O
deletion	B-UNK
described	B-UNK
previously	B-UNK
.	O

 	O
no	O
deletions	B-UNK
were	O
detected	B-UNK
in	O
seven	B-UNK
cases	B-UNK
of	O
popliteal	O
pterygia	O
syndrome	B-DISEASE
,	O
76	O
cases	B-UNK
of	O
mixed	B-UNK
syndromic	O
forms	B-UNK
of	O
cleft	B-DISEASE
lip	I-DISEASE
and	O
palate	O
,	O
and	O
178	O
cases	B-UNK
of	O
nonsyndromic	O
cleft	B-DISEASE
lip	I-DISEASE
and	O
palate	O
.	O

 	O
splicing	B-UNK
defects	B-UNK
in	O
the	O
ataxia	B-DISEASE
-	O
telangiectasia	B-DISEASE
gene	B-UNK
,	O
atm	B-UNK
:	O
underlying	B-UNK
mutations	B-UNK
and	O
consequences	O
.	O

 	O
mutations	B-UNK
resulting	B-UNK
in	O
defective	B-UNK
splicing	B-UNK
constitute	B-UNK
a	O
significant	B-UNK
proportion	B-UNK
(	O
30	O
/	O
62	O
[	O
48	O
%	O
]	O
)	O
of	O
a	O
new	B-UNK
series	B-UNK
of	O
mutations	B-UNK
in	O
the	O
atm	B-UNK
gene	B-UNK
in	O
patients	B-UNK
with	O
ataxia	B-DISEASE
-	O
telangiectasia	B-DISEASE
(	O
at	B-DISEASE
)	O
that	O
were	O
detected	B-UNK
by	O
the	O
protein	B-UNK
-	O
truncation	O
assay	B-UNK
followed	B-UNK
by	O
sequence	B-UNK
analysis	B-UNK
of	O
genomic	B-UNK
dna	I-UNK
.	O

 	O
fewer	B-UNK
than	O
half	B-UNK
of	O
the	O
splicing	B-UNK
mutations	B-UNK
involved	B-UNK
the	O
canonical	B-UNK
ag	B-UNK
splice	O
-	O
acceptor	B-UNK
site	B-UNK
or	O
gt	B-UNK
splice	O
-	O
donor	O
site	B-UNK
.	O

 	O
a	O
higher	B-UNK
percentage	B-UNK
of	O
mutations	B-UNK
occurred	B-UNK
at	B-DISEASE
less	O
stringently	O
conserved	B-UNK
sites	B-UNK
,	O
including	B-UNK
silent	B-UNK
mutations	B-UNK
of	O
the	O
last	O
nucleotide	B-UNK
of	O
exons	B-UNK
,	O
mutations	B-UNK
in	O
nucleotides	B-UNK
other	O
than	O
the	O
conserved	B-UNK
ag	B-UNK
and	O
gt	B-UNK
in	O
the	O
consensus	B-UNK
splice	O
sites	B-UNK
,	O
and	O
creation	O
of	O
splice	O
-	O
acceptor	B-UNK
or	O
splice	O
-	O
donor	O
sites	B-UNK
in	O
either	O
introns	B-UNK
or	O
exons	B-UNK
.	O

 	O
these	O
splicing	B-UNK
mutations	B-UNK
led	B-UNK
to	O
a	O
variety	B-UNK
of	O
consequences	O
,	O
including	B-UNK
exon	B-UNK
skipping	B-UNK
and	O
,	O
to	O
a	O
lesser	O
degree	B-UNK
,	O
intron	B-UNK
retention	O
,	O
activation	B-UNK
of	O
cryptic	O
splice	O
sites	B-UNK
,	O
or	O
creation	O
of	O
new	B-UNK
splice	O
sites	B-UNK
.	O

 	O
in	O
addition	B-UNK
,	O
5	O
of	O
12	O
nonsense	B-UNK
mutations	B-UNK
and	O
1	O
missense	B-UNK
mutation	I-UNK
were	O
associated	B-UNK
with	O
deletion	B-UNK
in	O
the	O
cdna	B-UNK
of	O
the	O
exons	B-UNK
in	O
which	O
the	O
mutations	B-UNK
occurred	B-UNK
.	O

 	O
no	O
atm	B-UNK
protein	B-UNK
was	O
detected	B-UNK
by	O
western	B-UNK
blotting	B-UNK
in	O
any	O
at	B-DISEASE
cell	B-UNK
line	B-UNK
in	O
which	O
splicing	B-UNK
mutations	B-UNK
were	O
identified	B-UNK
.	O

 	O
several	O
cases	B-UNK
of	O
exon	B-UNK
skipping	B-UNK
in	O
both	O
normal	B-UNK
controls	B-UNK
and	O
patients	B-UNK
for	O
whom	O
no	O
underlying	B-UNK
defect	B-UNK
could	O
be	O
found	B-UNK
in	O
genomic	B-UNK
dna	I-UNK
were	O
also	O
observed	B-UNK
,	O
suggesting	B-UNK
caution	O
in	O
the	O
interpretation	O
of	O
exon	B-UNK
deletions	B-UNK
observed	B-UNK
in	O
atm	B-UNK
cdna	B-UNK
when	O
there	O
is	O
no	O
accompanying	B-UNK
identification	B-UNK
of	O
genomic	B-UNK
mutations	B-UNK
.	O
.	O

 	O
alpha	B-UNK
-	O
cardiac	B-UNK
actin	B-UNK
is	O
a	O
novel	B-UNK
disease	B-DISEASE
gene	B-UNK
in	O
familial	B-UNK
hypertrophic	B-DISEASE
cardiomyopathy	I-DISEASE
.	O

 	O
we	O
identified	B-UNK
the	O
alpha	B-UNK
-	O
cardiac	B-UNK
actin	B-UNK
gene	B-UNK
(	O
actc	O
)	O
as	O
a	O
novel	B-UNK
disease	B-DISEASE
gene	B-UNK
in	O
a	O
pedigree	B-UNK
suffering	B-UNK
from	O
familial	B-UNK
hypertrophic	B-DISEASE
cardiomyopathy	I-DISEASE
(	O
fhc	O
)	O
.	O

 	B-UNK
linkage	I-UNK
analyses	B-UNK
excluded	B-UNK
all	O
the	O
previously	B-UNK
reported	I-UNK
fhc	O
loci	B-UNK
as	O
possible	B-UNK
disease	B-DISEASE
loci	B-UNK
in	O
the	O
family	B-UNK
studied	B-UNK
,	O
with	O
lod	B-UNK
scores	I-UNK
varying	B-UNK
between	O
-	O
2	O
.	O

 	O
5	O
and	O
-	O
6	O
.	O

 	O
0	O
0	O
.	O

 	O
further	O
linkage	B-UNK
analyses	B-UNK
of	O
plausible	O
candidate	B-UNK
genes	I-UNK
highly	B-UNK
expressed	B-UNK
in	O
the	O
adult	B-UNK
human	B-UNK
heart	B-UNK
identified	B-UNK
actc	O
as	O
the	O
most	O
likely	B-UNK
disease	B-DISEASE
gene	B-UNK
,	O
showing	B-UNK
a	O
maximal	B-UNK
lod	I-UNK
score	B-UNK
of	O
3	O
.	O

 	O
6	O
6	O
.	O

 	O
mutation	B-UNK
analysis	B-UNK
of	O
actc	O
revealed	B-UNK
an	O
ala295ser	O
mutation	B-UNK
in	O
exon	B-UNK
5	O
close	B-UNK
to	O
2	O
missense	B-UNK
mutations	I-UNK
recently	B-UNK
described	B-UNK
to	O
cause	B-UNK
the	O
inherited	B-UNK
form	B-UNK
of	O
idiopathic	O
dilated	B-DISEASE
cardiomyopathy	I-DISEASE
(	O
idc	O
)	O
.	O

 	O
overgrowth	B-UNK
of	O
oral	B-UNK
mucosa	B-UNK
and	O
facial	B-UNK
skin	B-DISEASE
,	O
a	O
novel	B-UNK
feature	B-UNK
of	O
aspartylglucosaminuria	B-DISEASE
.	O

 	O
aspartylglucosaminuria	B-DISEASE
(	O
agu	B-UNK
)	O
is	O
a	O
lysosomal	B-UNK
storage	B-UNK
disorder	I-UNK
caused	I-UNK
by	O
deficiency	B-UNK
of	O
aspartylglucosaminidase	B-UNK
(	O
aga	B-UNK
)	O
.	O

 	O
the	O
main	B-UNK
symptom	B-UNK
is	O
progressive	B-UNK
mental	B-DISEASE
retardation	I-DISEASE
.	O

 	O
a	O
spectrum	B-UNK
of	O
different	B-UNK
mutations	B-UNK
has	O
been	O
reported	B-UNK
in	O
this	O
disease	B-DISEASE
,	O
one	O
missense	B-UNK
mutation	I-UNK
(	O
cys163ser	O
)	O
being	O
responsible	B-UNK
for	O
the	O
majority	B-UNK
of	O
finnish	B-UNK
cases	B-UNK
.	O

 	O
we	O
were	O
able	O
to	O
examine	O
66	O
finnish	B-UNK
agu	B-UNK
patients	B-UNK
for	O
changes	B-UNK
in	O
the	O
oral	B-UNK
mucosa	B-UNK
and	O
44	O
of	O
these	O
for	O
changes	B-UNK
in	O
facial	B-UNK
skin	B-DISEASE
.	O

 	O
biopsy	B-UNK
specimens	B-UNK
of	O
16	O
oral	B-UNK
lesions	B-UNK
,	O
12	O
of	O
them	O
associated	B-UNK
with	O
the	O
teeth	B-DISEASE
,	O
plus	O
two	O
facial	B-UNK
lesions	B-UNK
were	O
studied	B-UNK
histologically	O
.	O

 	B-UNK
immunohistochemical	I-UNK
staining	B-UNK
for	O
aga	B-UNK
was	O
performed	B-UNK
on	O
15	O
oral	B-UNK
specimens	B-UNK
.	O

 	O
skin	B-DISEASE
was	O
seborrhoeic	O
in	O
adolescent	O
and	O
adult	B-UNK
patients	B-UNK
,	O
with	O
erythema	B-DISEASE
of	O
the	O
facial	B-UNK
skin	B-DISEASE
already	O
common	B-UNK
in	O
childhood	B-UNK
.	O

 	O
of	O
44	O
patients	B-UNK
,	O
nine	O
(	O
20	O
%	O
)	O
had	O
facial	B-UNK
angiofibromas	O
,	O
tumours	B-UNK
primarily	B-UNK
occurring	B-UNK
in	O
association	B-UNK
with	O
tuberous	B-DISEASE
sclerosis	I-DISEASE
.	O

 	O
oedemic	O
buccal	O
mucosa	B-UNK
(	O
leucoedema	O
)	O
and	O
gingival	O
overgrowths	O
were	O
more	O
frequent	B-UNK
in	O
agu	B-UNK
patients	B-UNK
than	O
in	O
controls	B-UNK
(	O
p	B-UNK
<	O
0	O
.	O
001	O
)	O
.	O

 	O
of	O
16	O
oral	B-UNK
mucosal	B-UNK
lesions	B-UNK
studied	B-UNK
histologically	O
,	O
15	O
represented	B-UNK
fibroepithelial	O
or	O
epithelial	O
hyperplasias	O
and	O
were	O
reactive	O
in	O
nature	B-UNK
.	O

 	O
cytoplasmic	B-UNK
vacuolisation	O
was	O
evident	O
in	O
four	O
.	O

 	O
immunohistochemically	O
,	O
expression	B-UNK
of	O
aga	B-UNK
in	O
agu	B-UNK
patients	B-UNK
mucosal	B-UNK
lesions	B-UNK
did	O
not	O
differ	B-UNK
from	O
that	O
seen	B-UNK
in	O
corresponding	B-UNK
lesions	B-UNK
of	O
normal	B-UNK
subjects	B-UNK
.	O

 	O
thus	O
,	O
the	O
high	B-UNK
frequency	B-UNK
of	O
mucosal	B-UNK
overgrowth	B-UNK
in	O
agu	B-UNK
patients	B-UNK
does	O
not	O
appear	B-UNK
to	O
be	O
directly	B-UNK
associated	B-UNK
with	O
lysosomal	B-UNK
storage	O
or	O
with	O
alterations	B-UNK
in	O
the	O
level	B-UNK
of	O
aga	B-UNK
expression	B-UNK
.	O

 	O
characterization	B-UNK
of	O
a	O
germline	B-UNK
mosaicism	B-UNK
in	O
families	B-UNK
with	O
lowe	O
syndrome	B-DISEASE
,	O
and	O
identification	B-UNK
of	O
seven	B-UNK
novel	B-UNK
mutations	B-UNK
in	O
the	O
ocrl1	B-UNK
gene	B-UNK
.	O

 	O
the	O
oculocerebrorenal	B-DISEASE
syndrome	I-DISEASE
of	O
lowe	O
(	O
ocrl	B-UNK
)	O
is	O
an	O
x	B-UNK
-	O
linked	B-UNK
disorder	O
characterized	B-UNK
by	O
major	B-UNK
abnormalities	B-DISEASE
of	O
eyes	O
,	O
nervous	B-UNK
system	I-UNK
,	O
and	O
kidneys	O
.	O

 	O
mutations	B-UNK
in	O
the	O
ocrl1	B-UNK
gene	B-UNK
have	O
been	O
associated	B-UNK
with	O
the	O
disease	B-DISEASE
.	O

 	O
ocrl1	B-UNK
encodes	B-UNK
a	O
phosphatidylinositol	B-UNK
4	O
,	O
5	O
-	O
biphosphate	O
(	O
ptdins	O
[	O
4	O
,	O
5	O
]	O
p2	O
)	O
5	O
-	O
phosphatase	B-UNK
.	O

 	O
we	O
have	O
examined	B-UNK
the	O
ocrl1	B-UNK
gene	B-UNK
in	O
eight	O
unrelated	B-UNK
patients	B-UNK
with	O
ocrl	B-UNK
and	O
have	O
found	B-UNK
seven	B-UNK
new	I-UNK
mutations	B-UNK
and	O
one	O
recurrent	B-UNK
in	O
-	O
frame	B-UNK
deletion	B-UNK
.	O

 	O
among	O
the	O
new	B-UNK
mutations	B-UNK
,	O
two	O
nonsense	B-UNK
mutations	B-UNK
(	O
r317x	O
and	O
e558x	O
)	O
and	O
three	O
other	O
frameshift	B-UNK
mutations	B-UNK
caused	B-UNK
premature	B-UNK
termination	I-UNK
of	O
the	O
protein	B-UNK
.	O

 	O
a	O
missense	B-UNK
mutation	I-UNK
,	O
r483	O
g	B-UNK
,	O
was	O
located	B-UNK
in	O
the	O
highly	B-UNK
conserved	I-UNK
ptdins	O
(	O
4	O
,	O
5	O
)	O
p2	O
5	O
-	O
phosphatase	B-UNK
domain	B-UNK
.	O

 	O
finally	B-UNK
,	O
one	O
frameshift	B-UNK
mutation	B-UNK
,	O
2799delc	O
,	O
modifies	O
the	O
c	B-UNK
-	O
terminal	B-UNK
part	O
of	O
ocrl1	B-UNK
,	O
with	O
an	O
extension	O
of	O
six	O
amino	O
acids	O
.	O

 	O
altogether	O
,	O
70	O
%	O
of	O
missense	B-UNK
mutations	I-UNK
are	O
located	B-UNK
in	O
exon	B-UNK
15	O
,	O
and	O
52	O
%	O
of	O
all	O
mutations	B-UNK
cluster	O
in	O
exons	B-UNK
11	O
-	O
15	O
.	O

 	O
we	O
also	O
identified	B-UNK
two	O
new	B-UNK
microsatellite	I-UNK
markers	B-UNK
for	O
the	O
ocrl1	B-UNK
locus	B-UNK
,	O
and	O
we	O
detected	B-UNK
a	O
germline	B-UNK
mosaicism	B-UNK
in	O
one	O
family	B-UNK
.	O

 	O
this	O
observation	B-UNK
has	O
direct	B-UNK
implications	B-UNK
for	O
genetic	B-UNK
counseling	B-UNK
of	O
lowe	O
syndrome	B-DISEASE
families	B-UNK
.	O
.	O

 	O
mefv	B-UNK
-	O
gene	B-UNK
analysis	B-UNK
in	O
armenian	B-UNK
patients	B-UNK
with	O
familial	B-DISEASE
mediterranean	I-DISEASE
fever	I-DISEASE
:	O
diagnostic	B-UNK
value	B-UNK
and	O
unfavorable	O
renal	B-DISEASE
prognosis	O
of	O
the	O
m694v	B-UNK
homozygous	B-UNK
genotype	B-UNK
-	O
genetic	B-UNK
and	O
therapeutic	B-UNK
implications	B-UNK
.	O

 	O
familial	B-DISEASE
mediterranean	I-DISEASE
fever	I-DISEASE
(	O
fmf	B-UNK
)	O
is	O
a	O
recessively	O
inherited	B-UNK
disorder	O
that	O
is	O
common	B-UNK
in	O
patients	B-UNK
of	O
armenian	B-UNK
ancestry	B-UNK
.	O

 	O
to	O
date	B-UNK
,	O
its	O
diagnosis	B-UNK
,	O
which	O
can	O
be	O
made	O
only	O
retrospectively	O
,	O
is	O
one	O
of	O
exclusion	B-UNK
,	O
based	B-UNK
entirely	B-UNK
on	O
nonspecific	O
clinical	B-UNK
signs	B-UNK
that	O
result	B-UNK
from	O
serosal	O
inflammation	B-DISEASE
and	O
that	O
may	O
lead	B-UNK
to	O
unnecessary	O
surgery	B-UNK
.	O

 	O
renal	B-DISEASE
amyloidosis	B-DISEASE
,	O
prevented	O
by	O
colchicine	B-UNK
,	O
is	O
the	O
most	O
severe	B-UNK
complication	O
of	O
fmf	B-UNK
,	O
a	O
disorder	O
associated	B-UNK
with	O
mutations	B-UNK
in	O
the	O
mefv	B-UNK
gene	B-UNK
.	O

 	O
to	O
evaluate	O
the	O
diagnostic	B-UNK
and	O
prognostic	B-UNK
value	B-UNK
of	O
mefv	B-UNK
-	O
gene	B-UNK
analysis	B-UNK
,	O
we	O
investigated	B-UNK
90	O
armenian	B-UNK
fmf	B-UNK
patients	B-UNK
from	O
77	O
unrelated	B-UNK
families	I-UNK
that	O
were	O
not	O
selected	B-UNK
through	O
genetic	B-UNK
-	O
linkage	B-UNK
analysis	I-UNK
.	O

 	O
eight	O
mutations	B-UNK
,	O
one	O
of	O
which	O
(	O
r408q	O
)	O
is	O
new	B-UNK
,	O
were	O
found	B-UNK
to	O
account	B-UNK
for	O
93	O
%	O
of	O
the	O
163	O
independent	B-UNK
fmf	B-UNK
alleles	B-UNK
,	O
with	O
both	O
fmf	B-UNK
alleles	B-UNK
identified	B-UNK
in	O
89	O
%	O
of	O
the	O
patients	B-UNK
.	O

 	O
in	O
several	O
instances	O
,	O
family	B-UNK
studies	I-UNK
provided	B-UNK
molecular	B-UNK
evidence	B-UNK
for	O
pseudodominant	O
transmission	B-UNK
and	O
incomplete	B-UNK
penetrance	B-UNK
of	O
the	O
disease	B-DISEASE
phenotype	B-UNK
.	O

 	O
the	O
m694v	B-UNK
homozygous	B-UNK
genotype	B-UNK
was	O
found	B-UNK
to	O
be	O
associated	B-UNK
with	O
a	O
higher	B-UNK
prevalence	B-UNK
of	O
renal	B-DISEASE
amyloidosis	B-DISEASE
and	O
arthritis	B-DISEASE
,	O
compared	B-UNK
with	O
other	O
genotypes	O
(	O
p	B-UNK
=	O
.	O
0002	O
and	O
p	B-UNK
=	O
.	O
006	O
,	O
respectively	B-UNK
)	O
.	O

 	O
the	O
demonstration	O
of	O
both	O
the	O
diagnostic	B-UNK
and	O
prognostic	B-UNK
value	B-UNK
of	O
mefv	B-UNK
analysis	B-UNK
and	O
particular	B-UNK
modes	O
of	O
inheritance	B-UNK
should	O
lead	B-UNK
to	O
new	B-UNK
ways	B-UNK
for	O
management	O
of	O
fmf	B-UNK
-	O
including	B-UNK
genetic	B-UNK
counseling	B-UNK
and	O
therapeutic	B-UNK
decisions	O
in	O
affected	B-UNK
families	B-UNK
.	O

 	O
noninvasive	O
test	B-UNK
for	O
fragile	B-DISEASE
x	I-DISEASE
syndrome	I-DISEASE
,	O
using	O
hair	B-UNK
root	O
analysis	B-UNK
.	O

 	O
identification	B-UNK
of	O
the	O
fmr1	B-UNK
gene	B-UNK
and	O
the	O
repeat	B-UNK
-	O
amplification	B-UNK
mechanism	B-UNK
causing	B-UNK
fragile	B-DISEASE
x	I-DISEASE
syndrome	I-DISEASE
led	B-UNK
to	O
development	B-UNK
of	O
reliable	B-UNK
dna	B-UNK
-	O
based	B-UNK
diagnostic	I-UNK
methods	B-UNK
,	O
including	B-UNK
southern	B-UNK
blot	I-UNK
hybridization	B-UNK
and	O
pcr	B-UNK
.	O

 	O
both	O
methods	B-UNK
are	O
performed	B-UNK
on	O
dna	B-UNK
isolated	B-UNK
from	O
peripheral	B-UNK
blood	I-UNK
cells	B-UNK
and	O
measure	O
the	O
repeat	B-UNK
size	B-UNK
in	O
fmr1	B-UNK
.	O

 	O
using	O
an	O
immunocytochemical	O
technique	B-UNK
on	O
blood	B-UNK
smears	O
,	O
we	O
recently	B-UNK
developed	B-UNK
a	O
novel	B-UNK
test	B-UNK
for	O
identification	B-UNK
of	O
patients	B-UNK
with	O
fragile	B-DISEASE
x	I-DISEASE
syndrome	I-DISEASE
.	O

 	O
this	O
method	B-UNK
,	O
also	O
called	B-UNK
"	O
antibody	B-UNK
test	B-UNK
,	O
"	O
uses	O
monoclonal	B-UNK
antibodies	B-UNK
against	O
the	O
fmr1	B-UNK
gene	B-UNK
product	B-UNK
(	O
fmrp	O
)	O
and	O
is	O
based	B-UNK
on	O
absence	B-UNK
of	O
fmrp	O
in	O
patients	B-UNK
cells	B-UNK
.	O

 	O
here	O
we	O
describe	B-UNK
a	O
new	B-UNK
diagnostic	B-UNK
test	B-UNK
to	O
identify	B-UNK
male	B-UNK
patients	I-UNK
with	O
fragile	B-DISEASE
x	I-DISEASE
syndrome	I-DISEASE
,	O
on	O
the	O
basis	B-UNK
of	O
lack	B-UNK
of	O
fmrp	O
in	O
their	O
hair	B-UNK
roots	B-UNK
.	O

 	O
expression	B-UNK
of	O
fmrp	O
in	O
hair	B-UNK
roots	B-UNK
was	O
studied	B-UNK
by	O
use	B-UNK
of	O
an	O
fmrp	O
-	O
specific	B-UNK
antibody	B-UNK
test	B-UNK
,	O
and	O
the	O
percentage	B-UNK
of	O
fmrp	O
-	O
expressing	B-UNK
hair	B-UNK
roots	B-UNK
in	O
controls	B-UNK
and	O
in	O
male	B-UNK
fragile	B-UNK
x	I-UNK
patients	B-UNK
was	O
determined	B-UNK
.	O

 	O
control	B-UNK
individuals	I-UNK
showed	B-UNK
clear	B-UNK
expression	B-UNK
of	O
fmrp	O
in	O
nearly	O
every	O
hair	B-UNK
root	O
,	O
whereas	O
male	B-UNK
fragile	B-UNK
x	I-UNK
patients	B-UNK
lacked	B-UNK
expression	B-UNK
of	O
fmrp	O
in	O
almost	O
all	O
their	O
hair	B-UNK
roots	B-UNK
.	O

 	O
mentally	B-UNK
retarded	I-UNK
female	B-UNK
patients	B-UNK
with	O
a	O
full	O
mutation	B-UNK
showed	B-UNK
fmrp	O
expression	B-UNK
in	O
only	O
some	O
of	O
their	O
hair	B-UNK
roots	B-UNK
(	O
<	O
55	O
%	O
)	O
,	O
and	O
no	O
overlap	O
with	O
normal	B-UNK
female	B-UNK
controls	B-UNK
was	O
observed	B-UNK
.	O

 	O
the	O
advantages	O
of	O
this	O
test	B-UNK
are	O
(	O
1	O
)	O
plucking	O
of	O
hair	B-UNK
follicles	O
does	O
no	O
appreciable	O
harm	O
to	O
the	O
mentally	B-UNK
retarded	I-UNK
patient	B-UNK
,	O
(	O
2	O
)	O
hairs	O
can	O
be	O
sent	O
in	O
a	O
simple	B-UNK
envelope	O
to	O
a	O
diagnostic	B-UNK
center	B-UNK
,	O
and	O
(	O
3	O
)	O
the	O
result	B-UNK
of	O
the	O
test	B-UNK
is	O
available	B-UNK
within	O
5	O
h	O
of	O
plucking	O
.	O

 	O
in	O
addition	B-UNK
,	O
this	O
test	B-UNK
enabled	B-UNK
us	O
to	O
identify	B-UNK
two	O
fragile	B-UNK
x	I-UNK
patients	B-UNK
who	O
did	O
not	O
show	O
the	O
full	O
mutation	B-UNK
by	O
analysis	B-UNK
of	O
dna	B-UNK
isolated	B-UNK
from	O
blood	B-UNK
cells	I-UNK
.	O
.	O

 	O
in	O
swedish	B-UNK
families	B-UNK
with	O
hereditary	B-UNK
prostate	B-DISEASE
cancer	I-DISEASE
,	O
linkage	B-UNK
to	O
the	O
hpc1	B-UNK
locus	B-UNK
on	O
chromosome	B-UNK
1q24	O
-	O
25	O
is	O
restricted	O
to	O
families	B-UNK
with	O
early	B-UNK
-	O
onset	B-UNK
prostate	B-DISEASE
cancer	I-DISEASE
.	O

 	O
prostate	B-DISEASE
cancer	I-DISEASE
clusters	O
in	O
some	O
families	B-UNK
,	O
and	O
an	O
estimated	B-UNK
5	O
%	O
-	O
10	O
%	O
of	O
all	O
cases	B-UNK
are	O
estimated	B-UNK
to	O
result	B-UNK
from	O
inheritance	B-UNK
of	O
prostate	B-DISEASE
cancer	I-DISEASE
-	O
susceptibility	B-UNK
genes	B-UNK
.	O

 	O
we	O
previously	B-UNK
reported	I-UNK
evidence	B-UNK
of	O
linkage	B-UNK
to	O
the	O
1q24	O
-	O
25	O
region	B-UNK
(	O
hpc1	B-UNK
)	O
in	O
91	O
north	B-UNK
american	I-UNK
and	O
swedish	B-UNK
families	B-UNK
each	O
with	O
multiple	B-UNK
cases	B-UNK
of	O
prostate	B-DISEASE
cancer	I-DISEASE
(	O
smith	O
et	O
al	O
.	O
1996	O
)	O
.	O

 	O
in	O
the	O
present	B-UNK
report	B-UNK
we	O
analyze	O
40	O
(	O
12	O
original	B-UNK
and	O
28	O
newly	B-UNK
identified	B-UNK
)	O
swedish	B-UNK
families	B-UNK
with	O
hereditary	B-UNK
prostate	B-DISEASE
cancer	I-DISEASE
(	O
hpc	O
)	O
that	O
,	O
on	O
the	O
basis	B-UNK
of	O
40	O
markers	B-UNK
spanning	B-UNK
a	O
25	O
-	O
cm	B-DISEASE
interval	B-UNK
within	O
1q24	O
-	O
25	O
,	O
have	O
evidence	B-UNK
of	O
linkage	B-UNK
.	O

 	O
in	O
the	O
complete	B-UNK
set	B-UNK
of	O
families	B-UNK
,	O
a	O
maximum	B-UNK
two	O
-	O
point	B-UNK
lod	B-UNK
score	I-UNK
of	O
1	O
.	O

 	O
10	O
was	O
observed	B-UNK
at	B-DISEASE
d1s413	O
(	O
at	B-DISEASE
a	O
recombination	B-UNK
fraction	B-UNK
[	O
theta	B-UNK
]	O
of	O
.	O
1	O
)	O
,	O
with	O
a	O
maximum	B-UNK
npl	O
(	O
nonparametric	O
linkage	B-UNK
)	O
z	B-UNK
score	B-UNK
of	O
1	O
.	O

 	O
64	O
at	B-DISEASE
d1s202	O
(	O
p	B-UNK
=	O
.	O
05	O
)	O
.	O

 	O
the	O
evidence	B-UNK
of	O
linkage	B-UNK
to	O
this	O
region	B-UNK
originated	B-UNK
almost	O
exclusively	B-UNK
from	O
the	O
subset	O
of	O
12	O
early	B-UNK
-	O
onset	B-UNK
(	O
age	B-UNK
<	O
65	O
years	B-UNK
)	O
families	B-UNK
,	O
which	O
yielded	B-UNK
a	O
maximum	B-UNK
lod	I-UNK
score	B-UNK
of	O
2	O
.	O

 	O
38	O
at	B-DISEASE
d1s413	O
(	O
straight	O
theta	B-UNK
=	I-UNK
0	O
)	O
and	O
an	O
npl	O
z	B-UNK
score	B-UNK
of	O
1	O
.	O

 	O
95	O
at	B-DISEASE
d1s422	O
(	O
p	B-UNK
=	O
.	O
03	O
)	O
.	O

 	O
estimates	B-UNK
from	O
heterogeneity	B-UNK
tests	B-UNK
suggest	B-UNK
that	O
,	O
within	O
sweden	O
,	O
as	O
many	O
as	O
50	O
%	O
of	O
early	B-UNK
-	O
onset	B-UNK
families	B-UNK
had	O
evidence	B-UNK
of	O
linkage	B-UNK
to	O
the	O
hpc1	B-UNK
region	B-UNK
.	O

 	O
these	O
results	B-UNK
are	O
consistent	B-UNK
with	O
the	O
hypothesis	O
of	O
linkage	B-UNK
to	O
hpc1	B-UNK
in	O
a	O
subset	O
of	O
families	B-UNK
with	O
prostate	B-DISEASE
cancer	I-DISEASE
,	O
particularly	B-UNK
those	O
with	O
an	O
early	B-UNK
age	B-UNK
at	B-DISEASE
diagnosis	B-UNK
.	O

 	B-UNK
molecular	I-UNK
basis	B-UNK
of	O
feline	B-UNK
beta	B-UNK
-	O
glucuronidase	B-UNK
deficiency	B-UNK
:	O
an	O
animal	B-UNK
model	B-UNK
of	O
mucopolysaccharidosis	B-DISEASE
vii	I-DISEASE
.	O

 	O
a	O
family	B-UNK
of	O
domestic	O
cats	O
was	O
found	B-UNK
that	O
exhibited	B-UNK
clinical	B-UNK
and	O
biochemical	B-UNK
abnormalities	B-DISEASE
consistent	B-UNK
with	O
mucopolysaccharidosis	B-DISEASE
vii	I-DISEASE
,	O
an	O
autosomal	O
recessive	O
lysosomal	B-UNK
storage	B-UNK
disorder	I-UNK
caused	I-UNK
by	O
beta	B-UNK
-	O
glucuronidase	B-UNK
deficiency	B-UNK
.	O

 	O
beta	B-UNK
-	O
glucuronidase	B-UNK
activity	B-UNK
was	O
undetectable	B-UNK
in	O
affected	B-UNK
cat	I-UNK
fibroblasts	B-UNK
and	O
restored	B-UNK
by	O
retroviral	B-UNK
gene	B-UNK
transfer	O
of	O
rat	B-UNK
beta	B-UNK
-	O
glucuronidase	B-UNK
cdna	B-UNK
.	O

 	O
beta	B-UNK
-	O
glucuronidase	B-UNK
mrna	B-UNK
was	O
normal	B-UNK
in	O
affected	B-UNK
cat	I-UNK
testis	O
by	O
northern	B-UNK
blot	O
analysis	B-UNK
.	O

 	B-UNK
normal	I-UNK
feline	B-UNK
beta	B-UNK
-	O
glucuronidase	B-UNK
cdna	B-UNK
was	O
cloned	B-UNK
and	O
characterized	B-UNK
,	O
and	O
amplified	B-UNK
from	O
affected	B-UNK
cat	I-UNK
fibroblasts	B-UNK
by	O
reverse	B-UNK
transcription	B-UNK
coupled	B-UNK
polymerase	B-UNK
chain	I-UNK
reaction	I-UNK
.	O

 	O
there	O
was	O
a	O
g	B-UNK
-	O
to	O
-	O
a	O
transition	B-UNK
in	O
the	O
affected	B-UNK
cat	I-UNK
cdna	B-UNK
that	O
predicted	B-UNK
an	O
e351k	O
substitution	B-UNK
,	O
destroyed	O
a	O
bsssi	O
site	B-UNK
,	O
and	O
eliminated	O
gusb	O
enzymatic	B-UNK
activity	I-UNK
in	O
expression	B-UNK
studies	B-UNK
.	O

 	O
multiple	B-UNK
species	B-UNK
comparison	B-UNK
and	O
the	O
crystal	O
structure	B-UNK
of	O
human	B-UNK
beta	B-UNK
-	O
glucuronidase	B-UNK
indicated	B-UNK
that	O
e351	O
is	O
a	O
highly	B-UNK
conserved	I-UNK
residue	B-UNK
most	O
likely	B-UNK
essential	B-UNK
in	O
maintenance	O
of	O
the	O
enzymes	B-UNK
conformation	O
.	O

 	O
bsssi	O
digestion	B-UNK
of	O
polymerase	B-UNK
chain	I-UNK
reaction	I-UNK
products	B-UNK
amplified	B-UNK
from	O
genomic	B-UNK
dna	I-UNK
indicated	B-UNK
that	O
affected	B-UNK
cats	O
were	O
homozygous	B-UNK
and	O
cats	O
with	O
half	B-UNK
-	O
normal	B-UNK
beta	B-UNK
-	O
glucuronidase	B-UNK
activity	B-UNK
were	O
heterozygous	B-UNK
for	O
the	O
missense	B-UNK
mutation	I-UNK
.	O

 	O
carriers	B-UNK
identified	B-UNK
in	O
this	O
manner	B-UNK
produced	B-UNK
affected	B-UNK
kittens	O
in	O
prospective	O
breedings	O
,	O
and	O
a	O
feline	B-UNK
mps	B-UNK
vii	O
breeding	O
colony	O
has	O
been	O
established	B-UNK
.	O
.	O

 	O
a	O
common	B-UNK
molecular	B-UNK
basis	I-UNK
for	O
rearrangement	B-UNK
disorders	B-UNK
on	O
chromosome	B-UNK
22q11	B-UNK
.	O

 	O
the	O
chromosome	B-UNK
22q11	B-UNK
region	B-UNK
is	O
susceptible	B-UNK
to	O
rearrangements	B-UNK
that	O
are	O
associated	B-UNK
with	O
congenital	B-DISEASE
anomaly	B-UNK
disorders	B-UNK
and	O
malignant	B-UNK
tumors	B-DISEASE
.	O

 	O
three	O
congenital	B-DISEASE
anomaly	B-UNK
disorders	B-UNK
,	O
cat	B-UNK
-	O
eye	B-UNK
syndrome	B-DISEASE
,	O
der	O
(	O
)	O
syndrome	B-DISEASE
and	O
velo	O
-	O
cardio	O
-	O
facial	B-UNK
syndrome	B-DISEASE
/	O
digeorge	B-DISEASE
syndrome	I-DISEASE
(	O
vcfs	O
/	O
dgs	B-UNK
)	O
are	O
associated	B-UNK
with	O
tetrasomy	B-DISEASE
,	O
trisomy	B-DISEASE
or	O
monosomy	B-DISEASE
,	O
respectively	B-UNK
,	O
for	O
part	O
of	O
chromosome	B-UNK
22q11	B-UNK
.	O

 	O
vcfs	O
/	O
dgs	B-UNK
is	O
the	O
most	O
common	B-UNK
syndrome	B-DISEASE
associated	B-UNK
with	O
22q11	B-UNK
rearrangements	B-UNK
.	O

 	O
in	O
order	B-UNK
to	O
determine	O
whether	O
there	O
are	O
particular	B-UNK
regions	B-UNK
on	O
22q11	B-UNK
that	O
are	O
prone	O
to	O
rearrangements	B-UNK
,	O
the	O
deletion	B-UNK
end	B-UNK
-	O
points	O
in	O
a	O
large	B-UNK
number	B-UNK
of	O
vcfs	O
/	O
dgs	B-UNK
patients	B-UNK
were	O
defined	B-UNK
by	O
haplotype	B-UNK
analysis	B-UNK
.	O

 	O
most	O
vcfs	O
/	O
dgs	B-UNK
patients	B-UNK
have	O
a	O
similar	B-UNK
3	O
mb	B-UNK
deletion	B-UNK
,	O
some	O
have	O
a	O
nested	B-UNK
distal	B-UNK
deletion	B-UNK
breakpoint	B-UNK
resulting	B-UNK
in	O
a	O
1	O
.	O

 	O
5	O
mb	B-UNK
deletion	B-UNK
and	O
a	O
few	O
rare	B-UNK
patients	B-UNK
have	O
unique	B-UNK
deletions	B-UNK
or	O
translocations	B-UNK
.	O

 	O
the	O
high	B-UNK
prevalence	B-UNK
of	O
the	O
disorder	O
in	O
the	O
population	B-UNK
and	O
the	O
fact	O
that	O
most	O
cases	B-UNK
occur	B-UNK
sporadically	O
suggest	B-UNK
that	O
sequences	B-UNK
at	B-DISEASE
or	O
near	B-UNK
the	O
breakpoints	B-UNK
confer	B-UNK
susceptibility	B-UNK
to	O
chromosome	B-UNK
rearrangements	B-UNK
.	O

 	O
to	O
investigate	O
this	O
hypothesis	O
,	O
we	O
developed	B-UNK
hamster	B-UNK
-	O
human	B-UNK
somatic	B-UNK
hybrid	B-UNK
cell	I-UNK
lines	I-UNK
from	O
vcfs	O
/	O
dgs	B-UNK
patients	B-UNK
with	O
all	O
three	O
classes	O
of	O
deletions	B-UNK
and	O
we	O
now	O
show	O
that	O
the	O
breakpoints	B-UNK
occur	B-UNK
within	O
similar	B-UNK
low	B-UNK
copy	B-UNK
repeats	B-UNK
,	O
termed	B-UNK
lcr22s	O
.	O

 	O
to	O
support	B-UNK
this	O
idea	O
further	O
,	O
we	O
identified	B-UNK
a	O
family	B-UNK
that	O
carries	O
an	O
interstitial	B-UNK
duplication	B-UNK
of	O
the	O
same	O
3	O
mb	B-UNK
region	B-UNK
that	O
is	O
deleted	B-UNK
in	O
vcfs	O
/	O
dgs	B-UNK
patients	B-UNK
.	O

 	O
we	O
present	B-UNK
models	B-UNK
to	O
explain	O
how	O
the	O
lcr22s	O
can	O
mediate	O
different	B-UNK
homologous	B-UNK
recombination	I-UNK
events	B-UNK
,	O
thereby	O
generating	O
a	O
number	B-UNK
of	O
rearrangements	B-UNK
that	O
are	O
associated	B-UNK
with	O
congenital	B-DISEASE
anomaly	B-UNK
disorders	B-UNK
.	O

 	O
we	O
identified	B-UNK
five	O
additional	B-UNK
copies	B-UNK
of	O
the	O
lcr22	O
on	O
22q11	B-UNK
that	O
may	O
mediate	O
other	O
rearrangements	B-UNK
leading	B-UNK
to	O
disease	B-DISEASE
.	O

 	B-UNK
functional	I-UNK
consequences	O
of	O
mutations	B-UNK
in	O
the	O
early	B-UNK
growth	B-UNK
response	B-UNK
2	O
gene	B-UNK
(	O
egr2	B-UNK
)	O
correlate	B-UNK
with	O
severity	B-UNK
of	O
human	B-UNK
myelinopathies	O
.	O

 	O
the	O
early	B-UNK
growth	B-UNK
response	B-UNK
2	O
gene	B-UNK
(	O
egr2	B-UNK
)	O
is	O
a	O
cys2his2zinc	O
finger	B-UNK
transcription	B-UNK
factor	B-UNK
which	O
is	O
thought	O
to	O
play	O
a	O
role	B-UNK
in	O
the	O
regulation	B-UNK
of	O
peripheral	B-UNK
nervous	B-UNK
system	I-UNK
myelination	O
.	O

 	O
this	O
idea	O
is	O
based	B-UNK
partly	O
on	O
the	O
phenotype	B-UNK
of	O
homozygous	B-UNK
krox20	O
(	O
egr2	B-UNK
)	O
knockout	O
mice	B-UNK
,	O
which	O
display	B-UNK
hypomyelination	B-DISEASE
of	O
the	O
pns	O
and	O
a	O
block	B-UNK
of	O
schwann	O
cells	B-UNK
at	B-DISEASE
an	O
early	B-UNK
stage	B-UNK
of	O
differentiation	B-UNK
.	O

 	O
mutations	B-UNK
in	O
the	O
human	B-UNK
egr2	B-UNK
gene	B-UNK
have	O
recently	B-UNK
been	O
associated	B-UNK
with	O
the	O
inherited	B-UNK
peripheral	B-UNK
neuropathies	O
charcot	O
-	O
marie	O
-	O
tooth	B-DISEASE
type	B-UNK
1	O
,	O
dejerine	O
-	O
sottas	O
syndrome	B-DISEASE
and	O
congenital	B-DISEASE
hypomyelinating	O
neuropathy	B-DISEASE
.	O

 	O
three	O
of	O
the	O
four	O
egr2	B-UNK
mutations	B-UNK
are	O
dominant	B-UNK
and	O
occur	B-UNK
within	O
the	O
zinc	B-DISEASE
finger	B-UNK
dna	B-UNK
-	O
binding	B-UNK
domain	I-UNK
.	O

 	O
the	O
fourth	B-UNK
mutation	B-UNK
is	O
recessive	O
and	O
affects	B-UNK
the	O
inhibitory	B-UNK
domain	B-UNK
(	O
r1	O
)	O
that	O
binds	O
the	O
nab	O
transcriptional	B-UNK
co	B-UNK
-	O
repressors	O
.	O

 	O
a	O
combination	O
of	O
dna	B-UNK
-	O
binding	B-UNK
assays	B-UNK
and	O
transcriptional	B-UNK
analysis	B-UNK
was	O
used	O
to	O
determine	O
the	O
functional	B-UNK
consequences	O
of	O
these	O
mutations	B-UNK
.	O

 	O
the	O
zinc	B-DISEASE
finger	B-UNK
mutations	B-UNK
affect	B-UNK
dna	B-UNK
binding	I-UNK
and	O
the	O
amount	O
of	O
residual	B-UNK
binding	B-UNK
directly	B-UNK
correlates	B-UNK
with	O
disease	B-DISEASE
severity	B-UNK
.	O

 	O
the	O
r1	O
domain	B-UNK
mutation	B-UNK
prevents	O
interaction	B-UNK
of	O
egr2	B-UNK
with	O
the	O
nab	O
co	B-UNK
-	O
repressors	O
and	O
thereby	O
increases	B-UNK
transcriptional	B-UNK
activity	B-UNK
.	O

 	O
these	O
data	B-UNK
provide	I-UNK
insight	B-UNK
into	O
the	O
possible	B-UNK
disease	B-DISEASE
mechanisms	B-UNK
underlying	I-UNK
egr2	B-UNK
mutations	B-UNK
and	O
the	O
reason	O
for	O
varying	B-UNK
severity	B-UNK
and	O
differences	B-UNK
in	O
inheritance	B-UNK
patterns	B-UNK
.	O
.	O

 	O
autosomal	O
recessive	O
familial	B-UNK
neurohypophyseal	I-UNK
diabetes	B-DISEASE
insipidus	I-DISEASE
with	O
continued	O
secretion	B-UNK
of	O
mutant	B-UNK
weakly	O
active	B-UNK
vasopressin	B-UNK
.	O

 	B-UNK
familial	I-UNK
neurohypophyseal	B-UNK
diabetes	B-DISEASE
insipidus	I-DISEASE
is	O
an	O
autosomal	O
dominant	B-UNK
disorder	O
characterized	B-UNK
by	O
post	O
-	O
natal	O
development	B-UNK
of	O
arginine	B-UNK
vasopressin	B-UNK
(	O
avp	B-UNK
)	O
deficiency	B-UNK
due	O
to	O
mutations	B-UNK
in	O
the	O
avp	B-UNK
gene	B-UNK
.	O

 	O
all	O
published	B-UNK
mutations	B-UNK
affect	B-UNK
the	O
signal	B-UNK
peptide	I-UNK
or	O
the	O
neurophysin	O
-	O
ii	B-UNK
carrier	B-UNK
protein	B-UNK
and	O
are	O
presumed	B-UNK
to	O
interfere	O
with	O
processing	B-UNK
of	O
the	O
preprohormone	O
,	O
leading	B-UNK
to	O
neuronal	B-DISEASE
damage	I-DISEASE
.	O

 	O
we	O
studied	B-UNK
an	O
unusual	B-UNK
palestinian	O
family	B-UNK
consisting	O
of	O
asymptomatic	B-UNK
first	O
cousin	O
parents	B-UNK
and	O
three	O
children	B-UNK
affected	B-UNK
with	O
neurohypophyseal	B-UNK
diabetes	B-DISEASE
insipidus	I-DISEASE
,	O
suggesting	B-UNK
autosomal	O
recessive	O
inheritance	B-UNK
.	O

 	O
all	O
three	O
affected	B-UNK
children	B-UNK
were	O
homozygous	B-UNK
and	O
the	O
parents	B-UNK
heterozygous	B-UNK
for	O
a	O
single	B-UNK
novel	B-UNK
mutation	B-UNK
(	O
c301	O
-	O
>	O
t	B-UNK
)	O
in	O
exon	B-UNK
1	O
,	O
replacing	O
pro7	O
of	O
mature	B-UNK
avp	B-UNK
with	O
leu	B-UNK
(	O
leu	B-UNK
-	O
avp	B-UNK
)	O
.	O

 	O
leu	B-UNK
-	O
avp	B-UNK
was	O
a	O
weak	O
agonist	O
with	O
approximately	B-UNK
30	O
-	O
fold	B-UNK
reduced	B-UNK
binding	B-UNK
to	O
the	O
human	B-UNK
v2	O
receptor	B-UNK
.	O

 	O
measured	B-UNK
by	O
radioimmunoassay	O
with	O
a	O
synthetic	B-UNK
leu	B-UNK
-	O
avp	B-UNK
standard	B-UNK
,	O
serum	B-UNK
leu	B-UNK
-	O
avp	B-UNK
levels	B-UNK
were	O
elevated	B-UNK
in	O
all	O
three	O
children	B-UNK
and	O
further	O
increased	B-UNK
during	O
water	O
deprivation	O
to	O
as	O
high	B-UNK
as	O
30	O
times	B-UNK
normal	B-UNK
.	O

 	O
the	O
youngest	O
child	B-UNK
(	O
2	O
years	B-UNK
old	B-UNK
)	O
was	O
only	O
mildly	B-UNK
affected	I-UNK
but	O
had	O
leu	B-UNK
-	O
avp	B-UNK
levels	B-UNK
similar	B-UNK
to	O
her	O
severely	B-UNK
affected	I-UNK
8	O
-	O
year	B-UNK
-	O
old	B-UNK
brother	B-UNK
,	O
suggesting	B-UNK
that	O
unknown	B-UNK
mechanisms	B-UNK
may	O
partially	B-UNK
compensate	O
for	O
a	O
deficiency	B-UNK
of	O
active	B-UNK
avp	B-UNK
in	O
very	O
young	B-UNK
children	B-UNK
.	O
.	O

 	O
x	B-DISEASE
inactivation	I-DISEASE
and	O
somatic	B-UNK
cell	B-UNK
selection	B-UNK
rescue	O
female	B-UNK
mice	B-UNK
carrying	I-UNK
a	O
piga	B-UNK
-	O
null	B-UNK
mutation	B-UNK
.	O

 	O
a	O
somatic	B-UNK
mutation	B-UNK
in	O
the	O
x	B-UNK
linked	I-UNK
piga	B-UNK
gene	B-UNK
is	O
responsible	B-UNK
for	O
the	O
deficiency	B-UNK
of	O
glycosyl	O
phosphatidylinositol	B-UNK
(	O
gpi	O
)	O
-	O
anchored	O
proteins	B-UNK
on	O
blood	B-UNK
cells	I-UNK
from	O
patients	B-UNK
with	O
paroxysmal	B-UNK
nocturnal	B-UNK
hemoglobinuria	B-DISEASE
.	O

 	O
no	O
inherited	B-UNK
form	B-UNK
of	O
gpi	O
-	O
anchor	O
deficiency	B-UNK
has	O
been	O
described	B-UNK
.	O

 	O
because	O
conventional	B-UNK
piga	B-UNK
gene	B-UNK
knockout	O
is	O
associated	B-UNK
with	O
high	B-UNK
embryonic	B-UNK
lethality	I-UNK
in	O
chimeric	B-UNK
mice	B-UNK
,	O
we	O
used	O
the	O
cre	O
/	O
loxp	B-UNK
system	B-UNK
.	O

 	O
we	O
generated	B-UNK
mice	B-UNK
in	O
which	O
two	O
loxp	B-UNK
sites	B-UNK
flank	O
part	O
of	O
piga	B-UNK
exon	B-UNK
2	O
.	O

 	O
after	O
crossbreeding	O
with	O
female	B-UNK
mice	B-UNK
of	O
the	O
eiia	O
-	O
cre	O
strain	O
,	O
the	O
floxed	O
allele	B-UNK
undergoes	O
cre	O
-	O
mediated	B-UNK
recombination	B-UNK
with	O
high	B-UNK
efficiency	O
during	O
early	B-UNK
embryonic	I-UNK
development	B-UNK
.	O

 	O
because	O
of	O
x	B-DISEASE
chromosome	I-DISEASE
inactivation	B-UNK
,	O
female	B-UNK
offspring	B-UNK
are	O
mosaic	B-UNK
for	O
cells	B-UNK
that	O
express	B-UNK
or	O
lack	B-UNK
gpi	O
-	O
linked	B-UNK
proteins	B-UNK
.	O

 	O
analysis	B-UNK
of	O
mosaic	B-UNK
mice	B-UNK
showed	B-UNK
that	O
in	O
heart	B-UNK
,	O
lung	B-DISEASE
,	O
kidney	B-UNK
,	O
brain	B-UNK
,	O
and	O
liver	B-DISEASE
,	O
mainly	B-UNK
wild	B-UNK
-	O
type	B-UNK
piga	B-UNK
is	O
active	B-UNK
,	O
suggesting	B-UNK
that	O
these	O
tissues	B-UNK
require	O
gpi	O
-	O
linked	B-UNK
proteins	B-UNK
.	O

 	O
the	O
salient	O
exceptions	O
were	O
spleen	O
,	O
thymus	O
,	O
and	O
red	B-UNK
blood	I-UNK
cells	B-UNK
,	O
which	O
had	O
almost	O
equal	B-UNK
numbers	O
of	O
cells	B-UNK
expressing	B-UNK
the	O
wild	B-UNK
-	O
type	B-UNK
or	O
the	O
recombined	O
allele	B-UNK
,	O
implying	O
that	O
gpi	O
-	O
linked	B-UNK
proteins	B-UNK
are	O
not	O
essential	B-UNK
for	O
the	O
derivation	O
of	O
these	O
tissues	B-UNK
.	O

 	O
piga	B-UNK
(	O
-	O
)	O
cells	B-UNK
had	O
no	O
growth	B-UNK
advantage	B-UNK
,	O
suggesting	B-UNK
that	O
other	O
factors	B-UNK
are	O
needed	O
for	O
their	O
clonal	B-UNK
dominance	O
in	O
patients	B-UNK
with	O
paroxysmal	B-UNK
nocturnal	B-UNK
hemoglobinuria	B-DISEASE
.	O
.	O

 	O
the	O
c282y	B-UNK
mutation	B-UNK
causing	B-UNK
hereditary	B-DISEASE
hemochromatosis	I-DISEASE
does	O
not	O
produce	B-UNK
a	O
null	B-UNK
allele	B-UNK
.	O

 	B-UNK
targeted	I-UNK
mutagenesis	B-UNK
was	O
used	O
to	O
produce	B-UNK
two	O
mutations	B-UNK
in	O
the	O
murine	B-UNK
hemochromatosis	B-DISEASE
gene	B-UNK
(	O
hfe	B-UNK
)	O
locus	B-UNK
.	O

 	O
the	O
first	O
mutation	B-UNK
deletes	O
a	O
large	B-UNK
portion	B-UNK
of	O
the	O
coding	B-UNK
sequence	B-UNK
,	O
generating	O
a	O
null	B-UNK
allele	B-UNK
.	O

 	O
the	O
second	B-UNK
mutation	B-UNK
introduces	B-UNK
a	O
missense	B-UNK
mutation	I-UNK
(	O
c282y	B-UNK
)	O
into	O
the	O
hfe	B-UNK
locus	B-UNK
,	O
but	O
otherwise	O
leaves	O
the	O
gene	B-UNK
intact	B-UNK
.	O

 	O
this	O
mutation	B-UNK
is	O
identical	B-UNK
to	O
the	O
disease	B-DISEASE
-	O
causing	B-UNK
mutation	B-UNK
in	O
patients	B-UNK
with	O
hereditary	B-DISEASE
hemochromatosis	I-DISEASE
.	O

 	B-UNK
mice	I-UNK
carrying	B-UNK
each	O
of	O
the	O
two	O
mutations	B-UNK
were	O
bred	O
and	O
analyzed	B-UNK
.	O

 	O
homozygosity	B-UNK
for	O
either	O
mutation	B-UNK
results	B-UNK
in	O
postnatal	B-UNK
iron	B-UNK
loading	O
.	O

 	O
the	O
effects	B-UNK
of	O
the	O
null	B-UNK
mutation	B-UNK
are	O
more	O
severe	B-UNK
than	O
the	O
effects	B-UNK
of	O
the	O
c282y	B-UNK
mutation	B-UNK
.	O

 	B-UNK
mice	I-UNK
heterozygous	B-UNK
for	O
either	O
mutation	B-UNK
accumulate	O
more	O
iron	B-UNK
than	O
normal	B-UNK
controls	B-UNK
.	O

 	O
interestingly	B-UNK
,	O
although	O
liver	B-DISEASE
iron	B-UNK
stores	O
are	O
greatly	B-UNK
increased	I-UNK
,	O
splenic	O
iron	B-UNK
is	O
decreased	B-UNK
.	O

 	O
we	O
conclude	O
that	O
the	O
c282y	B-UNK
mutation	B-UNK
does	O
not	O
result	B-UNK
in	O
a	O
null	B-UNK
allele	B-UNK
.	O
.	O

 	O
genotype	B-UNK
-	O
phenotype	B-UNK
analysis	B-UNK
in	O
x	B-DISEASE
-	I-DISEASE
linked	I-DISEASE
emery	I-DISEASE
-	I-DISEASE
dreifuss	I-DISEASE
muscular	I-DISEASE
dystrophy	I-DISEASE
and	O
identification	B-UNK
of	O
a	O
missense	B-UNK
mutation	I-UNK
associated	B-UNK
with	O
a	O
milder	B-UNK
phenotype	B-UNK
.	O

 	B-UNK
direct	I-UNK
sequencing	B-UNK
of	O
the	O
emerin	B-UNK
gene	B-UNK
in	O
22	O
families	B-UNK
with	O
emery	B-DISEASE
-	I-DISEASE
dreifuss	I-DISEASE
muscular	I-DISEASE
dystrophy	I-DISEASE
(	O
emd	O
)	O
revealed	B-UNK
mutations	B-UNK
in	O
21	O
(	O
95	O
%	O
)	O
,	O
confirming	O
that	O
emerin	B-UNK
mutations	B-UNK
can	O
be	O
identified	B-UNK
in	O
the	O
majority	B-UNK
of	O
families	B-UNK
with	O
x	B-UNK
-	O
linked	B-UNK
emd	O
.	O

 	O
most	O
emerin	B-UNK
mutations	B-UNK
result	B-UNK
in	O
absence	B-UNK
of	O
the	O
protein	B-UNK
.	O

 	O
in	O
this	O
study	B-UNK
three	O
mutations	B-UNK
(	O
a	O
missense	B-UNK
mutation	I-UNK
pro183thr	O
and	O
two	O
in	O
-	O
frame	B-UNK
deletions	B-UNK
removing	O
residues	B-UNK
95	O
-	O
99	O
and	O
236	O
-	O
241	O
,	O
respectively	B-UNK
)	O
were	O
unusual	B-UNK
in	O
being	O
associated	B-UNK
with	O
expression	B-UNK
of	O
mutant	B-UNK
protein	B-UNK
.	O

 	O
the	O
phenotype	B-UNK
in	O
these	O
families	B-UNK
was	O
compared	B-UNK
in	O
detail	O
with	O
the	O
clinical	B-UNK
features	I-UNK
in	O
cases	B-UNK
with	O
typical	B-UNK
null	B-UNK
mutations	B-UNK
.	O

 	O
for	O
the	O
in	O
-	O
frame	B-UNK
deletions	B-UNK
there	O
were	O
no	O
significant	B-UNK
differences	I-UNK
.	O

 	O
in	O
the	O
family	B-UNK
with	O
the	O
missense	B-UNK
mutation	I-UNK
the	O
phenotype	B-UNK
was	O
milder	B-UNK
.	O

 	O
age	B-UNK
at	B-DISEASE
onset	B-UNK
was	O
later	B-UNK
for	O
first	O
symptoms	B-UNK
and	O
for	O
development	B-UNK
of	O
ankle	O
contractures	B-DISEASE
and	O
muscle	B-DISEASE
weakness	I-DISEASE
.	O

 	O
these	O
findings	B-UNK
have	O
diagnostic	B-UNK
implications	B-UNK
as	O
well	O
as	O
pointing	O
to	O
functionally	B-UNK
important	I-UNK
regions	B-UNK
of	O
the	O
emerin	B-UNK
protein	B-UNK
.	O
.	O

 	O
severe	B-UNK
clinical	I-UNK
expression	B-UNK
in	O
x	B-DISEASE
-	I-DISEASE
linked	I-DISEASE
emery	I-DISEASE
-	I-DISEASE
dreifuss	I-DISEASE
muscular	I-DISEASE
dystrophy	I-DISEASE
.	O

 	O
x	B-DISEASE
-	I-DISEASE
linked	I-DISEASE
emery	I-DISEASE
-	I-DISEASE
dreifuss	I-DISEASE
muscular	I-DISEASE
dystrophy	I-DISEASE
(	O
edmd	B-UNK
)	O
is	O
a	O
relatively	B-UNK
rare	B-UNK
benign	B-UNK
neuromuscular	B-UNK
disorder	O
which	O
can	O
vary	O
remarkably	O
in	O
onset	B-UNK
,	O
course	B-UNK
and	O
severity	B-UNK
.	O

 	O
in	O
the	O
present	B-UNK
study	I-UNK
,	O
a	O
tctac	O
deletion	B-UNK
spanning	B-UNK
the	O
nucleotides	B-UNK
631	O
-	O
635	O
of	O
the	O
emerin	B-UNK
gene	B-UNK
caused	B-UNK
an	O
unusually	O
severe	B-UNK
disease	B-DISEASE
phenotype	B-UNK
including	B-UNK
loss	B-UNK
of	O
ambulation	O
and	O
severe	B-UNK
muscle	B-UNK
wasting	I-UNK
in	O
two	O
affected	B-UNK
brothers	B-UNK
.	O

 	O
the	O
same	O
mutation	B-UNK
has	O
been	O
reported	B-UNK
previously	B-UNK
in	O
an	O
unrelated	B-UNK
family	B-UNK
showing	B-UNK
a	O
significantly	B-UNK
milder	B-UNK
phenotype	B-UNK
.	O

 	O
the	O
interfamilial	O
heterogeneity	B-UNK
in	O
distribution	B-UNK
and	O
in	O
severity	B-UNK
of	O
the	O
features	B-UNK
in	O
the	O
two	O
families	B-UNK
point	B-UNK
to	O
environmental	B-UNK
or	O
genetic	B-UNK
modification	B-UNK
as	O
the	O
cause	B-UNK
of	O
clinical	B-UNK
variability	B-UNK
in	O
emery	B-DISEASE
-	I-DISEASE
dreifuss	I-DISEASE
muscular	I-DISEASE
dystrophy	I-DISEASE
.	O
.	O

 	O
common	B-UNK
mutations	B-UNK
in	O
brca1	B-UNK
and	O
brca2	B-UNK
do	O
not	O
contribute	B-UNK
to	O
early	B-UNK
prostate	B-DISEASE
cancer	I-DISEASE
in	O
jewish	B-UNK
men	B-UNK
.	O

 	B-UNK
background	I-UNK
families	B-UNK
with	O
a	O
high	B-UNK
incidence	O
of	O
hereditary	B-UNK
breast	B-DISEASE
cancer	I-DISEASE
,	O
and	O
subsequently	B-UNK
shown	B-UNK
to	O
have	O
terminating	O
mutations	B-UNK
in	O
brca1	B-UNK
or	O
brca2	B-UNK
,	O
appear	B-UNK
to	O
have	O
a	O
higher	B-UNK
incidence	O
of	O
prostate	B-DISEASE
cancer	I-DISEASE
among	O
male	B-UNK
relatives	B-UNK
.	O

 	O
we	O
aimed	O
to	O
determine	O
whether	O
the	O
common	B-UNK
germline	B-UNK
mutations	I-UNK
of	O
brca1	B-UNK
or	O
brca2	B-UNK
in	O
ashkenazi	B-UNK
jewish	I-UNK
men	B-UNK
predisposed	O
them	O
to	O
prostate	B-DISEASE
cancer	I-DISEASE
.	O

 	O
methods	B-UNK
we	O
examined	B-UNK
genomic	B-UNK
dna	I-UNK
from	O
83	O
(	O
for	O
brca1	B-UNK
185delag	B-UNK
)	O
or	O
82	O
(	O
for	O
brca2	B-UNK
6174delt	O
)	O
ashkenazi	B-UNK
jewish	I-UNK
prostate	B-DISEASE
cancer	I-DISEASE
patients	B-UNK
,	O
most	O
of	O
whom	O
were	O
treated	B-UNK
at	B-DISEASE
a	O
relatively	B-UNK
young	B-UNK
age	B-UNK
,	O
for	O
the	O
most	O
common	B-UNK
germline	B-UNK
mutation	B-UNK
in	O
each	O
gene	B-UNK
seen	B-UNK
in	O
the	O
ashkenazi	B-UNK
population	B-UNK
.	O

 	B-UNK
results	I-UNK
our	O
study	B-UNK
should	O
have	O
been	O
able	O
to	O
detect	B-UNK
a	O
4	O
-	O
5	O
-	O
fold	B-UNK
increase	B-UNK
in	O
the	O
risk	B-UNK
of	O
prostate	B-DISEASE
cancer	I-DISEASE
due	O
to	O
mutation	B-UNK
of	O
brca1	B-UNK
or	O
brca2	B-UNK
.	O

 	O
however	O
,	O
only	O
one	O
(	O
1	O
.	O
15	O
%	O
;	O
95	O
%	O
confidence	B-UNK
interval	B-UNK
,	O
0	O
-	O
3	O
.	O
6	O
%	O
)	O
of	O
the	O
patients	B-UNK
was	O
heterozygous	B-UNK
for	O
the	O
brca1	B-UNK
mutant	B-UNK
allele	I-UNK
,	O
and	O
only	O
two	O
were	O
heterozygous	B-UNK
for	O
the	O
brca2	B-UNK
mutation	B-UNK
(	O
2	O
.	O
4	O
%	O
;	O
95	O
%	O
confidence	B-UNK
interval	B-UNK
,	O
0	O
-	O
6	O
.	O
2	O
%	O
)	O
.	O

 	O
conclusions	B-UNK
the	O
incidence	O
of	O
each	O
of	O
the	O
germline	B-UNK
mutations	I-UNK
in	O
these	O
prostate	B-DISEASE
cancer	I-DISEASE
patients	B-UNK
closely	B-UNK
matched	B-UNK
their	O
incidence	O
(	O
about	O
1	O
%	O
)	O
in	O
the	O
general	B-UNK
ashkenazi	B-UNK
jewish	I-UNK
population	B-UNK
.	O

 	O
this	O
suggests	B-UNK
that	O
unlike	B-UNK
cases	B-UNK
of	O
breast	B-UNK
and	O
ovarian	B-UNK
cancers	B-DISEASE
,	O
mutations	B-UNK
in	O
brca1	B-UNK
or	O
brca2	B-UNK
do	O
not	O
significantly	B-UNK
predispose	B-UNK
men	B-UNK
to	O
prostate	B-DISEASE
cancer	I-DISEASE

 	O
beta	B-UNK
-	O
catenin	B-UNK
accumulation	B-UNK
and	O
mutation	B-UNK
of	O
the	O
ctnnb1	O
gene	B-UNK
in	O
hepatoblastoma	B-DISEASE
.	O

 	O
hepatoblastoma	B-DISEASE
is	O
a	O
rare	B-UNK
malignant	B-UNK
tumor	B-DISEASE
of	O
the	O
liver	B-DISEASE
that	O
occurs	B-UNK
in	O
children	B-UNK
at	B-DISEASE
an	O
average	B-UNK
age	B-UNK
of	O
2	O
to	O
3	O
years	B-UNK
.	O

 	O
epidemiologic	B-UNK
studies	B-UNK
have	O
shown	B-UNK
an	O
increased	B-UNK
frequency	B-UNK
of	O
this	O
tumor	B-DISEASE
type	B-UNK
in	O
families	B-UNK
affected	B-UNK
by	O
adenomatous	B-DISEASE
polyposis	I-DISEASE
coli	I-DISEASE
.	O

 	O
in	O
addition	B-UNK
to	O
the	O
epidemiologic	B-UNK
data	B-UNK
,	O
molecular	B-UNK
genetic	I-UNK
studies	B-UNK
suggest	I-UNK
that	O
inactivation	B-UNK
of	O
the	O
apc	B-UNK
tumor	B-DISEASE
suppressor	B-UNK
may	O
be	O
involved	B-UNK
in	O
hepatoblastoma	B-DISEASE
tumorigenesis	B-UNK
.	O

 	O
a	O
major	B-UNK
function	B-UNK
of	O
apc	B-UNK
is	O
the	O
downregulation	O
of	O
beta	B-UNK
-	O
catenin	B-UNK
,	O
a	O
transcription	B-UNK
-	O
activating	B-UNK
protein	B-UNK
with	O
oncogenic	B-UNK
potential	B-UNK
.	O

 	O
in	O
an	O
ongoing	O
immunohistochemical	O
study	B-UNK
of	O
beta	B-UNK
-	O
catenin	B-UNK
expression	B-UNK
in	O
sporadic	B-UNK
cases	B-UNK
of	O
tumor	B-DISEASE
types	B-UNK
that	O
are	O
associated	B-UNK
with	O
adenomatous	B-DISEASE
polyposis	I-DISEASE
coli	I-DISEASE
,	O
we	O
observed	B-UNK
increased	B-UNK
beta	B-UNK
-	O
catenin	B-UNK
levels	B-UNK
in	O
the	O
cytoplasm	O
and	O
in	O
the	O
nuclei	O
of	O
three	O
investigated	B-UNK
hepatoblastomas	O
.	O

 	O
sequencing	B-UNK
of	O
exon	B-UNK
3	O
of	O
the	O
beta	B-UNK
-	O
catenin	B-UNK
gene	B-UNK
(	O
ctnnb1	O
)	O
revealed	B-UNK
an	O
activating	B-UNK
mutation	B-UNK
in	O
one	O
of	O
the	O
tumor	B-DISEASE
samples	B-UNK
.	O

 	O
our	O
data	B-UNK
indicate	B-UNK
for	O
the	O
first	O
time	B-UNK
that	O
beta	B-UNK
-	O
catenin	B-UNK
accumulation	B-UNK
may	O
play	O
a	O
role	B-UNK
in	O
the	O
development	B-UNK
of	O
hepatoblastoma	B-DISEASE
and	O
that	O
activating	B-UNK
mutations	B-UNK
of	O
the	O
beta	B-UNK
-	O
catenin	B-UNK
gene	B-UNK
may	O
substitute	O
biallelic	O
apc	B-UNK
inactivation	B-UNK
in	O
this	O
tumor	B-DISEASE
type	B-UNK
.	O

 	O
genes	B-UNK
chromosomes	B-UNK
cancer	B-DISEASE
25	O
399	O
-	O
402	O
,	O
1999	O
.	O
.	O

 	O
decrease	B-UNK
in	O
gtp	B-UNK
cyclohydrolase	B-UNK
i	O
gene	B-UNK
expression	B-UNK
caused	B-UNK
by	O
inactivation	B-UNK
of	O
one	O
allele	B-UNK
in	O
hereditary	B-UNK
progressive	B-UNK
dystonia	B-DISEASE
with	O
marked	B-UNK
diurnal	O
fluctuation	O
.	O

 	B-UNK
hereditary	I-UNK
progressive	B-UNK
dystonia	B-DISEASE
with	O
marked	B-UNK
diurnal	O
fluctuation	O
(	O
hpd	O
;	O
dopa	O
-	O
responsive	O
dystonia	B-DISEASE
,	O
drd	O
)	O
have	O
been	O
recently	B-UNK
found	B-UNK
to	O
be	O
caused	B-UNK
by	O
a	O
genetic	B-UNK
defect	B-UNK
in	O
the	O
gtp	B-UNK
cyclohydrolase	B-UNK
i	O
(	O
gch1	B-UNK
)	O
gene	B-UNK
.	O

 	O
in	O
this	O
study	B-UNK
,	O
we	O
quantified	O
the	O
mrna	B-UNK
level	B-UNK
of	O
gch1	B-UNK
in	O
phytohemagglutinin	O
(	O
pha	O
)	O
-	O
stimulated	B-UNK
mononuclear	O
blood	B-UNK
cells	I-UNK
from	O
one	O
japanese	B-UNK
family	B-UNK
that	O
do	O
not	O
have	O
a	O
mutation	B-UNK
in	O
the	O
coding	B-UNK
region	I-UNK
or	O
splice	O
junctions	B-UNK
of	O
the	O
gene	B-UNK
.	O

 	O
the	O
results	B-UNK
showed	B-UNK
that	O
the	O
amounts	B-UNK
of	O
the	O
gch1	B-UNK
mrna	B-UNK
were	O
decreased	B-UNK
to	O
about	O
40	O
%	O
of	O
the	O
normal	B-UNK
level	B-UNK
in	O
both	O
patients	B-UNK
and	O
carriers	B-UNK
.	O

 	O
in	O
addition	B-UNK
,	O
we	O
found	B-UNK
that	O
the	O
gch1	B-UNK
mrna	B-UNK
was	O
transcribed	B-UNK
from	O
only	O
one	O
allele	B-UNK
,	O
indicating	B-UNK
that	O
the	O
other	O
allele	B-UNK
was	O
in	O
an	O
inactive	B-UNK
state	B-UNK
.	O

 	O
these	O
results	B-UNK
suggest	B-UNK
that	O
some	O
novel	B-UNK
mutations	B-UNK
should	O
exist	O
on	O
one	O
of	O
the	O
alleles	B-UNK
in	O
some	O
unknown	B-UNK
region	B-UNK
of	O
the	O
gch1	B-UNK
gene	B-UNK
,	O
and	O
may	O
decrease	B-UNK
the	O
gch1	B-UNK
mrna	B-UNK
causing	B-UNK
the	O
hpd	O
/	O
drd	O
symptoms	B-UNK
.	O
.	O

 	O
sulfate	B-UNK
transport	I-UNK
is	O
not	O
impaired	B-UNK
in	O
pendred	B-DISEASE
syndrome	I-DISEASE
thyrocytes	O
.	O

 	O
pendred	B-DISEASE
syndrome	I-DISEASE
is	O
the	O
most	O
common	B-UNK
form	B-UNK
of	O
syndromic	O
deafness	B-DISEASE
,	O
characterized	B-UNK
by	O
dyshormonogenic	O
goiter	B-DISEASE
associated	B-UNK
with	O
sensory	O
-	O
neural	B-UNK
deafness	B-DISEASE
.	O

 	O
the	O
gene	B-UNK
responsible	B-UNK
for	O
the	O
disease	B-DISEASE
(	O
pds	B-UNK
)	O
has	O
been	O
cloned	B-UNK
,	O
but	O
its	O
function	B-UNK
is	O
as	O
yet	O
unknown	B-UNK
and	O
the	O
connection	O
between	O
thyroid	B-DISEASE
goiter	B-DISEASE
and	O
sensory	O
-	O
neural	B-UNK
deafness	B-DISEASE
remains	B-UNK
an	O
enigma	O
.	O

 	O
pds	B-UNK
codes	O
for	O
a	O
novel	B-UNK
protein	B-UNK
,	O
pendrin	B-UNK
,	O
which	O
is	O
closely	B-UNK
related	B-UNK
to	O
a	O
number	B-UNK
of	O
sufate	O
transporters	B-UNK
.	O

 	O
mechanisms	B-UNK
by	O
which	O
abnormal	B-UNK
sulfate	B-UNK
transport	I-UNK
could	O
deleteriously	O
affect	B-UNK
iodide	B-UNK
organification	O
have	O
been	O
proposed	B-UNK
.	O

 	O
we	O
tested	B-UNK
sulfate	B-UNK
transport	I-UNK
in	O
thyrocytes	O
obtained	B-UNK
from	O
pendred	B-DISEASE
syndrome	I-DISEASE
patients	B-UNK
and	O
found	B-UNK
that	O
it	O
was	O
not	O
defective	B-UNK
.	O

 	O
this	O
suggests	B-UNK
that	O
pendrin	B-UNK
in	O
fact	O
may	O
not	O
be	O
a	O
sulfate	B-UNK
transporter	B-UNK
,	O
and	O
emphasizes	O
the	O
importance	O
of	O
functional	B-UNK
studies	B-UNK
on	O
this	O
novel	B-UNK
protein	B-UNK
.	O
.	O

 	B-UNK
small	I-UNK
deletions	B-UNK
in	O
the	O
type	B-UNK
ii	I-UNK
collagen	I-UNK
triple	B-UNK
helix	B-UNK
produce	B-UNK
kniest	B-DISEASE
dysplasia	I-DISEASE
.	O

 	O
kniest	B-DISEASE
dysplasia	I-DISEASE
is	O
a	O
moderately	B-UNK
severe	B-UNK
type	B-UNK
ii	I-UNK
collagenopathy	B-DISEASE
,	O
characterized	B-UNK
by	O
short	B-UNK
trunk	O
and	O
limbs	O
,	O
kyphoscoliosis	O
,	O
midface	B-DISEASE
hypoplasia	I-DISEASE
,	O
severe	B-UNK
myopia	B-DISEASE
,	O
and	O
hearing	B-DISEASE
loss	I-DISEASE
.	O

 	O
mutations	B-UNK
in	O
the	O
gene	B-UNK
that	O
encodes	B-UNK
type	B-UNK
ii	I-UNK
collagen	I-UNK
(	O
col2a1	B-UNK
)	O
,	O
the	O
predominant	B-UNK
protein	B-UNK
of	O
cartilage	O
,	O
have	O
been	O
identified	B-UNK
in	O
a	O
number	B-UNK
of	O
individuals	B-UNK
with	O
kniest	B-DISEASE
dysplasia	I-DISEASE
.	O

 	O
all	O
but	O
two	O
of	O
these	O
previously	B-UNK
described	I-UNK
mutations	B-UNK
cause	B-UNK
in	O
-	O
frame	B-UNK
deletions	B-UNK
in	O
type	B-UNK
ii	I-UNK
collagen	I-UNK
,	O
either	O
by	O
small	B-UNK
deletions	B-UNK
in	O
the	O
gene	B-UNK
or	O
splice	B-UNK
site	I-UNK
alterations	B-UNK
.	O

 	O
furthermore	B-UNK
,	O
all	O
but	O
one	O
of	O
these	O
mutations	B-UNK
is	O
located	B-UNK
between	O
exons	B-UNK
12	O
and	O
24	O
in	O
the	O
col2a1	B-UNK
gene	B-UNK
.	O

 	O
we	O
used	O
heteroduplex	B-UNK
analysis	B-UNK
to	O
identify	B-UNK
sequence	B-UNK
anomalies	B-UNK
in	O
five	O
individuals	B-UNK
with	O
kniest	B-DISEASE
dysplasia	I-DISEASE
.	O

 	O
sequencing	B-UNK
of	O
the	O
index	B-UNK
patients	B-UNK
genomic	B-UNK
dna	I-UNK
identified	B-UNK
four	O
new	B-UNK
dominant	B-UNK
mutations	B-UNK
in	O
col2a1	B-UNK
that	O
result	B-UNK
in	O
kniest	B-DISEASE
dysplasia	I-DISEASE
a	O
21	O
-	O
bp	B-UNK
deletion	I-UNK
in	O
exon	B-UNK
16	O
,	O
an	O
18	O
-	O
bp	B-UNK
deletion	I-UNK
in	O
exon	B-UNK
19	O
,	O
and	O
4	O
-	O
bp	B-UNK
deletions	B-UNK
in	O
the	O
splice	B-UNK
donor	I-UNK
sites	B-UNK
of	O
introns	B-UNK
14	O
and	O
20	O
.	O

 	O
a	O
previously	B-UNK
described	I-UNK
28	O
-	O
bp	B-UNK
deletion	I-UNK
at	B-DISEASE
the	O
col2a1	B-UNK
exon	B-UNK
12	O
-	O
intron	B-UNK
12	O
junction	B-UNK
,	O
deleting	O
the	O
splice	B-UNK
donor	I-UNK
site	I-UNK
,	O
was	O
identified	B-UNK
in	O
the	O
fifth	B-UNK
case	B-UNK
.	O

 	O
the	O
latter	O
three	O
mutations	B-UNK
are	O
predicted	B-UNK
to	O
result	B-UNK
in	O
exon	B-UNK
skipping	B-UNK
in	O
the	O
mrna	B-UNK
encoded	B-UNK
from	O
the	O
mutant	B-UNK
allele	I-UNK
.	O

 	O
these	O
data	B-UNK
suggest	B-UNK
that	O
kniest	B-DISEASE
dysplasia	I-DISEASE
results	B-UNK
from	O
shorter	B-UNK
type	B-UNK
ii	I-UNK
collagen	I-UNK
monomers	O
,	O
and	O
support	B-UNK
the	O
hypothesis	O
that	O
alteration	B-UNK
of	O
a	O
specific	B-UNK
col2a1	B-UNK
domain	B-UNK
,	O
which	O
may	O
span	B-UNK
from	O
exons	B-UNK
12	O
to	O
24	O
,	O
leads	B-UNK
to	O
the	O
kniest	B-DISEASE
dysplasia	I-DISEASE
phenotype	B-UNK
.	O
.	O

 	O
classical	B-UNK
galactosemia	B-UNK
and	O
mutations	B-UNK
at	B-DISEASE
the	O
galactose	B-UNK
-	O
1	O
-	O
phosphate	B-UNK
uridyl	I-UNK
transferase	O
(	O
galt	B-UNK
)	O
gene	B-UNK
.	O

 	O
classical	B-UNK
galactosemia	B-UNK
is	O
caused	B-UNK
by	O
a	O
deficiency	B-UNK
in	O
activity	B-UNK
of	O
the	O
enzyme	B-UNK
galactose	B-UNK
-	O
1	O
-	O
phosphate	B-UNK
uridyl	I-UNK
transferase	O
(	O
galt	B-UNK
)	O
,	O
which	O
,	O
in	O
turn	O
,	O
is	O
caused	B-UNK
by	O
mutations	B-UNK
at	B-DISEASE
the	O
galt	B-UNK
gene	B-UNK
.	O

 	O
the	O
disorder	O
exhibits	O
considerable	B-UNK
allelic	B-UNK
heterogeneity	I-UNK
and	O
,	O
at	B-DISEASE
the	O
end	B-UNK
of	O
1998	O
,	O
more	O
than	O
150	O
different	B-UNK
base	B-UNK
changes	B-UNK
were	O
recorded	O
in	O
24	O
different	B-UNK
populations	B-UNK
and	O
ethnic	B-UNK
groups	B-UNK
in	O
15	O
countries	B-UNK
worldwide	B-UNK
.	O

 	O
the	O
mutations	B-UNK
most	O
frequently	B-UNK
cited	O
are	O
q188r	O
,	O
k285n	O
,	O
s135l	B-UNK
,	O
and	O
n314d	B-UNK
.	O

 	O
q188r	O
is	O
the	O
most	O
common	B-UNK
mutation	B-UNK
in	O
european	B-UNK
populations	B-UNK
or	O
in	O
those	O
predominantly	B-UNK
of	O
european	B-UNK
descent	B-UNK
.	O

 	O
overall	B-UNK
,	O
it	O
accounts	O
for	O
60	O
-	O
70	O
%	O
of	O
mutant	B-UNK
chromosomes	B-UNK
,	O
but	O
there	O
are	O
significant	B-UNK
differences	I-UNK
in	O
its	O
relative	B-UNK
frequency	B-UNK
in	O
individual	B-UNK
populations	B-UNK
.	O

 	O
individuals	B-UNK
homoallelic	O
for	O
q188r	O
tend	O
to	O
have	O
a	O
severe	B-UNK
phenotype	B-UNK
and	O
this	O
is	O
in	O
keeping	O
with	O
the	O
virtually	B-UNK
complete	B-UNK
loss	B-UNK
of	O
enzyme	B-UNK
activity	I-UNK
observed	B-UNK
in	O
in	O
vitro	B-UNK
expression	I-UNK
systems	B-UNK
.	O

 	O
globally	O
,	O
k285n	O
is	O
rarer	O
,	O
but	O
in	O
many	O
european	B-UNK
populations	B-UNK
it	O
can	O
be	O
found	B-UNK
on	O
25	O
-	O
40	O
%	O
of	O
mutant	B-UNK
chromosomes	B-UNK
.	O

 	O
it	O
is	O
invariably	O
associated	B-UNK
with	O
a	O
severe	B-UNK
phenotype	B-UNK
.	O

 	O
s135l	B-UNK
is	O
found	B-UNK
almost	O
exclusively	B-UNK
in	O
african	B-UNK
americans	B-UNK
.	O

 	O
in	O
vitro	B-UNK
expression	I-UNK
results	B-UNK
are	O
discrepant	O
,	O
but	O
some	O
individuals	B-UNK
carrying	B-UNK
s135l	B-UNK
appear	B-UNK
to	O
exhibit	B-UNK
galt	B-UNK
activity	I-UNK
in	O
some	O
tissues	B-UNK
.	O

 	O
duarte	B-UNK
1	O
(	O
or	O
los	O
angeles	O
)	O
and	O
duarte	B-UNK
2	O
(	O
or	O
duarte	B-UNK
)	O
variants	B-UNK
carry	B-UNK
the	O
same	O
amino	B-UNK
acid	I-UNK
substitution	I-UNK
,	O
n314d	B-UNK
,	O
even	O
though	O
d1	O
is	O
associated	B-UNK
with	O
increased	B-UNK
erythrocyte	B-UNK
galt	B-UNK
activity	I-UNK
and	O
d2	B-UNK
with	O
reduced	B-UNK
activity	B-UNK
.	O

 	O
n314d	B-UNK
is	O
in	O
linkage	B-UNK
disequilibrium	I-UNK
with	O
other	O
base	B-UNK
changes	B-UNK
that	O
differ	B-UNK
on	O
the	O
d1	O
and	O
d2	B-UNK
alleles	B-UNK
.	O

 	O
n314d	B-UNK
does	O
not	O
impair	O
galt	B-UNK
activity	I-UNK
in	O
in	O
vitro	B-UNK
expression	I-UNK
systems	B-UNK
.	O

 	O
however	O
,	O
there	O
are	O
differences	B-UNK
in	O
the	O
abundance	O
of	O
galt	B-UNK
protein	B-UNK
in	O
lymphoblastoid	B-UNK
cells	B-UNK
lines	B-UNK
from	O
d2	B-UNK
and	O
d1	O
individuals	B-UNK
.	O

 	O
it	O
is	O
unclear	O
whether	O
the	O
specific	B-UNK
molecular	B-UNK
changes	B-UNK
that	O
distinguish	O
the	O
d1	O
and	O
d2	B-UNK
alleles	B-UNK
account	B-UNK
for	O
the	O
different	B-UNK
activities	B-UNK
.	O

 	O
the	O
considerable	B-UNK
genetic	B-UNK
heterogeneity	B-UNK
documented	B-UNK
to	O
date	B-UNK
undoubtedly	O
contributes	B-UNK
to	O
the	O
phenotypic	B-UNK
heterogeneity	B-UNK
that	O
is	O
observed	B-UNK
in	O
galactosemia	B-UNK
.	O

 	O
the	O
additional	B-UNK
effects	B-UNK
of	O
nonallelic	O
variation	B-UNK
and	O
other	O
constitutional	B-UNK
factors	B-UNK
on	O
phenotypic	B-UNK
variability	I-UNK
remain	O
to	O
be	O
elucidated	O
.	O
.	O

 	O
mutations	B-UNK
of	O
the	O
vhl	B-UNK
gene	B-UNK
in	O
sporadic	B-UNK
renal	B-DISEASE
cell	B-UNK
carcinoma	B-DISEASE
:	O
definition	O
of	O
a	O
risk	B-UNK
factor	B-UNK
for	O
vhl	B-UNK
patients	B-UNK
to	O
develop	B-UNK
an	O
rcc	O
.	O

 	O
to	O
investigate	O
the	O
nature	B-UNK
of	O
somatic	B-UNK
von	B-UNK
hippel	I-UNK
-	O
lindau	O
(	O
vhl	B-UNK
)	O
mutations	B-UNK
,	O
we	O
analyzed	B-UNK
173	O
primary	B-UNK
sporadic	B-UNK
human	B-UNK
renal	B-DISEASE
cell	B-UNK
carcinomas	B-UNK
for	O
mutations	B-UNK
of	O
the	O
vhl	B-UNK
tumor	B-DISEASE
suppressor	B-UNK
gene	B-UNK
,	O
using	O
polymerase	B-UNK
chain	I-UNK
reaction	I-UNK
(	O
pcr	B-UNK
)	O
and	O
single	B-UNK
-	O
strand	O
conformational	B-UNK
polymorphism	I-UNK
analysis	I-UNK
(	O
sscp	B-UNK
)	O
of	O
dna	B-UNK
.	O

 	O
we	O
detected	B-UNK
abnormal	B-UNK
sscp	B-UNK
pattern	B-UNK
in	O
73	O
samples	B-UNK
.	O

 	O
after	O
sequencing	B-UNK
,	O
we	O
identified	B-UNK
microdeletions	O
in	O
58	O
%	O
of	O
cases	B-UNK
,	O
microinsertions	O
in	O
17	O
%	O
,	O
nonsense	B-UNK
mutations	B-UNK
in	O
8	O
%	O
,	O
and	O
missense	B-UNK
mutations	I-UNK
in	O
17	O
%	O
.	O

 	O
among	O
these	O
mutations	B-UNK
,	O
50	O
%	O
correspond	O
to	O
new	B-UNK
mutations	B-UNK
.	O

 	O
vhl	B-UNK
mutations	B-UNK
were	O
found	B-UNK
only	O
in	O
the	O
nonpapillary	O
renal	B-DISEASE
cell	B-UNK
carcinoma	B-DISEASE
(	O
rcc	O
)	O
subtype	O
,	O
as	O
previously	B-UNK
reported	I-UNK
.	O

 	O
to	O
compare	O
somatic	B-UNK
and	O
germline	B-UNK
mutations	I-UNK
,	O
we	O
used	O
the	O
vhl	B-UNK
database	B-UNK
,	O
which	O
includes	B-UNK
507	O
mutations	B-UNK
.	O

 	O
the	O
study	B-UNK
of	O
mutational	B-UNK
events	I-UNK
revealed	B-UNK
a	O
significant	B-UNK
difference	B-UNK
between	O
somatic	B-UNK
and	O
germline	B-UNK
mutations	I-UNK
with	O
mutations	B-UNK
leading	B-UNK
to	O
truncated	B-UNK
proteins	B-UNK
observed	B-UNK
in	O
78	O
%	O
of	O
somatic	B-UNK
mutations	B-UNK
vs	B-UNK
only	O
37	O
%	O
in	O
germline	B-UNK
mutations	I-UNK
(	O
p	B-UNK
<	O
0	O
.	O
001	O
)	O
.	O

 	O
we	O
postulated	O
that	O
a	O
specific	B-UNK
pattern	B-UNK
of	O
vhl	B-UNK
mutations	B-UNK
is	O
associated	B-UNK
with	O
sporadic	B-UNK
rcc	O
.	O

 	O
this	O
pattern	B-UNK
corresponds	O
to	O
mutations	B-UNK
leading	B-UNK
mainly	B-UNK
to	O
truncated	B-UNK
proteins	B-UNK
with	O
few	O
specific	B-UNK
missense	B-UNK
mutations	I-UNK
.	O

 	O
we	O
then	O
analyzed	B-UNK
the	O
occurrence	B-UNK
of	O
rcc	O
in	O
vhl	B-UNK
families	B-UNK
,	O
based	B-UNK
on	O
the	O
nature	B-UNK
of	O
mutations	B-UNK
.	O

 	O
we	O
observed	B-UNK
rcc	O
in	O
at	B-DISEASE
least	O
one	O
member	B-UNK
of	O
the	O
vhl	B-UNK
families	B-UNK
in	O
77	O
%	O
of	O
cases	B-UNK
with	O
mutations	B-UNK
leading	B-UNK
to	O
truncated	B-UNK
proteins	B-UNK
versus	O
55	O
%	O
in	O
cases	B-UNK
with	O
missense	B-UNK
mutations	I-UNK
(	O
p	B-UNK
<	O
0	O
.	O
05	O
)	O
.	O

 	O
thus	O
,	O
mutations	B-UNK
resulting	B-UNK
in	O
truncated	B-UNK
proteins	B-UNK
may	O
lead	B-UNK
to	O
a	O
higher	B-UNK
risk	B-UNK
of	O
rcc	O
in	O
vhl	B-UNK
patients	B-UNK

 	B-UNK
defective	I-UNK
ctla	O
-	O
4	O
cycling	O
pathway	B-UNK
in	O
chediak	B-DISEASE
-	I-DISEASE
higashi	I-DISEASE
syndrome	I-DISEASE
:	O
a	O
possible	B-UNK
mechanism	B-UNK
for	O
deregulation	O
of	O
t	B-UNK
lymphocyte	I-UNK
activation	B-UNK
.	O

 	O
cytotoxic	O
t	B-UNK
lymphocyte	I-UNK
-	O
associated	B-UNK
antigen	B-UNK
4	O
(	O
ctla	O
-	O
4	O
,	O
also	O
known	B-UNK
as	O
cd152	O
)	O
has	O
been	O
shown	B-UNK
to	O
play	O
a	O
major	B-UNK
role	B-UNK
in	O
the	O
regulation	B-UNK
of	O
t	B-UNK
cell	B-UNK
activation	B-UNK
.	O

 	O
its	O
membrane	B-UNK
expression	B-UNK
is	O
highly	B-UNK
regulated	B-UNK
by	O
endocytosis	O
and	O
trafficking	O
through	O
the	O
secretory	O
lysosome	O
pathway	B-UNK
.	O

 	O
chediak	B-DISEASE
-	I-DISEASE
higashi	I-DISEASE
syndrome	I-DISEASE
(	O
chs	O
)	O
is	O
an	O
inherited	B-UNK
disorder	O
caused	B-UNK
by	O
mutations	B-UNK
in	O
the	O
lysosomal	B-UNK
trafficking	O
regulator	B-UNK
gene	B-UNK
,	O
lyst	O
.	O

 	O
it	O
results	B-UNK
in	O
defective	B-UNK
membrane	B-UNK
targeting	B-UNK
of	O
the	O
proteins	B-UNK
present	B-UNK
in	O
secretory	O
lysosomes	O
,	O
and	O
it	O
is	O
associated	B-UNK
with	O
a	O
variety	B-UNK
of	O
features	B-UNK
,	O
including	B-UNK
a	O
lymphoproliferative	B-DISEASE
syndrome	I-DISEASE
with	O
hemophagocytosis	O
.	O

 	O
the	O
murine	B-UNK
equivalent	O
of	O
chs	O
,	O
beige	O
mice	B-UNK
,	O
present	B-UNK
similar	B-UNK
characteristics	B-UNK
but	O
do	O
not	O
develop	B-UNK
the	O
lymphoproliferative	B-DISEASE
syndrome	I-DISEASE
.	O

 	O
we	O
show	O
herein	O
that	O
ctla	O
-	O
4	O
is	O
present	B-UNK
in	O
enlarged	O
,	O
abnormal	B-UNK
vesicles	B-UNK
in	O
chs	O
t	B-UNK
cells	I-UNK
and	O
is	O
not	O
properly	O
expressed	B-UNK
at	B-DISEASE
the	O
cell	B-UNK
surface	B-UNK
after	O
t	B-UNK
cell	B-UNK
activation	B-UNK
,	O
whereas	O
its	O
surface	B-UNK
expression	B-UNK
is	O
not	O
impaired	B-UNK
.	O

 	O
it	O
is	O
therefore	O
proposed	B-UNK
that	O
the	O
defective	B-UNK
surface	B-UNK
expression	B-UNK
of	O
ctla	O
-	O
4	O
by	O
chs	O
t	B-UNK
cells	I-UNK
is	O
involved	B-UNK
in	O
the	O
generation	B-UNK
of	O
lymphoproliferative	O
disease	B-DISEASE
.	O

 	O
this	O
observation	B-UNK
may	O
provide	B-UNK
insight	B-UNK
into	O
the	O
role	B-UNK
of	O
ctla	O
-	O
4	O
in	O
humans	B-UNK
.	O
.	O

 	O
proteolipoprotein	O
gene	B-UNK
analysis	B-UNK
in	O
82	O
patients	B-UNK
with	O
sporadic	B-UNK
pelizaeus	B-DISEASE
-	I-DISEASE
merzbacher	I-DISEASE
disease	I-DISEASE
:	O
duplications	O
,	O
the	O
major	B-UNK
cause	B-UNK
of	O
the	O
disease	B-DISEASE
,	O
originate	O
more	O
frequently	B-UNK
in	O
male	B-UNK
germ	O
cells	B-UNK
,	O
but	O
point	B-UNK
mutations	I-UNK
do	O
not	O
.	O

 	O
the	O
clinical	B-UNK
european	B-UNK
network	O
on	O
brain	B-UNK
dysmyelinating	B-UNK
disease	B-DISEASE
.	O

 	O
pelizaeus	B-DISEASE
-	I-DISEASE
merzbacher	I-DISEASE
disease	I-DISEASE
(	O
pmd	O
)	O
is	O
an	O
x	B-UNK
-	O
linked	B-UNK
developmental	B-UNK
defect	B-UNK
of	O
myelination	O
affecting	B-UNK
the	O
central	B-UNK
nervous	I-UNK
system	I-UNK
and	O
segregating	B-UNK
with	O
the	O
proteolipoprotein	O
(	O
plp	B-UNK
)	O
locus	B-UNK
.	O

 	O
investigating	O
82	O
strictly	O
selected	B-UNK
sporadic	B-UNK
cases	B-UNK
of	O
pmd	O
,	O
we	O
found	B-UNK
plp	B-UNK
mutations	B-UNK
in	O
77	O
%	O
;	O
complete	B-UNK
plp	B-UNK
-	O
gene	B-UNK
duplications	O
were	O
the	O
most	O
frequent	B-UNK
abnormality	B-UNK
(	O
62	O
%	O
)	O
,	O
whereas	O
point	B-UNK
mutations	I-UNK
in	O
coding	B-UNK
or	O
splice	O
-	O
site	B-UNK
regions	B-UNK
of	O
the	O
gene	B-UNK
were	O
involved	B-UNK
less	O
frequently	B-UNK
(	O
38	O
%	O
)	O
.	O

 	O
we	O
analyzed	B-UNK
the	O
maternal	B-UNK
status	B-UNK
of	O
56	O
cases	B-UNK
to	O
determine	O
the	O
origin	B-UNK
of	O
both	O
types	B-UNK
of	O
plp	B-UNK
mutation	B-UNK
,	O
since	O
this	O
is	O
relevant	B-UNK
to	O
genetic	B-UNK
counseling	B-UNK
.	O

 	O
in	O
the	O
22	O
point	B-UNK
mutations	I-UNK
,	O
68	O
%	O
of	O
mothers	B-UNK
were	O
heterozygous	B-UNK
for	O
the	O
mutation	B-UNK
,	O
a	O
value	B-UNK
identical	B-UNK
to	O
the	O
two	O
-	O
thirds	O
of	O
carrier	B-UNK
mothers	B-UNK
that	O
would	O
be	O
expected	B-UNK
if	O
there	O
were	O
an	O
equal	B-UNK
mutation	B-UNK
rate	B-UNK
in	O
male	B-UNK
and	O
female	B-UNK
germ	O
cells	B-UNK
.	O

 	O
in	O
sharp	O
contrast	B-UNK
,	O
among	O
the	O
34	O
duplicated	B-UNK
cases	B-UNK
,	O
91	O
%	O
of	O
mothers	B-UNK
were	O
carriers	B-UNK
,	O
a	O
value	B-UNK
significantly	B-UNK
(	O
chi2	O
=	O
9	O
.	O
20	O
,	O
p	B-UNK
<	O
.	O
01	O
)	O
in	O
favor	O
of	O
a	O
male	B-UNK
bias	B-UNK
,	O
with	O
an	O
estimation	B-UNK
of	O
the	O
male	B-UNK
/	O
female	B-UNK
mutation	B-UNK
frequency	B-UNK
(	O
k	B-UNK
)	O
of	O
9	O
.	O

 	O
3	O
3	O
.	O

 	O
moreover	O
,	O
we	O
observed	B-UNK
the	O
occurrence	B-UNK
of	O
de	B-UNK
novo	I-UNK
mutations	B-UNK
between	O
parental	B-UNK
and	O
grandparental	O
generations	B-UNK
in	O
17	O
three	O
-	O
generation	B-UNK
families	B-UNK
,	O
which	O
allowed	B-UNK
a	O
direct	B-UNK
estimation	B-UNK
of	O
the	O
k	B-UNK
value	B-UNK
(	O
k	B-UNK
=	O
11	O
)	O
.	O

 	O
again	O
,	O
a	O
significant	B-UNK
male	B-UNK
mutation	B-UNK
imbalance	O
was	O
observed	B-UNK
only	O
for	O
the	O
duplications	O
.	O

 	B-UNK
chromosome	I-UNK
breakage	O
in	O
the	O
prader	O
-	O
willi	O
and	O
angelman	O
syndromes	B-UNK
involves	B-UNK
recombination	B-UNK
between	O
large	B-UNK
,	O
transcribed	B-UNK
repeats	B-UNK
at	B-DISEASE
proximal	B-UNK
and	O
distal	B-UNK
breakpoints	B-UNK
.	O

 	O
prader	B-DISEASE
-	I-DISEASE
willi	I-DISEASE
syndrome	I-DISEASE
(	O
pws	B-UNK
)	O
and	O
angelman	B-DISEASE
syndrome	I-DISEASE
(	O
as	O
)	O
are	O
distinct	B-UNK
neurobehavioral	O
disorders	B-UNK
that	O
most	O
often	O
arise	O
from	O
a	O
4	O
-	O
mb	B-UNK
deletion	B-UNK
of	O
chromosome	B-UNK
15q11	I-UNK
-	O
q13	O
during	O
paternal	B-UNK
or	O
maternal	B-UNK
gametogenesis	O
,	O
respectively	B-UNK
.	O

 	O
at	B-DISEASE
a	O
de	B-UNK
novo	I-UNK
frequency	B-UNK
of	O
approximately	B-UNK
.	O

 	O
67	O
-	O
1	O
/	O
10	O
,	O
000	O
births	B-UNK
,	O
these	O
deletions	B-UNK
represent	B-UNK
a	O
common	B-UNK
structural	B-UNK
chromosome	B-UNK
change	B-UNK
in	O
the	O
human	B-UNK
genome	B-UNK
.	O

 	O
to	O
elucidate	O
the	O
mechanism	B-UNK
underlying	B-UNK
these	O
events	B-UNK
,	O
we	O
characterized	B-UNK
the	O
regions	B-UNK
that	O
contain	B-UNK
two	O
proximal	B-UNK
breakpoint	B-UNK
clusters	O
and	O
a	O
distal	B-UNK
cluster	O
.	O

 	B-UNK
novel	I-UNK
dna	B-UNK
sequences	I-UNK
potentially	B-UNK
associated	B-UNK
with	O
the	O
breakpoints	B-UNK
were	O
positionally	O
cloned	B-UNK
from	O
yacs	B-UNK
within	O
or	O
near	B-UNK
these	O
regions	B-UNK
.	O

 	O
analyses	B-UNK
of	O
rodent	O
-	O
human	B-UNK
somatic	B-UNK
-	O
cell	B-UNK
hybrids	O
,	O
yac	B-UNK
contigs	O
,	O
and	O
fish	B-UNK
of	O
normal	B-UNK
or	O
rearranged	B-UNK
chromosomes	B-UNK
15	O
identified	B-UNK
duplicated	B-UNK
sequences	B-UNK
(	O
the	O
end	B-UNK
repeats	B-UNK
)	O
at	B-DISEASE
or	O
near	B-UNK
the	O
breakpoints	B-UNK
.	O

 	O
the	O
end	B-UNK
-	O
repeat	B-UNK
units	B-UNK
are	O
derived	B-UNK
from	O
large	B-UNK
genomic	B-UNK
duplications	O
of	O
a	O
novel	B-UNK
gene	B-UNK
(	O
herc2	O
)	O
,	O
many	O
copies	B-UNK
of	O
which	O
are	O
transcriptionally	O
active	B-UNK
in	O
germline	B-UNK
tissues	B-UNK
.	O

 	O
one	O
of	O
five	O
pws	B-UNK
/	O
as	O
patients	B-UNK
analyzed	B-UNK
to	O
date	B-UNK
has	O
an	O
identifiable	O
,	O
rearranged	B-UNK
herc2	O
transcript	B-UNK
derived	B-UNK
from	O
the	O
deletion	B-UNK
event	B-UNK
.	O

 	O
we	O
postulate	O
that	O
the	O
end	B-UNK
repeats	B-UNK
flanking	B-UNK
15q11	B-UNK
-	O
q13	O
mediate	O
homologous	B-UNK
recombination	I-UNK
resulting	B-UNK
in	O
deletion	B-UNK
.	O

 	O
furthermore	B-UNK
,	O
we	O
propose	O
that	O
active	B-UNK
transcription	B-UNK
of	O
these	O
repeats	B-UNK
in	O
male	B-UNK
and	O
female	B-UNK
germ	O
cells	B-UNK
may	O
facilitate	B-UNK
the	O
homologous	B-UNK
recombination	I-UNK
process	B-UNK
.	O

 	B-UNK
linkage	I-UNK
analysis	B-UNK
in	O
a	O
large	B-UNK
brazilian	O
family	B-UNK
with	O
van	B-DISEASE
der	I-DISEASE
woude	I-DISEASE
syndrome	I-DISEASE
suggests	B-UNK
the	O
existence	O
of	O
a	O
susceptibility	B-UNK
locus	B-UNK
for	O
cleft	B-DISEASE
palate	I-DISEASE
at	B-DISEASE
17p11	O
.	O
2	O
-	O
11	O
.	O
1	O
.	O

 	O
van	B-DISEASE
der	I-DISEASE
woude	I-DISEASE
syndrome	I-DISEASE
(	O
vws	B-UNK
)	O
,	O
which	O
has	O
been	O
mapped	B-UNK
to	O
1q32	B-UNK
-	O
41	O
,	O
is	O
characterized	B-UNK
by	O
pits	O
and	O
/	O
or	O
sinuses	O
of	O
the	O
lower	B-UNK
lip	B-DISEASE
,	O
cleft	B-DISEASE
lip	I-DISEASE
/	O
palate	O
(	O
cl	O
/	O
p	B-UNK
)	O
,	O
cleft	B-DISEASE
palate	I-DISEASE
(	O
cp	O
)	O
,	O
bifid	O
uvula	O
,	O
and	O
hypodontia	B-DISEASE
(	O
h	O
)	O
.	O

 	O
the	O
expression	B-UNK
of	O
vws	B-UNK
,	O
which	O
has	O
incomplete	B-UNK
penetrance	B-UNK
,	O
is	O
highly	B-UNK
variable	B-UNK
.	O

 	O
both	O
the	O
occurrence	B-UNK
of	O
cl	O
/	O
p	B-UNK
and	O
cp	O
within	O
the	O
same	O
genealogy	O
and	O
a	O
recurrence	B-DISEASE
risk	B-UNK
<	O
40	O
%	O
for	O
cp	O
among	O
descendants	O
with	O
vws	B-UNK
have	O
suggested	B-UNK
that	O
the	O
development	B-UNK
of	O
clefts	O
in	O
this	O
syndrome	B-DISEASE
is	O
influenced	O
by	O
modifying	O
genes	B-UNK
at	B-DISEASE
other	O
loci	B-UNK
.	O

 	O
to	O
test	B-UNK
this	O
hypothesis	O
,	O
we	O
have	O
conducted	O
linkage	B-UNK
analysis	I-UNK
in	O
a	O
large	B-UNK
brazilian	O
kindred	B-UNK
with	O
vws	B-UNK
,	O
considering	O
as	O
affected	B-UNK
the	O
individuals	B-UNK
with	O
cp	O
,	O
regardless	O
of	O
whether	O
it	O
is	O
associated	B-UNK
with	O
other	O
clinical	B-UNK
signs	B-UNK
of	O
vws	B-UNK
.	O

 	O
our	O
results	B-UNK
suggest	B-UNK
that	O
a	O
gene	B-UNK
at	B-DISEASE
17p11	O
.	O

 	O
2	O
-	O
11	O
2	O
-	O
11	O
.	O

 	O
1	O
,	O
together	O
with	O
the	O
vws	B-UNK
gene	B-UNK
at	B-DISEASE
1p32	O
-	O
41	O
,	O
enhances	O
the	O
probability	O
of	O
cp	O
in	O
an	O
individual	B-UNK
carrying	B-UNK
the	O
two	O
at	B-DISEASE
-	O
risk	B-UNK
genes	B-UNK
.	O

 	O
if	O
this	O
hypothesis	O
is	O
confirmed	B-UNK
in	O
other	O
vws	B-UNK
pedigrees	B-UNK
,	O
it	O
will	O
represent	B-UNK
one	O
of	O
the	O
first	O
examples	O
of	O
a	O
gene	B-UNK
,	O
mapped	B-UNK
through	O
linkage	B-UNK
analysis	I-UNK
,	O
which	O
modifies	O
the	O
expression	B-UNK
of	O
a	O
major	B-UNK
gene	B-UNK
.	O

 	B-UNK
new	I-UNK
mutations	B-UNK
,	O
polymorphisms	B-UNK
,	O
and	O
rare	B-UNK
variants	B-UNK
in	O
the	O
atm	B-UNK
gene	B-UNK
detected	B-UNK
by	O
a	O
novel	B-UNK
sscp	B-UNK
strategy	O
.	O

 	O
the	O
gene	B-UNK
for	O
ataxia	B-DISEASE
-	O
telangiectasia	B-DISEASE
,	O
atm	B-UNK
,	O
spans	B-UNK
about	O
150	O
kb	B-UNK
of	O
genomic	B-UNK
dna	I-UNK
.	O

 	B-UNK
atm	I-UNK
mutations	B-UNK
are	O
found	B-UNK
along	O
the	O
entire	B-UNK
gene	B-UNK
,	O
with	O
no	O
evidence	B-UNK
of	O
a	O
mutational	B-UNK
hot	I-UNK
spot	B-UNK
.	O

 	O
using	O
dna	B-UNK
as	O
the	O
starting	B-UNK
material	B-UNK
,	O
we	O
screened	O
the	O
atm	B-UNK
gene	B-UNK
in	O
92	O
a	O
-	O
t	B-UNK
patients	B-UNK
,	O
using	O
an	O
optimized	O
single	B-UNK
-	O
strand	B-UNK
conformation	I-UNK
polymorphism	I-UNK
(	O
sscp	B-UNK
)	O
technique	B-UNK
that	O
detected	B-UNK
all	O
previously	B-UNK
known	B-UNK
mutations	B-UNK
in	O
the	O
polymerase	B-UNK
chain	I-UNK
reaction	I-UNK
(	O
pcr	B-UNK
)	O
segments	B-UNK
being	O
analyzed	B-UNK
.	O

 	O
to	O
expedite	O
screening	B-UNK
,	O
we	O
sequentially	O
loaded	B-UNK
the	O
sscp	B-UNK
gels	B-UNK
with	O
three	O
different	B-UNK
sets	O
of	O
pcr	B-UNK
products	B-UNK
that	O
were	O
pretested	O
to	O
avoid	B-UNK
overlapping	B-UNK
patterns	B-UNK
.	O

 	O
many	O
of	O
the	O
dna	B-UNK
changes	B-UNK
we	O
detected	B-UNK
were	O
intragenic	B-UNK
polymorphisms	B-UNK
.	O

 	O
of	O
an	O
expected	B-UNK
177	O
unknown	B-UNK
mutations	B-UNK
,	O
we	O
detected	B-UNK
approximately	B-UNK
70	O
%	O
,	O
mostly	O
protein	B-UNK
truncating	B-UNK
mutations	B-UNK
(	O
that	O
would	O
have	O
been	O
detectable	B-UNK
by	O
protein	B-UNK
truncation	O
testing	B-UNK
if	O
rna	B-UNK
starting	B-UNK
material	B-UNK
had	O
been	O
available	B-UNK
)	O
.	O

 	O
mutations	B-UNK
have	O
now	O
been	O
defined	B-UNK
for	O
every	O
exon	B-UNK
of	O
the	O
atm	B-UNK
gene	B-UNK
.	O

 	O
herein	O
,	O
we	O
present	B-UNK
35	O
new	B-UNK
mutations	B-UNK
and	O
34	O
new	B-UNK
intragenic	B-UNK
polymorphisms	B-UNK
or	O
rare	B-UNK
variants	B-UNK
within	O
the	O
atm	B-UNK
gene	B-UNK
.	O

 	O
this	O
is	O
the	O
most	O
comprehensive	B-UNK
compilation	O
of	O
atm	B-UNK
polymorphisms	B-UNK
assembled	O
to	O
date	B-UNK
.	O

 	O
defining	O
polymorphic	B-UNK
sites	B-UNK
as	O
well	O
as	O
mutations	B-UNK
in	O
the	O
atm	B-UNK
gene	B-UNK
will	O
be	O
of	O
great	B-UNK
importance	O
in	O
designing	O
automated	O
methods	B-UNK
for	O
detecting	B-UNK
mutations	B-UNK
.	O
.	O

 	O
a	O
novel	B-UNK
frameshift	B-UNK
mutation	B-UNK
in	O
the	O
mcleod	B-UNK
syndrome	B-DISEASE
gene	B-UNK
in	O
a	O
japanese	B-UNK
family	B-UNK
.	O

 	O
we	O
report	B-UNK
a	O
novel	B-UNK
mutation	B-UNK
in	O
the	O
xk	O
gene	B-UNK
(	O
xk	O
)	O
in	O
a	O
japanese	B-UNK
patient	B-UNK
with	O
mcleod	B-UNK
syndrome	B-DISEASE
.	O

 	O
a	O
50	O
-	O
year	B-UNK
-	O
old	B-UNK
man	B-UNK
showed	B-UNK
progressive	B-UNK
muscular	B-DISEASE
atrophy	I-DISEASE
,	O
choreic	O
movement	O
,	O
elevated	B-UNK
level	B-UNK
of	O
serum	B-UNK
creatinine	O
kinase	B-UNK
,	O
and	O
acanthocytosis	O
.	O

 	O
the	O
expression	B-UNK
level	B-UNK
of	O
all	O
the	O
kell	O
antigens	B-UNK
in	O
erythrocyte	B-UNK
was	O
decreased	B-UNK
and	O
molecular	B-UNK
analysis	B-UNK
revealed	B-UNK
a	O
single	B-UNK
-	O
base	B-UNK
(	O
t	B-UNK
)	O
deletion	B-UNK
at	B-DISEASE
the	O
nucleotide	B-UNK
position	B-UNK
1095	O
in	O
xk	O
.	O

 	O
this	O
deletion	B-UNK
caused	B-UNK
a	O
frameshift	B-UNK
in	O
translation	B-UNK
,	O
leading	B-UNK
to	O
a	O
premature	B-UNK
stop	B-UNK
codon	B-UNK
at	B-DISEASE
the	O
amino	B-UNK
acid	I-UNK
position	B-UNK
408	O
.	O

 	O
we	O
conclude	O
this	O
single	B-UNK
-	O
base	B-UNK
deletion	B-UNK
causes	B-UNK
defective	B-UNK
kx	O
protein	B-UNK
,	O
which	O
is	O
responsible	B-UNK
for	O
the	O
mcleod	B-UNK
phenotype	B-UNK
in	O
this	O
patient	B-UNK
.	O
.	O

 	O
association	B-UNK
of	O
brca1	B-UNK
with	O
the	O
hrad50	O
-	O
hmre11	B-UNK
-	O
p95	B-UNK
complex	B-UNK
and	O
the	O
dna	B-UNK
damage	I-UNK
response	B-UNK
.	O

 	B-UNK
brca1	I-UNK
encodes	B-UNK
a	O
tumor	B-DISEASE
suppressor	B-UNK
that	O
is	O
mutated	B-UNK
in	O
familial	B-UNK
breast	B-UNK
and	O
ovarian	B-UNK
cancers	B-DISEASE
.	O

 	O
here	O
,	O
it	O
is	O
shown	B-UNK
that	O
brca1	B-UNK
interacts	B-UNK
in	O
vitro	B-UNK
and	O
in	O
vivo	B-UNK
with	O
hrad50	O
,	O
which	O
forms	B-UNK
a	O
complex	B-UNK
with	O
hmre11	B-UNK
and	O
p95	B-UNK
/	O
nibrin	B-UNK
.	O

 	O
upon	O
irradiation	O
,	O
brca1	B-UNK
was	O
detected	B-UNK
in	O
discrete	B-UNK
foci	B-UNK
in	O
the	O
nucleus	O
,	O
which	O
colocalize	O
with	O
hrad50	O
.	O

 	O
formation	B-UNK
of	O
irradiation	O
-	O
induced	B-UNK
foci	B-UNK
positive	B-UNK
for	O
brca1	B-UNK
,	O
hrad50	O
,	O
hmre11	B-UNK
,	O
or	O
p95	B-UNK
was	O
dramatically	B-UNK
reduced	B-UNK
in	O
hcc	O
/	O
1937	O
breast	B-DISEASE
cancer	I-DISEASE
cells	B-UNK
carrying	B-UNK
a	O
homozygous	B-UNK
mutation	B-UNK
in	O
brca1	B-UNK
but	O
was	O
restored	B-UNK
by	O
transfection	O
of	O
wild	B-UNK
-	O
type	B-UNK
brca1	B-UNK
.	O

 	O
ectopic	B-UNK
expression	B-UNK
of	O
wild	B-UNK
-	O
type	B-UNK
,	O
but	O
not	O
mutated	B-UNK
,	O
brca1	B-UNK
in	O
these	O
cells	B-UNK
rendered	O
them	O
less	O
sensitive	B-UNK
to	O
the	O
dna	B-UNK
damage	I-UNK
agent	B-UNK
,	O
methyl	O
methanesulfonate	O
.	O

 	O
these	O
data	B-UNK
suggest	B-UNK
that	O
brca1	B-UNK
is	O
important	B-UNK
for	O
the	O
cellular	B-UNK
responses	B-UNK
to	O
dna	B-UNK
damage	I-UNK
that	O
are	O
mediated	B-UNK
by	O
the	O
hrad50	O
-	O
hmre11	B-UNK
-	O
p95	B-UNK
complex	B-UNK
.	O
.	O

 	O
relationship	B-UNK
among	O
genotype	B-UNK
,	O
biochemical	B-UNK
phenotype	B-UNK
,	O
and	O
cognitive	B-UNK
performance	I-UNK
in	O
females	B-UNK
with	O
phenylalanine	B-UNK
hydroxylase	I-UNK
deficiency	B-UNK
:	O
report	B-UNK
from	O
the	O
maternal	B-UNK
phenylketonuria	B-DISEASE
collaborative	B-UNK
study	B-UNK
.	O

 	O
objective	B-UNK
to	O
examine	O
the	O
relationship	B-UNK
of	O
phenylalanine	B-UNK
hydroxylase	I-UNK
(	O
pah	B-UNK
)	O
genotypes	O
to	O
biochemical	B-UNK
phenotype	B-UNK
and	O
cognitive	B-UNK
development	B-UNK
in	O
maternal	B-UNK
phenylketonuria	B-DISEASE
(	O
pku	B-DISEASE
)	O
.	O

 	O
methodology	O
pah	B-UNK
gene	B-UNK
mutations	B-UNK
were	O
examined	B-UNK
in	O
222	O
hyperphenylalaninemic	O
females	B-UNK
enrolled	O
in	O
the	O
maternal	B-UNK
pku	B-DISEASE
collaborative	B-UNK
study	B-UNK
(	O
mpkucs	O
)	O
.	O

 	O
a	O
total	B-UNK
of	O
84	O
different	B-UNK
mutations	B-UNK
were	O
detected	B-UNK
,	O
and	O
complete	B-UNK
genotype	B-UNK
was	O
obtained	B-UNK
in	O
199	O
individuals	B-UNK
.	O

 	O
based	B-UNK
on	O
previous	B-UNK
knowledge	B-UNK
about	O
mutation	B-UNK
-	O
phenotype	B-UNK
associations	B-UNK
,	O
78	O
of	O
the	O
mutations	B-UNK
could	O
be	O
assigned	B-UNK
to	O
one	O
of	O
four	O
classes	O
of	O
severity	B-UNK
(	O
severe	B-UNK
pku	B-DISEASE
,	O
moderate	B-UNK
pku	B-DISEASE
,	O
mild	B-UNK
pku	B-DISEASE
,	O
and	O
mild	B-UNK
hyperphenylalaninemia	B-DISEASE
[	O
mhp	O
]	O
)	O
.	O

 	O
then	O
,	O
189	O
mpkucs	O
subjects	B-UNK
were	O
grouped	O
according	B-UNK
to	O
the	O
various	O
combinations	O
of	O
mutation	B-UNK
classifications	O
.	O

 	O
the	O
sample	B-UNK
sizes	B-UNK
were	O
large	B-UNK
enough	O
for	O
statistical	O
testing	B-UNK
in	O
four	O
groups	B-UNK
with	O
at	B-DISEASE
least	O
one	O
mutation	B-UNK
that	O
completely	B-UNK
abolishes	B-UNK
enzyme	B-UNK
activity	I-UNK
.	O

 	O
these	O
patients	B-UNK
are	O
considered	B-UNK
functionally	B-UNK
hemizygous	B-UNK
.	O

 	B-UNK
results	I-UNK
the	O
biochemical	B-UNK
phenotype	B-UNK
predicted	B-UNK
from	O
the	O
genotype	B-UNK
in	O
functionally	B-UNK
hemizygous	B-UNK
patients	B-UNK
was	O
related	B-UNK
significantly	B-UNK
to	O
the	O
assigned	B-UNK
phenylalanine	O
level	B-UNK
.	O

 	O
cognitive	B-UNK
performance	I-UNK
(	O
iq	B-UNK
)	O
was	O
also	O
significantly	B-UNK
related	B-UNK
to	O
genotype	B-UNK
.	O

 	O
the	O
iq	B-UNK
of	O
pah	B-UNK
-	O
deficient	B-UNK
mothers	B-UNK
with	O
a	O
severe	B-UNK
pku	B-DISEASE
mutation	B-UNK
in	O
combination	O
with	O
a	O
mhp	O
mutation	B-UNK
or	O
a	O
mild	B-UNK
pku	B-DISEASE
mutation	B-UNK
was	O
99	O
and	O
96	O
,	O
respectively	B-UNK
,	O
whereas	O
the	O
iq	B-UNK
of	O
pku	B-DISEASE
mothers	B-UNK
with	O
two	O
severe	B-UNK
pku	B-DISEASE
mutations	B-UNK
or	O
with	O
one	O
severe	B-UNK
and	O
one	O
moderate	B-UNK
pku	B-DISEASE
mutation	B-UNK
was	O
83	O
and	O
84	O
,	O
respectively	B-UNK
.	O

 	O
of	O
the	O
patients	B-UNK
with	O
pku	B-DISEASE
,	O
92	O
%	O
had	O
been	O
treated	B-UNK
during	O
childhood	B-UNK
.	O

 	O
those	O
who	O
were	O
untreated	O
or	O
treated	B-UNK
late	B-UNK
had	O
lower	B-UNK
than	O
average	B-UNK
iq	B-UNK
scores	B-UNK
for	O
their	O
group	B-UNK
of	O
mutation	B-UNK
combinations	O
.	O

 	O
females	B-UNK
with	O
moderate	B-UNK
or	O
mild	B-UNK
pku	B-DISEASE
who	O
were	O
treated	B-UNK
early	B-UNK
and	O
treated	B-UNK
for	O
>	O
6	O
years	B-UNK
showed	B-UNK
iq	B-UNK
scores	B-UNK
10	O
points	O
above	O
average	B-UNK
for	O
their	O
group	B-UNK
.	O

 	O
conclusions	B-UNK
the	O
reproductive	B-UNK
outcome	B-UNK
in	O
maternal	B-UNK
phenylketonuria	B-DISEASE
is	O
dependent	B-UNK
on	O
prenatal	B-UNK
metabolic	B-UNK
control	B-UNK
and	O
postnatal	B-UNK
environmental	B-UNK
circumstances	O
.	O

 	O
both	O
factors	B-UNK
depend	O
on	O
the	O
intellectual	O
resources	O
of	O
the	O
mother	B-UNK
with	O
pku	B-DISEASE
.	O

 	O
the	O
significant	B-UNK
relationship	B-UNK
among	O
genotype	B-UNK
,	O
biochemical	B-UNK
phenotype	B-UNK
,	O
and	O
cognitive	B-UNK
performance	I-UNK
observed	B-UNK
in	O
the	O
present	B-UNK
study	I-UNK
is	O
of	O
importance	O
for	O
the	O
development	B-UNK
of	O
an	O
optimal	O
strategy	O
for	O
future	B-UNK
treatment	B-UNK
of	O
females	B-UNK
with	O
pku	B-DISEASE
who	O
plan	O
pregnancy	B-DISEASE
.	O
.	O

 	O
spinal	B-UNK
xanthomatosis	B-DISEASE
:	O
a	O
variant	B-UNK
of	O
cerebrotendinous	O
xanthomatosis	B-DISEASE
.	O

 	O
we	O
describe	B-UNK
seven	B-UNK
dutch	B-UNK
patients	B-UNK
from	O
six	O
families	B-UNK
with	O
a	O
slowly	B-UNK
progressive	B-UNK
,	O
mainly	B-UNK
spinal	B-UNK
cord	B-UNK
syndrome	B-DISEASE
that	O
remained	B-UNK
for	O
many	O
years	B-UNK
the	O
sole	O
expression	B-UNK
of	O
cerebrotendinous	O
xanthomatosis	B-DISEASE
(	O
ctx	B-UNK
)	O
.	O

 	O
mri	B-UNK
demonstrated	B-UNK
white	B-UNK
matter	I-UNK
abnormalities	B-DISEASE
in	O
the	O
lateral	O
and	O
dorsal	O
columns	O
of	O
the	O
spinal	B-UNK
cord	B-UNK
.	O

 	O
post	O
-	O
mortem	O
examination	B-UNK
of	O
one	O
of	O
the	O
patients	B-UNK
showed	I-UNK
extensive	B-UNK
myelin	B-UNK
loss	B-UNK
in	O
these	O
columns	O
.	O

 	O
an	O
array	B-UNK
of	O
genotypes	O
was	O
found	B-UNK
in	O
these	O
patients	B-UNK
.	O

 	O
we	O
conclude	O
that	O
spinal	B-UNK
xanthomatosis	B-DISEASE
is	O
a	O
clinical	B-UNK
and	O
radiological	O
separate	B-UNK
entity	B-UNK
of	O
ctx	B-UNK
that	O
should	O
be	O
included	B-UNK
in	O
the	O
differential	B-UNK
diagnosis	B-UNK
of	O
chronic	B-UNK
myelopathy	O
.	O
.	O

 	O
a	O
transgene	B-UNK
insertion	B-UNK
creating	B-UNK
a	O
heritable	O
chromosome	B-DISEASE
deletion	I-DISEASE
mouse	B-UNK
model	I-UNK
of	O
prader	O
-	O
willi	O
and	O
angelman	O
syndromes	B-UNK
.	O

 	O
prader	B-DISEASE
-	I-DISEASE
willi	I-DISEASE
syndrome	I-DISEASE
(	O
pws	B-UNK
)	O
and	O
angelman	B-DISEASE
syndrome	I-DISEASE
(	O
as	O
)	O
result	B-UNK
from	O
the	O
loss	B-UNK
of	O
function	B-UNK
of	O
imprinted	B-UNK
genes	B-UNK
in	O
human	B-UNK
chromosome	I-UNK
15q11	B-UNK
-	O
q13	O
.	O

 	O
the	O
central	B-UNK
part	O
of	O
mouse	B-UNK
chromosome	I-UNK
7	O
is	O
homologous	B-UNK
to	O
human	B-UNK
15q11	B-UNK
-	O
q13	O
,	O
with	O
conservation	B-UNK
of	O
both	O
gene	B-UNK
order	B-UNK
and	O
imprinted	B-UNK
features	B-UNK
.	O

 	O
we	O
report	B-UNK
here	O
the	O
characterization	B-UNK
of	O
a	O
transgene	B-UNK
insertion	B-UNK
(	O
epstein	O
-	O
barr	B-UNK
virus	B-UNK
latent	O
membrane	B-UNK
protein	B-UNK
2a	O
,	O
lmp2a	O
)	O
into	O
mouse	B-UNK
chromosome	I-UNK
7c	O
,	O
which	O
has	O
resulted	B-UNK
in	O
mouse	B-UNK
models	B-UNK
for	O
pws	B-UNK
and	O
as	O
dependent	B-UNK
on	O
the	O
sex	B-UNK
of	O
the	O
transmitting	B-UNK
parent	B-UNK
.	O

 	O
epigenotype	O
(	O
allelic	B-UNK
expression	B-UNK
and	O
dna	B-UNK
methylation	B-UNK
)	O
and	O
fluorescence	B-UNK
in	O
situ	B-UNK
hybridization	I-UNK
analyses	B-UNK
indicate	I-UNK
that	O
the	O
transgene	B-UNK
-	O
induced	B-UNK
mutation	B-UNK
has	O
generated	B-UNK
a	O
complete	B-UNK
deletion	B-UNK
of	O
the	O
pws	B-UNK
/	O
as	O
-	O
homologous	B-UNK
region	B-UNK
but	O
has	O
not	O
deleted	B-UNK
flanking	B-UNK
loci	B-UNK
.	O

 	O
because	O
the	O
intact	B-UNK
chromosome	B-DISEASE
7	I-DISEASE
,	O
opposite	O
the	O
deleted	B-UNK
homolog	B-UNK
,	O
maintains	O
the	O
correct	B-UNK
imprint	B-UNK
in	O
somatic	B-UNK
cells	B-UNK
of	O
pws	B-UNK
and	O
as	O
mice	B-UNK
and	O
establishes	O
the	O
correct	B-UNK
imprint	B-UNK
in	O
male	B-UNK
and	O
female	B-UNK
germ	O
cells	B-UNK
of	O
as	O
mice	B-UNK
,	O
homologous	B-UNK
association	B-UNK
and	O
replication	O
asynchrony	O
are	O
not	O
part	O
of	O
the	O
imprinting	B-UNK
mechanism	B-UNK
.	O

 	O
this	O
heritable	O
-	O
deletion	B-UNK
mouse	B-UNK
model	I-UNK
will	O
be	O
particularly	B-UNK
useful	B-UNK
for	O
the	O
identification	B-UNK
of	O
the	O
etiological	O
genes	B-UNK
and	O
mechanisms	B-UNK
,	O
phenotypic	B-UNK
basis	B-UNK
,	O
and	O
investigation	O
of	O
therapeutic	B-UNK
approaches	B-UNK
for	O
pws	B-UNK
.	O
.	O

 	B-UNK
linkage	I-UNK
analysis	B-UNK
of	O
5	O
novel	B-UNK
van	B-DISEASE
der	I-DISEASE
woude	I-DISEASE
syndrome	I-DISEASE
kindreds	B-UNK
to	O
1q32	B-UNK
-	O
q41	O
markers	B-UNK
further	O
supports	B-UNK
locus	B-UNK
homogeneity	B-UNK
of	O
the	O
disease	B-DISEASE
trait	B-UNK
.	O

 	O
van	B-DISEASE
der	I-DISEASE
woude	I-DISEASE
syndrome	I-DISEASE
(	O
vws	B-UNK
,	O
mim	O
119300	O
)	O
is	O
a	O
rare	B-UNK
autosomal	O
dominant	B-UNK
clefting	O
condition	B-UNK
with	O
cardinal	B-UNK
features	B-UNK
of	O
mucous	O
cysts	B-DISEASE
(	O
lower	B-UNK
-	O
lip	B-DISEASE
pits	O
)	O
and	O
clefts	O
to	O
the	O
lip	B-DISEASE
and	O
/	O
or	O
palate	O
.	O

 	O
the	O
vws	B-UNK
gene	B-UNK
has	O
been	O
assigned	B-UNK
to	O
a	O
locus	B-UNK
in	O
1q32	B-UNK
-	O
q41	O
by	O
linkage	B-UNK
analysis	I-UNK
and	O
physical	B-UNK
mapping	I-UNK
.	O

 	O
we	O
have	O
investigated	B-UNK
5	O
novel	B-UNK
vws	B-UNK
families	I-UNK
through	O
probands	B-UNK
attended	O
for	O
cleft	B-DISEASE
lip	I-DISEASE
and	O
/	O
or	O
palate	O
repair	B-UNK
at	B-DISEASE
the	O
department	O
of	O
maxillofacial	O
surgery	B-UNK
of	O
hopital	O
trousseau	O
,	O
paris	O
,	O
in	O
order	B-UNK
to	O
tentatively	O
refine	O
the	O
genetic	B-UNK
map	B-UNK
of	O
the	O
vws	B-UNK
region	B-UNK
in	O
1q32	B-UNK
-	O
q41	O
and	O
possibly	B-UNK
identify	B-UNK
unlinked	B-UNK
pedigrees	B-UNK
.	O

 	B-UNK
linkage	I-UNK
analysis	B-UNK
was	O
carried	B-UNK
out	O
to	O
6	O
microsatellite	B-UNK
markers	I-UNK
(	O
d1s249	O
,	O
d1s425	O
,	O
d1s491	O
,	O
d1s205	O
,	O
d1s414	O
,	O
d1s425	O
)	O
,	O
yielding	O
a	O
maximum	B-UNK
cumulative	O
lod	B-UNK
score	I-UNK
of	O
z	B-UNK
=	O
3	O
.	O

 	O
27	O
at	B-DISEASE
theta	B-UNK
=	I-UNK
0	O
.	O

 	O
00	O
for	O
d1s245	O
.	O

 	O
the	O
innermost	O
four	O
markers	B-UNK
were	O
found	B-UNK
to	O
be	O
tightly	B-UNK
linked	I-UNK
to	O
one	O
another	O
,	O
with	O
no	O
evidence	B-UNK
for	O
recombination	B-UNK
.	O

 	O
our	O
results	B-UNK
support	B-UNK
linkage	B-UNK
of	O
vws	B-UNK
within	O
a	O
region	B-UNK
of	O
tightly	B-UNK
linked	I-UNK
markers	B-UNK
and	O
do	O
not	O
favour	O
locus	B-UNK
heterogeneity	I-UNK
of	O
the	O
disease	B-DISEASE
trait	B-UNK
.	O

 	O
null	B-UNK
mutation	B-UNK
of	O
the	O
murine	B-UNK
atp7b	B-UNK
(	O
wilson	B-UNK
disease	B-DISEASE
)	O
gene	B-UNK
results	B-UNK
in	O
intracellular	B-UNK
copper	B-UNK
accumulation	B-UNK
and	O
late	B-UNK
-	O
onset	B-UNK
hepatic	B-UNK
nodular	O
transformation	O
.	O

 	O
the	O
atp7b	B-UNK
protein	B-UNK
is	O
a	O
copper	B-UNK
-	O
transporting	O
atpase	B-UNK
expressed	B-UNK
predominantly	B-UNK
in	O
the	O
liver	B-DISEASE
and	O
to	O
a	O
lesser	O
extent	B-UNK
in	O
most	O
other	O
tissues	B-UNK
.	O

 	O
mutations	B-UNK
in	O
the	O
atp7b	B-UNK
gene	B-UNK
lead	B-UNK
to	O
wilson	B-UNK
disease	B-DISEASE
,	O
a	O
copper	B-UNK
toxicity	B-DISEASE
disorder	O
characterized	B-UNK
by	O
dramatic	B-UNK
build	O
-	O
up	O
of	O
intracellular	B-UNK
hepatic	B-UNK
copper	B-UNK
with	O
subsequent	B-UNK
hepatic	B-UNK
and	O
neuro	O
-	O
logical	O
abnormalities	B-DISEASE
.	O

 	O
using	O
homologous	B-UNK
recombination	I-UNK
to	O
disrupt	O
the	O
normal	B-UNK
translation	B-UNK
of	O
atp7b	B-UNK
,	O
we	O
have	O
generated	B-UNK
a	O
strain	O
of	O
mice	B-UNK
that	O
are	O
homozygous	B-UNK
mutants	B-UNK
(	O
null	B-UNK
)	O
for	O
the	O
wilson	B-UNK
disease	B-DISEASE
gene	B-UNK
.	O

 	O
the	O
atp7b	B-UNK
null	B-UNK
mice	B-UNK
display	B-UNK
a	O
gradual	O
accumulation	B-UNK
of	O
hepatic	B-UNK
copper	B-UNK
that	O
increases	B-UNK
to	O
a	O
level	B-UNK
60	O
-	O
fold	B-UNK
greater	B-UNK
than	O
normal	B-UNK
by	O
5	O
months	O
of	O
age	B-UNK
.	O

 	O
an	O
increase	B-UNK
in	O
copper	B-UNK
concentration	B-UNK
was	O
also	O
observed	B-UNK
in	O
the	O
kidney	B-UNK
,	O
brain	B-UNK
,	O
placenta	B-DISEASE
and	O
lactating	O
mammary	O
glands	O
of	O
homo	O
-	O
zygous	O
mutants	B-UNK
,	O
although	O
milk	O
from	O
the	O
mutant	B-UNK
glands	O
was	O
copper	B-UNK
deficient	B-UNK
.	O

 	O
morphological	B-UNK
abnormalities	B-DISEASE
resembling	B-UNK
cirrhosis	B-DISEASE
developed	B-UNK
in	O
the	O
majority	B-UNK
of	O
the	O
livers	O
from	O
homozygous	B-UNK
mutants	B-UNK
older	B-UNK
than	O
7	O
months	O
of	O
age	B-UNK
.	O

 	O
progeny	O
of	O
the	O
homozygous	B-UNK
mutant	B-UNK
females	B-UNK
demonstrated	B-UNK
neurological	B-UNK
abnormalities	B-DISEASE
and	O
growth	B-DISEASE
retardation	I-DISEASE
characteristic	B-UNK
of	O
copper	B-DISEASE
deficiency	I-DISEASE
.	O

 	O
copper	B-UNK
concentration	B-UNK
in	O
the	O
livers	O
of	O
the	O
newborn	B-UNK
homozygous	B-UNK
null	B-UNK
mutants	B-UNK
was	O
decreased	B-UNK
dramatically	B-UNK
.	O

 	O
in	O
summary	O
,	O
inactivation	B-UNK
of	O
the	O
murine	B-UNK
atp7b	B-UNK
gene	B-UNK
produces	B-UNK
a	O
form	B-UNK
of	O
cirrhotic	O
liver	B-DISEASE
disease	I-DISEASE
that	O
resembles	O
wilson	B-UNK
disease	B-DISEASE
in	O
humans	B-UNK
and	O
the	O
toxic	B-UNK
milk	O
phenotype	B-UNK
in	O
the	O
mouse	B-UNK
.	O
.	O

 	O
french	B-UNK
machado	B-DISEASE
-	I-DISEASE
joseph	I-DISEASE
disease	I-DISEASE
patients	B-UNK
do	O
not	O
exhibit	B-UNK
gametic	O
segregation	B-UNK
distortion	I-UNK
:	O
a	O
sperm	B-UNK
typing	I-UNK
analysis	B-UNK
.	O

 	O
segregation	B-UNK
distortion	I-UNK
has	O
been	O
reported	B-UNK
to	O
occur	B-UNK
in	O
a	O
number	B-UNK
of	O
the	O
trinucleotide	B-UNK
repeat	I-UNK
disorders	B-UNK
.	O

 	O
on	O
the	O
basis	B-UNK
of	O
a	O
sperm	B-UNK
typing	I-UNK
study	B-UNK
performed	B-UNK
in	O
patients	B-UNK
of	O
japanese	B-UNK
descent	B-UNK
with	O
machado	B-DISEASE
-	I-DISEASE
joseph	I-DISEASE
disease	I-DISEASE
(	O
mjd	B-UNK
)	O
,	O
it	O
was	O
reported	B-UNK
that	O
disease	B-DISEASE
alleles	B-UNK
are	O
preferentially	B-UNK
transmitted	B-UNK
during	O
meiosis	O
.	O

 	O
we	O
performed	B-UNK
a	O
sperm	B-UNK
typing	I-UNK
study	B-UNK
of	O
five	O
mjd	B-UNK
patients	B-UNK
of	O
french	B-UNK
descent	B-UNK
and	O
analysis	B-UNK
of	O
the	O
pooled	O
data	B-UNK
shows	B-UNK
a	O
ratio	B-UNK
of	O
mutant	B-UNK
to	O
normal	B-UNK
alleles	B-UNK
of	O
379	O
436	O
(	O
46	O
.	O
5	O
53	O
.	O
5	O
%	O
)	O
,	O
which	O
does	O
not	O
support	B-UNK
meiotic	B-UNK
segregation	I-UNK
distortion	B-UNK
.	O

 	O
to	O
confirm	B-UNK
these	O
results	B-UNK
,	O
sperm	B-UNK
typing	I-UNK
analysis	B-UNK
was	O
also	O
performed	B-UNK
using	O
a	O
polymorphic	B-UNK
marker	B-UNK
,	O
d14s1050	O
,	O
closely	B-UNK
linked	I-UNK
to	O
the	O
mjd1	B-UNK
gene	B-UNK
.	O

 	O
among	O
910	O
sperm	B-UNK
analyzed	B-UNK
,	O
the	O
allele	B-UNK
linked	B-UNK
to	O
the	O
disease	B-DISEASE
chromosome	B-UNK
was	O
detected	B-UNK
in	O
50	O
.	O

 	O
3	O
%	O
of	O
the	O
samples	B-UNK
and	O
the	O
allele	B-UNK
linked	B-UNK
to	O
the	O
normal	B-UNK
chromosome	B-UNK
was	O
found	B-UNK
in	O
49	O
.	O

 	O
6	O
%	O
of	O
the	O
sperm	B-UNK
.	O

 	O
the	O
difference	B-UNK
in	O
frequency	B-UNK
of	O
these	O
two	O
alleles	B-UNK
is	O
not	O
significant	B-UNK
(	O
p	B-UNK
=	O
0	O
.	O
8423	O
)	O
.	O

 	O
likelihood	O
-	O
based	B-UNK
analysis	B-UNK
of	O
segregation	B-UNK
distortion	I-UNK
in	O
the	O
single	B-UNK
sperm	B-UNK
data	B-UNK
using	O
the	O
spermseg	O
program	B-UNK
also	O
showed	B-UNK
no	O
support	B-UNK
for	O
segregation	B-UNK
distortion	I-UNK
at	B-DISEASE
the	O
gamete	O
level	B-UNK
in	O
this	O
patient	B-UNK
population	B-UNK
.	O

 	O
the	O
previous	B-UNK
report	B-UNK
on	O
the	O
japanese	B-UNK
patients	I-UNK
also	O
suggested	B-UNK
that	O
disease	B-DISEASE
allele	B-UNK
stability	B-UNK
may	O
be	O
influenced	O
by	O
a	O
trans	B-UNK
effect	B-UNK
of	O
an	O
intragenic	B-UNK
polymorphism	O
(	O
987	O
g	B-UNK
/	O
c	B-UNK
)	O
in	O
the	O
wild	B-UNK
-	O
type	B-UNK
allele	B-UNK
.	O

 	O
all	O
of	O
the	O
french	B-UNK
patients	B-UNK
were	O
heterozygous	B-UNK
for	O
this	O
polymorphism	O
.	O

 	O
however	O
,	O
analysis	B-UNK
of	O
the	O
variance	O
in	O
repeat	B-UNK
number	B-UNK
in	O
sperm	B-UNK
from	O
the	O
french	B-UNK
mjd	B-UNK
patients	B-UNK
overlapped	O
significantly	B-UNK
with	O
the	O
variance	O
in	O
repeat	B-UNK
number	B-UNK
observed	B-UNK
in	O
the	O
c	B-UNK
/	O
c	B-UNK
homozygous	B-UNK
japanese	B-UNK
patients	I-UNK
.	O

 	B-UNK
missense	I-UNK
mutation	B-UNK
in	O
the	O
alternative	B-UNK
splice	O
region	B-UNK
of	O
the	O
pax6	B-UNK
gene	B-UNK
in	O
eye	B-UNK
anomalies	B-UNK
.	O

 	O
the	O
pax6	B-UNK
gene	B-UNK
is	O
involved	B-UNK
in	O
ocular	O
morphogenesis	O
,	O
and	O
pax6	B-UNK
mutations	B-UNK
have	O
been	O
detected	B-UNK
in	O
various	O
types	B-UNK
of	O
ocular	O
anomalies	B-UNK
,	O
including	B-UNK
aniridia	B-DISEASE
,	O
peters	B-DISEASE
anomaly	I-DISEASE
,	O
corneal	B-DISEASE
dystrophy	I-DISEASE
,	O
congenital	B-DISEASE
cataract	B-DISEASE
,	O
and	O
foveal	B-DISEASE
hypoplasia	I-DISEASE
.	O

 	O
the	O
gene	B-UNK
encodes	B-UNK
a	O
transcriptional	B-UNK
regulator	B-UNK
that	O
recognizes	O
target	B-UNK
genes	B-UNK
through	O
its	O
paired	B-UNK
-	O
type	B-UNK
dna	B-UNK
-	O
binding	B-UNK
domain	I-UNK
.	O

 	O
the	O
paired	B-UNK
domain	B-UNK
is	O
composed	O
of	O
two	O
distinct	B-UNK
dna	B-UNK
-	O
binding	B-UNK
subdomains	O
,	O
the	O
n	B-UNK
-	O
terminal	B-UNK
subdomain	O
(	O
nts	O
)	O
and	O
the	O
c	B-UNK
-	O
terminal	B-UNK
subdomain	O
(	O
cts	O
)	O
,	O
which	O
bind	B-UNK
respective	O
consensus	B-UNK
dna	B-UNK
sequences	I-UNK
.	O

 	O
the	O
human	B-UNK
pax6	B-UNK
gene	B-UNK
produces	B-UNK
two	O
alternative	B-UNK
splice	O
isoforms	B-UNK
that	O
have	O
the	O
distinct	B-UNK
structure	B-UNK
of	O
the	O
paired	B-UNK
domain	B-UNK
.	O

 	O
the	O
insertion	B-UNK
,	O
into	O
the	O
nts	O
,	O
of	O
14	O
additional	B-UNK
amino	O
acids	O
encoded	B-UNK
by	O
exon	B-UNK
5a	I-UNK
abolishes	B-UNK
the	O
dna	B-UNK
-	O
binding	B-UNK
activity	B-UNK
of	O
the	O
nts	O
and	O
unmasks	O
the	O
dna	B-UNK
-	O
binding	B-UNK
ability	B-UNK
of	O
the	O
cts	O
.	O

 	O
thus	O
,	O
exon	B-UNK
5a	I-UNK
appears	B-UNK
to	O
function	B-UNK
as	O
a	O
molecular	B-UNK
switch	O
that	O
specifies	O
target	B-UNK
genes	B-UNK
.	O

 	O
we	O
ascertained	B-UNK
a	O
novel	B-UNK
missense	I-UNK
mutation	B-UNK
in	O
four	O
pedigrees	B-UNK
with	O
peters	B-DISEASE
anomaly	I-DISEASE
,	O
congenital	B-DISEASE
cataract	B-DISEASE
,	O
axenfeldt	O
anomaly	B-UNK
,	O
and	O
/	O
or	O
foveal	B-DISEASE
hypoplasia	I-DISEASE
,	O
which	O
,	O
to	O
our	O
knowledge	B-UNK
,	O
is	O
the	O
first	O
mutation	B-UNK
identified	B-UNK
in	O
the	O
splice	O
-	O
variant	B-UNK
region	B-UNK
.	O

 	O
a	O
t	B-UNK
-	O
-	O
>	O
a	O
transition	B-UNK
at	B-DISEASE
the	O
20th	O
nucleotide	B-UNK
position	B-UNK
of	O
exon	B-UNK
5a	I-UNK
results	B-UNK
in	O
a	O
val	O
-	O
-	O
>	O
asp	B-UNK
(	O
gtc	O
-	O
-	O
>	O
gac	O
)	O
substitution	B-UNK
at	B-DISEASE
the	O
7th	O
codon	B-UNK
of	O
the	O
alternative	B-UNK
splice	O
region	B-UNK
.	O

 	B-UNK
functional	I-UNK
analyses	B-UNK
demonstrated	B-UNK
that	O
the	O
v54d	O
mutation	B-UNK
slightly	B-UNK
increased	B-UNK
nts	O
binding	B-UNK
and	O
decreased	B-UNK
cts	O
transactivation	O
activity	B-UNK
to	O
almost	O
half	B-UNK
.	O
.	O

 	O
penetrances	O
of	O
brca1	B-UNK
1675dela	O
and	O
1135insa	O
with	O
respect	O
to	O
breast	B-DISEASE
cancer	I-DISEASE
and	O
ovarian	B-DISEASE
cancer	I-DISEASE
.	O

 	O
for	O
genetic	B-UNK
counseling	B-UNK
and	O
predictive	B-UNK
testing	B-UNK
in	O
families	B-UNK
with	O
inherited	B-UNK
breast	B-DISEASE
-	I-DISEASE
ovarian	I-DISEASE
cancer	I-DISEASE
,	O
penetrances	O
and	O
expressions	B-UNK
of	O
the	O
underlying	B-UNK
mutations	B-UNK
should	O
be	O
known	B-UNK
.	O

 	O
we	O
have	O
previously	B-UNK
reported	I-UNK
two	O
brca1	B-UNK
founder	B-UNK
mutations	B-UNK
in	O
the	O
norwegian	O
population	B-UNK
.	O

 	O
index	B-UNK
cases	B-UNK
for	O
the	O
present	B-UNK
study	I-UNK
were	O
found	B-UNK
two	O
different	B-UNK
ways	B-UNK
through	O
a	O
series	B-UNK
of	O
consecutive	B-UNK
ovarian	B-UNK
cancers	B-DISEASE
(	O
n	B-UNK
=	O
16	O
)	O
and	O
through	O
our	O
family	B-UNK
cancer	B-DISEASE
clinic	B-UNK
(	O
n	B-UNK
=	O
14	O
)	O
.	O

 	O
altogether	O
,	O
20	O
of	O
the	O
patients	B-UNK
had	O
brca1	B-UNK
1675dela	O
,	O
and	O
10	O
had	O
1135insa	O
.	O

 	O
their	O
relatives	B-UNK
were	O
described	B-UNK
with	O
respect	O
to	O
absence	B-UNK
/	O
presence	B-UNK
of	O
breast	B-UNK
and	O
/	O
or	O
ovarian	B-DISEASE
cancer	I-DISEASE
.	O

 	O
of	O
133	O
living	B-UNK
female	B-UNK
relatives	B-UNK
,	O
83	O
(	O
62	O
%	O
)	O
were	O
tested	B-UNK
for	O
the	O
presence	B-UNK
of	O
a	O
mutation	B-UNK
.	O

 	O
no	O
difference	B-UNK
,	O
in	O
penetrance	B-UNK
and	O
expression	B-UNK
,	O
between	O
the	O
two	O
mutations	B-UNK
were	O
found	B-UNK
,	O
whereas	O
differences	B-UNK
according	B-UNK
to	O
method	B-UNK
of	O
ascertainment	O
were	O
seen	B-UNK
.	O

 	O
the	O
overall	B-UNK
findings	B-UNK
were	O
that	O
disease	B-DISEASE
started	O
to	O
occur	B-UNK
at	B-DISEASE
age	B-UNK
30	O
years	B-UNK
and	O
that	O
by	O
age	B-UNK
50	O
years	B-UNK
48	O
%	O
of	O
the	O
mutation	B-UNK
-	O
carrying	B-UNK
women	B-UNK
had	O
experienced	B-UNK
breast	B-UNK
and	O
/	O
or	O
ovarian	B-DISEASE
cancer	I-DISEASE
.	O

 	O
more	O
ovarian	B-UNK
cancers	B-DISEASE
than	O
breast	B-UNK
cancers	B-DISEASE
were	O
recorded	O
.	O

 	O
both	O
penetrance	B-UNK
and	O
expression	B-UNK
(	O
breast	B-DISEASE
cancer	I-DISEASE
vs	B-UNK
.	O
ovarian	B-DISEASE
cancer	I-DISEASE
)	O
were	O
different	B-UNK
from	O
those	O
in	O
reports	B-UNK
of	O
the	O
ashkenazi	B-UNK
founder	B-UNK
mutations	B-UNK
.	O

 	O
whether	O
the	O
reported	B-UNK
differences	B-UNK
reflect	B-UNK
true	B-UNK
differences	B-UNK
and	O
/	O
or	O
methodological	O
problems	B-UNK
is	O
discussed	O
.	O

 	O
an	O
observed	B-UNK
excess	B-UNK
of	O
mutation	B-UNK
carriers	B-UNK
could	O
not	O
be	O
accounted	B-UNK
for	O
by	O
methodological	O
problems	B-UNK
;	O
possible	B-UNK
explanations	O
were	O
a	O
"	O
true	B-UNK
"	O
low	B-UNK
penetrance	B-UNK
or	O
preferential	B-UNK
segregation	B-UNK
.	O
.	O

 	O
the	O
dermatofibrosarcoma	B-DISEASE
protuberans	I-DISEASE
-	O
associated	B-UNK
collagen	O
type	B-UNK
ialpha1	O
/	O
platelet	B-UNK
-	O
derived	B-UNK
growth	B-UNK
factor	B-UNK
(	O
pdgf	B-UNK
)	O
b	B-UNK
-	O
chain	O
fusion	B-UNK
gene	B-UNK
generates	B-UNK
a	O
transforming	B-UNK
protein	B-UNK
that	O
is	O
processed	B-UNK
to	O
functional	B-UNK
pdgf	B-UNK
-	O
bb	O
.	O

 	O
dermatofibrosarcoma	B-DISEASE
protuberans	I-DISEASE
(	O
dfsp	B-DISEASE
)	O
displays	B-UNK
chromosomal	B-UNK
rearrangements	I-UNK
involving	B-UNK
chromosome	B-DISEASE
17	I-DISEASE
and	O
22	O
,	O
which	O
fuse	O
the	O
collagen	O
type	B-UNK
ialpha1	O
(	O
colia1	O
)	O
gene	B-UNK
to	O
the	O
platelet	B-UNK
-	O
derived	B-UNK
growth	B-UNK
factor	B-UNK
(	O
pdgf	B-UNK
)	O
b	B-UNK
-	O
chain	O
(	O
pdgfb	B-UNK
)	O
gene	B-UNK
.	O

 	O
to	O
characterize	O
the	O
functional	B-UNK
and	O
structural	B-UNK
properties	B-UNK
of	O
the	O
colia1	O
/	O
pdgfb	B-UNK
fusion	B-UNK
protein	B-UNK
,	O
we	O
generated	B-UNK
a	O
stable	B-UNK
nih3t3	O
cell	B-UNK
line	B-UNK
that	O
contained	B-UNK
a	O
tumor	B-DISEASE
-	O
derived	B-UNK
chimeric	B-UNK
gene	B-UNK
resulting	B-UNK
from	O
a	O
coia1	O
intron	B-UNK
7	O
-	O
pdgfb	B-UNK
intron	B-UNK
1	O
fusion	B-UNK
.	O

 	O
expression	B-UNK
of	O
the	O
fusion	B-UNK
protein	B-UNK
led	B-UNK
to	O
morphological	B-UNK
transformation	O
and	O
increased	B-UNK
growth	B-UNK
rate	B-UNK
of	O
these	O
cells	B-UNK
.	O

 	O
the	O
pdgf	B-UNK
receptor	B-UNK
kinase	B-UNK
inhibitor	B-UNK
cgp57148b	O
reversed	O
the	O
transformed	B-UNK
phenotype	B-UNK
and	O
reduced	B-UNK
the	O
growth	B-UNK
rate	B-UNK
of	O
colia1	O
/	O
pdgfb	B-UNK
-	O
expressing	B-UNK
cells	B-UNK
but	O
had	O
no	O
effects	B-UNK
on	O
control	B-UNK
cells	B-UNK
.	O

 	O
the	O
presence	B-UNK
of	O
dimeric	O
colia1	O
/	O
pdgfb	B-UNK
precursors	O
was	O
demonstrated	B-UNK
through	O
pdgfb	B-UNK
immunoprecipitations	O
of	O
metabolically	O
labeled	B-UNK
cells	B-UNK
and	O
also	O
by	O
pdgfb	B-UNK
immunoprecipitations	O
followed	B-UNK
by	O
immunoblotting	O
with	O
colia1	O
antibodies	B-UNK
.	O

 	O
pulse	O
-	O
chase	O
studies	B-UNK
demonstrated	I-UNK
that	O
the	O
colia1	O
/	O
pdgfb	B-UNK
precursor	B-UNK
was	O
processed	B-UNK
to	O
an	O
end	B-UNK
product	B-UNK
that	O
was	O
indistinguishable	O
from	O
wild	B-UNK
-	O
type	B-UNK
pdgf	B-UNK
-	O
bb	O
.	O

 	O
finally	B-UNK
,	O
colia1	O
/	O
pdgfb	B-UNK
-	O
expressing	B-UNK
cells	B-UNK
generated	B-UNK
tumors	B-DISEASE
after	O
s	O
.	O

 	O
c	B-UNK
c	B-UNK
.	O
injection	O
into	O
nude	O
mice	B-UNK
,	O
and	O
tumor	B-DISEASE
growth	B-UNK
was	O
reduced	B-UNK
by	O
treatment	B-UNK
with	O
cgp57148b	O
.	O

 	O
we	O
conclude	O
that	O
the	O
colia1	O
/	O
pdgfb	B-UNK
fusion	B-UNK
associated	B-UNK
with	O
dfsp	B-DISEASE
contributes	B-UNK
to	O
tumor	B-DISEASE
development	B-UNK
through	O
ectopic	B-UNK
production	B-UNK
of	O
pdgf	B-UNK
-	O
bb	O
and	O
the	O
formation	B-UNK
of	O
an	O
autocrine	O
loop	B-UNK
.	O

 	O
our	O
findings	B-UNK
,	O
thus	O
,	O
suggest	B-UNK
that	O
pdgf	B-UNK
receptors	B-UNK
could	O
be	O
a	O
target	B-UNK
for	O
pharmacological	O
treatment	B-UNK
of	O
dfsp	B-DISEASE
and	O
giant	O
cell	B-UNK
fibroblastoma	O
,	O
e	B-UNK
.	O
g	B-UNK
.	O
,	O
through	O
the	O
use	B-UNK
of	O
pdgf	B-UNK
receptor	B-UNK
kinase	B-UNK
inhibitors	B-UNK
such	O
as	O
cgp57148b	O
.	O

 	O
identification	B-UNK
of	O
a	O
common	B-UNK
pex1	B-UNK
mutation	B-UNK
in	O
zellweger	B-DISEASE
syndrome	I-DISEASE
.	O

 	O
the	O
zellweger	O
spectrum	B-UNK
of	O
disease	B-DISEASE
,	O
encompassing	O
zellweger	B-DISEASE
syndrome	I-DISEASE
and	O
the	O
progressively	B-UNK
milder	B-UNK
phenotypes	B-UNK
of	O
neonatal	B-UNK
adrenoleukodystrophy	B-DISEASE
and	O
infantile	B-UNK
refsum	B-DISEASE
disease	I-DISEASE
,	O
is	O
due	O
to	O
a	O
failure	O
to	O
form	B-UNK
functional	B-UNK
peroxisomes	O
.	O

 	O
cell	B-UNK
fusion	B-UNK
complementation	B-UNK
studies	B-UNK
demonstrated	I-UNK
that	O
these	O
diseases	B-DISEASE
are	O
genetically	B-UNK
heterogeneous	B-UNK
,	O
with	O
two	O
-	O
thirds	O
of	O
all	O
patients	B-UNK
lying	O
within	O
a	O
single	B-UNK
complementation	B-UNK
group	B-UNK
,	O
cg1	B-UNK
.	O

 	B-UNK
molecular	I-UNK
genetic	B-UNK
and	O
cell	B-UNK
biology	O
studies	B-UNK
have	O
shown	B-UNK
that	O
pex1	B-UNK
is	O
deficient	B-UNK
in	O
many	O
cg1	B-UNK
patients	B-UNK
.	O

 	O
however	O
,	O
previous	B-UNK
studies	I-UNK
have	O
focused	O
on	O
mildly	B-UNK
affected	I-UNK
patients	B-UNK
and	O
there	O
is	O
still	O
no	O
report	B-UNK
of	O
two	O
mutant	B-UNK
pex1	B-UNK
alleles	B-UNK
in	O
any	O
zellweger	B-DISEASE
syndrome	I-DISEASE
patient	B-UNK
.	O

 	O
furthermore	B-UNK
,	O
mutations	B-UNK
in	O
the	O
pmp70	B-UNK
gene	B-UNK
have	O
also	O
been	O
identified	B-UNK
in	O
two	O
zellweger	B-DISEASE
syndrome	I-DISEASE
patients	B-UNK
from	O
cg1	B-UNK
,	O
raising	O
the	O
possibility	O
that	O
cg1	B-UNK
patients	B-UNK
may	O
represent	B-UNK
a	O
mixture	O
of	O
pex1	B-UNK
-	O
deficient	B-UNK
and	O
pmp70	B-UNK
-	O
deficient	B-UNK
individuals	B-UNK
.	O

 	O
to	O
address	O
the	O
molecular	B-UNK
basis	I-UNK
of	O
disease	B-DISEASE
in	O
zellweger	B-DISEASE
syndrome	I-DISEASE
patients	B-UNK
from	O
cg1	B-UNK
,	O
we	O
examined	B-UNK
all	O
24	O
pex1	B-UNK
exons	B-UNK
in	O
four	O
patients	B-UNK
,	O
including	B-UNK
both	O
patients	B-UNK
that	O
have	O
mutations	B-UNK
in	O
pmp70	B-UNK
.	O

 	O
pex1	B-UNK
mutations	B-UNK
were	O
detected	B-UNK
in	O
all	O
four	O
patients	B-UNK
,	O
including	B-UNK
a	O
1	O
-	O
bp	B-UNK
insertion	B-UNK
(	O
c	B-UNK
.	O
2097inst	O
)	O
in	O
exon	B-UNK
13	O
that	O
was	O
present	B-UNK
in	O
three	O
of	O
the	O
four	O
patients	B-UNK
.	O

 	O
subsequent	B-UNK
studies	B-UNK
demonstrated	I-UNK
that	O
this	O
mutation	B-UNK
is	O
present	B-UNK
in	O
one	O
-	O
half	B-UNK
of	O
all	O
cg1	B-UNK
patients	B-UNK
and	O
correlates	B-UNK
with	O
the	O
zellweger	B-DISEASE
syndrome	I-DISEASE
phenotype	B-UNK
.	O

 	O
as	O
this	O
mutation	B-UNK
leads	B-UNK
to	O
a	O
loss	B-UNK
of	O
protein	B-UNK
function	B-UNK
its	O
frequency	B-UNK
makes	O
it	O
the	O
most	O
common	B-UNK
cause	B-UNK
of	O
zellweger	B-DISEASE
syndrome	I-DISEASE
,	O
helping	O
to	O
explain	O
the	O
high	B-UNK
percentage	B-UNK
of	O
patients	B-UNK
that	O
belong	O
to	O
cg1	B-UNK
.	O

 	B-UNK
novel	I-UNK
mutations	B-UNK
in	O
the	O
wiskott	B-DISEASE
-	I-DISEASE
aldrich	I-DISEASE
syndrome	I-DISEASE
protein	B-UNK
gene	B-UNK
and	O
their	O
effects	B-UNK
on	O
transcriptional	B-UNK
,	O
translational	O
,	O
and	O
clinical	B-UNK
phenotypes	I-UNK
.	O

 	O
wiskott	B-DISEASE
-	I-DISEASE
aldrich	I-DISEASE
syndrome	I-DISEASE
(	O
was	O
)	O
is	O
an	O
x	B-UNK
-	O
linked	B-UNK
recessive	O
immunodeficiency	B-DISEASE
characterized	B-UNK
by	O
thrombocytopenia	B-DISEASE
,	O
eczema	B-DISEASE
,	O
and	O
recurrent	B-UNK
infections	B-DISEASE
,	O
and	O
caused	B-UNK
by	O
mutations	B-UNK
in	O
the	O
was	O
protein	B-UNK
(	O
wasp	B-UNK
)	O
gene	B-UNK
.	O

 	O
wasp	B-UNK
contains	B-UNK
several	O
functional	B-UNK
domains	B-UNK
through	O
which	O
it	O
interacts	B-UNK
with	O
proteins	B-UNK
involved	B-UNK
in	O
intracellular	B-UNK
signaling	B-UNK
and	O
regulation	B-UNK
of	O
the	O
actin	B-UNK
cytoskeleton	O
.	O

 	O
in	O
this	O
report	B-UNK
,	O
17	O
wasp	B-UNK
gene	B-UNK
mutations	B-UNK
were	O
identified	B-UNK
,	O
12	O
of	O
which	O
are	O
novel	B-UNK
.	O

 	B-UNK
dna	I-UNK
of	O
affected	B-UNK
males	B-UNK
and	O
obligate	B-UNK
carriers	B-UNK
was	O
pcr	B-UNK
amplified	B-UNK
and	O
analyzed	B-UNK
by	O
ssca	O
,	O
heteroduplex	B-UNK
analysis	B-UNK
,	O
and	O
direct	B-UNK
sequencing	I-UNK
.	O

 	O
the	O
effects	B-UNK
of	O
the	O
mutations	B-UNK
at	B-DISEASE
the	O
mrna	B-UNK
and	O
protein	B-UNK
level	B-UNK
were	O
ascertained	B-UNK
by	O
rt	O
-	O
pcr	B-UNK
and	O
western	B-UNK
blot	O
analyses	B-UNK
.	O

 	O
all	O
missense	B-UNK
mutations	I-UNK
were	O
located	B-UNK
in	O
exons	B-UNK
1	O
-	O
4	O
.	O

 	O
most	O
of	O
the	O
nonsense	B-UNK
,	O
frameshift	B-UNK
and	O
splice	B-UNK
site	I-UNK
mutations	B-UNK
were	O
found	B-UNK
in	O
exons	B-UNK
6	O
-	O
11	O
.	O

 	O
mutations	B-UNK
that	O
alter	B-UNK
splice	O
sites	B-UNK
led	B-UNK
to	O
the	O
synthesis	B-UNK
of	O
several	O
types	B-UNK
of	O
mrnas	B-UNK
,	O
a	O
fraction	B-UNK
of	O
which	O
represented	B-UNK
the	O
normally	B-UNK
spliced	I-UNK
product	B-UNK
.	O

 	O
the	O
presence	B-UNK
of	O
normally	B-UNK
spliced	I-UNK
transcripts	B-UNK
was	O
correlated	B-UNK
with	O
a	O
milder	B-UNK
phenotype	B-UNK
.	O

 	O
when	O
one	O
such	O
case	B-UNK
was	O
studied	B-UNK
by	O
western	B-UNK
blotting	B-UNK
,	O
reduced	B-UNK
amounts	B-UNK
of	O
normal	B-UNK
-	O
size	B-UNK
wasp	B-UNK
were	O
present	B-UNK
.	O

 	O
in	O
other	O
cases	B-UNK
as	O
well	O
,	O
a	O
correlation	B-UNK
was	O
found	B-UNK
between	O
the	O
amount	O
of	O
normal	B-UNK
or	O
mutant	B-UNK
wasp	B-UNK
present	B-UNK
and	O
the	O
phenotypes	B-UNK
of	O
the	O
affected	B-UNK
individuals	I-UNK
.	O

 	O
no	O
protein	B-UNK
was	O
detected	B-UNK
in	O
two	O
individuals	B-UNK
with	O
severe	B-UNK
was	O
.	O

 	O
reduced	B-UNK
levels	B-UNK
of	O
a	O
normal	B-UNK
-	O
size	B-UNK
wasp	B-UNK
with	O
a	O
missense	B-UNK
mutation	I-UNK
were	O
seen	B-UNK
in	O
two	O
individuals	B-UNK
with	O
xlt	O
.	O

 	O
it	O
is	O
concluded	O
that	O
mutation	B-UNK
analysis	B-UNK
at	B-DISEASE
the	O
dna	B-UNK
level	B-UNK
is	O
not	O
sufficient	B-UNK
for	O
predicting	B-UNK
clinical	B-UNK
course	B-UNK
.	O

 	O
studies	B-UNK
at	B-DISEASE
the	O
transcript	B-UNK
and	O
protein	B-UNK
level	B-UNK
are	O
needed	O
for	O
a	O
better	B-UNK
assessment	B-UNK
.	O
.	O

 	O
aminoglycoside	O
antibiotics	O
restore	O
dystrophin	B-UNK
function	B-UNK
to	O
skeletal	B-UNK
muscles	B-UNK
of	O
mdx	B-UNK
mice	B-UNK
.	O

 	O
duchenne	B-UNK
muscular	B-DISEASE
dystrophy	I-DISEASE
(	O
dmd	B-UNK
)	O
is	O
caused	B-UNK
by	O
mutations	B-UNK
in	O
the	O
dystrophin	B-UNK
gene	B-UNK
,	O
leading	B-UNK
to	O
the	O
absence	B-UNK
of	O
the	O
dystrophin	B-UNK
protein	B-UNK
in	O
striated	B-UNK
muscle	B-UNK
.	O

 	O
a	O
significant	B-UNK
number	B-UNK
of	O
these	O
mutations	B-UNK
are	O
premature	B-UNK
stop	B-UNK
codons	B-UNK
.	O

 	O
on	O
the	O
basis	B-UNK
of	O
the	O
observation	B-UNK
that	O
aminoglycoside	O
treatment	B-UNK
can	O
suppress	O
stop	B-UNK
codons	B-UNK
in	O
cultured	B-UNK
cells	B-UNK
,	O
we	O
tested	B-UNK
the	O
effect	B-UNK
of	O
gentamicin	O
on	O
cultured	B-UNK
muscle	B-UNK
cells	B-UNK
from	O
the	O
mdx	B-UNK
mouse	B-UNK
-	O
an	O
animal	B-UNK
model	B-UNK
for	O
dmd	B-UNK
that	O
possesses	O
a	O
premature	B-UNK
stop	B-UNK
codon	B-UNK
in	O
the	O
dystrophin	B-UNK
gene	B-UNK
.	O

 	O
exposure	B-UNK
of	O
mdx	B-UNK
myotubes	O
to	O
gentamicin	O
led	B-UNK
to	O
the	O
expression	B-UNK
and	O
localization	B-UNK
of	O
dystrophin	B-UNK
to	O
the	O
cell	B-UNK
membrane	B-UNK
.	O

 	O
we	O
then	O
evaluated	O
the	O
effects	B-UNK
of	O
differing	O
dosages	O
of	O
gentamicin	O
on	O
expression	B-UNK
and	O
functional	B-UNK
protection	O
of	O
the	O
muscles	B-UNK
of	O
mdx	B-UNK
mice	B-UNK
.	O

 	O
we	O
identified	B-UNK
a	O
treatment	B-UNK
regimen	O
that	O
resulted	B-UNK
in	O
the	O
presence	B-UNK
of	O
dystrophin	B-UNK
in	O
the	O
cell	B-UNK
membrane	B-UNK
in	O
all	O
striated	B-UNK
muscles	B-UNK
examined	B-UNK
and	O
that	O
provided	B-UNK
functional	B-UNK
protection	O
against	O
muscular	O
injury	O
.	O

 	O
to	O
our	O
knowledge	B-UNK
,	O
our	O
results	B-UNK
are	O
the	O
first	O
to	O
demonstrate	B-UNK
that	O
aminoglycosides	O
can	O
suppress	O
stop	B-UNK
codons	B-UNK
not	O
only	O
in	O
vitro	B-UNK
but	O
also	O
in	O
vivo	B-UNK
.	O

 	O
furthermore	B-UNK
,	O
these	O
results	B-UNK
raise	O
the	O
possibility	O
of	O
a	O
novel	B-UNK
treatment	B-UNK
regimen	O
for	O
muscular	B-DISEASE
dystrophy	I-DISEASE
and	O
other	O
diseases	B-DISEASE
caused	B-UNK
by	O
premature	B-UNK
stop	B-UNK
codon	B-UNK
mutations	B-UNK
.	O

 	O
this	O
treatment	B-UNK
could	O
prove	O
effective	B-UNK
in	O
up	O
to	O
15	O
%	O
of	O
patients	B-UNK
with	O
dmd	B-UNK
.	O
.	O

 	O
loss	B-UNK
of	O
the	O
ataxia	B-DISEASE
-	O
telangiectasia	B-DISEASE
gene	B-UNK
product	B-UNK
causes	B-UNK
oxidative	B-UNK
damage	B-UNK
in	O
target	B-UNK
organs	O
.	O

 	O
ataxia	B-DISEASE
-	O
telangiectasia	B-DISEASE
(	O
a	O
-	O
t	B-UNK
)	O
is	O
characterized	B-UNK
by	O
a	O
markedly	B-UNK
increased	B-UNK
sensitivity	B-UNK
to	O
ionizing	B-UNK
radiation	B-UNK
,	O
increased	B-UNK
incidence	I-UNK
of	O
cancer	B-DISEASE
,	O
and	O
neurodegeneration	O
,	O
especially	B-UNK
of	O
the	O
cerebellar	B-UNK
purkinje	B-UNK
cells	I-UNK
.	O

 	O
ionizing	B-UNK
radiation	B-UNK
oxidizes	O
macromolecules	O
and	O
causes	B-UNK
tissue	B-UNK
damage	B-UNK
through	O
the	O
generation	B-UNK
of	O
reactive	O
oxygen	O
species	B-UNK
(	O
ros	O
)	O
.	O

 	O
we	O
therefore	O
hypothesized	O
that	O
a	O
-	O
t	B-UNK
is	O
due	O
to	O
oxidative	B-UNK
damage	B-UNK
resulting	B-UNK
from	O
loss	B-UNK
of	O
function	B-UNK
of	O
the	O
a	O
-	O
t	B-UNK
gene	B-UNK
product	B-UNK
.	O

 	O
to	O
assess	B-UNK
this	O
hypothesis	O
,	O
we	O
employed	O
an	O
animal	B-UNK
model	B-UNK
of	O
a	O
-	O
t	B-UNK
,	O
the	O
mouse	B-UNK
with	O
a	O
disrupted	B-UNK
atm	B-UNK
gene	B-UNK
.	O

 	O
we	O
show	O
that	O
organs	O
which	O
develop	B-UNK
pathologic	B-UNK
changes	B-UNK
in	O
the	O
atm	B-UNK
-	O
deficient	B-UNK
mice	B-UNK
are	O
targets	O
of	O
oxidative	B-UNK
damage	B-UNK
,	O
and	O
that	O
cerebellar	B-UNK
purkinje	B-UNK
cells	I-UNK
are	O
particularly	B-UNK
affected	B-UNK
.	O

 	O
these	O
observations	B-UNK
provide	B-UNK
a	O
mechanistic	O
basis	B-UNK
for	O
the	O
a	O
-	O
t	B-UNK
phenotype	B-UNK
and	O
lay	O
a	O
rational	B-UNK
foundation	O
for	O
therapeutic	B-UNK
intervention	O
.	O
.	O

 	O
recessively	O
inherited	B-UNK
multiple	B-UNK
epiphyseal	B-DISEASE
dysplasia	I-DISEASE
with	O
normal	B-UNK
stature	O
,	O
club	O
foot	B-UNK
,	O
and	O
double	B-UNK
layered	O
patella	B-DISEASE
caused	B-UNK
by	O
a	O
dtdst	B-UNK
mutation	B-UNK
.	O

 	O
we	O
have	O
observed	B-UNK
over	O
25	O
different	B-UNK
mutations	B-UNK
in	O
the	O
diastrophic	B-DISEASE
dysplasia	I-DISEASE
sulphate	O
transporter	B-UNK
gene	B-UNK
(	O
dtdst	B-UNK
)	O
in	O
association	B-UNK
with	O
the	O
recessive	O
disorders	B-UNK
achondrogenesis	B-DISEASE
1b	O
,	O
atelosteogenesis	B-DISEASE
2	O
,	O
and	O
diastrophic	B-DISEASE
dysplasia	I-DISEASE
.	O

 	O
the	O
c862	O
t	B-UNK
(	O
r279w	O
)	O
transition	B-UNK
is	O
the	O
most	O
common	B-UNK
mutation	B-UNK
in	O
non	B-UNK
-	O
finnish	B-UNK
patients	B-UNK
,	O
but	O
in	O
these	O
disorders	B-UNK
it	O
is	O
usually	B-UNK
combined	B-UNK
with	O
other	O
dtdst	B-UNK
mutations	B-UNK
.	O

 	O
we	O
had	O
not	O
seen	B-UNK
a	O
case	B-UNK
of	O
homozygosity	B-UNK
for	O
c862	O
t	B-UNK
(	O
r279w	O
)	O
until	O
we	O
analysed	B-UNK
dna	B-UNK
from	O
a	O
36	O
year	B-UNK
old	I-UNK
male	B-UNK
with	O
tall	O
-	O
normal	B-UNK
stature	O
(	O
180	O
cm	B-DISEASE
)	O
who	O
asked	O
for	O
genetic	B-UNK
counselling	B-UNK
for	O
suspected	B-UNK
multiple	B-UNK
epiphyseal	B-DISEASE
dysplasia	I-DISEASE
.	O

 	O
he	O
was	O
treated	B-UNK
for	O
club	O
foot	B-UNK
and	O
hip	B-DISEASE
dysplasia	I-DISEASE
at	B-DISEASE
birth	O
.	O

 	O
skeletal	B-UNK
changes	B-UNK
consistent	B-UNK
with	O
multiple	B-UNK
epiphyseal	B-DISEASE
dysplasia	I-DISEASE
,	O
with	O
the	O
peculiar	O
finding	B-UNK
of	O
a	O
double	B-UNK
layered	O
patella	B-DISEASE
,	O
were	O
recognised	O
during	O
childhood	B-UNK
.	O

 	O
cleft	B-DISEASE
palate	I-DISEASE
,	O
swelling	B-DISEASE
of	O
the	O
ear	B-UNK
pinna	O
,	O
and	O
hitch	O
hiker	O
thumb	B-DISEASE
were	O
absent	B-UNK
.	O

 	O
he	O
was	O
found	B-UNK
to	O
be	O
homozygous	B-UNK
,	O
and	O
both	O
healthy	B-UNK
parents	B-UNK
heterozygous	B-UNK
,	O
for	O
the	O
r279w	O
mutation	B-UNK
in	O
dtdst	B-UNK
,	O
and	O
his	O
fibroblasts	B-UNK
showed	B-UNK
a	O
sulphate	O
incorporation	B-UNK
defect	B-UNK
typical	B-UNK
of	O
dtdst	B-UNK
disorders	B-UNK
.	O

 	O
counselling	B-UNK
was	O
given	B-UNK
for	O
a	O
recessive	O
disorder	O
,	O
thereby	O
considerably	O
reducing	B-UNK
the	O
probability	O
of	O
affected	B-UNK
offspring	B-UNK
.	O

 	O
multiple	B-UNK
epiphyseal	B-DISEASE
dysplasia	I-DISEASE
is	O
more	O
frequently	B-UNK
caused	B-UNK
by	O
dominant	B-UNK
mutations	B-UNK
in	O
the	O
comp	O
(	O
edm1	O
,	O
mckusick	O
132400	O
)	O
and	O
col9a2	O
genes	B-UNK
(	O
edm2	O
,	O
mckusick	O
600204	O
)	O
.	O

 	O
a	O
few	O
other	O
patients	B-UNK
and	O
families	B-UNK
with	O
features	B-UNK
similar	B-UNK
to	O
our	O
proband	B-UNK
have	O
been	O
described	B-UNK
previously	B-UNK
and	O
considered	B-UNK
to	O
have	O
autosomal	O
recessive	O
med	O
(	O
edm4	O
,	O
mckusick	O
226900	O
)	O
.	O

 	O
this	O
observation	B-UNK
confirms	B-UNK
the	O
existence	O
of	O
this	O
entity	B-UNK
and	O
assigns	O
it	O
to	O
the	O
phenotypic	B-UNK
spectrum	B-UNK
associated	B-UNK
with	O
mutations	B-UNK
at	B-DISEASE
the	O
dtdst	B-UNK
locus	B-UNK
.	O
.	O

 	O
homozygosity	B-UNK
for	O
a	O
novel	B-UNK
dtdst	B-UNK
mutation	B-UNK
in	O
a	O
child	B-UNK
with	O
a	O
'	O
broad	B-UNK
bone	O
-	O
platyspondylic	O
'	O
variant	B-UNK
of	O
diastrophic	B-DISEASE
dysplasia	I-DISEASE
.	O

 	O
atypical	B-UNK
or	O
variant	B-UNK
forms	B-UNK
of	O
well	O
-	O
known	B-UNK
chondrodysplasias	O
may	O
pose	O
diagnostic	B-UNK
problems	B-UNK
.	O

 	O
we	O
report	B-UNK
on	O
a	O
girl	B-UNK
with	O
clinical	B-UNK
features	I-UNK
suggesting	B-UNK
diastrophic	B-DISEASE
dysplasia	I-DISEASE
but	O
with	O
unusual	B-UNK
radiographic	O
features	B-UNK
including	B-UNK
severe	B-UNK
platyspondyly	O
,	O
wide	B-UNK
metaphyses	O
,	O
and	O
fibular	O
overgrowth	B-UNK
,	O
which	O
are	O
partially	B-UNK
reminiscent	O
of	O
metatropic	O
dysplasia	O
.	O

 	O
the	O
diagnosis	B-UNK
was	O
clarified	O
by	O
molecular	B-UNK
analysis	B-UNK
of	O
the	O
dtdst	B-UNK
gene	B-UNK
,	O
which	O
revealed	B-UNK
homozygosity	B-UNK
for	O
a	O
previously	B-UNK
undescribed	O
mutation	B-UNK
leading	B-UNK
to	O
a	O
q454p	O
substitution	B-UNK
in	O
the	O
10th	O
transmembrane	B-UNK
domain	B-UNK
of	O
the	O
dtdst	B-UNK
sulfate	B-UNK
transporter	B-UNK
.	O

 	B-UNK
molecular	I-UNK
analysis	B-UNK
may	O
be	O
of	O
particular	B-UNK
value	B-UNK
in	O
such	O
atypical	B-UNK
cases	B-UNK
.	O
.	O

 	O
the	O
type	B-UNK
of	O
somatic	B-UNK
mutation	B-UNK
at	B-DISEASE
apc	B-UNK
in	O
familial	B-DISEASE
adenomatous	I-DISEASE
polyposis	I-DISEASE
is	O
determined	B-UNK
by	O
the	O
site	B-UNK
of	O
the	O
germline	B-UNK
mutation	B-UNK
:	O
a	O
new	B-UNK
facet	O
to	O
knudson	O
'	O
s	O
'	O
two	O
-	O
hit	B-DISEASE
'	O
hypothesis	O
.	O

 	O
apc	B-UNK
is	O
often	O
cited	O
as	O
a	O
prime	O
example	O
of	O
a	O
tumor	B-DISEASE
suppressor	B-UNK
gene	B-UNK
.	O

 	O
truncating	B-UNK
germline	B-UNK
and	O
somatic	B-UNK
mutations	B-UNK
(	O
or	O
,	O
infrequently	O
,	O
allelic	B-UNK
loss	B-UNK
)	O
occur	B-UNK
in	O
tumors	B-DISEASE
in	O
fap	B-DISEASE
(	O
familial	B-DISEASE
adenomatous	I-DISEASE
polyposis	I-DISEASE
)	O
.	O

 	O
most	O
sporadic	B-UNK
colorectal	B-UNK
cancers	B-DISEASE
also	O
have	O
two	O
apc	B-UNK
mutations	B-UNK
.	O

 	O
clues	O
from	O
attenuated	O
polyposis	B-DISEASE
,	O
missense	B-UNK
germline	B-UNK
variants	B-UNK
with	O
mild	B-UNK
disease	B-DISEASE
and	O
the	O
somatic	B-UNK
mutation	B-UNK
cluster	B-UNK
region	I-UNK
(	O
codons	B-UNK
1	O
,	O
250	O
-	O
1	O
,	O
450	O
)	O
indicate	B-UNK
,	O
however	O
,	O
that	O
apc	B-UNK
mutations	B-UNK
might	O
not	O
result	B-UNK
in	O
simple	B-UNK
loss	B-UNK
of	O
protein	B-UNK
function	B-UNK
.	O

 	O
we	O
have	O
found	B-UNK
that	O
fap	B-DISEASE
patients	B-UNK
with	O
germline	B-UNK
apc	I-UNK
mutations	I-UNK
within	O
a	O
small	B-UNK
region	B-UNK
(	O
codons	B-UNK
1	O
,	O
194	O
-	O
1	O
,	O
392	O
at	B-DISEASE
most	O
)	O
mainly	B-UNK
show	O
allelic	B-UNK
loss	B-UNK
in	O
their	O
colorectal	B-UNK
adenomas	B-UNK
,	O
in	O
contrast	B-UNK
to	O
other	O
fap	B-DISEASE
patients	B-UNK
,	O
whose	O
second	B-UNK
hits	O
tend	O
to	O
occur	B-UNK
by	O
truncating	B-UNK
mutations	B-UNK
in	O
the	O
mutation	B-UNK
cluster	B-UNK
region	I-UNK
.	O

 	O
our	O
results	B-UNK
indicate	B-UNK
that	O
different	B-UNK
apc	B-UNK
mutations	B-UNK
provide	B-UNK
cells	B-UNK
with	O
different	B-UNK
selective	B-UNK
advantages	O
,	O
with	O
mutations	B-UNK
close	B-UNK
to	O
codon	B-UNK
1	O
,	O
300	O
providing	O
the	O
greatest	B-UNK
advantage	B-UNK
.	O

 	O
allelic	B-UNK
loss	B-UNK
is	O
selected	B-UNK
strongly	B-UNK
in	O
cells	B-UNK
with	O
one	O
mutation	B-UNK
near	B-UNK
codon	B-UNK
1	O
,	O
300	O
.	O

 	O
a	O
different	B-UNK
germline	B-UNK
-	O
somatic	B-UNK
apc	B-UNK
mutation	B-UNK
association	B-UNK
exists	B-UNK
in	O
fap	B-DISEASE
desmoids	O
.	O

 	O
apc	B-UNK
is	O
not	O
,	O
therefore	O
,	O
a	O
classical	B-UNK
tumor	B-DISEASE
suppressor	B-UNK
.	O

 	O
our	O
findings	B-UNK
also	O
indicate	B-UNK
a	O
new	B-UNK
mechanism	B-UNK
for	O
disease	B-DISEASE
severity	B-UNK
if	O
a	O
broader	O
spectrum	B-UNK
of	O
mutations	B-UNK
is	O
selected	B-UNK
in	O
tumors	B-DISEASE
,	O
the	O
somatic	B-UNK
mutation	B-UNK
rate	B-UNK
is	O
effectively	O
higher	B-UNK
and	O
more	O
tumors	B-DISEASE
grow	O
.	O
.	O

 	O
mxi1	B-UNK
mutations	B-UNK
in	O
human	B-UNK
neurofibrosarcomas	O
.	O

 	O
mxi1	B-UNK
is	O
thought	O
to	O
negatively	O
regulate	B-UNK
myc	O
function	B-UNK
and	O
may	O
therefore	O
be	O
a	O
potential	B-UNK
tumor	B-DISEASE
suppressor	B-UNK
gene	B-UNK
.	O

 	O
little	B-UNK
effort	O
has	O
yet	O
been	O
made	O
to	O
find	O
alterations	B-UNK
involving	B-UNK
this	O
gene	B-UNK
in	O
human	B-UNK
solid	B-UNK
tumors	B-DISEASE
.	O

 	O
we	O
screened	O
31	O
human	B-UNK
gastric	O
cancers	B-DISEASE
,	O
7	O
esophageal	O
cancers	B-DISEASE
,	O
85	O
bone	O
and	O
soft	B-UNK
tissue	B-UNK
tumors	B-DISEASE
of	O
various	O
types	B-UNK
,	O
including	B-UNK
4	O
neurofibrosarcomas	O
.	O

 	O
we	O
also	O
examined	B-UNK
29	O
human	B-UNK
tumor	B-DISEASE
cell	B-UNK
lines	B-UNK
consisting	O
of	O
12	O
esophageal	O
cancers	B-DISEASE
,	O
7	O
glioma	B-DISEASE
/	O
glioblastomas	O
and	O
10	O
others	O
for	O
mxi1	B-UNK
mutations	B-UNK
in	O
exons	B-UNK
1	O
,	O
2	O
,	O
4	O
(	O
hlh	O
domain	B-UNK
)	O
,	O
5	O
and	O
6	O
.	O

 	B-UNK
polymerase	I-UNK
chain	I-UNK
reaction	O
-	O
single	B-UNK
-	O
strand	B-UNK
conformation	I-UNK
polymorphism	I-UNK
(	O
pcr	B-UNK
-	O
sscp	B-UNK
)	O
and	O
subsequent	B-UNK
sequencing	B-UNK
revealed	I-UNK
three	O
distinct	B-UNK
polymorphisms	B-UNK
in	O
the	O
intron	B-UNK
-	O
exon	B-UNK
boundary	B-UNK
upstream	B-UNK
from	O
exon	B-UNK
6	O
.	O

 	O
we	O
discovered	O
a	O
missense	B-UNK
mutation	I-UNK
,	O
gca	O
to	O
gta	O
(	O
ala	B-UNK
54	O
val	O
)	O
,	O
in	O
exon	B-UNK
2	O
in	O
a	O
neurofibrosarcoma	B-DISEASE
patient	B-UNK
(	O
case	B-UNK
1	O
)	O
,	O
two	O
missense	B-UNK
mutations	I-UNK
,	O
aaa	O
to	O
caa	B-DISEASE
(	O
lys	O
118	O
gln	B-UNK
)	O
and	O
gaa	B-UNK
to	O
gga	O
(	O
glu	B-UNK
154	O
gly	B-UNK
)	O
in	O
exon	B-UNK
5	O
of	O
another	O
neurofibrosarcoma	B-DISEASE
patient	B-UNK
(	O
case	B-UNK
2	O
)	O
,	O
and	O
3	O
amino	B-UNK
acid	I-UNK
substitutions	B-UNK
,	O
gtg	O
to	O
gcg	O
(	O
val	O
179	O
ala	B-UNK
)	O
,	O
gtt	O
to	O
gct	O
(	O
val	O
181	O
ala	B-UNK
)	O
and	O
ttc	O
to	O
ctc	O
(	O
phe	O
186	O
leu	B-UNK
)	O
,	O
in	O
a	O
third	O
neurofibrosarcoma	B-DISEASE
patient	B-UNK
(	O
case	B-UNK
3	O
)	O
.	O

 	O
in	O
case	B-UNK
3	O
,	O
loss	B-UNK
of	O
heterozygosity	B-UNK
was	O
also	O
demonstrated	B-UNK
by	O
informative	B-UNK
(	O
ttc	O
)	O
3	O
/	O
(	O
ttc	O
)	O
2	O
polymorphism	O
.	O

 	O
our	O
data	B-UNK
demonstrate	B-UNK
that	O
mutations	B-UNK
occur	B-UNK
in	O
the	O
mxi1	B-UNK
gene	B-UNK
in	O
neurofibrosarcoma	B-DISEASE
.	O

 	B-UNK
missense	I-UNK
mutations	B-UNK
in	O
the	O
functional	B-UNK
domain	B-UNK
of	O
mxi1	B-UNK
in	O
these	O
cases	B-UNK
may	O
be	O
involved	B-UNK
in	O
the	O
pathogenesis	O
of	O
neurofibrosarcoma	B-DISEASE
.	O
.	O

 	O
a	O
population	B-UNK
-	O
based	B-UNK
study	B-UNK
of	O
the	O
clinical	B-UNK
expression	B-UNK
of	O
the	O
hemochromatosis	B-DISEASE
gene	B-UNK
.	O

 	B-UNK
background	I-UNK
and	O
methods	B-UNK
hereditary	B-DISEASE
hemochromatosis	I-DISEASE
is	O
associated	B-UNK
with	O
homozygosity	B-UNK
for	O
the	O
c282y	B-UNK
mutation	B-UNK
in	O
the	O
hemochromatosis	B-DISEASE
(	O
hfe	B-UNK
)	O
gene	B-UNK
on	O
chromosome	B-DISEASE
6	I-DISEASE
,	O
elevated	B-UNK
serum	B-UNK
transferrin	I-UNK
saturation	O
,	O
and	O
excess	B-UNK
iron	B-UNK
deposits	O
throughout	O
the	O
body	B-UNK
.	O

 	O
to	O
assess	B-UNK
the	O
prevalence	B-UNK
and	O
clinical	B-UNK
expression	B-UNK
of	O
the	O
hfe	B-UNK
gene	B-UNK
,	O
we	O
conducted	O
a	O
population	B-UNK
-	O
based	B-UNK
study	B-UNK
in	O
busselton	O
,	O
australia	O
.	O

 	O
in	O
1994	O
,	O
we	O
obtained	B-UNK
blood	B-UNK
samples	B-UNK
for	O
the	O
determination	B-UNK
of	O
serum	B-UNK
transferrin	I-UNK
saturation	O
and	O
ferritin	B-UNK
levels	I-UNK
and	O
the	O
presence	B-UNK
or	O
absence	B-UNK
of	O
the	O
c282y	B-UNK
mutation	B-UNK
and	O
the	O
h63d	B-UNK
mutation	B-UNK
(	O
which	O
may	O
contribute	B-UNK
to	O
increased	B-UNK
hepatic	B-UNK
iron	B-UNK
levels	B-UNK
)	O
in	O
3011	O
unrelated	B-UNK
white	B-UNK
adults	B-UNK
.	O

 	O
we	O
evaluated	O
all	O
subjects	B-UNK
who	O
had	O
persistently	O
elevated	B-UNK
transferrin	I-UNK
-	O
saturation	O
values	B-UNK
(	O
45	O
percent	O
or	O
higher	B-UNK
)	O
or	O
were	O
homozygous	B-UNK
for	O
the	O
c282y	B-UNK
mutation	B-UNK
.	O

 	O
we	O
recommended	O
liver	B-DISEASE
biopsy	B-UNK
for	O
subjects	B-UNK
with	O
serum	B-UNK
ferritin	I-UNK
levels	B-UNK
of	O
300	O
ng	O
per	O
milliliter	O
or	O
higher	B-UNK
.	O

 	O
the	O
subjects	B-UNK
were	O
followed	B-UNK
for	O
up	O
to	O
four	O
years	B-UNK
.	O

 	B-UNK
results	I-UNK
sixteen	O
of	O
the	O
subjects	B-UNK
(	O
0	O
.	O
5	O
percent	O
)	O
were	O
homozygous	B-UNK
for	O
the	O
c282y	B-UNK
mutation	B-UNK
,	O
and	O
424	O
(	O
14	O
.	O
1	O
percent	O
)	O
were	O
heterozygous	B-UNK
.	O

 	O
the	O
serum	B-UNK
transferrin	I-UNK
saturation	O
was	O
45	O
percent	O
or	O
higher	B-UNK
in	O
15	O
of	O
the	O
16	O
who	O
were	O
homozygous	B-UNK
;	O
in	O
1	O
subject	B-UNK
it	O
was	O
43	O
percent	O
.	O

 	O
four	O
of	O
the	O
homozygous	B-UNK
subjects	B-UNK
had	O
previously	B-UNK
been	O
given	B-UNK
a	O
diagnosis	B-UNK
of	O
hemochromatosis	B-DISEASE
,	O
and	O
12	O
had	O
not	O
.	O

 	B-UNK
seven	I-UNK
of	O
these	O
12	O
patients	B-UNK
had	O
elevated	B-UNK
serum	B-UNK
ferritin	I-UNK
levels	B-UNK
in	O
1994	O
;	O
6	O
of	O
the	O
7	O
had	O
further	O
increases	B-UNK
in	O
1998	O
,	O
and	O
1	O
had	O
a	O
decrease	B-UNK
,	O
although	O
the	O
value	B-UNK
remained	B-UNK
elevated	B-UNK
.	O

 	O
the	O
serum	B-UNK
ferritin	I-UNK
levels	B-UNK
in	O
the	O
four	O
other	O
homozygous	B-UNK
patients	B-UNK
remained	B-UNK
in	O
the	O
normal	B-UNK
range	B-UNK
.	O

 	O
eleven	O
of	O
the	O
16	O
homozygous	B-UNK
subjects	B-UNK
underwent	B-UNK
liver	B-DISEASE
biopsy	B-UNK
;	O
3	O
had	O
hepatic	B-DISEASE
fibrosis	I-DISEASE
,	O
and	O
1	O
,	O
who	O
had	O
a	O
history	B-UNK
of	O
excessive	B-UNK
alcohol	O
consumption	O
,	O
had	O
cirrhosis	B-DISEASE
and	O
mild	B-UNK
microvesicular	O
steatosis	O
.	O

 	O
eight	O
of	O
the	O
16	O
homozygous	B-UNK
subjects	B-UNK
had	O
clinical	B-UNK
findings	B-UNK
that	O
were	O
consistent	B-UNK
with	O
the	O
presence	B-UNK
of	O
hereditary	B-DISEASE
hemochromatosis	I-DISEASE
,	O
such	O
as	O
hepatomegaly	B-DISEASE
,	O
skin	B-DISEASE
pigmentation	O
,	O
and	O
arthritis	B-DISEASE
.	O

 	O
conclusions	B-UNK
in	O
a	O
population	B-UNK
of	O
white	B-UNK
adults	B-UNK
of	O
northern	B-UNK
european	I-UNK
ancestry	B-UNK
,	O
0	O
.	O

 	O
5	O
percent	O
were	O
homozygous	B-UNK
for	O
the	O
c282y	B-UNK
mutation	B-UNK
in	O
the	O
hfe	B-UNK
gene	B-UNK
.	O

 	O
however	O
,	O
only	O
half	B-UNK
of	O
those	O
who	O
were	O
homozygous	B-UNK
had	O
clinical	B-UNK
features	I-UNK
of	O
hemochromatosis	B-DISEASE
,	O
and	O
one	O
quarter	O
had	O
serum	B-UNK
ferritin	I-UNK
levels	B-UNK
that	O
remained	B-UNK
normal	B-UNK
over	O
a	O
four	O
-	O
year	B-UNK
period	B-UNK
.	O

 	O
large	B-UNK
heterozygous	B-UNK
deletion	I-UNK
masquerading	O
as	O
homozygous	B-UNK
missense	B-UNK
mutation	I-UNK
:	O
a	O
pitfall	O
in	O
diagnostic	B-UNK
mutation	B-UNK
analysis	B-UNK
.	O

 	O
the	O
clinical	B-UNK
use	B-UNK
of	O
molecular	B-UNK
analyses	B-UNK
in	O
recessive	O
disorders	B-UNK
relies	O
on	O
the	O
exact	O
characterization	B-UNK
of	O
both	O
mutant	B-UNK
alleles	I-UNK
in	O
the	O
affected	B-UNK
patient	B-UNK
.	O

 	O
this	O
can	O
be	O
problematic	O
when	O
only	O
part	O
of	O
the	O
gene	B-UNK
is	O
examined	B-UNK
or	O
when	O
relevant	B-UNK
dna	B-UNK
alterations	B-UNK
are	O
not	O
recognized	B-UNK
by	O
standard	B-UNK
methods	B-UNK
.	O

 	O
we	O
present	B-UNK
a	O
child	B-UNK
in	O
whom	O
phenylketonuria	B-DISEASE
was	O
apparently	B-UNK
caused	B-UNK
by	O
homozygosity	B-UNK
for	O
the	O
mutation	B-UNK
e390	O
g	B-UNK
in	O
exon	B-UNK
11	O
of	O
the	O
phenylalanine	B-UNK
hydroxylase	I-UNK
(	O
pah	B-UNK
)	O
gene	B-UNK
.	O

 	O
however	O
,	O
the	O
clinical	B-UNK
severity	B-UNK
of	O
the	O
disease	B-DISEASE
was	O
not	O
quite	O
as	O
mild	B-UNK
as	O
expected	B-UNK
,	O
the	O
mutation	B-UNK
was	O
not	O
identified	B-UNK
in	O
the	O
father	B-UNK
despite	B-UNK
confirmed	B-UNK
paternity	O
,	O
and	O
the	O
paternal	B-UNK
allele	B-UNK
showed	I-UNK
a	O
highly	B-UNK
unusual	B-UNK
pattern	B-UNK
of	O
polymorphic	B-UNK
markers	I-UNK
in	O
the	O
pah	B-UNK
gene	B-UNK
.	O

 	O
presence	B-UNK
of	O
a	O
large	B-UNK
deletion	B-UNK
involving	B-UNK
exons	B-UNK
9	O
,	O
10	O
and	O
11	O
of	O
the	O
phenylalanine	B-UNK
hydroxylase	I-UNK
gene	B-UNK
was	O
confirmed	B-UNK
by	O
long	B-UNK
-	O
range	B-UNK
pcr	B-UNK
.	O

 	O
diagnostic	B-UNK
dna	B-UNK
analyses	B-UNK
should	O
include	B-UNK
a	O
comprehensive	B-UNK
examination	B-UNK
of	O
the	O
whole	O
relevant	B-UNK
gene	B-UNK
in	O
the	O
patient	B-UNK
and	O
confirmation	O
of	O
carrier	B-UNK
status	B-UNK
in	O
both	O
parents	B-UNK
.	O
.	O

 	O
early	B-UNK
onset	I-UNK
of	O
x	B-DISEASE
-	I-DISEASE
linked	I-DISEASE
emery	I-DISEASE
-	I-DISEASE
dreifuss	I-DISEASE
muscular	I-DISEASE
dystrophy	I-DISEASE
in	O
a	O
boy	B-UNK
with	O
emerin	B-UNK
gene	B-UNK
deletion	B-UNK
.	O

 	O
a	O
boy	B-UNK
developed	B-UNK
contractures	B-DISEASE
of	O
the	O
achilles	B-UNK
tendons	B-UNK
at	B-DISEASE
3	O
years	B-UNK
and	O
of	O
the	O
postcervical	O
muscles	B-UNK
at	B-DISEASE
7	O
years	B-UNK
,	O
although	O
neither	O
contractures	B-DISEASE
of	O
the	O
elbows	O
nor	O
cardiac	B-UNK
abnormality	B-UNK
were	O
recognized	B-UNK
by	O
the	O
age	B-UNK
of	O
9	O
years	B-UNK
.	O

 	O
muscle	B-UNK
computed	B-UNK
tomography	B-UNK
scanning	B-UNK
revealed	B-UNK
changes	B-UNK
characteristic	B-UNK
of	O
muscle	B-UNK
involvement	B-UNK
.	O

 	O
emerin	B-UNK
was	O
not	O
detected	B-UNK
in	O
the	O
biopsied	O
muscle	B-UNK
,	O
and	O
rt	O
-	O
pcr	B-UNK
and	O
pcr	B-UNK
-	O
based	B-UNK
genomic	B-UNK
dna	I-UNK
analyses	B-UNK
of	O
the	O
emerin	B-UNK
gene	B-UNK
demonstrated	B-UNK
no	O
amplification	B-UNK
product	B-UNK
in	O
the	O
patient	B-UNK
.	O

 	O
these	O
results	B-UNK
confirmed	B-UNK
the	O
diagnosis	B-UNK
of	O
x	B-DISEASE
-	I-DISEASE
linked	I-DISEASE
emery	I-DISEASE
-	I-DISEASE
dreifuss	I-DISEASE
muscular	I-DISEASE
dystrophy	I-DISEASE
(	O
edmd	B-UNK
)	O
,	O
and	O
reinforce	O
the	O
necessity	O
of	O
molecular	B-UNK
genetic	I-UNK
diagnosis	B-UNK
of	O
the	O
membrane	B-UNK
protein	B-UNK
emerin	B-UNK
in	O
younger	B-UNK
patients	B-UNK
with	O
possible	B-UNK
edmd	B-UNK
before	O
appearance	O
of	O
the	O
typical	B-UNK
symptoms	B-UNK
,	O
to	O
avoid	B-UNK
sudden	O
cardiac	B-UNK
death	B-DISEASE
.	O
.	O

 	O
duchenne	B-UNK
/	O
becker	O
muscular	B-DISEASE
dystrophy	I-DISEASE
:	O
correlation	B-UNK
of	O
phenotype	B-UNK
by	O
electroretinography	O
with	O
sites	B-UNK
of	O
dystrophin	B-UNK
mutations	B-UNK
.	O

 	O
the	O
dark	O
-	O
adapted	O
electroretinogram	B-UNK
(	O
erg	B-UNK
)	O
of	O
patients	B-UNK
with	O
duchenne	B-UNK
and	O
becker	O
muscular	B-DISEASE
dystrophy	I-DISEASE
(	O
dmd	B-UNK
/	O
bmd	B-UNK
)	O
shows	B-UNK
a	O
marked	B-UNK
reduction	B-UNK
in	O
b	B-UNK
-	O
wave	B-UNK
amplitude	B-UNK
.	O

 	O
genotype	B-UNK
-	O
phenotype	B-UNK
studies	B-UNK
of	O
mouse	B-UNK
models	B-UNK
for	O
dmd	B-UNK
show	O
position	B-UNK
-	O
specific	B-UNK
effects	B-UNK
of	O
the	O
mutations	B-UNK
upon	O
the	O
phenotype	B-UNK
mice	B-UNK
with	O
5	O
defects	B-UNK
of	O
dystrophin	B-UNK
have	O
normal	B-UNK
ergs	B-UNK
,	O
those	O
with	O
defects	B-UNK
in	O
the	O
central	B-UNK
region	B-UNK
have	O
a	O
normal	B-UNK
b	B-UNK
-	O
wave	B-UNK
amplitude	B-UNK
associated	B-UNK
with	O
prolonged	B-UNK
implicit	O
times	B-UNK
for	O
both	O
the	O
b	B-UNK
-	O
wave	B-UNK
and	O
oscillatory	O
potentials	B-UNK
,	O
and	O
mice	B-UNK
with	O
3	O
defects	B-UNK
have	O
a	O
phenotype	B-UNK
similar	B-UNK
to	O
that	O
seen	B-UNK
in	O
dmd	B-UNK
/	O
bmd	B-UNK
patients	B-UNK
.	O

 	O
the	O
mouse	B-UNK
studies	B-UNK
suggest	I-UNK
a	O
key	B-UNK
role	B-UNK
for	O
the	O
carboxyl	B-UNK
terminal	B-UNK
dystrophin	B-UNK
isoform	B-UNK
,	O
dp260	O
,	O
in	O
retinal	B-UNK
electrophysiology	O
.	O

 	O
we	O
have	O
undertaken	O
a	O
systematic	O
evaluation	B-UNK
of	O
dmd	B-UNK
/	O
bmd	B-UNK
patients	B-UNK
through	O
clinical	B-UNK
examination	B-UNK
and	O
review	O
of	O
the	O
literature	O
in	O
order	B-UNK
to	O
determine	O
whether	O
the	O
position	B-UNK
-	O
specific	B-UNK
effects	B-UNK
of	O
mutations	B-UNK
noted	O
in	O
the	O
mouse	B-UNK
are	O
present	B-UNK
in	O
man	B-UNK
.	O

 	O
we	O
have	O
found	B-UNK
that	O
,	O
in	O
man	B-UNK
,	O
a	O
wider	O
variation	B-UNK
of	O
dmd	B-UNK
defects	B-UNK
correlate	B-UNK
with	O
reductions	O
in	O
the	O
b	B-UNK
-	O
wave	B-UNK
amplitude	B-UNK
.	O

 	O
individuals	B-UNK
with	O
normal	B-UNK
ergs	B-UNK
have	O
mutations	B-UNK
predominantly	B-UNK
located	B-UNK
5	O
of	O
the	O
transcript	B-UNK
initiation	B-UNK
site	B-UNK
of	O
dp260	O
.	O

 	O
our	O
results	B-UNK
suggest	B-UNK
that	O
the	O
most	O
important	B-UNK
determinant	B-UNK
in	O
the	O
erg	B-UNK
b	B-UNK
-	O
wave	B-UNK
phenotype	B-UNK
is	O
the	O
mutation	B-UNK
position	B-UNK
,	O
rather	O
than	O
muscle	B-UNK
disease	B-DISEASE
severity	B-UNK
.	O

 	O
forty	O
-	O
six	O
per	O
cent	O
of	O
patients	B-UNK
with	O
mutations	B-UNK
5	O
of	O
the	O
dp260	O
transcript	B-UNK
start	O
site	B-UNK
have	O
abnormal	B-UNK
ergs	B-UNK
,	O
as	O
opposed	O
to	O
94	O
%	O
with	O
more	O
distal	B-UNK
mutations	B-UNK
.	O

 	O
the	O
human	B-UNK
genotype	B-UNK
-	O
phenotype	B-UNK
correlations	B-UNK
are	O
consistent	B-UNK
with	O
a	O
role	B-UNK
for	O
dp260	O
in	O
normal	B-UNK
retinal	I-UNK
electrophysiology	O
and	O
may	O
also	O
reflect	B-UNK
the	O
expression	B-UNK
of	O
other	O
c	B-UNK
-	O
terminal	B-UNK
dystrophin	B-UNK
isoforms	B-UNK
and	O
their	O
contributions	O
to	O
retinal	B-UNK
signal	B-UNK
transmission	B-UNK
.	O
.	O

 	O
cis	B-UNK
and	O
trans	B-UNK
effects	B-UNK
of	O
the	O
myotonic	B-DISEASE
dystrophy	I-DISEASE
(	O
dm	B-DISEASE
)	O
mutation	B-UNK
in	O
a	O
cell	B-UNK
culture	B-UNK
model	B-UNK
.	O

 	O
the	O
mutation	B-UNK
causing	B-UNK
myotonic	B-DISEASE
dystrophy	I-DISEASE
(	O
dm	B-DISEASE
)	O
has	O
been	O
identified	B-UNK
as	O
a	O
ctg	B-UNK
expansion	I-UNK
in	O
the	O
3	O
-	O
untranslated	B-UNK
region	B-UNK
(	O
3	O
-	O
utr	B-UNK
)	O
of	O
the	O
dm	B-DISEASE
protein	B-UNK
kinase	B-UNK
gene	B-UNK
(	O
dmpk	B-UNK
)	O
,	O
but	O
the	O
mechanism	B-UNK
(	O
s	O
)	O
of	O
pathogenesis	O
remain	O
unknown	B-UNK
.	O

 	O
studies	B-UNK
using	O
dm	B-DISEASE
patient	B-UNK
materials	O
have	O
often	O
produced	B-UNK
confusing	O
results	B-UNK
.	O

 	O
therefore	O
,	O
to	O
study	B-UNK
the	O
effects	B-UNK
of	O
the	O
dm	B-DISEASE
mutation	B-UNK
in	O
a	O
controlled	O
environment	B-UNK
,	O
we	O
have	O
established	B-UNK
a	O
cell	B-UNK
culture	B-UNK
model	B-UNK
system	B-UNK
using	O
c2c12	O
mouse	B-UNK
myoblasts	O
.	O

 	O
by	O
expressing	B-UNK
chimeric	B-UNK
reporter	B-UNK
constructs	O
containing	B-UNK
a	O
reporter	B-UNK
gene	B-UNK
fused	O
to	O
a	O
human	B-UNK
dmpk	B-UNK
3	O
-	O
utr	B-UNK
,	O
we	O
identified	B-UNK
both	O
cis	B-UNK
and	O
trans	B-UNK
effects	B-UNK
that	O
are	O
mediated	B-UNK
by	O
the	O
dm	B-DISEASE
mutation	B-UNK
.	O

 	O
our	O
data	B-UNK
show	O
that	O
a	O
mutant	B-UNK
dmpk	B-UNK
3	O
-	O
utr	B-UNK
,	O
with	O
as	O
few	O
as	O
57	O
ctgs	O
,	O
had	O
a	O
negative	B-UNK
cis	B-UNK
effect	B-UNK
on	O
protein	B-UNK
expression	B-UNK
and	O
resulted	B-UNK
in	O
the	O
aggregation	O
of	O
reporter	B-UNK
transcripts	B-UNK
into	O
discrete	B-UNK
nuclear	B-UNK
foci	I-UNK
.	O

 	O
we	O
determined	B-UNK
by	O
deletion	B-UNK
analysis	B-UNK
that	O
an	O
expanded	B-UNK
(	O
ctg	B-UNK
)	O
(	O
n	B-UNK
)	O
tract	O
alone	O
was	O
sufficient	B-UNK
to	O
mediate	O
these	O
cis	B-UNK
effects	B-UNK
.	O

 	O
furthermore	B-UNK
,	O
in	O
contrast	B-UNK
to	O
the	O
normal	B-UNK
dmpk	B-UNK
3	O
-	O
utr	B-UNK
mrna	B-UNK
,	O
a	O
mutant	B-UNK
dmpk	B-UNK
3	O
-	O
utr	B-UNK
mrna	B-UNK
with	O
(	O
cug	O
)	O
(	O
200	O
)	O
selectively	O
inhibited	B-UNK
myogenic	B-UNK
differentiation	B-UNK
of	O
c2c12	O
myoblasts	O
.	O

 	B-UNK
genetic	I-UNK
analysis	B-UNK
and	O
the	O
cre	O
-	O
loxp	B-UNK
system	B-UNK
were	O
used	O
to	O
clearly	B-UNK
demonstrate	B-UNK
that	O
the	O
myoblast	O
fusion	B-UNK
defect	B-UNK
could	O
be	O
rescued	O
by	O
eliminating	O
the	O
expression	B-UNK
of	O
the	O
mutant	B-UNK
dmpk	B-UNK
3	O
-	O
utr	B-UNK
transcript	B-UNK
.	O

 	O
characterization	B-UNK
of	O
spontaneous	B-UNK
deletion	B-UNK
events	B-UNK
mapped	B-UNK
the	O
inhibitory	B-UNK
effect	B-UNK
to	O
the	O
(	O
ctg	B-UNK
)	O
(	O
n	B-UNK
)	O
expansion	B-UNK
and	O
/	O
or	O
the	O
3	O
end	B-UNK
of	O
the	O
dmpk	B-UNK
3	O
-	O
utr	B-UNK
.	O

 	O
these	O
results	B-UNK
provide	I-UNK
evidence	B-UNK
that	O
the	O
dm	B-DISEASE
mutation	B-UNK
acts	B-UNK
in	O
cis	B-UNK
to	O
reduce	B-UNK
protein	B-UNK
production	B-UNK
(	O
consistent	B-UNK
with	O
dmpk	B-UNK
haploinsufficiency	O
)	O
and	O
in	O
trans	B-UNK
as	O
a	O
riboregulator	O
to	O
inhibit	O
myogenesis	O
.	O
.	O

 	O
coats	O
'	O
disease	B-DISEASE
of	O
the	O
retina	O
(	O
unilateral	B-UNK
retinal	B-DISEASE
telangiectasis	I-DISEASE
)	O
caused	B-UNK
by	O
somatic	B-UNK
mutation	B-UNK
in	O
the	O
ndp	B-UNK
gene	B-UNK
:	O
a	O
role	B-UNK
for	O
norrin	O
in	O
retinal	B-UNK
angiogenesis	O
.	O

 	O
coats	O
disease	B-DISEASE
is	O
characterized	B-UNK
by	O
abnormal	B-UNK
retinal	B-UNK
vascular	O
development	B-UNK
(	O
so	O
-	O
called	B-UNK
retinal	B-DISEASE
telangiectasis	I-DISEASE
)	O
which	O
results	B-UNK
in	O
massive	B-UNK
intraretinal	O
and	O
subretinal	O
lipid	B-UNK
accumulation	B-UNK
(	O
exudative	O
retinal	B-DISEASE
detachment	I-DISEASE
)	O
.	O

 	O
the	O
classical	B-UNK
form	B-UNK
of	O
coats	O
disease	B-DISEASE
is	O
almost	O
invariably	O
isolated	B-UNK
,	O
unilateral	B-UNK
and	O
seen	B-UNK
in	O
males	B-UNK
.	O

 	O
a	O
female	B-UNK
with	O
a	O
unilateral	B-UNK
variant	B-UNK
of	O
coats	O
disease	B-DISEASE
gave	B-UNK
birth	O
to	O
a	O
son	O
affected	B-UNK
by	O
norrie	B-DISEASE
disease	I-DISEASE
.	O

 	O
both	O
carried	B-UNK
a	O
missense	B-UNK
mutation	I-UNK
within	O
the	O
ndp	B-UNK
gene	B-UNK
on	O
chromosome	B-UNK
xp11	B-UNK
.	O

 	O
2	O
2	O
.	O

 	O
subsequently	B-UNK
analysis	B-UNK
of	O
the	O
retinas	O
of	O
nine	O
enucleated	O
eyes	O
from	O
males	B-UNK
with	O
coats	O
disease	B-DISEASE
demonstrated	B-UNK
in	O
one	O
a	O
somatic	B-UNK
mutation	B-UNK
in	O
the	O
ndp	B-UNK
gene	B-UNK
which	O
was	O
not	O
present	B-UNK
within	O
non	B-UNK
-	O
retinal	B-UNK
tissue	B-UNK
.	O

 	O
we	O
suggest	B-UNK
that	O
coats	O
telangiectasis	B-DISEASE
is	O
secondary	B-UNK
to	O
somatic	B-UNK
mutation	B-UNK
in	O
the	O
ndp	B-UNK
gene	B-UNK
which	O
results	B-UNK
in	O
a	O
deficiency	B-UNK
of	O
norrin	O
(	O
the	O
protein	B-UNK
product	B-UNK
of	O
the	O
ndp	B-UNK
gene	B-UNK
)	O
within	O
the	O
developing	B-UNK
retina	O
.	O

 	O
this	O
supports	B-UNK
recent	B-UNK
observations	B-UNK
that	O
the	O
protein	B-UNK
is	O
critical	B-UNK
for	O
normal	B-UNK
retinal	I-UNK
vasculogenesis	O
.	O

 	B-UNK
hereditary	I-UNK
tp53	O
codon	B-UNK
292	O
and	O
somatic	B-UNK
p16ink4a	B-UNK
codon	B-UNK
94	O
mutations	B-UNK
in	O
a	O
li	B-DISEASE
-	I-DISEASE
fraumeni	I-DISEASE
syndrome	I-DISEASE
family	B-UNK
.	O

 	O
li	B-DISEASE
-	I-DISEASE
fraumeni	I-DISEASE
syndrome	I-DISEASE
is	O
an	O
autosomal	O
dominant	B-UNK
disorder	O
that	O
is	O
characterized	B-UNK
by	O
various	O
types	B-UNK
of	O
cancer	B-DISEASE
in	O
childhood	B-UNK
and	O
adult	B-UNK
cases	B-UNK
.	O

 	O
although	O
hereditary	B-UNK
tp53	I-UNK
mutation	B-UNK
is	O
very	O
rare	B-UNK
in	O
different	B-UNK
human	B-UNK
cancers	B-DISEASE
,	O
it	O
has	O
been	O
frequently	B-UNK
reported	B-UNK
in	O
li	B-DISEASE
-	I-DISEASE
fraumeni	I-DISEASE
syndrome	I-DISEASE
.	O

 	O
on	O
the	O
other	O
hand	B-DISEASE
,	O
hereditary	B-UNK
mutations	B-UNK
of	O
tp57kip2	O
,	O
p15ink4b	O
,	O
and	O
p16ink4a	B-UNK
,	O
which	O
affect	B-UNK
the	O
cell	B-UNK
cycle	B-UNK
similar	B-UNK
to	O
tp53	O
,	O
were	O
observed	B-UNK
in	O
some	O
types	B-UNK
of	O
cancer	B-DISEASE
.	O

 	O
in	O
a	O
turkish	B-UNK
family	B-UNK
with	O
the	O
diagnosis	B-UNK
of	O
li	B-DISEASE
-	I-DISEASE
fraumeni	I-DISEASE
syndrome	I-DISEASE
,	O
we	O
analyzed	B-UNK
the	O
mutation	B-UNK
pattern	B-UNK
of	O
tp53	O
,	O
p57kip2	O
,	O
p15ink4b	O
,	O
and	O
p16ink4a	B-UNK
in	O
the	O
peripheral	B-UNK
blood	I-UNK
,	O
and	O
loss	B-UNK
of	O
heterozygosity	B-UNK
(	O
homo	O
/	O
hemizygous	B-UNK
deletion	B-UNK
)	O
pattern	B-UNK
of	O
tp53	O
and	O
p15ink4b	O
/	O
p16ink4a	B-UNK
in	O
two	O
tumor	B-DISEASE
tissues	B-UNK
.	O

 	O
the	O
propositus	O
had	O
a	O
seminoma	B-DISEASE
,	O
his	O
daughter	O
a	O
medulloblastoma	B-DISEASE
,	O
and	O
one	O
of	O
his	O
healthy	B-UNK
cousins	O
,	O
a	O
tp53	O
codon	B-UNK
292	O
missense	B-UNK
point	B-UNK
mutation	I-UNK
(	O
aaa	O
-	O
-	O
>	O
ata	O
;	O
lys	O
-	O
-	O
>	O
ile	B-UNK
)	O
in	O
the	O
peripheral	B-UNK
blood	I-UNK
cells	B-UNK
.	O

 	O
tumor	B-DISEASE
tissue	B-UNK
obtained	B-UNK
from	O
the	O
propositus	O
with	O
the	O
seminoma	B-DISEASE
revealed	B-UNK
loss	B-UNK
of	O
heterozygosity	B-UNK
in	O
the	O
tp53	O
gene	B-UNK
.	O

 	O
in	O
the	O
analyses	B-UNK
of	O
tumor	B-DISEASE
tissues	B-UNK
from	O
the	O
propositus	O
and	O
his	O
daughter	O
,	O
a	O
p16ink4a	B-UNK
codon	B-UNK
94	O
missense	B-UNK
point	B-UNK
mutation	I-UNK
(	O
gcg	O
-	O
-	O
>	O
gag	O
;	O
ala	B-UNK
-	O
-	O
>	O
glu	B-UNK
)	O
was	O
observed	B-UNK
with	O
the	O
hereditary	B-UNK
tp53	I-UNK
mutation	B-UNK
.	O

 	O
p16ink4a	B-UNK
codon	B-UNK
94	O
mutation	B-UNK
observed	B-UNK
in	O
our	O
family	B-UNK
is	O
a	O
novel	B-UNK
mutation	B-UNK
in	O
li	B-DISEASE
-	I-DISEASE
fraumeni	I-DISEASE
syndrome	I-DISEASE
.	O

 	O
no	O
other	O
gene	B-UNK
alteration	B-UNK
in	O
tp53	O
,	O
p57kip2	O
,	O
p15ink4b	O
,	O
and	O
p16ink4a	B-UNK
was	O
observed	B-UNK
.	O

 	O
existence	O
of	O
the	O
p16ink4a	B-UNK
mutation	B-UNK
and	O
the	O
hereditary	B-UNK
tp53	I-UNK
mutation	B-UNK
with	O
or	O
without	O
loss	B-UNK
of	O
heterozygosity	B-UNK
in	O
the	O
tp53	O
gene	B-UNK
(	O
seminoma	B-DISEASE
/	O
medulloblastoma	B-DISEASE
)	O
may	O
be	O
evidence	B-UNK
for	O
a	O
common	B-UNK
mechanism	B-UNK
involved	B-UNK
in	O
tumorogenesis	O
.	O

 	O
the	O
gene	B-UNK
alterations	B-UNK
in	O
tp53	O
and	O
p16ink4a	B-UNK
genes	B-UNK
may	O
be	O
used	O
as	O
tumor	B-DISEASE
markers	B-UNK
in	O
our	O
family	B-UNK
.	O
.	O

 	O
a	O
novel	B-UNK
mutation	B-UNK
in	O
the	O
sodium	B-UNK
/	O
iodide	B-UNK
symporter	O
gene	B-UNK
in	O
the	O
largest	O
family	B-UNK
with	O
iodide	B-UNK
transport	I-UNK
defect	B-UNK
.	O

 	O
we	O
previously	B-UNK
reported	I-UNK
nine	O
children	B-UNK
with	O
an	O
autosomally	O
recessive	O
form	B-UNK
of	O
congenital	B-DISEASE
hypothyroidism	I-DISEASE
due	O
to	O
an	O
iodide	B-UNK
transport	I-UNK
defect	B-UNK
in	O
a	O
large	B-UNK
hutterite	O
family	B-UNK
with	O
extensive	B-UNK
consanguinity	O
living	B-UNK
in	O
central	B-UNK
canada	B-UNK
.	O

 	O
since	O
the	O
original	B-UNK
report	B-UNK
,	O
we	O
have	O
diagnosed	B-UNK
congenital	B-DISEASE
hypothyroidism	I-DISEASE
by	O
newborn	B-UNK
tsh	O
screening	B-UNK
in	O
9	O
additional	B-UNK
children	B-UNK
from	O
the	O
family	B-UNK
.	O

 	O
we	O
performed	B-UNK
direct	B-UNK
sequencing	I-UNK
of	O
the	O
pcr	B-UNK
products	B-UNK
of	O
each	O
nis	B-UNK
(	O
sodium	B-UNK
/	O
iodide	B-UNK
symporter	O
)	O
gene	B-UNK
exon	B-UNK
with	O
flanking	B-UNK
introns	B-UNK
amplified	B-UNK
from	O
genomic	B-UNK
dna	I-UNK
extracted	O
from	O
peripheral	B-UNK
blood	I-UNK
cells	B-UNK
of	O
the	O
patients	B-UNK
.	O

 	O
we	O
identified	B-UNK
a	O
novel	B-UNK
nis	B-UNK
gene	B-UNK
mutation	B-UNK
,	O
g395r	O
(	O
gly395	O
-	O
-	O
>	O
arg	B-UNK
;	O
gga	O
-	O
-	O
>	O
aga	B-UNK
)	O
,	O
in	O
10	O
patients	B-UNK
examined	B-UNK
in	O
the	O
present	B-UNK
study	I-UNK
.	O

 	O
all	O
of	O
the	O
parents	B-UNK
tested	B-UNK
were	O
heterozygous	B-UNK
for	O
the	O
mutation	B-UNK
,	O
suggesting	B-UNK
that	O
the	O
patients	B-UNK
were	O
homozygous	B-UNK
.	O

 	O
the	O
mutation	B-UNK
was	O
located	B-UNK
in	O
the	O
10th	O
transmembrane	B-UNK
helix	B-UNK
.	O

 	O
expression	B-UNK
experiments	B-UNK
by	O
transfection	O
of	O
the	O
mutant	B-UNK
nis	B-UNK
complimentary	O
dna	B-UNK
into	O
cos	B-UNK
-	O
7	O
cells	B-UNK
showed	B-UNK
no	O
perchlorate	B-UNK
-	O
sensitive	B-UNK
iodide	B-UNK
uptake	B-UNK
,	O
confirming	O
that	O
the	O
mutation	B-UNK
is	O
the	O
direct	B-UNK
cause	B-UNK
of	O
the	O
iodide	B-UNK
transport	I-UNK
defect	B-UNK
in	O
these	O
patients	B-UNK
.	O

 	O
a	O
patient	B-UNK
who	O
showed	B-UNK
an	O
intermediate	B-UNK
saliva	O
/	O
serum	B-UNK
technetium	O
ratio	B-UNK
(	O
14	O
.	O
0	O
;	O
normal	B-UNK
,	O
>	O
or	O
=	O
20	O
)	O
and	O
was	O
considered	B-UNK
to	O
have	O
a	O
partial	B-UNK
or	O
less	O
severe	B-UNK
defect	B-UNK
in	O
the	O
previous	B-UNK
report	B-UNK
(	O
ix	O
-	O
24	O
)	O
did	O
not	O
have	O
a	O
nis	B-UNK
gene	B-UNK
mutation	B-UNK
.	O

 	O
it	O
is	O
now	O
possible	B-UNK
to	O
use	B-UNK
gene	B-UNK
diagnostics	O
of	O
this	O
unique	B-UNK
nis	B-UNK
mutation	B-UNK
to	O
identify	B-UNK
patients	B-UNK
with	O
congenital	B-DISEASE
hypothyroidism	I-DISEASE
due	O
to	O
an	O
iodide	B-UNK
transport	I-UNK
defect	B-UNK
in	O
this	O
family	B-UNK
and	O
to	O
determine	O
the	O
carrier	B-UNK
state	B-UNK
of	O
potential	B-UNK
parents	B-UNK
for	O
genetic	B-UNK
counseling	B-UNK
and	O
arranging	O
rapid	B-UNK
and	O
early	B-UNK
diagnosis	B-UNK
of	O
their	O
infants	O
.	O

 	B-UNK
molecular	I-UNK
analysis	B-UNK
in	O
familial	B-UNK
neurohypophyseal	I-UNK
diabetes	B-DISEASE
insipidus	I-DISEASE
:	O
early	B-UNK
diagnosis	B-UNK
of	O
an	O
asymptomatic	B-UNK
carrier	B-UNK
.	O

 	B-UNK
familial	I-UNK
neurohypophyseal	B-UNK
diabetes	B-DISEASE
insipidus	I-DISEASE
(	O
fndi	O
)	O
is	O
an	O
inherited	B-UNK
deficiency	B-UNK
of	O
the	O
hormone	B-UNK
arginine	B-UNK
vasopressin	B-UNK
(	O
avp	B-UNK
)	O
and	O
is	O
transmitted	B-UNK
as	O
an	O
autosomal	O
dominant	B-UNK
trait	B-UNK
.	O

 	O
in	O
the	O
present	B-UNK
study	I-UNK
we	O
have	O
analyzed	B-UNK
the	O
avp	B-UNK
-	O
neurophysin	O
ii	B-UNK
(	O
avp	B-UNK
-	O
npii	O
)	O
gene	B-UNK
in	O
a	O
spanish	B-UNK
kindred	B-UNK
.	O

 	O
studies	B-UNK
were	O
performed	B-UNK
on	O
seven	B-UNK
members	B-UNK
(	O
four	O
clinically	B-UNK
affected	B-UNK
)	O
of	O
the	O
family	B-UNK
.	O

 	B-UNK
patients	I-UNK
were	O
diagnosed	B-UNK
at	B-DISEASE
the	O
hospital	B-UNK
universitario	O
gregorio	O
maranon	O
(	O
madrid	O
,	O
spain	O
)	O
.	O

 	O
the	O
entire	B-UNK
coding	I-UNK
region	B-UNK
of	O
the	O
avp	B-UNK
-	O
npii	O
gene	B-UNK
of	O
all	O
family	B-UNK
members	I-UNK
was	O
amplified	B-UNK
by	O
pcr	B-UNK
and	O
sequenced	B-UNK
.	O

 	O
all	O
affected	B-UNK
individuals	I-UNK
presented	B-UNK
a	O
missense	B-UNK
mutation	I-UNK
(	O
g1757	O
-	O
-	O
>	O
a	O
)	O
that	O
replaces	O
glycine	B-UNK
at	B-DISEASE
position	B-UNK
23	O
with	O
arginine	B-UNK
within	O
the	O
npii	O
domain	B-UNK
.	O

 	O
the	O
substitution	B-UNK
was	O
confirmed	B-UNK
by	O
restriction	O
endonuclease	O
analysis	B-UNK
and	O
was	O
present	B-UNK
in	O
heterozygosis	O
.	O

 	O
additionally	B-UNK
,	O
one	O
of	O
the	O
asymptomatic	B-UNK
relatives	B-UNK
(	O
a	O
girl	B-UNK
8	O
months	O
old	B-UNK
at	B-DISEASE
the	O
time	B-UNK
of	O
study	B-UNK
)	O
was	O
identified	B-UNK
as	O
carrier	B-UNK
of	O
the	O
same	O
mutation	B-UNK
and	O
developed	B-UNK
the	O
disease	B-DISEASE
3	O
months	O
later	B-UNK
.	O

 	O
the	O
alteration	B-UNK
found	B-UNK
in	O
the	O
second	B-UNK
exon	B-UNK
of	O
the	O
gene	B-UNK
in	O
this	O
family	B-UNK
seems	O
to	O
be	O
responsible	B-UNK
for	O
the	O
disease	B-DISEASE
,	O
as	O
all	O
individuals	B-UNK
harboring	O
the	O
mutation	B-UNK
had	O
been	O
previously	B-UNK
diagnosed	B-UNK
or	O
have	O
eventually	O
developed	B-UNK
fndi	O
.	O

 	O
identification	B-UNK
of	O
the	O
molecular	B-UNK
defect	B-UNK
underlying	B-UNK
fndi	O
in	O
affected	B-UNK
families	B-UNK
is	O
a	O
powerful	O
tool	B-UNK
for	O
early	B-UNK
asymptomatic	B-UNK
diagnosis	B-UNK
in	O
infants	O
.	O
.	O

 	O
deficit	O
of	O
in	O
vivo	B-UNK
mitochondrial	B-UNK
atp	B-UNK
production	B-UNK
in	O
patients	B-UNK
with	O
friedreich	B-DISEASE
ataxia	I-DISEASE
.	O

 	O
friedreich	B-DISEASE
ataxia	I-DISEASE
(	O
frda	B-UNK
)	O
,	O
the	O
most	O
common	B-UNK
of	O
the	O
inherited	B-UNK
ataxias	O
,	O
is	O
an	O
autosomal	O
recessive	O
degenerative	O
disorder	O
,	O
characterized	B-UNK
clinically	B-UNK
by	O
onset	B-UNK
before	O
the	O
age	B-UNK
of	O
25	O
of	O
progressive	B-UNK
gait	O
and	O
limb	B-UNK
ataxia	B-DISEASE
,	O
absence	B-UNK
of	O
deep	O
tendon	B-UNK
reflexes	I-UNK
,	O
extensor	O
plantar	O
responses	B-UNK
,	O
and	O
loss	B-UNK
of	O
position	B-UNK
and	O
vibration	B-UNK
sense	B-UNK
in	O
the	O
lower	B-UNK
limbs	O
.	O

 	O
frda	B-UNK
is	O
caused	B-UNK
by	O
a	O
gaa	B-UNK
triplet	B-UNK
expansion	B-UNK
in	O
the	O
first	O
intron	B-UNK
of	O
the	O
frda	B-UNK
gene	B-UNK
on	O
chromosome	B-UNK
9q13	O
in	O
97	O
%	O
of	O
patients	B-UNK
.	O

 	O
the	O
frda	B-UNK
gene	B-UNK
encodes	B-UNK
a	O
widely	B-UNK
expressed	B-UNK
210	O
-	O
aa	B-UNK
protein	B-UNK
,	O
frataxin	B-UNK
,	O
which	O
is	O
located	B-UNK
in	O
mitochondria	O
and	O
is	O
severely	B-UNK
reduced	B-UNK
in	O
frda	B-UNK
patients	B-UNK
.	O

 	O
frataxin	B-UNK
function	B-UNK
is	O
still	O
unknown	B-UNK
but	O
the	O
knockout	O
of	O
the	O
yeast	B-UNK
frataxin	I-UNK
homologue	B-UNK
gene	B-UNK
(	O
yfh1	O
)	O
showed	B-UNK
a	O
severe	B-UNK
defect	B-UNK
of	O
mitochondrial	B-UNK
respiration	O
and	O
loss	B-UNK
of	O
mtdna	B-UNK
associated	B-UNK
with	O
elevated	B-UNK
intramitochondrial	O
iron	B-UNK
.	O

 	O
here	O
we	O
report	B-UNK
in	O
vivo	B-UNK
evidence	B-UNK
of	O
impaired	B-UNK
mitochondrial	B-UNK
respiration	O
in	O
skeletal	B-UNK
muscle	I-UNK
of	O
frda	B-UNK
patients	B-UNK
.	O

 	O
using	O
phosphorus	O
magnetic	B-UNK
resonance	I-UNK
spectroscopy	O
we	O
demonstrated	B-UNK
a	O
maximum	B-UNK
rate	B-UNK
of	O
muscle	B-UNK
mitochondrial	B-UNK
atp	B-UNK
production	B-UNK
(	O
v	O
(	O
max	O
)	O
)	O
below	O
the	O
normal	B-UNK
range	B-UNK
in	O
all	O
12	O
frda	B-UNK
patients	B-UNK
and	O
a	O
strong	B-UNK
negative	B-UNK
correlation	B-UNK
between	O
mitochondrial	B-UNK
v	O
(	O
max	O
)	O
and	O
the	O
number	B-UNK
of	O
gaa	B-UNK
repeats	B-UNK
in	O
the	O
smaller	B-UNK
allele	B-UNK
.	O

 	O
our	O
results	B-UNK
show	O
that	O
frda	B-UNK
is	O
a	O
nuclear	B-UNK
-	O
encoded	B-UNK
mitochondrial	B-UNK
disorder	O
affecting	B-UNK
oxidative	B-UNK
phosphorylation	B-UNK
and	O
give	O
a	O
rationale	O
for	O
treatments	B-UNK
aimed	O
to	O
improve	O
mitochondrial	B-UNK
function	B-UNK
in	O
this	O
condition	B-UNK
.	O
.	O

 	O
identification	B-UNK
of	O
a	O
novel	B-UNK
r21x	O
mutation	B-UNK
in	O
the	O
liver	B-DISEASE
-	O
type	B-UNK
arginase	O
gene	B-UNK
(	O
arg1	O
)	O
in	O
four	O
portuguese	B-UNK
patients	B-UNK
with	O
argininemia	O
.	O

 	O
argininemia	O
is	O
a	O
rare	B-UNK
autossomal	O
recessive	O
disorder	O
caused	B-UNK
by	O
deficiency	B-UNK
in	O
the	O
cytosolic	O
liver	B-DISEASE
-	O
type	B-UNK
arginase	O
enzyme	B-UNK
(	O
l	B-UNK
-	O
arginine	B-UNK
urea	O
-	O
hydrolase	O
;	O
e	B-UNK
.	O
c	B-UNK
.	O
3	O
.	O
5	O
.	O
3	O
.	O
1	O
)	O
.	O

 	O
in	O
order	B-UNK
to	O
investigate	O
the	O
molecular	B-UNK
basis	I-UNK
for	O
argininemia	O
in	O
four	O
unrelated	B-UNK
portuguese	B-UNK
patients	B-UNK
(	O
two	O
from	O
northern	B-UNK
portugal	O
and	O
two	O
from	O
madeira	O
island	B-UNK
)	O
we	O
performed	B-UNK
a	O
dna	B-UNK
sequence	I-UNK
analysis	B-UNK
of	O
all	O
the	O
exons	B-UNK
and	O
exon	B-UNK
/	O
intron	B-UNK
boundaries	B-UNK
of	O
the	O
liver	B-DISEASE
-	O
type	B-UNK
arginase	O
gene	B-UNK
(	O
arg1	O
)	O
.	O

 	O
all	O
patients	B-UNK
were	O
found	B-UNK
to	O
be	O
homozygous	B-UNK
for	O
a	O
newly	B-UNK
identified	B-UNK
c	B-UNK
-	O
>	O
t	B-UNK
transition	I-UNK
in	O
codon	B-UNK
21	O
(	O
exon	B-UNK
2	O
)	O
substituting	O
arginine	B-UNK
for	O
a	O
premature	B-UNK
stop	B-UNK
codon	B-UNK
(	O
r21x	O
cga	O
to	O
tga	B-DISEASE
)	O
and	O
generating	O
a	O
nlaiii	O
restriction	O
site	B-UNK
.	O

 	O
restriction	O
digestion	B-UNK
following	B-UNK
pcr	B-UNK
amplification	I-UNK
of	O
arg1	O
exon	B-UNK
2	O
confirmed	B-UNK
the	O
presence	B-UNK
of	O
the	O
mutation	B-UNK
.	O

 	O
mutation	B-UNK
of	O
the	O
sterol	O
27	O
-	O
hydroxylase	O
gene	B-UNK
(	O
cyp27	O
)	O
results	B-UNK
in	O
truncation	O
of	O
mrna	B-UNK
expressed	B-UNK
in	O
leucocytes	B-UNK
in	O
a	O
japanese	B-UNK
family	B-UNK
with	O
cerebrotendinous	O
xanthomatosis	B-DISEASE
.	O

 	O
objectives	B-UNK
a	O
japanese	B-UNK
family	B-UNK
with	O
cerebrotendinous	O
xanthomatosis	B-DISEASE
(	O
ctx	B-UNK
)	O
was	O
investigated	B-UNK
for	O
a	O
sequence	B-UNK
alteration	B-UNK
in	O
the	O
sterol	O
27	O
-	O
hydroxylase	O
gene	B-UNK
(	O
cyp27	O
)	O
.	O

 	O
the	O
expression	B-UNK
of	O
cyp27	O
has	O
been	O
mostly	O
explored	O
using	O
cultured	B-UNK
fibroblasts	B-UNK
,	O
prompting	O
the	O
examination	B-UNK
of	O
the	O
transcripts	B-UNK
from	O
blood	B-UNK
leucocytes	B-UNK
as	O
a	O
simple	B-UNK
and	O
rapid	B-UNK
technique	B-UNK
.	O

 	O
methods	B-UNK
an	O
alteration	B-UNK
in	O
cyp27	O
of	O
the	O
proband	B-UNK
was	O
searched	O
for	O
by	O
polymerase	B-UNK
chain	I-UNK
reaction	I-UNK
-	O
single	B-UNK
strand	I-UNK
conformation	I-UNK
polymorphism	O
(	O
pcr	B-UNK
-	O
sscp	B-UNK
)	O
analysis	B-UNK
and	O
subsequent	B-UNK
sequencing	B-UNK
.	O

 	O
samples	B-UNK
of	O
rna	B-UNK
were	O
subjected	O
to	O
reverse	B-UNK
transcription	B-UNK
pcr	B-UNK
(	O
rt	O
-	O
pcr	B-UNK
)	O
and	O
the	O
product	B-UNK
of	O
the	O
proband	B-UNK
was	O
amplified	B-UNK
with	O
nested	B-UNK
primers	B-UNK
and	O
sequenced	B-UNK
.	O

 	B-UNK
results	I-UNK
a	O
homozygous	B-UNK
g	B-UNK
to	O
a	O
transition	B-UNK
at	B-DISEASE
the	O
5	O
end	B-UNK
of	O
intron	B-UNK
7	O
was	O
detected	B-UNK
in	O
the	O
patient	B-UNK
.	O

 	O
in	O
rt	O
-	O
pcr	B-UNK
analysis	B-UNK
,	O
only	O
a	O
truncated	B-UNK
transcript	B-UNK
was	O
detected	B-UNK
in	O
the	O
patient	B-UNK
,	O
whereas	O
both	O
normal	B-UNK
and	O
truncated	B-UNK
transcripts	B-UNK
were	O
detected	B-UNK
in	O
the	O
siblings	B-UNK
.	O

 	O
the	O
sequencing	B-UNK
of	O
the	O
patients	B-UNK
cdna	B-UNK
fragment	O
disclosed	B-UNK
a	O
direct	B-UNK
conjuction	O
of	O
exon	B-UNK
6	O
and	O
exon	B-UNK
8	O
.	O

 	O
conclusion	B-UNK
the	O
mutation	B-UNK
at	B-DISEASE
splice	B-UNK
donor	I-UNK
site	I-UNK
and	O
the	O
truncation	O
of	O
mrna	B-UNK
were	O
identical	B-UNK
with	O
those	O
of	O
a	O
recently	B-UNK
reported	B-UNK
italian	B-UNK
patient	B-UNK
,	O
although	O
different	B-UNK
in	O
symptomatology	O
.	O

 	O
the	O
application	O
of	O
blood	B-UNK
leucocytes	B-UNK
can	O
be	O
a	O
simple	B-UNK
technique	B-UNK
on	O
analysing	O
a	O
constructive	O
abnormality	B-UNK
of	O
cyp27	O
mrna	B-UNK
.	O
.	O

 	B-UNK
clinical	I-UNK
and	O
molecular	B-UNK
genetic	I-UNK
analysis	B-UNK
of	O
19	O
wolfram	B-DISEASE
syndrome	I-DISEASE
kindreds	B-UNK
demonstrating	B-UNK
a	O
wide	B-UNK
spectrum	B-UNK
of	O
mutations	B-UNK
in	O
wfs1	O
.	O

 	O
wolfram	B-DISEASE
syndrome	I-DISEASE
is	O
an	O
autosomal	O
recessive	O
neurodegenerative	B-DISEASE
disorder	I-DISEASE
characterized	B-UNK
by	O
juvenile	B-UNK
-	O
onset	B-UNK
diabetes	B-DISEASE
mellitus	I-DISEASE
and	O
progressive	B-UNK
optic	B-DISEASE
atrophy	I-DISEASE
.	O

 	O
mtdna	B-UNK
deletions	B-UNK
have	O
been	O
described	B-UNK
,	O
and	O
a	O
gene	B-UNK
(	O
wfs1	O
)	O
recently	B-UNK
has	O
been	O
identified	B-UNK
,	O
on	O
chromosome	B-UNK
4p16	B-UNK
,	O
encoding	B-UNK
a	O
predicted	B-UNK
890	O
amino	B-UNK
acid	I-UNK
transmembrane	B-UNK
protein	B-UNK
.	O

 	B-UNK
direct	I-UNK
dna	B-UNK
sequencing	I-UNK
was	O
done	O
to	O
screen	B-UNK
the	O
entire	B-UNK
coding	I-UNK
region	B-UNK
of	O
the	O
wfs1	O
gene	B-UNK
in	O
30	O
patients	B-UNK
from	O
19	O
british	B-UNK
kindreds	B-UNK
with	O
wolfram	B-DISEASE
syndrome	I-DISEASE
.	O

 	B-UNK
dna	I-UNK
was	O
also	O
screened	O
for	O
structural	B-UNK
rearrangements	B-UNK
(	O
deletions	B-UNK
and	O
duplications	O
)	O
and	O
point	B-UNK
mutations	I-UNK
in	O
mtdna	B-UNK
.	O

 	O
no	O
pathogenic	O
mtdna	B-UNK
mutations	B-UNK
were	O
found	B-UNK
in	O
our	O
cohort	B-UNK
.	O

 	O
we	O
identified	B-UNK
24	O
mutations	B-UNK
in	O
the	O
wfs1	O
gene	B-UNK
8	O
nonsense	B-UNK
mutations	B-UNK
,	O
8	O
missense	B-UNK
mutations	I-UNK
,	O
3	O
in	O
-	O
frame	B-UNK
deletions	B-UNK
,	O
1	O
in	O
-	O
frame	B-UNK
insertion	B-UNK
,	O
and	O
4	O
frameshift	B-UNK
mutations	B-UNK
.	O

 	O
of	O
these	O
,	O
23	O
were	O
novel	B-UNK
mutations	B-UNK
,	O
and	O
most	O
occurred	B-UNK
in	O
exon	B-UNK
8	O
.	O

 	O
the	O
majority	B-UNK
of	O
patients	B-UNK
were	O
compound	B-UNK
heterozygotes	B-UNK
for	O
two	O
mutations	B-UNK
,	O
and	O
there	O
was	O
no	O
common	B-UNK
founder	B-UNK
mutation	B-UNK
.	O

 	O
the	O
data	B-UNK
were	O
also	O
analyzed	B-UNK
for	O
genotype	B-UNK
-	O
phenotype	B-UNK
relationships	B-UNK
.	O

 	O
although	O
some	O
interesting	O
cases	B-UNK
were	O
noted	O
,	O
consideration	O
of	O
the	O
small	B-UNK
sample	B-UNK
size	B-UNK
and	O
frequency	B-UNK
of	O
each	O
mutation	B-UNK
indicated	B-UNK
no	O
clear	B-UNK
-	O
cut	O
correlations	B-UNK
between	O
any	O
of	O
the	O
observed	B-UNK
mutations	B-UNK
and	O
disease	B-DISEASE
severity	B-UNK
.	O

 	O
there	O
were	O
no	O
obvious	B-UNK
mutation	B-UNK
hot	O
spots	O
or	O
clusters	O
.	O

 	O
hence	O
,	O
molecular	B-UNK
screening	B-UNK
for	O
wolfram	B-DISEASE
syndrome	I-DISEASE
in	O
affected	B-UNK
families	B-UNK
and	O
for	O
wolfram	B-DISEASE
syndrome	I-DISEASE
-	O
carrier	B-UNK
status	B-UNK
in	O
subjects	B-UNK
with	O
psychiatric	B-DISEASE
disorders	B-UNK
or	O
diabetes	B-DISEASE
mellitus	I-DISEASE
will	O
require	O
complete	B-UNK
analysis	B-UNK
of	O
exon	B-UNK
8	O
and	O
upstream	B-UNK
exons	B-UNK
.	O
.	O

 	O
late	B-UNK
-	O
onset	B-UNK
familial	B-DISEASE
mediterranean	I-DISEASE
fever	I-DISEASE
(	O
fmf	B-UNK
)	O
:	O
a	O
subset	O
with	O
distinct	B-UNK
clinical	B-UNK
,	O
demographic	O
,	O
and	O
molecular	B-UNK
genetic	I-UNK
characteristics	B-UNK
.	O

 	O
to	O
determine	O
the	O
prevalence	B-UNK
and	O
characterize	O
demographic	O
,	O
clinical	B-UNK
,	O
and	O
genetic	B-UNK
features	B-UNK
of	O
familial	B-DISEASE
mediterranean	I-DISEASE
fever	I-DISEASE
(	O
fmf	B-UNK
)	O
of	O
late	B-UNK
onset	B-UNK
,	O
all	O
patients	B-UNK
experiencing	O
their	O
first	O
fmf	B-UNK
attack	O
at	B-DISEASE
age	B-UNK
40	O
years	B-UNK
or	O
more	O
were	O
identified	B-UNK
using	O
the	O
computerized	O
registry	O
of	O
our	O
fmf	B-UNK
clinic	B-UNK
,	O
and	O
then	O
thoroughly	O
interviewed	O
and	O
examined	B-UNK
.	O

 	O
the	O
control	B-UNK
group	B-UNK
consisted	B-UNK
of	O
40	O
consecutive	B-UNK
fmf	B-UNK
patients	B-UNK
,	O
who	O
arrived	O
at	B-DISEASE
the	O
fmf	B-UNK
clinic	B-UNK
for	O
their	O
regular	B-UNK
follow	B-UNK
-	O
up	O
visit	O
and	O
were	O
40	O
years	B-UNK
of	O
age	B-UNK
or	O
older	B-UNK
at	B-DISEASE
the	O
time	B-UNK
of	O
the	O
examination	B-UNK
.	O

 	O
the	O
severity	B-UNK
of	O
the	O
disease	B-DISEASE
in	O
patients	B-UNK
and	O
controls	B-UNK
was	O
determined	B-UNK
using	O
a	O
modified	B-UNK
score	B-UNK
,	O
developed	B-UNK
previously	B-UNK
.	O

 	B-UNK
mutational	I-UNK
analysis	B-UNK
in	O
the	O
fmf	B-UNK
gene	B-UNK
was	O
performed	B-UNK
using	O
a	O
commercial	O
kit	B-UNK
.	O

 	O
only	O
20	O
of	O
4000	O
(	O
0	O
.	O
5	O
%	O
)	O
patients	B-UNK
had	O
late	B-UNK
-	O
onset	B-UNK
fmf	B-UNK
.	O

 	O
these	O
patients	B-UNK
were	O
mostly	O
men	B-UNK
,	O
of	O
non	B-UNK
-	O
north	B-UNK
african	B-UNK
origin	B-UNK
,	O
p	B-UNK
<	O
0	O
.	O

 	O
05	O
compared	B-UNK
to	O
controls	B-UNK
.	O

 	O
all	O
had	O
abdominal	O
attacks	B-UNK
and	O
in	O
most	O
these	O
were	O
the	O
only	O
manifestation	B-UNK
of	O
their	O
disease	B-DISEASE
,	O
p	B-UNK
<	O
0	O
.	O

 	O
001	O
001	O
.	O

 	O
none	O
had	O
chronic	B-UNK
or	O
prolonged	B-UNK
manifestations	B-UNK
of	O
fmf	B-UNK
,	O
for	O
example	O
,	O
amyloidosis	B-DISEASE
,	O
chronic	B-UNK
arthritis	B-DISEASE
,	O
or	O
protracted	O
myalgia	B-DISEASE
,	O
p	B-UNK
<	O
0	O
.	O

 	O
001	O
.	O

 	O
the	O
response	B-UNK
to	O
treatment	B-UNK
was	O
good	B-UNK
despite	B-UNK
using	O
low	B-UNK
colchicine	B-UNK
dose	O
,	O
p	B-UNK
<	O
0	O
.	O

 	O
05	O
.	O

 	O
the	O
overall	B-UNK
severity	B-UNK
score	B-UNK
indicated	B-UNK
a	O
mild	B-UNK
disease	B-DISEASE
,	O
p	B-UNK
<	O
0	O
.	O

 	O
001	O
.	O

 	B-UNK
mutational	I-UNK
analysis	B-UNK
revealed	B-UNK
absence	B-UNK
of	O
m694v	B-UNK
homozygosity	B-UNK
,	O
p	B-UNK
<	O
0	O
.	O

 	O
01	O
,	O
compared	B-UNK
to	O
our	O
regular	B-UNK
fmf	B-UNK
population	B-UNK
.	O

 	O
we	O
conclude	O
that	O
the	O
onset	B-UNK
of	O
fmf	B-UNK
in	O
a	O
late	B-UNK
age	B-UNK
defines	O
a	O
milder	B-UNK
form	B-UNK
of	O
disease	B-DISEASE
with	O
typical	B-UNK
clinical	B-UNK
,	O
demographic	O
,	O
and	O
molecular	B-UNK
genetic	I-UNK
characteristics	B-UNK

 	O
a	O
highly	B-UNK
accurate	B-UNK
,	O
low	B-UNK
cost	O
test	B-UNK
for	O
brca1	B-UNK
mutations	I-UNK
.	O

 	O
the	O
hereditary	B-DISEASE
breast	I-DISEASE
and	I-DISEASE
ovarian	I-DISEASE
cancer	I-DISEASE
syndrome	I-DISEASE
is	O
associated	B-UNK
with	O
a	O
high	B-UNK
frequency	B-UNK
of	O
brca1	B-UNK
mutations	I-UNK
.	O

 	O
however	O
,	O
the	O
widespread	O
use	B-UNK
of	O
brca1	B-UNK
testing	B-UNK
has	O
been	O
limited	B-UNK
to	O
date	B-UNK
by	O
three	O
principal	B-UNK
concerns	O
the	O
fear	O
of	O
loss	B-UNK
of	O
health	B-UNK
and	O
life	B-UNK
insurance	O
,	O
the	O
uncertain	O
clinical	B-UNK
value	B-UNK
of	O
a	O
positive	B-UNK
test	B-UNK
result	B-UNK
,	O
and	O
the	O
current	B-UNK
lack	B-UNK
of	O
an	O
inexpensive	O
and	O
sensitive	B-UNK
screening	B-UNK
test	B-UNK
for	O
brca1	B-UNK
mutations	I-UNK
.	O

 	O
we	O
have	O
developed	B-UNK
an	O
inexpensive	O
system	B-UNK
for	O
gene	B-UNK
mutational	B-UNK
scanning	B-UNK
,	O
based	B-UNK
on	O
a	O
combination	O
of	O
extensive	B-UNK
multiplex	B-UNK
pcr	B-UNK
amplification	I-UNK
and	O
two	O
dimensional	O
electrophoresis	B-UNK
.	O

 	O
the	O
efficiency	O
of	O
this	O
system	B-UNK
,	O
as	O
a	O
screening	B-UNK
test	B-UNK
for	O
brca1	B-UNK
mutations	I-UNK
,	O
was	O
evaluated	O
in	O
a	O
panel	O
of	O
60	O
samples	B-UNK
from	O
high	B-UNK
risk	B-UNK
women	B-UNK
,	O
14	O
of	O
which	O
contained	B-UNK
a	O
previously	B-UNK
identified	I-UNK
mutation	B-UNK
in	O
brca1	B-UNK
.	O

 	O
all	O
14	O
mutations	B-UNK
were	O
identified	B-UNK
,	O
as	O
well	O
as	O
an	O
additional	B-UNK
five	O
that	O
had	O
previously	B-UNK
escaped	O
detection	B-UNK
.	O

 	O
in	O
addition	B-UNK
to	O
the	O
19	O
mutations	B-UNK
,	O
a	O
total	B-UNK
of	O
15	O
different	B-UNK
polymorphic	B-UNK
variants	I-UNK
were	O
scored	O
,	O
most	O
of	O
which	O
were	O
recurring	O
.	O

 	O
all	O
were	O
confirmed	B-UNK
by	O
nucleotide	B-UNK
sequencing	B-UNK
.	O

 	O
the	O
cost	O
of	O
screening	B-UNK
per	O
sample	B-UNK
was	O
calculated	O
to	O
be	O
approximately	B-UNK
us	O
$	O
70	O
for	O
the	O
manual	O
technique	B-UNK
used	O
in	O
this	O
study	B-UNK
,	O
and	O
may	O
be	O
reduced	B-UNK
to	O
approximately	B-UNK
us	O
$	O
10	O
with	O
the	O
introduction	O
of	O
commercially	O
available	B-UNK
pcr	B-UNK
robotics	O
and	O
fluorescent	B-UNK
imaging	O
.	O

 	O
implementation	O
of	O
this	O
method	B-UNK
of	O
mutation	B-UNK
screening	B-UNK
in	O
the	O
research	B-UNK
and	O
clinical	B-UNK
setting	B-UNK
should	O
permit	B-UNK
rapid	B-UNK
accrual	O
of	O
quantitative	B-UNK
data	B-UNK
on	O
genotype	B-UNK
-	O
phenotype	B-UNK
associations	B-UNK
for	O
the	O
evaluation	B-UNK
of	O
diagnostic	B-UNK
testing	B-UNK
.	O
.	O

 	O
maternal	B-UNK
uniparental	B-DISEASE
disomy	I-DISEASE
for	O
chromosome	B-DISEASE
14	I-DISEASE
in	O
a	O
boy	B-UNK
with	O
a	O
normal	B-UNK
karyotype	B-UNK
.	O

 	O
we	O
report	B-UNK
on	O
a	O
boy	B-UNK
with	O
a	O
maternal	B-UNK
uniparental	B-DISEASE
disomy	I-DISEASE
for	O
chromosome	B-DISEASE
14	I-DISEASE
(	O
upd	B-UNK
(	O
14	O
)	O
)	O
.	O

 	O
at	B-DISEASE
7	O
years	B-UNK
of	O
age	B-UNK
he	O
was	O
referred	O
to	O
us	O
by	O
the	O
paediatrician	O
because	O
of	O
symptoms	B-UNK
of	O
prader	B-DISEASE
-	I-DISEASE
willi	I-DISEASE
syndrome	I-DISEASE
(	O
pws	B-UNK
)	O
.	O

 	O
he	O
showed	B-UNK
short	B-DISEASE
stature	I-DISEASE
,	O
obesity	B-DISEASE
,	O
mild	B-UNK
developmental	B-DISEASE
delay	I-DISEASE
,	O
cryptorchidism	B-DISEASE
,	O
and	O
some	O
mild	B-UNK
dysmorphic	B-UNK
features	B-UNK
.	O

 	O
the	O
history	B-UNK
further	O
indicated	B-UNK
intrauterine	B-DISEASE
growth	I-DISEASE
retardation	I-DISEASE
at	B-DISEASE
the	O
end	B-UNK
of	O
the	O
pregnancy	B-DISEASE
.	O

 	O
his	O
mother	B-UNK
was	O
44	O
years	B-UNK
of	O
age	B-UNK
at	B-DISEASE
the	O
time	B-UNK
of	O
his	O
birth	O
.	O

 	O
after	O
birth	O
he	O
showed	B-UNK
hypotonia	B-DISEASE
with	O
poor	B-UNK
sucking	O
,	O
for	O
which	O
gavage	O
feeding	O
was	O
needed	O
.	O

 	O
motor	B-UNK
development	B-UNK
was	O
delayed	O
.	O

 	O
after	O
1	O
year	B-UNK
he	O
became	O
obese	O
despite	B-UNK
a	O
normal	B-UNK
appetite	O
.	O

 	B-UNK
recurrent	I-UNK
middle	B-UNK
ear	B-UNK
infections	B-DISEASE
,	O
a	O
high	B-UNK
pain	B-DISEASE
threshold	O
,	O
and	O
a	O
great	B-UNK
skill	O
with	O
jigsaw	O
puzzles	O
were	O
reported	B-UNK
.	O

 	O
there	O
were	O
no	O
behavioural	O
problems	B-UNK
or	O
sleep	O
disturbance	O
.	O

 	B-UNK
chromosomal	I-UNK
analysis	B-UNK
was	O
normal	B-UNK
(	O
46	O
,	O
xy	O
)	O
.	O

 	B-UNK
dna	I-UNK
analysis	B-UNK
for	O
prader	B-DISEASE
-	I-DISEASE
willi	I-DISEASE
syndrome	I-DISEASE
showed	B-UNK
no	O
abnormalities	B-DISEASE
.	O

 	O
two	O
years	B-UNK
later	B-UNK
he	O
was	O
re	O
-	O
examined	B-UNK
because	O
we	O
thought	O
his	O
features	B-UNK
fitted	O
the	O
pws	B-UNK
-	O
like	B-UNK
phenotype	B-UNK
associated	B-UNK
with	O
maternal	B-UNK
upd	B-UNK
(	O
14	O
)	O
.	O

 	O
at	B-DISEASE
that	O
time	B-UNK
precocious	B-DISEASE
puberty	I-DISEASE
was	O
evident	O
.	O

 	B-UNK
dna	I-UNK
analysis	B-UNK
showed	B-UNK
maternal	B-UNK
heterodisomy	O
for	O
chromosome	B-DISEASE
14	I-DISEASE
.	O

 	O
in	O
all	O
the	O
previously	B-UNK
described	I-UNK
11	O
cases	B-UNK
with	O
maternal	B-UNK
upd	B-UNK
(	O
14	O
)	O
,	O
a	O
robertsonian	O
translocation	B-DISEASE
involving	B-UNK
chromosome	B-DISEASE
14	I-DISEASE
was	O
detected	B-UNK
cytogenetically	B-UNK
before	O
dna	B-UNK
analysis	B-UNK
.	O

 	O
this	O
is	O
the	O
first	O
report	B-UNK
of	O
diagnosis	B-UNK
of	O
maternal	B-UNK
upd	B-UNK
(	O
14	O
)	O
based	B-UNK
on	O
clinical	B-UNK
features	I-UNK
.	O

 	O
this	O
finding	B-UNK
underlines	O
the	O
importance	O
of	O
dna	B-UNK
analysis	B-UNK
for	O
maternal	B-UNK
upd	B-UNK
(	O
14	O
)	O
in	O
patients	B-UNK
with	O
a	O
similar	B-UNK
pws	B-UNK
-	O
like	B-UNK
phenotype	B-UNK
even	O
without	O
previous	B-UNK
identification	B-UNK
of	O
a	O
robertsonian	O
translocation	B-DISEASE
involving	B-UNK
chromosome	B-DISEASE
14	I-DISEASE
.	O
.	O

 	B-UNK
clinical	I-UNK
and	O
genetic	B-UNK
study	B-UNK
of	O
friedreich	B-DISEASE
ataxia	I-DISEASE
in	O
an	O
australian	O
population	B-UNK
.	O

 	O
friedreich	B-DISEASE
ataxia	I-DISEASE
is	O
an	O
autosomal	O
recessive	O
disorder	O
caused	B-UNK
by	O
mutations	B-UNK
in	O
the	O
frda	B-UNK
gene	B-UNK
that	O
encodes	B-UNK
a	O
210	O
-	O
amino	B-UNK
acid	I-UNK
protein	B-UNK
called	B-UNK
frataxin	B-UNK
.	O

 	O
an	O
expansion	B-UNK
of	O
a	O
gaa	B-UNK
trinucleotide	I-UNK
repeat	B-UNK
in	O
intron	B-UNK
1	O
of	O
the	O
gene	B-UNK
is	O
present	B-UNK
in	O
more	O
than	O
95	O
%	O
of	O
mutant	B-UNK
alleles	I-UNK
.	O

 	O
of	O
the	O
83	O
people	B-UNK
we	O
studied	B-UNK
who	O
have	O
mutations	B-UNK
in	O
frda	B-UNK
,	O
78	O
are	O
homozygous	B-UNK
for	O
an	O
expanded	B-UNK
gaa	B-UNK
repeat	I-UNK
;	O
the	O
other	O
five	O
patients	B-UNK
have	O
an	O
expansion	B-UNK
in	O
one	O
allele	B-UNK
and	O
a	O
point	B-UNK
mutation	I-UNK
in	O
the	O
other	O
.	O

 	O
here	O
we	O
present	B-UNK
a	O
detailed	B-UNK
clinical	B-UNK
and	O
genetic	B-UNK
study	B-UNK
of	O
a	O
subset	O
of	O
51	O
patients	B-UNK
homozygous	B-UNK
for	O
an	O
expansion	B-UNK
of	O
the	O
gaa	B-UNK
repeat	I-UNK
.	O

 	O
we	O
found	B-UNK
a	O
correlation	B-UNK
between	O
the	O
size	B-UNK
of	O
the	O
smaller	B-UNK
of	O
the	O
two	O
expanded	B-UNK
alleles	B-UNK
and	O
age	B-UNK
at	B-DISEASE
onset	B-UNK
,	O
age	B-UNK
into	O
wheelchair	O
,	O
scoliosis	B-DISEASE
,	O
impaired	B-UNK
vibration	B-UNK
sense	B-UNK
,	O
and	O
the	O
presence	B-UNK
of	O
foot	B-UNK
deformity	B-UNK
.	O

 	O
there	O
was	O
no	O
significant	B-UNK
correlation	B-UNK
between	O
the	O
size	B-UNK
of	O
the	O
smaller	B-UNK
allele	B-UNK
and	O
cardiomyopathy	B-DISEASE
,	O
diabetes	B-DISEASE
mellitus	I-DISEASE
,	O
loss	B-UNK
of	O
proprioception	O
,	O
or	O
bladder	B-UNK
symptoms	B-UNK
.	O

 	O
the	O
larger	O
allele	B-UNK
size	B-UNK
correlated	B-UNK
with	O
bladder	B-UNK
symptoms	B-UNK
and	O
the	O
presence	B-UNK
of	O
foot	B-UNK
deformity	B-UNK
.	O

 	O
the	O
duration	O
of	O
disease	B-DISEASE
is	O
correlated	B-UNK
with	O
wheelchair	O
use	B-UNK
and	O
the	O
presence	B-UNK
of	O
diabetes	B-DISEASE
,	O
scoliosis	B-DISEASE
,	O
bladder	B-UNK
symptoms	B-UNK
and	O
impaired	B-UNK
proprioception	O
,	O
and	O
vibration	B-UNK
sense	B-UNK
but	O
no	O
other	O
complications	O
studied	B-UNK
.	O
.	O

 	B-UNK
novel	I-UNK
mutations	B-UNK
in	O
xlrs1	B-UNK
causing	B-UNK
retinoschisis	B-DISEASE
,	O
including	B-UNK
first	O
evidence	B-UNK
of	O
putative	B-UNK
leader	B-UNK
sequence	B-UNK
change	B-UNK
.	O

 	O
juvenile	B-UNK
retinoschisis	B-DISEASE
is	O
an	O
x	B-UNK
-	O
linked	B-UNK
recessive	O
disease	B-DISEASE
caused	B-UNK
by	O
mutations	B-UNK
in	O
the	O
xlrs1	B-UNK
gene	B-UNK
.	O

 	O
we	O
screened	O
31	O
new	B-UNK
unrelated	B-UNK
patients	B-UNK
and	O
families	B-UNK
for	O
xlrs1	B-UNK
mutations	B-UNK
in	O
addition	B-UNK
to	O
previously	B-UNK
reported	I-UNK
mutations	B-UNK
for	O
60	O
of	O
our	O
families	B-UNK
(	O
retinoschisis	B-DISEASE
consortium	B-UNK
,	O
hum	B-UNK
mol	O
genet	B-UNK
1998	O
;	O
7	O
1185	O
-	O
1192	O
)	O
.	O

 	O
twenty	O
-	O
three	O
different	B-UNK
mutations	B-UNK
including	B-UNK
12	O
novel	B-UNK
ones	O
were	O
identified	B-UNK
in	O
28	O
patients	B-UNK
.	O

 	O
mutations	B-UNK
identified	B-UNK
in	O
this	O
study	B-UNK
include	B-UNK
19	O
missense	B-UNK
mutations	I-UNK
,	O
two	O
nonsense	B-UNK
mutations	B-UNK
,	O
one	O
intragenic	B-UNK
deletion	B-UNK
,	O
four	O
microdeletions	O
,	O
one	O
insertion	B-UNK
,	O
and	O
one	O
intronic	B-UNK
sequence	B-UNK
substitution	B-UNK
that	O
is	O
likely	B-UNK
to	O
result	B-UNK
in	O
a	O
splice	B-UNK
site	I-UNK
defect	B-UNK
.	O

 	O
two	O
novel	B-UNK
mutations	B-UNK
,	O
c	B-UNK
.	O

 	O
38	O
t	B-UNK
-	O
-	O
>	O
c	B-UNK
(	O
l13p	O
)	O
and	O
c	B-UNK
.	O

 	O
667	O
t	B-UNK
-	O
-	O
>	O
c	B-UNK
(	O
c223r	O
)	O
,	O
respectively	B-UNK
,	O
present	B-UNK
the	O
first	O
genetic	B-UNK
evidence	B-UNK
for	O
the	O
functional	B-UNK
significance	B-UNK
of	O
the	O
putative	B-UNK
leader	B-UNK
peptide	B-UNK
sequence	B-UNK
and	O
for	O
the	O
functional	B-UNK
significance	B-UNK
at	B-DISEASE
the	O
carboxyl	B-UNK
terminal	B-UNK
of	O
the	O
xlrs1	B-UNK
protein	B-UNK
beyond	O
the	O
discoidin	B-UNK
domain	B-UNK
.	O

 	O
mutations	B-UNK
in	O
25	O
of	O
the	O
families	B-UNK
were	O
localized	B-UNK
to	O
exons	B-UNK
4	O
-	O
6	O
,	O
emphasizing	O
the	O
critical	B-UNK
functional	B-UNK
significance	B-UNK
of	O
the	O
discoidin	B-UNK
domain	B-UNK
of	O
the	O
xlrs1	B-UNK
protein	B-UNK

 	O
growth	B-UNK
hormone	B-UNK
treatment	B-UNK
increases	B-UNK
co	B-UNK
(	O
2	O
)	O
response	B-UNK
,	O
ventilation	O
and	O
central	B-UNK
inspiratory	O
drive	B-UNK
in	O
children	B-UNK
with	O
prader	B-DISEASE
-	I-DISEASE
willi	I-DISEASE
syndrome	I-DISEASE
.	O

 	O
we	O
studied	B-UNK
whether	O
the	O
beneficial	O
effects	B-UNK
of	O
growth	B-UNK
hormone	B-UNK
(	O
gh	B-UNK
)	O
treatment	B-UNK
on	O
growth	B-UNK
and	O
body	B-UNK
composition	B-UNK
in	O
pws	B-UNK
are	O
accompanied	O
by	O
an	O
improvement	O
in	O
respiratory	B-UNK
function	B-UNK
.	O

 	O
we	O
measured	B-UNK
resting	B-UNK
ventilation	O
,	O
airway	O
occlusion	O
pressure	B-UNK
(	O
p	B-UNK
(	O
0	O
.	O
1	O
)	O
)	O
and	O
ventilatory	O
response	B-UNK
to	O
co	B-UNK
(	O
2	O
)	O
in	O
nine	O
children	B-UNK
,	O
aged	O
7	O
-	O
14	O
years	B-UNK
,	O
before	O
and	O
6	O
-	O
9	O
months	O
after	O
the	O
start	O
of	O
gh	B-UNK
treatment	B-UNK
.	O

 	O
during	O
gh	B-UNK
treatment	B-UNK
,	O
resting	B-UNK
ventilation	O
increased	B-UNK
by	O
26	O
%	O
,	O
p	B-UNK
(	O
0	O
.	O
1	O
)	O
by	O
72	O
%	O
and	O
the	O
response	B-UNK
to	O
co	B-UNK
(	O
2	O
)	O
by	O
65	O
%	O
(	O
p	B-UNK
<	O
0	O
.	O
002	O
,	O
<	O
0	O
.	O
04	O
and	O
<	O
0	O
.	O
02	O
,	O
respectively	B-UNK
)	O
.	O

 	O
this	O
observed	B-UNK
increase	B-UNK
in	O
ventilatory	O
output	O
was	O
not	O
correlated	B-UNK
to	O
changes	B-UNK
in	O
body	B-UNK
mass	B-UNK
index	B-UNK
.	O

 	O
conclusion	B-UNK
treatment	B-UNK
of	O
children	B-UNK
with	O
prader	B-DISEASE
-	I-DISEASE
willi	I-DISEASE
syndrome	I-DISEASE
(	O
pws	B-UNK
)	O
seems	O
to	O
have	O
a	O
stimulatory	O
effect	B-UNK
on	O
central	B-UNK
respiratory	B-UNK
structures	B-UNK
.	O

 	O
the	O
observed	B-UNK
increase	B-UNK
in	O
ventilation	O
and	O
inspiratory	O
drive	B-UNK
may	O
contribute	B-UNK
to	O
the	O
improved	B-UNK
activity	B-UNK
level	B-UNK
reported	B-UNK
by	O
parents	B-UNK
of	O
pws	B-UNK
children	B-UNK
during	O
growth	B-UNK
hormone	B-UNK
therapy	B-UNK

 	O
g130v	B-UNK
,	O
a	O
common	B-UNK
frda	B-UNK
point	B-UNK
mutation	I-UNK
,	O
appears	B-UNK
to	O
have	O
arisen	O
from	O
a	O
common	B-UNK
founder	B-UNK
.	O

 	O
friedreich	B-DISEASE
ataxia	I-DISEASE
(	O
frda	B-UNK
)	O
is	O
the	O
most	O
common	B-UNK
inherited	B-UNK
ataxia	B-DISEASE
.	O

 	O
about	O
98	O
%	O
of	O
mutant	B-UNK
alleles	I-UNK
have	O
an	O
expansion	B-UNK
of	O
a	O
gaa	B-UNK
trinucleotide	I-UNK
repeat	B-UNK
in	O
intron	B-UNK
1	O
of	O
the	O
affected	B-UNK
gene	B-UNK
,	O
frda	B-UNK
.	O

 	O
the	O
other	O
2	O
%	O
are	O
point	B-UNK
mutations	I-UNK
.	O

 	O
of	O
the	O
17	O
point	B-UNK
mutations	I-UNK
so	O
far	B-UNK
described	B-UNK
,	O
three	O
appear	B-UNK
to	O
be	O
more	O
common	B-UNK
.	O

 	O
one	O
of	O
these	O
is	O
the	O
g130v	B-UNK
mutation	B-UNK
in	O
exon	B-UNK
4	O
of	O
frda	B-UNK
.	O

 	O
g130v	B-UNK
,	O
when	O
present	B-UNK
with	O
an	O
expanded	B-UNK
gaa	B-UNK
repeat	I-UNK
on	O
the	O
other	O
allele	B-UNK
,	O
is	O
associated	B-UNK
with	O
an	O
atypical	B-UNK
frda	B-UNK
phenotype	B-UNK
.	O

 	B-UNK
haplotype	I-UNK
analysis	B-UNK
was	O
undertaken	O
on	O
the	O
four	O
families	B-UNK
who	O
have	O
been	O
described	B-UNK
with	O
this	O
mutation	B-UNK
.	O

 	O
the	O
results	B-UNK
suggest	B-UNK
a	O
common	B-UNK
founder	B-UNK
for	O
this	O
mutation	B-UNK
.	O

 	O
although	O
marked	B-UNK
differences	B-UNK
in	O
extragenic	O
marker	B-UNK
haplotypes	B-UNK
were	O
seen	B-UNK
in	O
one	O
family	B-UNK
,	O
similar	B-UNK
intragenic	B-UNK
haplotyping	B-UNK
suggests	B-UNK
the	O
same	O
mutation	B-UNK
founder	B-UNK
for	O
this	O
family	B-UNK
with	O
the	O
differences	B-UNK
explicable	O
by	O
two	O
recombination	B-UNK
events	I-UNK
.	O
.	O

 	O
synergistic	B-UNK
effect	B-UNK
of	O
histone	B-UNK
hyperacetylation	B-UNK
and	O
dna	B-UNK
demethylation	B-UNK
in	O
the	O
reactivation	O
of	O
the	O
fmr1	B-UNK
gene	B-UNK
.	O

 	O
most	O
fragile	B-DISEASE
x	I-DISEASE
syndrome	I-DISEASE
patients	B-UNK
have	O
expansion	B-UNK
of	O
a	O
(	O
cgg	B-UNK
)	O
(	O
n	B-UNK
)	O
sequence	B-UNK
with	O
>	O
200	O
repeats	B-UNK
(	O
full	O
mutation	B-UNK
)	O
in	O
the	O
fmr1	B-UNK
gene	B-UNK
responsible	B-UNK
for	O
this	O
condition	B-UNK
.	O

 	O
hypermethylation	O
of	O
the	O
expanded	B-UNK
repeat	B-UNK
and	O
of	O
the	O
fmr1	B-UNK
promoter	B-UNK
is	O
almost	O
always	O
present	B-UNK
and	O
apparently	B-UNK
suppresses	O
transcription	B-UNK
,	O
resulting	B-UNK
in	O
absence	B-UNK
of	O
the	O
fmr1	B-UNK
protein	B-UNK
.	O

 	O
we	O
recently	B-UNK
showed	B-UNK
that	O
transcriptional	B-UNK
reactivation	O
of	O
fmr1	B-UNK
full	O
mutations	B-UNK
can	O
be	O
achieved	O
by	O
inducing	B-UNK
dna	B-UNK
demethylation	B-UNK
with	O
5	O
-	O
azadeoxycytidine	O
(	O
5	O
-	O
azadc	O
)	O
.	O

 	O
the	O
level	B-UNK
of	O
histone	B-UNK
acetylation	O
is	O
another	O
important	B-UNK
factor	B-UNK
in	O
regulating	O
gene	B-UNK
expression	B-UNK
;	O
therefore	O
,	O
we	O
treated	B-UNK
lymphoblastoid	B-UNK
cell	B-UNK
lines	B-UNK
of	O
non	B-UNK
-	O
mosaic	B-UNK
full	O
mutation	B-UNK
patients	B-UNK
with	O
three	O
drugs	B-UNK
capable	O
of	O
inducing	B-UNK
histone	B-UNK
hyperacetylation	B-UNK
.	O

 	O
we	O
observed	B-UNK
a	O
consistent	B-UNK
,	O
although	O
modest	O
,	O
reactivation	O
of	O
the	O
fmr1	B-UNK
gene	B-UNK
with	O
4	O
-	O
phenylbutyrate	O
,	O
sodium	B-UNK
butyrate	O
and	O
trichostatin	O
a	O
,	O
as	O
shown	B-UNK
by	O
rt	O
-	O
pcr	B-UNK
.	O

 	O
however	O
,	O
we	O
report	B-UNK
that	O
combining	B-UNK
these	O
drugs	B-UNK
with	O
5	O
-	O
azadc	O
results	B-UNK
in	O
a	O
2	O
-	O
to	O
5	O
-	O
fold	B-UNK
increase	B-UNK
in	O
fmr1	B-UNK
mrna	B-UNK
levels	I-UNK
obtained	B-UNK
with	O
5	O
-	O
azadc	O
alone	O
,	O
thus	O
showing	B-UNK
a	O
marked	B-UNK
synergistic	B-UNK
effect	B-UNK
of	O
histone	B-UNK
hyperacetylation	B-UNK
and	O
dna	B-UNK
demethylation	B-UNK
in	O
the	O
reactivation	O
of	O
fmr1	B-UNK
full	O
mutations	B-UNK
.	O
.	O

 	O
constitutional	B-UNK
von	B-UNK
hippel	I-UNK
-	O
lindau	O
(	O
vhl	B-UNK
)	O
gene	B-UNK
deletions	B-UNK
detected	B-UNK
in	O
vhl	B-UNK
families	B-UNK
by	O
fluorescence	B-UNK
in	O
situ	B-UNK
hybridization	I-UNK
.	O

 	O
von	B-UNK
hippel	I-UNK
-	O
lindau	O
(	O
vhl	B-UNK
)	O
disease	B-DISEASE
is	O
an	O
autosomal	O
dominantly	B-UNK
inherited	I-UNK
cancer	B-DISEASE
syndrome	B-DISEASE
predisposing	B-UNK
to	O
a	O
variety	B-UNK
of	O
tumor	B-DISEASE
types	B-UNK
that	O
include	B-UNK
retinal	B-UNK
hemangioblastomas	O
,	O
hemangioblastomas	O
of	O
the	O
central	B-UNK
nervous	I-UNK
system	I-UNK
,	O
renal	B-DISEASE
cell	B-UNK
carcinomas	B-UNK
,	O
pancreatic	B-DISEASE
cysts	I-DISEASE
and	O
tumors	B-DISEASE
,	O
pheochromocytomas	O
,	O
endolymphatic	O
sac	O
tumors	B-DISEASE
,	O
and	O
epididymal	O
cystadenomas	O
[	O
w	O
.	O

 	O
m	B-UNK
.	O

 	O
linehan	O
et	O
al	O
.	O
,	O
j	B-UNK
.	O

 	O
am	O
.	O
med	O
.	O
assoc	O
.	O
,	O
273	O
564	O
-	O
570	O
,	O
1995	O
;	O
e	B-UNK
.	O
a	O
.	O
maher	O
and	O
w	O
.	O
g	B-UNK
.	O
kaelin	O
,	O
jr	O
.	O
,	O
medicine	O
(	O
baltimore	O
)	O
,	O
76	O
381	O
-	O
391	O
,	O
1997	O
;	O
w	O
.	O
m	B-UNK
.	O
linehan	O
and	O
r	B-UNK
.	O
d	B-UNK
.	O
klausner	O
,	O
in	O
b	B-UNK
.	O
vogelstein	O
and	O
k	B-UNK
.	O
kinzler	O
(	O
eds	O
.	O
)	O
,	O
the	O
genetic	B-UNK
basis	B-UNK
of	O
human	B-UNK
cancer	B-DISEASE
,	O
pp	O
.	O

 	O
455	O
-	O
473	O
,	O
mcgraw	O
-	O
hill	O
,	O
1998	O
]	O
.	O

 	O
the	O
vhl	B-UNK
gene	B-UNK
was	O
localized	B-UNK
to	O
chromosome	B-UNK
3p25	O
-	O
26	O
and	O
cloned	B-UNK
[	O
f	B-UNK
.	O
latif	O
et	O
al	O
.	O
,	O
science	O
(	O
washington	O
dc	O
)	O
,	O
260	O
1317	O
-	O
1320	O
,	O
1993	O
]	O
.	O

 	B-UNK
germline	I-UNK
mutations	B-UNK
in	O
the	O
vhl	B-UNK
gene	B-UNK
have	O
been	O
detected	B-UNK
in	O
the	O
majority	B-UNK
of	O
vhl	B-UNK
kindreds	B-UNK
.	O

 	O
the	O
reported	B-UNK
frequency	B-UNK
of	O
detection	B-UNK
of	O
vhl	B-UNK
germline	B-UNK
mutations	I-UNK
has	O
varied	B-UNK
from	O
39	O
to	O
80	O
%	O
(	O
j	B-UNK
.	O
m	B-UNK
.	O
whaley	O
et	O
al	O
.	O
,	O
am	O
.	O
j	B-UNK
.	O
hum	B-UNK
.	O
genet	B-UNK
.	O
,	O
55	O
1092	O
-	O
1102	O
,	O
1994	O
;	O
clinical	B-UNK
research	B-UNK
group	B-UNK
for	O
japan	O
,	O
hum	B-UNK
.	O
mol	O
.	O
genet	B-UNK
.	O
,	O
4	O
2233	O
-	O
2237	O
,	O
1995	O
;	O
f	B-UNK
.	O
chen	O
et	O
al	O
.	O
,	O
hum	B-UNK
.	O
mutat	O
.	O
,	O
5	O
66	O
-	O
75	O
,	O
1995	O
;	O
e	B-UNK
.	O
r	B-UNK
.	O
maher	O
et	O
al	O
.	O
,	O
j	B-UNK
.	O
med	O
.	O
genet	B-UNK
.	O
,	O
33	O
328	O
-	O
332	O
,	O
1996	O
;	O
b	B-UNK
.	O
zbar	O
,	O
cancer	B-DISEASE
surv	O
.	O
,	O
25	O
219	O
-	O
232	O
,	O
1995	O
)	O
.	O

 	O
recently	B-UNK
a	O
quantitative	B-UNK
southern	O
blotting	B-UNK
procedure	B-UNK
was	O
found	B-UNK
to	O
improve	O
this	O
frequency	B-UNK
(	O
c	B-UNK
.	O
stolle	O
et	O
al	O
.	O
,	O
hum	B-UNK
.	O
mutat	O
.	O
,	O
12	O
417	O
-	O
423	O
,	O
1998	O
)	O
.	O

 	O
in	O
the	O
present	B-UNK
study	I-UNK
,	O
we	O
report	B-UNK
the	O
use	B-UNK
of	O
fluorescence	B-UNK
in	O
situ	B-UNK
hybridization	I-UNK
(	O
fish	B-UNK
)	O
as	O
a	O
method	B-UNK
to	O
detect	B-UNK
and	O
characterize	O
vhl	B-UNK
germline	B-UNK
deletions	B-UNK
.	O

 	O
we	O
reexamined	O
a	O
group	B-UNK
of	O
vhl	B-UNK
patients	B-UNK
shown	B-UNK
previously	B-UNK
by	O
single	B-UNK
-	O
strand	O
conformation	O
and	O
sequencing	B-UNK
analysis	B-UNK
not	O
to	O
harbor	O
point	B-UNK
mutations	I-UNK
in	O
the	O
vhl	B-UNK
locus	B-UNK
.	O

 	O
we	O
found	B-UNK
constitutional	B-UNK
deletions	B-UNK
in	O
29	O
of	O
30	O
vhl	B-UNK
patients	B-UNK
in	O
this	O
group	B-UNK
using	O
cosmid	B-UNK
and	O
p1	B-UNK
probes	B-UNK
that	O
cover	O
the	O
vhl	B-UNK
locus	B-UNK
.	O

 	O
we	O
then	O
tested	B-UNK
six	O
phenotypically	B-UNK
normal	I-UNK
offspring	B-UNK
from	O
four	O
of	O
these	O
vhl	B-UNK
families	B-UNK
two	O
were	O
found	B-UNK
to	O
carry	B-UNK
the	O
deletion	B-UNK
and	O
the	O
other	O
four	O
were	O
deletion	B-UNK
-	O
free	B-UNK
.	O

 	O
in	O
addition	B-UNK
,	O
germline	B-UNK
mosaicism	B-UNK
of	O
the	O
vhl	B-UNK
gene	B-UNK
was	O
identified	B-UNK
in	O
one	O
family	B-UNK
.	O

 	O
in	O
sum	O
,	O
fish	B-UNK
was	O
found	B-UNK
to	O
be	O
a	O
simple	B-UNK
and	O
reliable	B-UNK
method	B-UNK
to	O
detect	B-UNK
vhl	B-UNK
germline	B-UNK
deletions	B-UNK
and	O
practically	O
useful	B-UNK
in	O
cases	B-UNK
where	O
other	O
methods	B-UNK
of	O
screening	B-UNK
have	O
failed	B-UNK
to	O
detect	B-UNK
a	O
vhl	B-UNK
gene	B-UNK
abnormality	B-UNK

 	O
spectrum	B-UNK
of	O
hsnf5	O
/	O
ini1	B-UNK
somatic	B-UNK
mutations	B-UNK
in	O
human	B-UNK
cancer	B-DISEASE
and	O
genotype	B-UNK
-	O
phenotype	B-UNK
correlations	B-UNK
.	O

 	O
the	O
hsnf5	O
/	O
ini1	B-UNK
gene	B-UNK
which	O
encodes	B-UNK
a	O
member	B-UNK
of	O
the	O
swi	O
/	O
snf	O
chromatin	B-UNK
atp	B-UNK
-	O
dependent	B-UNK
remodeling	B-UNK
complex	B-UNK
,	O
is	O
a	O
new	B-UNK
tumor	B-DISEASE
suppressor	B-UNK
gene	B-UNK
localized	B-UNK
on	O
chromosome	B-UNK
22q11	B-UNK
.	O

 	O
2	O
and	O
recently	B-UNK
shown	B-UNK
to	O
be	O
mutated	B-UNK
in	O
malignant	B-UNK
rhabdoid	O
tumors	B-DISEASE
.	O

 	O
we	O
have	O
searched	O
for	O
hsnf5	O
/	O
ini1	B-UNK
mutations	B-UNK
in	O
229	O
tumors	B-DISEASE
of	O
various	O
origins	B-UNK
using	O
a	O
screening	B-UNK
method	I-UNK
based	B-UNK
on	O
denaturing	B-UNK
high	B-UNK
-	O
performance	B-UNK
liquid	O
chromatography	O
.	O

 	O
a	O
total	B-UNK
of	O
31	O
homozygous	B-UNK
deletions	B-UNK
and	O
36	O
point	B-UNK
alterations	B-UNK
were	O
identified	B-UNK
.	O

 	B-UNK
point	I-UNK
mutations	B-UNK
were	O
scattered	O
along	O
the	O
coding	B-UNK
sequence	B-UNK
and	O
included	B-UNK
15	O
nonsense	B-UNK
,	O
15	O
frameshift	B-UNK
,	O
three	O
splice	B-UNK
site	I-UNK
,	O
two	O
missense	B-UNK
and	O
one	O
editing	O
mutations	B-UNK
.	O

 	O
mutations	B-UNK
were	O
retrieved	O
in	O
most	O
rhabdoid	O
tumors	B-DISEASE
,	O
whatever	O
their	O
sites	B-UNK
of	O
occurrence	B-UNK
,	O
indicating	B-UNK
the	O
common	B-UNK
pathogenetic	B-UNK
origin	B-UNK
of	O
these	O
tumors	B-DISEASE
.	O

 	B-UNK
recurrent	I-UNK
hsnf5	O
/	O
ini1	B-UNK
alterations	B-UNK
were	O
also	O
observed	B-UNK
in	O
choroid	O
plexus	O
carcinomas	B-UNK
and	O
in	O
a	O
subset	O
of	O
central	B-UNK
primitive	B-UNK
neuroectodermal	B-DISEASE
tumors	I-DISEASE
(	O
cpnets	O
)	O
and	O
medulloblastomas	O
.	O

 	O
in	O
contrast	B-UNK
,	O
hsnf5	O
/	O
ini1	B-UNK
point	B-UNK
mutations	I-UNK
were	O
not	O
detected	B-UNK
in	O
breast	B-UNK
cancers	B-DISEASE
,	O
wilms	B-UNK
tumors	B-DISEASE
,	O
gliomas	O
,	O
ependymomas	O
,	O
sarcomas	O
and	O
other	O
tumor	B-DISEASE
types	B-UNK
,	O
even	O
though	O
most	O
analyzed	B-UNK
cases	B-UNK
harbored	O
loss	B-UNK
of	O
heterozygosity	B-UNK
at	B-DISEASE
22q11	B-UNK
.	O

 	O
2	O
loci	B-UNK
.	O

 	O
these	O
results	B-UNK
suggest	B-UNK
that	O
rhabdoid	O
tumors	B-DISEASE
,	O
choroid	O
plexus	O
carcinomas	B-UNK
and	O
a	O
subset	O
of	O
medulloblastomas	O
and	O
cpnets	O
share	B-UNK
common	B-UNK
pathways	B-UNK
of	O
oncogenesis	O
related	B-UNK
to	O
hsnf5	O
/	O
ini1	B-UNK
alteration	B-UNK
and	O
that	O
hsnf5	O
/	O
ini1	B-UNK
mutations	B-UNK
define	B-UNK
a	O
genetically	B-UNK
homogeneous	B-UNK
family	B-UNK
of	O
highly	B-UNK
aggressive	B-UNK
cancers	B-DISEASE
mainly	B-UNK
occurring	B-UNK
in	O
young	B-UNK
children	B-UNK
and	O
frequently	B-UNK
,	O
but	O
not	O
always	O
,	O
exhibiting	B-UNK
a	O
rhabdoid	O
phenotype	B-UNK

 	O
ataxin	B-UNK
-	O
3	O
with	O
an	O
altered	B-UNK
conformation	O
that	O
exposes	O
the	O
polyglutamine	B-UNK
domain	B-UNK
is	O
associated	B-UNK
with	O
the	O
nuclear	B-UNK
matrix	B-UNK
.	O

 	O
spinocerebellar	B-DISEASE
ataxia	I-DISEASE
type	B-UNK
-	O
3	O
or	O
machado	B-DISEASE
-	I-DISEASE
joseph	I-DISEASE
disease	I-DISEASE
(	O
sca3	B-UNK
/	O
mjd	B-UNK
)	O
is	O
a	O
member	B-UNK
of	O
the	O
cag	B-UNK
/	O
polyglutamine	B-UNK
repeat	B-UNK
disease	B-DISEASE
family	B-UNK
.	O

 	O
in	O
this	O
family	B-UNK
of	O
disorders	B-UNK
,	O
a	O
normally	B-UNK
polymorphic	B-UNK
cag	B-UNK
repeat	I-UNK
becomes	O
expanded	B-UNK
,	O
resulting	B-UNK
in	O
expression	B-UNK
of	O
an	O
expanded	B-UNK
polyglutamine	I-UNK
domain	B-UNK
in	O
the	O
disease	B-DISEASE
gene	B-UNK
product	B-UNK
.	O

 	O
experimental	B-UNK
models	B-UNK
of	O
polyglutamine	B-UNK
disease	B-DISEASE
implicate	B-UNK
the	O
nucleus	O
in	O
pathogenesis	O
;	O
however	O
,	O
the	O
link	B-UNK
between	O
intranuclear	O
expression	B-UNK
of	O
expanded	B-UNK
polyglutamine	I-UNK
and	O
neuronal	B-UNK
dysfunction	B-UNK
remains	B-UNK
unclear	O
.	O

 	O
here	O
we	O
demonstrate	B-UNK
that	O
ataxin	B-UNK
-	O
3	O
,	O
the	O
disease	B-DISEASE
protein	B-UNK
in	O
sca3	B-UNK
/	O
mjd	B-UNK
,	O
adopts	O
a	O
unique	B-UNK
conformation	O
when	O
expressed	B-UNK
within	O
the	O
nucleus	O
of	O
transfected	B-UNK
cells	B-UNK
.	O

 	O
the	O
monoclonal	B-UNK
antibody	I-UNK
1c2	O
is	O
known	B-UNK
preferentially	B-UNK
to	O
bind	B-UNK
expanded	B-UNK
polyglutamine	I-UNK
,	O
but	O
we	O
find	O
that	O
it	O
also	O
binds	O
a	O
fragment	O
of	O
ataxin	B-UNK
-	O
3	O
containing	B-UNK
a	O
normal	B-UNK
glutamine	B-UNK
repeat	B-UNK
.	O

 	O
in	O
addition	B-UNK
,	O
expression	B-UNK
of	O
ataxin	B-UNK
-	O
3	O
within	O
the	O
nucleus	O
exposes	O
the	O
glutamine	B-UNK
domain	B-UNK
of	O
the	O
full	O
-	O
length	O
non	B-UNK
-	O
pathological	B-UNK
protein	B-UNK
,	O
allowing	B-UNK
it	O
to	O
bind	B-UNK
the	O
monoclonal	B-UNK
antibody	I-UNK
1c2	O
.	O

 	O
fractionation	O
and	O
immunochemical	B-UNK
experiments	B-UNK
indicate	B-UNK
that	O
this	O
novel	B-UNK
conformation	O
of	O
intranuclear	O
ataxin	B-UNK
-	O
3	O
is	O
not	O
due	O
to	O
proteolysis	O
,	O
suggesting	B-UNK
instead	B-UNK
that	O
association	B-UNK
with	O
nuclear	B-UNK
protein	B-UNK
(	O
s	O
)	O
alters	O
the	O
structure	B-UNK
of	O
full	O
-	O
length	O
ataxin	B-UNK
-	O
3	O
which	O
exposes	O
the	O
polyglutamine	B-UNK
domain	B-UNK
.	O

 	O
this	O
conformationally	O
altered	B-UNK
ataxin	B-UNK
-	O
3	O
is	O
bound	O
to	O
the	O
nuclear	B-UNK
matrix	B-UNK
.	O

 	O
the	O
pathological	B-UNK
form	B-UNK
of	O
ataxin	B-UNK
-	O
3	O
with	O
an	O
expanded	B-UNK
polyglutamine	I-UNK
domain	B-UNK
also	O
associates	O
with	O
the	O
nuclear	B-UNK
matrix	B-UNK
.	O

 	O
these	O
data	B-UNK
suggest	B-UNK
that	O
an	O
early	B-UNK
event	B-UNK
in	O
the	O
pathogenesis	O
of	O
sca3	B-UNK
/	O
mjd	B-UNK
may	O
be	O
an	O
altered	B-UNK
conformation	O
of	O
ataxin	B-UNK
-	O
3	O
within	O
the	O
nucleus	O
that	O
exposes	O
the	O
polyglutamine	B-UNK
domain	B-UNK
.	O
.	O

 	O
the	O
human	B-UNK
magel2	B-UNK
gene	B-UNK
and	O
its	O
mouse	B-UNK
homologue	B-UNK
are	O
paternally	B-UNK
expressed	I-UNK
and	O
mapped	B-UNK
to	O
the	O
prader	O
-	O
willi	O
region	B-UNK
.	O

 	O
prader	B-DISEASE
-	I-DISEASE
willi	I-DISEASE
syndrome	I-DISEASE
(	O
pws	B-UNK
)	O
is	O
a	O
complex	B-UNK
neurogenetic	O
disorder	O
.	O

 	O
the	O
phenotype	B-UNK
is	O
likely	B-UNK
to	O
be	O
a	O
contiguous	B-UNK
gene	B-UNK
syndrome	B-DISEASE
involving	B-UNK
genes	B-UNK
which	O
are	O
paternally	B-UNK
expressed	I-UNK
only	O
,	O
located	B-UNK
in	O
the	O
human	B-UNK
15q11	B-UNK
-	O
q13	O
region	B-UNK
.	O

 	O
four	O
mouse	B-UNK
models	B-UNK
of	O
pws	B-UNK
have	O
been	O
reported	B-UNK
but	O
these	O
do	O
not	O
definitively	O
allow	B-UNK
the	O
delineation	O
of	O
the	O
critical	B-UNK
region	I-UNK
and	O
the	O
associated	B-UNK
genes	B-UNK
involved	B-UNK
in	O
the	O
aetiology	O
of	O
pws	B-UNK
.	O

 	O
moreover	O
,	O
targeted	B-UNK
mutagenesis	B-UNK
of	O
mouse	B-UNK
homologues	B-UNK
of	O
the	O
human	B-UNK
candidate	B-UNK
pws	B-UNK
genes	B-UNK
does	O
not	O
appear	B-UNK
to	O
result	B-UNK
in	O
any	O
of	O
the	O
features	B-UNK
of	O
pws	B-UNK
.	O

 	O
therefore	O
,	O
the	O
isolation	B-UNK
of	O
new	B-UNK
genes	B-UNK
in	O
this	O
region	B-UNK
remains	B-UNK
crucial	B-UNK
for	O
a	O
better	B-UNK
understanding	B-UNK
of	O
the	O
molecular	B-UNK
basis	I-UNK
of	O
pws	B-UNK
.	O

 	O
in	O
this	O
manuscript	O
,	O
we	O
report	B-UNK
the	O
characterization	B-UNK
of	O
magel2	B-UNK
and	O
its	O
mouse	B-UNK
homologue	B-UNK
magel2	B-UNK
.	O

 	O
these	O
are	O
located	B-UNK
in	O
the	O
human	B-UNK
15q11	B-UNK
-	O
q13	O
and	O
mouse	B-UNK
7c	O
regions	B-UNK
,	O
in	O
close	B-UNK
proximity	O
to	O
ndn	O
/	O
ndn	O
.	O

 	O
by	O
northern	B-UNK
blot	O
analysis	B-UNK
we	O
did	O
not	O
detect	B-UNK
any	O
expression	B-UNK
of	O
magel2	B-UNK
/	O
magel2	B-UNK
but	O
by	O
rt	O
-	O
pcr	B-UNK
analysis	B-UNK
,	O
specific	B-UNK
expression	B-UNK
was	O
detected	B-UNK
in	O
fetal	B-UNK
and	O
adult	B-UNK
brain	B-UNK
and	O
in	O
placenta	B-DISEASE
.	O

 	O
both	O
genes	B-UNK
are	O
intronless	O
with	O
tandem	O
direct	B-UNK
repeat	B-UNK
sequences	B-UNK
contained	B-UNK
within	O
a	O
cpg	B-UNK
island	B-UNK
in	O
the	O
5	O
-	O
untranscribed	O
region	B-UNK
.	O

 	O
the	O
transcripts	B-UNK
encode	O
putative	B-UNK
proteins	B-UNK
that	O
are	O
homologous	B-UNK
to	O
the	O
mage	O
proteins	B-UNK
and	O
ndn	O
.	O

 	O
moreover	O
,	O
magel2	B-UNK
/	O
magel2	B-UNK
are	O
expressed	B-UNK
only	O
from	O
the	O
paternal	B-UNK
allele	B-UNK
in	O
brain	B-UNK
,	O
suggesting	B-UNK
a	O
potential	B-UNK
role	B-UNK
in	O
the	O
aetiology	O
of	O
pws	B-UNK
and	O
its	O
mouse	B-UNK
model	I-UNK
,	O
respectively	B-UNK
.	O
.	O

 	O
cdna	B-UNK
microarrays	O
detect	B-UNK
activation	B-UNK
of	O
a	O
myogenic	B-UNK
transcription	B-UNK
program	B-UNK
by	O
the	O
pax3	B-UNK
-	O
fkhr	B-UNK
fusion	I-UNK
oncogene	B-UNK
.	O

 	O
alveolar	O
rhabdomyosarcoma	B-DISEASE
is	O
an	O
aggressive	B-UNK
pediatric	O
cancer	B-DISEASE
of	O
striated	B-UNK
muscle	B-UNK
characterized	B-UNK
in	O
60	O
%	O
of	O
cases	B-UNK
by	O
a	O
t	B-UNK
(	O
2	O
;	O
13	O
)	O
(	O
q35	O
;	O
q14	O
)	O
.	O

 	O
this	O
results	B-UNK
in	O
the	O
fusion	B-UNK
of	O
pax3	B-UNK
,	O
a	O
developmental	B-UNK
transcription	B-UNK
factor	B-UNK
required	B-UNK
for	O
limb	B-UNK
myogenesis	O
,	O
with	O
fkhr	B-UNK
,	O
a	O
member	B-UNK
of	O
the	O
forkhead	B-UNK
family	B-UNK
of	O
transcription	B-UNK
factors	I-UNK
.	O

 	O
the	O
resultant	B-UNK
pax3	B-UNK
-	O
fkhr	B-UNK
gene	B-UNK
possesses	O
transforming	B-UNK
properties	B-UNK
;	O
however	O
,	O
the	O
effects	B-UNK
of	O
this	O
chimeric	B-UNK
oncogene	B-UNK
on	O
gene	B-UNK
expression	B-UNK
are	O
largely	B-UNK
unknown	B-UNK
.	O

 	O
to	O
investigate	O
the	O
actions	O
of	O
these	O
transcription	B-UNK
factors	I-UNK
,	O
both	O
pax3	B-UNK
and	O
pax3	B-UNK
-	O
fkhr	B-UNK
were	O
introduced	O
into	O
nih	B-UNK
3t3	I-UNK
cells	B-UNK
,	O
and	O
the	O
resultant	B-UNK
gene	B-UNK
expression	B-UNK
changes	B-UNK
were	O
analyzed	B-UNK
with	O
a	O
murine	B-UNK
cdna	B-UNK
microarray	O
containing	B-UNK
2	O
,	O
225	O
elements	B-UNK
.	O

 	O
we	O
found	B-UNK
that	O
pax3	B-UNK
-	O
fkhr	B-UNK
but	O
not	O
pax3	B-UNK
activated	B-UNK
a	O
myogenic	B-UNK
transcription	B-UNK
program	B-UNK
including	B-UNK
the	O
induction	O
of	O
transcription	B-UNK
factors	I-UNK
myod	O
,	O
myogenin	O
,	O
six1	O
,	O
and	O
slug	O
as	O
well	O
as	O
a	O
battery	O
of	O
genes	B-UNK
involved	B-UNK
in	O
several	O
aspects	O
of	O
muscle	B-UNK
function	B-UNK
.	O

 	O
notable	O
among	O
this	O
group	B-UNK
were	O
the	O
growth	B-UNK
factor	B-UNK
gene	B-UNK
igf2	O
and	O
its	O
binding	B-UNK
protein	B-UNK
igfbp5	O
.	O

 	O
relevance	B-UNK
of	O
this	O
model	B-UNK
was	O
suggested	B-UNK
by	O
verification	O
that	O
three	O
of	O
these	O
genes	B-UNK
(	O
igfbp5	O
,	O
hsix1	O
,	O
and	O
slug	O
)	O
were	O
also	O
expressed	B-UNK
in	O
alveolar	O
rhabdomyosarcoma	B-DISEASE
cell	B-UNK
lines	B-UNK
.	O

 	O
this	O
study	B-UNK
utilizes	O
cdna	B-UNK
microarrays	O
to	O
elucidate	O
the	O
pattern	B-UNK
of	O
gene	B-UNK
expression	B-UNK
induced	B-UNK
by	O
an	O
oncogenic	B-UNK
transcription	B-UNK
factor	B-UNK
and	O
demonstrates	B-UNK
the	O
profound	O
myogenic	B-UNK
properties	B-UNK
of	O
pax3	B-UNK
-	O
fkhr	B-UNK
in	O
nih	B-UNK
3t3	I-UNK
cells	B-UNK
.	O
.	O

 	O
experimental	B-UNK
hemochromatosis	B-DISEASE
due	O
to	O
mhc	B-UNK
class	B-UNK
i	O
hfe	B-UNK
deficiency	B-UNK
:	O
immune	B-UNK
status	B-UNK
and	O
iron	B-UNK
metabolism	B-DISEASE
.	O

 	O
the	O
puzzling	O
linkage	B-UNK
between	O
genetic	B-UNK
hemochromatosis	B-DISEASE
and	O
histocompatibility	O
loci	B-UNK
became	O
even	O
more	O
so	O
when	O
the	O
gene	B-UNK
involved	B-UNK
,	O
hfe	B-UNK
,	O
was	O
identified	B-UNK
.	O

 	O
indeed	O
,	O
within	O
the	O
well	O
defined	B-UNK
,	O
mainly	B-UNK
peptide	B-UNK
-	O
binding	B-UNK
,	O
mhc	B-UNK
class	B-UNK
i	O
family	B-UNK
of	O
molecules	O
,	O
hfe	B-UNK
seems	O
to	O
perform	O
an	O
unusual	B-UNK
yet	O
essential	B-UNK
function	B-UNK
.	O

 	O
as	O
yet	O
,	O
our	O
understanding	B-UNK
of	O
hfe	B-UNK
function	B-UNK
in	O
iron	B-UNK
homeostasis	I-UNK
is	O
only	O
partial	B-UNK
;	O
an	O
even	O
more	O
open	O
question	O
is	O
its	O
possible	B-UNK
role	B-UNK
in	O
the	O
immune	B-UNK
system	B-UNK
.	O

 	O
to	O
advance	O
on	O
both	O
of	O
these	O
avenues	O
,	O
we	O
report	B-UNK
the	O
deletion	B-UNK
of	O
hfe	B-UNK
alpha1	O
and	O
alpha2	O
putative	B-UNK
ligand	B-UNK
binding	B-UNK
domains	B-UNK
in	O
vivo	B-UNK
.	O

 	O
hfe	B-UNK
-	O
deficient	B-UNK
animals	O
were	O
analyzed	B-UNK
for	O
a	O
comprehensive	B-UNK
set	B-UNK
of	O
metabolic	B-UNK
and	O
immune	B-UNK
parameters	B-UNK
.	O

 	O
faithfully	O
mimicking	O
human	B-UNK
hemochromatosis	B-DISEASE
,	O
mice	B-UNK
homozygous	B-UNK
for	O
this	O
deletion	B-UNK
develop	B-UNK
iron	B-DISEASE
overload	I-DISEASE
,	O
characterized	B-UNK
by	O
a	O
higher	B-UNK
plasma	B-UNK
iron	B-UNK
content	I-UNK
and	O
a	O
raised	B-UNK
transferrin	B-UNK
saturation	I-UNK
as	O
well	O
as	O
an	O
elevated	B-UNK
hepatic	B-UNK
iron	B-UNK
load	O
.	O

 	O
the	O
primary	B-UNK
defect	B-UNK
could	O
,	O
indeed	O
,	O
be	O
traced	O
to	O
an	O
augmented	O
duodenal	B-UNK
iron	B-UNK
absorption	I-UNK
.	O

 	O
in	O
parallel	O
,	O
measurement	O
of	O
the	O
gut	O
mucosal	B-UNK
iron	B-UNK
content	I-UNK
as	O
well	O
as	O
iron	B-UNK
regulatory	B-UNK
proteins	B-UNK
allows	B-UNK
a	O
more	O
informed	O
evaluation	B-UNK
of	O
various	O
hypotheses	O
regarding	O
the	O
precise	B-UNK
role	B-UNK
of	O
hfe	B-UNK
in	O
iron	B-UNK
homeostasis	I-UNK
.	O

 	O
finally	B-UNK
,	O
an	O
extensive	B-UNK
phenotyping	O
of	O
primary	B-UNK
and	O
secondary	B-UNK
lymphoid	O
organs	O
including	B-UNK
the	O
gut	O
provides	B-UNK
no	O
compelling	O
evidence	B-UNK
for	O
an	O
obvious	B-UNK
immune	B-UNK
-	O
linked	B-UNK
function	B-UNK
for	O
hfe	B-UNK
.	O
.	O

 	O
somatic	B-UNK
rearrangement	B-UNK
of	O
chromosome	B-DISEASE
14	I-DISEASE
in	O
human	B-UNK
lymphocytes	B-UNK
.	O

 	O
ataxia	B-DISEASE
-	O
telangiectasia	B-DISEASE
is	O
a	O
rare	B-UNK
genetic	B-UNK
disorder	O
associated	B-UNK
with	O
immune	B-DISEASE
deficiency	I-DISEASE
,	O
chromosome	B-UNK
instability	B-UNK
,	O
and	O
a	O
predisposition	B-UNK
to	O
lymphoid	O
malignancy	B-DISEASE
.	O

 	O
we	O
have	O
detected	B-UNK
chromosomally	O
anomalous	O
clones	B-UNK
of	O
lymphocytes	B-UNK
in	O
eight	O
patients	B-UNK
with	O
this	O
disorder	O
.	O

 	B-UNK
chromosome	I-UNK
banding	B-UNK
disclosed	B-UNK
that	O
the	O
clones	B-UNK
are	O
consistently	O
marked	B-UNK
by	O
structural	B-UNK
rearrangement	B-UNK
of	O
the	O
long	B-UNK
arm	B-UNK
(	O
q	B-UNK
)	O
of	O
chromosome	B-DISEASE
14	I-DISEASE
.	O

 	O
a	O
translocation	B-DISEASE
involving	B-UNK
14q	O
was	O
found	B-UNK
in	O
clones	B-UNK
obtained	B-UNK
from	O
seven	B-UNK
of	O
the	O
eight	O
patients	B-UNK
whereas	O
a	O
ring	O
14	O
chromosome	B-UNK
was	O
found	B-UNK
in	O
a	O
clone	B-UNK
obtained	B-UNK
from	O
the	O
other	O
.	O

 	O
these	O
findings	B-UNK
as	O
well	O
as	O
data	B-UNK
obtained	B-UNK
by	O
others	O
for	O
patients	B-UNK
with	O
ataxia	B-DISEASE
-	O
telangiectasia	B-DISEASE
suggest	B-UNK
that	O
structural	B-UNK
rearrangement	B-UNK
of	O
14q	O
is	O
the	O
initial	B-UNK
chromosomal	B-UNK
change	B-UNK
in	O
lymphocyte	B-UNK
clones	B-UNK
of	O
patients	B-UNK
with	O
this	O
disorder	O
.	O

 	O
chromosomes	B-UNK
of	O
lymphocytes	B-UNK
from	O
one	O
of	O
the	O
patients	B-UNK
were	O
studied	B-UNK
before	O
and	O
after	O
the	O
onset	B-UNK
of	O
chronic	B-DISEASE
lymphocytic	I-DISEASE
leukemia	I-DISEASE
.	O

 	O
before	O
leukemia	B-DISEASE
was	O
diagnosed	B-UNK
,	O
the	O
patient	B-UNK
had	O
a	O
lymphocyte	B-UNK
clone	B-UNK
with	O
a	O
14q	O
translocation	B-DISEASE
.	O

 	O
this	O
clone	B-UNK
appears	B-UNK
to	O
have	O
given	B-UNK
rise	B-UNK
to	O
the	O
leukemic	O
cells	B-UNK
.	O

 	O
we	O
hypothesize	O
that	O
structural	B-UNK
rearrangement	B-UNK
of	O
14q	O
is	O
directly	B-UNK
related	B-UNK
to	O
abnormal	B-UNK
growth	B-UNK
of	O
lymphocytes	B-UNK
and	O
that	O
it	O
may	O
be	O
a	O
step	O
toward	O
the	O
development	B-UNK
of	O
lymphoid	O
malignancies	B-DISEASE
.	O

 	O
increasing	B-UNK
evidence	B-UNK
,	O
provided	B-UNK
by	O
others	O
,	O
for	O
the	O
nonrandom	B-UNK
involvement	B-UNK
of	O
14q	O
in	O
african	B-UNK
-	O
type	B-UNK
burkitts	O
lymphoma	B-DISEASE
and	O
other	O
lymphoid	O
neoplasms	B-DISEASE
further	O
strengthens	O
this	O
hypothesis	O
.	O
.	O

 	O
exon	B-UNK
9	O
mutations	B-UNK
in	O
the	O
wt1	B-UNK
gene	B-UNK
,	O
without	O
influencing	O
kts	O
splice	O
isoforms	B-UNK
,	O
are	O
also	O
responsible	B-UNK
for	O
frasier	B-DISEASE
syndrome	I-DISEASE
.	O

 	O
we	O
report	B-UNK
new	B-UNK
mutations	B-UNK
in	O
exon	B-UNK
9	O
of	O
the	O
wt1	B-UNK
gene	B-UNK
that	O
did	O
not	O
alter	B-UNK
the	O
ratio	B-UNK
of	O
+	O
/	O
-	O
kts	O
splice	O
isoforms	B-UNK
in	O
two	O
unrelated	B-UNK
patients	B-UNK
with	O
frasier	B-DISEASE
syndrome	I-DISEASE
(	O
fs	O
)	O
.	O

 	O
the	O
mutation	B-UNK
of	O
intron	B-UNK
9	O
inducing	B-UNK
defective	B-UNK
alternative	B-UNK
splicing	I-UNK
was	O
reported	B-UNK
to	O
be	O
responsible	B-UNK
for	O
this	O
syndrome	B-DISEASE
.	O

 	O
the	O
mutations	B-UNK
found	B-UNK
in	O
our	O
cases	B-UNK
occurred	B-UNK
in	O
the	O
same	O
exon	B-UNK
of	O
the	O
wt1	B-UNK
gene	B-UNK
as	O
detected	B-UNK
in	O
denys	B-DISEASE
-	I-DISEASE
drash	I-DISEASE
syndrome	I-DISEASE
(	O
dds	O
)	O
and	O
could	O
not	O
be	O
explained	O
by	O
the	O
previously	B-UNK
proposed	B-UNK
mechanism	B-UNK
.	O

 	O
the	O
results	B-UNK
suggest	B-UNK
that	O
the	O
two	O
syndromes	B-UNK
originate	O
from	O
the	O
same	O
wt1	B-UNK
gene	B-UNK
abnormality	B-UNK
.	O

 	O
from	O
a	O
molecular	B-UNK
biological	B-UNK
point	B-UNK
of	O
view	O
,	O
we	O
concluded	O
that	O
the	O
two	O
diseases	B-DISEASE
were	O
not	O
separable	O
,	O
and	O
that	O
fs	O
should	O
be	O
included	B-UNK
as	O
an	O
atypical	B-UNK
form	B-UNK
of	O
dds	O
.	O
.	O

 	O
splice	O
-	O
site	B-UNK
mutation	B-UNK
in	O
the	O
pds	B-UNK
gene	B-UNK
may	O
result	B-UNK
in	O
intrafamilial	B-UNK
variability	B-UNK
for	O
deafness	B-DISEASE
in	O
pendred	B-DISEASE
syndrome	I-DISEASE
.	O

 	O
pendred	B-DISEASE
syndrome	I-DISEASE
is	O
a	O
recessive	O
inherited	B-UNK
disorder	O
that	O
consists	B-UNK
of	O
developmental	B-UNK
abnormalities	B-DISEASE
of	O
the	O
cochlea	O
,	O
sensorineural	B-DISEASE
hearing	I-DISEASE
loss	I-DISEASE
,	O
and	O
diffuse	O
thyroid	B-DISEASE
enlargement	O
(	O
goiter	B-DISEASE
)	O
.	O

 	O
this	O
disorder	O
may	O
account	B-UNK
for	O
up	O
to	O
10	O
%	O
of	O
cases	B-UNK
of	O
hereditary	B-UNK
deafness	B-DISEASE
.	O

 	O
the	O
disease	B-DISEASE
gene	B-UNK
(	O
pds	B-UNK
)	O
has	O
been	O
mapped	B-UNK
to	O
chromosome	B-UNK
7q22	O
-	O
q31	O
,	O
and	O
encodes	B-UNK
a	O
chloride	B-UNK
-	O
iodide	B-UNK
transport	I-UNK
protein	B-UNK
.	O

 	O
we	O
performed	B-UNK
mutation	B-UNK
analysis	B-UNK
of	O
individual	B-UNK
exons	B-UNK
of	O
the	O
pds	B-UNK
gene	B-UNK
in	O
one	O
spanish	B-UNK
family	B-UNK
that	O
shows	B-UNK
intrafamilial	B-UNK
variability	B-UNK
of	O
the	O
deafness	B-DISEASE
phenotype	B-UNK
(	O
two	O
patients	B-UNK
with	O
profound	O
and	O
one	O
with	O
moderate	B-UNK
-	O
severe	B-UNK
deafness	B-DISEASE
)	O
.	O

 	O
we	O
identified	B-UNK
a	O
new	B-UNK
splice	O
-	O
site	B-UNK
mutation	B-UNK
affecting	B-UNK
intron	B-UNK
4	O
of	O
the	O
pds	B-UNK
gene	B-UNK
,	O
at	B-DISEASE
nucleotide	B-UNK
position	B-UNK
639	O
+	O
7	O
.	O

 	O
rna	B-UNK
analysis	B-UNK
from	O
lymphocytes	B-UNK
of	O
the	O
affected	B-UNK
patients	I-UNK
showed	B-UNK
that	O
mutation	B-UNK
639	O
+	O
7a	O
-	O
-	O
>	O
g	B-UNK
generates	B-UNK
a	O
new	B-UNK
donor	B-UNK
splice	I-UNK
site	I-UNK
,	O
leading	B-UNK
to	O
an	O
mrna	B-UNK
with	O
an	O
insertion	B-UNK
of	O
six	O
nucleotides	B-UNK
from	O
intron	B-UNK
4	O
of	O
pds	B-UNK
.	O

 	O
since	O
the	O
newly	B-UNK
created	B-UNK
donor	B-UNK
splice	I-UNK
site	I-UNK
is	O
likely	B-UNK
to	O
compete	O
with	O
the	O
normal	B-UNK
one	O
,	O
variations	O
of	O
the	O
levels	B-UNK
of	O
normal	B-UNK
and	O
aberrant	B-UNK
transcripts	B-UNK
of	O
the	O
pds	B-UNK
gene	B-UNK
in	O
the	O
cochlea	O
may	O
explain	O
the	O
variability	B-UNK
in	O
the	O
deafness	B-DISEASE
presentation	O
.	O
.	O

 	O
the	O
molecular	B-UNK
basis	I-UNK
of	O
sjogren	B-DISEASE
-	I-DISEASE
larsson	I-DISEASE
syndrome	I-DISEASE
:	O
mutation	B-UNK
analysis	B-UNK
of	O
the	O
fatty	O
aldehyde	O
dehydrogenase	B-UNK
gene	B-UNK
.	O

 	O
sjogren	B-DISEASE
-	I-DISEASE
larsson	I-DISEASE
syndrome	I-DISEASE
(	O
sls	B-UNK
)	O
is	O
an	O
autosomal	B-UNK
recessive	I-UNK
disorder	I-UNK
characterized	I-UNK
by	O
ichthyosis	B-DISEASE
,	O
mental	B-DISEASE
retardation	I-DISEASE
,	O
spasticity	O
,	O
and	O
deficient	B-UNK
activity	B-UNK
of	O
fatty	O
aldehyde	O
dehydrogenase	B-UNK
(	O
faldh	B-UNK
)	O
.	O

 	O
to	O
define	B-UNK
the	O
molecular	B-UNK
defects	B-UNK
causing	B-UNK
sls	B-UNK
,	O
we	O
performed	B-UNK
mutation	B-UNK
analysis	B-UNK
of	O
the	O
faldh	B-UNK
gene	B-UNK
in	O
probands	B-UNK
from	O
63	O
kindreds	B-UNK
with	O
sls	B-UNK
.	O

 	O
among	O
these	O
patients	B-UNK
,	O
49	O
different	B-UNK
mutations	B-UNK
-	O
including	B-UNK
10	O
deletions	B-UNK
,	O
2	O
insertions	B-UNK
,	O
22	O
amino	B-UNK
acid	I-UNK
substitutions	B-UNK
,	O
3	O
nonsense	B-UNK
mutations	B-UNK
,	O
9	O
splice	O
-	O
site	B-UNK
defects	B-UNK
,	O
and	O
3	O
complex	B-UNK
mutations	B-UNK
-	O
were	O
found	B-UNK
.	O

 	O
all	O
of	O
the	O
patients	B-UNK
with	O
sls	B-UNK
were	O
found	B-UNK
to	O
carry	B-UNK
mutations	B-UNK
.	O

 	O
nineteen	O
of	O
the	O
missense	B-UNK
mutations	I-UNK
resulted	B-UNK
in	O
a	O
severe	B-UNK
reduction	B-UNK
of	O
faldh	B-UNK
enzyme	B-UNK
catalytic	B-UNK
activity	B-UNK
when	O
expressed	B-UNK
in	O
mammalian	B-UNK
cells	B-UNK
,	O
but	O
one	O
mutation	B-UNK
(	O
798	O
g	B-UNK
-	O
-	O
>	O
c	B-UNK
[	O
k266n	O
]	O
)	O
seemed	O
to	O
have	O
a	O
greater	B-UNK
effect	B-UNK
on	O
mrna	B-UNK
stability	B-UNK
.	O

 	O
the	O
splice	O
-	O
site	B-UNK
mutations	B-UNK
led	B-UNK
to	O
exon	B-UNK
skipping	B-UNK
or	O
utilization	B-UNK
of	O
cryptic	O
acceptor	B-UNK
-	O
splice	O
sites	B-UNK
.	O

 	O
thirty	B-UNK
-	O
seven	B-UNK
mutations	B-UNK
were	O
private	O
,	O
and	O
12	O
mutations	B-UNK
were	O
seen	B-UNK
in	O
two	O
or	O
more	O
probands	B-UNK
of	O
european	B-UNK
or	O
middle	B-UNK
eastern	B-UNK
descent	B-UNK
.	O

 	O
four	O
single	B-UNK
-	O
nucleotide	B-UNK
polymorphisms	B-UNK
(	O
snps	O
)	O
were	O
found	B-UNK
in	O
the	O
faldh	B-UNK
gene	B-UNK
.	O

 	O
at	B-DISEASE
least	O
four	O
of	O
the	O
common	B-UNK
mutations	B-UNK
(	O
551c	O
-	O
-	O
>	O
t	B-UNK
,	O
682c	O
-	O
-	O
>	O
t	B-UNK
,	O
733	O
g	B-UNK
-	O
-	O
>	O
a	O
,	O
and	O
798	O
+	O
1delg	O
)	O
were	O
associated	B-UNK
with	O
multiple	B-UNK
snp	O
haplotypes	B-UNK
,	O
suggesting	B-UNK
that	O
these	O
mutations	B-UNK
originated	B-UNK
independently	B-UNK
on	O
more	O
than	O
one	O
occasion	O
or	O
were	O
ancient	B-UNK
sls	B-UNK
genes	B-UNK
that	O
had	O
undergone	O
intragenic	B-UNK
recombination	B-UNK
.	O

 	O
our	O
results	B-UNK
demonstrate	B-UNK
that	O
sls	B-UNK
is	O
caused	B-UNK
by	O
a	O
strikingly	B-UNK
heterogeneous	B-UNK
group	I-UNK
of	O
mutations	B-UNK
in	O
the	O
faldh	B-UNK
gene	B-UNK
and	O
provide	B-UNK
a	O
framework	O
for	O
understanding	B-UNK
the	O
genetic	B-UNK
basis	B-UNK
of	O
sls	B-UNK
and	O
the	O
development	B-UNK
of	O
dna	B-UNK
-	O
based	B-UNK
diagnostic	I-UNK
tests	B-UNK
.	O
.	O

 	O
loss	B-UNK
-	O
of	O
-	O
function	B-UNK
mutations	B-UNK
in	O
the	O
cathepsin	B-UNK
c	I-UNK
gene	B-UNK
result	B-UNK
in	O
periodontal	B-DISEASE
disease	I-DISEASE
and	O
palmoplantar	O
keratosis	B-DISEASE
.	O

 	O
papillon	O
-	O
lefevre	O
syndrome	B-DISEASE
,	O
or	O
keratosis	B-DISEASE
palmoplantaris	O
with	O
periodontopathia	O
(	O
pls	B-DISEASE
,	O
mim	O
245000	O
)	O
,	O
is	O
an	O
autosomal	O
recessive	O
disorder	O
that	O
is	O
mainly	B-UNK
ascertained	B-UNK
by	O
dentists	O
because	O
of	O
the	O
severe	B-UNK
periodontitis	B-DISEASE
that	O
afflicts	O
patients	B-UNK
.	O

 	O
both	O
the	O
deciduous	O
and	O
permanent	O
dentitions	O
are	O
affected	B-UNK
,	O
resulting	B-UNK
in	O
premature	B-UNK
tooth	B-DISEASE
loss	I-DISEASE
.	O

 	O
palmoplantar	O
keratosis	B-DISEASE
,	O
varying	B-UNK
from	O
mild	B-UNK
psoriasiform	O
scaly	O
skin	B-DISEASE
to	O
overt	O
hyperkeratosis	B-DISEASE
,	O
typically	B-UNK
develops	O
within	O
the	O
first	O
three	O
years	B-UNK
of	O
life	B-UNK
.	O

 	O
keratosis	B-DISEASE
also	O
affects	B-UNK
other	O
sites	B-UNK
such	O
as	O
elbows	O
and	O
knees	O
.	O

 	O
most	O
pls	B-DISEASE
patients	B-UNK
display	B-UNK
both	O
periodontitis	B-DISEASE
and	O
hyperkeratosis	B-DISEASE
.	O

 	O
some	O
patients	B-UNK
have	O
only	O
palmoplantar	O
keratosis	B-DISEASE
or	O
periodontitis	B-DISEASE
,	O
and	O
in	O
rare	B-UNK
individuals	B-UNK
the	O
periodontitis	B-DISEASE
is	O
mild	B-UNK
and	O
of	O
late	B-UNK
onset	B-UNK
.	O

 	O
the	O
pls	B-DISEASE
locus	B-UNK
has	O
been	O
mapped	B-UNK
to	O
chromosome	B-UNK
11q14	O
-	O
q21	O
(	O
refs	O
7	O
,	O
8	O
,	O
9	O
)	O
.	O

 	O
using	O
homozygosity	B-UNK
mapping	B-UNK
in	O
eight	O
small	B-UNK
consanguineous	B-UNK
families	B-UNK
,	O
we	O
have	O
narrowed	O
the	O
candidate	B-UNK
region	B-UNK
to	O
a	O
1	O
.	O

 	O
2	O
-	O
cm	B-DISEASE
interval	B-UNK
between	O
d11s4082	O
and	O
d11s931	O
.	O

 	O
the	O
gene	B-UNK
(	O
ctsc	B-UNK
)	O
encoding	B-UNK
the	O
lysosomal	B-UNK
protease	B-UNK
cathepsin	B-UNK
c	I-UNK
(	O
or	O
dipeptidyl	O
aminopeptidase	O
i	O
)	O
lies	B-UNK
within	O
this	O
interval	B-UNK
.	O

 	O
we	O
defined	B-UNK
the	O
genomic	B-UNK
structure	B-UNK
of	O
ctsc	B-UNK
and	O
found	B-UNK
mutations	B-UNK
in	O
all	O
eight	O
families	B-UNK
.	O

 	O
in	O
two	O
of	O
these	O
families	B-UNK
we	O
used	O
a	O
functional	B-UNK
assay	B-UNK
to	O
demonstrate	B-UNK
an	O
almost	O
total	B-UNK
loss	B-UNK
of	O
cathepsin	B-UNK
c	I-UNK
activity	B-UNK
in	O
pls	B-DISEASE
patients	B-UNK
and	O
reduced	B-UNK
activity	B-UNK
in	O
obligate	B-UNK
carriers	B-UNK
.	O

 	O
confirmation	O
of	O
linkage	B-UNK
of	O
van	B-DISEASE
der	I-DISEASE
woude	I-DISEASE
syndrome	I-DISEASE
to	O
chromosome	B-UNK
1q32	B-UNK
:	O
evidence	B-UNK
of	O
association	B-UNK
with	O
str	O
alleles	B-UNK
suggests	B-UNK
possible	B-UNK
unique	B-UNK
origin	B-UNK
of	O
the	O
disease	B-DISEASE
mutation	B-UNK
.	O

 	O
van	B-DISEASE
der	I-DISEASE
woude	I-DISEASE
syndrome	I-DISEASE
(	O
vws	B-UNK
)	O
is	O
an	O
autosomal	O
dominant	B-UNK
craniofacial	O
disorder	O
with	O
high	B-UNK
penetrance	B-UNK
and	O
variable	B-UNK
expression	B-UNK
.	O

 	O
its	O
clinical	B-UNK
features	I-UNK
are	O
variably	O
expressed	B-UNK
,	O
but	O
include	B-UNK
cleft	B-DISEASE
lip	I-DISEASE
and	O
/	O
or	O
cleft	B-DISEASE
palate	I-DISEASE
,	O
lip	B-DISEASE
pits	O
and	O
hypodontia	B-DISEASE
.	O

 	O
all	O
vws	B-UNK
families	I-UNK
studied	B-UNK
to	O
date	B-UNK
map	B-UNK
the	O
disease	B-DISEASE
gene	B-UNK
to	O
a	O
<	O
2	O
cm	B-DISEASE
region	B-UNK
of	O
chromosome	B-UNK
1q32	B-UNK
,	O
with	O
no	O
evidence	B-UNK
of	O
locus	B-UNK
heterogeneity	I-UNK
.	O

 	O
the	O
aim	O
of	O
this	O
study	B-UNK
is	O
to	O
refine	O
the	O
localization	B-UNK
of	O
the	O
vws	B-UNK
gene	B-UNK
and	O
to	O
further	O
assess	B-UNK
possible	B-UNK
heterogeneity	B-UNK
.	O

 	O
we	O
analyzed	B-UNK
four	O
multiplex	B-UNK
vws	B-UNK
families	I-UNK
.	O

 	O
all	O
available	B-UNK
members	B-UNK
were	O
clinically	B-UNK
assessed	B-UNK
and	O
genotyped	O
for	O
19	O
short	B-UNK
tandem	I-UNK
repeat	B-UNK
markers	B-UNK
on	O
chromosome	B-DISEASE
1	I-DISEASE
in	O
the	O
vws	B-UNK
candidate	B-UNK
gene	B-UNK
region	B-UNK
.	O

 	O
we	O
performed	B-UNK
two	O
-	O
point	B-UNK
and	O
multipoint	B-UNK
limit	B-UNK
of	O
detection	B-UNK
(	O
lod	O
)	O
score	B-UNK
analyses	B-UNK
using	O
a	O
high	B-UNK
penetrance	B-UNK
autosomal	O
dominant	B-UNK
model	B-UNK
.	O

 	O
all	O
families	B-UNK
showed	B-UNK
positive	B-UNK
lod	I-UNK
scores	I-UNK
without	O
any	O
recombination	B-UNK
in	O
the	O
candidate	B-UNK
region	B-UNK
.	O

 	O
the	O
largest	O
two	O
-	O
point	B-UNK
lod	B-UNK
score	I-UNK
was	O
5	O
.	O

 	O
87	O
87	O
.	O

 	O
our	O
assay	B-UNK
method	B-UNK
for	O
short	B-UNK
tandem	I-UNK
repeat	B-UNK
(	O
str	O
)	O
markers	B-UNK
provided	B-UNK
highly	B-UNK
accurate	B-UNK
size	B-UNK
estimation	B-UNK
of	O
marker	B-UNK
allele	B-UNK
fragment	O
sizes	B-UNK
,	O
and	O
therefore	O
enabled	B-UNK
us	O
to	O
determine	O
the	O
specific	B-UNK
alleles	B-UNK
segregating	B-UNK
with	O
the	O
vws	B-UNK
gene	B-UNK
in	O
each	O
of	O
our	O
four	O
families	B-UNK
.	O

 	O
we	O
observed	B-UNK
a	O
striking	B-UNK
pattern	B-UNK
of	O
str	O
allele	B-UNK
sharing	I-UNK
at	B-DISEASE
several	O
closely	B-UNK
linked	I-UNK
loci	B-UNK
among	O
our	O
four	O
caucasian	B-UNK
vws	B-UNK
families	I-UNK
recruited	O
at	B-DISEASE
three	O
different	B-UNK
locations	B-UNK
in	O
the	O
us	O
.	O

 	O
these	O
results	B-UNK
suggest	B-UNK
the	O
possibility	O
of	O
a	O
unique	B-UNK
origin	B-UNK
for	O
a	O
mutation	B-UNK
responsible	B-UNK
for	O
many	O
or	O
most	O
cases	B-UNK
of	O
vws	B-UNK
.	O

 	O
a	O
point	B-UNK
mutation	I-UNK
thr	O
(	O
799	O
)	O
met	O
on	O
the	O
alpha	B-UNK
(	O
2	O
)	O
integrin	O
leads	B-UNK
to	O
the	O
formation	B-UNK
of	O
new	B-UNK
human	B-UNK
platelet	B-UNK
alloantigen	O
sit	O
(	O
a	O
)	O
and	O
affects	B-UNK
collagen	O
-	O
induced	B-UNK
aggregation	O
.	O

 	O
a	O
new	B-UNK
platelet	B-UNK
-	O
specific	B-UNK
alloantigen	O
,	O
termed	B-UNK
sit	O
(	O
a	O
)	O
,	O
was	O
identified	B-UNK
in	O
a	O
severe	B-UNK
case	B-UNK
of	O
neonatal	B-UNK
alloimmune	O
thrombocytopenia	B-DISEASE
.	O

 	O
the	O
sit	O
(	O
a	O
)	O
alloantigen	O
is	O
of	O
low	B-UNK
frequency	B-UNK
(	O
1	O
/	O
400	O
)	O
in	O
the	O
german	B-UNK
population	B-UNK
.	O

 	O
immunochemical	B-UNK
studies	B-UNK
demonstrated	I-UNK
that	O
the	O
sit	O
(	O
a	O
)	O
epitopes	O
reside	O
on	O
platelet	B-UNK
glycoprotein	B-UNK
(	O
gp	O
)	O
ia	O
.	O

 	O
nucleotide	B-UNK
sequence	I-UNK
analysis	I-UNK
of	O
gpia	B-UNK
cdna	B-UNK
derived	B-UNK
from	O
sit	O
(	O
a	O
)	O
-	O
positive	B-UNK
platelets	B-UNK
showed	B-UNK
c	B-UNK
(	O
2531	O
)	O
-	O
-	O
>	O
t	B-UNK
(	O
2531	O
)	O
point	B-UNK
mutation	I-UNK
,	O
resulting	B-UNK
in	O
thr	O
(	O
799	O
)	O
met	O
dimorphism	O
.	O

 	O
analysis	B-UNK
of	O
genomic	B-UNK
dna	I-UNK
from	O
22	O
sit	O
(	O
a	O
)	O
-	O
negative	B-UNK
normal	B-UNK
individuals	B-UNK
showed	I-UNK
that	O
the	O
thr	O
(	O
799	O
)	O
is	O
encoded	B-UNK
by	O
acg	O
(	O
2532	O
)	O
(	O
90	O
.	O
9	O
%	O
)	O
or	O
aca	O
(	O
2532	O
)	O
(	O
9	O
.	O
1	O
%	O
)	O
.	O

 	O
to	O
establish	O
a	O
dna	B-UNK
typing	B-UNK
technique	B-UNK
,	O
we	O
elucidated	O
the	O
organization	B-UNK
of	O
the	O
gpia	B-UNK
gene	B-UNK
adjacent	B-UNK
to	O
the	O
polymorphic	B-UNK
bases	B-UNK
.	O

 	O
the	O
introns	B-UNK
(	O
421	O
bp	B-UNK
and	O
1	O
.	O
2	O
kb	B-UNK
)	O
encompass	O
a	O
142	O
-	O
bp	B-UNK
exon	B-UNK
with	O
the	O
2	O
polymorphic	B-UNK
bases	B-UNK
2531	O
and	O
2532	O
.	O

 	B-UNK
polymerase	I-UNK
chain	I-UNK
reaction	O
-	O
restriction	B-UNK
fragment	I-UNK
length	I-UNK
polymorphism	I-UNK
analysis	B-UNK
on	O
dna	B-UNK
derived	B-UNK
from	O
100	O
donors	O
using	O
the	O
restriction	O
enzyme	B-UNK
mae	O
iii	B-UNK
showed	B-UNK
that	O
the	O
met	O
(	O
799	O
)	O
form	B-UNK
of	O
gpia	B-UNK
is	O
restricted	O
to	O
sit	O
(	O
a	O
)	O
(	O
+	O
)	O
phenotype	B-UNK
.	O

 	O
analysis	B-UNK
of	O
stable	B-UNK
chinese	B-UNK
hamster	B-UNK
ovary	O
transfectants	O
expressing	B-UNK
allele	B-UNK
-	O
specific	B-UNK
recombinant	B-UNK
forms	B-UNK
of	O
gpia	B-UNK
showed	B-UNK
that	O
anti	O
-	O
sit	O
(	O
a	O
)	O
exclusively	B-UNK
reacted	O
with	O
the	O
glu	B-UNK
(	O
505	O
)	O
met	O
(	O
799	O
)	O
,	O
but	O
not	O
with	O
the	O
glu	B-UNK
(	O
505	O
)	O
thr	O
(	O
799	O
)	O
and	O
the	O
lys	O
(	O
505	O
)	O
thr	O
(	O
799	O
)	O
isoforms	B-UNK
.	O

 	O
in	O
contrast	B-UNK
,	O
anti	O
-	O
br	O
(	O
a	O
)	O
(	O
hpa	O
-	O
5b	O
)	O
only	O
recognized	B-UNK
the	O
lys	O
(	O
505	O
)	O
thr	O
(	O
799	O
)	O
form	B-UNK
,	O
whereas	O
anti	O
-	O
br	O
(	O
b	B-UNK
)	O
(	O
hpa	O
-	O
5a	O
)	O
reacted	O
with	O
both	O
glu	B-UNK
(	O
505	O
)	O
thr	O
(	O
799	O
)	O
and	O
glu	B-UNK
(	O
505	O
)	O
met	O
(	O
799	O
)	O
isoforms	B-UNK
.	O

 	O
these	O
results	B-UNK
demonstrated	B-UNK
that	O
the	O
met	O
(	O
799	O
)	O
is	O
responsible	B-UNK
for	O
formation	B-UNK
of	O
the	O
sit	O
(	O
a	O
)	O
alloantigenic	O
determinants	O
,	O
whereas	O
amino	B-UNK
acid	I-UNK
505	O
(	O
lys	O
or	O
glu	B-UNK
)	O
specifically	B-UNK
controls	B-UNK
the	O
expression	B-UNK
of	O
br	O
(	O
a	O
)	O
and	O
br	O
(	O
b	B-UNK
)	O
epitopes	O
,	O
respectively	B-UNK
.	O

 	O
platelet	B-DISEASE
aggregation	I-DISEASE
responses	B-UNK
of	O
sit	O
(	O
a	O
)	O
(	O
+	O
)	O
individuals	B-UNK
were	O
diminished	B-UNK
in	O
response	B-UNK
to	O
collagen	O
,	O
indicating	B-UNK
that	O
the	O
thr	O
(	O
799	O
)	O
met	O
mutation	B-UNK
affects	B-UNK
the	O
function	B-UNK
of	O
the	O
gpia	B-UNK
/	O
iia	O
complex	B-UNK

 	O
mutations	B-UNK
of	O
the	O
cathepsin	B-UNK
c	I-UNK
gene	B-UNK
are	O
responsible	B-UNK
for	O
papillon	O
-	O
lefevre	O
syndrome	B-DISEASE
.	O

 	O
papillon	O
-	O
lefevre	O
syndrome	B-DISEASE
(	O
pls	B-DISEASE
)	O
is	O
an	O
autosomal	O
recessive	O
disorder	O
characterised	B-UNK
by	O
palmoplantar	O
hyperkeratosis	B-DISEASE
and	O
severe	B-UNK
early	B-UNK
onset	I-UNK
periodontitis	B-DISEASE
that	O
results	B-UNK
in	O
the	O
premature	B-UNK
loss	B-UNK
of	O
the	O
primary	B-UNK
and	O
secondary	B-UNK
dentitions	O
.	O

 	O
a	O
major	B-UNK
gene	B-UNK
locus	B-UNK
for	O
pls	B-DISEASE
has	O
been	O
mapped	B-UNK
to	O
a	O
2	O
.	O

 	O
8	O
cm	B-DISEASE
interval	B-UNK
on	O
chromosome	B-UNK
11q14	O
.	O

 	O
correlation	B-UNK
of	O
physical	B-UNK
and	O
genetic	B-UNK
maps	B-UNK
of	O
this	O
interval	B-UNK
indicate	B-UNK
it	O
includes	B-UNK
at	B-DISEASE
least	O
40	O
ests	O
and	O
six	O
known	B-UNK
genes	B-UNK
including	B-UNK
the	O
lysosomal	B-UNK
protease	B-UNK
cathepsin	B-UNK
c	I-UNK
gene	B-UNK
(	O
ctsc	B-UNK
)	O
.	O

 	O
the	O
ctsc	B-UNK
message	O
is	O
expressed	B-UNK
at	B-DISEASE
high	B-UNK
levels	B-UNK
in	O
a	O
variety	B-UNK
of	O
immune	B-UNK
cells	B-UNK
including	B-UNK
polymorphonuclear	B-UNK
leucocytes	B-UNK
,	O
macrophages	O
,	O
and	O
their	O
precursors	O
.	O

 	O
by	O
rt	O
-	O
pcr	B-UNK
,	O
we	O
found	B-UNK
ctsc	B-UNK
is	O
also	O
expressed	B-UNK
in	O
epithelial	O
regions	B-UNK
commonly	O
affected	B-UNK
by	O
pls	B-DISEASE
,	O
including	B-UNK
the	O
palms	O
,	O
soles	O
,	O
knees	O
,	O
and	O
oral	B-UNK
keratinised	O
gingiva	O
.	O

 	O
the	O
4	O
.	O

 	O
7	O
kb	B-UNK
ctsc	B-UNK
gene	B-UNK
consists	B-UNK
of	O
two	O
exons	B-UNK
.	O

 	O
sequence	B-UNK
analysis	B-UNK
of	O
ctsc	B-UNK
from	O
subjects	B-UNK
affected	I-UNK
with	O
pls	B-DISEASE
from	O
five	O
consanguineous	B-UNK
turkish	B-UNK
families	B-UNK
identified	B-UNK
four	O
different	B-UNK
mutations	B-UNK
.	O

 	O
an	O
exon	B-UNK
1	O
nonsense	B-UNK
mutation	B-UNK
(	O
856c	O
-	O
-	O
>	O
t	B-UNK
)	O
introduces	B-UNK
a	O
premature	B-UNK
stop	B-UNK
codon	B-UNK
at	B-DISEASE
amino	B-UNK
acid	I-UNK
286	O
.	O

 	O
three	O
exon	B-UNK
2	O
mutations	B-UNK
were	O
identified	B-UNK
,	O
including	B-UNK
a	O
single	B-UNK
nucleotide	B-UNK
deletion	B-UNK
(	O
2692dela	O
)	O
of	O
codon	B-UNK
349	O
introducing	O
a	O
frameshift	B-UNK
and	O
premature	B-UNK
termination	I-UNK
codon	B-UNK
,	O
a	O
2	O
bp	B-UNK
deletion	I-UNK
(	O
2673	O
-	O
2674delct	O
)	O
that	O
results	B-UNK
in	O
introduction	O
of	O
a	O
stop	B-UNK
codon	B-UNK
at	B-DISEASE
amino	B-UNK
acid	I-UNK
343	O
,	O
and	O
a	O
g	B-UNK
-	O
-	O
>	O
a	O
substitution	B-UNK
in	O
codon	B-UNK
429	O
(	O
2931	O
g	B-UNK
-	O
-	O
>	O
a	O
)	O
introducing	O
a	O
premature	B-UNK
termination	I-UNK
codon	B-UNK
.	O

 	O
all	O
pls	B-DISEASE
patients	B-UNK
were	O
homozygous	B-UNK
for	O
cathepsin	B-UNK
c	I-UNK
mutations	B-UNK
inherited	B-UNK
from	O
a	O
common	B-UNK
ancestor	B-UNK
.	O

 	O
parents	B-UNK
and	O
sibs	B-UNK
heterozygous	B-UNK
for	O
cathepsin	B-UNK
c	I-UNK
mutations	B-UNK
do	O
not	O
show	O
either	O
the	O
palmoplantar	O
hyperkeratosis	B-DISEASE
or	O
severe	B-UNK
early	B-UNK
onset	I-UNK
periodontitis	B-DISEASE
characteristic	B-UNK
of	O
pls	B-DISEASE
.	O

 	O
a	O
more	O
complete	B-UNK
understanding	B-UNK
of	O
the	O
functional	B-UNK
physiology	O
of	O
cathepsin	B-UNK
c	I-UNK
carries	O
significant	B-UNK
implications	B-UNK
for	O
understanding	B-UNK
normal	B-UNK
and	O
abnormal	B-UNK
skin	B-DISEASE
development	B-UNK
and	O
periodontal	B-DISEASE
disease	I-DISEASE
susceptibility	B-UNK

 	B-UNK
mutational	I-UNK
analysis	B-UNK
of	O
the	O
hgo	B-UNK
gene	B-UNK
in	O
finnish	B-UNK
alkaptonuria	B-DISEASE
patients	B-UNK
.	O

 	O
alkaptonuria	B-DISEASE
(	O
aku	B-UNK
)	O
,	O
the	O
prototypic	O
inborn	B-DISEASE
error	I-DISEASE
of	I-DISEASE
metabolism	I-DISEASE
,	O
has	O
recently	B-UNK
been	O
shown	B-UNK
to	O
be	O
caused	B-UNK
by	O
loss	B-UNK
of	O
function	B-UNK
mutations	B-UNK
in	O
the	O
homogentisate	O
-	O
1	O
,	O
2	O
-	O
dioxygenase	B-UNK
gene	B-UNK
(	O
hgo	B-UNK
)	O
.	O

 	O
so	O
far	B-UNK
17	O
mutations	B-UNK
have	O
been	O
characterised	B-UNK
in	O
aku	B-UNK
patients	B-UNK
of	O
different	B-UNK
ethnic	B-UNK
origin	B-UNK
.	O

 	O
we	O
describe	B-UNK
three	O
novel	B-UNK
mutations	B-UNK
(	O
r58fs	O
,	O
r330s	O
,	O
and	O
h371r	O
)	O
and	O
one	O
common	B-UNK
aku	B-UNK
mutation	B-UNK
(	O
m368v	O
)	O
,	O
detected	B-UNK
by	O
mutational	B-UNK
and	O
polymorphism	O
analysis	B-UNK
of	O
the	O
hgo	B-UNK
gene	B-UNK
in	O
five	O
finnish	B-UNK
aku	B-UNK
pedigrees	B-UNK
.	O

 	O
the	O
three	O
novel	B-UNK
aku	B-UNK
mutations	B-UNK
are	O
most	O
likely	B-UNK
specific	B-UNK
for	O
the	O
finnish	B-UNK
population	B-UNK
and	O
have	O
originated	B-UNK
recently	B-UNK
.	O
.	O

 	O
the	O
identical	B-UNK
5	O
'	O
splice	O
-	O
site	B-UNK
acceptor	B-UNK
mutation	B-UNK
in	O
five	O
attenuated	O
apc	B-UNK
families	B-UNK
from	O
newfoundland	B-UNK
demonstrates	B-UNK
a	O
founder	B-UNK
effect	B-UNK
.	O

 	B-UNK
inherited	I-UNK
mutations	B-UNK
of	O
the	O
apc	B-UNK
gene	B-UNK
predispose	B-UNK
carriers	B-UNK
to	O
multiple	B-UNK
adenomatous	B-DISEASE
polyps	I-DISEASE
of	O
the	O
colon	O
and	O
rectum	O
and	O
to	O
colorectal	B-DISEASE
cancer	I-DISEASE
.	O

 	O
mutations	B-UNK
located	B-UNK
at	B-DISEASE
the	O
extreme	B-UNK
5	O
end	B-UNK
of	O
the	O
apc	B-UNK
gene	B-UNK
,	O
however	O
,	O
are	O
associated	B-UNK
with	O
a	O
less	O
severe	B-UNK
disease	B-DISEASE
known	B-UNK
as	O
attenuated	O
adenomatous	B-DISEASE
polyposis	I-DISEASE
coli	I-DISEASE
(	O
aapc	O
)	O
.	O

 	O
many	O
individuals	B-UNK
with	O
aapc	O
develop	B-UNK
relatively	B-UNK
few	O
colorectal	B-UNK
polyps	B-DISEASE
but	O
are	O
still	O
at	B-DISEASE
high	B-UNK
risk	B-UNK
for	O
colorectal	B-DISEASE
cancer	I-DISEASE
.	O

 	O
we	O
report	B-UNK
here	O
the	O
identification	B-UNK
of	O
a	O
5	O
apc	B-UNK
germline	B-UNK
mutation	B-UNK
in	O
five	O
separately	B-UNK
ascertained	B-UNK
aapc	O
families	B-UNK
from	O
newfoundland	B-UNK
,	O
canada	B-UNK
.	O

 	O
this	O
disease	B-DISEASE
-	O
causing	B-UNK
mutation	B-UNK
is	O
a	O
single	B-UNK
basepair	O
change	B-UNK
(	O
g	B-UNK
to	O
a	O
)	O
in	O
the	O
splice	O
-	O
acceptor	B-UNK
region	B-UNK
of	O
apc	B-UNK
intron	B-UNK
3	O
that	O
creates	O
a	O
mutant	B-UNK
rna	B-UNK
without	O
exon	B-UNK
4	O
of	O
apc	B-UNK
.	O

 	O
the	O
observation	B-UNK
of	O
the	O
same	O
apc	B-UNK
mutation	B-UNK
in	O
five	O
families	B-UNK
from	O
the	O
same	O
geographic	B-UNK
area	B-UNK
demonstrates	B-UNK
a	O
founder	B-UNK
effect	B-UNK
.	O

 	O
furthermore	B-UNK
,	O
the	O
identification	B-UNK
of	O
this	O
germline	B-UNK
mutation	B-UNK
strengthens	O
the	O
correlation	B-UNK
between	O
the	O
5	O
location	B-UNK
of	O
an	O
apc	B-UNK
disease	B-DISEASE
-	O
causing	B-UNK
mutation	B-UNK
and	O
the	O
attenuated	O
polyposis	B-DISEASE
phenotype	B-UNK
.	O
.	O

 	O
alstrom	B-DISEASE
syndrome	I-DISEASE
:	O
further	O
evidence	B-UNK
for	O
linkage	B-UNK
to	O
human	B-UNK
chromosome	I-UNK
2p13	B-UNK
.	O

 	O
alstrom	B-DISEASE
syndrome	I-DISEASE
is	O
a	O
rare	B-UNK
autosomal	I-UNK
recessive	I-UNK
disorder	I-UNK
characterized	B-UNK
by	O
retinal	B-DISEASE
degeneration	I-DISEASE
,	O
sensorineural	B-DISEASE
hearing	I-DISEASE
loss	I-DISEASE
,	O
early	B-UNK
-	O
onset	B-UNK
obesity	B-DISEASE
,	O
and	O
non	B-UNK
-	O
insulin	O
-	O
dependent	B-UNK
diabetes	B-DISEASE
mellitus	I-DISEASE
.	O

 	O
the	O
gene	B-UNK
for	O
alstrom	B-DISEASE
syndrome	I-DISEASE
(	O
alms1	O
)	O
has	O
been	O
previously	B-UNK
localized	B-UNK
to	O
human	B-UNK
chromosome	I-UNK
2p13	B-UNK
by	O
homozygosity	B-UNK
mapping	B-UNK
in	O
two	O
distinct	B-UNK
isolated	B-UNK
populations	B-UNK
-	O
french	B-UNK
acadian	O
and	O
north	B-UNK
african	B-UNK
.	O

 	O
pair	O
-	O
wise	O
analyses	B-UNK
resulted	B-UNK
in	O
maximum	B-UNK
lod	I-UNK
(	O
logarithm	O
of	O
the	O
odds	O
ratio	B-UNK
)	O
scores	B-UNK
of	O
3	O
.	O

 	O
84	O
and	O
2	O
.	O

 	O
9	O
,	O
respectively	B-UNK
.	O

 	O
to	O
confirm	B-UNK
these	O
findings	B-UNK
,	O
a	O
large	B-UNK
linkage	B-UNK
study	I-UNK
was	O
performed	B-UNK
in	O
twelve	O
additional	B-UNK
families	B-UNK
segregating	B-UNK
for	O
alstrom	B-DISEASE
syndrome	I-DISEASE
.	O

 	O
a	O
maximum	B-UNK
two	O
-	O
point	B-UNK
lod	B-UNK
score	I-UNK
of	O
7	O
.	O

 	O
13	O
(	O
theta	B-UNK
=	I-UNK
0	O
.	O
00	O
)	O
for	O
marker	B-UNK
d2s2110	O
and	O
a	O
maximum	B-UNK
cumulative	O
multipoint	B-UNK
lod	B-UNK
score	I-UNK
of	O
9	O
.	O

 	O
16	O
for	O
marker	B-UNK
d2s2110	O
were	O
observed	B-UNK
,	O
further	O
supporting	B-UNK
linkage	B-UNK
to	O
chromosome	B-UNK
2p13	B-UNK
.	O

 	O
no	O
evidence	B-UNK
of	O
genetic	B-UNK
heterogeneity	B-UNK
was	O
observed	B-UNK
in	O
these	O
families	B-UNK
.	O

 	O
meiotic	B-UNK
recombination	B-UNK
events	I-UNK
have	O
localized	B-UNK
the	O
critical	B-UNK
region	I-UNK
containing	B-UNK
alms1	O
to	O
a	O
6	O
.	O

 	O
1	O
-	O
cm	B-DISEASE
interval	B-UNK
flanked	O
by	O
markers	B-UNK
d2s327	O
and	O
d2s286	O
.	O

 	O
a	O
fine	B-UNK
resolution	B-UNK
radiation	B-UNK
hybrid	O
map	B-UNK
of	O
31	O
genes	B-UNK
and	O
markers	B-UNK
has	O
been	O
constructed	B-UNK
.	O

 	O
pendred	B-DISEASE
syndrome	I-DISEASE
:	O
phenotypic	B-UNK
variability	I-UNK
in	O
two	O
families	B-UNK
carrying	B-UNK
the	O
same	O
pds	B-UNK
missense	B-UNK
mutation	I-UNK
.	O

 	O
pendred	B-DISEASE
syndrome	I-DISEASE
comprises	O
congenital	B-DISEASE
sensorineural	B-DISEASE
hearing	I-DISEASE
loss	I-DISEASE
,	O
thyroid	B-DISEASE
goiter	B-DISEASE
,	O
and	O
positive	B-UNK
perchlorate	B-UNK
discharge	O
test	B-UNK
.	O

 	O
recently	B-UNK
,	O
this	O
autosomal	O
recessive	O
disorder	O
was	O
shown	B-UNK
to	O
be	O
caused	B-UNK
by	O
mutations	B-UNK
in	O
the	O
pds	B-UNK
gene	B-UNK
,	O
which	O
encodes	B-UNK
an	O
anion	B-UNK
transporter	B-UNK
called	B-UNK
pendrin	B-UNK
.	O

 	B-UNK
molecular	I-UNK
analysis	B-UNK
of	O
the	O
pds	B-UNK
gene	B-UNK
was	O
performed	B-UNK
in	O
two	O
consanguineous	B-UNK
large	B-UNK
families	B-UNK
from	O
southern	O
tunisia	O
comprising	B-UNK
a	O
total	B-UNK
of	O
23	O
individuals	B-UNK
affected	B-UNK
with	O
profound	O
congenital	B-DISEASE
deafness	B-DISEASE
;	O
the	O
same	O
missense	B-UNK
mutation	I-UNK
,	O
l445w	O
,	O
was	O
identified	B-UNK
in	O
all	O
affected	B-UNK
individuals	I-UNK
.	O

 	O
a	O
widened	O
vestibular	B-UNK
aqueduct	I-UNK
was	O
found	B-UNK
in	O
all	O
patients	B-UNK
who	O
underwent	B-UNK
computed	B-UNK
tomography	B-UNK
(	O
ct	B-UNK
)	O
scan	O
exploration	O
of	O
the	O
inner	B-UNK
ear	B-UNK
.	O

 	O
in	O
contrast	B-UNK
,	O
goiter	B-DISEASE
was	O
present	B-UNK
in	O
only	O
11	O
affected	B-UNK
individuals	I-UNK
,	O
who	O
interestingly	B-UNK
had	O
a	O
normal	B-UNK
result	B-UNK
of	O
the	O
perchlorate	B-UNK
discharge	O
test	B-UNK
whenever	O
performed	B-UNK
.	O

 	O
the	O
present	B-UNK
results	B-UNK
question	O
the	O
sensitivity	B-UNK
of	O
the	O
perchlorate	B-UNK
test	B-UNK
for	O
the	O
diagnosis	B-UNK
of	O
pendred	B-DISEASE
syndrome	I-DISEASE
and	O
support	B-UNK
the	O
use	B-UNK
of	O
a	O
molecular	B-UNK
analysis	B-UNK
of	O
the	O
pds	B-UNK
gene	B-UNK
in	O
the	O
assessment	B-UNK
of	O
individuals	B-UNK
with	O
severe	B-UNK
to	O
profound	O
congenital	B-DISEASE
hearing	B-DISEASE
loss	I-DISEASE
associated	B-UNK
with	O
inner	B-UNK
ear	B-UNK
morphological	B-UNK
anomaly	B-UNK
even	O
in	O
the	O
absence	B-UNK
of	O
a	O
thyroid	B-DISEASE
goiter	B-DISEASE
.	O
.	O

 	O
knobloch	B-DISEASE
syndrome	I-DISEASE
involving	B-UNK
midline	B-UNK
scalp	I-UNK
defect	B-UNK
of	O
the	O
frontal	O
region	B-UNK
.	O

 	O
we	O
report	B-UNK
on	O
a	O
4	O
-	O
year	B-UNK
-	O
old	B-UNK
boy	B-UNK
with	O
knobloch	B-DISEASE
syndrome	I-DISEASE
.	O

 	O
he	O
has	O
vitreoretinal	O
degeneration	B-UNK
,	O
high	B-UNK
myopia	B-DISEASE
,	O
cataract	B-DISEASE
,	O
telecanthus	B-DISEASE
,	O
hypertelorism	B-DISEASE
,	O
and	O
a	O
high	B-UNK
-	O
arched	O
palate	O
.	O

 	O
he	O
also	O
has	O
a	O
defect	B-UNK
of	O
the	O
anterior	O
midline	B-UNK
scalp	I-UNK
with	O
involvement	B-UNK
of	O
the	O
frontal	O
bone	O
as	O
documented	B-UNK
by	O
a	O
computed	B-UNK
tomography	B-UNK
(	O
ct	B-UNK
)	O
scan	O
.	O

 	O
the	O
brain	B-UNK
was	O
normal	B-UNK
on	O
ct	B-UNK
scan	O
and	O
magnetic	B-UNK
resonance	I-UNK
imaging	O
.	O

 	O
we	O
present	B-UNK
a	O
review	O
of	O
the	O
23	O
published	B-UNK
cases	B-UNK
with	O
this	O
syndrome	B-DISEASE
.	O

 	O
our	O
patient	B-UNK
illustrates	B-UNK
the	O
importance	O
of	O
investigating	O
for	O
underlying	B-UNK
ocular	O
and	O
central	B-UNK
nervous	I-UNK
system	I-UNK
pathology	B-UNK
whenever	O
midline	B-UNK
scalp	I-UNK
defects	B-UNK
are	O
present	B-UNK
.	O
.	O

 	O
the	O
dna	B-UNK
double	B-UNK
-	O
strand	O
break	O
repair	B-UNK
gene	B-UNK
hmre11	B-UNK
is	O
mutated	B-UNK
in	O
individuals	B-UNK
with	O
an	O
ataxia	B-DISEASE
-	O
telangiectasia	B-DISEASE
-	O
like	B-UNK
disorder	O
.	O

 	O
we	O
show	O
that	O
hypomorphic	O
mutations	B-UNK
in	O
hmre11	B-UNK
,	O
but	O
not	O
in	O
atm	B-UNK
,	O
are	O
present	B-UNK
in	O
certain	B-UNK
individuals	B-UNK
with	O
an	O
ataxia	B-DISEASE
-	O
telangiectasia	B-DISEASE
-	O
like	B-UNK
disorder	O
(	O
atld	O
)	O
.	O

 	O
the	O
cellular	B-UNK
features	B-UNK
resulting	B-UNK
from	O
these	O
hmre11	B-UNK
mutations	B-UNK
are	O
similar	B-UNK
to	O
those	O
seen	B-UNK
in	O
a	O
-	O
t	B-UNK
as	O
well	O
as	O
nbs	B-UNK
and	O
include	B-UNK
hypersensitivity	B-DISEASE
to	O
ionizing	B-UNK
radiation	B-UNK
,	O
radioresistant	O
dna	B-UNK
synthesis	B-UNK
,	O
and	O
abrogation	O
of	O
atm	B-UNK
-	O
dependent	B-UNK
events	B-UNK
,	O
such	O
as	O
the	O
activation	B-UNK
of	O
jun	O
kinase	B-UNK
following	B-UNK
exposure	B-UNK
to	O
gamma	B-UNK
irradiation	O
.	O

 	O
although	O
the	O
mutant	B-UNK
hmre11	B-UNK
proteins	B-UNK
retain	O
some	O
ability	B-UNK
to	O
interact	B-UNK
with	O
hrad50	O
and	O
nbs1	B-UNK
,	O
formation	B-UNK
of	O
ionizing	B-UNK
radiation	B-UNK
-	O
induced	B-UNK
hmre11	B-UNK
and	O
nbs1	B-UNK
foci	B-UNK
was	O
absent	B-UNK
in	O
hmre11	B-UNK
mutant	B-UNK
cells	B-UNK
.	O

 	O
these	O
data	B-UNK
demonstrate	B-UNK
that	O
atm	B-UNK
and	O
the	O
hmre11	B-UNK
/	O
hrad50	O
/	O
nbs1	B-UNK
protein	B-UNK
complex	B-UNK
act	B-UNK
in	O
the	O
same	O
dna	B-UNK
damage	I-UNK
response	B-UNK
pathway	B-UNK
and	O
link	B-UNK
hmre11	B-UNK
to	O
the	O
complex	B-UNK
pathology	B-UNK
of	O
a	O
-	O
t	B-UNK
.	O
.	O

 	O
mutations	B-UNK
in	O
tnfrsf11a	O
,	O
affecting	B-UNK
the	O
signal	B-UNK
peptide	I-UNK
of	O
rank	B-UNK
,	O
cause	B-UNK
familial	B-UNK
expansile	O
osteolysis	B-DISEASE
.	O

 	B-UNK
familial	I-UNK
expansile	O
osteolysis	B-DISEASE
(	O
feo	O
,	O
mim	O
174810	O
)	O
is	O
a	O
rare	B-UNK
,	O
autosomal	O
dominant	B-UNK
bone	O
disorder	O
characterized	B-UNK
by	O
focal	O
areas	B-UNK
of	O
increased	B-UNK
bone	O
remodelling	O
.	O

 	O
the	O
osteolytic	O
lesions	B-UNK
,	O
which	O
develop	B-UNK
usually	B-UNK
in	O
the	O
long	B-UNK
bones	O
during	O
early	B-UNK
adulthood	O
,	O
show	O
increased	B-UNK
osteoblast	O
and	O
osteoclast	O
activity	B-UNK
.	O

 	O
our	O
previous	B-UNK
linkage	I-UNK
studies	B-UNK
mapped	B-UNK
the	O
gene	B-UNK
responsible	B-UNK
for	O
feo	O
to	O
an	O
interval	B-UNK
of	O
less	O
than	O
5	O
cm	B-DISEASE
between	O
d18s64	O
and	O
d18s51	O
on	O
chromosome	B-UNK
18q21	O
.	O

 	O
2	O
-	O
21	O
2	O
-	O
21	O
.	O

 	O
3	O
in	O
a	O
large	B-UNK
northern	B-UNK
irish	B-UNK
family	B-UNK
.	O

 	O
the	O
gene	B-UNK
encoding	B-UNK
receptor	B-UNK
activator	B-UNK
of	O
nuclear	B-UNK
factor	B-UNK
-	O
kappa	O
b	B-UNK
(	O
rank	B-UNK
;	O
ref	O
.	O
5	O
)	O
,	O
tnfrsf11a	O
,	O
maps	B-UNK
to	O
this	O
region	B-UNK
.	O

 	O
rank	B-UNK
is	O
essential	B-UNK
in	O
osteoclast	O
formation	B-UNK
.	O

 	O
we	O
identified	B-UNK
two	O
heterozygous	B-UNK
insertion	B-UNK
mutations	B-UNK
in	O
exon	B-UNK
1	O
of	O
tnfrsf11a	O
in	O
affected	B-UNK
members	B-UNK
of	O
four	O
families	B-UNK
with	O
feo	O
or	O
familial	B-UNK
paget	B-DISEASE
disease	I-DISEASE
of	O
bone	O
(	O
pdb	O
)	O
.	O

 	O
one	O
was	O
a	O
duplication	B-UNK
of	O
18	O
bases	B-UNK
and	O
the	O
other	O
a	O
duplication	B-UNK
of	O
27	O
bases	B-UNK
,	O
both	O
of	O
which	O
affected	B-UNK
the	O
signal	B-UNK
peptide	I-UNK
region	B-UNK
of	O
the	O
rank	B-UNK
molecule	B-UNK
.	O

 	O
expression	B-UNK
of	O
recombinant	B-UNK
forms	B-UNK
of	O
the	O
mutant	B-UNK
rank	B-UNK
proteins	B-UNK
revealed	B-UNK
perturbations	O
in	O
expression	B-UNK
levels	B-UNK
and	O
lack	B-UNK
of	O
normal	B-UNK
cleavage	B-UNK
of	O
the	O
signal	B-UNK
peptide	I-UNK
.	O

 	O
both	O
mutations	B-UNK
caused	B-UNK
an	O
increase	B-UNK
in	O
rank	B-UNK
-	O
mediated	B-UNK
nuclear	B-UNK
factor	B-UNK
-	O
kappab	O
(	O
nf	O
-	O
kappab	O
)	O
signalling	B-UNK
in	O
vitro	B-UNK
,	O
consistent	B-UNK
with	O
the	O
presence	B-UNK
of	O
an	O
activating	B-UNK
mutation	B-UNK
.	O

 	O
cardiac	B-UNK
na	B-UNK
(	O
+	O
)	O
channel	B-UNK
dysfunction	B-UNK
in	O
brugada	B-DISEASE
syndrome	I-DISEASE
is	O
aggravated	O
by	O
beta	B-UNK
(	O
1	O
)	O
-	O
subunit	B-UNK
.	O

 	B-UNK
background	I-UNK
mutations	B-UNK
in	O
the	O
gene	B-UNK
encoding	B-UNK
the	O
human	B-UNK
cardiac	B-UNK
na	B-UNK
(	O
+	O
)	O
channel	B-UNK
alpha	B-UNK
-	O
subunit	B-UNK
(	O
hh1	B-UNK
)	O
are	O
responsible	B-UNK
for	O
chromosome	B-DISEASE
3	I-DISEASE
-	O
linked	B-UNK
congenital	B-DISEASE
long	B-UNK
-	O
qt	O
syndrome	B-DISEASE
(	O
lqt3	O
)	O
and	O
idiopathic	B-DISEASE
ventricular	I-DISEASE
fibrillation	I-DISEASE
(	O
ivf	O
)	O
.	O

 	O
an	O
auxiliary	O
beta	B-UNK
(	O
1	O
)	O
-	O
subunit	B-UNK
,	O
widely	B-UNK
expressed	B-UNK
in	O
excitable	O
tissues	B-UNK
,	O
shifts	O
the	O
voltage	O
dependence	B-DISEASE
of	O
steady	O
-	O
state	B-UNK
inactivation	B-UNK
toward	O
more	O
negative	B-UNK
potentials	B-UNK
and	O
restores	O
normal	B-UNK
gating	O
kinetics	O
of	O
brain	B-UNK
and	O
skeletal	B-UNK
muscle	I-UNK
na	B-UNK
(	O
+	O
)	O
channels	O
expressed	B-UNK
in	O
xenopus	B-UNK
oocytes	B-UNK
but	O
has	O
little	B-UNK
if	O
any	O
functional	B-UNK
effect	B-UNK
on	O
the	O
cardiac	B-UNK
isoform	B-UNK
.	O

 	O
here	O
,	O
we	O
characterize	O
the	O
altered	B-UNK
effects	B-UNK
of	O
a	O
human	B-UNK
beta	B-UNK
(	O
1	O
)	O
-	O
subunit	B-UNK
(	O
hbeta	O
(	O
1	O
)	O
)	O
on	O
the	O
heterologously	O
expressed	B-UNK
hh1	B-UNK
mutation	B-UNK
(	O
t1620	B-UNK
m	B-UNK
)	O
previously	B-UNK
associated	B-UNK
with	O
ivf	O
.	O

 	O
methods	B-UNK
and	O
results	B-UNK
when	O
expressed	B-UNK
alone	O
in	O
xenopus	B-UNK
oocytes	B-UNK
,	O
t1620	B-UNK
m	B-UNK
exhibited	B-UNK
no	O
persistent	O
currents	O
,	O
in	O
contrast	B-UNK
to	O
the	O
lqt3	O
mutant	B-UNK
channels	O
,	O
but	O
the	O
midpoint	O
of	O
steady	O
-	O
state	B-UNK
inactivation	B-UNK
(	O
v	O
(	O
1	O
/	O
2	O
)	O
)	O
was	O
significantly	B-UNK
shifted	O
toward	O
more	O
positive	B-UNK
potentials	B-UNK
than	O
for	O
wild	B-UNK
-	O
type	B-UNK
hh1	B-UNK
.	O

 	O
coexpression	O
of	O
hbeta	O
(	O
1	O
)	O
did	O
not	O
significantly	B-UNK
alter	B-UNK
current	B-UNK
decay	O
or	O
recovery	O
from	O
inactivation	B-UNK
of	O
wild	B-UNK
-	O
type	B-UNK
hh1	B-UNK
;	O
however	O
,	O
it	O
further	O
shifted	O
the	O
v	O
(	O
1	O
/	O
2	O
)	O
and	O
accelerated	B-UNK
the	O
recovery	O
from	O
inactivation	B-UNK
of	O
t1620	B-UNK
m	B-UNK
.	O

 	O
oocyte	O
macropatch	O
analysis	B-UNK
revealed	B-UNK
that	O
the	O
activation	B-UNK
kinetics	O
of	O
t1620	B-UNK
m	B-UNK
were	O
normal	B-UNK
.	O

 	O
conclusions	B-UNK
it	O
is	O
suggested	B-UNK
that	O
coexpression	O
of	O
hbeta	O
(	O
1	O
)	O
exposes	O
a	O
more	O
severe	B-UNK
functional	B-UNK
defect	B-UNK
that	O
results	B-UNK
in	O
a	O
greater	B-UNK
overlap	O
in	O
the	O
relationship	B-UNK
between	O
channel	B-UNK
inactivation	B-UNK
and	O
activation	B-UNK
(	O
window	O
current	B-UNK
)	O
in	O
t1620	B-UNK
m	B-UNK
,	O
which	O
is	O
proposed	B-UNK
to	O
be	O
a	O
potential	B-UNK
pathophysiological	O
mechanism	B-UNK
of	O
ivf	O
in	O
vivo	B-UNK
.	O

 	O
one	O
possible	B-UNK
explanation	B-UNK
for	O
our	O
finding	B-UNK
is	O
an	O
altered	B-UNK
alpha	B-UNK
-	O
/	O
beta	B-UNK
(	O
1	O
)	O
-	O
subunit	B-UNK
association	B-UNK
in	O
the	O
mutant	B-UNK
.	O
.	O

 	O
meiotic	B-UNK
segregation	I-UNK
analysis	B-UNK
of	O
rb1	B-UNK
alleles	B-UNK
in	O
retinoblastoma	B-DISEASE
pedigrees	B-UNK
by	O
use	B-UNK
of	O
single	B-UNK
-	O
sperm	B-UNK
typing	I-UNK
.	O

 	O
in	O
hereditary	B-UNK
retinoblastoma	B-DISEASE
,	O
different	B-UNK
epidemiological	O
studies	B-UNK
have	O
indicated	B-UNK
a	O
preferential	B-UNK
paternal	B-UNK
transmission	B-UNK
of	O
mutant	B-UNK
retinoblastoma	B-DISEASE
alleles	B-UNK
to	O
offspring	B-UNK
,	O
suggesting	B-UNK
the	O
occurrence	B-UNK
of	O
a	O
meiotic	B-UNK
drive	B-UNK
.	O

 	O
to	O
investigate	O
this	O
mechanism	B-UNK
,	O
we	O
analyzed	B-UNK
sperm	B-UNK
samples	B-UNK
from	O
six	O
individuals	B-UNK
from	O
five	O
unrelated	B-UNK
families	I-UNK
affected	B-UNK
with	O
hereditary	B-UNK
retinoblastoma	B-DISEASE
.	O

 	O
single	B-UNK
-	O
sperm	B-UNK
typing	I-UNK
techniques	B-UNK
were	O
performed	B-UNK
for	O
each	O
sample	B-UNK
by	O
study	B-UNK
of	O
two	O
informative	B-UNK
short	B-UNK
tandem	I-UNK
repeats	B-UNK
located	B-UNK
either	O
in	O
or	O
close	B-UNK
to	O
the	O
retinoblastoma	B-DISEASE
gene	B-UNK
(	O
rb1	B-UNK
)	O
.	O

 	O
the	O
segregation	B-UNK
probability	O
of	O
mutant	B-UNK
rb1	I-UNK
alleles	B-UNK
in	O
sperm	B-UNK
samples	B-UNK
was	O
assessed	B-UNK
by	O
use	B-UNK
of	O
the	O
spermseg	O
program	B-UNK
,	O
which	O
includes	B-UNK
experimental	B-UNK
parameters	B-UNK
,	O
recombination	B-UNK
fractions	O
between	O
the	O
markers	B-UNK
,	O
and	O
segregation	B-UNK
parameters	B-UNK
.	O

 	O
a	O
total	B-UNK
of	O
2	O
,	O
952	O
single	B-UNK
sperm	B-UNK
from	O
the	O
six	O
donors	O
were	O
analyzed	B-UNK
.	O

 	O
we	O
detected	B-UNK
a	O
significant	B-UNK
segregation	B-UNK
distortion	I-UNK
in	O
the	O
data	B-UNK
as	O
a	O
whole	O
(	O
p	B-UNK
=	O
.	O
0099	O
)	O
and	O
a	O
significant	B-UNK
heterogeneity	B-UNK
in	O
the	O
segregation	B-UNK
rate	B-UNK
across	O
donors	O
(	O
.	O
0092	O
)	O
.	O

 	O
further	O
analysis	B-UNK
shows	B-UNK
that	O
this	O
result	B-UNK
can	O
be	O
explained	O
by	O
segregation	B-UNK
distortion	I-UNK
in	O
favor	O
of	O
the	O
normal	B-UNK
allele	B-UNK
in	O
one	O
donor	O
only	O
and	O
that	O
it	O
does	O
not	O
provide	B-UNK
evidence	I-UNK
of	O
a	O
significant	B-UNK
segregation	B-UNK
distortion	I-UNK
in	O
the	O
other	O
donors	O
.	O

 	O
the	O
segregation	B-UNK
distortion	I-UNK
favoring	O
the	O
mutant	B-UNK
rb1	I-UNK
allele	B-UNK
does	O
not	O
seem	O
to	O
occur	B-UNK
during	O
spermatogenesis	O
,	O
and	O
,	O
thus	O
,	O
meiotic	B-UNK
drive	B-UNK
may	O
result	B-UNK
either	O
from	O
various	O
mechanisms	B-UNK
,	O
including	B-UNK
a	O
fertilization	O
advantage	B-UNK
or	O
a	O
better	B-UNK
mobility	B-UNK
in	O
sperm	B-UNK
bearing	B-UNK
a	O
mutant	B-UNK
rb1	I-UNK
gene	B-UNK
,	O
or	O
from	O
the	O
existence	O
of	O
a	O
defectively	O
imprinted	B-UNK
gene	B-UNK
located	B-UNK
on	O
the	O
human	B-UNK
x	B-DISEASE
chromosome	I-DISEASE
.	O

 	O
friedreich	B-DISEASE
ataxia	I-DISEASE
:	O
an	O
overview	O
.	O

 	O
friedreich	B-DISEASE
ataxia	I-DISEASE
,	O
an	O
autosomal	O
recessive	O
neurodegenerative	B-DISEASE
disease	I-DISEASE
,	O
is	O
the	O
most	O
common	B-UNK
of	O
the	O
inherited	B-UNK
ataxias	O
.	O

 	O
the	O
recent	B-UNK
discovery	B-UNK
of	O
the	O
gene	B-UNK
that	O
is	O
mutated	B-UNK
in	O
this	O
condition	B-UNK
,	O
frda	B-UNK
,	O
has	O
led	B-UNK
to	O
rapid	B-UNK
advances	O
in	O
the	O
understanding	B-UNK
of	O
the	O
pathogenesis	O
of	O
friedreich	B-DISEASE
ataxia	I-DISEASE
.	O

 	O
about	O
98	O
%	O
of	O
mutant	B-UNK
alleles	I-UNK
have	O
an	O
expansion	B-UNK
of	O
a	O
gaa	B-UNK
trinucleotide	I-UNK
repeat	B-UNK
in	O
intron	B-UNK
1	O
of	O
the	O
gene	B-UNK
.	O

 	O
this	O
leads	B-UNK
to	O
reduced	B-UNK
levels	B-UNK
of	O
the	O
protein	B-UNK
,	O
frataxin	B-UNK
.	O

 	O
there	O
is	O
mounting	O
evidence	B-UNK
to	O
suggest	B-UNK
that	O
friedreich	B-DISEASE
ataxia	I-DISEASE
is	O
the	O
result	B-UNK
of	O
accumulation	B-UNK
of	O
iron	B-UNK
in	O
mitochondria	O
leading	B-UNK
to	O
excess	B-UNK
production	B-UNK
of	O
free	B-UNK
radicals	O
,	O
which	O
then	O
results	B-UNK
in	O
cellular	B-UNK
damage	B-UNK
and	O
death	B-DISEASE
.	O

 	O
currently	B-UNK
there	O
is	O
no	O
known	B-UNK
treatment	B-UNK
that	O
alters	O
the	O
natural	B-UNK
course	B-UNK
of	O
the	O
disease	B-DISEASE
.	O

 	O
the	O
discovery	B-UNK
of	O
the	O
frda	B-UNK
gene	B-UNK
and	O
its	O
possible	B-UNK
function	B-UNK
has	O
raised	B-UNK
hope	O
that	O
rational	B-UNK
therapeutic	B-UNK
strategies	B-UNK
will	O
be	O
developed	B-UNK
.	O
.	O

 	O
x	B-UNK
-	O
linked	B-UNK
retinoschisis	B-DISEASE
with	O
point	B-UNK
mutations	I-UNK
in	O
the	O
xlrs1	B-UNK
gene	B-UNK
.	O

 	B-UNK
background	I-UNK
x	B-UNK
-	O
linked	B-UNK
retinoschisis	B-DISEASE
(	O
xlrs	O
)	O
is	O
a	O
relatively	B-UNK
rare	B-UNK
vitreoretinal	O
dystrophy	B-UNK
that	O
causes	B-UNK
visual	B-DISEASE
loss	I-DISEASE
in	O
young	B-UNK
men	B-UNK
.	O

 	O
recently	B-UNK
,	O
a	O
gene	B-UNK
responsible	B-UNK
for	O
this	O
disease	B-DISEASE
,	O
designated	B-UNK
xlrs1	B-UNK
,	O
was	O
identified	B-UNK
,	O
and	O
several	O
deleterious	O
gene	B-UNK
mutations	B-UNK
were	O
reported	B-UNK
.	O

 	O
objective	B-UNK
to	O
analyze	O
japanese	B-UNK
patients	I-UNK
clinically	B-UNK
diagnosed	B-UNK
as	O
having	B-UNK
xlrs	O
formutational	O
changes	B-UNK
in	O
the	O
xlrs1	B-UNK
gene	B-UNK
.	O

 	O
methods	B-UNK
ten	B-DISEASE
patients	B-UNK
with	O
xlrs	O
underwent	B-UNK
full	O
ophthalmologic	O
examination	B-UNK
,	O
including	B-UNK
slitlamp	O
biomicroscopy	O
and	O
dilated	O
funduscopy	O
.	O

 	B-UNK
genomic	I-UNK
dna	B-UNK
was	O
isolated	B-UNK
from	O
leukocytes	B-UNK
,	O
and	O
all	O
exons	B-UNK
of	O
the	O
xlrs1	B-UNK
gene	B-UNK
were	O
amplified	B-UNK
by	O
polymerase	B-UNK
chain	I-UNK
reaction	I-UNK
and	O
analyzed	B-UNK
using	O
a	O
direct	B-UNK
sequencing	I-UNK
method	B-UNK
.	O

 	B-UNK
results	I-UNK
point	B-UNK
mutations	I-UNK
in	O
the	O
xlrs1	B-UNK
gene	B-UNK
were	O
identified	B-UNK
in	O
all	O
10	O
patients	B-UNK
.	O

 	O
the	O
mutations	B-UNK
were	O
identical	B-UNK
in	O
each	O
of	O
2	O
pairs	B-UNK
of	O
brothers	B-UNK
.	O

 	O
six	O
of	O
the	O
point	B-UNK
mutations	I-UNK
represented	B-UNK
missense	B-UNK
mutations	I-UNK
,	O
1	O
was	O
a	O
nonsense	B-UNK
mutation	B-UNK
,	O
and	O
1	O
was	O
a	O
frameshift	B-UNK
mutation	B-UNK
.	O

 	O
five	O
of	O
the	O
mutations	B-UNK
are	O
newly	B-UNK
reported	B-UNK
herein	O
.	O

 	O
conclusions	B-UNK
the	O
discovery	B-UNK
of	O
new	B-UNK
point	B-UNK
mutations	I-UNK
in	O
this	O
study	B-UNK
increases	B-UNK
the	O
available	B-UNK
information	B-UNK
regarding	O
the	O
spectrum	B-UNK
of	O
genetic	B-UNK
abnormalities	B-DISEASE
and	O
clinical	B-UNK
manifestations	B-UNK
of	O
xlrs	O
.	O

 	O
however	O
,	O
the	O
limited	B-UNK
data	B-UNK
failed	B-UNK
to	O
reveal	B-UNK
a	O
correlation	B-UNK
between	O
mutation	B-UNK
and	O
disease	B-DISEASE
phenotype	B-UNK
.	O

 	B-UNK
clinical	I-UNK
relevance	B-UNK
identification	B-UNK
of	O
mutations	B-UNK
in	O
the	O
xlrs1	B-UNK
gene	B-UNK
and	O
expanded	B-UNK
information	B-UNK
on	O
clinical	B-UNK
manifestations	B-UNK
will	O
facilitate	B-UNK
early	B-UNK
diagnosis	B-UNK
,	O
appropriate	B-UNK
early	B-UNK
therapy	B-UNK
,	O
and	O
genetic	B-UNK
counseling	B-UNK
regarding	O
the	O
prognosis	O
of	O
xlrs	O
.	O
.	O

 	B-UNK
atm	I-UNK
and	O
bax	B-UNK
cooperate	O
in	O
ionizing	B-UNK
radiation	B-UNK
-	O
induced	B-UNK
apoptosis	B-UNK
in	O
the	O
central	B-UNK
nervous	I-UNK
system	I-UNK
.	O

 	O
ataxia	B-DISEASE
-	O
telangiectasia	B-DISEASE
is	O
a	O
hereditary	B-UNK
multisystemic	O
disease	B-DISEASE
resulting	B-UNK
from	O
mutations	B-UNK
of	O
ataxia	B-DISEASE
telangiectasia	I-DISEASE
,	O
mutated	B-UNK
(	O
atm	B-UNK
)	O
and	O
is	O
characterized	B-UNK
by	O
neurodegeneration	O
,	O
cancer	B-DISEASE
,	O
immune	B-UNK
defects	B-UNK
,	O
and	O
hypersensitivity	B-DISEASE
to	O
ionizing	B-UNK
radiation	B-UNK
.	O

 	O
the	O
molecular	B-UNK
details	O
of	O
atm	B-UNK
function	B-UNK
in	O
the	O
nervous	B-UNK
system	I-UNK
are	O
unclear	O
,	O
although	O
the	O
neurological	B-UNK
lesion	B-UNK
in	O
ataxia	B-DISEASE
-	O
telangiectasia	B-DISEASE
becomes	O
apparent	B-UNK
early	B-UNK
in	O
life	B-UNK
,	O
suggesting	B-UNK
a	O
developmental	B-UNK
origin	B-UNK
.	O

 	O
the	O
central	B-UNK
nervous	I-UNK
system	I-UNK
(	O
cns	B-UNK
)	O
of	O
atm	B-UNK
-	O
null	B-UNK
mice	B-UNK
shows	B-UNK
a	O
pronounced	O
defect	B-UNK
in	O
apoptosis	B-UNK
induced	B-UNK
by	O
genotoxic	O
stress	B-UNK
,	O
suggesting	B-UNK
atm	B-UNK
functions	B-UNK
to	O
eliminate	O
neurons	B-UNK
with	O
excessive	B-UNK
genomic	B-UNK
damage	B-UNK
.	O

 	O
here	O
,	O
we	O
report	B-UNK
that	O
the	O
death	B-DISEASE
effector	O
bax	B-UNK
is	O
required	B-UNK
for	O
a	O
large	B-UNK
proportion	B-UNK
of	O
atm	B-UNK
-	O
dependent	B-UNK
apoptosis	B-UNK
in	O
the	O
developing	B-UNK
cns	B-UNK
after	O
ionizing	B-UNK
radiation	B-UNK
(	O
ir	O
)	O
.	O

 	O
although	O
many	O
of	O
the	O
same	O
regions	B-UNK
of	O
the	O
cns	B-UNK
in	O
both	O
bax	B-UNK
-	O
/	O
-	O
and	O
atm	B-UNK
-	O
/	O
-	O
mice	B-UNK
were	O
radioresistant	O
,	O
mice	B-UNK
nullizygous	O
for	O
both	O
bax	B-UNK
and	O
atm	B-UNK
showed	B-UNK
additional	B-UNK
reduction	B-UNK
in	O
ir	O
-	O
induced	B-UNK
apoptosis	B-UNK
in	O
the	O
cns	B-UNK
.	O

 	O
therefore	O
,	O
although	O
the	O
major	B-UNK
ir	O
-	O
induced	B-UNK
apoptotic	B-UNK
pathway	B-UNK
in	O
the	O
cns	B-UNK
requires	B-UNK
atm	B-UNK
and	O
bax	B-UNK
,	O
a	O
p53	O
-	O
dependent	B-UNK
collateral	O
pathway	B-UNK
exists	B-UNK
that	O
has	O
both	O
atm	B-UNK
-	O
and	O
bax	B-UNK
-	O
independent	B-UNK
branches	B-UNK
.	O

 	O
further	O
,	O
atm	B-UNK
-	O
and	O
bax	B-UNK
-	O
dependent	B-UNK
apoptosis	B-UNK
in	O
the	O
cns	B-UNK
also	O
required	B-UNK
caspase	O
-	O
3	O
activation	B-UNK
.	O

 	O
these	O
data	B-UNK
implicate	B-UNK
bax	B-UNK
and	O
caspase	O
-	O
3	O
as	O
death	B-DISEASE
effectors	O
in	O
neurodegenerative	O
pathways	B-UNK
.	O
.	O

 	O
haim	O
-	O
munk	O
syndrome	B-DISEASE
and	O
papillon	O
-	O
lefevre	O
syndrome	B-DISEASE
are	O
allelic	B-UNK
mutations	B-UNK
in	O
cathepsin	B-UNK
c	I-UNK
.	O

 	O
of	O
the	O
many	O
palmoplantar	B-DISEASE
keratoderma	I-DISEASE
(	O
ppk	O
)	O
conditions	B-UNK
,	O
only	O
papillon	O
-	O
lefevre	O
syndrome	B-DISEASE
(	O
pls	B-DISEASE
)	O
and	O
haim	O
-	O
munk	O
syndrome	B-DISEASE
(	O
hms	B-UNK
)	O
are	O
associated	B-UNK
with	O
premature	B-UNK
periodontal	O
destruction	O
.	O

 	O
although	O
both	O
pls	B-DISEASE
and	O
hms	B-UNK
share	B-UNK
the	O
cardinal	B-UNK
features	B-UNK
of	O
ppk	O
and	O
severe	B-UNK
periodontitis	B-DISEASE
,	O
a	O
number	B-UNK
of	O
additional	B-UNK
findings	B-UNK
are	O
reported	B-UNK
in	O
hms	B-UNK
including	B-UNK
arachnodactyly	B-DISEASE
,	O
acro	B-DISEASE
-	I-DISEASE
osteolysis	I-DISEASE
,	O
atrophic	O
changes	B-UNK
of	O
the	O
nails	B-DISEASE
,	O
and	O
a	O
radiographic	O
deformity	B-UNK
of	O
the	O
fingers	O
.	O

 	O
while	O
pls	B-DISEASE
cases	B-UNK
have	O
been	O
identified	B-UNK
throughout	O
the	O
world	O
,	O
hms	B-UNK
has	O
only	O
been	O
described	B-UNK
among	O
descendants	O
of	O
a	O
religious	O
isolate	B-UNK
originally	B-UNK
from	O
cochin	O
,	O
india	O
.	O

 	O
parental	B-UNK
consanguinity	O
is	O
a	O
characteristic	B-UNK
of	O
many	O
cases	B-UNK
of	O
both	O
conditions	B-UNK
.	O

 	O
although	O
autosomal	O
recessive	O
transmission	B-UNK
of	O
pls	B-DISEASE
is	O
evident	O
,	O
a	O
more	O
"	O
complex	B-UNK
"	O
autosomal	O
recessive	O
pattern	B-UNK
of	O
inheritance	B-UNK
with	O
phenotypic	B-UNK
influences	B-UNK
from	O
a	O
closely	B-UNK
linked	I-UNK
modifying	O
locus	B-UNK
has	O
been	O
hypothesised	O
for	O
hms	B-UNK
.	O

 	O
recently	B-UNK
,	O
mutations	B-UNK
of	O
the	O
cathepsin	B-UNK
c	I-UNK
gene	B-UNK
have	O
been	O
identified	B-UNK
as	O
the	O
underlying	B-UNK
genetic	B-UNK
defect	B-UNK
in	O
pls	B-DISEASE
.	O

 	O
to	O
determine	O
if	O
a	O
cathepsin	B-UNK
c	I-UNK
mutation	B-UNK
is	O
also	O
responsible	B-UNK
for	O
hms	B-UNK
,	O
we	O
sequenced	B-UNK
the	O
gene	B-UNK
in	O
affected	B-UNK
and	O
unaffected	B-UNK
subjects	B-UNK
from	O
the	O
cochin	O
isolate	B-UNK
in	O
which	O
both	O
the	O
pls	B-DISEASE
and	O
hms	B-UNK
phenotypes	B-UNK
appear	B-UNK
.	O

 	O
here	O
we	O
report	B-UNK
identification	B-UNK
of	O
a	O
mutation	B-UNK
of	O
cathepsin	B-UNK
c	I-UNK
(	O
exon	B-UNK
6	O
,	O
2127a	O
-	O
-	O
>	O
g	B-UNK
)	O
that	O
changes	B-UNK
a	O
highly	B-UNK
conserved	I-UNK
amino	B-UNK
acid	I-UNK
in	O
the	O
cathepsin	B-UNK
c	I-UNK
peptide	B-UNK
.	O

 	O
this	O
mutation	B-UNK
segregates	B-UNK
with	O
hms	B-UNK
in	O
four	O
nuclear	B-UNK
families	B-UNK
.	O

 	O
additionally	B-UNK
,	O
the	O
existence	O
of	O
a	O
shared	B-UNK
common	B-UNK
haplotype	B-UNK
for	O
genetic	B-UNK
loci	B-UNK
flanking	B-UNK
the	O
cathepsin	B-UNK
c	I-UNK
gene	B-UNK
suggests	B-UNK
that	O
affected	B-UNK
subjects	B-UNK
descended	O
from	O
the	O
cochin	O
isolate	B-UNK
are	O
homozygous	B-UNK
for	O
a	O
mutation	B-UNK
inherited	B-UNK
"	O
identical	B-UNK
by	O
descent	B-UNK
"	O
from	O
a	O
common	B-UNK
ancestor	B-UNK
.	O

 	O
this	O
finding	B-UNK
supports	B-UNK
simple	B-UNK
autosomal	O
recessive	O
inheritance	B-UNK
for	O
hms	B-UNK
in	O
these	O
families	B-UNK
.	O

 	O
we	O
also	O
report	B-UNK
a	O
mutation	B-UNK
of	O
the	O
same	O
exon	B-UNK
6	O
ctsc	B-UNK
codon	B-UNK
(	O
2126c	O
-	O
-	O
>	O
t	B-UNK
)	O
in	O
a	O
turkish	B-UNK
family	B-UNK
with	O
classical	B-UNK
pls	B-DISEASE
.	O

 	O
these	O
findings	B-UNK
provide	I-UNK
evidence	B-UNK
that	O
pls	B-DISEASE
and	O
hms	B-UNK
are	O
allelic	B-UNK
variants	B-UNK
of	O
cathepsin	B-UNK
c	I-UNK
gene	B-UNK
mutations	B-UNK
.	O
.	O

 	B-UNK
atm	I-UNK
-	O
heterozygous	B-UNK
germline	B-UNK
mutations	I-UNK
contribute	B-UNK
to	O
breast	B-DISEASE
cancer	I-DISEASE
-	O
susceptibility	B-UNK
.	O

 	O
approximately	B-UNK
0	O
.	O

 	O
5	O
%	O
-	O
1	O
%	O
of	O
the	O
general	B-UNK
population	B-UNK
has	O
been	O
estimated	B-UNK
to	O
be	O
heterozygous	B-UNK
for	O
a	O
germline	B-UNK
mutation	B-UNK
in	O
the	O
atm	B-UNK
gene	B-UNK
.	O

 	O
mutations	B-UNK
in	O
the	O
atm	B-UNK
gene	B-UNK
are	O
responsible	B-UNK
for	O
the	O
autosomal	O
recessive	O
disorder	O
ataxia	B-DISEASE
-	O
telangiectasia	B-DISEASE
(	O
a	O
-	O
t	B-UNK
)	O
(	O
mim	O
208900	O
)	O
.	O

 	O
the	O
finding	B-UNK
that	O
atm	B-UNK
-	O
heterozygotes	B-UNK
have	O
an	O
increased	B-UNK
relative	B-UNK
risk	B-UNK
for	O
breast	B-DISEASE
cancer	I-DISEASE
was	O
supported	B-UNK
by	O
some	O
studies	B-UNK
but	O
not	O
confirmed	B-UNK
by	O
others	O
.	O

 	O
in	O
view	O
of	O
this	O
discrepancy	O
,	O
we	O
examined	B-UNK
the	O
frequency	B-UNK
of	O
atm	B-UNK
germline	B-UNK
mutations	I-UNK
in	O
a	O
selected	B-UNK
group	B-UNK
of	O
dutch	B-UNK
patients	B-UNK
with	O
breast	B-DISEASE
cancer	I-DISEASE
.	O

 	O
we	O
have	O
analyzed	B-UNK
atm	B-UNK
germline	B-UNK
mutations	I-UNK
in	O
normal	B-UNK
blood	B-UNK
lymphocytes	B-UNK
,	O
using	O
the	O
protein	B-UNK
-	O
truncation	B-UNK
test	I-UNK
followed	B-UNK
by	O
genomic	B-UNK
-	O
sequence	B-UNK
analysis	B-UNK
.	O

 	O
a	O
high	B-UNK
percentage	B-UNK
of	O
atm	B-UNK
germline	B-UNK
mutations	I-UNK
was	O
demonstrated	B-UNK
among	O
patients	B-UNK
with	O
sporadic	B-UNK
breast	B-DISEASE
cancer	I-DISEASE
.	O

 	O
the	O
82	O
patients	B-UNK
included	B-UNK
in	O
this	O
study	B-UNK
had	O
developed	B-UNK
breast	B-DISEASE
cancer	I-DISEASE
at	B-DISEASE
age	B-UNK
<	O
45	O
and	O
had	O
survived	O
>	O
/	O
=	O
5	O
years	B-UNK
(	O
mean	B-UNK
15	O
years	B-UNK
)	O
,	O
and	O
in	O
33	O
(	O
40	O
%	O
)	O
of	O
the	O
patients	B-UNK
a	O
contralateral	O
breast	B-UNK
tumor	B-DISEASE
had	O
been	O
diagnosed	B-UNK
.	O

 	O
among	O
these	O
patients	B-UNK
we	O
identified	B-UNK
seven	B-UNK
(	O
8	O
.	O
5	O
%	O
)	O
atm	B-UNK
germline	B-UNK
mutations	I-UNK
,	O
of	O
which	O
five	O
are	O
distinct	B-UNK
.	O

 	O
one	O
splice	O
-	O
site	B-UNK
mutation	B-UNK
(	O
ivs10	O
-	O
6	O
t	B-UNK
-	O
-	O
>	O
g	B-UNK
)	O
was	O
detected	B-UNK
three	O
times	B-UNK
in	O
our	O
series	B-UNK
.	O

 	O
four	O
heterozygous	B-UNK
carriers	B-UNK
were	O
patients	B-UNK
with	O
bilateral	B-UNK
breast	B-DISEASE
cancer	I-DISEASE
.	O

 	O
our	O
results	B-UNK
indicate	B-UNK
that	O
the	O
mutations	B-UNK
identified	B-UNK
in	O
this	O
study	B-UNK
are	O
"	O
a	O
-	O
t	B-UNK
disease	B-DISEASE
-	O
causing	B-UNK
"	O
mutations	B-UNK
that	O
might	O
be	O
associated	B-UNK
with	O
an	O
increased	B-UNK
risk	B-UNK
of	O
breast	B-DISEASE
cancer	I-DISEASE
in	O
heterozygotes	B-UNK
.	O

 	O
we	O
conclude	O
that	O
atm	B-UNK
heterozygotes	B-UNK
have	O
an	O
approximately	B-UNK
ninefold	O
-	O
increased	B-UNK
risk	B-UNK
of	O
developing	B-UNK
a	O
type	B-UNK
of	O
breast	B-DISEASE
cancer	I-DISEASE
characterized	B-UNK
by	O
frequent	B-UNK
bilateral	B-UNK
occurrence	B-UNK
,	O
early	B-UNK
age	B-UNK
at	B-DISEASE
onset	B-UNK
,	O
and	O
long	B-UNK
-	O
term	B-UNK
survival	B-UNK
.	O

 	O
the	O
specific	B-UNK
characteristics	B-UNK
of	O
our	O
population	B-UNK
of	O
patients	B-UNK
may	O
explain	O
why	O
such	O
a	O
high	B-UNK
frequency	B-UNK
was	O
not	O
found	B-UNK
in	O
other	O
series	B-UNK
.	O

 	B-UNK
human	I-UNK
mutations	B-UNK
in	O
glucose	B-UNK
6	O
-	O
phosphate	B-UNK
dehydrogenase	I-UNK
reflect	B-UNK
evolutionary	B-UNK
history	B-UNK
.	O

 	O
glucose	B-UNK
6	O
-	O
phosphate	B-UNK
dehydrogenase	I-UNK
(	O
g6pd	B-UNK
)	O
is	O
a	O
cytosolic	O
enzyme	B-UNK
encoded	B-UNK
by	O
a	O
housekeeping	B-UNK
x	B-UNK
-	O
linked	B-UNK
gene	B-UNK
whose	O
main	B-UNK
function	B-UNK
is	O
to	O
produce	B-UNK
nadph	B-UNK
,	O
a	O
key	B-UNK
electron	B-UNK
donor	O
in	O
the	O
defense	O
against	O
oxidizing	O
agents	B-UNK
and	O
in	O
reductive	O
biosynthetic	O
reactions	B-UNK
.	O

 	B-UNK
inherited	I-UNK
g6pd	B-UNK
deficiency	I-UNK
is	O
associated	B-UNK
with	O
either	O
episodic	O
hemolytic	B-DISEASE
anemia	I-DISEASE
(	O
triggered	O
by	O
fava	O
beans	B-UNK
or	O
other	O
agents	B-UNK
)	O
or	O
life	B-UNK
-	O
long	B-UNK
hemolytic	B-DISEASE
anemia	I-DISEASE
.	O

 	O
we	O
show	O
here	O
that	O
an	O
evolutionary	B-UNK
analysis	B-UNK
is	O
a	O
key	B-UNK
to	O
understanding	B-UNK
the	O
biology	O
of	O
a	O
housekeeping	B-UNK
gene	B-UNK
.	O

 	O
from	O
the	O
alignment	O
of	O
the	O
amino	B-UNK
acid	I-UNK
(	O
aa	B-UNK
)	O
sequence	B-UNK
of	O
52	O
glucose	B-UNK
6	O
-	O
phosphate	B-UNK
dehydrogenase	I-UNK
(	O
g6pd	B-UNK
)	O
species	B-UNK
from	O
42	O
different	B-UNK
organisms	O
,	O
we	O
found	B-UNK
a	O
striking	B-UNK
correlation	B-UNK
between	O
the	O
aa	B-UNK
replacements	O
that	O
cause	B-UNK
g6pd	I-UNK
deficiency	B-UNK
in	O
humans	B-UNK
and	O
the	O
sequence	B-UNK
conservation	B-UNK
of	O
g6pd	B-UNK
two	O
-	O
thirds	O
of	O
such	O
replacements	O
are	O
in	O
highly	B-UNK
and	O
moderately	B-UNK
conserved	B-UNK
(	O
50	O
-	O
99	O
%	O
)	O
aa	B-UNK
;	O
relatively	B-UNK
few	O
are	O
in	O
fully	B-UNK
conserved	B-UNK
aa	B-UNK
(	O
where	O
they	O
might	O
be	O
lethal	B-UNK
)	O
or	O
in	O
poorly	B-UNK
conserved	B-UNK
aa	B-UNK
,	O
where	O
presumably	O
they	O
simply	O
would	O
not	O
cause	B-UNK
g6pd	I-UNK
deficiency	B-UNK
.	O

 	O
this	O
is	O
consistent	B-UNK
with	O
the	O
notion	O
that	O
all	O
human	B-UNK
mutants	B-UNK
have	O
residual	B-UNK
enzyme	B-UNK
activity	I-UNK
and	O
that	O
null	B-UNK
mutations	B-UNK
are	O
lethal	B-UNK
at	B-DISEASE
some	O
stage	B-UNK
of	O
development	B-UNK
.	O

 	O
comparing	B-UNK
the	O
distribution	B-UNK
of	O
mutations	B-UNK
in	O
a	O
human	B-UNK
housekeeping	B-UNK
gene	B-UNK
with	O
evolutionary	B-UNK
conservation	B-UNK
is	O
a	O
useful	B-UNK
tool	B-UNK
for	O
pinpointing	O
amino	B-UNK
acid	I-UNK
residues	B-UNK
important	B-UNK
for	O
the	O
stability	B-UNK
or	O
the	O
function	B-UNK
of	O
the	O
corresponding	B-UNK
protein	B-UNK
.	O

 	O
in	O
view	O
of	O
the	O
current	B-UNK
explosive	O
increase	B-UNK
in	O
full	O
genome	B-UNK
sequencing	B-UNK
projects	O
,	O
this	O
tool	B-UNK
will	O
become	O
rapidly	B-UNK
available	B-UNK
for	O
numerous	B-UNK
other	O
genes	B-UNK
.	O
.	O

 	O
constitutive	O
and	O
regulated	B-UNK
modes	O
of	O
splicing	B-UNK
produce	B-UNK
six	O
major	B-UNK
myotonic	B-DISEASE
dystrophy	I-DISEASE
protein	B-UNK
kinase	B-UNK
(	O
dmpk	B-UNK
)	O
isoforms	B-UNK
with	O
distinct	B-UNK
properties	B-UNK
.	O

 	O
myotonic	B-DISEASE
dystrophy	I-DISEASE
(	O
dm	B-DISEASE
)	O
is	O
the	O
most	O
prevalent	B-UNK
inherited	B-UNK
neuromuscular	B-DISEASE
disease	I-DISEASE
in	O
adults	B-UNK
.	O

 	O
the	O
genetic	B-UNK
defect	B-UNK
is	O
a	O
ctg	B-UNK
triplet	B-UNK
repeat	I-UNK
expansion	B-UNK
in	O
the	O
3	O
-	O
untranslated	B-UNK
region	B-UNK
of	O
the	O
myotonic	B-DISEASE
dystrophy	I-DISEASE
protein	B-UNK
kinase	B-UNK
(	O
dmpk	B-UNK
)	O
gene	B-UNK
,	O
consisting	O
of	O
15	O
exons	B-UNK
.	O

 	O
using	O
a	O
transgenic	B-UNK
dmpk	B-UNK
-	O
overexpressor	O
mouse	B-UNK
model	I-UNK
,	O
we	O
demonstrate	B-UNK
here	O
that	O
the	O
endogenous	B-UNK
mouse	B-UNK
dmpk	B-UNK
gene	B-UNK
and	O
the	O
human	B-UNK
dmpk	B-UNK
transgene	B-UNK
produce	B-UNK
six	O
major	B-UNK
alternatively	B-UNK
spliced	I-UNK
mrnas	B-UNK
which	O
have	O
almost	O
identical	B-UNK
cell	B-UNK
type	B-UNK
-	O
dependent	B-UNK
distribution	B-UNK
frequencies	B-UNK
and	O
expression	B-UNK
patterns	B-UNK
.	O

 	O
use	B-UNK
of	O
a	O
cryptic	O
5	O
splice	B-UNK
site	I-UNK
in	O
exon	B-UNK
8	O
,	O
which	O
results	B-UNK
in	O
absence	B-UNK
or	O
presence	B-UNK
of	O
15	O
nucleotides	B-UNK
specifying	O
a	O
vsggg	O
peptide	B-UNK
motif	B-UNK
,	O
and	O
/	O
or	O
use	B-UNK
of	O
a	O
cryptic	O
3	O
splice	B-UNK
site	I-UNK
in	O
exon	B-UNK
14	O
,	O
which	O
leads	B-UNK
to	O
a	O
frameshift	B-UNK
in	O
the	O
mrna	B-UNK
reading	B-UNK
frame	I-UNK
,	O
occur	B-UNK
as	O
independent	B-UNK
stochastic	O
events	B-UNK
in	O
all	O
tissues	B-UNK
examined	B-UNK
.	O

 	O
in	O
contrast	B-UNK
,	O
the	O
excision	O
of	O
exons	B-UNK
13	O
/	O
14	O
that	O
causes	B-UNK
a	O
frameshift	B-UNK
and	O
creates	O
a	O
c	B-UNK
-	O
terminally	B-UNK
truncated	B-UNK
protein	B-UNK
is	O
clearly	B-UNK
cell	B-UNK
type	B-UNK
dependent	B-UNK
and	O
occurs	B-UNK
predominantly	B-UNK
in	O
smooth	B-UNK
muscle	B-UNK
.	O

 	O
we	O
generated	B-UNK
all	O
six	O
full	O
-	O
length	O
mouse	B-UNK
cdnas	B-UNK
that	O
result	B-UNK
from	O
combinations	O
of	O
these	O
three	O
major	B-UNK
splicing	B-UNK
events	B-UNK
and	O
show	O
that	O
their	O
transfection	O
into	O
cells	B-UNK
in	O
culture	B-UNK
leads	B-UNK
to	O
production	B-UNK
of	O
four	O
different	B-UNK
approximately	B-UNK
74	O
kda	B-UNK
full	O
-	O
length	O
(	O
heart	B-UNK
-	O
,	O
skeletal	B-UNK
muscle	I-UNK
-	O
or	O
brain	B-UNK
-	O
specific	B-UNK
)	O
and	O
two	O
c	B-UNK
-	O
terminally	B-UNK
truncated	B-UNK
approximately	B-UNK
68	O
kda	B-UNK
(	O
smooth	B-UNK
muscle	B-UNK
-	O
specific	B-UNK
)	O
isoforms	B-UNK
.	O

 	O
information	B-UNK
on	O
dmpk	B-UNK
mrna	I-UNK
and	O
protein	B-UNK
isoform	B-UNK
expression	B-UNK
patterns	B-UNK
will	O
be	O
useful	B-UNK
for	O
recognizing	O
differential	B-UNK
effects	B-UNK
of	O
(	O
ctg	B-UNK
)	O
(	O
n	B-UNK
)	O
expansion	B-UNK
in	O
dm	B-DISEASE
manifestation	B-UNK
.	O
.	O

 	B-UNK
genetic	I-UNK
analysis	B-UNK
,	O
phenotypic	B-UNK
diagnosis	B-UNK
,	O
and	O
risk	B-UNK
of	O
venous	B-DISEASE
thrombosis	I-DISEASE
in	O
families	B-UNK
with	O
inherited	B-UNK
deficiencies	B-UNK
of	O
protein	B-UNK
s	O
.	O

 	O
protein	B-DISEASE
s	I-DISEASE
deficiency	I-DISEASE
is	O
a	O
recognized	B-UNK
risk	B-UNK
factor	B-UNK
for	O
venous	B-DISEASE
thrombosis	I-DISEASE
.	O

 	O
of	O
all	O
the	O
inherited	B-UNK
thrombophilic	O
conditions	B-UNK
,	O
it	O
remains	B-UNK
the	O
most	O
difficult	O
to	O
diagnose	O
because	O
of	O
phenotypic	B-UNK
variability	I-UNK
,	O
which	O
can	O
lead	B-UNK
to	O
inconclusive	O
results	B-UNK
.	O

 	O
we	O
have	O
overcome	O
this	O
problem	O
by	O
studying	O
a	O
cohort	B-UNK
of	O
patients	B-UNK
from	O
a	O
single	B-UNK
center	B-UNK
where	O
the	O
diagnosis	B-UNK
was	O
confirmed	B-UNK
at	B-DISEASE
the	O
genetic	B-UNK
level	B-UNK
.	O

 	O
twenty	O
-	O
eight	O
index	B-UNK
patients	B-UNK
with	O
protein	B-DISEASE
s	I-DISEASE
deficiency	I-DISEASE
and	O
a	O
pros1	B-UNK
gene	B-UNK
defect	B-UNK
were	O
studied	B-UNK
,	O
together	O
with	O
109	O
first	O
-	O
degree	B-UNK
relatives	B-UNK
.	O

 	O
to	O
avoid	B-UNK
selection	B-UNK
bias	B-UNK
,	O
we	O
confined	O
analysis	B-UNK
of	O
total	B-UNK
and	O
free	B-UNK
protein	B-UNK
s	O
levels	B-UNK
and	O
thrombotic	B-DISEASE
risk	B-UNK
to	O
the	O
patients	B-UNK
relatives	B-UNK
.	O

 	O
in	O
this	O
group	B-UNK
of	O
relatives	B-UNK
,	O
a	O
low	B-UNK
free	B-UNK
protein	B-UNK
s	O
level	B-UNK
was	O
the	O
most	O
reliable	B-UNK
predictor	O
of	O
a	O
pros1	B-UNK
gene	B-UNK
defect	B-UNK
(	O
sensitivity	B-UNK
97	O
.	O
7	O
%	O
,	O
specificity	B-UNK
100	O
%	O
)	O
.	O

 	O
first	O
-	O
degree	B-UNK
relatives	B-UNK
with	O
a	O
pros1	B-UNK
gene	B-UNK
defect	B-UNK
had	O
a	O
5	O
.	O

 	O
0	O
-	O
fold	B-UNK
higher	B-UNK
risk	B-UNK
of	O
thrombosis	B-DISEASE
(	O
95	O
%	O
confidence	B-UNK
interval	B-UNK
,	O
1	O
.	O
5	O
-	O
16	O
.	O
8	O
)	O
than	O
those	O
with	O
a	O
normal	B-UNK
pros1	B-UNK
gene	B-UNK
and	O
no	O
other	O
recognized	B-UNK
thrombophilic	O
defect	B-UNK
.	O

 	O
although	O
pregnancy	B-DISEASE
/	O
puerperium	O
and	O
immobility	O
/	O
trauma	B-DISEASE
were	O
important	B-UNK
precipitating	O
factors	B-UNK
for	O
thrombosis	B-DISEASE
,	O
almost	O
half	B-UNK
of	O
the	O
events	B-UNK
were	O
spontaneous	B-UNK
.	O

 	O
relatives	B-UNK
with	O
splice	O
-	O
site	B-UNK
or	O
major	B-UNK
structural	B-UNK
defects	B-UNK
in	O
the	O
pros1	B-UNK
gene	B-UNK
were	O
more	O
likely	B-UNK
to	O
have	O
had	O
a	O
thrombotic	B-DISEASE
event	B-UNK
and	O
had	O
significantly	B-UNK
lower	B-UNK
total	B-UNK
and	O
free	B-UNK
protein	B-UNK
s	O
levels	B-UNK
than	O
those	O
relatives	B-UNK
having	B-UNK
missense	B-UNK
mutations	I-UNK
.	O

 	O
we	O
conclude	O
that	O
persons	B-UNK
with	O
pros1	B-UNK
gene	B-UNK
defects	B-UNK
and	O
protein	B-DISEASE
s	I-DISEASE
deficiency	I-DISEASE
are	O
at	B-DISEASE
increased	B-UNK
risk	B-UNK
of	O
thrombosis	B-DISEASE
and	O
that	O
free	B-UNK
protein	B-UNK
s	O
estimation	B-UNK
offers	O
the	O
most	O
reliable	B-UNK
way	O
of	O
diagnosing	O
the	O
deficiency	B-UNK
.	O

 	O
(	O
blood	B-UNK
.	O
2000	O
;	O
95	O
1935	O
-	O
1941	O
)	O
.	O

 	O
autoimmune	B-DISEASE
lymphoproliferative	I-DISEASE
syndrome	I-DISEASE
(	O
alps	B-UNK
)	O
in	O
a	O
child	B-UNK
from	O
consanguineous	B-UNK
parents	B-UNK
:	O
a	O
dominant	B-UNK
or	O
recessive	O
disease	B-DISEASE
?	O

 	O
autoimmune	B-DISEASE
lymphoproliferative	I-DISEASE
syndrome	I-DISEASE
(	O
alps	B-UNK
)	O
is	O
characterized	B-UNK
by	O
autoimmune	B-UNK
features	B-UNK
and	O
lymphoproliferations	O
and	O
is	O
generally	B-UNK
caused	B-UNK
by	O
defective	B-UNK
fas	B-UNK
-	O
mediated	B-UNK
apoptosis	B-UNK
.	O

 	O
this	O
report	B-UNK
describes	B-UNK
a	O
child	B-UNK
with	O
clinical	B-UNK
features	I-UNK
of	O
alps	B-UNK
without	O
detectable	B-UNK
fas	B-UNK
expression	B-UNK
on	O
freshly	O
isolated	B-UNK
blood	B-UNK
leukocytes	I-UNK
.	O

 	O
detection	B-UNK
of	O
fas	B-UNK
transcripts	B-UNK
via	O
real	O
-	O
time	B-UNK
quantitative	B-UNK
pcr	B-UNK
made	O
a	O
severe	B-UNK
transcriptional	B-UNK
defect	B-UNK
unlikely	O
.	O

 	O
sequencing	B-UNK
of	O
the	O
fas	B-UNK
gene	B-UNK
revealed	B-UNK
a	O
20	O
-	O
nucleotide	B-UNK
duplication	B-UNK
in	O
the	O
last	O
exon	B-UNK
affecting	B-UNK
the	O
cytoplasmic	B-UNK
signaling	B-UNK
domain	B-UNK
.	O

 	O
the	O
patient	B-UNK
was	O
homozygous	B-UNK
for	O
this	O
mutation	B-UNK
,	O
whereas	O
the	O
consanguineous	B-UNK
parents	B-UNK
and	O
the	O
siblings	B-UNK
were	O
heterozygous	B-UNK
.	O

 	O
the	O
patient	B-UNK
reported	B-UNK
here	O
is	O
a	O
human	B-UNK
homologue	B-UNK
of	O
the	O
fas	B-UNK
-	O
null	B-UNK
mouse	B-UNK
,	O
inasmuch	O
as	O
she	O
carries	O
an	O
autosomal	O
homozygous	B-UNK
mutation	B-UNK
in	O
the	O
fas	B-UNK
gene	B-UNK
and	O
she	O
shows	B-UNK
the	O
severe	B-UNK
and	O
accelerated	B-UNK
alps	B-UNK
phenotype	B-UNK
.	O

 	O
the	O
heterozygous	B-UNK
family	I-UNK
members	B-UNK
did	O
not	O
have	O
the	O
alps	B-UNK
phenotype	B-UNK
,	O
indicating	B-UNK
that	O
the	O
disease	B-DISEASE
-	O
causing	B-UNK
fas	B-UNK
mutation	B-UNK
in	O
this	O
family	B-UNK
is	O
autosomal	O
recessive	O
.	O
.	O

 	O
identification	B-UNK
of	O
novel	B-UNK
imprinted	B-UNK
transcripts	B-UNK
in	O
the	O
prader	B-DISEASE
-	I-DISEASE
willi	I-DISEASE
syndrome	I-DISEASE
and	O
angelman	B-DISEASE
syndrome	I-DISEASE
deletion	B-UNK
region	I-UNK
:	O
further	O
evidence	B-UNK
for	O
regional	B-UNK
imprinting	B-UNK
control	B-UNK
.	O

 	O
deletions	B-UNK
and	O
other	O
abnormalities	B-DISEASE
of	O
human	B-UNK
chromosome	I-UNK
15q11	B-UNK
-	O
q13	O
are	O
associated	B-UNK
with	O
two	O
developmental	B-UNK
disorders	B-UNK
,	O
prader	B-DISEASE
-	I-DISEASE
willi	I-DISEASE
syndrome	I-DISEASE
(	O
pws	B-UNK
)	O
and	O
angelman	B-DISEASE
syndrome	I-DISEASE
(	O
as	O
)	O
.	O

 	O
loss	B-UNK
of	O
expression	B-UNK
of	O
imprinted	B-UNK
,	O
paternally	B-UNK
expressed	I-UNK
genes	B-UNK
has	O
been	O
implicated	O
in	O
pws	B-UNK
.	O

 	O
however	O
,	O
the	O
number	B-UNK
of	O
imprinted	B-UNK
genes	B-UNK
that	O
contribute	B-UNK
to	O
pws	B-UNK
,	O
and	O
the	O
range	B-UNK
over	O
which	O
the	O
imprinting	B-UNK
signal	B-UNK
acts	B-UNK
to	O
silence	O
one	O
copy	B-UNK
of	O
the	O
gene	B-UNK
in	O
a	O
parent	B-UNK
-	O
of	O
-	O
origin	B-UNK
-	O
specific	B-UNK
manner	B-UNK
,	O
are	O
unknown	B-UNK
.	O

 	O
to	O
identify	B-UNK
additional	B-UNK
imprinted	B-UNK
genes	B-UNK
that	O
could	O
contribute	B-UNK
to	O
the	O
pws	B-UNK
phenotype	B-UNK
and	O
to	O
understand	O
the	O
regional	B-UNK
control	B-UNK
of	O
imprinting	B-UNK
in	O
15q11	B-UNK
-	O
q13	O
,	O
we	O
have	O
constructed	B-UNK
an	O
imprinted	B-UNK
transcript	B-UNK
map	B-UNK
of	O
the	O
pws	B-UNK
-	O
as	O
deletion	B-UNK
interval	B-UNK
.	O

 	O
the	O
imprinting	B-UNK
status	B-UNK
of	O
22	O
expressed	B-UNK
sequence	B-UNK
tags	O
derived	B-UNK
from	O
the	O
radiation	B-UNK
-	O
hybrid	O
human	B-UNK
transcript	B-UNK
maps	B-UNK
or	O
physical	B-UNK
maps	B-UNK
was	O
determined	B-UNK
in	O
a	O
reverse	B-UNK
transcriptase	B-UNK
-	O
pcr	B-UNK
assay	B-UNK
and	O
correlated	B-UNK
with	O
the	O
position	B-UNK
of	O
the	O
transcripts	B-UNK
on	O
the	O
physical	B-UNK
map	B-UNK
.	O

 	B-UNK
seven	I-UNK
new	B-UNK
paternally	B-UNK
expressed	I-UNK
transcripts	B-UNK
localize	B-UNK
to	O
an	O
approximately	B-UNK
1	O
.	O

 	O
5	O
-	O
mb	B-UNK
domain	B-UNK
surrounding	B-UNK
the	O
snrpn	B-UNK
-	O
associated	B-UNK
imprinting	B-UNK
center	I-UNK
,	O
which	O
already	O
includes	B-UNK
four	O
imprinted	B-UNK
,	O
paternally	B-UNK
expressed	I-UNK
genes	B-UNK
.	O

 	O
all	O
other	O
tested	B-UNK
new	B-UNK
transcripts	B-UNK
in	O
the	O
deletion	B-UNK
region	I-UNK
were	O
expressed	B-UNK
from	O
both	O
alleles	B-UNK
.	O

 	O
a	O
domain	B-UNK
of	O
exclusive	B-UNK
paternal	B-UNK
expression	B-UNK
surrounding	B-UNK
the	O
imprinting	B-UNK
center	I-UNK
suggests	B-UNK
strong	B-UNK
regional	B-UNK
control	B-UNK
of	O
the	O
imprinting	B-UNK
process	B-UNK
.	O

 	O
this	O
study	B-UNK
provides	B-UNK
the	O
means	O
for	O
further	O
investigation	O
of	O
additional	B-UNK
genes	B-UNK
that	O
cause	B-UNK
or	O
modify	B-UNK
the	O
phenotypes	B-UNK
associated	B-UNK
with	O
rearrangements	B-UNK
of	O
15q11	B-UNK
-	O
q13	O
.	O

 	B-UNK
combined	I-UNK
analysis	B-UNK
of	O
hereditary	B-UNK
prostate	B-DISEASE
cancer	I-DISEASE
linkage	B-UNK
to	O
1q24	O
-	O
25	O
:	O
results	B-UNK
from	O
772	O
hereditary	B-UNK
prostate	B-DISEASE
cancer	I-DISEASE
families	B-UNK
from	O
the	O
international	B-UNK
consortium	B-UNK
for	O
prostate	B-DISEASE
cancer	I-DISEASE
genetics	B-UNK
.	O

 	O
a	O
previous	B-UNK
linkage	I-UNK
study	B-UNK
provided	B-UNK
evidence	B-UNK
for	O
a	O
prostate	B-DISEASE
cancer	I-DISEASE
-	O
susceptibility	B-UNK
locus	B-UNK
at	B-DISEASE
1q24	O
-	O
25	O
.	O

 	O
subsequent	B-UNK
reports	B-UNK
in	O
additional	B-UNK
collections	O
of	O
families	B-UNK
have	O
yielded	B-UNK
conflicting	B-UNK
results	I-UNK
.	O

 	O
in	O
addition	B-UNK
,	O
evidence	B-UNK
for	O
locus	B-UNK
heterogeneity	I-UNK
has	O
been	O
provided	B-UNK
by	O
the	O
identification	B-UNK
of	O
other	O
putative	B-UNK
hereditary	B-UNK
prostate	B-DISEASE
cancer	I-DISEASE
loci	B-UNK
on	O
xq27	O
-	O
28	O
,	O
1q42	O
-	O
43	O
,	O
and	O
1p36	O
.	O

 	O
the	O
present	B-UNK
study	I-UNK
describes	B-UNK
a	O
combined	B-UNK
analysis	B-UNK
for	O
six	O
markers	B-UNK
in	O
the	O
1q24	O
-	O
25	O
region	B-UNK
in	O
772	O
families	B-UNK
affected	B-UNK
by	O
hereditary	B-UNK
prostate	B-DISEASE
cancer	I-DISEASE
and	O
ascertained	B-UNK
by	O
the	O
members	B-UNK
of	O
the	O
international	B-UNK
consortium	B-UNK
for	O
prostate	B-DISEASE
cancer	I-DISEASE
genetics	B-UNK
(	O
icpcg	O
)	O
from	O
north	B-UNK
america	O
,	O
australia	O
,	O
finland	B-UNK
,	O
norway	O
,	O
sweden	O
,	O
and	O
the	O
united	B-UNK
kingdom	O
.	O

 	O
overall	B-UNK
,	O
there	O
was	O
some	O
evidence	B-UNK
for	O
linkage	B-UNK
,	O
with	O
a	O
peak	B-UNK
parametric	O
multipoint	B-UNK
lod	B-UNK
score	I-UNK
assuming	O
heterogeneity	B-UNK
(	O
hlod	B-UNK
)	O
of	O
1	O
.	O

 	O
40	O
(	O
p	B-UNK
=	O
.	O
01	O
)	O
at	B-DISEASE
d1s212	O
.	O

 	O
the	O
estimated	B-UNK
proportion	B-UNK
of	O
families	B-UNK
(	O
alpha	B-UNK
)	O
linked	B-UNK
to	O
the	O
locus	B-UNK
was	O
.	O

 	O
06	O
(	O
1	O
-	O
lod	O
support	B-UNK
interval	I-UNK
.	O
01	O
-	O
.	O
12	O
)	O
.	O

 	O
this	O
evidence	B-UNK
was	O
not	O
observed	B-UNK
by	O
a	O
nonparametric	O
approach	B-UNK
,	O
presumably	O
because	O
of	O
the	O
extensive	B-UNK
heterogeneity	B-UNK
.	O

 	O
further	O
parametric	O
analysis	B-UNK
revealed	B-UNK
a	O
significant	B-UNK
effect	B-UNK
of	O
the	O
presence	B-UNK
of	O
male	B-UNK
-	O
to	O
-	O
male	B-UNK
disease	B-DISEASE
transmission	B-UNK
within	O
the	O
families	B-UNK
.	O

 	O
in	O
the	O
subset	O
of	O
491	O
such	O
families	B-UNK
,	O
the	O
peak	B-UNK
hlod	B-UNK
was	O
2	O
.	O

 	O
in	O
the	O
subset	O
of	O
491	O
such	O
families	B-UNK
,	O
the	O
peak	B-UNK
hlod	B-UNK
was	O
2	O
.	O

 	O
56	O
(	O
p	B-UNK
=	O
.	O
0006	O
)	O
and	O
alpha	B-UNK
=	O
.	O

 	O
11	O
(	O
1	O
-	O
lod	O
support	B-UNK
interval	I-UNK
.	O
04	O
-	O
.	O
19	O
)	O
,	O
compared	B-UNK
with	O
hlods	O
of	O
0	O
in	O
the	O
remaining	B-UNK
281	O
families	B-UNK
.	O

 	O
within	O
the	O
families	B-UNK
with	O
male	B-UNK
-	O
to	O
-	O
male	B-UNK
disease	B-DISEASE
transmission	B-UNK
,	O
alpha	B-UNK
increased	B-UNK
with	O
the	O
early	B-UNK
mean	B-UNK
age	B-UNK
at	B-DISEASE
diagnosis	B-UNK
(	O
<	O
65	O
years	B-UNK
,	O
alpha	B-UNK
=	O
.	O
19	O
,	O
with	O
1	O
-	O
lod	O
support	B-UNK
interval	I-UNK
.	O
06	O
-	O
.	O
34	O
)	O
and	O
the	O
number	B-UNK
of	O
affected	B-UNK
family	B-UNK
members	I-UNK
(	O
five	O
or	O
more	O
family	B-UNK
members	I-UNK
,	O
alpha	B-UNK
=	O
.	O
15	O
,	O
with	O
1	O
-	O
lod	O
support	B-UNK
interval	I-UNK
.	O
04	O
-	O
.	O
28	O
)	O
.	O

 	O
the	O
highest	B-UNK
value	B-UNK
of	O
alpha	B-UNK
was	O
observed	B-UNK
for	O
the	O
48	O
families	B-UNK
that	O
met	O
all	O
three	O
criteria	B-UNK
(	O
peak	B-UNK
hlod	B-UNK
=	O
2	O
.	O
25	O
,	O
p	B-UNK
=	O
.	O
001	O
,	O
alpha	B-UNK
=	O
.	O
29	O
,	O
with	O
1	O
-	O
lod	O
support	B-UNK
interval	I-UNK
.	O
08	O
-	O
.	O
53	O
)	O
.	O

 	O
these	O
results	B-UNK
support	B-UNK
the	O
finding	B-UNK
of	O
a	O
prostate	B-DISEASE
cancer	I-DISEASE
-	O
susceptibility	B-UNK
gene	B-UNK
linked	B-UNK
to	O
1q24	O
-	O
25	O
,	O
albeit	O
in	O
a	O
defined	B-UNK
subset	O
of	O
prostate	B-DISEASE
cancer	I-DISEASE
families	B-UNK
.	O

 	O
although	O
hpc1	B-UNK
accounts	O
for	O
only	O
a	O
small	B-UNK
proportion	B-UNK
of	O
all	O
families	B-UNK
affected	B-UNK
by	O
hereditary	B-UNK
prostate	B-DISEASE
cancer	I-DISEASE
,	O
it	O
appears	B-UNK
to	O
play	O
a	O
more	O
prominent	B-UNK
role	B-UNK
in	O
the	O
subset	O
of	O
families	B-UNK
with	O
several	O
members	B-UNK
affected	B-UNK
at	B-DISEASE
an	O
early	B-UNK
age	B-UNK
and	O
with	O
male	B-UNK
-	O
to	O
-	O
male	B-UNK
disease	B-DISEASE
transmission	B-UNK
.	O

 	O
a	O
recurrent	B-UNK
expansion	B-UNK
of	O
a	O
maternal	B-UNK
allele	B-UNK
with	O
36	O
cag	B-UNK
repeats	B-UNK
causes	B-UNK
huntington	B-DISEASE
disease	I-DISEASE
in	O
two	O
sisters	O
.	O

 	O
large	B-UNK
intergenerational	B-UNK
repeat	B-UNK
expansions	B-UNK
of	O
the	O
cag	B-UNK
trinucleotide	B-UNK
repeat	I-UNK
in	O
the	O
hd	B-UNK
gene	B-UNK
have	O
been	O
well	O
documented	B-UNK
for	O
the	O
male	B-UNK
germline	B-UNK
.	O

 	O
we	O
describe	B-UNK
a	O
recurrent	B-UNK
large	B-UNK
expansion	B-UNK
of	O
a	O
maternal	B-UNK
allele	B-UNK
with	O
36	O
cag	B-UNK
repeats	B-UNK
(	O
to	O
66	O
and	O
57	O
repeats	B-UNK
,	O
respectively	B-UNK
,	O
in	O
two	O
daughters	O
)	O
associated	B-UNK
with	O
onset	B-UNK
of	O
huntington	B-DISEASE
disease	I-DISEASE
(	O
hd	B-UNK
)	O
in	O
the	O
second	B-UNK
and	O
third	O
decade	O
in	O
a	O
family	B-UNK
without	O
history	B-UNK
of	O
hd	B-UNK
.	O

 	O
our	O
findings	B-UNK
give	O
evidence	B-UNK
of	O
a	O
gonadal	B-UNK
mosaicism	B-UNK
in	O
the	O
unaffected	B-UNK
mother	B-UNK
.	O

 	O
we	O
hypothesize	O
that	O
large	B-UNK
expansions	B-UNK
also	O
occur	B-UNK
in	O
the	O
female	B-UNK
germline	B-UNK
and	O
that	O
a	O
negative	B-UNK
selection	B-UNK
of	O
oocytes	B-UNK
with	O
long	B-UNK
repeats	B-UNK
might	O
explain	O
the	O
different	B-UNK
instability	B-UNK
behavior	O
of	O
the	O
male	B-UNK
and	O
the	O
female	B-UNK
germlines	O
.	O
.	O

 	B-UNK
abnormal	I-UNK
development	B-UNK
of	O
purkinje	B-UNK
cells	I-UNK
and	O
lymphocytes	B-UNK
in	O
atm	B-UNK
mutant	I-UNK
mice	B-UNK
.	O

 	O
motor	B-UNK
incoordination	O
,	O
immune	B-UNK
deficiencies	B-UNK
,	O
and	O
an	O
increased	B-UNK
risk	B-UNK
of	O
cancer	B-DISEASE
are	O
the	O
characteristic	B-UNK
features	B-UNK
of	O
the	O
hereditary	B-UNK
disease	B-DISEASE
ataxia	B-DISEASE
-	O
telangiectasia	B-DISEASE
(	O
a	O
-	O
t	B-UNK
)	O
,	O
which	O
is	O
caused	B-UNK
by	O
mutations	B-UNK
in	O
the	O
atm	B-UNK
gene	B-UNK
.	O

 	O
through	O
gene	B-UNK
targeting	B-UNK
,	O
we	O
have	O
generated	B-UNK
a	O
line	B-UNK
of	O
atm	B-UNK
mutant	I-UNK
mice	B-UNK
,	O
atm	B-UNK
(	O
y	O
/	O
y	O
)	O
mice	B-UNK
.	O

 	O
in	O
contrast	B-UNK
to	O
other	O
atm	B-UNK
mutant	I-UNK
mice	B-UNK
,	O
atm	B-UNK
(	O
y	O
/	O
y	O
)	O
mice	B-UNK
show	O
a	O
lower	B-UNK
incidence	O
of	O
thymic	O
lymphoma	B-DISEASE
and	O
survive	O
beyond	O
a	O
few	O
months	O
of	O
age	B-UNK
.	O

 	B-UNK
atm	I-UNK
(	O
y	O
/	O
y	O
)	O
mice	B-UNK
exhibit	B-UNK
deficits	B-UNK
in	O
motor	B-UNK
learning	O
indicative	O
of	O
cerebellar	B-UNK
dysfunction	B-UNK
.	O

 	O
even	O
though	O
we	O
found	B-UNK
no	O
gross	O
cerebellar	B-DISEASE
degeneration	I-DISEASE
in	O
older	B-UNK
atm	B-UNK
(	O
y	O
/	O
y	O
)	O
animals	O
,	O
ectopic	B-UNK
and	O
abnormally	B-UNK
differentiated	O
purkinje	B-UNK
cells	I-UNK
were	O
apparent	B-UNK
in	O
mutant	B-UNK
mice	I-UNK
of	O
all	O
ages	O
.	O

 	O
these	O
findings	B-UNK
establish	O
that	O
some	O
neuropathological	O
abnormalities	B-DISEASE
seen	B-UNK
in	O
a	O
-	O
t	B-UNK
patients	B-UNK
also	O
are	O
present	B-UNK
in	O
atm	B-UNK
mutant	I-UNK
mice	B-UNK
.	O

 	O
in	O
addition	B-UNK
,	O
we	O
report	B-UNK
a	O
previously	B-UNK
unrecognized	O
effect	B-UNK
of	O
atm	B-UNK
deficiency	B-UNK
on	O
development	B-UNK
or	O
maintenance	O
of	O
cd4	O
(	O
+	O
)	O
8	O
(	O
+	O
)	O
thymocytes	O
.	O

 	O
we	O
discuss	O
these	O
findings	B-UNK
in	O
the	O
context	O
of	O
the	O
hypothesis	O
that	O
abnormal	B-UNK
development	B-UNK
of	O
purkinje	B-UNK
cells	I-UNK
and	O
lymphocytes	B-UNK
contributes	B-UNK
to	O
the	O
pathogenesis	O
of	O
a	O
-	O
t	B-UNK
.	O
.	O

 	B-UNK
novel	I-UNK
mutations	B-UNK
of	O
the	O
atp7b	B-UNK
gene	B-UNK
in	O
japanese	B-UNK
patients	I-UNK
with	O
wilson	B-UNK
disease	B-DISEASE
.	O

 	O
wilson	B-UNK
disease	B-DISEASE
(	O
wd	O
)	O
is	O
an	O
autosomal	B-UNK
recessive	I-UNK
disorder	I-UNK
characterized	I-UNK
by	O
copper	B-UNK
accumulation	B-UNK
in	O
the	O
liver	B-DISEASE
,	O
brain	B-UNK
,	O
kidneys	O
,	O
and	O
corneas	O
,	O
and	O
culminating	O
in	O
copper	B-UNK
toxication	O
in	O
these	O
organs	O
.	O

 	O
in	O
this	O
study	B-UNK
,	O
we	O
analyzed	B-UNK
mutations	B-UNK
of	O
the	O
responsible	B-UNK
gene	B-UNK
,	O
atp7b	B-UNK
,	O
in	O
four	O
japanese	B-UNK
patients	I-UNK
with	O
wd	O
.	O

 	O
by	O
direct	B-UNK
sequencing	I-UNK
,	O
we	O
identified	B-UNK
five	O
mutations	B-UNK
,	O
of	O
which	O
two	O
were	O
novel	B-UNK
,	O
and	O
16	O
polymorphisms	B-UNK
,	O
of	O
which	O
6	O
were	O
novel	B-UNK
.	O

 	O
the	O
mutations	B-UNK
2871delc	O
and	O
2513dela	O
shift	B-UNK
the	O
reading	B-UNK
frame	I-UNK
so	O
that	O
truncated	B-UNK
abnormal	B-UNK
protein	B-UNK
is	O
expected	B-UNK
.	O

 	O
in	O
contrast	B-UNK
to	O
these	O
mutations	B-UNK
found	B-UNK
in	O
patients	B-UNK
with	O
hepatic	B-UNK
-	O
type	B-UNK
of	O
early	B-UNK
onset	I-UNK
,	O
the	O
mutations	B-UNK
a874v	O
,	O
r778l	O
,	O
and	O
3892delgtc	O
were	O
either	O
missense	B-UNK
mutations	I-UNK
or	O
in	O
frame	B-UNK
1	O
-	O
amino	B-UNK
acid	I-UNK
deletion	B-UNK
,	O
and	O
occurred	B-UNK
in	O
the	O
patients	B-UNK
with	O
hepato	O
-	O
neurologic	B-DISEASE
type	B-UNK
of	O
late	B-UNK
onset	B-UNK
.	O

 	O
the	O
mutations	B-UNK
2871delc	O
and	O
r778l	O
have	O
been	O
previously	B-UNK
reported	I-UNK
in	O
a	O
relatively	B-UNK
large	B-UNK
number	B-UNK
of	O
japanese	B-UNK
patients	I-UNK
.	O

 	O
in	O
particular	B-UNK
,	O
r778l	O
is	O
known	B-UNK
to	O
be	O
more	O
prevalent	B-UNK
in	O
asian	O
countries	B-UNK
than	O
in	O
other	O
countries	B-UNK
of	O
the	O
world	O
.	O

 	O
our	O
data	B-UNK
are	O
compatible	O
with	O
the	O
hypothesis	O
that	O
the	O
mutations	B-UNK
tend	O
to	O
occur	B-UNK
in	O
a	O
population	B-UNK
-	O
specific	B-UNK
manner	B-UNK
.	O

 	O
therefore	O
,	O
the	O
accumulation	B-UNK
of	O
the	O
types	B-UNK
of	O
mutations	B-UNK
in	O
japanese	B-UNK
patients	I-UNK
with	O
wd	O
will	O
facilitate	B-UNK
the	O
fast	B-UNK
and	O
effective	B-UNK
genetic	B-UNK
diagnosis	B-UNK
of	O
wd	O
in	O
japanese	B-UNK
patients	I-UNK
.	O
.	O

 	O
autoinhibition	O
and	O
activation	B-UNK
mechanisms	B-UNK
of	O
the	O
wiskott	B-DISEASE
-	I-DISEASE
aldrich	I-DISEASE
syndrome	I-DISEASE
protein	B-UNK
.	O

 	O
the	O
rho	O
-	O
family	B-UNK
gtpase	O
,	O
cdc42	O
,	O
can	O
regulate	B-UNK
the	O
actin	B-UNK
cytoskeleton	O
through	O
activation	B-UNK
of	O
wiskott	B-DISEASE
-	I-DISEASE
aldrich	I-DISEASE
syndrome	I-DISEASE
protein	B-UNK
(	O
wasp	B-UNK
)	O
family	B-UNK
members	I-UNK
.	O

 	O
activation	B-UNK
relieves	O
an	O
autoinhibitory	O
contact	O
between	O
the	O
gtpase	O
-	O
binding	B-UNK
domain	I-UNK
and	O
the	O
carboxy	O
-	O
terminal	B-UNK
region	B-UNK
of	O
wasp	B-UNK
proteins	B-UNK
.	O

 	O
here	O
we	O
report	B-UNK
the	O
autoinhibited	O
structure	B-UNK
of	O
the	O
gtpase	O
-	O
binding	B-UNK
domain	I-UNK
of	O
wasp	B-UNK
,	O
which	O
can	O
be	O
induced	B-UNK
by	O
the	O
c	B-UNK
-	O
terminal	B-UNK
region	B-UNK
or	O
by	O
organic	O
co	B-UNK
-	O
solvents	O
.	O

 	O
in	O
the	O
autoinhibited	O
complex	B-UNK
,	O
intramolecular	O
interactions	B-UNK
with	O
the	O
gtpase	O
-	O
binding	B-UNK
domain	I-UNK
occlude	O
residues	B-UNK
of	O
the	O
c	B-UNK
terminus	B-UNK
that	O
regulate	B-UNK
the	O
arp2	O
/	O
3	O
actin	B-UNK
-	O
nucleating	O
complex	B-UNK
.	O

 	O
binding	B-UNK
of	O
cdc42	O
to	O
the	O
gtpase	O
-	O
binding	B-UNK
domain	I-UNK
causes	B-UNK
a	O
dramatic	B-UNK
conformational	O
change	B-UNK
,	O
resulting	B-UNK
in	O
disruption	B-UNK
of	O
the	O
hydrophobic	B-UNK
core	O
and	O
release	B-UNK
of	O
the	O
c	B-UNK
terminus	B-UNK
,	O
enabling	O
its	O
interaction	B-UNK
with	O
the	O
actin	B-UNK
regulatory	B-UNK
machinery	O
.	O

 	O
these	O
data	B-UNK
show	O
that	O
intrinsically	O
unstructured	O
peptides	O
such	O
as	O
the	O
gtpase	O
-	O
binding	B-UNK
domain	I-UNK
of	O
wasp	B-UNK
can	O
be	O
induced	B-UNK
into	O
distinct	B-UNK
structural	B-UNK
and	O
functional	B-UNK
states	B-UNK
depending	O
on	O
context	O
.	O
.	O

 	O
hcds1	O
-	O
mediated	B-UNK
phosphorylation	B-UNK
of	O
brca1	B-UNK
regulates	B-UNK
the	O
dna	B-UNK
damage	I-UNK
response	B-UNK
.	O

 	O
mutations	B-UNK
in	O
the	O
brca1	B-UNK
(	O
ref	O
.	O
1	O
)	O
tumour	B-UNK
suppressor	I-UNK
gene	B-UNK
are	O
found	B-UNK
in	O
almost	O
all	O
of	O
the	O
families	B-UNK
with	O
inherited	B-UNK
breast	B-UNK
and	O
ovarian	B-UNK
cancers	B-DISEASE
and	O
about	O
half	B-UNK
of	O
the	O
families	B-UNK
with	O
only	O
breast	B-DISEASE
cancer	I-DISEASE
.	O

 	O
although	O
the	O
biochemical	B-UNK
function	B-UNK
of	O
brca1	B-UNK
is	O
not	O
well	O
understood	O
,	O
it	O
is	O
important	B-UNK
for	O
dna	B-UNK
damage	I-UNK
repair	B-UNK
and	O
cell	B-UNK
-	O
cycle	B-UNK
checkpoint	B-UNK
.	O

 	B-UNK
brca1	I-UNK
exists	B-UNK
in	O
nuclear	B-UNK
foci	I-UNK
but	O
is	O
hyperphosphorylated	O
and	O
disperses	O
after	O
dna	B-UNK
damage	I-UNK
.	O

 	O
it	O
is	O
not	O
known	B-UNK
whether	O
brca1	B-UNK
phosphorylation	B-UNK
and	O
dispersion	O
and	O
its	O
function	B-UNK
in	O
dna	B-UNK
damage	I-UNK
response	B-UNK
are	O
related	B-UNK
.	O

 	O
in	O
yeast	B-UNK
the	O
dna	B-UNK
damage	I-UNK
response	B-UNK
and	O
the	O
replication	O
-	O
block	B-UNK
checkpoint	B-UNK
are	O
mediated	B-UNK
partly	O
through	O
the	O
cds1	O
kinase	B-UNK
family	B-UNK
.	O

 	O
here	O
we	O
report	B-UNK
that	O
the	O
human	B-UNK
cds1	O
kinase	B-UNK
(	O
hcds1	O
/	O
chk2	O
)	O
regulates	B-UNK
brca1	B-UNK
function	B-UNK
after	O
dna	B-UNK
damage	I-UNK
by	O
phosphorylating	O
serine	B-UNK
988	O
of	O
brca1	B-UNK
.	O

 	O
we	O
show	O
that	O
hcds1	O
and	O
brca1	B-UNK
interact	B-UNK
and	O
co	B-UNK
-	O
localize	B-UNK
within	O
discrete	B-UNK
nuclear	B-UNK
foci	I-UNK
but	O
separate	B-UNK
after	O
gamma	B-UNK
irradiation	O
.	O

 	O
phosphorylation	B-UNK
of	O
brca1	B-UNK
at	B-DISEASE
serine	B-UNK
988	O
is	O
required	B-UNK
for	O
the	O
release	B-UNK
of	O
brca1	B-UNK
from	O
hcds1	O
.	O

 	O
this	O
phosphorylation	B-UNK
is	O
also	O
important	B-UNK
for	O
the	O
ability	B-UNK
of	O
brca1	B-UNK
to	O
restore	O
survival	B-UNK
after	O
dna	B-UNK
damage	I-UNK
in	O
the	O
brca1	B-UNK
-	O
mutated	B-UNK
cell	B-UNK
line	B-UNK
hcc1937	O
.	O
.	O

 	O
characterization	B-UNK
of	O
the	O
rat	B-UNK
spinocerebellar	B-DISEASE
ataxia	I-DISEASE
type	B-UNK
3	O
gene	B-UNK
.	O

 	O
machado	B-DISEASE
-	I-DISEASE
joseph	I-DISEASE
disease	I-DISEASE
(	O
mjd	B-UNK
)	O
belongs	O
to	O
a	O
group	B-UNK
of	O
clinically	B-UNK
and	O
genetically	B-UNK
heterogeneous	B-UNK
neurodegenerative	B-DISEASE
disorders	I-DISEASE
characterized	B-UNK
by	O
progressive	B-UNK
cerebellar	B-DISEASE
ataxia	I-DISEASE
.	O

 	O
the	O
disease	B-DISEASE
-	O
causing	B-UNK
mutation	B-UNK
has	O
recently	B-UNK
been	O
identified	B-UNK
as	O
an	O
unstable	B-UNK
and	O
expanded	B-UNK
(	O
cag	B-UNK
)	O
n	B-UNK
trinucleotide	B-UNK
repeat	I-UNK
in	O
a	O
novel	B-UNK
gene	B-UNK
of	O
unknown	B-UNK
function	B-UNK
.	O

 	O
in	O
caucasians	B-UNK
,	O
repeat	B-UNK
expansions	B-UNK
in	O
the	O
mjd1	B-UNK
gene	B-UNK
have	O
also	O
been	O
found	B-UNK
in	O
patients	B-UNK
with	O
the	O
clinically	B-UNK
distinct	I-UNK
autosomal	O
dominant	B-UNK
spinocerebellar	B-DISEASE
ataxia	I-DISEASE
type	B-UNK
3	O
(	O
sca3	B-UNK
)	O
.	O

 	O
in	O
order	B-UNK
to	O
gain	O
insight	B-UNK
into	O
the	O
biology	O
of	O
the	O
mjd1	B-UNK
/	O
sca3	B-UNK
gene	B-UNK
we	O
cloned	B-UNK
the	O
rat	B-UNK
homologue	B-UNK
and	O
studied	B-UNK
its	O
expression	B-UNK
.	O

 	O
the	O
rat	B-UNK
and	O
human	B-UNK
ataxin	B-UNK
-	O
3	O
genes	B-UNK
are	O
highly	B-UNK
homologous	B-UNK
with	O
an	O
overall	B-UNK
sequence	B-UNK
identity	O
of	O
approximately	B-UNK
88	O
%	O
.	O

 	O
however	O
,	O
the	O
c	B-UNK
-	O
terminal	B-UNK
end	B-UNK
of	O
the	O
putative	B-UNK
protein	B-UNK
differs	O
strongly	B-UNK
from	O
the	O
published	B-UNK
human	B-UNK
sequence	B-UNK
.	O

 	O
the	O
(	O
cag	B-UNK
)	O
n	B-UNK
block	B-UNK
in	O
the	O
rat	B-UNK
cdna	B-UNK
consists	B-UNK
of	O
just	O
three	O
interrupted	O
units	B-UNK
suggesting	B-UNK
that	O
a	O
long	B-UNK
polyglutamine	B-UNK
stretch	O
is	O
not	O
essential	B-UNK
for	O
the	O
normal	B-UNK
function	B-UNK
of	O
the	O
ataxin	B-UNK
-	O
3	O
protein	B-UNK
in	O
rodents	O
.	O

 	O
the	O
expression	B-UNK
pattern	B-UNK
of	O
the	O
sca3	B-UNK
gene	B-UNK
in	O
various	O
rat	B-UNK
and	O
human	B-UNK
tissues	B-UNK
was	O
investigated	B-UNK
by	O
northern	B-UNK
blot	O
analyses	B-UNK
.	O

 	O
the	O
mature	B-UNK
transcript	B-UNK
is	O
approximately	B-UNK
6	O
kb	B-UNK
in	O
length	O
.	O

 	O
in	O
rat	B-UNK
testis	O
,	O
a	O
smaller	B-UNK
transcript	B-UNK
of	O
1	O
.	O

 	O
3	O
kb	B-UNK
was	O
identified	B-UNK
.	O

 	O
transcription	B-UNK
of	O
rsca3	O
was	O
detected	B-UNK
in	O
most	O
rat	B-UNK
tissues	B-UNK
including	B-UNK
brain	B-UNK
.	O

 	O
analyzing	O
the	O
expression	B-UNK
level	B-UNK
of	O
the	O
sca3	B-UNK
gene	B-UNK
in	O
several	O
human	B-UNK
brain	B-UNK
sections	B-UNK
revealed	B-UNK
no	O
significant	B-UNK
higher	B-UNK
mrna	B-UNK
level	B-UNK
in	O
regions	B-UNK
predominantly	B-UNK
affected	B-UNK
in	O
mjd	B-UNK
.	O

 	O
thus	O
additional	B-UNK
molecules	O
and	O
/	O
or	O
regulatory	B-UNK
events	B-UNK
are	O
necessary	O
to	O
explain	O
the	O
exclusive	B-UNK
degeneration	B-UNK
of	O
certain	B-UNK
brain	B-UNK
areas	B-UNK
.	O

 	O
emerin	B-UNK
,	O
deficiency	B-UNK
of	O
which	O
causes	B-UNK
emery	B-DISEASE
-	I-DISEASE
dreifuss	I-DISEASE
muscular	I-DISEASE
dystrophy	I-DISEASE
,	O
is	O
localized	B-UNK
at	B-DISEASE
the	O
inner	B-UNK
nuclear	I-UNK
membrane	B-UNK
.	O

 	O
x	B-UNK
-	O
linked	B-UNK
recessive	O
emery	B-DISEASE
-	I-DISEASE
dreifuss	I-DISEASE
muscular	I-DISEASE
dystrophy	I-DISEASE
(	O
edmd	B-UNK
)	O
is	O
an	O
inherited	B-UNK
muscle	B-UNK
disorder	O
characterized	B-UNK
by	O
the	O
clinical	B-UNK
triad	O
of	O
progressive	B-UNK
wasting	O
of	O
humero	O
-	O
peroneal	O
muscles	B-UNK
,	O
early	B-UNK
contractures	B-DISEASE
of	O
the	O
elbows	O
,	O
achilles	B-UNK
tendons	B-UNK
and	O
postcervical	O
muscles	B-UNK
,	O
and	O
cardiac	B-UNK
conduction	I-UNK
block	B-UNK
with	O
a	O
high	B-UNK
risk	B-UNK
of	O
sudden	O
death	B-DISEASE
.	O

 	O
the	O
gene	B-UNK
for	O
edmd	B-UNK
on	O
xq28	B-UNK
encodes	B-UNK
a	O
novel	B-UNK
protein	B-UNK
named	O
emerin	B-UNK
that	O
localizes	O
at	B-DISEASE
the	O
nuclear	B-UNK
membrane	I-UNK
of	O
skeletal	B-UNK
,	O
cardiac	B-UNK
and	O
smooth	B-UNK
muscles	B-UNK
and	O
some	O
other	O
non	B-UNK
-	O
muscle	B-UNK
tissues	B-UNK
.	O

 	O
to	O
investigate	O
a	O
possible	B-UNK
physiological	B-UNK
role	B-UNK
for	O
emerin	B-UNK
,	O
we	O
examined	B-UNK
the	O
ultrastructural	B-UNK
localization	B-UNK
of	O
the	O
protein	B-UNK
in	O
human	B-UNK
skeletal	B-UNK
muscle	I-UNK
and	O
hela	B-UNK
cells	B-UNK
,	O
using	O
ultrathin	O
cryosections	O
.	O

 	O
we	O
found	B-UNK
that	O
the	O
immune	B-UNK
-	O
labeled	B-UNK
colloidal	O
gold	O
particles	B-UNK
were	O
localized	B-UNK
on	O
the	O
nucleoplasmic	O
surface	B-UNK
of	O
the	O
inner	B-UNK
nuclear	I-UNK
membrane	B-UNK
,	O
but	O
not	O
on	O
the	O
nuclear	B-UNK
pore	O
.	O

 	O
emerin	B-UNK
stayed	O
on	O
the	O
cytoplasmic	B-UNK
surface	B-UNK
of	O
the	O
nuclear	B-UNK
lamina	B-UNK
,	O
even	O
after	O
detergent	O
treatment	B-UNK
that	O
solubilizes	O
membrane	B-UNK
lipids	O
and	O
washes	O
out	O
membrane	B-UNK
proteins	B-UNK
.	O

 	O
these	O
results	B-UNK
suggest	B-UNK
that	O
emerin	B-UNK
anchors	O
at	B-DISEASE
the	O
inner	B-UNK
nuclear	I-UNK
membrane	B-UNK
through	O
the	O
hydrophobic	B-UNK
stretch	O
,	O
and	O
protrudes	O
from	O
the	O
hydrophilic	O
region	B-UNK
to	O
the	O
nucleoplasm	O
where	O
it	O
interacts	B-UNK
with	O
the	O
nuclear	B-UNK
lamina	B-UNK
.	O

 	O
we	O
speculate	O
that	O
emerin	B-UNK
contributes	B-UNK
to	O
maintain	O
the	O
nuclear	B-UNK
structure	B-UNK
and	O
stability	B-UNK
,	O
as	O
well	O
as	O
nuclear	B-UNK
functions	B-UNK
,	O
particularly	B-UNK
in	O
muscle	B-UNK
tissues	B-UNK
that	O
have	O
severe	B-UNK
stress	B-UNK
with	O
rigorous	O
contraction	B-UNK
-	O
relaxation	O
movements	O
and	O
calcium	O
flux	O
.	O
.	O

 	O
locus	B-UNK
heterogeneity	I-UNK
in	O
friedreich	B-DISEASE
ataxia	I-DISEASE
.	O

 	O
friedreich	B-DISEASE
ataxia	I-DISEASE
(	O
frda	B-UNK
)	O
is	O
the	O
most	O
common	B-UNK
form	B-UNK
of	O
autosomal	O
recessive	O
ataxia	B-DISEASE
.	O

 	O
the	O
disease	B-DISEASE
locus	B-UNK
was	O
assigned	B-UNK
to	O
chromosome	B-DISEASE
9	I-DISEASE
and	O
the	O
disease	B-DISEASE
gene	B-UNK
,	O
stm7	O
/	O
x25	O
,	O
has	O
been	O
isolated	B-UNK
.	O

 	O
to	O
date	B-UNK
most	O
data	B-UNK
suggest	B-UNK
locus	B-UNK
homogeneity	B-UNK
in	O
frda	B-UNK
.	O

 	O
we	O
now	O
provide	B-UNK
strong	B-UNK
evidence	B-UNK
of	O
a	O
second	B-UNK
frda	B-UNK
locus	B-UNK
.	O

 	O
studying	O
two	O
siblings	B-UNK
with	O
frda	B-UNK
from	O
two	O
families	B-UNK
we	O
did	O
not	O
detect	B-UNK
a	O
mutation	B-UNK
in	O
stm7	O
/	O
x25	O
.	O

 	B-UNK
haplotype	I-UNK
analysis	B-UNK
of	O
the	O
stm7	O
/	O
x25	O
region	B-UNK
of	O
chromosome	B-DISEASE
9	I-DISEASE
demonstrated	B-UNK
that	O
the	O
relevant	B-UNK
portion	B-UNK
of	O
chromosome	B-DISEASE
9	I-DISEASE
differs	O
in	O
the	O
patients	B-UNK
.	O

 	O
although	O
the	O
patients	B-UNK
studied	B-UNK
had	O
typical	B-UNK
frda	B-UNK
,	O
one	O
sibpair	O
had	O
the	O
uncommon	B-UNK
symptom	B-UNK
of	O
retained	B-UNK
tendon	I-UNK
reflexes	O
.	O

 	O
in	O
order	B-UNK
to	O
investigate	O
whether	O
retained	B-UNK
tendon	I-UNK
reflexes	O
are	O
characteristic	B-UNK
of	O
frda	B-UNK
caused	B-UNK
by	O
the	O
second	B-UNK
locus	B-UNK
,	O
frda2	O
,	O
we	O
studied	B-UNK
an	O
unrelated	B-UNK
frda	B-UNK
patient	B-UNK
with	O
retained	B-UNK
tendon	I-UNK
reflexes	O
.	O

 	O
the	O
observation	B-UNK
of	O
typical	B-UNK
mutations	B-UNK
in	O
stm7	O
/	O
x25	O
(	O
gaa	B-UNK
expansions	B-UNK
)	O
in	O
this	O
patient	B-UNK
demonstrates	B-UNK
that	O
the	O
two	O
genetically	B-UNK
different	B-UNK
forms	B-UNK
of	O
frda	B-UNK
can	O
not	O
be	O
distinguished	O
clinically	B-UNK
.	O
.	O

 	O
glycerol	B-UNK
as	O
a	O
correlate	B-UNK
of	O
impaired	B-DISEASE
glucose	I-DISEASE
tolerance	I-DISEASE
:	O
dissection	O
of	O
a	O
complex	B-UNK
system	B-UNK
by	O
use	B-UNK
of	O
a	O
simple	B-UNK
genetic	B-UNK
trait	B-UNK
.	O

 	O
glycerol	B-UNK
kinase	B-UNK
(	O
gk	O
)	O
represents	B-UNK
the	O
primary	B-UNK
entry	O
of	O
glycerol	B-UNK
into	O
glucose	B-UNK
and	O
triglyceride	O
metabolism	B-DISEASE
.	O

 	O
impaired	B-DISEASE
glucose	I-DISEASE
tolerance	I-DISEASE
(	O
igt	O
)	O
and	O
hypertriglyceridemia	B-DISEASE
are	O
associated	B-UNK
with	O
an	O
increased	B-UNK
risk	B-UNK
of	O
diabetes	B-DISEASE
mellitus	I-DISEASE
and	O
cardiovascular	B-DISEASE
disease	I-DISEASE
.	O

 	O
the	O
relationship	B-UNK
between	O
glycerol	B-UNK
and	O
the	O
risk	B-UNK
of	O
igt	O
,	O
however	O
,	O
is	O
poorly	B-UNK
understood	O
.	O

 	O
we	O
therefore	O
undertook	O
the	O
study	B-UNK
of	O
fasting	O
plasma	B-UNK
glycerol	B-UNK
levels	B-UNK
in	O
a	O
cohort	B-UNK
of	O
1	O
,	O
056	O
unrelated	B-UNK
men	B-UNK
and	O
women	B-UNK
of	O
french	B-UNK
-	O
canadian	B-UNK
descent	B-UNK
.	O

 	B-UNK
family	I-UNK
screening	B-UNK
in	O
the	O
initial	B-UNK
cohort	B-UNK
identified	B-UNK
18	O
men	B-UNK
from	O
five	O
families	B-UNK
with	O
severe	B-UNK
hyperglycerolemia	O
(	O
values	B-UNK
above	O
2	O
.	O
0	O
mmol	O
/	O
liter	O
)	O
and	O
demonstrated	B-UNK
an	O
x	B-UNK
-	O
linked	B-UNK
pattern	B-UNK
of	O
inheritance	B-UNK
.	O

 	B-UNK
linkage	I-UNK
analysis	B-UNK
of	O
the	O
data	B-UNK
from	O
12	O
microsatellite	B-UNK
markers	I-UNK
surrounding	B-UNK
the	O
xp21	B-UNK
.	O

 	O
3	O
gk	O
gene	B-UNK
resulted	B-UNK
in	O
a	O
peak	B-UNK
lod	B-UNK
score	I-UNK
of	O
3	O
.	O

 	O
46	O
,	O
centered	O
around	O
marker	B-UNK
dxs8039	O
.	O

 	O
in	O
addition	B-UNK
,	O
since	O
all	O
of	O
the	O
families	B-UNK
originated	B-UNK
in	O
a	O
population	B-UNK
with	O
a	O
proven	O
founder	B-UNK
effect	B-UNK
-	O
the	O
saguenay	O
lac	O
-	O
st	O
.	O

 	O
-	O
jean	O
region	B-UNK
of	O
quebec	O
-	O
a	O
common	B-UNK
disease	B-DISEASE
haplotype	B-UNK
was	O
sought	O
.	O

 	O
indeed	O
,	O
a	O
six	O
-	O
marker	B-UNK
haplotype	B-UNK
extending	B-UNK
over	O
a	O
region	B-UNK
of	O
5	O
.	O

 	O
5	O
cm	B-DISEASE
was	O
observed	B-UNK
in	O
all	O
families	B-UNK
.	O

 	O
resequencing	O
of	O
the	O
gk	O
gene	B-UNK
in	O
family	B-UNK
members	I-UNK
led	B-UNK
to	O
the	O
discovery	B-UNK
of	O
a	O
n288d	O
missense	B-UNK
mutation	I-UNK
in	O
exon	B-UNK
10	O
,	O
which	O
resulted	B-UNK
in	O
the	O
substitution	B-UNK
of	O
a	O
highly	B-UNK
conserved	I-UNK
asparagine	O
residue	B-UNK
by	O
a	O
negatively	O
charged	O
aspartic	O
acid	O
.	O

 	B-UNK
clinical	I-UNK
and	O
molecular	B-UNK
genetics	B-UNK
of	O
primary	B-UNK
dystonias	B-UNK
.	O

 	O
primary	B-UNK
dystonias	B-UNK
are	O
movement	B-DISEASE
disorders	I-DISEASE
with	O
dystonia	B-DISEASE
as	O
a	O
major	B-UNK
symptom	B-UNK
.	O

 	O
they	O
are	O
frequently	B-UNK
inherited	B-UNK
as	O
mendelian	O
traits	O
.	O

 	O
there	O
are	O
at	B-DISEASE
least	O
eight	O
clinically	B-UNK
distinct	I-UNK
autosomal	O
dominant	B-UNK
and	O
two	O
x	B-UNK
-	O
linked	B-UNK
recessive	O
forms	B-UNK
.	O

 	O
in	O
addition	B-UNK
,	O
pedigree	B-UNK
analyses	B-UNK
suggest	B-UNK
the	O
occurrence	B-UNK
of	O
an	O
autosomal	O
recessive	O
variant	B-UNK
.	O

 	O
the	O
clinical	B-UNK
classification	B-UNK
is	O
increasingly	O
being	O
replaced	O
by	O
a	O
genetic	B-UNK
one	O
.	O

 	O
to	O
date	B-UNK
gene	B-UNK
loci	B-UNK
have	O
been	O
identified	B-UNK
in	O
at	B-DISEASE
least	O
six	O
autosomal	O
dominant	B-UNK
forms	B-UNK
,	O
i	O
.	O
e	B-UNK
.	O
,	O
in	O
idiopathic	O
torsion	B-DISEASE
dystonia	B-DISEASE
(	O
9q34	O
)	O
,	O
focal	O
dystonia	B-DISEASE
(	O
18p	O
)	O
,	O
adult	B-UNK
-	O
onset	B-UNK
idiopathic	O
torsion	B-DISEASE
dystonia	B-DISEASE
of	O
mixed	B-UNK
type	B-UNK
(	O
8p21	O
-	O
q22	O
)	O
,	O
dopa	O
-	O
responsive	O
dystonia	B-DISEASE
(	O
14q22	O
.	O
1	O
-	O
q22	O
.	O
2	O
)	O
,	O
and	O
paroxysmal	B-UNK
dystonic	O
choreoathetosis	B-DISEASE
(	O
2q25	O
-	O
q33	O
;	O
1p21	O
-	O
p13	O
.	O
3	O
)	O
.	O

 	O
gene	B-UNK
loci	B-UNK
in	O
the	O
x	B-UNK
-	O
linked	B-UNK
recessive	O
forms	B-UNK
have	O
been	O
assigned	B-UNK
to	O
xq13	O
.	O

 	O
1	O
in	O
the	O
x	B-UNK
-	O
linked	B-UNK
dystonia	B-DISEASE
parkinsonism	B-DISEASE
syndrome	B-DISEASE
and	O
to	O
xq22	O
in	O
x	B-UNK
-	O
linked	B-UNK
sensorineural	O
deafness	B-DISEASE
,	O
dystonia	B-DISEASE
,	O
and	O
mental	B-DISEASE
retardation	I-DISEASE
.	O

 	O
the	O
disease	B-DISEASE
genes	B-UNK
have	O
been	O
identified	B-UNK
in	O
two	O
autosomal	O
dominant	B-UNK
forms	B-UNK
and	O
in	O
one	O
x	B-UNK
-	O
linked	B-UNK
recessive	O
form	B-UNK
.	O

 	O
mutations	B-UNK
in	O
a	O
gene	B-UNK
coding	B-UNK
for	O
an	O
atp	B-UNK
-	O
binding	B-UNK
protein	B-UNK
were	O
detected	B-UNK
in	O
idiopathic	O
torsion	B-DISEASE
dystonia	B-DISEASE
(	O
dyt1	O
)	O
,	O
and	O
the	O
gtp	B-UNK
cyclohydrolase	B-UNK
1	O
gene	B-UNK
is	O
mutated	B-UNK
in	O
dopa	O
-	O
responsive	O
dystonia	B-DISEASE
(	O
dyt5	O
)	O
.	O

 	O
in	O
sensorineural	O
deafness	B-DISEASE
,	O
dystonia	B-DISEASE
,	O
and	O
mental	B-DISEASE
retardation	I-DISEASE
,	O
mutations	B-UNK
were	O
found	B-UNK
in	O
the	O
gene	B-UNK
ddp	O
coding	B-UNK
for	O
a	O
polypeptide	B-UNK
of	O
unknown	B-UNK
function	B-UNK
.	O

 	O
this	O
article	O
reviews	O
the	O
clinical	B-UNK
and	O
molecular	B-UNK
genetics	B-UNK
of	O
primary	B-UNK
dystonias	B-UNK
,	O
critically	O
discusses	O
present	B-UNK
findings	B-UNK
,	O
and	O
proposes	O
referring	O
to	O
the	O
known	B-UNK
forms	B-UNK
,	O
most	O
of	O
which	O
can	O
be	O
distinguished	O
by	O
genetic	B-UNK
criteria	B-UNK
,	O
as	O
dystonias	B-UNK
1	O
-	O
12	O
.	O

 	O
determination	B-UNK
of	O
30	O
x	B-UNK
-	O
linked	B-UNK
adrenoleukodystrophy	B-DISEASE
mutations	B-UNK
,	O
including	B-UNK
15	O
not	O
previously	B-UNK
described	I-UNK
.	O

 	O
x	B-UNK
-	O
linked	B-UNK
adrenoleukodystrophy	B-DISEASE
(	O
x	B-UNK
-	O
ald	B-UNK
)	O
is	O
the	O
most	O
frequent	B-UNK
peroxisomal	B-UNK
disease	B-DISEASE
.	O

 	O
it	O
mainly	B-UNK
involves	B-UNK
the	O
nervous	B-UNK
system	I-UNK
white	B-UNK
matter	I-UNK
,	O
adrenal	B-UNK
cortex	O
and	O
testes	O
.	O

 	O
several	O
distinct	B-UNK
clinical	B-UNK
phenotypes	I-UNK
are	O
known	B-UNK
.	O

 	O
the	O
principal	B-UNK
biochemical	B-UNK
abnormality	B-UNK
is	O
the	O
accumulation	B-UNK
of	O
saturated	O
very	O
-	O
long	B-UNK
-	O
chain	B-UNK
fatty	I-UNK
acids	I-UNK
(	O
vlcfas	O
>	O
c22	O
0	O
,	O
mainly	B-UNK
c26	B-UNK
0	O
)	O
,	O
which	O
is	O
due	O
to	O
impaired	B-UNK
capacity	B-UNK
for	O
beta	B-UNK
-	O
oxidation	B-UNK
in	O
peroxisomes	O
.	O

 	O
diagnosis	B-UNK
is	O
usually	B-UNK
based	B-UNK
on	O
the	O
vlcfa	B-UNK
levels	B-UNK
in	O
plasma	B-UNK
or	O
cultured	B-UNK
skin	B-DISEASE
fibroblasts	B-UNK
in	O
both	O
patients	B-UNK
and	O
carriers	B-UNK
.	O

 	O
in	O
0	O
.	O

 	O
1	O
%	O
of	O
affected	B-UNK
males	B-UNK
,	O
however	O
,	O
the	O
plasma	B-UNK
c26	B-UNK
0	O
level	B-UNK
is	O
borderline	O
normal	B-UNK
,	O
and	O
15	O
%	O
of	O
obligate	B-UNK
female	B-UNK
carriers	B-UNK
have	O
normal	B-UNK
results	B-UNK
.	O

 	O
effective	B-UNK
mutation	B-UNK
detection	B-UNK
in	O
these	O
families	B-UNK
is	O
therefore	O
fundamental	O
to	O
unambiguously	B-UNK
determine	O
the	O
genetic	B-UNK
status	B-UNK
of	O
each	O
individual	B-UNK
at	B-DISEASE
risk	B-UNK
.	O

 	O
of	O
particular	B-UNK
concern	O
are	O
female	B-UNK
members	B-UNK
of	O
kindreds	B-UNK
segregating	B-UNK
x	B-UNK
-	O
ald	B-UNK
mutations	B-UNK
,	O
because	O
normal	B-UNK
vlcfa	B-UNK
levels	B-UNK
do	O
not	O
guarantee	O
lack	B-UNK
of	O
carrier	B-UNK
status	B-UNK
.	O

 	O
we	O
describe	B-UNK
a	O
fast	B-UNK
method	B-UNK
for	O
detection	B-UNK
of	O
x	B-UNK
-	O
ald	B-UNK
mutations	B-UNK
.	O

 	O
the	O
method	B-UNK
is	O
based	B-UNK
on	O
sscp	B-UNK
analysis	B-UNK
of	O
nested	B-UNK
pcr	B-UNK
fragments	B-UNK
followed	B-UNK
by	O
sequence	B-UNK
-	O
determination	B-UNK
reactions	B-UNK
.	O

 	O
using	O
this	O
methodology	O
we	O
have	O
found	B-UNK
x	B-UNK
-	O
ald	B-UNK
mutations	B-UNK
in	O
30	O
kindreds	B-UNK
,	O
including	B-UNK
15	O
not	O
previously	B-UNK
reported	I-UNK
.	O

 	O
beta	B-UNK
-	O
galactosidase	B-UNK
gene	B-UNK
mutations	B-UNK
affecting	B-UNK
the	O
lysosomal	B-UNK
enzyme	B-UNK
and	O
the	O
elastin	O
-	O
binding	B-UNK
protein	B-UNK
in	O
gm1	O
-	O
gangliosidosis	B-DISEASE
patients	B-UNK
with	O
cardiac	B-UNK
involvement	B-UNK
.	O

 	O
gm1	O
-	O
gangliosidosis	B-DISEASE
is	O
a	O
lysosomal	B-UNK
storage	B-UNK
disorder	I-UNK
caused	I-UNK
by	O
deficiency	B-UNK
of	O
acid	O
beta	B-UNK
-	O
galactosidase	B-UNK
(	O
glb1	O
)	O
.	O

 	O
we	O
report	B-UNK
five	O
new	B-UNK
beta	B-UNK
-	O
galactosidase	B-UNK
gene	B-UNK
mutations	B-UNK
in	O
nine	O
italian	B-UNK
patients	B-UNK
and	O
one	O
fetus	B-UNK
,	O
segregating	B-UNK
in	O
seven	B-UNK
unrelated	B-UNK
families	I-UNK
.	O

 	O
six	O
of	O
the	O
eight	O
patients	B-UNK
with	O
the	O
infantile	B-UNK
,	O
severe	B-UNK
form	B-UNK
of	O
the	O
disease	B-DISEASE
presented	B-UNK
cardiac	B-UNK
involvement	B-UNK
,	O
a	O
feature	B-UNK
rarely	B-UNK
associated	B-UNK
with	O
gm1	O
-	O
gangliosidosis	B-DISEASE
.	O

 	B-UNK
molecular	I-UNK
analysis	B-UNK
of	O
the	O
patients	B-UNK
rna	B-UNK
and	O
dna	B-UNK
identified	B-UNK
two	O
new	B-UNK
rna	B-UNK
splicing	I-UNK
defects	B-UNK
,	O
three	O
new	B-UNK
and	O
three	O
previously	B-UNK
described	I-UNK
amino	B-UNK
acid	I-UNK
substitutions	B-UNK
.	O

 	O
interestingly	B-UNK
,	O
all	O
patients	B-UNK
with	O
cardiac	B-UNK
involvement	B-UNK
were	O
homozygous	B-UNK
for	O
one	O
of	O
these	O
mutations	B-UNK
r59h	O
,	O
y591c	O
,	O
y591n	O
,	O
or	O
ivs14	O
-	O
2a	O
>	O
g	B-UNK
.	O

 	O
in	O
contrast	B-UNK
,	O
all	O
other	O
patients	B-UNK
were	O
compound	B-UNK
heterozygous	B-UNK
for	O
one	O
of	O
the	O
following	B-UNK
mutations	B-UNK
r201h	O
,	O
r482h	O
,	O
g579d	O
,	O
ivs8	O
+	O
2	O
t	B-UNK
>	O
c	B-UNK
.	O

 	O
although	O
we	O
could	O
not	O
directly	B-UNK
correlate	B-UNK
the	O
presence	B-UNK
of	O
cardiac	B-UNK
abnormalities	B-DISEASE
with	O
specific	B-UNK
genetic	B-UNK
lesions	B-UNK
,	O
the	O
mutations	B-UNK
identified	B-UNK
in	O
patients	B-UNK
with	O
cardiomyopathy	B-DISEASE
fell	O
in	O
the	O
glb1	O
cdna	B-UNK
region	B-UNK
common	B-UNK
to	O
the	O
lysosomal	B-UNK
enzyme	B-UNK
and	O
the	O
hbeta	O
-	O
gal	O
-	O
related	B-UNK
protein	B-UNK
,	O
also	O
known	B-UNK
as	O
the	O
elastin	O
binding	B-UNK
protein	B-UNK
(	O
ebp	O
)	O
.	O

 	O
consequently	B-UNK
,	O
both	O
molecules	O
are	O
affected	B-UNK
by	O
the	O
mutations	B-UNK
,	O
and	O
they	O
may	O
contribute	B-UNK
differently	B-UNK
to	O
the	O
occurrence	B-UNK
of	O
specific	B-UNK
clinical	B-UNK
manifestations	B-UNK
.	O
.	O

 	O
in	O
vivo	B-UNK
modulation	O
of	O
hmgic	B-UNK
reduces	B-UNK
obesity	B-DISEASE
.	O

 	O
the	O
hmgi	O
family	B-UNK
of	O
proteins	B-UNK
consists	B-UNK
of	O
three	O
members	B-UNK
,	O
hmgic	B-UNK
,	O
hmgi	O
and	O
hmgi	O
(	O
y	O
)	O
,	O
that	O
function	B-UNK
as	O
architectural	O
factors	B-UNK
and	O
are	O
essential	B-UNK
components	B-UNK
of	O
the	O
enhancesome	O
.	O

 	O
hmgic	B-UNK
is	O
predominantly	B-UNK
expressed	B-UNK
in	O
proliferating	O
,	O
undifferentiated	O
mesenchymal	B-UNK
cells	B-UNK
and	O
is	O
not	O
detected	B-UNK
in	O
adult	B-UNK
tissues	B-UNK
.	O

 	O
it	O
is	O
disrupted	B-UNK
and	O
misexpressed	O
in	O
a	O
number	B-UNK
of	O
mesenchymal	B-UNK
tumour	B-UNK
cell	B-UNK
types	B-UNK
,	O
including	B-UNK
fat	B-UNK
-	O
cell	B-UNK
tumours	B-UNK
(	O
lipomas	O
)	O
.	O

 	O
in	O
addition	B-UNK
hmgic	B-UNK
-	O
/	O
-	O
mice	B-UNK
have	O
a	O
deficiency	B-UNK
in	O
fat	B-UNK
tissue	B-UNK
.	O

 	O
to	O
study	B-UNK
its	O
role	B-UNK
in	O
adipogenesis	O
and	O
obesity	B-DISEASE
,	O
we	O
examined	B-UNK
hmgic	B-UNK
expression	B-UNK
in	O
the	O
adipose	O
tissue	B-UNK
of	O
adult	B-UNK
,	O
obese	O
mice	B-UNK
.	O

 	B-UNK
mice	I-UNK
with	O
a	O
partial	B-UNK
or	O
complete	B-UNK
deficiency	B-UNK
of	O
hmgic	B-UNK
resisted	O
diet	O
-	O
induced	B-UNK
obesity	B-DISEASE
.	O

 	O
disruption	B-UNK
of	O
hmgic	B-UNK
caused	B-UNK
a	O
reduction	B-UNK
in	O
the	O
obesity	B-DISEASE
induced	B-UNK
by	O
leptin	O
deficiency	B-UNK
(	O
lepob	O
/	O
lepob	O
)	O
in	O
a	O
gene	B-UNK
-	O
dose	O
-	O
dependent	B-UNK
manner	B-UNK
.	O

 	O
our	O
studies	B-UNK
implicate	B-UNK
a	O
role	B-UNK
for	O
hmgic	B-UNK
in	O
fat	B-UNK
-	O
cell	B-UNK
proliferation	B-UNK
,	O
indicating	B-UNK
that	O
it	O
may	O
be	O
an	O
adipose	O
-	O
specific	B-UNK
target	B-UNK
for	O
the	O
treatment	B-UNK
of	O
obesity	B-DISEASE
.	O
.	O

 	B-UNK
molecular	I-UNK
analysis	B-UNK
of	O
the	O
genotype	B-UNK
-	O
phenotype	B-UNK
relationship	B-UNK
in	O
factor	B-DISEASE
x	I-DISEASE
deficiency	I-DISEASE
.	O

 	O
factor	B-DISEASE
x	I-DISEASE
deficiency	I-DISEASE
is	O
a	O
rare	B-UNK
haemorrhagic	O
condition	B-UNK
,	O
normally	B-UNK
inherited	B-UNK
as	O
an	O
autosomal	O
recessive	O
trait	B-UNK
,	O
in	O
which	O
a	O
variable	B-UNK
clinical	I-UNK
presentation	O
correlates	B-UNK
poorly	B-UNK
with	O
laboratory	B-UNK
phenotype	B-UNK
.	O

 	O
the	O
factor	B-UNK
x	B-UNK
(	O
f10	B-UNK
)	O
genes	B-UNK
of	O
14	O
unrelated	B-UNK
individuals	B-UNK
with	O
factor	B-DISEASE
x	I-DISEASE
deficiency	I-DISEASE
(	O
12	O
familial	B-UNK
and	O
two	O
sporadic	B-UNK
cases	B-UNK
)	O
were	O
sequenced	B-UNK
yielding	O
a	O
total	B-UNK
of	O
13	O
novel	B-UNK
mutations	B-UNK
.	O

 	B-UNK
family	I-UNK
studies	B-UNK
were	O
performed	B-UNK
in	O
order	B-UNK
to	O
distinguish	O
the	O
contributions	O
of	O
individual	B-UNK
mutant	B-UNK
f10	B-UNK
alleles	B-UNK
to	O
the	O
clinical	B-UNK
and	O
laboratory	B-UNK
phenotypes	B-UNK
.	O

 	B-UNK
missense	I-UNK
mutations	B-UNK
were	O
studied	B-UNK
by	O
means	O
of	O
molecular	B-UNK
modelling	O
,	O
whereas	O
single	B-UNK
basepair	O
substitutions	B-UNK
in	O
splice	O
sites	B-UNK
and	O
the	O
5	O
flanking	B-UNK
region	B-UNK
were	O
examined	B-UNK
by	O
in	O
vitro	B-UNK
splicing	B-UNK
assay	B-UNK
and	O
luciferase	O
reporter	B-UNK
gene	B-UNK
assay	B-UNK
respectively	B-UNK
.	O

 	O
the	O
deletion	B-UNK
allele	B-UNK
of	O
a	O
novel	B-UNK
hexanucleotide	O
insertion	B-UNK
/	O
deletion	B-UNK
polymorphism	O
in	O
the	O
f10	B-UNK
gene	B-UNK
promoter	B-UNK
region	I-UNK
was	O
shown	B-UNK
by	O
reporter	B-UNK
gene	B-UNK
assay	B-UNK
,	O
to	O
reduce	B-UNK
promoter	B-UNK
activity	B-UNK
by	O
approximately	B-UNK
20	O
%	O
.	O

 	O
one	O
family	B-UNK
manifesting	O
an	O
autosomal	O
dominant	B-UNK
pattern	B-UNK
of	O
inheritance	B-UNK
possessed	O
three	O
clinically	B-UNK
affected	B-UNK
members	B-UNK
who	O
were	O
heterozygous	B-UNK
for	O
a	O
splice	O
-	O
site	B-UNK
mutation	B-UNK
that	O
was	O
predicted	B-UNK
to	O
lead	B-UNK
to	O
the	O
production	B-UNK
of	O
a	O
truncated	B-UNK
protein	B-UNK
product	B-UNK
.	O

 	O
a	O
model	B-UNK
which	O
accounts	O
for	O
the	O
dominant	B-UNK
negative	I-UNK
effect	B-UNK
of	O
this	O
lesion	B-UNK
is	O
presented	B-UNK
.	O

 	O
variation	B-UNK
in	O
the	O
antigen	B-UNK
level	B-UNK
of	O
heterozygous	B-UNK
relatives	B-UNK
of	O
probands	B-UNK
was	O
found	B-UNK
to	O
be	O
significantly	B-UNK
higher	B-UNK
between	O
families	B-UNK
than	O
within	O
families	B-UNK
,	O
consistent	B-UNK
with	O
the	O
view	O
that	O
the	O
nature	B-UNK
of	O
the	O
f10	B-UNK
lesion	B-UNK
(	O
s	O
)	O
segregating	B-UNK
in	O
a	O
given	B-UNK
family	B-UNK
is	O
a	O
prime	O
determinant	B-UNK
of	O
the	O
laboratory	B-UNK
phenotype	B-UNK
.	O

 	O
by	O
contrast	B-UNK
,	O
no	O
such	O
relationship	B-UNK
could	O
be	O
discerned	O
between	O
laboratory	B-UNK
phenotype	B-UNK
and	O
polymorphism	O
genotype	B-UNK
.	O
.	O

 	O
transgenic	B-UNK
mice	I-UNK
expressing	B-UNK
a	O
truncated	B-UNK
form	B-UNK
of	O
the	O
high	B-UNK
mobility	B-UNK
group	B-UNK
i	O
-	O
c	B-UNK
protein	B-UNK
develop	B-UNK
adiposity	O
and	O
an	O
abnormally	B-UNK
high	B-UNK
prevalence	B-UNK
of	O
lipomas	O
.	O

 	B-UNK
chromosomal	I-UNK
translocations	B-UNK
in	O
human	B-UNK
lipomas	O
frequently	B-UNK
create	O
fusion	B-UNK
transcripts	B-UNK
encoding	B-UNK
high	B-UNK
mobility	B-UNK
group	B-UNK
(	O
hmg	O
)	O
i	O
-	O
c	B-UNK
dna	B-UNK
-	O
binding	B-UNK
domains	B-UNK
and	O
c	B-UNK
-	O
terminal	B-UNK
sequences	B-UNK
from	O
different	B-UNK
presumed	B-UNK
transcription	B-UNK
factors	I-UNK
,	O
suggesting	B-UNK
a	O
potential	B-UNK
role	B-UNK
for	O
hmg	O
i	O
-	O
c	B-UNK
in	O
the	O
development	B-UNK
of	O
lipomas	O
.	O

 	O
to	O
evaluate	O
the	O
role	B-UNK
of	O
the	O
hmg	O
i	O
-	O
c	B-UNK
component	B-UNK
,	O
the	O
three	O
dna	B-UNK
-	O
binding	B-UNK
domains	B-UNK
of	O
hmg	O
i	O
-	O
c	B-UNK
have	O
now	O
been	O
expressed	B-UNK
in	O
transgenic	B-UNK
mice	I-UNK
.	O

 	O
despite	B-UNK
the	O
ubiquitous	O
expression	B-UNK
of	O
the	O
truncated	B-UNK
hmg	O
i	O
-	O
c	B-UNK
protein	B-UNK
,	O
the	O
transgenic	B-UNK
mice	I-UNK
develop	B-UNK
a	O
selective	B-UNK
abundance	O
of	O
fat	B-UNK
tissue	B-UNK
early	B-UNK
in	O
life	B-UNK
,	O
show	O
marked	B-UNK
adipose	O
tissue	B-UNK
inflammation	B-DISEASE
,	O
and	O
have	O
an	O
abnormally	B-UNK
high	B-UNK
incidence	O
of	O
lipomas	O
.	O

 	O
these	O
findings	B-UNK
demonstrate	B-UNK
that	O
the	O
dna	B-UNK
-	O
binding	B-UNK
domains	B-UNK
of	O
hmg	O
i	O
-	O
c	B-UNK
,	O
in	O
the	O
absence	B-UNK
of	O
a	O
c	B-UNK
-	O
terminal	B-UNK
fusion	B-UNK
partner	O
,	O
are	O
sufficient	B-UNK
to	O
perturb	O
adipogenesis	O
and	O
predispose	B-UNK
to	O
lipomas	O
.	O

 	O
we	O
provide	B-UNK
data	B-UNK
supporting	B-UNK
the	O
central	B-UNK
utility	O
of	O
this	O
animal	B-UNK
model	B-UNK
as	O
a	O
tool	B-UNK
to	O
understand	O
the	O
molecular	B-UNK
mechanisms	I-UNK
underlying	B-UNK
the	O
development	B-UNK
of	O
one	O
of	O
the	O
most	O
common	B-UNK
kind	O
of	O
human	B-UNK
benign	B-UNK
tumors	B-DISEASE
.	O
.	O

 	B-UNK
atm	I-UNK
phosphorylates	O
p95	B-UNK
/	O
nbs1	B-UNK
in	O
an	O
s	O
-	O
phase	B-UNK
checkpoint	I-UNK
pathway	B-UNK
.	O

 	O
the	O
rare	B-DISEASE
diseases	I-DISEASE
ataxia	B-DISEASE
-	O
telangiectasia	B-DISEASE
(	O
at	B-DISEASE
)	O
,	O
caused	B-UNK
by	O
mutations	B-UNK
in	O
the	O
atm	B-UNK
gene	B-UNK
,	O
and	O
nijmegen	B-DISEASE
breakage	I-DISEASE
syndrome	I-DISEASE
(	O
nbs	B-UNK
)	O
,	O
with	O
mutations	B-UNK
in	O
the	O
p95	B-UNK
/	O
nbs1	B-UNK
gene	B-UNK
,	O
share	B-UNK
a	O
variety	B-UNK
of	O
phenotypic	B-UNK
abnormalities	B-DISEASE
such	O
as	O
chromosomal	B-DISEASE
instability	I-DISEASE
,	O
radiation	B-UNK
sensitivity	B-UNK
and	O
defects	B-UNK
in	O
cell	B-UNK
-	O
cycle	B-UNK
checkpoints	O
in	O
response	B-UNK
to	O
ionizing	B-UNK
radiation	B-UNK
.	O

 	O
the	O
atm	B-UNK
gene	B-UNK
encodes	B-UNK
a	O
protein	B-UNK
kinase	B-UNK
that	O
is	O
activated	B-UNK
by	O
ionizing	B-UNK
radiation	B-UNK
or	O
radiomimetic	O
drugs	B-UNK
,	O
whereas	O
p95	B-UNK
/	O
nbs1	B-UNK
is	O
part	O
of	O
a	O
protein	B-UNK
complex	B-UNK
that	O
is	O
involved	B-UNK
in	O
responses	B-UNK
to	O
dna	B-UNK
double	B-UNK
-	O
strand	O
breaks	B-UNK
.	O

 	O
here	O
,	O
because	O
of	O
the	O
similarities	O
between	O
at	B-DISEASE
and	O
nbs	B-UNK
,	O
we	O
evaluated	O
the	O
functional	B-UNK
interactions	B-UNK
between	O
atm	B-UNK
and	O
p95	B-UNK
/	O
nbs1	B-UNK
.	O

 	O
activation	B-UNK
of	O
the	O
atm	B-UNK
kinase	B-UNK
by	O
ionizing	B-UNK
radiation	B-UNK
and	O
induction	O
of	O
atm	B-UNK
-	O
dependent	B-UNK
responses	B-UNK
in	O
nbs	B-UNK
cells	B-UNK
indicated	B-UNK
that	O
p95	B-UNK
/	O
nbs1	B-UNK
may	O
not	O
be	O
required	B-UNK
for	O
signalling	B-UNK
to	O
atm	B-UNK
after	O
ionizing	B-UNK
radiation	B-UNK
.	O

 	O
however	O
,	O
p95	B-UNK
/	O
nbs1	B-UNK
was	O
phosphorylated	O
on	O
serine	B-UNK
343	O
in	O
an	O
atm	B-UNK
-	O
dependent	B-UNK
manner	B-UNK
in	O
vitro	B-UNK
and	O
in	O
vivo	B-UNK
after	O
ionizing	B-UNK
radiation	B-UNK
.	O

 	O
a	O
p95	B-UNK
/	O
nbs1	B-UNK
construct	B-UNK
mutated	B-UNK
at	B-DISEASE
the	O
atm	B-UNK
phosphorylation	B-UNK
site	B-UNK
abrogated	O
an	O
s	O
-	O
phase	B-UNK
checkpoint	I-UNK
induced	B-UNK
by	O
ionizing	B-UNK
radiation	B-UNK
in	O
normal	B-UNK
cells	B-UNK
and	O
failed	B-UNK
to	O
compensate	O
for	O
this	O
functional	B-UNK
deficiency	B-UNK
in	O
nbs	B-UNK
cells	B-UNK
.	O

 	O
these	O
observations	B-UNK
link	B-UNK
atm	B-UNK
and	O
p95	B-UNK
/	O
nbs1	B-UNK
in	O
a	O
common	B-UNK
signalling	B-UNK
pathway	B-UNK
and	O
provide	B-UNK
an	O
explanation	B-UNK
for	O
phenotypic	B-UNK
similarities	O
in	O
these	O
two	O
diseases	B-DISEASE
.	O
.	O

 	O
understanding	B-UNK
the	O
molecular	B-UNK
basis	I-UNK
of	O
fragile	B-DISEASE
x	I-DISEASE
syndrome	I-DISEASE
.	O

 	O
fragile	B-DISEASE
x	I-DISEASE
syndrome	I-DISEASE
,	O
a	O
common	B-UNK
form	B-UNK
of	O
inherited	B-UNK
mental	B-DISEASE
retardation	I-DISEASE
,	O
is	O
mainly	B-UNK
caused	B-UNK
by	O
massive	B-UNK
expansion	B-UNK
of	O
cgg	B-UNK
triplet	B-UNK
repeats	I-UNK
located	B-UNK
in	O
the	O
5	O
-	O
untranslated	B-UNK
region	B-UNK
of	O
the	O
fragile	B-UNK
x	I-UNK
mental	B-DISEASE
retardation	I-DISEASE
-	O
1	O
(	O
fmr1	B-UNK
)	O
gene	B-UNK
.	O

 	O
in	O
patients	B-UNK
with	O
fragile	B-DISEASE
x	I-DISEASE
syndrome	I-DISEASE
,	O
the	O
expanded	B-UNK
cgg	B-UNK
triplet	B-UNK
repeats	I-UNK
are	O
hypermethylated	O
and	O
the	O
expression	B-UNK
of	O
the	O
fmr1	B-UNK
gene	B-UNK
is	O
repressed	O
,	O
which	O
leads	B-UNK
to	O
the	O
absence	B-UNK
of	O
fmr1	B-UNK
protein	B-UNK
(	O
fmrp	O
)	O
and	O
subsequent	B-UNK
mental	B-DISEASE
retardation	I-DISEASE
.	O

 	O
fmrp	O
is	O
an	O
rna	B-UNK
-	O
binding	B-UNK
protein	B-UNK
that	O
shuttles	O
between	O
the	O
nucleus	O
and	O
cytoplasm	O
.	O

 	O
this	O
protein	B-UNK
has	O
been	O
implicated	O
in	O
protein	B-UNK
translation	B-UNK
as	O
it	O
is	O
found	B-UNK
associated	B-UNK
with	O
polyribosomes	O
and	O
the	O
rough	O
endoplasmic	O
reticulum	O
.	O

 	O
we	O
discuss	O
here	O
the	O
recent	B-UNK
progress	O
made	O
towards	O
understanding	B-UNK
the	O
molecular	B-UNK
mechanism	B-UNK
of	O
cgg	B-UNK
repeat	B-UNK
expansion	I-UNK
and	O
physiological	B-UNK
function	B-UNK
(	O
s	O
)	O
of	O
fmrp	O
.	O

 	O
these	O
studies	B-UNK
will	O
not	O
only	O
help	O
to	O
illuminate	O
the	O
molecular	B-UNK
basis	I-UNK
of	O
the	O
general	B-UNK
class	B-UNK
of	O
human	B-UNK
diseases	B-DISEASE
with	O
trinucleotide	B-UNK
repeat	I-UNK
expansion	B-UNK
but	O
also	O
provide	B-UNK
an	O
avenue	O
to	O
understand	O
aspects	O
of	O
human	B-UNK
cognition	O
and	O
intelligence	B-UNK
.	O
.	O

 	O
haploinsufficiency	O
of	O
the	O
transcription	B-UNK
factors	I-UNK
foxc1	B-UNK
and	O
foxc2	O
results	B-UNK
in	O
aberrant	B-UNK
ocular	O
development	B-UNK
.	O

 	O
anterior	B-UNK
segment	I-UNK
developmental	B-UNK
disorders	B-UNK
,	O
including	B-UNK
axenfeld	O
-	O
rieger	O
anomaly	B-UNK
(	O
ara	O
)	O
,	O
variably	O
associate	O
with	O
harmfully	O
elevated	B-UNK
intraocular	O
pressure	B-UNK
(	O
iop	O
)	O
,	O
which	O
causes	B-UNK
glaucoma	B-DISEASE
.	O

 	O
clinically	B-UNK
observed	B-UNK
dysgenesis	O
does	O
not	O
correlate	B-UNK
with	O
iop	O
,	O
however	O
,	O
and	O
the	O
etiology	B-UNK
of	O
glaucoma	B-DISEASE
development	B-UNK
is	O
not	O
understood	O
.	O

 	O
the	O
forkhead	B-UNK
transcription	B-UNK
factor	B-UNK
genes	B-UNK
foxc1	B-UNK
(	O
formerly	O
mf1	O
)	O
and	O
foxc2	O
(	O
formerly	O
mfh1	O
)	O
are	O
expressed	B-UNK
in	O
the	O
mesenchyme	O
from	O
which	O
the	O
ocular	O
drainage	O
structures	B-UNK
derive	O
.	O

 	O
mutations	B-UNK
in	O
the	O
human	B-UNK
homolog	B-UNK
of	O
foxc1	B-UNK
,	O
fkhl7	O
,	O
cause	B-UNK
dominant	B-UNK
anterior	B-UNK
segment	I-UNK
defects	B-UNK
and	O
glaucoma	B-DISEASE
in	O
various	O
families	B-UNK
.	O

 	O
we	O
show	O
that	O
foxc1	B-UNK
(	O
+	O
/	O
-	O
)	O
mice	B-UNK
have	O
anterior	B-UNK
segment	I-UNK
abnormalities	B-DISEASE
similar	B-UNK
to	O
those	O
reported	B-UNK
in	O
human	B-UNK
patients	B-UNK
.	O

 	O
these	O
abnormalities	B-DISEASE
include	B-UNK
small	B-UNK
or	O
absent	B-UNK
schlemms	O
canal	O
,	O
aberrantly	B-UNK
developed	B-UNK
trabecular	O
meshwork	O
,	O
iris	B-UNK
hypoplasia	B-UNK
,	O
severely	B-UNK
eccentric	O
pupils	O
and	O
displaced	O
schwalbes	O
line	B-UNK
.	O

 	O
the	O
penetrance	B-UNK
of	O
clinically	B-UNK
obvious	B-UNK
abnormalities	B-DISEASE
varies	B-UNK
with	O
genetic	B-UNK
background	B-UNK
.	O

 	O
in	O
some	O
affected	B-UNK
eyes	O
,	O
collagen	O
bundles	O
were	O
half	B-UNK
normal	B-UNK
diameter	O
,	O
or	O
collagen	O
and	O
elastic	O
tissue	B-UNK
were	O
very	O
sparse	O
.	O

 	O
thus	O
,	O
abnormalities	B-DISEASE
in	O
extracellular	B-UNK
matrix	B-UNK
synthesis	B-UNK
or	O
organization	B-UNK
may	O
contribute	B-UNK
to	O
development	B-UNK
of	O
the	O
ocular	O
phenotypes	B-UNK
.	O

 	O
despite	B-UNK
the	O
abnormalities	B-DISEASE
in	O
ocular	O
drainage	O
structures	B-UNK
in	O
foxc1	B-UNK
(	O
+	O
/	O
-	O
)	O
mice	B-UNK
,	O
iop	O
was	O
normal	B-UNK
in	O
almost	O
all	O
mice	B-UNK
analyzed	B-UNK
,	O
on	O
all	O
genetic	B-UNK
backgrounds	O
and	O
at	B-DISEASE
all	O
ages	O
.	O

 	O
similar	B-UNK
abnormalities	B-DISEASE
were	O
found	B-UNK
in	O
foxc2	O
(	O
+	O
/	O
-	O
)	O
mice	B-UNK
,	O
but	O
no	O
disease	B-DISEASE
-	O
associated	B-UNK
mutations	B-UNK
were	O
identified	B-UNK
in	O
the	O
human	B-UNK
homolog	B-UNK
fkhl14	O
in	O
32	O
ara	O
patients	B-UNK
.	O

 	O
foxc1	B-UNK
(	O
+	O
/	O
-	O
)	O
and	O
foxc2	O
(	O
+	O
/	O
-	O
)	O
mice	B-UNK
are	O
useful	B-UNK
models	B-UNK
for	O
studying	O
anterior	B-UNK
segment	I-UNK
development	B-UNK
and	O
its	O
anomalies	B-UNK
,	O
and	O
may	O
allow	B-UNK
identification	B-UNK
of	O
genes	B-UNK
that	O
interact	B-UNK
with	O
foxc1	B-UNK
and	O
foxc2	O
(	O
or	O
fkhl7	O
and	O
fkhl14	O
)	O
to	O
produce	B-UNK
a	O
phenotype	B-UNK
with	O
elevated	B-UNK
iop	O
and	O
glaucoma	B-DISEASE
.	O
.	O

 	O
(	O
over	O
)	O
correction	O
of	O
fmr1	B-UNK
deficiency	B-UNK
with	O
yac	B-UNK
transgenics	O
:	O
behavioral	B-UNK
and	O
physical	B-UNK
features	B-UNK
.	O

 	O
fragile	B-DISEASE
x	I-DISEASE
syndrome	I-DISEASE
is	O
a	O
common	B-UNK
cause	B-UNK
of	O
mental	B-DISEASE
retardation	I-DISEASE
involving	B-UNK
loss	B-UNK
of	O
expression	B-UNK
of	O
the	O
fmr1	B-UNK
gene	B-UNK
.	O

 	O
the	O
role	B-UNK
of	O
fmr1	B-UNK
remains	B-UNK
undetermined	O
but	O
the	O
protein	B-UNK
appears	B-UNK
to	O
be	O
involved	B-UNK
in	O
rna	B-UNK
metabolism	B-DISEASE
.	O

 	O
fmr1	B-UNK
knockout	I-UNK
mice	B-UNK
exhibit	B-UNK
a	O
phenotype	B-UNK
with	O
some	O
similarities	O
to	O
humans	B-UNK
,	O
such	O
as	O
macroorchidism	O
and	O
behavioral	B-UNK
abnormalities	B-DISEASE
.	O

 	O
as	O
a	O
step	O
toward	O
understanding	B-UNK
the	O
function	B-UNK
of	O
fmr1	B-UNK
and	O
the	O
determination	B-UNK
of	O
the	O
potential	B-UNK
for	O
therapeutic	B-UNK
approaches	B-UNK
to	O
fragile	B-DISEASE
x	I-DISEASE
syndrome	I-DISEASE
,	O
yeast	B-UNK
artificial	I-UNK
chromosome	B-UNK
(	O
yac	B-UNK
)	O
transgenic	B-UNK
mice	I-UNK
were	O
generated	B-UNK
in	O
order	B-UNK
to	O
determine	O
whether	O
the	O
fmr1	B-UNK
knockout	I-UNK
mouse	B-UNK
phenotype	B-UNK
could	O
be	O
rescued	O
.	O

 	O
several	O
transgenic	B-UNK
lines	B-UNK
were	O
generated	B-UNK
that	O
carried	B-UNK
the	O
entire	B-UNK
fmr1	B-UNK
locus	B-UNK
with	O
extensive	B-UNK
amounts	B-UNK
of	O
flanking	B-UNK
sequence	B-UNK
.	O

 	O
we	O
observed	B-UNK
that	O
the	O
yac	B-UNK
transgene	B-UNK
supported	B-UNK
production	B-UNK
of	O
the	O
human	B-UNK
protein	B-UNK
(	O
fmrp	O
)	O
which	O
was	O
present	B-UNK
at	B-DISEASE
levels	B-UNK
10	O
to	O
15	O
times	B-UNK
that	O
of	O
endogenous	B-UNK
protein	B-UNK
and	O
was	O
expressed	B-UNK
in	O
a	O
cell	B-UNK
-	O
and	O
tissue	B-UNK
-	O
specific	B-UNK
manner	B-UNK
.	O

 	O
macro	O
-	O
orchidism	O
was	O
absent	B-UNK
in	O
knockout	O
mice	B-UNK
carrying	I-UNK
the	O
yac	B-UNK
transgene	B-UNK
indicating	B-UNK
functional	B-UNK
rescue	O
by	O
the	O
human	B-UNK
protein	B-UNK
.	O

 	O
given	B-UNK
the	O
complex	B-UNK
behavioral	B-UNK
phenotype	B-UNK
in	O
fragile	B-UNK
x	I-UNK
patients	B-UNK
and	O
the	O
mild	B-UNK
phenotype	B-UNK
previously	B-UNK
reported	I-UNK
for	O
the	O
fmr1	B-UNK
knockout	I-UNK
mouse	B-UNK
,	O
we	O
performed	B-UNK
a	O
more	O
thorough	O
evaluation	B-UNK
of	O
the	O
fmr1	B-UNK
knockout	I-UNK
phenotype	B-UNK
using	O
additional	B-UNK
behavioral	B-UNK
assays	B-UNK
that	O
had	O
not	O
previously	B-UNK
been	O
reported	B-UNK
for	O
this	O
animal	B-UNK
model	B-UNK
.	O

 	O
the	O
mouse	B-UNK
displayed	O
reduced	B-UNK
anxiety	B-DISEASE
-	O
related	B-UNK
responses	B-UNK
with	O
increased	B-UNK
exploratory	O
behavior	O
.	O

 	O
fmr1	B-UNK
yac	B-UNK
transgenic	B-UNK
mice	I-UNK
overexpressing	O
the	O
human	B-UNK
protein	B-UNK
did	O
produce	B-UNK
opposing	O
behavioral	B-UNK
responses	B-UNK
and	O
additional	B-UNK
abnormal	B-UNK
behaviors	O
were	O
also	O
observed	B-UNK
.	O

 	O
these	O
findings	B-UNK
have	O
significant	B-UNK
implications	B-UNK
for	O
gene	B-UNK
therapy	B-UNK
for	O
fragile	B-DISEASE
x	I-DISEASE
syndrome	I-DISEASE
since	O
overexpression	B-UNK
of	O
the	O
gene	B-UNK
may	O
harbor	O
its	O
own	O
phenotype	B-UNK
.	O
.	O

 	O
transgenic	B-UNK
mice	I-UNK
carrying	B-UNK
large	B-UNK
human	B-UNK
genomic	B-UNK
sequences	I-UNK
with	O
expanded	B-UNK
ctg	B-UNK
repeat	I-UNK
mimic	O
closely	B-UNK
the	O
dm	B-DISEASE
ctg	B-UNK
repeat	I-UNK
intergenerational	B-UNK
and	O
somatic	B-UNK
instability	B-UNK
.	O

 	O
myotonic	B-DISEASE
dystrophy	I-DISEASE
(	O
dm	B-DISEASE
)	O
is	O
caused	B-UNK
by	O
a	O
ctg	B-UNK
repeat	I-UNK
expansion	B-UNK
in	O
the	O
3utr	O
of	O
the	O
dm	B-DISEASE
protein	B-UNK
kinase	B-UNK
(	O
dmpk	B-UNK
)	O
gene	B-UNK
.	O

 	O
a	O
very	O
high	B-UNK
level	B-UNK
of	O
instability	B-UNK
is	O
observed	B-UNK
through	O
successive	O
generations	B-UNK
and	O
the	O
size	B-UNK
of	O
the	O
repeat	B-UNK
is	O
generally	B-UNK
correlated	B-UNK
with	O
the	O
severity	B-UNK
of	O
the	O
disease	B-DISEASE
and	O
with	O
age	B-UNK
at	B-DISEASE
onset	B-UNK
.	O

 	O
furthermore	B-UNK
,	O
tissues	B-UNK
from	O
dm	B-DISEASE
patients	B-UNK
exhibit	B-UNK
somatic	B-UNK
mosaicism	B-UNK
that	O
increases	B-UNK
with	O
age	B-UNK
.	O

 	O
we	O
generated	B-UNK
transgenic	B-UNK
mice	I-UNK
carrying	B-UNK
large	B-UNK
human	B-UNK
genomic	B-UNK
sequences	I-UNK
with	O
20	O
,	O
55	O
or	O
>	O
300	O
ctg	B-UNK
,	O
cloned	B-UNK
from	O
patients	B-UNK
from	O
the	O
same	O
affected	B-UNK
dm	B-DISEASE
family	B-UNK
.	O

 	O
using	O
large	B-UNK
human	B-UNK
flanking	B-UNK
sequences	B-UNK
and	O
a	O
large	B-UNK
amplification	B-UNK
,	O
we	O
demonstrate	B-UNK
that	O
the	O
intergenerational	B-UNK
ctg	B-UNK
repeat	I-UNK
instability	B-UNK
is	O
reproduced	O
in	O
mice	B-UNK
,	O
with	O
a	O
strong	B-UNK
bias	B-UNK
towards	O
expansions	B-UNK
and	O
with	O
the	O
same	O
sex	B-UNK
-	O
and	O
size	B-UNK
-	O
dependent	B-UNK
characteristics	B-UNK
as	O
in	O
humans	B-UNK
.	O

 	O
moreover	O
,	O
a	O
high	B-UNK
level	B-UNK
of	O
instability	B-UNK
,	O
increasing	B-UNK
with	O
age	B-UNK
,	O
can	O
be	O
observed	B-UNK
in	O
tissues	B-UNK
and	O
in	O
sperm	B-UNK
.	O

 	O
although	O
we	O
did	O
not	O
observe	O
dramatic	B-UNK
expansions	B-UNK
(	O
or	O
big	O
jumps	O
over	O
several	O
hundred	O
ctg	B-UNK
repeats	B-UNK
)	O
as	O
in	O
congenital	B-DISEASE
forms	B-UNK
of	O
dm	B-DISEASE
,	O
our	O
model	B-UNK
carrying	B-UNK
>	O
300	O
ctg	B-UNK
is	O
the	O
first	O
to	O
show	O
instability	B-UNK
so	O
close	B-UNK
to	O
the	O
human	B-UNK
dm	B-DISEASE
situation	O
.	O

 	O
our	O
three	O
models	B-UNK
carrying	B-UNK
different	B-UNK
sizes	B-UNK
of	O
ctg	B-UNK
repeat	I-UNK
provide	B-UNK
insight	B-UNK
on	O
the	O
different	B-UNK
factors	B-UNK
modulating	O
the	O
ctg	B-UNK
repeat	I-UNK
instability	B-UNK
.	O
.	O

 	O
inactivation	B-UNK
of	O
the	O
friedreich	B-DISEASE
ataxia	I-DISEASE
mouse	B-UNK
gene	B-UNK
leads	B-UNK
to	O
early	B-UNK
embryonic	I-UNK
lethality	O
without	O
iron	B-UNK
accumulation	B-UNK
.	O

 	O
friedreich	B-DISEASE
ataxia	I-DISEASE
(	O
frda	B-UNK
)	O
,	O
the	O
most	O
common	B-UNK
autosomal	O
recessive	O
ataxia	B-DISEASE
,	O
is	O
caused	B-UNK
in	O
almost	O
all	O
cases	B-UNK
by	O
homozygous	B-UNK
intronic	B-UNK
expansions	B-UNK
resulting	B-UNK
in	O
the	O
loss	B-UNK
of	O
frataxin	B-UNK
,	O
a	O
mitochondrial	B-UNK
protein	B-UNK
conserved	B-UNK
through	O
evolution	O
,	O
and	O
involved	B-UNK
in	O
mitochondrial	B-UNK
iron	I-UNK
homeostasis	B-UNK
.	O

 	O
yeast	B-UNK
knockout	O
models	B-UNK
,	O
and	O
histological	O
and	O
biochemical	B-UNK
data	B-UNK
from	O
patient	B-UNK
heart	B-UNK
biopsies	B-UNK
or	O
autopsies	O
indicate	B-UNK
that	O
the	O
frataxin	B-UNK
defect	B-UNK
causes	B-UNK
a	O
specific	B-UNK
iron	B-UNK
-	O
sulfur	O
protein	B-DISEASE
deficiency	I-DISEASE
and	O
mitochondrial	B-UNK
iron	I-UNK
accumulation	B-UNK
leading	B-UNK
to	O
the	O
pathological	B-UNK
changes	B-UNK
.	O

 	B-UNK
affected	I-UNK
human	B-UNK
tissues	B-UNK
are	O
rarely	B-UNK
available	B-UNK
to	O
further	O
examine	O
this	O
hypothesis	O
.	O

 	O
to	O
study	B-UNK
the	O
mechanism	B-UNK
of	O
the	O
disease	B-DISEASE
,	O
we	O
generated	B-UNK
a	O
mouse	B-UNK
model	I-UNK
by	O
deletion	B-UNK
of	O
exon	B-UNK
4	O
leading	B-UNK
to	O
inactivation	B-UNK
of	O
the	O
frda	B-UNK
gene	B-UNK
product	B-UNK
.	O

 	O
we	O
show	O
that	O
homozygous	B-UNK
deletions	B-UNK
cause	B-UNK
embryonic	B-UNK
lethality	I-UNK
a	O
few	O
days	O
after	O
implantation	O
,	O
demonstrating	B-UNK
an	O
important	B-UNK
role	B-UNK
for	O
frataxin	B-UNK
during	O
early	B-UNK
development	B-UNK
.	O

 	O
these	O
results	B-UNK
suggest	B-UNK
that	O
the	O
milder	B-UNK
phenotype	B-UNK
in	O
humans	B-UNK
is	O
due	O
to	O
residual	B-UNK
frataxin	B-UNK
expression	B-UNK
associated	B-UNK
with	O
the	O
expansion	B-UNK
mutations	B-UNK
.	O

 	O
surprisingly	B-UNK
,	O
in	O
the	O
frataxin	B-UNK
knockout	B-UNK
mouse	I-UNK
,	O
no	O
iron	B-UNK
accumulation	B-UNK
was	O
observed	B-UNK
during	O
embryonic	O
resorption	O
,	O
suggesting	B-UNK
that	O
cell	B-UNK
death	B-DISEASE
could	O
be	O
due	O
to	O
a	O
mechanism	B-UNK
independent	B-UNK
of	O
iron	B-UNK
accumulation	B-UNK
.	O
.	O

 	O
gaucher	B-DISEASE
disease	I-DISEASE
:	O
the	O
origins	B-UNK
of	O
the	O
ashkenazi	B-UNK
jewish	I-UNK
n370s	O
and	O
84gg	B-UNK
acid	O
beta	B-UNK
-	O
glucosidase	O
mutations	B-UNK
.	O

 	O
type	B-UNK
1	O
gaucher	B-DISEASE
disease	I-DISEASE
(	O
gd	B-UNK
)	O
,	O
a	O
non	B-UNK
-	O
neuronopathic	B-UNK
lysosomal	B-UNK
storage	O
disorder	O
,	O
results	B-UNK
from	O
the	O
deficient	B-UNK
activity	B-UNK
of	O
acid	O
beta	B-UNK
-	O
glucosidase	O
(	O
gba	B-UNK
)	O
.	O

 	O
type	B-UNK
1	O
disease	B-DISEASE
is	O
panethnic	O
but	O
is	O
more	O
prevalent	B-UNK
in	O
individuals	B-UNK
of	O
ashkenazi	B-UNK
jewish	I-UNK
(	O
aj	B-UNK
)	O
descent	B-UNK
.	O

 	O
of	O
the	O
causative	B-UNK
gba	B-UNK
mutations	B-UNK
,	O
n370s	O
is	O
particularly	B-UNK
frequent	B-UNK
in	O
the	O
aj	B-UNK
population	B-UNK
,	O
(	O
q	B-UNK
approximately	B-UNK
.	O
03	O
)	O
,	O
whereas	O
the	O
84gg	B-UNK
insertion	B-UNK
(	O
q	B-UNK
approximately	B-UNK
.	O
003	O
)	O
occurs	B-UNK
exclusively	B-UNK
in	O
the	O
ashkenazim	O
.	O

 	O
to	O
investigate	O
the	O
genetic	B-UNK
history	B-UNK
of	O
these	O
mutations	B-UNK
in	O
the	O
aj	B-UNK
population	B-UNK
,	O
short	B-UNK
tandem	I-UNK
repeat	B-UNK
(	O
str	O
)	O
markers	B-UNK
were	O
used	O
to	O
map	B-UNK
a	O
9	O
.	O

 	O
3	O
-	O
cm	B-DISEASE
region	B-UNK
containing	I-UNK
the	O
gba	B-UNK
locus	B-UNK
and	O
to	O
genotype	B-UNK
261	O
aj	B-UNK
n370s	B-UNK
chromosomes	I-UNK
,	O
60	O
european	B-UNK
non	B-UNK
-	O
jewish	B-UNK
n370s	I-UNK
chromosomes	B-UNK
,	O
and	O
62	O
aj	B-UNK
84gg	B-UNK
chromosomes	B-UNK
.	O

 	O
a	O
highly	B-UNK
conserved	I-UNK
haplotype	B-UNK
at	B-DISEASE
four	O
markers	B-UNK
flanking	B-UNK
gba	B-UNK
(	O
pklr	O
,	O
d1s1595	O
,	O
d1s2721	O
,	O
and	O
d1s2777	O
)	O
was	O
observed	B-UNK
on	O
both	O
the	O
aj	B-UNK
chromosomes	B-UNK
and	O
the	O
non	B-UNK
-	O
jewish	B-UNK
n370s	I-UNK
chromosomes	B-UNK
,	O
suggesting	B-UNK
the	O
occurrence	B-UNK
of	O
a	O
founder	B-UNK
common	B-UNK
to	O
both	O
populations	B-UNK
.	O

 	O
of	O
note	O
,	O
the	O
presence	B-UNK
of	O
different	B-UNK
divergent	O
haplotypes	B-UNK
suggested	B-UNK
the	O
occurrence	B-UNK
of	O
de	B-UNK
novo	I-UNK
,	O
recurrent	B-UNK
n370s	O
mutations	B-UNK
.	O

 	O
in	O
contrast	B-UNK
,	O
a	O
different	B-UNK
conserved	B-UNK
haplotype	B-UNK
at	B-DISEASE
these	O
markers	B-UNK
was	O
identified	B-UNK
on	O
the	O
84gg	B-UNK
chromosomes	B-UNK
,	O
which	O
was	O
unique	B-UNK
to	O
the	O
aj	B-UNK
population	B-UNK
.	O

 	O
on	O
the	O
basis	B-UNK
of	O
the	O
linkage	B-UNK
disequilibrium	I-UNK
(	O
ld	O
)	O
delta	B-UNK
values	B-UNK
,	O
the	O
non	B-UNK
-	O
jewish	B-UNK
european	B-UNK
n370s	B-UNK
chromosomes	I-UNK
had	O
greater	B-UNK
haplotype	B-UNK
diversity	O
and	O
less	O
ld	O
at	B-DISEASE
the	O
markers	B-UNK
flanking	B-UNK
the	O
conserved	B-UNK
haplotype	B-UNK
than	O
did	O
the	O
aj	B-UNK
n370s	B-UNK
chromosomes	I-UNK
.	O

 	O
this	O
finding	B-UNK
is	O
consistent	B-UNK
with	O
the	O
presence	B-UNK
of	O
the	O
n370s	O
mutation	B-UNK
in	O
the	O
non	B-UNK
-	O
jewish	B-UNK
european	B-UNK
population	I-UNK
prior	B-UNK
to	O
the	O
founding	B-UNK
of	O
the	O
aj	B-UNK
population	B-UNK
.	O

 	O
coalescence	O
analyses	B-UNK
for	O
the	O
n370s	O
and	O
84gg	B-UNK
mutations	B-UNK
estimated	B-UNK
similar	B-UNK
coalescence	O
times	B-UNK
,	O
of	O
48	O
and	O
55	O
.	O
5	O
generations	B-UNK
ago	B-UNK
,	O
respectively	B-UNK
.	O

 	O
the	O
results	B-UNK
of	O
these	O
studies	B-UNK
are	O
consistent	B-UNK
with	O
a	O
significant	B-UNK
bottleneck	O
occurring	B-UNK
in	O
the	O
aj	B-UNK
population	B-UNK
during	O
the	O
first	O
millennium	O
,	O
when	O
the	O
population	B-UNK
became	O
established	B-UNK
in	O
europe	B-UNK
.	O

 	O
hla	B-UNK
b27	I-UNK
and	O
the	O
genetics	B-UNK
of	O
ankylosing	B-DISEASE
spondylitis	I-DISEASE
.	O

 	O
one	O
hundred	O
and	O
twenty	O
-	O
eight	O
of	O
145	O
patients	B-UNK
with	O
ankylosing	B-DISEASE
spondylitis	I-DISEASE
(	O
as	O
)	O
were	O
found	B-UNK
to	O
be	O
hla	B-UNK
b27	I-UNK
positive	B-UNK
.	O

 	O
five	O
patients	B-UNK
had	O
evidence	B-UNK
of	O
a	O
sero	O
-	O
negative	B-UNK
peripheral	B-UNK
arthritis	B-DISEASE
resembling	B-UNK
peripheral	B-UNK
psoriatic	B-DISEASE
arthritis	I-DISEASE
and	O
3	O
of	O
these	O
were	O
b27	B-UNK
negative	B-UNK
.	O

 	O
one	O
further	O
b27	B-UNK
negative	B-UNK
patients	B-UNK
had	O
a	O
sister	O
with	O
ankylosing	B-DISEASE
spondylitis	I-DISEASE
and	O
ulcerative	B-DISEASE
colitis	I-DISEASE
and	O
a	O
mother	B-UNK
with	O
ulcerative	B-DISEASE
colitis	I-DISEASE
.	O

 	O
there	O
was	O
evidence	B-UNK
of	O
a	O
somewhat	B-UNK
later	B-UNK
age	B-UNK
of	O
onset	B-UNK
of	O
symptoms	B-UNK
in	O
b27	B-UNK
negative	B-UNK
patients	B-UNK
.	O

 	O
these	O
findings	B-UNK
are	O
interpreted	O
as	O
suggesting	B-UNK
some	O
degree	B-UNK
of	O
clinical	B-UNK
and	O
genetic	B-UNK
heterogeneity	B-UNK
in	O
ankylosing	B-DISEASE
spondylitis	I-DISEASE
with	O
genes	B-UNK
for	O
psoriasis	B-DISEASE
and	O
inflammatory	B-DISEASE
bowel	I-DISEASE
disease	I-DISEASE
being	O
important	B-UNK
in	O
some	O
individuals	B-UNK
,	O
particularly	B-UNK
those	O
who	O
are	O
b27	B-UNK
negative	B-UNK
.	O

 	O
twenty	O
-	O
five	O
first	O
-	O
degree	B-UNK
relatives	B-UNK
with	O
ankylosing	B-DISEASE
spondylitis	I-DISEASE
were	O
all	O
b27	B-UNK
positive	B-UNK
.	O

 	O
the	O
only	O
instance	O
of	O
disassociation	O
of	O
b27	B-UNK
and	O
spondylitis	B-DISEASE
in	O
a	O
family	B-UNK
was	O
where	O
the	O
proband	B-UNK
had	O
ulcerative	B-DISEASE
colitis	I-DISEASE
as	O
well	O
as	O
spondylitis	B-DISEASE
.	O

 	O
of	O
13	O
b27	B-UNK
positive	B-UNK
fathers	B-UNK
3	O
could	O
be	O
diagnosed	B-UNK
as	O
having	B-UNK
definite	O
ankylosing	B-DISEASE
spondylitis	I-DISEASE
(	O
23	O
%	O
)	O
.	O

 	O
these	O
findings	B-UNK
are	O
thought	O
to	O
provide	B-UNK
evidence	I-UNK
against	O
the	O
concept	O
that	O
the	O
gene	B-UNK
for	O
ankylosing	B-DISEASE
spondylitis	I-DISEASE
is	O
not	O
b27	B-UNK
but	O
a	O
closely	B-UNK
linked	I-UNK
gene	B-UNK
and	O
favour	O
the	O
occurrence	B-UNK
of	O
an	O
environmental	B-UNK
event	B-UNK
affecting	B-UNK
approximately	B-UNK
one	O
-	O
fifth	B-UNK
of	O
b27	B-UNK
positive	B-UNK
males	B-UNK
to	O
result	B-UNK
in	O
disease	B-DISEASE
.	O
.	O

 	O
founder	B-UNK
mutations	B-UNK
in	O
the	O
brca1	B-UNK
gene	B-UNK
in	O
polish	B-UNK
families	B-UNK
with	O
breast	B-DISEASE
-	I-DISEASE
ovarian	I-DISEASE
cancer	I-DISEASE
.	O

 	O
we	O
have	O
undertaken	O
a	O
hospital	B-UNK
-	O
based	B-UNK
study	B-UNK
,	O
to	O
identify	B-UNK
possible	B-UNK
brca1	B-UNK
and	O
brca2	B-UNK
founder	B-UNK
mutations	B-UNK
in	O
the	O
polish	B-UNK
population	B-UNK
.	O

 	O
the	O
study	B-UNK
group	B-UNK
consisted	B-UNK
of	O
66	O
polish	B-UNK
families	B-UNK
with	O
cancer	B-DISEASE
who	O
have	O
at	B-DISEASE
least	O
three	O
related	B-UNK
females	B-UNK
affected	B-UNK
with	O
breast	B-UNK
or	O
ovarian	B-DISEASE
cancer	I-DISEASE
and	O
who	O
had	O
cancer	B-DISEASE
diagnosed	B-UNK
,	O
in	O
at	B-DISEASE
least	O
one	O
of	O
the	O
three	O
affected	B-UNK
females	B-UNK
,	O
at	B-DISEASE
age	B-UNK
<	O
50	O
years	B-UNK
.	O

 	O
a	O
total	B-UNK
of	O
26	O
families	B-UNK
had	O
both	O
breast	B-UNK
and	O
ovarian	B-UNK
cancers	B-DISEASE
,	O
4	O
families	B-UNK
had	O
ovarian	B-UNK
cancers	B-DISEASE
only	O
,	O
and	O
36	O
families	B-UNK
had	O
breast	B-UNK
cancers	B-DISEASE
only	O
.	O

 	B-UNK
genomic	I-UNK
dna	B-UNK
was	O
prepared	O
from	O
the	O
peripheral	B-UNK
blood	I-UNK
leukocytes	B-UNK
of	O
at	B-DISEASE
least	O
one	O
affected	B-UNK
woman	B-UNK
from	O
each	O
family	B-UNK
.	O

 	O
the	O
entire	B-UNK
coding	I-UNK
region	B-UNK
of	O
brca1	B-UNK
and	O
brca2	B-UNK
was	O
screened	O
for	O
the	O
presence	B-UNK
of	O
germline	B-UNK
mutations	I-UNK
,	O
by	O
use	B-UNK
of	O
sscp	B-UNK
followed	B-UNK
by	O
direct	B-UNK
sequencing	I-UNK
of	O
observed	B-UNK
variants	B-UNK
.	O

 	O
mutations	B-UNK
were	O
found	B-UNK
in	O
35	O
(	O
53	O
%	O
)	O
of	O
the	O
66	O
families	B-UNK
studied	B-UNK
.	O

 	O
all	O
but	O
one	O
of	O
the	O
mutations	B-UNK
were	O
detected	B-UNK
within	O
the	O
brca1	B-UNK
gene	B-UNK
.	O

 	B-UNK
brca1	I-UNK
abnormalities	B-DISEASE
were	O
identified	B-UNK
in	O
all	O
four	O
families	B-UNK
with	O
ovarian	B-DISEASE
cancer	I-DISEASE
only	O
,	O
in	O
67	O
%	O
of	O
27	O
families	B-UNK
with	O
both	O
breast	B-UNK
and	O
ovarian	B-DISEASE
cancer	I-DISEASE
,	O
and	O
in	O
34	O
%	O
of	O
35	O
families	B-UNK
with	O
breast	B-DISEASE
cancer	I-DISEASE
only	O
.	O

 	O
the	O
single	B-UNK
family	B-UNK
with	O
a	O
brca2	B-UNK
mutation	B-UNK
had	O
the	O
breast	B-DISEASE
-	I-DISEASE
ovarian	I-DISEASE
cancer	I-DISEASE
syndrome	B-DISEASE
.	O

 	B-UNK
seven	I-UNK
distinct	B-UNK
mutations	B-UNK
were	O
identified	B-UNK
;	O
five	O
of	O
these	O
occurred	B-UNK
in	O
two	O
or	O
more	O
families	B-UNK
.	O

 	O
in	O
total	B-UNK
,	O
recurrent	B-UNK
mutations	B-UNK
were	O
found	B-UNK
in	O
33	O
(	O
94	O
%	O
)	O
of	O
the	O
35	O
families	B-UNK
with	O
detected	B-UNK
mutations	B-UNK
.	O

 	O
three	O
brca1	B-UNK
abnormalities	B-DISEASE
-	O
5382insc	O
,	O
c61	O
g	B-UNK
,	O
and	O
4153dela	O
-	O
accounted	B-UNK
for	O
51	O
%	O
,	O
20	O
%	O
,	O
and	O
11	O
%	O
of	O
the	O
identified	B-UNK
mutations	B-UNK
,	O
respectively	B-UNK
.	O
.	O

 	B-UNK
molecular	I-UNK
basis	B-UNK
of	O
very	O
long	B-UNK
chain	O
acyl	B-UNK
-	O
coa	B-UNK
dehydrogenase	I-UNK
deficiency	B-UNK
in	O
three	O
israeli	O
patients	B-UNK
:	O
identification	B-UNK
of	O
a	O
complex	B-UNK
mutant	B-UNK
allele	I-UNK
with	O
p65l	O
and	O
k247q	O
mutations	B-UNK
,	O
the	O
former	O
being	O
an	O
exonic	B-UNK
mutation	B-UNK
causing	B-UNK
exon	B-UNK
3	O
skipping	B-UNK
.	O

 	O
very	O
long	B-UNK
chain	O
acyl	B-UNK
-	O
coa	B-UNK
dehydrogenase	I-UNK
(	O
vlcad	B-UNK
)	O
deficiency	B-UNK
is	O
a	O
life	B-UNK
-	O
threatening	O
disorder	O
of	O
mitochondrial	B-UNK
fatty	B-UNK
acid	I-UNK
beta	I-UNK
-	O
oxidation	B-UNK
.	O

 	O
we	O
identified	B-UNK
four	O
novel	B-UNK
mutations	B-UNK
in	O
three	O
unrelated	B-UNK
patients	B-UNK
.	O

 	O
all	O
patients	B-UNK
had	O
the	O
severe	B-UNK
childhood	I-UNK
form	B-UNK
of	O
vlcad	B-DISEASE
deficiency	I-DISEASE
with	O
early	B-UNK
onset	I-UNK
and	O
high	B-UNK
mortality	O
.	O

 	O
immunoblot	O
analysis	B-UNK
revealed	B-UNK
that	O
vlcad	B-UNK
protein	B-UNK
was	O
undetectable	B-UNK
in	O
patients	B-UNK
2	O
and	O
3	O
,	O
whereas	O
normal	B-UNK
-	O
size	B-UNK
vlcad	B-UNK
protein	B-UNK
and	O
an	O
aberrant	B-UNK
form	B-UNK
of	O
vlcad	B-UNK
(	O
4kda	O
smaller	B-UNK
)	O
were	O
detected	B-UNK
in	O
patient	B-UNK
1	O
.	O

 	O
as	O
expected	B-UNK
,	O
null	B-UNK
mutations	B-UNK
were	O
found	B-UNK
in	O
patients	B-UNK
2	O
and	O
3	O
patient	B-UNK
2	O
is	O
homozygous	B-UNK
for	O
a	O
frameshift	B-UNK
mutation	B-UNK
,	O
del	O
4	O
bp	B-UNK
at	B-DISEASE
798	O
-	O
801	O
,	O
and	O
patient	B-UNK
3	O
is	O
homozygous	B-UNK
for	O
a	O
nonsense	B-UNK
mutation	B-UNK
65c	O
>	O
a	O
(	O
s22x	O
)	O
.	O

 	O
patient	B-UNK
1	O
was	O
homozygous	B-UNK
for	O
a	O
complex	B-UNK
mutant	B-UNK
allele	I-UNK
containing	B-UNK
two	O
alterations	B-UNK
,	O
including	B-UNK
a	O
194c	O
>	O
t	B-UNK
transition	I-UNK
(	O
p65l	O
)	O
and	O
739a	O
>	O
c	B-UNK
transversion	B-UNK
(	O
k247q	O
)	O
;	O
in	O
the	O
case	B-UNK
of	O
p65l	O
,	O
the	O
amino	B-UNK
acid	I-UNK
change	B-UNK
does	O
not	O
reduce	B-UNK
enzyme	B-UNK
activity	I-UNK
.	O

 	O
however	O
,	O
the	O
nucleotide	B-UNK
change	B-UNK
resulted	B-UNK
in	O
exon	B-UNK
3	O
skipping	B-UNK
,	O
whereas	O
the	O
latter	O
k247q	O
mutation	B-UNK
had	O
a	O
drastic	O
effect	B-UNK
on	O
enzyme	B-UNK
activity	I-UNK
.	O

 	O
we	O
verified	O
these	O
events	B-UNK
by	O
in	O
vivo	B-UNK
splicing	B-UNK
experiments	B-UNK
and	O
transient	B-UNK
expression	I-UNK
analysis	B-UNK
of	O
mutant	B-UNK
cdnas	I-UNK
.	O

 	O
the	O
p65l	O
mutation	B-UNK
locates	O
11	O
bases	B-UNK
upstream	B-UNK
of	O
a	O
splice	B-UNK
donor	I-UNK
site	I-UNK
of	O
intron	B-UNK
3	O
.	O

 	O
this	O
is	O
an	O
example	O
of	O
an	O
exonic	B-UNK
mutation	B-UNK
which	O
affects	B-UNK
exon	B-UNK
-	O
splicing	B-UNK
.	O
.	O

 	O
submicroscopic	B-UNK
deletion	I-UNK
in	O
cousins	O
with	O
prader	B-DISEASE
-	I-DISEASE
willi	I-DISEASE
syndrome	I-DISEASE
causes	B-UNK
a	O
grandmatrilineal	O
inheritance	B-UNK
pattern	B-UNK
:	O
effects	B-UNK
of	O
imprinting	B-UNK
.	O

 	O
the	O
prader	B-DISEASE
-	I-DISEASE
willi	I-DISEASE
syndrome	I-DISEASE
(	O
pws	B-UNK
)	O
critical	B-UNK
region	I-UNK
on	O
15q11	B-UNK
-	O
q13	O
is	O
subject	B-UNK
to	O
imprinting	B-UNK
.	O

 	O
pws	B-UNK
becomes	O
apparent	B-UNK
when	O
genes	B-UNK
on	O
the	O
paternally	B-UNK
inherited	B-UNK
chromosome	B-UNK
are	O
not	O
expressed	B-UNK
.	O

 	B-UNK
familial	I-UNK
pws	B-UNK
is	O
rare	B-UNK
.	O

 	O
we	O
report	B-UNK
on	O
a	O
family	B-UNK
in	O
which	O
a	O
male	B-UNK
and	O
a	O
female	B-UNK
paternal	B-UNK
first	O
cousin	O
both	O
have	O
pws	B-UNK
with	O
cytogenetically	B-UNK
normal	B-UNK
karyotypes	B-UNK
.	O

 	O
fluorescence	B-UNK
in	O
situ	B-UNK
hybridization	I-UNK
(	O
fish	B-UNK
)	O
analysis	B-UNK
shows	B-UNK
a	O
submicroscopic	B-UNK
deletion	I-UNK
of	O
snrpn	B-UNK
,	O
but	O
not	O
the	O
closely	B-UNK
associated	B-UNK
loci	B-UNK
d15s10	O
,	O
d15s11	O
,	O
d15s63	O
,	O
and	O
gabrb3	O
.	O

 	O
the	O
cousins	O
fathers	B-UNK
and	O
two	O
paternal	B-UNK
aunts	O
have	O
the	O
same	O
deletion	B-UNK
and	O
are	O
clinically	B-UNK
normal	B-UNK
.	O

 	O
the	O
grandmother	O
of	O
the	O
cousins	O
is	O
deceased	O
and	O
not	O
available	B-UNK
for	O
study	B-UNK
,	O
and	O
their	O
grandfather	O
is	O
not	O
deleted	B-UNK
for	O
snrpn	B-UNK
.	O

 	B-UNK
dna	I-UNK
methylation	B-UNK
analysis	B-UNK
of	O
d15s63	O
is	O
consistent	B-UNK
with	O
an	O
abnormality	B-UNK
of	O
the	O
imprinting	B-UNK
center	I-UNK
associated	B-UNK
with	O
pws	B-UNK
.	O

 	O
"	O
grandmatrilineal	O
"	O
inheritance	B-UNK
occurs	B-UNK
when	O
a	O
woman	B-UNK
with	O
deletion	B-UNK
of	O
an	O
imprinted	B-UNK
,	O
paternally	B-UNK
expressed	I-UNK
gene	B-UNK
is	O
at	B-DISEASE
risk	B-UNK
of	O
having	B-UNK
affected	B-UNK
grandchildren	O
through	O
her	O
sons	O
.	O

 	O
in	O
this	O
case	B-UNK
,	O
pws	B-UNK
does	O
not	O
become	O
evident	O
as	O
long	B-UNK
as	O
the	O
deletion	B-UNK
is	O
passed	O
through	O
the	O
matrilineal	O
line	B-UNK
.	O

 	O
this	O
represents	B-UNK
a	O
unique	B-UNK
inheritance	B-UNK
pattern	B-UNK
due	O
to	O
imprinting	B-UNK
.	O
.	O

 	B-UNK
human	I-UNK
glycine	B-UNK
decarboxylase	O
gene	B-UNK
(	O
gldc	B-UNK
)	O
and	O
its	O
highly	B-UNK
conserved	I-UNK
processed	B-UNK
pseudogene	B-UNK
(	O
psigldc	O
)	O
:	O
their	O
structure	B-UNK
and	O
expression	B-UNK
,	O
and	O
the	O
identification	B-UNK
of	O
a	O
large	B-UNK
deletion	B-UNK
in	O
a	O
family	B-UNK
with	O
nonketotic	O
hyperglycinemia	B-DISEASE
.	O

 	O
mutations	B-UNK
in	O
the	O
glycine	B-UNK
decarboxylase	O
gene	B-UNK
(	O
gldc	B-UNK
)	O
cause	B-UNK
nonketotic	O
hyperglycinemia	B-DISEASE
(	O
nkh	O
)	O
,	O
an	O
in	O
-	O
born	O
error	B-UNK
of	O
metabolism	B-DISEASE
characterized	B-UNK
by	O
severe	B-UNK
neurological	B-UNK
disturbance	O
.	O

 	O
we	O
have	O
determined	B-UNK
the	O
structure	B-UNK
of	O
gldc	B-UNK
and	O
of	O
its	O
pseudogene	B-UNK
(	O
psigldc	O
)	O
and	O
studied	B-UNK
their	O
expression	B-UNK
for	O
a	O
molecular	B-UNK
analysis	B-UNK
of	O
nkh	O
.	O

 	O
the	O
gldc	B-UNK
gene	B-UNK
spans	B-UNK
at	B-DISEASE
least	O
135	O
kb	B-UNK
and	O
consists	B-UNK
of	O
25	O
exons	B-UNK
.	O

 	O
all	O
donor	O
and	O
acceptor	B-UNK
sites	B-UNK
adhere	O
to	O
the	O
canonical	B-UNK
gt	B-UNK
-	O
ag	B-UNK
rule	O
,	O
except	O
for	O
the	O
donor	O
site	B-UNK
of	O
intron	B-UNK
21	O
,	O
where	O
a	O
variant	B-UNK
form	B-UNK
gc	B-UNK
is	O
used	O
instead	B-UNK
of	O
gt	B-UNK
.	O

 	O
the	O
transcription	B-UNK
initiation	B-UNK
site	B-UNK
has	O
been	O
assigned	B-UNK
to	O
a	O
residue	B-UNK
163	O
bp	B-UNK
upstream	B-UNK
from	O
the	O
translation	B-UNK
initiation	I-UNK
triplet	B-UNK
by	O
primer	B-UNK
extension	O
analysis	B-UNK
.	O

 	O
the	O
psigldc	O
gene	B-UNK
has	O
no	O
intron	B-UNK
and	O
shares	B-UNK
97	O
.	O

 	O
5	O
%	O
homology	B-UNK
with	O
the	O
coding	B-UNK
region	I-UNK
of	O
functional	B-UNK
gldc	B-UNK
,	O
suggesting	B-UNK
that	O
psigldc	O
is	O
a	O
processed	B-UNK
pseudogene	B-UNK
that	O
arose	B-UNK
from	O
the	O
gldc	B-UNK
transcript	B-UNK
about	O
4	O
-	O
8	O
million	B-UNK
years	B-UNK
ago	B-UNK
.	O

 	O
rna	B-UNK
blotting	B-UNK
analysis	B-UNK
has	O
revealed	B-UNK
that	O
gldc	B-UNK
is	O
expressed	B-UNK
in	O
human	B-UNK
liver	B-DISEASE
,	O
kidney	B-UNK
,	O
brain	B-UNK
,	O
and	O
placenta	B-DISEASE
.	O

 	O
we	O
have	O
also	O
examined	B-UNK
a	O
patient	B-UNK
with	O
nkh	O
with	O
no	O
detectable	B-UNK
gldc	B-UNK
mrna	B-UNK
in	O
his	O
lymphoblasts	O
.	O

 	O
exons	B-UNK
1	O
-	O
3	O
of	O
the	O
functional	B-UNK
gldc	B-UNK
gene	B-UNK
from	O
this	O
patient	B-UNK
are	O
not	O
amplified	B-UNK
by	O
polymerase	B-UNK
chain	I-UNK
reaction	I-UNK
(	O
pcr	B-UNK
)	O
,	O
whereas	O
those	O
from	O
control	B-UNK
subjects	B-UNK
are	O
.	O

 	O
these	O
results	B-UNK
suggest	B-UNK
a	O
large	B-UNK
homozygous	B-UNK
deletion	B-UNK
(	O
at	B-DISEASE
least	O
30	O
kb	B-UNK
)	O
in	O
the	O
patient	B-UNK
.	O

 	O
furthermore	B-UNK
,	O
we	O
have	O
devised	O
a	O
semi	O
-	O
quantitative	B-UNK
pcr	B-UNK
to	O
estimate	B-UNK
the	O
number	B-UNK
of	O
gldc	B-UNK
alleles	B-UNK
by	O
using	O
psigldc	O
as	O
an	O
internal	B-UNK
control	B-UNK
and	O
have	O
confirmed	B-UNK
the	O
homozygosity	B-UNK
and	O
heterozygosity	B-UNK
of	O
the	O
deletion	B-UNK
in	O
the	O
patient	B-UNK
and	O
his	O
parents	B-UNK
,	O
respectively	B-UNK
.	O

 	O
structural	B-UNK
information	B-UNK
of	O
gldc	B-UNK
and	O
psigldc	O
should	O
facilitate	B-UNK
the	O
molecular	B-UNK
analysis	B-UNK
of	O
nkh	O
.	O

 	O
de	B-UNK
novo	I-UNK
deletions	B-UNK
of	O
snrpn	B-UNK
exon	B-UNK
1	O
in	O
early	B-UNK
human	B-UNK
and	O
mouse	B-UNK
embryos	B-UNK
result	B-UNK
in	O
a	O
paternal	B-UNK
to	O
maternal	B-UNK
imprint	B-UNK
switch	O
.	O

 	O
prader	B-DISEASE
-	I-DISEASE
willi	I-DISEASE
syndrome	I-DISEASE
(	O
pws	B-UNK
)	O
is	O
a	O
neurogenetic	O
disease	B-DISEASE
characterized	B-UNK
by	O
infantile	B-UNK
hypotonia	B-DISEASE
,	O
gonadal	B-UNK
hypoplasia	B-UNK
,	O
obsessive	O
behaviour	O
and	O
neonatal	B-UNK
feeding	O
difficulties	O
followed	B-UNK
by	O
hyperphagia	B-DISEASE
,	O
leading	B-UNK
to	O
profound	O
obesity	B-DISEASE
.	O

 	O
pws	B-UNK
is	O
due	O
to	O
a	O
lack	B-UNK
of	O
paternal	B-UNK
genetic	B-UNK
information	B-UNK
at	B-DISEASE
15q11	B-UNK
-	O
q13	O
(	O
ref	O
.	O
2	O
)	O
.	O

 	O
five	O
imprinted	B-UNK
,	O
paternally	B-UNK
expressed	I-UNK
genes	B-UNK
map	B-UNK
to	O
the	O
pws	B-UNK
region	B-UNK
,	O
mkrn3	O
(	O
ref	O
.	O
3	O
)	O
,	O
ndn	O
(	O
ref	O
.	O
4	O
)	O
,	O
ndnl1	O
(	O
ref	O
.	O
5	O
)	O
,	O
snrpn	B-UNK
(	O
refs	O
6	O
-	O
8	O
)	O
and	O
ipw	O
(	O
ref	O
.	O
9	O
)	O
,	O
as	O
well	O
as	O
two	O
poorly	B-UNK
characterized	B-UNK
framents	O
designated	B-UNK
par	O
-	O
1	O
and	O
par	O
-	O
5	O
(	O
ref	O
.	O
10	O
)	O
.	O

 	O
imprinting	B-UNK
of	O
this	O
region	B-UNK
involves	B-UNK
a	O
bipartite	O
imprinting	B-UNK
centre	B-UNK
(	O
ic	B-UNK
)	O
,	O
which	O
overlaps	B-UNK
snrpn	B-UNK
(	O
refs	O
10	O
,	O
11	O
)	O
.	O

 	O
deletion	B-UNK
of	O
the	O
snrpn	B-UNK
promoter	B-UNK
/	O
exon	B-UNK
1	O
region	B-UNK
(	O
the	O
pws	B-UNK
ic	B-UNK
element	B-UNK
)	O
appears	B-UNK
to	O
impair	O
the	O
establishment	O
of	O
the	O
paternal	B-UNK
imprint	B-UNK
in	O
the	O
male	B-UNK
germ	B-UNK
line	I-UNK
and	O
leads	B-UNK
to	O
pws	B-UNK
.	O

 	O
here	O
we	O
report	B-UNK
a	O
pws	B-UNK
family	B-UNK
in	O
which	O
the	O
father	B-UNK
is	O
mosaic	B-UNK
for	O
an	O
ic	B-UNK
deletion	B-UNK
on	O
his	O
paternal	B-UNK
chromosome	B-UNK
.	O

 	O
the	O
deletion	B-UNK
chromosome	B-UNK
has	O
acquired	O
a	O
maternal	B-UNK
methylation	B-UNK
imprint	B-UNK
in	O
his	O
somatic	B-UNK
cells	B-UNK
.	O

 	O
we	O
have	O
made	O
identical	B-UNK
findings	B-UNK
in	O
chimaeric	O
mice	B-UNK
generated	B-UNK
from	O
two	O
independent	B-UNK
embryonic	O
stem	O
(	O
es	O
)	O
cell	B-UNK
lines	B-UNK
harbouring	O
a	O
similar	B-UNK
deletion	B-UNK
.	O

 	O
our	O
studies	B-UNK
demonstrate	B-UNK
that	O
the	O
pws	B-UNK
ic	B-UNK
element	B-UNK
is	O
not	O
only	O
required	B-UNK
for	O
the	O
establishment	O
of	O
the	O
paternal	B-UNK
imprint	B-UNK
,	O
but	O
also	O
for	O
its	O
postzygotic	O
maintenance	O
.	O
.	O

 	B-UNK
mice	I-UNK
deficient	B-UNK
in	O
six5	B-UNK
develop	B-UNK
cataracts	B-DISEASE
:	O
implications	B-UNK
for	O
myotonic	B-DISEASE
dystrophy	I-DISEASE
.	O

 	O
expansion	B-UNK
of	O
a	O
ctg	B-UNK
trinucleotide	B-UNK
repeat	I-UNK
in	O
the	O
3	O
utr	B-UNK
of	O
the	O
gene	B-UNK
dmpk	B-UNK
at	B-DISEASE
the	O
dm1	O
locus	B-UNK
on	O
chromosome	B-DISEASE
19	I-DISEASE
causes	B-UNK
myotonic	B-DISEASE
dystrophy	I-DISEASE
,	O
a	O
dominantly	B-UNK
inherited	I-UNK
disease	B-DISEASE
characterized	B-UNK
by	O
skeletal	B-UNK
muscle	I-UNK
dystrophy	B-UNK
and	O
myotonia	B-DISEASE
,	O
cataracts	B-DISEASE
and	O
cardiac	B-UNK
conduction	I-UNK
defects	B-UNK
.	O

 	B-UNK
targeted	I-UNK
deletion	B-UNK
of	O
dm15	O
,	O
the	O
mouse	B-UNK
orthologue	O
of	O
human	B-UNK
dmpk	B-UNK
,	O
produced	B-UNK
mice	B-UNK
with	O
a	O
mild	B-UNK
myopathy	B-DISEASE
and	O
cardiac	B-UNK
conduction	I-UNK
abnormalities	B-DISEASE
,	O
but	O
without	O
other	O
features	B-UNK
of	O
myotonic	B-DISEASE
dystrophy	I-DISEASE
,	O
such	O
as	O
myotonia	B-DISEASE
and	O
cataracts	B-DISEASE
.	O

 	O
we	O
,	O
and	O
others	O
,	O
have	O
demonstrated	B-UNK
that	O
repeat	B-UNK
expansion	I-UNK
decreases	B-UNK
expression	B-UNK
of	O
the	O
adjacent	B-UNK
gene	B-UNK
six5	B-UNK
(	O
refs	O
7	O
,	O
8	O
)	O
,	O
which	O
encodes	B-UNK
a	O
homeodomain	O
transcription	B-UNK
factor	B-UNK
.	O

 	O
to	O
determine	O
whether	O
six5	B-UNK
deficiency	B-UNK
contributes	B-UNK
to	O
the	O
myotonic	B-DISEASE
dystrophy	I-DISEASE
phenotype	B-UNK
,	O
we	O
disrupted	B-UNK
mouse	B-UNK
six5	B-UNK
by	O
replacing	O
the	O
first	O
exon	B-UNK
with	O
a	O
beta	B-UNK
-	O
galactosidase	B-UNK
reporter	B-UNK
.	O

 	O
six5	B-UNK
-	O
mutant	B-UNK
mice	I-UNK
showed	B-UNK
reporter	B-UNK
expression	B-UNK
in	O
multiple	B-UNK
tissues	B-UNK
,	O
including	B-UNK
the	O
developing	B-UNK
lens	O
.	O

 	B-UNK
homozygous	I-UNK
mutant	B-UNK
mice	I-UNK
had	O
no	O
apparent	B-UNK
abnormalities	B-DISEASE
of	O
skeletal	B-UNK
muscle	I-UNK
function	B-UNK
,	O
but	O
developed	B-UNK
lenticular	O
opacities	O
at	B-DISEASE
a	O
higher	B-UNK
rate	B-UNK
than	O
controls	B-UNK
.	O

 	O
our	O
results	B-UNK
suggest	B-UNK
that	O
six5	B-UNK
deficiency	B-UNK
contributes	B-UNK
to	O
the	O
cataract	B-DISEASE
phenotype	B-UNK
in	O
myotonic	B-DISEASE
dystrophy	I-DISEASE
,	O
and	O
that	O
myotonic	B-DISEASE
dystrophy	I-DISEASE
represents	B-UNK
a	O
multigenic	O
disorder	O
.	O
.	O

 	B-UNK
heterozygous	I-UNK
loss	B-UNK
of	O
six5	B-UNK
in	O
mice	B-UNK
is	O
sufficient	B-UNK
to	O
cause	B-UNK
ocular	O
cataracts	B-DISEASE
.	O

 	O
myotonic	B-DISEASE
dystrophy	I-DISEASE
(	O
dm	B-DISEASE
)	O
is	O
an	O
autosomal	O
dominant	B-UNK
disorder	O
characterized	B-UNK
by	O
skeletal	B-UNK
muscle	I-UNK
wasting	O
,	O
myotonia	B-DISEASE
,	O
cardiac	B-DISEASE
arrhythmia	I-DISEASE
,	O
hyperinsulinaemia	O
,	O
mental	B-DISEASE
retardation	I-DISEASE
and	O
ocular	O
cataracts	B-DISEASE
.	O

 	O
the	O
genetic	B-UNK
defect	B-UNK
in	O
dm	B-DISEASE
is	O
a	O
ctg	B-UNK
repeat	I-UNK
expansion	B-UNK
located	B-UNK
in	O
the	O
3	O
untranslated	B-UNK
region	B-UNK
of	O
dmpk	B-UNK
and	O
5	O
of	O
a	O
homeodomain	O
-	O
encoding	B-UNK
gene	B-UNK
,	O
six5	B-UNK
(	O
formerly	O
dmahp	O
;	O
refs	O
2	O
-	O
5	O
)	O
.	O

 	O
there	O
are	O
three	O
mechanisms	B-UNK
by	O
which	O
ctg	B-UNK
expansion	I-UNK
can	O
result	B-UNK
in	O
dm	B-DISEASE
.	O

 	O
first	O
,	O
repeat	B-UNK
expansion	I-UNK
may	O
alter	B-UNK
the	O
processing	B-UNK
or	O
transport	B-UNK
of	O
the	O
mutant	B-UNK
dmpk	B-UNK
mrna	I-UNK
and	O
consequently	B-UNK
reduce	B-UNK
dmpk	B-UNK
levels	B-UNK
.	O

 	O
second	B-UNK
,	O
ctg	B-UNK
expansion	I-UNK
may	O
establish	O
a	O
region	B-UNK
of	O
heterochromatin	O
3	O
of	O
the	O
repeat	B-UNK
sequence	B-UNK
and	O
decrease	B-UNK
six5	B-UNK
transcription	B-UNK
.	O

 	O
third	O
,	O
toxic	B-UNK
effects	B-UNK
of	O
the	O
repeat	B-UNK
expansion	I-UNK
may	O
be	O
intrinsic	O
to	O
the	O
repeated	B-UNK
elements	B-UNK
at	B-DISEASE
the	O
level	B-UNK
of	O
dna	B-UNK
or	O
rna	B-UNK
(	O
refs	O
10	O
,	O
11	O
)	O
.	O

 	B-UNK
previous	I-UNK
studies	B-UNK
have	O
demonstrated	B-UNK
that	O
a	O
dose	O
-	O
dependent	B-UNK
loss	B-UNK
of	O
dm15	O
(	O
the	O
mouse	B-UNK
dmpk	B-UNK
homologue	B-UNK
)	O
in	O
mice	B-UNK
produces	B-UNK
a	O
partial	B-UNK
dm	B-DISEASE
phenotype	B-UNK
characterized	B-UNK
by	O
decreased	B-UNK
development	B-UNK
of	O
skeletal	B-UNK
muscle	I-UNK
force	O
and	O
cardiac	B-UNK
conduction	I-UNK
disorders	B-UNK
.	O

 	O
to	O
test	B-UNK
the	O
role	B-UNK
of	O
six5	B-UNK
loss	B-UNK
in	O
dm	B-DISEASE
,	O
we	O
have	O
analysed	B-UNK
a	O
strain	O
of	O
mice	B-UNK
in	O
which	O
six5	B-UNK
was	O
deleted	B-UNK
.	O

 	O
our	O
results	B-UNK
demonstrate	B-UNK
that	O
the	O
rate	B-UNK
and	O
severity	B-UNK
of	O
cataract	B-DISEASE
formation	B-UNK
is	O
inversely	B-UNK
related	B-UNK
to	O
six5	B-UNK
dosage	O
and	O
is	O
temporally	O
progressive	B-UNK
.	O

 	O
six5	B-UNK
+	O
/	O
-	O
and	O
six5	B-UNK
-	O
/	O
-	O
mice	B-UNK
show	O
increased	B-UNK
steady	O
-	O
state	B-UNK
levels	B-UNK
of	O
the	O
na	B-UNK
+	O
/	O
k	B-UNK
+	O
-	O
atpase	B-UNK
alpha	B-UNK
-	O
1	O
subunit	B-UNK
and	O
decreased	B-UNK
dm15	O
mrna	B-UNK
levels	I-UNK
.	O

 	O
thus	O
,	O
altered	B-UNK
ion	O
homeostasis	B-UNK
within	O
the	O
lens	O
may	O
contribute	B-UNK
to	O
cataract	B-DISEASE
formation	B-UNK
.	O

 	O
as	O
ocular	O
cataracts	B-DISEASE
are	O
a	O
characteristic	B-UNK
feature	B-UNK
of	O
dm	B-DISEASE
,	O
these	O
results	B-UNK
demonstrate	B-UNK
that	O
decreased	B-UNK
six5	B-UNK
transcription	B-UNK
is	O
important	B-UNK
in	O
the	O
aetiology	O
of	O
dm	B-DISEASE
.	O

 	O
our	O
data	B-UNK
support	B-UNK
the	O
hypothesis	O
that	O
dm	B-DISEASE
is	O
a	O
contiguous	B-UNK
gene	B-UNK
syndrome	B-DISEASE
associated	B-UNK
with	O
the	O
partial	B-UNK
loss	B-UNK
of	O
both	O
dmpk	B-UNK
and	O
six5	B-UNK
.	O
.	O

 	B-UNK
atm	I-UNK
-	O
dependent	B-UNK
phosphorylation	B-UNK
of	O
nibrin	B-UNK
in	O
response	B-UNK
to	O
radiation	B-UNK
exposure	B-UNK
.	O

 	O
mutations	B-UNK
in	O
the	O
gene	B-UNK
atm	B-UNK
are	O
responsible	B-UNK
for	O
the	O
genetic	B-UNK
disorder	O
ataxia	B-DISEASE
-	O
telangiectasia	B-DISEASE
(	O
a	O
-	O
t	B-UNK
)	O
,	O
which	O
is	O
characterized	B-UNK
by	O
cerebellar	B-UNK
dysfunction	B-UNK
,	O
radiosensitivity	O
,	O
chromosomal	B-DISEASE
instability	I-DISEASE
and	O
cancer	B-DISEASE
predisposition	B-UNK
.	O

 	O
both	O
the	O
a	O
-	O
t	B-UNK
phenotype	B-UNK
and	O
the	O
similarity	B-UNK
of	O
the	O
atm	B-UNK
protein	B-UNK
to	O
other	O
dna	B-UNK
-	O
damage	B-UNK
sensors	O
suggests	B-UNK
a	O
role	B-UNK
for	O
atm	B-UNK
in	O
biochemical	B-UNK
pathways	B-UNK
involved	B-UNK
in	O
the	O
recognition	B-UNK
,	O
signalling	B-UNK
and	O
repair	B-UNK
of	O
dna	B-UNK
double	B-UNK
-	O
strand	O
breaks	B-UNK
(	O
dsbs	O
)	O
.	O

 	O
there	O
are	O
strong	B-UNK
parallels	O
between	O
the	O
pattern	B-UNK
of	O
radiosensitivity	O
,	O
chromosomal	B-DISEASE
instability	I-DISEASE
and	O
cancer	B-DISEASE
predisposition	B-UNK
in	O
a	O
-	O
t	B-UNK
patients	B-UNK
and	O
that	O
in	O
patients	B-UNK
with	O
nijmegen	B-DISEASE
breakage	I-DISEASE
syndrome	I-DISEASE
(	O
nbs	B-UNK
)	O
.	O

 	O
the	O
protein	B-UNK
defective	B-UNK
in	O
nbs	B-UNK
,	O
nibrin	B-UNK
(	O
encoded	B-UNK
by	O
nbs1	B-UNK
)	O
,	O
forms	B-UNK
a	O
complex	B-UNK
with	O
mre11	O
and	O
rad50	B-UNK
(	O
refs	O
1	O
,	O
2	O
)	O
.	O

 	O
this	O
complex	B-UNK
localizes	O
to	O
dsbs	O
within	O
30	O
minutes	O
after	O
cellular	B-UNK
exposure	B-UNK
to	O
ionizing	B-UNK
radiation	B-UNK
(	O
ir	O
)	O
and	O
is	O
observed	B-UNK
in	O
brightly	O
staining	B-UNK
nuclear	B-UNK
foci	I-UNK
after	O
a	O
longer	O
period	B-UNK
of	O
time	B-UNK
.	O

 	O
the	O
overlap	O
between	O
clinical	B-UNK
and	O
cellular	B-UNK
phenotypes	B-UNK
in	O
a	O
-	O
t	B-UNK
and	O
nbs	B-UNK
suggests	B-UNK
that	O
atm	B-UNK
and	O
nibrin	B-UNK
may	O
function	B-UNK
in	O
the	O
same	O
biochemical	B-UNK
pathway	B-UNK
.	O

 	O
here	O
we	O
demonstrate	B-UNK
that	O
nibrin	B-UNK
is	O
phosphorylated	O
within	O
one	O
hour	O
of	O
treatment	B-UNK
of	O
cells	B-UNK
with	O
ir	O
.	O

 	O
this	O
response	B-UNK
is	O
abrogated	O
in	O
a	O
-	O
t	B-UNK
cells	I-UNK
that	O
either	O
do	O
not	O
express	B-UNK
atm	B-UNK
protein	B-UNK
or	O
express	B-UNK
near	B-UNK
full	O
-	O
length	O
mutant	B-UNK
protein	B-UNK
.	O

 	O
we	O
also	O
show	O
that	O
atm	B-UNK
physically	O
interacts	B-UNK
with	O
and	O
phosphorylates	O
nibrin	B-UNK
on	O
serine	B-UNK
343	O
both	O
in	O
vivo	B-UNK
and	O
in	O
vitro	B-UNK
.	O

 	O
phosphorylation	B-UNK
of	O
this	O
site	B-UNK
appears	B-UNK
to	O
be	O
functionally	B-UNK
important	I-UNK
because	O
mutated	B-UNK
nibrin	B-UNK
(	O
s343a	O
)	O
does	O
not	O
completely	B-UNK
complement	B-UNK
radiosensitivity	O
in	O
nbs	B-UNK
cells	B-UNK
.	O

 	B-UNK
atm	I-UNK
phosphorylation	B-UNK
of	O
nibrin	B-UNK
does	O
not	O
affect	B-UNK
nibrin	B-UNK
-	O
mre11	O
-	O
rad50	B-UNK
association	B-UNK
as	O
revealed	B-UNK
by	O
radiation	B-UNK
-	O
induced	B-UNK
foci	B-UNK
formation	B-UNK
.	O

 	O
our	O
data	B-UNK
provide	I-UNK
a	O
biochemical	B-UNK
explanation	B-UNK
for	O
the	O
similarity	B-UNK
in	O
phenotype	B-UNK
between	O
a	O
-	O
t	B-UNK
and	O
nbs	B-UNK
.	O
.	O

 	O
clinicopathologic	O
features	B-UNK
of	O
brca	B-UNK
-	O
linked	B-UNK
and	O
sporadic	B-UNK
ovarian	B-DISEASE
cancer	I-DISEASE
.	O

 	O
context	O
most	O
hereditary	B-UNK
ovarian	B-UNK
cancers	B-DISEASE
are	O
associated	B-UNK
with	O
germline	B-UNK
mutations	I-UNK
in	O
brca1	B-UNK
or	O
brca2	B-UNK
.	O

 	O
attempts	O
to	O
define	B-UNK
the	O
clinical	B-UNK
significance	B-UNK
of	O
brca	B-UNK
mutation	B-UNK
status	B-UNK
in	O
ovarian	B-DISEASE
cancer	I-DISEASE
have	O
produced	B-UNK
conflicting	B-UNK
results	I-UNK
,	O
especially	B-UNK
regarding	O
survival	B-UNK
.	O

 	O
objective	B-UNK
to	O
determine	O
whether	O
hereditary	B-UNK
ovarian	B-UNK
cancers	B-DISEASE
have	O
distinct	B-UNK
clinical	B-UNK
and	O
pathological	B-UNK
features	B-UNK
compared	B-UNK
with	O
sporadic	B-UNK
(	O
nonhereditary	O
)	O
ovarian	B-UNK
cancers	B-DISEASE
.	O

 	O
design	B-UNK
and	O
setting	B-UNK
retrospective	B-UNK
cohort	B-UNK
study	B-UNK
of	O
a	O
consecutive	B-UNK
series	B-UNK
of	O
933	O
ovarian	B-UNK
cancers	B-DISEASE
diagnosed	B-UNK
and	O
treated	B-UNK
at	B-DISEASE
our	O
institution	O
,	O
which	O
is	O
a	O
comprehensive	B-UNK
cancer	B-DISEASE
center	B-UNK
as	O
designated	B-UNK
by	O
the	O
national	O
cancer	B-DISEASE
institute	O
,	O
over	O
a	O
12	O
-	O
year	B-UNK
period	B-UNK
(	O
december	O
1986	O
to	O
august	O
1998	O
)	O
.	O

 	B-UNK
patients	I-UNK
the	O
study	B-UNK
was	O
restricted	O
to	O
patients	B-UNK
of	O
jewish	B-UNK
origin	B-UNK
because	O
of	O
the	O
ease	O
of	O
brca1	B-UNK
and	O
brca2	B-UNK
genotyping	B-UNK
in	O
this	O
ethnic	B-UNK
group	B-UNK
.	O

 	O
from	O
the	O
189	O
patients	B-UNK
who	O
identified	B-UNK
themselves	O
as	O
jewish	B-UNK
,	O
88	O
hereditary	B-UNK
cases	B-UNK
were	O
identified	B-UNK
with	O
the	O
presence	B-UNK
of	O
a	O
germline	B-UNK
founder	B-UNK
mutation	B-UNK
in	O
brca1	B-UNK
or	O
brca2	B-UNK
.	O

 	O
the	O
remaining	B-UNK
101	O
cases	B-UNK
from	O
the	O
same	O
series	B-UNK
not	O
associated	B-UNK
with	O
a	O
brca	B-UNK
mutation	B-UNK
and	O
2	O
additional	B-UNK
groups	B-UNK
(	O
gynecologic	O
oncology	O
group	B-UNK
protocols	O
52	O
and	O
111	O
)	O
with	O
ovarian	B-DISEASE
cancer	I-DISEASE
from	O
clinical	B-UNK
trials	O
(	O
for	O
the	O
survival	B-UNK
analysis	B-UNK
)	O
were	O
included	B-UNK
for	O
comparison	B-UNK
.	O

 	O
main	B-UNK
outcome	B-UNK
measures	O
age	B-UNK
at	B-DISEASE
diagnosis	B-UNK
,	O
surgical	O
stage	B-UNK
,	O
histologic	O
cell	B-UNK
type	B-UNK
and	O
grade	O
,	O
and	O
surgical	O
outcome	B-UNK
;	O
and	O
response	B-UNK
to	O
chemotherapy	O
and	O
survival	B-UNK
for	O
advanced	B-UNK
-	O
stage	B-UNK
(	O
ii	B-UNK
and	O
iv	B-UNK
)	O
cases	B-UNK
.	O

 	B-UNK
results	I-UNK
hereditary	B-UNK
cancers	B-DISEASE
were	O
rarely	B-UNK
diagnosed	B-UNK
before	O
age	B-UNK
40	O
years	B-UNK
and	O
were	O
common	B-UNK
after	O
age	B-UNK
60	O
years	B-UNK
,	O
with	O
mean	B-UNK
age	B-UNK
at	B-DISEASE
diagnosis	B-UNK
being	O
significantly	B-UNK
younger	B-UNK
for	O
brca1	B-UNK
-	O
vs	B-UNK
brca2	B-UNK
-	O
linked	B-UNK
patients	B-UNK
(	O
54	O
vs	B-UNK
62	O
years	B-UNK
;	O
p	B-UNK
=	O
.	O
04	O
)	O
.	O

 	O
histology	O
,	O
grade	O
,	O
stage	B-UNK
,	O
and	O
success	O
of	O
cytoreductive	O
surgery	B-UNK
were	O
similar	B-UNK
for	O
hereditary	B-UNK
and	O
sporadic	B-UNK
cases	B-UNK
.	O

 	O
the	O
hereditary	B-UNK
group	B-UNK
had	O
a	O
longer	O
disease	B-DISEASE
-	O
free	B-UNK
interval	B-UNK
following	B-UNK
primary	B-UNK
chemotherapy	O
in	O
comparison	B-UNK
with	O
the	O
nonhereditary	O
group	B-UNK
,	O
with	O
a	O
median	O
time	B-UNK
to	O
recurrence	B-DISEASE
of	O
14	O
months	O
and	O
7	O
months	O
,	O
respectively	B-UNK
(	O
p	B-UNK
<	O
.	O
001	O
)	O
.	O

 	O
those	O
with	O
hereditary	B-UNK
cancers	B-DISEASE
had	O
improved	B-UNK
survival	B-UNK
compared	B-UNK
with	O
the	O
nonhereditary	O
group	B-UNK
(	O
p	B-UNK
=	O
.	O
004	O
)	O
.	O

 	O
for	O
stage	B-UNK
iii	B-UNK
cancers	B-DISEASE
,	O
brca	B-UNK
mutation	B-UNK
status	B-UNK
was	O
an	O
independent	B-UNK
prognostic	B-UNK
variable	B-UNK
(	O
p	B-UNK
=	O
.	O
03	O
)	O
.	O

 	O
conclusions	B-UNK
although	O
brca	B-UNK
-	O
associated	B-UNK
hereditary	B-UNK
ovarian	B-UNK
cancers	B-DISEASE
in	O
this	O
population	B-UNK
have	O
surgical	O
and	O
pathological	B-UNK
characteristics	B-UNK
similar	B-UNK
to	O
those	O
of	O
sporadic	B-UNK
cancers	B-DISEASE
,	O
advanced	B-UNK
-	O
stage	B-UNK
hereditary	B-UNK
cancer	B-DISEASE
patients	B-UNK
survive	O
longer	O
than	O
nonhereditary	O
cancer	B-DISEASE
patients	B-UNK
.	O

 	O
age	B-UNK
penetrance	B-UNK
is	O
greater	B-UNK
for	O
brca1	B-UNK
-	O
linked	B-UNK
than	O
for	O
brca2	B-UNK
-	O
linked	B-UNK
cancers	B-DISEASE
in	O
this	O
population	B-UNK
.	O

 	O
the	O
gene	B-UNK
for	O
familial	B-DISEASE
mediterranean	I-DISEASE
fever	I-DISEASE
,	O
mefv	B-UNK
,	O
is	O
expressed	B-UNK
in	O
early	B-UNK
leukocyte	B-UNK
development	B-UNK
and	O
is	O
regulated	B-UNK
in	O
response	B-UNK
to	O
inflammatory	B-UNK
mediators	O
.	O

 	O
familial	B-DISEASE
mediterranean	I-DISEASE
fever	I-DISEASE
(	O
fmf	B-UNK
)	O
is	O
a	O
recessive	O
disorder	O
characterized	B-UNK
by	O
episodes	O
of	O
fever	B-DISEASE
and	O
neutrophil	O
-	O
mediated	B-UNK
serosal	O
inflammation	B-DISEASE
.	O

 	O
we	O
recently	B-UNK
identified	B-UNK
the	O
gene	B-UNK
causing	B-UNK
fmf	B-UNK
,	O
designated	B-UNK
mefv	B-UNK
,	O
and	O
found	B-UNK
it	O
to	O
be	O
expressed	B-UNK
in	O
mature	B-UNK
neutrophils	B-UNK
,	O
suggesting	B-UNK
that	O
it	O
functions	B-UNK
as	O
an	O
inflammatory	B-UNK
regulator	B-UNK
.	O

 	O
to	O
facilitate	B-UNK
our	O
understanding	B-UNK
of	O
the	O
normal	B-UNK
function	B-UNK
of	O
mefv	B-UNK
,	O
we	O
extended	B-UNK
our	O
previous	B-UNK
studies	I-UNK
.	O

 	O
mefv	B-UNK
messenger	B-UNK
rna	I-UNK
was	O
detected	B-UNK
by	O
reverse	B-UNK
transcriptase	B-UNK
-	O
polymerase	B-UNK
chain	I-UNK
reaction	I-UNK
in	O
bone	B-UNK
marrow	I-UNK
leukocytes	B-UNK
,	O
with	O
differential	B-UNK
expression	B-UNK
observed	B-UNK
among	O
cells	B-UNK
by	O
in	O
situ	B-UNK
hybridization	I-UNK
.	O

 	O
cd34	O
hematopoietic	B-UNK
stem	O
-	O
cell	B-UNK
cultures	B-UNK
induced	B-UNK
toward	O
the	O
granulocytic	O
lineage	B-UNK
expressed	B-UNK
mefv	B-UNK
at	B-DISEASE
the	O
myelocyte	O
stage	B-UNK
,	O
concurrently	O
with	O
lineage	B-UNK
commitment	O
.	O

 	O
the	O
prepromyelocytic	O
cell	B-UNK
line	B-UNK
hl60	O
expressed	B-UNK
mefv	B-UNK
only	O
at	B-DISEASE
granulocytic	O
and	O
monocytic	O
differentiation	B-UNK
.	O

 	O
mefv	B-UNK
was	O
also	O
expressed	B-UNK
in	O
the	O
monocytic	O
cell	B-UNK
lines	B-UNK
u937	O
and	O
thp	O
-	O
1	O
.	O

 	O
among	O
peripheral	B-UNK
blood	I-UNK
leukocytes	B-UNK
,	O
mefv	B-UNK
expression	B-UNK
was	O
detected	B-UNK
in	O
neutrophils	B-UNK
,	O
eosinophils	O
,	O
and	O
to	O
varying	B-UNK
degrees	B-UNK
,	O
monocytes	O
.	O

 	O
consistent	B-UNK
with	O
the	O
tissue	B-UNK
specificity	B-UNK
of	O
expression	B-UNK
,	O
complete	B-UNK
sequencing	B-UNK
and	O
analysis	B-UNK
of	O
upstream	B-UNK
regulatory	B-UNK
regions	B-UNK
of	O
mefv	B-UNK
revealed	B-UNK
homology	B-UNK
to	O
myeloid	O
-	O
specific	B-UNK
promoters	O
and	O
to	O
more	O
broadly	O
expressed	B-UNK
inflammatory	B-UNK
promoter	B-UNK
elements	B-UNK
.	O

 	O
in	O
vitro	B-UNK
stimulation	B-UNK
of	O
monocytes	O
with	O
the	O
proinflammatory	O
agents	B-UNK
interferon	O
(	O
ifn	O
)	O
gamma	B-UNK
,	O
tumor	B-DISEASE
necrosis	B-DISEASE
factor	B-UNK
,	O
and	O
lipopolysaccharide	O
induced	B-UNK
mefv	B-UNK
expression	B-UNK
,	O
whereas	O
the	O
antiinflammatory	O
cytokines	O
interleukin	O
(	O
il	O
)	O
4	O
,	O
il	O
-	O
10	O
,	O
and	O
transforming	B-UNK
growth	B-UNK
factor	B-UNK
beta	B-UNK
inhibited	B-UNK
such	O
expression	B-UNK
.	O

 	O
induction	O
by	O
ifn	O
-	O
gamma	B-UNK
occurred	B-UNK
rapidly	B-UNK
and	O
was	O
resistant	O
to	O
cycloheximide	O
.	O

 	O
ifn	O
-	O
alpha	B-UNK
also	O
induced	B-UNK
mefv	B-UNK
expression	B-UNK
.	O

 	O
in	O
granulocytes	B-UNK
,	O
mefv	B-UNK
was	O
up	O
-	O
regulated	B-UNK
by	O
ifn	O
-	O
gamma	B-UNK
and	O
the	O
combination	O
of	O
ifn	O
-	O
alpha	B-UNK
and	O
colchicine	B-UNK
.	O

 	O
these	O
results	B-UNK
refine	O
understanding	B-UNK
of	O
mefv	B-UNK
by	O
placing	O
the	O
gene	B-UNK
in	O
the	O
myelomonocytic	O
-	O
specific	B-UNK
proinflammatory	O
pathway	B-UNK
and	O
identifying	B-UNK
it	O
as	O
an	O
ifn	O
-	O
gamma	B-UNK
immediate	B-UNK
early	B-UNK
gene	B-UNK
.	O
.	O

 	B-UNK
biochemical	I-UNK
and	O
structural	B-UNK
analysis	B-UNK
of	O
missense	B-UNK
mutations	I-UNK
in	O
n	B-UNK
-	O
acetylgalactosamine	O
-	O
6	O
-	O
sulfate	B-UNK
sulfatase	B-UNK
causing	B-UNK
mucopolysaccharidosis	B-UNK
iva	I-UNK
phenotypes	B-UNK
.	O

 	B-UNK
mucopolysaccharidosis	I-UNK
iva	B-UNK
(	O
mps	B-UNK
iva	B-UNK
;	O
omim	O
#	O
253000	O
)	O
,	O
a	O
lysosomal	B-UNK
storage	B-UNK
disorder	I-UNK
caused	I-UNK
by	O
a	O
deficiency	B-UNK
of	O
n	B-UNK
-	O
acetylgalactosamine	O
-	O
6	O
-	O
sulfate	B-UNK
sulfatase	B-UNK
(	O
galns	B-UNK
)	O
,	O
has	O
variable	B-UNK
clinical	I-UNK
phenotypes	B-UNK
.	O

 	O
to	O
date	B-UNK
we	O
have	O
identified	B-UNK
65	O
missense	B-UNK
mutations	I-UNK
in	O
the	O
galns	B-UNK
gene	B-UNK
from	O
mps	B-UNK
iva	B-UNK
patients	B-UNK
,	O
but	O
the	O
correlation	B-UNK
between	O
genotype	B-UNK
and	O
phenotype	B-UNK
has	O
remained	B-UNK
unclear	O
.	O

 	O
we	O
studied	B-UNK
17	O
missense	B-UNK
mutations	I-UNK
using	O
biochemical	B-UNK
approaches	B-UNK
and	O
32	O
missense	B-UNK
mutations	I-UNK
,	O
using	O
structural	B-UNK
analyses	B-UNK
.	O

 	O
fifteen	O
missense	B-UNK
mutations	I-UNK
and	O
two	O
newly	B-UNK
engineered	O
active	B-UNK
site	B-UNK
mutations	B-UNK
(	O
c79s	O
,	O
c79	B-UNK
t	B-UNK
)	O
were	O
characterized	B-UNK
by	O
transient	B-UNK
expression	I-UNK
analysis	B-UNK
.	O

 	B-UNK
mutant	I-UNK
proteins	B-UNK
,	O
except	O
for	O
c79s	O
and	O
c79	B-UNK
t	B-UNK
,	O
were	O
destabilized	O
and	O
detected	B-UNK
as	O
insoluble	O
precursor	B-UNK
forms	B-UNK
while	O
the	O
c79s	O
and	O
c79	B-UNK
t	B-UNK
mutants	B-UNK
were	O
of	O
a	O
soluble	B-UNK
mature	B-UNK
size	B-UNK
.	O

 	O
mutants	B-UNK
found	B-UNK
in	O
the	O
severe	B-UNK
phenotype	B-UNK
had	O
no	O
activity	B-UNK
.	O

 	O
mutants	B-UNK
found	B-UNK
in	O
the	O
mild	B-UNK
phenotype	B-UNK
had	O
a	O
considerable	B-UNK
residual	B-UNK
activity	B-UNK
(	O
1	O
.	O
3	O
-	O
13	O
.	O
3	O
%	O
of	O
wild	B-UNK
-	O
type	B-UNK
galns	B-UNK
activity	B-UNK
)	O
.	O

 	O
sulfatases	O
,	O
including	B-UNK
galns	B-UNK
,	O
are	O
members	B-UNK
of	O
a	O
highly	B-UNK
conserved	I-UNK
gene	B-UNK
family	B-UNK
sharing	B-UNK
an	O
extensive	B-UNK
sequence	B-UNK
homology	B-UNK
.	O

 	O
thus	O
,	O
a	O
tertiary	O
structural	B-UNK
model	B-UNK
of	O
human	B-UNK
galns	B-UNK
was	O
constructed	B-UNK
from	O
the	O
x	B-UNK
-	O
ray	O
crystal	O
structure	B-UNK
of	O
n	B-UNK
-	O
acetylgalacto	O
-	O
samine	O
-	O
4	O
-	O
sulfatase	B-UNK
and	O
arylsulfatase	B-UNK
a	O
,	O
using	O
homology	B-UNK
modeling	O
,	O
and	O
32	O
missense	B-UNK
mutations	I-UNK
were	O
investigated	B-UNK
.	O

 	O
consequently	B-UNK
,	O
we	O
propose	O
that	O
there	O
are	O
at	B-DISEASE
least	O
three	O
different	B-UNK
reasons	O
for	O
the	O
severe	B-UNK
phenotype	B-UNK
(	O
i	O
)	O
destruction	O
of	O
the	O
hydrophobic	B-UNK
core	O
or	O
modification	B-UNK
of	O
the	O
packing	O
;	O
(	O
ii	B-UNK
)	O
removal	O
of	O
a	O
salt	O
bridge	O
to	O
destabilize	O
the	O
entire	B-UNK
conformation	O
;	O
(	O
iii	B-UNK
)	O
modification	B-UNK
of	O
the	O
active	B-UNK
site	B-UNK
.	O

 	O
in	O
contrast	B-UNK
,	O
mild	B-UNK
mutations	B-UNK
were	O
mostly	O
located	B-UNK
on	O
the	O
surface	B-UNK
of	O
the	O
galns	B-UNK
protein	B-UNK
.	O

 	O
these	O
studies	B-UNK
shed	O
further	O
light	O
on	O
the	O
genotype	B-UNK
-	O
phenotype	B-UNK
correlation	B-UNK
of	O
mps	B-UNK
iva	B-UNK
and	O
structure	B-UNK
-	O
function	B-UNK
relationship	B-UNK
in	O
the	O
sulfatase	B-UNK
family	B-UNK
.	O

 	O
mutations	B-UNK
at	B-DISEASE
the	O
ataxia	B-DISEASE
-	O
telangiectasia	B-DISEASE
locus	B-UNK
and	O
clinical	B-UNK
phenotypes	I-UNK
of	O
a	O
-	O
t	B-UNK
patients	B-UNK
.	O

 	O
mutations	B-UNK
at	B-DISEASE
the	O
ataxia	B-DISEASE
-	O
telangiectasia	B-DISEASE
(	O
a	O
-	O
t	B-UNK
)	O
locus	B-UNK
on	O
chromosome	B-UNK
band	B-UNK
11q22	O
cause	B-UNK
a	O
distinctive	B-UNK
autosomal	O
recessive	O
syndrome	B-DISEASE
in	O
homozygotes	B-UNK
and	O
predispose	B-UNK
heterozygotes	B-UNK
to	O
cancer	B-DISEASE
,	O
ischemic	B-DISEASE
heart	I-DISEASE
disease	I-DISEASE
,	O
and	O
early	B-UNK
mortality	O
.	O

 	O
pcr	B-UNK
amplification	I-UNK
from	O
genomic	B-UNK
dna	I-UNK
and	O
automated	O
sequencing	B-UNK
of	O
the	O
entire	B-UNK
coding	I-UNK
region	B-UNK
(	O
66	O
exons	B-UNK
)	O
and	O
splice	O
junctions	B-UNK
detected	B-UNK
77	O
mutations	B-UNK
(	O
85	O
%	O
)	O
in	O
90	O
a	O
-	O
t	B-UNK
chromosomes	B-UNK
.	O

 	O
heteroduplex	B-UNK
analysis	B-UNK
detected	B-UNK
another	O
42	O
mutations	B-UNK
at	B-DISEASE
the	O
a	O
-	O
t	B-UNK
locus	B-UNK
.	O

 	O
out	O
of	O
a	O
total	B-UNK
of	O
71	O
unique	B-UNK
mutations	B-UNK
,	O
50	O
were	O
found	B-UNK
only	O
in	O
a	O
single	B-UNK
family	B-UNK
,	O
and	O
51	O
had	O
not	O
been	O
reported	B-UNK
previously	B-UNK
.	O

 	O
most	O
(	O
58	O
/	O
71	O
,	O
82	O
%	O
)	O
mutations	B-UNK
were	O
frameshift	B-UNK
and	O
nonsense	B-UNK
mutations	B-UNK
that	O
are	O
predicted	B-UNK
to	O
cause	B-UNK
truncation	O
of	O
the	O
a	O
-	O
t	B-UNK
protein	B-UNK
;	O
the	O
less	O
common	B-UNK
mutation	B-UNK
types	B-UNK
were	O
missense	B-UNK
(	O
9	O
/	O
71	O
,	O
13	O
%	O
)	O
,	O
splicing	B-UNK
(	O
3	O
/	O
71	O
,	O
4	O
%	O
)	O
and	O
one	O
in	O
-	O
frame	B-UNK
deletion	B-UNK
,	O
2546	O
3	O
(	O
1	O
/	O
71	O
,	O
1	O
%	O
)	O
.	O

 	O
the	O
mean	B-UNK
survival	B-UNK
and	O
height	O
distribution	B-UNK
of	O
134	O
a	O
-	O
t	B-UNK
patients	B-UNK
correlated	B-UNK
significantly	B-UNK
with	O
the	O
specific	B-UNK
mutations	B-UNK
present	B-UNK
in	O
the	O
patients	B-UNK
.	O

 	B-UNK
patients	I-UNK
homozygous	B-UNK
for	O
a	O
single	B-UNK
truncating	B-UNK
mutation	B-UNK
,	O
typically	B-UNK
near	B-UNK
the	O
n	B-UNK
-	O
terminal	B-UNK
end	B-UNK
of	O
the	O
gene	B-UNK
,	O
or	O
heterozygous	B-UNK
for	O
the	O
in	O
-	O
frame	B-UNK
deletion	B-UNK
2546	O
3	O
,	O
were	O
shorter	B-UNK
and	O
had	O
significantly	B-UNK
shorter	B-UNK
survival	B-UNK
than	O
those	O
heterozygous	B-UNK
for	O
a	O
splice	B-UNK
site	I-UNK
or	O
missense	B-UNK
mutation	I-UNK
,	O
or	O
heterozygous	B-UNK
for	O
two	O
truncating	B-UNK
mutations	B-UNK
.	O

 	O
alterations	B-UNK
of	O
the	O
length	O
or	O
amino	B-UNK
acid	I-UNK
composition	B-UNK
of	O
the	O
a	O
-	O
t	B-UNK
gene	B-UNK
product	B-UNK
affect	B-UNK
the	O
a	O
-	O
t	B-UNK
clinical	B-UNK
phenotype	I-UNK
in	O
different	B-UNK
ways	B-UNK
.	O

 	O
mutation	B-UNK
analysis	B-UNK
at	B-DISEASE
the	O
a	O
-	O
t	B-UNK
locus	B-UNK
may	O
help	O
estimate	B-UNK
the	O
prognosis	O
of	O
a	O
-	O
t	B-UNK
patients	B-UNK
.	O
.	O

 	O
isolation	B-UNK
,	O
genomic	B-UNK
organization	B-UNK
,	O
and	O
expression	B-UNK
analysis	B-UNK
of	O
the	O
mouse	B-UNK
and	O
rat	B-UNK
homologs	O
of	O
mefv	B-UNK
,	O
the	O
gene	B-UNK
for	O
familial	B-DISEASE
mediterranean	I-DISEASE
fever	I-DISEASE
.	O

 	O
familial	B-DISEASE
mediterranean	I-DISEASE
fever	I-DISEASE
(	O
fmf	B-UNK
)	O
is	O
a	O
recessive	O
disorder	O
characterized	B-UNK
by	O
episodes	O
of	O
fever	B-DISEASE
with	O
serositis	B-DISEASE
or	O
synovitis	B-DISEASE
.	O

 	O
recently	B-UNK
the	O
fmf	B-UNK
gene	B-UNK
(	O
mefv	B-UNK
)	O
was	O
cloned	B-UNK
;	O
the	O
protein	B-UNK
product	B-UNK
,	O
pyrin	O
/	O
marenostrin	O
,	O
is	O
thought	O
to	O
regulate	B-UNK
inflammation	B-DISEASE
in	O
myeloid	O
cells	B-UNK
.	O

 	O
in	O
this	O
manuscript	O
we	O
report	B-UNK
the	O
mouse	B-UNK
and	O
rat	B-UNK
homologs	O
of	O
mefv	B-UNK
.	O

 	O
the	O
murine	B-UNK
gene	B-UNK
contains	B-UNK
ten	B-DISEASE
exons	B-UNK
with	O
a	O
coding	B-UNK
sequence	B-UNK
of	O
2304	O
bp	B-UNK
,	O
while	O
the	O
rat	B-UNK
homolog	B-UNK
has	O
nine	O
exons	B-UNK
with	O
a	O
coding	B-UNK
sequence	B-UNK
of	O
2253	O
bp	B-UNK
.	O

 	O
a	O
considerable	B-UNK
amino	B-UNK
acid	I-UNK
sequence	I-UNK
homology	B-UNK
was	O
observed	B-UNK
between	O
the	O
mouse	B-UNK
and	O
human	B-UNK
(	O
47	O
.	O
6	O
%	O
identity	O
and	O
65	O
.	O
5	O
%	O
similarity	B-UNK
)	O
and	O
between	O
the	O
mouse	B-UNK
and	O
rat	B-UNK
genes	B-UNK
(	O
73	O
.	O
5	O
%	O
identity	O
and	O
82	O
.	O
1	O
%	O
similarity	B-UNK
)	O
.	O

 	O
the	O
predicted	B-UNK
rodent	O
proteins	B-UNK
have	O
several	O
important	B-UNK
domains	B-UNK
and	O
signals	B-UNK
found	B-UNK
in	O
human	B-UNK
pyrin	O
,	O
including	B-UNK
a	O
b	B-UNK
-	O
box	B-UNK
zinc	B-DISEASE
finger	B-UNK
domain	B-UNK
,	O
robbins	O
-	O
dingwall	O
nuclear	B-UNK
localization	B-UNK
signal	B-UNK
,	O
and	O
coiled	O
-	O
coil	O
domain	B-UNK
.	O

 	O
however	O
,	O
perhaps	O
because	O
of	O
an	O
ancient	B-UNK
frame	B-UNK
-	O
shift	B-UNK
mutation	B-UNK
,	O
neither	O
the	O
mouse	B-UNK
nor	O
the	O
rat	B-UNK
protein	B-UNK
has	O
an	O
intact	B-UNK
c	B-UNK
-	O
terminal	B-UNK
b30	O
.	O

 	O
2	O
domain	B-UNK
,	O
in	O
which	O
most	O
fmf	B-UNK
-	O
associated	B-UNK
mutations	B-UNK
have	O
been	O
found	B-UNK
in	O
human	B-UNK
mefv	B-UNK
.	O

 	O
nevertheless	O
,	O
like	B-UNK
the	O
human	B-UNK
gene	B-UNK
,	O
mouse	B-UNK
mefv	B-UNK
is	O
expressed	B-UNK
in	O
peripheral	B-UNK
blood	I-UNK
granulocytes	B-UNK
but	O
not	O
lymphocytes	B-UNK
.	O

 	O
consistent	B-UNK
with	O
its	O
expression	B-UNK
in	O
granulocytes	B-UNK
,	O
mefv	B-UNK
was	O
detected	B-UNK
at	B-DISEASE
high	B-UNK
levels	B-UNK
in	O
the	O
primary	B-UNK
follicles	O
and	O
marginal	O
zones	O
of	O
the	O
splenic	O
white	B-UNK
pulp	O
.	O

 	O
mefv	B-UNK
is	O
localized	B-UNK
on	O
mouse	B-UNK
chromosome	I-UNK
(	O
chr	O
)	O
16	O
,	O
region	B-UNK
a3	O
-	O
b1	O
,	O
extending	B-UNK
a	O
region	B-UNK
of	O
synteny	B-UNK
with	O
human	B-UNK
chr	O
16p13	O
.	O

 	O
3	O
.	O

 	O
development	B-UNK
of	O
knockout	O
and	O
knockin	O
mouse	B-UNK
models	B-UNK
may	O
provide	B-UNK
further	O
insights	O
into	O
the	O
functional	B-UNK
evolution	O
of	O
this	O
gene	B-UNK
.	O

 	B-UNK
additional	I-UNK
copies	B-UNK
of	O
the	O
proteolipid	B-UNK
protein	B-UNK
gene	B-UNK
causing	B-UNK
pelizaeus	B-DISEASE
-	I-DISEASE
merzbacher	I-DISEASE
disease	I-DISEASE
arise	O
by	O
separate	B-UNK
integration	O
into	O
the	O
x	B-DISEASE
chromosome	I-DISEASE
.	O

 	O
the	O
proteolipid	B-UNK
protein	B-UNK
gene	B-UNK
(	O
plp	B-UNK
)	O
is	O
normally	B-UNK
present	B-UNK
at	B-DISEASE
chromosome	B-UNK
xq22	O
.	O

 	O
mutations	B-UNK
and	O
duplications	O
of	O
this	O
gene	B-UNK
are	O
associated	B-UNK
with	O
pelizaeus	B-DISEASE
-	I-DISEASE
merzbacher	I-DISEASE
disease	I-DISEASE
(	O
pmd	O
)	O
.	O

 	O
here	O
we	O
describe	B-UNK
two	O
new	B-UNK
families	B-UNK
in	O
which	O
males	B-UNK
affected	B-UNK
with	O
pmd	O
were	O
found	B-UNK
to	O
have	O
a	O
copy	B-UNK
of	O
plp	B-UNK
on	O
the	O
short	B-UNK
arm	B-UNK
of	O
the	O
x	B-DISEASE
chromosome	I-DISEASE
,	O
in	O
addition	B-UNK
to	O
a	O
normal	B-UNK
copy	B-UNK
on	O
xq22	O
.	O

 	O
in	O
the	O
first	O
family	B-UNK
,	O
the	O
extra	O
copy	B-UNK
was	O
first	O
detected	B-UNK
by	O
the	O
presence	B-UNK
of	O
heterozygosity	B-UNK
of	O
the	O
ahaii	O
dimorphism	O
within	O
the	O
plp	B-UNK
gene	B-UNK
.	O

 	O
the	O
results	B-UNK
of	O
fish	B-UNK
analysis	B-UNK
showed	B-UNK
an	O
additional	B-UNK
copy	B-UNK
of	O
plp	B-UNK
in	O
xp22	O
.	O

 	O
1	O
,	O
although	O
no	O
chromosomal	B-UNK
rearrangements	I-UNK
could	O
be	O
detected	B-UNK
by	O
standard	B-UNK
karyotype	B-UNK
analysis	B-UNK
.	O

 	O
another	O
three	O
affected	B-UNK
males	B-UNK
from	O
the	O
family	B-UNK
had	O
similar	B-UNK
findings	B-UNK
.	O

 	O
in	O
a	O
second	B-UNK
unrelated	B-UNK
family	B-UNK
with	O
signs	B-UNK
of	O
pmd	O
,	O
cytogenetic	B-UNK
analysis	B-UNK
showed	B-UNK
a	O
pericentric	O
inversion	B-UNK
of	O
the	O
x	B-DISEASE
chromosome	I-DISEASE
.	O

 	O
in	O
the	O
inv	O
(	O
x	B-UNK
)	O
carried	B-UNK
by	O
several	O
affected	B-UNK
family	B-UNK
members	I-UNK
,	O
fish	B-UNK
showed	B-UNK
plp	B-UNK
signals	B-UNK
at	B-DISEASE
xp11	B-UNK
.	O

 	O
4	O
and	O
xq22	O
.	O

 	O
a	O
third	O
family	B-UNK
has	O
previously	B-UNK
been	O
reported	B-UNK
,	O
in	O
which	O
affected	B-UNK
members	B-UNK
had	O
an	O
extra	O
copy	B-UNK
of	O
the	O
plp	B-UNK
gene	B-UNK
detected	B-UNK
at	B-DISEASE
xq26	O
in	O
a	O
chromosome	B-UNK
with	O
an	O
otherwise	O
normal	B-UNK
banding	B-UNK
pattern	B-UNK
.	O

 	O
the	O
identification	B-UNK
of	O
three	O
separate	B-UNK
families	B-UNK
in	O
which	O
plp	B-UNK
is	O
duplicated	B-UNK
at	B-DISEASE
a	O
noncontiguous	O
site	B-UNK
suggests	B-UNK
that	O
such	O
duplications	O
could	O
be	O
a	O
relatively	B-UNK
common	B-UNK
but	O
previously	B-UNK
undetected	O
cause	B-UNK
of	O
genetic	B-UNK
disorders	B-UNK
.	O

 	O
the	O
exon	B-UNK
13	O
duplication	B-UNK
in	O
the	O
brca1	B-UNK
gene	B-UNK
is	O
a	O
founder	B-UNK
mutation	B-UNK
present	B-UNK
in	O
geographically	O
diverse	B-UNK
populations	B-UNK
.	O

 	O
the	O
brca1	B-UNK
exon	B-UNK
13	O
duplication	B-UNK
screening	B-UNK
group	B-UNK
.	O

 	O
recently	B-UNK
,	O
a	O
6	O
-	O
kb	B-UNK
duplication	B-UNK
of	O
exon	B-UNK
13	O
,	O
which	O
creates	O
a	O
frameshift	B-UNK
in	O
the	O
coding	B-UNK
sequence	B-UNK
of	O
the	O
brca1	B-UNK
gene	B-UNK
,	O
has	O
been	O
described	B-UNK
in	O
three	O
unrelated	B-UNK
u	B-UNK
.	O

 	O
s	O
s	O
.	O
families	B-UNK
of	O
european	B-UNK
ancestry	B-UNK
and	O
in	O
one	O
portuguese	B-UNK
family	B-UNK
.	O

 	O
here	O
,	O
our	O
goal	O
was	O
to	O
estimate	B-UNK
the	O
frequency	B-UNK
and	O
geographic	B-UNK
diversity	O
of	O
carriers	B-UNK
of	O
this	O
duplication	B-UNK
.	O

 	O
to	O
do	O
this	O
,	O
a	O
collaborative	B-UNK
screening	B-UNK
study	B-UNK
was	O
set	B-UNK
up	O
that	O
involved	B-UNK
39	O
institutions	O
from	O
19	O
countries	B-UNK
and	O
included	B-UNK
3	O
,	O
580	O
unrelated	B-UNK
individuals	B-UNK
with	O
a	O
family	B-UNK
history	B-UNK
of	O
the	O
disease	B-DISEASE
and	O
934	O
early	B-UNK
-	O
onset	B-UNK
breast	B-UNK
and	O
/	O
or	O
ovarian	B-DISEASE
cancer	I-DISEASE
cases	B-UNK
.	O

 	O
a	O
total	B-UNK
of	O
11	O
additional	B-UNK
families	B-UNK
carrying	B-UNK
this	O
mutation	B-UNK
were	O
identified	B-UNK
in	O
australia	O
(	O
1	O
)	O
,	O
belgium	O
(	O
1	O
)	O
,	O
canada	B-UNK
(	O
1	O
)	O
,	O
great	B-UNK
britain	O
(	O
6	O
)	O
,	O
and	O
the	O
united	B-UNK
states	B-UNK
(	O
2	O
)	O
.	O

 	O
haplotyping	B-UNK
showed	B-UNK
that	O
they	O
are	O
likely	B-UNK
to	O
derive	O
from	O
a	O
common	B-UNK
ancestor	B-UNK
,	O
possibly	B-UNK
of	O
northern	B-UNK
british	B-UNK
origin	B-UNK
.	O

 	O
our	O
results	B-UNK
demonstrate	B-UNK
that	O
it	O
is	O
strongly	B-UNK
advisable	O
,	O
for	O
laboratories	O
carrying	B-UNK
out	O
screening	B-UNK
either	O
in	O
english	O
-	O
speaking	O
countries	B-UNK
or	O
in	O
countries	B-UNK
with	O
historical	O
links	O
with	O
britain	O
,	O
to	O
include	B-UNK
within	O
their	O
brca1	B-UNK
screening	B-UNK
protocols	O
the	O
polymerase	B-UNK
chain	I-UNK
reaction	I-UNK
-	O
based	B-UNK
assay	B-UNK
described	B-UNK
in	O
this	O
report	B-UNK
.	O

 	O
genotype	B-UNK
-	O
phenotype	B-UNK
correlations	B-UNK
in	O
families	B-UNK
with	O
deletions	B-UNK
in	O
the	O
von	B-UNK
hippel	I-UNK
-	O
lindau	O
(	O
vhl	B-UNK
)	O
gene	B-UNK
.	O

 	O
von	B-UNK
hippel	I-UNK
-	O
lindau	O
(	O
vhl	B-UNK
)	O
disease	B-DISEASE
is	O
a	O
hereditary	B-UNK
tumor	B-DISEASE
syndrome	B-DISEASE
characterized	B-UNK
by	O
predisposition	B-UNK
for	O
bilateral	B-UNK
and	O
multi	O
-	O
centric	O
hemangioblastoma	B-DISEASE
in	O
the	O
retina	O
and	O
central	B-UNK
nervous	I-UNK
system	I-UNK
,	O
pheochromocytoma	B-DISEASE
,	O
renal	B-DISEASE
cell	B-UNK
carcinoma	B-DISEASE
,	O
and	O
cysts	B-DISEASE
in	O
the	O
kidney	B-UNK
,	O
pancreas	O
,	O
and	O
epididymis	O
.	O

 	O
we	O
describe	B-UNK
five	O
families	B-UNK
for	O
which	O
direct	B-UNK
sequencing	I-UNK
of	O
the	O
coding	B-UNK
region	I-UNK
of	O
the	O
vhl	B-UNK
gene	B-UNK
had	O
failed	B-UNK
to	O
identify	B-UNK
the	O
family	B-UNK
-	O
specific	B-UNK
mutation	B-UNK
.	O

 	O
further	O
molecular	B-UNK
analysis	B-UNK
revealed	B-UNK
deletions	B-UNK
involving	I-UNK
the	O
vhl	B-UNK
gene	B-UNK
in	O
each	O
of	O
these	O
families	B-UNK
.	O

 	O
in	O
four	O
families	B-UNK
,	O
partial	B-UNK
deletions	B-UNK
of	O
one	O
or	O
more	O
exons	B-UNK
were	O
detected	B-UNK
by	O
southern	B-UNK
blot	I-UNK
analysis	I-UNK
.	O

 	O
in	O
the	O
fifth	B-UNK
family	B-UNK
,	O
fish	B-UNK
analysis	B-UNK
demonstrated	B-UNK
the	O
deletion	B-UNK
of	O
the	O
entire	B-UNK
vhl	B-UNK
gene	B-UNK
.	O

 	O
our	O
results	B-UNK
show	O
that	O
(	O
quantitative	B-UNK
)	O
southern	B-UNK
blot	I-UNK
analysis	I-UNK
is	O
a	O
sensitive	B-UNK
method	B-UNK
for	O
detecting	B-UNK
germline	B-UNK
deletions	B-UNK
of	O
the	O
vhl	B-UNK
gene	B-UNK
and	O
should	O
be	O
implemented	O
in	O
routine	B-UNK
dna	B-UNK
diagnosis	B-UNK
for	O
vhl	B-UNK
disease	B-DISEASE
.	O

 	O
our	O
data	B-UNK
support	B-UNK
the	O
previously	B-UNK
established	B-UNK
observation	B-UNK
that	O
families	B-UNK
with	O
a	O
germline	B-UNK
deletion	B-UNK
have	O
a	O
low	B-UNK
risk	B-UNK
for	O
pheochromocytoma	B-DISEASE
.	O

 	O
further	O
unraveling	O
of	O
genotype	B-UNK
-	O
phenotype	B-UNK
correlations	B-UNK
in	O
vhl	B-UNK
disease	B-DISEASE
has	O
revealed	B-UNK
that	O
families	B-UNK
with	O
a	O
full	O
or	O
partial	B-UNK
deletion	B-UNK
of	O
the	O
vhl	B-UNK
gene	B-UNK
exhibit	B-UNK
a	O
phenotype	B-UNK
with	O
a	O
preponderance	O
of	O
central	B-UNK
nervous	I-UNK
system	I-UNK
hemangioblastoma	B-DISEASE
.	O
.	O

 	O
age	B-UNK
of	O
the	O
intronic	B-UNK
gaa	B-UNK
triplet	B-UNK
repeat	I-UNK
expansion	B-UNK
mutation	B-UNK
in	O
friedreich	B-DISEASE
ataxia	I-DISEASE
.	O

 	O
friedreich	B-DISEASE
ataxia	I-DISEASE
(	O
frda	B-UNK
)	O
,	O
the	O
most	O
frequently	B-UNK
inherited	B-UNK
ataxia	B-DISEASE
,	O
is	O
due	O
in	O
the	O
vast	B-UNK
majority	B-UNK
of	O
cases	B-UNK
to	O
a	O
large	B-UNK
expansion	B-UNK
of	O
an	O
intronic	B-UNK
gaa	B-UNK
repeat	I-UNK
.	O

 	O
using	O
linkage	B-UNK
disequilibrium	I-UNK
analysis	B-UNK
based	B-UNK
on	O
haplotype	B-UNK
data	I-UNK
of	O
seven	B-UNK
polymorphic	B-UNK
markers	I-UNK
close	B-UNK
to	O
the	O
frataxin	B-UNK
gene	B-UNK
,	O
the	O
age	B-UNK
of	O
frda	B-UNK
founding	B-UNK
mutational	B-UNK
event	B-UNK
(	O
s	O
)	O
is	O
estimated	B-UNK
to	O
be	O
at	B-DISEASE
least	O
682	O
+	O
/	O
-	O
203	O
generations	B-UNK
(	O
95	O
%	O
confidence	B-UNK
interval	B-UNK
564	O
-	O
801	O
g	B-UNK
)	O
,	O
a	O
dating	O
which	O
is	O
consistent	B-UNK
with	O
little	B-UNK
or	O
no	O
negative	B-UNK
selection	B-UNK
and	O
provides	B-UNK
further	O
evidence	B-UNK
for	O
an	O
ancient	B-UNK
spread	B-UNK
of	O
a	O
pre	O
-	O
mutation	B-UNK
(	O
at	B-DISEASE
-	O
risk	B-UNK
alleles	B-UNK
)	O
in	O
western	B-UNK
europe	B-UNK
.	O
.	O

 	B-UNK
functional	I-UNK
link	B-UNK
between	O
ataxia	B-DISEASE
-	O
telangiectasia	B-DISEASE
and	O
nijmegen	B-DISEASE
breakage	I-DISEASE
syndrome	I-DISEASE
gene	B-UNK
products	B-UNK
.	O

 	O
ataxia	B-DISEASE
-	O
telangiectasia	B-DISEASE
(	O
a	O
-	O
t	B-UNK
)	O
and	O
nijmegen	B-DISEASE
breakage	I-DISEASE
syndrome	I-DISEASE
(	O
nbs	B-UNK
)	O
are	O
recessive	O
genetic	B-UNK
disorders	B-UNK
with	O
susceptibility	B-UNK
to	O
cancer	B-DISEASE
and	O
similar	B-UNK
cellular	B-UNK
phenotypes	B-UNK
.	O

 	O
the	O
protein	B-UNK
product	B-UNK
of	O
the	O
gene	B-UNK
responsible	B-UNK
for	O
a	O
-	O
t	B-UNK
,	O
designated	B-UNK
atm	B-UNK
,	O
is	O
a	O
member	B-UNK
of	O
a	O
family	B-UNK
of	O
kinases	O
characterized	B-UNK
by	O
a	O
carboxy	O
-	O
terminal	B-UNK
phosphatidylinositol	B-UNK
3	O
-	O
kinase	B-UNK
-	O
like	B-UNK
domain	B-UNK
.	O

 	O
the	O
nbs1	B-UNK
protein	B-UNK
is	O
specifically	B-UNK
mutated	B-UNK
in	O
patients	B-UNK
with	O
nijmegen	B-DISEASE
breakage	I-DISEASE
syndrome	I-DISEASE
and	O
forms	B-UNK
a	O
complex	B-UNK
with	O
the	O
dna	B-UNK
repair	B-UNK
proteins	B-UNK
rad50	B-UNK
and	O
mrel1	O
.	O

 	O
here	O
we	O
show	O
that	O
phosphorylation	B-UNK
of	O
nbs1	B-UNK
,	O
induced	B-UNK
by	O
ionizing	B-UNK
radiation	B-UNK
,	O
requires	B-UNK
catalytically	O
active	B-UNK
atm	B-UNK
.	O

 	O
complexes	B-UNK
containing	B-UNK
atm	B-UNK
and	O
nbs1	B-UNK
exist	O
in	O
vivo	B-UNK
in	O
both	O
untreated	O
cells	B-UNK
and	O
cells	B-UNK
treated	B-UNK
with	O
ionizing	B-UNK
radiation	B-UNK
.	O

 	O
we	O
have	O
identified	B-UNK
two	O
residues	B-UNK
of	O
nbs1	B-UNK
,	O
ser	B-UNK
278	O
and	O
ser	B-UNK
343	O
that	O
are	O
phosphorylated	O
in	O
vitro	B-UNK
by	O
atm	B-UNK
and	O
whose	O
modification	B-UNK
in	O
vivo	B-UNK
is	O
essential	B-UNK
for	O
the	O
cellular	B-UNK
response	B-UNK
to	O
dna	B-UNK
damage	I-UNK
.	O

 	O
this	O
response	B-UNK
includes	B-UNK
s	O
-	O
phase	B-UNK
checkpoint	I-UNK
activation	B-UNK
,	O
formation	B-UNK
of	O
the	O
nbs1	B-UNK
/	O
mrel1	O
/	O
rad50	B-UNK
nuclear	B-UNK
foci	I-UNK
and	O
rescue	O
of	O
hypersensitivity	B-DISEASE
to	O
ionizing	B-UNK
radiation	B-UNK
.	O

 	O
together	O
,	O
these	O
results	B-UNK
demonstrate	B-UNK
a	O
biochemical	B-UNK
link	B-UNK
between	O
cell	B-UNK
-	O
cycle	B-UNK
checkpoints	O
activated	B-UNK
by	O
dna	B-UNK
damage	I-UNK
and	O
dna	B-UNK
repair	B-UNK
in	O
two	O
genetic	B-DISEASE
diseases	I-DISEASE
with	O
overlapping	B-UNK
phenotypes	B-UNK
.	O
.	O

 	O
homozygosity	B-UNK
mapping	B-UNK
in	O
a	O
family	B-UNK
with	O
microcephaly	B-DISEASE
,	O
mental	B-DISEASE
retardation	I-DISEASE
,	O
and	O
short	B-DISEASE
stature	I-DISEASE
to	O
a	O
cohen	B-DISEASE
syndrome	I-DISEASE
region	B-UNK
on	O
8q21	O
.	O
3	O
-	O
8q22	O
.	O
1	O
:	O
redefining	O
a	O
clinical	B-UNK
entity	B-UNK
.	O

 	O
a	O
syndrome	B-DISEASE
of	O
microcephaly	B-DISEASE
,	O
progressive	B-UNK
postnatal	B-UNK
growth	B-UNK
deficiency	B-UNK
,	O
and	O
mental	B-DISEASE
retardation	I-DISEASE
was	O
observed	B-UNK
in	O
two	O
brothers	B-UNK
and	O
their	O
cousin	O
from	O
a	O
multiply	O
consanguineous	B-UNK
kindred	B-UNK
of	O
lebanese	O
descent	B-UNK
.	O

 	O
hypotonia	B-DISEASE
,	O
chorioretinal	B-DISEASE
dystrophy	I-DISEASE
,	O
and	O
myopia	B-DISEASE
were	O
also	O
identified	B-UNK
.	O

 	O
the	O
severity	B-UNK
of	O
the	O
condition	B-UNK
varied	B-UNK
among	O
the	O
closely	B-UNK
related	B-UNK
patients	B-UNK
.	O

 	O
because	O
of	O
absence	B-UNK
of	O
a	O
distinctive	B-UNK
facial	B-UNK
appearance	O
,	O
the	O
degree	B-UNK
of	O
mental	B-DISEASE
retardation	I-DISEASE
,	O
and	O
short	B-DISEASE
stature	I-DISEASE
,	O
the	O
initially	B-UNK
considered	B-UNK
clinical	B-UNK
diagnosis	B-UNK
of	O
cohen	B-DISEASE
syndrome	I-DISEASE
was	O
withdrawn	O
and	O
a	O
novel	B-UNK
genetic	B-UNK
entity	B-UNK
was	O
assumed	O
.	O

 	O
homozygosity	B-UNK
mapping	B-UNK
in	O
this	O
family	B-UNK
assigned	B-UNK
the	O
gene	B-UNK
to	O
a	O
26	O
.	O

 	O
8	O
-	O
cm	B-DISEASE
region	B-UNK
on	O
the	O
chromosome	B-UNK
band	B-UNK
8q21	O
.	O

 	O
3	O
-	O
22	O
.	O

 	O
1	O
,	O
between	O
the	O
microsatellites	O
at	B-DISEASE
d8s270	O
and	O
d8s514	O
.	O

 	O
the	O
maximum	B-UNK
two	O
-	O
point	B-UNK
lod	B-UNK
score	I-UNK
was	O
found	B-UNK
for	O
marker	B-UNK
at	B-DISEASE
d8s267	O
(	O
zmax	B-UNK
=	O
3	O
.	O
.	O
237	O
at	B-DISEASE
omax	O
=	O
0	O
.	O
00	O
)	O
.	O

 	O
intriguingly	O
enough	O
,	O
the	O
identified	B-UNK
gene	B-UNK
region	B-UNK
overlaps	B-UNK
the	O
refined	O
gene	B-UNK
region	B-UNK
for	O
cohen	B-DISEASE
syndrome	I-DISEASE
(	O
coh1	O
)	O
[	O
kolehmainen	O
et	O
al	O
.	O
,	O
1997	O
euro	O
j	B-UNK
hum	B-UNK
genet	B-UNK
5	O
206	O
-	O
213	O
]	O
.	O

 	O
this	O
fact	O
encourages	O
the	O
hypothesis	O
that	O
the	O
described	B-UNK
kindred	B-UNK
segregates	B-UNK
for	O
a	O
variant	B-UNK
of	O
cohen	B-DISEASE
syndrome	I-DISEASE
and	O
suggests	B-UNK
a	O
redefinition	O
of	O
its	O
phenotype	B-UNK

 	O
polymorphisms	B-UNK
of	O
the	O
cyp2d6	B-UNK
gene	B-UNK
increase	B-UNK
susceptibility	B-UNK
to	O
ankylosing	B-DISEASE
spondylitis	I-DISEASE
.	O

 	O
ankylosing	B-DISEASE
spondylitis	I-DISEASE
(	O
as	O
)	O
is	O
a	O
common	B-UNK
and	O
highly	B-UNK
familial	B-UNK
rheumatic	O
disorder	O
.	O

 	O
the	O
sibling	B-UNK
recurrence	B-DISEASE
risk	B-UNK
ratio	B-UNK
for	O
the	O
disease	B-DISEASE
is	O
63	O
and	O
heritability	O
assessed	B-UNK
in	O
twins	B-DISEASE
>	O
90	O
%	O
.	O

 	O
although	O
mhc	B-UNK
genes	B-UNK
,	O
including	B-UNK
hla	B-UNK
-	O
b27	B-UNK
,	O
contribute	B-UNK
only	O
20	O
-	O
50	O
%	O
of	O
the	O
genetic	B-UNK
risk	B-UNK
for	O
the	O
disease	B-DISEASE
,	O
no	O
non	B-UNK
-	O
mhc	B-UNK
gene	B-UNK
has	O
yet	O
been	O
convincingly	O
demonstrated	B-UNK
to	O
influence	O
either	O
susceptibility	B-UNK
to	O
the	O
disease	B-DISEASE
or	O
its	O
phenotypic	B-UNK
expression	B-UNK
.	O

 	B-UNK
previous	I-UNK
linkage	B-UNK
and	O
association	B-UNK
studies	B-UNK
have	O
suggested	B-UNK
the	O
presence	B-UNK
of	O
a	O
susceptibility	B-UNK
gene	B-UNK
for	O
as	O
close	B-UNK
to	O
,	O
or	O
within	O
,	O
the	O
cytochrome	B-UNK
p450	B-UNK
2d6	O
gene	B-UNK
(	O
cyp2d6	B-UNK
,	O
debrisoquine	O
hydroxylase	O
)	O
located	B-UNK
at	B-DISEASE
chromosome	B-UNK
22q13	O
.	O
1	O
.	O

 	O
we	O
performed	B-UNK
a	O
linkage	B-UNK
study	I-UNK
of	O
chromosome	B-DISEASE
22	I-DISEASE
in	O
200	O
families	B-UNK
with	O
as	O
affected	B-UNK
sibling	B-UNK
-	O
pairs	B-UNK
.	O

 	O
association	B-UNK
of	O
alleles	B-UNK
of	O
the	O
cyp2d6	B-UNK
gene	B-UNK
was	O
examined	B-UNK
by	O
both	O
case	B-UNK
-	O
control	B-UNK
and	O
within	O
-	O
family	B-UNK
means	O
.	O

 	O
for	O
case	B-UNK
-	O
control	B-UNK
studies	B-UNK
,	O
617	O
unrelated	B-UNK
individuals	B-UNK
with	O
as	O
(	O
361	O
probands	B-UNK
from	O
sibling	B-UNK
-	O
pair	O
and	O
parent	B-UNK
-	O
case	B-UNK
trio	O
families	B-UNK
and	O
256	O
unrelated	B-UNK
non	B-UNK
-	O
familial	B-UNK
sporadic	B-UNK
cases	B-UNK
)	O
and	O
402	O
healthy	B-UNK
ethnically	O
matched	B-UNK
controls	B-UNK
were	O
employed	O
.	O

 	O
for	O
within	O
-	O
family	B-UNK
association	B-UNK
studies	B-UNK
,	O
361	O
families	B-UNK
including	B-UNK
161	O
parent	B-UNK
-	O
case	B-UNK
trios	O
and	O
200	O
affected	B-UNK
sibling	B-UNK
-	O
pair	O
families	B-UNK
were	O
employed	O
.	O

 	O
homozygosity	B-UNK
for	O
poor	B-UNK
metabolizer	O
alleles	B-UNK
was	O
found	B-UNK
to	O
be	O
associated	B-UNK
with	O
as	O
.	O

 	O
heterozygosity	B-UNK
for	O
the	O
most	O
frequent	B-UNK
poor	B-UNK
metabolizer	O
allele	B-UNK
(	O
cyp2d6	B-UNK
*	O
4	O
)	O
was	O
not	O
associated	B-UNK
with	O
increased	B-UNK
susceptibility	B-UNK
to	O
as	O
.	O

 	B-UNK
significant	I-UNK
within	O
-	O
family	B-UNK
association	B-UNK
of	O
cyp2d6	B-UNK
*	O
4	O
alleles	B-UNK
and	O
as	O
was	O
demonstrated	B-UNK
.	O

 	O
weak	O
linkage	B-UNK
was	O
also	O
demonstrated	B-UNK
between	O
cyp2d6	B-UNK
and	O
as	O
.	O

 	O
we	O
postulate	O
that	O
altered	B-UNK
metabolism	B-DISEASE
of	O
a	O
natural	B-UNK
toxin	O
or	O
antigen	B-UNK
by	O
the	O
cyp2d6	B-UNK
gene	B-UNK
may	O
increase	B-UNK
susceptibility	B-UNK
to	O
as	O
.	O

 	B-UNK
functional	I-UNK
differences	B-UNK
of	O
the	O
pds	B-UNK
gene	B-UNK
product	B-UNK
are	O
associated	B-UNK
with	O
phenotypic	B-UNK
variation	B-UNK
in	O
patients	B-UNK
with	O
pendred	B-DISEASE
syndrome	I-DISEASE
and	O
non	B-UNK
-	O
syndromic	O
hearing	B-DISEASE
loss	I-DISEASE
(	O
dfnb4	O
)	O
.	O

 	O
the	O
pds	B-UNK
gene	B-UNK
encodes	B-UNK
a	O
transmembrane	B-UNK
protein	B-UNK
,	O
known	B-UNK
as	O
pendrin	B-UNK
,	O
which	O
functions	B-UNK
as	O
a	O
transporter	B-UNK
of	O
iodide	B-UNK
and	O
chloride	B-UNK
.	O

 	O
mutations	B-UNK
in	O
this	O
gene	B-UNK
are	O
responsible	B-UNK
for	O
pendred	B-DISEASE
syndrome	I-DISEASE
and	O
autosomal	O
recessive	O
non	B-UNK
-	O
syndromic	O
hearing	B-DISEASE
loss	I-DISEASE
at	B-DISEASE
the	O
dfnb4	O
locus	B-UNK
on	O
chromosome	B-UNK
7q31	O
.	O

 	O
a	O
screen	B-UNK
of	O
20	O
individuals	B-UNK
from	O
the	O
midwestern	O
usa	O
with	O
non	B-UNK
-	O
syndromic	O
hearing	B-DISEASE
loss	I-DISEASE
and	O
dilated	O
vestibular	O
aqueducts	O
identified	B-UNK
three	O
people	B-UNK
(	O
15	O
%	O
)	O
with	O
pds	B-UNK
mutations	B-UNK
.	O

 	O
to	O
determine	O
whether	O
pds	B-UNK
mutations	B-UNK
in	O
individuals	B-UNK
with	O
pendred	B-DISEASE
syndrome	I-DISEASE
differ	B-UNK
functionally	B-UNK
from	O
pds	B-UNK
mutations	B-UNK
in	O
individuals	B-UNK
with	O
non	B-UNK
-	O
syndromic	O
hearing	B-DISEASE
loss	I-DISEASE
,	O
we	O
compared	B-UNK
three	O
common	B-UNK
pendred	B-DISEASE
syndrome	I-DISEASE
allele	B-UNK
variants	B-UNK
(	O
l236p	O
,	O
t416p	O
and	O
e384	O
g	B-UNK
)	O
,	O
with	O
three	O
pds	B-UNK
mutations	B-UNK
reported	B-UNK
only	O
in	O
individuals	B-UNK
with	O
non	B-UNK
-	O
syndromic	O
hearing	B-DISEASE
loss	I-DISEASE
(	O
v480d	O
,	O
v653a	O
and	O
i490l	O
/	O
g497s	O
)	O
.	O

 	O
the	O
mutations	B-UNK
associated	B-UNK
with	O
pendred	B-DISEASE
syndrome	I-DISEASE
have	O
complete	B-UNK
loss	B-UNK
of	O
pendrin	B-UNK
-	O
induced	B-UNK
chloride	B-UNK
and	O
iodide	B-UNK
transport	I-UNK
,	O
while	O
alleles	B-UNK
unique	B-UNK
to	O
people	B-UNK
with	O
dfnb4	O
are	O
able	O
to	O
transport	B-UNK
both	O
iodide	B-UNK
and	O
chloride	B-UNK
,	O
albeit	O
at	B-DISEASE
a	O
much	O
lower	B-UNK
level	B-UNK
than	O
wild	B-UNK
-	O
type	B-UNK
pendrin	B-UNK
.	O

 	O
we	O
hypothesize	O
that	O
this	O
residual	B-UNK
level	B-UNK
of	O
anion	B-UNK
transport	B-UNK
is	O
sufficient	B-UNK
to	O
eliminate	O
or	O
postpone	O
the	O
onset	B-UNK
of	O
goiter	B-DISEASE
in	O
individuals	B-UNK
with	O
dfnb4	O
.	O

 	O
we	O
propose	O
a	O
model	B-UNK
for	O
pendrin	B-UNK
function	B-UNK
in	O
the	O
thyroid	B-DISEASE
in	O
which	O
pendrin	B-UNK
transports	O
iodide	B-UNK
across	O
the	O
apical	O
membrane	B-UNK
of	O
the	O
thyrocyte	O
into	O
the	O
colloid	O
space	O
.	O
.	O

 	O
the	O
human	B-UNK
factor	B-UNK
ix	O
gene	B-UNK
as	O
germline	B-UNK
mutagen	O
test	B-UNK
:	O
samples	B-UNK
from	O
mainland	O
china	O
have	O
the	O
putatively	B-UNK
endogenous	B-UNK
pattern	B-UNK
of	O
mutation	B-UNK
.	O

 	B-UNK
germline	I-UNK
mutations	B-UNK
are	O
the	O
major	B-UNK
source	O
of	O
genetic	B-UNK
variation	B-UNK
that	O
allows	B-UNK
a	O
species	B-UNK
to	O
evolve	O
over	O
time	B-UNK
but	O
at	B-DISEASE
the	O
cost	O
of	O
mendelian	O
disease	B-DISEASE
and	O
genetic	B-UNK
predisposition	B-UNK
to	O
multifactorial	O
diseases	B-DISEASE
.	O

 	B-UNK
previous	I-UNK
analyses	B-UNK
have	O
revealed	B-UNK
that	O
the	O
pattern	B-UNK
of	O
germline	B-UNK
mutations	I-UNK
in	O
the	O
factor	B-UNK
ix	O
gene	B-UNK
(	O
f9	O
)	O
is	O
similar	B-UNK
among	O
a	O
variety	B-UNK
of	O
ethnically	O
and	O
geographically	O
diverse	B-UNK
populations	B-UNK
and	O
compatible	O
with	O
the	O
ancient	B-UNK
pattern	B-UNK
that	O
has	O
shaped	O
the	O
mammalian	B-UNK
genome	B-UNK
.	O

 	O
here	O
,	O
we	O
compare	O
the	O
pattern	B-UNK
of	O
germline	B-UNK
mutation	B-UNK
in	O
a	O
population	B-UNK
of	O
hemophilia	B-DISEASE
b	I-DISEASE
patients	B-UNK
from	O
mainland	O
china	O
(	O
n	B-UNK
=	O
66	O
)	O
to	O
that	O
in	O
u	B-UNK
.	O

 	O
s	O
.	O

 	O
caucasians	B-UNK
,	O
blacks	O
,	O
and	O
mexican	B-UNK
hispanics	O
and	O
stratify	O
by	O
disease	B-DISEASE
severity	B-UNK
and	O
ethnicity	O
.	O

 	O
the	O
similar	B-UNK
pattern	B-UNK
of	O
germline	B-UNK
mutation	B-UNK
in	O
all	O
ethnic	B-UNK
groups	B-UNK
studied	B-UNK
to	O
date	B-UNK
provides	B-UNK
additional	B-UNK
data	B-UNK
compatible	O
with	O
the	O
inference	O
that	O
endogenous	B-UNK
processes	B-UNK
predominate	O
in	O
germline	B-UNK
mutations	I-UNK
.	O

 	O
fas	B-UNK
preassociation	O
required	B-UNK
for	O
apoptosis	B-UNK
signaling	B-UNK
and	O
dominant	B-UNK
inhibition	B-UNK
by	O
pathogenic	O
mutations	B-UNK
.	O

 	B-UNK
heterozygous	I-UNK
mutations	B-UNK
encoding	B-UNK
abnormal	B-UNK
forms	B-UNK
of	O
the	O
death	B-DISEASE
receptor	B-UNK
fas	B-UNK
dominantly	B-UNK
interfere	O
with	O
fas	B-UNK
-	O
induced	B-UNK
lymphocyte	B-UNK
apoptosis	B-UNK
in	O
human	B-UNK
autoimmune	B-DISEASE
lymphoproliferative	I-DISEASE
syndrome	I-DISEASE
.	O

 	O
this	O
effect	B-UNK
,	O
rather	O
than	O
depending	O
on	O
ligand	B-UNK
-	O
induced	B-UNK
receptor	B-UNK
oligomerization	O
,	O
was	O
found	B-UNK
to	O
stem	O
from	O
ligand	B-UNK
-	O
independent	B-UNK
interaction	B-UNK
of	O
wild	B-UNK
-	O
type	B-UNK
and	O
mutant	B-UNK
fas	B-UNK
receptors	B-UNK
through	O
a	O
specific	B-UNK
region	B-UNK
in	O
the	O
extracellular	B-UNK
domain	B-UNK
.	O

 	O
preassociated	O
fas	B-UNK
complexes	B-UNK
were	O
found	B-UNK
in	O
living	B-UNK
cells	B-UNK
by	O
means	O
of	O
fluorescence	B-UNK
resonance	O
energy	O
transfer	O
between	O
variants	B-UNK
of	O
green	B-UNK
fluorescent	B-UNK
protein	B-UNK
.	O

 	O
these	O
results	B-UNK
show	O
that	O
formation	B-UNK
of	O
preassociated	O
receptor	B-UNK
complexes	B-UNK
is	O
necessary	O
for	O
fas	B-UNK
signaling	B-UNK
and	O
dominant	B-UNK
interference	O
in	O
human	B-UNK
disease	B-DISEASE
.	O
.	O

 	O
determination	B-UNK
of	O
carrier	B-UNK
status	B-UNK
for	O
the	O
wiskott	B-DISEASE
-	I-DISEASE
aldrich	I-DISEASE
syndrome	I-DISEASE
by	O
flow	B-UNK
cytometric	O
analysis	B-UNK
of	O
wiskott	B-DISEASE
-	I-DISEASE
aldrich	I-DISEASE
syndrome	I-DISEASE
protein	B-UNK
expression	B-UNK
in	O
peripheral	B-UNK
blood	I-UNK
mononuclear	O
cells	B-UNK
.	O

 	O
the	O
wiskott	B-DISEASE
-	I-DISEASE
aldrich	I-DISEASE
syndrome	I-DISEASE
(	O
was	O
)	O
is	O
caused	B-UNK
by	O
defects	B-UNK
in	O
the	O
was	O
protein	B-UNK
(	O
wasp	B-UNK
)	O
gene	B-UNK
on	O
the	O
x	B-DISEASE
chromosome	I-DISEASE
.	O

 	B-UNK
previous	I-UNK
study	B-UNK
disclosed	B-UNK
that	O
flow	B-UNK
cytometric	O
analysis	B-UNK
of	O
intracellular	B-UNK
wasp	B-UNK
expression	B-UNK
(	O
fcm	O
-	O
wasp	B-UNK
analysis	B-UNK
)	O
in	O
lymphocytes	B-UNK
was	O
useful	B-UNK
for	O
the	O
diagnosis	B-UNK
of	O
was	O
patients	B-UNK
.	O

 	O
lymphocytes	B-UNK
from	O
all	O
was	O
patients	B-UNK
showed	I-UNK
waspdim	B-UNK
instead	B-UNK
of	O
waspbright	O
.	O

 	O
here	O
we	O
report	B-UNK
that	O
fcm	O
-	O
wasp	B-UNK
analysis	B-UNK
in	O
monocytes	O
could	O
be	O
a	O
useful	B-UNK
tool	B-UNK
for	O
the	O
was	O
carrier	B-UNK
diagnosis	B-UNK
.	O

 	O
monocytes	O
from	O
all	O
nine	O
was	O
carriers	B-UNK
showed	B-UNK
varied	B-UNK
population	B-UNK
of	O
waspdim	B-UNK
together	O
with	O
waspbright	O
.	O

 	O
none	O
of	O
control	B-UNK
individuals	I-UNK
possessed	O
the	O
waspdim	B-UNK
population	B-UNK
.	O

 	O
in	O
contrast	B-UNK
,	O
lymphocytes	B-UNK
from	O
all	O
the	O
carriers	B-UNK
except	O
two	O
lacked	B-UNK
the	O
waspdim	B-UNK
population	B-UNK
.	O

 	O
the	O
difference	B-UNK
of	O
the	O
waspdim	B-UNK
population	B-UNK
in	O
monocytes	O
and	O
lymphocytes	B-UNK
observed	B-UNK
in	O
was	O
carriers	B-UNK
suggests	B-UNK
that	O
wasp	B-UNK
plays	O
a	O
more	O
critical	B-UNK
role	B-UNK
in	O
the	O
development	B-UNK
of	O
lymphocytes	B-UNK
than	O
in	O
that	O
of	O
monocytes	O
.	O

 	O
the	O
present	B-UNK
studies	B-UNK
suggest	I-UNK
that	O
a	O
skewed	O
x	B-UNK
-	O
chromosomal	B-UNK
inactivation	B-UNK
pattern	B-UNK
observed	B-UNK
in	O
was	O
carrier	B-UNK
peripheral	B-UNK
blood	I-UNK
cells	B-UNK
is	O
not	O
fixed	O
at	B-DISEASE
the	O
hemopoietic	B-UNK
stem	O
cell	B-UNK
level	B-UNK
but	O
progresses	O
after	O
the	O
lineage	B-UNK
commitment	O
.	O
.	O

 	O
restoration	O
of	O
photoreceptor	B-UNK
ultrastructure	O
and	O
function	B-UNK
in	O
retinal	B-DISEASE
degeneration	I-DISEASE
slow	B-UNK
mice	B-UNK
by	O
gene	B-UNK
therapy	B-UNK
.	O

 	O
the	O
gene	B-UNK
prph2	B-UNK
encodes	B-UNK
a	O
photoreceptor	B-UNK
-	O
specific	B-UNK
membrane	B-UNK
glycoprotein	B-UNK
,	O
peripherin	O
-	O
2	O
(	O
also	O
known	B-UNK
as	O
peripherin	O
/	O
rds	B-UNK
)	O
,	O
which	O
is	O
inserted	O
into	O
the	O
rims	O
of	O
photoreceptor	B-UNK
outer	B-UNK
segment	B-UNK
discs	B-UNK
in	O
a	O
complex	B-UNK
with	O
rom	O
-	O
1	O
(	O
ref	O
.	O
2	O
)	O
.	O

 	O
the	O
complex	B-UNK
is	O
necessary	O
for	O
the	O
stabilization	O
of	O
the	O
discs	B-UNK
,	O
which	O
are	O
renewed	O
constantly	O
throughout	O
life	B-UNK
,	O
and	O
which	O
contain	B-UNK
the	O
visual	O
pigments	O
necessary	O
for	O
photon	O
capture	O
.	O

 	O
mutations	B-UNK
in	O
prph2	B-UNK
have	O
been	O
shown	B-UNK
to	O
result	B-UNK
in	O
a	O
variety	B-UNK
of	O
photoreceptor	B-UNK
dystrophies	O
,	O
including	B-UNK
autosomal	O
dominant	B-UNK
retinitis	B-DISEASE
pigmentosa	I-DISEASE
and	O
macular	B-DISEASE
dystrophy	I-DISEASE
.	O

 	O
a	O
common	B-UNK
feature	B-UNK
of	O
these	O
diseases	B-DISEASE
is	O
the	O
loss	B-UNK
of	O
photoreceptor	B-UNK
function	B-UNK
,	O
also	O
seen	B-UNK
in	O
the	O
retinal	B-DISEASE
degeneration	I-DISEASE
slow	B-UNK
(	O
rds	B-UNK
or	O
prph2	B-UNK
rd2	O
/	O
rd2	O
)	O
mouse	B-UNK
,	O
which	O
is	O
homozygous	B-UNK
for	O
a	O
null	B-UNK
mutation	B-UNK
in	O
prph2	B-UNK
.	O

 	O
it	O
is	O
characterized	B-UNK
by	O
a	O
complete	B-UNK
failure	O
to	O
develop	B-UNK
photoreceptor	B-UNK
discs	B-UNK
and	O
outer	B-UNK
segments	B-UNK
,	O
downregulation	O
of	O
rhodopsin	O
and	O
apoptotic	B-UNK
loss	B-UNK
of	O
photoreceptor	B-UNK
cells	B-UNK
.	O

 	O
the	O
electroretinograms	B-UNK
(	O
ergs	B-UNK
)	O
of	O
prph2rd2	O
/	O
rd2	O
mice	B-UNK
have	O
greatly	B-UNK
diminished	B-UNK
a	O
-	O
wave	B-UNK
and	O
b	B-UNK
-	O
wave	B-UNK
amplitudes	O
,	O
which	O
decline	O
to	O
virtually	B-UNK
undetectable	B-UNK
concentrations	B-UNK
by	O
two	O
months	O
.	O

 	O
subretinal	O
injection	O
of	O
recombinant	B-UNK
adeno	O
-	O
associated	B-UNK
virus	B-UNK
(	O
aav	O
)	O
encoding	B-UNK
a	O
prph2	B-UNK
transgene	B-UNK
results	B-UNK
in	O
stable	B-UNK
generation	B-UNK
of	O
outer	B-UNK
segment	B-UNK
structures	B-UNK
and	O
formation	B-UNK
of	O
new	B-UNK
stacks	O
of	O
discs	B-UNK
containing	B-UNK
both	O
perpherin	O
-	O
2	O
and	O
rhodopsin	O
,	O
which	O
in	O
many	O
cases	B-UNK
are	O
morphologically	B-UNK
similar	B-UNK
to	O
normal	B-UNK
outer	B-UNK
segments	B-UNK
.	O

 	O
moreover	O
,	O
the	O
re	O
-	O
establishment	O
of	O
the	O
structural	B-UNK
integrity	O
of	O
the	O
photoreceptor	B-UNK
layer	O
also	O
results	B-UNK
in	O
electrophysiological	B-UNK
correction	O
.	O

 	O
these	O
studies	B-UNK
demonstrate	B-UNK
for	O
the	O
first	O
time	B-UNK
that	O
a	O
complex	B-UNK
ultrastructural	B-UNK
cell	B-UNK
defect	B-UNK
can	O
be	O
corrected	O
both	O
morphologically	B-UNK
and	O
functionally	B-UNK
by	O
in	O
vivo	B-UNK
gene	B-UNK
transfer	O
.	O
.	O

 	O
mutations	B-UNK
in	O
the	O
fibrinogen	B-UNK
aalpha	O
gene	B-UNK
account	B-UNK
for	O
the	O
majority	B-UNK
of	O
cases	B-UNK
of	O
congenital	B-DISEASE
afibrinogenemia	B-DISEASE
.	O

 	O
congenital	B-DISEASE
afibrinogenemia	B-DISEASE
is	O
a	O
rare	B-UNK
,	O
autosomal	O
,	O
recessive	O
disorder	O
characterized	B-UNK
by	O
the	O
complete	B-UNK
absence	B-UNK
of	O
detectable	B-UNK
fibrinogen	B-UNK
.	O

 	O
we	O
previously	B-UNK
identified	I-UNK
the	O
first	O
causative	B-UNK
mutations	B-UNK
in	O
a	O
nonconsanguineous	O
swiss	O
family	B-UNK
;	O
the	O
4	O
affected	B-UNK
persons	B-UNK
have	O
homozygous	B-UNK
deletions	B-UNK
of	O
approximately	B-UNK
11	O
kb	B-UNK
of	O
the	O
fibrinogen	B-UNK
alpha	B-UNK
(	O
fga	O
)	O
gene	B-UNK
.	O

 	B-UNK
haplotype	I-UNK
data	B-UNK
implied	O
that	O
these	O
deletions	B-UNK
occurred	B-UNK
on	O
distinct	B-UNK
ancestral	B-UNK
chromosomes	B-UNK
,	O
suggesting	B-UNK
that	O
this	O
region	B-UNK
may	O
be	O
susceptible	B-UNK
to	O
deletion	B-UNK
by	O
a	O
common	B-UNK
mechanism	B-UNK
.	O

 	O
we	O
subsequently	B-UNK
showed	B-UNK
that	O
all	O
the	O
deletions	B-UNK
were	O
identical	B-UNK
to	O
the	O
base	B-UNK
pair	I-UNK
and	O
probably	B-UNK
resulted	B-UNK
from	O
a	O
nonhomologous	O
recombination	B-UNK
mediated	B-UNK
by	O
7	O
-	O
bp	B-UNK
direct	B-UNK
repeats	I-UNK
.	O

 	O
in	O
this	O
study	B-UNK
,	O
we	O
have	O
collected	B-UNK
data	B-UNK
on	O
13	O
additional	B-UNK
unrelated	B-UNK
patients	B-UNK
to	O
identify	B-UNK
the	O
causative	B-UNK
mutations	B-UNK
and	O
to	O
determine	O
the	O
prevalence	B-UNK
of	O
the	O
11	O
-	O
kb	B-UNK
deletion	B-UNK
.	O

 	O
a	O
common	B-UNK
recurrent	B-UNK
mutation	B-UNK
,	O
at	B-DISEASE
the	O
donor	B-UNK
splice	I-UNK
site	I-UNK
of	O
fga	O
intron	B-UNK
4	O
(	O
ivs4	O
+	O
1	O
g	B-UNK
>	I-UNK
t	B-UNK
)	O
,	O
accounted	B-UNK
for	O
14	O
of	O
the	O
26	O
(	O
54	O
%	O
)	O
alleles	B-UNK
.	O

 	O
one	O
patient	B-UNK
was	O
heterozygous	B-UNK
for	O
the	O
previously	B-UNK
identified	I-UNK
deletion	B-UNK
.	O

 	O
three	O
more	O
frameshift	B-UNK
mutations	B-UNK
,	O
2	O
nonsense	B-UNK
mutations	B-UNK
,	O
and	O
a	O
second	B-UNK
splice	B-UNK
site	I-UNK
mutation	I-UNK
were	O
also	O
identified	B-UNK
.	O

 	O
consequently	B-UNK
,	O
86	O
%	O
of	O
afibrinogenemia	B-DISEASE
alleles	B-UNK
analyzed	B-UNK
to	O
date	B-UNK
have	O
truncating	B-UNK
mutations	B-UNK
of	O
fga	O
,	O
though	O
mutations	B-UNK
in	O
all	O
3	O
fibrinogen	B-UNK
genes	B-UNK
,	O
fgg	O
,	O
fga	O
,	O
and	O
fgb	O
,	O
might	O
be	O
predicted	B-UNK
to	O
cause	B-UNK
congenital	B-DISEASE
afibrinogenemia	B-DISEASE
.	O
.	O

 	O
myotonic	B-DISEASE
dystrophy	I-DISEASE
:	O
the	O
role	B-UNK
of	O
the	O
cug	O
triplet	B-UNK
repeats	I-UNK
in	O
splicing	B-UNK
of	O
a	O
novel	B-UNK
dmpk	B-UNK
exon	B-UNK
and	O
altered	B-UNK
cytoplasmic	B-UNK
dmpk	B-UNK
mrna	I-UNK
isoform	B-UNK
ratios	O
.	O

 	O
the	O
mechanism	B-UNK
by	O
which	O
(	O
ctg	B-UNK
)	O
n	B-UNK
expansion	B-UNK
in	O
the	O
3	O
utr	B-UNK
of	O
the	O
dmpk	B-UNK
gene	B-UNK
causes	B-UNK
myotonic	B-DISEASE
dystrophy	I-DISEASE
(	O
dm	B-DISEASE
)	O
is	O
unknown	B-UNK
.	O

 	O
we	O
identified	B-UNK
four	O
rna	B-UNK
splicing	I-UNK
factors	B-UNK
-	O
-	O
hnrnp	O
c	B-UNK
,	O
u2af	O
(	O
u2	O
auxiliary	O
factor	B-UNK
)	O
,	O
ptb	O
(	O
polypyrimidine	O
tract	O
binding	B-UNK
protein	B-UNK
)	O
,	O
and	O
psf	O
(	O
ptb	O
associated	B-UNK
splicing	B-UNK
factor	B-UNK
)	O
-	O
-	O
that	O
bind	B-UNK
to	O
two	O
short	B-UNK
regions	B-UNK
3	O
of	O
the	O
(	O
cug	O
)	O
n	B-UNK
,	O
and	O
found	B-UNK
a	O
novel	B-UNK
3	O
dmpk	B-UNK
exon	B-UNK
resulting	B-UNK
in	O
an	O
mrna	B-UNK
lacking	B-UNK
the	O
repeats	B-UNK
.	O

 	O
we	O
propose	O
that	O
the	O
(	O
cug	O
)	O
n	B-UNK
is	O
an	O
essential	B-UNK
cis	B-UNK
acting	O
element	B-UNK
for	O
this	O
splicing	B-UNK
event	B-UNK
.	O

 	O
in	O
contrast	B-UNK
to	O
(	O
cug	O
)	O
n	B-UNK
containing	B-UNK
mrnas	B-UNK
,	O
the	O
novel	B-UNK
isoform	B-UNK
is	O
not	O
retained	B-UNK
in	O
the	O
nucleus	O
in	O
dm	B-DISEASE
cells	B-UNK
,	O
resulting	B-UNK
in	O
imbalances	O
in	O
relative	B-UNK
levels	B-UNK
of	O
cytoplasmic	B-UNK
dmpk	B-UNK
mrna	I-UNK
isoforms	B-UNK
and	O
a	O
new	B-UNK
dominant	B-UNK
effect	B-UNK
of	O
the	O
mutation	B-UNK
on	O
dmpk	B-UNK
.	O
.	O

 	O
expression	B-UNK
and	O
imprinting	B-UNK
of	O
magel2	B-UNK
suggest	B-UNK
a	O
role	B-UNK
in	O
prader	B-DISEASE
-	I-DISEASE
willi	I-DISEASE
syndrome	I-DISEASE
and	O
the	O
homologous	B-UNK
murine	B-UNK
imprinting	B-UNK
phenotype	B-UNK
.	O

 	O
prader	B-DISEASE
-	I-DISEASE
willi	I-DISEASE
syndrome	I-DISEASE
(	O
pws	B-UNK
)	O
is	O
caused	B-UNK
by	O
the	O
loss	B-UNK
of	O
expression	B-UNK
of	O
imprinted	B-UNK
genes	B-UNK
in	O
chromosome	B-UNK
15q11	I-UNK
-	O
q13	O
.	O

 	B-UNK
affected	I-UNK
individuals	B-UNK
exhibit	B-UNK
neonatal	B-UNK
hypotonia	B-DISEASE
,	O
developmental	B-DISEASE
delay	I-DISEASE
and	O
childhood	B-UNK
-	O
onset	B-UNK
obesity	B-DISEASE
.	O

 	O
necdin	O
,	O
a	O
protein	B-UNK
implicated	O
in	O
the	O
terminal	B-UNK
differentiation	B-UNK
of	O
neurons	B-UNK
,	O
is	O
the	O
only	O
pws	B-UNK
candidate	B-UNK
gene	B-UNK
to	O
reduce	B-UNK
viability	O
when	O
disrupted	B-UNK
in	O
a	O
mouse	B-UNK
model	I-UNK
.	O

 	O
in	O
this	O
study	B-UNK
,	O
we	O
have	O
characterized	B-UNK
magel2	B-UNK
(	O
also	O
known	B-UNK
as	O
ndnl1	O
)	O
,	O
a	O
gene	B-UNK
with	O
51	O
%	O
amino	B-UNK
acid	I-UNK
sequence	I-UNK
similarity	B-UNK
to	O
necdin	O
and	O
located	B-UNK
41	O
kb	B-UNK
distal	B-UNK
to	O
ndn	O
in	O
the	O
pws	B-UNK
deletion	B-UNK
region	I-UNK
.	O

 	O
magel2	B-UNK
is	O
expressed	B-UNK
predominantly	B-UNK
in	O
brain	B-UNK
,	O
the	O
primary	B-UNK
tissue	B-UNK
affected	B-UNK
in	O
pws	B-UNK
and	O
in	O
several	O
fetal	B-UNK
tissues	B-UNK
as	O
shown	B-UNK
by	O
northern	B-UNK
blot	O
analysis	B-UNK
.	O

 	O
magel2	B-UNK
is	O
imprinted	B-UNK
with	O
monoallelic	O
expression	B-UNK
in	O
control	B-UNK
brain	B-UNK
,	O
and	O
paternal	B-UNK
-	O
only	O
expression	B-UNK
in	O
the	O
central	B-UNK
nervous	I-UNK
system	I-UNK
as	O
demonstrated	B-UNK
by	O
its	O
lack	B-UNK
of	O
expression	B-UNK
in	O
brain	B-UNK
from	O
a	O
pws	B-UNK
-	O
affected	B-UNK
individual	B-UNK
.	O

 	O
the	O
orthologous	O
mouse	B-UNK
gene	B-UNK
(	O
magel2	B-UNK
)	O
is	O
located	B-UNK
within	O
150	O
kb	B-UNK
of	O
ndn	O
,	O
is	O
imprinted	B-UNK
with	O
paternal	B-UNK
-	O
only	O
expression	B-UNK
and	O
is	O
expressed	B-UNK
predominantly	B-UNK
in	O
late	B-UNK
developmental	B-UNK
stages	O
and	O
adult	B-UNK
brain	B-UNK
as	O
shown	B-UNK
by	O
northern	B-UNK
blotting	B-UNK
,	O
rt	O
-	O
pcr	B-UNK
and	O
whole	O
-	O
mount	O
rna	B-UNK
in	O
situ	B-UNK
hybridization	I-UNK
.	O

 	O
magel2	B-UNK
distribution	B-UNK
partially	B-UNK
overlaps	B-UNK
that	O
of	O
ndn	O
,	O
with	O
strong	B-UNK
expression	B-UNK
being	O
detected	B-UNK
in	O
the	O
central	B-UNK
nervous	I-UNK
system	I-UNK
in	O
mid	O
-	O
gestation	O
mouse	B-UNK
embryos	B-UNK
by	O
in	O
situ	B-UNK
hybridization	I-UNK
.	O

 	O
we	O
hypothesize	O
that	O
,	O
although	O
loss	B-UNK
of	O
necdin	O
expression	B-UNK
may	O
be	O
important	B-UNK
in	O
the	O
neonatal	B-UNK
presentation	O
of	O
pws	B-UNK
,	O
loss	B-UNK
of	O
magel2	B-UNK
may	O
be	O
critical	B-UNK
to	O
abnormalities	B-DISEASE
in	O
brain	B-UNK
development	B-UNK
and	O
dysmorphic	B-UNK
features	B-UNK
in	O
individuals	B-UNK
with	O
pws	B-UNK
.	O
.	O

 	O
retinoschisin	B-UNK
,	O
the	O
x	B-UNK
-	O
linked	B-UNK
retinoschisis	B-DISEASE
protein	B-UNK
,	O
is	O
a	O
secreted	B-UNK
photoreceptor	B-UNK
protein	B-UNK
,	O
and	O
is	O
expressed	B-UNK
and	O
released	O
by	O
weri	O
-	O
rb1	B-UNK
cells	B-UNK
.	O

 	O
x	B-UNK
-	O
linked	B-UNK
retinoschisis	B-DISEASE
is	O
characterized	B-UNK
by	O
microcystic	O
-	O
like	B-UNK
changes	B-UNK
of	O
the	O
macular	O
region	B-UNK
and	O
schisis	O
within	O
the	O
inner	B-UNK
retinal	B-UNK
layers	O
,	O
leading	B-UNK
to	O
visual	O
deterioration	B-UNK
in	O
males	B-UNK
.	O

 	O
many	O
missense	B-UNK
and	O
protein	B-UNK
-	O
truncating	B-UNK
mutations	B-UNK
of	O
the	O
causative	B-UNK
gene	B-UNK
rs1	B-UNK
have	O
now	O
been	O
identified	B-UNK
and	O
are	O
thought	O
to	O
be	O
inactivating	B-UNK
.	O

 	O
rs1	B-UNK
encodes	B-UNK
a	O
224	O
amino	B-UNK
acid	I-UNK
protein	B-UNK
,	O
retinoschisin	B-UNK
,	O
which	O
contains	B-UNK
a	O
discoidin	B-UNK
domain	B-UNK
but	O
is	O
of	O
unknown	B-UNK
function	B-UNK
.	O

 	O
we	O
have	O
generated	B-UNK
a	O
polyclonal	O
antibody	B-UNK
against	O
a	O
peptide	B-UNK
from	O
a	O
unique	B-UNK
region	B-UNK
within	O
retinoschisin	B-UNK
,	O
which	O
detects	O
a	O
protein	B-UNK
of	O
approximately	B-UNK
28	O
kda	B-UNK
in	O
retinal	B-UNK
samples	B-UNK
reduced	B-UNK
with	O
dithiothreitol	O
,	O
but	O
multimers	B-UNK
sized	B-UNK
>	O
40	O
kda	B-UNK
under	O
non	B-UNK
-	O
reducing	B-UNK
conditions	B-UNK
.	O

 	O
a	O
screen	B-UNK
of	O
human	B-UNK
tissues	B-UNK
with	O
this	O
antibody	B-UNK
reveals	B-UNK
retinoschisin	B-UNK
to	O
be	O
retina	O
specific	B-UNK
and	O
the	O
antibody	B-UNK
detects	O
a	O
protein	B-UNK
of	O
similar	B-UNK
size	B-UNK
in	O
bovine	O
and	O
murine	B-UNK
retinae	O
.	O

 	O
we	O
investigated	B-UNK
the	O
expression	B-UNK
pattern	B-UNK
in	O
the	O
retina	O
of	O
both	O
rs1	B-UNK
mrna	B-UNK
(	O
using	O
in	O
situ	B-UNK
hybridization	I-UNK
with	O
riboprobes	O
)	O
and	O
retinoschisin	B-UNK
(	O
using	O
immunohistochemistry	O
)	O
.	O

 	O
the	O
antisense	B-UNK
riboprobe	O
detected	B-UNK
rs1	B-UNK
mrna	B-UNK
only	O
in	O
the	O
photoreceptor	B-UNK
layer	O
but	O
the	O
protein	B-UNK
product	B-UNK
of	O
the	O
gene	B-UNK
was	O
present	B-UNK
both	O
in	O
the	O
photoreceptors	O
and	O
within	O
the	O
inner	B-UNK
portions	O
of	O
the	O
retina	O
.	O

 	O
furthermore	B-UNK
,	O
differentiated	O
retinoblastoma	B-DISEASE
cells	B-UNK
(	O
weri	O
-	O
rb1	B-UNK
cells	B-UNK
)	O
were	O
found	B-UNK
to	O
express	B-UNK
rs1	B-UNK
mrna	B-UNK
and	O
to	O
release	B-UNK
retinoschisin	B-UNK
.	O

 	O
these	O
results	B-UNK
suggest	B-UNK
that	O
retinoschisin	B-UNK
is	O
released	O
by	O
photo	O
-	O
receptors	B-UNK
and	O
has	O
functions	B-UNK
within	O
the	O
inner	B-UNK
retinal	B-UNK
layers	O
.	O

 	O
thus	O
,	O
x	B-UNK
-	O
linked	B-UNK
retinoschisis	B-DISEASE
is	O
caused	B-UNK
by	O
abnormalities	B-DISEASE
in	O
a	O
putative	B-UNK
secreted	B-UNK
photoreceptor	B-UNK
protein	B-UNK
and	O
is	O
the	O
first	O
example	O
of	O
a	O
secreted	B-UNK
photo	O
-	O
receptor	B-UNK
protein	B-UNK
associated	B-UNK
with	O
a	O
retinal	B-DISEASE
dystrophy	I-DISEASE
.	O
.	O

 	O
study	B-UNK
of	O
the	O
voltage	O
-	O
gated	O
sodium	B-UNK
channel	I-UNK
beta	B-UNK
1	O
subunit	B-UNK
gene	B-UNK
(	O
scn1b	O
)	O
in	O
the	O
benign	B-UNK
familial	B-UNK
infantile	B-UNK
convulsions	B-DISEASE
syndrome	B-DISEASE
(	O
bfic	B-UNK
)	O
.	O

 	O
benign	B-UNK
familial	B-UNK
infantile	B-UNK
convulsions	B-DISEASE
(	O
bfic	B-UNK
)	O
is	O
a	O
rare	B-UNK
autosomal	O
dominant	B-UNK
epilepsy	B-DISEASE
syndrome	B-DISEASE
.	O

 	O
this	O
syndrome	B-DISEASE
has	O
been	O
recently	B-UNK
described	B-UNK
in	O
italian	B-UNK
and	O
french	B-UNK
pedigrees	B-UNK
.	O

 	B-UNK
patients	I-UNK
present	B-UNK
with	O
partial	B-UNK
,	O
then	O
generalized	O
seizures	B-DISEASE
,	O
with	O
onset	B-UNK
at	B-DISEASE
age	B-UNK
three	O
months	O
.	O

 	O
the	O
seizures	B-DISEASE
usually	B-UNK
spontaneously	B-UNK
cease	O
after	O
one	O
year	B-UNK
without	O
treatment	B-UNK
,	O
leaving	O
no	O
neurological	B-UNK
abnormalities	B-DISEASE
.	O

 	O
we	O
have	O
mapped	B-UNK
bfic	B-UNK
to	O
chromosome	B-UNK
19q	O
in	O
five	O
italian	B-UNK
pedigrees	B-UNK
.	O

 	O
the	O
sodium	B-UNK
channel	I-UNK
beta1	O
subunit	B-UNK
gene	B-UNK
(	O
scn1b	O
)	O
maps	B-UNK
to	O
this	O
candidate	B-UNK
region	B-UNK
and	O
has	O
been	O
shown	B-UNK
to	O
be	O
involved	B-UNK
in	O
one	O
australian	O
pedigree	B-UNK
with	O
generalized	O
epilepsy	B-DISEASE
and	O
febrile	B-DISEASE
seizures	I-DISEASE
"	O
plus	O
"	O
(	O
gefs	B-UNK
+	O
)	O
.	O

 	O
in	O
this	O
family	B-UNK
,	O
a	O
missense	B-UNK
mutation	I-UNK
in	O
scn1b	O
cosegregates	O
with	O
the	O
gefs	B-UNK
+	O
phenotype	B-UNK
.	O

 	O
bfic	B-UNK
and	O
gefs	B-UNK
+	O
have	O
clinical	B-UNK
features	I-UNK
in	O
common	B-UNK
,	O
therefore	O
scn1b	O
is	O
a	O
candidate	B-UNK
gene	B-UNK
for	O
bfic	B-UNK
.	O

 	O
we	O
studied	B-UNK
scn1b	O
exons	B-UNK
1	O
,	O
2	O
,	O
3	O
,	O
4	O
,	O
and	O
5	O
,	O
using	O
four	O
sscp	B-UNK
methods	B-UNK
in	O
10	O
caucasian	B-UNK
bfic	B-UNK
probands	B-UNK
of	O
western	B-UNK
europe	B-UNK
.	O

 	O
we	O
found	B-UNK
no	O
exon	B-UNK
variants	B-UNK
.	O

 	O
one	O
variant	B-UNK
was	O
identified	B-UNK
in	O
intron	B-UNK
5	O
(	O
ivs5	O
-	O
10c	O
>	O
g	B-UNK
)	O
,	O
which	O
did	O
not	O
segregate	O
with	O
bfic	B-UNK
and	O
was	O
observed	B-UNK
in	O
9	O
.	O

 	O
2	O
%	O
controls	B-UNK
.	O

 	O
a	O
second	B-UNK
variant	B-UNK
in	O
intron	B-UNK
5	O
was	O
identified	B-UNK
(	O
ivs5	O
+	O
30	O
g	B-UNK
>	I-UNK
a	O
)	O
.	O

 	O
it	O
was	O
rare	B-UNK
,	O
as	O
not	O
observed	B-UNK
in	O
controls	B-UNK
,	O
but	O
not	O
segregating	B-UNK
with	O
the	O
bfic	B-UNK
phenotype	B-UNK
.	O

 	O
inactivation	B-UNK
of	O
germline	B-UNK
mutant	B-UNK
apc	B-UNK
alleles	B-UNK
by	O
attenuated	O
somatic	B-UNK
mutations	B-UNK
:	O
a	O
molecular	B-UNK
genetic	I-UNK
mechanism	B-UNK
for	O
attenuated	B-DISEASE
familial	I-DISEASE
adenomatous	I-DISEASE
polyposis	I-DISEASE
.	O

 	B-UNK
germline	I-UNK
mutations	B-UNK
of	O
the	O
adenomatous	B-DISEASE
polyposis	I-DISEASE
coli	I-DISEASE
(	O
apc	B-UNK
)	O
tumor	B-DISEASE
-	O
suppressor	B-UNK
gene	B-UNK
result	B-UNK
in	O
familial	B-DISEASE
adenomatous	I-DISEASE
polyposis	I-DISEASE
(	O
fap	B-DISEASE
)	O
.	O

 	B-UNK
patients	I-UNK
with	O
fap	B-DISEASE
typically	B-UNK
develop	B-UNK
hundreds	O
to	O
thousands	O
of	O
benign	B-UNK
colorectal	B-UNK
tumors	B-DISEASE
and	O
early	B-UNK
-	O
onset	B-UNK
colorectal	B-DISEASE
cancer	I-DISEASE
.	O

 	O
a	O
subset	O
of	O
germline	B-UNK
apc	I-UNK
mutations	I-UNK
results	B-UNK
in	O
an	O
attenuated	O
fap	B-DISEASE
(	O
afap	O
)	O
phenotype	B-UNK
,	O
in	O
which	O
patients	B-UNK
develop	B-UNK
fewer	B-UNK
tumors	B-DISEASE
and	O
develop	B-UNK
them	O
at	B-DISEASE
an	O
older	B-UNK
age	B-UNK
.	O

 	O
although	O
a	O
genotype	B-UNK
-	O
phenotype	B-UNK
correlation	B-UNK
between	O
the	O
locations	B-UNK
of	O
apc	B-UNK
germline	B-UNK
mutations	I-UNK
and	O
the	O
development	B-UNK
of	O
afap	O
has	O
been	O
well	O
documented	B-UNK
,	O
the	O
mechanism	B-UNK
for	O
afap	O
has	O
not	O
been	O
well	O
defined	B-UNK
.	O

 	O
we	O
investigated	B-UNK
the	O
mechanism	B-UNK
for	O
afap	O
in	O
patients	B-UNK
carrying	B-UNK
a	O
mutant	B-UNK
apc	B-UNK
allele	B-UNK
(	O
apc	B-UNK
(	O
as9	O
)	O
)	O
that	O
has	O
a	O
mutation	B-UNK
in	O
the	O
alternatively	B-UNK
spliced	I-UNK
region	B-UNK
of	O
exon	B-UNK
9	O
.	O

 	O
apc	B-UNK
(	O
as9	O
)	O
was	O
found	B-UNK
to	O
down	O
-	O
regulate	B-UNK
beta	B-UNK
-	O
catenin	B-UNK
-	O
regulated	B-UNK
transcription	B-UNK
,	O
the	O
major	B-UNK
tumor	B-DISEASE
-	O
suppressor	B-UNK
function	B-UNK
of	O
apc	B-UNK
,	O
as	O
did	O
the	O
wild	B-UNK
-	O
type	B-UNK
apc	B-UNK
.	O

 	O
mutation	B-UNK
analysis	B-UNK
showed	B-UNK
that	O
both	O
apc	B-UNK
(	O
as9	O
)	O
and	O
the	O
wild	B-UNK
-	O
type	B-UNK
apc	B-UNK
alleles	B-UNK
were	O
somatically	O
mutated	B-UNK
in	O
most	O
colorectal	B-UNK
tumors	B-DISEASE
from	O
these	O
patients	B-UNK
.	O

 	B-UNK
functional	I-UNK
analysis	B-UNK
showed	B-UNK
that	O
4666insa	O
,	O
a	O
common	B-UNK
somatic	B-UNK
mutation	B-UNK
in	O
apc	B-UNK
(	O
as9	O
)	O
in	O
these	O
tumors	B-DISEASE
,	O
did	O
not	O
inactivate	O
the	O
wild	B-UNK
-	O
type	B-UNK
apc	B-UNK
.	O

 	O
our	O
results	B-UNK
indicate	B-UNK
that	O
carriers	B-UNK
of	O
apc	B-UNK
(	O
as9	O
)	O
develop	B-UNK
fewer	B-UNK
colorectal	B-UNK
tumors	B-DISEASE
than	O
do	O
typical	B-UNK
patients	B-UNK
with	O
fap	B-DISEASE
because	O
somatic	B-UNK
inactivation	B-UNK
of	O
both	O
apc	B-UNK
alleles	B-UNK
is	O
necessary	O
for	O
colorectal	B-UNK
tumorigenesis	B-UNK
.	O

 	O
however	O
,	O
these	O
patients	B-UNK
develop	B-UNK
colorectal	B-UNK
tumors	B-DISEASE
more	O
frequently	B-UNK
than	O
does	O
the	O
general	B-UNK
population	B-UNK
because	O
apc	B-UNK
(	O
as9	O
)	O
is	O
inactivated	O
by	O
mutations	B-UNK
that	O
do	O
not	O
inactivate	O
the	O
wild	B-UNK
-	O
type	B-UNK
apc	B-UNK
.	O
.	O

 	O
iron	B-UNK
-	O
dependent	B-UNK
self	O
-	O
assembly	B-UNK
of	O
recombinant	B-UNK
yeast	B-UNK
frataxin	I-UNK
:	O
implications	B-UNK
for	O
friedreich	B-DISEASE
ataxia	I-DISEASE
.	O

 	O
frataxin	B-UNK
deficiency	B-UNK
is	O
the	O
primary	B-UNK
cause	B-UNK
of	O
friedreich	B-DISEASE
ataxia	I-DISEASE
(	O
frda	B-UNK
)	O
,	O
an	O
autosomal	O
recessive	O
cardiodegenerative	O
and	O
neurodegenerative	B-DISEASE
disease	I-DISEASE
.	O

 	O
frataxin	B-UNK
is	O
a	O
nuclear	B-UNK
-	O
encoded	B-UNK
mitochondrial	B-UNK
protein	B-UNK
that	O
is	O
widely	B-UNK
conserved	B-UNK
among	O
eukaryotes	O
.	O

 	B-UNK
genetic	I-UNK
inactivation	B-UNK
of	O
the	O
yeast	B-UNK
frataxin	I-UNK
homologue	B-UNK
(	O
yfh1p	O
)	O
results	B-UNK
in	O
mitochondrial	B-UNK
iron	I-UNK
accumulation	B-UNK
and	O
hypersensitivity	B-DISEASE
to	O
oxidative	B-UNK
stress	B-UNK
.	O

 	B-UNK
increased	I-UNK
iron	B-UNK
deposition	O
and	O
evidence	B-UNK
of	O
oxidative	B-UNK
damage	B-UNK
have	O
also	O
been	O
observed	B-UNK
in	O
cardiac	B-UNK
tissue	B-UNK
and	O
cultured	B-UNK
fibroblasts	B-UNK
from	O
patients	B-UNK
with	O
frda	B-UNK
.	O

 	O
these	O
findings	B-UNK
indicate	B-UNK
that	O
frataxin	B-UNK
is	O
essential	B-UNK
for	O
mitochondrial	B-UNK
iron	I-UNK
homeostasis	B-UNK
and	O
protection	O
from	O
iron	B-UNK
-	O
induced	B-UNK
formation	B-UNK
of	O
free	B-UNK
radicals	O
.	O

 	O
the	O
functional	B-UNK
mechanism	B-UNK
of	O
frataxin	B-UNK
,	O
however	O
,	O
is	O
still	O
unknown	B-UNK
.	O

 	O
we	O
have	O
expressed	B-UNK
the	O
mature	B-UNK
form	B-UNK
of	O
yfh1p	O
(	O
myfh1p	B-UNK
)	O
in	O
escherichia	B-UNK
coli	B-UNK
and	O
have	O
analyzed	B-UNK
its	O
function	B-UNK
in	O
vitro	B-UNK
.	O

 	O
isolated	B-UNK
myfh1p	B-UNK
is	O
a	O
soluble	B-UNK
monomer	O
(	O
13	O
,	O
783	O
da	O
)	O
that	O
contains	B-UNK
no	O
iron	B-UNK
and	O
shows	B-UNK
no	O
significant	B-UNK
tendency	O
to	O
self	O
-	O
associate	O
.	O

 	O
aerobic	O
addition	B-UNK
of	O
ferrous	O
iron	B-UNK
to	O
myfh1p	B-UNK
results	B-UNK
in	O
assembly	B-UNK
of	O
regular	B-UNK
spherical	O
multimers	B-UNK
with	O
a	O
molecular	B-UNK
mass	B-UNK
of	O
approximately	B-UNK
1	O
.	O

 	O
1	O
mda	O
(	O
megadaltons	O
)	O
and	O
a	O
diameter	O
of	O
13	O
+	O
/	O
-	O
2	O
nm	O
.	O

 	O
each	O
multimer	O
consists	B-UNK
of	O
approximately	B-UNK
60	O
subunits	O
and	O
can	O
sequester	O
>	O
3	O
,	O
000	O
atoms	O
of	O
iron	B-UNK
.	O

 	O
titration	O
of	O
myfh1p	B-UNK
with	O
increasing	B-UNK
iron	B-UNK
concentrations	B-UNK
supports	B-UNK
a	O
stepwise	O
mechanism	B-UNK
of	O
multimer	O
assembly	B-UNK
.	O

 	O
sequential	O
addition	B-UNK
of	O
an	O
iron	B-UNK
chelator	O
and	O
a	O
reducing	B-UNK
agent	B-UNK
results	B-UNK
in	O
quantitative	B-UNK
iron	B-UNK
release	B-UNK
with	O
concomitant	O
disassembly	O
of	O
the	O
multimer	O
,	O
indicating	B-UNK
that	O
myfh1p	B-UNK
sequesters	O
iron	B-UNK
in	O
an	O
available	B-UNK
form	B-UNK
.	O

 	O
in	O
yeast	B-UNK
mitochondria	O
,	O
native	B-UNK
myfh1p	B-UNK
exists	B-UNK
as	O
monomer	O
and	O
a	O
higher	B-UNK
-	O
order	B-UNK
species	B-UNK
with	O
a	O
molecular	B-UNK
weight	I-UNK
>	O
600	O
,	O
000	O
.	O

 	O
after	O
addition	B-UNK
of	O
(	O
55	O
)	O
fe	O
to	O
the	O
medium	O
,	O
immunoprecipitates	O
of	O
this	O
species	B-UNK
contain	B-UNK
>	O
16	O
atoms	O
of	O
(	O
55	O
)	O
fe	O
per	O
molecule	B-UNK
of	O
myfh1p	B-UNK
.	O

 	O
we	O
propose	O
that	O
iron	B-UNK
-	O
dependent	B-UNK
self	O
-	O
assembly	B-UNK
of	O
recombinant	B-UNK
myfh1p	B-UNK
reflects	O
a	O
physiological	B-UNK
role	B-UNK
for	O
frataxin	B-UNK
in	O
mitochondrial	B-UNK
iron	I-UNK
sequestration	O
and	O
bioavailability	O
.	O
.	O

 	O
a	O
mutation	B-UNK
in	O
the	O
pleckstrin	O
homology	B-UNK
(	O
ph	B-UNK
)	O
domain	B-UNK
of	O
the	O
fgd1	B-UNK
gene	B-UNK
in	O
an	O
italian	B-UNK
family	B-UNK
with	O
faciogenital	O
dysplasia	O
(	O
aarskog	O
-	O
scott	B-DISEASE
syndrome	I-DISEASE
)	O
.	O

 	O
aarskog	O
-	O
scott	B-DISEASE
syndrome	I-DISEASE
(	O
aas	B-UNK
)	O
is	O
an	O
x	B-UNK
-	O
linked	B-UNK
disorder	O
characterised	B-UNK
by	O
short	B-DISEASE
stature	I-DISEASE
and	O
multiple	B-UNK
facial	B-UNK
,	O
limb	B-UNK
and	O
genital	O
abnormalities	B-DISEASE
.	O

 	O
a	O
gene	B-UNK
,	O
fgd1	B-UNK
,	O
altered	B-UNK
in	O
a	O
patient	B-UNK
with	O
aas	B-UNK
phenotype	B-UNK
,	O
has	O
been	O
identified	B-UNK
and	O
found	B-UNK
to	O
encode	O
a	O
protein	B-UNK
with	O
homology	B-UNK
to	O
rho	O
/	O
rac	O
guanine	B-UNK
nucleotide	B-UNK
exchange	B-UNK
factors	B-UNK
(	O
rho	O
/	O
rac	O
gef	O
)	O
.	O

 	O
however	O
,	O
since	O
this	O
original	B-UNK
report	B-UNK
on	O
identification	B-UNK
of	O
a	O
mutated	B-UNK
fgd1	B-UNK
gene	B-UNK
in	O
an	O
aas	B-UNK
patient	B-UNK
,	O
no	O
additional	B-UNK
mutations	B-UNK
in	O
the	O
fgd1	B-UNK
gene	B-UNK
have	O
been	O
described	B-UNK
.	O

 	O
we	O
analysed	B-UNK
13	O
independent	B-UNK
patients	B-UNK
with	O
clinical	B-UNK
diagnosis	B-UNK
of	O
aas	B-UNK
.	O

 	O
one	O
patient	B-UNK
presented	B-UNK
a	O
mutation	B-UNK
that	O
results	B-UNK
in	O
a	O
nucleotide	B-UNK
change	B-UNK
in	O
exon	B-UNK
10	O
of	O
the	O
fgd1	B-UNK
gene	B-UNK
(	O
g2559	O
>	O
a	O
)	O
substituting	O
a	O
gln	B-UNK
for	O
arg	B-UNK
in	O
position	B-UNK
610	O
.	O

 	O
the	O
mutation	B-UNK
was	O
found	B-UNK
to	O
segregate	O
with	O
the	O
aas	B-UNK
phenotype	B-UNK
in	O
affected	B-UNK
males	B-UNK
and	O
carrier	B-UNK
females	B-UNK
in	O
the	O
family	B-UNK
of	O
this	O
patient	B-UNK
.	O

 	O
interestingly	B-UNK
,	O
arg	B-UNK
-	O
610	O
is	O
located	B-UNK
within	O
one	O
of	O
the	O
two	O
pleckstrin	O
homology	B-UNK
(	O
ph	B-UNK
)	O
domains	B-UNK
of	O
the	O
fgd1	B-UNK
gene	B-UNK
and	O
it	O
corresponds	O
to	O
a	O
highly	B-UNK
conserved	I-UNK
residue	B-UNK
which	O
has	O
been	O
involved	B-UNK
in	O
insp	O
binding	B-UNK
in	O
ph	B-UNK
domains	B-UNK
of	O
other	O
proteins	B-UNK
.	O

 	O
the	O
same	O
residue	B-UNK
is	O
often	O
mutated	B-UNK
in	O
the	O
brutons	O
tyrosine	O
kinase	B-UNK
(	O
btk	O
)	O
gene	B-UNK
in	O
patients	B-UNK
with	O
an	O
x	B-DISEASE
-	I-DISEASE
linked	I-DISEASE
agammaglobulinemia	I-DISEASE
.	O

 	O
the	O
arg610gln	O
mutation	B-UNK
represents	B-UNK
the	O
first	O
case	B-UNK
of	O
a	O
mutation	B-UNK
in	O
the	O
ph	B-UNK
domain	B-UNK
of	O
the	O
fgd1	B-UNK
gene	B-UNK
and	O
additional	B-UNK
evidence	I-UNK
that	O
mutations	B-UNK
in	O
ph	B-UNK
domains	B-UNK
can	O
be	O
associated	B-UNK
to	O
human	B-UNK
diseases	B-DISEASE
.	O
.	O

 	O
amino	O
-	O
terminal	B-UNK
fragments	B-UNK
of	O
mutant	B-UNK
huntingtin	I-UNK
show	O
selective	B-UNK
accumulation	B-UNK
in	O
striatal	B-UNK
neurons	B-UNK
and	O
synaptic	B-UNK
toxicity	B-DISEASE
.	O

 	O
huntington	B-DISEASE
disease	I-DISEASE
(	O
hd	B-UNK
)	O
is	O
caused	B-UNK
by	O
expansion	B-UNK
of	O
a	O
glutamine	B-UNK
repeat	B-UNK
in	O
the	O
amino	O
-	O
terminal	B-UNK
region	B-UNK
of	O
huntingtin	B-UNK
.	O

 	O
despite	B-UNK
its	O
widespread	O
expression	B-UNK
,	O
mutant	B-UNK
huntingtin	I-UNK
induces	B-UNK
selective	B-UNK
neuronal	B-UNK
loss	B-UNK
in	O
striatal	B-UNK
neurons	B-UNK
.	O

 	O
here	O
we	O
report	B-UNK
that	O
,	O
in	O
mutant	B-UNK
mice	I-UNK
expressing	B-UNK
hd	B-UNK
repeats	B-UNK
,	O
the	O
production	B-UNK
and	O
aggregation	O
of	O
n	B-UNK
-	O
terminal	B-UNK
huntingtin	B-UNK
fragments	B-UNK
preferentially	B-UNK
occur	B-UNK
in	O
hd	B-UNK
-	O
affected	B-UNK
neurons	B-UNK
and	O
their	O
processes	B-UNK
and	O
axonal	B-UNK
terminals	O
.	O

 	O
n	B-UNK
-	O
terminal	B-UNK
fragments	B-UNK
of	O
mutant	B-UNK
huntingtin	I-UNK
form	B-UNK
aggregates	O
and	O
induce	O
neuritic	O
degeneration	B-UNK
in	O
cultured	B-UNK
striatal	B-UNK
neurons	B-UNK
.	O

 	O
n	B-UNK
-	O
terminal	B-UNK
mutant	B-UNK
huntingtin	I-UNK
also	O
binds	O
to	O
synaptic	B-UNK
vesicles	B-UNK
and	O
inhibits	B-UNK
their	O
glutamate	O
uptake	B-UNK
in	O
vitro	B-UNK
.	O

 	O
the	O
specific	B-UNK
processing	B-UNK
and	O
accumulation	B-UNK
of	O
toxic	B-UNK
fragments	B-UNK
of	O
n	B-UNK
-	O
terminal	B-UNK
huntingtin	B-UNK
in	O
hd	B-UNK
-	O
affected	B-UNK
striatal	B-UNK
neurons	B-UNK
,	O
especially	B-UNK
in	O
their	O
neuronal	B-UNK
processes	B-UNK
and	O
axonal	B-UNK
terminals	O
,	O
may	O
contribute	B-UNK
to	O
the	O
selective	B-UNK
neuropathology	O
of	O
hd	B-UNK
.	O
.	O

 	B-UNK
brca1	I-UNK
is	O
associated	B-UNK
with	O
a	O
human	B-UNK
swi	O
/	O
snf	O
-	O
related	B-UNK
complex	B-UNK
:	O
linking	O
chromatin	B-UNK
remodeling	B-UNK
to	O
breast	B-DISEASE
cancer	I-DISEASE
.	O

 	B-UNK
germline	I-UNK
mutations	B-UNK
in	O
the	O
tumor	B-DISEASE
suppressor	B-UNK
gene	B-UNK
,	O
brca1	B-UNK
,	O
predispose	B-UNK
individuals	B-UNK
to	O
breast	B-UNK
and	O
ovarian	B-UNK
cancers	B-DISEASE
.	O

 	O
using	O
a	O
combination	O
of	O
affinity	B-UNK
-	O
and	O
conventional	B-UNK
chromatographic	O
techniques	B-UNK
,	O
we	O
have	O
isolated	B-UNK
a	O
predominant	B-UNK
form	B-UNK
of	O
a	O
multiprotein	O
brca1	B-UNK
-	O
containing	B-UNK
complex	B-UNK
from	O
human	B-UNK
cells	B-UNK
displaying	O
chromatin	B-UNK
-	O
remodeling	B-UNK
activity	B-UNK
.	O

 	O
mass	B-UNK
spectrometric	O
sequencing	B-UNK
of	O
components	B-UNK
of	O
this	O
complex	B-UNK
indicated	B-UNK
that	O
brca1	B-UNK
is	O
associated	B-UNK
with	O
a	O
swi	O
/	O
snf	O
-	O
related	B-UNK
complex	B-UNK
.	O

 	O
we	O
show	O
that	O
brca1	B-UNK
can	O
directly	B-UNK
interact	B-UNK
with	O
the	O
brg1	O
subunit	B-UNK
of	O
the	O
swi	O
/	O
snf	O
complex	B-UNK
.	O

 	O
moreover	O
,	O
p53	O
-	O
mediated	B-UNK
stimulation	B-UNK
of	O
transcription	B-UNK
by	O
brca1	B-UNK
was	O
completely	B-UNK
abrogated	O
by	O
either	O
a	O
dominant	B-UNK
-	O
negative	B-UNK
mutant	B-UNK
of	O
brg1	O
or	O
the	O
cancer	B-DISEASE
-	O
causing	B-UNK
deletion	B-UNK
in	O
exon	B-UNK
11	O
of	O
brca1	B-UNK
.	O

 	O
these	O
findings	B-UNK
reveal	B-UNK
a	O
direct	B-UNK
function	B-UNK
for	O
brca1	B-UNK
in	O
transcriptional	B-UNK
control	B-UNK
through	O
modulation	O
of	O
chromatin	B-UNK
structure	B-UNK
.	O
.	O

 	O
asef	B-UNK
,	O
a	O
link	B-UNK
between	O
the	O
tumor	B-DISEASE
suppressor	B-UNK
apc	B-UNK
and	O
g	B-UNK
-	O
protein	B-UNK
signaling	B-UNK
.	O

 	O
the	O
adenomatous	B-DISEASE
polyposis	I-DISEASE
coli	I-DISEASE
gene	B-UNK
(	O
apc	B-UNK
)	O
is	O
mutated	B-UNK
in	O
familial	B-DISEASE
adenomatous	I-DISEASE
polyposis	I-DISEASE
and	O
in	O
sporadic	B-UNK
colorectal	B-UNK
tumors	B-DISEASE
.	O

 	O
here	O
the	O
apc	B-UNK
gene	B-UNK
product	B-UNK
is	O
shown	B-UNK
to	O
bind	B-UNK
through	O
its	O
armadillo	O
repeat	B-UNK
domain	B-UNK
to	O
a	O
rac	O
-	O
specific	B-UNK
guanine	B-UNK
nucleotide	B-UNK
exchange	B-UNK
factor	B-UNK
(	O
gef	O
)	O
,	O
termed	B-UNK
asef	B-UNK
.	O

 	O
endogenous	B-UNK
apc	B-UNK
colocalized	O
with	O
asef	B-UNK
in	O
mouse	B-UNK
colon	O
epithelial	B-UNK
cells	I-UNK
and	O
neuronal	B-UNK
cells	B-UNK
.	O

 	O
furthermore	B-UNK
,	O
apc	B-UNK
enhanced	B-UNK
the	O
gef	O
activity	B-UNK
of	O
asef	B-UNK
and	O
stimulated	B-UNK
asef	B-UNK
-	O
mediated	B-UNK
cell	B-UNK
flattening	O
,	O
membrane	B-UNK
ruffling	O
,	O
and	O
lamellipodia	O
formation	B-UNK
in	O
mdck	O
cells	B-UNK
.	O

 	O
these	O
results	B-UNK
suggest	B-UNK
that	O
the	O
apc	B-UNK
-	O
asef	B-UNK
complex	B-UNK
may	O
regulate	B-UNK
the	O
actin	B-UNK
cytoskeletal	B-UNK
network	O
,	O
cell	B-UNK
morphology	O
and	O
migration	B-UNK
,	O
and	O
neuronal	B-UNK
function	B-UNK
.	O
.	O

 	O
function	B-UNK
of	O
an	O
axonal	B-UNK
chemoattractant	O
modulated	O
by	O
metalloprotease	O
activity	B-UNK
.	O

 	O
the	O
axonal	B-UNK
chemoattractant	O
netrin	B-UNK
-	O
1	O
guides	O
spinal	B-UNK
commissural	O
axons	O
by	O
activating	B-UNK
its	O
receptor	B-UNK
dcc	O
(	O
deleted	B-UNK
in	O
colorectal	B-DISEASE
cancer	I-DISEASE
)	O
.	O

 	O
we	O
have	O
found	B-UNK
that	O
chemical	B-UNK
inhibitors	B-UNK
of	O
metalloproteases	O
potentiate	O
netrin	B-UNK
-	O
mediated	B-UNK
axon	B-UNK
outgrowth	O
in	O
vitro	B-UNK
.	O

 	O
we	O
have	O
also	O
found	B-UNK
that	O
dcc	O
is	O
a	O
substrate	B-UNK
for	O
metalloprotease	O
-	O
dependent	B-UNK
ectodomain	O
shedding	O
,	O
and	O
that	O
the	O
inhibitors	B-UNK
block	B-UNK
proteolytic	O
processing	B-UNK
of	O
dcc	O
and	O
cause	B-UNK
an	O
increase	B-UNK
in	O
dcc	O
protein	B-UNK
levels	B-UNK
on	O
axons	O
within	O
spinal	B-UNK
cord	B-UNK
explants	O
.	O

 	O
thus	O
,	O
potentiation	O
of	O
netrin	B-UNK
activity	B-UNK
by	O
inhibitors	B-UNK
may	O
result	B-UNK
from	O
stabilization	O
of	O
dcc	O
on	O
the	O
axons	O
,	O
and	O
proteolytic	O
activity	B-UNK
may	O
regulate	B-UNK
axon	B-UNK
migration	B-UNK
by	O
controlling	O
the	O
number	B-UNK
of	O
functional	B-UNK
extracellular	B-UNK
axon	B-UNK
guidance	O
receptors	B-UNK
.	O
.	O

 	O
myotonic	B-DISEASE
dystrophy	I-DISEASE
in	O
transgenic	B-UNK
mice	I-UNK
expressing	B-UNK
an	O
expanded	B-UNK
cug	I-UNK
repeat	B-UNK
.	O

 	O
myotonic	B-DISEASE
dystrophy	I-DISEASE
(	O
dm	B-DISEASE
)	O
,	O
the	O
most	O
common	B-UNK
form	B-UNK
of	O
muscular	B-DISEASE
dystrophy	I-DISEASE
in	O
adult	B-UNK
humans	B-UNK
,	O
results	B-UNK
from	O
expansion	B-UNK
of	O
a	O
ctg	B-UNK
repeat	I-UNK
in	O
the	O
3	O
untranslated	B-UNK
region	B-UNK
of	O
the	O
dmpk	B-UNK
gene	B-UNK
.	O

 	O
the	O
mutant	B-UNK
dmpk	B-UNK
messenger	B-UNK
rna	I-UNK
(	O
mrna	B-UNK
)	O
contains	B-UNK
an	O
expanded	B-UNK
cug	I-UNK
repeat	B-UNK
and	O
is	O
retained	B-UNK
in	O
the	O
nucleus	O
.	O

 	O
we	O
have	O
expressed	B-UNK
an	O
untranslated	B-UNK
cug	B-UNK
repeat	I-UNK
in	O
an	O
unrelated	B-UNK
mrna	B-UNK
in	O
transgenic	B-UNK
mice	I-UNK
.	O

 	B-UNK
mice	I-UNK
that	O
expressed	B-UNK
expanded	B-UNK
cug	I-UNK
repeats	B-UNK
developed	B-UNK
myotonia	B-DISEASE
and	O
myopathy	B-DISEASE
,	O
whereas	O
mice	B-UNK
expressing	I-UNK
a	O
nonexpanded	O
repeat	B-UNK
did	O
not	O
.	O

 	O
thus	O
,	O
transcripts	B-UNK
with	O
expanded	B-UNK
cug	I-UNK
repeats	B-UNK
are	O
sufficient	B-UNK
to	O
generate	B-UNK
a	O
dm	B-DISEASE
phenotype	B-UNK
.	O

 	O
this	O
result	B-UNK
supports	B-UNK
a	O
role	B-UNK
for	O
rna	B-UNK
gain	O
of	O
function	B-UNK
in	O
disease	B-DISEASE
pathogenesis	O
.	O
.	O

 	B-UNK
genomic	I-UNK
rearrangements	B-UNK
of	O
the	O
apc	B-UNK
tumor	B-DISEASE
-	O
suppressor	B-UNK
gene	B-UNK
in	O
familial	B-DISEASE
adenomatous	I-DISEASE
polyposis	I-DISEASE
.	O

 	B-UNK
germline	I-UNK
mutations	B-UNK
of	O
the	O
adenomatous	B-DISEASE
polyposis	I-DISEASE
coli	I-DISEASE
(	O
apc	B-UNK
)	O
tumor	B-DISEASE
-	O
suppressor	B-UNK
gene	B-UNK
result	B-UNK
in	O
the	O
hereditary	B-UNK
colorectal	B-DISEASE
cancer	I-DISEASE
syndrome	B-DISEASE
familial	B-DISEASE
adenomatous	I-DISEASE
polyposis	I-DISEASE
(	O
fap	B-DISEASE
)	O
.	O

 	O
almost	O
all	O
apc	B-UNK
mutations	B-UNK
that	O
have	O
been	O
identified	B-UNK
are	O
single	B-UNK
-	O
nucleotide	B-UNK
alterations	B-UNK
,	O
small	B-UNK
insertions	B-UNK
,	O
or	O
small	B-UNK
deletions	B-UNK
that	O
would	O
truncate	O
the	O
protein	B-UNK
product	B-UNK
of	O
the	O
gene	B-UNK
.	O

 	O
no	O
well	O
-	O
characterized	B-UNK
intragenic	B-UNK
rearrangement	B-UNK
of	O
apc	B-UNK
has	O
been	O
described	B-UNK
,	O
and	O
the	O
prevalence	B-UNK
of	O
this	O
type	B-UNK
of	O
mutation	B-UNK
in	O
fap	B-DISEASE
patients	B-UNK
is	O
not	O
clear	B-UNK
.	O

 	O
we	O
screened	O
49	O
potential	B-UNK
fap	B-DISEASE
families	B-UNK
and	O
identified	B-UNK
26	O
different	B-UNK
germline	B-UNK
apc	I-UNK
mutations	I-UNK
in	O
30	O
families	B-UNK
.	O

 	O
four	O
of	O
these	O
mutations	B-UNK
were	O
genomic	B-UNK
rearrangements	I-UNK
resulting	B-UNK
from	O
homologous	B-UNK
and	O
nonhomologous	O
recombinations	B-UNK
mediated	B-UNK
by	O
alu	B-UNK
elements	B-UNK
.	O

 	O
two	O
of	O
these	O
four	O
rearrangements	B-UNK
were	O
complex	B-UNK
,	O
involving	B-UNK
deletion	B-UNK
and	O
insertion	B-UNK
of	O
nucleotides	B-UNK
.	O

 	O
of	O
these	O
four	O
rearrangements	B-UNK
,	O
one	O
resulted	B-UNK
in	O
the	O
deletion	B-UNK
of	O
exons	B-UNK
11	O
and	O
12	O
and	O
two	O
others	O
resulted	B-UNK
in	O
either	O
complete	B-UNK
or	O
partial	B-UNK
deletion	B-UNK
of	O
exon	B-UNK
14	O
.	O

 	O
the	O
fourth	B-UNK
rearrangement	B-UNK
grossly	O
altered	B-UNK
the	O
sequence	B-UNK
within	O
intron	B-UNK
14	O
.	O

 	O
although	O
this	O
rearrangement	B-UNK
did	O
not	O
affect	B-UNK
any	O
coding	B-UNK
sequence	B-UNK
of	O
apc	B-UNK
at	B-DISEASE
the	O
genomic	B-UNK
dna	I-UNK
level	B-UNK
,	O
it	O
caused	B-UNK
inappropriate	O
splicing	B-UNK
of	O
exon	B-UNK
14	O
.	O

 	O
these	O
rearrangements	B-UNK
were	O
initially	B-UNK
revealed	B-UNK
by	O
analyzing	O
cdnas	B-UNK
and	O
could	O
not	O
have	O
been	O
identified	B-UNK
by	O
using	O
mutation	B-UNK
detection	B-UNK
methods	B-UNK
that	O
screened	O
each	O
exon	B-UNK
individually	O
.	O

 	O
the	O
identification	B-UNK
of	O
a	O
rearrangement	B-UNK
that	O
did	O
not	O
alter	B-UNK
any	O
coding	B-UNK
exons	B-UNK
yet	O
affected	B-UNK
the	O
splicing	B-UNK
further	O
underscores	O
the	O
importance	O
of	O
using	O
cdna	B-UNK
for	O
mutation	B-UNK
analysis	B-UNK
.	O

 	O
the	O
identification	B-UNK
of	O
four	O
genomic	B-UNK
rearrangements	I-UNK
among	O
30	O
mutations	B-UNK
suggests	B-UNK
that	O
genomic	B-UNK
rearrangements	I-UNK
are	O
frequent	B-UNK
germline	B-UNK
apc	I-UNK
mutations	I-UNK
.	O
.	O

 	O
detection	B-UNK
of	O
a	O
novel	B-UNK
missense	I-UNK
mutation	B-UNK
and	O
second	B-UNK
recurrent	B-UNK
mutation	B-UNK
in	O
the	O
cacna1a	B-UNK
gene	B-UNK
in	O
individuals	B-UNK
with	O
ea	O
-	O
2	O
and	O
fhm	O
.	O

 	O
mutations	B-UNK
in	O
the	O
brain	B-UNK
specific	B-UNK
p	B-UNK
/	O
q	B-UNK
type	B-UNK
ca2	O
+	O
channel	B-UNK
alpha1	O
subunit	B-UNK
gene	B-UNK
,	O
cacna1a	B-UNK
,	O
have	O
been	O
identified	B-UNK
in	O
three	O
clinically	B-UNK
distinct	I-UNK
disorders	B-UNK
,	O
viz	O
.	O
episodic	B-DISEASE
ataxia	I-DISEASE
type	B-UNK
2	O
(	O
ea	O
-	O
2	O
)	O
,	O
familial	B-DISEASE
hemiplegic	I-DISEASE
migraine	I-DISEASE
(	O
fhm	O
)	O
and	O
spinocerebellar	B-DISEASE
ataxia	I-DISEASE
6	O
(	O
sca6	O
)	O
.	O

 	O
for	O
individuals	B-UNK
with	O
ea	O
-	O
2	O
,	O
the	O
mutations	B-UNK
described	B-UNK
thus	O
far	B-UNK
are	O
presumed	B-UNK
to	O
result	B-UNK
in	O
a	O
truncated	B-UNK
protein	B-UNK
product	B-UNK
.	O

 	O
several	O
different	B-UNK
missense	B-UNK
mutations	I-UNK
have	O
been	O
identified	B-UNK
in	O
patients	B-UNK
with	O
fhm	O
.	O

 	O
at	B-DISEASE
least	O
two	O
of	O
these	O
mutations	B-UNK
have	O
been	O
identified	B-UNK
on	O
two	O
different	B-UNK
chromosome	B-UNK
19p13	O
haplotypes	B-UNK
and	O
thus	O
represent	B-UNK
recurrent	B-UNK
mutations	B-UNK
.	O

 	O
in	O
the	O
present	B-UNK
study	I-UNK
,	O
we	O
have	O
screened	O
several	O
individuals	B-UNK
for	O
mutations	B-UNK
in	O
all	O
47	O
exons	B-UNK
in	O
the	O
cacna1a	B-UNK
gene	B-UNK
by	O
single	B-UNK
-	O
strand	O
conformation	O
analysis	B-UNK
.	O

 	O
we	O
have	O
characterised	B-UNK
a	O
novel	B-UNK
missense	I-UNK
mutation	B-UNK
,	O
g5260a	O
,	O
in	O
exon	B-UNK
32	O
in	O
a	O
family	B-UNK
segregating	B-UNK
for	O
ea	O
-	O
2	O
.	O

 	O
the	O
consequence	O
of	O
this	O
mutation	B-UNK
is	O
an	O
amino	B-UNK
acid	I-UNK
substitution	I-UNK
at	B-DISEASE
a	O
highly	B-UNK
conserved	I-UNK
position	B-UNK
within	O
the	O
cacna1a	B-UNK
gene	B-UNK
.	O

 	O
this	O
represents	B-UNK
the	O
first	O
point	B-UNK
mutation	I-UNK
not	O
resulting	B-UNK
in	O
a	O
proposed	B-UNK
truncated	B-UNK
protein	B-UNK
.	O

 	O
furthermore	B-UNK
,	O
this	O
mutation	B-UNK
has	O
been	O
detected	B-UNK
in	O
a	O
family	B-UNK
member	B-UNK
with	O
mild	B-UNK
clinical	B-UNK
signs	B-UNK
including	B-UNK
only	O
migraine	B-DISEASE
.	O

 	O
additionally	B-UNK
,	O
a	O
second	B-UNK
previously	B-UNK
identified	I-UNK
recurrent	B-UNK
muta	O
tion	O
,	O
c2272	O
t	B-UNK
,	O
in	O
exon	B-UNK
16	O
has	O
been	O
discovered	O
in	O
a	O
patient	B-UNK
with	O
fhm	O
.	O
.	O

 	O
analbuminemia	B-UNK
in	O
a	O
neonate	O
.	O

 	O
a	O
small	B-UNK
-	O
for	O
-	O
gestational	O
-	O
age	B-UNK
infant	B-DISEASE
,	O
found	B-UNK
to	O
have	O
analbuminemia	B-UNK
in	O
the	O
neonatal	B-UNK
period	B-UNK
,	O
is	O
reported	B-UNK
and	O
the	O
twelve	O
cases	B-UNK
recorded	O
in	O
the	O
world	O
literature	O
are	O
reviewed	O
.	O

 	B-UNK
patients	I-UNK
lacking	B-UNK
this	O
serum	B-UNK
protein	B-UNK
are	O
essentially	O
asymptomatic	B-UNK
,	O
apart	O
from	O
minimal	B-UNK
ankle	O
edema	B-DISEASE
and	O
ease	O
of	O
fatigue	B-DISEASE
.	O

 	O
apparent	B-UNK
compensatory	B-UNK
mechanisms	B-UNK
which	O
come	O
into	O
play	O
when	O
serum	B-UNK
albumin	B-UNK
is	O
low	B-UNK
include	B-UNK
prolonged	B-UNK
half	B-UNK
-	O
life	B-UNK
of	O
albumin	B-UNK
and	O
transferrin	O
,	O
an	O
increase	B-UNK
in	O
serum	B-UNK
globulins	O
,	O
beta	B-UNK
lipoprotein	B-UNK
,	O
and	O
glycoproteins	O
,	O
arterial	O
hypotension	B-DISEASE
with	O
reduced	B-UNK
capillary	O
hydrostatic	O
pressure	B-UNK
,	O
and	O
the	O
ability	B-UNK
to	O
respond	O
with	O
rapid	B-UNK
sodium	B-UNK
and	O
chloride	B-UNK
diuresis	O
in	O
response	B-UNK
to	O
small	B-UNK
volume	O
changes	B-UNK
.	O

 	O
examination	B-UNK
of	O
plasma	B-UNK
amino	O
acids	O
,	O
an	O
investigation	O
not	O
previously	B-UNK
reported	I-UNK
,	O
revealed	B-UNK
an	O
extremely	B-UNK
low	B-UNK
plasma	B-UNK
tryptophan	O
level	B-UNK
,	O
a	O
finding	B-UNK
which	O
may	O
be	O
important	B-UNK
in	O
view	O
of	O
the	O
role	B-UNK
of	O
tryptophan	O
in	O
albumin	B-UNK
synthesis	B-UNK
.	O
.	O

 	O
histidinemia	B-DISEASE
.	O

 	O
classical	B-UNK
and	O
atypical	B-UNK
form	B-UNK
in	O
siblings	B-UNK
.	O

 	O
two	O
brothers	B-UNK
,	O
6	O
and	O
13	O
years	B-UNK
old	B-UNK
,	O
had	O
histidinemia	B-DISEASE
.	O

 	O
on	O
the	O
basis	B-UNK
of	O
clinical	B-UNK
and	O
biochemical	B-UNK
observations	B-UNK
,	O
the	O
younger	B-UNK
boy	B-UNK
was	O
considered	B-UNK
to	O
have	O
a	O
classical	B-UNK
type	B-UNK
of	O
the	O
disease	B-DISEASE
,	O
while	O
the	O
older	B-UNK
boy	B-UNK
had	O
an	O
atypical	B-UNK
form	B-UNK
characterized	B-UNK
by	O
partial	B-UNK
impairment	O
of	O
the	O
skin	B-DISEASE
histidase	B-UNK
activity	B-UNK
and	O
a	O
moderately	B-UNK
prolonged	B-UNK
half	B-UNK
-	O
life	B-UNK
of	O
blood	B-UNK
histidine	B-UNK
.	O

 	O
the	O
mother	B-UNK
is	O
a	O
heterozygous	B-UNK
carrier	B-UNK
,	O
while	O
the	O
father	B-UNK
and	O
sister	O
seem	O
to	O
be	O
normal	B-UNK
.	O
.	O

 	O
carrier	B-UNK
detection	I-UNK
of	O
pyruvate	B-UNK
carboxylase	I-UNK
deficiency	B-UNK
in	O
fibroblasts	B-UNK
and	O
lymphocytes	B-UNK
.	O

 	O
pyruvate	B-UNK
carboxylase	I-UNK
(	O
e	B-UNK
.	O
c	B-UNK
.	O
6	O
.	O
4	O
.	O
1	O
.	O
1	O
)	O
activity	B-UNK
was	O
determined	B-UNK
in	O
the	O
circulating	B-UNK
peripheral	B-UNK
lymphocytes	B-UNK
and	O
cultured	B-UNK
skin	B-DISEASE
fibroblasts	B-UNK
from	O
the	O
family	B-UNK
of	O
a	O
patient	B-UNK
with	O
hepatic	B-UNK
,	O
cerebral	O
,	O
renal	B-DISEASE
cortical	O
,	O
leukocyte	B-UNK
,	O
and	O
fibroblast	B-UNK
pyruvate	B-UNK
carboxylase	I-UNK
deficiency	B-UNK
(	O
pc	O
portland	O
deficiency	B-UNK
)	O
.	O

 	O
lymphocyte	B-UNK
activities	B-UNK
were	O
mother	B-UNK
,	O
33	O
-	O
-	O
39	O
%	O
;	O
father	B-UNK
,	O
11	O
-	O
-	O
29	O
%	O
;	O
brother	B-UNK
,	O
82	O
-	O
-	O
103	O
%	O
;	O
and	O
sister	O
,	O
38	O
-	O
-	O
48	O
%	O
of	O
the	O
lowest	O
normal	B-UNK
.	O

 	O
fibroblasts	B-UNK
from	O
the	O
patients	B-UNK
mother	B-UNK
and	O
father	B-UNK
had	O
42	O
and	O
34	O
%	O
,	O
respectively	B-UNK
,	O
of	O
the	O
activity	B-UNK
of	O
the	O
lowest	O
normal	B-UNK
.	O

 	O
these	O
data	B-UNK
demonstrate	B-UNK
that	O
the	O
disease	B-DISEASE
is	O
inherited	B-UNK
in	O
an	O
autosomal	O
recessive	O
manner	B-UNK
and	O
that	O
lymphocytes	B-UNK
and	O
fibroblasts	B-UNK
can	O
be	O
used	O
to	O
detect	B-UNK
carriers	B-UNK
.	O

 	O
neither	O
pyruvate	B-UNK
carboxylase	I-UNK
nor	O
mitochondrial	B-UNK
pepck	O
activity	B-UNK
in	O
lymphocytes	B-UNK
was	O
increased	B-UNK
by	O
a	O
21	O
-	O
hr	O
fast	B-UNK
.	O

 	O
glucose	B-UNK
-	O
6	O
-	O
phosphate	B-UNK
dehydrogenase	I-UNK
variants	B-UNK
from	O
italian	B-UNK
subjects	B-UNK
associated	B-UNK
with	O
severe	B-UNK
neonatal	B-UNK
jaundice	B-DISEASE
.	O

 	O
screening	B-UNK
for	O
the	O
g6pd	B-UNK
deficiency	I-UNK
was	O
carried	B-UNK
out	O
at	B-DISEASE
the	O
maternity	O
division	O
of	O
the	O
galliera	O
hospital	B-UNK
in	O
genoa	O
,	O
italy	B-UNK
.	O

 	O
two	O
groups	B-UNK
of	O
subjects	B-UNK
with	O
hyperbilirubinaemia	O
of	O
non	B-UNK
-	O
immunological	B-UNK
origin	B-UNK
were	O
examined	B-UNK
(	O
a	O
)	O
302	O
newborn	B-UNK
babies	O
of	O
sardinian	B-UNK
extraction	B-UNK
(	O
on	O
cord	B-UNK
blood	B-UNK
)	O
and	O
(	O
b	B-UNK
)	O
201	O
newborn	B-UNK
babies	O
of	O
south	O
italian	B-UNK
ancestry	B-UNK
(	O
on	O
peripheral	B-UNK
blood	I-UNK
)	O
.	O

 	O
among	O
503	O
subjects	B-UNK
,	O
43	O
showed	B-UNK
an	O
enzyme	B-UNK
deficiency	B-UNK
;	O
in	O
39	O
the	O
defect	B-UNK
was	O
of	O
the	O
mediterranean	B-UNK
type	B-UNK
.	O

 	O
in	O
one	O
case	B-UNK
,	O
previously	B-UNK
described	I-UNK
,	O
the	O
enzyme	B-UNK
was	O
of	O
the	O
a	O
-	O
type	B-UNK
.	O

 	O
in	O
the	O
remaining	B-UNK
cases	B-UNK
three	O
different	B-UNK
variants	B-UNK
were	O
identified	B-UNK
.	O

 	O
in	O
the	O
present	B-UNK
work	O
these	O
three	O
cases	B-UNK
,	O
each	O
with	O
severe	B-UNK
neonatal	B-UNK
jaundice	B-DISEASE
,	O
are	O
reported	B-UNK
.	O

 	O
their	O
parents	B-UNK
originated	B-UNK
from	O
calabria	O
,	O
from	O
sardinia	O
and	O
from	O
sicily	O
.	O

 	O
the	O
abnormal	B-UNK
enzymes	B-UNK
are	O
respectively	B-UNK
designated	B-UNK
as	O
gddcbrousse	O
-	O
like	B-UNK
,	O
gdgallura	O
and	O
gdagrigento	O
.	O
.	O

 	B-UNK
cytogenetic	I-UNK
investigations	O
in	O
families	B-UNK
with	O
ataxia	B-DISEASE
-	O
telangiectasia	B-DISEASE
.	O

 	B-UNK
chromosomal	I-UNK
studies	B-UNK
were	O
performed	B-UNK
on	O
peripheral	B-UNK
blood	I-UNK
lymphocytes	B-UNK
and	O
cultured	B-UNK
skin	B-DISEASE
fibroblasts	B-UNK
from	O
five	O
israeli	O
-	O
moroccan	B-UNK
families	B-UNK
with	O
ataxia	B-DISEASE
-	O
telangiectasia	B-DISEASE
.	O

 	O
a	O
total	B-UNK
of	O
24	O
individuals	B-UNK
,	O
including	B-UNK
seven	B-UNK
propositi	O
,	O
was	O
investigated	B-UNK
.	O

 	O
among	O
the	O
probands	B-UNK
,	O
significantly	B-UNK
elevated	B-UNK
rates	B-UNK
of	O
chromosome	B-UNK
damage	B-UNK
were	O
observed	B-UNK
in	O
both	O
blood	B-UNK
and	O
skin	B-DISEASE
.	O

 	O
skin	B-DISEASE
fibroblasts	B-UNK
of	O
affected	B-UNK
individuals	I-UNK
showed	B-UNK
several	O
orders	O
of	O
magnitude	O
more	O
chromosome	B-DISEASE
breakage	I-DISEASE
than	O
lymphocytes	B-UNK
.	O

 	B-UNK
increased	I-UNK
rates	B-UNK
of	O
chromosome	B-UNK
damage	B-UNK
were	O
also	O
observed	B-UNK
in	O
the	O
fibroblasts	B-UNK
of	O
some	O
phenotypically	B-UNK
normal	I-UNK
family	B-UNK
members	I-UNK
(	O
obligate	B-UNK
heterozygotes	B-UNK
and	O
sibs	B-UNK
)	O
when	O
compared	B-UNK
to	O
normal	B-UNK
controls	B-UNK
.	O

 	O
an	O
apparent	B-UNK
abnormal	B-UNK
clone	B-UNK
of	O
cells	B-UNK
,	O
possessing	O
a	O
large	B-UNK
acrocentric	O
marker	B-UNK
chromosome	B-UNK
(	O
14q	O
+	O
)	O
,	O
was	O
observed	B-UNK
in	O
varying	B-UNK
proportions	O
among	O
cells	B-UNK
of	O
all	O
the	O
propositi	O
(	O
2	O
-	O
5	O
%	O
of	O
lymphocytes	B-UNK
;	O
1	O
-	O
9	O
%	O
of	O
fibroblasts	B-UNK
)	O
.	O
.	O

 	O
prenatal	B-UNK
diagnosis	I-UNK
of	O
wolman	B-DISEASE
disease	I-DISEASE
.	O

 	O
two	O
pregnancies	O
at	B-DISEASE
risk	B-UNK
for	O
wolman	B-DISEASE
disease	I-DISEASE
were	O
monitored	O
by	O
assay	B-UNK
and	O
electrophoresis	B-UNK
of	O
acid	O
lipase	B-UNK
in	O
cultured	B-UNK
amniotic	B-UNK
-	O
fluid	B-UNK
cells	B-UNK
.	O

 	O
cells	B-UNK
from	O
patient	B-UNK
1	O
had	O
5	O
%	O
of	O
control	B-UNK
levels	B-UNK
of	O
acid	O
lipase	B-UNK
,	O
using	O
14c	O
-	O
triolein	O
as	O
substrate	B-UNK
;	O
however	O
,	O
when	O
artificial	O
substrates	B-UNK
(	O
esters	O
of	O
4	O
-	O
methylumbelliferone	O
and	O
p	B-UNK
-	O
nitrophenol	O
)	O
were	O
used	O
to	O
measure	O
acid	O
lipase	B-UNK
,	O
these	O
cells	B-UNK
had	O
30	O
%	O
of	O
control	B-UNK
levels	B-UNK
.	O

 	O
electrophoresis	B-UNK
of	O
cell	B-UNK
extracts	B-UNK
revealed	B-UNK
the	O
absence	B-UNK
of	O
the	O
a	O
form	B-UNK
of	O
acid	O
lipase	B-UNK
,	O
consistent	B-UNK
with	O
the	O
diagnosis	B-UNK
of	O
wolman	B-DISEASE
disease	I-DISEASE
.	O

 	O
analysis	B-UNK
of	O
fetal	B-UNK
tissues	B-UNK
following	B-UNK
prostaglandin	O
termination	B-UNK
of	O
this	O
pregnancy	B-DISEASE
confirmed	B-UNK
the	O
diagnosis	B-UNK
.	O

 	O
assay	B-UNK
of	O
fetal	B-UNK
-	O
skin	B-DISEASE
fibroblasts	B-UNK
with	O
14c	O
-	O
triolein	O
,	O
as	O
well	O
as	O
with	O
artificial	O
substrates	B-UNK
,	O
showed	B-UNK
marked	B-UNK
deficiency	B-UNK
of	O
acid	O
lipase	B-UNK
activity	B-UNK
.	O

 	O
electrophoresis	B-UNK
of	O
fetal	B-UNK
-	O
tissue	B-UNK
extracts	B-UNK
also	O
demonstrated	B-UNK
the	O
absence	B-UNK
of	O
the	O
a	O
form	B-UNK
of	O
acid	O
lipase	B-UNK
.	O

 	O
amniotic	B-UNK
-	O
fluid	B-UNK
cells	B-UNK
from	O
patient	B-UNK
2	O
showed	B-UNK
normal	B-UNK
levels	B-UNK
of	O
acid	O
lipase	B-UNK
with	O
all	O
substrates	B-UNK
tested	B-UNK
;	O
the	O
electrophoretic	B-UNK
pattern	B-UNK
of	O
acid	O
lipase	B-UNK
was	O
normal	B-UNK
.	O

 	O
the	O
results	B-UNK
suggest	B-UNK
that	O
the	O
prenatal	B-UNK
diagnosis	I-UNK
of	O
wolman	B-DISEASE
disease	I-DISEASE
be	O
made	O
using	O
the	O
radioassay	O
of	O
acid	O
lipase	B-UNK
and	O
/	O
or	O
electrophoresis	B-UNK
.	O
.	O

 	O
malignant	B-UNK
neoplasms	B-DISEASE
in	O
the	O
families	B-UNK
of	O
patients	B-UNK
with	O
ataxia	B-DISEASE
-	O
telangiectasia	B-DISEASE
.	O

 	O
ataxia	B-DISEASE
-	O
telangiectasia	B-DISEASE
(	O
a	O
-	O
t	B-UNK
)	O
is	O
an	O
autosomal	O
recessive	O
syndrome	B-DISEASE
associated	B-UNK
with	O
a	O
greatly	B-UNK
increased	I-UNK
incidence	O
of	O
malignant	B-UNK
neoplasms	B-DISEASE
in	O
homozygous	B-UNK
affected	B-UNK
individuals	I-UNK
.	O

 	O
heterozygotes	B-UNK
for	O
the	O
gene	B-UNK
for	O
a	O
-	O
t	B-UNK
are	O
thought	O
to	O
comprise	O
about	O
1	O
%	O
of	O
the	O
general	B-UNK
population	B-UNK
and	O
,	O
therefore	O
,	O
it	O
is	O
important	B-UNK
to	O
know	O
whether	O
this	O
gene	B-UNK
also	O
predisposes	O
the	O
heterozygous	B-UNK
carrier	B-UNK
to	O
cancers	B-DISEASE
.	O

 	B-UNK
heterozygous	I-UNK
carriers	B-UNK
of	O
this	O
gene	B-UNK
are	O
common	B-UNK
among	O
the	O
close	B-UNK
relatives	B-UNK
of	O
patients	B-UNK
with	O
a	O
-	O
t	B-UNK
,	O
although	O
individual	B-UNK
carriers	B-UNK
can	O
not	O
be	O
identified	B-UNK
by	O
any	O
clinical	B-UNK
criterion	O
or	O
laboratory	B-UNK
test	B-UNK
.	O

 	O
for	O
this	O
reason	O
,	O
we	O
compared	B-UNK
the	O
incidence	O
of	O
death	B-DISEASE
from	O
malignant	B-UNK
neoplasms	B-DISEASE
in	O
2	O
families	B-UNK
of	O
patients	B-UNK
with	O
a	O
-	O
t	B-UNK
to	O
that	O
expected	B-UNK
in	O
a	O
random	B-UNK
sample	B-UNK
of	O
the	O
general	B-UNK
population	B-UNK
.	O

 	O
there	O
were	O
59	O
deaths	B-DISEASE
from	O
malignant	B-UNK
neoplasms	B-DISEASE
in	O
relatives	B-UNK
dying	B-UNK
before	O
age	B-UNK
75	O
,	O
compared	B-UNK
to	O
42	O
.	O

 	O
6	O
expected	B-UNK
(	O
p	B-UNK
less	O
than	O
0	O
.	O
02	O
)	O
.	O

 	O
for	O
a	O
-	O
t	B-UNK
heterozygotes	B-UNK
younger	B-UNK
than	O
age	B-UNK
45	O
,	O
the	O
risk	B-UNK
of	O
dying	B-UNK
from	O
a	O
malignant	B-UNK
neoplasm	B-DISEASE
was	O
estimated	B-UNK
to	O
be	O
greater	B-UNK
than	O
5	O
times	B-UNK
the	O
risk	B-UNK
for	O
the	O
general	B-UNK
population	B-UNK
.	O

 	O
a	O
-	O
t	B-UNK
heterozygotes	B-UNK
may	O
comprise	O
more	O
than	O
5	O
%	O
of	O
all	O
persons	B-UNK
dying	B-UNK
from	O
a	O
cancer	B-DISEASE
before	O
age	B-UNK
45	O
.	O

 	O
the	O
incidence	O
of	O
ovarian	B-UNK
,	O
gastric	O
,	O
and	O
biliary	O
system	B-UNK
carcinomas	B-UNK
and	O
of	O
leukemia	B-DISEASE
and	O
lymphoma	B-DISEASE
was	O
increased	B-UNK
in	O
these	O
a	O
-	O
t	B-UNK
families	B-UNK
.	O

 	O
other	O
neoplasms	B-DISEASE
that	O
may	O
be	O
associated	B-UNK
with	O
this	O
gene	B-UNK
in	O
heterozygotes	B-UNK
include	B-UNK
pancreatic	O
,	O
basal	O
cell	B-UNK
,	O
colonic	O
,	O
breast	B-UNK
,	O
and	O
cervical	O
carcinomas	B-UNK
.	O

 	O
striking	B-UNK
prevalence	B-UNK
of	O
ankylosing	B-DISEASE
spondylitis	I-DISEASE
in	O
"	O
healthy	B-UNK
"	O
w27	O
positive	B-UNK
males	B-UNK
and	O
females	B-UNK
.	O

 	O
ankylosing	B-DISEASE
spondylitis	I-DISEASE
is	O
diagnosed	B-UNK
once	O
or	O
twice	O
in	O
each	O
1000	O
males	B-UNK
and	O
one	O
tenth	O
as	O
frequently	B-UNK
in	O
females	B-UNK
,	O
but	O
the	O
true	B-UNK
prevalence	B-UNK
is	O
unknown	B-UNK
.	O

 	O
indentification	O
of	O
genetic	B-UNK
marker	B-UNK
,	O
hl	O
-	O
a	O
w27	O
,	O
for	O
susceptible	B-UNK
persons	B-UNK
has	O
provided	B-UNK
a	O
tool	B-UNK
facilitating	O
epidemiologic	B-UNK
studies	B-UNK
and	O
allowing	B-UNK
identification	B-UNK
of	O
"	O
control	B-UNK
"	O
populations	B-UNK
without	O
the	O
marker	B-UNK
.	O

 	O
evaluation	B-UNK
by	O
postal	O
questionnaires	O
,	O
and	O
pelvic	O
radiography	O
of	O
78	O
hl	O
-	O
a	O
27w	O
-	O
positive	B-UNK
blood	B-UNK
donors	O
selected	B-UNK
from	O
a	O
group	B-UNK
of	O
apparently	B-UNK
healthy	B-UNK
subjects	B-UNK
revealed	B-UNK
14	O
who	O
satisfied	O
the	O
criteria	B-UNK
for	O
definite	O
ankylosing	B-DISEASE
spondylitis	I-DISEASE
.	O

 	O
the	O
prevalence	B-UNK
was	O
similar	B-UNK
in	O
both	O
sexes	O
.	O

 	O
one	O
hundred	O
and	O
twenty	O
-	O
six	O
w27	O
-	O
negative	B-UNK
controls	B-UNK
matched	B-UNK
for	O
race	O
,	O
sex	B-UNK
,	O
and	O
age	B-UNK
failed	B-UNK
to	O
yield	O
a	O
single	B-UNK
case	B-UNK
.	O

 	O
for	O
a	O
person	O
of	O
either	O
sex	B-UNK
with	O
hl	O
-	O
a	O
w27	O
,	O
there	O
appears	B-UNK
to	O
be	O
about	O
a	O
20	O
per	O
cent	O
chance	O
that	O
ankylosing	B-DISEASE
spondylitis	I-DISEASE
will	O
develop	B-UNK
,	O
suggesting	B-UNK
a	O
prevalence	B-UNK
of	O
10	O
to	O
15	O
per	O
thousand	O
.	O

 	O
hitherto	B-UNK
accepted	O
figures	O
may	O
underestimate	O
the	O
frequency	B-UNK
by	O
a	O
factor	B-UNK
of	O
10	O
to	O
20	O
.	O
.	O

 	O
analbuminemia	B-UNK
in	O
an	O
american	B-UNK
indian	B-UNK
girl	B-UNK
.	O

 	O
analbuminemia	B-UNK
was	O
fortuitously	O
detected	B-UNK
in	O
a	O
nonedematous	O
12	O
-	O
year	B-UNK
-	O
old	B-UNK
american	B-UNK
indian	B-UNK
girl	B-UNK
with	O
atopic	B-DISEASE
dermatitis	I-DISEASE
,	O
mild	B-UNK
bronchial	O
asthma	B-DISEASE
,	O
a	O
mild	B-UNK
seizure	B-DISEASE
disorder	I-DISEASE
,	O
and	O
hyperlipoproteinemia	B-DISEASE
with	O
a	O
corneal	O
arcus	O
.	O

 	O
immunologic	B-UNK
methods	B-UNK
revealed	B-UNK
trace	B-UNK
amounts	B-UNK
(	O
17	O
mg	O
/	O
100	O
ml	O
)	O
of	O
apparently	B-UNK
normal	I-UNK
serum	B-UNK
albumin	B-UNK
.	O

 	O
the	O
patients	B-UNK
parents	B-UNK
were	O
remotely	O
related	B-UNK
.	O

 	O
the	O
pedigree	B-UNK
and	O
clinical	B-UNK
findings	B-UNK
were	O
compatible	O
with	O
autosomal	O
recessive	O
transmission	B-UNK
of	O
analbuminemia	B-UNK
.	O

 	O
heterozygotes	B-UNK
had	O
subnormal	O
levels	B-UNK
of	O
serum	B-UNK
albumin	B-UNK
.	O

 	O
the	O
gc	B-UNK
-	O
locus	B-UNK
is	O
closely	B-UNK
linked	I-UNK
to	O
the	O
structural	B-UNK
albumin	B-UNK
locus	B-UNK
.	O

 	O
gc	B-UNK
-	O
protein	B-UNK
levels	B-UNK
were	O
normal	B-UNK
in	O
the	O
patient	B-UNK
and	O
together	O
with	O
normal	B-UNK
chromosomal	B-UNK
banding	B-UNK
studies	B-UNK
make	O
it	O
unlikely	O
that	O
a	O
chromosomal	B-UNK
deletion	B-UNK
caused	B-UNK
analbuminemia	B-UNK
.	O

 	O
gc	B-UNK
-	O
types	B-UNK
in	O
the	O
family	B-UNK
were	O
compatible	O
with	O
,	O
but	O
did	O
not	O
prove	O
,	O
linkage	B-UNK
of	O
analbuminemia	B-UNK
to	O
the	O
gc	B-UNK
-	O
locus	B-UNK
.	O

 	O
these	O
findings	B-UNK
suggest	B-UNK
a	O
"	O
thalassemia	B-DISEASE
"	O
-	O
like	B-UNK
mutation	B-UNK
for	O
this	O
disorder	O
.	O
.	O

 	O
deletion	B-UNK
of	O
the	O
kit	B-UNK
and	O
pdgfra	B-UNK
genes	B-UNK
in	O
a	O
patient	B-UNK
with	O
piebaldism	B-DISEASE
.	O

 	O
we	O
have	O
previously	B-UNK
shown	B-UNK
that	O
human	B-UNK
piebaldism	B-DISEASE
results	B-UNK
from	O
mutations	B-UNK
of	O
the	O
kit	B-UNK
gene	B-UNK
,	O
which	O
encodes	B-UNK
the	O
receptor	B-UNK
for	O
the	O
mast	O
/	O
stem	B-UNK
cell	I-UNK
growth	I-UNK
factor	B-UNK
and	O
is	O
located	B-UNK
in	O
chromosome	B-UNK
segment	B-UNK
4q12	O
.	O

 	O
using	O
dna	B-UNK
of	O
a	O
patient	B-UNK
with	O
piebaldism	B-DISEASE
,	O
mental	B-DISEASE
retardation	I-DISEASE
,	O
and	O
multiple	B-UNK
congenital	B-DISEASE
anomalies	B-UNK
associated	B-UNK
with	O
a	O
46	O
,	O
xy	O
,	O
del	O
(	O
4	O
)	O
(	O
q12q21	O
.	O
1	O
)	O
karyotype	B-UNK
,	O
we	O
carried	B-UNK
out	O
quantitative	B-UNK
southern	B-UNK
blot	I-UNK
hybridization	B-UNK
analyses	B-UNK
of	O
the	O
kit	B-UNK
gene	B-UNK
and	O
the	O
adjacent	B-UNK
pdgfra	B-UNK
(	O
platelet	B-UNK
-	O
derived	B-UNK
growth	B-UNK
factor	I-UNK
receptor	I-UNK
alpha	B-UNK
subunit	B-UNK
)	O
genes	B-UNK
.	O

 	O
the	O
patient	B-UNK
was	O
hemizygous	B-UNK
for	O
both	O
the	O
kit	B-UNK
and	O
pdgfra	B-UNK
genes	B-UNK
,	O
indicating	B-UNK
that	O
both	O
of	O
these	O
genes	B-UNK
are	O
included	B-UNK
within	O
the	O
deleted	B-UNK
region	B-UNK
.	O

 	O
therefore	O
,	O
deletion	B-UNK
of	O
the	O
kit	B-UNK
and	O
pdgfra	B-UNK
genes	B-UNK
may	O
account	B-UNK
for	O
the	O
piebald	O
phenotype	B-UNK
in	O
this	O
patient	B-UNK
.	O

 	O
a	O
germ	B-UNK
line	I-UNK
mutation	B-UNK
within	O
the	O
coding	B-UNK
sequence	B-UNK
for	O
the	O
putative	B-UNK
5	O
-	O
phosphoribosyl	O
-	O
1	O
-	O
pyrophosphate	O
binding	B-UNK
site	B-UNK
of	O
hypoxanthine	B-UNK
-	O
guanine	B-UNK
phosphoribosyltransferase	I-UNK
(	O
hprt	B-UNK
)	O
in	O
a	O
lesch	O
-	O
nyhan	B-UNK
patient	B-UNK
:	O
missense	B-UNK
mutations	I-UNK
within	O
a	O
functionally	B-UNK
important	I-UNK
region	B-UNK
probably	B-UNK
cause	B-UNK
disease	B-DISEASE
.	O

 	O
lesch	B-DISEASE
-	I-DISEASE
nyhan	I-DISEASE
syndrome	I-DISEASE
caused	B-UNK
by	O
a	O
complete	B-UNK
deficiency	B-UNK
of	O
hypoxanthine	B-UNK
guanine	B-UNK
phosphoribosyltransferase	I-UNK
(	O
hprt	B-UNK
)	O
is	O
the	O
result	B-UNK
of	O
a	O
heterogeneous	B-UNK
group	I-UNK
of	O
germ	B-UNK
line	I-UNK
mutations	I-UNK
.	O

 	O
identification	B-UNK
of	O
each	O
mutant	B-UNK
gene	B-UNK
provides	B-UNK
valuable	B-UNK
information	B-UNK
as	O
to	O
the	O
type	B-UNK
of	O
mutation	B-UNK
that	O
occurs	B-UNK
spontaneously	B-UNK
.	O

 	O
we	O
report	B-UNK
here	O
a	O
newly	B-UNK
identified	B-UNK
hprt	B-UNK
mutation	B-UNK
in	O
a	O
japanese	B-UNK
patient	B-UNK
with	O
lesch	B-DISEASE
-	I-DISEASE
nyhan	I-DISEASE
syndrome	I-DISEASE
.	O

 	O
this	O
gene	B-UNK
,	O
designated	B-UNK
hprt	B-UNK
tokyo	O
,	O
had	O
a	O
single	B-UNK
nucleotide	B-UNK
change	B-UNK
from	O
g	B-UNK
to	O
a	O
,	O
as	O
identified	B-UNK
by	O
sequencing	B-UNK
cdna	B-UNK
amplified	B-UNK
by	O
the	O
polymerase	B-UNK
chain	I-UNK
reaction	I-UNK
.	O

 	O
allele	B-UNK
specific	B-UNK
oligonucleotide	I-UNK
hybridization	B-UNK
analysis	B-UNK
using	O
amplified	B-UNK
genomic	I-UNK
dna	B-UNK
showed	B-UNK
that	O
the	O
mutant	B-UNK
gene	B-UNK
was	O
transmitted	B-UNK
from	O
the	O
maternal	B-UNK
germ	B-UNK
line	I-UNK
.	O

 	O
this	O
mutation	B-UNK
would	O
lead	B-UNK
to	O
an	O
amino	B-UNK
acid	I-UNK
substitution	I-UNK
of	O
asp	B-UNK
for	O
gly	B-UNK
at	B-DISEASE
the	O
amino	B-UNK
acid	I-UNK
position	B-UNK
140	O
located	B-UNK
within	O
the	O
putative	B-UNK
5	O
-	O
phosphoribosyl	O
-	O
1	O
-	O
pyrophosphate	O
(	O
prpp	O
)	O
binding	B-UNK
region	B-UNK
.	O

 	B-UNK
missense	I-UNK
mutations	B-UNK
in	O
human	B-UNK
hprt	B-UNK
deficient	B-UNK
patients	I-UNK
thus	O
far	B-UNK
reported	B-UNK
tend	O
to	O
accumulate	O
in	O
this	O
functionally	B-UNK
active	B-UNK
region	B-UNK
.	O

 	O
however	O
,	O
a	O
comparison	B-UNK
of	O
the	O
data	B-UNK
suggested	B-UNK
that	O
both	O
missense	B-UNK
and	O
synonymous	O
mutations	B-UNK
can	O
occur	B-UNK
at	B-DISEASE
any	O
coding	B-UNK
sequence	B-UNK
of	O
the	O
human	B-UNK
germ	B-UNK
line	I-UNK
hprt	B-UNK
gene	B-UNK
,	O
but	O
that	O
a	O
limited	B-UNK
percentage	B-UNK
of	O
all	O
the	O
missense	B-UNK
mutations	I-UNK
cause	B-UNK
disease	B-DISEASE
.	O

 	O
the	O
probability	O
that	O
a	O
mutation	B-UNK
will	O
cause	B-UNK
disease	B-DISEASE
tends	O
to	O
be	O
higher	B-UNK
when	O
the	O
missense	B-UNK
mutation	I-UNK
is	O
within	O
a	O
functionally	B-UNK
important	I-UNK
sequence	B-UNK
.	O
.	O

 	O
characterisation	O
of	O
a	O
new	B-UNK
rare	B-UNK
fragile	B-UNK
site	B-UNK
easily	O
confused	O
with	O
the	O
fragile	B-UNK
x	I-UNK
.	O

 	O
a	O
new	B-UNK
fragile	B-UNK
site	B-UNK
(	O
fraxe	O
)	O
in	O
xq28	B-UNK
is	O
described	B-UNK
.	O

 	O
it	O
appears	B-UNK
to	O
be	O
a	O
typical	B-UNK
folate	O
sensitive	B-UNK
fragile	B-UNK
site	B-UNK
.	O

 	O
the	O
fragile	B-UNK
site	B-UNK
is	O
not	O
associated	B-UNK
with	O
mental	B-DISEASE
retardation	I-DISEASE
,	O
it	O
does	O
not	O
give	O
abnormal	B-UNK
results	B-UNK
when	O
subjected	O
to	O
southern	O
analysis	B-UNK
with	O
probe	B-UNK
pfxa3	O
which	O
detects	O
the	O
unstable	B-UNK
dna	B-UNK
sequence	I-UNK
characteristic	B-UNK
of	O
fragile	B-DISEASE
x	I-DISEASE
syndrome	I-DISEASE
.	O

 	O
in	O
situ	B-UNK
hybridization	I-UNK
mapping	B-UNK
locates	O
the	O
fragile	B-UNK
site	B-UNK
between	O
150	O
kb	B-UNK
and	O
600	O
kb	B-UNK
distal	B-UNK
to	O
fraxa	O
.	O

 	O
the	O
distinction	O
between	O
the	O
two	O
fragile	B-UNK
sites	B-UNK
is	O
important	B-UNK
clinically	B-UNK
since	O
cytogenetic	B-UNK
detection	B-UNK
of	O
fraxe	O
,	O
without	O
molecular	B-UNK
analysis	B-UNK
,	O
could	O
result	B-UNK
in	O
misdiagnosis	O
of	O
fragile	B-DISEASE
x	I-DISEASE
syndrome	I-DISEASE
.	O
.	O

 	O
the	O
norrie	B-DISEASE
disease	I-DISEASE
gene	B-UNK
maps	B-UNK
to	O
a	O
150	O
kb	B-UNK
region	B-UNK
on	O
chromosome	B-UNK
xp11	B-UNK
.	O
3	O
.	O

 	O
norrie	B-DISEASE
disease	I-DISEASE
is	O
a	O
human	B-UNK
x	B-UNK
-	O
linked	B-UNK
recessive	O
disorder	O
of	O
unknown	B-UNK
etiology	B-UNK
characterized	B-UNK
by	O
congenital	B-DISEASE
blindness	B-DISEASE
,	O
sensory	O
neural	B-UNK
deafness	B-DISEASE
and	O
mental	B-DISEASE
retardation	I-DISEASE
.	O

 	O
this	O
disease	B-DISEASE
gene	B-UNK
was	O
previously	B-UNK
linked	B-UNK
to	O
the	O
dxs7	B-UNK
(	O
l1	O
.	O
28	O
)	O
locus	B-UNK
and	O
the	O
mao	B-UNK
genes	B-UNK
in	O
band	B-UNK
xp11	B-UNK
.	O

 	O
3	O
3	O
.	O

 	O
we	O
report	B-UNK
here	O
fine	B-UNK
physical	B-UNK
mapping	I-UNK
of	O
the	O
obligate	B-UNK
region	B-UNK
containing	I-UNK
the	O
norrie	B-DISEASE
disease	I-DISEASE
gene	B-UNK
(	O
ndp	B-UNK
)	O
defined	B-UNK
by	O
a	O
recombination	B-UNK
and	O
by	O
the	O
smallest	B-UNK
submicroscopic	B-UNK
chromosomal	B-UNK
deletion	B-UNK
associated	B-UNK
with	O
norrie	B-DISEASE
disease	I-DISEASE
identified	B-UNK
to	O
date	B-UNK
.	O

 	O
analysis	B-UNK
,	O
using	O
in	O
addition	B-UNK
two	O
overlapping	B-UNK
yac	B-UNK
clones	I-UNK
from	O
this	O
region	B-UNK
,	O
allowed	B-UNK
orientation	O
of	O
the	O
maoa	O
and	O
maob	B-UNK
genes	B-UNK
in	O
a	O
5	O
-	O
3	O
-	O
3	O
-	O
5	O
configuration	O
.	O

 	O
a	O
recombination	B-UNK
event	B-UNK
between	O
a	O
(	O
gt	B-UNK
)	O
n	B-UNK
polymorphism	O
in	O
intron	B-UNK
2	O
of	O
the	O
maob	B-UNK
gene	B-UNK
and	O
the	O
ndp	B-UNK
locus	B-UNK
,	O
in	O
a	O
family	B-UNK
previously	I-UNK
reported	B-UNK
to	O
have	O
a	O
recombination	B-UNK
between	O
dxs7	B-UNK
and	O
ndp	B-UNK
,	O
delineates	O
a	O
flanking	B-UNK
marker	B-UNK
telomeric	B-UNK
to	O
this	O
disease	B-DISEASE
gene	B-UNK
.	O

 	O
an	O
anonymous	B-UNK
dna	I-UNK
probe	B-UNK
,	O
dc12	O
,	O
present	B-UNK
in	O
one	O
of	O
the	O
yacs	B-UNK
and	O
in	O
a	O
patient	B-UNK
with	O
a	O
submicroscopic	B-UNK
deletion	I-UNK
which	O
includes	B-UNK
maoa	O
and	O
maob	B-UNK
but	O
not	O
l1	O
.	O

 	O
28	O
,	O
serves	O
as	O
a	O
flanking	B-UNK
marker	B-UNK
centromeric	B-UNK
to	O
the	O
disease	B-DISEASE
gene	B-UNK
.	O

 	O
an	O
alu	B-UNK
-	O
pcr	B-UNK
fragment	O
from	O
the	O
right	O
arm	B-UNK
of	O
the	O
mao	B-UNK
yac	B-UNK
(	O
ymao	O
.	O
alur	O
)	O
is	O
not	O
deleted	B-UNK
in	O
this	O
patient	B-UNK
and	O
also	O
delineates	O
the	O
centromeric	B-UNK
extent	B-UNK
of	O
the	O
obligate	B-UNK
disease	B-DISEASE
region	B-UNK
.	O

 	O
the	O
apparent	B-UNK
order	B-UNK
of	O
these	O
loci	B-UNK
is	O
telomere	O
.	O

 	O
dxs7	B-UNK
-	O
maoa	O
-	O
maob	B-UNK
-	O
ndp	B-UNK
-	O
dc12	O
-	O
ymao	O
dxs7	B-UNK
-	O
maoa	O
-	O
maob	B-UNK
-	O
ndp	B-UNK
-	O
dc12	O
-	O
ymao	O
.	O

 	O
alur	O
.	O
centromere	O
.	O

 	O
together	O
these	O
data	B-UNK
define	B-UNK
the	O
obligate	B-UNK
region	B-UNK
containing	I-UNK
the	O
ndp	B-UNK
gene	B-UNK
to	O
a	O
chromosomal	B-UNK
segment	B-UNK
less	O
than	O
150	O
kb	B-UNK
.	O

 	B-UNK
molecular	I-UNK
basis	B-UNK
of	O
phenylketonuria	B-DISEASE
and	O
related	B-UNK
hyperphenylalaninemias	O
:	O
mutations	B-UNK
and	O
polymorphisms	B-UNK
in	O
the	O
human	B-UNK
phenylalanine	B-UNK
hydroxylase	I-UNK
gene	B-UNK
.	O

 	O
mutations	B-UNK
in	O
the	O
human	B-UNK
phenylalanine	B-UNK
hydroxylase	I-UNK
gene	B-UNK
producing	B-UNK
phenylketonuria	B-DISEASE
or	O
hyperphenylalaninemia	B-DISEASE
have	O
now	O
been	O
identified	B-UNK
in	O
many	O
patients	B-UNK
from	O
various	O
ethnic	B-UNK
groups	B-UNK
.	O

 	O
these	O
mutations	B-UNK
all	O
exhibit	B-UNK
a	O
high	B-UNK
degree	B-UNK
of	O
association	B-UNK
with	O
specific	B-UNK
restriction	O
fragment	O
-	O
length	O
polymorphism	O
haplotypes	B-UNK
at	B-DISEASE
the	O
pah	B-UNK
locus	B-UNK
.	O

 	O
about	O
50	O
of	O
these	O
mutations	B-UNK
are	O
single	B-UNK
-	O
base	B-UNK
substitutions	B-UNK
,	O
including	B-UNK
six	O
nonsense	B-UNK
mutations	B-UNK
and	O
eight	O
splicing	B-UNK
mutations	B-UNK
,	O
with	O
the	O
remainder	O
being	O
missense	B-UNK
mutations	I-UNK
.	O

 	O
one	O
splicing	B-UNK
mutation	B-UNK
results	B-UNK
in	O
a	O
3	O
amino	B-UNK
acid	I-UNK
in	O
-	O
frame	B-UNK
insertion	B-UNK
.	O

 	O
two	O
or	O
3	O
large	B-UNK
deletions	B-UNK
,	O
2	O
single	B-UNK
codon	B-UNK
deletions	B-UNK
,	O
and	O
2	O
single	B-UNK
base	B-UNK
deletions	B-UNK
have	O
been	O
found	B-UNK
.	O

 	O
twelve	O
of	O
the	O
missense	B-UNK
mutations	I-UNK
apparently	B-UNK
result	B-UNK
from	O
the	O
methylation	B-UNK
and	O
subsequent	B-UNK
deamination	O
of	O
highly	B-UNK
mutagenic	O
cpg	B-UNK
dinucleotides	O
.	O

 	B-UNK
recurrent	I-UNK
mutation	B-UNK
has	O
been	O
observed	B-UNK
at	B-DISEASE
several	O
of	O
these	O
sites	B-UNK
,	O
producing	B-UNK
associations	B-UNK
with	O
different	B-UNK
haplotypes	B-UNK
in	O
different	B-UNK
populations	B-UNK
.	O

 	O
about	O
half	B-UNK
of	O
all	O
missense	B-UNK
mutations	I-UNK
have	O
been	O
examined	B-UNK
by	O
in	O
vitro	B-UNK
expression	I-UNK
analysis	B-UNK
,	O
and	O
a	O
significant	B-UNK
correlation	B-UNK
has	O
been	O
observed	B-UNK
between	O
residual	B-UNK
pah	B-UNK
activity	B-UNK
and	O
disease	B-DISEASE
phenotype	B-UNK
.	O

 	O
since	O
continuing	O
advances	O
in	O
molecular	B-UNK
methodologies	O
have	O
dramatically	B-UNK
accelerated	B-UNK
the	O
rate	B-UNK
in	O
which	O
new	B-UNK
mutations	B-UNK
are	O
being	O
identified	B-UNK
and	O
characterized	B-UNK
,	O
this	O
register	O
of	O
mutations	B-UNK
will	O
be	O
updated	O
periodically	O
.	O
.	O

 	O
a	O
glycine250	O
-	O
-	O
>	O
aspartate	O
substitution	B-UNK
in	O
the	O
alpha	B-UNK
-	O
subunit	B-UNK
of	O
hexosaminidase	O
a	O
causes	B-UNK
juvenile	B-UNK
-	O
onset	B-UNK
tay	B-DISEASE
-	I-DISEASE
sachs	I-DISEASE
disease	I-DISEASE
in	O
a	O
lebanese	O
-	O
canadian	B-UNK
family	B-UNK
.	O

 	O
the	O
mutation	B-UNK
causing	B-UNK
juvenile	B-UNK
tay	B-DISEASE
-	I-DISEASE
sachs	I-DISEASE
disease	I-DISEASE
(	O
tsd	B-UNK
)	O
in	O
two	O
sibs	B-UNK
of	O
lebanese	O
-	O
maronite	O
origin	B-UNK
is	O
described	B-UNK
.	O

 	O
an	O
mrna	B-UNK
-	O
containing	B-UNK
extract	O
of	O
cultured	B-UNK
fibroblasts	B-UNK
obtained	B-UNK
from	O
one	O
of	O
the	O
probands	B-UNK
was	O
used	O
as	O
a	O
template	O
to	O
amplify	O
the	O
coding	B-UNK
sequence	B-UNK
of	O
the	O
hexosaminidase	O
a	O
(	O
hex	O
a	O
)	O
alpha	B-UNK
-	O
subunit	B-UNK
.	O

 	O
sequencing	B-UNK
of	O
amplified	B-UNK
cdna	B-UNK
fragments	B-UNK
revealed	B-UNK
a	O
single	B-UNK
alteration	B-UNK
,	O
guanine	B-UNK
to	O
adenine	O
at	B-DISEASE
nt	O
749	O
creating	B-UNK
a	O
g250d	O
mutation	B-UNK
.	O

 	O
the	O
mutation	B-UNK
introduces	B-UNK
a	O
new	B-UNK
recognition	B-UNK
site	B-UNK
for	O
the	O
restriction	O
enzyme	B-UNK
eco	O
rv	O
,	O
permitting	O
identification	B-UNK
of	O
heterozygotes	B-UNK
for	O
this	O
allele	B-UNK
following	B-UNK
pcr	B-UNK
amplification	I-UNK
and	O
eco	O
rv	O
digestion	B-UNK
of	O
exon	B-UNK
7	O
sequences	B-UNK
from	O
genomic	B-UNK
dna	I-UNK
templates	O
.	O

 	O
in	O
order	B-UNK
to	O
test	B-UNK
the	O
effect	B-UNK
of	O
this	O
substitution	B-UNK
,	O
an	O
in	O
vitro	B-UNK
mutagenized	O
cdna	B-UNK
construct	B-UNK
was	O
introduced	O
into	O
a	O
mammalian	B-UNK
expression	B-UNK
vector	I-UNK
and	O
transfected	B-UNK
into	O
monkey	O
cos	B-UNK
-	O
1	O
cells	B-UNK
separately	B-UNK
or	O
along	O
with	O
a	O
beta	B-UNK
-	O
cdna	B-UNK
expression	B-UNK
vector	I-UNK
.	O

 	O
when	O
the	O
mutant	B-UNK
alpha	B-UNK
-	O
cdna	B-UNK
was	O
the	O
only	O
gene	B-UNK
introduced	O
into	O
cos	B-UNK
cells	B-UNK
no	O
enzymatic	B-UNK
activity	I-UNK
above	O
endogenous	B-UNK
cos	B-UNK
cell	B-UNK
activity	B-UNK
was	O
detected	B-UNK
.	O

 	O
cotransfection	O
of	O
normal	B-UNK
alpha	B-UNK
-	O
cdna	B-UNK
and	O
beta	B-UNK
-	O
cdna	B-UNK
followed	B-UNK
by	O
immunoprecipitation	O
of	O
human	B-UNK
hex	O
a	O
resulted	B-UNK
in	O
20	O
-	O
fold	B-UNK
increase	B-UNK
in	O
the	O
ratio	B-UNK
between	O
positive	B-UNK
and	O
negative	B-UNK
(	O
mock	O
transfection	O
)	O
control	B-UNK
values	B-UNK
.	O

 	O
this	O
allowed	B-UNK
the	O
detection	B-UNK
of	O
some	O
residual	B-UNK
activity	B-UNK
(	O
12	O
%	O
of	O
the	O
positive	B-UNK
control	B-UNK
)	O
when	O
the	O
mutant	B-UNK
alpha	B-UNK
-	O
cdna	B-UNK
replaced	O
its	O
wild	B-UNK
-	O
type	B-UNK
counterpart	O
.	O

 	O
the	O
predicted	B-UNK
protein	B-UNK
environment	B-UNK
in	O
which	O
the	O
mutation	B-UNK
occurs	B-UNK
is	O
compared	B-UNK
to	O
that	O
of	O
the	O
adult	B-UNK
-	O
onset	B-UNK
tay	B-DISEASE
-	I-DISEASE
sachs	I-DISEASE
disease	I-DISEASE
mutation	B-UNK
caused	B-UNK
by	O
a	O
gly269	O
-	O
-	O
>	O
ser	B-UNK
substitution	B-UNK
in	O
exon	B-UNK
7	O
.	O

 	O
(	O
abstract	B-UNK
truncated	B-UNK
at	B-DISEASE
250	O
words	O
)	O
.	O

 	B-UNK
novel	I-UNK
tay	B-DISEASE
-	I-DISEASE
sachs	I-DISEASE
disease	I-DISEASE
mutations	B-UNK
from	O
china	O
.	O

 	O
we	O
describe	B-UNK
three	O
hexa	B-UNK
mutations	B-UNK
associated	B-UNK
with	O
infantile	B-UNK
tay	B-DISEASE
-	I-DISEASE
sachs	I-DISEASE
disease	I-DISEASE
(	O
tsd	B-UNK
)	O
in	O
three	O
unrelated	B-UNK
nonconsanguineous	O
chinese	B-UNK
families	B-UNK
.	O

 	B-UNK
novel	I-UNK
mutations	B-UNK
were	O
found	B-UNK
in	O
two	O
of	O
these	O
families	B-UNK
.	O

 	O
the	O
third	O
is	O
a	O
previously	B-UNK
reported	I-UNK
mutation	B-UNK
(	O
g	B-UNK
-	O
-	O
>	O
a	O
transition	B-UNK
at	B-DISEASE
nt	O
1444	O
)	O
(	O
nakano	O
et	O
al	O
.	O
,	O
1988	O
)	O
.	O

 	B-UNK
direct	I-UNK
sequencing	B-UNK
of	O
pcr	B-UNK
products	B-UNK
identified	B-UNK
a	O
novel	B-UNK
insertion	B-UNK
of	O
an	O
a	O
after	O
nt	O
547	O
in	O
family	B-UNK
1	O
.	O

 	O
this	O
change	B-UNK
generates	B-UNK
an	O
early	B-UNK
termination	B-UNK
codon	I-UNK
6	O
bp	B-UNK
downstream	B-UNK
from	O
the	O
insertion	B-UNK
site	B-UNK
.	O

 	O
allele	B-UNK
-	O
specific	B-UNK
oligonucleotide	I-UNK
hybridization	B-UNK
confirmed	B-UNK
homozygosity	B-UNK
in	O
the	O
proband	B-UNK
.	O

 	O
single	B-UNK
strand	I-UNK
conformational	I-UNK
polymorphism	O
analysis	B-UNK
and	O
direct	B-UNK
sequencing	I-UNK
of	O
amplified	B-UNK
exon	B-UNK
13	O
revealed	B-UNK
a	O
t	B-UNK
-	O
-	O
>	O
c	B-UNK
transition	B-UNK
at	B-DISEASE
nt	O
1453	O
with	O
the	O
corresponding	B-UNK
amino	B-UNK
acid	I-UNK
substitution	I-UNK
w485r	O
in	O
the	O
second	B-UNK
family	B-UNK
.	O

 	O
this	O
mutation	B-UNK
creates	O
an	O
fnu4hi	O
restriction	O
site	B-UNK
.	O

 	O
the	O
proband	B-UNK
is	O
homozygous	B-UNK
for	O
this	O
allele	B-UNK
.	O

 	O
when	O
the	O
site	B-UNK
-	O
specific	B-UNK
mutagenized	O
alpha	B-UNK
cdna	B-UNK
carrying	B-UNK
the	O
t	B-UNK
-	O
-	O
>	O
c	B-UNK
transition	B-UNK
at	B-DISEASE
nt	O
1453	O
was	O
expressed	B-UNK
in	O
cos	B-UNK
1	O
cells	B-UNK
hexosaminidase	O
s	O
activity	B-UNK
was	O
not	O
detectable	B-UNK
above	O
background	B-UNK
.	O

 	O
a	O
g	B-UNK
-	O
-	O
>	O
a	O
transition	B-UNK
at	B-DISEASE
nt	O
1444	O
(	O
exon	B-UNK
13	O
)	O
corresponding	B-UNK
to	O
the	O
e482k	O
substitution	B-UNK
was	O
found	B-UNK
in	O
the	O
third	O
family	B-UNK
.	O

 	O
this	O
mutation	B-UNK
occurs	B-UNK
at	B-DISEASE
a	O
cpg	B-UNK
dinucleotide	B-UNK
.	O

 	O
it	O
has	O
been	O
reported	B-UNK
in	O
an	O
italian	B-UNK
tsd	B-UNK
proband	B-UNK
and	O
causes	B-UNK
defective	B-UNK
intracellular	B-UNK
transport	B-UNK
of	O
the	O
alpha	B-UNK
-	O
subunit	B-UNK
from	O
the	O
rough	O
endoplasmic	O
reticulum	O
to	O
the	O
golgi	O
apparatus	O
.	O

 	O
two	O
missense	B-UNK
mutations	I-UNK
causing	B-UNK
mild	B-UNK
hyperphenylalaninemia	B-DISEASE
associated	B-UNK
with	O
dna	B-UNK
haplotype	B-UNK
12	O
.	O

 	O
the	O
genetic	B-UNK
defects	B-UNK
responsible	B-UNK
for	O
most	O
phenylketonuria	B-DISEASE
(	O
pku	B-DISEASE
)	O
and	O
hyperphenylalaninemia	B-DISEASE
(	O
hpa	O
)	O
cases	B-UNK
are	O
located	B-UNK
in	O
the	O
phenylalanine	B-UNK
hydroxylase	I-UNK
(	O
pah	B-UNK
)	O
gene	B-UNK
.	O

 	O
approximately	B-UNK
50	O
-	O
60	O
mutations	B-UNK
have	O
been	O
reported	B-UNK
in	O
caucasians	B-UNK
and	O
are	O
reflected	O
in	O
a	O
wide	B-UNK
range	B-UNK
of	O
clinical	B-UNK
severities	O
.	O

 	O
most	O
mutations	B-UNK
are	O
linked	B-UNK
to	O
specific	B-UNK
haplotypes	B-UNK
,	O
as	O
defined	B-UNK
by	O
eight	O
polymorphic	B-UNK
restriction	O
sites	B-UNK
in	O
the	O
pah	B-UNK
gene	B-UNK
.	O

 	O
we	O
hypothesized	O
that	O
there	O
is	O
at	B-DISEASE
least	O
one	O
mild	B-UNK
mutation	B-UNK
linked	B-UNK
to	O
haplotype	B-UNK
12	O
in	O
the	O
swedish	B-UNK
pku	B-DISEASE
/	O
hpa	O
population	B-UNK
,	O
since	O
7	O
of	O
8	O
patients	B-UNK
carrying	B-UNK
haplotype	B-UNK
12	O
had	O
mild	B-UNK
hpa	O
.	O

 	O
sequence	B-UNK
analysis	B-UNK
revealed	B-UNK
a	O
c	B-UNK
-	O
to	O
-	O
g	B-UNK
transversion	B-UNK
at	B-DISEASE
the	O
second	B-UNK
base	B-UNK
of	O
codon	B-UNK
322	O
,	O
resulting	B-UNK
in	O
a	O
substitution	B-UNK
of	O
glycine	B-UNK
for	O
alanine	O
,	O
in	O
four	O
mutant	B-UNK
haplotype	B-UNK
12	O
genes	B-UNK
,	O
and	O
a	O
g	B-UNK
-	O
to	O
-	O
a	O
transition	B-UNK
at	B-DISEASE
the	O
second	B-UNK
base	B-UNK
of	O
codon	B-UNK
408	O
,	O
resulting	B-UNK
in	O
a	O
substitution	B-UNK
of	O
glutamine	B-UNK
for	O
arginine	B-UNK
,	O
in	O
another	O
three	O
mutant	B-UNK
haplotype	B-UNK
12	O
genes	B-UNK
.	O

 	O
these	O
mutations	B-UNK
segregated	B-UNK
with	O
mutant	B-UNK
haplotype	B-UNK
12	O
alleles	B-UNK
in	O
nuclear	B-UNK
families	B-UNK
but	O
were	O
not	O
present	B-UNK
on	O
normal	B-UNK
or	O
other	O
mutant	B-UNK
alleles	I-UNK
.	O

 	O
both	O
mutations	B-UNK
were	O
tested	B-UNK
in	O
a	O
eukaryotic	B-UNK
expression	B-UNK
system	B-UNK
in	O
which	O
enzyme	B-UNK
activities	B-UNK
of	O
different	B-UNK
mutant	B-UNK
pah	I-UNK
enzymes	B-UNK
reflect	B-UNK
the	O
relative	B-UNK
severities	O
of	O
the	O
mutations	B-UNK
,	O
although	O
these	O
in	O
vitro	B-UNK
activities	B-UNK
can	O
not	O
be	O
translated	B-UNK
directly	B-UNK
into	O
in	O
vivo	B-UNK
hepatic	B-UNK
activities	B-UNK
.	O

 	O
the	O
a322	O
g	B-UNK
mutant	B-UNK
pah	I-UNK
had	O
about	O
75	O
%	O
and	O
the	O
r408q	O
mutant	B-UNK
pah	I-UNK
about	O
55	O
%	O
of	O
the	O
wild	B-UNK
-	O
type	B-UNK
pah	B-UNK
enzyme	B-UNK
activity	I-UNK
.	O

 	O
these	O
in	O
vitro	B-UNK
activities	B-UNK
are	O
the	O
highest	B-UNK
reported	B-UNK
for	O
mutant	B-UNK
pah	I-UNK
enzymes	B-UNK
produced	B-UNK
in	O
the	O
same	O
expression	B-UNK
system	B-UNK
.	O

 	O
(	O
abstract	B-UNK
truncated	B-UNK
at	B-DISEASE
250	O
words	O
)	O
.	O

 	O
in	O
vitro	B-UNK
and	O
in	O
vivo	B-UNK
correlations	B-UNK
for	O
i65	B-UNK
t	B-UNK
and	O
m1v	O
mutations	B-UNK
at	B-DISEASE
the	O
phenylalanine	B-UNK
hydroxylase	I-UNK
locus	B-UNK
.	O

 	O
mutations	B-UNK
at	B-DISEASE
the	O
phenylalanine	B-UNK
hydroxylase	I-UNK
(	O
pah	B-UNK
)	O
locus	B-UNK
are	O
the	O
major	B-UNK
cause	B-UNK
of	O
hyperphenylalaninemia	B-DISEASE
.	O

 	O
we	O
have	O
previously	B-UNK
described	I-UNK
four	O
mutations	B-UNK
(	O
m1v	O
,	O
ivs12nt1	O
,	O
r408w	O
,	O
and	O
s349p	O
)	O
at	B-DISEASE
the	O
pah	B-UNK
locus	B-UNK
in	O
french	B-UNK
canadians	O
with	O
ancestry	B-UNK
in	O
eastern	B-UNK
quebec	O
.	O

 	O
here	O
we	O
report	B-UNK
(	O
1	O
)	O
identification	B-UNK
of	O
another	O
mutation	B-UNK
,	O
on	O
a	O
haplotype	B-UNK
9	O
chromosome	B-UNK
,	O
which	O
converts	B-UNK
codon	B-UNK
65	O
from	O
isoleucine	O
(	O
att	O
)	O
to	O
threonine	B-UNK
(	O
act	B-UNK
)	O
,	O
(	O
2	O
)	O
expression	B-UNK
analysis	B-UNK
of	O
the	O
i65	B-UNK
t	B-UNK
mutation	B-UNK
in	O
cos	B-UNK
cells	B-UNK
demonstrating	B-UNK
75	O
%	O
loss	B-UNK
of	O
both	O
immunoreactive	B-UNK
protein	B-UNK
and	O
enzyme	B-UNK
activity	I-UNK
,	O
and	O
(	O
3	O
)	O
expression	B-UNK
analysis	B-UNK
of	O
the	O
most	O
prevalent	B-UNK
pku	B-DISEASE
allele	B-UNK
(	O
m1v	O
)	O
in	O
eastern	B-UNK
quebec	O
,	O
showing	B-UNK
nondetectable	O
levels	B-UNK
of	O
pah	B-UNK
protein	B-UNK
and	O
activity	B-UNK
,	O
a	O
finding	B-UNK
compatible	O
with	O
a	O
mutation	B-UNK
in	O
the	O
translation	B-UNK
initiation	I-UNK
codon	B-UNK
.	O

 	O
homozygosity	B-UNK
for	O
m1v	O
and	O
codominant	B-UNK
inheritance	B-UNK
of	O
i65	B-UNK
t	B-UNK
/	O
r408w	O
were	O
both	O
associated	B-UNK
with	O
classical	B-UNK
phenylketonuria	B-DISEASE
.	O
.	O

 	B-UNK
molecular	I-UNK
basis	B-UNK
of	O
hexosaminidase	B-DISEASE
a	I-DISEASE
deficiency	I-DISEASE
and	O
pseudodeficiency	O
in	O
the	O
berks	O
county	O
pennsylvania	B-UNK
dutch	I-UNK
.	O

 	O
following	B-UNK
the	O
birth	O
of	O
two	O
infants	O
with	O
tay	B-DISEASE
-	I-DISEASE
sachs	I-DISEASE
disease	I-DISEASE
(	O
tsd	B-UNK
)	O
,	O
a	O
non	B-UNK
-	O
jewish	B-UNK
,	O
pennsylvania	B-UNK
dutch	I-UNK
kindred	B-UNK
was	O
screened	O
for	O
tsd	B-UNK
carriers	B-UNK
using	O
the	O
biochemical	B-UNK
assay	B-UNK
.	O

 	O
a	O
high	B-UNK
frequency	B-UNK
of	O
individuals	B-UNK
who	O
appeared	B-UNK
to	O
be	O
tsd	B-UNK
heterozygotes	B-UNK
was	O
detected	B-UNK
(	O
kelly	O
et	O
al	O
.	O
,	O
1975	O
)	O
.	O

 	B-UNK
clinical	I-UNK
and	O
biochemical	B-UNK
evidence	B-UNK
suggested	B-UNK
that	O
the	O
increased	B-UNK
carrier	B-UNK
frequency	I-UNK
was	O
due	O
to	O
at	B-DISEASE
least	O
two	O
altered	B-UNK
alleles	B-UNK
for	O
the	O
hexosaminidase	O
a	O
alpha	B-UNK
-	O
subunit	B-UNK
.	O

 	O
we	O
now	O
report	B-UNK
two	O
mutant	B-UNK
alleles	I-UNK
in	O
this	O
pennsylvania	B-UNK
dutch	I-UNK
kindred	B-UNK
,	O
and	O
one	O
polymorphism	O
.	O

 	O
one	O
allele	B-UNK
,	O
reported	B-UNK
originally	B-UNK
in	O
a	O
french	B-UNK
tsd	B-UNK
patient	B-UNK
(	O
akli	O
et	O
al	O
.	O
,	O
1991	O
)	O
,	O
is	O
a	O
gt	B-UNK
-	O
-	O
>	O
at	B-DISEASE
transition	B-UNK
at	B-DISEASE
the	O
donor	O
splice	O
-	O
site	B-UNK
of	O
intron	B-UNK
9	O
.	O

 	O
the	O
second	B-UNK
,	O
a	O
c	B-UNK
-	O
-	O
>	O
t	B-UNK
transition	I-UNK
at	B-DISEASE
nucleotide	B-UNK
739	O
(	O
arg247trp	O
)	O
,	O
has	O
been	O
shown	B-UNK
by	O
triggs	O
-	O
raine	O
et	O
al	O
.	O

 	O
(	O
1992	O
)	O
to	O
be	O
a	O
clinically	B-UNK
benign	B-UNK
"	O
pseudodeficient	O
"	O
allele	B-UNK
associated	B-UNK
with	O
reduced	B-UNK
enzyme	B-UNK
activity	I-UNK
against	O
artificial	O
substrate	B-UNK
.	O

 	O
finally	B-UNK
,	O
a	O
polymorphism	O
[	O
g	B-UNK
-	O
-	O
>	O
a	O
(	O
759	O
)	O
]	O
,	O
which	O
leaves	O
valine	O
at	B-DISEASE
codon	B-UNK
253	O
unchanged	O
,	O
is	O
described	B-UNK
.	O

 	O
a	O
mutation	B-UNK
common	B-UNK
in	O
non	B-UNK
-	O
jewish	B-UNK
tay	B-DISEASE
-	I-DISEASE
sachs	I-DISEASE
disease	I-DISEASE
:	O
frequency	B-UNK
and	O
rna	B-UNK
studies	B-UNK
.	O

 	O
tay	B-DISEASE
-	I-DISEASE
sachs	I-DISEASE
disease	I-DISEASE
(	O
tsd	B-UNK
)	O
is	O
an	O
autosomal	B-UNK
recessive	I-UNK
genetic	I-UNK
disorder	I-UNK
resulting	B-UNK
from	O
mutation	B-UNK
of	O
the	O
hexa	B-UNK
gene	B-UNK
encoding	B-UNK
the	O
alpha	B-UNK
-	O
subunit	B-UNK
of	O
the	O
lysosomal	B-UNK
enzyme	B-UNK
,	O
beta	B-UNK
-	O
n	B-UNK
-	O
acetylhexosaminidase	O
a	O
(	O
hex	O
a	O
)	O
.	O

 	O
we	O
have	O
discovered	O
that	O
a	O
tay	O
-	O
sachs	B-UNK
mutation	B-UNK
,	O
ivs	O
-	O
9	O
+	O
1	O
g	B-UNK
-	O
-	O
>	O
a	O
,	O
first	O
detected	B-UNK
by	O
akli	O
et	O
al	O
.	O

 	O
(	O
genomics	O
11	O
124	O
-	O
134	O
,	O
1991	O
)	O
,	O
is	O
a	O
common	B-UNK
disease	B-DISEASE
allele	B-UNK
in	O
non	B-UNK
-	O
jewish	B-UNK
caucasians	B-UNK
(	O
10	O
/	O
58	O
alleles	B-UNK
examined	B-UNK
)	O
.	O

 	O
a	O
pcr	B-UNK
-	O
based	B-UNK
diagnostic	I-UNK
test	B-UNK
,	O
which	O
detects	O
an	O
nlaiii	O
site	B-UNK
generated	B-UNK
by	O
the	O
mutation	B-UNK
,	O
revealed	B-UNK
a	O
frequency	B-UNK
among	O
enzyme	B-UNK
-	O
defined	B-UNK
carriers	B-UNK
of	O
9	O
/	O
64	O
(	O
14	O
%	O
)	O
.	O

 	O
most	O
of	O
those	O
carrying	B-UNK
the	O
allele	B-UNK
trace	B-UNK
their	O
origins	B-UNK
to	O
the	O
united	B-UNK
kingdom	O
,	O
ireland	O
,	O
or	O
western	B-UNK
europe	B-UNK
.	O

 	O
it	O
was	O
not	O
identified	B-UNK
among	O
12	O
black	B-UNK
american	I-UNK
tsd	B-UNK
alleles	I-UNK
or	O
in	O
any	O
of	O
18	O
ashkenazi	B-UNK
jewish	I-UNK
,	O
enzyme	B-UNK
-	O
defined	B-UNK
carriers	B-UNK
who	O
did	O
not	O
carry	B-UNK
any	O
of	O
the	O
mutations	B-UNK
common	B-UNK
to	O
this	O
population	B-UNK
.	O

 	O
no	O
normally	B-UNK
spliced	I-UNK
rna	B-UNK
was	O
detected	B-UNK
in	O
pcr	B-UNK
products	B-UNK
generated	B-UNK
from	O
reverse	B-UNK
transcription	B-UNK
of	O
rna	B-UNK
carrying	B-UNK
the	O
ivs	O
-	O
9	O
mutation	B-UNK
.	O

 	O
instead	B-UNK
,	O
the	O
low	B-UNK
levels	B-UNK
of	O
mrna	B-UNK
from	O
this	O
allele	B-UNK
were	O
comprised	O
of	O
aberrant	B-UNK
species	B-UNK
resulting	B-UNK
from	O
the	O
use	B-UNK
of	O
either	O
of	O
two	O
cryptic	O
donor	O
sites	B-UNK
,	O
one	O
truncating	B-UNK
exon	B-UNK
9	O
and	O
the	O
other	O
within	O
ivs	O
-	O
9	O
,	O
spliced	O
to	O
exon	B-UNK
10	O
.	O

 	O
numerous	B-UNK
additional	B-UNK
splice	O
products	B-UNK
were	O
detected	B-UNK
,	O
most	O
involving	B-UNK
skipping	B-UNK
of	O
one	O
or	O
more	O
surrounding	B-UNK
exons	B-UNK
.	O

 	O
together	O
with	O
a	O
recently	B-UNK
identified	B-UNK
allele	B-UNK
responsible	B-UNK
for	O
hex	O
a	O
pseudodeficiency	O
(	O
triggs	O
-	O
raine	O
et	O
al	O
.	O
am	O
j	B-UNK
hum	B-UNK
genet	B-UNK
,	O
1992	O
)	O
,	O
these	O
two	O
alleles	B-UNK
accounted	B-UNK
for	O
almost	O
50	O
%	O
(	O
29	O
/	O
64	O
)	O
of	O
tsd	B-UNK
or	O
carrier	B-UNK
alleles	B-UNK
ascertained	B-UNK
by	O
enzyme	B-UNK
screening	B-UNK
tests	B-UNK
in	O
non	B-UNK
-	O
jewish	B-UNK
caucasians	B-UNK
.	O
.	O

 	B-UNK
aberrant	I-UNK
splicing	B-UNK
of	O
the	O
chm	B-UNK
gene	B-UNK
is	O
a	O
significant	B-UNK
cause	B-UNK
of	O
choroideremia	B-DISEASE
.	O

 	O
choroideremia	B-DISEASE
(	O
chm	B-UNK
)	O
is	O
an	O
x	B-UNK
-	O
linked	B-UNK
progressive	B-UNK
degeneration	B-UNK
of	O
the	O
choroid	O
and	O
retina	O
.	O

 	O
12	O
%	O
of	O
unrelated	B-UNK
male	B-UNK
patients	I-UNK
carry	B-UNK
deletions	B-UNK
of	O
the	O
partially	B-UNK
cloned	B-UNK
chm	B-UNK
gene	B-UNK
.	O

 	O
in	O
finland	B-UNK
,	O
there	O
are	O
more	O
than	O
120	O
living	B-UNK
chm	B-UNK
patients	B-UNK
belonging	O
to	O
eight	O
apparently	B-UNK
unrelated	B-UNK
pedigrees	B-UNK
.	O

 	B-UNK
molecular	I-UNK
deletions	B-UNK
involving	I-UNK
the	O
chm	B-UNK
gene	B-UNK
have	O
been	O
detected	B-UNK
in	O
three	O
families	B-UNK
.	O

 	O
we	O
have	O
screened	O
the	O
remaining	B-UNK
five	O
families	B-UNK
for	O
point	B-UNK
mutations	I-UNK
.	O

 	O
in	O
one	O
large	B-UNK
family	B-UNK
a	O
single	B-UNK
nucleotide	B-UNK
(	O
t	B-UNK
)	O
insertion	B-UNK
into	O
the	O
donor	B-UNK
splice	I-UNK
site	I-UNK
of	O
exon	B-UNK
c	B-UNK
leads	B-UNK
to	O
two	O
aberrantly	B-UNK
spliced	O
mrnas	B-UNK
both	O
producing	B-UNK
a	O
premature	B-UNK
stop	B-UNK
codon	B-UNK
.	O

 	O
the	O
mutation	B-UNK
can	O
be	O
assayed	O
easily	O
by	O
amplification	B-UNK
and	O
digestion	B-UNK
with	O
msel	O
.	O

 	O
our	O
findings	B-UNK
provide	I-UNK
additional	B-UNK
evidence	I-UNK
for	O
the	O
pathogenetic	B-UNK
role	B-UNK
of	O
chm	B-UNK
mutations	B-UNK
and	O
provide	B-UNK
a	O
diagnostic	B-UNK
tool	B-UNK
for	O
one	O
fifth	B-UNK
of	O
the	O
worlds	O
known	B-UNK
chm	B-UNK
patients	B-UNK
.	O
.	O

 	B-UNK
germline	I-UNK
intronic	B-UNK
and	O
exonic	B-UNK
mutations	B-UNK
in	O
the	O
wilms	B-UNK
'	O
tumour	B-UNK
gene	B-UNK
(	O
wt1	B-UNK
)	O
affecting	B-UNK
urogenital	B-UNK
development	B-UNK
.	O

 	O
denys	B-DISEASE
-	I-DISEASE
drash	I-DISEASE
syndrome	I-DISEASE
is	O
a	O
rare	B-UNK
human	B-UNK
developmental	B-UNK
disorder	O
affecting	B-UNK
the	O
urogenital	B-UNK
system	B-UNK
and	O
leading	B-UNK
to	O
renal	B-DISEASE
failure	I-DISEASE
,	O
intersex	O
disorders	B-UNK
and	O
wilms	B-UNK
tumour	B-UNK
.	O

 	O
in	O
this	O
report	B-UNK
,	O
four	O
individuals	B-UNK
with	O
this	O
syndrome	B-DISEASE
are	O
described	B-UNK
carrying	B-UNK
germline	B-UNK
point	B-UNK
mutations	I-UNK
in	O
the	O
wilms	B-UNK
tumour	B-UNK
suppressor	I-UNK
gene	B-UNK
,	O
wt1	B-UNK
.	O

 	O
three	O
of	O
these	O
mutations	B-UNK
were	O
in	O
the	O
zinc	B-DISEASE
finger	B-UNK
domains	B-UNK
of	O
wt1	B-UNK
.	O

 	O
the	O
fourth	B-UNK
occurred	B-UNK
within	O
intron	B-UNK
9	O
,	O
preventing	O
splicing	B-UNK
at	B-DISEASE
one	O
of	O
the	O
alternatively	O
chosen	O
splice	B-UNK
donor	I-UNK
sites	B-UNK
of	O
exon	B-UNK
9	O
when	O
assayed	O
in	O
vitro	B-UNK
.	O

 	O
these	O
results	B-UNK
provide	I-UNK
genetic	B-UNK
evidence	B-UNK
for	O
distinct	B-UNK
functional	B-UNK
roles	O
of	O
the	O
wt1	B-UNK
isoforms	B-UNK
in	O
urogenital	B-UNK
development	B-UNK
.	O
.	O

 	O
characterization	B-UNK
of	O
the	O
myotonic	B-DISEASE
dystrophy	I-DISEASE
region	B-UNK
predicts	B-UNK
multiple	B-UNK
protein	B-UNK
isoform	B-UNK
-	O
encoding	B-UNK
mrnas	B-UNK
.	O

 	O
the	O
mutation	B-UNK
underlying	B-UNK
myotonic	B-DISEASE
dystrophy	I-DISEASE
(	O
dm	B-DISEASE
)	O
has	O
been	O
identified	B-UNK
as	O
an	O
expansion	B-UNK
of	O
a	O
polymorphic	B-UNK
ctg	B-UNK
-	O
repeat	B-UNK
in	O
a	O
gene	B-UNK
encoding	B-UNK
protein	B-UNK
kinase	B-UNK
activity	B-UNK
.	O

 	O
brain	B-UNK
and	O
heart	B-UNK
transcripts	B-UNK
of	O
the	O
dm	B-DISEASE
-	O
kinase	B-UNK
(	O
dmr	O
-	O
b15	O
)	O
gene	B-UNK
are	O
subject	B-UNK
to	O
alternative	B-UNK
rna	B-UNK
splicing	I-UNK
in	O
both	O
human	B-UNK
and	O
mouse	B-UNK
.	O

 	O
the	O
unstable	B-UNK
[	O
ctg	B-UNK
]	O
5	O
-	O
30	O
motif	B-UNK
is	O
found	B-UNK
uniquely	O
in	O
humans	B-UNK
,	O
although	O
the	O
flanking	B-UNK
nucleotides	B-UNK
are	O
also	O
present	B-UNK
in	O
mouse	B-UNK
.	O

 	O
characterization	B-UNK
of	O
the	O
dm	B-DISEASE
region	B-UNK
of	O
both	O
species	B-UNK
reveals	B-UNK
another	O
active	B-UNK
gene	B-UNK
(	O
dmr	O
-	O
n9	O
)	O
in	O
close	B-UNK
proximity	O
to	O
the	O
kinase	B-UNK
gene	B-UNK
.	O

 	O
dmr	O
-	O
n9	O
transcripts	B-UNK
,	O
mainly	B-UNK
expressed	B-UNK
in	O
brain	B-UNK
and	O
testis	O
,	O
possess	O
a	O
single	B-UNK
,	O
large	B-UNK
open	B-UNK
reading	I-UNK
frame	B-UNK
,	O
but	O
the	O
function	B-UNK
of	O
its	O
protein	B-UNK
product	B-UNK
is	O
unknown	B-UNK
.	O

 	B-UNK
clinical	I-UNK
manifestation	B-UNK
of	O
dm	B-DISEASE
may	O
be	O
caused	B-UNK
by	O
the	O
expanded	B-UNK
ctg	B-UNK
-	O
repeat	B-UNK
compromising	O
the	O
(	O
alternative	B-UNK
)	O
expression	B-UNK
of	O
dm	B-DISEASE
-	O
kinase	B-UNK
or	O
dmr	O
-	O
n9	O
proteins	B-UNK
.	O
.	O

 	O
fragile	B-DISEASE
x	I-DISEASE
syndrome	I-DISEASE
without	O
ccg	B-UNK
amplification	B-UNK
has	O
an	O
fmr1	B-UNK
deletion	B-UNK
.	O

 	O
we	O
describe	B-UNK
a	O
patient	B-UNK
with	O
typical	B-UNK
clinical	B-UNK
features	I-UNK
of	O
the	O
fragile	B-DISEASE
x	I-DISEASE
syndrome	I-DISEASE
,	O
but	O
without	O
cytogenetic	B-UNK
expression	B-UNK
of	O
the	O
fragile	B-UNK
x	I-UNK
or	O
an	O
amplified	B-UNK
ccg	B-UNK
trinucleotide	B-UNK
repeat	I-UNK
fragment	O
.	O

 	O
the	O
patient	B-UNK
has	O
a	O
previously	B-UNK
uncharacterized	B-UNK
submicroscopic	B-UNK
deletion	I-UNK
encompassing	O
the	O
ccg	B-UNK
repeat	B-UNK
,	O
the	O
entire	B-UNK
fmr1	B-UNK
gene	B-UNK
and	O
about	O
2	O
.	O

 	O
5	O
megabases	O
of	O
flanking	B-UNK
sequences	B-UNK
.	O

 	O
this	O
finding	B-UNK
confirms	B-UNK
that	O
the	O
fragile	B-UNK
x	I-UNK
phenotype	B-UNK
can	O
exist	O
,	O
without	O
amplification	B-UNK
of	O
the	O
ccg	B-UNK
repeat	B-UNK
or	O
cytogenetic	B-UNK
expression	B-UNK
of	O
the	O
fragile	B-UNK
x	I-UNK
,	O
and	O
that	O
fragile	B-DISEASE
x	I-DISEASE
syndrome	I-DISEASE
is	O
a	O
genetically	B-UNK
homogeneous	B-UNK
disorder	O
involving	B-UNK
fmr1	B-UNK
.	O

 	O
we	O
also	O
found	B-UNK
random	B-UNK
x	B-UNK
-	O
inactivation	B-UNK
in	O
the	O
mother	B-UNK
of	O
the	O
patient	B-UNK
who	O
was	O
shown	B-UNK
to	O
be	O
a	O
carrier	B-UNK
of	O
this	O
deletion	B-UNK
.	O

 	O
cloning	B-UNK
of	O
the	O
huntington	B-DISEASE
disease	I-DISEASE
region	B-UNK
in	O
yeast	B-UNK
artificial	I-UNK
chromosomes	B-UNK
.	O

 	O
the	O
gene	B-UNK
responsible	B-UNK
for	O
huntington	B-DISEASE
disease	I-DISEASE
has	O
been	O
localized	B-UNK
to	O
a	O
2	O
.	O

 	O
5	O
million	B-UNK
base	B-UNK
pair	I-UNK
(	O
mb	B-UNK
)	O
region	B-UNK
between	O
the	O
loci	B-UNK
d4s10	B-UNK
and	O
d4s168	O
on	O
the	O
short	B-UNK
arm	B-UNK
of	O
chromosome	B-DISEASE
4	I-DISEASE
.	O

 	O
as	O
part	O
of	O
a	O
strategy	O
to	O
clone	B-UNK
the	O
hd	B-UNK
gene	B-UNK
on	O
the	O
basis	B-UNK
of	O
its	O
chromosomal	B-UNK
location	B-UNK
,	O
we	O
isolated	B-UNK
genomic	B-UNK
dna	I-UNK
from	O
the	O
hd	B-UNK
region	B-UNK
as	O
a	O
set	B-UNK
of	O
overlapping	B-UNK
yeast	B-UNK
artificial	I-UNK
chromosome	B-UNK
(	O
yac	B-UNK
)	O
clones	B-UNK
.	O

 	O
twenty	O
-	O
eight	O
yac	B-UNK
clones	I-UNK
were	O
identified	B-UNK
by	O
screening	B-UNK
human	B-UNK
yac	B-UNK
libraries	B-UNK
with	O
twelve	O
pcr	B-UNK
-	O
based	B-UNK
sequence	B-UNK
-	O
tagged	B-UNK
sites	B-UNK
(	O
stss	O
)	O
from	O
the	O
region	B-UNK
.	O

 	O
we	O
assembled	O
the	O
yac	B-UNK
clones	I-UNK
into	O
overlapping	B-UNK
sets	O
by	O
hybridizing	O
them	O
to	O
a	O
large	B-UNK
number	B-UNK
of	O
dna	B-UNK
probes	I-UNK
from	O
the	O
hd	B-UNK
region	B-UNK
,	O
including	B-UNK
the	O
stss	O
.	O

 	O
in	O
addition	B-UNK
,	O
we	O
isolated	B-UNK
the	O
ends	O
of	O
the	O
human	B-UNK
dna	B-UNK
inserts	B-UNK
of	O
most	O
of	O
the	O
yac	B-UNK
clones	I-UNK
to	O
assist	O
in	O
the	O
construction	O
of	O
the	O
contig	B-UNK
.	O

 	O
although	O
almost	O
half	B-UNK
of	O
the	O
yacs	B-UNK
appear	B-UNK
to	O
contain	B-UNK
chimeric	B-UNK
inserts	B-UNK
and	O
several	O
contain	B-UNK
internal	B-UNK
deletions	B-UNK
or	O
other	O
rearrangements	B-UNK
,	O
we	O
were	O
able	O
to	O
obtain	O
over	O
2	O
.	O

 	O
2	O
mb	B-UNK
of	O
the	O
hd	B-UNK
region	B-UNK
in	O
yacs	B-UNK
,	O
including	B-UNK
one	O
continuous	B-UNK
segment	B-UNK
of	O
2	O
.	O

 	O
0	O
mb	B-UNK
covering	B-UNK
the	O
region	B-UNK
that	O
most	O
likely	B-UNK
contains	B-UNK
the	O
hd	B-UNK
gene	B-UNK
.	O

 	O
ten	B-DISEASE
of	O
the	O
twenty	O
eight	O
yac	B-UNK
clones	I-UNK
comprise	O
a	O
minimal	B-UNK
set	B-UNK
spanning	B-UNK
the	O
2	O
.	O

 	O
2	O
mb	B-UNK
.	O

 	O
these	O
clones	B-UNK
provide	B-UNK
reagents	B-UNK
for	O
the	O
complete	B-UNK
characterization	B-UNK
of	O
this	O
region	B-UNK
of	O
the	O
genome	B-UNK
and	O
for	O
the	O
eventual	O
isolation	B-UNK
of	O
the	O
hd	B-UNK
gene	B-UNK
.	O

 	O
characterization	B-UNK
of	O
a	O
yac	B-UNK
containing	B-UNK
part	O
or	O
all	O
of	O
the	O
norrie	B-DISEASE
disease	I-DISEASE
locus	B-UNK
.	O

 	O
it	O
has	O
been	O
shown	B-UNK
from	O
pulsed	O
-	O
field	B-UNK
gel	I-UNK
electrophoresis	B-UNK
(	O
pfge	O
)	O
that	O
the	O
monoamine	O
oxidase	B-UNK
genes	B-UNK
a	O
and	O
b	B-UNK
(	O
maoa	O
&	O
maob	B-UNK
)	O
and	O
dxs7	B-UNK
loci	B-UNK
are	O
physically	O
very	O
close	B-UNK
.	O

 	O
we	O
have	O
therefore	O
extended	B-UNK
studies	B-UNK
on	O
their	O
relationship	B-UNK
through	O
the	O
characterisation	O
of	O
a	O
650	O
kb	B-UNK
yac	B-UNK
isolated	B-UNK
using	O
l1	O
.	O

 	O
28	O
(	O
recognising	O
the	O
dxs7	B-UNK
locus	B-UNK
)	O
as	O
a	O
probe	B-UNK
.	O

 	O
restriction	O
mapping	B-UNK
of	O
the	O
yac	B-UNK
indicates	B-UNK
that	O
it	O
contains	B-UNK
both	O
maoa	O
and	O
maob	B-UNK
genes	B-UNK
in	O
addition	B-UNK
to	O
the	O
dxs7	B-UNK
locus	B-UNK
.	O

 	O
the	O
map	B-UNK
derived	B-UNK
from	O
the	O
yl1	O
.	O

 	O
28	O
-	O
yac	B-UNK
is	O
compatible	O
both	O
with	O
the	O
map	B-UNK
from	O
an	O
independently	B-UNK
derived	B-UNK
yac	B-UNK
carrying	B-UNK
maoa	O
and	O
b	B-UNK
genes	B-UNK
and	O
with	O
the	O
long	B-UNK
range	B-UNK
genomic	B-UNK
map	B-UNK
for	O
the	O
region	B-UNK
.	O

 	O
a	O
series	B-UNK
of	O
subclones	O
prepared	O
from	O
a	O
phage	B-UNK
library	B-UNK
(	O
lambda	B-UNK
dash	O
ii	B-UNK
)	O
of	O
the	O
yac	B-UNK
have	O
been	O
characterised	B-UNK
and	O
have	O
been	O
employed	O
to	O
determine	O
the	O
end	B-UNK
point	B-UNK
of	O
the	O
deletion	B-UNK
of	O
a	O
norrie	B-DISEASE
disease	I-DISEASE
(	O
ndp	B-UNK
)	O
patient	B-UNK
who	O
has	O
been	O
shown	B-UNK
to	O
lack	B-UNK
both	O
dxs7	B-UNK
and	O
mao	B-UNK
coding	B-UNK
sequences	I-UNK
.	O

 	O
the	O
pattern	B-UNK
of	O
retention	O
of	O
subclones	O
in	O
the	O
deletion	B-UNK
patient	B-UNK
place	B-UNK
the	O
end	B-UNK
point	B-UNK
of	O
the	O
deletion	B-UNK
within	O
30	O
-	O
130	O
kb	B-UNK
of	O
the	O
proximal	B-UNK
end	B-UNK
of	O
the	O
yac	B-UNK
.	O

 	O
by	O
combining	B-UNK
the	O
data	B-UNK
with	O
established	B-UNK
recombination	B-UNK
analysis	B-UNK
,	O
we	O
provide	B-UNK
evidence	I-UNK
that	O
all	O
or	O
part	O
of	O
the	O
ndp	B-UNK
lies	B-UNK
in	O
the	O
interval	B-UNK
of	O
approximately	B-UNK
250	O
kb	B-UNK
within	O
the	O
yac	B-UNK
.	O

 	O
both	O
mutations	B-UNK
in	O
g6pd	B-UNK
a	O
-	O
are	O
necessary	O
to	O
produce	B-UNK
the	O
g6pd	B-UNK
deficient	B-UNK
phenotype	B-UNK
.	O

 	O
the	O
high	B-UNK
prevalence	B-UNK
of	O
glucose	B-UNK
6	O
-	O
phosphate	B-UNK
dehydrogenase	I-UNK
(	O
g6pd	B-UNK
)	O
deficiency	B-UNK
in	O
african	B-UNK
populations	B-UNK
is	O
due	O
almost	O
entirely	B-UNK
to	O
the	O
enzyme	B-UNK
variant	B-UNK
a	O
-	O
,	O
which	O
differs	O
from	O
the	O
wild	B-UNK
-	O
type	B-UNK
g6pd	B-UNK
b	B-UNK
by	O
two	O
amino	B-UNK
acid	I-UNK
replacements	O
,	O
68	O
val	O
-	O
-	O
>	O
met	O
and	O
126	O
asn	O
-	O
-	O
>	O
asp	B-UNK
.	O

 	O
the	O
non	B-UNK
-	O
deficient	B-UNK
polymorphic	B-UNK
variant	B-UNK
g6pd	B-UNK
a	O
contains	B-UNK
only	O
the	O
mutation	B-UNK
126	O
asn	O
-	O
-	O
>	O
asp	B-UNK
.	O

 	O
the	O
frequencies	B-UNK
of	O
the	O
g6pd	B-UNK
a	O
and	O
of	O
the	O
g6pd	B-UNK
a	O
-	O
genes	B-UNK
in	O
parts	B-UNK
of	O
africa	O
are	O
both	O
about	O
0	O
.	O

 	O
2	O
.	O

 	O
the	O
68	O
val	O
-	O
-	O
>	O
met	O
mutation	B-UNK
has	O
not	O
been	O
found	B-UNK
in	O
a	O
b	B-UNK
background	B-UNK
.	O

 	O
this	O
could	O
be	O
because	O
the	O
68	O
val	O
-	O
-	O
>	O
met	O
mutation	B-UNK
happened	O
to	O
arise	O
in	O
an	O
a	O
gene	B-UNK
in	O
the	O
first	O
instance	O
,	O
or	O
because	O
the	O
68	O
val	O
-	O
-	O
>	O
met	O
mutation	B-UNK
alone	O
is	O
not	O
sufficient	B-UNK
to	O
cause	B-UNK
g6pd	I-UNK
deficiency	B-UNK
.	O

 	O
we	O
have	O
approached	O
this	O
question	O
by	O
producing	B-UNK
g6pd	B-UNK
b	B-UNK
,	O
a	O
,	O
a	O
-	O
,	O
and	O
g6pd	B-UNK
68	O
val	O
-	O
-	O
>	O
met	O
in	O
a	O
bacterial	B-UNK
expression	B-UNK
system	B-UNK
and	O
analysing	O
their	O
biochemical	B-UNK
properties	B-UNK
.	O

 	O
with	O
each	O
single	B-UNK
mutation	B-UNK
we	O
found	B-UNK
a	O
slight	O
decrease	B-UNK
in	O
both	O
the	O
specific	B-UNK
activity	B-UNK
and	O
the	O
yield	O
of	O
enzyme	B-UNK
when	O
compared	B-UNK
to	O
g6pd	B-UNK
b	B-UNK
.	O

 	O
when	O
both	O
mutations	B-UNK
were	O
introduced	O
together	O
,	O
there	O
was	O
a	O
roughly	O
additive	O
effect	B-UNK
on	O
specific	B-UNK
activity	B-UNK
,	O
but	O
a	O
much	O
more	O
drastic	O
effect	B-UNK
on	O
enzyme	B-UNK
yield	O
(	O
4	O
%	O
of	O
normal	B-UNK
)	O
.	O

 	O
this	O
synergistic	B-UNK
effect	B-UNK
was	O
also	O
demonstrated	B-UNK
on	O
thermal	B-UNK
stability	B-UNK
,	O
especially	B-UNK
at	B-DISEASE
low	B-UNK
nadp	B-UNK
concentrations	B-UNK
.	O

 	O
comparable	B-UNK
results	B-UNK
were	O
produced	B-UNK
when	O
the	O
replacement	O
119	O
gln	B-UNK
-	O
-	O
>	O
glu	B-UNK
was	O
studied	B-UNK
instead	B-UNK
of	O
126	O
asn	O
-	O
-	O
>	O
asp	B-UNK
.	O

 	O
we	O
infer	O
that	O
the	O
coexistence	O
of	O
the	O
two	O
mutations	B-UNK
is	O
responsible	B-UNK
for	O
enzyme	B-UNK
deficiency	B-UNK
in	O
g6pd	B-UNK
a	O
-	O
because	O
they	O
act	B-UNK
synergistically	O
in	O
causing	B-UNK
instability	B-UNK
of	O
the	O
enzyme	B-UNK
.	O

 	B-UNK
small	I-UNK
nuclear	B-UNK
ribonucleoprotein	O
polypeptide	B-UNK
n	B-UNK
(	O
snrpn	B-UNK
)	O
,	O
an	O
expressed	B-UNK
gene	B-UNK
in	O
the	O
prader	B-DISEASE
-	I-DISEASE
willi	I-DISEASE
syndrome	I-DISEASE
critical	B-UNK
region	I-UNK
.	O

 	O
prader	B-DISEASE
-	I-DISEASE
willi	I-DISEASE
syndrome	I-DISEASE
(	O
pws	B-UNK
)	O
is	O
associated	B-UNK
with	O
paternally	B-UNK
derived	I-UNK
chromosomal	B-UNK
deletions	B-UNK
in	O
region	B-UNK
15q11	B-UNK
-	O
13	O
or	O
with	O
maternal	B-UNK
disomy	B-UNK
for	O
chromosome	B-DISEASE
15	I-DISEASE
.	O

 	O
therefore	O
,	O
loss	B-UNK
of	O
the	O
expressed	B-UNK
paternal	B-UNK
alleles	B-UNK
of	O
maternally	B-UNK
imprinted	B-UNK
genes	B-UNK
must	O
be	O
responsible	B-UNK
for	O
the	O
pws	B-UNK
phenotype	B-UNK
.	O

 	O
we	O
have	O
mapped	B-UNK
the	O
gene	B-UNK
encoding	B-UNK
the	O
small	B-UNK
nuclear	B-UNK
rna	B-UNK
associated	B-UNK
polypeptide	B-UNK
smn	O
(	O
snrpn	B-UNK
)	O
to	O
human	B-UNK
chromosome	I-UNK
15q12	O
and	O
a	O
processed	B-UNK
pseudogene	B-UNK
snrpnp1	O
to	O
chromosome	B-UNK
region	I-UNK
6pter	O
-	O
p21	O
.	O

 	O
furthermore	B-UNK
,	O
snrpn	B-UNK
was	O
mapped	B-UNK
to	O
the	O
minimal	B-UNK
deletion	B-UNK
interval	B-UNK
that	O
is	O
critical	B-UNK
for	O
pws	B-UNK
.	O

 	O
the	O
fact	O
that	O
the	O
mouse	B-UNK
snrpn	B-UNK
gene	B-UNK
is	O
maternally	B-UNK
imprinted	B-UNK
in	O
brain	B-UNK
suggests	B-UNK
that	O
loss	B-UNK
of	O
the	O
paternally	B-UNK
derived	I-UNK
snrpn	B-UNK
allele	B-UNK
may	O
be	O
involved	B-UNK
in	O
the	O
pws	B-UNK
phenotype	B-UNK
.	O
.	O

 	O
the	O
presence	B-UNK
of	O
two	O
different	B-UNK
infantile	B-UNK
tay	B-DISEASE
-	I-DISEASE
sachs	I-DISEASE
disease	I-DISEASE
mutations	B-UNK
in	O
a	O
cajun	B-UNK
population	B-UNK
.	O

 	O
a	O
study	B-UNK
was	O
undertaken	O
to	O
characterize	O
the	O
mutation	B-UNK
(	O
s	O
)	O
responsible	B-UNK
for	O
tay	B-DISEASE
-	I-DISEASE
sachs	I-DISEASE
disease	I-DISEASE
(	O
tsd	B-UNK
)	O
in	O
a	O
cajun	B-UNK
population	B-UNK
in	O
southwest	O
louisiana	O
and	O
to	O
identify	B-UNK
the	O
origins	B-UNK
of	O
these	O
mutations	B-UNK
.	O

 	O
eleven	O
of	O
12	O
infantile	B-UNK
tsd	B-UNK
alleles	I-UNK
examined	B-UNK
in	O
six	O
families	B-UNK
had	O
the	O
beta	B-UNK
-	O
hexosaminidase	O
a	O
(	O
hex	O
a	O
)	O
alpha	B-UNK
-	O
subunit	B-UNK
exon	B-UNK
11	O
insertion	B-UNK
mutation	B-UNK
that	O
is	O
present	B-UNK
in	O
approximately	B-UNK
70	O
%	O
of	O
ashkenazi	B-UNK
jewish	I-UNK
tsd	B-UNK
heterozygotes	B-UNK
.	O

 	O
the	O
mutation	B-UNK
in	O
the	O
remaining	B-UNK
allele	B-UNK
was	O
a	O
single	B-UNK
-	O
base	B-UNK
transition	B-UNK
in	O
the	O
donor	B-UNK
splice	I-UNK
site	I-UNK
of	O
the	O
alpha	B-UNK
-	O
subunit	B-UNK
intron	B-UNK
9	O
.	O

 	O
to	O
determine	O
the	O
origins	B-UNK
of	O
these	O
two	O
mutations	B-UNK
in	O
the	O
cajun	B-UNK
population	B-UNK
,	O
the	O
tsd	B-UNK
carrier	I-UNK
status	B-UNK
was	O
enzymatically	B-UNK
determined	B-UNK
for	O
90	O
members	B-UNK
of	O
four	O
of	O
the	O
six	O
families	B-UNK
,	O
and	O
extensive	B-UNK
pedigrees	B-UNK
were	O
constructed	B-UNK
for	O
all	O
carriers	B-UNK
.	O

 	O
a	O
single	B-UNK
ancestral	B-UNK
couple	O
from	O
france	O
was	O
found	B-UNK
to	O
be	O
common	B-UNK
to	O
most	O
of	O
the	O
carriers	B-UNK
of	O
the	O
exon	B-UNK
11	O
insertion	B-UNK
.	O

 	O
pedigree	B-UNK
data	B-UNK
suggest	B-UNK
that	O
this	O
mutation	B-UNK
has	O
been	O
in	O
the	O
cajun	B-UNK
population	B-UNK
since	O
its	O
founding	B-UNK
over	O
2	O
centuries	O
ago	B-UNK
and	O
that	O
it	O
may	O
be	O
widely	B-UNK
distributed	B-UNK
within	O
the	O
population	B-UNK
.	O

 	O
in	O
contrast	B-UNK
,	O
the	O
intron	B-UNK
9	O
mutation	B-UNK
apparently	B-UNK
was	O
introduced	O
within	O
the	O
last	O
century	O
and	O
probably	B-UNK
is	O
limited	B-UNK
to	O
a	O
few	O
louisiana	O
families	B-UNK
.	O
.	O

 	O
mutations	B-UNK
in	O
the	O
candidate	B-UNK
gene	B-UNK
for	O
norrie	B-DISEASE
disease	I-DISEASE
.	O

 	O
recently	B-UNK
,	O
we	O
and	O
others	O
have	O
isolated	B-UNK
a	O
candidate	B-UNK
gene	B-UNK
for	O
x	B-UNK
linked	I-UNK
norrie	B-DISEASE
disease	I-DISEASE
(	O
nd	B-UNK
)	O
which	O
was	O
found	B-UNK
to	O
be	O
deleted	B-UNK
or	O
disrupted	B-UNK
in	O
several	O
patients	B-UNK
.	O

 	O
as	O
a	O
prerequisite	O
for	O
the	O
identification	B-UNK
of	O
point	B-UNK
mutations	I-UNK
in	O
the	O
nd	B-UNK
gene	B-UNK
we	O
have	O
established	B-UNK
the	O
exon	B-UNK
-	O
intron	B-UNK
structure	B-UNK
of	O
this	O
gene	B-UNK
.	O

 	O
in	O
17	O
unrelated	B-UNK
patients	B-UNK
and	O
15	O
controls	B-UNK
,	O
pcr	B-UNK
products	B-UNK
derived	B-UNK
from	O
the	O
promoter	B-UNK
region	I-UNK
,	O
exons	B-UNK
1	O
and	O
2	O
as	O
well	O
as	O
the	O
coding	B-UNK
part	O
of	O
exon	B-UNK
3	O
were	O
analysed	B-UNK
with	O
the	O
single	B-UNK
strand	I-UNK
conformation	I-UNK
polymorphism	O
(	O
sscp	B-UNK
)	O
technique	B-UNK
.	O

 	O
in	O
12	O
patients	B-UNK
altered	B-UNK
pcr	B-UNK
fragments	B-UNK
were	O
detected	B-UNK
which	O
were	O
studied	B-UNK
in	O
detail	O
by	O
direct	B-UNK
sequencing	I-UNK
.	O

 	O
eleven	O
different	B-UNK
mutations	B-UNK
were	O
found	B-UNK
,	O
and	O
all	O
but	O
one	O
are	O
likely	B-UNK
to	O
give	O
rise	B-UNK
to	O
significant	B-UNK
structural	B-UNK
changes	B-UNK
in	O
the	O
predicted	B-UNK
protein	B-UNK
.	O

 	O
these	O
findings	B-UNK
,	O
and	O
the	O
absence	B-UNK
of	O
functionally	B-UNK
relevant	B-UNK
base	B-UNK
changes	B-UNK
in	O
healthy	B-UNK
controls	B-UNK
,	O
emphasize	O
the	O
causal	B-UNK
role	B-UNK
of	O
this	O
candidate	B-UNK
gene	B-UNK
in	O
norrie	B-DISEASE
disease	I-DISEASE
and	O
pave	O
the	O
way	O
for	O
reliable	B-UNK
diagnosis	B-UNK
and	O
carrier	B-UNK
detection	I-UNK
.	O
.	O

 	O
detection	B-UNK
of	O
a	O
nonsense	B-UNK
mutation	B-UNK
in	O
the	O
dystrophin	B-UNK
gene	B-UNK
by	O
multiple	B-UNK
sscp	B-UNK
.	O

 	O
a	O
combination	O
of	O
multiplex	B-UNK
pcr	B-UNK
with	O
the	O
single	B-UNK
strand	I-UNK
conformation	I-UNK
polymorphism	O
(	O
sscp	B-UNK
)	O
technique	B-UNK
was	O
employed	O
to	O
screen	B-UNK
for	O
point	B-UNK
mutations	I-UNK
in	O
the	O
human	B-UNK
dystrophin	B-UNK
gene	B-UNK
.	O

 	O
co	B-UNK
-	O
amplification	B-UNK
of	O
11	O
exons	B-UNK
from	O
genomic	B-UNK
dna	I-UNK
of	O
duchenne	B-UNK
and	O
becker	O
muscular	B-DISEASE
dystrophy	I-DISEASE
(	O
dmd	B-UNK
/	O
bmd	B-UNK
)	O
patients	B-UNK
with	O
no	O
deletion	B-UNK
or	O
duplication	B-UNK
was	O
performed	B-UNK
and	O
the	O
samples	B-UNK
subjected	O
to	O
multiple	B-UNK
sscp	B-UNK
analysis	B-UNK
.	O

 	O
we	O
report	B-UNK
the	O
case	B-UNK
of	O
a	O
nonsense	B-UNK
mutation	B-UNK
in	O
a	O
duchenne	B-UNK
patient	B-UNK
identified	B-UNK
by	O
this	O
approach	B-UNK
.	O

 	O
the	O
mutation	B-UNK
introduces	B-UNK
a	O
termination	B-UNK
codon	I-UNK
within	O
exon	B-UNK
8	O
of	O
the	O
dystrophin	B-UNK
gene	B-UNK
.	O

 	O
it	O
is	O
predicted	B-UNK
to	O
cause	B-UNK
a	O
very	O
premature	B-UNK
translational	O
termination	B-UNK
accounting	O
for	O
the	O
severe	B-UNK
phenotype	B-UNK
observed	B-UNK
.	O

 	O
the	O
patient	B-UNK
inherited	B-UNK
this	O
mutation	B-UNK
from	O
his	O
mother	B-UNK
.	O

 	O
in	O
addition	B-UNK
the	O
analysis	B-UNK
revealed	B-UNK
5	O
polymorphisms	B-UNK
useful	B-UNK
for	O
internal	B-UNK
control	B-UNK
.	O
.	O

 	O
proliferation	B-UNK
-	O
related	B-UNK
expression	B-UNK
of	O
p19	O
/	O
nm23	B-UNK
nucleoside	O
diphosphate	O
kinase	B-UNK
.	O

 	O
high	B-UNK
level	B-UNK
expression	B-UNK
of	O
the	O
nm23	B-UNK
-	O
h1	B-UNK
gene	B-UNK
,	O
which	O
encodes	B-UNK
for	O
a	O
nucleoside	O
diphosphate	O
kinase	B-UNK
,	O
has	O
been	O
found	B-UNK
to	O
correlate	B-UNK
with	O
diminished	B-UNK
metastasis	O
in	O
some	O
tumors	B-DISEASE
but	O
not	O
in	O
others	O
.	O

 	O
we	O
have	O
previously	B-UNK
identified	I-UNK
the	O
protein	B-UNK
product	B-UNK
of	O
the	O
nm23	B-UNK
-	O
h1	B-UNK
gene	B-UNK
in	O
two	O
-	O
dimensional	O
electrophoretic	B-UNK
gels	B-UNK
and	O
have	O
designated	B-UNK
it	O
p19	O
/	O
nm23	B-UNK
.	O

 	O
in	O
neuroblastoma	B-DISEASE
,	O
higher	B-UNK
levels	B-UNK
of	O
p19	O
/	O
nm23	B-UNK
,	O
which	O
are	O
associated	B-UNK
with	O
amplification	B-UNK
of	O
the	O
n	B-UNK
-	O
myc	O
oncogene	B-UNK
,	O
large	B-UNK
tumor	B-DISEASE
mass	B-UNK
,	O
and	O
metastasis	O
,	O
were	O
observed	B-UNK
in	O
advanced	B-UNK
stage	B-UNK
tumors	B-DISEASE
compared	B-UNK
with	O
limited	B-UNK
stage	B-UNK
disease	B-DISEASE
.	O

 	O
because	O
of	O
the	O
variable	B-UNK
expression	B-UNK
of	O
nm23	B-UNK
-	O
h1	B-UNK
in	O
different	B-UNK
tumors	B-DISEASE
,	O
we	O
have	O
investigated	B-UNK
the	O
relationship	B-UNK
between	O
amounts	B-UNK
of	O
the	O
protein	B-UNK
and	O
cell	B-UNK
proliferation	B-UNK
.	O

 	O
the	O
levels	B-UNK
of	O
p19	O
/	O
nm23	B-UNK
were	O
compared	B-UNK
between	O
resting	B-UNK
and	O
mitotically	O
stimulated	B-UNK
normal	B-UNK
human	I-UNK
pbls	O
and	O
in	O
leukemia	B-DISEASE
cells	B-UNK
.	O

 	O
the	O
amount	O
of	O
p19	O
/	O
nm23	B-UNK
increased	B-UNK
in	O
normal	B-UNK
lymphocytes	B-UNK
in	O
response	B-UNK
to	O
mitotic	B-UNK
stimulation	B-UNK
and	O
paralleled	O
the	O
increase	B-UNK
in	O
dna	B-UNK
synthesis	B-UNK
.	O

 	O
in	O
leukemia	B-DISEASE
cells	B-UNK
obtained	B-UNK
from	O
patients	B-UNK
with	O
different	B-UNK
subtypes	O
of	O
acute	B-UNK
leukemia	B-DISEASE
,	O
p19	O
/	O
nm23	B-UNK
levels	B-UNK
were	O
also	O
increased	B-UNK
relative	B-UNK
to	O
resting	B-UNK
normal	B-UNK
lymphocytes	B-UNK
.	O

 	O
treatment	B-UNK
of	O
mitotically	O
stimulated	B-UNK
lymphocytes	B-UNK
with	O
cyclosporin	O
,	O
which	O
inhibits	B-UNK
proliferation	B-UNK
,	O
blocked	O
the	O
increase	B-UNK
in	O
p19	O
/	O
nm23	B-UNK
;	O
treatment	B-UNK
of	O
the	O
leukemia	B-DISEASE
cell	B-UNK
line	B-UNK
hl	O
-	O
60	O
with	O
dimethylsulfoxide	O
,	O
which	O
induces	B-UNK
terminal	B-UNK
differentiation	B-UNK
,	O
resulted	B-UNK
in	O
diminished	B-UNK
levels	B-UNK
of	O
p19	O
/	O
nm23	B-UNK
.	O

 	O
our	O
data	B-UNK
therefore	O
provide	B-UNK
evidence	I-UNK
that	O
nm23	B-UNK
-	O
h1	B-UNK
expression	B-UNK
is	O
related	B-UNK
to	O
cell	B-UNK
proliferative	B-UNK
activity	B-UNK
.	O
.	O

 	O
an	O
intrachromosomal	O
insertion	B-UNK
causing	B-UNK
5q22	B-UNK
deletion	B-UNK
and	O
familial	B-DISEASE
adenomatous	I-DISEASE
polyposis	I-DISEASE
coli	B-UNK
in	O
two	O
generations	B-UNK
.	O

 	O
we	O
report	B-UNK
familial	B-DISEASE
adenomatous	I-DISEASE
polyposis	I-DISEASE
coli	B-UNK
(	O
fapc	O
)	O
with	O
epidermoid	B-DISEASE
cysts	I-DISEASE
,	O
osteomata	O
,	O
and	O
areas	B-UNK
of	O
congenital	B-DISEASE
hypertrophy	B-DISEASE
of	O
the	O
retinal	B-UNK
pigment	I-UNK
epithelium	O
(	O
chrpes	O
)	O
in	O
a	O
male	B-UNK
patient	B-UNK
and	O
his	O
maternal	B-UNK
aunt	B-UNK
,	O
both	O
of	O
whom	O
suffered	O
a	O
mild	B-UNK
to	O
moderate	B-UNK
degree	B-UNK
of	O
mental	O
handicap	O
.	O

 	O
both	O
had	O
an	O
interstitial	B-UNK
deletion	B-UNK
of	O
the	O
long	B-UNK
arm	B-UNK
of	O
chromosome	B-DISEASE
5	I-DISEASE
(	O
del	O
(	O
5	O
)	O
(	O
q22q23	O
.	O
2	O
)	O
)	O
.	O

 	O
two	O
other	O
normal	B-UNK
family	B-UNK
members	I-UNK
had	O
the	O
underlying	B-UNK
direct	B-UNK
insertion	B-UNK
of	O
chromosome	B-DISEASE
5	I-DISEASE
(	O
dir	O
ins	O
(	O
5	O
)	O
(	O
q31	O
.	O
3q22q23	O
3q22q23	O
.	O
2	O
)	O
)	O
.	O

 	B-UNK
molecular	I-UNK
genetic	B-UNK
and	O
fluorescent	B-UNK
hybridisation	B-UNK
studies	B-UNK
have	O
shown	B-UNK
that	O
loci	B-UNK
d5s37	O
and	O
d5s98	O
are	O
outside	O
the	O
deletion	B-UNK
whereas	O
loci	B-UNK
detected	B-UNK
by	O
probes	B-UNK
ef5	O
.	O

 	O
44	O
and	O
yn5	O
.	O

 	O
48	O
are	O
lost	O
.	O

 	O
as	O
expected	B-UNK
,	O
the	O
molecular	B-UNK
analyses	B-UNK
indicate	I-UNK
loss	B-UNK
of	O
one	O
allele	B-UNK
at	B-DISEASE
the	O
mcc	O
and	O
apc	B-UNK
loci	B-UNK
.	O

 	O
the	O
apc	B-UNK
gene	B-UNK
is	O
located	B-UNK
within	O
band	B-UNK
5q22	B-UNK
.	O

 	B-UNK
familial	I-UNK
direct	B-UNK
insertions	B-UNK
should	O
be	O
considered	B-UNK
as	O
a	O
cause	B-UNK
of	O
recurrent	B-UNK
microdeletion	O
syndromes	B-UNK
.	O

 	B-UNK
chromosome	I-UNK
mapping	B-UNK
of	O
the	O
rod	B-UNK
photoreceptor	B-UNK
cgmp	O
phosphodiesterase	O
beta	B-UNK
-	O
subunit	B-UNK
gene	B-UNK
in	O
mouse	B-UNK
and	O
human	B-UNK
:	O
tight	B-UNK
linkage	B-UNK
to	O
the	O
huntington	B-DISEASE
disease	I-DISEASE
region	B-UNK
(	O
4p16	B-UNK
.	O
3	O
)	O
.	O

 	O
the	O
retinal	B-DISEASE
degeneration	I-DISEASE
mouse	B-UNK
(	O
gene	B-UNK
symbol	O
,	O
rd	O
)	O
is	O
an	O
animal	B-UNK
model	B-UNK
for	O
certain	B-UNK
forms	B-UNK
of	O
human	B-UNK
hereditary	B-UNK
retinopathies	O
.	O

 	B-UNK
recent	I-UNK
findings	B-UNK
of	O
a	O
nonsense	B-UNK
mutation	B-UNK
in	O
the	O
rd	O
mouse	B-UNK
pde	O
beta	B-UNK
-	O
subunit	B-UNK
gene	B-UNK
(	O
pdeb	O
)	O
prompted	O
us	O
to	O
investigate	O
the	O
chromosome	B-UNK
locations	B-UNK
of	O
the	O
mouse	B-UNK
and	O
human	B-UNK
genes	B-UNK
.	O

 	O
we	O
have	O
utilized	O
backcross	B-UNK
analysis	B-UNK
in	O
mice	B-UNK
to	O
verify	O
and	O
define	B-UNK
more	O
precisely	O
the	O
location	B-UNK
of	O
the	O
pdeb	O
locus	B-UNK
6	O
.	O

 	O
1	O
+	O
/	O
-	O
2	O
.	O

 	O
3	O
cm	B-DISEASE
distal	B-UNK
of	O
mgsa	O
on	O
mouse	B-UNK
chromosome	I-UNK
5	O
.	O

 	O
we	O
have	O
determined	B-UNK
that	O
the	O
human	B-UNK
gene	B-UNK
(	O
pdeb	O
)	O
maps	B-UNK
to	O
4p16	B-UNK
.	O

 	O
3	O
,	O
very	O
close	B-UNK
to	O
the	O
huntington	B-DISEASE
disease	I-DISEASE
(	O
hd	B-UNK
)	O
region	B-UNK
.	O

 	O
analysis	B-UNK
of	O
the	O
comparative	O
map	B-UNK
for	O
mice	B-UNK
and	O
humans	B-UNK
shows	B-UNK
that	O
the	O
mouse	B-UNK
homologue	B-UNK
of	O
the	O
hd	B-UNK
gene	B-UNK
will	O
reside	O
on	O
chromosome	B-DISEASE
5	I-DISEASE
.	O

 	B-UNK
linkage	I-UNK
of	O
the	O
mouse	B-UNK
pdeb	O
locus	B-UNK
with	O
other	O
homologues	B-UNK
in	O
the	O
human	B-UNK
4p16	B-UNK
.	O

 	O
3	O
region	B-UNK
is	O
maintained	O
but	O
gene	B-UNK
order	B-UNK
is	O
not	O
,	O
suggesting	B-UNK
at	B-DISEASE
least	O
three	O
possible	B-UNK
sites	B-UNK
for	O
the	O
corresponding	B-UNK
mouse	B-UNK
hd	B-UNK
gene	B-UNK
.	O

 	O
coincident	O
kaposi	O
sarcoma	B-DISEASE
and	O
t	B-UNK
-	O
cell	B-UNK
lymphoma	B-DISEASE
in	O
a	O
patient	B-UNK
with	O
the	O
wiskott	B-DISEASE
-	I-DISEASE
aldrich	I-DISEASE
syndrome	I-DISEASE
.	O

 	O
a	O
24	O
year	B-UNK
old	I-UNK
male	B-UNK
with	O
a	O
history	B-UNK
of	O
eczema	B-DISEASE
,	O
recurrent	B-UNK
mild	B-UNK
infections	B-DISEASE
,	O
and	O
thrombocytopenia	B-DISEASE
consistent	B-UNK
with	O
the	O
wiskott	B-DISEASE
-	I-DISEASE
aldrich	I-DISEASE
syndrome	I-DISEASE
(	O
was	O
)	O
presented	B-UNK
with	O
a	O
mediastinal	O
mass	B-UNK
,	O
generalized	O
lymphadenopathy	B-DISEASE
,	O
splenomegaly	B-DISEASE
,	O
and	O
severe	B-UNK
thrombocytopenia	B-DISEASE
.	O

 	O
studies	B-UNK
of	O
immune	B-UNK
function	B-UNK
including	B-UNK
immunoglobulin	B-UNK
levels	B-UNK
and	O
t	B-UNK
-	O
cell	B-UNK
subsets	O
were	O
normal	B-UNK
.	O

 	O
furthermore	B-UNK
,	O
his	O
t	B-UNK
lymphocytes	I-UNK
proliferated	O
normally	B-UNK
in	O
response	B-UNK
to	O
phytohemagglutinin	O
,	O
concanavalin	O
a	O
,	O
and	O
the	O
combination	O
of	O
neuraminidase	O
/	O
galactose	B-UNK
oxidase	B-UNK
.	O

 	O
however	O
,	O
their	O
proliferative	B-UNK
responses	B-UNK
to	O
anti	O
-	O
cd43	O
antibody	B-UNK
and	O
periodate	O
were	O
diminished	B-UNK
,	O
consistent	B-UNK
with	O
the	O
clinical	B-UNK
diagnosis	B-UNK
of	O
was	O
.	O

 	O
an	O
initial	B-UNK
inguinal	O
lymph	O
node	O
biopsy	B-UNK
surprisingly	B-UNK
revealed	B-UNK
kaposi	O
sarcoma	B-DISEASE
.	O

 	O
however	O
,	O
following	B-UNK
splenectomy	O
to	O
increase	B-UNK
the	O
platelet	B-UNK
count	O
,	O
biopsy	B-UNK
of	O
the	O
mediastinal	O
mass	B-UNK
revealed	B-UNK
t	B-UNK
-	O
cell	B-UNK
large	B-UNK
cell	B-UNK
lymphoma	B-DISEASE
.	O

 	O
studies	B-UNK
of	O
biopsied	O
tissue	B-UNK
for	O
the	O
presence	B-UNK
of	O
epstein	O
-	O
barr	B-UNK
virus	B-UNK
and	O
cytomegalovirus	O
were	O
negative	B-UNK
,	O
as	O
were	O
studies	B-UNK
of	O
blood	B-UNK
,	O
including	B-UNK
the	O
polymerase	B-UNK
chain	I-UNK
reaction	I-UNK
,	O
for	O
the	O
presence	B-UNK
of	O
the	O
human	B-DISEASE
immunodeficiency	I-DISEASE
virus	I-DISEASE
(	O
hiv	O
)	O
.	O

 	O
this	O
is	O
the	O
first	O
report	B-UNK
of	O
kaposi	O
sarcoma	B-DISEASE
arising	O
in	O
a	O
patient	B-UNK
with	O
a	O
congenital	B-DISEASE
immunodeficiency	B-DISEASE
syndrome	I-DISEASE
.	O

 	O
although	O
kaposi	O
sarcoma	B-DISEASE
can	O
arise	O
in	O
the	O
face	O
of	O
the	O
severe	B-UNK
immunosuppression	O
that	O
follows	O
allograft	O
transplantation	O
and	O
in	O
patients	B-UNK
infected	B-UNK
with	O
hiv	O
,	O
we	O
postulate	O
that	O
longevity	O
in	O
the	O
face	O
of	O
mild	B-UNK
immunosuppression	O
was	O
the	O
major	B-UNK
factor	B-UNK
in	O
the	O
development	B-UNK
of	O
kaposi	O
sarcoma	B-DISEASE
in	O
this	O
patient	B-UNK
.	O
.	O

 	O
the	O
apc	B-UNK
gene	B-UNK
,	O
responsible	B-UNK
for	O
familial	B-DISEASE
adenomatous	I-DISEASE
polyposis	I-DISEASE
,	O
is	O
mutated	B-UNK
in	O
human	B-UNK
gastric	B-DISEASE
cancer	I-DISEASE
.	O

 	O
although	O
gastric	B-DISEASE
cancer	I-DISEASE
is	O
the	O
most	O
common	B-UNK
cancer	B-DISEASE
in	O
the	O
world	O
,	O
genetic	B-UNK
changes	B-UNK
during	O
its	O
carcinogenesis	B-DISEASE
are	O
not	O
well	O
understood	O
.	O

 	O
since	O
some	O
gastric	O
cancers	B-DISEASE
are	O
considered	B-UNK
to	O
originate	O
from	O
the	O
intestinal	B-UNK
metaplasia	B-DISEASE
,	O
it	O
is	O
likely	B-UNK
that	O
the	O
adenomatous	B-DISEASE
polyposis	I-DISEASE
coli	I-DISEASE
(	O
apc	B-UNK
)	O
gene	B-UNK
,	O
the	O
mutation	B-UNK
of	O
which	O
causes	B-UNK
adenomatous	B-DISEASE
polyps	I-DISEASE
in	O
the	O
colon	O
,	O
is	O
associated	B-UNK
with	O
carcinogenesis	B-DISEASE
of	O
gastric	B-DISEASE
cancer	I-DISEASE
.	O

 	O
based	B-UNK
on	O
this	O
idea	O
,	O
dnas	B-UNK
isolated	B-UNK
from	O
gastric	O
cancers	B-DISEASE
were	O
examined	B-UNK
by	O
means	O
of	O
a	O
rnase	B-UNK
protection	I-UNK
analysis	B-UNK
coupled	B-UNK
with	O
polymerase	B-UNK
chain	I-UNK
reaction	I-UNK
followed	B-UNK
by	O
sequencing	B-UNK
of	O
the	O
polymerase	B-UNK
chain	I-UNK
reaction	I-UNK
products	B-UNK
.	O

 	O
by	O
screening	B-UNK
nearly	O
one	O
-	O
half	B-UNK
of	O
the	O
coding	B-UNK
region	I-UNK
of	O
the	O
apc	B-UNK
gene	B-UNK
in	O
44	O
tumors	B-DISEASE
,	O
somatic	B-UNK
mutations	B-UNK
were	O
detected	B-UNK
in	O
three	O
tumors	B-DISEASE
a	O
missense	B-UNK
mutation	I-UNK
,	O
a	O
nonsense	B-UNK
mutation	B-UNK
,	O
and	O
a	O
5	O
-	O
base	B-UNK
pair	I-UNK
deletion	B-UNK
resulting	B-UNK
in	O
a	O
frame	B-UNK
shift	B-UNK
which	O
causes	B-UNK
truncation	O
of	O
the	O
gene	B-UNK
product	B-UNK
.	O

 	O
these	O
results	B-UNK
suggest	B-UNK
that	O
the	O
mutation	B-UNK
of	O
the	O
apc	B-UNK
gene	B-UNK
also	O
plays	O
an	O
important	B-UNK
role	B-UNK
during	O
the	O
carcinogenesis	B-DISEASE
of	O
at	B-DISEASE
least	O
some	O
gastric	O
cancers	B-DISEASE
.	O
.	O

 	O
a	O
71	O
-	O
kilodalton	O
protein	B-UNK
is	O
a	O
major	B-UNK
product	B-UNK
of	O
the	O
duchenne	B-UNK
muscular	B-DISEASE
dystrophy	I-DISEASE
gene	B-UNK
in	O
brain	B-UNK
and	O
other	O
nonmuscle	O
tissues	B-UNK
.	O

 	O
the	O
known	B-UNK
duchenne	B-UNK
muscular	B-DISEASE
dystrophy	I-DISEASE
(	O
dmd	B-UNK
)	O
gene	B-UNK
products	B-UNK
,	O
the	O
muscle	B-UNK
-	O
and	O
brain	B-UNK
-	O
type	B-UNK
dystrophin	B-UNK
isoforms	B-UNK
,	O
are	O
427	O
-	O
kda	B-UNK
proteins	B-UNK
translated	B-UNK
from	O
14	O
-	O
kilobase	O
(	O
kb	B-UNK
)	O
mrnas	B-UNK
.	O

 	O
recently	B-UNK
we	O
described	B-UNK
a	O
6	O
.	O

 	O
5	O
-	O
kb	B-UNK
mrna	B-UNK
that	O
also	O
is	O
transcribed	B-UNK
from	O
the	O
dmd	B-UNK
gene	B-UNK
.	O

 	O
cloning	B-UNK
and	O
in	O
vitro	B-UNK
transcription	B-UNK
and	O
translation	B-UNK
of	O
the	O
entire	B-UNK
coding	I-UNK
region	B-UNK
show	O
that	O
the	O
6	O
.	O

 	O
5	O
-	O
kb	B-UNK
mrna	B-UNK
encodes	B-UNK
a	O
70	O
.	O

 	O
8	O
-	O
kda	B-UNK
protein	B-UNK
that	O
is	O
a	O
major	B-UNK
product	B-UNK
of	O
the	O
dmd	B-UNK
gene	B-UNK
.	O

 	O
it	O
contains	B-UNK
the	O
c	B-UNK
-	O
terminal	B-UNK
and	O
the	O
cysteine	O
-	O
rich	B-UNK
domains	B-UNK
of	O
dystrophin	B-UNK
,	O
seven	B-UNK
additional	B-UNK
amino	O
acids	O
at	B-DISEASE
the	O
n	B-UNK
terminus	B-UNK
,	O
and	O
some	O
modifications	O
formed	B-UNK
by	O
alternative	B-UNK
splicing	I-UNK
in	O
the	O
c	B-UNK
-	O
terminal	B-UNK
domain	B-UNK
.	O

 	O
it	O
lacks	O
the	O
entire	B-UNK
large	B-UNK
domain	B-UNK
of	O
spectrin	O
-	O
like	B-UNK
repeats	B-UNK
and	O
the	O
actin	B-UNK
-	O
binding	B-UNK
n	B-UNK
-	O
terminal	B-UNK
domain	B-UNK
of	O
dystrophin	B-UNK
.	O

 	O
this	O
protein	B-UNK
is	O
the	O
major	B-UNK
dmd	B-UNK
gene	B-UNK
product	B-UNK
in	O
brain	B-UNK
and	O
other	O
nonmuscle	O
tissues	B-UNK
but	O
is	O
undetectable	B-UNK
in	O
skeletal	B-UNK
muscle	I-UNK
extracts	B-UNK
.	O

 	O
correlation	B-UNK
between	O
the	O
location	B-UNK
of	O
germ	O
-	O
line	B-UNK
mutations	B-UNK
in	O
the	O
apc	B-UNK
gene	B-UNK
and	O
the	O
number	B-UNK
of	O
colorectal	B-UNK
polyps	B-DISEASE
in	O
familial	B-DISEASE
adenomatous	I-DISEASE
polyposis	I-DISEASE
patients	B-UNK
.	O

 	O
recently	B-UNK
we	O
have	O
isolated	B-UNK
the	O
adenomatous	B-DISEASE
polyposis	I-DISEASE
coli	I-DISEASE
(	O
apc	B-UNK
)	O
gene	B-UNK
which	O
causes	B-UNK
familial	B-DISEASE
adenomatous	I-DISEASE
polyposis	I-DISEASE
(	O
fap	B-DISEASE
)	O
,	O
and	O
its	O
germ	O
-	O
line	B-UNK
mutations	B-UNK
in	O
a	O
substantial	B-UNK
number	B-UNK
of	O
fap	B-DISEASE
patients	B-UNK
have	O
been	O
identified	B-UNK
.	O

 	O
on	O
the	O
basis	B-UNK
of	O
this	O
information	B-UNK
,	O
we	O
compared	B-UNK
the	O
location	B-UNK
of	O
germ	O
-	O
line	B-UNK
mutations	B-UNK
in	O
the	O
apc	B-UNK
gene	B-UNK
in	O
22	O
unrelated	B-UNK
patients	B-UNK
(	O
12	O
of	O
whom	O
have	O
been	O
reported	B-UNK
previously	B-UNK
)	O
with	O
the	O
number	B-UNK
of	O
colorectal	B-UNK
polyps	B-DISEASE
developed	B-UNK
in	O
fap	B-DISEASE
patients	B-UNK
;	O
17	O
were	O
sparse	O
types	B-UNK
and	O
five	O
were	O
profuse	O
types	B-UNK
.	O

 	O
all	O
but	O
one	O
of	O
the	O
mutations	B-UNK
were	O
considered	B-UNK
to	O
cause	B-UNK
truncation	O
of	O
the	O
gene	B-UNK
product	B-UNK
by	O
frame	B-UNK
-	O
shift	B-UNK
due	O
to	O
deletion	B-UNK
(	O
14	O
cases	B-UNK
)	O
or	O
nonsense	B-UNK
mutation	B-UNK
(	O
seven	B-UNK
cases	B-UNK
)	O
.	O

 	O
the	O
location	B-UNK
of	O
the	O
germ	O
-	O
line	B-UNK
mutations	B-UNK
seems	O
to	O
correlate	B-UNK
with	O
the	O
two	O
clinical	B-UNK
types	B-UNK
;	O
germ	O
-	O
line	B-UNK
mutations	B-UNK
in	O
five	O
fap	B-DISEASE
patients	B-UNK
with	O
profuse	O
polyps	B-DISEASE
were	O
observed	B-UNK
between	O
codon	B-UNK
1250	O
and	O
codon	B-UNK
1464	O
,	O
whereas	O
mutations	B-UNK
in	O
17	O
fap	B-DISEASE
patients	B-UNK
with	O
fewer	B-UNK
polyps	B-DISEASE
were	O
observed	B-UNK
in	O
the	O
other	O
regions	B-UNK
of	O
the	O
apc	B-UNK
gene	B-UNK
.	O

 	O
the	O
result	B-UNK
suggests	B-UNK
that	O
the	O
number	B-UNK
of	O
colorectal	B-UNK
polyps	B-DISEASE
in	O
fap	B-DISEASE
patients	B-UNK
may	O
be	O
associated	B-UNK
with	O
a	O
difference	B-UNK
in	O
the	O
stability	B-UNK
or	O
biological	B-UNK
function	B-UNK
of	O
the	O
truncated	B-UNK
apc	B-UNK
protein	B-UNK
.	O
.	O

 	O
identification	B-UNK
and	O
rapid	B-UNK
detection	B-UNK
of	O
three	O
tay	O
-	O
sachs	B-UNK
mutations	B-UNK
in	O
the	O
moroccan	B-UNK
jewish	I-UNK
population	B-UNK
.	O

 	O
infantile	B-UNK
tay	B-DISEASE
-	I-DISEASE
sachs	I-DISEASE
disease	I-DISEASE
(	O
tsd	B-UNK
)	O
is	O
caused	B-UNK
by	O
mutations	B-UNK
in	O
the	O
hexa	B-UNK
gene	B-UNK
that	O
result	B-UNK
in	O
the	O
complete	B-UNK
absence	B-UNK
of	O
beta	B-UNK
-	O
hexosaminidase	O
a	O
activity	B-UNK
.	O

 	O
it	O
is	O
well	O
known	B-UNK
that	O
an	O
elevated	B-UNK
frequency	B-UNK
of	O
tsd	B-UNK
mutations	B-UNK
exists	B-UNK
among	O
ashkenazi	B-UNK
jews	B-UNK
.	O

 	O
more	O
recently	B-UNK
it	O
has	O
become	O
apparent	B-UNK
that	O
elevated	B-UNK
carrier	B-UNK
frequencies	B-UNK
for	O
tsd	B-UNK
also	O
occur	B-UNK
in	O
several	O
other	O
ethnic	B-UNK
groups	B-UNK
,	O
including	B-UNK
moroccan	B-UNK
jews	B-UNK
,	O
a	O
subgroup	O
of	O
sephardic	O
jews	B-UNK
.	O

 	O
elsewhere	O
we	O
reported	B-UNK
an	O
in	O
-	O
frame	B-UNK
deletion	B-UNK
of	O
one	O
of	O
the	O
two	O
adjacent	B-UNK
phenylalanine	O
codons	B-UNK
at	B-DISEASE
position	B-UNK
304	O
or	O
305	O
(	O
delta	B-UNK
f304	O
/	O
305	O
)	O
in	O
one	O
hexa	B-UNK
allele	B-UNK
of	O
a	O
moroccan	B-UNK
jewish	I-UNK
tsd	B-UNK
patient	B-UNK
and	O
in	O
three	O
obligate	B-UNK
carriers	B-UNK
from	O
six	O
unrelated	B-UNK
moroccan	B-UNK
jewish	I-UNK
families	B-UNK
.	O

 	O
we	O
have	O
now	O
identified	B-UNK
two	O
additional	B-UNK
mutations	B-UNK
within	O
exon	B-UNK
5	O
of	O
the	O
hexa	B-UNK
gene	B-UNK
that	O
account	B-UNK
for	O
the	O
remaining	B-UNK
tsd	B-UNK
alleles	I-UNK
in	O
the	O
patient	B-UNK
and	O
carriers	B-UNK
.	O

 	O
one	O
of	O
the	O
mutations	B-UNK
is	O
a	O
novel	B-UNK
c	B-UNK
-	O
to	O
-	O
g	B-UNK
transversion	B-UNK
,	O
resulting	B-UNK
in	O
a	O
replacement	O
of	O
tyr180	O
by	O
a	O
stop	B-UNK
codon	B-UNK
.	O

 	O
the	O
other	O
mutation	B-UNK
is	O
a	O
g	B-UNK
-	O
to	O
-	O
a	O
transition	B-UNK
resulting	B-UNK
in	O
an	O
arg170	O
-	O
to	O
-	O
gln	B-UNK
substitution	B-UNK
.	O

 	O
this	O
mutation	B-UNK
is	O
at	B-DISEASE
a	O
cpg	B-UNK
site	B-UNK
in	O
a	O
japanese	B-UNK
infant	B-DISEASE
with	O
tay	B-DISEASE
-	I-DISEASE
sachs	I-DISEASE
disease	I-DISEASE
and	O
was	O
described	B-UNK
elsewhere	O
.	O

 	O
analysis	B-UNK
of	O
nine	O
obligate	B-UNK
carriers	B-UNK
from	O
seven	B-UNK
unrelated	B-UNK
families	I-UNK
showed	B-UNK
that	O
four	O
harbor	O
the	O
delta	B-UNK
f304	O
/	O
305	O
mutation	B-UNK
,	O
two	O
the	O
arg170	O
-	O
-	O
-	O
-	O
gln	B-UNK
mutation	B-UNK
,	O
and	O
one	O
the	O
tyr180	O
-	O
-	O
-	O
-	O
stop	B-UNK
mutation	B-UNK
.	O

 	O
we	O
also	O
have	O
developed	B-UNK
rapid	B-UNK
,	O
nonradioactive	O
assays	B-UNK
for	O
the	O
detection	B-UNK
of	O
each	O
mutation	B-UNK
,	O
which	O
should	O
be	O
helpful	O
for	O
carrier	B-UNK
screening	B-UNK
.	O
.	O

 	B-UNK
molecular	I-UNK
characterization	B-UNK
of	O
glucose	B-UNK
-	O
6	O
-	O
phosphate	B-UNK
dehydrogenase	I-UNK
(	O
g6pd	B-UNK
)	O
deficiency	B-UNK
by	O
natural	B-UNK
and	O
amplification	B-UNK
created	B-UNK
restriction	O
sites	B-UNK
:	O
five	O
mutations	B-UNK
account	B-UNK
for	O
most	O
g6pd	B-UNK
deficiency	I-UNK
cases	B-UNK
in	O
taiwan	O
.	O

 	O
we	O
have	O
developed	B-UNK
a	O
rapid	B-UNK
and	O
simple	B-UNK
method	B-UNK
to	O
diagnose	O
the	O
molecular	B-UNK
defects	B-UNK
of	O
glucose	B-UNK
-	O
6	O
-	O
phosphate	B-UNK
dehydrogenase	I-UNK
(	O
g6pd	B-UNK
)	O
deficiency	B-UNK
in	O
chinese	B-UNK
in	O
taiwan	O
.	O

 	O
this	O
method	B-UNK
involves	B-UNK
the	O
selective	B-UNK
amplification	B-UNK
of	O
a	O
dna	B-UNK
fragment	O
from	O
human	B-UNK
g6pd	B-UNK
gene	B-UNK
with	O
specific	B-UNK
oligonucleotide	I-UNK
primers	B-UNK
followed	B-UNK
by	O
digestion	B-UNK
with	O
restriction	O
enzymes	B-UNK
that	O
recognize	O
artificially	O
created	B-UNK
or	O
naturally	O
occurring	B-UNK
restriction	O
sites	B-UNK
.	O

 	O
ninety	O
-	O
four	O
chinese	B-UNK
males	B-UNK
with	O
g6pd	B-UNK
deficiency	I-UNK
were	O
studied	B-UNK
.	O

 	O
the	O
results	B-UNK
show	O
that	O
50	O
%	O
(	O
47	O
of	O
94	O
)	O
were	O
g	B-UNK
to	O
t	B-UNK
mutation	B-UNK
at	B-DISEASE
nucleotide	B-UNK
(	O
nt	O
)	O
1376	O
,	O
21	O
.	O

 	O
3	O
%	O
(	O
20	O
of	O
94	O
)	O
were	O
g	B-UNK
to	O
a	O
mutation	B-UNK
at	B-DISEASE
nt	O
1388	O
,	O
7	O
.	O

 	O
4	O
%	O
(	O
7	O
of	O
94	O
)	O
were	O
a	O
to	O
g	B-UNK
mutation	B-UNK
at	B-DISEASE
nt	O
493	O
,	O
7	O
.	O

 	O
4	O
%	O
(	O
7	O
of	O
94	O
)	O
were	O
a	O
to	O
g	B-UNK
mutation	B-UNK
at	B-DISEASE
nt	O
95	O
,	O
4	O
.	O

 	O
2	O
%	O
(	O
4	O
of	O
94	O
)	O
were	O
c	B-UNK
to	O
t	B-UNK
mutation	B-UNK
at	B-DISEASE
nt	O
1024	O
,	O
1	O
.	O

 	O
1	O
%	O
(	O
1	O
of	O
94	O
)	O
was	O
g	B-UNK
to	O
t	B-UNK
mutation	B-UNK
at	B-DISEASE
nt	O
392	O
,	O
and	O
1	O
.	O

 	O
1	O
%	O
(	O
1	O
of	O
94	O
)	O
was	O
g	B-UNK
to	O
a	O
mutation	B-UNK
at	B-DISEASE
nt	O
487	O
.	O

 	O
these	O
results	B-UNK
show	O
that	O
the	O
former	O
five	O
mutations	B-UNK
account	B-UNK
for	O
more	O
than	O
90	O
%	O
of	O
g6pd	B-UNK
deficiency	I-UNK
cases	B-UNK
in	O
taiwan	O
.	O

 	O
aside	O
from	O
showing	B-UNK
that	O
g	B-UNK
to	O
t	B-UNK
change	B-UNK
at	B-DISEASE
nt	O
1376	O
is	O
the	O
most	O
common	B-UNK
mutation	B-UNK
,	O
our	O
research	B-UNK
indicates	B-UNK
that	O
nt	O
493	O
mutation	B-UNK
is	O
a	O
frequent	B-UNK
mutation	B-UNK
among	O
chinese	B-UNK
in	O
taiwan	O
.	O

 	O
we	O
compared	B-UNK
g6pd	B-UNK
activity	I-UNK
among	O
different	B-UNK
mutations	B-UNK
,	O
without	O
discovering	O
significant	B-UNK
differences	I-UNK
between	O
them	O
.	O

 	O
eight	O
novel	B-UNK
inactivating	B-UNK
germ	B-UNK
line	I-UNK
mutations	I-UNK
at	B-DISEASE
the	O
apc	B-UNK
gene	B-UNK
identified	B-UNK
by	O
denaturing	B-UNK
gradient	B-UNK
gel	B-UNK
electrophoresis	I-UNK
.	O

 	O
familial	B-DISEASE
adenomatous	I-DISEASE
polyposis	I-DISEASE
(	O
fap	B-DISEASE
)	O
is	O
a	O
dominantly	B-UNK
inherited	I-UNK
condition	B-UNK
predisposing	B-UNK
to	O
colorectal	B-DISEASE
cancer	I-DISEASE
.	O

 	O
the	O
recent	B-UNK
isolation	B-UNK
of	O
the	O
responsible	B-UNK
gene	B-UNK
(	O
adenomatous	B-DISEASE
polyposis	I-DISEASE
coli	I-DISEASE
or	O
apc	B-UNK
)	O
has	O
facilitated	O
the	O
search	O
for	O
germ	B-UNK
line	I-UNK
mutations	I-UNK
in	O
affected	B-UNK
individuals	I-UNK
.	O

 	B-UNK
previous	I-UNK
authors	B-UNK
have	O
used	O
the	O
rnase	B-UNK
protection	I-UNK
assay	B-UNK
and	O
the	O
single	B-UNK
-	O
strand	O
conformation	O
polymorphisms	B-UNK
procedure	B-UNK
to	O
screen	B-UNK
for	O
mutations	B-UNK
.	O

 	O
in	O
this	O
study	B-UNK
we	O
used	O
denaturing	B-UNK
gradient	B-UNK
gel	B-UNK
electrophoresis	I-UNK
(	O
dgge	B-UNK
)	O
.	O

 	O
dgge	B-UNK
analysis	B-UNK
of	O
10	O
apc	B-UNK
exons	B-UNK
(	O
4	O
,	O
5	O
,	O
7	O
,	O
8	O
,	O
9	O
,	O
10	O
,	O
12	O
,	O
13	O
,	O
14	O
,	O
and	O
part	O
of	O
15	O
)	O
in	O
33	O
unrelated	B-UNK
dutch	B-UNK
fap	B-DISEASE
patients	B-UNK
has	O
led	B-UNK
to	O
the	O
identification	B-UNK
of	O
eight	O
novel	B-UNK
germ	B-UNK
line	I-UNK
mutations	I-UNK
resulting	B-UNK
in	O
stop	B-UNK
codons	B-UNK
or	O
frameshifts	O
.	O

 	O
the	O
results	B-UNK
reported	B-UNK
here	O
indicate	B-UNK
that	O
(	O
1	O
)	O
familial	B-DISEASE
adenomatous	I-DISEASE
polyposis	I-DISEASE
is	O
caused	B-UNK
by	O
an	O
extremely	B-UNK
heterogeneous	B-UNK
spectrum	B-UNK
of	O
point	B-UNK
mutations	I-UNK
;	O
(	O
2	O
)	O
all	O
the	O
mutations	B-UNK
found	B-UNK
in	O
this	O
study	B-UNK
are	O
chain	O
terminating	O
;	O
and	O
(	O
3	O
)	O
dgge	B-UNK
represents	B-UNK
a	O
rapid	B-UNK
and	O
sensitive	B-UNK
technique	B-UNK
for	O
the	O
detection	B-UNK
of	O
mutations	B-UNK
in	O
the	O
unusually	O
large	B-UNK
apc	B-UNK
gene	B-UNK
.	O

 	O
an	O
extension	O
of	O
the	O
dgge	B-UNK
analysis	B-UNK
to	O
the	O
entire	B-UNK
coding	I-UNK
region	B-UNK
in	O
a	O
sufficient	B-UNK
number	B-UNK
of	O
clinically	B-UNK
well	O
-	O
characterized	B-UNK
,	O
unrelated	B-UNK
patients	B-UNK
will	O
facilitate	B-UNK
the	O
establishment	O
of	O
genotype	B-UNK
-	O
phenotype	B-UNK
correlations	B-UNK
.	O

 	O
on	O
the	O
other	O
hand	B-DISEASE
,	O
the	O
occurrence	B-UNK
of	O
an	O
extremely	B-UNK
heterogeneous	B-UNK
spectrum	B-UNK
of	O
mutations	B-UNK
spread	B-UNK
throughout	O
the	O
entire	B-UNK
length	O
of	O
the	O
large	B-UNK
apc	B-UNK
gene	B-UNK
among	O
the	O
fap	B-DISEASE
patients	B-UNK
indicates	B-UNK
that	O
this	O
approach	B-UNK
may	O
not	O
be	O
useful	B-UNK
as	O
a	O
rapid	B-UNK
presymptomatic	B-UNK
diagnostic	B-UNK
procedure	B-UNK
in	O
a	O
routine	B-UNK
laboratory	B-UNK
.	O

 	O
nevertheless	O
,	O
the	O
above	O
dgge	B-UNK
approach	B-UNK
has	O
incidentally	O
led	B-UNK
to	O
the	O
identification	B-UNK
of	O
a	O
common	B-UNK
polymorphism	O
in	O
exon	B-UNK
13	O
.	O

 	O
such	O
intragenic	B-UNK
polymorphisms	B-UNK
offer	O
a	O
practical	B-UNK
approach	B-UNK
to	O
a	O
more	O
rapid	B-UNK
procedure	B-UNK
for	O
presymptomatic	B-UNK
diagnosis	B-UNK
of	O
fap	B-DISEASE
by	O
linkage	B-UNK
analysis	I-UNK
in	O
informative	B-UNK
families	B-UNK
.	O
.	O

 	O
yeast	B-UNK
artificial	I-UNK
chromosomes	B-UNK
for	O
the	O
molecular	B-UNK
analysis	B-UNK
of	O
the	O
familial	B-UNK
polyposis	B-DISEASE
apc	B-UNK
gene	B-UNK
region	B-UNK
.	O

 	O
two	O
yeast	B-UNK
artificial	I-UNK
chromosomes	B-UNK
(	O
yacs	B-UNK
)	O
spanning	B-UNK
a	O
total	B-UNK
distance	B-UNK
of	O
1	O
.	O

 	O
1	O
megabase	O
pairs	B-UNK
of	O
dna	B-UNK
around	O
the	O
mcc	O
(	O
for	O
mutated	B-UNK
in	O
colorectal	B-UNK
carcinoma	B-DISEASE
)	O
and	O
apc	B-UNK
(	O
for	O
adenomatous	B-DISEASE
polyposis	I-DISEASE
coli	I-DISEASE
)	O
genes	B-UNK
at	B-DISEASE
5q21	O
have	O
been	O
isolated	B-UNK
and	O
characterized	B-UNK
.	O

 	O
starting	B-UNK
from	O
the	O
mcc	O
gene	B-UNK
,	O
a	O
strategy	O
was	O
undertaken	O
to	O
identify	B-UNK
constitutional	B-UNK
submicroscopic	B-UNK
deletions	B-UNK
in	O
familial	B-DISEASE
adenomatous	I-DISEASE
polyposis	I-DISEASE
patients	B-UNK
that	O
might	O
considerably	O
narrow	B-UNK
down	O
the	O
position	B-UNK
of	O
the	O
apc	B-UNK
gene	B-UNK
.	O

 	O
to	O
this	O
end	B-UNK
,	O
yacs	B-UNK
identified	B-UNK
by	O
the	O
mcc	O
gene	B-UNK
were	O
screened	O
across	O
a	O
chromosome	B-DISEASE
5	I-DISEASE
-	O
specific	B-UNK
cosmid	B-UNK
library	B-UNK
to	O
provide	B-UNK
a	O
source	O
of	O
dna	B-UNK
probes	I-UNK
for	O
genomic	B-UNK
scanning	B-UNK
.	O

 	O
the	O
cosmids	O
isolated	B-UNK
from	O
these	O
experiments	B-UNK
were	O
used	O
to	O
screen	B-UNK
a	O
panel	O
of	O
somatic	B-UNK
cell	I-UNK
hybrids	I-UNK
containing	B-UNK
chromosome	B-DISEASE
5	I-DISEASE
segregated	B-UNK
from	O
patients	B-UNK
suspected	B-UNK
to	O
carry	B-UNK
putative	B-UNK
interstitial	B-UNK
deletions	B-UNK
.	O

 	O
this	O
screening	B-UNK
approach	B-UNK
led	B-UNK
to	O
the	O
confirmation	O
of	O
a	O
small	B-UNK
heterozygous	B-UNK
deletion	I-UNK
in	O
a	O
polyposis	B-DISEASE
patient	B-UNK
that	O
overlaps	B-UNK
one	O
of	O
the	O
two	O
isolated	B-UNK
yacs	B-UNK
.	O

 	O
this	O
yac	B-UNK
has	O
been	O
shown	B-UNK
to	O
contain	B-UNK
the	O
entire	B-UNK
apc	B-UNK
gene	B-UNK
,	O
in	O
addition	B-UNK
to	O
a	O
significant	B-UNK
portion	B-UNK
of	O
dna	B-UNK
flanking	B-UNK
the	O
5	O
end	B-UNK
of	O
the	O
gene	B-UNK
,	O
and	O
should	O
therefore	O
prove	O
a	O
valuable	B-UNK
resource	O
for	O
functional	B-UNK
studies	B-UNK
by	O
transfer	O
to	O
colorectal	B-UNK
tumor	B-DISEASE
-	O
derived	B-UNK
cell	B-UNK
lines	B-UNK
.	O

 	B-UNK
inherited	I-UNK
wt1	B-UNK
mutation	B-UNK
in	O
denys	B-DISEASE
-	I-DISEASE
drash	I-DISEASE
syndrome	I-DISEASE
.	O

 	B-UNK
patients	I-UNK
with	O
the	O
denys	B-DISEASE
-	I-DISEASE
drash	I-DISEASE
syndrome	I-DISEASE
(	O
wilms	B-DISEASE
tumor	I-DISEASE
,	O
genital	O
anomalies	B-UNK
,	O
and	O
nephropathy	B-DISEASE
)	O
have	O
been	O
demonstrated	B-UNK
to	O
carry	B-UNK
de	B-UNK
novo	I-UNK
constitutional	B-UNK
mutations	B-UNK
in	O
wt1	B-UNK
,	O
the	O
wilms	B-DISEASE
tumor	I-DISEASE
gene	B-UNK
at	B-DISEASE
chromosome	B-UNK
11p13	B-UNK
.	O

 	O
we	O
report	B-UNK
three	O
new	B-UNK
cases	B-UNK
,	O
two	O
carrying	B-UNK
a	O
previously	B-UNK
described	I-UNK
wt1	B-UNK
exon	B-UNK
9	O
mutation	B-UNK
and	O
one	O
with	O
a	O
novel	B-UNK
wt1	B-UNK
exon	B-UNK
8	O
mutation	B-UNK
.	O

 	O
however	O
,	O
unlike	B-UNK
patients	B-UNK
in	O
previous	B-UNK
reports	B-UNK
,	O
one	O
of	O
our	O
three	O
patients	B-UNK
inherited	B-UNK
the	O
affected	B-UNK
allele	B-UNK
from	O
his	O
phenotypically	O
unaffected	B-UNK
father	B-UNK
.	O

 	O
this	O
observation	B-UNK
indicates	B-UNK
that	O
the	O
wt1	B-UNK
exon	B-UNK
9	O
mutation	B-UNK
affecting	B-UNK
394arg	O
demonstrated	B-UNK
in	O
over	O
one	O
-	O
half	B-UNK
of	O
the	O
patients	B-UNK
with	O
the	O
denys	B-DISEASE
-	I-DISEASE
drash	I-DISEASE
syndrome	I-DISEASE
may	O
exhibit	B-UNK
incomplete	B-UNK
penetrance	B-UNK
.	O

 	O
consequently	B-UNK
,	O
familial	B-UNK
studies	B-UNK
in	O
patients	B-UNK
affected	B-UNK
by	O
this	O
syndrome	B-DISEASE
are	O
recommended	O
.	O
.	O

 	O
submicroscopic	B-UNK
deletions	B-UNK
at	B-DISEASE
the	O
wagr	B-UNK
locus	B-UNK
,	O
revealed	B-UNK
by	O
nonradioactive	O
in	O
situ	B-UNK
hybridization	I-UNK
.	O

 	O
fluorescence	B-UNK
in	O
situ	B-UNK
hybridization	I-UNK
(	O
fish	B-UNK
)	O
with	O
biotin	O
-	O
labeled	B-UNK
probes	B-UNK
mapping	B-UNK
to	O
11p13	B-UNK
has	O
been	O
used	O
for	O
the	O
molecular	B-UNK
analysis	B-UNK
of	O
deletions	B-UNK
of	O
the	O
wagr	B-UNK
(	O
wilms	B-DISEASE
tumor	I-DISEASE
,	O
aniridia	B-DISEASE
,	O
genitourinary	O
abnormalities	B-DISEASE
,	O
and	O
mental	B-DISEASE
retardation	I-DISEASE
)	O
locus	B-UNK
.	O

 	O
we	O
have	O
detected	B-UNK
a	O
submicroscopic	B-UNK
11p13	B-UNK
deletion	B-UNK
in	O
a	O
child	B-UNK
with	O
inherited	B-UNK
aniridia	B-DISEASE
who	O
subsequently	B-UNK
presented	B-UNK
with	O
wilms	B-DISEASE
tumor	I-DISEASE
in	O
a	O
horseshoe	O
kidney	B-UNK
,	O
only	O
revealed	B-UNK
at	B-DISEASE
surgery	B-UNK
.	O

 	O
the	O
mother	B-UNK
,	O
who	O
has	O
aniridia	B-DISEASE
,	O
was	O
also	O
found	B-UNK
to	O
carry	B-UNK
a	O
deletion	B-UNK
including	B-UNK
both	O
the	O
aniridia	B-DISEASE
candidate	B-UNK
gene	B-UNK
(	O
an2	B-UNK
)	O
and	O
the	O
wilms	B-DISEASE
tumor	I-DISEASE
predisposition	B-UNK
gene	B-UNK
(	O
wt1	B-UNK
)	O
.	O

 	O
this	O
is	O
therefore	O
a	O
rare	B-UNK
case	B-UNK
of	O
an	O
inherited	B-UNK
wagr	B-UNK
deletion	B-UNK
.	O

 	O
wilms	B-DISEASE
tumor	I-DISEASE
has	O
so	O
far	B-UNK
only	O
been	O
associated	B-UNK
with	O
sporadic	B-UNK
de	B-UNK
novo	I-UNK
aniridia	B-DISEASE
cases	B-UNK
.	O

 	O
we	O
have	O
shown	B-UNK
that	O
a	O
cosmid	B-UNK
probe	B-UNK
for	O
a	O
candidate	B-UNK
aniridia	B-DISEASE
gene	B-UNK
,	O
homologous	B-UNK
to	O
the	O
mouse	B-UNK
pax	B-UNK
-	O
6	O
gene	B-UNK
,	O
is	O
deleted	B-UNK
in	O
cell	B-UNK
lines	B-UNK
from	O
aniridia	B-DISEASE
patients	B-UNK
with	O
previously	B-UNK
characterized	B-UNK
deletions	B-UNK
at	B-DISEASE
11p13	B-UNK
,	O
while	O
another	O
cosmid	B-UNK
marker	B-UNK
mapping	B-UNK
between	O
two	O
aniridia	B-DISEASE
-	O
associated	B-UNK
translocation	B-DISEASE
breakpoints	B-UNK
(	O
and	O
hence	O
a	O
second	B-UNK
candidate	B-UNK
marker	B-UNK
)	O
is	O
present	B-UNK
on	O
both	O
chromosomes	B-UNK
.	O

 	O
these	O
results	B-UNK
support	B-UNK
the	O
pax	B-UNK
-	O
6	O
homologue	B-UNK
as	O
a	O
strong	B-UNK
candidate	B-UNK
for	O
the	O
an2	B-UNK
gene	B-UNK
.	O

 	O
fish	B-UNK
with	O
cosmid	B-UNK
probes	B-UNK
has	O
proved	O
to	O
be	O
a	O
fast	B-UNK
and	O
reliable	B-UNK
technique	B-UNK
for	O
the	O
molecular	B-UNK
analysis	B-UNK
of	O
deletions	B-UNK
.	O

 	O
it	O
can	O
be	O
used	O
with	O
limited	B-UNK
amounts	B-UNK
of	O
material	B-UNK
and	O
has	O
strong	B-UNK
potential	B-UNK
for	O
clinical	B-UNK
applications	O
.	O
.	O

 	B-UNK
linkage	I-UNK
of	O
gene	B-UNK
for	O
c2	B-UNK
deficiency	I-UNK
and	O
the	O
major	B-UNK
histocompatibility	I-UNK
complex	B-UNK
mhc	B-UNK
in	O
man	B-UNK
.	O

 	B-UNK
family	I-UNK
study	B-UNK
of	O
a	O
further	O
case	B-UNK
.	O

 	O
close	B-UNK
linkage	I-UNK
between	O
hl	O
-	O
a	O
and	O
c2	B-UNK
deficiency	I-UNK
was	O
first	O
reported	B-UNK
by	O
fu	O
and	O
co	B-UNK
-	O
workers	O
in	O
1974	O
.	O

 	O
we	O
present	B-UNK
here	O
a	O
pedigree	B-UNK
of	O
a	O
31	O
-	O
year	B-UNK
-	O
old	B-UNK
c2	B-UNK
-	O
deficient	B-UNK
individual	B-UNK
with	O
clinical	B-UNK
manifestations	B-UNK
of	O
hodgkins	O
disease	B-DISEASE
.	O

 	O
the	O
following	B-UNK
markers	B-UNK
were	O
tested	B-UNK
c2	B-UNK
levels	B-UNK
,	O
factor	B-UNK
b	B-UNK
polymorphism	O
,	O
blood	B-UNK
groups	B-UNK
,	O
and	O
enzyme	B-UNK
typing	B-UNK
.	O

 	O
in	O
addition	B-UNK
to	O
close	B-UNK
linkage	I-UNK
between	O
hl	O
-	O
a	O
and	O
c2	B-UNK
deficiency	I-UNK
,	O
both	O
parents	B-UNK
were	O
heterozygous	B-UNK
for	O
bf	O
(	O
hl	O
-	O
a	O
linked	B-UNK
,	O
electrophoretic	B-UNK
variation	B-UNK
of	O
b	B-UNK
)	O
.	O

 	O
the	O
two	O
hl	O
-	O
a	O
haplotypes	B-UNK
closely	B-UNK
linked	I-UNK
to	O
c2	B-UNK
deficiency	I-UNK
are	O
different	B-UNK
2	O
,	O
w18	O
and	O
w24	O
,	O
w18	O
.	O

 	O
they	O
share	B-UNK
,	O
however	O
,	O
the	O
sd2	O
antigen	B-UNK
w18	O
and	O
the	O
ld	O
type	B-UNK
7a	O
.	O
.	O

 	O
screening	B-UNK
for	O
germ	O
-	O
line	B-UNK
mutations	B-UNK
in	O
familial	B-DISEASE
adenomatous	I-DISEASE
polyposis	I-DISEASE
patients	B-UNK
:	O
61	O
new	B-UNK
patients	B-UNK
and	O
a	O
summary	O
of	O
150	O
unrelated	B-UNK
patients	B-UNK
.	O

 	O
we	O
report	B-UNK
here	O
the	O
result	B-UNK
of	O
a	O
screening	B-UNK
for	O
germ	O
-	O
line	B-UNK
mutations	B-UNK
in	O
the	O
adenomatous	B-DISEASE
polyposis	I-DISEASE
coli	I-DISEASE
(	O
apc	B-UNK
)	O
gene	B-UNK
in	O
61	O
new	B-UNK
familial	B-DISEASE
adenomatous	I-DISEASE
polyposis	I-DISEASE
(	O
fap	B-DISEASE
)	O
patients	B-UNK
as	O
well	O
as	O
a	O
summary	O
of	O
the	O
results	B-UNK
of	O
150	O
patients	B-UNK
.	O

 	O
examination	B-UNK
of	O
the	O
entire	B-UNK
coding	I-UNK
region	B-UNK
of	O
the	O
apc	B-UNK
gene	B-UNK
,	O
based	B-UNK
on	O
a	O
ribonuclease	B-UNK
protection	B-UNK
assay	I-UNK
coupled	B-UNK
with	O
the	O
polymerase	B-UNK
chain	I-UNK
reaction	I-UNK
(	O
pcr	B-UNK
)	O
,	O
disclosed	B-UNK
mutations	B-UNK
that	O
were	O
considered	B-UNK
to	O
cause	B-UNK
significant	B-UNK
defects	B-UNK
in	O
the	O
apc	B-UNK
product	B-UNK
in	O
97	O
of	O
150	O
unrelated	B-UNK
fap	B-DISEASE
patients	B-UNK
.	O

 	O
our	O
findings	B-UNK
revealed	B-UNK
the	O
following	B-UNK
characteristics	B-UNK
of	O
the	O
germ	O
-	O
line	B-UNK
mutations	B-UNK
of	O
apc	B-UNK
1	O
)	O
the	O
great	B-UNK
majority	B-UNK
of	O
the	O
mutations	B-UNK
were	O
found	B-UNK
to	O
truncate	O
the	O
apc	B-UNK
product	B-UNK
;	O
2	O
)	O
almost	O
all	O
of	O
the	O
mutations	B-UNK
were	O
located	B-UNK
within	O
the	O
first	O
half	B-UNK
of	O
the	O
coding	B-UNK
region	I-UNK
;	O
3	O
)	O
no	O
correlation	B-UNK
was	O
observed	B-UNK
between	O
the	O
locations	B-UNK
of	O
germ	O
-	O
line	B-UNK
mutations	B-UNK
and	O
extracolonic	O
manifestations	B-UNK
in	O
fap	B-DISEASE
patients	B-UNK
;	O
4	O
)	O
more	O
than	O
80	O
%	O
of	O
base	B-UNK
substitutions	B-UNK
in	O
the	O
apc	B-UNK
gene	B-UNK
were	O
from	O
cytosine	O
to	O
other	O
nucleotides	B-UNK
,	O
nearly	O
one	O
-	O
third	O
of	O
which	O
occurred	B-UNK
at	B-DISEASE
the	O
gpg	O
site	B-UNK
.	O

 	O
our	O
results	B-UNK
provide	I-UNK
information	B-UNK
helpful	O
to	O
an	O
understanding	B-UNK
of	O
the	O
apc	B-UNK
gene	B-UNK
and	O
will	O
also	O
contribute	B-UNK
to	O
presymptomatic	B-UNK
diagnosis	B-UNK
of	O
members	B-UNK
in	O
fap	B-DISEASE
families	B-UNK
.	O
.	O

 	O
somatic	B-UNK
mutations	B-UNK
of	O
the	O
apc	B-UNK
gene	B-UNK
in	O
colorectal	B-UNK
tumors	B-DISEASE
:	O
mutation	B-UNK
cluster	B-UNK
region	I-UNK
in	O
the	O
apc	B-UNK
gene	B-UNK
.	O

 	O
we	O
examined	B-UNK
somatic	B-UNK
mutations	B-UNK
of	O
the	O
adenomatous	B-DISEASE
polyposis	I-DISEASE
coli	I-DISEASE
(	O
apc	B-UNK
)	O
gene	B-UNK
in	O
63	O
colorectal	B-UNK
tumors	B-DISEASE
(	O
16	O
adenomas	B-UNK
and	O
47	O
carcinomas	B-UNK
)	O
developed	B-UNK
in	O
familial	B-DISEASE
adenomatous	I-DISEASE
polyposis	I-DISEASE
(	O
fap	B-DISEASE
)	O
and	O
non	B-UNK
-	O
fap	B-DISEASE
patients	B-UNK
.	O

 	O
in	O
addition	B-UNK
to	O
loss	B-UNK
of	O
heterozygosity	B-UNK
(	O
loh	O
)	O
at	B-DISEASE
the	O
apc	B-UNK
locus	B-UNK
in	O
30	O
tumors	B-DISEASE
,	O
43	O
other	O
somatic	B-UNK
mutations	B-UNK
were	O
detected	B-UNK
.	O

 	O
twenty	O
-	O
one	O
of	O
them	O
were	O
point	B-UNK
mutations	I-UNK
;	O
16	O
nonsense	B-UNK
and	O
two	O
missense	B-UNK
mutations	I-UNK
,	O
and	O
three	O
occurred	B-UNK
in	O
introns	B-UNK
at	B-DISEASE
the	O
splicing	B-UNK
site	B-UNK
.	O

 	O
twenty	O
-	O
two	O
tumors	B-DISEASE
had	O
frameshift	B-UNK
mutations	B-UNK
due	O
to	O
deletion	B-UNK
or	O
insertion	B-UNK
;	O
nineteen	O
of	O
them	O
were	O
deletions	B-UNK
of	O
one	O
to	O
31	O
bp	B-UNK
and	O
three	O
were	O
a	O
1	O
-	O
bp	B-UNK
insertion	B-UNK
.	O

 	O
one	O
tumor	B-DISEASE
had	O
a	O
1	O
-	O
bp	B-UNK
deletion	I-UNK
in	O
an	O
intron	B-UNK
near	B-UNK
the	O
splicing	B-UNK
site	B-UNK
.	O

 	O
hence	O
,	O
41	O
(	O
95	O
%	O
)	O
of	O
43	O
mutations	B-UNK
resulted	B-UNK
in	O
truncation	O
of	O
the	O
apc	B-UNK
protein	B-UNK
.	O

 	O
over	O
60	O
%	O
of	O
the	O
somatic	B-UNK
mutations	B-UNK
in	O
the	O
apc	B-UNK
gene	B-UNK
were	O
clustered	O
within	O
a	O
small	B-UNK
region	B-UNK
of	O
exon	B-UNK
15	O
,	O
designated	B-UNK
as	O
mcr	O
(	O
mutation	B-UNK
cluster	B-UNK
region	I-UNK
)	O
,	O
which	O
accounted	B-UNK
for	O
less	O
than	O
10	O
%	O
of	O
the	O
coding	B-UNK
region	I-UNK
.	O

 	O
combining	B-UNK
these	O
data	B-UNK
and	O
the	O
results	B-UNK
of	O
loh	O
,	O
more	O
than	O
80	O
%	O
of	O
tumors	B-DISEASE
(	O
14	O
adenomas	B-UNK
and	O
39	O
carcinomas	B-UNK
)	O
had	O
at	B-DISEASE
least	O
one	O
mutation	B-UNK
in	O
the	O
apc	B-UNK
gene	B-UNK
,	O
of	O
which	O
more	O
than	O
60	O
%	O
(	O
9	O
adenomas	B-UNK
and	O
23	O
carcinomas	B-UNK
)	O
had	O
two	O
mutations	B-UNK
.	O

 	O
these	O
results	B-UNK
strongly	B-UNK
suggest	B-UNK
that	O
somatic	B-UNK
mutations	B-UNK
of	O
the	O
apc	B-UNK
gene	B-UNK
are	O
associated	B-UNK
with	O
development	B-UNK
of	O
a	O
great	B-UNK
majority	B-UNK
of	O
colorectal	B-UNK
tumors	B-DISEASE
.	O
.	O

 	O
constitutional	B-UNK
mutations	B-UNK
in	O
the	O
wt1	B-UNK
gene	B-UNK
in	O
patients	B-UNK
with	O
denys	B-DISEASE
-	I-DISEASE
drash	I-DISEASE
syndrome	I-DISEASE
.	O

 	O
the	O
denys	B-DISEASE
-	I-DISEASE
drash	I-DISEASE
syndrome	I-DISEASE
is	O
characterised	B-UNK
by	O
a	O
typical	B-UNK
nephropathy	B-DISEASE
,	O
genital	O
abnormalities	B-DISEASE
and	O
also	O
predisposes	O
to	O
the	O
development	B-UNK
of	O
wilms	B-DISEASE
tumor	I-DISEASE
.	O

 	O
these	O
patients	B-UNK
eventually	O
go	O
into	O
end	B-UNK
stage	B-UNK
renal	B-DISEASE
failure	I-DISEASE
.	O

 	O
a	O
candidate	B-UNK
wilms	B-DISEASE
tumor	I-DISEASE
gene	B-UNK
,	O
wt1	B-UNK
,	O
from	O
the	O
11p13	B-UNK
chromosome	B-UNK
region	I-UNK
has	O
recently	B-UNK
been	O
cloned	B-UNK
.	O

 	O
we	O
have	O
analysed	B-UNK
the	O
dna	B-UNK
sequence	I-UNK
in	O
constitutional	B-UNK
cells	B-UNK
from	O
eight	O
patients	B-UNK
and	O
have	O
shown	B-UNK
heterozygous	B-UNK
mutations	B-UNK
in	O
six	O
of	O
them	O
.	O

 	O
four	O
of	O
the	O
mutations	B-UNK
were	O
in	O
exon	B-UNK
9	O
,	O
all	O
resulting	B-UNK
in	O
missense	B-UNK
mutations	I-UNK
.	O

 	O
three	O
were	O
at	B-DISEASE
nucleotide	B-UNK
position	B-UNK
1180	O
resulting	B-UNK
in	O
an	O
arg	B-UNK
>	O
trp	O
amino	B-UNK
acid	I-UNK
change	B-UNK
.	O

 	O
the	O
other	O
was	O
at	B-DISEASE
position	B-UNK
1186	O
converting	O
an	O
asp	B-UNK
>	O
asn	O
in	O
the	O
predicted	B-UNK
resultant	B-UNK
protein	B-UNK
.	O

 	O
one	O
patient	B-UNK
had	O
a	O
missense	B-UNK
mutation	I-UNK
in	O
exon	B-UNK
8	O
,	O
converting	O
an	O
arg	B-UNK
>	O
his	O
.	O

 	O
a	O
single	B-UNK
base	B-UNK
pair	I-UNK
insertion	B-UNK
at	B-DISEASE
nucleotide	B-UNK
position	B-UNK
821	O
in	O
exon	B-UNK
6	O
resulted	B-UNK
in	O
the	O
generation	B-UNK
of	O
a	O
premature	B-UNK
stop	B-UNK
codon	B-UNK
in	O
the	O
last	O
patient	B-UNK
.	O

 	O
we	O
were	O
unable	O
to	O
find	O
a	O
mutation	B-UNK
in	O
one	O
patient	B-UNK
despite	B-UNK
complete	B-UNK
sequencing	B-UNK
of	O
the	O
genomic	B-UNK
sequence	B-UNK
of	O
the	O
gene	B-UNK
.	O

 	O
the	O
last	O
patient	B-UNK
carried	B-UNK
a	O
constitutional	B-UNK
deletion	B-UNK
of	O
the	O
11p13	B-UNK
region	B-UNK
and	O
no	O
additional	B-UNK
mutation	B-UNK
was	O
found	B-UNK
.	O

 	O
there	O
was	O
no	O
obvious	B-UNK
correlation	B-UNK
between	O
the	O
type	B-UNK
of	O
mutation	B-UNK
and	O
phenotypic	B-UNK
expression	B-UNK
.	O

 	O
these	O
results	B-UNK
further	O
demonstrate	B-UNK
that	O
the	O
wt1	B-UNK
gene	B-UNK
is	O
important	B-UNK
in	O
both	O
the	O
development	B-UNK
of	O
the	O
kidney	B-UNK
and	O
the	O
genito	O
-	O
urinary	O
system	B-UNK
.	O
.	O

 	B-UNK
linkage	I-UNK
disequilibrium	B-UNK
mapping	B-UNK
in	O
isolated	B-UNK
founder	B-UNK
populations	B-UNK
:	O
diastrophic	B-DISEASE
dysplasia	I-DISEASE
in	O
finland	B-UNK
.	O

 	B-UNK
linkage	I-UNK
disequilibrium	B-UNK
mapping	B-UNK
in	O
isolated	B-UNK
populations	B-UNK
provides	B-UNK
a	O
powerful	O
tool	B-UNK
for	O
fine	B-UNK
structure	B-UNK
localization	B-UNK
of	O
disease	B-DISEASE
genes	B-UNK
.	O

 	O
here	O
,	O
luria	O
and	O
delbrucks	O
classical	B-UNK
methods	B-UNK
for	O
analysing	O
bacterial	B-UNK
cultures	B-UNK
are	O
adapted	O
to	O
the	O
study	B-UNK
of	O
human	B-UNK
isolated	B-UNK
founder	B-UNK
populations	B-UNK
in	O
order	B-UNK
to	O
estimate	B-UNK
(	O
i	O
)	O
the	O
recombination	B-UNK
fraction	B-UNK
between	O
a	O
disease	B-DISEASE
locus	B-UNK
and	O
a	O
marker	B-UNK
;	O
(	O
ii	B-UNK
)	O
the	O
expected	B-UNK
degree	B-UNK
of	O
allelic	B-UNK
homogeneity	B-UNK
in	O
a	O
population	B-UNK
;	O
and	O
(	O
iii	B-UNK
)	O
the	O
mutation	B-UNK
rate	B-UNK
of	O
marker	B-UNK
loci	B-UNK
.	O

 	O
using	O
these	O
methods	B-UNK
,	O
we	O
report	B-UNK
striking	B-UNK
linkage	B-UNK
disequilibrium	I-UNK
for	O
diastrophic	B-DISEASE
dysplasia	I-DISEASE
(	O
dtd	O
)	O
in	O
finland	B-UNK
indicating	B-UNK
that	O
the	O
dtd	O
gene	B-UNK
should	O
lie	O
within	O
0	O
.	O

 	O
06	O
centimorgans	O
(	O
or	O
about	O
60	O
kilobases	O
)	O
of	O
the	O
csf1r	O
gene	B-UNK
.	O

 	O
predictions	O
about	O
allelic	B-UNK
homogeneity	B-UNK
in	O
finland	B-UNK
and	O
mutation	B-UNK
rates	B-UNK
in	O
simple	B-UNK
sequence	B-UNK
repeats	B-UNK
are	O
confirmed	B-UNK
by	O
independent	B-UNK
observations	B-UNK
.	O

 	O
the	O
wiskott	B-DISEASE
-	I-DISEASE
aldrich	I-DISEASE
syndrome	I-DISEASE
:	O
refinement	O
of	O
the	O
localization	B-UNK
on	O
xp	O
and	O
identification	B-UNK
of	O
another	O
closely	B-UNK
linked	I-UNK
marker	B-UNK
locus	B-UNK
,	O
oatl1	O
.	O

 	O
the	O
wiskott	B-DISEASE
-	I-DISEASE
aldrich	I-DISEASE
syndrome	I-DISEASE
(	O
was	O
)	O
has	O
previously	B-UNK
been	O
mapped	B-UNK
to	O
the	O
proximal	B-UNK
short	B-UNK
arm	B-UNK
of	O
the	O
x	B-DISEASE
chromosome	I-DISEASE
between	O
the	O
dxs14	O
and	O
dxs7	B-UNK
loci	B-UNK
.	O

 	O
in	O
this	O
study	B-UNK
,	O
further	O
segregation	B-UNK
analysis	B-UNK
has	O
been	O
performed	B-UNK
using	O
a	O
newly	B-UNK
identified	B-UNK
was	O
family	B-UNK
as	O
well	O
as	O
an	O
additional	B-UNK
marker	B-UNK
probe	B-UNK
,	O
hoatl1	O
.	O

 	O
the	O
results	B-UNK
indicate	B-UNK
close	B-UNK
linkage	I-UNK
between	O
the	O
was	O
and	O
oatl1	O
loci	B-UNK
(	O
z	B-UNK
=	O
6	O
.	O
08	O
at	B-DISEASE
theta	B-UNK
=	I-UNK
0	O
.	O
00	O
)	O
and	O
localize	B-UNK
the	O
timp	O
,	O
oatl1	O
,	O
dxs255	O
,	O
and	O
was	O
loci	B-UNK
distal	B-UNK
to	O
dxs146	O
and	O
the	O
oatl1	O
and	O
was	O
loci	B-UNK
proximal	B-UNK
to	O
timp	O
.	O

 	O
these	O
linkage	B-UNK
data	B-UNK
narrow	B-UNK
the	O
boundaries	B-UNK
within	O
which	O
the	O
was	O
locus	B-UNK
maps	B-UNK
to	O
the	O
chromosomal	B-UNK
region	B-UNK
bracketed	O
by	O
timp	O
and	O
dxs146	O
and	O
support	B-UNK
the	O
loci	B-UNK
order	B-UNK
xpter	O
-	O
dxs7	B-UNK
-	O
timp	O
-	O
(	O
oatl1	O
,	O
was	O
,	O
dxs255	O
)	O
-	O
dxs146	O
.	O

 	O
detection	B-UNK
of	O
an	O
unstable	B-UNK
fragment	O
of	O
dna	B-UNK
specific	B-UNK
to	O
individuals	B-UNK
with	O
myotonic	B-DISEASE
dystrophy	I-DISEASE
.	O

 	O
myotonic	B-DISEASE
dystrophy	I-DISEASE
(	O
dm	B-DISEASE
)	O
is	O
the	O
most	O
common	B-UNK
form	B-UNK
of	O
adult	B-UNK
muscular	B-DISEASE
dystrophy	I-DISEASE
,	O
with	O
a	O
prevalence	B-UNK
of	O
2	O
-	O
14	O
per	O
100	O
,	O
000	O
individuals	B-UNK
.	O

 	O
the	O
disease	B-DISEASE
is	O
characterized	B-UNK
by	O
progressive	B-UNK
muscle	B-DISEASE
weakness	I-DISEASE
and	O
sustained	O
muscle	B-UNK
contraction	B-UNK
,	O
often	O
with	O
a	O
wide	B-UNK
range	B-UNK
of	O
accompanying	B-UNK
symptoms	B-UNK
.	O

 	O
the	O
age	B-UNK
at	B-DISEASE
onset	B-UNK
and	O
severity	B-UNK
of	O
the	O
disease	B-DISEASE
show	O
extreme	B-UNK
variation	B-UNK
,	O
both	O
within	O
and	O
between	O
families	B-UNK
.	O

 	O
despite	B-UNK
its	O
clinical	B-UNK
variability	B-UNK
,	O
this	O
dominant	B-UNK
condition	B-UNK
segregates	B-UNK
as	O
a	O
single	B-UNK
locus	B-UNK
at	B-DISEASE
chromosome	B-UNK
19q13	O
.	O

 	O
3	O
in	O
every	O
population	B-UNK
studied	B-UNK
.	O

 	O
it	O
is	O
flanked	O
by	O
the	O
tightly	B-UNK
linked	I-UNK
genetic	B-UNK
markers	B-UNK
ercc1	O
proximally	O
and	O
d19s51	O
distally	O
;	O
these	O
define	B-UNK
the	O
dm	B-DISEASE
critical	B-UNK
region	I-UNK
.	O

 	O
we	O
report	B-UNK
the	O
isolation	B-UNK
of	O
an	O
expressed	B-UNK
sequence	B-UNK
from	O
this	O
region	B-UNK
which	O
detects	O
a	O
dna	B-UNK
fragment	O
that	O
is	O
larger	O
in	O
affected	B-UNK
individuals	I-UNK
than	O
in	O
normal	B-UNK
siblings	B-UNK
or	O
unaffected	B-UNK
controls	B-UNK
.	O

 	O
the	O
size	B-UNK
of	O
this	O
fragment	O
varies	B-UNK
between	O
affected	B-UNK
siblings	B-UNK
,	O
and	O
increases	B-UNK
in	O
size	B-UNK
through	O
generations	B-UNK
in	O
parallel	O
with	O
increasing	B-UNK
severity	B-UNK
of	O
the	O
disease	B-DISEASE
.	O

 	O
we	O
postulate	O
that	O
this	O
unstable	B-UNK
dna	B-UNK
sequence	I-UNK
is	O
the	O
molecular	B-UNK
feature	B-UNK
that	O
underlies	O
dm	B-DISEASE
.	O

 	O
common	B-UNK
sequence	B-UNK
motifs	B-UNK
at	B-DISEASE
the	O
rearrangement	B-UNK
sites	B-UNK
of	O
a	O
constitutional	B-UNK
x	B-UNK
/	O
autosome	O
translocation	B-DISEASE
and	O
associated	B-UNK
deletion	B-UNK
.	O

 	O
reciprocal	B-UNK
chromosome	B-UNK
translocations	B-UNK
are	O
common	B-UNK
de	B-UNK
novo	I-UNK
rearrangements	B-UNK
that	O
occur	B-UNK
randomly	B-UNK
throughout	O
the	O
human	B-UNK
genome	B-UNK
.	O

 	O
to	O
learn	O
about	O
causative	B-UNK
mechanisms	B-UNK
,	O
we	O
have	O
cloned	B-UNK
and	O
sequenced	B-UNK
the	O
breakpoints	B-UNK
of	O
a	O
cytologically	O
balanced	B-UNK
constitutional	B-UNK
reciprocal	B-UNK
translocation	B-DISEASE
,	O
t	B-UNK
(	O
x	B-UNK
;	O
4	O
)	O
(	O
p21	O
.	O
2	O
;	O
q31	O
.	O
22	O
)	O
,	O
present	B-UNK
in	O
a	O
girl	B-UNK
with	O
duchenne	B-UNK
muscular	B-DISEASE
dystrophy	I-DISEASE
(	O
dmd	B-UNK
)	O
.	O

 	B-UNK
physical	I-UNK
mapping	B-UNK
of	O
the	O
derivative	B-UNK
chromosomes	B-UNK
,	O
after	O
their	O
separation	O
in	O
somatic	B-UNK
cell	I-UNK
hybrids	I-UNK
,	O
reveals	B-UNK
that	O
the	O
translocation	B-DISEASE
disrupts	O
the	O
dmd	B-UNK
gene	B-UNK
in	O
xp21	B-UNK
within	O
the	O
18	O
-	O
kb	B-UNK
intron	B-UNK
16	O
.	O

 	O
restriction	O
mapping	B-UNK
and	O
sequencing	B-UNK
of	O
clones	B-UNK
that	O
span	B-UNK
both	O
translocation	B-DISEASE
breakpoints	B-UNK
as	O
well	O
as	O
the	O
corresponding	B-UNK
normal	B-UNK
regions	B-UNK
indicate	B-UNK
the	O
loss	B-UNK
of	O
approximately	B-UNK
5	O
kb	B-UNK
in	O
the	O
formation	B-UNK
of	O
the	O
derivative	B-UNK
x	B-DISEASE
chromosome	I-DISEASE
,	O
with	O
4	O
-	O
6	O
bp	B-UNK
deleted	B-UNK
from	O
chromosome	B-DISEASE
4	I-DISEASE
.	O

 	O
rflp	B-UNK
and	O
southern	O
analyses	B-UNK
indicate	I-UNK
that	O
the	O
de	B-UNK
novo	I-UNK
translocation	B-DISEASE
is	O
a	O
paternal	B-UNK
origin	B-UNK
and	O
that	O
the	O
fathers	B-UNK
x	B-DISEASE
chromosome	I-DISEASE
contains	B-UNK
the	O
dna	B-UNK
that	O
is	O
deleted	B-UNK
in	O
the	O
derivative	B-UNK
x	B-UNK
.	O

 	O
most	O
likely	B-UNK
,	O
deletion	B-UNK
and	O
translation	B-UNK
arose	B-UNK
simultaneously	O
from	O
a	O
complex	B-UNK
rearrangement	B-UNK
event	B-UNK
that	O
involves	B-UNK
three	O
chromosomal	B-UNK
breakpoints	B-UNK
.	O

 	O
short	B-UNK
regions	B-UNK
of	O
sequence	B-UNK
homology	B-UNK
were	O
present	B-UNK
at	B-DISEASE
the	O
three	O
sites	B-UNK
.	O

 	O
a	O
5	O
-	O
bp	B-UNK
sequence	B-UNK
,	O
ggaat	O
,	O
found	B-UNK
exactly	O
at	B-DISEASE
the	O
translocation	B-DISEASE
breakpoints	B-UNK
on	O
both	O
normal	B-UNK
chromosomes	I-UNK
x	B-UNK
and	O
4	O
,	O
has	O
been	O
preserved	O
only	O
on	O
the	O
der	O
(	O
4	O
)	O
chromosome	B-UNK
.	O

 	O
it	O
is	O
likely	B-UNK
that	O
the	O
x	B-UNK
-	O
derived	B-UNK
sequence	B-UNK
ggaatca	O
has	O
been	O
lost	O
in	O
the	O
formation	B-UNK
of	O
the	O
der	O
(	O
x	B-UNK
)	O
chromosome	B-UNK
,	O
as	O
it	O
matches	O
an	O
inverted	B-UNK
gaatca	O
sequence	B-UNK
present	B-UNK
on	O
the	O
opposite	O
strand	O
exactly	O
at	B-DISEASE
the	O
other	O
end	B-UNK
of	O
the	O
deleted	B-UNK
5	O
-	O
kb	B-UNK
fragment	O
.	O

 	O
a	O
genetic	B-UNK
etiology	B-UNK
for	O
digeorge	B-DISEASE
syndrome	I-DISEASE
:	O
consistent	B-UNK
deletions	B-UNK
and	O
microdeletions	O
of	O
22q11	B-UNK
.	O

 	O
digeorge	B-DISEASE
syndrome	I-DISEASE
(	O
dgs	B-UNK
)	O
,	O
a	O
developmental	B-UNK
field	B-UNK
defect	B-UNK
of	O
the	O
third	O
and	O
fourth	B-UNK
pharyngeal	O
pouches	O
,	O
is	O
characterized	B-UNK
by	O
aplasia	O
or	O
hypoplasia	B-UNK
of	O
the	O
thymus	O
and	O
parathyroid	B-DISEASE
glands	I-DISEASE
and	O
by	O
conotruncal	O
cardiac	B-UNK
malformations	O
.	O

 	B-UNK
cytogenetic	I-UNK
studies	B-UNK
support	B-UNK
the	O
presence	B-UNK
of	O
a	O
dgs	B-UNK
critical	B-UNK
region	I-UNK
in	O
band	B-UNK
22q11	B-UNK
.	O

 	O
in	O
the	O
present	B-UNK
study	I-UNK
,	O
we	O
report	B-UNK
the	O
results	B-UNK
of	O
clinical	B-UNK
,	O
cytogenetic	B-UNK
,	O
and	O
molecular	B-UNK
studies	I-UNK
of	O
14	O
patients	B-UNK
with	O
dgs	B-UNK
.	O

 	B-UNK
chromosome	I-UNK
analysis	B-UNK
,	O
utilizing	B-UNK
high	B-UNK
-	O
resolution	B-UNK
banding	I-UNK
techniques	B-UNK
,	O
detected	B-UNK
interstitial	B-UNK
deletions	B-UNK
in	O
five	O
probands	B-UNK
and	O
was	O
inconclusive	O
for	O
a	O
deletion	B-UNK
in	O
three	O
probands	B-UNK
.	O

 	O
the	O
remaining	B-UNK
six	O
patients	B-UNK
had	O
normal	B-UNK
karyotypes	B-UNK
.	O

 	O
in	O
contrast	B-UNK
,	O
molecular	B-UNK
analysis	B-UNK
detected	B-UNK
dna	B-UNK
deletions	B-UNK
in	O
all	O
14	O
probands	B-UNK
.	O

 	O
two	O
of	O
10	O
loci	B-UNK
tested	B-UNK
,	O
d22s75	O
and	O
d22s259	O
,	O
are	O
deleted	B-UNK
in	O
all	O
14	O
patients	B-UNK
.	O

 	O
a	O
third	O
locus	B-UNK
,	O
d22s66	O
,	O
is	O
deleted	B-UNK
in	O
the	O
eight	O
dgs	B-UNK
probands	B-UNK
tested	B-UNK
.	O

 	B-UNK
physical	I-UNK
mapping	B-UNK
using	O
somatic	B-UNK
cell	I-UNK
hybrids	I-UNK
places	O
d22s66	O
between	O
d22s75	O
and	O
d22s259	O
,	O
suggesting	B-UNK
that	O
it	O
should	O
be	O
deleted	B-UNK
in	O
the	O
remaining	B-UNK
six	O
cases	B-UNK
.	O

 	O
parent	B-UNK
-	O
of	O
-	O
origin	B-UNK
studies	B-UNK
were	O
performed	B-UNK
in	O
five	O
families	B-UNK
.	O

 	O
four	O
probands	B-UNK
failed	B-UNK
to	O
inherit	O
a	O
maternal	B-UNK
allele	B-UNK
,	O
and	O
one	O
failed	B-UNK
to	O
inherit	O
a	O
paternal	B-UNK
allele	B-UNK
.	O

 	O
on	O
the	O
basis	B-UNK
of	O
these	O
families	B-UNK
,	O
and	O
of	O
six	O
maternally	B-UNK
and	O
five	O
paternally	B-UNK
derived	I-UNK
unbalanced	B-UNK
-	O
translocation	B-DISEASE
dgs	B-UNK
probands	B-UNK
in	O
the	O
literature	O
,	O
parent	B-UNK
of	O
origin	B-UNK
or	O
imprinting	B-UNK
does	O
not	O
appear	B-UNK
to	O
play	O
an	O
important	B-UNK
role	B-UNK
in	O
the	O
pathogenesis	O
of	O
dgs	B-UNK
.	O

 	O
deletion	B-UNK
of	O
the	O
same	O
three	O
loci	B-UNK
in	O
all	O
14	O
dgs	B-UNK
probands	B-UNK
begins	O
to	O
delineate	O
the	O
region	B-UNK
of	O
chromosome	B-DISEASE
22	I-DISEASE
critical	B-UNK
for	O
dgs	B-UNK
and	O
confirms	B-UNK
the	O
hypothesis	O
that	O
submicroscopic	B-UNK
deletions	B-UNK
of	O
22q11	B-UNK
are	O
etiologic	O
in	O
the	O
vast	B-UNK
majority	B-UNK
of	O
cases	B-UNK
.	O
.	O

 	O
loss	B-UNK
of	O
normal	B-UNK
allele	B-UNK
of	O
the	O
apc	B-UNK
gene	B-UNK
in	O
an	O
adrenocortical	B-DISEASE
carcinoma	I-DISEASE
from	O
a	O
patient	B-UNK
with	O
familial	B-DISEASE
adenomatous	I-DISEASE
polyposis	I-DISEASE
.	O

 	O
endocrine	O
neoplasms	B-DISEASE
have	O
been	O
reported	B-UNK
occasionally	B-UNK
in	O
patients	B-UNK
with	O
familial	B-DISEASE
adenomatous	I-DISEASE
polyposis	I-DISEASE
(	O
fap	B-DISEASE
)	O
.	O

 	O
an	O
adrenocorotical	O
carcinoma	B-DISEASE
was	O
studied	B-UNK
in	O
a	O
patient	B-UNK
with	O
a	O
family	B-UNK
history	B-UNK
of	O
fap	B-DISEASE
.	O

 	O
loss	B-UNK
of	O
heterozygosity	B-UNK
(	O
loh	O
)	O
in	O
the	O
region	B-UNK
close	B-UNK
to	O
the	O
adenomatous	B-DISEASE
polyposis	I-DISEASE
coli	I-DISEASE
(	O
apc	B-UNK
)	O
gene	B-UNK
was	O
detected	B-UNK
in	O
this	O
carcinoma	B-DISEASE
,	O
and	O
evidence	B-UNK
was	O
obtained	B-UNK
that	O
there	O
was	O
a	O
loss	B-UNK
of	O
the	O
normal	B-UNK
allele	B-UNK
of	O
the	O
apc	B-UNK
gene	B-UNK
.	O

 	O
this	O
is	O
the	O
first	O
demonstration	O
of	O
loh	O
at	B-DISEASE
the	O
apc	B-UNK
locus	B-UNK
in	O
adrenocortical	O
tumors	B-DISEASE
.	O

 	O
the	O
present	B-UNK
results	B-UNK
and	O
our	O
previous	B-UNK
data	B-UNK
on	O
loh	O
in	O
a	O
recurring	O
desmoid	O
tumor	B-DISEASE
suggest	B-UNK
that	O
the	O
heterozygous	B-UNK
mutant	B-UNK
/	O
wild	B-UNK
-	O
type	B-UNK
condition	B-UNK
of	O
the	O
apc	B-UNK
gene	B-UNK
may	O
give	O
rise	B-UNK
to	O
benign	B-UNK
tumors	B-DISEASE
,	O
and	O
that	O
functional	B-UNK
loss	B-UNK
of	O
this	O
gene	B-UNK
leads	B-UNK
to	O
development	B-UNK
of	O
tumors	B-DISEASE
not	O
only	O
in	O
the	O
colon	O
but	O
also	O
in	O
other	O
various	O
parts	B-UNK
of	O
the	O
body	B-UNK
in	O
fap	B-DISEASE
patients	B-UNK
.	O
.	O

 	O
oncogenic	B-UNK
point	B-UNK
mutations	I-UNK
in	O
exon	B-UNK
20	O
of	O
the	O
rb1	B-UNK
gene	B-UNK
in	O
families	B-UNK
showing	B-UNK
incomplete	B-UNK
penetrance	B-UNK
and	O
mild	B-UNK
expression	B-UNK
of	O
the	O
retinoblastoma	B-DISEASE
phenotype	B-UNK
.	O

 	O
the	O
retinoblastoma	B-DISEASE
-	O
predisposition	B-UNK
gene	B-UNK
,	O
rb1	B-UNK
,	O
segregates	B-UNK
as	O
an	O
autosomal	O
dominant	B-UNK
trait	B-UNK
with	O
high	B-UNK
(	O
90	O
%	O
)	O
penetrance	B-UNK
.	O

 	O
certain	B-UNK
families	B-UNK
,	O
however	O
,	O
show	O
an	O
unusual	B-UNK
low	B-UNK
-	O
penetrance	B-UNK
phenotype	B-UNK
with	O
many	O
individuals	B-UNK
being	O
unaffected	B-UNK
,	O
unilaterally	O
affected	B-UNK
,	O
or	O
with	O
evidence	B-UNK
of	O
spontaneously	B-UNK
regressed	O
tumors	B-DISEASE
.	O

 	O
we	O
have	O
used	O
single	B-UNK
-	O
strand	B-UNK
conformation	I-UNK
polymorphism	I-UNK
analysis	B-UNK
and	O
pcr	B-UNK
sequencing	B-UNK
to	O
study	B-UNK
two	O
such	O
families	B-UNK
.	O

 	O
mutations	B-UNK
were	O
found	B-UNK
in	O
exon	B-UNK
20	O
of	O
rb1	B-UNK
in	O
both	O
cases	B-UNK
.	O

 	O
in	O
one	O
family	B-UNK
a	O
c	B-UNK
-	O
-	O
-	O
-	O
t	B-UNK
transition	I-UNK
in	O
codon	B-UNK
661	O
converts	B-UNK
an	O
arginine	B-UNK
(	O
cgg	B-UNK
)	O
to	O
a	O
tryptophan	O
(	O
tgg	O
)	O
codon	B-UNK
.	O

 	O
in	O
this	O
family	B-UNK
,	O
incomplete	B-UNK
penetrance	B-UNK
and	O
mild	B-UNK
phenotypic	B-UNK
expression	B-UNK
were	O
observed	B-UNK
in	O
virtually	B-UNK
all	O
patients	B-UNK
,	O
possibly	B-UNK
indicating	B-UNK
that	O
single	B-UNK
amino	I-UNK
acid	I-UNK
changes	B-UNK
may	O
modify	B-UNK
protein	B-UNK
structure	B-UNK
/	O
function	B-UNK
such	O
that	O
tumorigenesis	B-UNK
is	O
not	O
inevitable	O
.	O

 	O
in	O
the	O
second	B-UNK
family	B-UNK
the	O
mutation	B-UNK
in	O
codon	B-UNK
675	O
is	O
a	O
g	B-UNK
-	O
-	O
-	O
-	O
t	B-UNK
transversion	B-UNK
that	O
converts	B-UNK
a	O
glutamine	B-UNK
(	O
gaa	B-UNK
)	O
to	O
a	O
stop	B-UNK
(	O
taa	O
)	O
codon	B-UNK
.	O

 	O
however	O
,	O
this	O
mutation	B-UNK
also	O
occurs	B-UNK
near	B-UNK
a	O
potential	B-UNK
cryptic	O
splice	O
acceptor	B-UNK
site	B-UNK
,	O
raising	O
the	O
possibility	O
of	O
alternative	B-UNK
splicing	I-UNK
resulting	B-UNK
in	O
a	O
less	O
severely	B-UNK
disrupted	B-UNK
protein	B-UNK
.	O
.	O

 	O
late	B-UNK
-	O
onset	B-UNK
metachromatic	B-DISEASE
leukodystrophy	I-DISEASE
:	O
molecular	B-UNK
pathology	B-UNK
in	O
two	O
siblings	B-UNK
.	O

 	O
we	O
report	B-UNK
on	O
a	O
new	B-UNK
allele	B-UNK
at	B-DISEASE
the	O
arylsulfatase	B-UNK
a	O
(	O
arsa	B-UNK
)	O
locus	B-UNK
causing	B-UNK
late	B-UNK
-	O
onset	B-UNK
metachromatic	B-DISEASE
leukodystrophy	I-DISEASE
(	O
mld	B-UNK
)	O
.	O

 	O
in	O
that	O
allele	B-UNK
arginine84	O
,	O
a	O
residue	B-UNK
that	O
is	O
highly	B-UNK
conserved	I-UNK
in	O
the	O
arylsulfatase	B-UNK
gene	B-UNK
family	B-UNK
,	O
is	O
replaced	O
by	O
glutamine	B-UNK
.	O

 	O
in	O
contrast	B-UNK
to	O
alleles	B-UNK
that	O
cause	B-UNK
early	B-UNK
-	O
onset	B-UNK
mld	B-UNK
,	O
the	O
arginine84	O
to	O
glutamine	B-UNK
substitution	B-UNK
is	O
associated	B-UNK
with	O
some	O
residual	B-UNK
arsa	B-UNK
activity	I-UNK
.	O

 	O
a	O
comparison	B-UNK
of	O
genotypes	O
,	O
arsa	B-UNK
activities	B-UNK
,	O
and	O
clinical	B-UNK
data	B-UNK
on	O
4	O
individuals	B-UNK
carrying	B-UNK
the	O
allele	B-UNK
of	O
81	O
patients	B-UNK
with	O
mld	B-UNK
examined	B-UNK
,	O
further	O
validates	O
the	O
concept	O
that	O
different	B-UNK
degrees	B-UNK
of	O
residual	B-UNK
arsa	B-UNK
activity	I-UNK
are	O
the	O
basis	B-UNK
of	O
phenotypical	O
variation	B-UNK
in	O
mld	B-UNK
.	O
.	O

 	O
trisomy	B-DISEASE
15	O
with	O
loss	B-UNK
of	O
the	O
paternal	B-UNK
15	O
as	O
a	O
cause	B-UNK
of	O
prader	B-DISEASE
-	I-DISEASE
willi	I-DISEASE
syndrome	I-DISEASE
due	O
to	O
maternal	B-UNK
disomy	B-UNK
.	O

 	O
uniparental	B-DISEASE
disomy	I-DISEASE
has	O
recently	B-UNK
been	O
recognized	B-UNK
to	O
cause	B-UNK
human	B-UNK
disorders	B-UNK
,	O
including	B-UNK
prader	B-DISEASE
-	I-DISEASE
willi	I-DISEASE
syndrome	I-DISEASE
(	O
pws	B-UNK
)	O
.	O

 	O
we	O
describe	B-UNK
a	O
particularly	B-UNK
instructive	O
case	B-UNK
which	O
raises	B-UNK
important	B-UNK
issues	O
concerning	B-UNK
the	O
mechanisms	B-UNK
producing	B-UNK
uniparental	B-DISEASE
disomy	I-DISEASE
and	O
whose	O
evaluation	B-UNK
provides	B-UNK
evidence	I-UNK
that	O
trisomy	B-DISEASE
may	O
precede	O
uniparental	B-DISEASE
disomy	I-DISEASE
in	O
a	O
fetus	B-UNK
.	O

 	O
chorionic	O
villus	O
sampling	O
performed	B-UNK
for	O
advanced	B-UNK
maternal	B-UNK
age	B-UNK
revealed	B-UNK
trisomy	B-DISEASE
15	O
in	O
all	O
direct	B-UNK
and	O
cultured	B-UNK
cells	B-UNK
,	O
though	O
the	O
fetus	B-UNK
appeared	B-UNK
normal	B-UNK
.	O

 	B-UNK
chromosome	I-UNK
analysis	B-UNK
of	O
amniocytes	O
obtained	B-UNK
at	B-DISEASE
15	O
wk	O
was	O
normal	B-UNK
in	O
over	O
100	O
cells	B-UNK
studied	B-UNK
.	O

 	O
the	O
child	B-UNK
was	O
hypotonic	O
at	B-DISEASE
birth	O
,	O
and	O
high	B-UNK
-	O
resolution	B-UNK
banding	I-UNK
failed	B-UNK
to	O
reveal	B-UNK
the	O
deletion	B-UNK
of	O
15q11	B-UNK
-	O
13	O
,	O
a	O
deletion	B-UNK
which	O
is	O
found	B-UNK
in	O
50	O
%	O
-	O
70	O
%	O
of	O
patients	B-UNK
with	O
pws	B-UNK
.	O

 	O
over	O
time	B-UNK
,	O
typical	B-UNK
features	B-UNK
of	O
pws	B-UNK
developed	B-UNK
.	O

 	B-UNK
molecular	I-UNK
genetic	B-UNK
analysis	B-UNK
using	O
probes	B-UNK
for	O
chromosome	B-DISEASE
15	I-DISEASE
revealed	B-UNK
maternal	B-UNK
disomy	B-UNK
.	O

 	O
maternal	B-UNK
nondisjunction	B-DISEASE
with	O
fertilization	O
of	O
a	O
disomic	O
egg	O
by	O
a	O
normal	B-UNK
sperm	B-UNK
,	O
followed	B-UNK
by	O
loss	B-UNK
of	O
the	O
paternal	B-UNK
15	O
,	O
is	O
a	O
likely	B-UNK
cause	B-UNK
of	O
confined	O
placental	O
mosaicism	B-UNK
and	O
uniparental	B-DISEASE
disomy	I-DISEASE
in	O
this	O
case	B-UNK
of	O
pws	B-UNK
,	O
and	O
advanced	B-UNK
maternal	B-UNK
age	B-UNK
may	O
be	O
a	O
predisposing	B-UNK
factor	B-UNK
.	O
.	O

 	B-UNK
genetic	I-UNK
heterogeneity	B-UNK
in	O
x	B-UNK
-	O
linked	B-UNK
amelogenesis	B-DISEASE
imperfecta	I-DISEASE
.	O

 	O
the	O
amelx	O
gene	B-UNK
located	B-UNK
at	B-DISEASE
xp22	O
.	O

 	O
1	O
-	O
p22	O
.	O

 	O
3	O
encodes	B-UNK
for	O
the	O
enamel	B-UNK
protein	B-UNK
amelogenin	O
and	O
has	O
been	O
implicated	O
as	O
the	O
gene	B-UNK
responsible	B-UNK
for	O
the	O
inherited	B-UNK
dental	O
abnormality	B-UNK
x	B-UNK
-	O
linked	B-UNK
amelogenesis	B-DISEASE
imperfecta	I-DISEASE
(	O
xai	O
)	O
.	O

 	O
three	O
families	B-UNK
with	O
xai	O
have	O
been	O
investigated	B-UNK
using	O
polymorphic	B-UNK
dna	I-UNK
markers	B-UNK
flanking	B-UNK
the	O
position	B-UNK
of	O
amelx	O
.	O

 	O
using	O
two	O
-	O
point	B-UNK
linkage	I-UNK
analysis	B-UNK
,	O
linkage	B-UNK
was	O
established	B-UNK
between	O
xai	O
and	O
several	O
of	O
these	O
markers	B-UNK
in	O
two	O
families	B-UNK
,	O
with	O
a	O
combined	B-UNK
lod	B-UNK
score	I-UNK
of	O
6	O
.	O

 	O
05	O
for	O
dxs16	O
at	B-DISEASE
theta	B-UNK
=	I-UNK
0	O
.	O

 	O
04	O
04	O
.	O

 	O
this	O
supports	B-UNK
the	O
involvement	B-UNK
of	O
amelx	O
,	O
located	B-UNK
close	B-UNK
to	O
dxs16	O
,	O
in	O
the	O
xai	O
disease	B-DISEASE
process	B-UNK
(	O
aih1	B-UNK
)	O
in	O
those	O
families	B-UNK
.	O

 	O
using	O
multipoint	B-UNK
linkage	I-UNK
analysis	B-UNK
,	O
the	O
combined	B-UNK
maximum	B-UNK
lod	I-UNK
score	B-UNK
for	O
these	O
two	O
families	B-UNK
was	O
7	O
.	O

 	O
30	O
for	O
a	O
location	B-UNK
of	O
aih1	B-UNK
at	B-DISEASE
2	O
cm	B-DISEASE
distal	B-UNK
to	O
dxs16	O
.	O

 	O
the	O
support	B-UNK
interval	I-UNK
around	O
this	O
location	B-UNK
extended	B-UNK
about	O
8	O
cm	B-DISEASE
proximal	B-UNK
to	O
dxs92	O
,	O
and	O
the	O
aih1	B-UNK
location	B-UNK
could	O
not	O
be	O
precisely	O
defined	B-UNK
by	O
multipoint	B-UNK
mapping	B-UNK
.	O

 	O
study	B-UNK
of	O
recombination	B-UNK
events	I-UNK
indicated	B-UNK
that	O
aih1	B-UNK
lies	B-UNK
in	O
the	O
interval	B-UNK
between	O
dxs143	O
and	O
dxs85	O
.	O

 	O
there	O
was	O
significant	B-UNK
evidence	B-UNK
against	O
linkage	B-UNK
to	O
this	O
region	B-UNK
in	O
the	O
third	O
family	B-UNK
,	O
indicating	B-UNK
locus	B-UNK
heterogeneity	I-UNK
in	O
xai	O
.	O

 	O
further	O
analysis	B-UNK
with	O
markers	B-UNK
on	O
the	O
long	B-UNK
arm	B-UNK
of	O
the	O
x	B-DISEASE
chromosome	I-DISEASE
showed	B-UNK
evidence	B-UNK
of	O
linkage	B-UNK
to	O
dxs144e	O
and	O
f9	O
with	O
no	O
recombination	B-UNK
with	O
either	O
of	O
these	O
markers	B-UNK
.	O

 	O
two	O
-	O
point	B-UNK
analysis	B-UNK
gave	B-UNK
a	O
peak	B-UNK
lod	B-UNK
score	I-UNK
at	B-DISEASE
dxs144e	O
with	O
a	O
maximum	B-UNK
lod	I-UNK
score	B-UNK
of	O
2	O
.	O

 	O
83	O
at	B-DISEASE
theta	B-UNK
=	I-UNK
0	O
,	O
with	O
a	O
peak	B-UNK
lod	B-UNK
score	I-UNK
in	O
multipoint	B-UNK
linkage	I-UNK
analysis	B-UNK
of	O
2	O
.	O

 	O
84	O
at	B-DISEASE
theta	B-UNK
=	I-UNK
0	O
.	O

 	O
the	O
support	B-UNK
interval	I-UNK
extended	B-UNK
9	O
cm	B-DISEASE
proximal	B-UNK
to	O
dxs144e	O
and	O
14	O
cm	B-DISEASE
distal	B-UNK
to	O
f9	O
.	O

 	O
(	O
abstract	B-UNK
truncated	B-UNK
at	B-DISEASE
250	O
words	O
)	O
.	O

 	O
multiple	B-UNK
origins	B-UNK
for	O
phenylketonuria	B-DISEASE
in	O
europe	B-UNK
.	O

 	O
phenylketonuria	B-DISEASE
(	O
pku	B-DISEASE
)	O
,	O
a	O
disorder	O
of	O
amino	B-DISEASE
acid	I-DISEASE
metabolism	I-DISEASE
prevalent	B-UNK
among	O
caucasians	B-UNK
and	O
other	O
ethnic	B-UNK
groups	B-UNK
,	O
is	O
caused	B-UNK
primarily	B-UNK
by	O
a	O
deficiency	B-UNK
of	O
the	O
hepatic	B-UNK
enzyme	I-UNK
phenylalanine	I-UNK
hydroxylase	O
(	O
pah	B-UNK
)	O
.	O

 	O
pku	B-DISEASE
is	O
a	O
highly	B-UNK
heterogeneous	B-UNK
disorder	O
,	O
with	O
more	O
than	O
60	O
molecular	B-UNK
lesions	B-UNK
identified	B-UNK
in	O
the	O
pah	B-UNK
gene	B-UNK
.	O

 	O
the	O
haplotype	B-UNK
associations	B-UNK
,	O
relative	B-UNK
frequencies	B-UNK
,	O
and	O
distributions	O
of	O
five	O
prevalent	B-UNK
pah	B-UNK
mutations	B-UNK
(	O
r158q	O
,	O
r261q	O
,	O
ivs10nt546	O
,	O
r408w	O
,	O
and	O
ivs12n1	O
)	O
were	O
established	B-UNK
in	O
a	O
comprehensive	B-UNK
european	B-UNK
sample	B-UNK
population	B-UNK
and	O
subsequently	B-UNK
were	O
examined	B-UNK
to	O
determine	O
the	O
potential	B-UNK
roles	O
of	O
several	O
genetic	B-UNK
mechanisms	B-UNK
in	O
explaining	O
the	O
present	B-UNK
distribution	B-UNK
of	O
the	O
major	B-UNK
pku	B-DISEASE
alleles	B-UNK
.	O

 	O
each	O
of	O
these	O
five	O
mutations	B-UNK
was	O
strongly	B-UNK
associated	B-UNK
with	O
only	O
one	O
of	O
the	O
more	O
than	O
70	O
chromosomal	B-UNK
haplotypes	B-UNK
defined	B-UNK
by	O
eight	O
rflps	B-UNK
in	O
or	O
near	B-UNK
the	O
pah	B-UNK
gene	B-UNK
.	O

 	O
these	O
findings	B-UNK
suggest	B-UNK
that	O
each	O
of	O
these	O
mutations	B-UNK
arose	B-UNK
through	O
a	O
single	B-UNK
founding	B-UNK
event	B-UNK
that	O
occurred	B-UNK
within	O
time	B-UNK
periods	O
ranging	O
from	O
several	O
hundred	O
to	O
several	O
thousand	O
years	B-UNK
ago	B-UNK
.	O

 	O
from	O
the	O
significant	B-UNK
differences	I-UNK
observed	B-UNK
in	O
the	O
relative	B-UNK
frequencies	B-UNK
and	O
distributions	O
of	O
these	O
five	O
alleles	B-UNK
throughout	O
europe	B-UNK
,	O
four	O
of	O
these	O
putative	B-UNK
founding	B-UNK
events	B-UNK
could	O
be	O
localized	B-UNK
to	O
specific	B-UNK
ethnic	B-UNK
subgroups	O
.	O

 	O
together	O
,	O
these	O
data	B-UNK
suggest	B-UNK
that	O
there	O
were	O
multiple	B-UNK
,	O
geographically	O
and	O
ethnically	O
distinct	B-UNK
origins	B-UNK
for	O
pku	B-DISEASE
within	O
the	O
european	B-UNK
population	I-UNK
.	O
.	O

 	B-UNK
complement	I-UNK
factor	B-UNK
2	O
deficiency	B-UNK
:	O
a	O
clinical	B-UNK
and	O
serological	O
family	B-UNK
study	I-UNK
.	O

 	B-UNK
inherited	I-UNK
complement	B-UNK
deficiencies	B-UNK
are	O
associated	B-UNK
with	O
a	O
variety	B-UNK
of	O
connective	B-DISEASE
tissue	I-DISEASE
diseases	I-DISEASE
.	O

 	O
a	O
family	B-UNK
with	O
inherited	B-UNK
deficiency	B-UNK
of	O
complement	B-UNK
factor	B-UNK
2	O
(	O
c2	B-UNK
)	O
is	O
described	B-UNK
in	O
which	O
two	O
family	B-UNK
members	I-UNK
with	O
homozygous	B-UNK
c2	B-UNK
deficiency	I-UNK
developed	B-UNK
cutaneous	O
vasculitis	B-DISEASE
and	O
sicca	O
syndrome	B-DISEASE
.	O

 	O
the	O
other	O
family	B-UNK
members	I-UNK
had	O
heterozygous	B-UNK
c2	I-UNK
deficiency	B-UNK
and	O
each	O
member	B-UNK
had	O
the	O
hla	B-UNK
-	O
a25	O
,	O
b18	O
,	O
dr2	O
(	O
w15	O
)	O
haplotype	B-UNK
.	O

 	O
the	O
mother	B-UNK
had	O
seropositive	O
rheumatoid	B-DISEASE
arthritis	I-DISEASE
.	O

 	O
further	O
studies	B-UNK
showed	B-UNK
the	O
presence	B-UNK
of	O
cryoglobulins	O
,	O
antibodies	B-UNK
against	O
endothelial	O
cells	B-UNK
,	O
and	O
anticardiolipin	O
antibodies	B-UNK
.	O
.	O

 	B-UNK
new	I-UNK
variant	B-UNK
in	O
exon	B-UNK
3	O
of	O
the	O
proteolipid	B-UNK
protein	B-UNK
(	O
plp	B-UNK
)	O
gene	B-UNK
in	O
a	O
family	B-UNK
with	O
pelizaeus	B-DISEASE
-	I-DISEASE
merzbacher	I-DISEASE
disease	I-DISEASE
.	O

 	O
a	O
c	B-UNK
-	O
-	O
greater	B-UNK
than	O
g	B-UNK
transversion	B-UNK
has	O
been	O
found	B-UNK
in	O
exon	B-UNK
3	O
of	O
the	O
plp	B-UNK
gene	B-UNK
of	O
affected	B-UNK
males	B-UNK
and	O
their	O
mother	B-UNK
in	O
a	O
single	B-UNK
sibship	O
with	O
pelizaeus	B-DISEASE
-	I-DISEASE
merzbacher	I-DISEASE
disease	I-DISEASE
(	O
pmd	O
)	O
.	O

 	O
the	O
transversion	B-UNK
should	O
not	O
result	B-UNK
in	O
an	O
amino	B-UNK
acid	I-UNK
change	B-UNK
in	O
the	O
protein	B-UNK
but	O
it	O
does	O
result	B-UNK
in	O
the	O
loss	B-UNK
of	O
a	O
haeiii	O
restriction	O
endonuclease	O
cleavage	B-UNK
site	B-UNK
.	O

 	O
it	O
is	O
concordant	O
with	O
the	O
disease	B-DISEASE
in	O
this	O
family	B-UNK
.	O

 	O
one	O
-	O
hundred	O
-	O
ten	B-DISEASE
unrelated	B-UNK
x	B-UNK
chromosomes	I-UNK
are	O
negative	B-UNK
for	O
this	O
mutation	B-UNK
.	O

 	O
no	O
other	O
sequence	B-UNK
defect	B-UNK
was	O
found	B-UNK
in	O
the	O
plp	B-UNK
exons	B-UNK
of	O
the	O
affected	B-UNK
males	B-UNK
.	O

 	O
the	O
cause	B-UNK
of	O
disease	B-DISEASE
in	O
this	O
family	B-UNK
remains	B-UNK
unknown	B-UNK
,	O
but	O
the	O
association	B-UNK
between	O
this	O
rare	B-UNK
mutation	B-UNK
and	O
pmd	O
is	O
intriguing	O
.	O

 	O
the	O
mutation	B-UNK
can	O
serve	O
as	O
a	O
marker	B-UNK
for	O
following	B-UNK
segregation	B-UNK
of	O
the	O
plp	B-UNK
gene	B-UNK
.	O
.	O

 	O
uncoupling	O
of	O
hypomyelination	B-DISEASE
and	O
glial	B-UNK
cell	B-UNK
death	B-DISEASE
by	O
a	O
mutation	B-UNK
in	O
the	O
proteolipid	B-UNK
protein	B-UNK
gene	B-UNK
.	O

 	O
proteolipid	B-UNK
protein	B-UNK
(	O
plp	B-UNK
;	O
m	B-UNK
(	O
r	B-UNK
)	O
30	O
,	O
000	O
)	O
is	O
a	O
highly	B-UNK
conserved	I-UNK
major	B-UNK
polytopic	O
membrane	B-UNK
protein	B-UNK
in	O
myelin	B-UNK
but	O
its	O
cellular	B-UNK
function	B-UNK
remains	B-UNK
obscure	O
.	O

 	O
neurological	B-UNK
mutant	B-UNK
mice	I-UNK
can	O
often	O
provide	B-UNK
model	B-UNK
systems	B-UNK
for	O
human	B-UNK
genetic	B-UNK
disorders	B-UNK
.	O

 	O
mutations	B-UNK
of	O
the	O
x	B-UNK
-	O
chromosome	B-UNK
-	O
linked	B-UNK
plp	B-UNK
gene	B-UNK
are	O
lethal	B-UNK
,	O
identified	B-UNK
first	O
in	O
the	O
jimpy	O
mouse	B-UNK
and	O
subsequently	B-UNK
in	O
patients	B-UNK
with	O
pelizaeus	B-DISEASE
-	I-DISEASE
merzbacher	I-DISEASE
disease	I-DISEASE
.	O

 	O
the	O
unexplained	O
phenotype	B-UNK
of	O
these	O
mutations	B-UNK
includes	B-UNK
degeneration	B-UNK
and	O
premature	B-UNK
cell	B-UNK
death	B-DISEASE
of	O
oligodendrocytes	O
with	O
associated	B-UNK
hypomyelination	B-DISEASE
.	O

 	O
here	O
we	O
show	O
that	O
a	O
new	B-UNK
mouse	B-UNK
mutant	B-UNK
rumpshaker	O
is	O
defined	B-UNK
by	O
the	O
amino	O
-	O
acid	O
substitution	B-UNK
ile	B-UNK
-	O
to	O
-	O
thr	O
at	B-DISEASE
residue	B-UNK
186	O
in	O
a	O
membrane	B-UNK
-	O
embedded	O
domain	B-UNK
of	O
plp	B-UNK
.	O

 	O
surprisingly	B-UNK
,	O
rumpshaker	O
mice	B-UNK
,	O
although	O
myelin	B-UNK
-	O
deficient	B-UNK
,	O
have	O
normal	B-UNK
longevity	O
and	O
a	O
full	O
complement	B-UNK
of	O
morphologically	B-UNK
normal	B-UNK
oligodendrocytes	O
.	O

 	O
hypomyelination	B-DISEASE
can	O
thus	O
be	O
genetically	B-UNK
separated	O
from	O
the	O
plp	B-UNK
-	O
dependent	B-UNK
oligodendrocyte	O
degeneration	B-UNK
.	O

 	O
we	O
suggest	B-UNK
that	O
plp	B-UNK
has	O
a	O
vital	O
function	B-UNK
in	O
glial	B-UNK
cell	B-UNK
development	B-UNK
,	O
distinct	B-UNK
from	O
its	O
later	B-UNK
role	B-UNK
in	O
myelin	B-UNK
assembly	B-UNK
,	O
and	O
that	O
this	O
dichotomy	O
of	O
action	O
may	O
explain	O
the	O
clinical	B-UNK
spectrum	B-UNK
of	O
pelizaeus	B-DISEASE
-	I-DISEASE
merzbacher	I-DISEASE
disease	I-DISEASE
.	O
.	O

 	O
a	O
pseudodeficiency	O
allele	B-UNK
common	B-UNK
in	O
non	B-UNK
-	O
jewish	B-UNK
tay	O
-	O
sachs	B-UNK
carriers	B-UNK
:	O
implications	B-UNK
for	O
carrier	B-UNK
screening	B-UNK
.	O

 	O
deficiency	B-UNK
of	O
beta	B-UNK
-	O
hexosaminidase	O
a	O
(	O
hex	O
a	O
)	O
activity	B-UNK
typically	B-UNK
results	B-UNK
in	O
tay	B-DISEASE
-	I-DISEASE
sachs	I-DISEASE
disease	I-DISEASE
.	O

 	O
however	O
,	O
healthy	B-UNK
subjects	B-UNK
found	B-UNK
to	O
be	O
deficient	B-UNK
in	O
hex	O
a	O
activity	B-UNK
(	O
i	O
.	O
e	B-UNK
.	O
,	O
pseudodeficient	O
)	O
by	O
means	O
of	O
in	O
vitro	B-UNK
biochemical	B-UNK
tests	B-UNK
have	O
been	O
described	B-UNK
.	O

 	O
we	O
analyzed	B-UNK
the	O
hexa	B-UNK
gene	B-UNK
of	O
one	O
pseudodeficient	O
subject	B-UNK
and	O
identified	B-UNK
both	O
a	O
c739	O
-	O
to	O
-	O
t	B-UNK
substitution	B-UNK
that	O
changes	B-UNK
arg247	O
-	O
-	O
-	O
-	O
trp	O
on	O
one	O
allele	B-UNK
and	O
a	O
previously	B-UNK
identified	I-UNK
tay	B-DISEASE
-	I-DISEASE
sachs	I-DISEASE
disease	I-DISEASE
mutation	B-UNK
on	O
the	O
second	B-UNK
allele	B-UNK
.	O

 	O
six	O
additional	B-UNK
pseudodeficient	O
subjects	B-UNK
were	O
found	B-UNK
to	O
have	O
the	O
c739	O
-	O
to	O
-	O
t	B-UNK
mutation	B-UNK
.	O

 	O
this	O
allele	B-UNK
accounted	B-UNK
for	O
32	O
%	O
(	O
20	O
/	O
62	O
)	O
of	O
non	B-UNK
-	O
jewish	B-UNK
enzyme	B-UNK
-	O
defined	B-UNK
tay	B-DISEASE
-	I-DISEASE
sachs	I-DISEASE
disease	I-DISEASE
carriers	B-UNK
but	O
for	O
none	O
of	O
36	O
jewish	B-UNK
enzyme	B-UNK
-	O
defined	B-UNK
carriers	B-UNK
who	O
did	O
not	O
have	O
one	O
of	O
three	O
known	B-UNK
mutations	B-UNK
common	B-UNK
to	O
this	O
group	B-UNK
.	O

 	O
the	O
c739	O
-	O
to	O
-	O
t	B-UNK
allele	B-UNK
,	O
together	O
with	O
a	O
"	O
true	B-UNK
"	O
tay	B-DISEASE
-	I-DISEASE
sachs	I-DISEASE
disease	I-DISEASE
allele	B-UNK
,	O
causes	B-UNK
hex	O
a	O
pseudodeficiency	O
.	O

 	O
given	B-UNK
both	O
the	O
large	B-UNK
proportion	B-UNK
of	O
non	B-UNK
-	O
jewish	B-UNK
carriers	B-UNK
with	O
this	O
allele	B-UNK
and	O
that	O
standard	B-UNK
biochemical	B-UNK
screening	B-UNK
can	O
not	O
differentiate	O
between	O
heterozygotes	B-UNK
for	O
the	O
c739	O
-	O
to	O
-	O
t	B-UNK
mutations	B-UNK
and	O
tay	B-DISEASE
-	I-DISEASE
sachs	I-DISEASE
disease	I-DISEASE
carriers	B-UNK
,	O
dna	B-UNK
testing	B-UNK
for	O
this	O
mutation	B-UNK
in	O
at	B-DISEASE
-	O
risk	B-UNK
couples	O
is	O
essential	B-UNK
.	O

 	O
pelizaeus	B-DISEASE
-	I-DISEASE
merzbacher	I-DISEASE
disease	I-DISEASE
:	O
detection	B-UNK
of	O
mutations	B-UNK
thr181	O
-	O
-	O
-	O
-	O
pro	O
and	O
leu223	O
-	O
-	O
-	O
-	O
pro	O
in	O
the	O
proteolipid	B-UNK
protein	B-UNK
gene	B-UNK
,	O
and	O
prenatal	B-UNK
diagnosis	I-UNK
.	O

 	O
a	O
family	B-UNK
with	O
an	O
apparent	B-UNK
history	B-UNK
of	O
x	B-UNK
-	O
linked	B-UNK
pelizaeus	B-DISEASE
-	I-DISEASE
merzbacher	I-DISEASE
disease	I-DISEASE
presented	B-UNK
for	O
genetic	B-UNK
counseling	B-UNK
,	O
requesting	O
carrier	B-UNK
detection	I-UNK
and	O
prenatal	B-UNK
diagnosis	I-UNK
.	O

 	O
rflp	B-UNK
analysis	B-UNK
using	O
the	O
proteolipid	B-UNK
protein	B-UNK
(	O
plp	B-UNK
)	O
gene	B-UNK
probe	B-UNK
was	O
uninformative	O
in	O
this	O
family	B-UNK
.	O

 	O
a	O
prenatal	B-UNK
diagnosis	I-UNK
on	O
a	O
chorionic	O
villus	O
sample	B-UNK
(	O
cvs	O
)	O
was	O
carried	B-UNK
out	O
using	O
single	B-UNK
-	O
strand	B-UNK
conformation	I-UNK
polymorphism	I-UNK
(	O
sscp	B-UNK
)	O
analysis	B-UNK
of	O
a	O
variant	B-UNK
in	O
exon	B-UNK
4	O
of	O
the	O
plp	B-UNK
gene	B-UNK
.	O

 	O
the	O
fetus	B-UNK
was	O
predicted	B-UNK
to	O
be	O
unaffected	B-UNK
.	O

 	O
sequencing	B-UNK
of	O
the	O
exon	B-UNK
from	O
the	O
cvs	O
,	O
the	O
predicted	B-UNK
-	O
carrier	B-UNK
mother	B-UNK
,	O
and	O
the	O
obligate	B-UNK
-	O
carrier	B-UNK
grandmother	O
revealed	B-UNK
an	O
a	O
-	O
to	O
-	O
c	B-UNK
change	B-UNK
at	B-DISEASE
nucleotide	B-UNK
541	O
in	O
the	O
two	O
women	B-UNK
but	O
not	O
in	O
the	O
fetus	B-UNK
.	O

 	O
as	O
this	O
change	B-UNK
results	B-UNK
in	O
a	O
thr	O
-	O
to	O
-	O
pro	O
change	B-UNK
at	B-DISEASE
amino	B-UNK
acid	I-UNK
181	O
in	O
a	O
region	B-UNK
of	O
the	O
gene	B-UNK
predicted	B-UNK
to	O
be	O
part	O
of	O
a	O
transmembrane	B-UNK
segment	B-UNK
,	O
it	O
was	O
concluded	O
that	O
this	O
was	O
the	O
mutation	B-UNK
causing	B-UNK
the	O
disease	B-DISEASE
in	O
this	O
family	B-UNK
.	O

 	O
in	O
addition	B-UNK
,	O
in	O
a	O
second	B-UNK
family	B-UNK
,	O
an	O
exon	B-UNK
5	O
variant	B-UNK
band	B-UNK
pattern	B-UNK
on	O
sscp	B-UNK
analysis	B-UNK
was	O
shown	B-UNK
by	O
sequencing	B-UNK
to	O
be	O
due	O
to	O
a	O
t	B-UNK
-	O
to	O
-	O
c	B-UNK
change	B-UNK
at	B-DISEASE
nucleotide	B-UNK
668	O
.	O

 	O
this	O
results	B-UNK
in	O
a	O
leu	B-UNK
-	O
to	O
-	O
pro	O
change	B-UNK
in	O
a	O
carrier	B-UNK
mother	B-UNK
and	O
in	O
her	O
two	O
affected	B-UNK
sons	O
.	O

 	O
these	O
results	B-UNK
provide	I-UNK
further	O
examples	O
of	O
mutations	B-UNK
in	O
plp	B-UNK
that	O
cause	B-UNK
pelizaeus	B-DISEASE
-	I-DISEASE
merzbacher	I-DISEASE
disease	I-DISEASE
and	O
illustrate	O
the	O
value	B-UNK
of	O
sscp	B-UNK
in	O
genetic	B-UNK
analysis	B-UNK
.	O
.	O

 	O
von	B-DISEASE
willebrand	I-DISEASE
disease	I-DISEASE
type	B-UNK
b	B-UNK
:	O
a	O
missense	B-UNK
mutation	I-UNK
selectively	O
abolishes	B-UNK
ristocetin	B-UNK
-	O
induced	B-UNK
von	B-DISEASE
willebrand	I-DISEASE
factor	I-DISEASE
binding	B-UNK
to	O
platelet	B-UNK
glycoprotein	B-UNK
ib	I-UNK
.	O

 	O
von	B-DISEASE
willebrand	I-DISEASE
factor	I-DISEASE
(	O
vwf	B-UNK
)	O
is	O
a	O
multimeric	O
glycoprotein	B-UNK
that	O
mediates	O
the	O
adhesion	O
of	O
platelets	B-UNK
to	O
the	O
subendothelium	O
by	O
binding	B-UNK
to	O
platelet	B-UNK
glycoprotein	B-UNK
ib	I-UNK
.	O

 	O
for	O
human	B-UNK
vwf	B-UNK
,	O
this	O
interaction	B-UNK
can	O
be	O
induced	B-UNK
in	O
vitro	B-UNK
by	O
the	O
antibiotic	O
ristocetin	B-UNK
or	O
the	O
snake	O
venom	O
protein	B-UNK
botrocetin	B-UNK
.	O

 	O
a	O
missense	B-UNK
mutation	I-UNK
,	O
gly	B-UNK
-	O
561	O
-	O
-	O
>	O
ser	B-UNK
,	O
was	O
identified	B-UNK
within	O
the	O
proposed	B-UNK
glycoprotein	B-UNK
ib	I-UNK
binding	B-UNK
domain	I-UNK
of	O
vwf	B-UNK
in	O
the	O
proband	B-UNK
with	O
von	B-DISEASE
willebrand	I-DISEASE
disease	I-DISEASE
type	B-UNK
b	B-UNK
,	O
a	O
unique	B-UNK
variant	B-UNK
characterized	B-UNK
by	O
no	O
ristocetin	B-UNK
-	O
induced	B-UNK
,	O
but	O
normal	B-UNK
botrocetin	B-UNK
-	O
induced	B-UNK
,	O
binding	B-UNK
to	O
glycoprotein	B-UNK
ib	I-UNK
.	O

 	O
the	O
corresponding	B-UNK
mutant	B-UNK
recombinant	B-UNK
protein	B-UNK
,	O
rvwf	O
(	O
g561s	O
)	O
,	O
formed	B-UNK
normal	B-UNK
multimers	B-UNK
and	O
exhibited	B-UNK
the	O
same	O
functional	B-UNK
defect	B-UNK
as	O
the	O
patients	B-UNK
plasma	B-UNK
vwf	B-UNK
,	O
confirming	O
that	O
this	O
mutation	B-UNK
causes	B-UNK
von	B-DISEASE
willebrand	I-DISEASE
disease	I-DISEASE
type	B-UNK
b	B-UNK
.	O

 	O
these	O
data	B-UNK
show	O
that	O
botrocetin	B-UNK
and	O
ristocetin	B-UNK
cofactor	O
activities	B-UNK
of	O
vwf	B-UNK
can	O
be	O
dissociated	O
by	O
a	O
point	B-UNK
mutation	I-UNK
and	O
confirm	B-UNK
that	O
these	O
mediators	O
promote	O
vwf	B-UNK
binding	B-UNK
to	O
platelets	B-UNK
by	O
different	B-UNK
mechanisms	B-UNK
.	O

 	O
the	O
normal	B-UNK
botrocetin	B-UNK
-	O
induced	B-UNK
binding	B-UNK
and	O
the	O
defective	B-UNK
ristocetin	B-UNK
-	O
induced	B-UNK
binding	B-UNK
of	O
rvwf	O
(	O
g561s	O
)	O
suggest	B-UNK
that	O
the	O
primary	B-UNK
defect	B-UNK
in	O
von	B-DISEASE
willebrand	I-DISEASE
disease	I-DISEASE
type	B-UNK
b	B-UNK
may	O
be	O
a	O
failure	O
of	O
normal	B-UNK
allosteric	O
regulation	B-UNK
of	O
the	O
glycoprotein	B-UNK
ib	I-UNK
binding	B-UNK
function	B-UNK
of	O
vwf	B-UNK
.	O
.	O

 	O
typical	B-UNK
and	O
partial	B-UNK
cat	B-UNK
eye	B-UNK
syndrome	B-DISEASE
:	O
identification	B-UNK
of	O
the	O
marker	B-UNK
chromosome	B-UNK
by	O
fish	B-UNK
.	O

 	O
three	O
children	B-UNK
are	O
reported	B-UNK
with	O
typical	B-UNK
cat	B-UNK
eye	B-UNK
syndrome	B-DISEASE
(	O
ces	O
)	O
and	O
three	O
more	O
children	B-UNK
with	O
partial	B-UNK
ces	O
because	O
of	O
absence	B-UNK
of	O
coloboma	B-DISEASE
,	O
in	O
which	O
the	O
supernumerary	O
marker	B-UNK
chromosome	B-UNK
was	O
studied	B-UNK
by	O
fish	B-UNK
.	O

 	O
using	O
a	O
genomic	B-UNK
library	B-UNK
,	O
and	O
also	O
a	O
centromeric	B-UNK
and	O
particularly	B-UNK
a	O
cosmid	B-UNK
probe	B-UNK
of	O
22q11	B-UNK
,	O
partial	B-UNK
tetrasomy	B-DISEASE
was	O
shown	B-UNK
in	O
all	O
cases	B-UNK
.	O
.	O

 	O
[	O
genetic	B-UNK
heterogeneity	B-UNK
of	O
g6pd	B-UNK
deficiency	I-UNK
:	O
mutant	B-UNK
alleles	I-UNK
of	O
g6pd	B-UNK
in	O
the	O
shekii	B-UNK
district	B-UNK
of	O
azerbaijan	O
]	O

 	O
examination	B-UNK
on	O
g6pd	B-UNK
deficiency	I-UNK
in	O
349	O
patients	B-UNK
of	O
shekii	B-UNK
district	B-UNK
hospital	B-UNK
(	O
azerbaijan	O
)	O
revealed	B-UNK
16	O
hemi	O
-	O
,	O
4	O
homo	O
-	O
and	O
9	O
heterozygotic	O
carriers	B-UNK
of	O
the	O
defect	B-UNK
.	O

 	O
gd	B-UNK
-	O
frequency	B-UNK
,	O
calculated	O
from	O
the	O
data	B-UNK
obtained	B-UNK
(	O
7	O
.	O
7	O
%	O
)	O
,	O
may	O
be	O
compared	B-UNK
to	O
neighbouring	O
regions	B-UNK
frequencies	B-UNK
(	O
6	O
-	O
30	O
%	O
)	O
.	O

 	O
carriers	B-UNK
of	O
g6pd	B-UNK
deficiency	I-UNK
are	O
residents	O
of	O
11	O
villages	O
located	B-UNK
in	O
alasani	O
-	O
aphtalan	O
valley	O
,	O
highly	B-UNK
endemic	O
with	O
malaria	B-DISEASE
in	O
the	O
past	O
;	O
nearly	O
all	O
marriages	O
are	O
endogamic	O
.	O

 	O
physico	O
-	O
chemical	B-UNK
and	O
kinetic	B-UNK
study	B-UNK
of	O
10	O
mutant	B-UNK
forms	B-UNK
of	O
g6pd	B-UNK
,	O
according	B-UNK
to	O
who	O
program	B-UNK
,	O
led	B-UNK
to	O
identification	B-UNK
of	O
5	O
variants	B-UNK
of	O
the	O
ii	B-UNK
class	B-UNK
(	O
shekii	B-UNK
,	O
bideiz	O
,	O
shirin	O
-	O
bulakh	O
,	O
okhut	O
i	O
and	O
zakataly	O
)	O
and	O
2	O
variants	B-UNK
of	O
the	O
iii	B-UNK
class	B-UNK
(	O
okhut	O
ii	B-UNK
and	O
martinique	O
-	O
like	B-UNK
)	O
.	O

 	O
resemblance	O
of	O
the	O
majority	B-UNK
of	O
variants	B-UNK
in	O
electrophoretic	B-UNK
mobility	I-UNK
and	O
the	O
level	B-UNK
of	O
erythrocyte	B-UNK
enzyme	B-UNK
activity	I-UNK
permit	B-UNK
to	O
suggest	B-UNK
the	O
existence	O
of	O
a	O
common	B-UNK
parental	B-UNK
mutant	B-UNK
g6pd	B-UNK
allele	B-UNK
distributed	B-UNK
in	O
this	O
area	B-UNK
.	O

 	O
craniofrontonasal	B-DISEASE
dysplasia	I-DISEASE
.	O

 	O
we	O
report	B-UNK
on	O
nine	O
patients	B-UNK
with	O
craniofrontonasal	B-DISEASE
dysplasia	I-DISEASE
(	O
cfnd	O
)	O
.	O

 	B-UNK
seven	I-UNK
classical	B-UNK
cases	I-UNK
had	O
facial	B-UNK
features	B-UNK
suggestive	O
of	O
frontonasal	B-DISEASE
dysplasia	I-DISEASE
and	O
coronal	O
craniosynostosis	B-DISEASE
.	O

 	O
extracranial	O
abnormalities	B-DISEASE
such	O
as	O
brittle	O
nails	B-DISEASE
with	O
prominent	B-UNK
longitudinal	O
grooves	O
or	O
syndactyly	B-DISEASE
of	O
fingers	O
and	O
toes	O
were	O
observed	B-UNK
in	O
individual	B-UNK
patients	B-UNK
.	O

 	O
in	O
two	O
families	B-UNK
the	O
father	B-UNK
of	O
classical	B-UNK
cases	I-UNK
showed	B-UNK
a	O
milder	B-UNK
pattern	B-UNK
of	O
abnormalities	B-DISEASE
,	O
consistent	B-UNK
with	O
the	O
diagnosis	B-UNK
.	O

 	O
we	O
present	B-UNK
a	O
2	O
-	O
to	O
13	O
-	O
year	B-UNK
follow	B-UNK
-	O
up	O
on	O
our	O
patients	B-UNK
.	O

 	O
hypotonia	B-DISEASE
and	O
laxity	O
of	O
joints	O
are	O
common	B-UNK
and	O
may	O
necessitate	O
supportive	O
measures	O
.	O

 	O
mild	B-UNK
developmental	B-DISEASE
delay	I-DISEASE
was	O
noted	O
in	O
three	O
out	O
of	O
six	O
classical	B-UNK
cases	I-UNK
studied	B-UNK
in	O
detail	O
.	O

 	O
unlike	B-UNK
almost	O
all	O
other	O
x	B-UNK
-	O
linked	B-UNK
disorders	B-UNK
,	O
clinical	B-UNK
expression	B-UNK
in	O
cfnd	O
is	O
generally	B-UNK
much	O
more	O
severe	B-UNK
in	O
females	B-UNK
than	O
in	O
males	B-UNK
.	O

 	O
in	O
contrast	B-UNK
to	O
previous	B-UNK
reports	B-UNK
of	O
this	O
condition	B-UNK
,	O
one	O
of	O
our	O
severely	B-UNK
affected	I-UNK
cases	B-UNK
is	O
a	O
male	B-UNK
.	O
.	O

 	O
the	O
intron	B-UNK
7	O
donor	B-UNK
splice	I-UNK
site	I-UNK
transition	B-UNK
:	O
a	O
second	B-UNK
tay	B-DISEASE
-	I-DISEASE
sachs	I-DISEASE
disease	I-DISEASE
mutation	B-UNK
in	O
french	B-UNK
canada	B-UNK
.	O

 	O
mutations	B-UNK
at	B-DISEASE
the	O
hexosaminidase	O
a	O
(	O
hexa	B-UNK
)	O
gene	B-UNK
which	O
cause	B-UNK
tay	B-DISEASE
-	I-DISEASE
sachs	I-DISEASE
disease	I-DISEASE
(	O
tsd	B-UNK
)	O
have	O
elevated	B-UNK
frequency	B-UNK
in	O
the	O
ashkenazi	B-UNK
jewish	I-UNK
and	O
french	B-UNK
-	O
canadian	B-UNK
populations	B-UNK
.	O

 	O
we	O
report	B-UNK
a	O
novel	B-UNK
tsd	B-UNK
allele	B-UNK
in	O
the	O
french	B-UNK
-	O
canadian	B-UNK
population	B-UNK
associated	B-UNK
with	O
the	O
infantile	B-UNK
form	B-UNK
of	O
the	O
disease	B-DISEASE
.	O

 	O
the	O
mutation	B-UNK
,	O
a	O
g	B-UNK
-	O
-	O
>	O
a	O
transition	B-UNK
at	B-DISEASE
the	O
+	O
1	O
position	B-UNK
of	O
intron	B-UNK
7	O
,	O
abolishes	B-UNK
the	O
donor	B-UNK
splice	I-UNK
site	I-UNK
.	O

 	O
cultured	B-UNK
human	B-UNK
fibroblasts	B-UNK
from	O
a	O
compound	B-UNK
heterozygote	B-UNK
for	O
this	O
transition	B-UNK
(	O
and	O
for	O
a	O
deletion	B-UNK
mutation	B-UNK
)	O
produce	B-UNK
no	O
detectable	B-UNK
hexa	B-UNK
mrna	B-UNK
.	O

 	O
the	O
intron	B-UNK
7	O
+	O
1	O
mutation	B-UNK
occurs	B-UNK
in	O
the	O
base	B-UNK
adjacent	B-UNK
to	O
the	O
site	B-UNK
of	O
the	O
adult	B-UNK
-	O
onset	B-UNK
tsd	B-UNK
mutation	B-UNK
(	O
g805a	O
)	O
.	O

 	O
in	O
both	O
mutations	B-UNK
a	O
restriction	O
site	B-UNK
for	O
the	O
endonuclease	O
ecorii	O
is	O
abolished	O
.	O

 	O
unambiguous	O
diagnosis	B-UNK
,	O
therefore	O
,	O
requires	B-UNK
allele	B-UNK
-	O
specific	B-UNK
oligonucleotide	I-UNK
hybridization	B-UNK
to	O
distinguish	O
between	O
these	O
two	O
mutant	B-UNK
alleles	I-UNK
.	O

 	O
the	O
intron	B-UNK
7	O
+	O
1	O
mutation	B-UNK
has	O
been	O
detected	B-UNK
in	O
three	O
unrelated	B-UNK
families	I-UNK
.	O

 	O
obligate	B-UNK
heterozygotes	B-UNK
for	O
the	O
intron	B-UNK
7	O
+	O
1	O
mutation	B-UNK
were	O
born	O
in	O
the	O
saguenay	O
-	O
lac	O
-	O
st	O
-	O
jean	O
region	B-UNK
of	O
quebec	O
.	O

 	O
the	O
most	O
recent	B-UNK
ancestors	O
common	B-UNK
to	O
obligate	B-UNK
carriers	B-UNK
of	O
this	O
mutation	B-UNK
were	O
from	O
the	O
charlevoix	O
region	B-UNK
of	O
the	O
province	O
of	O
quebec	O
.	O

 	O
this	O
mutation	B-UNK
thus	O
has	O
a	O
different	B-UNK
geographic	B-UNK
centre	B-UNK
of	O
diffusion	O
and	O
is	O
probably	B-UNK
less	O
common	B-UNK
than	O
the	O
exon	B-UNK
1	O
deletion	B-UNK
tsd	B-UNK
mutation	B-UNK
in	O
french	B-UNK
canadians	O
.	O

 	O
neither	O
mutation	B-UNK
has	O
been	O
detected	B-UNK
in	O
france	O
,	O
the	O
ancestral	B-UNK
homeland	O
of	O
french	B-UNK
canada	B-UNK
.	O
.	O

 	O
assignment	B-UNK
of	O
the	O
aspartylglucosaminidase	B-UNK
gene	B-UNK
(	O
aga	B-UNK
)	O
to	O
4q33	O
-	O
-	O
-	O
-	O
q35	O
based	B-UNK
on	O
decreased	B-UNK
activity	B-UNK
in	O
a	O
girl	B-UNK
with	O
a	O
46	O
,	O
xx	O
,	O
del	O
(	O
4	O
)	O
(	O
q33	O
)	O
karyotype	B-UNK
.	O

 	O
aspartylglucosaminuria	B-DISEASE
(	O
agu	B-UNK
)	O
is	O
a	O
recessive	O
autosomally	O
inherited	B-UNK
lysosomal	B-UNK
storage	O
disorder	O
due	O
to	O
deficiency	B-UNK
of	O
the	O
enzyme	B-UNK
aspartylglucosaminidase	B-UNK
(	O
aga	B-UNK
)	O
.	O

 	O
the	O
structural	B-UNK
gene	B-UNK
for	O
this	O
human	B-UNK
enzyme	B-UNK
(	O
aga	B-UNK
)	O
has	O
been	O
assigned	B-UNK
to	O
the	O
region	B-UNK
4q21	O
-	O
-	O
-	O
-	O
qter	O
.	O

 	O
we	O
determined	B-UNK
the	O
aga	B-UNK
activity	B-UNK
in	O
cultured	B-UNK
fibroblasts	B-UNK
of	O
a	O
girl	B-UNK
with	O
a	O
46	O
,	O
xx	O
,	O
del	O
(	O
4	O
)	O
(	O
q33	O
)	O
karyotype	B-UNK
.	O

 	O
the	O
results	B-UNK
indicate	B-UNK
that	O
the	O
girl	B-UNK
is	O
a	O
hemizygote	O
for	O
aga	B-UNK
,	O
permitting	O
the	O
assignment	B-UNK
of	O
human	B-UNK
aga	B-UNK
to	O
the	O
region	B-UNK
4q33	O
-	O
-	O
-	O
-	O
qter	O
.	O
.	O

 	O
resolution	B-UNK
of	O
the	O
two	O
loci	B-UNK
for	O
autosomal	O
dominant	B-UNK
aniridia	B-DISEASE
,	O
an1	O
and	O
an2	B-UNK
,	O
to	O
a	O
single	B-UNK
locus	B-UNK
on	O
chromosome	B-UNK
11p13	B-UNK
.	O

 	O
two	O
distinct	B-UNK
loci	B-UNK
have	O
been	O
proposed	B-UNK
for	O
aniridia	B-DISEASE
;	O
an1	O
for	O
autosomal	O
dominant	B-UNK
aniridia	B-DISEASE
on	O
chromosome	B-UNK
2p	B-UNK
and	O
an2	B-UNK
for	O
the	O
aniridia	B-DISEASE
in	O
the	O
wagr	B-UNK
contiguous	B-UNK
gene	B-UNK
syndrome	B-DISEASE
on	O
chromosome	B-UNK
11p13	B-UNK
.	O

 	O
in	O
this	O
report	B-UNK
,	O
the	O
kindred	B-UNK
segregating	B-UNK
for	O
autosomal	O
dominant	B-UNK
aniridia	B-DISEASE
,	O
which	O
suggested	B-UNK
linkage	B-UNK
to	O
acid	O
phosphatase	B-UNK
-	O
1	O
(	O
acp1	O
)	O
and	O
led	B-UNK
to	O
the	O
assignment	B-UNK
of	O
the	O
an1	O
locus	B-UNK
on	O
chromosome	B-UNK
2p	B-UNK
,	O
has	O
been	O
updated	O
and	O
expanded	B-UNK
.	O

 	B-UNK
linkage	I-UNK
analysis	B-UNK
between	O
the	O
aniridia	B-DISEASE
phenotype	B-UNK
and	O
acp1	O
does	O
not	O
support	B-UNK
the	O
original	B-UNK
linkage	B-UNK
results	B-UNK
,	O
excluding	O
linkage	B-UNK
up	O
to	O
theta	B-UNK
=	I-UNK
0	O
.	O

 	O
17	O
with	O
z	B-UNK
=	O
-	O
2	O
.	O

 	O
tests	B-UNK
for	O
linkage	B-UNK
to	O
other	O
chromosome	B-UNK
2p	B-UNK
markers	B-UNK
.	O

 	O
apob	B-UNK
,	O
d2s71	O
,	O
d2s5	O
,	O
and	O
d2s1	O
,	O
also	O
excluded	B-UNK
linkage	B-UNK
to	O
aniridia	B-DISEASE
.	O

 	O
markers	B-UNK
that	O
have	O
been	O
isolated	B-UNK
from	O
the	O
chromosome	B-UNK
11p13	B-UNK
region	B-UNK
were	O
then	O
analyzed	B-UNK
in	O
this	O
aniridia	B-DISEASE
family	B-UNK
.	O

 	O
two	O
rflps	B-UNK
at	B-DISEASE
the	O
d11s323	O
locus	B-UNK
give	O
significant	B-UNK
evidence	B-UNK
for	O
linkage	B-UNK
.	O

 	O
the	O
pvuii	O
polymorphism	O
detected	B-UNK
by	O
probe	B-UNK
p5s1	O
.	O

 	O
6	O
detects	O
no	O
recombinants	O
,	O
with	O
a	O
maximum	B-UNK
lod	I-UNK
score	B-UNK
of	O
z	B-UNK
=	O
6	O
.	O

 	O
97	O
at	B-DISEASE
theta	B-UNK
=	I-UNK
0	O
.	O

 	O
00	O
00	O
.	O

 	O
the	O
haeiii	O
polymorphism	O
detected	B-UNK
by	O
the	O
probe	B-UNK
p5be1	O
.	O

 	O
2	O
gives	O
a	O
maximum	B-UNK
lod	I-UNK
score	B-UNK
of	O
z	B-UNK
=	O
2	O
.	O

 	O
57	O
at	B-DISEASE
theta	B-UNK
=	I-UNK
0	O
.	O

 	O
00	O
00	O
.	O

 	O
locus	B-UNK
d11s325	O
gives	O
a	O
lod	B-UNK
score	I-UNK
of	O
z	B-UNK
=	O
1	O
.	O

 	O
53	O
at	B-DISEASE
theta	B-UNK
=	I-UNK
0	O
.	O

 	O
00	O
00	O
.	O

 	O
these	O
data	B-UNK
suggest	B-UNK
that	O
a	O
locus	B-UNK
for	O
aniridia	B-DISEASE
(	O
an1	O
)	O
on	O
chromosome	B-UNK
2p	B-UNK
has	O
been	O
misassigned	O
and	O
that	O
this	O
autosomal	O
dominant	B-UNK
aniridia	B-DISEASE
family	B-UNK
is	O
segregating	B-UNK
for	O
an	O
aniridia	B-DISEASE
mutation	B-UNK
linked	B-UNK
to	O
markers	B-UNK
in	O
the	O
11p13	B-UNK
region	B-UNK
.	O

 	O
fatal	B-UNK
pyoderma	B-DISEASE
gangrenosum	I-DISEASE
in	O
association	B-UNK
with	O
c7	B-UNK
deficiency	I-UNK
.	O

 	O
although	O
pyoderma	B-DISEASE
gangrenosum	I-DISEASE
(	O
pg	O
)	O
is	O
often	O
associated	B-UNK
with	O
systemic	O
diseases	B-DISEASE
,	O
it	O
has	O
not	O
been	O
reported	B-UNK
in	O
association	B-UNK
with	O
congenital	B-DISEASE
complement	B-UNK
deficiencies	B-UNK
.	O

 	O
we	O
describe	B-UNK
an	O
aggressive	B-UNK
and	O
ultimately	O
fatal	B-UNK
case	B-UNK
of	O
pg	O
in	O
a	O
patient	B-UNK
with	O
a	O
congenital	B-DISEASE
c7	B-UNK
deficiency	I-UNK
.	O

 	O
deficiencies	B-UNK
of	O
c7	B-UNK
can	O
be	O
associated	B-UNK
with	O
decreased	B-UNK
neutrophil	O
chemotaxis	B-UNK
,	O
phagocytosis	B-DISEASE
,	O
and	O
opsonization	O
,	O
similar	B-UNK
to	O
the	O
immunologic	B-UNK
abnormalities	B-DISEASE
described	B-UNK
in	O
patients	B-UNK
with	O
pg	O
.	O

 	O
our	O
patients	B-UNK
decreased	B-UNK
complement	B-UNK
level	B-UNK
,	O
if	O
not	O
directly	B-UNK
related	B-UNK
to	O
the	O
development	B-UNK
of	O
pg	O
,	O
may	O
have	O
contributed	O
to	O
the	O
aggressive	B-UNK
nature	B-UNK
of	O
her	O
disease	B-DISEASE
.	O
.	O

 	O
diverse	B-UNK
point	B-UNK
mutations	I-UNK
result	B-UNK
in	O
glucose	B-UNK
-	O
6	O
-	O
phosphate	B-UNK
dehydrogenase	I-UNK
(	O
g6pd	B-UNK
)	O
polymorphism	O
in	O
taiwan	O
.	O

 	O
glucose	B-UNK
-	O
6	O
-	O
phosphate	B-UNK
dehydrogenase	I-UNK
(	O
g6pd	B-UNK
;	O
ec	O
1	O
.	O
1	O
.	O
1	O
.	O
49	O
)	O
deficiency	B-UNK
is	O
the	O
most	O
common	B-UNK
human	B-UNK
enzymopathy	B-UNK
,	O
affecting	B-UNK
more	O
than	O
200	O
million	B-UNK
people	B-UNK
worldwide	B-UNK
.	O

 	O
although	O
greater	B-UNK
than	O
400	O
variants	B-UNK
have	O
been	O
described	B-UNK
based	B-UNK
on	O
clinical	B-UNK
and	O
biochemical	B-UNK
criteria	B-UNK
,	O
little	B-UNK
is	O
known	B-UNK
about	O
the	O
molecular	B-UNK
basis	I-UNK
of	O
these	O
g6pd	B-UNK
deficiencies	B-UNK
.	O

 	O
recently	B-UNK
,	O
the	O
gene	B-UNK
that	O
encodes	B-UNK
human	B-UNK
g6pd	B-UNK
has	O
been	O
cloned	B-UNK
and	O
sequenced	B-UNK
,	O
which	O
enables	O
us	O
to	O
examine	O
directly	B-UNK
the	O
heterogeneity	B-UNK
of	O
g6pd	B-UNK
at	B-DISEASE
the	O
dna	B-UNK
level	B-UNK
.	O

 	O
during	O
the	O
past	O
10	O
years	B-UNK
,	O
we	O
examined	B-UNK
the	O
g6pd	B-UNK
activity	I-UNK
in	O
21	O
,	O
271	O
newborn	B-UNK
chinese	B-UNK
infants	O
(	O
11	O
,	O
400	O
males	B-UNK
and	O
9	O
,	O
871	O
females	B-UNK
)	O
and	O
identified	B-UNK
314	O
(	O
2	O
.	O
8	O
%	O
)	O
males	B-UNK
and	O
246	O
(	O
2	O
.	O
5	O
%	O
)	O
females	B-UNK
having	B-UNK
low	B-UNK
g6pd	B-UNK
activity	I-UNK
.	O

 	O
the	O
g6pd	B-UNK
gene	B-UNK
from	O
10	O
randomly	B-UNK
selected	B-UNK
affected	B-UNK
individuals	I-UNK
and	O
their	O
relatives	B-UNK
was	O
polymerase	B-UNK
chain	I-UNK
reaction	I-UNK
(	O
pcr	B-UNK
)	O
amplified	B-UNK
,	O
subcloned	O
,	O
and	O
sequenced	B-UNK
.	O

 	O
our	O
results	B-UNK
indicate	B-UNK
that	O
at	B-DISEASE
least	O
four	O
types	B-UNK
of	O
mutation	B-UNK
are	O
responsible	B-UNK
for	O
the	O
g6pd	B-UNK
polymorphism	O
in	O
taiwan	O
.	O

 	O
the	O
first	O
type	B-UNK
of	O
mutation	B-UNK
(	O
487	O
g	B-UNK
-	O
-	O
-	O
-	O
a	O
)	O
was	O
found	B-UNK
in	O
an	O
affected	B-UNK
chinese	B-UNK
with	O
a	O
g	B-UNK
to	O
a	O
change	B-UNK
at	B-DISEASE
nucleotide	B-UNK
487	O
,	O
which	O
results	B-UNK
in	O
a	O
(	O
163	O
)	O
gly	B-UNK
to	O
ser	B-UNK
substitution	B-UNK
.	O

 	O
the	O
second	B-UNK
type	B-UNK
of	O
mutation	B-UNK
(	O
493	O
a	O
-	O
-	O
-	O
-	O
g	B-UNK
)	O
is	O
a	O
novel	B-UNK
mutation	B-UNK
that	O
has	O
not	O
been	O
reported	B-UNK
in	O
any	O
other	O
ethnic	B-UNK
group	B-UNK
and	O
was	O
identified	B-UNK
in	O
two	O
affected	B-UNK
chinese	B-UNK
.	O

 	O
this	O
mutation	B-UNK
causes	B-UNK
an	O
a	O
to	O
g	B-UNK
change	B-UNK
at	B-DISEASE
nucleotide	B-UNK
position	B-UNK
493	O
,	O
producing	B-UNK
an	O
(	O
165	O
)	O
asn	O
to	O
asp	B-UNK
substitution	B-UNK
.	O

 	O
interestingly	B-UNK
,	O
the	O
487	O
g	B-UNK
-	O
-	O
-	O
-	O
a	O
and	O
493	O
a	O
-	O
-	O
-	O
-	O
g	B-UNK
mutations	B-UNK
create	O
alu	B-UNK
i	O
and	O
ava	O
ii	B-UNK
recognition	B-UNK
sites	B-UNK
,	O
respectively	B-UNK
,	O
which	O
enabled	B-UNK
us	O
to	O
rapidly	B-UNK
detect	B-UNK
these	O
two	O
mutations	B-UNK
by	O
pcr	B-UNK
/	O
restriction	O
enzyme	B-UNK
(	O
re	O
)	O
digestion	B-UNK
method	B-UNK
.	O

 	O
the	O
third	O
mutation	B-UNK
(	O
1376	O
g	B-UNK
-	O
-	O
-	O
-	O
t	B-UNK
)	O
was	O
found	B-UNK
in	O
four	O
affected	B-UNK
chinese	B-UNK
.	O

 	O
this	O
mutation	B-UNK
causes	B-UNK
a	O
g	B-UNK
to	O
t	B-UNK
change	B-UNK
at	B-DISEASE
nucleotide	B-UNK
position	B-UNK
1376	O
that	O
results	B-UNK
in	O
an	O
(	O
459	O
)	O
arg	B-UNK
to	O
leu	B-UNK
substitution	B-UNK
.	O

 	O
the	O
1376	O
g	B-UNK
-	O
-	O
-	O
-	O
t	B-UNK
mutation	B-UNK
seems	O
to	O
be	O
the	O
dominant	B-UNK
allele	B-UNK
that	O
causes	B-UNK
g6pd	B-UNK
deficiency	I-UNK
in	O
taiwan	O
.	O

 	O
finally	B-UNK
,	O
two	O
affected	B-UNK
chinese	B-UNK
were	O
identified	B-UNK
as	O
having	B-UNK
the	O
fourth	B-UNK
mutation	B-UNK
(	O
1388	O
g	B-UNK
-	O
-	O
-	O
-	O
a	O
)	O
.	O

 	O
this	O
mutation	B-UNK
causes	B-UNK
a	O
g	B-UNK
to	O
a	O
change	B-UNK
at	B-DISEASE
nucleotide	B-UNK
1388	O
that	O
produces	B-UNK
an	O
(	O
463	O
)	O
arg	B-UNK
to	O
his	O
substitution	B-UNK
.	O

 	O
our	O
studies	B-UNK
provide	B-UNK
the	O
direct	B-UNK
proof	O
of	O
the	O
genetic	B-UNK
heterogeneity	B-UNK
of	O
g6pd	B-UNK
deficiency	I-UNK
in	O
the	O
chinese	B-UNK
populations	B-UNK
of	O
taiwan	O
and	O
the	O
pcr	B-UNK
/	O
re	O
digestion	B-UNK
method	B-UNK
is	O
suitable	O
for	O
simultaneous	O
detection	B-UNK
of	O
the	O
487	O
g	B-UNK
-	O
-	O
-	O
-	O
a	O
and	O
493	O
a	O
-	O
-	O
-	O
-	O
g	B-UNK
mutations	B-UNK
.	O

 	O
an	O
error	B-UNK
in	O
dystrophin	B-UNK
mrna	B-UNK
processing	B-UNK
in	O
golden	O
retriever	O
muscular	B-DISEASE
dystrophy	I-DISEASE
,	O
an	O
animal	B-UNK
homologue	B-UNK
of	O
duchenne	B-UNK
muscular	B-DISEASE
dystrophy	I-DISEASE
.	O

 	O
golden	O
retriever	O
muscular	B-DISEASE
dystrophy	I-DISEASE
(	O
grmd	O
)	O
is	O
a	O
spontaneous	B-UNK
,	O
x	B-UNK
-	O
linked	B-UNK
,	O
progressively	B-UNK
fatal	B-UNK
disease	B-DISEASE
of	O
dogs	O
and	O
is	O
also	O
a	O
homologue	B-UNK
of	O
duchenne	B-UNK
muscular	B-DISEASE
dystrophy	I-DISEASE
(	O
dmd	B-UNK
)	O
.	O

 	O
two	O
-	O
thirds	O
of	O
dmd	B-UNK
patients	B-UNK
carry	B-UNK
detectable	B-UNK
deletions	B-UNK
in	O
their	O
dystrophin	B-UNK
gene	B-UNK
.	O

 	O
the	O
defect	B-UNK
underlying	B-UNK
the	O
remaining	B-UNK
one	O
-	O
third	O
of	O
dmd	B-UNK
patients	B-UNK
is	O
undetermined	O
.	O

 	O
analysis	B-UNK
of	O
the	O
canine	B-UNK
dystrophin	B-UNK
gene	B-UNK
in	O
normal	B-UNK
and	O
grmd	O
dogs	O
has	O
failed	B-UNK
to	O
demonstrate	B-UNK
any	O
detectable	B-UNK
loss	B-UNK
of	O
exons	B-UNK
.	O

 	O
here	O
,	O
we	O
have	O
demonstrated	B-UNK
a	O
rna	B-UNK
processing	B-UNK
error	B-UNK
in	O
grmd	O
that	O
results	B-UNK
from	O
a	O
single	B-UNK
base	B-UNK
change	I-UNK
in	O
the	O
3	O
consensus	B-UNK
splice	B-UNK
site	I-UNK
of	O
intron	B-UNK
6	O
.	O

 	O
the	O
seventh	B-UNK
exon	B-UNK
is	O
then	O
skipped	O
,	O
which	O
predicts	B-UNK
a	O
termination	B-UNK
of	O
the	O
dystrophin	B-UNK
reading	B-UNK
frame	I-UNK
within	O
its	O
n	B-UNK
-	O
terminal	B-UNK
domain	B-UNK
in	O
exon	B-UNK
8	O
.	O

 	O
this	O
is	O
the	O
first	O
example	O
of	O
dystrophin	B-UNK
deficiency	B-UNK
caused	B-UNK
by	O
a	O
splice	O
-	O
site	B-UNK
mutation	B-UNK
.	O
.	O

 	O
type	B-UNK
i	O
human	B-UNK
complement	B-UNK
c2	B-UNK
deficiency	I-UNK
.	O

 	O
a	O
28	O
-	O
base	B-UNK
pair	I-UNK
gene	B-UNK
deletion	B-UNK
causes	B-UNK
skipping	B-UNK
of	O
exon	B-UNK
6	O
during	O
rna	B-UNK
splicing	I-UNK
.	O

 	O
two	O
variants	B-UNK
of	O
a	O
genetic	B-UNK
deficiency	B-UNK
of	O
complement	B-UNK
protein	B-UNK
c2	B-UNK
(	O
c2d	O
)	O
have	O
been	O
previously	B-UNK
identified	I-UNK
.	O

 	O
no	O
c2	B-UNK
protein	B-UNK
translation	B-UNK
is	O
detected	B-UNK
in	O
type	B-UNK
i	O
deficiency	B-UNK
,	O
while	O
type	B-UNK
ii	I-UNK
deficiency	B-UNK
is	O
characterized	B-UNK
by	O
a	O
selective	B-UNK
block	B-UNK
in	O
c2	B-UNK
secretion	B-UNK
.	O

 	O
type	B-UNK
i	O
c2	B-UNK
deficiency	I-UNK
was	O
described	B-UNK
in	O
a	O
family	B-UNK
in	O
which	O
the	O
c2	B-UNK
null	B-UNK
allele	B-UNK
(	O
c2q0	B-UNK
)	O
is	O
associated	B-UNK
with	O
the	O
major	B-UNK
histocompatibility	I-UNK
haplotype	B-UNK
/	O
complotype	B-UNK
hla	B-UNK
-	O
a25	O
,	O
b18	O
,	O
c2q0	B-UNK
,	O
bfs	O
,	O
c4a4	O
,	O
c4b2	O
,	O
drw2	O
;	O
this	O
extended	B-UNK
haplotype	B-UNK
occurs	B-UNK
in	O
over	O
90	O
%	O
of	O
c2	B-UNK
-	O
deficient	B-UNK
individuals	B-UNK
(	O
common	B-UNK
complotype	B-UNK
/	O
haplotype	B-UNK
)	O
.	O

 	O
to	O
determine	O
the	O
molecular	B-UNK
basis	I-UNK
of	O
type	B-UNK
i	O
c2	B-UNK
deficiency	I-UNK
,	O
the	O
c2	B-UNK
gene	B-UNK
and	O
cdna	B-UNK
were	O
characterized	B-UNK
from	O
a	O
homozygous	B-UNK
type	B-UNK
i	O
c2	B-UNK
-	O
deficient	B-UNK
individual	B-UNK
with	O
the	O
common	B-UNK
associated	B-UNK
haplotype	B-UNK
/	O
complotype	B-UNK
.	O

 	O
we	O
found	B-UNK
a	O
28	O
-	O
base	B-UNK
pair	I-UNK
deletion	B-UNK
in	O
the	O
type	B-UNK
i	O
c2q0	B-UNK
gene	B-UNK
,	O
beginning	O
9	O
base	B-UNK
pairs	I-UNK
upstream	B-UNK
of	O
the	O
3	O
-	O
end	B-UNK
of	O
exon	B-UNK
6	O
,	O
that	O
generates	B-UNK
a	O
c2	B-UNK
transcript	B-UNK
with	O
a	O
complete	B-UNK
deletion	B-UNK
of	O
exon	B-UNK
6	O
(	O
134	O
base	B-UNK
pair	I-UNK
)	O
and	O
a	O
premature	B-UNK
termination	I-UNK
codon	B-UNK
.	O

 	O
in	O
studies	B-UNK
of	O
eight	O
kindred	B-UNK
,	O
the	O
28	O
-	O
base	B-UNK
pair	I-UNK
deletion	B-UNK
was	O
observed	B-UNK
in	O
all	O
c2q0	B-UNK
alleles	B-UNK
associated	B-UNK
with	O
the	O
common	B-UNK
type	B-UNK
i	O
deficient	B-UNK
complotype	B-UNK
/	O
haplotype	B-UNK
;	O
this	O
deletion	B-UNK
was	O
not	O
present	B-UNK
in	O
normal	B-UNK
c2	B-UNK
nor	O
in	O
type	B-UNK
ii	I-UNK
c2	B-UNK
-	O
deficient	B-UNK
genes	B-UNK
.	O

 	O
these	O
data	B-UNK
demonstrate	B-UNK
that	O
1	O
)	O
type	B-UNK
i	O
human	B-UNK
complement	B-UNK
c2	B-UNK
deficiency	I-UNK
is	O
caused	B-UNK
by	O
a	O
28	O
-	O
base	B-UNK
pair	I-UNK
genomic	B-UNK
deletion	B-UNK
that	O
causes	B-UNK
skipping	B-UNK
of	O
exon	B-UNK
6	O
during	O
rna	B-UNK
splicing	I-UNK
,	O
resulting	B-UNK
in	O
generation	B-UNK
of	O
a	O
premature	B-UNK
termination	I-UNK
codon	B-UNK
,	O
2	O
)	O
the	O
28	O
-	O
base	B-UNK
pair	I-UNK
deletion	B-UNK
in	O
the	O
type	B-UNK
i	O
c2q0	B-UNK
gene	B-UNK
is	O
strongly	B-UNK
associated	B-UNK
with	O
the	O
hla	B-UNK
haplotype	B-UNK
/	O
complotype	B-UNK
a25	O
,	O
b18	O
,	O
c2q0	B-UNK
,	O
bfs	O
,	O
c4a4	O
,	O
c4b2	O
,	O
drw2	O
,	O
suggesting	B-UNK
that	O
all	O
c2	B-UNK
-	O
deficient	B-UNK
individuals	B-UNK
with	O
this	O
haplotype	B-UNK
/	O
complotype	B-UNK
will	O
harbor	O
the	O
28	O
-	O
base	B-UNK
pair	I-UNK
c2	B-UNK
gene	B-UNK
deletion	B-UNK
,	O
and	O
3	O
)	O
type	B-UNK
ii	I-UNK
c2	B-UNK
deficiency	I-UNK
is	O
caused	B-UNK
by	O
a	O
different	B-UNK
,	O
as	O
yet	O
uncharacterized	B-UNK
,	O
molecular	B-UNK
genetic	I-UNK
defect	B-UNK
.	O
.	O

 	B-UNK
molecular	I-UNK
characterization	B-UNK
of	O
two	O
galactosemia	B-UNK
mutations	B-UNK
and	O
one	O
polymorphism	O
:	O
implications	B-UNK
for	O
structure	B-UNK
-	O
function	B-UNK
analysis	B-UNK
of	O
human	B-UNK
galactose	B-UNK
-	O
1	O
-	O
phosphate	B-UNK
uridyltransferase	B-UNK
.	O

 	O
we	O
report	B-UNK
here	O
the	O
molecular	B-UNK
characterization	I-UNK
of	O
two	O
galactosemia	B-UNK
mutations	B-UNK
,	O
l74p	O
and	O
f171s	O
,	O
and	O
one	O
polymorphism	O
,	O
s135l	B-UNK
,	O
in	O
human	B-UNK
galactose	B-UNK
-	O
1	O
-	O
phosphate	B-UNK
uridyltransferase	B-UNK
(	O
galt	B-UNK
)	O
.	O

 	O
both	O
galactosemia	B-UNK
mutations	B-UNK
result	B-UNK
in	O
reduced	B-UNK
enzymatic	B-UNK
activity	I-UNK
when	O
reconstructed	O
in	O
the	O
cdna	B-UNK
and	O
overexpressed	O
.	O

 	O
the	O
polymorphism	O
,	O
in	O
contrast	B-UNK
,	O
has	O
near	B-UNK
normal	B-UNK
activity	B-UNK
.	O

 	O
both	O
mutations	B-UNK
affect	B-UNK
evolutionarily	O
conserved	B-UNK
residues	B-UNK
,	O
suggesting	B-UNK
that	O
they	O
are	O
functionally	B-UNK
important	I-UNK
,	O
while	O
the	O
polymorphism	O
occurs	B-UNK
in	O
a	O
nonconserved	O
domain	B-UNK
which	O
is	O
presumably	O
not	O
critical	B-UNK
for	O
enzymatic	B-UNK
function	B-UNK
.	O

 	O
the	O
f171s	O
mutation	B-UNK
is	O
close	B-UNK
to	O
the	O
putative	B-UNK
active	B-UNK
-	O
site	B-UNK
nucleophile	O
.	O

 	O
our	O
data	B-UNK
further	O
support	B-UNK
the	O
notion	O
of	O
molecular	B-UNK
heterogeneity	B-UNK
of	O
galactosemia	B-UNK
and	O
suggest	B-UNK
that	O
galactosemia	B-UNK
mutations	B-UNK
and	O
galt	B-UNK
polymorphisms	B-UNK
may	O
be	O
useful	B-UNK
tools	O
in	O
highlighting	O
different	B-UNK
functional	B-UNK
domains	B-UNK
in	O
human	B-UNK
galt	B-UNK
.	O
.	O

 	B-UNK
linkage	I-UNK
relationship	B-UNK
of	O
c2	B-UNK
deficiency	I-UNK
,	O
hla	B-UNK
and	O
glyoxalase	O
i	O
loci	B-UNK
.	O

 	O
immunogenetic	O
analysis	B-UNK
of	O
a	O
homozygous	B-UNK
c2	B-UNK
-	O
deficient	B-UNK
individual	B-UNK
and	O
family	B-UNK
members	I-UNK
demonstrated	B-UNK
linkage	B-UNK
of	O
hla	B-UNK
-	O
a25	O
,	O
b18	O
and	O
c2o	B-UNK
.	O

 	O
hla	B-UNK
-	O
d	B-UNK
typing	B-UNK
showed	B-UNK
that	O
5	O
members	B-UNK
typed	O
with	O
homozygous	B-UNK
dw2	O
typing	B-UNK
cells	B-UNK
from	O
an	O
individual	B-UNK
with	O
c2	B-UNK
deficiency	I-UNK
but	O
not	O
with	O
dw2	O
typing	B-UNK
cells	B-UNK
from	O
2	O
individuals	B-UNK
with	O
normal	B-UNK
c2	B-UNK
.	O

 	O
the	O
homozygous	B-UNK
c2	B-UNK
-	O
deficient	B-UNK
propositus	O
and	O
brother	B-UNK
were	O
hla	B-UNK
-	O
a	O
and	O
b	B-UNK
homozygous	B-UNK
but	O
heterozygous	B-UNK
at	B-DISEASE
the	O
hla	B-UNK
-	O
d	B-UNK
and	O
glyoxalase	O
i	O
loci	B-UNK
.	O

 	O
therefore	O
,	O
in	O
this	O
family	B-UNK
,	O
the	O
c2o	B-UNK
gene	B-UNK
is	O
linked	B-UNK
with	O
two	O
distinct	B-UNK
haplotypes	B-UNK
hla	B-UNK
-	O
a25	O
,	O
b18	O
,	O
dw2	O
,	O
glo1	O
and	O
hla	B-UNK
-	O
a25	O
,	O
b18	O
,	O
d	B-UNK
unknown	B-UNK
,	O
gl02	O
.	O

 	O
these	O
results	B-UNK
could	O
be	O
explained	O
by	O
an	O
ancestral	B-UNK
recombinant	B-UNK
event	B-UNK
,	O
which	O
occurred	B-UNK
between	O
the	O
c2o	B-UNK
locus	B-UNK
and	O
hla	B-UNK
-	O
d	B-UNK
locus	B-UNK
in	O
which	O
c2o	B-UNK
segregated	B-UNK
with	O
hla	B-UNK
-	O
b	B-UNK
.	O

 	O
this	O
would	O
suggest	B-UNK
that	O
the	O
locus	B-UNK
for	O
the	O
c2o	B-UNK
gene	B-UNK
maps	B-UNK
between	O
hla	B-UNK
-	O
b	B-UNK
and	O
hla	B-UNK
-	O
d	B-UNK
on	O
the	O
sixth	B-UNK
chromosome	B-UNK
.	O
.	O

 	B-UNK
germline	I-UNK
mutations	B-UNK
in	O
the	O
wilms	B-DISEASE
'	I-DISEASE
tumor	I-DISEASE
suppressor	B-UNK
gene	B-UNK
are	O
associated	B-UNK
with	O
abnormal	B-UNK
urogenital	B-UNK
development	B-UNK
in	O
denys	B-DISEASE
-	I-DISEASE
drash	I-DISEASE
syndrome	I-DISEASE
.	O

 	O
denys	B-DISEASE
-	I-DISEASE
drash	I-DISEASE
syndrome	I-DISEASE
is	O
a	O
rare	B-UNK
human	B-UNK
condition	B-UNK
in	O
which	O
severe	B-UNK
urogenital	B-UNK
aberrations	O
result	B-UNK
in	O
renal	B-DISEASE
failure	I-DISEASE
,	O
pseudohermaphroditism	B-DISEASE
,	O
and	O
wilms	B-DISEASE
tumor	I-DISEASE
(	O
nephroblastoma	O
)	O
.	O

 	O
to	O
investigate	O
its	O
possible	B-UNK
role	B-UNK
,	O
we	O
have	O
analyzed	B-UNK
the	O
coding	B-UNK
exons	B-UNK
of	O
the	O
wilms	B-DISEASE
tumor	I-DISEASE
suppressor	B-UNK
gene	B-UNK
(	O
wt1	B-UNK
)	O
for	O
germline	B-UNK
mutations	I-UNK
.	O

 	O
in	O
ten	B-DISEASE
independent	B-UNK
cases	B-UNK
of	O
denys	B-DISEASE
-	I-DISEASE
drash	I-DISEASE
syndrome	I-DISEASE
,	O
point	B-UNK
mutations	I-UNK
in	O
the	O
zinc	B-DISEASE
finger	B-UNK
domains	B-UNK
of	O
one	O
wt1	B-UNK
gene	B-UNK
copy	B-UNK
were	O
found	B-UNK
.	O

 	O
nine	O
of	O
these	O
mutations	B-UNK
are	O
found	B-UNK
within	O
exon	B-UNK
9	O
(	O
zinc	B-DISEASE
finger	B-UNK
iii	B-UNK
)	O
;	O
the	O
remaining	B-UNK
mutation	B-UNK
is	O
in	O
exon	B-UNK
8	O
(	O
zinc	B-DISEASE
finger	B-UNK
ii	B-UNK
)	O
.	O

 	O
these	O
mutations	B-UNK
directly	B-UNK
affect	B-UNK
dna	B-UNK
sequence	I-UNK
recognition	B-UNK
.	O

 	O
in	O
two	O
families	B-UNK
analyzed	B-UNK
,	O
the	O
mutations	B-UNK
were	O
shown	B-UNK
to	O
arise	O
de	B-UNK
novo	I-UNK
.	O

 	O
wilms	B-UNK
tumors	B-DISEASE
from	O
three	O
individuals	B-UNK
and	O
one	O
juvenile	B-UNK
granulosa	B-DISEASE
cell	I-DISEASE
tumor	I-DISEASE
demonstrate	B-UNK
reduction	B-UNK
to	O
homozygosity	B-UNK
for	O
the	O
mutated	B-UNK
wt1	B-UNK
allele	B-UNK
.	O

 	O
our	O
results	B-UNK
provide	I-UNK
evidence	B-UNK
of	O
a	O
direct	B-UNK
role	B-UNK
for	O
wt1	B-UNK
in	O
denys	B-DISEASE
-	I-DISEASE
drash	I-DISEASE
syndrome	I-DISEASE
and	O
thus	O
urogenital	B-UNK
system	B-UNK
development	B-UNK
.	O
.	O

 	B-UNK
linkage	I-UNK
analysis	B-UNK
in	O
x	B-UNK
-	O
linked	B-UNK
adrenoleukodystrophy	B-DISEASE
and	O
application	O
in	O
post	O
-	O
and	O
prenatal	B-UNK
diagnosis	I-UNK
.	O

 	O
we	O
have	O
performed	B-UNK
linkage	B-UNK
analysis	I-UNK
with	O
the	O
dna	B-UNK
markers	I-UNK
dxs52	O
and	O
the	O
clotting	O
factor	B-UNK
viii	O
gene	B-UNK
(	O
f8c	O
)	O
,	O
in	O
several	O
large	B-UNK
families	B-UNK
with	O
x	B-UNK
-	O
linked	B-UNK
adrenoleukodystrophy	B-DISEASE
(	O
ald	B-UNK
)	O
.	O

 	O
the	O
tight	B-UNK
linkage	B-UNK
to	O
dxs52	O
could	O
be	O
extended	B-UNK
giving	O
a	O
maximal	B-UNK
lod	I-UNK
score	B-UNK
of	O
22	O
.	O

 	O
5	O
at	B-DISEASE
1	O
cm	B-DISEASE
.	O

 	O
f8c	O
was	O
also	O
tightly	B-UNK
linked	I-UNK
to	O
ald	B-UNK
with	O
a	O
maximal	B-UNK
lod	I-UNK
score	B-UNK
of	O
7	O
.	O

 	O
8	O
without	O
recombination	B-UNK
.	O

 	B-UNK
multipoint	I-UNK
linkage	B-UNK
analysis	I-UNK
with	O
the	O
markers	B-UNK
dxs304	O
,	O
dxs52	O
,	O
and	O
f8c	O
indicated	B-UNK
that	O
both	O
the	O
gene	B-UNK
for	O
ald	B-UNK
and	O
for	O
f8c	O
are	O
distal	B-UNK
to	O
dxs52	O
.	O

 	O
in	O
four	O
patients	B-UNK
with	O
ald	B-UNK
,	O
no	O
major	B-UNK
structural	B-UNK
rearrangement	B-UNK
in	O
the	O
xqter	O
region	B-UNK
was	O
observed	B-UNK
;	O
in	O
particular	B-UNK
,	O
there	O
were	O
no	O
abnormalities	B-DISEASE
in	O
the	O
vision	B-DISEASE
blindness	B-DISEASE
genes	B-UNK
.	O

 	B-UNK
dna	I-UNK
analysis	B-UNK
appeared	B-UNK
to	O
be	O
of	O
use	B-UNK
in	O
determination	B-UNK
of	O
the	O
carrier	B-UNK
status	B-UNK
of	O
females	B-UNK
at	B-DISEASE
risk	B-UNK
,	O
for	O
the	O
determination	B-UNK
of	O
the	O
origin	B-UNK
of	O
the	O
mutation	B-UNK
in	O
a	O
particular	B-UNK
family	B-UNK
,	O
and	O
for	O
prenatal	B-UNK
diagnosis	I-UNK
.	O

 	O
two	O
distinct	B-UNK
mutations	B-UNK
at	B-DISEASE
a	O
single	B-UNK
bamhi	O
site	B-UNK
in	O
phenylketonuria	B-DISEASE
.	O

 	O
classical	B-UNK
phenylketonuria	B-DISEASE
is	O
an	O
autosomal	O
recessive	O
disease	B-DISEASE
caused	B-UNK
by	O
a	O
deficiency	B-UNK
of	O
hepatic	B-UNK
phenylalanine	B-UNK
hydroxylase	I-UNK
(	O
pah	B-UNK
)	O
.	O

 	O
the	O
abolition	O
of	O
an	O
invariant	O
bamhi	O
site	B-UNK
located	B-UNK
in	O
the	O
coding	B-UNK
sequence	B-UNK
of	O
the	O
pah	B-UNK
gene	B-UNK
(	O
exon	B-UNK
7	O
)	O
led	B-UNK
to	O
the	O
recognition	B-UNK
of	O
two	O
new	B-UNK
point	B-UNK
mutations	I-UNK
at	B-DISEASE
codon	B-UNK
272	O
and	O
273	O
(	O
272gly	O
-	O
-	O
-	O
-	O
stop	B-UNK
and	O
273ser	O
-	O
-	O
-	O
-	O
phe	O
,	O
respectively	B-UNK
)	O
.	O

 	O
both	O
mutations	B-UNK
were	O
detected	B-UNK
in	O
north	B-UNK
eastern	B-UNK
france	O
or	O
belgium	O
and	O
occurred	B-UNK
on	O
the	O
background	B-UNK
of	O
rflp	B-UNK
haplotype	B-UNK
7	O
alleles	B-UNK
.	O

 	O
the	O
present	B-UNK
study	I-UNK
supports	B-UNK
the	O
view	O
that	O
the	O
clinical	B-UNK
heterogeneity	B-UNK
in	O
pku	B-DISEASE
is	O
accounted	B-UNK
for	O
by	O
the	O
large	B-UNK
variety	B-UNK
of	O
mutant	B-UNK
genotypes	O
associated	B-UNK
with	O
pah	B-UNK
deficiencies	B-UNK
.	O
.	O

 	O
a	O
detailed	B-UNK
multipoint	B-UNK
map	B-UNK
of	O
human	B-UNK
chromosome	I-UNK
4	O
provides	B-UNK
evidence	I-UNK
for	O
linkage	B-UNK
heterogeneity	B-UNK
and	O
position	B-UNK
-	O
specific	B-UNK
recombination	B-UNK
rates	B-UNK
.	O

 	O
utilizing	B-UNK
the	O
ceph	O
reference	B-UNK
panel	O
and	O
genotypic	O
data	B-UNK
for	O
53	O
markers	B-UNK
,	O
we	O
have	O
constructed	B-UNK
a	O
20	O
-	O
locus	B-UNK
multipoint	B-UNK
genetic	B-UNK
map	B-UNK
of	O
human	B-UNK
chromosome	I-UNK
4	O
.	O

 	B-UNK
new	I-UNK
rflps	B-UNK
are	O
reported	B-UNK
for	O
four	O
loci	B-UNK
.	O

 	O
the	O
map	B-UNK
integrates	O
a	O
high	B-UNK
-	O
resolution	B-UNK
genetic	B-UNK
map	B-UNK
of	O
4p16	B-UNK
into	O
a	O
continuous	B-UNK
map	B-UNK
extending	B-UNK
to	O
4q31	O
and	O
an	O
unlinked	B-UNK
cluster	O
of	O
three	O
loci	B-UNK
at	B-DISEASE
4q35	O
.	O

 	O
the	O
20	O
linked	B-UNK
markers	I-UNK
form	B-UNK
a	O
continuous	B-UNK
linkage	B-UNK
group	B-UNK
of	O
152	O
cm	B-DISEASE
in	O
males	B-UNK
and	O
202	O
cm	B-DISEASE
in	O
females	B-UNK
.	O

 	O
likely	B-UNK
genetic	B-UNK
locations	B-UNK
are	O
provided	B-UNK
for	O
25	O
polymorphic	B-UNK
anonymous	B-UNK
sequences	B-UNK
and	O
28	O
gene	B-UNK
-	O
specific	B-UNK
rflps	B-UNK
.	O

 	O
the	O
map	B-UNK
was	O
constructed	B-UNK
employing	B-UNK
the	O
linkage	B-UNK
and	O
crimap	O
computational	O
methodologies	O
to	O
build	O
the	O
multipoint	B-UNK
map	B-UNK
via	O
a	O
stepwise	O
algorithm	O
.	O

 	O
a	O
detailed	B-UNK
10	O
-	O
point	B-UNK
map	B-UNK
of	O
the	O
4p16	B-UNK
region	B-UNK
constructed	B-UNK
from	O
the	O
ceph	O
panel	O
provides	B-UNK
evidence	I-UNK
for	O
heterogeneity	B-UNK
in	O
the	O
linkage	B-UNK
maps	B-UNK
constructed	B-UNK
from	O
families	B-UNK
segregating	B-UNK
for	O
huntington	B-DISEASE
disease	I-DISEASE
(	O
hd	B-UNK
)	O
.	O

 	O
it	O
additionally	B-UNK
provides	B-UNK
evidence	I-UNK
for	O
position	B-UNK
-	O
specific	B-UNK
recombination	B-UNK
frequencies	B-UNK
in	O
the	O
telomeric	B-UNK
region	B-UNK
of	O
4p	O
.	O
.	O

 	O
carrier	B-UNK
detection	I-UNK
and	O
prenatal	B-UNK
diagnosis	I-UNK
of	O
pelizaeus	B-DISEASE
-	I-DISEASE
merzbacher	I-DISEASE
disease	I-DISEASE
using	O
a	O
combination	O
of	O
anonymous	B-UNK
dna	I-UNK
polymorphisms	B-UNK
and	O
the	O
proteolipid	B-UNK
protein	B-UNK
(	O
plp	B-UNK
)	O
gene	B-UNK
cdna	B-UNK
.	O

 	O
we	O
report	B-UNK
carrier	B-UNK
identification	B-UNK
and	O
a	O
prenatal	B-UNK
diagnosis	I-UNK
using	O
dna	B-UNK
polymorphisms	B-UNK
in	O
2	O
families	B-UNK
with	O
x	B-UNK
-	O
linked	B-UNK
pelizaeus	B-DISEASE
-	I-DISEASE
merzbacher	I-DISEASE
disease	I-DISEASE
(	O
pmd	O
)	O
.	O

 	O
in	O
both	O
families	B-UNK
,	O
the	O
proteolipid	B-UNK
protein	B-UNK
(	O
plp	B-UNK
)	O
gene	B-UNK
in	O
the	O
single	B-UNK
affected	B-UNK
male	B-UNK
could	O
be	O
traced	O
back	O
to	O
his	O
unaffected	B-UNK
maternal	B-UNK
grandfather	O
.	O

 	O
therefore	O
,	O
each	O
family	B-UNK
contains	B-UNK
a	O
new	B-UNK
mutation	B-UNK
.	O

 	O
in	O
the	O
case	B-UNK
of	O
the	O
prenatal	B-UNK
diagnosis	I-UNK
,	O
the	O
fetus	B-UNK
was	O
shown	B-UNK
by	O
cytogenetic	B-UNK
analysis	B-UNK
to	O
be	O
a	O
female	B-UNK
,	O
who	O
we	O
predict	O
will	O
be	O
a	O
noncarrier	O
of	O
pmd	O
based	B-UNK
on	O
her	O
genotype	B-UNK
with	O
the	O
plp	B-UNK
intragenic	B-UNK
polymorphism	O
.	O
.	O

 	O
identification	B-UNK
of	O
deletion	B-UNK
mutations	B-UNK
and	O
three	O
new	B-UNK
genes	B-UNK
at	B-DISEASE
the	O
familial	B-UNK
polyposis	B-DISEASE
locus	B-UNK
.	O

 	B-UNK
small	I-UNK
(	O
100	O
-	O
260	O
kb	B-UNK
)	O
,	O
nested	B-UNK
deletions	B-UNK
were	O
characterized	B-UNK
in	O
dna	B-UNK
from	O
two	O
unrelated	B-UNK
patients	B-UNK
with	O
familial	B-DISEASE
adenomatous	I-DISEASE
polyposis	I-DISEASE
coli	B-UNK
(	O
apc	B-UNK
)	O
.	O

 	O
three	O
candidate	B-UNK
genes	I-UNK
located	B-UNK
within	O
the	O
deleted	B-UNK
region	B-UNK
were	O
ascertained	B-UNK
and	O
a	O
previous	B-UNK
candidate	B-UNK
gene	B-UNK
,	O
mcc	O
,	O
was	O
shown	B-UNK
to	O
be	O
located	B-UNK
outside	O
the	O
deleted	B-UNK
region	B-UNK
.	O

 	O
one	O
of	O
the	O
new	B-UNK
genes	B-UNK
contained	B-UNK
sequence	B-UNK
identical	B-UNK
to	O
srp19	O
,	O
the	O
gene	B-UNK
coding	B-UNK
for	O
the	O
19	O
kd	O
component	B-UNK
of	O
the	O
ribosomal	O
signal	B-UNK
recognition	B-UNK
particle	O
.	O

 	O
the	O
second	B-UNK
,	O
provisionally	B-UNK
designated	B-UNK
dp1	O
(	O
deleted	B-UNK
in	O
polyposis	B-DISEASE
1	O
)	O
,	O
was	O
found	B-UNK
to	O
be	O
transcribed	B-UNK
in	O
the	O
same	O
orientation	O
as	O
mcc	O
.	O

 	O
two	O
other	O
cdnas	B-UNK
,	O
dp2	O
and	O
dp3	O
,	O
were	O
found	B-UNK
to	O
overlap	O
,	O
forming	O
a	O
single	B-UNK
gene	B-UNK
,	O
dp2	O
.	O

 	O
5	O
,	O
that	O
is	O
transcribed	B-UNK
in	O
the	O
same	O
orientation	O
as	O
srp19	O
.	O

 	O
exclusion	B-UNK
of	O
linkage	B-UNK
between	O
familial	B-DISEASE
mediterranean	I-DISEASE
fever	I-DISEASE
and	O
the	O
human	B-UNK
serum	B-UNK
amyloid	B-UNK
a	O
(	O
saa	O
)	O
gene	B-UNK
cluster	O
.	O

 	O
we	O
studied	B-UNK
the	O
relationship	B-UNK
between	O
the	O
autosomal	O
recessive	O
trait	B-UNK
familial	B-DISEASE
mediterranean	I-DISEASE
fever	I-DISEASE
(	O
fmf	B-UNK
)	O
and	O
the	O
serum	B-UNK
amyloid	B-UNK
a	O
(	O
saa	O
)	O
genes	B-UNK
by	O
comparing	B-UNK
alleles	B-UNK
of	O
a	O
highly	B-UNK
polymorphic	I-UNK
dinucleotide	B-UNK
repeat	B-UNK
and	O
a	O
conventional	B-UNK
restriction	B-UNK
fragment	I-UNK
length	I-UNK
polymorphism	I-UNK
(	O
rflp	B-UNK
)	O
in	O
the	O
saa	O
gene	B-UNK
cluster	O
in	O
israeli	O
fmf	B-UNK
kindreds	B-UNK
.	O

 	O
by	O
haplotype	B-UNK
analysis	B-UNK
,	O
our	O
data	B-UNK
indicate	B-UNK
a	O
minimum	O
crossover	B-UNK
frequency	B-UNK
of	O
22	O
%	O
between	O
the	O
saa	O
gene	B-UNK
marker	B-UNK
and	O
fmf	B-UNK
.	O

 	O
by	O
conventional	B-UNK
linkage	B-UNK
analysis	I-UNK
this	O
eliminates	O
a	O
minimum	O
of	O
10	O
.	O

 	O
4	O
cm	B-DISEASE
including	B-UNK
and	O
surrounding	B-UNK
the	O
saa	O
gene	B-UNK
cluster	O
as	O
the	O
site	B-UNK
of	O
the	O
fmf	B-UNK
mutation	B-UNK
although	O
saa	O
proteins	B-UNK
are	O
prominent	B-UNK
physiologic	O
markers	B-UNK
of	O
the	O
acute	B-UNK
attacks	B-UNK
.	O

 	O
prad1	B-UNK
,	O
a	O
candidate	B-UNK
bcl1	B-UNK
oncogene	B-UNK
:	O
mapping	B-UNK
and	O
expression	B-UNK
in	O
centrocytic	O
lymphoma	B-DISEASE
.	O

 	O
rearrangement	B-UNK
of	O
the	O
bcl1	B-UNK
(	O
b	B-UNK
-	O
cell	B-UNK
lymphoma	B-DISEASE
1	O
)	O
region	B-UNK
on	O
chromosome	B-UNK
11q13	O
appears	B-UNK
to	O
be	O
highly	B-UNK
characteristic	B-UNK
of	O
centrocytic	O
lymphoma	B-DISEASE
and	O
also	O
is	O
found	B-UNK
infrequently	O
in	O
other	O
b	B-UNK
-	O
cell	B-UNK
neoplasms	B-DISEASE
.	O

 	O
rearrangement	B-UNK
is	O
thought	O
to	O
deregulate	O
a	O
nearby	B-UNK
protooncogene	O
,	O
but	O
transcribed	B-UNK
sequences	B-UNK
in	O
the	O
immediate	B-UNK
vicinity	O
of	O
bcl1	B-UNK
breakpoints	B-UNK
had	O
not	O
been	O
identified	B-UNK
.	O

 	O
prad1	B-UNK
,	O
previously	B-UNK
designated	B-UNK
d11s287e	O
,	O
was	O
identified	B-UNK
on	O
11q13	O
as	O
a	O
chromosomal	B-UNK
breakpoint	B-UNK
region	B-UNK
rearranged	B-UNK
with	O
the	O
parathyroid	O
hormone	B-UNK
gene	B-UNK
in	O
a	O
subset	O
of	O
parathyroid	O
adenomas	B-UNK
;	O
this	O
highly	B-UNK
conserved	I-UNK
putative	B-UNK
oncogene	B-UNK
,	O
which	O
encodes	B-UNK
a	O
novel	B-UNK
cyclin	O
,	O
has	O
been	O
linked	B-UNK
to	O
bcl1	B-UNK
and	O
implicated	O
also	O
in	O
subsets	O
of	O
breast	B-UNK
and	O
squamous	O
cell	B-UNK
neoplasms	B-DISEASE
with	O
11q13	O
amplification	B-UNK
.	O

 	O
we	O
report	B-UNK
pulsed	O
-	O
field	B-UNK
gel	I-UNK
electrophoresis	B-UNK
data	B-UNK
showing	B-UNK
bcl1	B-UNK
and	O
prad1	B-UNK
to	O
be	O
no	O
more	O
than	O
130	O
kilobases	O
apart	O
.	O

 	O
prad1	B-UNK
mrna	B-UNK
is	O
abundantly	O
expressed	B-UNK
in	O
seven	B-UNK
of	O
seven	B-UNK
centrocytic	O
lymphomas	B-UNK
(	O
kiel	O
classification	B-UNK
)	O
,	O
in	O
contrast	B-UNK
to	O
13	O
closely	B-UNK
related	B-UNK
but	O
noncentrocytic	O
lymphomas	B-UNK
.	O

 	O
three	O
of	O
the	O
seven	B-UNK
centrocytic	O
lymphomas	B-UNK
had	O
detectable	B-UNK
bcl1	B-UNK
dna	B-UNK
rearrangement	B-UNK
.	O

 	O
also	O
,	O
two	O
unusual	B-UNK
cases	B-UNK
of	O
cll	B-DISEASE
with	O
bcl1	B-UNK
rearrangement	B-UNK
overexpressed	O
prad1	B-UNK
,	O
in	O
contrast	B-UNK
to	O
five	O
cll	B-DISEASE
controls	B-UNK
.	O

 	O
thus	O
,	O
prad1	B-UNK
is	O
an	O
excellent	O
candidate	B-UNK
"	O
bcl1	B-UNK
oncogene	B-UNK
.	O

 	O
"	O
its	O
overexpression	B-UNK
may	O
be	O
a	O
key	B-UNK
consequence	O
of	O
rearrangement	B-UNK
of	O
the	O
bcl1	B-UNK
vicinity	O
in	O
b	B-UNK
-	O
cell	B-UNK
neoplasms	B-DISEASE
and	O
a	O
unifying	O
pathogenetic	B-UNK
feature	B-UNK
in	O
centrocytic	O
lymphoma	B-DISEASE
.	O

 	O
two	O
new	B-UNK
arylsulfatase	B-UNK
a	O
(	O
arsa	B-UNK
)	O
mutations	B-UNK
in	O
a	O
juvenile	B-UNK
metachromatic	B-DISEASE
leukodystrophy	I-DISEASE
(	O
mld	B-UNK
)	O
patient	B-UNK
.	O

 	O
fragments	B-UNK
of	O
the	O
arylsulfatase	B-UNK
a	O
(	O
arsa	B-UNK
)	O
gene	B-UNK
from	O
a	O
patient	B-UNK
with	O
juvenile	B-UNK
-	O
onset	B-UNK
metachromatic	B-DISEASE
leukodystrophy	I-DISEASE
(	O
mld	B-UNK
)	O
were	O
amplified	B-UNK
by	O
pcr	B-UNK
and	O
ligated	O
into	O
mp13	O
cloning	B-UNK
vectors	O
.	O

 	O
clones	B-UNK
hybridizing	O
with	O
cdna	B-UNK
for	O
human	B-UNK
arsa	B-UNK
were	O
selected	B-UNK
,	O
examined	B-UNK
for	O
appropriate	B-UNK
size	B-UNK
inserts	B-UNK
,	O
and	O
used	O
to	O
prepare	O
single	B-UNK
-	O
stranded	O
phage	B-UNK
dna	B-UNK
.	O

 	O
examination	B-UNK
of	O
the	O
entire	B-UNK
coding	I-UNK
and	O
most	O
of	O
the	O
intronic	B-UNK
sequence	B-UNK
revealed	B-UNK
two	O
putative	B-UNK
disease	B-DISEASE
-	O
related	B-UNK
mutations	B-UNK
.	O

 	O
one	O
,	O
a	O
point	B-UNK
mutation	I-UNK
in	O
exon	B-UNK
3	O
,	O
resulted	B-UNK
in	O
the	O
substitution	B-UNK
of	O
isoleucine	O
by	O
serine	B-UNK
.	O

 	O
introduction	O
of	O
this	O
alteration	B-UNK
into	O
the	O
normal	B-UNK
arsa	B-UNK
cdna	B-UNK
sequence	B-UNK
resulted	B-UNK
in	O
a	O
substantial	B-UNK
decrease	B-UNK
in	O
arsa	B-UNK
activity	I-UNK
on	O
transient	B-UNK
expression	I-UNK
in	O
cultured	B-UNK
baby	O
hamster	B-UNK
kidney	B-UNK
cells	B-UNK
.	O

 	O
about	O
5	O
%	O
of	O
the	O
control	B-UNK
expression	B-UNK
was	O
observed	B-UNK
,	O
suggesting	B-UNK
a	O
small	B-UNK
residual	B-UNK
activity	B-UNK
in	O
the	O
mutated	B-UNK
arsa	B-UNK
.	O

 	O
the	O
second	B-UNK
mutation	B-UNK
,	O
a	O
g	B-UNK
-	O
to	O
-	O
a	O
transition	B-UNK
,	O
occurred	B-UNK
in	O
the	O
other	O
allele	B-UNK
and	O
resulted	B-UNK
in	O
an	O
altered	B-UNK
splice	O
-	O
recognition	B-UNK
sequence	B-UNK
between	O
exon	B-UNK
7	O
and	O
the	O
following	B-UNK
intron	B-UNK
.	O

 	O
the	O
mutation	B-UNK
also	O
resulted	B-UNK
in	O
the	O
loss	B-UNK
of	O
a	O
restriction	O
site	B-UNK
.	O

 	O
apparently	B-UNK
normal	I-UNK
levels	B-UNK
of	O
mrna	B-UNK
were	O
generated	B-UNK
from	O
this	O
allele	B-UNK
,	O
but	O
no	O
arsa	B-UNK
activity	I-UNK
or	O
immuno	O
-	O
cross	B-UNK
-	O
reactive	O
material	B-UNK
could	O
be	O
detected	B-UNK
.	O

 	O
a	O
collection	O
of	O
dna	B-UNK
samples	I-UNK
from	O
known	B-UNK
or	O
suspected	B-UNK
mld	B-UNK
patients	I-UNK
,	O
members	B-UNK
of	O
their	O
families	B-UNK
,	O
and	O
normal	B-UNK
controls	B-UNK
was	O
screened	O
for	O
these	O
mutations	B-UNK
.	O

 	O
four	O
additional	B-UNK
individuals	B-UNK
carrying	B-UNK
each	O
of	O
the	O
mutations	B-UNK
were	O
found	B-UNK
among	O
the	O
nearly	O
100	O
mld	B-UNK
patients	I-UNK
in	O
the	O
sample	B-UNK
.	O

 	O
gene	B-UNK
segregation	B-UNK
in	O
the	O
original	B-UNK
patients	B-UNK
family	B-UNK
was	O
consistent	B-UNK
with	O
available	B-UNK
clinical	B-UNK
and	O
biochemical	B-UNK
data	B-UNK
.	O

 	O
no	O
individuals	B-UNK
homozygous	B-UNK
for	O
either	O
of	O
these	O
two	O
mutations	B-UNK
were	O
identified	B-UNK
.	O

 	O
however	O
,	O
combinations	O
with	O
other	O
mld	B-UNK
mutations	B-UNK
suggest	B-UNK
that	O
the	O
point	B-UNK
mutation	I-UNK
in	O
exon	B-UNK
3	O
does	O
result	B-UNK
in	O
some	O
residual	B-UNK
enzyme	B-UNK
activity	I-UNK
and	O
is	O
associated	B-UNK
with	O
late	B-UNK
-	O
onset	B-UNK
forms	B-UNK
of	O
the	O
disease	B-DISEASE
.	O

 	O
the	O
splice	O
-	O
site	B-UNK
mutation	B-UNK
following	B-UNK
exon	B-UNK
7	O
produces	B-UNK
late	B-UNK
-	O
infantile	B-UNK
mld	B-UNK
when	O
combined	B-UNK
with	O
other	O
enzyme	B-UNK
-	O
null	B-UNK
mutations	B-UNK
,	O
implying	O
that	O
it	O
is	O
completely	B-UNK
silent	B-UNK
enzymatically	B-UNK
.	O
.	O

 	O
analysis	B-UNK
of	O
x	B-UNK
-	O
chromosome	B-UNK
inactivation	B-UNK
and	O
presumptive	O
expression	B-UNK
of	O
the	O
wiskott	B-DISEASE
-	I-DISEASE
aldrich	I-DISEASE
syndrome	I-DISEASE
(	O
was	O
)	O
gene	B-UNK
in	O
hematopoietic	B-UNK
cell	B-UNK
lineages	O
of	O
a	O
thrombocytopenic	B-UNK
carrier	B-UNK
female	B-UNK
of	O
was	O
.	O

 	O
we	O
report	B-UNK
on	O
a	O
thrombocytopenic	B-UNK
female	B-UNK
belonging	O
to	O
a	O
pedigree	B-UNK
with	O
the	O
wiskott	B-DISEASE
-	I-DISEASE
aldrich	I-DISEASE
syndrome	I-DISEASE
(	O
was	O
)	O
.	O

 	O
restriction	B-UNK
fragment	I-UNK
length	I-UNK
polymorphism	I-UNK
(	O
rflp	B-UNK
)	O
analysis	B-UNK
with	O
probe	B-UNK
m27	O
beta	B-UNK
,	O
closely	B-UNK
linked	I-UNK
to	O
the	O
was	O
gene	B-UNK
,	O
demonstrated	B-UNK
that	O
she	O
is	O
a	O
carrier	B-UNK
of	O
was	O
.	O

 	O
both	O
small	B-UNK
-	O
sized	B-UNK
and	O
normal	B-UNK
-	O
sized	B-UNK
platelets	B-UNK
were	O
present	B-UNK
,	O
suggesting	B-UNK
that	O
,	O
unlike	B-UNK
the	O
vast	B-UNK
majority	B-UNK
of	O
was	O
carriers	B-UNK
,	O
she	O
does	O
not	O
manifest	O
nonrandom	B-UNK
x	B-UNK
-	O
chromosome	B-UNK
inactivation	B-UNK
in	O
the	O
thrombopoietic	O
cell	B-UNK
lineage	B-UNK
.	O

 	O
study	B-UNK
of	O
x	B-UNK
-	O
chromosome	B-UNK
inactivation	B-UNK
by	O
means	O
of	O
rflp	B-UNK
and	O
methylation	B-UNK
analysis	B-UNK
demonstrated	B-UNK
that	O
the	O
pattern	B-UNK
of	O
x	B-UNK
-	O
chromosome	B-UNK
inactivation	B-UNK
was	O
nonrandom	B-UNK
in	O
t	B-UNK
lymphocytes	I-UNK
,	O
but	O
random	B-UNK
in	O
granulocytes	B-UNK
.	O

 	O
while	O
this	O
is	O
the	O
first	O
complete	B-UNK
report	B-UNK
on	O
the	O
occurrence	B-UNK
of	O
thrombocytopenia	B-DISEASE
in	O
a	O
carrier	B-UNK
female	B-UNK
of	O
was	O
as	O
the	O
result	B-UNK
of	O
atypical	B-UNK
lyonization	O
,	O
it	O
also	O
suggests	B-UNK
that	O
expression	B-UNK
of	O
the	O
was	O
gene	B-UNK
occurs	B-UNK
at	B-DISEASE
(	O
or	O
extends	O
up	O
to	O
)	O
a	O
later	B-UNK
stage	B-UNK
than	O
the	O
multipotent	O
stem	O
cell	B-UNK
along	O
the	O
hematopoietic	B-UNK
differentiation	B-UNK
pathway	B-UNK
.	O
.	O

 	O
a	O
new	B-UNK
mutation	B-UNK
in	O
the	O
proteolipid	B-UNK
protein	B-UNK
(	O
plp	B-UNK
)	O
gene	B-UNK
in	O
a	O
german	B-UNK
family	B-UNK
with	O
pelizaeus	B-DISEASE
-	I-DISEASE
merzbacher	I-DISEASE
disease	I-DISEASE
.	O

 	O
a	O
c	B-UNK
-	O
to	O
-	O
t	B-UNK
transition	I-UNK
in	O
exon	B-UNK
4	O
of	O
the	O
plp	B-UNK
gene	B-UNK
was	O
found	B-UNK
in	O
2	O
affected	B-UNK
males	B-UNK
and	O
two	O
obligate	B-UNK
carriers	B-UNK
in	O
a	O
german	B-UNK
family	B-UNK
with	O
pelizaeus	B-DISEASE
-	I-DISEASE
merzbacher	I-DISEASE
disease	I-DISEASE
.	O

 	O
the	O
mutation	B-UNK
,	O
which	O
causes	B-UNK
loss	B-UNK
of	O
an	O
hphi	O
site	B-UNK
and	O
changes	B-UNK
amino	B-UNK
acid	I-UNK
155	O
from	O
threonine	B-UNK
to	O
isoleucine	O
,	O
was	O
absent	B-UNK
from	O
108	O
normal	B-UNK
chromosomes	I-UNK
.	O

 	O
there	O
are	O
5	O
concordances	O
and	O
1	O
discrepancy	O
between	O
these	O
results	B-UNK
and	O
those	O
obtained	B-UNK
by	O
magnetic	B-UNK
resonance	I-UNK
imaging	O
in	O
this	O
family	B-UNK
.	O
.	O

 	O
a	O
3	O
-	O
base	B-UNK
pair	I-UNK
in	O
-	O
frame	B-UNK
deletion	B-UNK
of	O
the	O
phenylalanine	B-UNK
hydroxylase	I-UNK
gene	B-UNK
results	B-UNK
in	O
a	O
kinetic	B-UNK
variant	B-UNK
of	O
phenylketonuria	B-DISEASE
.	O

 	O
phenylketonuria	B-DISEASE
(	O
pku	B-DISEASE
)	O
is	O
an	O
autosomal	O
recessive	O
disease	B-DISEASE
due	O
to	O
deficiency	B-UNK
of	O
a	O
hepatic	B-UNK
enzyme	B-UNK
,	O
phenylalanine	B-UNK
hydroxylase	I-UNK
(	O
pah	B-UNK
)	O
.	O

 	O
the	O
absence	B-UNK
of	O
pah	B-UNK
activity	B-UNK
results	B-UNK
in	O
typical	B-UNK
pku	B-DISEASE
while	O
persistence	O
of	O
a	O
residual	B-UNK
enzyme	B-UNK
activity	I-UNK
gives	O
rise	B-UNK
to	O
variant	B-UNK
forms	B-UNK
of	O
the	O
disease	B-DISEASE
.	O

 	O
we	O
report	B-UNK
here	O
a	O
3	O
-	O
base	B-UNK
pair	I-UNK
in	O
-	O
frame	B-UNK
deletion	B-UNK
of	O
the	O
pah	B-UNK
gene	B-UNK
(	O
delta	B-UNK
194	O
)	O
in	O
a	O
mild	B-UNK
variant	B-UNK
,	O
with	O
markedly	B-UNK
reduced	B-UNK
affinity	B-UNK
of	O
the	O
enzyme	B-UNK
for	O
phenylalanine	O
(	O
km	B-UNK
=	O
160	O
nm	O
)	O
,	O
and	O
we	O
provide	B-UNK
functional	B-UNK
evidence	B-UNK
for	O
responsibility	O
of	O
the	O
deletion	B-UNK
in	O
the	O
mutant	B-UNK
phenotype	B-UNK
.	O

 	O
since	O
the	O
deletion	B-UNK
was	O
located	B-UNK
in	O
the	O
third	O
exon	B-UNK
of	O
the	O
gene	B-UNK
,	O
which	O
presents	O
no	O
homology	B-UNK
with	O
other	O
hydroxylases	O
,	O
we	O
suggest	B-UNK
that	O
exon	B-UNK
3	O
is	O
involved	B-UNK
in	O
the	O
specificity	B-UNK
of	O
the	O
enzyme	B-UNK
for	O
phenylalanine	O
.	O

 	O
finally	B-UNK
,	O
since	O
none	O
of	O
the	O
98	O
pku	B-DISEASE
patients	B-UNK
tested	B-UNK
were	O
found	B-UNK
to	O
carry	B-UNK
this	O
particular	B-UNK
deletion	B-UNK
,	O
our	O
study	B-UNK
suggests	B-UNK
that	O
this	O
molecular	B-UNK
event	B-UNK
probably	B-UNK
occurred	B-UNK
recently	B-UNK
on	O
the	O
background	B-UNK
of	O
a	O
haplotype	B-UNK
2	O
gene	B-UNK
in	O
portugal	O
.	O
.	O

 	O
mutation	B-UNK
of	O
the	O
kit	B-UNK
(	O
mast	O
/	O
stem	B-UNK
cell	I-UNK
growth	I-UNK
factor	B-UNK
receptor	B-UNK
)	O
protooncogene	O
in	O
human	B-UNK
piebaldism	B-DISEASE
.	O

 	O
piebaldism	B-DISEASE
is	O
an	O
autosomal	O
dominant	B-UNK
genetic	B-UNK
disorder	O
characterized	B-UNK
by	O
cogenital	O
patches	O
of	O
skin	B-DISEASE
and	O
hair	B-UNK
from	O
which	O
melanocytes	O
are	O
completely	B-UNK
absent	B-UNK
.	O

 	O
a	O
similar	B-UNK
disorder	O
of	O
mouse	B-UNK
,	O
dominant	B-UNK
white	B-UNK
spotting	O
(	O
w	O
)	O
,	O
results	B-UNK
from	O
mutations	B-UNK
of	O
the	O
c	B-UNK
-	O
kit	B-UNK
protooncogene	O
,	O
which	O
encodes	B-UNK
and	O
receptor	B-UNK
for	O
mast	O
/	O
stem	B-UNK
cell	I-UNK
growth	I-UNK
factor	B-UNK
.	O

 	O
we	O
identified	B-UNK
a	O
kit	B-UNK
gene	B-UNK
mutation	B-UNK
in	O
a	O
proband	B-UNK
with	O
classic	B-UNK
autosomal	O
dominant	B-UNK
piebaldism	B-DISEASE
.	O

 	O
this	O
mutation	B-UNK
results	B-UNK
in	O
a	O
gly	B-UNK
-	O
-	O
-	O
-	O
arg	B-UNK
substitution	B-UNK
at	B-DISEASE
codon	B-UNK
664	O
,	O
within	O
the	O
tyrosine	O
kinase	B-UNK
domain	B-UNK
.	O

 	O
this	O
substitution	B-UNK
was	O
not	O
seen	B-UNK
in	O
any	O
normal	B-UNK
individuals	B-UNK
and	O
was	O
completely	B-UNK
linked	B-UNK
to	O
the	O
piebald	O
phenotype	B-UNK
in	O
the	O
probands	B-UNK
family	B-UNK
.	O

 	O
piebaldism	B-DISEASE
in	O
this	O
family	B-UNK
thus	O
appears	B-UNK
to	O
be	O
the	O
human	B-UNK
homologue	B-UNK
to	O
dominant	B-UNK
white	B-UNK
spotting	O
(	O
w	O
)	O
of	O
the	O
mouse	B-UNK
.	O
.	O

 	B-UNK
genetic	I-UNK
analysis	B-UNK
of	O
a	O
japanese	B-UNK
family	B-UNK
with	O
normotriglyceridemic	O
abetalipoproteinemia	B-DISEASE
indicates	B-UNK
a	O
lack	B-UNK
of	O
linkage	B-UNK
to	O
the	O
apolipoprotein	B-UNK
b	B-UNK
gene	B-UNK
.	O

 	O
normotriglyceridemic	O
abetalipoproteinemia	B-DISEASE
is	O
a	O
rare	B-UNK
familial	B-UNK
disorder	O
characterized	B-UNK
by	O
an	O
isolated	B-UNK
deficiency	B-UNK
of	O
apob	B-UNK
-	O
100	O
.	O

 	O
we	O
have	O
previously	B-UNK
reported	I-UNK
a	O
patient	B-UNK
with	O
this	O
disease	B-DISEASE
,	O
who	O
had	O
normal	B-UNK
apob	B-UNK
-	O
48	O
but	O
no	O
apob	B-UNK
-	O
100	O
.	O

 	O
to	O
elucidate	O
the	O
genetic	B-UNK
abnormalities	B-DISEASE
in	O
this	O
family	B-UNK
,	O
we	O
studied	B-UNK
the	O
linkage	B-UNK
of	O
apob	B-UNK
gene	B-UNK
using	O
three	O
genetic	B-UNK
markers	B-UNK
.	O

 	O
the	O
proband	B-UNK
and	O
her	O
affected	B-UNK
brother	B-UNK
showed	B-UNK
completely	B-UNK
different	B-UNK
apob	B-UNK
gene	B-UNK
alleles	B-UNK
,	O
suggesting	B-UNK
that	O
the	O
apob	B-UNK
gene	B-UNK
itself	O
is	O
not	O
related	B-UNK
to	O
this	O
disorder	O
in	O
this	O
family	B-UNK
.	O

 	O
by	O
contrast	B-UNK
,	O
an	O
american	B-UNK
case	B-UNK
had	O
a	O
point	B-UNK
substitution	B-UNK
in	O
the	O
apob	B-UNK
gene	B-UNK
generating	O
an	O
in	O
-	O
frame	B-UNK
stop	B-UNK
codon	B-UNK
.	O

 	O
these	O
results	B-UNK
indicate	B-UNK
that	O
this	O
disorder	O
can	O
be	O
caused	B-UNK
by	O
defect	B-UNK
(	O
s	O
)	O
of	O
either	O
an	O
apob	B-UNK
gene	B-UNK
or	O
other	O
genes	B-UNK
.	O
.	O

 	O
localisation	B-UNK
of	O
the	O
gene	B-UNK
for	O
norrie	B-DISEASE
disease	I-DISEASE
to	O
between	O
dxs7	B-UNK
and	O
dxs426	O
on	O
xp	O
.	O

 	O
a	O
highly	B-UNK
informative	B-UNK
microsatellite	O
marker	B-UNK
,	O
dxs426	O
,	O
which	O
maps	B-UNK
proximal	B-UNK
to	O
dxs7	B-UNK
in	O
the	O
interval	B-UNK
xp11	B-UNK
.	O

 	O
4	O
-	O
xp11	B-UNK
4	O
-	O
xp11	B-UNK
.	O

 	O
23	O
,	O
has	O
been	O
used	O
to	O
refine	O
further	O
the	O
localisation	B-UNK
of	O
the	O
gene	B-UNK
for	O
norrie	B-DISEASE
disease	I-DISEASE
(	O
ndp	B-UNK
)	O
.	O

 	O
the	O
results	B-UNK
from	O
a	O
multiply	O
informative	B-UNK
crossover	B-UNK
localize	B-UNK
the	O
ndp	B-UNK
gene	B-UNK
proximal	B-UNK
to	O
dxs7	B-UNK
.	O

 	O
in	O
conjunction	O
with	O
information	B-UNK
from	O
2	O
ndp	B-UNK
patients	B-UNK
who	O
have	O
a	O
deletion	B-UNK
for	O
dxs7	B-UNK
but	O
not	O
for	O
dsx426	O
,	O
our	O
data	B-UNK
indicate	B-UNK
that	O
the	O
ndp	B-UNK
gene	B-UNK
lies	B-UNK
between	O
dxs7	B-UNK
and	O
dxs426	O
on	O
proximal	B-UNK
xp	O
.	O

 	B-UNK
aberrant	I-UNK
splicing	B-UNK
of	O
phenylalanine	B-UNK
hydroxylase	I-UNK
mrna	B-UNK
:	O
the	O
major	B-UNK
cause	B-UNK
for	O
phenylketonuria	B-DISEASE
in	O
parts	B-UNK
of	O
southern	O
europe	B-UNK
.	O

 	O
we	O
report	B-UNK
a	O
mutation	B-UNK
within	O
the	O
phenylalanine	B-UNK
hydroxylase	I-UNK
(	O
pah	B-UNK
)	O
gene	B-UNK
that	O
causes	B-UNK
aberrant	B-UNK
splicing	I-UNK
of	O
the	O
mrna	B-UNK
and	O
that	O
is	O
in	O
tight	B-UNK
association	B-UNK
with	O
chromosomal	B-UNK
haplotypes	B-UNK
6	O
,	O
10	O
,	O
and	O
36	O
.	O

 	O
because	O
of	O
the	O
high	B-UNK
frequency	B-UNK
of	O
these	O
particular	B-UNK
haplotypes	B-UNK
in	O
bulgaria	O
,	O
italy	B-UNK
,	O
and	O
turkey	O
,	O
it	O
appears	B-UNK
to	O
be	O
one	O
of	O
the	O
more	O
frequent	B-UNK
defects	B-UNK
in	O
the	O
pah	B-UNK
gene	B-UNK
causing	B-UNK
classical	B-UNK
phenylketonuria	B-DISEASE
in	O
this	O
part	O
of	O
europe	B-UNK
.	O

 	O
the	O
mutation	B-UNK
is	O
a	O
g	B-UNK
to	O
a	O
transition	B-UNK
at	B-DISEASE
position	B-UNK
546	O
in	O
intron	B-UNK
10	O
of	O
the	O
pah	B-UNK
gene	B-UNK
,	O
11	O
bp	B-UNK
upstream	B-UNK
from	O
the	O
intron	B-UNK
10	O
/	O
exon	B-UNK
11	O
boundary	B-UNK
.	O

 	O
it	O
activates	O
a	O
cryptic	O
splice	B-UNK
site	I-UNK
and	O
results	B-UNK
in	O
an	O
in	O
-	O
frame	B-UNK
insertion	B-UNK
of	O
9	O
nucleotides	B-UNK
between	O
exon	B-UNK
10	O
and	O
exon	B-UNK
11	O
of	O
the	O
processed	B-UNK
mrna	B-UNK
.	O

 	B-UNK
normal	I-UNK
amounts	B-UNK
of	O
liver	B-DISEASE
pah	B-UNK
protein	B-UNK
are	O
present	B-UNK
in	O
homozygous	B-UNK
patients	B-UNK
,	O
but	O
no	O
catalytic	B-UNK
activity	B-UNK
can	O
be	O
detected	B-UNK
.	O

 	O
this	O
loss	B-UNK
of	O
enzyme	B-UNK
activity	I-UNK
is	O
probably	B-UNK
caused	B-UNK
by	O
conformational	O
changes	B-UNK
resulting	B-UNK
from	O
the	O
insertion	B-UNK
of	O
three	O
additional	B-UNK
amino	O
acids	O
(	O
gly	B-UNK
-	O
leu	B-UNK
-	O
gln	B-UNK
)	O
between	O
the	O
normal	B-UNK
sequences	B-UNK
encoded	B-UNK
by	O
exon	B-UNK
10	O
and	O
exon	B-UNK
11	O
.	O
.	O

 	O
gardner	B-DISEASE
syndrome	I-DISEASE
in	O
a	O
boy	B-UNK
with	O
interstitial	B-UNK
deletion	B-UNK
of	O
the	O
long	B-UNK
arm	B-UNK
of	O
chromosome	B-DISEASE
5	I-DISEASE
.	O

 	O
we	O
described	B-UNK
a	O
15	O
-	O
year	B-UNK
-	O
old	B-UNK
boy	B-UNK
with	O
gardner	B-DISEASE
syndrome	I-DISEASE
(	O
gs	O
)	O
,	O
mental	B-DISEASE
retardation	I-DISEASE
,	O
and	O
craniofacial	B-DISEASE
abnormalities	I-DISEASE
.	O

 	O
high	B-UNK
-	O
resolution	B-UNK
banding	I-UNK
analysis	B-UNK
showed	B-UNK
an	O
interstitial	B-UNK
deletion	B-UNK
of	O
the	O
long	B-UNK
arm	B-UNK
of	O
chromosome	B-DISEASE
5	I-DISEASE
(	O
q22	O
.	O
1	O
-	O
-	O
-	O
-	O
q31	O
1	O
-	O
-	O
-	O
-	O
q31	O
.	O
1	O
)	O
.	O

 	O
the	O
breakpoints	B-UNK
in	O
the	O
present	B-UNK
case	B-UNK
and	O
in	O
3	O
previously	B-UNK
reported	I-UNK
5q	O
-	O
patients	B-UNK
with	O
adenomatous	B-DISEASE
polyposis	I-DISEASE
coli	I-DISEASE
suggest	B-UNK
that	O
the	O
gene	B-UNK
responsible	B-UNK
for	O
gs	O
/	O
or	O
familial	B-UNK
polyposis	B-DISEASE
coli	B-UNK
(	O
fpc	O
)	O
is	O
in	O
the	O
5q22	B-UNK
region	B-UNK
,	O
a	O
result	B-UNK
consistent	B-UNK
with	O
the	O
findings	B-UNK
of	O
linkage	B-UNK
studies	I-UNK

 	O
huntington	B-DISEASE
disease	I-DISEASE
and	O
childhood	B-UNK
-	O
onset	B-UNK
tourette	B-DISEASE
syndrome	I-DISEASE
.	O

 	O
a	O
40	O
-	O
year	B-UNK
-	O
old	B-UNK
man	B-UNK
with	O
childhood	B-UNK
-	O
onset	B-UNK
tourette	B-DISEASE
syndrome	I-DISEASE
(	O
ts	O
)	O
developed	B-UNK
huntington	B-DISEASE
disease	I-DISEASE
(	O
hd	B-UNK
)	O
.	O

 	O
we	O
believe	O
this	O
to	O
be	O
the	O
first	O
reported	B-UNK
case	B-UNK
of	O
childhood	B-UNK
-	O
onset	B-UNK
ts	O
with	O
adult	B-UNK
onset	I-UNK
hd	B-UNK
.	O

 	O
discovery	B-UNK
of	O
other	O
cases	B-UNK
with	O
both	O
disorders	B-UNK
may	O
provide	B-UNK
clues	O
to	O
the	O
pathophysiology	O
of	O
both	O
conditions	B-UNK
.	O
.	O

 	O
sequence	B-UNK
of	O
dna	B-UNK
flanking	B-UNK
the	O
exons	B-UNK
of	O
the	O
hexa	B-UNK
gene	B-UNK
,	O
and	O
identification	B-UNK
of	O
mutations	B-UNK
in	O
tay	B-DISEASE
-	I-DISEASE
sachs	I-DISEASE
disease	I-DISEASE
.	O

 	O
the	O
rapid	B-UNK
identification	B-UNK
of	O
mutations	B-UNK
causing	B-UNK
tay	B-DISEASE
-	I-DISEASE
sachs	I-DISEASE
disease	I-DISEASE
requires	B-UNK
the	O
capacity	B-UNK
to	O
readily	O
screen	B-UNK
the	O
regions	B-UNK
of	O
the	O
hexa	B-UNK
gene	B-UNK
most	O
likely	B-UNK
to	O
be	O
affected	B-UNK
by	O
mutation	B-UNK
.	O

 	O
we	O
have	O
sequenced	B-UNK
the	O
portions	O
of	O
the	O
introns	B-UNK
flanking	B-UNK
each	O
of	O
the	O
14	O
hexa	B-UNK
exons	B-UNK
in	O
order	B-UNK
to	O
specify	O
oligonucleotide	B-UNK
primers	I-UNK
for	O
the	O
pcr	B-UNK
-	O
dependent	B-UNK
amplification	B-UNK
of	O
each	O
exon	B-UNK
and	O
splice	O
-	O
junction	B-UNK
sequence	B-UNK
.	O

 	O
the	O
amplified	B-UNK
products	B-UNK
were	O
analyzed	B-UNK
,	O
by	O
electrophoresis	B-UNK
in	O
nondenaturing	O
polyacrylamide	O
gels	B-UNK
,	O
for	O
the	O
presence	B-UNK
of	O
either	O
heteroduplexes	O
,	O
derived	B-UNK
from	O
the	O
annealing	O
of	O
normal	B-UNK
and	O
mutant	B-UNK
dna	B-UNK
strands	O
,	O
or	O
single	B-UNK
-	O
strand	O
conformational	O
polymorphisms	B-UNK
(	O
sscp	B-UNK
)	O
,	O
derived	B-UNK
from	O
the	O
renaturation	O
of	O
single	B-UNK
-	O
stranded	O
dna	B-UNK
.	O

 	O
five	O
novel	B-UNK
mutations	B-UNK
from	O
tay	B-DISEASE
-	I-DISEASE
sachs	I-DISEASE
disease	I-DISEASE
patients	B-UNK
were	O
detected	B-UNK
a	O
5	O
-	O
bp	B-UNK
deletion	I-UNK
of	O
tctcc	O
in	O
ivs	O
-	O
9	O
;	O
a	O
2	O
-	O
bp	B-UNK
deletion	I-UNK
of	O
tg	B-DISEASE
in	O
exon	B-UNK
5	O
;	O
g78	O
to	O
a	O
,	O
giving	O
a	O
stop	B-UNK
codon	B-UNK
in	O
exon	B-UNK
1	O
;	O
g533	O
to	O
t	B-UNK
in	O
exon	B-UNK
5	O
,	O
producing	B-UNK
the	O
third	O
amino	B-UNK
acid	I-UNK
substitution	I-UNK
detected	B-UNK
at	B-DISEASE
this	O
site	B-UNK
;	O
and	O
g	B-UNK
to	O
c	B-UNK
at	B-DISEASE
position	B-UNK
1	O
of	O
ivs	O
-	O
2	O
,	O
expected	B-UNK
to	O
produce	B-UNK
abnormal	B-UNK
splicing	B-UNK
.	O

 	O
in	O
addition	B-UNK
,	O
two	O
mutations	B-UNK
,	O
(	O
g1496	O
to	O
a	O
in	O
exon	B-UNK
13	O
and	O
a	O
4	O
-	O
bp	B-UNK
insertion	B-UNK
in	O
exon	B-UNK
11	O
)	O
that	O
have	O
previously	B-UNK
been	O
reported	B-UNK
were	O
identified	B-UNK
.	O
.	O

 	B-UNK
molecular	I-UNK
characterization	B-UNK
of	O
two	O
galactosemia	B-UNK
mutations	B-UNK
:	O
correlation	B-UNK
of	O
mutations	B-UNK
with	O
highly	B-UNK
conserved	I-UNK
domains	B-UNK
in	O
galactose	B-UNK
-	O
1	O
-	O
phosphate	B-UNK
uridyl	I-UNK
transferase	O
.	O

 	O
galactosemia	B-UNK
is	O
an	O
autosomal	O
recessive	O
disorder	O
of	O
human	B-UNK
galactose	B-UNK
metabolism	B-DISEASE
caused	B-UNK
by	O
deficiency	B-UNK
of	O
the	O
enzyme	B-UNK
galactose	B-UNK
-	O
1	O
-	O
phosphate	B-UNK
uridyl	I-UNK
transferase	O
(	O
galt	B-UNK
)	O
.	O

 	O
the	O
molecular	B-UNK
basis	I-UNK
of	O
this	O
disorder	O
is	O
at	B-DISEASE
present	B-UNK
not	O
well	O
understood	O
.	O

 	O
we	O
report	B-UNK
here	O
two	O
missense	B-UNK
mutations	I-UNK
which	O
result	B-UNK
in	O
low	B-UNK
or	O
undetectable	B-UNK
enzymatic	B-UNK
activity	I-UNK
.	O

 	O
first	O
,	O
we	O
identified	B-UNK
at	B-DISEASE
nucleotide	B-UNK
591	O
a	O
transition	B-UNK
which	O
substitutes	O
glutamine	B-UNK
188	O
by	O
arginine	B-UNK
.	O

 	O
the	O
mutated	B-UNK
glutamine	B-UNK
is	O
not	O
only	O
highly	B-UNK
conserved	I-UNK
in	O
evolution	O
(	O
conserved	B-UNK
also	O
in	O
escherichia	B-UNK
coli	B-UNK
and	O
saccharomyces	O
cerevisiae	O
)	O
,	O
but	O
is	O
also	O
two	O
amino	B-UNK
acid	I-UNK
residues	B-UNK
downstream	B-UNK
from	O
the	O
active	B-UNK
site	B-UNK
histidine	B-UNK
-	O
proline	O
-	O
histidine	B-UNK
triad	O
and	O
results	B-UNK
in	O
about	O
10	O
%	O
of	O
normal	B-UNK
enzymatic	B-UNK
activity	I-UNK
.	O

 	O
the	O
arginine	B-UNK
188	O
mutation	B-UNK
is	O
the	O
most	O
common	B-UNK
galactosemia	B-UNK
mutation	B-UNK
characterized	B-UNK
to	O
date	B-UNK
.	O

 	O
it	O
accounts	O
for	O
one	O
-	O
fourth	B-UNK
of	O
the	O
galactosemia	B-UNK
alleles	B-UNK
studied	B-UNK
.	O

 	O
second	B-UNK
,	O
we	O
report	B-UNK
the	O
substitution	B-UNK
of	O
arginine	B-UNK
333	O
by	O
tryptophan	O
,	O
caused	B-UNK
by	O
a	O
transition	B-UNK
at	B-DISEASE
nucleotide	B-UNK
1025	O
.	O

 	O
the	O
area	B-UNK
surrounding	B-UNK
this	O
missense	B-UNK
mutation	I-UNK
is	O
the	O
most	O
highly	B-UNK
conserved	I-UNK
domain	B-UNK
in	O
the	O
homologous	B-UNK
enzymes	B-UNK
from	O
e	B-DISEASE
.	I-DISEASE
coli	I-DISEASE
,	O
yeast	B-UNK
,	O
and	O
humans	B-UNK
,	O
and	O
this	O
mutation	B-UNK
results	B-UNK
in	O
undetectable	B-UNK
enzymatic	B-UNK
activity	I-UNK
,	O
suggesting	B-UNK
that	O
this	O
is	O
a	O
severe	B-UNK
mutation	B-UNK
.	O

 	O
this	O
second	B-UNK
mutation	B-UNK
appears	B-UNK
to	O
be	O
rare	B-UNK
,	O
since	O
it	O
was	O
found	B-UNK
only	O
in	O
the	O
patient	B-UNK
we	O
sequenced	B-UNK
.	O

 	O
our	O
data	B-UNK
provide	I-UNK
further	O
evidence	B-UNK
for	O
the	O
heterogeneity	B-UNK
of	O
galactosemia	B-UNK
at	B-DISEASE
the	O
molecular	B-UNK
level	B-UNK
,	O
heterogeneity	B-UNK
which	O
might	O
be	O
related	B-UNK
to	O
the	O
variable	B-UNK
clinical	I-UNK
outcome	B-UNK
observed	B-UNK
in	O
this	O
disorder	O
.	O
.	O

 	O
hypoxanthine	B-UNK
-	O
guanine	B-UNK
phosphoribosyltransferase	I-UNK
deficiency	B-UNK
:	O
analysis	B-UNK
of	O
hprt	B-UNK
mutations	B-UNK
by	O
direct	B-UNK
sequencing	I-UNK
and	O
allele	B-UNK
-	O
specific	B-UNK
amplification	B-UNK
.	O

 	O
the	O
lesch	B-DISEASE
-	I-DISEASE
nyhan	I-DISEASE
syndrome	I-DISEASE
is	O
a	O
severe	B-UNK
x	B-DISEASE
chromosome	I-DISEASE
-	O
linked	B-UNK
human	B-UNK
disease	B-DISEASE
caused	B-UNK
by	O
a	O
virtual	O
absence	B-UNK
of	O
hypoxanthine	B-UNK
-	O
guanine	B-UNK
phosphoribosyltransferase	I-UNK
(	O
hprt	B-UNK
)	O
activity	B-UNK
.	O

 	O
a	O
partial	B-UNK
deficiency	B-UNK
in	O
the	O
activity	B-UNK
of	O
this	O
enzyme	B-UNK
can	O
result	B-UNK
in	O
gouty	O
arthritis	B-DISEASE
.	O

 	O
to	O
determine	O
the	O
genetic	B-UNK
basis	B-UNK
for	O
reduction	B-UNK
or	O
loss	B-UNK
of	O
enzyme	B-UNK
activity	I-UNK
,	O
we	O
have	O
amplified	B-UNK
and	O
sequenced	B-UNK
the	O
coding	B-UNK
region	I-UNK
of	O
hprt	B-UNK
cdna	B-UNK
from	O
four	O
patients	B-UNK
one	O
with	O
lesch	B-DISEASE
-	I-DISEASE
nyhan	I-DISEASE
syndrome	I-DISEASE
(	O
hprtperth	O
)	O
and	O
three	O
with	O
partial	B-UNK
deficiencies	B-UNK
of	O
hprt	B-UNK
activity	B-UNK
,	O
which	O
have	O
been	O
designated	B-UNK
hprturangan	O
,	O
hprtswan	O
and	O
hprttoowong	O
.	O

 	O
in	O
all	O
four	O
patients	B-UNK
,	O
the	O
only	O
mutation	B-UNK
identified	B-UNK
was	O
a	O
single	B-UNK
base	B-UNK
substitution	B-UNK
in	O
exons	B-UNK
2	O
or	O
3	O
of	O
the	O
coding	B-UNK
region	I-UNK
,	O
which	O
in	O
each	O
case	B-UNK
predicts	B-UNK
a	O
single	B-UNK
amino	I-UNK
acid	I-UNK
substitution	B-UNK
in	O
the	O
translated	B-UNK
protein	B-UNK
.	O

 	O
each	O
base	B-UNK
change	I-UNK
was	O
confirmed	B-UNK
by	O
allele	B-UNK
-	O
specific	B-UNK
amplification	B-UNK
of	O
the	O
patients	B-UNK
genomic	B-UNK
dna	I-UNK
.	O

 	O
it	O
is	O
interesting	O
to	O
note	O
that	O
the	O
mutation	B-UNK
found	B-UNK
for	O
hprtperth	O
is	O
identical	B-UNK
to	O
that	O
reported	B-UNK
for	O
hprtflint	O
.	O

 	O
it	O
appears	B-UNK
that	O
the	O
two	O
mutations	B-UNK
are	O
de	B-UNK
novo	I-UNK
events	B-UNK
.	O
.	O

 	B-UNK
molecular	I-UNK
and	O
metabolic	B-UNK
basis	B-UNK
for	O
the	O
metabolic	B-UNK
disorder	O
normotriglyceridemic	O
abetalipoproteinemia	B-DISEASE
.	O

 	O
we	O
have	O
previously	B-UNK
described	I-UNK
a	O
disorder	O
,	O
normotriglyceridemic	O
abetalipoproteinemia	B-DISEASE
,	O
that	O
is	O
characterized	B-UNK
by	O
the	O
virtual	O
absence	B-UNK
of	O
plasma	B-UNK
low	B-UNK
density	B-UNK
lipoproteins	I-UNK
and	O
complete	B-UNK
absence	B-UNK
of	O
apob	B-UNK
-	O
100	O
,	O
but	O
with	O
apparently	B-UNK
normal	I-UNK
secretion	B-UNK
of	O
triglyceride	O
-	O
rich	B-UNK
lipoproteins	O
containing	B-UNK
apob	B-UNK
-	O
48	O
.	O

 	O
the	O
patients	B-UNK
plasma	B-UNK
lipoproteins	O
were	O
shown	B-UNK
on	O
polyacrylamide	O
gels	B-UNK
and	O
by	O
antibody	B-UNK
mapping	B-UNK
to	O
have	O
a	O
new	B-UNK
truncated	B-UNK
apob	B-UNK
variant	B-UNK
,	O
apob	B-UNK
-	O
50	O
,	O
circulating	B-UNK
along	O
with	O
her	O
apob	B-UNK
-	O
48	O
.	O

 	O
we	O
have	O
found	B-UNK
this	O
individual	B-UNK
to	O
be	O
homozygous	B-UNK
for	O
a	O
single	B-UNK
c	B-UNK
-	O
to	O
-	O
t	B-UNK
nucleotide	B-UNK
substitution	B-UNK
at	B-DISEASE
apob	B-UNK
codon	B-UNK
2252	O
,	O
which	O
produces	B-UNK
a	O
premature	B-UNK
in	O
-	O
frame	B-UNK
stop	B-UNK
codon	B-UNK
.	O

 	O
thus	O
,	O
this	O
is	O
a	O
rare	B-UNK
example	O
of	O
homozygous	B-UNK
hypobetalipoproteinemia	B-DISEASE
.	O

 	O
electron	B-UNK
photomicrographs	O
revealed	B-UNK
that	O
the	O
diameters	O
of	O
particles	B-UNK
in	O
the	O
d	B-UNK
less	O
than	O
1	O
.	O

 	O
006	O
g	B-UNK
/	O
ml	O
lipoprotein	B-UNK
fraction	B-UNK
,	O
in	O
both	O
the	O
postprandial	O
and	O
postabsorptive	O
state	B-UNK
,	O
are	O
bimodally	O
distributed	B-UNK
.	O

 	O
the	O
molar	O
ratio	B-UNK
of	O
apoe	B-UNK
to	O
apob	B-UNK
in	O
these	O
particles	B-UNK
is	O
3	O
.	O

 	O
5	O
1	O
,	O
similar	B-UNK
to	O
normal	B-UNK
vldl	O
.	O

 	O
the	O
plasma	B-UNK
ldl	O
interval	B-UNK
contains	B-UNK
both	O
spherical	O
and	O
cuboidal	O
particles	B-UNK
.	O

 	O
autologous	B-UNK
reinfusion	O
of	O
labeled	B-UNK
d	B-UNK
less	O
than	O
1	O
.	O

 	O
006	O
g	B-UNK
/	O
ml	O
lipoproteins	O
showed	B-UNK
exponential	O
disappearance	O
from	O
plasma	B-UNK
,	O
with	O
an	O
apparent	B-UNK
half	B-UNK
-	O
removal	O
time	B-UNK
of	O
50	O
min	O
,	O
somewhat	B-UNK
slower	O
than	O
for	O
normal	B-UNK
chylomicrons	O
but	O
within	O
the	O
normal	B-UNK
range	B-UNK
for	O
vldl	O
.	O

 	O
the	O
calculated	O
production	B-UNK
rate	B-UNK
for	O
apob	B-UNK
was	O
within	O
the	O
normal	B-UNK
range	B-UNK
in	O
this	O
subject	B-UNK
.	O

 	O
a	O
single	B-UNK
origin	B-UNK
of	O
phenylketonuria	B-DISEASE
in	O
yemenite	B-UNK
jews	B-UNK
.	O

 	O
phenylketonuria	B-DISEASE
(	O
pku	B-DISEASE
)	O
is	O
a	O
metabolic	B-UNK
disease	B-DISEASE
caused	B-UNK
by	O
recessive	O
mutations	B-UNK
of	O
the	O
gene	B-UNK
encoding	B-UNK
the	O
hepatic	B-UNK
enzyme	I-UNK
phenylalanine	I-UNK
hydroxylase	O
(	O
pah	B-UNK
)	O
.	O

 	O
the	O
incidence	O
of	O
pku	B-DISEASE
varies	B-UNK
widely	B-UNK
across	O
different	B-UNK
geographic	B-UNK
areas	B-UNK
,	O
and	O
is	O
highest	B-UNK
(	O
about	O
1	O
in	O
5	O
,	O
000	O
live	B-UNK
births	B-UNK
)	O
in	O
ireland	O
and	O
western	B-UNK
scotland	O
,	O
and	O
among	O
yemenite	B-UNK
jews	B-UNK
.	O

 	O
a	O
limited	B-UNK
number	B-UNK
of	O
point	B-UNK
mutations	I-UNK
account	B-UNK
for	O
most	O
of	O
the	O
pku	B-DISEASE
cases	B-UNK
in	O
the	O
european	B-UNK
population	I-UNK
.	O

 	O
here	O
we	O
report	B-UNK
that	O
a	O
single	B-UNK
molecular	B-UNK
defect	B-UNK
-	O
-	O
a	O
deletion	B-UNK
spanning	B-UNK
the	O
third	O
exon	B-UNK
of	O
the	O
pah	B-UNK
gene	B-UNK
-	O
-	O
is	O
responsible	B-UNK
for	O
all	O
the	O
pku	B-DISEASE
cases	B-UNK
among	O
the	O
yemenite	B-UNK
jews	B-UNK
.	O

 	O
examination	B-UNK
of	O
a	O
random	B-UNK
sample	B-UNK
of	O
yemenite	B-UNK
jews	B-UNK
using	O
a	O
molecular	B-UNK
probe	B-UNK
that	O
detects	O
the	O
carriers	B-UNK
of	O
this	O
deletion	B-UNK
indicated	B-UNK
a	O
high	B-UNK
frequency	B-UNK
of	O
the	O
defective	B-UNK
gene	B-UNK
in	O
this	O
community	O
.	O

 	O
although	O
the	O
deleted	B-UNK
pah	B-UNK
gene	B-UNK
was	O
traced	O
to	O
25	O
different	B-UNK
locations	B-UNK
throughout	O
yemen	O
,	O
family	B-UNK
histories	O
and	O
official	O
documents	O
of	O
the	O
yemenite	B-UNK
jewish	B-UNK
community	O
showed	B-UNK
that	O
the	O
common	B-UNK
ancestor	B-UNK
of	O
all	O
the	O
carriers	B-UNK
of	O
this	O
genetic	B-UNK
defect	B-UNK
lived	O
in	O
sana	O
,	O
the	O
capital	O
of	O
yemen	O
,	O
before	O
the	O
eighteenth	O
century	O
.	O
.	O

 	B-UNK
linkage	I-UNK
of	O
aspartylglucosaminuria	B-DISEASE
(	O
agu	B-UNK
)	O
to	O
marker	B-UNK
loci	B-UNK
on	O
the	O
long	B-UNK
arm	B-UNK
of	O
chromosome	B-DISEASE
4	I-DISEASE
.	O

 	O
aspartylglucosaminuria	B-DISEASE
(	O
agu	B-UNK
)	O
is	O
caused	B-UNK
by	O
deficient	B-UNK
activity	B-UNK
of	O
the	O
enzyme	B-UNK
aspartylglucosaminidase	B-UNK
(	O
aga	B-UNK
)	O
.	O

 	O
the	O
structural	B-UNK
gene	B-UNK
for	O
aga	B-UNK
has	O
been	O
assigned	B-UNK
to	O
the	O
region	B-UNK
4q21	O
-	O
qter	O
of	O
chromosome	B-DISEASE
4	I-DISEASE
.	O

 	O
we	O
have	O
studied	B-UNK
the	O
map	B-UNK
position	I-UNK
of	O
the	O
agu	B-UNK
locus	B-UNK
in	O
relation	O
to	O
other	O
marker	B-UNK
loci	B-UNK
on	O
the	O
long	B-UNK
arm	B-UNK
of	O
chromosome	B-DISEASE
4	I-DISEASE
using	O
linkage	B-UNK
analyses	B-UNK
.	O

 	O
restriction	B-UNK
fragment	I-UNK
length	I-UNK
polymorphism	I-UNK
alleles	B-UNK
for	O
the	O
adh2	O
,	O
adh3	O
,	O
egf	O
,	O
fg	O
alpha	B-UNK
and	O
fg	O
beta	B-UNK
loci	B-UNK
and	O
blood	B-UNK
group	B-UNK
antigens	B-UNK
for	O
the	O
mns	O
locus	B-UNK
were	O
determined	B-UNK
in	O
a	O
panel	O
of	O
12	O
finnish	B-UNK
agu	B-UNK
families	B-UNK
.	O

 	O
the	O
heterozygous	B-UNK
family	I-UNK
members	B-UNK
were	O
identified	B-UNK
by	O
reduced	B-UNK
activity	B-UNK
of	O
aga	B-UNK
in	O
lymphocytes	B-UNK
.	O

 	B-UNK
linkage	I-UNK
studies	B-UNK
were	O
performed	B-UNK
using	O
both	O
pairwise	O
and	O
multipoint	B-UNK
analyses	B-UNK
.	O

 	O
loose	O
linkage	B-UNK
of	O
the	O
agu	B-UNK
locus	B-UNK
to	O
the	O
fg	O
and	O
mns	O
loci	B-UNK
was	O
observed	B-UNK
(	O
z	B-UNK
=	O
1	O
.	O
16	O
,	O
z	B-UNK
=	O
1	O
.	O
39	O
,	O
respectively	B-UNK
)	O
.	O

 	B-UNK
multipoint	I-UNK
analysis	B-UNK
to	O
the	O
fixed	O
map	B-UNK
[	O
adh	O
-	O
(	O
0	O
.	O
03	O
)	O
-	O
egf	O
-	O
(	O
0	O
.	O
35	O
)	O
-	O
fg	O
-	O
(	O
0	O
.	O
11	O
)	O
-	O
mns	O
]	O
suggests	B-UNK
that	O
the	O
location	B-UNK
of	O
the	O
agu	B-UNK
locus	B-UNK
is	O
0	O
.	O

 	O
05	O
-	O
0	O
.	O

 	O
30	O
recombination	B-UNK
units	B-UNK
distal	B-UNK
to	O
mns	O
(	O
z	B-UNK
=	O
3	O
.	O
03	O
)	O
.	O

 	O
the	O
order	B-UNK
cen	B-UNK
-	O
adh	O
-	O
egf	O
-	O
fg	O
-	O
mns	O
-	O
agu	B-UNK
is	O
35	O
times	B-UNK
more	O
likely	B-UNK
than	O
the	O
next	O
best	O
order	B-UNK
cen	B-UNK
-	O
adh	O
-	O
egf	O
-	O
agu	B-UNK
-	O
fg	O
-	O
mns	O
.	O

 	B-UNK
linkage	I-UNK
relationships	B-UNK
of	O
the	O
apolipoprotein	B-UNK
c1	B-UNK
gene	B-UNK
and	O
a	O
cytochrome	B-UNK
p450	B-UNK
gene	B-UNK
(	O
cyp2a	B-UNK
)	O
to	O
myotonic	B-DISEASE
dystrophy	I-DISEASE
.	O

 	O
we	O
have	O
studied	B-UNK
the	O
genetic	B-UNK
linkage	B-UNK
of	O
two	O
markers	B-UNK
,	O
the	O
apolipoprotein	B-UNK
c1	B-UNK
(	O
apoc1	O
)	O
gene	B-UNK
and	O
a	O
cytochrome	B-UNK
p450	B-UNK
(	O
cyp2a	B-UNK
)	O
gene	B-UNK
,	O
in	O
relation	O
to	O
the	O
gene	B-UNK
for	O
myotonic	B-DISEASE
dystrophy	I-DISEASE
(	O
dm	B-DISEASE
)	O
.	O

 	O
a	O
peak	B-UNK
lod	B-UNK
score	I-UNK
of	O
9	O
.	O

 	O
29	O
at	B-DISEASE
2	O
cm	B-DISEASE
was	O
observed	B-UNK
for	O
apoc1	O
-	O
dm	B-DISEASE
,	O
with	O
a	O
lod	B-UNK
score	I-UNK
of	O
8	O
.	O

 	O
55	O
at	B-DISEASE
4	O
cm	B-DISEASE
for	O
cyp2a	B-UNK
-	O
dm	B-DISEASE
.	O

 	O
these	O
two	O
markers	B-UNK
also	O
show	O
close	B-UNK
linkage	I-UNK
to	O
each	O
other	O
(	O
theta	B-UNK
max	B-UNK
=	I-UNK
0	O
.	O
05	O
,	O
zmax	B-UNK
=	O
9	O
.	O
09	O
)	O
.	O

 	O
from	O
examination	B-UNK
of	O
the	O
genotypes	O
of	O
the	O
recombinant	B-UNK
individuals	B-UNK
,	O
cyp2a	B-UNK
appears	B-UNK
to	O
map	B-UNK
proximal	B-UNK
to	O
dm	B-DISEASE
because	O
in	O
one	O
recombinant	B-UNK
individual	B-UNK
cyp2a	B-UNK
,	O
apoc2	B-UNK
and	O
ckmm	O
had	O
all	O
recombined	O
with	O
dm	B-DISEASE
.	O

 	O
evidence	B-UNK
from	O
another	O
cyp2a	B-UNK
-	O
dm	B-DISEASE
recombinant	B-UNK
individual	B-UNK
places	O
cyp2a	B-UNK
proximal	B-UNK
to	O
apoc2	B-UNK
and	O
ckmm	O
.	O

 	O
localisation	B-UNK
of	O
cyp2a	B-UNK
on	O
a	O
panel	O
of	O
somatic	B-UNK
cell	I-UNK
hybrids	I-UNK
also	O
suggests	B-UNK
that	O
it	O
is	O
proximal	B-UNK
to	O
dm	B-DISEASE
and	O
apoc2	B-UNK
/	O
c1	B-UNK
/	O
e	B-UNK
gene	B-UNK
cluster	O
.	O

 	B-UNK
genetic	I-UNK
linkage	B-UNK
map	B-UNK
of	O
six	O
polymorphic	B-UNK
dna	I-UNK
markers	B-UNK
around	O
the	O
gene	B-UNK
for	O
familial	B-DISEASE
adenomatous	I-DISEASE
polyposis	I-DISEASE
on	O
chromosome	B-DISEASE
5	I-DISEASE
.	O

 	O
a	O
genetic	B-UNK
linkage	B-UNK
map	B-UNK
of	O
six	O
polymorphic	B-UNK
dna	I-UNK
markers	B-UNK
close	B-UNK
to	O
the	O
gene	B-UNK
(	O
apc	B-UNK
)	O
for	O
familial	B-DISEASE
adenomatous	I-DISEASE
polyposis	I-DISEASE
(	O
fap	B-DISEASE
)	O
on	O
chromosome	B-UNK
5q	O
is	O
reported	B-UNK
.	O

 	O
one	O
hundred	O
fifty	O
-	O
five	O
typed	O
members	B-UNK
of	O
nine	O
fap	B-DISEASE
kindred	B-UNK
provided	B-UNK
more	O
than	O
90	O
meioses	B-UNK
for	O
linkage	B-UNK
analysis	I-UNK
.	O

 	O
a	O
number	B-UNK
of	O
crucial	B-UNK
recombination	B-UNK
events	I-UNK
have	O
been	O
identified	B-UNK
which	O
are	O
informative	B-UNK
at	B-DISEASE
three	O
or	O
more	O
loci	B-UNK
,	O
allowing	B-UNK
confident	O
ordering	O
of	O
parts	B-UNK
of	O
the	O
map	B-UNK
.	O

 	O
there	O
was	O
no	O
evidence	B-UNK
of	O
genetic	B-UNK
heterogeneity	B-UNK
,	O
with	O
all	O
families	B-UNK
showing	B-UNK
linkage	B-UNK
of	O
at	B-DISEASE
least	O
one	O
chromosome	B-DISEASE
5	I-DISEASE
marker	B-UNK
to	O
the	O
gene	B-UNK
.	O

 	O
recombination	B-UNK
data	B-UNK
and	O
two	O
-	O
point	B-UNK
linkage	I-UNK
analysis	B-UNK
support	B-UNK
a	O
locus	B-UNK
order	B-UNK
of	O
centromere	O
-	O
pi	O
227	O
-	O
c11p11	O
-	O
ecb27	O
-	O
l5	O
.	O

 	O
62	O
-	O
apc	B-UNK
-	O
ef5	O
62	O
-	O
apc	B-UNK
-	O
ef5	O
.	O

 	O
44	O
-	O
yn5	O
44	O
-	O
yn5	O
.	O

 	O
48	O
-	O
telomer	O
e	B-UNK
,	O
although	O
ef5	O
.	O

 	O
44	O
could	O
lie	O
in	O
the	O
interval	B-UNK
l5	O
.	O

 	O
62	O
-	O
apc	B-UNK
or	O
ecb27	O
-	O
l5	O
.	O

 	O
62	O
.	O

 	O
no	O
recombinants	O
were	O
identified	B-UNK
between	O
apc	B-UNK
and	O
either	O
ef5	O
.	O

 	O
44	O
or	O
yn5	O
.	O

 	O
48	O
,	O
but	O
published	B-UNK
deletion	B-UNK
mapping	B-UNK
in	O
colorectal	B-UNK
carcinomas	B-UNK
and	O
linkage	B-UNK
analysis	I-UNK
in	O
fap	B-DISEASE
suggest	B-UNK
that	O
yn5	O
.	O

 	O
48	O
is	O
1	O
-	O
3	O
cm	B-DISEASE
from	O
apc	B-UNK
.	O

 	O
the	O
present	B-UNK
study	I-UNK
suggests	B-UNK
that	O
yn5	O
.	O

 	O
48	O
and	O
l5	O
.	O

 	O
62	O
delineate	O
a	O
small	B-UNK
region	B-UNK
of	O
chromosome	B-DISEASE
5	I-DISEASE
within	O
which	O
the	O
ef5	O
.	O

 	O
44	O
locus	B-UNK
lies	B-UNK
very	O
close	B-UNK
to	O
the	O
apc	B-UNK
gene	B-UNK
.	O

 	O
these	O
data	B-UNK
not	O
only	O
allow	B-UNK
use	B-UNK
of	O
flanking	B-UNK
markers	B-UNK
for	O
presymptomatic	B-UNK
diagnosis	B-UNK
of	O
fap	B-DISEASE
but	O
also	O
provide	B-UNK
a	O
high	B-UNK
-	O
density	O
map	B-UNK
of	O
the	O
region	B-UNK
for	O
isolation	B-UNK
of	O
the	O
apc	B-UNK
gene	B-UNK
itself	O
and	O
for	O
further	O
assessment	B-UNK
of	O
the	O
role	B-UNK
of	O
chromosome	B-DISEASE
5	I-DISEASE
deletions	B-UNK
in	O
the	O
biology	O
of	O
sporadic	B-UNK
colorectal	B-DISEASE
cancer	I-DISEASE
.	O

 	B-UNK
serum	I-UNK
amyloid	B-UNK
a	O
and	O
p	B-UNK
protein	B-UNK
genes	B-UNK
in	O
familial	B-DISEASE
mediterranean	I-DISEASE
fever	I-DISEASE
.	O

 	O
two	O
recent	B-UNK
studies	B-UNK
have	O
suggested	B-UNK
the	O
involvement	B-UNK
of	O
serum	B-UNK
amyloid	B-UNK
a	O
(	O
saa	O
)	O
and	O
p	B-UNK
(	O
apcs	O
)	O
genes	B-UNK
in	O
familial	B-DISEASE
mediterranean	I-DISEASE
fever	I-DISEASE
(	O
mef	B-UNK
)	O
.	O

 	O
to	O
test	B-UNK
the	O
role	B-UNK
of	O
saa	O
and	O
apcs	O
in	O
mef	B-UNK
and	O
mef	B-UNK
-	O
amyloidosis	B-DISEASE
,	O
we	O
studied	B-UNK
17	O
informative	B-UNK
families	B-UNK
(	O
15	O
armenians	O
,	O
2	O
non	B-UNK
-	O
ashkenazi	B-UNK
jews	B-UNK
)	O
and	O
8	O
mef	B-UNK
patients	B-UNK
with	O
amyloidosis	B-DISEASE
using	O
a	O
candidate	B-UNK
gene	B-UNK
approach	B-UNK
.	O

 	O
no	O
evidence	B-UNK
for	O
any	O
mef	B-UNK
-	O
associated	B-UNK
polymorphism	O
was	O
found	B-UNK
in	O
any	O
of	O
the	O
41	O
armenian	B-UNK
and	O
jewish	B-UNK
mef	B-UNK
patients	B-UNK
tested	B-UNK
.	O

 	O
our	O
family	B-UNK
studies	I-UNK
allowed	B-UNK
us	O
to	O
rule	O
out	O
tight	B-UNK
linkage	B-UNK
between	O
saa	O
and	O
mef	B-UNK
(	O
lod	B-UNK
score	I-UNK
=	O
-	O
2	O
.	O
16	O
,	O
theta	B-UNK
less	O
than	O
or	O
equal	B-UNK
to	O
0	O
.	O
06	O
)	O
.	O

 	O
for	O
apcs	O
we	O
found	B-UNK
that	O
the	O
allele	B-UNK
frequency	B-UNK
in	O
the	O
mef	B-UNK
-	O
amyloidosis	B-DISEASE
patients	B-UNK
was	O
similar	B-UNK
to	O
that	O
in	O
18	O
unrelated	B-UNK
mef	B-UNK
patients	B-UNK
without	O
amyloidosis	B-DISEASE
and	O
their	O
33	O
healthy	B-UNK
parents	B-UNK
.	O

 	O
some	O
mexican	B-UNK
glucose	B-UNK
-	O
6	O
-	O
phosphate	B-UNK
dehydrogenase	I-UNK
variants	B-UNK
revisited	O
.	O

 	O
glucose	B-UNK
-	O
6	O
-	O
phosphate	B-UNK
dehydrogenase	I-UNK
(	O
g6pd	B-UNK
)	O
deficiency	B-UNK
appears	B-UNK
to	O
be	O
fairly	O
common	B-UNK
in	O
mexico	O
.	O

 	O
we	O
have	O
now	O
examined	B-UNK
the	O
dna	B-UNK
of	O
three	O
previously	B-UNK
reported	I-UNK
electrophoretically	O
fast	B-UNK
mexican	B-UNK
g6pd	B-UNK
variants	I-UNK
,	O
-	O
g6pd	B-UNK
distrito	O
federal	O
,	O
g6pd	B-UNK
tepic	O
,	O
and	O
g6pd	B-UNK
castilla	O
.	O

 	O
all	O
three	O
of	O
these	O
variants	B-UNK
,	O
believed	O
on	O
the	O
basis	B-UNK
of	O
biochemical	B-UNK
characterization	I-UNK
and	O
population	B-UNK
origin	B-UNK
to	O
be	O
unique	B-UNK
,	O
have	O
the	O
g	B-UNK
-	O
-	O
-	O
-	O
a	O
transition	B-UNK
at	B-DISEASE
nucleotide	B-UNK
202	O
and	O
the	O
a	O
-	O
-	O
-	O
-	O
g	B-UNK
transition	B-UNK
at	B-DISEASE
nucleotide	B-UNK
376	O
,	O
mutations	B-UNK
that	O
we	O
now	O
recognize	O
to	O
be	O
characteristic	B-UNK
of	O
g6pd	B-UNK
a	O
-	O
.	O

 	O
two	O
other	O
mexican	B-UNK
males	B-UNK
with	O
g6pd	B-UNK
deficiency	I-UNK
were	O
found	B-UNK
to	O
have	O
the	O
same	O
mutation	B-UNK
.	O

 	O
all	O
five	O
have	O
the	O
(	O
nlaiii	O
/	O
foki	O
/	O
pvuii	O
/	O
psti	O
)	O
haplotype	B-UNK
characteristic	B-UNK
of	O
g6pd	B-UNK
a	O
-	O
in	O
africa	O
.	O

 	O
since	O
the	O
pvuii	O
+	O
genotype	B-UNK
seems	O
to	O
be	O
rare	B-UNK
in	O
europe	B-UNK
,	O
we	O
conclude	O
that	O
all	O
of	O
these	O
g6pd	B-UNK
a	O
-	O
genes	B-UNK
had	O
their	O
ancient	B-UNK
origin	B-UNK
in	O
africa	O
,	O
although	O
in	O
many	O
of	O
the	O
mexican	B-UNK
patients	B-UNK
with	O
g6pd	B-UNK
a	O
-	O
202a	O
/	O
376	O
g	B-UNK
the	O
gene	B-UNK
may	O
have	O
been	O
imported	O
more	O
recently	B-UNK
from	O
spain	O
,	O
where	O
this	O
variant	B-UNK
,	O
formerly	O
known	B-UNK
as	O
g6pd	B-UNK
betica	B-UNK
,	O
is	O
also	O
prevalent	B-UNK
.	O
.	O

 	B-UNK
hereditary	I-UNK
deficiency	B-UNK
of	O
c5	B-UNK
in	O
association	B-UNK
with	O
discoid	O
lupus	B-DISEASE
erythematosus	I-DISEASE
.	O

 	O
a	O
29	O
-	O
year	B-UNK
-	O
old	B-UNK
woman	B-UNK
with	O
discoid	O
lupus	B-DISEASE
erythematosus	I-DISEASE
had	O
undetectable	B-UNK
classic	B-UNK
pathway	B-UNK
complement	B-UNK
activity	I-UNK
.	O

 	O
hypocomplementemia	O
was	O
due	O
to	O
selective	B-UNK
deficiency	B-UNK
of	O
c5	B-UNK
.	O

 	O
one	O
of	O
her	O
children	B-UNK
was	O
also	O
deficient	B-UNK
.	O

 	O
to	O
our	O
knowledge	B-UNK
this	O
is	O
the	O
first	O
documented	B-UNK
case	B-UNK
of	O
an	O
association	B-UNK
between	O
discoid	O
lupus	B-DISEASE
erythematosus	I-DISEASE
and	O
c5	B-UNK
deficiency	B-UNK
.	O
.	O

 	O
founder	B-UNK
effect	B-UNK
of	O
a	O
prevalent	B-UNK
phenylketonuria	B-DISEASE
mutation	B-UNK
in	O
the	O
oriental	O
population	B-UNK
.	O

 	O
a	O
missense	B-UNK
mutation	I-UNK
has	O
been	O
identified	B-UNK
in	O
the	O
human	B-UNK
phenylalanine	B-UNK
hydroxylase	I-UNK
[	O
pah	B-UNK
;	O
phenylalanine	O
4	O
-	O
monooxygenase	O
;	O
l	B-UNK
-	O
phenylalanine	O
,	O
tetrahydrobiopterin	O
oxygen	O
oxidoreductase	B-UNK
(	O
4	O
-	O
hydroxylating	O
)	O
,	O
ec	O
1	O
.	O
14	O
.	O
16	O
.	O
1	O
]	O
gene	B-UNK
in	O
a	O
chinese	B-UNK
patient	B-UNK
with	O
classic	B-UNK
phenylketonuria	B-DISEASE
(	O
pku	B-DISEASE
)	O
.	O

 	O
a	O
g	B-UNK
-	O
to	O
-	O
c	B-UNK
transition	B-UNK
at	B-DISEASE
the	O
second	B-UNK
base	B-UNK
of	O
codon	B-UNK
413	O
in	O
exon	B-UNK
12	O
of	O
the	O
gene	B-UNK
results	B-UNK
in	O
the	O
substitution	B-UNK
of	O
pro413	O
for	O
arg413	O
in	O
the	O
mutant	B-UNK
protein	B-UNK
.	O

 	O
this	O
mutation	B-UNK
(	O
r413p	O
)	O
results	B-UNK
in	O
negligible	O
enzymatic	B-UNK
activity	I-UNK
when	O
expressed	B-UNK
in	O
heterologous	O
mammalian	B-UNK
cells	B-UNK
and	O
is	O
compatible	O
with	O
a	O
classic	B-UNK
pku	B-DISEASE
phenotype	B-UNK
in	O
the	O
patient	B-UNK
.	O

 	O
population	B-UNK
genetic	B-UNK
studies	B-UNK
reveal	B-UNK
that	O
this	O
mutation	B-UNK
is	O
tightly	B-UNK
linked	I-UNK
to	O
restriction	B-UNK
fragment	I-UNK
length	I-UNK
polymorphism	I-UNK
haplotype	B-UNK
4	O
,	O
which	O
is	O
the	O
predominant	B-UNK
haplotype	B-UNK
of	O
the	O
pah	B-UNK
locus	B-UNK
in	O
the	O
oriental	O
population	B-UNK
.	O

 	O
it	O
accounts	O
for	O
13	O
.	O

 	O
8	O
%	O
of	O
northern	B-UNK
chinese	B-UNK
and	O
27	O
%	O
of	O
japanese	B-UNK
pku	B-DISEASE
alleles	B-UNK
,	O
but	O
it	O
is	O
rare	B-UNK
in	O
southern	O
chinese	B-UNK
(	O
2	O
.	O
2	O
%	O
)	O
and	O
is	O
absent	B-UNK
in	O
the	O
caucasian	B-UNK
population	B-UNK
.	O

 	O
the	O
data	B-UNK
demonstrate	B-UNK
unambiguously	B-UNK
that	O
the	O
mutation	B-UNK
occurred	B-UNK
after	O
racial	O
divergence	O
of	O
orientals	O
and	O
caucasians	B-UNK
and	O
suggest	B-UNK
that	O
the	O
allele	B-UNK
has	O
spread	B-UNK
throughout	O
the	O
orient	O
by	O
a	O
founder	B-UNK
effect	B-UNK
.	O

 	B-UNK
previous	I-UNK
protein	B-UNK
polymorphism	O
studies	B-UNK
in	O
eastern	B-UNK
asia	O
have	O
led	B-UNK
to	O
the	O
hypothesis	O
that	O
"	O
northern	B-UNK
mongoloids	O
"	O
represented	B-UNK
a	O
founding	B-UNK
population	B-UNK
in	O
asia	O
.	O

 	O
our	O
results	B-UNK
are	O
compatible	O
with	O
this	O
hypothesis	O
in	O
that	O
the	O
pku	B-DISEASE
mutation	B-UNK
might	O
have	O
occurred	B-UNK
in	O
northern	B-UNK
mongoloids	O
and	O
subsequently	B-UNK
spread	B-UNK
to	O
the	O
chinese	B-UNK
and	O
japanese	B-UNK
populations	B-UNK
.	O

 	O
glucose	B-UNK
/	O
galactose	B-UNK
malabsorption	B-UNK
caused	B-UNK
by	O
a	O
defect	B-UNK
in	O
the	O
na	B-UNK
+	O
/	O
glucose	B-UNK
cotransporter	O
.	O

 	O
glucose	B-UNK
/	O
galactose	B-UNK
malabsorption	B-UNK
(	O
ggm	O
)	O
is	O
an	O
autosomal	O
recessive	O
disease	B-DISEASE
manifesting	O
within	O
the	O
first	O
weeks	O
of	O
life	B-UNK
and	O
characterized	B-UNK
by	O
a	O
selective	B-UNK
failure	O
to	O
absorb	O
dietary	B-UNK
glucose	B-UNK
and	O
galactose	B-UNK
from	O
the	O
intestine	O
.	O

 	O
the	O
consequent	O
severe	B-UNK
diarrhoea	O
and	O
dehydration	B-DISEASE
are	O
usually	B-UNK
fatal	B-UNK
unless	O
these	O
sugars	O
are	O
eliminated	O
from	O
the	O
diet	O
.	O

 	O
intestinal	B-UNK
biopsies	B-UNK
of	O
ggm	O
patients	B-UNK
have	O
revealed	B-UNK
a	O
specific	B-UNK
defect	B-UNK
in	O
na	B-UNK
(	O
+	O
)	O
-	O
dependent	B-UNK
absorption	B-UNK
of	O
glucose	B-UNK
in	O
the	O
brush	B-UNK
border	B-UNK
.	O

 	B-UNK
normal	I-UNK
glucose	B-UNK
absorption	B-UNK
is	O
mediated	B-UNK
by	O
the	O
na	B-UNK
+	O
/	O
glucose	B-UNK
cotransporter	O
in	O
the	O
brush	B-UNK
border	B-UNK
membrane	B-UNK
of	O
the	O
intestinal	B-UNK
epithelium	O
.	O

 	O
cellular	B-UNK
influx	O
is	O
driven	O
by	O
the	O
transmembrane	B-UNK
na	B-UNK
+	O
electrochemical	O
potential	B-UNK
gradient	B-UNK
;	O
thereafter	O
the	O
sugar	O
moves	O
to	O
the	O
blood	B-UNK
across	O
the	O
basolateral	O
membrane	B-UNK
via	O
the	O
facilitated	O
glucose	B-UNK
carrier	B-UNK
.	O

 	O
we	O
have	O
previously	B-UNK
cloned	B-UNK
and	O
sequenced	B-UNK
a	O
na	B-UNK
+	O
/	O
glucose	B-UNK
cotransporter	O
from	O
normal	B-UNK
human	I-UNK
ileum	O
and	O
shown	B-UNK
that	O
this	O
gene	B-UNK
,	O
sglt1	B-UNK
,	O
resides	O
on	O
the	O
distal	B-UNK
q	B-UNK
arm	B-UNK
of	O
chromosome	B-DISEASE
22	I-DISEASE
.	O

 	O
we	O
have	O
now	O
amplified	B-UNK
sglt1	B-UNK
complementary	B-UNK
dna	I-UNK
and	O
genomic	B-UNK
dna	I-UNK
from	O
members	B-UNK
of	O
a	O
family	B-UNK
affected	B-UNK
with	O
ggm	O
by	O
the	O
polymerase	B-UNK
chain	I-UNK
reaction	I-UNK
.	O

 	O
sequence	B-UNK
analysis	B-UNK
of	O
the	O
amplified	B-UNK
products	B-UNK
has	O
revealed	B-UNK
a	O
single	B-UNK
missense	B-UNK
mutation	I-UNK
in	O
sglt1	B-UNK
which	O
cosegregates	O
with	O
the	O
ggm	O
phenotype	B-UNK
and	O
results	B-UNK
in	O
a	O
complete	B-UNK
loss	B-UNK
of	O
na	B-UNK
(	O
+	O
)	O
-	O
dependent	B-UNK
glucose	B-UNK
transport	B-UNK
in	O
xenopus	B-UNK
oocytes	B-UNK
injected	O
with	O
this	O
complementary	O
rna	B-UNK
.	O
.	O

 	O
a	O
de	B-UNK
novo	I-UNK
unbalanced	B-UNK
reciprocal	B-UNK
translocation	B-DISEASE
identified	B-UNK
as	O
paternal	B-UNK
in	O
origin	B-UNK
in	O
the	O
prader	B-DISEASE
-	I-DISEASE
willi	I-DISEASE
syndrome	I-DISEASE
.	O

 	O
interstitial	B-UNK
cytogenetic	B-UNK
deletions	B-UNK
involving	I-UNK
the	O
paternally	B-UNK
derived	I-UNK
chromosome	B-UNK
15q11	I-UNK
-	O
13	O
have	O
been	O
described	B-UNK
in	O
patients	B-UNK
with	O
the	O
prader	B-DISEASE
-	I-DISEASE
willi	I-DISEASE
syndrome	I-DISEASE
(	O
pws	B-UNK
)	O
.	O

 	O
we	O
report	B-UNK
a	O
child	B-UNK
with	O
pws	B-UNK
and	O
a	O
de	B-UNK
novo	I-UNK
unbalanced	B-UNK
karyotype	B-UNK
-	O
45	O
,	O
xy	O
,	O
-	O
9	O
,	O
-	O
15	O
,	O
+	O
der	O
(	O
9	O
)	O
t	B-UNK
(	O
9	O
;	O
15	O
)	O
(	O
q34	O
;	O
q13	O
)	O
.	O

 	B-UNK
molecular	I-UNK
studies	B-UNK
with	O
the	O
dna	B-UNK
probe	I-UNK
pml34	O
confirmed	B-UNK
that	O
only	O
a	O
single	B-UNK
prader	O
willi	O
critical	B-UNK
region	I-UNK
(	O
pwcr	O
15q11	B-UNK
.	O
2	O
-	O
q12	O
)	O
copy	B-UNK
was	O
present	B-UNK
.	O

 	O
hybridisation	B-UNK
of	O
patient	B-UNK
and	O
parental	B-UNK
dna	B-UNK
with	O
the	O
multi	O
-	O
allelic	B-UNK
probe	B-UNK
cmw1	O
,	O
which	O
maps	B-UNK
to	O
pter	O
-	O
15q13	O
,	O
showed	B-UNK
that	O
the	O
chromosome	B-UNK
involved	B-UNK
in	O
the	O
translocation	B-DISEASE
was	O
paternal	B-UNK
in	O
origin	B-UNK
.	O

 	O
this	O
is	O
the	O
first	O
example	O
of	O
a	O
paternally	B-UNK
-	O
derived	B-UNK
pwcr	O
allele	B-UNK
loss	B-UNK
caused	B-UNK
by	O
an	O
unbalanced	B-UNK
translocation	B-DISEASE
that	O
has	O
arisen	O
de	B-UNK
novo	I-UNK
.	O

 	O
localisation	B-UNK
of	O
the	O
myotonic	B-DISEASE
dystrophy	I-DISEASE
locus	B-UNK
to	O
19q13	O
.	O
2	O
-	O
19q13	O
.	O
3	O
and	O
its	O
relationship	B-UNK
to	O
twelve	O
polymorphic	B-UNK
loci	B-UNK
on	O
19q	O
.	O

 	O
the	O
order	B-UNK
of	O
fourteen	O
polymorphic	B-UNK
markers	I-UNK
localised	B-UNK
to	O
the	O
long	B-UNK
arm	B-UNK
of	O
human	B-UNK
chromosome	I-UNK
19	O
has	O
been	O
established	B-UNK
by	O
multipoint	B-UNK
mapping	B-UNK
in	O
a	O
set	B-UNK
of	O
40	O
ceph	O
(	O
centre	B-UNK
detude	O
de	B-UNK
polymorphisme	O
humain	O
,	O
paris	O
)	O
reference	B-UNK
families	B-UNK
.	O

 	O
we	O
report	B-UNK
here	O
the	O
linkage	B-UNK
relationship	B-UNK
of	O
the	O
myotonic	B-DISEASE
dystrophy	I-DISEASE
(	O
dm	B-DISEASE
)	O
locus	B-UNK
to	O
twelve	O
of	O
these	O
markers	B-UNK
as	O
studied	B-UNK
in	O
45	O
families	B-UNK
with	O
dm	B-DISEASE
.	O

 	O
the	O
resulting	B-UNK
genetic	B-UNK
map	B-UNK
is	O
supported	B-UNK
by	O
the	O
localisation	B-UNK
of	O
the	O
dna	B-UNK
markers	I-UNK
in	O
a	O
panel	O
of	O
somatic	B-UNK
cell	I-UNK
hybrids	I-UNK
.	O

 	O
ten	B-DISEASE
of	O
the	O
twelve	O
markers	B-UNK
have	O
been	O
shown	B-UNK
to	O
be	O
proximal	B-UNK
to	O
the	O
dm	B-DISEASE
gene	B-UNK
and	O
two	O
,	O
prkcg	O
and	O
d19s22	O
,	O
distal	B-UNK
but	O
at	B-DISEASE
distances	O
of	O
approximately	B-UNK
25	O
cm	B-DISEASE
and	O
15	O
cm	B-DISEASE
,	O
respectively	B-UNK
.	O

 	O
the	O
closest	O
proximal	B-UNK
markers	B-UNK
are	O
apoc2	B-UNK
(	O
apolipoprotein	B-UNK
c	B-UNK
-	O
ii	B-UNK
)	O
and	O
ckm	O
(	O
creatine	B-UNK
kinase	B-UNK
,	O
muscle	B-UNK
)	O
approximately	B-UNK
3	O
cm	B-DISEASE
and	O
2	O
cm	B-DISEASE
from	O
the	O
dm	B-DISEASE
gene	B-UNK
respectively	B-UNK
,	O
in	O
the	O
order	B-UNK
apoc2	B-UNK
-	O
ckm	O
-	O
dm	B-DISEASE
.	O

 	O
the	O
distance	B-UNK
between	O
apoc2	B-UNK
,	O
ckm	O
and	O
dm	B-DISEASE
(	O
of	O
the	O
order	B-UNK
of	O
2	O
million	B-UNK
base	B-UNK
pairs	I-UNK
)	O
and	O
their	O
known	B-UNK
orientation	O
should	O
permit	B-UNK
directional	O
chromosome	B-UNK
walking	O
and	O
jumping	O
.	O

 	O
the	O
data	B-UNK
presented	B-UNK
here	O
should	O
enable	O
us	O
to	O
determine	O
whether	O
or	O
not	O
new	B-UNK
markers	B-UNK
are	O
distal	B-UNK
to	O
apoc2	B-UNK
/	O
ckm	O
and	O
thus	O
potentially	B-UNK
flank	O
the	O
dm	B-DISEASE
gene	B-UNK
.	O
.	O

 	O
localization	B-UNK
of	O
histidase	B-UNK
to	O
human	B-UNK
chromosome	I-UNK
region	B-UNK
12q22	O
-	O
-	O
-	O
-	O
q24	O
.	O
1	O
and	O
mouse	B-UNK
chromosome	I-UNK
region	B-UNK
10c2	O
-	O
-	O
-	O
-	O
d1	O
.	O

 	O
the	O
human	B-UNK
gene	B-UNK
for	O
histidase	B-UNK
(	O
histidine	B-UNK
ammonia	O
-	O
lyase	O
;	O
hal	O
)	O
,	O
the	O
enzyme	B-UNK
deficient	B-UNK
in	O
histidinemia	B-DISEASE
,	O
was	O
assigned	B-UNK
to	O
human	B-UNK
chromosome	I-UNK
12	O
by	O
southern	B-UNK
blot	I-UNK
analysis	I-UNK
of	O
human	B-UNK
x	B-UNK
mouse	B-UNK
somatic	B-UNK
cell	I-UNK
hybrid	I-UNK
dna	B-UNK
.	O

 	O
the	O
gene	B-UNK
was	O
sublocalized	O
to	O
region	B-UNK
12q22	O
-	O
-	O
-	O
-	O
q24	O
.	O

 	O
1	O
by	O
in	O
situ	B-UNK
hybridization	I-UNK
,	O
using	O
a	O
human	B-UNK
histidase	B-UNK
cdna	B-UNK
.	O

 	O
the	O
homologous	B-UNK
locus	B-UNK
in	O
the	O
mouse	B-UNK
(	O
hal	O
)	O
was	O
mapped	B-UNK
to	O
region	B-UNK
10c2	O
-	O
-	O
-	O
-	O
d1	O
by	O
in	O
situ	B-UNK
hybridization	I-UNK
,	O
using	O
a	O
cell	B-UNK
line	B-UNK
from	O
a	O
mouse	B-UNK
homozygous	B-UNK
for	O
a	O
1	O
.	O

 	O
10	O
robertsonian	O
translocation	B-DISEASE
.	O

 	O
these	O
assignments	O
extend	O
the	O
conserved	B-UNK
syntenic	O
region	B-UNK
between	O
human	B-UNK
chromosome	I-UNK
12	O
and	O
mouse	B-UNK
chromosome	I-UNK
10	O
that	O
includes	B-UNK
the	O
genes	B-UNK
for	O
phenylalanine	B-UNK
hydroxylase	I-UNK
,	O
gamma	B-UNK
interferon	O
,	O
peptidase	O
,	O
and	O
citrate	O
synthase	O
.	O

 	O
the	O
localization	B-UNK
of	O
histidase	B-UNK
to	O
mouse	B-UNK
chromosome	I-UNK
10	O
suggests	B-UNK
that	O
the	O
histidase	B-UNK
regulatory	B-UNK
locus	B-UNK
(	O
hsd	O
)	O
and	O
the	O
histidinemia	B-DISEASE
mutation	B-UNK
(	O
his	O
)	O
,	O
which	O
are	O
both	O
known	B-UNK
to	O
be	O
on	O
chromosome	B-DISEASE
10	I-DISEASE
,	O
may	O
be	O
alleles	B-UNK
of	O
the	O
histidase	B-UNK
structural	B-UNK
gene	B-UNK
locus	B-UNK
.	O

 	O
determination	B-UNK
of	O
the	O
mutations	B-UNK
responsible	B-UNK
for	O
the	O
lesch	B-DISEASE
-	I-DISEASE
nyhan	I-DISEASE
syndrome	I-DISEASE
in	O
17	O
subjects	B-UNK
.	O

 	O
hypoxanthine	B-UNK
-	O
-	O
guanine	B-UNK
phosphoribosyltransferase	I-UNK
(	O
hprt	B-UNK
)	O
is	O
a	O
purine	O
salvage	B-UNK
enzyme	B-UNK
that	O
catalyzes	O
the	O
conversion	O
of	O
hypoxanthine	B-UNK
to	O
inosine	O
monophosphate	O
and	O
guanine	B-UNK
to	O
guanosine	O
monophosphate	O
.	O

 	B-UNK
previous	I-UNK
studies	B-UNK
of	O
mutant	B-UNK
hprt	I-UNK
proteins	B-UNK
analyzed	B-UNK
at	B-DISEASE
the	O
molecular	B-UNK
level	B-UNK
have	O
shown	B-UNK
a	O
significant	B-UNK
heterogeneity	B-UNK
.	O

 	O
this	O
investigation	O
further	O
verifies	O
this	O
heterogeneity	B-UNK
and	O
identifies	O
insertions	B-UNK
,	O
deletions	B-UNK
,	O
and	O
point	B-UNK
mutations	I-UNK
.	O

 	O
the	O
direct	B-UNK
sequencing	I-UNK
of	O
the	O
polymerase	B-UNK
chain	I-UNK
reaction	I-UNK
-	O
amplified	B-UNK
product	B-UNK
of	O
reverse	B-UNK
-	O
transcribed	B-UNK
hprt	B-UNK
mrna	B-UNK
enabled	B-UNK
the	O
rapid	B-UNK
identification	B-UNK
of	O
the	O
mutations	B-UNK
found	B-UNK
in	O
17	O
previously	B-UNK
uncharacterized	B-UNK
cell	B-UNK
lines	B-UNK
derived	B-UNK
from	O
patients	B-UNK
with	O
the	O
lesch	B-DISEASE
-	I-DISEASE
nyhan	I-DISEASE
syndrome	I-DISEASE
.	O
.	O

 	B-UNK
linkage	I-UNK
of	O
dna	B-UNK
markers	I-UNK
at	B-DISEASE
xq28	B-UNK
to	O
adrenoleukodystrophy	B-DISEASE
and	O
adrenomyeloneuropathy	B-UNK
present	B-UNK
within	O
the	O
same	O
family	B-UNK
.	O

 	O
we	O
present	B-UNK
a	O
large	B-UNK
kindred	B-UNK
that	O
contained	B-UNK
patients	B-UNK
with	O
either	O
adrenoleukodystrophy	B-DISEASE
(	O
ald	B-UNK
)	O
or	O
adrenomyeloneuropathy	B-UNK
(	O
amn	B-UNK
)	O
.	O

 	O
the	O
pedigree	B-UNK
clearly	B-UNK
supported	B-UNK
the	O
x	B-UNK
-	O
linked	B-UNK
mode	B-UNK
of	O
inheritance	B-UNK
of	O
the	O
nonneonatal	O
form	B-UNK
of	O
ald	B-UNK
/	O
amn	B-UNK
.	O

 	O
analysis	B-UNK
with	O
dna	B-UNK
markers	I-UNK
at	B-DISEASE
xq28	B-UNK
suggested	B-UNK
segregation	B-UNK
of	O
both	O
ald	B-UNK
and	O
amn	B-UNK
with	O
an	O
identical	B-UNK
haplotype	B-UNK
.	O

 	O
this	O
indicated	B-UNK
that	O
nonneonatal	O
ald	B-UNK
and	O
amn	B-UNK
are	O
caused	B-UNK
by	O
a	O
mutation	B-UNK
in	O
the	O
same	O
gene	B-UNK
at	B-DISEASE
xq28	B-UNK
.	O

 	O
it	O
showed	B-UNK
,	O
furthermore	B-UNK
,	O
that	O
phenotypic	B-UNK
differences	B-UNK
between	O
ald	B-UNK
and	O
amn	B-UNK
are	O
not	O
necessarily	O
the	O
consequence	O
of	O
allelic	B-UNK
heterogeneity	I-UNK
due	O
to	O
different	B-UNK
mutations	B-UNK
within	O
the	O
same	O
gene	B-UNK
.	O

 	O
the	O
maximal	B-UNK
lod	I-UNK
score	B-UNK
for	O
linkage	B-UNK
of	O
the	O
ald	B-UNK
/	O
amn	B-UNK
gene	B-UNK
and	O
the	O
multiallelic	O
anonymous	B-UNK
dna	I-UNK
marker	B-UNK
at	B-DISEASE
dxs52	O
was	O
3	O
.	O

 	O
0	O
at	B-DISEASE
a	O
recombination	B-UNK
fraction	B-UNK
of	O
0	O
.	O

 	O
00	O
.	O

 	O
this	O
made	O
a	O
prenatal	B-UNK
or	O
presymptomatic	B-UNK
diagnosis	B-UNK
and	O
heterozygote	B-UNK
detection	B-UNK
by	O
dna	B-UNK
analysis	B-UNK
with	O
this	O
marker	B-UNK
reliable	B-UNK
.	O

 	O
skewed	O
x	B-DISEASE
inactivation	I-DISEASE
in	O
a	O
female	B-UNK
mz	B-UNK
twin	B-UNK
results	B-UNK
in	O
duchenne	B-UNK
muscular	B-DISEASE
dystrophy	I-DISEASE
.	O

 	O
one	O
of	O
female	B-UNK
mz	B-UNK
twins	B-DISEASE
presented	B-UNK
with	O
muscular	B-DISEASE
dystrophy	I-DISEASE
.	O

 	B-UNK
physical	I-UNK
examination	B-UNK
,	O
creatine	B-DISEASE
phosphokinase	I-DISEASE
levels	B-UNK
,	O
and	O
muscle	B-UNK
biopsy	B-UNK
were	O
consistent	B-UNK
with	O
duchenne	B-UNK
muscular	B-DISEASE
dystrophy	I-DISEASE
(	O
dmd	B-UNK
)	O
.	O

 	O
however	O
,	O
because	O
of	O
her	O
sex	B-UNK
she	O
was	O
diagnosed	B-UNK
as	O
having	B-UNK
limb	B-DISEASE
-	I-DISEASE
girdle	I-DISEASE
muscular	I-DISEASE
dystrophy	I-DISEASE
.	O

 	O
with	O
cdna	B-UNK
probes	B-UNK
to	O
the	O
dmd	B-UNK
gene	B-UNK
,	O
a	O
gene	B-UNK
deletion	B-UNK
was	O
detected	B-UNK
in	O
the	O
twins	B-DISEASE
and	O
their	O
mother	B-UNK
.	O

 	O
the	O
de	B-UNK
novo	I-UNK
mutation	B-UNK
which	O
arose	B-UNK
in	O
the	O
mother	B-UNK
was	O
shown	B-UNK
by	O
novel	B-UNK
junction	B-UNK
fragments	B-UNK
generated	B-UNK
by	O
hindiii	B-UNK
,	O
psti	O
,	O
or	O
taqi	O
when	O
probed	O
with	O
cdna8	O
.	O

 	B-UNK
additional	I-UNK
evidence	B-UNK
of	O
a	O
large	B-UNK
gene	B-UNK
deletion	B-UNK
was	O
given	B-UNK
by	O
novel	B-UNK
sfii	O
junction	B-UNK
fragments	B-UNK
detected	B-UNK
by	O
probes	B-UNK
p20	O
,	O
j	B-UNK
-	O
bir	O
,	O
and	O
j	B-UNK
-	O
66	O
on	O
pulsed	O
-	O
field	B-UNK
gel	I-UNK
electrophoresis	B-UNK
(	O
pfge	O
)	O
.	O

 	O
immunoblot	O
analysis	B-UNK
of	O
muscle	B-UNK
from	O
the	O
affected	B-UNK
twin	B-UNK
showed	B-UNK
dystrophin	B-UNK
of	O
normal	B-UNK
size	B-UNK
but	O
of	O
reduced	B-UNK
amount	O
.	O

 	O
immunofluorescent	O
visualization	O
of	O
dystrophin	B-UNK
revealed	B-UNK
foci	B-UNK
of	O
dystrophin	B-UNK
-	O
positive	B-UNK
fibers	B-UNK
adjacent	B-UNK
to	O
foci	B-UNK
of	O
dystrophin	B-UNK
-	O
negative	B-UNK
fibers	B-UNK
.	O

 	O
these	O
data	B-UNK
indicate	B-UNK
that	O
the	O
affected	B-UNK
twin	B-UNK
is	O
a	O
manifesting	O
carrier	B-UNK
of	O
an	O
abnormal	B-UNK
dmd	B-UNK
gene	B-UNK
,	O
her	O
myopathy	B-DISEASE
being	O
a	O
direct	B-UNK
result	B-UNK
of	O
underexpression	O
of	O
dystrophin	B-UNK
.	O

 	B-UNK
cytogenetic	I-UNK
analysis	B-UNK
revealed	B-UNK
normal	B-UNK
karyotypes	B-UNK
,	O
eliminating	O
the	O
possibility	O
of	O
a	O
translocation	B-DISEASE
affecting	B-UNK
dmd	B-UNK
gene	B-UNK
function	B-UNK
.	O

 	O
both	O
linkage	B-UNK
analysis	I-UNK
and	O
dna	B-UNK
fingerprint	B-UNK
analysis	B-UNK
revealed	B-UNK
that	O
each	O
twin	B-UNK
has	O
two	O
different	B-UNK
x	B-UNK
chromosomes	I-UNK
,	O
eliminating	O
the	O
possibility	O
of	O
uniparental	B-DISEASE
disomy	I-DISEASE
as	O
a	O
mechanism	B-UNK
for	O
dmd	B-UNK
expression	B-UNK
.	O

 	O
on	O
the	O
basis	B-UNK
of	O
methylation	B-UNK
differences	B-UNK
of	O
the	O
paternal	B-UNK
and	O
maternal	B-UNK
x	B-UNK
chromosomes	I-UNK
in	O
these	O
mz	B-UNK
twins	B-DISEASE
,	O
we	O
propose	O
uneven	O
lyonization	O
(	O
x	B-DISEASE
chromosome	I-DISEASE
inactivation	B-UNK
)	O
as	O
the	O
underlying	B-UNK
mechanism	B-UNK
for	O
disease	B-DISEASE
expression	B-UNK
in	O
the	O
affected	B-UNK
female	B-UNK
.	O
.	O

 	O
adrenoleukodystrophy	B-DISEASE
and	O
adrenomyeloneuropathy	B-UNK
associated	B-UNK
with	O
partial	B-UNK
adrenal	B-DISEASE
insufficiency	I-DISEASE
in	O
three	O
generations	B-UNK
of	O
a	O
kindred	B-UNK
.	O

 	O
four	O
cases	B-UNK
of	O
adrenoleukodystrophy	B-DISEASE
(	O
ald	B-UNK
)	O
and	O
one	O
case	B-UNK
of	O
adrenomyeloneuropathy	B-UNK
(	O
amn	B-UNK
)	O
have	O
developed	B-UNK
in	O
a	O
kindred	B-UNK
over	O
three	O
generations	B-UNK
demonstrating	B-UNK
that	O
amn	B-UNK
is	O
a	O
clinical	B-UNK
variant	B-UNK
of	O
ald	B-UNK
.	O

 	O
pituitary	O
-	O
adrenal	B-UNK
function	B-UNK
studies	B-UNK
were	O
performed	B-UNK
in	O
10	O
family	B-UNK
members	I-UNK
,	O
including	B-UNK
two	O
affected	B-UNK
males	B-UNK
and	O
four	O
females	B-UNK
identified	B-UNK
as	O
carriers	B-UNK
of	O
ald	B-UNK
/	O
amn	B-UNK
.	O

 	O
no	O
pituitary	O
-	O
adrenal	B-UNK
abnormality	B-UNK
was	O
found	B-UNK
in	O
the	O
carriers	B-UNK
.	O

 	O
however	O
,	O
basal	O
morning	O
plasma	B-UNK
adrenocorticotropic	O
hormone	B-UNK
(	O
acth	O
)	O
levels	B-UNK
were	O
markedly	B-UNK
elevated	B-UNK
in	O
the	O
two	O
males	B-UNK
with	O
ald	B-UNK
and	O
amn	B-UNK
,	O
despite	B-UNK
the	O
fact	O
that	O
they	O
had	O
no	O
clinical	B-UNK
signs	B-UNK
of	O
adrenal	B-DISEASE
insufficiency	I-DISEASE
and	O
that	O
morning	O
plasma	B-UNK
cortisol	O
levels	B-UNK
and	O
their	O
response	B-UNK
to	O
maximal	O
exogenous	B-UNK
acth	O
stimulation	B-UNK
appeared	B-UNK
to	O
be	O
normal	B-UNK
.	O

 	O
in	O
addition	B-UNK
,	O
the	O
integrated	O
24	O
-	O
hour	O
response	B-UNK
to	O
the	O
administration	O
were	O
also	O
subnormal	O
in	O
these	O
two	O
cases	B-UNK
.	O

 	O
thus	O
,	O
people	B-UNK
with	O
ald	B-UNK
and	O
amn	B-UNK
may	O
have	O
subclinical	O
partial	B-UNK
adrenocrotical	O
insufficiency	B-UNK
.	O

 	O
no	O
other	O
endocrinologic	O
dysfunction	B-UNK
was	O
identified	B-UNK
.	O
.	O

 	B-UNK
regional	I-UNK
localisation	B-UNK
of	O
the	O
friedreich	B-DISEASE
ataxia	I-DISEASE
locus	B-UNK
to	O
human	B-UNK
chromosome	I-UNK
9q13	O
-	O
-	O
-	O
-	O
q21	O
.	O
1	O
.	O

 	O
we	O
have	O
previously	B-UNK
assigned	B-UNK
the	O
friedreich	B-DISEASE
ataxia	I-DISEASE
locus	B-UNK
(	O
frda	B-UNK
)	O
to	O
chromosome	B-DISEASE
9	I-DISEASE
;	O
the	O
current	B-UNK
maximal	B-UNK
lod	I-UNK
score	B-UNK
between	O
frda	B-UNK
and	O
mct112	O
(	O
d9s15	O
)	O
is	O
greater	B-UNK
than	O
50	O
at	B-DISEASE
a	O
recombination	B-UNK
fraction	B-UNK
of	O
theta	B-UNK
=	I-UNK
0	O
.	O

 	O
the	O
physical	B-UNK
assignment	B-UNK
of	O
the	O
locus	B-UNK
defined	B-UNK
by	O
mct112	O
,	O
and	O
hence	O
frda	B-UNK
,	O
has	O
not	O
been	O
determined	B-UNK
,	O
although	O
linkage	B-UNK
analysis	I-UNK
of	O
mct112	O
with	O
other	O
chromosome	B-DISEASE
9	I-DISEASE
markers	B-UNK
inferred	O
a	O
location	B-UNK
close	B-UNK
to	O
the	O
centromere	O
.	O

 	O
we	O
have	O
used	O
in	O
situ	B-UNK
hybridisation	B-UNK
with	O
mct112	O
,	O
a	O
corresponding	B-UNK
cosmid	B-UNK
mj1	O
,	O
and	O
dr47	O
(	O
d9s5	O
)	O
,	O
coupled	B-UNK
with	O
mapping	B-UNK
studies	B-UNK
on	O
hybrid	O
cell	B-UNK
panels	O
,	O
to	O
define	B-UNK
more	O
precisely	O
the	O
location	B-UNK
of	O
the	O
disease	B-DISEASE
locus	B-UNK
.	O

 	O
the	O
in	O
situ	B-UNK
location	B-UNK
of	O
all	O
three	O
probes	B-UNK
is	O
9q13	O
-	O
-	O
-	O
-	O
q21	O
.	O

 	O
1	O
,	O
distal	B-UNK
to	O
the	O
variable	B-UNK
heterochromatin	O
region	B-UNK
.	O

 	B-UNK
physical	I-UNK
assignment	B-UNK
of	O
frda	B-UNK
will	O
allow	B-UNK
us	O
to	O
identify	B-UNK
hybrid	B-UNK
cell	I-UNK
lines	I-UNK
containing	B-UNK
the	O
mutated	B-UNK
gene	B-UNK
.	O

 	B-UNK
increased	I-UNK
high	B-UNK
-	O
density	B-UNK
lipoprotein	I-UNK
levels	B-UNK
caused	B-UNK
by	O
a	O
common	B-UNK
cholesteryl	O
-	O
ester	B-UNK
transfer	I-UNK
protein	I-UNK
gene	I-UNK
mutation	B-UNK
.	O

 	B-UNK
background	I-UNK
and	O
methods	B-UNK
.	O

 	O
the	O
plasma	B-UNK
cholesteryl	O
-	O
ester	O
transfer	O
protein	B-UNK
(	O
cetp	B-UNK
)	O
catalyzes	O
the	O
transfer	O
of	O
cholesteryl	O
esters	O
from	O
high	B-UNK
-	O
density	B-UNK
lipoprotein	I-UNK
(	O
hdl	B-UNK
)	O
to	O
other	O
lipoproteins	O
.	O

 	O
we	O
recently	B-UNK
described	B-UNK
a	O
japanese	B-UNK
family	B-UNK
with	O
increased	B-UNK
hdl	I-UNK
levels	B-UNK
and	O
cetp	B-UNK
deficiency	I-UNK
due	O
to	O
a	O
splicing	B-UNK
defect	B-UNK
of	O
the	O
cetp	B-UNK
gene	B-UNK
.	O

 	O
to	O
assess	B-UNK
the	O
frequency	B-UNK
and	O
phenotype	B-UNK
of	O
this	O
condition	B-UNK
,	O
we	O
screened	O
11	O
additional	B-UNK
families	B-UNK
with	O
high	B-UNK
hdl	B-UNK
levels	I-UNK
by	O
means	O
of	O
a	O
radioimmunoassay	O
for	O
cetp	B-UNK
and	O
dna	B-UNK
analysis	B-UNK
.	O

 	B-UNK
results	I-UNK
.	O

 	O
we	O
found	B-UNK
the	O
same	O
cetp	B-UNK
gene	B-UNK
mutation	B-UNK
in	O
four	O
families	B-UNK
from	O
three	O
different	B-UNK
regions	B-UNK
of	O
japan	O
.	O

 	O
analysis	B-UNK
of	O
restriction	O
-	O
fragment	O
-	O
length	O
polymorphisms	B-UNK
of	O
the	O
mutant	B-UNK
cetp	B-UNK
allele	B-UNK
showed	I-UNK
that	O
all	O
probands	B-UNK
were	O
homozygous	B-UNK
for	O
the	O
identical	B-UNK
haplotype	B-UNK
.	O

 	B-UNK
family	I-UNK
members	B-UNK
homozygous	B-UNK
for	O
cetp	B-UNK
deficiency	I-UNK
(	O
n	B-UNK
=	O
10	O
)	O
had	O
moderate	B-UNK
hypercholesterolemia	B-DISEASE
(	O
mean	B-UNK
total	B-UNK
cholesterol	B-UNK
level	B-UNK
[	O
+	O
/	O
-	O
sd	O
]	O
,	O
7	O
.	O
01	O
+	O
/	O
-	O
0	O
.	O
83	O
mmol	O
per	O
liter	O
)	O
,	O
markedly	B-UNK
increased	B-UNK
levels	I-UNK
of	O
hdl	B-UNK
cholesterol	B-UNK
(	O
4	O
.	O
24	O
+	O
/	O
-	O
1	O
.	O
01	O
mmol	O
per	O
liter	O
)	O
and	O
apolipoprotein	B-UNK
a	O
-	O
i	O
,	O
and	O
decreased	B-UNK
levels	B-UNK
of	O
low	B-UNK
-	O
density	B-UNK
lipoprotein	I-UNK
cholesterol	B-UNK
(	O
1	O
.	O
99	O
+	O
/	O
-	O
0	O
.	O
80	O
mmol	O
per	O
liter	O
)	O
and	O
apolipoprotein	B-UNK
b	B-UNK
.	O

 	O
members	B-UNK
heterozygous	B-UNK
for	O
the	O
deficiency	B-UNK
(	O
n	B-UNK
=	O
20	O
)	O
,	O
whose	O
cetp	B-UNK
levels	B-UNK
were	O
in	O
the	O
lower	B-UNK
part	O
of	O
the	O
normal	B-UNK
range	B-UNK
,	O
had	O
moderately	B-UNK
increased	B-UNK
levels	I-UNK
of	O
hdl	B-UNK
cholesterol	B-UNK
and	O
apolipoprotein	B-UNK
a	O
-	O
i	O
and	O
an	O
increased	B-UNK
ratio	B-UNK
of	O
hdl	B-UNK
subclass	B-UNK
2	O
to	O
hdl	B-UNK
subclass	B-UNK
3	O
,	O
as	O
compared	B-UNK
with	O
unaffected	B-UNK
family	B-UNK
members	I-UNK
(	O
1	O
.	O
5	O
+	O
/	O
-	O
0	O
.	O
8	O
vs	B-UNK
.	O
0	O
.	O
7	O
+	O
/	O
-	O
0	O
.	O
4	O
)	O
.	O

 	B-UNK
cetp	I-UNK
deficiency	B-UNK
was	O
not	O
found	B-UNK
in	O
six	O
unrelated	B-UNK
subjects	B-UNK
with	O
elevated	B-UNK
hdl	B-UNK
cholesterol	B-UNK
levels	B-UNK
who	O
were	O
from	O
different	B-UNK
parts	B-UNK
of	O
the	O
united	B-UNK
states	B-UNK
.	O

 	O
conclusions	B-UNK
.	O

 	B-UNK
cetp	I-UNK
deficiency	B-UNK
appears	B-UNK
to	O
be	O
a	O
frequent	B-UNK
cause	B-UNK
of	O
increased	B-UNK
hdl	I-UNK
levels	B-UNK
in	O
the	O
population	B-UNK
of	O
japan	O
,	O
possibly	B-UNK
because	O
of	O
a	O
founder	B-UNK
effect	B-UNK
.	O

 	O
the	O
results	B-UNK
that	O
we	O
observed	B-UNK
in	O
heterozygotes	B-UNK
suggest	B-UNK
that	O
cetp	B-UNK
normally	B-UNK
plays	O
a	O
part	O
in	O
the	O
regulation	B-UNK
of	O
levels	B-UNK
of	O
hdl	B-UNK
subclass	B-UNK
2	O
.	O

 	O
there	O
was	O
no	O
evidence	B-UNK
of	O
premature	B-UNK
atherosclerosis	B-DISEASE
in	O
the	O
families	B-UNK
with	O
cetp	B-UNK
deficiency	I-UNK
.	O

 	O
in	O
fact	O
,	O
the	O
lipoprotein	B-UNK
profile	B-UNK
of	O
persons	B-UNK
with	O
cetp	B-UNK
deficiency	I-UNK
is	O
potentially	B-UNK
antiatherogenic	O
and	O
may	O
be	O
associated	B-UNK
with	O
an	O
increased	B-UNK
life	B-UNK
span	B-UNK
.	O

 	O
further	O
mapping	B-UNK
of	O
an	O
ataxia	B-DISEASE
-	O
telangiectasia	B-DISEASE
locus	B-UNK
to	O
the	O
chromosome	B-UNK
11q23	O
region	B-UNK
.	O

 	O
we	O
recently	B-UNK
mapped	B-UNK
the	O
gene	B-UNK
for	O
ataxia	B-DISEASE
-	O
telangiectasia	B-DISEASE
group	B-UNK
a	O
(	O
ata	O
)	O
to	O
chromosome	B-UNK
11q22	O
-	O
23	O
by	O
linkage	B-UNK
analysis	I-UNK
,	O
using	O
the	O
genetic	B-UNK
markers	B-UNK
thy1	O
and	O
pynb3	O
.	O

 	O
12	O
(	O
d11s144	O
)	O
.	O

 	O
the	O
most	O
likely	B-UNK
order	B-UNK
was	O
cent	O
-	O
at	B-DISEASE
-	O
s144	O
-	O
thy1	O
.	O

 	O
the	O
present	B-UNK
paper	B-UNK
describes	B-UNK
further	O
mapping	B-UNK
of	O
the	O
at	B-DISEASE
locus	B-UNK
by	O
means	O
of	O
a	O
panel	O
of	O
10	O
markers	B-UNK
that	O
span	B-UNK
approximately	B-UNK
60	O
cm	B-DISEASE
in	O
the	O
11q22	O
-	O
23	O
region	B-UNK
centered	O
around	O
s144	O
and	O
thy1	O
.	O

 	O
location	B-UNK
scores	B-UNK
indicate	B-UNK
that	O
three	O
contiguous	B-UNK
subsegments	O
within	O
the	O
[	O
s144	O
-	O
thy1	O
]	O
segment	B-UNK
,	O
as	O
well	O
as	O
three	O
contiguous	B-UNK
segments	B-UNK
telomeric	B-UNK
to	O
thy1	O
,	O
are	O
each	O
unlikely	O
to	O
contain	B-UNK
the	O
at	B-DISEASE
locus	B-UNK
,	O
while	O
the	O
more	O
centromeric	B-UNK
[	O
stmy	O
-	O
s144	O
]	O
segment	B-UNK
is	O
most	O
likely	B-UNK
to	O
contain	B-UNK
the	O
at	B-DISEASE
locus	B-UNK
.	O

 	O
these	O
data	B-UNK
,	O
together	O
with	O
recent	B-UNK
refinements	O
in	O
the	O
linkage	B-UNK
and	O
physical	B-UNK
maps	B-UNK
of	O
11q22	O
-	O
23	O
,	O
place	B-UNK
the	O
at	B-DISEASE
locus	B-UNK
at	B-DISEASE
11q23	O
.	O

 	B-UNK
recurrent	I-UNK
meningitis	B-DISEASE
in	O
a	O
patient	B-UNK
with	O
congenital	B-DISEASE
deficiency	B-UNK
of	O
the	O
c9	B-UNK
component	B-UNK
of	O
complement	B-UNK
.	O

 	O
first	O
case	B-UNK
of	O
c9	B-DISEASE
deficiency	I-DISEASE
in	O
europe	B-UNK
.	O

 	O
we	O
describe	B-UNK
the	O
first	O
cases	B-UNK
,	O
to	O
our	O
knowledge	B-UNK
,	O
of	O
c9	B-DISEASE
deficiency	I-DISEASE
in	O
europe	B-UNK
that	O
were	O
detected	B-UNK
in	O
a	O
swiss	O
family	B-UNK
,	O
of	O
which	O
two	O
members	B-UNK
-	O
-	O
one	O
with	O
a	O
complete	B-UNK
deficiency	B-UNK
and	O
the	O
other	O
with	O
approximately	B-UNK
half	B-UNK
-	O
normal	B-UNK
c9	B-UNK
levels	B-UNK
-	O
-	O
experienced	B-UNK
bacterial	B-UNK
meningitis	B-DISEASE
.	O

 	O
the	O
index	B-UNK
patient	B-UNK
,	O
a	O
56	O
-	O
year	B-UNK
-	O
old	B-UNK
white	B-UNK
man	B-UNK
with	O
a	O
history	B-UNK
of	O
purulent	O
meningitis	B-DISEASE
at	B-DISEASE
the	O
age	B-UNK
of	O
23	O
years	B-UNK
,	O
presented	B-UNK
with	O
an	O
acute	B-UNK
meningococcal	B-UNK
meningitis	B-DISEASE
.	O

 	O
no	O
impairment	O
of	O
cellular	B-UNK
immunity	B-UNK
or	O
immunoglobulin	B-UNK
deficiency	B-UNK
could	O
be	O
found	B-UNK
.	O

 	B-UNK
complement	I-UNK
assays	B-UNK
showed	B-UNK
a	O
complete	B-UNK
deficiency	B-UNK
of	O
the	O
c9	B-UNK
component	B-UNK
,	O
while	O
the	O
other	O
individual	B-UNK
component	B-UNK
levels	B-UNK
were	O
normal	B-UNK
and	O
the	O
hemolytic	B-UNK
activity	B-UNK
(	O
measured	B-UNK
using	O
the	O
ch50	O
assay	B-UNK
)	O
was	O
only	O
slightly	B-UNK
reduced	B-UNK
.	O

 	O
a	O
family	B-UNK
study	I-UNK
revealed	B-UNK
complete	B-UNK
c9	B-DISEASE
deficiency	I-DISEASE
in	O
the	O
patients	B-UNK
healthy	B-UNK
brother	B-UNK
and	O
half	B-UNK
-	O
normal	B-UNK
c9	B-UNK
concentrations	B-UNK
in	O
his	O
sister	O
,	O
his	O
son	O
(	O
who	O
also	O
had	O
experienced	B-UNK
an	O
episode	O
of	O
bacterial	B-UNK
meningitis	B-DISEASE
)	O
,	O
and	O
his	O
niece	O
,	O
consistent	B-UNK
with	O
an	O
inherited	B-UNK
c9	B-DISEASE
deficiency	I-DISEASE
.	O

 	O
this	O
first	O
case	B-UNK
of	O
recurrent	B-UNK
meningitis	B-DISEASE
in	O
a	O
white	B-UNK
patient	B-UNK
with	O
complete	B-UNK
c9	B-DISEASE
deficiency	I-DISEASE
suggests	B-UNK
that	O
this	O
complement	B-UNK
defect	B-UNK
may	O
also	O
be	O
a	O
risk	B-UNK
factor	B-UNK
for	O
bacterial	B-UNK
,	O
especially	B-UNK
neisserial	B-UNK
,	O
infections	B-DISEASE
.	O
.	O

 	O
detection	B-UNK
of	O
98	O
%	O
of	O
dmd	B-UNK
/	O
bmd	B-UNK
gene	B-UNK
deletions	B-UNK
by	O
polymerase	B-UNK
chain	I-UNK
reaction	I-UNK
.	O

 	O
we	O
describe	B-UNK
oligonucleotide	O
primer	B-UNK
sequences	B-UNK
that	O
can	O
be	O
used	O
to	O
amplify	O
eight	O
exons	B-UNK
plus	O
the	O
muscle	B-UNK
promoter	B-UNK
of	O
the	O
dystrophin	B-UNK
gene	B-UNK
in	O
a	O
single	B-UNK
multiplex	B-UNK
polymerase	B-UNK
chain	I-UNK
reaction	I-UNK
(	O
pcr	B-UNK
)	O
.	O

 	O
when	O
used	O
in	O
conjunction	O
with	O
an	O
existing	O
primer	B-UNK
set	B-UNK
,	O
these	O
two	O
multiplex	B-UNK
reactions	B-UNK
detect	B-UNK
about	O
98	O
%	O
of	O
deletions	B-UNK
in	O
patients	B-UNK
with	O
duchenne	B-UNK
or	O
becker	O
muscular	B-DISEASE
dystrophy	I-DISEASE
(	O
dmd	B-UNK
,	O
bmd	B-UNK
)	O
.	O

 	O
furthermore	B-UNK
,	O
these	O
primers	B-UNK
amplify	O
most	O
of	O
the	O
exons	B-UNK
in	O
the	O
deletion	B-UNK
prone	O
"	O
hot	B-UNK
spot	I-UNK
"	O
region	B-UNK
around	O
exons	B-UNK
44	O
to	O
53	O
,	O
allowing	B-UNK
determination	B-UNK
of	O
deletion	B-UNK
endpoints	B-UNK
and	O
prediction	O
of	O
mutational	B-UNK
effects	B-UNK
on	O
the	O
translational	B-UNK
reading	I-UNK
frame	B-UNK
.	O

 	O
thus	O
,	O
use	B-UNK
of	O
these	O
pcr	B-UNK
-	O
based	B-UNK
assays	B-UNK
will	O
allow	B-UNK
deletion	B-UNK
detection	B-UNK
and	O
prenatal	B-UNK
diagnosis	I-UNK
for	O
most	O
dmd	B-UNK
/	O
bmd	B-UNK
patients	B-UNK
in	O
a	O
fraction	B-UNK
of	O
the	O
time	B-UNK
required	B-UNK
for	O
southern	B-UNK
blot	I-UNK
analysis	I-UNK
.	O
.	O

 	B-UNK
genetic	I-UNK
heterogeneity	B-UNK
at	B-DISEASE
the	O
glucose	B-UNK
-	O
6	O
-	O
phosphate	B-UNK
dehydrogenase	I-UNK
locus	B-UNK
in	O
southern	O
italy	B-UNK
:	O
a	O
study	B-UNK
on	O
a	O
population	B-UNK
from	O
the	O
matera	O
district	B-UNK
.	O

 	O
glucose	B-UNK
-	O
6	O
-	O
phosphate	B-UNK
dehydrogenase	I-UNK
(	O
g6pd	B-UNK
)	O
has	O
been	O
analyzed	B-UNK
by	O
gel	B-UNK
electrophoresis	I-UNK
and	O
by	O
quantitative	B-UNK
assay	B-UNK
in	O
an	O
unselected	B-UNK
sample	B-UNK
of	O
1524	O
schoolboys	O
from	O
the	O
province	O
of	O
matera	O
(	O
lucania	O
)	O
in	O
southern	O
italy	B-UNK
.	O

 	O
we	O
have	O
identified	B-UNK
43	O
subjects	B-UNK
with	O
a	O
g6pd	B-UNK
variant	B-UNK
.	O

 	O
of	O
these	O
,	O
31	O
had	O
severe	B-UNK
g6pd	B-UNK
deficiency	I-UNK
,	O
nine	O
had	O
mild	B-UNK
to	O
moderate	B-UNK
deficiency	B-UNK
,	O
and	O
three	O
had	O
a	O
non	B-UNK
-	O
deficient	B-UNK
electrophoretic	B-UNK
variant	B-UNK
.	O

 	O
the	O
overall	B-UNK
rate	B-UNK
of	O
g6pd	B-UNK
deficiency	I-UNK
was	O
2	O
.	O

 	O
6	O
%	O
.	O

 	O
the	O
frequency	B-UNK
of	O
g6pd	B-UNK
deficiency	I-UNK
,	O
ranging	O
from	O
7	O
.	O

 	O
2	O
%	O
on	O
the	O
ionian	O
coast	O
to	O
zero	O
on	O
the	O
eastern	B-UNK
side	O
of	O
the	O
lucanian	O
apennines	O
,	O
appears	B-UNK
to	O
be	O
inversely	B-UNK
related	B-UNK
to	O
the	O
distance	B-UNK
of	O
each	O
town	O
examined	B-UNK
from	O
the	O
ionian	O
coast	O
,	O
suggesting	B-UNK
that	O
this	O
geographic	B-UNK
distribution	B-UNK
may	O
reflect	B-UNK
,	O
at	B-DISEASE
least	O
in	O
part	O
,	O
gene	B-UNK
flow	B-UNK
from	O
greek	O
settlers	O
.	O

 	B-UNK
biochemical	I-UNK
characterization	B-UNK
has	O
shown	B-UNK
that	O
most	O
of	O
the	O
g6pd	B-UNK
deficiency	I-UNK
in	O
this	O
population	B-UNK
is	O
accounted	B-UNK
for	O
by	O
g6pd	B-UNK
mediterranean	I-UNK
.	O

 	O
in	O
addition	B-UNK
,	O
we	O
have	O
found	B-UNK
several	O
examples	O
of	O
two	O
other	O
known	B-UNK
polymorphic	B-UNK
variants	I-UNK
(	O
g6pd	B-UNK
cagliari	O
and	O
g6pd	B-UNK
a	O
-	O
)	O
;	O
three	O
new	B-UNK
polymorphic	B-UNK
variants	I-UNK
,	O
g6pd	B-UNK
metaponto	O
(	O
class	B-UNK
iii	B-UNK
)	O
,	O
g6pd	B-UNK
montalbano	O
(	O
class	B-UNK
iii	B-UNK
)	O
,	O
and	O
g6pd	B-UNK
pisticci	O
(	O
class	B-UNK
iv	B-UNK
)	O
;	O
and	O
two	O
sporadic	B-UNK
variants	B-UNK
,	O
g6pd	B-UNK
tursi	O
(	O
class	B-UNK
iii	B-UNK
)	O
and	O
g6pd	B-UNK
ferrandina	O
(	O
class	B-UNK
ii	B-UNK
)	O
.	O

 	O
these	O
data	B-UNK
provide	I-UNK
further	O
evidence	B-UNK
for	O
the	O
marked	B-UNK
genetic	B-UNK
heterogeneity	B-UNK
of	O
g6pd	B-UNK
deficiency	I-UNK
within	O
a	O
relatively	B-UNK
narrow	B-UNK
geographic	B-UNK
area	B-UNK
and	O
they	O
prove	O
the	O
presence	B-UNK
in	O
the	O
italian	B-UNK
peninsula	O
of	O
a	O
gene	B-UNK
(	O
gda	O
-	O
)	O
regarded	O
as	O
characteristically	O
african	B-UNK
.	O

 	O
deficiency	B-UNK
of	O
the	O
murine	B-UNK
fifth	B-UNK
complement	B-UNK
component	I-UNK
(	O
c5	B-UNK
)	O
.	O

 	O
a	O
2	O
-	O
base	B-UNK
pair	I-UNK
gene	B-UNK
deletion	B-UNK
in	O
a	O
5	O
'	O
-	O
exon	B-UNK
.	O

 	O
to	O
ascertain	O
the	O
molecular	B-UNK
mechanism	B-UNK
that	O
causes	B-UNK
murine	B-UNK
c5	B-UNK
deficiency	B-UNK
,	O
genomic	B-UNK
and	O
cdna	B-UNK
libraries	B-UNK
were	O
constructed	B-UNK
from	O
mouse	B-UNK
liver	B-DISEASE
dna	B-UNK
and	O
mrna	B-UNK
employing	B-UNK
the	O
congenic	O
strains	B-UNK
b10	O
.	O

 	O
d2	B-UNK
/	O
nsnj	O
and	O
b10	O
.	O

 	O
d2	B-UNK
/	O
osnj	O
that	O
are	O
sufficient	B-UNK
and	O
deficient	B-UNK
for	O
c5	B-UNK
,	O
respectively	B-UNK
.	O

 	B-UNK
genomic	I-UNK
fragments	B-UNK
were	O
isolated	B-UNK
which	O
correspond	O
to	O
pvuii	O
and	O
hindiii	B-UNK
restriction	B-UNK
fragment	I-UNK
length	I-UNK
polymorphisms	I-UNK
associated	B-UNK
with	O
c5	B-UNK
deficiency	B-UNK
.	O

 	O
sequence	B-UNK
analyses	B-UNK
demonstrated	B-UNK
that	O
each	O
of	O
these	O
polymorphisms	B-UNK
resulted	B-UNK
from	O
single	B-UNK
base	B-UNK
pair	I-UNK
substitutions	B-UNK
and	O
that	O
neither	O
substitution	B-UNK
would	O
probably	B-UNK
cause	B-UNK
or	O
contribute	B-UNK
to	O
the	O
c5	B-UNK
deficiency	B-UNK
.	O

 	O
sequence	B-UNK
analyses	B-UNK
of	O
c5	B-UNK
sufficient	B-UNK
and	O
deficient	B-UNK
cdnas	B-UNK
revealed	B-UNK
a	O
2	O
base	B-UNK
-	O
pair	B-UNK
deletion	I-UNK
in	O
the	O
deficient	B-UNK
cdnas	B-UNK
.	O

 	O
the	O
"	O
ta	O
"	O
deletion	B-UNK
was	O
located	B-UNK
near	B-UNK
the	O
5	O
end	B-UNK
of	O
the	O
cdna	B-UNK
.	O

 	O
this	O
deletion	B-UNK
shifts	O
the	O
reading	B-UNK
frame	I-UNK
of	O
the	O
c5	B-UNK
mrna	B-UNK
so	O
that	O
the	O
termination	B-UNK
codon	I-UNK
uga	O
is	O
present	B-UNK
4	O
base	B-UNK
pairs	I-UNK
downstream	B-UNK
from	O
the	O
deletion	B-UNK
.	O

 	B-UNK
genomic	I-UNK
dna	B-UNK
was	O
amplified	B-UNK
and	O
sequenced	B-UNK
corresponding	B-UNK
to	O
the	O
area	B-UNK
surrounding	B-UNK
the	O
2	O
-	O
base	B-UNK
pair	I-UNK
deletion	B-UNK
.	O

 	O
six	O
c5	B-UNK
-	O
deficient	B-UNK
strains	B-UNK
,	O
a	O
/	O
hej	O
,	O
akr	O
/	O
j	B-UNK
,	O
dba	O
/	O
2j	O
,	O
nzb	O
/	O
b1nj	O
,	O
swr	O
/	O
j	B-UNK
,	O
and	O
b10	O
.	O

 	O
d2	B-UNK
/	O
osnj	O
,	O
and	O
four	O
c5	B-UNK
-	O
sufficient	B-UNK
strains	B-UNK
,	O
balb	O
/	O
cj	O
,	O
c57bl	O
/	O
6j	O
,	O
dba	O
/	O
1j	O
,	O
and	O
b10	O
.	O

 	O
d2	B-UNK
/	O
nsnj	O
,	O
were	O
analyzed	B-UNK
.	O

 	O
the	O
sequencing	B-UNK
data	B-UNK
revealed	B-UNK
that	O
the	O
2	O
base	B-UNK
pairs	I-UNK
were	O
deleted	B-UNK
from	O
the	O
c5	B-UNK
gene	B-UNK
of	O
each	O
deficient	B-UNK
mouse	B-UNK
tested	B-UNK
but	O
not	O
from	O
the	O
c5	B-UNK
gene	B-UNK
of	O
any	O
sufficient	B-UNK
mouse	B-UNK
.	O

 	O
these	O
data	B-UNK
demonstrate	B-UNK
that	O
1	O
)	O
there	O
is	O
an	O
identical	B-UNK
2	O
-	O
base	B-UNK
pair	I-UNK
deletion	B-UNK
in	O
an	O
exon	B-UNK
of	O
the	O
c5	B-UNK
gene	B-UNK
in	O
several	O
different	B-UNK
c5	B-UNK
-	O
deficient	B-UNK
mouse	B-UNK
strains	B-UNK
;	O
2	O
)	O
the	O
mrna	B-UNK
transcribed	B-UNK
from	O
the	O
c5d	B-UNK
gene	B-UNK
retains	O
this	O
deletion	B-UNK
;	O
and	O
3	O
)	O
this	O
mutation	B-UNK
should	O
result	B-UNK
in	O
c5	B-UNK
protein	B-DISEASE
deficiency	I-DISEASE
.	O

 	B-UNK
molecular	I-UNK
genetics	B-UNK
of	O
pku	B-DISEASE
in	O
eastern	B-UNK
europe	B-UNK
:	O
a	O
nonsense	B-UNK
mutation	B-UNK
associated	B-UNK
with	O
haplotype	B-UNK
4	O
of	O
the	O
phenylalanine	B-UNK
hydroxylase	I-UNK
gene	B-UNK
.	O

 	O
phenylketonuria	B-DISEASE
(	O
pku	B-DISEASE
)	O
is	O
a	O
genetic	B-UNK
disorder	O
secondary	B-UNK
to	O
a	O
deficiency	B-UNK
of	O
hepatic	B-UNK
phenylalanine	B-UNK
hydroxylase	I-UNK
(	O
pah	B-UNK
)	O
.	O

 	O
several	O
mutations	B-UNK
in	O
the	O
pah	B-UNK
gene	B-UNK
have	O
recently	B-UNK
been	O
reported	B-UNK
,	O
and	O
linkage	B-UNK
disequilibrium	I-UNK
was	O
observed	B-UNK
between	O
rflp	B-UNK
haplotypes	B-UNK
and	O
specific	B-UNK
mutations	B-UNK
.	O

 	O
a	O
new	B-UNK
molecular	B-UNK
lesion	B-UNK
has	O
been	O
identified	B-UNK
in	O
exon	B-UNK
7	O
of	O
the	O
pah	B-UNK
gene	B-UNK
in	O
a	O
hungarian	O
pku	B-DISEASE
patient	B-UNK
by	O
direct	B-UNK
sequencing	I-UNK
of	O
pcr	B-UNK
-	O
amplified	B-UNK
dna	B-UNK
.	O

 	O
the	O
c	B-UNK
-	O
to	O
-	O
t	B-UNK
transition	I-UNK
causes	B-UNK
the	O
substitution	B-UNK
of	O
arg243	O
to	O
a	O
termination	B-UNK
codon	I-UNK
,	O
and	O
the	O
mutant	B-UNK
allele	I-UNK
is	O
associated	B-UNK
with	O
haplotype	B-UNK
4	O
of	O
the	O
pah	B-UNK
gene	B-UNK
.	O

 	O
the	O
mutation	B-UNK
is	O
present	B-UNK
in	O
two	O
of	O
nine	O
mutant	B-UNK
haplotype	B-UNK
4	O
alleles	B-UNK
among	O
eastern	B-UNK
europeans	O
and	O
is	O
not	O
present	B-UNK
among	O
western	B-UNK
europeans	O
and	O
asians	O
.	O

 	O
the	O
rarity	O
of	O
this	O
mutant	B-UNK
allele	I-UNK
and	O
its	O
restricted	O
geographic	B-UNK
distribution	B-UNK
suggest	B-UNK
that	O
the	O
mutational	B-UNK
event	B-UNK
occurred	B-UNK
recently	B-UNK
on	O
a	O
normal	B-UNK
haplotype	B-UNK
4	O
background	B-UNK
in	O
eastern	B-UNK
europe	B-UNK
.	O
.	O

 	O
the	O
red	B-UNK
-	O
green	B-UNK
visual	B-UNK
pigment	I-UNK
gene	B-UNK
region	B-UNK
in	O
adrenoleukodystrophy	B-DISEASE
.	O

 	O
although	O
recent	B-UNK
data	B-UNK
established	B-UNK
that	O
a	O
specific	B-UNK
very	O
-	O
long	B-UNK
-	O
chain	O
fatty	O
acyl	B-UNK
-	O
coa	B-UNK
synthetase	O
is	O
defective	B-UNK
in	O
x	B-UNK
-	O
linked	B-UNK
adrenoleukodystrophy	B-DISEASE
(	O
ald	B-UNK
)	O
,	O
the	O
ald	B-UNK
gene	B-UNK
is	O
still	O
unidentified	B-UNK
.	O

 	O
the	O
ald	B-UNK
locus	B-UNK
has	O
been	O
mapped	B-UNK
to	O
xq28	B-UNK
,	O
like	B-UNK
the	O
red	B-UNK
and	O
green	B-UNK
color	B-UNK
pigment	I-UNK
genes	B-UNK
.	O

 	B-UNK
abnormal	I-UNK
color	B-UNK
vision	B-DISEASE
has	O
been	O
observed	B-UNK
in	O
12	O
of	O
27	O
patients	B-UNK
with	O
adrenomyeloneuropathy	B-UNK
(	O
amn	B-UNK
)	O
,	O
a	O
milder	B-UNK
form	B-UNK
of	O
ald	B-UNK
.	O

 	O
furthermore	B-UNK
,	O
rearrangements	B-UNK
of	O
the	O
color	B-UNK
vision	B-DISEASE
gene	B-UNK
cluster	O
were	O
found	B-UNK
in	O
four	O
of	O
eight	O
ald	B-UNK
kindreds	B-UNK
.	O

 	O
this	O
led	B-UNK
us	O
to	O
propose	O
that	O
a	O
single	B-UNK
dna	B-UNK
rearrangement	B-UNK
could	O
underlie	O
both	O
ald	B-UNK
and	O
abnormal	B-UNK
color	B-UNK
vision	B-DISEASE
in	O
these	O
patients	B-UNK
.	O

 	O
study	B-UNK
of	O
34	O
french	B-UNK
ald	B-UNK
patients	I-UNK
failed	B-UNK
to	O
reveal	B-UNK
a	O
higher	B-UNK
than	O
expected	B-UNK
frequency	B-UNK
of	O
green	B-UNK
/	O
red	B-UNK
visual	B-UNK
pigment	I-UNK
rearrangements	B-UNK
3	O
to	O
the	O
red	B-UNK
/	O
green	B-UNK
color	B-UNK
vision	B-DISEASE
gene	B-UNK
complex	B-UNK
.	O

 	O
the	O
previous	B-UNK
report	B-UNK
of	O
such	O
rearrangements	B-UNK
was	O
based	B-UNK
on	O
small	B-UNK
numbers	O
and	O
lack	B-UNK
of	O
knowledge	B-UNK
that	O
the	O
frequency	B-UNK
of	O
"	O
abnormal	B-UNK
"	O
color	B-UNK
vision	B-DISEASE
arrays	O
on	O
molecular	B-UNK
analysis	B-UNK
was	O
twice	O
as	O
high	B-UNK
as	O
expected	B-UNK
on	O
the	O
basis	B-UNK
of	O
the	O
frequency	B-UNK
of	O
phenotypic	B-UNK
color	B-DISEASE
vision	I-DISEASE
defects	I-DISEASE
.	O

 	O
the	O
red	B-UNK
/	O
green	B-UNK
color	B-UNK
pigment	I-UNK
(	O
r	B-UNK
/	O
gcp	O
)	O
region	B-UNK
was	O
studied	B-UNK
by	O
pulsed	O
-	O
field	B-UNK
gel	I-UNK
electrophoresis	B-UNK
in	O
14	O
of	O
these	O
patients	B-UNK
,	O
and	O
we	O
did	O
not	O
find	O
any	O
fragment	O
size	B-UNK
difference	B-UNK
between	O
the	O
patients	B-UNK
and	O
normal	B-UNK
individuals	B-UNK
who	O
have	O
the	O
same	O
number	B-UNK
of	O
pigment	B-UNK
genes	I-UNK
.	O

 	O
the	O
r	B-UNK
/	O
gcp	O
region	B-UNK
was	O
also	O
analyzed	B-UNK
in	O
29	O
french	B-UNK
and	O
seven	B-UNK
north	B-UNK
american	I-UNK
ald	B-UNK
patients	I-UNK
by	O
using	O
six	O
genomic	B-UNK
dna	I-UNK
probes	B-UNK
,	O
isolated	B-UNK
from	O
a	O
cosmid	B-UNK
walk	O
,	O
that	O
flank	O
the	O
color	B-UNK
vision	B-DISEASE
genes	B-UNK
.	O

 	O
no	O
deletions	B-UNK
were	O
found	B-UNK
with	O
probes	B-UNK
that	O
lie	O
3	O
of	O
the	O
green	B-UNK
pigment	B-UNK
genes	I-UNK
.	O

 	O
one	O
of	O
the	O
eight	O
previously	B-UNK
reported	I-UNK
ald	B-UNK
individuals	B-UNK
has	O
a	O
long	B-UNK
deletion	B-UNK
5	O
of	O
the	O
red	B-UNK
pigment	O
gene	B-UNK
,	O
a	O
deletion	B-UNK
causing	B-UNK
blue	O
cone	B-UNK
monochromacy	O
.	O

 	O
this	O
finding	B-UNK
and	O
the	O
previous	B-UNK
findings	B-UNK
of	O
a	O
45	O
%	O
frequency	B-UNK
of	O
phenotypic	B-UNK
color	B-DISEASE
vision	I-DISEASE
defects	I-DISEASE
in	O
patients	B-UNK
with	O
amn	B-UNK
may	O
suggest	B-UNK
that	O
the	O
ald	B-UNK
/	O
amn	B-UNK
gene	B-UNK
lies	B-UNK
5	O
to	O
the	O
red	B-UNK
pigment	O
gene	B-UNK
and	O
that	O
the	O
frequent	B-UNK
phenotypic	B-UNK
color	B-UNK
vision	B-DISEASE
anomalies	B-UNK
owe	O
their	O
origin	B-UNK
to	O
deleted	B-UNK
dna	B-UNK
that	O
includes	B-UNK
regulatory	B-UNK
genes	B-UNK
for	O
color	B-UNK
vision	B-DISEASE
.	O

 	O
it	O
is	O
possible	B-UNK
,	O
however	O
,	O
that	O
phenotypic	B-UNK
color	B-UNK
vision	B-DISEASE
anomalies	B-UNK
in	O
amn	B-UNK
may	O
be	O
phenocopies	O
secondary	B-UNK
to	O
retinal	B-UNK
or	O
neural	B-UNK
involvement	B-UNK
by	O
the	O
disease	B-DISEASE
.	O

 	O
the	O
single	B-UNK
case	B-UNK
of	O
blue	O
cone	B-UNK
monochromacy	O
may	O
therefore	O
be	O
a	O
fortuitous	O
coincidence	O
of	O
two	O
diseases	B-DISEASE
.	O
.	O

 	O
paroxysmal	B-UNK
nocturnal	B-UNK
haemoglobinuria	B-UNK
with	O
coexisting	O
deficiency	B-UNK
of	O
the	O
ninth	B-UNK
component	B-UNK
of	O
complement	B-UNK
:	O
lack	B-UNK
of	O
massive	B-UNK
haemolytic	B-UNK
attack	O
.	O

 	O
a	O
47	O
-	O
year	B-UNK
-	O
old	B-UNK
woman	B-UNK
with	O
paroxysmal	B-UNK
nocturnal	B-UNK
haemoglobinuria	B-UNK
(	O
pnh	O
)	O
was	O
found	B-UNK
to	O
have	O
an	O
inherited	B-UNK
deficiency	B-UNK
in	O
the	O
ninth	B-UNK
complement	B-UNK
component	I-UNK
(	O
c9	B-UNK
)	O
.	O

 	O
in	O
complement	B-UNK
-	O
sensitivity	B-UNK
lysis	O
tests	B-UNK
,	O
80	O
%	O
of	O
her	O
erythrocytes	O
were	O
markedly	B-UNK
complement	B-UNK
-	O
sensitive	B-UNK
(	O
pnh	O
-	O
iii	B-UNK
)	O
.	O

 	O
laser	O
cytofluorimetry	O
with	O
a	O
monoclonal	B-UNK
antibody	I-UNK
against	O
decay	O
-	O
accelerating	O
factor	B-UNK
(	O
daf	O
)	O
revealed	B-UNK
that	O
95	O
%	O
of	O
her	O
erythrocytes	O
were	O
daf	O
-	O
negative	B-UNK
.	O

 	O
surprisingly	B-UNK
,	O
she	O
has	O
suffered	O
only	O
mild	B-UNK
haemolysis	B-UNK
and	O
has	O
never	O
experienced	B-UNK
massive	B-UNK
spontaneous	B-UNK
haemolysis	B-UNK
.	O

 	O
gross	O
haemoglobinuria	B-UNK
and	O
jaundice	B-DISEASE
occurred	B-UNK
only	O
after	O
receiving	O
postoperative	O
transfusion	O
of	O
whole	O
blood	B-UNK
.	O

 	O
in	O
her	O
serum	B-UNK
,	O
c9	B-UNK
was	O
not	O
detectable	B-UNK
either	O
by	O
immunological	B-UNK
or	O
by	O
functional	B-UNK
assays	B-UNK
.	O

 	O
both	O
the	O
ham	O
test	B-UNK
and	O
the	O
sugar	O
water	O
test	B-UNK
using	O
normal	B-UNK
human	I-UNK
serum	B-UNK
or	O
plasma	B-UNK
yielded	B-UNK
marked	B-UNK
haemolysis	B-UNK
of	O
the	O
patients	B-UNK
erythrocytes	O
.	O

 	O
when	O
the	O
patients	B-UNK
serum	B-UNK
or	O
plasma	B-UNK
was	O
used	O
,	O
only	O
a	O
trace	B-UNK
of	O
lysis	O
was	O
detected	B-UNK
.	O

 	O
addition	B-UNK
of	O
purified	B-UNK
human	B-UNK
c9	B-UNK
to	O
her	O
plasma	B-UNK
fully	B-UNK
restored	B-UNK
haemolysis	B-UNK
.	O

 	O
these	O
observations	B-UNK
indicated	B-UNK
that	O
c9	B-UNK
may	O
play	O
a	O
critical	B-UNK
role	B-UNK
in	O
haemolytic	B-UNK
attacks	B-UNK
in	O
patients	B-UNK
with	O
pnh	O
and	O
that	O
characteristic	B-UNK
haemolysis	B-UNK
in	O
pnh	O
may	O
be	O
tempered	O
by	O
coexisting	O
c9	B-DISEASE
deficiency	I-DISEASE
.	O
.	O

 	O
duplicational	O
mutation	B-UNK
at	B-DISEASE
the	O
duchenne	B-UNK
muscular	B-DISEASE
dystrophy	I-DISEASE
locus	B-UNK
:	O
its	O
frequency	B-UNK
,	O
distribution	B-UNK
,	O
origin	B-UNK
,	O
and	O
phenotypegenotype	O
correlation	B-UNK
.	O

 	B-UNK
partial	I-UNK
gene	B-UNK
deletion	B-UNK
is	O
the	O
major	B-UNK
cause	B-UNK
of	O
mutation	B-UNK
leading	B-UNK
to	O
duchenne	B-UNK
muscular	B-DISEASE
dystrophy	I-DISEASE
(	O
dmd	B-UNK
)	O
and	O
becker	O
muscular	B-DISEASE
dystrophy	I-DISEASE
(	O
bmd	B-UNK
)	O
.	O

 	B-UNK
partial	I-UNK
gene	B-UNK
duplication	B-UNK
has	O
also	O
been	O
recognized	B-UNK
in	O
a	O
few	O
cases	B-UNK
.	O

 	O
we	O
have	O
conducted	O
a	O
survey	B-UNK
for	O
duplication	B-UNK
in	O
72	O
unrelated	B-UNK
nondeletion	O
patients	B-UNK
,	O
analyzed	B-UNK
by	O
southern	B-UNK
blot	I-UNK
hybridization	B-UNK
with	O
clones	B-UNK
representing	B-UNK
the	O
entire	B-UNK
dmd	B-UNK
cdna	B-UNK
.	O

 	O
with	O
careful	O
quantitative	B-UNK
analysis	B-UNK
of	O
hybridization	B-UNK
band	B-UNK
intensity	O
,	O
10	O
cases	B-UNK
were	O
found	B-UNK
to	O
carry	B-UNK
a	O
duplication	B-UNK
of	O
part	O
of	O
the	O
gene	B-UNK
,	O
a	O
frequency	B-UNK
of	O
14	O
%	O
for	O
nondeletion	O
cases	B-UNK
(	O
10	O
/	O
72	O
)	O
,	O
or	O
6	O
%	O
for	O
all	O
cases	B-UNK
(	O
10	O
/	O
181	O
)	O
.	O

 	O
the	O
extent	B-UNK
of	O
these	O
duplications	O
has	O
been	O
characterized	B-UNK
according	B-UNK
to	O
the	O
published	B-UNK
exon	B-UNK
-	O
containing	B-UNK
hindiii	B-UNK
fragment	O
map	B-UNK
,	O
and	O
in	O
six	O
of	O
the	O
10	O
duplications	O
a	O
novel	B-UNK
restriction	O
fragment	O
that	O
spanned	O
the	O
duplication	B-UNK
junction	B-UNK
was	O
detected	B-UNK
.	O

 	O
the	O
resulting	B-UNK
translational	B-UNK
reading	I-UNK
frame	B-UNK
of	O
mrna	B-UNK
has	O
been	O
predicted	B-UNK
for	O
nine	O
duplications	O
.	O

 	O
a	O
shift	B-UNK
of	O
the	O
reading	B-UNK
frame	I-UNK
was	O
predicted	B-UNK
in	O
four	O
of	O
the	O
six	O
dmd	B-UNK
cases	B-UNK
and	O
in	O
one	O
of	O
the	O
two	O
intermediate	B-UNK
cases	B-UNK
,	O
while	O
the	O
reading	B-UNK
frame	I-UNK
remained	B-UNK
uninterrupted	O
in	O
both	O
bmd	B-UNK
cases	B-UNK
.	O

 	O
rflp	B-UNK
and	O
quantitative	B-UNK
southern	B-UNK
blot	I-UNK
analyses	B-UNK
revealed	B-UNK
a	O
grandpaternal	O
origin	B-UNK
of	O
duplication	B-UNK
in	O
four	O
families	B-UNK
and	O
grandmaternal	O
origin	B-UNK
in	O
one	O
family	B-UNK
.	O

 	O
in	O
all	O
five	O
families	B-UNK
,	O
the	O
duplication	B-UNK
was	O
found	B-UNK
to	O
originate	O
from	O
a	O
single	B-UNK
x	B-DISEASE
chromosome	I-DISEASE
.	O

 	O
unequal	B-UNK
sister	O
-	O
chromatid	O
exchange	B-UNK
is	O
proposed	B-UNK
to	O
be	O
the	O
mechanism	B-UNK
for	O
the	O
formation	B-UNK
of	O
these	O
duplications	O
.	O
.	O

 	O
glucose	B-UNK
6	O
-	O
phosphate	B-UNK
dehydrogenase	I-UNK
variants	B-UNK
:	O
gd	B-UNK
(	O
+	O
)	O
alexandra	O
associated	B-UNK
with	O
neonatal	B-UNK
jaundice	B-DISEASE
and	O
gd	B-UNK
(	O
-	O
)	O
camperdown	O
in	O
a	O
young	B-UNK
man	B-UNK
with	O
lamellar	O
cataracts	B-DISEASE
.	O

 	O
two	O
male	B-UNK
subjects	B-UNK
are	O
described	B-UNK
,	O
with	O
unusual	B-UNK
clinical	B-UNK
presentations	B-UNK
and	O
with	O
hitherto	B-UNK
undescribed	O
g6pd	B-UNK
variants	I-UNK
.	O

 	O
the	O
first	O
,	O
of	O
italian	B-UNK
extraction	B-UNK
,	O
suffered	O
from	O
severe	B-UNK
neonatal	B-UNK
jaundice	B-DISEASE
following	B-UNK
maternal	B-UNK
ingestion	O
of	O
fresh	B-UNK
broad	B-UNK
beans	B-UNK
(	O
vicia	O
fava	O
)	O
both	O
prenatally	O
and	O
postnatally	O
the	O
expression	B-UNK
of	O
the	O
enzymatic	B-UNK
defect	B-UNK
was	O
much	O
more	O
severe	B-UNK
in	O
the	O
neonatal	B-UNK
period	B-UNK
than	O
on	O
retesting	O
in	O
adolescence	O
,	O
when	O
biochemical	B-UNK
characterization	I-UNK
showed	B-UNK
unique	B-UNK
features	B-UNK
which	O
justify	O
designation	O
as	O
a	O
new	B-UNK
variant	B-UNK
gd	B-UNK
(	O
+	O
)	O
alexandra	O
.	O

 	O
the	O
second	B-UNK
patient	B-UNK
,	O
a	O
boy	B-UNK
of	O
maltese	O
extraction	B-UNK
who	O
was	O
found	B-UNK
to	O
have	O
bilateral	B-UNK
lamellar	O
cataracts	B-DISEASE
at	B-DISEASE
the	O
age	B-UNK
of	O
4	O
years	B-UNK
,	O
was	O
identified	B-UNK
as	O
g6pd	B-UNK
deficient	B-UNK
only	O
as	O
a	O
result	B-UNK
of	O
a	O
survey	B-UNK
of	O
children	B-UNK
of	O
mediterranean	B-UNK
origin	B-UNK
with	O
unexplained	O
cataract	B-DISEASE
formation	B-UNK
;	O
he	O
has	O
approximately	B-UNK
15	O
%	O
of	O
normal	B-UNK
enzyme	B-UNK
activity	I-UNK
,	O
with	O
another	O
unique	B-UNK
combination	O
of	O
biochemical	B-UNK
characteristics	B-UNK
which	O
has	O
led	B-UNK
to	O
its	O
designation	O
as	O
gd	B-UNK
(	O
-	O
)	O
camperdown	O
.	O

 	O
although	O
this	O
association	B-UNK
may	O
be	O
coincidental	O
,	O
it	O
prompts	O
further	O
attention	O
to	O
the	O
possibility	O
that	O
under	O
certain	B-UNK
circumstances	O
g6pd	B-UNK
deficiency	I-UNK
may	O
favor	O
cataract	B-DISEASE
formation	B-UNK
.	O

 	O
the	O
two	O
cases	B-UNK
illustrate	O
the	O
value	B-UNK
of	O
characterization	B-UNK
of	O
the	O
mutant	B-UNK
enzyme	B-UNK
whenever	O
unexpected	B-UNK
clinical	B-UNK
or	O
laboratory	B-UNK
results	B-UNK
are	O
obtained	B-UNK
.	O
.	O

 	O
statistical	O
analysis	B-UNK
of	O
the	O
two	O
stage	B-UNK
mutation	B-UNK
model	B-UNK
in	O
von	B-DISEASE
hippel	I-DISEASE
-	I-DISEASE
lindau	I-DISEASE
disease	I-DISEASE
,	O
and	O
in	O
sporadic	B-UNK
cerebellar	I-UNK
haemangioblastoma	O
and	O
renal	B-DISEASE
cell	B-UNK
carcinoma	B-DISEASE
.	O

 	O
analysis	B-UNK
of	O
the	O
age	B-UNK
incidence	I-UNK
curves	O
for	O
unilateral	B-UNK
and	O
bilateral	B-UNK
retinoblastoma	B-DISEASE
led	B-UNK
knudson	O
to	O
propose	O
that	O
hereditary	B-UNK
tumours	B-UNK
may	O
arise	O
by	O
a	O
single	B-UNK
event	B-UNK
and	O
sporadic	B-UNK
tumours	B-UNK
by	O
a	O
two	O
stage	B-UNK
mutation	B-UNK
process	B-UNK
.	O

 	O
it	O
has	O
been	O
suggested	B-UNK
recently	B-UNK
that	O
sporadic	B-UNK
renal	B-DISEASE
cell	B-UNK
carcinoma	B-DISEASE
may	O
arise	O
from	O
a	O
two	O
stage	B-UNK
mutation	B-UNK
process	B-UNK
.	O

 	O
we	O
analysed	B-UNK
the	O
age	B-UNK
incidence	I-UNK
curves	O
for	O
symptomatic	B-UNK
renal	B-DISEASE
cell	B-UNK
carcinoma	B-DISEASE
(	O
n	B-UNK
=	O
26	O
)	O
and	O
cerebellar	B-UNK
haemangioblastoma	I-UNK
(	O
n	B-UNK
=	O
68	O
)	O
in	O
109	O
patients	B-UNK
with	O
von	B-UNK
hippel	I-UNK
-	O
lindau	O
(	O
vhl	B-UNK
)	O
disease	B-DISEASE
,	O
and	O
compared	B-UNK
them	O
to	O
104	O
patients	B-UNK
with	O
sporadic	B-UNK
renal	B-DISEASE
cell	B-UNK
carcinoma	B-DISEASE
and	O
43	O
patients	B-UNK
with	O
sporadic	B-UNK
cerebellar	I-UNK
haemangioblastoma	O
.	O

 	O
the	O
age	B-UNK
incidence	I-UNK
curves	O
for	O
renal	B-DISEASE
cell	B-UNK
carcinoma	B-DISEASE
and	O
cerebellar	B-UNK
haemangioblastoma	I-UNK
in	O
vhl	B-UNK
disease	B-DISEASE
were	O
compatible	O
with	O
a	O
single	B-UNK
mutation	B-UNK
model	B-UNK
,	O
whereas	O
the	O
age	B-UNK
incidence	I-UNK
curves	O
for	O
sporadic	B-UNK
renal	B-DISEASE
cell	B-UNK
carcinoma	B-DISEASE
and	O
cerebellar	B-UNK
haemangioblastoma	I-UNK
suggested	B-UNK
a	O
two	O
stage	B-UNK
mutation	B-UNK
process	B-UNK
.	O

 	O
these	O
data	B-UNK
are	O
compatible	O
with	O
the	O
vhl	B-UNK
gene	B-UNK
functioning	O
as	O
a	O
recessive	O
tumour	B-UNK
suppressor	I-UNK
gene	B-UNK
.	O

 	O
sporadic	B-UNK
cerebellar	I-UNK
haemangioblastoma	O
and	O
some	O
renal	B-DISEASE
cell	B-UNK
carcinoma	B-DISEASE
may	O
arise	O
from	O
somatic	B-UNK
mutations	B-UNK
inactivating	B-UNK
both	O
alleles	B-UNK
at	B-DISEASE
the	O
vhl	B-UNK
locus	B-UNK
.	O
.	O

 	O
screening	B-UNK
for	O
carriers	B-UNK
of	O
tay	B-DISEASE
-	I-DISEASE
sachs	I-DISEASE
disease	I-DISEASE
among	O
ashkenazi	B-UNK
jews	B-UNK
.	O

 	O
a	O
comparison	B-UNK
of	O
dna	B-UNK
-	O
based	B-UNK
and	O
enzyme	B-UNK
-	O
based	B-UNK
tests	B-UNK
.	O

 	B-UNK
background	I-UNK
and	O
methods	B-UNK
.	O

 	O
the	O
prevention	O
of	O
tay	B-DISEASE
-	I-DISEASE
sachs	I-DISEASE
disease	I-DISEASE
(	O
gm2	O
gangliosidosis	B-DISEASE
,	O
type	B-UNK
1	O
)	O
depends	O
on	O
the	O
identification	B-UNK
of	O
carriers	B-UNK
of	O
the	O
gene	B-UNK
for	O
this	O
autosomal	O
recessive	O
disorder	O
.	O

 	O
we	O
compared	B-UNK
the	O
enzyme	B-UNK
-	O
based	B-UNK
test	B-UNK
widely	B-UNK
used	O
in	O
screening	B-UNK
for	O
tay	B-DISEASE
-	I-DISEASE
sachs	I-DISEASE
disease	I-DISEASE
with	O
a	O
test	B-UNK
based	B-UNK
on	O
analysis	B-UNK
of	O
dna	B-UNK
.	O

 	O
we	O
developed	B-UNK
methods	B-UNK
to	O
detect	B-UNK
the	O
three	O
mutations	B-UNK
in	O
the	O
hexa	B-UNK
gene	B-UNK
that	O
occur	B-UNK
with	O
high	B-UNK
frequency	B-UNK
among	O
ashkenazi	B-UNK
jews	B-UNK
two	O
mutations	B-UNK
cause	B-UNK
infantile	B-UNK
tay	B-DISEASE
-	I-DISEASE
sachs	I-DISEASE
disease	I-DISEASE
,	O
and	O
the	O
third	O
causes	B-UNK
the	O
adult	B-UNK
-	O
onset	B-UNK
form	B-UNK
of	O
the	O
disease	B-DISEASE
.	O

 	B-UNK
dna	I-UNK
segments	B-UNK
containing	B-UNK
these	O
mutation	B-UNK
sites	B-UNK
were	O
amplified	B-UNK
with	O
the	O
polymerase	B-UNK
chain	I-UNK
reaction	I-UNK
and	O
analyzed	B-UNK
for	O
the	O
presence	B-UNK
of	O
the	O
mutations	B-UNK
.	O

 	B-UNK
results	I-UNK
.	O

 	O
among	O
62	O
ashkenazi	B-UNK
obligate	B-UNK
carriers	B-UNK
of	O
tay	B-DISEASE
-	I-DISEASE
sachs	I-DISEASE
disease	I-DISEASE
,	O
the	O
three	O
specific	B-UNK
mutations	B-UNK
accounted	B-UNK
for	O
all	O
but	O
one	O
of	O
the	O
mutant	B-UNK
alleles	I-UNK
(	O
98	O
percent	O
)	O
.	O

 	O
in	O
216	O
ashkenazi	B-UNK
carriers	B-UNK
identified	B-UNK
by	O
the	O
enzyme	B-UNK
test	B-UNK
,	O
dna	B-UNK
analysis	B-UNK
showed	B-UNK
that	O
177	O
(	O
82	O
percent	O
)	O
had	O
one	O
of	O
the	O
identified	B-UNK
mutations	B-UNK
.	O

 	O
of	O
the	O
177	O
,	O
79	O
percent	O
had	O
the	O
exon	B-UNK
11	O
insertion	B-UNK
mutation	B-UNK
,	O
18	O
percent	O
had	O
the	O
intron	B-UNK
12	O
splice	O
-	O
junction	B-UNK
mutation	B-UNK
,	O
and	O
3	O
percent	O
had	O
the	O
less	O
severe	B-UNK
exon	B-UNK
7	O
mutation	B-UNK
associated	B-UNK
with	O
adult	B-UNK
-	O
onset	B-UNK
disease	B-DISEASE
.	O

 	O
the	O
results	B-UNK
of	O
the	O
enzyme	B-UNK
tests	B-UNK
in	O
the	O
39	O
subjects	B-UNK
(	O
18	O
percent	O
)	O
who	O
were	O
defined	B-UNK
as	O
carriers	B-UNK
but	O
in	O
whom	O
dna	B-UNK
analysis	B-UNK
did	O
not	O
identify	B-UNK
a	O
mutant	B-UNK
allele	I-UNK
were	O
probably	B-UNK
false	O
positive	B-UNK
(	O
although	O
there	O
remains	B-UNK
some	O
possibility	O
of	O
unidentified	B-UNK
mutations	B-UNK
)	O
.	O

 	O
in	O
addition	B-UNK
,	O
of	O
152	O
persons	B-UNK
defined	B-UNK
as	O
noncarriers	O
by	O
the	O
enzyme	B-UNK
-	O
based	B-UNK
test	B-UNK
,	O
1	O
was	O
identified	B-UNK
as	O
a	O
carrier	B-UNK
by	O
dna	B-UNK
analysis	B-UNK
(	O
i	O
.	O
e	B-UNK
e	B-UNK
.	O
,	O
a	O
false	O
negative	B-UNK
enzyme	B-UNK
-	O
test	B-UNK
result	B-UNK
)	O
.	O

 	O
conclusions	B-UNK
.	O

 	O
the	O
increased	B-UNK
specificity	B-UNK
and	O
predictive	B-UNK
value	B-UNK
of	O
the	O
dna	B-UNK
-	O
based	B-UNK
test	B-UNK
make	O
it	O
a	O
useful	B-UNK
adjunct	O
to	O
the	O
diagnostic	B-UNK
tests	B-UNK
currently	B-UNK
used	O
to	O
screen	B-UNK
for	O
carriers	B-UNK
of	O
tay	B-DISEASE
-	I-DISEASE
sachs	I-DISEASE
disease	I-DISEASE
.	O

 	O
total	B-UNK
deficiency	B-UNK
of	O
plasma	B-UNK
cholesteryl	B-UNK
ester	I-UNK
transfer	I-UNK
protein	I-UNK
in	O
subjects	B-UNK
homozygous	B-UNK
and	O
heterozygous	B-UNK
for	O
the	O
intron	B-UNK
14	O
splicing	B-UNK
defect	B-UNK
.	O

 	O
the	O
molecular	B-UNK
basis	I-UNK
of	O
cholesteryl	B-UNK
ester	I-UNK
transfer	I-UNK
protein	I-UNK
(	O
cetp	B-UNK
)	O
deficiency	B-UNK
was	O
investigated	B-UNK
in	O
4	O
unrelated	B-UNK
cetp	B-UNK
-	O
deficient	B-UNK
families	B-UNK
.	O

 	O
the	O
high	B-UNK
density	I-UNK
lipoprotein	B-UNK
-	O
cholesterol	B-UNK
levels	B-UNK
of	O
the	O
probands	B-UNK
exceeded	O
150	O
mg	O
/	O
dl	O
.	O

 	O
the	O
plasma	B-UNK
of	O
the	O
probands	B-UNK
was	O
totally	B-UNK
deficient	B-UNK
in	O
cetp	B-UNK
activity	I-UNK
and	O
mass	B-UNK
.	O

 	O
the	O
genomic	B-UNK
dna	I-UNK
of	O
the	O
patients	B-UNK
was	O
amplified	B-UNK
by	O
polymerase	B-UNK
chain	I-UNK
reaction	I-UNK
,	O
using	O
two	O
oligonucleotide	B-UNK
primers	I-UNK
located	B-UNK
in	O
the	O
intron	B-UNK
12	O
and	O
14	O
of	O
the	O
cetp	B-UNK
gene	B-UNK
,	O
and	O
the	O
amplified	B-UNK
products	B-UNK
were	O
directly	B-UNK
sequenced	B-UNK
.	O

 	O
two	O
patients	B-UNK
were	O
homozygous	B-UNK
for	O
a	O
g	B-UNK
-	O
to	O
-	O
a	O
change	B-UNK
at	B-DISEASE
the	O
5	O
-	O
splice	B-UNK
donor	I-UNK
site	I-UNK
of	O
the	O
intron	B-UNK
14	O
.	O

 	O
the	O
g	B-UNK
-	O
to	O
-	O
a	O
change	B-UNK
would	O
cause	B-UNK
impaired	B-UNK
splicing	B-UNK
of	O
pre	O
-	O
messenger	B-UNK
rna	I-UNK
.	O

 	O
the	O
other	O
two	O
probands	B-UNK
were	O
heterozygous	B-UNK
for	O
the	O
mutation	B-UNK
,	O
but	O
totally	B-UNK
lacked	B-UNK
cetp	B-UNK
.	O

 	O
their	O
lipoprotein	B-UNK
patterns	B-UNK
were	O
also	O
similar	B-UNK
to	O
those	O
of	O
the	O
two	O
homozygotes	B-UNK
.	O

 	O
thus	O
,	O
other	O
genetic	B-UNK
defects	B-UNK
or	O
metabolic	B-UNK
factors	B-UNK
influencing	O
cetp	B-UNK
expression	B-UNK
are	O
implicated	O
.	O

 	O
the	O
data	B-UNK
suggest	B-UNK
that	O
the	O
g	B-UNK
-	O
to	O
-	O
a	O
mutation	B-UNK
may	O
be	O
common	B-UNK
in	O
human	B-UNK
plasma	B-UNK
cetp	B-UNK
deficiency	I-UNK
.	O

 	O
furthermore	B-UNK
,	O
there	O
could	O
be	O
compound	B-UNK
heterozygotes	B-UNK
who	O
totally	B-UNK
lack	B-UNK
plasma	B-UNK
cetp	B-UNK
and	O
have	O
lipoprotein	B-UNK
profiles	O
similar	B-UNK
to	O
those	O
of	O
homozygotes	B-UNK
.	O
.	O

 	B-UNK
molecular	I-UNK
genetics	B-UNK
of	O
the	O
glucose	B-UNK
-	O
6	O
-	O
phosphate	B-UNK
dehydrogenase	I-UNK
(	O
g6pd	B-UNK
)	O
mediterranean	B-UNK
variant	B-UNK
and	O
description	O
of	O
a	O
new	B-UNK
g6pd	B-UNK
mutant	B-UNK
,	O
g6pd	B-UNK
andalus1361a	O
.	O

 	O
glucose	B-UNK
-	O
6	O
-	O
phosphate	B-UNK
dehydrogenase	I-UNK
(	O
g6pd	B-UNK
;	O
e	B-UNK
.	O
c	B-UNK
.	O
1	O
.	O
1	O
.	O
1	O
.	O
49	O
)	O
deficiency	B-UNK
is	O
the	O
most	O
common	B-UNK
human	B-UNK
enzymopathy	B-UNK
;	O
more	O
than	O
300	O
different	B-UNK
biochemical	B-UNK
variants	B-UNK
of	O
the	O
enzyme	B-UNK
have	O
been	O
described	B-UNK
.	O

 	O
in	O
many	O
parts	B-UNK
of	O
the	O
world	O
the	O
mediterranean	B-UNK
type	B-UNK
of	O
g6pd	B-UNK
deficiency	I-UNK
is	O
prevalent	B-UNK
.	O

 	O
however	O
,	O
g6pd	B-UNK
mediterranean	I-UNK
has	O
come	O
to	O
be	O
regarded	O
as	O
a	O
generic	O
term	B-UNK
applied	O
to	O
similar	B-UNK
g6pd	B-UNK
mutations	B-UNK
thought	O
,	O
however	O
,	O
to	O
represent	B-UNK
a	O
somewhat	B-UNK
heterogeneous	B-UNK
group	I-UNK
.	O

 	O
a	O
c	B-UNK
-	O
-	O
-	O
-	O
t	B-UNK
mutation	B-UNK
at	B-DISEASE
nucleotide	B-UNK
563	O
of	O
g6pd	B-UNK
mediterranean	I-UNK
has	O
been	O
identified	B-UNK
by	O
vulliamy	O
et	O
al	O
.	O
,	O
and	O
the	O
same	O
mutation	B-UNK
has	O
been	O
found	B-UNK
by	O
de	B-UNK
vita	O
et	O
al	O
.	O
in	O
g6pd	B-UNK
mediterranean	I-UNK
,	O
g6pd	B-UNK
sassari	O
,	O
and	O
g6pd	B-UNK
cagliari	O
.	O

 	O
the	O
latter	O
subjects	B-UNK
had	O
an	O
additional	B-UNK
mutation	B-UNK
,	O
at	B-DISEASE
nucleotide	B-UNK
1311	O
,	O
that	O
did	O
not	O
produce	B-UNK
a	O
coding	B-UNK
change	B-UNK
.	O

 	O
we	O
have	O
examined	B-UNK
genomic	B-UNK
dna	I-UNK
of	O
five	O
patients	B-UNK
-	O
-	O
four	O
of	O
spanish	B-UNK
origin	B-UNK
and	O
one	O
of	O
jewish	B-UNK
origin	B-UNK
-	O
-	O
having	B-UNK
enzymatically	B-UNK
documented	B-UNK
g6pd	B-UNK
mediterranean	I-UNK
.	O

 	O
all	O
had	O
both	O
the	O
mutation	B-UNK
at	B-DISEASE
nucleotide	B-UNK
563	O
and	O
that	O
at	B-DISEASE
nucleotide	B-UNK
1311	O
.	O

 	O
a	O
sixth	B-UNK
sample	B-UNK
,	O
resembling	B-UNK
g6pd	B-UNK
mediterranean	I-UNK
kinetically	O
but	O
with	O
a	O
slightly	B-UNK
rapid	B-UNK
electrophoretic	B-UNK
mobility	I-UNK
,	O
was	O
designated	B-UNK
g6pd	I-UNK
andalus	O
and	O
was	O
found	B-UNK
to	O
have	O
a	O
different	B-UNK
mutation	B-UNK
,	O
a	O
g	B-UNK
-	O
-	O
-	O
-	O
a	O
transition	B-UNK
at	B-DISEASE
nucleotide	B-UNK
1361	O
,	O
producing	B-UNK
an	O
arginine	B-UNK
-	O
to	O
-	O
histidine	B-UNK
substitution	B-UNK
.	O

 	O
these	O
studies	B-UNK
suggest	I-UNK
that	O
g6pd	B-UNK
mediterranean	I-UNK
is	O
,	O
after	O
all	O
,	O
relatively	B-UNK
homogeneous	B-UNK
.	O

 	O
a	O
normal	B-UNK
male	B-UNK
with	O
an	O
inherited	B-UNK
deletion	B-UNK
of	O
one	O
exon	B-UNK
within	O
the	O
dmd	B-UNK
gene	B-UNK
.	O

 	O
we	O
describe	B-UNK
two	O
brothers	B-UNK
with	O
identical	B-UNK
inherited	B-UNK
deletions	B-UNK
of	O
one	O
single	B-UNK
exon	B-UNK
within	O
the	O
middle	B-UNK
of	O
the	O
dmd	B-UNK
gene	B-UNK
;	O
one	O
brother	B-UNK
has	O
becker	O
muscular	B-DISEASE
dystrophy	I-DISEASE
diagnosed	B-UNK
at	B-DISEASE
11	O
years	B-UNK
of	O
age	B-UNK
,	O
whereas	O
the	O
older	B-UNK
brother	B-UNK
is	O
normal	B-UNK
at	B-DISEASE
18	O
.	O

 	O
these	O
results	B-UNK
have	O
implications	B-UNK
for	O
genetic	B-UNK
counselling	B-UNK
and	O
prenatal	B-UNK
diagnosis	I-UNK
in	O
families	B-UNK
with	O
becker	O
muscular	B-DISEASE
dystrophy	I-DISEASE
.	O
.	O

 	O
duchenne	B-UNK
muscular	B-DISEASE
dystrophy	I-DISEASE
gene	B-UNK
expression	B-UNK
in	O
normal	B-UNK
and	O
diseased	O
human	B-UNK
muscle	B-UNK
.	O

 	O
a	O
probe	B-UNK
for	O
the	O
5	O
end	B-UNK
of	O
the	O
duchenne	B-UNK
muscular	B-DISEASE
dystrophy	I-DISEASE
(	O
dmd	B-UNK
)	O
gene	B-UNK
was	O
used	O
to	O
study	B-UNK
expression	B-UNK
of	O
the	O
gene	B-UNK
in	O
normal	B-UNK
human	I-UNK
muscle	B-UNK
,	O
myogenic	B-UNK
cell	B-UNK
cultures	B-UNK
,	O
and	O
muscle	B-UNK
from	O
patients	B-UNK
with	O
dmd	B-UNK
.	O

 	O
expression	B-UNK
was	O
found	B-UNK
in	O
rna	B-UNK
from	O
normal	B-UNK
fetal	B-UNK
muscle	B-UNK
,	O
adult	B-UNK
cardiac	B-UNK
and	O
skeletal	B-UNK
muscle	I-UNK
,	O
and	O
cultured	B-UNK
muscle	B-UNK
after	O
myoblast	O
fusion	B-UNK
.	O

 	O
in	O
dmd	B-UNK
muscle	B-UNK
,	O
expression	B-UNK
of	O
this	O
portion	B-UNK
of	O
the	O
gene	B-UNK
was	O
also	O
revealed	B-UNK
by	O
in	O
situ	B-UNK
rna	B-UNK
hybridization	B-UNK
,	O
particularly	B-UNK
in	O
regenerating	O
muscle	B-UNK
fibers	B-UNK
.	O
.	O

 	B-UNK
molecular	I-UNK
and	O
phenotypic	B-UNK
analysis	B-UNK
of	O
patients	B-UNK
with	O
deletions	B-UNK
within	O
the	O
deletion	B-UNK
-	O
rich	B-UNK
region	B-UNK
of	O
the	O
duchenne	B-UNK
muscular	B-DISEASE
dystrophy	I-DISEASE
(	O
dmd	B-UNK
)	O
gene	B-UNK
.	O

 	O
eighty	O
unrelated	B-UNK
individuals	B-UNK
with	O
duchenne	B-UNK
muscular	B-DISEASE
dystrophy	I-DISEASE
(	O
dmd	B-UNK
)	O
or	O
becker	O
muscular	B-DISEASE
dystrophy	I-DISEASE
(	O
bmd	B-UNK
)	O
were	O
found	B-UNK
to	O
have	O
deletions	B-UNK
in	O
the	O
major	B-UNK
deletion	B-UNK
-	O
rich	B-UNK
region	B-UNK
of	O
the	O
dmd	B-UNK
locus	B-UNK
.	O

 	O
this	O
region	B-UNK
includes	B-UNK
the	O
last	O
five	O
exons	B-UNK
detected	B-UNK
by	O
cdna5b	O
-	O
7	O
,	O
all	O
exons	B-UNK
detected	B-UNK
by	O
cdna8	O
,	O
and	O
the	O
first	O
two	O
exons	B-UNK
detected	B-UNK
by	O
cdna9	O
.	O

 	O
these	O
80	O
individuals	B-UNK
account	B-UNK
for	O
approximately	B-UNK
75	O
%	O
of	O
109	O
deletions	B-UNK
of	O
the	O
gene	B-UNK
,	O
detected	B-UNK
among	O
181	O
patients	B-UNK
analyzed	B-UNK
with	O
the	O
entire	B-UNK
dystrophin	B-UNK
cdna	B-UNK
.	O

 	O
endpoints	B-UNK
for	O
many	O
of	O
these	O
deletions	B-UNK
were	O
further	O
characterized	B-UNK
using	O
two	O
genomic	B-UNK
probes	B-UNK
,	O
p20	O
(	O
dxs269	O
;	O
wapenaar	O
et	O
al	O
.	O
)	O
and	O
gmgx11	O
(	O
dxs239	O
;	O
present	B-UNK
paper	B-UNK
)	O
.	O

 	B-UNK
clinical	I-UNK
findings	B-UNK
are	O
presented	B-UNK
for	O
all	O
80	O
patients	B-UNK
allowing	B-UNK
a	O
correlation	B-UNK
of	O
phenotypic	B-UNK
severity	B-UNK
with	O
the	O
genotype	B-UNK
.	O

 	O
thirty	B-UNK
-	O
eight	O
independent	B-UNK
patients	B-UNK
were	O
old	B-UNK
enough	O
to	O
be	O
classified	O
as	O
dmd	B-UNK
,	O
bmd	B-UNK
,	O
or	O
intermediate	B-UNK
phenotype	B-UNK
and	O
had	O
deletions	B-UNK
of	O
exons	B-UNK
with	O
sequenced	B-UNK
intron	B-UNK
/	O
exon	B-UNK
boundaries	B-UNK
.	O

 	O
of	O
these	O
,	O
eight	O
bmd	B-UNK
patients	B-UNK
and	O
one	O
intermediate	B-UNK
patient	B-UNK
had	O
gene	B-UNK
deletions	B-UNK
predicted	B-UNK
to	O
leave	O
the	O
reading	B-UNK
frame	I-UNK
intact	B-UNK
,	O
while	O
21	O
dmd	B-UNK
patients	B-UNK
,	O
7	O
intermediate	B-UNK
patients	B-UNK
,	O
and	O
1	O
bmd	B-UNK
patient	B-UNK
had	O
gene	B-UNK
deletions	B-UNK
predicted	B-UNK
to	O
disrupt	O
the	O
reading	B-UNK
frame	I-UNK
.	O

 	O
thus	O
,	O
with	O
two	O
exceptions	O
,	O
frameshift	B-UNK
deletions	B-UNK
of	O
the	O
gene	B-UNK
resulted	B-UNK
in	O
more	O
severe	B-UNK
phenotype	B-UNK
than	O
did	O
in	O
-	O
frame	B-UNK
deletions	B-UNK
.	O

 	O
this	O
is	O
in	O
agreement	O
with	O
recent	B-UNK
findings	B-UNK
by	O
baumbach	O
et	O
al	O
.	O
and	O
koenig	O
et	O
al	O
.	O
but	O
is	O
in	O
contrast	B-UNK
to	O
findings	B-UNK
,	O
by	O
malhotra	O
et	O
al	O
.	O
at	B-DISEASE
the	O
5	O
'	O
end	B-UNK
of	O
the	O
gene	B-UNK
.	O

 	O
cloning	B-UNK
of	O
breakpoints	B-UNK
of	O
a	O
chromosome	B-UNK
translocation	B-DISEASE
identifies	O
the	O
an2	B-UNK
locus	B-UNK
.	O

 	B-UNK
chromosome	I-UNK
translocations	B-UNK
involving	B-UNK
11p13	B-UNK
have	O
been	O
associated	B-UNK
with	O
familial	B-UNK
aniridia	B-DISEASE
in	O
two	O
kindreds	B-UNK
highlighting	O
the	O
chromosomal	B-UNK
localization	B-UNK
of	O
the	O
an2	B-UNK
locus	B-UNK
.	O

 	O
this	O
locus	B-UNK
is	O
also	O
part	O
of	O
the	O
wagr	B-UNK
complex	B-UNK
(	O
wilms	B-DISEASE
tumor	I-DISEASE
,	O
aniridia	B-DISEASE
,	O
genitourinary	O
abnormalities	B-DISEASE
,	O
and	O
mental	B-DISEASE
retardation	I-DISEASE
)	O
.	O

 	O
in	O
one	O
kindred	B-UNK
,	O
the	O
translocation	B-DISEASE
is	O
associated	B-UNK
with	O
a	O
deletion	B-UNK
,	O
and	O
probes	B-UNK
for	O
this	O
region	B-UNK
were	O
used	O
to	O
identify	B-UNK
and	O
clone	B-UNK
the	O
breakpoints	B-UNK
of	O
the	O
translocation	B-DISEASE
in	O
the	O
second	B-UNK
kindred	B-UNK
.	O

 	O
comparison	B-UNK
of	O
phage	B-UNK
restriction	O
maps	B-UNK
exclude	O
the	O
presence	B-UNK
of	O
any	O
sizable	O
deletion	B-UNK
in	O
this	O
case	B-UNK
.	O

 	O
sequences	B-UNK
at	B-DISEASE
the	O
chromosome	B-DISEASE
11	I-DISEASE
breakpoint	B-UNK
are	O
conserved	B-UNK
in	O
multiple	B-UNK
species	B-UNK
,	O
suggesting	B-UNK
that	O
the	O
translocation	B-DISEASE
falls	O
within	O
the	O
an2	B-UNK
gene	B-UNK
.	O
.	O

 	B-UNK
linkage	I-UNK
analysis	B-UNK
of	O
the	O
apolipoprotein	B-UNK
c2	B-UNK
gene	B-UNK
and	O
myotonic	B-DISEASE
dystrophy	I-DISEASE
on	O
human	B-UNK
chromosome	I-UNK
19	O
reveals	B-UNK
linkage	B-UNK
disequilibrium	I-UNK
in	O
a	O
french	B-UNK
-	O
canadian	B-UNK
population	B-UNK
.	O

 	O
the	O
gene	B-UNK
for	O
human	B-UNK
apolipoprotein	B-UNK
c2	B-UNK
(	O
apoc2	B-UNK
)	O
,	O
situated	O
on	O
the	O
proximal	B-UNK
long	B-UNK
arm	B-UNK
of	O
chromosome	B-DISEASE
19	I-DISEASE
,	O
is	O
closely	B-UNK
linked	I-UNK
to	O
the	O
gene	B-UNK
for	O
the	O
most	O
common	B-UNK
form	B-UNK
of	O
adult	B-UNK
muscular	B-DISEASE
dystrophy	I-DISEASE
,	O
myotonic	B-DISEASE
dystrophy	I-DISEASE
(	O
dm	B-DISEASE
)	O
.	O

 	O
six	O
apoc2	B-UNK
rflps	B-UNK
(	O
taqi	O
,	O
bgli	O
,	O
bani	O
,	O
bamhi	O
,	O
ncoi	O
,	O
and	O
avaii	O
)	O
have	O
been	O
identified	B-UNK
to	O
date	B-UNK
.	O

 	O
we	O
have	O
conducted	O
a	O
comprehensive	B-UNK
dm	B-DISEASE
linkage	B-UNK
study	I-UNK
utilizing	B-UNK
all	O
six	O
rflps	B-UNK
and	O
involving	B-UNK
50	O
families	B-UNK
and	O
372	O
individuals	B-UNK
.	O

 	O
the	O
most	O
informative	B-UNK
rflps	B-UNK
are	O
,	O
in	O
descending	O
order	B-UNK
,	O
ncoi	O
(	O
lod	O
=	O
6	O
.	O
64	O
,	O
theta	B-UNK
=	I-UNK
0	O
.	O
05	O
)	O
,	O
bgli	O
(	O
lod	O
=	O
6	O
.	O
12	O
,	O
theta	B-UNK
=	I-UNK
0	O
.	O
05	O
)	O
,	O
avaii	O
(	O
lod	O
=	O
6	O
.	O
02	O
,	O
theta	B-UNK
=	I-UNK
0	O
.	O
03	O
)	O
,	O
bani	O
(	O
lod	O
=	O
5	O
.	O
76	O
,	O
theta	B-UNK
=	I-UNK
0	O
.	O
04	O
)	O
,	O
taqi	O
(	O
lod	O
=	O
4	O
.	O
29	O
,	O
theta	B-UNK
=	I-UNK
0	O
.	O
06	O
)	O
,	O
and	O
bamhi	O
(	O
lod	O
=	O
1	O
.	O
75	O
,	O
theta	B-UNK
=	I-UNK
0	O
.	O
01	O
)	O
.	O

 	O
a	O
substantial	B-UNK
increase	B-UNK
in	O
the	O
lod	B-UNK
scores	I-UNK
over	O
those	O
seen	B-UNK
with	O
the	O
individual	B-UNK
rflps	B-UNK
was	O
obtained	B-UNK
when	O
the	O
linkage	B-UNK
of	O
the	O
entire	B-UNK
apoc2	B-UNK
haplotype	B-UNK
(	O
composed	O
of	O
the	O
six	O
rflps	B-UNK
)	O
was	O
studied	B-UNK
(	O
lod	O
=	O
17	O
.	O
87	O
,	O
theta	B-UNK
=	I-UNK
0	O
.	O
04	O
)	O
.	O

 	O
we	O
have	O
observed	B-UNK
significant	B-UNK
inter	B-UNK
-	O
apoc2	B-UNK
rflp	B-UNK
linkage	B-UNK
disequilibrium	I-UNK
.	O

 	O
consequently	B-UNK
,	O
the	O
three	O
most	O
informative	B-UNK
rflps	B-UNK
have	O
been	O
found	B-UNK
to	O
be	O
bani	O
,	O
taqi	O
,	O
and	O
either	O
bgli	O
,	O
avaii	O
,	O
or	O
ncoi	O
polymorphisms	B-UNK
.	O

 	O
we	O
also	O
demonstrate	B-UNK
linkage	B-UNK
disequilibrium	I-UNK
between	O
dm	B-DISEASE
and	O
apoc2	B-UNK
in	O
our	O
french	B-UNK
-	O
canadian	B-UNK
population	B-UNK
(	O
standardized	O
disequilibrium	B-UNK
constant	B-UNK
phi	O
=	O
.	O
22	O
,	O
chi	O
2	O
=	O
5	O
.	O
12	O
,	O
df	O
=	O
1	O
,	O
p	B-UNK
less	O
than	O
0	O
.	O
04	O
)	O
.	O

 	O
this	O
represents	B-UNK
the	O
first	O
evidence	B-UNK
of	O
linkage	B-UNK
disequilibrium	I-UNK
between	O
apoc2	B-UNK
and	O
the	O
dm	B-DISEASE
locus	B-UNK
.	O

 	O
phenylalanine	B-UNK
hydroxylase	I-UNK
gene	B-UNK
haplotypes	B-UNK
in	O
polynesians	O
:	O
evolutionary	B-UNK
origins	B-UNK
and	O
absence	B-UNK
of	O
alleles	B-UNK
associated	B-UNK
with	O
severe	B-UNK
phenylketonuria	B-DISEASE
.	O

 	O
a	O
total	B-UNK
of	O
630	O
haplotypes	B-UNK
for	O
the	O
phenylalanine	B-UNK
hydroxylase	I-UNK
(	O
pah	B-UNK
)	O
gene	B-UNK
locus	B-UNK
were	O
established	B-UNK
in	O
five	O
groups	B-UNK
of	O
polynesians	O
comprising	B-UNK
samoans	O
,	O
tongans	O
,	O
cook	O
islanders	O
,	O
maori	B-UNK
,	O
and	O
niueans	O
.	O

 	O
considerable	B-UNK
genetic	B-UNK
continuity	O
was	O
demonstrated	B-UNK
between	O
these	O
widely	B-UNK
dispersed	O
populations	B-UNK
,	O
since	O
three	O
common	B-UNK
haplotypes	B-UNK
(	O
4	O
,	O
1	O
,	O
and	O
7	O
)	O
constituted	O
over	O
95	O
%	O
of	O
alleles	B-UNK
.	O

 	O
a	O
control	B-UNK
group	B-UNK
of	O
individuals	B-UNK
from	O
southeast	O
asia	O
shared	B-UNK
the	O
same	O
major	B-UNK
haplotypes	B-UNK
,	O
4	O
,	O
1	O
,	O
and	O
7	O
,	O
with	O
polynesians	O
.	O

 	O
these	O
data	B-UNK
provide	I-UNK
further	O
support	B-UNK
for	O
the	O
theories	O
of	O
genetic	B-UNK
homogeneity	B-UNK
and	O
of	O
asian	O
affinities	O
of	O
the	O
polynesian	O
precursor	B-UNK
populations	B-UNK
.	O

 	O
the	O
absence	B-UNK
of	O
severe	B-UNK
phenylketonuria	B-DISEASE
(	O
pku	B-DISEASE
)	O
in	O
both	O
polynesians	O
and	O
southeast	O
asians	O
is	O
consistent	B-UNK
with	O
the	O
lack	B-UNK
of	O
pah	B-UNK
haplotypes	B-UNK
2	O
and	O
3	O
,	O
on	O
which	O
the	O
severe	B-UNK
pku	B-DISEASE
mutants	B-UNK
have	O
arisen	O
among	O
caucasians	B-UNK
.	O
.	O

 	O
preferential	B-UNK
germline	B-UNK
mutation	B-UNK
of	O
the	O
paternal	B-UNK
allele	B-UNK
in	O
retinoblastoma	B-DISEASE
.	O

 	O
the	O
event	B-UNK
triggering	O
malignant	B-UNK
proliferation	B-UNK
in	O
70	O
%	O
of	O
retinoblastoma	B-DISEASE
tumours	B-UNK
is	O
loss	B-UNK
of	O
heterozygosity	B-UNK
for	O
chromosome	B-UNK
13q14	B-UNK
,	O
whereby	O
the	O
normal	B-UNK
retinoblastoma	B-DISEASE
gene	B-UNK
(	O
rb1	B-UNK
)	O
allele	B-UNK
is	O
lost	O
and	O
an	O
already	O
mutated	B-UNK
rb1	B-UNK
allele	I-UNK
remains	B-UNK
in	O
the	O
tumour	B-UNK
.	O

 	O
the	O
first	O
allele	B-UNK
suffers	O
a	O
mutational	B-UNK
event	B-UNK
-	O
-	O
deletion	B-UNK
,	O
duplication	B-UNK
or	O
point	B-UNK
mutation	I-UNK
(	O
manuscript	O
in	O
preparation	O
)	O
-	O
-	O
either	O
in	O
the	O
germ	B-UNK
line	I-UNK
(	O
all	O
bilateral	B-UNK
patients	B-UNK
)	O
or	O
in	O
a	O
somatic	B-UNK
retinal	B-UNK
cell	B-UNK
(	O
most	O
unilateral	B-UNK
patients	B-UNK
)	O
.	O

 	O
most	O
bilateral	B-UNK
patients	B-UNK
have	O
no	O
family	B-UNK
history	B-UNK
of	O
retinoblastoma	B-DISEASE
and	O
are	O
presumed	B-UNK
to	O
have	O
new	B-UNK
germline	B-UNK
mutations	I-UNK
which	O
arose	B-UNK
in	O
the	O
egg	O
,	O
sperm	B-UNK
or	O
early	B-UNK
embryo	O
.	O

 	O
we	O
have	O
determined	B-UNK
the	O
parental	B-UNK
origin	B-UNK
of	O
the	O
retained	B-UNK
allele	B-UNK
in	O
nine	O
retinoblastoma	B-DISEASE
tumours	B-UNK
from	O
eight	O
unrelated	B-UNK
non	B-UNK
-	O
familial	B-UNK
cases	B-UNK
by	O
using	O
rb1	B-UNK
-	O
linked	B-UNK
genetic	B-UNK
markers	B-UNK
.	O

 	O
six	O
tumours	B-UNK
retained	B-UNK
the	O
paternal	B-UNK
allele	B-UNK
and	O
three	O
retained	B-UNK
the	O
maternal	B-UNK
allele	B-UNK
.	O

 	O
of	O
the	O
three	O
unilateral	B-UNK
tumours	B-UNK
,	O
only	O
one	O
retained	B-UNK
the	O
paternal	B-UNK
rb1	I-UNK
allele	B-UNK
.	O

 	O
thus	O
,	O
there	O
is	O
no	O
evidence	B-UNK
that	O
the	O
paternal	B-UNK
rb1	I-UNK
allele	B-UNK
is	O
preferentially	B-UNK
retained	B-UNK
in	O
retinoblastoma	B-DISEASE
,	O
as	O
has	O
been	O
suggested	B-UNK
to	O
be	O
the	O
case	B-UNK
in	O
osteosarcoma	B-DISEASE
.	O

 	O
by	O
contrast	B-UNK
,	O
tumours	B-UNK
from	O
four	O
of	O
the	O
five	O
bilateral	B-UNK
patients	B-UNK
retained	B-UNK
the	O
paternal	B-UNK
rb1	I-UNK
allele	B-UNK
.	O

 	O
this	O
suggests	B-UNK
either	O
that	O
new	B-UNK
germline	B-UNK
rb1	B-UNK
mutations	B-UNK
arise	O
more	O
frequently	B-UNK
during	O
spermatogenesis	O
than	O
during	O
oogenesis	O
,	O
or	O
that	O
imprinting	B-UNK
in	O
the	O
early	B-UNK
embryo	O
affects	B-UNK
chromosomal	B-UNK
susceptibility	B-UNK
to	O
mutation	B-UNK
.	O
.	O

 	B-UNK
haplotype	I-UNK
analysis	B-UNK
of	O
the	O
phenylalanine	B-UNK
hydroxylase	I-UNK
gene	B-UNK
in	O
turkish	B-UNK
phenylketonuria	B-DISEASE
families	B-UNK
.	O

 	O
we	O
have	O
estimated	B-UNK
the	O
haplotype	B-UNK
distribution	B-UNK
of	O
mutant	B-UNK
and	O
normal	B-UNK
phenylalanine	B-UNK
hydroxylase	I-UNK
(	O
pah	B-UNK
)	O
alleles	B-UNK
for	O
17	O
turkish	B-UNK
phenylketonuria	B-DISEASE
(	O
pku	B-DISEASE
)	O
families	B-UNK
20	O
normal	B-UNK
and	O
27	O
mutated	B-UNK
pah	B-UNK
alleles	B-UNK
could	O
be	O
identified	B-UNK
.	O

 	O
of	O
the	O
latter	O
,	O
the	O
most	O
prevalent	B-UNK
were	O
associated	B-UNK
with	O
haplotype	B-UNK
6	O
(	O
29	O
.	O
6	O
%	O
)	O
,	O
1	O
(	O
18	O
.	O
5	O
%	O
)	O
and	O
36	O
(	O
11	O
.	O
1	O
%	O
)	O
,	O
while	O
the	O
normal	B-UNK
alleles	B-UNK
were	O
preferentially	B-UNK
associated	B-UNK
with	O
haplotype	B-UNK
1	O
(	O
20	O
%	O
)	O
.	O

 	O
of	O
the	O
19	O
different	B-UNK
haplotypes	B-UNK
observed	B-UNK
,	O
5	O
have	O
not	O
been	O
described	B-UNK
previously	B-UNK
.	O

 	O
the	O
haplotype	B-UNK
distribution	B-UNK
differed	B-UNK
significantly	B-UNK
from	O
that	O
of	O
the	O
northern	B-UNK
european	I-UNK
population	B-UNK
.	O

 	O
two	O
of	O
the	O
eight	O
polymorphic	B-UNK
sites	B-UNK
were	O
in	O
association	B-UNK
with	O
pku	B-DISEASE
.	O

 	O
no	O
deletions	B-UNK
of	O
exon	B-UNK
sequences	B-UNK
were	O
found	B-UNK
in	O
the	O
families	B-UNK
analysed	B-UNK
.	O

 	O
huntington	B-DISEASE
disease	I-DISEASE
:	O
no	O
evidence	B-UNK
for	O
locus	B-UNK
heterogeneity	I-UNK
.	O

 	O
a	O
total	B-UNK
of	O
63	O
families	B-UNK
with	O
huntington	B-DISEASE
disease	I-DISEASE
(	O
hd	B-UNK
)	O
were	O
examined	B-UNK
for	O
linkage	B-UNK
between	O
hd	B-UNK
and	O
g8	O
(	O
d4s10	B-UNK
)	O
.	O

 	O
the	O
families	B-UNK
included	B-UNK
57	O
caucasian	B-UNK
,	O
four	O
black	B-UNK
american	I-UNK
,	O
and	O
two	O
japanese	B-UNK
.	O

 	O
the	O
combined	B-UNK
maximum	B-UNK
lod	I-UNK
score	B-UNK
was	O
87	O
.	O

 	O
69	O
at	B-DISEASE
theta	B-UNK
=	I-UNK
0	O
.	O

 	O
04	O
(	O
99	O
%	O
confidence	B-UNK
interval	B-UNK
0	O
.	O
018	O
-	O
0	O
.	O
071	O
)	O
.	O

 	O
the	O
maximum	B-UNK
frequency	B-UNK
of	O
recombination	B-UNK
was	O
0	O
.	O

 	O
03	O
in	O
males	B-UNK
and	O
0	O
.	O

 	O
05	O
in	O
females	B-UNK
.	O

 	O
fifty	O
-	O
seven	B-UNK
families	B-UNK
gave	B-UNK
positive	B-UNK
lod	I-UNK
scores	I-UNK
;	O
five	O
small	B-UNK
families	B-UNK
gave	B-UNK
mildly	O
negative	B-UNK
lod	B-UNK
scores	I-UNK
.	O

 	O
the	O
maximum	B-UNK
likelihood	O
estimate	B-UNK
of	O
alpha	B-UNK
,	O
the	O
proportion	B-UNK
of	O
linked	B-UNK
loci	B-UNK
,	O
was	O
1	O
.	O

 	O
0	O
with	O
a	O
lower	B-UNK
99	O
%	O
confidence	B-UNK
interval	B-UNK
of	O
0	O
.	O

 	O
88	O
.	O

 	O
these	O
data	B-UNK
suggest	B-UNK
that	O
there	O
is	O
only	O
one	O
hd	B-UNK
locus	B-UNK
,	O
although	O
a	O
second	B-UNK
rare	B-UNK
locus	B-UNK
can	O
not	O
be	O
ruled	O
out	O
.	O

 	B-UNK
haplotype	I-UNK
and	O
multipoint	B-UNK
linkage	I-UNK
analysis	B-UNK
in	O
finnish	B-UNK
choroideremia	B-DISEASE
families	B-UNK
.	O

 	B-UNK
multipoint	I-UNK
linkage	B-UNK
analysis	I-UNK
of	O
choroideremia	B-DISEASE
(	O
tcd	B-UNK
)	O
and	O
seven	B-UNK
x	B-UNK
chromosomal	B-UNK
restriction	B-UNK
fragment	I-UNK
length	I-UNK
polymorphisms	I-UNK
(	O
rflps	B-UNK
)	O
was	O
carried	B-UNK
out	O
in	O
18	O
finnish	B-UNK
tcd	B-UNK
families	B-UNK
.	O

 	O
the	O
data	B-UNK
place	B-UNK
tcd	B-UNK
distal	B-UNK
to	O
pgk	O
and	O
dxs72	O
,	O
very	O
close	B-UNK
to	O
dxys1	O
and	O
dxys5	O
(	O
zmax	B-UNK
=	O
24	O
at	B-DISEASE
theta	B-UNK
=	I-UNK
0	O
)	O
and	O
proximal	B-UNK
to	O
dxys4	O
and	O
dxys12	O
.	O

 	O
this	O
agrees	O
with	O
the	O
data	B-UNK
obtained	B-UNK
from	O
other	O
linkage	B-UNK
studies	I-UNK
and	O
from	O
physical	B-UNK
mapping	I-UNK
.	O

 	O
all	O
the	O
tcd	B-UNK
males	B-UNK
and	O
carrier	B-UNK
females	B-UNK
studied	B-UNK
have	O
the	O
same	O
dxys1	O
allele	B-UNK
in	O
coupling	O
with	O
tcd	B-UNK
.	O

 	O
in	O
northeastern	O
finland	B-UNK
,	O
66	O
/	O
69	O
chromosomes	B-UNK
carrying	B-UNK
tcd	B-UNK
had	O
the	O
same	O
haplotype	B-UNK
at	B-DISEASE
loci	B-UNK
dxs72	O
,	O
dxys1	O
,	O
dxys4	O
,	O
and	O
dxys12	O
.	O

 	O
the	O
same	O
haplotype	B-UNK
is	O
seen	B-UNK
in	O
only	O
15	O
/	O
99	O
chromosomes	B-UNK
not	O
carrying	B-UNK
tcd	B-UNK
.	O

 	O
moreover	O
,	O
in	O
71	O
/	O
104	O
non	B-UNK
-	O
tcd	B-UNK
chromosomes	B-UNK
,	O
the	O
haplotype	B-UNK
at	B-DISEASE
six	O
marker	B-UNK
loci	B-UNK
is	O
different	B-UNK
from	O
those	O
seen	B-UNK
in	O
any	O
of	O
the	O
76	O
tcd	B-UNK
chromosomes	B-UNK
.	O

 	O
this	O
supports	B-UNK
the	O
previously	B-UNK
described	I-UNK
hypothesis	O
that	O
the	O
large	B-UNK
northern	B-UNK
finnish	B-UNK
choroideremia	B-DISEASE
pedigrees	B-UNK
,	O
comprising	B-UNK
a	O
total	B-UNK
of	O
over	O
80	O
living	B-UNK
patients	B-UNK
representing	B-UNK
more	O
than	O
a	O
fifth	B-UNK
of	O
all	O
tcd	B-UNK
patients	B-UNK
described	B-UNK
worldwide	B-UNK
,	O
carry	B-UNK
the	O
same	O
mutation	B-UNK
.	O

 	O
these	O
linkage	B-UNK
and	O
haplotype	B-UNK
data	I-UNK
provide	B-UNK
improved	B-UNK
opportunities	O
for	O
prenatal	B-UNK
diagnosis	I-UNK
based	B-UNK
on	O
rflp	B-UNK
studies	B-UNK
.	O
.	O

 	O
autosomal	O
dominant	B-UNK
aniridia	B-DISEASE
linked	B-UNK
to	O
the	O
chromosome	B-UNK
11p13	B-UNK
markers	B-UNK
catalase	O
and	O
d11s151	O
in	O
a	O
large	B-UNK
dutch	B-UNK
family	B-UNK
.	O

 	O
in	O
a	O
large	B-UNK
pedigree	B-UNK
with	O
autosomal	O
dominant	B-UNK
aniridia	B-DISEASE
,	O
we	O
found	B-UNK
close	B-UNK
linkage	I-UNK
between	O
the	O
aniridia	B-DISEASE
locus	B-UNK
an2	B-UNK
and	O
the	O
markers	B-UNK
catalase	O
(	O
cat	B-UNK
)	O
(	O
zeta	O
=	O
7	O
.	O
27	O
at	B-DISEASE
theta	B-UNK
=	I-UNK
0	O
.	O
00	O
)	O
and	O
d11s151	O
(	O
zeta	O
=	O
3	O
.	O
86	O
at	B-DISEASE
theta	B-UNK
=	I-UNK
0	O
.	O
10	O
)	O
flanking	B-UNK
the	O
an2	B-UNK
locus	B-UNK
on	O
11p13	B-UNK
.	O

 	O
positive	B-UNK
lod	I-UNK
scores	I-UNK
were	O
also	O
obtained	B-UNK
for	O
the	O
11p13	B-UNK
-	O
-	O
-	O
-	O
11p14	O
markers	B-UNK
d11s16	O
and	O
fshb	O
with	O
the	O
linkage	B-UNK
group	B-UNK
cat	B-UNK
/	O
an2	B-UNK
/	O
d11s151	O
.	O

 	O
we	O
conclude	O
that	O
the	O
autosomal	O
dominant	B-UNK
aniridia	B-DISEASE
in	O
this	O
family	B-UNK
is	O
due	O
to	O
a	O
mutation	B-UNK
at	B-DISEASE
the	O
an2	B-UNK
locus	B-UNK
on	O
11p13	B-UNK
.	O

 	O
we	O
have	O
excluded	B-UNK
linkage	B-UNK
(	O
zeta	O
less	O
than	O
-	O
2	O
at	B-DISEASE
theta	B-UNK
less	O
than	O
0	O
.	O
18	O
)	O
between	O
the	O
aniridia	B-DISEASE
and	O
the	O
chromosome	B-UNK
2p25	O
marker	B-UNK
d2s1	O
(	O
linked	B-UNK
to	O
acp1	O
)	O
.	O

 	O
recombination	B-UNK
events	I-UNK
that	O
locate	O
myotonic	B-DISEASE
dystrophy	I-DISEASE
distal	B-UNK
to	O
apoc2	B-UNK
on	O
19q	O
.	O

 	O
we	O
previously	B-UNK
reported	I-UNK
a	O
recombination	B-UNK
in	O
an	O
individual	B-UNK
with	O
myotonic	B-DISEASE
dystrophy	I-DISEASE
(	O
dm	B-DISEASE
)	O
which	O
placed	O
the	O
markers	B-UNK
d19s19	O
and	O
apoc2	B-UNK
on	O
the	O
same	O
side	O
of	O
the	O
dm	B-DISEASE
locus	B-UNK
.	O

 	O
haplotyping	B-UNK
of	O
this	O
family	B-UNK
with	O
more	O
recently	B-UNK
characterized	B-UNK
probes	B-UNK
which	O
are	O
either	O
tightly	B-UNK
linked	I-UNK
to	O
dm	B-DISEASE
or	O
distal	B-UNK
to	O
the	O
linkage	B-UNK
group	B-UNK
at	B-DISEASE
q13	O
.	O

 	O
2	O
shows	B-UNK
that	O
the	O
dm	B-DISEASE
locus	B-UNK
is	O
distal	B-UNK
to	O
apoc2	B-UNK
.	O

 	O
this	O
is	O
confirmed	B-UNK
by	O
other	O
recombinants	O
where	O
dm	B-DISEASE
segregates	B-UNK
with	O
distal	B-UNK
probes	B-UNK
.	O

 	B-UNK
additional	I-UNK
marker	B-UNK
to	O
marker	B-UNK
recombinations	B-UNK
in	O
unaffected	B-UNK
individuals	B-UNK
are	O
reported	B-UNK
and	O
support	B-UNK
the	O
order	B-UNK
and	O
orientation	O
of	O
the	O
dm	B-DISEASE
linkage	B-UNK
group	B-UNK
as	O
pter	O
-	O
(	O
insr	O
,	O
ldlr	O
,	O
s9	O
)	O
-	O
(	O
s19	O
,	O
bcl3	O
,	O
apoc2	B-UNK
)	O
-	O
(	O
ckmm	O
,	O
dm	B-DISEASE
)	O
-	O
(	O
s22	O
,	O
+	O
+	O
+	O
prkcg	O
)	O
-	O
qter	O
.	O

 	O
the	O
data	B-UNK
presented	B-UNK
here	O
can	O
not	O
determine	O
whether	O
dm	B-DISEASE
is	O
proximal	B-UNK
or	O
distal	B-UNK
to	O
ckmm	O
.	O

 	O
the	O
consequences	O
of	O
this	O
probe	B-UNK
order	B-UNK
for	O
antenatal	O
diagnosis	B-UNK
and	O
future	B-UNK
research	B-UNK
aiming	O
to	O
isolate	B-UNK
the	O
gene	B-UNK
which	O
is	O
affected	B-UNK
in	O
dm	B-DISEASE
are	O
discussed	O
.	O

 	O
mutations	B-UNK
in	O
the	O
rb1	B-UNK
gene	B-UNK
and	O
their	O
effects	B-UNK
on	O
transcription	B-UNK
.	O

 	O
inactivation	B-UNK
of	O
both	O
alleles	B-UNK
of	O
the	O
rb1	B-UNK
gene	B-UNK
during	O
normal	B-UNK
retinal	I-UNK
development	B-UNK
initiates	O
the	O
formation	B-UNK
of	O
a	O
retinoblastoma	B-DISEASE
(	O
rb	O
)	O
tumor	B-DISEASE
.	O

 	O
to	O
identify	B-UNK
the	O
mutations	B-UNK
which	O
inactivate	O
rb1	B-UNK
,	O
21	O
rb	O
tumors	B-DISEASE
isolated	B-UNK
from	O
19	O
patients	B-UNK
were	O
analyzed	B-UNK
with	O
the	O
polymerase	B-UNK
chain	I-UNK
reaction	I-UNK
or	O
an	O
rnase	B-UNK
protection	I-UNK
assay	B-UNK
or	O
both	O
.	O

 	O
mutations	B-UNK
were	O
identified	B-UNK
in	O
13	O
of	O
21	O
rb	O
tumors	B-DISEASE
;	O
in	O
8	O
tumors	B-DISEASE
,	O
the	O
precise	B-UNK
errors	B-UNK
in	O
nucleotide	B-UNK
sequence	B-UNK
were	O
characterized	B-UNK
.	O

 	O
each	O
of	O
four	O
germ	B-UNK
line	I-UNK
mutations	I-UNK
involved	B-UNK
a	O
small	B-UNK
deletion	B-UNK
or	O
duplication	B-UNK
,	O
while	O
three	O
somatic	B-UNK
mutations	B-UNK
were	O
point	B-UNK
mutations	I-UNK
leading	B-UNK
to	O
splice	O
alterations	B-UNK
and	O
loss	B-UNK
of	O
an	O
exon	B-UNK
from	O
the	O
mature	B-UNK
rb1	B-UNK
mrna	B-UNK
.	O

 	O
we	O
were	O
unable	O
to	O
detect	B-UNK
expression	B-UNK
of	O
the	O
mutant	B-UNK
allele	I-UNK
in	O
lymphoblasts	O
of	O
three	O
bilaterally	O
affected	B-UNK
patients	I-UNK
,	O
although	O
the	O
mutation	B-UNK
was	O
present	B-UNK
in	O
the	O
genomic	B-UNK
dna	I-UNK
and	O
transcripts	B-UNK
containing	B-UNK
the	O
mutations	B-UNK
were	O
obvious	B-UNK
in	O
the	O
rb	O
tumors	B-DISEASE
in	O
the	O
absence	B-UNK
of	O
a	O
normal	B-UNK
rb1	B-UNK
allele	I-UNK
.	O

 	O
the	O
variations	O
in	O
the	O
level	B-UNK
of	O
expression	B-UNK
of	O
mutant	B-UNK
transcripts	B-UNK
suggest	B-UNK
deregulation	O
of	O
rb1	B-UNK
transcription	B-UNK
in	O
the	O
absence	B-UNK
of	O
a	O
functional	B-UNK
rb1	B-UNK
gene	B-UNK
product	B-UNK
.	O
.	O

 	B-UNK
partial	I-UNK
deletion	B-UNK
8q	O
without	O
langer	B-DISEASE
-	I-DISEASE
giedion	I-DISEASE
syndrome	I-DISEASE
:	O
a	O
recognisable	O
syndrome	B-DISEASE
.	O

 	O
we	O
report	B-UNK
two	O
de	B-UNK
novo	I-UNK
cases	B-UNK
of	O
del	O
(	O
8	O
)	O
(	O
pter	O
-	O
-	O
-	O
-	O
q24	O
.	O
1	O
)	O
with	O
breakpoints	B-UNK
involving	B-UNK
the	O
distal	B-UNK
part	O
of	O
band	B-UNK
8q24	B-UNK
.	O

 	O
1	O
1	O
.	O

 	O
the	O
clinical	B-UNK
features	I-UNK
were	O
similar	B-UNK
and	O
there	O
were	O
no	O
obvious	B-UNK
stigmata	O
of	O
langer	B-DISEASE
-	I-DISEASE
giedion	I-DISEASE
syndrome	I-DISEASE
(	O
lgs	O
)	O
.	O

 	O
there	O
are	O
three	O
other	O
cases	B-UNK
reported	B-UNK
with	O
a	O
deletion	B-UNK
of	O
chromosome	B-DISEASE
8	I-DISEASE
at	B-DISEASE
approximately	B-UNK
the	O
same	O
breakpoint	B-UNK
,	O
one	O
without	O
lgs	O
and	O
some	O
similarities	O
to	O
our	O
cases	B-UNK
,	O
the	O
other	O
two	O
with	O
lgs	O
.	O

 	O
our	O
findings	B-UNK
would	O
support	B-UNK
the	O
observation	B-UNK
that	O
the	O
critical	B-UNK
segment	B-UNK
for	O
the	O
assignment	B-UNK
of	O
lgs	O
is	O
proximal	B-UNK
to	O
or	O
involves	B-UNK
the	O
proximal	B-UNK
part	O
of	O
8q24	B-UNK
.	O

 	O
1	O
,	O
but	O
a	O
review	O
of	O
published	B-UNK
reports	B-UNK
suggests	B-UNK
that	O
the	O
aetiology	O
of	O
lgs	O
may	O
be	O
a	O
more	O
complex	B-UNK
issue	O

 	O
myotonic	B-DISEASE
dystrophy	I-DISEASE
is	O
closely	B-UNK
linked	I-UNK
to	O
the	O
gene	B-UNK
for	O
muscle	B-UNK
-	O
type	B-UNK
creatine	B-UNK
kinase	B-UNK
(	O
ckmm	O
)	O
.	O

 	O
we	O
have	O
studied	B-UNK
genetic	B-UNK
linkage	B-UNK
between	O
the	O
gene	B-UNK
for	O
creatine	B-UNK
kinase	B-UNK
muscle	B-UNK
type	B-UNK
(	O
ckmm	O
)	O
and	O
the	O
gene	B-UNK
for	O
myotonic	B-DISEASE
dystrophy	I-DISEASE
(	O
dm	B-DISEASE
)	O
.	O

 	O
in	O
a	O
panel	O
of	O
65	O
myotonic	B-DISEASE
dystrophy	I-DISEASE
families	B-UNK
from	O
canada	B-UNK
and	O
the	O
netherlands	O
,	O
a	O
maximum	B-UNK
lod	I-UNK
score	B-UNK
(	O
zmax	B-UNK
)	O
of	O
22	O
.	O

 	O
8	O
at	B-DISEASE
a	O
recombination	B-UNK
frequency	B-UNK
(	O
theta	B-UNK
)	O
of	O
0	O
.	O

 	O
03	O
was	O
obtained	B-UNK
.	O

 	O
tight	B-UNK
linkage	B-UNK
was	O
also	O
demonstrated	B-UNK
for	O
ckmm	O
and	O
the	O
gene	B-UNK
for	O
apolipoprotein	B-UNK
c2	B-UNK
(	O
apoc2	B-UNK
)	O
.	O

 	O
this	O
establishes	O
ckmm	O
as	O
a	O
useful	B-UNK
marker	B-UNK
for	O
myotonic	B-DISEASE
dystrophy	I-DISEASE

 	O
color	B-DISEASE
vision	I-DISEASE
defects	I-DISEASE
in	O
adrenomyeloneuropathy	B-UNK
.	O

 	O
the	O
relationship	B-UNK
between	O
abnormal	B-UNK
color	B-UNK
vision	B-DISEASE
and	O
adrenomyeloneuropathy	B-UNK
(	O
amn	B-UNK
)	O
was	O
investigated	B-UNK
in	O
27	O
amn	B-UNK
patients	B-UNK
and	O
31	O
age	B-UNK
-	O
matched	B-UNK
controls	B-UNK
by	O
using	O
the	O
farnsworth	O
-	O
munsell	O
100	O
hue	O
test	B-UNK
.	O

 	O
twelve	O
(	O
44	O
%	O
)	O
of	O
27	O
patients	B-UNK
showed	I-UNK
test	B-UNK
scores	B-UNK
significantly	B-UNK
above	O
normal	B-UNK
.	O

 	O
the	O
axes	O
of	O
bipolarity	O
determined	B-UNK
by	O
the	O
testing	B-UNK
differed	B-UNK
widely	B-UNK
between	O
the	O
patients	B-UNK
with	O
abnormal	B-UNK
scores	B-UNK
,	O
compatible	O
with	O
the	O
notion	O
that	O
different	B-UNK
alterations	B-UNK
in	O
visual	B-UNK
pigment	I-UNK
genes	B-UNK
occur	B-UNK
in	O
different	B-UNK
amn	B-UNK
kindreds	B-UNK
.	O

 	O
these	O
observations	B-UNK
confirm	B-UNK
our	O
earlier	B-UNK
impression	O
that	O
the	O
frequency	B-UNK
of	O
abnormal	B-UNK
color	B-UNK
vision	B-DISEASE
is	O
increased	B-UNK
in	O
these	O
kindreds	B-UNK
,	O
and	O
it	O
supports	B-UNK
our	O
contentions	O
that	O
(	O
1	O
)	O
amn	B-UNK
(	O
and	O
its	O
companion	O
,	O
adrenoleukodystrophy	B-DISEASE
)	O
are	O
very	O
closely	B-UNK
linked	I-UNK
to	O
the	O
visual	B-UNK
pigment	I-UNK
loci	B-UNK
at	B-DISEASE
xq28	B-UNK
and	O
(	O
2	O
)	O
this	O
proximity	O
might	O
provide	B-UNK
the	O
opportunity	O
to	O
observe	O
contiguous	B-UNK
gene	B-UNK
defects	B-UNK
.	O
.	O

 	B-UNK
molecular	I-UNK
analysis	B-UNK
of	O
a	O
female	B-UNK
lesch	O
-	O
nyhan	B-UNK
patient	B-UNK
.	O

 	O
we	O
report	B-UNK
the	O
identification	B-UNK
of	O
a	O
female	B-UNK
patient	B-UNK
with	O
the	O
x	B-UNK
-	O
linked	B-UNK
recessive	O
lesch	B-DISEASE
-	I-DISEASE
nyhan	I-DISEASE
syndrome	I-DISEASE
(	O
hypoxanthine	B-UNK
phosphoribosyltransferase	B-UNK
[	O
hprt	B-UNK
]	O
deficiency	B-UNK
)	O
.	O

 	B-UNK
cytogenetic	I-UNK
and	O
carrier	B-UNK
studies	B-UNK
revealed	B-UNK
structurally	O
normal	B-UNK
chromosomes	I-UNK
for	O
this	O
patient	B-UNK
and	O
her	O
parents	B-UNK
and	O
demonstrated	B-UNK
that	O
this	O
mutation	B-UNK
arose	B-UNK
through	O
a	O
de	B-UNK
novo	I-UNK
gametic	O
event	B-UNK
.	O

 	O
comparison	B-UNK
of	O
this	O
patients	B-UNK
dna	B-UNK
with	O
the	O
dna	B-UNK
of	O
her	O
parents	B-UNK
revealed	B-UNK
that	O
a	O
microdeletion	O
,	O
which	O
occurred	B-UNK
within	O
a	O
maternal	B-UNK
gamete	O
and	O
involved	B-UNK
the	O
entire	B-UNK
hprt	B-UNK
gene	B-UNK
,	O
was	O
partially	B-UNK
responsible	B-UNK
for	O
the	O
disease	B-DISEASE
in	O
this	O
patient	B-UNK
.	O

 	O
somatic	B-UNK
cell	I-UNK
hybrids	I-UNK
,	O
generated	B-UNK
to	O
separate	B-UNK
maternal	B-UNK
and	O
paternal	B-UNK
x	B-UNK
chromosomes	I-UNK
,	O
showed	B-UNK
that	O
expression	B-UNK
of	O
two	O
additional	B-UNK
x	B-UNK
-	O
linked	B-UNK
enzymes	B-UNK
,	O
phosphoglycerate	O
kinase	B-UNK
and	O
glucose	B-UNK
-	O
6	O
-	O
phosphate	B-UNK
dehydrogenase	I-UNK
,	O
were	O
expressed	B-UNK
only	O
in	O
cells	B-UNK
that	O
contained	B-UNK
the	O
maternal	B-UNK
x	B-DISEASE
chromosome	I-DISEASE
,	O
suggesting	B-UNK
the	O
presence	B-UNK
of	O
a	O
functionally	B-UNK
inactive	B-UNK
paternal	B-UNK
x	B-DISEASE
chromosome	I-DISEASE
.	O

 	O
furthermore	B-UNK
,	O
comparison	B-UNK
of	O
methylation	B-UNK
patterns	B-UNK
within	O
a	O
region	B-UNK
of	O
the	O
hprt	B-UNK
gene	B-UNK
known	B-UNK
to	O
be	O
important	B-UNK
in	O
gene	B-UNK
regulation	B-UNK
revealed	B-UNK
differences	B-UNK
between	O
dna	B-UNK
from	O
the	O
father	B-UNK
and	O
the	O
patient	B-UNK
,	O
in	O
keeping	O
with	O
an	O
active	B-UNK
hprt	B-UNK
locus	I-UNK
in	O
the	O
father	B-UNK
and	O
an	O
inactive	B-UNK
hprt	B-UNK
locus	I-UNK
in	O
the	O
patient	B-UNK
.	O

 	O
together	O
these	O
data	B-UNK
indicate	B-UNK
that	O
nonrandom	B-UNK
inactivation	B-UNK
of	O
the	O
cytogenetically	B-UNK
normal	B-UNK
paternal	B-UNK
x	B-DISEASE
chromosome	I-DISEASE
and	O
a	O
microdeletion	O
of	O
the	O
hprt	B-UNK
gene	B-UNK
on	O
an	O
active	B-UNK
maternal	B-UNK
x	B-DISEASE
chromosome	I-DISEASE
were	O
responsible	B-UNK
for	O
the	O
absence	B-UNK
of	O
hprt	B-UNK
in	O
this	O
patient	B-UNK
.	O
.	O

 	O
pelizaeus	B-DISEASE
-	I-DISEASE
merzbacher	I-DISEASE
disease	I-DISEASE
:	O
an	O
x	B-UNK
-	O
linked	B-UNK
neurologic	B-DISEASE
disorder	O
of	O
myelin	B-UNK
metabolism	B-DISEASE
with	O
a	O
novel	B-UNK
mutation	B-UNK
in	O
the	O
gene	B-UNK
encoding	B-UNK
proteolipid	B-UNK
protein	B-UNK
.	O

 	O
the	O
nosology	O
of	O
the	O
inborn	B-UNK
errors	B-UNK
of	O
myelin	B-UNK
metabolism	B-DISEASE
has	O
been	O
stymied	O
by	O
the	O
lack	B-UNK
of	O
molecular	B-UNK
genetic	I-UNK
analysis	B-UNK
.	O

 	O
historically	O
,	O
pelizaeus	B-DISEASE
-	I-DISEASE
merzbacher	I-DISEASE
disease	I-DISEASE
has	O
encompassed	O
a	O
host	O
of	O
neurologic	B-DISEASE
disorders	B-UNK
that	O
present	B-UNK
with	O
a	O
deficit	O
of	O
myelin	B-UNK
,	O
the	O
membrane	B-UNK
elaborated	O
by	O
glial	B-UNK
cells	B-UNK
that	O
encircles	O
and	O
successively	O
enwraps	O
axons	O
.	O

 	O
we	O
describe	B-UNK
here	O
a	O
pelizaeus	O
-	O
merzbacher	O
pedigree	B-UNK
of	O
the	O
classical	B-UNK
type	B-UNK
,	O
with	O
x	B-UNK
-	O
linked	B-UNK
inheritance	B-UNK
,	O
a	O
typical	B-UNK
clinical	B-UNK
progression	O
,	O
and	O
a	O
pathologic	B-UNK
loss	B-UNK
of	O
myelinating	O
cells	B-UNK
and	O
myelin	B-UNK
in	O
the	O
central	B-UNK
nervous	I-UNK
system	I-UNK
.	O

 	O
to	O
discriminate	O
variants	B-UNK
of	O
pelizaeus	B-DISEASE
-	I-DISEASE
merzbacher	I-DISEASE
disease	I-DISEASE
,	O
a	O
set	B-UNK
of	O
oligonucleotide	B-UNK
primers	I-UNK
was	O
constructed	B-UNK
to	O
polymerase	O
-	O
chain	O
-	O
reaction	O
(	O
pcr	B-UNK
)	O
amplify	O
and	O
sequence	B-UNK
the	O
gene	B-UNK
encoding	B-UNK
proteolipid	B-UNK
protein	B-UNK
(	O
plp	B-UNK
)	O
,	O
a	O
structural	B-UNK
protein	B-UNK
that	O
comprises	O
half	B-UNK
of	O
the	O
protein	B-UNK
of	O
the	O
myelin	B-UNK
sheath	O
.	O

 	O
the	O
plp	B-UNK
gene	B-UNK
in	O
one	O
of	O
two	O
affected	B-UNK
males	B-UNK
and	O
the	O
carrier	B-UNK
mother	B-UNK
of	O
this	O
family	B-UNK
exhibited	B-UNK
a	O
single	B-UNK
base	B-UNK
difference	B-UNK
in	O
the	O
more	O
than	O
2	O
kb	B-UNK
of	O
the	O
plp	B-UNK
gene	B-UNK
sequenced	B-UNK
,	O
a	O
c	B-UNK
-	O
-	O
-	O
-	O
t	B-UNK
transition	I-UNK
that	O
would	O
create	O
a	O
serine	B-UNK
substitution	B-UNK
for	O
proline	O
at	B-DISEASE
the	O
carboxy	O
end	B-UNK
of	O
the	O
protein	B-UNK
.	O

 	O
our	O
results	B-UNK
delineate	O
the	O
clinical	B-UNK
features	I-UNK
of	O
pelizaeus	B-DISEASE
-	I-DISEASE
merzbacher	I-DISEASE
disease	I-DISEASE
,	O
define	B-UNK
the	O
possible	B-UNK
molecular	B-UNK
pathology	B-UNK
of	O
this	O
dysmyelinating	B-UNK
disorder	O
,	O
and	O
address	O
the	O
molecular	B-UNK
classification	B-UNK
of	O
inborn	B-UNK
errors	B-UNK
of	O
myelin	B-UNK
metabolism	B-DISEASE
.	O

 	B-UNK
patients	I-UNK
with	O
the	O
classical	B-UNK
form	B-UNK
(	O
type	B-UNK
i	O
)	O
and	O
the	O
more	O
severely	B-UNK
affected	I-UNK
,	O
connatal	O
variant	B-UNK
of	O
pelizaeus	B-DISEASE
-	I-DISEASE
merzbacher	I-DISEASE
disease	I-DISEASE
(	O
type	B-UNK
ii	I-UNK
)	O
would	O
be	O
predicted	B-UNK
to	O
display	B-UNK
mutation	B-UNK
at	B-DISEASE
the	O
plp	B-UNK
locus	B-UNK
.	O

 	O
the	O
other	O
variants	B-UNK
(	O
types	B-UNK
iii	B-UNK
-	O
vi	O
)	O
,	O
which	O
have	O
sometimes	O
been	O
categorized	O
as	O
pelizaeus	B-DISEASE
-	I-DISEASE
merzbacher	I-DISEASE
disease	I-DISEASE
,	O
may	O
represent	B-UNK
mutations	B-UNK
in	O
genes	B-UNK
encoding	B-UNK
other	O
structural	B-UNK
myelin	B-UNK
proteins	B-UNK
or	O
proteins	B-UNK
critical	B-UNK
to	O
myelination	O
.	O
.	O

 	B-UNK
molecular	I-UNK
basis	B-UNK
of	O
human	B-UNK
von	B-DISEASE
willebrand	I-DISEASE
disease	I-DISEASE
:	O
analysis	B-UNK
of	O
platelet	B-UNK
von	B-DISEASE
willebrand	I-DISEASE
factor	I-DISEASE
mrna	B-UNK
.	O

 	O
von	B-DISEASE
willebrand	I-DISEASE
disease	I-DISEASE
(	O
vwd	O
)	O
,	O
the	O
most	O
common	B-UNK
inherited	B-UNK
bleeding	B-DISEASE
disorder	I-DISEASE
in	O
humans	B-UNK
,	O
can	O
result	B-UNK
from	O
either	O
a	O
quantitative	B-UNK
or	O
a	O
qualitative	O
defect	B-UNK
in	O
the	O
adhesive	O
glycoprotein	B-UNK
,	O
von	B-DISEASE
willebrand	I-DISEASE
factor	I-DISEASE
(	O
vwf	B-UNK
)	O
.	O

 	B-UNK
molecular	I-UNK
studies	B-UNK
of	O
vwd	O
have	O
been	O
limited	B-UNK
by	O
the	O
large	B-UNK
size	B-UNK
of	O
the	O
vwf	B-UNK
gene	B-UNK
and	O
difficulty	O
in	O
obtaining	O
the	O
vwf	B-UNK
mrna	B-UNK
from	O
patients	B-UNK
.	O

 	O
by	O
use	B-UNK
of	O
an	O
adaptation	O
of	O
the	O
polymerase	B-UNK
chain	I-UNK
reaction	I-UNK
,	O
vwf	B-UNK
mrna	B-UNK
was	O
amplified	B-UNK
and	O
sequenced	B-UNK
from	O
peripheral	B-UNK
blood	I-UNK
platelets	B-UNK
.	O

 	O
a	O
silent	B-UNK
vwf	B-UNK
allele	B-UNK
was	O
identified	B-UNK
,	O
resulting	B-UNK
from	O
a	O
cis	B-UNK
defect	B-UNK
in	O
vwf	B-UNK
mrna	B-UNK
transcription	B-UNK
or	O
processing	B-UNK
.	O

 	O
in	O
two	O
type	B-UNK
iia	O
vwd	O
patients	B-UNK
,	O
two	O
different	B-UNK
but	O
adjacent	B-UNK
missense	B-UNK
mutations	I-UNK
were	O
identified	B-UNK
,	O
the	O
locations	B-UNK
of	O
which	O
may	O
identify	B-UNK
an	O
important	B-UNK
vwf	B-UNK
functional	B-UNK
domain	B-UNK
.	O

 	O
expression	B-UNK
in	O
heterologous	O
cells	B-UNK
of	O
recombinant	B-UNK
vwf	B-UNK
containing	B-UNK
one	O
of	O
these	O
latter	O
mutations	B-UNK
reproduced	O
the	O
characteristic	B-UNK
structural	B-UNK
abnormality	B-UNK
seen	B-UNK
in	O
type	B-UNK
iia	O
vwd	O
plasma	B-UNK
.	O
.	O

 	B-UNK
familial	I-UNK
deficiency	B-UNK
of	O
the	O
seventh	B-UNK
component	B-UNK
of	O
complement	B-UNK
associated	B-UNK
with	O
recurrent	B-UNK
meningococcal	B-DISEASE
infections	I-DISEASE
.	O

 	O
we	O
describe	B-UNK
an	O
11	O
-	O
year	B-UNK
-	O
old	B-UNK
girl	B-UNK
suffering	B-UNK
from	O
recurrent	B-UNK
meningitis	B-DISEASE
with	O
a	O
complete	B-UNK
absence	B-UNK
of	O
the	O
seventh	B-UNK
component	B-UNK
of	O
complement	B-UNK
(	O
c7	B-UNK
)	O
.	O

 	O
diagnosis	B-UNK
was	O
established	B-UNK
by	O
haemolytic	B-UNK
titration	O
and	O
western	B-UNK
blotting	B-UNK
.	O

 	O
the	O
patients	B-UNK
serum	B-UNK
lacked	B-UNK
the	O
85	O
kda	B-UNK
c7	B-UNK
chain	O
.	O

 	O
haemolytic	B-UNK
activity	B-UNK
of	O
serum	B-UNK
was	O
reconstituted	O
with	O
either	O
pooled	O
normal	B-UNK
human	I-UNK
serum	B-UNK
or	O
with	O
purified	B-UNK
c7	B-UNK
.	O

 	O
the	O
relatives	B-UNK
(	O
parents	B-UNK
and	O
one	O
sister	O
)	O
had	O
half	B-UNK
-	O
normal	B-UNK
levels	B-UNK
of	O
both	O
immunochemically	O
and	O
functionally	B-UNK
determined	B-UNK
c7	B-UNK
,	O
indicating	B-UNK
a	O
heterozygous	B-UNK
state	B-UNK
for	O
c7	B-UNK
deficiency	I-UNK
.	O
.	O

 	O
translocation	B-DISEASE
t	B-UNK
(	O
5	O
;	O
11	O
)	O
(	O
q13	O
.	O
1	O
;	O
p13	O
)	O
associated	B-UNK
with	O
familial	B-UNK
isolated	B-UNK
aniridia	B-DISEASE
.	O

 	O
a	O
father	B-UNK
and	O
daughter	O
with	O
isolated	B-UNK
aniridia	B-DISEASE
were	O
observed	B-UNK
to	O
have	O
an	O
apparently	B-UNK
balanced	B-UNK
,	O
reciprocal	B-UNK
translocation	B-DISEASE
involving	B-UNK
chromosomes	B-UNK
5	O
and	O
11	O
[	O
t	B-UNK
(	O
5	O
;	O
11	O
)	O
(	O
q13	O
.	O
1	O
;	O
p13	O
)	O
]	O
.	O

 	O
no	O
other	O
clinical	B-UNK
characteristics	B-UNK
often	O
associated	B-UNK
with	O
the	O
deletion	B-UNK
of	O
11p13	B-UNK
were	O
observed	B-UNK
in	O
this	O
family	B-UNK
.	O

 	O
this	O
finding	B-UNK
,	O
in	O
association	B-UNK
with	O
3	O
other	O
instances	O
of	O
single	B-UNK
breaks	B-UNK
at	B-DISEASE
11p13	B-UNK
and	O
aniridia	B-DISEASE
,	O
supports	B-UNK
the	O
assignment	B-UNK
of	O
an2	B-UNK
to	O
11p13	B-UNK
.	O

 	B-UNK
homozygous	I-UNK
hypobetalipoproteinemia	B-DISEASE
:	O
a	O
disease	B-DISEASE
distinct	B-UNK
from	O
abetalipoproproteinemia	O
at	B-DISEASE
the	O
molecular	B-UNK
level	B-UNK
.	O

 	O
apob	B-UNK
dna	B-UNK
,	O
rna	B-UNK
,	O
and	O
protein	B-UNK
from	O
two	O
patients	B-UNK
with	O
homozygous	B-UNK
hypobetalipoproteinemia	B-DISEASE
(	O
hbl	B-UNK
)	O
were	O
evaluated	O
and	O
compared	B-UNK
with	O
normal	B-UNK
individuals	B-UNK
.	O

 	B-UNK
southern	I-UNK
blot	I-UNK
analysis	B-UNK
with	O
10	O
different	B-UNK
cdna	B-UNK
probes	B-UNK
revealed	B-UNK
a	O
normal	B-UNK
gene	B-UNK
without	O
major	B-UNK
insertions	B-UNK
,	O
deletions	B-UNK
,	O
or	O
rearrangements	B-UNK
.	O

 	O
northern	B-UNK
and	O
slot	O
blot	O
analyses	B-UNK
of	O
total	B-UNK
liver	B-DISEASE
mrna	B-UNK
from	O
hbl	B-UNK
patients	B-UNK
documented	B-UNK
a	O
normal	B-UNK
size	B-UNK
apob	B-UNK
mrna	I-UNK
that	O
was	O
present	B-UNK
in	O
greatly	B-UNK
reduced	B-UNK
quantities	B-UNK
.	O

 	O
apob	B-UNK
protein	B-UNK
was	O
detected	B-UNK
within	O
hbl	B-UNK
hepatocytes	O
utilizing	B-UNK
immunohistochemical	O
techniques	B-UNK
;	O
however	O
,	O
it	O
was	O
markedly	B-UNK
reduced	B-UNK
in	O
quantity	O
when	O
compared	B-UNK
with	O
control	B-UNK
samples	B-UNK
.	O

 	O
no	O
apob	B-UNK
was	O
detectable	B-UNK
in	O
the	O
plasma	B-UNK
of	O
hbl	B-UNK
individuals	B-UNK
with	O
an	O
elisa	O
assay	B-UNK
.	O

 	O
these	O
data	B-UNK
are	O
most	O
consistent	B-UNK
with	O
a	O
mutation	B-UNK
in	O
the	O
coding	B-UNK
portion	B-UNK
of	O
the	O
apob	B-UNK
gene	B-UNK
in	O
hbl	B-UNK
patients	B-UNK
,	O
leading	B-UNK
to	O
an	O
abnormal	B-UNK
apob	B-UNK
protein	B-UNK
and	O
apob	B-UNK
mrna	I-UNK
instability	B-UNK
.	O

 	O
these	O
results	B-UNK
are	O
distinct	B-UNK
from	O
those	O
previously	B-UNK
noted	O
in	O
abetalipoproteinemia	B-DISEASE
,	O
which	O
was	O
characterized	B-UNK
by	O
an	O
elevated	B-UNK
level	B-UNK
of	O
hepatic	B-UNK
apob	B-UNK
mrna	I-UNK
and	O
accumulation	B-UNK
of	O
intracellular	B-UNK
hepatic	B-UNK
apob	B-UNK
protein	B-UNK
.	O
.	O

 	O
spontaneous	B-UNK
reversion	B-UNK
of	O
novel	B-UNK
lesch	O
-	O
nyhan	B-UNK
mutation	B-UNK
by	O
hprt	B-UNK
gene	B-UNK
rearrangement	B-UNK
.	O

 	B-UNK
molecular	I-UNK
analysis	B-UNK
of	O
an	O
unusual	B-UNK
patient	B-UNK
with	O
the	O
lesch	B-DISEASE
-	I-DISEASE
nyhan	I-DISEASE
syndrome	I-DISEASE
has	O
suggested	B-UNK
that	O
the	O
mutation	B-UNK
is	O
due	O
to	O
a	O
partial	B-UNK
hprt	B-UNK
gene	B-UNK
duplication	B-UNK
.	O

 	O
we	O
now	O
report	B-UNK
the	O
cloning	B-UNK
and	O
sequencing	B-UNK
of	O
the	O
mutant	B-UNK
hprt	I-UNK
cdna	B-UNK
which	O
shows	B-UNK
the	O
precise	B-UNK
duplication	B-UNK
of	O
exons	B-UNK
2	O
and	O
3	O
.	O

 	O
this	O
mutation	B-UNK
is	O
the	O
result	B-UNK
of	O
an	O
internal	B-UNK
duplication	B-UNK
of	O
16	O
-	O
20	O
kilobases	O
of	O
the	O
gene	B-UNK
.	O

 	O
the	O
structure	B-UNK
of	O
the	O
mutant	B-UNK
gene	B-UNK
suggests	B-UNK
that	O
the	O
duplication	B-UNK
was	O
not	O
generated	B-UNK
by	O
a	O
single	B-UNK
unequal	B-UNK
crossing	O
-	O
over	O
event	B-UNK
between	O
two	O
normal	B-UNK
hprt	B-UNK
alleles	B-UNK
.	O

 	O
growth	B-UNK
of	O
epstein	O
-	O
barr	B-UNK
virus	B-UNK
-	O
transformed	B-UNK
lymphoblasts	O
from	O
this	O
patient	B-UNK
in	O
selective	B-UNK
medium	O
has	O
permitted	O
isolation	B-UNK
of	O
spontaneous	B-UNK
hprt	B-UNK
+	O
revertants	O
of	O
this	O
mutation	B-UNK
.	O

 	O
the	O
reversion	B-UNK
event	B-UNK
involves	B-UNK
a	O
second	B-UNK
major	B-UNK
hprt	B-UNK
gene	B-UNK
rearrangement	B-UNK
where	O
most	O
or	O
all	O
of	O
the	O
duplicated	B-UNK
portion	B-UNK
of	O
the	O
mutant	B-UNK
gene	B-UNK
is	O
deleted	B-UNK
.	O

 	O
the	O
original	B-UNK
mutation	B-UNK
therefore	O
has	O
the	O
potential	B-UNK
for	O
spontaneous	B-UNK
somatic	B-UNK
reversion	B-UNK
.	O

 	O
this	O
may	O
explain	O
the	O
relatively	B-UNK
mild	B-UNK
symptoms	B-UNK
of	O
the	O
lesch	B-DISEASE
-	I-DISEASE
nyhan	I-DISEASE
syndrome	I-DISEASE
exhibited	B-UNK
by	O
this	O
patient	B-UNK
.	O
.	O

 	O
complex	B-UNK
glycerol	B-DISEASE
kinase	I-DISEASE
deficiency	I-DISEASE
:	O
molecular	B-UNK
-	O
genetic	B-UNK
,	O
cytogenetic	B-UNK
,	O
and	O
clinical	B-UNK
studies	B-UNK
of	O
five	O
japanese	B-UNK
patients	I-UNK
.	O

 	O
five	O
male	B-UNK
japanese	B-UNK
patients	I-UNK
with	O
complex	B-UNK
glycerol	B-DISEASE
kinase	I-DISEASE
deficiency	I-DISEASE
(	O
cgkd	O
)	O
and	O
their	O
relatives	B-UNK
were	O
studied	B-UNK
clinically	B-UNK
,	O
cytogenetically	B-UNK
,	O
and	O
molecular	B-UNK
-	O
genetically	B-UNK
.	O

 	O
all	O
patients	B-UNK
had	O
muscular	B-DISEASE
dystrophy	I-DISEASE
or	O
muscle	B-DISEASE
weakness	I-DISEASE
,	O
mental	B-DISEASE
retardation	I-DISEASE
,	O
congenital	B-DISEASE
adrenal	B-DISEASE
hypoplasia	I-DISEASE
,	O
and	O
glycerol	B-DISEASE
kinase	I-DISEASE
deficiency	I-DISEASE
.	O

 	O
high	B-UNK
-	O
resolution	B-UNK
gtg	O
-	O
banded	O
chromosomes	B-UNK
showed	B-UNK
a	O
microdeletion	O
in	O
the	O
xp21	B-UNK
region	B-UNK
in	O
all	O
four	O
patients	B-UNK
examined	B-UNK
and	O
in	O
all	O
five	O
mothers	B-UNK
.	O

 	O
southern	O
hybridizations	O
,	O
after	O
digestions	O
by	O
restriction	O
endonucleases	O
,	O
with	O
various	O
cloned	B-UNK
dnas	B-UNK
(	O
d2	B-UNK
,	O
99	O
-	O
6	O
,	O
b24	O
,	O
c7	B-UNK
,	O
l1	O
-	O
4	O
,	O
cdmd13	O
-	O
14	O
,	O
j66	O
-	O
hi	O
,	O
p20	O
,	O
j	B-UNK
-	O
bir	O
,	O
ert87	O
-	O
30	O
,	O
ert87	O
-	O
15	O
,	O
ert87	O
-	O
8	O
,	O
ert87	O
-	O
1	O
,	O
xj	O
-	O
1	O
.	O
1	O
,	O
754	O
,	O
cx5	O
.	O
7	O
,	O
and	O
otc	O
-	O
1	O
)	O
that	O
are	O
located	B-UNK
around	O
xp21	B-UNK
also	O
showed	B-UNK
a	O
deletion	B-UNK
in	O
the	O
genome	B-UNK
of	O
all	O
patients	B-UNK
and	O
mothers	B-UNK
.	O

 	O
although	O
the	O
deletion	B-UNK
differed	B-UNK
in	O
size	B-UNK
among	O
patients	B-UNK
,	O
a	O
segment	B-UNK
commonly	O
absent	B-UNK
was	O
located	B-UNK
between	O
the	O
genomic	B-UNK
sequences	I-UNK
corresponding	B-UNK
to	O
l1	O
-	O
4	O
and	O
cdmd13	O
-	O
14	O
.	O

 	O
this	O
finding	B-UNK
indicated	B-UNK
that	O
the	O
gene	B-UNK
coding	B-UNK
for	O
glycerol	B-UNK
kinase	B-UNK
(	O
gk	O
)	O
is	O
located	B-UNK
within	O
this	O
segment	B-UNK
.	O

 	O
a	O
comparison	B-UNK
of	O
the	O
clinical	B-UNK
manifestations	B-UNK
of	O
the	O
present	B-UNK
five	O
patients	B-UNK
and	O
reported	B-UNK
cgkd	O
or	O
duchenne	B-UNK
muscular	B-DISEASE
dystrophy	I-DISEASE
(	O
dmd	B-UNK
)	O
patients	B-UNK
with	O
dna	B-UNK
deletion	B-UNK
suggests	B-UNK
the	O
existence	O
of	O
a	O
certain	B-UNK
gene	B-UNK
responsible	B-UNK
for	O
gonadotropin	O
deficiency	B-UNK
(	O
gtd	O
)	O
.	O

 	O
the	O
result	B-UNK
of	O
the	O
present	B-UNK
study	I-UNK
and	O
results	B-UNK
of	O
previous	B-UNK
studies	I-UNK
suggest	B-UNK
that	O
genes	B-UNK
for	O
ornithine	O
transcarbamylase	O
(	O
otc	O
)	O
,	O
dmd	B-UNK
,	O
and	O
gk	O
and	O
putative	B-UNK
genes	B-UNK
responsible	B-UNK
for	O
congenital	B-DISEASE
adrenal	B-DISEASE
hypoplasia	I-DISEASE
(	O
ahc	O
)	O
and	O
gtd	O
are	O
arranged	O
from	O
telomere	O
to	O
centromere	O
as	O
pter	O
-	O
-	O
gtd	O
-	O
-	O
ahc	O
-	O
-	O
gk	O
-	O
-	O
dmd	B-UNK
-	O
-	O
otc	O
-	O
-	O
cen	B-UNK

 	O
genetically	B-UNK
determined	I-UNK
low	B-UNK
c4	B-UNK
:	O
a	O
predisposing	B-UNK
factor	B-UNK
to	O
autoimmune	B-UNK
chronic	B-UNK
active	B-UNK
hepatitis	B-DISEASE
.	O

 	O
of	O
26	O
patients	B-UNK
with	O
autoimmune	B-UNK
chronic	B-UNK
active	B-UNK
hepatitis	B-DISEASE
(	O
cah	O
)	O
starting	B-UNK
in	O
childhood	B-UNK
18	O
(	O
69	O
%	O
)	O
had	O
low	B-UNK
c4	B-UNK
and	O
5	O
(	O
19	O
%	O
)	O
had	O
low	B-UNK
c3	B-UNK
serum	B-UNK
levels	B-UNK
.	O

 	O
impaired	B-UNK
hepatic	B-UNK
synthesis	B-UNK
and	O
immune	B-UNK
-	O
consumption	O
were	O
unlikely	O
since	O
transferrin	O
levels	B-UNK
were	O
normal	B-UNK
in	O
all	O
patients	B-UNK
,	O
albumin	B-UNK
levels	B-UNK
were	O
persistently	O
low	B-UNK
in	O
only	O
3	O
,	O
and	O
only	O
3	O
had	O
raised	B-UNK
levels	B-UNK
of	O
activation	B-UNK
fragment	O
c3d	O
.	O

 	O
c4d	O
was	O
normal	B-UNK
in	O
all	O
patients	B-UNK
studied	B-UNK
.	O

 	O
in	O
the	O
families	B-UNK
of	O
12	O
probands	B-UNK
with	O
low	B-UNK
c4	B-UNK
,	O
7	O
parents	B-UNK
had	O
low	B-UNK
c4	B-UNK
and	O
2	O
had	O
levels	B-UNK
which	O
were	O
at	B-DISEASE
the	O
lower	B-UNK
limit	B-UNK
of	O
normal	B-UNK
.	O

 	O
5	O
of	O
10	O
siblings	B-UNK
from	O
5	O
families	B-UNK
had	O
low	B-UNK
c4	B-UNK
.	O

 	O
these	O
results	B-UNK
suggest	B-UNK
that	O
low	B-UNK
c4	B-UNK
levels	B-UNK
in	O
cah	O
are	O
genetically	B-UNK
determined	I-UNK
.	O

 	O
c4	B-UNK
phenotyping	O
in	O
20	O
patients	B-UNK
and	O
in	O
26	O
parents	B-UNK
showed	B-UNK
that	O
90	O
%	O
and	O
81	O
%	O
,	O
respectively	B-UNK
,	O
had	O
null	B-UNK
allotypes	O
at	B-DISEASE
either	O
the	O
c4a	O
or	O
c4b	O
locus	B-UNK
compared	B-UNK
with	O
59	O
%	O
in	O
controls	B-UNK
,	O
indicating	B-UNK
that	O
defective	B-UNK
expression	B-UNK
of	O
structural	B-UNK
genes	B-UNK
may	O
contribute	B-UNK
to	O
the	O
observed	B-UNK
c4	B-UNK
deficiency	B-UNK
.	O
.	O

 	O
an	O
amino	O
-	O
acid	O
substitution	B-UNK
involved	B-UNK
in	O
phenylketonuria	B-DISEASE
is	O
in	O
linkage	B-UNK
disequilibrium	I-UNK
with	O
dna	B-UNK
haplotype	B-UNK
2	O
.	O

 	O
phenylketonuria	B-DISEASE
(	O
pku	B-DISEASE
)	O
is	O
an	O
autosomal	O
recessive	O
human	B-UNK
genetic	B-UNK
disorder	O
caused	B-UNK
by	O
a	O
deficiency	B-UNK
of	O
hepatic	B-UNK
phenylalanine	B-UNK
hydroxylase	I-UNK
(	O
pah	B-UNK
,	O
phenylalanine	O
4	O
-	O
monooxygenase	O
,	O
ec	O
1	O
.	O
14	O
.	O
16	O
.	O
1	O
)	O
.	O

 	O
pku	B-DISEASE
is	O
a	O
common	B-UNK
inborn	B-UNK
error	B-UNK
of	O
amino	O
-	O
acid	O
metabolism	B-DISEASE
in	O
caucasian	B-UNK
populations	B-UNK
and	O
approximately	B-UNK
1	O
in	O
50	O
individuals	B-UNK
are	O
carriers	B-UNK
of	O
a	O
pku	B-DISEASE
allele	B-UNK
.	O

 	O
to	O
define	B-UNK
the	O
molecular	B-UNK
basis	I-UNK
of	O
pku	B-DISEASE
,	O
we	O
characterized	B-UNK
twelve	O
restriction	O
fragment	O
-	O
length	O
polymorphism	O
(	O
rflp	B-UNK
)	O
haplotypes	B-UNK
of	O
the	O
pah	B-UNK
locus	B-UNK
in	O
the	O
northern	B-UNK
european	I-UNK
population	B-UNK
and	O
observed	B-UNK
that	O
90	O
%	O
of	O
the	O
pku	B-DISEASE
alleles	B-UNK
in	O
this	O
population	B-UNK
are	O
confined	O
to	O
four	O
common	B-UNK
rflp	B-UNK
haplotypes	B-UNK
.	O

 	O
we	O
have	O
recently	B-UNK
reported	B-UNK
a	O
splicing	B-UNK
mutation	B-UNK
in	O
the	O
pah	B-UNK
gene	B-UNK
that	O
is	O
associated	B-UNK
with	O
rflp	B-UNK
haplotype	B-UNK
3	O
which	O
is	O
present	B-UNK
at	B-DISEASE
about	O
40	O
%	O
of	O
mutant	B-UNK
alleles	I-UNK
.	O

 	O
we	O
now	O
report	B-UNK
the	O
molecular	B-UNK
lesion	B-UNK
associated	B-UNK
with	O
the	O
rflp	B-UNK
haplotype	B-UNK
2	O
mutant	B-UNK
allele	I-UNK
.	O

 	O
this	O
defect	B-UNK
is	O
caused	B-UNK
by	O
a	O
c	B-UNK
-	O
to	O
-	O
t	B-UNK
transition	I-UNK
in	O
exon	B-UNK
12	O
resulting	B-UNK
in	O
an	O
amino	O
-	O
acid	O
substitution	B-UNK
(	O
arg	B-UNK
to	O
trp	O
)	O
at	B-DISEASE
residue	B-UNK
408	O
of	O
pah	B-UNK
.	O

 	B-UNK
direct	I-UNK
hybridization	B-UNK
analysis	B-UNK
of	O
the	O
point	B-UNK
mutation	I-UNK
using	O
a	O
specific	B-UNK
oligonucleotide	I-UNK
probe	B-UNK
demonstrated	B-UNK
that	O
this	O
mutation	B-UNK
is	O
also	O
in	O
linkage	B-UNK
disequilibrium	I-UNK
with	O
rflp	B-UNK
haplotype	B-UNK
2	O
alleles	B-UNK
that	O
make	O
up	O
about	O
20	O
%	O
of	O
mutant	B-UNK
pah	I-UNK
genes	B-UNK

 	O
choroideremia	B-DISEASE
:	O
close	B-UNK
linkage	I-UNK
to	O
dxys1	O
and	O
dxys12	O
demonstrated	B-UNK
by	O
segregation	B-UNK
analysis	B-UNK
and	O
historical	O
-	O
genealogical	B-UNK
evidence	B-UNK
.	O

 	B-UNK
linkage	I-UNK
studies	B-UNK
using	O
restriction	B-UNK
fragment	I-UNK
length	I-UNK
polymorphisms	I-UNK
were	O
conducted	O
in	O
the	O
x	B-UNK
-	O
linked	B-UNK
disorder	O
,	O
choroideremia	B-DISEASE
,	O
designated	B-UNK
tcd	B-UNK
for	O
progressive	B-UNK
tapeto	O
-	O
choroidal	B-DISEASE
dystrophy	I-DISEASE
.	O

 	O
previously	B-UNK
demonstrated	B-UNK
close	B-UNK
linkage	I-UNK
with	O
locus	B-UNK
dxys1	O
was	O
confirmed	B-UNK
(	O
lod	O
11	O
.	O
44	O
at	B-DISEASE
0	O
recombination	B-UNK
distance	B-UNK
)	O
.	O

 	O
in	O
addition	B-UNK
,	O
locus	B-UNK
dxys12	O
was	O
found	B-UNK
to	O
be	O
closely	B-UNK
linked	I-UNK
with	O
tcd	B-UNK
(	O
lod	O
3	O
.	O
31	O
at	B-DISEASE
0	O
recombination	B-UNK
distance	B-UNK
)	O
.	O

 	O
the	O
disease	B-DISEASE
mainly	B-UNK
occurs	B-UNK
in	O
three	O
large	B-UNK
kindreds	B-UNK
in	O
remote	O
northern	B-UNK
finland	B-UNK
.	O

 	O
while	O
formal	O
genealogical	B-UNK
proof	O
is	O
lacking	B-UNK
,	O
all	O
presently	O
living	B-UNK
(	O
more	O
than	O
80	O
affected	B-UNK
males	B-UNK
and	O
120	O
carrier	B-UNK
females	B-UNK
)	O
probably	B-UNK
originate	O
from	O
a	O
common	B-UNK
founder	B-UNK
couple	O
born	O
in	O
1644	O
and	O
1646	O
,	O
twelve	O
generations	B-UNK
ago	B-UNK
.	O

 	O
all	O
36	O
patients	B-UNK
and	O
48	O
carriers	B-UNK
tested	B-UNK
from	O
the	O
three	O
kindreds	B-UNK
had	O
the	O
same	O
haplotype	B-UNK
(	O
tcd	B-UNK
/	O
dxys1	O
,	O
11	O
kb	B-UNK
/	O
dxys12	O
,	O
1	O
.	O
6	O
kb	B-UNK
)	O
.	O

 	O
given	B-UNK
that	O
at	B-DISEASE
least	O
105	O
female	B-UNK
meioses	B-UNK
transmitting	B-UNK
tcd	B-UNK
have	O
occurred	B-UNK
since	O
1650	O
in	O
these	O
kindreds	B-UNK
,	O
extremely	B-UNK
close	B-UNK
linkage	I-UNK
between	O
tcd	B-UNK
,	O
dxys1	O
and	O
dxys12	O
is	O
suggested	B-UNK
.	O

 	O
the	O
above	O
haplotype	B-UNK
is	O
a	O
very	O
useful	B-UNK
diagnostic	B-UNK
tool	B-UNK
in	O
these	O
tcd	B-UNK
families	B-UNK
.	O

 	O
we	O
suggest	B-UNK
that	O
our	O
historical	O
-	O
genealogical	B-UNK
approach	B-UNK
to	O
linkage	B-UNK
analysis	I-UNK
may	O
be	O
possible	B-UNK
elsewhere	O
in	O
similar	B-UNK
isolated	B-UNK
populations	B-UNK

 	O
von	B-DISEASE
hippel	I-DISEASE
-	I-DISEASE
lindau	I-DISEASE
disease	I-DISEASE
maps	B-UNK
to	O
the	O
region	B-UNK
of	O
chromosome	B-DISEASE
3	I-DISEASE
associated	B-UNK
with	O
renal	B-DISEASE
cell	B-UNK
carcinoma	B-DISEASE
.	O

 	O
von	B-DISEASE
hippel	I-DISEASE
-	I-DISEASE
lindau	I-DISEASE
disease	I-DISEASE
(	O
vhl	B-UNK
)	O
is	O
an	O
autosomal	O
dominant	B-UNK
disorder	O
with	O
inherited	B-UNK
susceptibility	B-UNK
to	O
various	O
forms	B-UNK
of	O
cancer	B-DISEASE
,	O
including	B-UNK
hemangioblastomas	O
of	O
the	O
central	B-UNK
nervous	I-UNK
system	I-UNK
,	O
phaeochromocytomas	O
,	O
pancreatic	O
malignancies	B-DISEASE
,	O
and	O
renal	B-DISEASE
cell	B-UNK
carcinomas	B-UNK
.	O

 	O
renal	B-DISEASE
cell	B-UNK
carcinomas	B-UNK
constitute	B-UNK
a	O
particularly	B-UNK
frequent	B-UNK
cause	B-UNK
of	O
death	B-DISEASE
in	O
this	O
disorder	O
,	O
occurring	B-UNK
as	O
bilateral	B-UNK
and	O
multifocal	O
tumours	B-UNK
,	O
and	O
presenting	B-UNK
at	B-DISEASE
an	O
earlier	B-UNK
age	B-UNK
than	O
in	O
sporadic	B-UNK
,	O
non	B-UNK
-	O
familial	B-UNK
cases	B-UNK
of	O
this	O
tumour	B-UNK
type	B-UNK
.	O

 	O
we	O
report	B-UNK
here	O
that	O
the	O
vhl	B-UNK
gene	B-UNK
is	O
linked	B-UNK
to	O
the	O
locus	B-UNK
encoding	B-UNK
the	O
human	B-UNK
homologoue	O
of	O
the	O
raf1	O
oncogene	B-UNK
,	O
which	O
maps	B-UNK
to	O
chromosome	B-UNK
3p25	O
(	O
ref	O
.	O
4	O
)	O
.	O

 	O
crossovers	O
with	O
the	O
vhl	B-UNK
locus	B-UNK
suggest	B-UNK
that	O
the	O
defect	B-UNK
responsible	B-UNK
for	O
the	O
vhl	B-UNK
phenotype	B-UNK
is	O
not	O
a	O
mutation	B-UNK
in	O
the	O
raf1	O
gene	B-UNK
itself	O
.	O

 	O
an	O
alternative	B-UNK
or	O
prior	B-UNK
event	B-UNK
to	O
oncogene	B-UNK
activation	B-UNK
in	O
tumour	B-UNK
formation	B-UNK
may	O
be	O
the	O
inactivation	B-UNK
of	O
a	O
putative	B-UNK
tumour	B-UNK
suppressor	I-UNK
which	O
can	O
be	O
associated	B-UNK
with	O
both	O
the	O
inherited	B-UNK
and	O
sporadic	B-UNK
forms	B-UNK
of	O
the	O
cancer	B-DISEASE
.	O

 	O
sporadic	B-UNK
renal	B-DISEASE
cell	B-UNK
carcinomas	B-UNK
have	O
previously	B-UNK
been	O
associated	B-UNK
with	O
the	O
loss	B-UNK
of	O
regions	B-UNK
on	O
chromosome	B-UNK
3p	O
(	O
refs	O
5	O
,	O
6	O
)	O
.	O

 	O
consequently	B-UNK
,	O
sporadic	B-UNK
and	O
vhl	B-UNK
-	O
associated	B-UNK
forms	B-UNK
of	O
renal	B-DISEASE
cell	B-UNK
carcinoma	B-DISEASE
might	O
both	O
result	B-UNK
from	O
alterations	B-UNK
causing	B-UNK
loss	B-UNK
of	O
function	B-UNK
of	O
the	O
same	O
tumour	B-UNK
suppressor	I-UNK
gene	B-UNK
on	O
this	O
chromosome	B-UNK
.	O
.	O

 	O
tightly	B-UNK
linked	I-UNK
flanking	B-UNK
markers	B-UNK
for	O
the	O
lowe	O
oculocerebrorenal	B-DISEASE
syndrome	I-DISEASE
,	O
with	O
application	O
to	O
carrier	B-UNK
assessment	B-UNK
.	O

 	O
the	O
lowe	O
oculocerebrorenal	B-DISEASE
syndrome	I-DISEASE
(	O
ocrl	B-UNK
)	O
is	O
characterized	B-UNK
by	O
congenital	B-DISEASE
cataract	B-DISEASE
,	O
mental	B-DISEASE
retardation	I-DISEASE
,	O
and	O
defective	B-UNK
renal	B-DISEASE
tubular	O
function	B-UNK
.	O

 	O
a	O
map	B-UNK
assignment	B-UNK
of	O
ocrl	B-UNK
to	O
xq24	O
-	O
q26	O
has	O
been	O
made	O
previously	B-UNK
by	O
linkage	B-UNK
analysis	I-UNK
with	O
dxs42	O
at	B-DISEASE
xq24	O
-	O
q26	O
(	O
theta	B-UNK
=	I-UNK
0	O
,	O
z	B-UNK
=	O
5	O
.	O
09	O
)	O
and	O
with	O
dxs10	O
at	B-DISEASE
xq26	O
(	O
theta	B-UNK
=	I-UNK
0	O
,	O
z	B-UNK
=	O
6	O
.	O
45	O
)	O
.	O

 	O
two	O
additional	B-UNK
families	B-UNK
were	O
studied	B-UNK
and	O
three	O
additional	B-UNK
polymorphisms	B-UNK
were	O
identified	B-UNK
at	B-DISEASE
dxs42	O
by	O
using	O
a	O
35	O
-	O
kb	B-UNK
sequence	B-UNK
isolated	B-UNK
with	O
the	O
probe	B-UNK
detecting	B-UNK
the	O
original	B-UNK
polymorphism	O
at	B-DISEASE
dxs42	O
.	O

 	O
with	O
additional	B-UNK
ocrl	B-UNK
families	B-UNK
made	O
informative	B-UNK
for	O
dxs42	O
,	O
theta	B-UNK
remained	B-UNK
0	O
with	O
z	B-UNK
=	O
6	O
.	O

 	O
63	O
;	O
and	O
for	O
dxs10	O
theta	B-UNK
=	I-UNK
0	O
.	O

 	O
03	O
and	O
z	B-UNK
=	O
7	O
.	O

 	O
07	O
.	O

 	O
evidence	B-UNK
for	O
placing	O
ocrl	B-UNK
at	B-DISEASE
xq25	B-UNK
also	O
comes	O
from	O
a	O
female	B-UNK
with	O
lowe	O
syndrome	B-DISEASE
and	O
an	O
x	B-UNK
;	O
3	O
translocation	B-DISEASE
.	O

 	O
we	O
have	O
used	O
the	O
xq25	B-UNK
breakpoint	B-UNK
in	O
this	O
patient	B-UNK
to	O
determine	O
the	O
position	B-UNK
of	O
ocrl	B-UNK
relative	B-UNK
to	O
the	O
two	O
linked	B-UNK
markers	I-UNK
.	O

 	O
each	O
derivative	B-UNK
chromosome	B-UNK
was	O
isolated	B-UNK
away	O
from	O
its	O
normal	B-UNK
counterpart	O
in	O
somatic	B-UNK
cell	I-UNK
hybrids	I-UNK
.	O

 	O
dxs42	O
was	O
mapped	B-UNK
to	O
the	O
derivative	B-UNK
chromosome	B-UNK
x	B-UNK
containing	B-UNK
xpterq25	O
,	O
and	O
dxs10	O
was	O
mapped	B-UNK
to	O
the	O
derivative	B-UNK
chromosome	B-DISEASE
3	I-DISEASE
containing	B-UNK
xq25	B-UNK
-	O
qter	O
.	O

 	O
the	O
markers	B-UNK
dxs10	O
and	O
dxs42	O
therefore	O
show	O
tight	B-UNK
linkage	B-UNK
with	O
ocrl	B-UNK
in	O
six	O
families	B-UNK
and	O
flank	O
the	O
xq25	B-UNK
breakpoint	B-UNK
in	O
a	O
female	B-UNK
patient	B-UNK
with	O
an	O
x	B-UNK
;	O
3	O
translocation	B-DISEASE
.	O

 	B-UNK
linkage	I-UNK
analysis	B-UNK
with	O
flanking	B-UNK
markers	B-UNK
was	O
used	O
to	O
assess	B-UNK
ocrl	B-UNK
carrier	B-UNK
status	B-UNK
in	O
women	B-UNK
at	B-DISEASE
risk	B-UNK
.	O

 	B-UNK
results	I-UNK
,	O
when	O
compared	B-UNK
with	O
carrier	B-UNK
determination	B-UNK
by	O
ophthalmologic	O
examination	B-UNK
,	O
indicated	B-UNK
that	O
the	O
slit	O
-	O
lamp	O
exam	O
can	O
be	O
a	O
sensitive	B-UNK
and	O
specific	B-UNK
method	B-UNK
of	O
carrier	B-UNK
determination	B-UNK
in	O
many	O
cases	B-UNK

 	O
identification	B-UNK
of	O
a	O
single	B-UNK
nucleotide	B-UNK
change	B-UNK
in	O
the	O
hypoxanthine	B-UNK
-	O
guanine	B-UNK
phosphoribosyltransferase	I-UNK
gene	B-UNK
(	O
hprtyale	O
)	O
responsible	B-UNK
for	O
lesch	B-DISEASE
-	I-DISEASE
nyhan	I-DISEASE
syndrome	I-DISEASE
.	O

 	O
complete	B-UNK
deficiency	B-UNK
of	O
hypoxanthine	B-UNK
-	O
guanine	B-UNK
phosphoribosyltransferase	I-UNK
(	O
hprt	B-UNK
)	O
causes	B-UNK
the	O
lesch	B-DISEASE
-	I-DISEASE
nyhan	I-DISEASE
syndrome	I-DISEASE
.	O

 	B-UNK
previous	I-UNK
characterization	B-UNK
of	O
a	O
mutant	B-UNK
form	B-UNK
of	O
hprt	B-UNK
,	O
hprtyale	O
,	O
from	O
a	O
subject	B-UNK
with	O
the	O
lesch	B-DISEASE
-	I-DISEASE
nyhan	I-DISEASE
syndrome	I-DISEASE
revealed	B-UNK
normal	B-UNK
mrna	B-UNK
and	O
protein	B-UNK
concentrations	B-UNK
,	O
no	O
residual	B-UNK
catalytic	B-UNK
activity	B-UNK
,	O
and	O
cathodal	O
migration	B-UNK
upon	O
page	O
.	O

 	O
we	O
have	O
cloned	B-UNK
and	O
sequenced	B-UNK
hprtyale	O
cdna	B-UNK
.	O

 	O
the	O
nucleotide	B-UNK
sequence	B-UNK
of	O
full	O
-	O
length	O
hprtyale	O
cdna	B-UNK
revealed	B-UNK
a	O
single	B-UNK
nucleotide	B-UNK
substitution	B-UNK
compared	B-UNK
with	O
normal	B-UNK
hprt	B-UNK
cdna	B-UNK
g	B-UNK
-	O
-	O
-	O
-	O
c	B-UNK
at	B-DISEASE
nucleotide	B-UNK
position	B-UNK
211	O
.	O

 	O
this	O
transversion	B-UNK
predicts	B-UNK
substitution	B-UNK
of	O
arginine	B-UNK
for	O
glycine	B-UNK
at	B-DISEASE
amino	B-UNK
acid	I-UNK
position	B-UNK
71	O
,	O
explaining	O
the	O
cathodal	O
migration	B-UNK
of	O
hprtyale	O
.	O

 	O
chou	O
-	O
fasman	O
secondary	B-UNK
structure	B-UNK
analysis	B-UNK
predicts	B-UNK
a	O
change	B-UNK
in	O
the	O
probability	O
of	O
beta	B-UNK
-	O
turn	O
formation	B-UNK
in	O
the	O
region	B-UNK
containing	I-UNK
the	O
mutation	B-UNK
.	O

 	O
inclusion	O
of	O
the	O
bulky	O
arginine	B-UNK
side	O
chain	O
in	O
place	B-UNK
of	O
glycine	B-UNK
probably	B-UNK
disrupts	O
protein	B-UNK
folding	O
as	O
well	O
.	O

 	O
cloning	B-UNK
mutant	B-UNK
forms	B-UNK
of	O
cdna	B-UNK
allows	B-UNK
identification	B-UNK
of	O
specific	B-UNK
mutations	B-UNK
,	O
provides	B-UNK
insight	B-UNK
into	O
mutational	B-UNK
mechanisms	B-UNK
,	O
and	O
facilitates	O
structure	B-UNK
-	O
function	B-UNK
analysis	B-UNK
of	O
mutant	B-UNK
proteins	B-UNK
.	O
.	O

 	O
two	O
point	B-UNK
mutations	I-UNK
are	O
responsible	B-UNK
for	O
g6pd	B-UNK
polymorphism	O
in	O
sardinia	O
.	O

 	O
the	O
human	B-UNK
x	B-UNK
-	O
linked	B-UNK
gene	B-UNK
encoding	B-UNK
glucose	B-UNK
6	O
-	O
phosphate	B-UNK
dehydrogenase	I-UNK
(	O
g6pd	B-UNK
)	O
is	O
highly	B-UNK
polymorphic	I-UNK
;	O
more	O
than	O
300	O
g6pd	B-UNK
variants	I-UNK
have	O
been	O
identified	B-UNK
.	O

 	B-UNK
g6pd	I-UNK
deficiency	B-UNK
in	O
different	B-UNK
geographical	O
areas	B-UNK
appears	B-UNK
to	O
have	O
arisen	O
through	O
independent	B-UNK
mutational	B-UNK
events	I-UNK
,	O
but	O
within	O
the	O
same	O
population	B-UNK
it	O
may	O
also	O
be	O
heterogeneous	B-UNK
.	O

 	O
one	O
example	O
is	O
the	O
island	B-UNK
of	O
sardinia	O
,	O
where	O
careful	O
clinical	B-UNK
and	O
biochemical	B-UNK
studies	B-UNK
have	O
identified	B-UNK
four	O
different	B-UNK
g6pd	B-UNK
variants	I-UNK
.	O

 	O
we	O
cloned	B-UNK
and	O
sequenced	B-UNK
the	O
four	O
g6pd	B-UNK
variants	I-UNK
from	O
sardinia	O
and	O
found	B-UNK
that	O
only	O
two	O
mutations	B-UNK
are	O
responsible	B-UNK
for	O
g6pd	B-UNK
deficiency	I-UNK
in	O
this	O
area	B-UNK
one	O
mutation	B-UNK
is	O
the	O
cause	B-UNK
of	O
the	O
g6pd	B-UNK
seattle	O
-	O
like	B-UNK
phenotype	B-UNK
,	O
a	O
milder	B-UNK
form	B-UNK
of	O
g6pd	B-UNK
deficiency	I-UNK
;	O
the	O
other	O
mutation	B-UNK
is	O
responsible	B-UNK
for	O
all	O
forms	B-UNK
of	O
very	O
severe	B-UNK
g6pd	B-UNK
deficiency	I-UNK
in	O
sardinia	O
and	O
,	O
possibly	B-UNK
,	O
in	O
the	O
mediterranean	B-UNK
.	O
.	O

 	O
chronic	B-UNK
nonspherocytic	B-UNK
hemolytic	B-DISEASE
anemia	I-DISEASE
(	O
cnsha	O
)	O
and	O
glucose	B-UNK
6	O
phosphate	B-UNK
dehydrogenase	I-UNK
(	O
g6pd	B-UNK
)	O
deficiency	B-UNK
in	O
a	O
patient	B-UNK
with	O
familial	B-UNK
amyloidotic	O
polyneuropathy	B-DISEASE
(	O
fap	B-DISEASE
)	O
.	O

 	B-UNK
molecular	I-UNK
study	B-UNK
of	O
a	O
new	B-UNK
variant	B-UNK
(	O
g6pd	B-UNK
clinic	B-UNK
)	O
with	O
markedly	B-UNK
acidic	O
ph	B-UNK
optimum	I-UNK
.	O

 	O
a	O
new	B-UNK
glucose	B-UNK
-	O
6	O
-	O
phosphate	B-UNK
dehydrogenase	I-UNK
(	O
g6pd	B-UNK
)	O
variant	B-UNK
with	O
severe	B-UNK
erythrocytic	O
g6pd	B-UNK
deficiency	I-UNK
and	O
a	O
unique	B-UNK
ph	B-UNK
optimum	I-UNK
is	O
described	B-UNK
in	O
a	O
young	B-UNK
patient	B-UNK
with	O
chronic	B-UNK
nonspherocytic	B-UNK
hemolytic	B-DISEASE
anemia	I-DISEASE
(	O
cnsha	O
)	O
and	O
familial	B-UNK
amyloidotic	O
polyneuropathy	B-DISEASE
(	O
fap	B-DISEASE
)	O
.	O

 	O
chronic	B-UNK
hemolysis	B-DISEASE
was	O
present	B-UNK
in	O
the	O
absence	B-UNK
of	O
infections	B-DISEASE
,	O
oxidant	O
drugs	B-UNK
or	O
ingestion	O
of	O
faba	O
beans	B-UNK
.	O

 	O
residual	B-UNK
enzyme	B-UNK
activity	I-UNK
was	O
about	O
2	O
.	O

 	O
6	O
%	O
and	O
63	O
%	O
of	O
normal	B-UNK
activity	B-UNK
in	O
erythrocytes	O
and	O
leucocytes	B-UNK
,	O
respectively	B-UNK
.	O

 	O
a	O
molecular	B-UNK
study	B-UNK
using	O
standard	B-UNK
methods	B-UNK
showed	B-UNK
g6pd	B-UNK
in	O
the	O
patient	B-UNK
to	O
have	O
normal	B-UNK
electrophoretic	I-UNK
mobility	B-UNK
(	O
at	B-DISEASE
ph	B-UNK
7	O
.	O
0	O
,	O
8	O
.	O
0	O
and	O
8	O
.	O
8	O
)	O
,	O
normal	B-UNK
apparent	B-UNK
affinity	B-UNK
for	O
substrates	B-UNK
(	O
km	B-UNK
,	O
g6p	O
and	O
nadp	B-UNK
)	O
and	O
a	O
slightly	B-UNK
abnormal	B-UNK
utilization	B-UNK
of	O
substrate	B-UNK
analogues	B-UNK
(	O
decreased	B-UNK
deamino	O
-	O
nadp	B-UNK
and	O
increased	B-UNK
2	O
-	O
deoxyglucose	O
-	O
6	O
-	O
phosphate	B-UNK
utilization	B-UNK
)	O
.	O

 	O
heat	B-UNK
stability	B-UNK
was	O
found	B-UNK
to	O
be	O
markedly	B-UNK
decreased	B-UNK
(	O
8	O
%	O
of	O
residual	B-UNK
activity	B-UNK
after	O
20	O
min	O
of	O
incubation	O
at	B-DISEASE
46	O
degrees	B-UNK
c	B-UNK
)	O
and	O
a	O
particular	B-UNK
characteristic	B-UNK
of	O
this	O
enzyme	B-UNK
was	O
a	O
biphasic	O
ph	B-UNK
curve	I-UNK
with	O
a	O
greatly	B-UNK
increased	I-UNK
activity	B-UNK
at	B-DISEASE
low	B-UNK
ph	B-UNK
.	O

 	O
although	O
molecular	B-UNK
characteristics	B-UNK
of	O
this	O
variant	B-UNK
closely	B-UNK
resemble	O
those	O
of	O
g6pd	B-UNK
bangkok	O
and	O
g6pd	B-UNK
duarte	B-UNK
,	O
it	O
can	O
be	O
distinguished	O
from	O
these	O
and	O
all	O
other	O
previously	B-UNK
reported	I-UNK
variants	B-UNK
by	O
virtue	O
of	O
its	O
unusual	B-UNK
ph	B-UNK
curve	I-UNK
.	O

 	O
therefore	O
the	O
present	B-UNK
variant	B-UNK
has	O
been	O
designated	B-UNK
g6pd	I-UNK
clinic	B-UNK
to	O
distinguish	O
it	O
from	O
other	O
g6pd	B-UNK
variants	I-UNK
previously	B-UNK
described	I-UNK

 	B-UNK
molecular	I-UNK
detection	B-UNK
of	O
chromosomal	B-UNK
translocations	B-UNK
that	O
disrupt	O
the	O
putative	B-UNK
retinoblastoma	B-DISEASE
susceptibility	B-UNK
locus	B-UNK
.	O

 	O
a	O
candidate	B-UNK
dna	B-UNK
sequence	I-UNK
with	O
many	O
of	O
the	O
properties	B-UNK
predicted	B-UNK
for	O
the	O
retinoblastoma	B-DISEASE
susceptibility	B-UNK
(	O
rb1	B-UNK
)	O
locus	B-UNK
has	O
been	O
cloned	B-UNK
(	O
s	O
.	O
h	O
.	O
friend	O
,	O
r	B-UNK
.	O
bernards	O
,	O
s	O
.	O
rogelj	O
,	O
r	B-UNK
.	O
a	O
.	O
weinberg	O
,	O
j	B-UNK
.	O
m	B-UNK
.	O
rapaport	O
,	O
d	B-UNK
.	O
m	B-UNK
.	O
albert	O
,	O
and	O
t	B-UNK
.	O
p	B-UNK
.	O
dryja	O
,	O
nature	B-UNK
[	O
london	O
]	O
323	O
643	O
-	O
645	O
,	O
1986	O
)	O
.	O

 	O
the	O
large	B-UNK
size	B-UNK
of	O
this	O
gene	B-UNK
(	O
ca	O
.	O
200	O
kilobases	O
[	O
kb	B-UNK
]	O
)	O
and	O
its	O
multiple	B-UNK
dispersed	O
exons	B-UNK
(	O
wiggs	O
et	O
al	O
.	O
,	O
n	B-UNK
.	O
engl	O
.	O
j	B-UNK
.	O
med	O
.	O
318	O
151	O
-	O
157	O
,	O
1988	O
)	O
complicate	O
molecular	B-UNK
screening	B-UNK
strategies	B-UNK
important	B-UNK
in	O
prenatal	B-UNK
and	O
presymptomatic	B-UNK
diagnosis	B-UNK
and	O
in	O
carrier	B-UNK
detection	I-UNK
.	O

 	O
here	O
we	O
used	O
field	B-UNK
inversion	B-UNK
gel	B-UNK
electrophoresis	I-UNK
(	O
fige	O
)	O
to	O
construct	B-UNK
a	O
restriction	O
map	B-UNK
of	O
approximately	B-UNK
1	O
,	O
000	O
kb	B-UNK
of	O
dna	B-UNK
surrounding	B-UNK
the	O
rb1	B-UNK
locus	B-UNK
and	O
to	O
detect	B-UNK
the	O
translocation	B-DISEASE
breakpoints	B-UNK
in	O
three	O
retinoblastoma	B-DISEASE
patients	B-UNK
.	O

 	B-UNK
dna	I-UNK
probes	B-UNK
from	O
either	O
the	O
5	O
or	O
3	O
end	B-UNK
of	O
the	O
gene	B-UNK
were	O
used	O
to	O
detect	B-UNK
a	O
250	O
-	O
kb	B-UNK
eagi	O
restriction	O
fragment	O
in	O
dna	B-UNK
from	O
unaffected	B-UNK
individuals	B-UNK
.	O

 	O
both	O
probes	B-UNK
identified	B-UNK
an	O
additional	B-UNK
hybridizing	O
fragment	O
in	O
the	O
dna	B-UNK
from	O
each	O
patient	B-UNK
,	O
permitting	O
the	O
breakpoints	B-UNK
in	O
all	O
three	O
to	O
be	O
mapped	B-UNK
within	O
the	O
cloned	B-UNK
rb1	B-UNK
gene	B-UNK
.	O

 	O
analysis	B-UNK
of	O
the	O
breakpoint	B-UNK
in	O
one	O
translocation	B-DISEASE
cell	B-UNK
line	B-UNK
allowed	B-UNK
the	O
rb1	B-UNK
gene	B-UNK
to	O
be	O
oriented	O
with	O
its	O
5	O
end	B-UNK
toward	O
the	O
centromere	O
.	O

 	O
the	O
5	O
end	B-UNK
of	O
the	O
gene	B-UNK
also	O
appeared	B-UNK
to	O
be	O
associated	B-UNK
with	O
a	O
clustering	O
of	O
sites	B-UNK
for	O
several	O
infrequently	O
cleaving	O
restriction	O
enzymes	B-UNK
,	O
indicating	B-UNK
the	O
presence	B-UNK
of	O
an	O
hpaii	O
tiny	O
fragment	O
island	B-UNK
.	O

 	O
the	O
detection	B-UNK
and	O
mapping	B-UNK
of	O
the	O
translocation	B-DISEASE
breakpoints	B-UNK
of	O
all	O
three	O
retinoblastoma	B-DISEASE
patients	B-UNK
to	O
within	O
the	O
putative	B-UNK
rb1	B-UNK
gene	B-UNK
substantiated	O
the	O
authenticity	O
of	O
this	O
candidate	B-UNK
sequence	B-UNK
and	O
demonstrated	B-UNK
the	O
utility	O
of	O
fige	O
in	O
detecting	B-UNK
chromosomal	B-UNK
rearrangements	I-UNK
affecting	B-UNK
this	O
locus	B-UNK
.	O

 	B-UNK
inherited	I-UNK
c3	B-UNK
deficiency	I-UNK
with	O
recurrent	B-UNK
infections	B-DISEASE
and	O
glomerulonephritis	B-DISEASE
.	O

 	O
a	O
10	O
-	O
year	B-UNK
-	O
old	B-UNK
laotian	O
boy	B-UNK
had	O
homozygous	B-UNK
deficiency	B-UNK
of	O
the	O
third	O
component	B-UNK
of	O
complement	B-UNK
and	O
recurrent	B-UNK
bacterial	B-DISEASE
infections	I-DISEASE
beginning	O
at	B-DISEASE
age	B-UNK
5	O
months	O
.	O

 	O
cellular	B-UNK
and	O
humoral	O
immunity	B-UNK
were	O
normal	B-UNK
,	O
as	O
were	O
polymorphonuclear	B-UNK
leukocyte	B-UNK
chemotaxis	B-UNK
and	O
bactericidal	B-UNK
activities	B-UNK
.	O

 	B-UNK
serum	I-UNK
complement	B-UNK
-	O
mediated	B-UNK
hemolytic	B-UNK
,	O
chemotactic	B-UNK
,	O
and	O
opsonic	B-UNK
activities	B-UNK
were	O
deficient	B-UNK
.	O

 	O
in	O
vitro	B-UNK
addition	B-UNK
of	O
purified	B-UNK
c3	B-UNK
to	O
patient	B-UNK
serum	B-UNK
restored	B-UNK
hemolytic	B-UNK
complement	I-UNK
to	O
normal	B-UNK
levels	B-UNK
,	O
and	O
plasma	B-UNK
infusion	B-UNK
during	O
each	O
of	O
four	O
episodes	O
of	O
pneumonia	B-DISEASE
significantly	B-UNK
enhanced	B-UNK
serum	B-UNK
opsonic	B-UNK
activity	B-UNK
for	O
as	O
long	B-UNK
as	O
36	O
hours	O
.	O

 	O
a	O
renal	B-DISEASE
biopsy	B-UNK
specimen	O
revealed	B-UNK
mesangiopathic	O
glomerulonephritis	B-DISEASE
,	O
although	O
significant	B-UNK
levels	B-UNK
of	O
circulating	B-UNK
igg	O
immune	B-UNK
complexes	B-UNK
were	O
not	O
detected	B-UNK
.	O

 	O
these	O
findings	B-UNK
further	O
support	B-UNK
the	O
association	B-UNK
of	O
c3	B-UNK
deficiency	I-UNK
with	O
immune	B-UNK
-	O
complex	B-UNK
disease	B-DISEASE
and	O
suggest	B-UNK
that	O
plasma	B-UNK
infusion	B-UNK
may	O
be	O
an	O
adjunct	O
to	O
antibiotic	O
therapy	B-UNK
in	O
the	O
management	O
of	O
severe	B-UNK
pyogenic	O
infections	B-DISEASE
in	O
patients	B-UNK
with	O
c3	B-UNK
deficiency	I-UNK
.	O
.	O

 	B-UNK
dna	I-UNK
restriction	O
fragments	B-UNK
associated	B-UNK
with	O
alpha	B-UNK
1	O
-	O
antitrypsin	O
indicate	B-UNK
a	O
single	B-UNK
origin	B-UNK
for	O
deficiency	B-UNK
allele	B-UNK
pi	B-UNK
z	I-UNK
.	O

 	O
the	O
alpha	B-UNK
1	O
-	O
protease	B-UNK
inhibitor	B-UNK
,	O
or	O
alpha	B-UNK
-	O
antitrypsin	O
(	O
aat	O
)	O
,	O
a	O
major	B-UNK
plasma	B-UNK
inhibitor	B-UNK
of	O
leukocyte	B-UNK
elastase	O
and	O
bacterial	B-UNK
proteases	O
,	O
is	O
encoded	B-UNK
at	B-DISEASE
the	O
pi	O
locus	B-UNK
on	O
chromosome	B-DISEASE
14	I-DISEASE
(	O
14q24	O
.	O
3	O
-	O
q32	O
.	O
1	O
)	O
.	O

 	O
a	O
deficiency	B-UNK
of	O
aat	O
in	O
individuals	B-UNK
homozygous	B-UNK
for	O
the	O
pi	B-UNK
z	I-UNK
allele	B-UNK
occurs	B-UNK
in	O
about	O
1	O
in	O
2	O
,	O
000	O
-	O
8	O
,	O
000	O
caucasians	B-UNK
and	O
is	O
associated	B-UNK
with	O
an	O
increased	B-UNK
risk	B-UNK
of	O
early	B-UNK
adult	B-UNK
onset	I-UNK
emphysema	B-DISEASE
and	O
liver	B-DISEASE
disease	I-DISEASE
in	O
childhood	B-UNK
.	O

 	O
we	O
have	O
now	O
used	O
dna	B-UNK
polymorphisms	B-UNK
associated	B-UNK
with	O
the	O
aat	O
gene	B-UNK
to	O
investigate	O
the	O
origin	B-UNK
of	O
the	O
pi	B-UNK
z	I-UNK
allele	B-UNK
.	O

 	O
using	O
two	O
genomic	B-UNK
probes	B-UNK
extending	B-UNK
into	O
the	O
5	O
and	O
3	O
flanking	B-UNK
regions	B-UNK
,	O
respectively	B-UNK
,	O
we	O
have	O
identified	B-UNK
eight	O
polymorphic	B-UNK
restriction	O
sites	B-UNK
.	O

 	O
extensive	B-UNK
linkage	B-UNK
disequilibrium	I-UNK
occurs	B-UNK
throughout	O
the	O
probed	O
region	B-UNK
with	O
the	O
pi	B-UNK
z	I-UNK
allele	B-UNK
,	O
but	O
not	O
with	O
normal	B-UNK
pi	O
m	B-UNK
alleles	B-UNK
.	O

 	O
the	O
z	B-UNK
allele	I-UNK
occurs	B-UNK
mainly	B-UNK
with	O
one	O
haplotype	B-UNK
,	O
indicating	B-UNK
a	O
single	B-UNK
,	O
relatively	B-UNK
recent	B-UNK
,	O
origin	B-UNK
in	O
caucasians	B-UNK

 	O
segregation	B-UNK
analysis	B-UNK
of	O
a	O
marker	B-UNK
localised	B-UNK
xp21	B-UNK
.	O
2	O
-	O
xp21	B-UNK
.	O
3	O
in	O
duchenne	B-UNK
and	O
becker	O
muscular	B-DISEASE
dystrophy	I-DISEASE
families	B-UNK
.	O

 	O
a	O
dna	B-UNK
marker	B-UNK
c7	B-UNK
,	O
localised	B-UNK
xp21	B-UNK
.	O

 	O
1	O
-	O
xp21	B-UNK
.	O

 	O
3	O
,	O
has	O
been	O
studied	B-UNK
in	O
kindreds	B-UNK
segregating	B-UNK
for	O
duchenne	B-UNK
muscular	B-DISEASE
dystrophy	I-DISEASE
(	O
dmd	B-UNK
)	O
and	O
becker	O
muscular	B-DISEASE
dystrophy	I-DISEASE
(	O
bmd	B-UNK
)	O
.	O

 	O
in	O
dmd	B-UNK
families	B-UNK
four	O
crossovers	O
were	O
observed	B-UNK
in	O
38	O
informative	B-UNK
meioses	B-UNK
between	O
c7	B-UNK
and	O
the	O
dmd	B-UNK
locus	B-UNK
(	O
theta	B-UNK
=	I-UNK
0	O
.	O
12	O
,	O
z	B-UNK
max	B-UNK
=	I-UNK
+	O
2	O
.	O
72	O
)	O
.	O

 	O
in	O
bmd	B-UNK
families	B-UNK
no	O
recombinants	O
were	O
observed	B-UNK
in	O
the	O
16	O
informative	B-UNK
meioses	B-UNK
studied	B-UNK
.	O

 	O
these	O
data	B-UNK
are	O
consistent	B-UNK
with	O
the	O
localisation	B-UNK
of	O
the	O
mutations	B-UNK
in	O
these	O
disorders	B-UNK
being	O
in	O
the	O
same	O
region	B-UNK
of	O
xp21	B-UNK
.	O

 	O
studies	B-UNK
in	O
families	B-UNK
also	O
segregating	B-UNK
for	O
the	O
dna	B-UNK
marker	B-UNK
754	O
support	B-UNK
the	O
previously	B-UNK
reported	I-UNK
physical	B-UNK
order	B-UNK
of	O
these	O
loci	B-UNK
as	O
x	B-UNK
centromere	O
-	O
754	O
-	O
dmd	B-UNK
-	O
bmd	B-UNK
-	O
c7	B-UNK
-	O
x	B-UNK
telomere	O
.	O

 	O
a	O
recombination	B-UNK
fraction	B-UNK
of	O
0	O
.	O

 	O
11	O
(	O
z	B-UNK
max	B-UNK
=	I-UNK
+	O
5	O
.	O
58	O
)	O
was	O
found	B-UNK
between	O
dmd	B-UNK
-	O
754	O
by	O
combining	B-UNK
our	O
previously	B-UNK
published	I-UNK
data	B-UNK
with	O
the	O
data	B-UNK
presented	B-UNK
here	O
.	O

 	O
c7	B-UNK
and	O
754	O
thus	O
provide	B-UNK
good	B-UNK
bridging	O
markers	B-UNK
for	O
the	O
diagnosis	B-UNK
of	O
dmd	B-UNK
and	O
bmd	B-UNK

 	O
isolation	B-UNK
of	O
molecular	B-UNK
probes	B-UNK
associated	B-UNK
with	O
the	O
chromosome	B-DISEASE
15	I-DISEASE
instability	B-UNK
in	O
the	O
prader	B-DISEASE
-	I-DISEASE
willi	I-DISEASE
syndrome	I-DISEASE
.	O

 	O
flow	B-UNK
cytometry	O
and	O
recombinant	B-UNK
dna	B-UNK
techniques	B-UNK
have	O
been	O
used	O
to	O
obtain	O
reagents	B-UNK
for	O
a	O
molecular	B-UNK
analysis	B-UNK
of	O
the	O
prader	B-DISEASE
-	I-DISEASE
willi	I-DISEASE
syndrome	I-DISEASE
(	O
pws	B-UNK
)	O
.	O

 	O
hindiii	B-UNK
total	B-UNK
-	O
digest	O
libraries	B-UNK
were	O
prepared	O
in	O
lambda	B-UNK
phage	B-UNK
charon	O
21a	O
from	O
flow	B-UNK
-	O
sorted	O
inverted	B-UNK
duplicated	B-UNK
no	O
.	O
15	O
human	B-UNK
chromosomes	B-UNK
and	O
propagated	O
on	O
recombination	B-UNK
-	O
proficient	O
(	O
le392	O
)	O
and	O
recbc	O
-	O
,	O
sbcb	O
-	O
(	O
db1257	O
)	O
bacteria	O
.	O

 	O
twelve	O
distinct	B-UNK
chromosome	B-DISEASE
15	I-DISEASE
-	O
specific	B-UNK
probes	B-UNK
have	O
been	O
isolated	B-UNK
.	O

 	O
eight	O
localized	B-UNK
to	O
the	O
region	B-UNK
15q11	B-UNK
-	O
-	O
-	O
-	O
13	O
.	O

 	O
four	O
of	O
these	O
eight	O
sublocalized	O
to	O
band	B-UNK
15q11	B-UNK
.	O

 	O
2	O
and	O
are	O
shown	B-UNK
to	O
be	O
deleted	B-UNK
in	O
dna	B-UNK
of	O
one	O
of	O
two	O
patients	B-UNK
examined	B-UNK
with	O
the	O
pws	B-UNK
.	O

 	O
heteroduplex	B-UNK
analysis	B-UNK
of	O
two	O
of	O
these	O
clones	B-UNK
,	O
which	O
grew	O
on	O
db1257	O
but	O
not	O
on	O
le392	O
,	O
revealed	B-UNK
stem	O
-	O
loop	B-UNK
structures	B-UNK
in	O
the	O
inserts	B-UNK
,	O
indicative	O
of	O
inverted	B-UNK
,	O
repeated	B-UNK
dna	B-UNK
elements	B-UNK
.	O

 	O
such	O
dna	B-UNK
repeats	B-UNK
might	O
account	B-UNK
for	O
some	O
of	O
the	O
cloning	B-UNK
instability	B-UNK
of	O
dna	B-UNK
segments	B-UNK
from	O
proximal	B-UNK
15q	O
.	O

 	O
analysis	B-UNK
of	O
the	O
genetic	B-UNK
and	O
physical	B-UNK
instability	B-UNK
associated	B-UNK
with	O
the	O
repeated	B-UNK
sequences	B-UNK
we	O
have	O
isolated	B-UNK
from	O
band	B-UNK
15q11	B-UNK
.	O

 	O
2	O
may	O
elucidate	O
the	O
molecular	B-UNK
basis	I-UNK
for	O
the	O
instability	B-UNK
of	O
this	O
chromosomal	B-UNK
region	B-UNK
in	O
patients	B-UNK
with	O
the	O
pws	B-UNK
or	O
other	O
diseases	B-DISEASE
associated	B-UNK
with	O
chromosomal	B-UNK
abnormalities	B-DISEASE
in	O
the	O
proximal	B-UNK
long	B-UNK
arm	B-UNK
of	O
human	B-UNK
chromosome	I-UNK
15	O

 	O
analysis	B-UNK
of	O
deletions	B-UNK
in	O
dna	B-UNK
from	O
patients	B-UNK
with	O
becker	O
and	O
duchenne	B-UNK
muscular	B-DISEASE
dystrophy	I-DISEASE
.	O

 	O
duchenne	B-UNK
muscular	B-DISEASE
dystrophy	I-DISEASE
(	O
dmd	B-UNK
)	O
is	O
an	O
x	B-UNK
-	O
linked	B-UNK
recessive	O
genetic	B-UNK
disorder	O
for	O
which	O
the	O
biochemical	B-UNK
defect	B-UNK
is	O
as	O
yet	O
unknown	B-UNK
.	O

 	O
recently	B-UNK
,	O
two	O
cloned	B-UNK
segments	B-UNK
of	O
human	B-UNK
x	B-UNK
-	O
chromosome	B-UNK
dna	B-UNK
have	O
been	O
described	B-UNK
which	O
detect	B-UNK
structural	B-UNK
alterations	B-UNK
within	O
or	O
near	B-UNK
the	O
genetic	B-UNK
locus	B-UNK
responsible	B-UNK
for	O
the	O
disorder	O
.	O

 	O
both	O
of	O
these	O
cloned	B-UNK
segments	B-UNK
were	O
described	B-UNK
as	O
tightly	B-UNK
linked	I-UNK
to	O
the	O
locus	B-UNK
and	O
were	O
capable	O
of	O
detecting	B-UNK
deletions	B-UNK
in	O
the	O
dna	B-UNK
of	O
boys	B-UNK
affected	B-UNK
with	O
dmd	B-UNK
.	O

 	O
in	O
an	O
attempt	O
to	O
determine	O
more	O
precisely	O
the	O
occurrence	B-UNK
of	O
these	O
deletions	B-UNK
within	O
a	O
large	B-UNK
population	B-UNK
of	O
dmd	B-UNK
patients	B-UNK
and	O
the	O
accuracy	O
of	O
one	O
of	O
the	O
segments	B-UNK
,	O
dxs164	B-UNK
(	O
pert87	O
)	O
,	O
in	O
determining	O
the	O
inheritance	B-UNK
of	O
the	O
dmd	B-UNK
x	B-DISEASE
chromosome	I-DISEASE
,	O
the	O
subclones	O
1	O
,	O
8	O
and	O
15	O
were	O
made	O
available	B-UNK
to	O
many	O
investigators	O
throughout	O
the	O
world	O
.	O

 	O
here	O
we	O
describe	B-UNK
the	O
combined	B-UNK
results	B-UNK
of	O
more	O
than	O
20	O
research	B-UNK
laboratories	O
with	O
respect	O
to	O
the	O
occurrence	B-UNK
of	O
deletions	B-UNK
at	B-DISEASE
the	O
dxs164	B-UNK
locus	B-UNK
in	O
dna	B-UNK
samples	I-UNK
isolated	B-UNK
from	O
patients	B-UNK
with	O
dmd	B-UNK
and	O
becker	O
muscular	B-DISEASE
dystrophy	I-DISEASE
(	O
bmd	B-UNK
)	O
.	O

 	O
the	O
results	B-UNK
indicate	B-UNK
that	O
the	O
dxs164	B-UNK
locus	B-UNK
apparently	B-UNK
recombines	O
with	O
dmd	B-UNK
5	O
%	O
of	O
the	O
time	B-UNK
,	O
but	O
is	O
probably	B-UNK
located	B-UNK
between	O
independent	B-UNK
sites	B-UNK
of	O
mutation	B-UNK
which	O
yield	O
dmd	B-UNK
.	O

 	O
the	O
breakpoints	B-UNK
of	O
some	O
deletions	B-UNK
are	O
delineated	O
within	O
the	O
dxs164	B-UNK
locus	B-UNK
,	O
and	O
it	O
is	O
evident	O
that	O
the	O
deletions	B-UNK
at	B-DISEASE
the	O
dmd	B-UNK
locus	B-UNK
are	O
frequent	B-UNK
and	O
extremely	B-UNK
large	B-UNK
.	O
.	O

 	O
a	O
potential	B-UNK
animal	B-UNK
model	B-UNK
for	O
lesch	B-DISEASE
-	I-DISEASE
nyhan	I-DISEASE
syndrome	I-DISEASE
through	O
introduction	O
of	O
hprt	B-UNK
mutations	B-UNK
into	O
mice	B-UNK
.	O

 	O
the	O
human	B-UNK
lesch	B-DISEASE
-	I-DISEASE
nyhan	I-DISEASE
syndrome	I-DISEASE
is	O
a	O
rare	B-UNK
neurological	B-UNK
and	O
behavioural	O
disorder	O
,	O
affecting	B-UNK
only	O
males	B-UNK
,	O
which	O
is	O
caused	B-UNK
by	O
an	O
inherited	B-UNK
deficiency	B-UNK
in	O
the	O
level	B-UNK
of	O
activity	B-UNK
of	O
the	O
purine	O
salvage	B-UNK
enzyme	B-UNK
hypoxanthine	B-UNK
-	O
guanosine	O
phosphoribosyl	O
transferase	O
(	O
hprt	B-UNK
)	O
.	O

 	O
how	O
the	O
resulting	B-UNK
alterations	B-UNK
in	O
purine	O
metabolism	B-DISEASE
lead	B-UNK
to	O
the	O
severe	B-UNK
symptoms	B-UNK
characteristic	B-UNK
of	O
lesch	O
-	O
nyhan	B-UNK
patients	B-UNK
is	O
still	O
not	O
understood	O
.	O

 	O
no	O
mutations	B-UNK
at	B-DISEASE
the	O
hprt	B-UNK
locus	I-UNK
leading	B-UNK
to	O
loss	B-UNK
of	O
activity	B-UNK
have	O
been	O
described	B-UNK
in	O
laboratory	B-UNK
animals	O
.	O

 	O
to	O
derive	O
an	O
animal	B-UNK
model	B-UNK
for	O
the	O
lesch	B-DISEASE
-	I-DISEASE
nyhan	I-DISEASE
syndrome	I-DISEASE
,	O
we	O
have	O
used	O
cultured	B-UNK
mouse	B-UNK
embryonic	O
stem	O
cells	B-UNK
,	O
mutagenized	O
by	O
retroviral	B-UNK
insertion	B-UNK
and	O
selected	B-UNK
for	O
loss	B-UNK
of	O
hprt	B-UNK
activity	B-UNK
,	O
to	O
construct	B-UNK
chimaeric	O
mice	B-UNK
.	O

 	O
two	O
clonal	B-UNK
lines	B-UNK
carrying	B-UNK
different	B-UNK
mutant	B-UNK
hprt	I-UNK
alleles	B-UNK
have	O
given	B-UNK
rise	B-UNK
to	O
germ	O
cells	B-UNK
in	O
chimaeras	O
,	O
allowing	B-UNK
the	O
derivation	O
of	O
strains	B-UNK
of	O
mutant	B-UNK
mice	I-UNK
having	B-UNK
the	O
same	O
biochemical	B-UNK
defect	B-UNK
as	O
lesch	O
-	O
nyhan	B-UNK
patients	B-UNK
.	O

 	O
male	B-UNK
mice	B-UNK
carrying	I-UNK
the	O
mutant	B-UNK
alleles	I-UNK
are	O
viable	O
and	O
analysis	B-UNK
of	O
their	O
cells	B-UNK
shows	B-UNK
a	O
total	B-UNK
lack	B-UNK
of	O
hprt	B-UNK
activity	B-UNK
.	O
.	O

 	O
re	O
-	O
evaluation	B-UNK
of	O
the	O
sublocalization	O
of	O
esterase	O
d	B-UNK
and	O
its	O
relation	O
to	O
the	O
retinoblastoma	B-DISEASE
locus	B-UNK
by	O
in	O
situ	B-UNK
hybridization	I-UNK
.	O

 	O
in	O
situ	B-UNK
hybridization	I-UNK
of	O
a	O
cdna	B-UNK
probe	B-UNK
for	O
the	O
esterase	O
d	B-UNK
gene	B-UNK
(	O
esd	O
)	O
was	O
carried	B-UNK
out	O
on	O
human	B-UNK
chromosomes	B-UNK
.	O

 	O
the	O
probe	B-UNK
hybridized	O
most	O
strongly	B-UNK
to	O
13q14	B-UNK
.	O

 	O
2	O
and	O
13q14	B-UNK
.	O

 	O
3	O
.	O

 	O
this	O
observation	B-UNK
raises	B-UNK
doubts	O
concerning	B-UNK
the	O
most	O
recently	B-UNK
published	B-UNK
assignment	B-UNK
of	O
esd	O
to	O
13q14	B-UNK
.	O

 	O
1	O
.	O

 	O
a	O
deletion	B-UNK
in	O
an	O
individual	B-UNK
with	O
retinoblastoma	B-DISEASE
was	O
reported	B-UNK
to	O
separate	B-UNK
the	O
closely	B-UNK
linked	I-UNK
esd	O
and	O
retinoblastoma	B-DISEASE
(	O
rb1	B-UNK
)	O
loci	B-UNK
,	O
placing	O
esd	O
proximal	B-UNK
to	O
rb1	B-UNK
.	O

 	O
quantitative	B-UNK
in	O
situ	B-UNK
hybridization	I-UNK
studies	B-UNK
of	O
this	O
deletion	B-UNK
do	O
not	O
confirm	B-UNK
this	O
interpretation	O
.	O

 	O
rather	O
,	O
they	O
suggest	B-UNK
that	O
esd	O
is	O
missing	O
from	O
the	O
deleted	B-UNK
chromosome	B-UNK
13	O
and	O
duplicated	B-UNK
on	O
the	O
normal	B-UNK
homolog	B-UNK
.	O

 	O
from	O
these	O
findings	B-UNK
,	O
we	O
conclude	O
that	O
the	O
deletion	B-UNK
in	O
this	O
individual	B-UNK
can	O
not	O
be	O
used	O
to	O
determine	O
the	O
orientation	O
nor	O
the	O
sublocalization	O
of	O
esd	O
and	O
rb1	B-UNK
within	O
the	O
13q14	B-UNK
region	B-UNK
.	O

 	B-UNK
hereditary	I-UNK
c2	B-UNK
deficiency	I-UNK
associated	B-UNK
with	O
common	B-DISEASE
variable	I-DISEASE
immunodeficiency	I-DISEASE
.	O

 	B-UNK
homozygous	I-UNK
c2	B-UNK
deficiency	I-UNK
in	O
a	O
19	O
-	O
year	B-UNK
-	O
old	B-UNK
boy	B-UNK
was	O
associated	B-UNK
with	O
variable	B-UNK
immunodeficiency	B-DISEASE
manifested	O
by	O
marked	B-UNK
hypoimmunoglobulinemia	O
and	O
impaired	B-UNK
antibody	B-UNK
responses	B-UNK
,	O
normal	B-UNK
circulating	B-UNK
b	B-UNK
lymphocytes	B-UNK
,	O
and	O
subnormal	O
t	B-UNK
-	O
cell	B-UNK
functions	B-UNK
.	O

 	O
neither	O
antilymphocytic	O
autoantibodies	O
nor	O
chromosomal	B-UNK
abnormalities	B-DISEASE
were	O
found	B-UNK
.	O

 	B-UNK
serum	I-UNK
immunoglobulin	B-UNK
levels	B-UNK
were	O
within	O
normal	B-UNK
limits	O
in	O
his	O
parents	B-UNK
and	O
brother	B-UNK
who	O
were	O
heterozygous	B-UNK
for	O
c2	B-UNK
deficiency	I-UNK
.	O

 	O
the	O
patients	B-UNK
lymphocytes	B-UNK
were	O
homozygous	B-UNK
at	B-DISEASE
the	O
hla	B-UNK
-	O
d	B-UNK
locus	B-UNK
but	O
expressed	B-UNK
an	O
antigen	B-UNK
different	B-UNK
from	O
dw2	O
.	O
.	O

 	O
mild	B-UNK
and	O
severe	B-UNK
muscular	B-DISEASE
dystrophy	I-DISEASE
associated	B-UNK
with	O
deletions	B-UNK
in	O
xp21	B-UNK
of	O
the	O
human	B-UNK
x	B-DISEASE
chromosome	I-DISEASE
.	O

 	O
we	O
have	O
analysed	B-UNK
over	O
300	O
patients	B-UNK
suffering	B-UNK
from	O
duchenne	B-UNK
or	O
becker	O
muscular	B-DISEASE
dystrophy	I-DISEASE
(	O
dmd	B-UNK
or	O
bmd	B-UNK
)	O
.	O

 	O
deletions	B-UNK
have	O
been	O
characterised	B-UNK
which	O
encompass	O
either	O
the	O
pert87	O
(	O
dxs164	B-UNK
)	O
locus	B-UNK
only	O
,	O
the	O
xj1	O
.	O

 	O
1	O
(	O
dxs206	O
)	O
and	O
hip25	O
loci	B-UNK
only	O
,	O
or	O
all	O
three	O
loci	B-UNK
.	O

 	O
these	O
loci	B-UNK
have	O
been	O
shown	B-UNK
to	O
lie	O
within	O
the	O
dmd	B-UNK
region	B-UNK
covering	B-UNK
several	O
hundred	O
kilobases	O
(	O
kb	B-UNK
)	O
of	O
dna	B-UNK
.	O

 	O
one	O
mildly	B-UNK
affected	I-UNK
bmd	B-UNK
patient	B-UNK
possesses	O
a	O
deletion	B-UNK
of	O
at	B-DISEASE
least	O
110	O
kb	B-UNK
including	B-UNK
exons	B-UNK
of	O
the	O
dmd	B-UNK
gene	B-UNK
.	O

 	O
other	O
patients	B-UNK
with	O
similar	B-UNK
exon	B-UNK
deletions	B-UNK
,	O
or	O
smaller	B-UNK
deletions	B-UNK
,	O
show	O
the	O
more	O
severe	B-UNK
phenotype	B-UNK
typical	B-UNK
of	O
dmd	B-UNK
.	O

 	O
we	O
conclude	O
from	O
these	O
studies	B-UNK
that	O
the	O
severity	B-UNK
of	O
the	O
clinical	B-UNK
phenotype	I-UNK
can	O
not	O
be	O
explained	O
on	O
the	O
basis	B-UNK
of	O
the	O
size	B-UNK
of	O
the	O
deletion	B-UNK
.	O

 	O
we	O
discuss	O
this	O
in	O
the	O
context	O
of	O
candidate	B-UNK
gene	B-UNK
sequences	B-UNK
.	O

 	O
patterns	B-UNK
of	O
exon	B-UNK
deletions	B-UNK
in	O
duchenne	B-UNK
and	O
becker	O
muscular	B-DISEASE
dystrophy	I-DISEASE
.	O

 	O
a	O
panel	O
of	O
patients	B-UNK
with	O
duchenne	B-UNK
and	O
becker	O
muscular	B-DISEASE
dystrophy	I-DISEASE
(	O
dmd	B-UNK
and	O
bmd	B-UNK
)	O
has	O
been	O
screened	O
with	O
the	O
cdna	B-UNK
probes	B-UNK
cf56a	O
and	O
cf23a	O
,	O
which	O
detect	B-UNK
exons	B-UNK
in	O
the	O
central	B-UNK
part	O
of	O
the	O
dmd	B-UNK
gene	B-UNK
.	O

 	O
one	O
or	O
more	O
exons	B-UNK
were	O
deleted	B-UNK
in	O
60	O
%	O
of	O
patients	B-UNK
.	O

 	O
the	O
deletions	B-UNK
were	O
mapped	B-UNK
and	O
prove	O
to	O
be	O
heterogeneous	B-UNK
in	O
size	B-UNK
and	O
extent	B-UNK
,	O
particularly	B-UNK
in	O
dmd	B-UNK
.	O

 	O
deletions	B-UNK
specific	B-UNK
to	O
dmd	B-UNK
and	O
to	O
bmd	B-UNK
are	O
described	B-UNK
.	O

 	O
half	B-UNK
of	O
all	O
bmd	B-UNK
patients	B-UNK
have	O
a	O
deletion	B-UNK
of	O
one	O
particular	B-UNK
small	B-UNK
group	B-UNK
of	O
exons	B-UNK
;	O
smaller	B-UNK
deletions	B-UNK
within	O
this	O
same	O
group	B-UNK
produce	B-UNK
the	O
more	O
severe	B-UNK
dmd	B-UNK
.	O
.	O

 	B-UNK
hereditary	I-UNK
deficiency	B-UNK
of	O
the	O
third	O
component	B-UNK
of	O
complement	B-UNK
in	O
a	O
child	B-UNK
with	O
fever	B-DISEASE
,	O
skin	B-DISEASE
rash	B-DISEASE
,	O
and	O
arthralgias	O
:	O
response	B-UNK
to	O
transfusion	O
of	O
whole	O
blood	B-UNK
.	O

 	O
a	O
previously	B-UNK
well	O
34	O
-	O
month	O
-	O
old	B-UNK
male	I-UNK
presenting	B-UNK
with	O
fever	B-DISEASE
,	O
skin	B-DISEASE
rash	B-DISEASE
,	O
and	O
arthralgias	O
was	O
found	B-UNK
to	O
lack	B-UNK
c3	B-UNK
by	O
immunochemical	B-UNK
(	O
undetectable	B-UNK
)	O
and	O
hemolytic	B-UNK
(	O
1	O
%	O
normal	B-UNK
)	O
assays	B-UNK
.	O

 	O
no	O
infectious	B-UNK
agent	B-UNK
could	O
be	O
demonstrated	B-UNK
.	O

 	O
protein	B-UNK
levels	B-UNK
of	O
clq	O
.	O

 	O
c4	B-UNK
,	O
c5	B-UNK
,	O
properdin	O
,	O
and	O
c3b	O
-	O
ina	O
and	O
hemolytic	B-UNK
activities	B-UNK
of	O
complement	B-UNK
components	B-UNK
c1	B-UNK
to	O
c9	B-UNK
except	O
c3	B-UNK
were	O
normal	B-UNK
or	O
elevated	B-UNK
;	O
total	B-UNK
hemolytic	B-UNK
complement	I-UNK
activity	B-UNK
was	O
13	O
%	O
of	O
normal	B-UNK
and	O
was	O
reconstituted	O
by	O
purified	B-UNK
c3	B-UNK
.	O

 	O
properdin	O
factor	B-UNK
b	B-UNK
was	O
702	O
(	O
normal	B-UNK
175	O
to	O
275	O
)	O
mug	O
/	O
ml	O
,	O
and	O
was	O
not	O
cleaver	O
upon	O
addition	B-UNK
of	O
zymosan	O
or	O
cobra	O
venom	O
factor	B-UNK
.	O

 	O
the	O
serum	B-UNK
had	O
normal	B-UNK
immune	B-UNK
adherence	O
activity	B-UNK
,	O
but	O
was	O
deficient	B-UNK
in	O
ability	B-UNK
to	O
opsonize	O
candida	O
albicans	O
for	O
uptake	B-UNK
and	O
escherichia	B-UNK
coli	B-UNK
for	O
killing	O
by	O
neurophils	O
,	O
generate	B-UNK
neutrophil	O
chemotactic	B-UNK
factors	B-UNK
and	O
inhibit	O
the	O
growth	B-UNK
of	O
e	B-DISEASE
.	I-DISEASE
coli	I-DISEASE
;	O
these	O
activities	B-UNK
were	O
restored	B-UNK
by	O
purified	B-UNK
c3	B-UNK
.	O

 	O
a	O
transfusion	O
of	O
320	O
ml	O
1	O
-	O
hour	O
-	O
old	B-UNK
normal	B-UNK
whole	O
blood	B-UNK
on	O
the	O
fifty	O
-	O
second	B-UNK
day	B-UNK
resulted	B-UNK
in	O
transitory	O
elevation	O
of	O
the	O
c3	B-UNK
level	B-UNK
to	O
25	O
mg	O
/	O
dl	O
with	O
a	O
fall	O
-	O
off	O
(	O
approximately	B-UNK
2	O
1	O
/	O
2	O
%	O
per	O
hour	O
)	O
to	O
undetectable	B-UNK
levels	B-UNK
by	O
69	O
hours	O
;	O
it	O
was	O
followed	B-UNK
by	O
disappearance	O
of	O
the	O
skin	B-DISEASE
rash	B-DISEASE
and	O
arthralgias	O
and	O
return	O
to	O
normal	B-UNK
of	O
the	O
previously	B-UNK
elevated	B-UNK
temperature	O
and	O
crp	O
levels	B-UNK
.	O

 	O
c3	B-UNK
levels	B-UNK
in	O
family	B-UNK
members	I-UNK
(	O
seven	B-UNK
of	O
24	O
half	B-UNK
-	O
normal	B-UNK
)	O
,	O
lack	B-UNK
of	O
anti	O
-	O
c3	B-UNK
activity	B-UNK
,	O
normal	B-UNK
c3b	O
-	O
ina	O
levels	B-UNK
and	O
a	O
normal	B-UNK
rate	B-UNK
of	O
catabolism	O
of	O
transfused	O
c3	B-UNK
indicated	B-UNK
that	O
the	O
deficiency	B-UNK
was	O
inherited	B-UNK
with	O
autosomal	O
codominance	O
and	O
involved	B-UNK
decreased	B-UNK
synthesis	B-UNK
of	O
c3	B-UNK
.	O

 	O
thus	O
,	O
this	O
child	B-UNK
is	O
a	O
unique	B-UNK
individual	B-UNK
with	O
inherited	B-UNK
c3	B-UNK
deficiency	I-UNK
presenting	B-UNK
with	O
absence	B-UNK
of	O
repeated	B-UNK
infections	B-DISEASE
,	O
whose	O
symptoms	B-UNK
of	O
fever	B-DISEASE
,	O
skin	B-DISEASE
rash	B-DISEASE
,	O
and	O
arthralgia	B-DISEASE
were	O
abated	O
by	O
whole	O
blood	B-UNK
transfusion	O
.	O
.	O

 	O
glucose	B-UNK
-	O
6	O
-	O
phosphate	B-UNK
dehydrogenase	I-UNK
variants	B-UNK
and	O
their	O
frequency	B-UNK
in	O
guangdong	O
,	O
china	O
.	O

 	O
erythrocyte	B-UNK
glucose	B-UNK
-	O
6	O
-	O
phosphate	B-UNK
dehydrogenase	I-UNK
(	O
g6pd	B-UNK
)	O
was	O
characterized	B-UNK
in	O
blood	B-UNK
samples	B-UNK
obtained	B-UNK
from	O
97	O
randomly	B-UNK
selected	B-UNK
males	B-UNK
with	O
enzyme	B-UNK
deficiency	B-UNK
from	O
various	O
regions	B-UNK
of	O
guangdong	O
province	O
,	O
china	O
.	O

 	O
nine	O
new	B-UNK
variants	B-UNK
(	O
gd	B-UNK
kaiping	O
,	O
gd	B-UNK
boluo	O
,	O
gd	B-UNK
huiyang	O
,	O
gd	B-UNK
gaomin	O
,	O
gd	B-UNK
qing	O
-	O
baijiang	O
,	O
gd	B-UNK
gaozhou	O
,	O
gd	B-UNK
huazhou	O
,	O
gd	B-UNK
nanhai	O
,	O
and	O
gd	B-UNK
guangzhou	O
)	O
were	O
identified	B-UNK
.	O

 	O
of	O
the	O
31	O
variants	B-UNK
found	B-UNK
in	O
this	O
province	O
,	O
gd	B-UNK
kaiping	O
,	O
gd	B-UNK
taiwan	O
-	O
hakka	O
,	O
gd	B-UNK
haad	O
yai	O
,	O
gd	B-UNK
haad	O
yai	O
-	O
like	B-UNK
and	O
gd	B-UNK
huiyang	O
occurred	B-UNK
most	O
frequently	B-UNK
.	O

 	O
the	O
frequency	B-UNK
of	O
each	O
variant	B-UNK
was	O
calculated	O
.	O

 	O
the	O
results	B-UNK
demonstrated	B-UNK
that	O
the	O
genetic	B-UNK
heterogeneity	B-UNK
of	O
g6pd	B-UNK
deficiency	I-UNK
was	O
high	B-UNK
in	O
this	O
area	B-UNK
.	O
.	O

 	B-UNK
homozygous	I-UNK
and	O
heterozygous	B-UNK
deletions	B-UNK
of	O
the	O
von	B-DISEASE
willebrand	I-DISEASE
factor	I-DISEASE
gene	B-UNK
in	O
patients	B-UNK
and	O
carriers	B-UNK
of	O
severe	B-UNK
von	B-DISEASE
willebrand	I-DISEASE
disease	I-DISEASE
.	O

 	O
severe	B-UNK
von	B-DISEASE
willebrand	I-DISEASE
disease	I-DISEASE
is	O
characterized	B-UNK
by	O
undetectable	B-UNK
or	O
trace	B-UNK
quantities	B-UNK
of	O
von	B-DISEASE
willebrand	I-DISEASE
factor	I-DISEASE
in	O
plasma	B-UNK
and	O
tissue	B-UNK
stores	O
.	O

 	O
we	O
have	O
studied	B-UNK
the	O
genomic	B-UNK
dna	I-UNK
of	O
10	O
affected	B-UNK
individuals	I-UNK
from	O
six	O
families	B-UNK
with	O
this	O
disorder	O
using	O
probes	B-UNK
from	O
the	O
5	O
and	O
3	O
ends	O
of	O
the	O
vwf	B-UNK
cdna	B-UNK
and	O
with	O
a	O
probe	B-UNK
extending	B-UNK
from	O
the	O
5	O
end	B-UNK
into	O
the	O
central	B-UNK
region	B-UNK
.	O

 	O
southern	O
blots	B-UNK
of	O
restriction	O
endonuclease	O
digests	O
and	O
gene	B-UNK
dosage	O
analysis	B-UNK
measurements	O
carried	B-UNK
out	O
with	O
quantitative	B-UNK
slot	O
blots	B-UNK
of	O
undigested	O
genomic	B-UNK
dna	I-UNK
separated	O
these	O
patients	B-UNK
into	O
three	O
groups	B-UNK
.	O

 	O
the	O
first	O
group	B-UNK
consisted	B-UNK
of	O
a	O
family	B-UNK
with	O
complete	B-UNK
homozygous	B-UNK
deletions	B-UNK
of	O
the	O
vwf	B-UNK
gene	B-UNK
in	O
the	O
four	O
probands	B-UNK
.	O

 	O
gene	B-UNK
dosage	O
analysis	B-UNK
was	O
consistent	B-UNK
with	O
heterozygous	B-UNK
deletions	B-UNK
in	O
both	O
of	O
the	O
asymptomatic	B-UNK
parents	B-UNK
and	O
four	O
asymptomatic	B-UNK
siblings	B-UNK
of	O
this	O
kindred	B-UNK
(	O
p	B-UNK
less	O
than	O
0	O
.	O
01	O
)	O
.	O

 	O
the	O
second	B-UNK
group	B-UNK
was	O
comprised	O
of	O
a	O
family	B-UNK
in	O
which	O
there	O
was	O
a	O
complete	B-UNK
heterozygous	B-UNK
deletion	I-UNK
of	O
the	O
vwf	B-UNK
gene	B-UNK
in	O
the	O
proband	B-UNK
and	O
one	O
asymptomatic	B-UNK
parent	B-UNK
,	O
suggesting	B-UNK
that	O
a	O
different	B-UNK
type	B-UNK
of	O
genetic	B-UNK
abnormality	B-UNK
was	O
inherited	B-UNK
from	O
the	O
other	O
parent	B-UNK
.	O

 	O
thus	O
,	O
the	O
patient	B-UNK
appeared	B-UNK
to	O
be	O
doubly	O
heterozygous	B-UNK
for	O
interacting	O
genetic	B-UNK
abnormalities	B-DISEASE
affecting	B-UNK
vwf	B-UNK
expression	B-UNK
.	O

 	O
in	O
the	O
third	O
group	B-UNK
,	O
no	O
gene	B-UNK
deletions	B-UNK
could	O
be	O
detected	B-UNK
.	O

 	O
alloantibodies	O
developed	B-UNK
only	O
in	O
the	O
kindred	B-UNK
with	O
homozygous	B-UNK
deletions	B-UNK
.	O

 	O
these	O
techniques	B-UNK
should	O
prove	O
useful	B-UNK
in	O
identifying	B-UNK
carriers	B-UNK
of	O
severe	B-UNK
von	B-DISEASE
willebrand	I-DISEASE
disease	I-DISEASE
and	O
also	O
in	O
defining	O
patients	B-UNK
predictably	O
at	B-DISEASE
risk	B-UNK
of	O
developing	B-UNK
alloantibodies	O
to	O
vwf	B-UNK
.	O

 	O
sjogren	B-DISEASE
-	I-DISEASE
larsson	I-DISEASE
syndrome	I-DISEASE
.	O

 	O
impaired	B-UNK
fatty	O
alcohol	O
oxidation	B-UNK
in	O
cultured	B-UNK
fibroblasts	B-UNK
due	O
to	O
deficient	B-UNK
fatty	O
alcohol	O
:	O
nicotinamide	O
adenine	O
dinucleotide	B-UNK
oxidoreductase	B-UNK
activity	B-UNK
.	O

 	O
lipid	B-DISEASE
metabolism	I-DISEASE
was	O
studied	B-UNK
in	O
cultured	B-UNK
skin	B-DISEASE
fibroblasts	B-UNK
from	O
patients	B-UNK
with	O
the	O
inherited	B-UNK
disorder	O
,	O
sjogren	B-DISEASE
-	I-DISEASE
larsson	I-DISEASE
syndrome	I-DISEASE
(	O
sls	B-UNK
)	O
.	O

 	O
intact	B-UNK
sls	B-UNK
fibroblasts	B-UNK
incubated	O
in	O
the	O
presence	B-UNK
of	O
[	O
1	O
-	O
14c	O
]	O
palmitate	O
accumulated	O
more	O
radioactive	O
hexadecanol	B-UNK
than	O
did	O
normal	B-UNK
cells	B-UNK
,	O
whereas	O
incorporation	B-UNK
of	O
radioactivity	O
into	O
other	O
cellular	B-UNK
lipids	O
was	O
unaltered	O
.	O

 	O
the	O
hexadecanol	B-UNK
content	B-UNK
of	O
sls	B-UNK
fibroblasts	B-UNK
was	O
abnormally	B-UNK
elevated	B-UNK
.	O

 	O
hexadecanol	B-UNK
accumulation	B-UNK
was	O
not	O
due	O
to	O
increased	B-UNK
fatty	O
alcohol	O
synthesis	B-UNK
nor	O
its	O
deficient	B-UNK
utilization	B-UNK
for	O
glycerol	B-UNK
ether	O
synthesis	B-UNK
.	O

 	O
the	O
half	B-UNK
-	O
life	B-UNK
of	O
intracellular	B-UNK
hexadecanol	B-UNK
loaded	B-UNK
into	O
sls	B-UNK
fibroblasts	B-UNK
was	O
increased	B-UNK
(	O
70	O
min	O
)	O
compared	B-UNK
with	O
normal	B-UNK
(	O
15	O
min	O
)	O
,	O
and	O
intact	B-UNK
sls	B-UNK
fibroblasts	B-UNK
showed	B-UNK
impaired	B-UNK
oxidation	B-UNK
of	O
[	O
14c	O
]	O
-	O
hexadecanol	B-UNK
to	O
fatty	O
acid	O
.	O

 	O
fatty	O
alcohol	O
nad	O
+	O
oxidoreductase	B-UNK
,	O
the	O
enzyme	B-UNK
catalyzing	O
this	O
reaction	O
,	O
was	O
deficient	B-UNK
in	O
sls	B-UNK
fibroblasts	B-UNK
.	O

 	O
mean	B-UNK
total	B-UNK
activity	B-UNK
in	O
sls	B-UNK
fibroblasts	B-UNK
(	O
n	B-UNK
=	O
5	O
)	O
was	O
13	O
%	O
of	O
that	O
in	O
normal	B-UNK
fibroblasts	B-UNK
,	O
and	O
palmitoyl	B-UNK
coa	B-UNK
-	O
inhibitable	O
activity	B-UNK
was	O
1	O
%	O
of	O
normal	B-UNK
.	O

 	O
fibroblasts	B-UNK
from	O
two	O
obligate	B-UNK
sls	B-UNK
heterozygotes	B-UNK
had	O
enzyme	B-UNK
activities	B-UNK
intermediate	B-UNK
between	O
that	O
in	O
normal	B-UNK
fibroblasts	B-UNK
and	O
individuals	B-UNK
with	O
sls	B-UNK
.	O

 	O
these	O
results	B-UNK
suggest	B-UNK
that	O
the	O
primary	B-UNK
defect	B-UNK
in	O
sls	B-UNK
is	O
deficiency	B-UNK
of	O
fatty	O
alcohol	O
nad	O
+	O
oxidoreductase	B-UNK
.	O

 	O
sls	B-UNK
represents	B-UNK
the	O
first	O
inherited	B-UNK
disorder	O
in	O
man	B-UNK
associated	B-UNK
with	O
an	O
isolated	B-UNK
abnormality	B-UNK
in	O
fatty	O
alcohol	O
metabolism	B-DISEASE
.	O
.	O

 	O
germinal	B-UNK
mosaicism	I-UNK
in	O
duchenne	B-UNK
muscular	B-DISEASE
dystrophy	I-DISEASE
.	O

 	O
we	O
have	O
identified	B-UNK
a	O
duchenne	B-UNK
muscular	B-DISEASE
dystrophy	I-DISEASE
(	O
dmd	B-UNK
)	O
pedigree	B-UNK
where	O
the	O
disease	B-DISEASE
is	O
associated	B-UNK
with	O
a	O
molecular	B-UNK
deletion	B-UNK
within	O
the	O
dmd	B-UNK
locus	B-UNK
.	O

 	O
we	O
have	O
examined	B-UNK
the	O
meiotic	B-UNK
segregation	I-UNK
products	B-UNK
of	O
the	O
common	B-UNK
female	B-UNK
ancestor	B-UNK
using	O
marker	B-UNK
restriction	B-UNK
fragment	I-UNK
length	I-UNK
polymorphisms	I-UNK
(	O
rflps	B-UNK
)	O
detected	B-UNK
by	O
probes	B-UNK
that	O
lie	O
within	O
this	O
deletion	B-UNK
.	O

 	O
these	O
studies	B-UNK
show	O
that	O
this	O
female	B-UNK
has	O
transmitted	B-UNK
three	O
distinct	B-UNK
types	B-UNK
of	O
x	B-DISEASE
chromosome	I-DISEASE
to	O
her	O
offspring	B-UNK
.	O

 	O
this	O
observation	B-UNK
may	O
be	O
explained	O
by	O
postulating	O
that	O
the	O
mutation	B-UNK
arose	B-UNK
as	O
a	O
postzygotic	O
deletion	B-UNK
within	O
this	O
common	B-UNK
ancestor	B-UNK
,	O
who	O
was	O
consequently	B-UNK
germinally	O
mosaic	B-UNK
.	O
.	O

 	O
nebulin	B-UNK
seen	B-UNK
in	O
dmd	B-UNK
males	B-UNK
including	B-UNK
one	O
patient	B-UNK
with	O
a	O
large	B-UNK
dna	B-UNK
deletion	B-UNK
encompassing	I-UNK
the	O
dmd	B-UNK
gene	B-UNK
.	O

 	O
the	O
presence	B-UNK
of	O
nebulin	B-UNK
in	O
a	O
muscle	B-UNK
specimen	O
from	O
a	O
patient	B-UNK
with	O
duchenne	B-UNK
muscular	B-DISEASE
dystrophy	I-DISEASE
(	O
dmd	B-UNK
)	O
due	O
to	O
a	O
large	B-UNK
deletion	B-UNK
precludes	O
the	O
possibility	O
that	O
this	O
protein	B-UNK
is	O
the	O
dmd	B-UNK
gene	B-UNK
product	B-UNK
.	O
.	O

 	O
expression	B-UNK
of	O
the	O
murine	B-UNK
duchenne	B-UNK
muscular	B-DISEASE
dystrophy	I-DISEASE
gene	B-UNK
in	O
muscle	B-UNK
and	O
brain	B-UNK
.	O

 	O
complementary	B-UNK
dna	I-UNK
clones	B-UNK
were	O
isolated	B-UNK
that	O
represent	B-UNK
the	O
5	O
terminal	B-UNK
2	O
.	O

 	O
5	O
kilobases	O
of	O
the	O
murine	B-UNK
duchenne	B-UNK
muscular	B-DISEASE
dystrophy	I-DISEASE
(	O
dmd	B-UNK
)	O
messenger	B-UNK
rna	I-UNK
(	O
mrna	B-UNK
)	O
.	O

 	O
mouse	B-UNK
dmd	B-UNK
mrna	B-UNK
was	O
detectable	B-UNK
in	O
skeletal	B-UNK
and	O
cardiac	B-UNK
muscle	B-UNK
and	O
at	B-DISEASE
a	O
level	B-UNK
approximately	B-UNK
90	O
percent	O
lower	B-UNK
in	O
brain	B-UNK
.	O

 	O
dmd	B-UNK
mrna	B-UNK
is	O
also	O
present	B-UNK
,	O
but	O
at	B-DISEASE
much	O
lower	B-UNK
than	O
normal	B-UNK
levels	B-UNK
,	O
in	O
both	O
the	O
muscle	B-UNK
and	O
brain	B-UNK
of	O
three	O
different	B-UNK
strains	B-UNK
of	O
dystrophic	B-UNK
mdx	B-UNK
mice	B-UNK
.	O

 	O
the	O
identification	B-UNK
of	O
dmd	B-UNK
mrna	B-UNK
in	O
brain	B-UNK
raises	B-UNK
the	O
possibility	O
of	O
a	O
relation	O
between	O
human	B-UNK
duchenne	B-UNK
muscular	B-DISEASE
dystrophy	I-DISEASE
(	O
dmd	B-UNK
)	O
gene	B-UNK
expression	B-UNK
and	O
the	O
mental	B-DISEASE
retardation	I-DISEASE
found	B-UNK
in	O
some	O
dmd	B-UNK
males	B-UNK
.	O

 	O
these	O
results	B-UNK
also	O
provide	B-UNK
evidence	I-UNK
that	O
the	O
mdx	B-UNK
mutations	B-UNK
are	O
allelic	B-UNK
variants	B-UNK
of	O
mouse	B-UNK
dmd	B-UNK
gene	B-UNK
mutations	B-UNK
.	O

 	O
glucose	B-UNK
6	O
-	O
phosphate	B-UNK
dehydrogenase	I-UNK
deficiency	B-UNK
and	O
incidence	O
of	O
hematologic	O
malignancy	B-DISEASE
.	O

 	O
we	O
have	O
evaluated	O
the	O
hypothesis	O
of	O
a	O
negative	B-UNK
association	B-UNK
between	O
glucose	B-UNK
6	O
-	O
phosphate	B-UNK
dehydrogenase	I-UNK
(	O
g6pd	B-UNK
)	O
deficiency	B-UNK
and	O
cancer	B-DISEASE
in	O
a	O
cohort	B-UNK
of	O
481	O
sardinian	B-UNK
males	B-UNK
with	O
hematological	O
malignancies	B-DISEASE
.	O

 	O
the	O
frequency	B-UNK
of	O
g6pd	B-UNK
deficiency	I-UNK
in	O
the	O
patients	B-UNK
was	O
not	O
different	B-UNK
from	O
the	O
incidence	O
in	O
a	O
group	B-UNK
of	O
16	O
,	O
219	O
controls	B-UNK
.	O

 	O
the	O
same	O
conclusion	B-UNK
resulted	B-UNK
from	O
the	O
comparison	B-UNK
of	O
the	O
frequency	B-UNK
of	O
expression	B-UNK
of	O
the	O
gdb	O
gene	B-UNK
in	O
23	O
heterozygous	B-UNK
women	B-UNK
having	B-UNK
a	O
clonal	B-UNK
hematologic	O
disease	B-DISEASE
and	O
a	O
control	B-UNK
group	B-UNK
of	O
37	O
healthy	B-UNK
heterozygotes	B-UNK
.	O

 	O
therefore	O
at	B-DISEASE
present	B-UNK
there	O
is	O
no	O
evidence	B-UNK
that	O
g6pd	B-UNK
deficiency	I-UNK
has	O
a	O
protective	O
effect	B-UNK
against	O
development	B-UNK
of	O
hematologic	B-DISEASE
neoplasms	I-DISEASE
.	O
.	O

 	O
hepatoblastoma	B-DISEASE
,	O
pigmented	B-UNK
ocular	I-UNK
fundus	I-UNK
lesions	B-UNK
and	O
jaw	B-DISEASE
lesions	B-UNK
in	O
gardner	B-DISEASE
syndrome	I-DISEASE
.	O

 	O
hepatoblastoma	B-DISEASE
is	O
a	O
rare	B-UNK
neoplasm	B-DISEASE
of	O
infants	O
and	O
children	B-UNK
only	O
recently	B-UNK
documented	B-UNK
in	O
association	B-UNK
with	O
hereditary	B-UNK
adenomatous	O
polyposis	B-DISEASE
of	O
the	O
colon	O
[	O
kingston	O
et	O
al	O
.	O
,	O
1983	O
]	O
.	O

 	O
we	O
report	B-UNK
four	O
children	B-UNK
with	O
hepatoblastoma	B-DISEASE
from	O
four	O
unrelated	B-UNK
families	I-UNK
with	O
gardner	B-DISEASE
syndrome	I-DISEASE
(	O
gs	O
)	O
.	O

 	O
one	O
child	B-UNK
,	O
now	O
19	O
years	B-UNK
old	B-UNK
,	O
survived	O
after	O
a	O
resection	O
of	O
a	O
hepatoblastoma	B-DISEASE
in	O
infancy	O
and	O
recently	B-UNK
was	O
found	B-UNK
to	O
have	O
gs	O
.	O

 	O
he	O
has	O
an	O
associated	B-UNK
odontoma	B-DISEASE
and	O
pigmented	B-UNK
ocular	I-UNK
fundus	I-UNK
lesions	B-UNK
,	O
both	O
of	O
which	O
have	O
been	O
shown	B-UNK
to	O
be	O
clinical	B-UNK
markers	B-UNK
of	O
gs	O
.	O

 	O
many	O
individuals	B-UNK
in	O
these	O
four	O
gs	O
families	B-UNK
,	O
both	O
affected	B-UNK
and	O
at	B-DISEASE
risk	B-UNK
,	O
have	O
osteomatous	O
jaw	B-DISEASE
lesions	B-UNK
and	O
pigmented	B-UNK
ocular	I-UNK
fundus	I-UNK
lesions	B-UNK
.	O

 	O
a	O
search	O
for	O
colonic	B-DISEASE
polyps	I-DISEASE
should	O
be	O
made	O
in	O
families	B-UNK
of	O
infants	O
and	O
children	B-UNK
with	O
hepatoblastoma	B-DISEASE
.	O

 	O
if	O
the	O
child	B-UNK
survives	O
,	O
he	O
or	O
she	O
should	O
be	O
monitored	O
for	O
the	O
later	B-UNK
appearance	O
of	O
colonic	B-DISEASE
polyps	I-DISEASE
.	O

 	O
the	O
finding	B-UNK
of	O
jaw	B-DISEASE
lesions	B-UNK
and	O
/	O
or	O
pigmented	B-UNK
ocular	I-UNK
fundus	I-UNK
lesions	B-UNK
in	O
relatives	B-UNK
at	B-DISEASE
risk	B-UNK
are	O
indications	O
of	O
the	O
possible	B-UNK
presence	B-UNK
of	O
the	O
gs	O
gene	B-UNK
.	O

 	O
identification	B-UNK
of	O
an	O
altered	B-UNK
splice	B-UNK
site	I-UNK
in	O
ashkenazi	B-UNK
tay	B-DISEASE
-	I-DISEASE
sachs	I-DISEASE
disease	I-DISEASE
.	O

 	O
tay	B-DISEASE
-	I-DISEASE
sachs	I-DISEASE
disease	I-DISEASE
is	O
an	O
autosomal	B-UNK
recessive	I-UNK
genetic	I-UNK
disorder	I-UNK
resulting	B-UNK
from	O
mutation	B-UNK
of	O
the	O
hexa	B-UNK
gene	B-UNK
encoding	B-UNK
the	O
alpha	B-UNK
-	O
subunit	B-UNK
of	O
the	O
lysosomal	B-UNK
enzyme	B-UNK
,	O
beta	B-UNK
-	O
n	B-UNK
-	O
acetylhexosaminidase	O
a	O
(	O
ref	O
.	O
1	O
)	O
.	O

 	O
a	O
relatively	B-UNK
high	B-UNK
frequency	B-UNK
of	O
carriers	B-UNK
(	O
1	O
/	O
27	O
)	O
of	O
a	O
lethal	B-UNK
,	O
infantile	B-UNK
form	B-UNK
of	O
the	O
disease	B-DISEASE
is	O
found	B-UNK
in	O
the	O
ashkenazi	B-UNK
jewish	I-UNK
population	B-UNK
,	O
but	O
it	O
is	O
not	O
yet	O
evident	O
whether	O
this	O
has	O
resulted	B-UNK
from	O
a	O
founder	B-UNK
effect	B-UNK
and	O
random	B-UNK
genetic	B-UNK
drift	O
or	O
from	O
a	O
selective	B-UNK
advantage	B-UNK
of	O
heterozygotes	B-UNK
.	O

 	O
we	O
have	O
identified	B-UNK
a	O
single	B-UNK
-	O
base	B-UNK
mutation	B-UNK
in	O
a	O
cloned	B-UNK
fragment	O
of	O
the	O
hexa	B-UNK
gene	B-UNK
from	O
an	O
ashkenazi	B-UNK
jewish	I-UNK
patient	B-UNK
.	O

 	O
this	O
change	B-UNK
,	O
the	O
substitution	B-UNK
of	O
a	O
c	B-UNK
for	O
g	B-UNK
in	O
the	O
first	O
nucleotide	B-UNK
of	O
intron	B-UNK
12	O
is	O
expected	B-UNK
to	O
result	B-UNK
in	O
defective	B-UNK
splicing	B-UNK
of	O
the	O
messenger	B-UNK
rna	I-UNK
.	O

 	O
a	O
test	B-UNK
for	O
the	O
mutant	B-UNK
allele	I-UNK
based	B-UNK
on	O
amplification	B-UNK
of	O
dna	B-UNK
by	O
the	O
polymerase	O
chain	O
rection	O
and	O
cleavage	B-UNK
of	O
a	O
ddei	O
restriction	O
site	B-UNK
generated	B-UNK
by	O
the	O
mutation	B-UNK
revealed	B-UNK
that	O
this	O
case	B-UNK
and	O
two	O
other	O
cases	B-UNK
of	O
the	O
ashkenazi	B-UNK
,	O
infantile	B-UNK
form	B-UNK
of	O
tay	B-DISEASE
-	I-DISEASE
sachs	I-DISEASE
disease	I-DISEASE
are	O
heterozygous	B-UNK
for	O
two	O
different	B-UNK
mutations	B-UNK
.	O

 	O
the	O
occurrence	B-UNK
of	O
multiple	B-UNK
mutant	B-UNK
alleles	I-UNK
warrants	O
further	O
examination	B-UNK
of	O
the	O
selective	B-UNK
advantage	B-UNK
hypothesis	O
.	O
.	O

 	O
x	B-UNK
-	O
linked	B-UNK
glucose	B-UNK
-	O
6	O
-	O
phosphate	B-UNK
dehydrogenase	I-UNK
deficiency	B-UNK
in	O
mus	O
musculus	O
.	O

 	O
a	O
mouse	B-UNK
with	O
x	B-UNK
-	O
linked	B-UNK
glucose	B-UNK
-	O
6	O
-	O
phosphate	B-UNK
dehydrogenase	I-UNK
(	O
g6pd	B-UNK
)	O
deficiency	B-UNK
has	O
been	O
recovered	O
in	O
offspring	B-UNK
of	O
1	O
-	O
ethyl	O
-	O
1	O
-	O
nitrosourea	O
-	O
treated	B-UNK
male	B-UNK
mice	B-UNK
.	O

 	O
the	O
activity	B-UNK
alteration	B-UNK
was	O
detected	B-UNK
in	O
blood	B-UNK
but	O
can	O
also	O
be	O
observed	B-UNK
in	O
other	O
tissue	B-UNK
extracts	B-UNK
.	O

 	O
hemizygous	B-UNK
,	O
heterozygous	B-UNK
,	O
and	O
homozygous	B-UNK
mutants	B-UNK
have	O
,	O
respectively	B-UNK
,	O
about	O
15	O
,	O
60	O
,	O
and	O
15	O
%	O
g6pd	B-UNK
remaining	B-UNK
activity	B-UNK
in	O
the	O
blood	B-UNK
as	O
compared	B-UNK
to	O
the	O
wild	B-UNK
type	B-UNK
.	O

 	O
erythrocyte	B-UNK
indices	O
did	O
not	O
show	O
differences	B-UNK
between	O
mutants	B-UNK
and	O
wild	B-UNK
types	B-UNK
.	O

 	O
the	O
mutation	B-UNK
does	O
not	O
affect	B-UNK
the	O
electrophoretic	B-UNK
migration	B-UNK
,	O
the	O
isoelectric	O
point	B-UNK
,	O
or	O
the	O
thermal	B-UNK
stability	B-UNK
.	O

 	O
kinetic	B-UNK
properties	B-UNK
,	O
such	O
as	O
the	O
km	B-UNK
for	O
glucose	B-UNK
-	O
6	O
-	O
phosphate	B-UNK
or	O
for	O
nadp	B-UNK
and	O
the	O
relative	B-UNK
utilization	B-UNK
of	O
substrate	B-UNK
analogues	B-UNK
,	O
showed	B-UNK
no	O
differences	B-UNK
between	O
wild	B-UNK
types	B-UNK
and	O
mutants	B-UNK
with	O
the	O
exception	O
of	O
the	O
relative	B-UNK
utilization	B-UNK
of	O
deamino	O
-	O
nadp	B-UNK
which	O
was	O
significantly	B-UNK
lower	B-UNK
in	O
mutants	B-UNK
.	O

 	O
this	O
is	O
presently	O
the	O
only	O
animal	B-UNK
model	B-UNK
for	O
x	B-UNK
-	O
linked	B-UNK
g6pd	B-UNK
deficiency	I-UNK
in	O
humans	B-UNK
.	O
.	O

 	O
diverse	B-UNK
point	B-UNK
mutations	I-UNK
in	O
the	O
human	B-UNK
glucose	B-UNK
-	O
6	O
-	O
phosphate	B-UNK
dehydrogenase	I-UNK
gene	B-UNK
cause	B-UNK
enzyme	B-UNK
deficiency	B-UNK
and	O
mild	B-UNK
or	O
severe	B-UNK
hemolytic	B-DISEASE
anemia	I-DISEASE
.	O

 	O
glucose	B-UNK
-	O
6	O
-	O
phosphate	B-UNK
dehydrogenase	I-UNK
(	O
g6pd	B-UNK
;	O
ec	O
1	O
.	O
1	O
.	O
1	O
.	O
49	O
)	O
deficiency	B-UNK
is	O
a	O
common	B-UNK
genetic	B-UNK
abnormality	B-UNK
affecting	B-UNK
an	O
estimated	B-UNK
400	O
million	B-UNK
people	B-UNK
worldwide	B-UNK
.	O

 	B-UNK
clinical	I-UNK
and	O
biochemical	B-UNK
analyses	B-UNK
have	O
identified	B-UNK
many	O
variants	B-UNK
exhibiting	B-UNK
a	O
range	B-UNK
of	O
phenotypes	B-UNK
,	O
which	O
have	O
been	O
well	O
characterized	B-UNK
from	O
the	O
hematological	O
point	B-UNK
of	O
view	O
.	O

 	O
however	O
,	O
until	O
now	O
,	O
their	O
precise	B-UNK
molecular	B-UNK
basis	I-UNK
has	O
remained	B-UNK
unknown	B-UNK
.	O

 	O
we	O
have	O
cloned	B-UNK
and	O
sequenced	B-UNK
seven	B-UNK
mutant	B-UNK
g6pd	B-UNK
alleles	B-UNK
.	O

 	O
in	O
the	O
nondeficient	O
polymorphic	B-UNK
african	B-UNK
variant	B-UNK
g6pd	B-UNK
a	O
we	O
have	O
found	B-UNK
a	O
single	B-UNK
point	B-UNK
mutation	I-UNK
.	O

 	O
the	O
other	O
six	O
mutants	B-UNK
investigated	B-UNK
were	O
all	O
associated	B-UNK
with	O
enzyme	B-UNK
deficiency	B-UNK
.	O

 	O
in	O
one	O
of	O
the	O
commonest	O
,	O
g6pd	B-UNK
mediterranean	I-UNK
,	O
which	O
is	O
associated	B-UNK
with	O
favism	B-DISEASE
among	O
other	O
clinical	B-UNK
manifestations	B-UNK
,	O
a	O
single	B-UNK
amino	I-UNK
acid	I-UNK
replacement	O
was	O
found	B-UNK
(	O
serine	B-UNK
-	O
-	O
-	O
-	O
phenylalanine	O
)	O
it	O
must	O
be	O
responsible	B-UNK
for	O
the	O
decreased	B-UNK
stability	B-UNK
and	O
the	O
reduced	B-UNK
catalytic	B-UNK
efficiency	O
of	O
this	O
enzyme	B-UNK
.	O

 	O
single	B-UNK
point	B-UNK
mutations	I-UNK
were	O
also	O
found	B-UNK
in	O
g6pd	B-UNK
metaponto	O
(	O
southern	O
italy	B-UNK
)	O
and	O
in	O
g6pd	B-UNK
ilesha	O
(	O
nigeria	O
)	O
,	O
which	O
are	O
asymptomatic	B-UNK
,	O
and	O
in	O
g6pd	B-UNK
chatham	O
,	O
which	O
was	O
observed	B-UNK
in	O
an	O
indian	B-UNK
boy	B-UNK
with	O
neonatal	B-UNK
jaundice	B-DISEASE
.	O

 	O
in	O
g6pd	B-UNK
"	O
matera	O
,	O
"	O
which	O
is	O
now	O
known	B-UNK
to	O
be	O
the	O
same	O
as	O
g6pd	B-UNK
a	O
-	O
,	O
two	O
separate	B-UNK
point	B-UNK
mutations	I-UNK
were	O
found	B-UNK
,	O
one	O
of	O
which	O
is	O
the	O
same	O
as	O
in	O
g6pd	B-UNK
a	O
.	O

 	O
in	O
g6pd	B-UNK
santiago	O
,	O
a	O
de	B-UNK
novo	I-UNK
mutation	B-UNK
(	O
glycine	B-UNK
-	O
-	O
-	O
-	O
arginine	B-UNK
)	O
is	O
associated	B-UNK
with	O
severe	B-UNK
chronic	B-UNK
hemolytic	B-DISEASE
anemia	I-DISEASE
.	O

 	O
the	O
mutations	B-UNK
observed	B-UNK
show	O
a	O
striking	B-UNK
predominance	O
of	O
c	B-UNK
-	O
-	O
-	O
-	O
t	B-UNK
transitions	B-UNK
,	O
with	O
cg	O
doublets	O
involved	B-UNK
in	O
four	O
of	O
seven	B-UNK
cases	B-UNK
.	O

 	O
thus	O
,	O
diverse	B-UNK
point	B-UNK
mutations	I-UNK
may	O
account	B-UNK
largely	B-UNK
for	O
the	O
phenotypic	B-UNK
heterogeneity	B-UNK
of	O
g6pd	B-UNK
deficiency	I-UNK
.	O

 	O
tight	B-UNK
linkage	B-UNK
between	O
myotonic	B-DISEASE
dystrophy	I-DISEASE
and	O
apolipoprotein	B-DISEASE
e	I-DISEASE
genes	B-UNK
revealed	B-UNK
with	O
allele	B-UNK
-	O
specific	B-UNK
oligonucleotides	B-UNK
.	O

 	O
in	O
16	O
families	B-UNK
with	O
myotonic	B-DISEASE
dystrophy	I-DISEASE
(	O
dm	B-DISEASE
)	O
a	O
novel	B-UNK
approach	B-UNK
based	B-UNK
on	O
use	B-UNK
of	O
allele	B-UNK
-	O
specific	B-UNK
oligonucleotides	B-UNK
has	O
been	O
employed	O
to	O
study	B-UNK
the	O
linkage	B-UNK
relationship	B-UNK
between	O
the	O
apolipoprotein	B-DISEASE
e	I-DISEASE
(	O
apoe	B-UNK
)	O
gene	B-UNK
and	O
dm	B-DISEASE
.	O

 	O
synthetic	B-UNK
oligonucleotides	B-UNK
,	O
designed	O
to	O
discriminate	O
between	O
apoe	B-UNK
alleles	B-UNK
epsilon	O
3	O
and	O
epsilon	O
4	O
,	O
enabled	B-UNK
us	O
to	O
distinguish	O
heterozygous	B-UNK
carriers	B-UNK
in	O
a	O
hybridization	B-UNK
assay	B-UNK
.	O

 	O
in	O
a	O
subset	O
of	O
families	B-UNK
,	O
the	O
relevant	B-UNK
segment	B-UNK
of	O
the	O
apoe	B-UNK
gene	B-UNK
was	O
enzymatically	B-UNK
amplified	B-UNK
to	O
increase	B-UNK
the	O
sensitivity	B-UNK
of	O
the	O
method	B-UNK
.	O

 	O
for	O
dm	B-DISEASE
and	O
apoe	B-UNK
,	O
a	O
maximum	B-UNK
lod	I-UNK
score	B-UNK
(	O
zmax	B-UNK
of	O
7	O
.	O

 	O
47	O
was	O
obtained	B-UNK
at	B-DISEASE
a	O
recombination	B-UNK
frequency	B-UNK
(	O
theta	B-UNK
)	O
of	O
0	O
.	O

 	O
047	O
(	O
male	B-UNK
theta	B-UNK
=	I-UNK
female	B-UNK
theta	B-UNK
)	O
.	O

 	O
no	O
recombination	B-UNK
(	O
maximum	B-UNK
lod	I-UNK
score	B-UNK
of	O
5	O
.	O
61	O
at	B-DISEASE
theta	B-UNK
=	I-UNK
0	O
.	O
0	O
)	O
was	O
found	B-UNK
between	O
apoe	B-UNK
and	O
the	O
apolipoprotein	B-UNK
cii	O
(	O
apoc2	B-UNK
)	O
gene	B-UNK
.	O

 	O
these	O
results	B-UNK
suggest	B-UNK
that	O
,	O
in	O
addition	B-UNK
to	O
apoc2	B-UNK
,	O
apoe	B-UNK
is	O
a	O
useful	B-UNK
marker	B-UNK
for	O
presymptomatic	B-UNK
dm	B-DISEASE
diagnosis	B-UNK
.	O

 	B-UNK
regional	I-UNK
localization	B-UNK
of	O
polymorphic	B-UNK
dna	I-UNK
loci	B-UNK
on	O
the	O
proximal	B-UNK
long	B-UNK
arm	B-UNK
of	O
the	O
x	B-DISEASE
chromosome	I-DISEASE
using	O
deletions	B-UNK
associated	B-UNK
with	O
choroideremia	B-DISEASE
.	O

 	O
in	O
two	O
unrelated	B-UNK
families	I-UNK
,	O
males	B-UNK
have	O
been	O
identified	B-UNK
who	O
suffer	O
from	O
choroideremia	B-DISEASE
and	O
at	B-DISEASE
the	O
same	O
time	B-UNK
have	O
an	O
interstitial	B-UNK
deletion	B-UNK
on	O
the	O
proximal	B-UNK
long	B-UNK
arm	B-UNK
of	O
the	O
x	B-DISEASE
chromosome	I-DISEASE
.	O

 	O
by	O
high	B-UNK
-	O
resolution	B-UNK
banding	I-UNK
we	O
have	O
characterized	B-UNK
the	O
deletion	B-UNK
chromosomes	B-UNK
as	O
del	O
(	O
x	B-UNK
)	O
(	O
q21	O
.	O
1	O
-	O
q21	O
1	O
-	O
q21	O
.	O
33	O
)	O
and	O
del	O
(	O
x	B-UNK
)	O
(	O
q21	O
.	O
2	O
-	O
q21	O
2	O
-	O
q21	O
.	O
31	O
)	O
respectively	B-UNK
.	O

 	O
by	O
southern	B-UNK
blot	I-UNK
analysis	I-UNK
we	O
have	O
mapped	B-UNK
ten	B-DISEASE
different	B-UNK
polymorphic	B-UNK
dna	I-UNK
loci	B-UNK
relative	B-UNK
to	O
the	O
position	B-UNK
of	O
the	O
deletion	B-UNK
and	O
the	O
choroideremia	B-DISEASE
locus	B-UNK
tcd	B-UNK
.	O

 	O
one	O
probe	B-UNK
,	O
p31	O
,	O
was	O
shown	B-UNK
to	O
cover	O
one	O
of	O
the	O
breakpoints	B-UNK
of	O
the	O
smallest	B-UNK
deletion	B-UNK
.	O

 	O
the	O
following	B-UNK
order	B-UNK
of	O
the	O
loci	B-UNK
was	O
suggested	B-UNK
by	O
deletion	B-UNK
mapping	B-UNK
cen	B-UNK
-	O
dxs106	O
-	O
dxs72	O
-	O
tcd	B-UNK
-	O
(	O
dxys1	O
/	O
dxys23	O
/	O
dxys5	O
)	O
-	O
dxys2	O
-	O
(	O
dxys12	O
/	O
dxs3	O
)	O
-	O
(	O
dxs17	O
/	O
dxs101	O
)	O
-	O
xqter	O
.	O

 	O
retroviral	B-UNK
-	O
mediated	B-UNK
gene	B-UNK
transfer	O
of	O
human	B-UNK
phenylalanine	B-UNK
hydroxylase	I-UNK
into	O
nih	B-UNK
3t3	I-UNK
and	O
hepatoma	B-UNK
cells	B-UNK
.	O

 	O
phenylketonuria	B-DISEASE
(	O
pku	B-DISEASE
)	O
is	O
caused	B-UNK
by	O
deficiency	B-UNK
of	O
the	O
hepatic	B-UNK
enzyme	I-UNK
phenylalanine	I-UNK
hydroxylase	O
(	O
pah	B-UNK
)	O
.	O

 	O
a	O
full	O
-	O
length	O
human	B-UNK
pah	I-UNK
cdna	I-UNK
sequence	B-UNK
has	O
been	O
inserted	O
into	O
pzip	O
-	O
neosv	O
(	O
x	B-UNK
)	O
,	O
which	O
is	O
a	O
retroviral	B-UNK
vector	O
containing	B-UNK
the	O
bacterial	B-UNK
neo	O
gene	B-UNK
.	O

 	O
the	O
recombinant	B-UNK
has	O
been	O
transfected	B-UNK
into	O
psi	O
2	O
cells	B-UNK
,	O
which	O
provide	B-UNK
synthesis	B-UNK
of	O
the	O
retroviral	B-UNK
capsid	O
.	O

 	O
recombinant	B-UNK
virus	B-UNK
was	O
detected	B-UNK
in	O
the	O
culture	B-UNK
medium	O
of	O
the	O
transfected	B-UNK
psi	O
2	O
cells	B-UNK
,	O
which	O
is	O
capable	O
of	O
transmitting	B-UNK
the	O
human	B-UNK
pah	I-UNK
gene	B-UNK
into	O
mouse	B-UNK
nih	B-UNK
3t3	I-UNK
cells	B-UNK
by	O
infection	B-DISEASE
leading	B-UNK
to	O
stable	B-UNK
incorporation	B-UNK
of	O
the	O
recombinant	B-UNK
provirus	O
.	O

 	O
infected	B-UNK
cells	B-UNK
express	B-UNK
pah	B-UNK
mrna	B-UNK
,	O
immunoreactive	B-UNK
pah	B-UNK
protein	B-UNK
,	O
and	O
exhibit	B-UNK
pterin	O
-	O
dependent	B-UNK
phenylalanine	B-UNK
hydroxylase	I-UNK
activity	B-UNK
.	O

 	O
the	O
recombinant	B-UNK
virus	B-UNK
is	O
also	O
capable	O
of	O
infecting	O
a	O
mouse	B-UNK
hepatoma	B-UNK
cell	B-UNK
line	B-UNK
that	O
does	O
not	O
normally	B-UNK
synthesize	O
pah	B-UNK
.	O

 	O
pah	B-UNK
activity	B-UNK
is	O
present	B-UNK
in	O
the	O
cellular	B-UNK
extracts	B-UNK
and	O
the	O
entire	B-UNK
hydroxylation	O
system	B-UNK
is	O
reconstituted	O
in	O
the	O
hepatoma	B-UNK
cells	B-UNK
infected	B-UNK
with	O
the	O
recombinant	B-UNK
viruses	O
.	O

 	O
thus	O
,	O
recombinant	B-UNK
viruses	O
containing	B-UNK
human	B-UNK
pah	I-UNK
cdna	I-UNK
provide	B-UNK
a	O
means	O
for	O
introducing	O
functional	B-UNK
pah	B-UNK
into	O
mammalian	B-UNK
cells	B-UNK
of	O
hepatic	B-UNK
origin	B-UNK
and	O
can	O
potentially	B-UNK
be	O
introduced	O
into	O
whole	O
animals	O
as	O
a	O
model	B-UNK
for	O
somatic	B-UNK
gene	B-UNK
therapy	B-UNK
for	O
pku	B-DISEASE
.	O
.	O

 	O
estimation	B-UNK
of	O
the	O
male	B-UNK
to	O
female	B-UNK
ratio	B-UNK
of	O
mutation	B-UNK
rates	B-UNK
from	O
the	O
segregation	B-UNK
of	O
x	B-UNK
-	O
chromosomal	B-UNK
dna	B-UNK
haplotypes	I-UNK
in	O
duchenne	B-UNK
muscular	B-DISEASE
dystrophy	I-DISEASE
families	B-UNK
.	O

 	O
a	O
novel	B-UNK
procedure	B-UNK
is	O
presented	B-UNK
to	O
estimate	B-UNK
the	O
ratio	B-UNK
of	O
male	B-UNK
to	O
female	B-UNK
mutation	B-UNK
rates	B-UNK
for	O
duchenne	B-UNK
muscular	B-DISEASE
dystrophy	I-DISEASE
(	O
dmd	B-UNK
)	O
.	O

 	O
x	B-UNK
-	O
specific	B-UNK
restriction	B-UNK
fragment	I-UNK
length	I-UNK
polymorphisms	I-UNK
are	O
used	O
to	O
establish	O
dna	B-UNK
haplotypes	I-UNK
in	O
three	O
-	O
generation	B-UNK
dmd	B-UNK
families	B-UNK
.	O

 	O
from	O
the	O
proportion	B-UNK
of	O
dmd	B-UNK
patients	B-UNK
who	O
have	O
inherited	B-UNK
their	O
maternal	B-UNK
grandfathers	O
x	B-DISEASE
chromosome	I-DISEASE
,	O
the	O
ratio	B-UNK
of	O
mutation	B-UNK
rates	B-UNK
can	O
be	O
calculated	O
.	O

 	O
in	O
contrast	B-UNK
to	O
classical	B-UNK
methods	B-UNK
,	O
the	O
proposed	B-UNK
procedure	B-UNK
is	O
not	O
restricted	O
to	O
sporadic	B-UNK
or	O
familiar	O
cases	B-UNK
nor	O
is	O
any	O
information	B-UNK
on	O
the	O
carrier	B-UNK
status	B-UNK
of	O
female	B-UNK
relatives	B-UNK
required	B-UNK
.	O
.	O

 	O
deletions	B-UNK
of	O
a	O
dna	B-UNK
sequence	I-UNK
in	O
retinoblastomas	O
and	O
mesenchymal	B-UNK
tumors	B-DISEASE
:	O
organization	B-UNK
of	O
the	O
sequence	B-UNK
and	O
its	O
encoded	B-UNK
protein	B-UNK
.	O

 	O
retinoblastoma	B-DISEASE
is	O
a	O
childhood	B-UNK
tumor	B-DISEASE
that	O
can	O
arise	O
because	O
of	O
mutant	B-UNK
alleles	I-UNK
acquired	O
as	O
somatic	B-UNK
or	O
germinal	O
mutations	B-UNK
.	O

 	O
the	O
mutant	B-UNK
allele	I-UNK
can	O
be	O
carried	B-UNK
in	O
the	O
germ	B-UNK
line	I-UNK
.	O

 	O
the	O
mutations	B-UNK
creating	B-UNK
these	O
alleles	B-UNK
act	B-UNK
by	O
inactivating	B-UNK
copies	B-UNK
of	O
a	O
recessive	O
oncogene	B-UNK
located	B-UNK
within	O
band	B-UNK
q14	O
of	O
chromosome	B-UNK
13	O
and	O
termed	B-UNK
the	O
rb1	B-UNK
locus	B-UNK
.	O

 	O
we	O
have	O
reported	B-UNK
isolation	B-UNK
of	O
a	O
cdna	B-UNK
fragment	O
that	O
recognizes	O
chromosomal	B-UNK
sequences	B-UNK
possessing	O
many	O
of	O
the	O
attributes	O
of	O
the	O
retinoblastoma	B-DISEASE
gene	B-UNK
associated	B-UNK
with	O
the	O
rb1	B-UNK
locus	B-UNK
.	O

 	O
we	O
now	O
report	B-UNK
that	O
this	O
segment	B-UNK
is	O
additionally	B-UNK
the	O
target	B-UNK
of	O
somatic	B-UNK
mutations	B-UNK
in	O
mesenchymal	B-UNK
tumors	B-DISEASE
among	O
patients	B-UNK
having	B-UNK
no	O
apparent	B-UNK
predisposition	B-UNK
to	O
retinoblastoma	B-DISEASE
and	O
no	O
previous	B-UNK
evidence	B-UNK
of	O
retinoblastoma	B-DISEASE
.	O

 	O
these	O
tumors	B-DISEASE
provide	B-UNK
additional	B-UNK
evidence	I-UNK
that	O
the	O
cloned	B-UNK
sequences	B-UNK
are	O
representative	O
of	O
a	O
gene	B-UNK
that	O
is	O
a	O
frequent	B-UNK
target	B-UNK
of	O
inactivation	B-UNK
during	O
tumorigenesis	B-UNK
.	O

 	O
sequence	B-UNK
analysis	B-UNK
of	O
this	O
cdna	B-UNK
provides	B-UNK
little	B-UNK
insight	B-UNK
into	O
its	O
normal	B-UNK
functional	B-UNK
role	B-UNK
.	O
.	O

 	O
treatment	B-UNK
of	O
duchenne	B-UNK
muscular	B-DISEASE
dystrophy	I-DISEASE
with	O
growth	B-UNK
hormone	B-UNK
inhibitors	B-UNK
.	O

 	O
a	O
controlled	O
,	O
double	B-UNK
-	O
blind	B-UNK
therapeutic	B-UNK
trial	O
with	O
the	O
drug	O
mazindol	O
,	O
a	O
growth	B-UNK
hormone	B-UNK
inhibitor	B-UNK
,	O
was	O
performed	B-UNK
in	O
a	O
pair	O
of	O
7	O
1	O
/	O
2	O
year	B-UNK
-	O
old	B-UNK
monozygotic	B-UNK
twins	B-DISEASE
,	O
with	O
duchenne	B-UNK
muscular	B-DISEASE
dystrophy	I-DISEASE
(	O
dmd	B-UNK
)	O
.	O

 	O
the	O
rationale	O
for	O
this	O
trial	O
was	O
based	B-UNK
on	O
a	O
patient	B-UNK
(	O
reported	B-UNK
previously	B-UNK
)	O
affected	B-UNK
simultaneously	O
with	O
dmd	B-UNK
and	O
growth	B-UNK
hormone	B-UNK
(	O
gh	B-UNK
)	O
deficiency	B-UNK
,	O
who	O
is	O
showing	B-UNK
a	O
benign	B-UNK
course	B-UNK
of	O
the	O
dystrophic	B-UNK
process	B-UNK
and	O
is	O
still	O
walking	O
at	B-DISEASE
18	O
years	B-UNK
.	O

 	O
one	O
of	O
the	O
twins	B-DISEASE
received	O
2	O
mg	O
of	O
mazindol	O
daily	O
,	O
while	O
the	O
other	O
received	O
a	O
placebo	O
.	O

 	O
the	O
assessment	B-UNK
,	O
repeated	B-UNK
every	O
2	O
months	O
,	O
included	B-UNK
weight	O
and	O
height	O
measurements	O
,	O
functional	B-UNK
and	O
motor	B-UNK
ability	B-UNK
tests	B-UNK
,	O
ergometry	O
and	O
determinations	O
of	O
serum	B-UNK
enzymes	B-UNK
and	O
gh	B-UNK
levels	B-UNK
.	O

 	O
after	O
one	O
year	B-UNK
of	O
trial	O
the	O
code	O
was	O
broken	O
and	O
it	O
was	O
seen	B-UNK
that	O
the	O
twin	B-UNK
under	O
placebo	O
treatment	B-UNK
was	O
strikingly	B-UNK
worse	O
than	O
his	O
brother	B-UNK
,	O
the	O
progression	O
of	O
whose	O
condition	B-UNK
was	O
practically	O
arrested	O
.	O

 	O
these	O
results	B-UNK
strongly	B-UNK
suggest	B-UNK
that	O
treatment	B-UNK
with	O
a	O
gh	B-UNK
inhibitor	B-UNK
is	O
beneficial	O
for	O
dmd	B-UNK
patients	B-UNK
.	O
.	O

 	O
identification	B-UNK
and	O
localization	B-UNK
of	O
mutations	B-UNK
at	B-DISEASE
the	O
lesch	O
-	O
nyhan	B-UNK
locus	B-UNK
by	O
ribonuclease	B-UNK
a	O
cleavage	B-UNK
.	O

 	O
many	O
mutations	B-UNK
leading	B-UNK
to	O
human	B-UNK
disease	B-DISEASE
are	O
the	O
result	B-UNK
of	O
single	B-UNK
dna	B-UNK
base	B-UNK
pair	I-UNK
changes	B-UNK
that	O
can	O
not	O
be	O
identified	B-UNK
by	O
southern	O
analysis	B-UNK
.	O

 	O
this	O
has	O
prompted	O
the	O
development	B-UNK
of	O
alternative	B-UNK
assays	B-UNK
for	O
point	B-UNK
mutation	I-UNK
detection	B-UNK
.	O

 	O
the	O
recently	B-UNK
described	B-UNK
ribonuclease	B-UNK
a	O
cleavage	B-UNK
procedure	B-UNK
,	O
with	O
a	O
polyuridylic	O
acid	O
-	O
paper	B-UNK
affinity	B-UNK
chromatography	O
step	O
,	O
has	O
been	O
used	O
to	O
identify	B-UNK
the	O
mutational	B-UNK
lesions	B-UNK
in	O
the	O
hypoxanthine	B-UNK
phosphoribosyltransferase	B-UNK
(	O
hprt	B-UNK
)	O
messenger	O
rnas	B-UNK
of	O
patients	B-UNK
with	O
lesch	B-DISEASE
-	I-DISEASE
nyhan	I-DISEASE
syndrome	I-DISEASE
.	O

 	O
distinctive	B-UNK
ribonuclease	B-UNK
a	O
cleavage	B-UNK
patterns	B-UNK
were	O
identified	B-UNK
in	O
messenger	B-UNK
rna	I-UNK
from	O
5	O
of	O
14	O
lesch	O
-	O
nyhan	B-UNK
patients	B-UNK
who	O
were	O
chosen	O
because	O
no	O
hprt	B-UNK
southern	O
or	O
northern	B-UNK
blotting	B-UNK
pattern	B-UNK
changes	B-UNK
had	O
been	O
found	B-UNK
.	O

 	O
this	O
approach	B-UNK
now	O
allows	B-UNK
hprt	B-UNK
mutation	B-UNK
detection	B-UNK
in	O
50	O
percent	O
of	O
the	O
cases	B-UNK
of	O
lesch	B-DISEASE
-	I-DISEASE
nyhan	I-DISEASE
syndrome	I-DISEASE
.	O

 	O
the	O
polyuridylic	O
acid	O
-	O
paper	B-UNK
affinity	B-UNK
procedure	B-UNK
provides	B-UNK
a	O
general	B-UNK
method	B-UNK
for	O
analysis	B-UNK
of	O
low	B-UNK
abundance	O
messenger	O
rnas	B-UNK
.	O
.	O

 	O
two	O
new	B-UNK
variants	B-UNK
of	O
glucose	B-UNK
-	O
6	O
-	O
phosphate	B-UNK
dehydrogenase	I-UNK
associated	B-UNK
with	O
hereditary	B-UNK
non	B-UNK
-	O
spherocytic	O
hemolytic	B-DISEASE
anemia	I-DISEASE
:	O
g6pd	B-UNK
wayne	B-UNK
and	O
g6pd	B-UNK
huron	B-UNK
.	O

 	O
two	O
new	B-UNK
deficient	B-UNK
variants	B-UNK
of	O
glucose	B-UNK
-	O
6	O
-	O
phosphate	B-UNK
dehydrogenase	I-UNK
(	O
g6pd	B-UNK
)	O
causing	B-UNK
hereditary	B-UNK
nonspherocytic	B-UNK
hemolytic	B-DISEASE
anemia	I-DISEASE
(	O
hnsha	O
)	O
are	O
described	B-UNK
.	O

 	O
both	O
of	O
these	O
are	O
unique	B-UNK
and	O
they	O
have	O
been	O
named	O
g6pd	B-UNK
wayne	B-UNK
and	O
g6pd	B-UNK
huron	B-UNK
.	O

 	B-UNK
patients	I-UNK
with	O
g6pd	B-UNK
wayne	B-UNK
underwent	B-UNK
splenectomy	O
and	O
no	O
objective	B-UNK
improvement	O
was	O
noted	O
.	O

 	O
the	O
patients	B-UNK
with	O
g6pd	B-UNK
huron	B-UNK
were	O
under	O
medical	O
observation	B-UNK
for	O
a	O
considerable	B-UNK
period	B-UNK
of	O
time	B-UNK
without	O
the	O
diagnosis	B-UNK
of	O
g6pd	B-UNK
deficiency	I-UNK
being	O
entertained	O
because	O
the	O
family	B-UNK
was	O
of	O
northern	B-UNK
european	I-UNK
origin	B-UNK
.	O

 	O
since	O
sporadic	B-UNK
variants	B-UNK
of	O
g6pd	B-UNK
causing	B-UNK
hnsha	O
show	O
no	O
special	O
racial	O
predilection	O
,	O
the	O
diagnosis	B-UNK
of	O
g6pd	B-UNK
deficiency	I-UNK
should	O
always	O
be	O
considered	B-UNK
in	O
patients	B-UNK
with	O
this	O
syndrome	B-DISEASE
.	O
.	O

 	O
sialophorin	O
,	O
a	O
surface	B-UNK
sialoglycoprotein	O
defective	B-UNK
in	O
the	O
wiskott	B-DISEASE
-	I-DISEASE
aldrich	I-DISEASE
syndrome	I-DISEASE
,	O
is	O
involved	B-UNK
in	O
human	B-UNK
t	B-UNK
lymphocyte	I-UNK
proliferation	B-UNK
.	O

 	O
the	O
mab	B-UNK
l10	B-UNK
was	O
used	O
to	O
determine	O
the	O
distribution	B-UNK
and	O
the	O
function	B-UNK
of	O
sialophorin	O
,	O
the	O
heavily	O
glycosylated	O
surface	B-UNK
molecule	B-UNK
that	O
is	O
deficient	B-UNK
/	O
defective	B-UNK
in	O
lymphocytes	B-UNK
of	O
patients	B-UNK
with	O
the	O
x	B-UNK
-	O
linked	B-UNK
immunodeficiency	B-DISEASE
wiskott	B-DISEASE
-	I-DISEASE
aldrich	I-DISEASE
syndrome	I-DISEASE
.	O

 	O
dual	O
-	O
parameter	O
facs	O
analysis	B-UNK
indicated	B-UNK
that	O
sialophorin	O
is	O
expressed	B-UNK
on	O
cd4	O
+	O
and	O
cd8	O
+	O
lymphocytes	B-UNK
,	O
on	O
a	O
subpopulation	O
of	O
peripheral	B-UNK
blood	I-UNK
b	B-UNK
lymphocytes	B-UNK
,	O
on	O
all	O
thymocytes	O
,	O
and	O
on	O
a	O
subpopulation	O
of	O
bone	B-UNK
marrow	I-UNK
cells	B-UNK
.	O

 	B-UNK
functional	I-UNK
studies	B-UNK
demonstrated	I-UNK
that	O
l10	B-UNK
mab	B-UNK
stimulates	O
the	O
proliferation	B-UNK
of	O
peripheral	B-UNK
blood	I-UNK
t	B-UNK
lymphocytes	I-UNK
as	O
measured	B-UNK
by	O
stimulation	B-UNK
of	O
[	O
3h	O
]	O
thymidine	B-UNK
incorporation	B-UNK
.	O

 	O
the	O
time	B-UNK
course	B-UNK
and	O
magnitude	O
of	O
increased	B-UNK
[	O
3h	O
]	O
thymidine	B-UNK
incorporation	B-UNK
by	O
t	B-UNK
lymphocytes	I-UNK
in	O
response	B-UNK
to	O
l10	B-UNK
mab	B-UNK
paralleled	O
that	O
induced	B-UNK
by	O
anti	O
-	O
cd3	O
mab	B-UNK
.	O

 	O
effective	B-UNK
stimulation	B-UNK
was	O
dependent	B-UNK
on	O
the	O
presence	B-UNK
of	O
monocytes	O
and	O
the	O
fc	O
portion	B-UNK
of	O
l10	B-UNK
mab	B-UNK
.	O

 	O
stimulation	B-UNK
of	O
lymphocytes	B-UNK
by	O
l10	B-UNK
,	O
like	B-UNK
stimulation	B-UNK
by	O
anti	O
-	O
cd3	O
mab	B-UNK
,	O
involves	B-UNK
increased	B-UNK
expression	B-UNK
of	O
4f2	O
,	O
hla	B-UNK
-	O
dr	O
,	O
and	O
il	O
-	O
2	O
-	O
r	B-UNK
.	O

 	O
these	O
observations	B-UNK
suggest	B-UNK
that	O
sialophorin	O
functions	B-UNK
in	O
t	B-UNK
cell	B-UNK
activation	B-UNK
.	O
.	O

 	O
hypopigmentation	B-DISEASE
in	O
the	O
prader	B-DISEASE
-	I-DISEASE
willi	I-DISEASE
syndrome	I-DISEASE
.	O

 	O
cutaneous	O
and	O
ocular	O
pigmentation	O
were	O
evaluated	O
in	O
29	O
individuals	B-UNK
with	O
the	O
prader	B-DISEASE
-	I-DISEASE
willi	I-DISEASE
syndrome	I-DISEASE
(	O
pws	B-UNK
)	O
.	O

 	O
criteria	B-UNK
for	O
hypopigmentation	B-DISEASE
included	B-UNK
the	O
presence	B-UNK
of	O
type	B-UNK
i	O
or	O
ii	B-UNK
skin	B-DISEASE
,	O
the	O
lightest	O
skin	B-DISEASE
type	B-UNK
in	O
the	O
family	B-UNK
by	O
history	B-UNK
,	O
and	O
iris	B-UNK
translucency	O
on	O
globe	O
transillumination	O
.	O

 	O
on	O
the	O
basis	B-UNK
of	O
these	O
criteria	B-UNK
,	O
48	O
%	O
of	O
the	O
pws	B-UNK
individuals	B-UNK
were	O
hypopigmented	O
.	O

 	O
the	O
presence	B-UNK
of	O
hypopigmentation	B-DISEASE
correlated	B-UNK
with	O
a	O
small	B-UNK
interstitial	B-UNK
deletion	B-UNK
on	O
the	O
proximal	B-UNK
long	B-UNK
arm	B-UNK
of	O
chromosome	B-DISEASE
15	I-DISEASE
;	O
however	O
,	O
this	O
deletion	B-UNK
was	O
also	O
found	B-UNK
in	O
individuals	B-UNK
who	O
did	O
not	O
meet	O
the	O
full	O
criteria	B-UNK
for	O
hypopigmentation	B-DISEASE
.	O

 	O
hairbulb	O
tyrosinase	O
activity	B-UNK
and	O
glutathione	O
content	B-UNK
,	O
as	O
well	O
as	O
urine	B-DISEASE
cysteinyldopa	O
excretion	O
,	O
were	O
low	B-UNK
in	O
pws	B-UNK
individuals	B-UNK
with	O
and	O
without	O
hypopigmentation	B-DISEASE
and	O
did	O
not	O
separate	B-UNK
these	O
two	O
groups	B-UNK
.	O

 	O
we	O
conclude	O
that	O
hypopigmentation	B-DISEASE
is	O
found	B-UNK
in	O
a	O
significant	B-UNK
proportion	B-UNK
of	O
individuals	B-UNK
with	O
pws	B-UNK
and	O
that	O
the	O
hypopigmentation	B-DISEASE
may	O
be	O
associated	B-UNK
with	O
a	O
deletion	B-UNK
of	O
the	O
long	B-UNK
arm	B-UNK
of	O
chromosome	B-DISEASE
15	I-DISEASE
.	O

 	O
the	O
mechanism	B-UNK
for	O
the	O
hypopigmentation	B-DISEASE
is	O
unknown	B-UNK
.	O
.	O

 	O
phenotype	B-UNK
heterogeneity	B-UNK
among	O
hemizygotes	B-UNK
in	O
a	O
family	B-UNK
biochemically	B-UNK
screened	O
for	O
adrenoleukodystrophy	B-DISEASE
.	O

 	O
we	O
report	B-UNK
on	O
two	O
clinically	B-UNK
,	O
neurologically	O
normal	B-UNK
relatives	B-UNK
of	O
a	O
boy	B-UNK
affected	B-UNK
by	O
adrenoleukodystrophy	B-DISEASE
(	O
ald	B-UNK
)	O
;	O
they	O
were	O
found	B-UNK
repeatedly	O
to	O
have	O
the	O
biochemical	B-UNK
defect	B-UNK
of	O
an	O
ald	B-UNK
hemizygote	O
.	O

 	O
the	O
assay	B-UNK
consisted	B-UNK
in	O
the	O
determination	B-UNK
of	O
very	O
-	O
long	B-UNK
-	O
chain	B-UNK
fatty	I-UNK
acids	I-UNK
in	O
lyophilized	O
and	O
reconstituted	O
plasma	B-UNK
.	O

 	O
while	O
no	O
evidence	B-UNK
of	O
neurologic	B-DISEASE
disease	I-DISEASE
(	O
leukodystrophy	B-DISEASE
or	O
myeloneuropathy	O
)	O
was	O
present	B-UNK
in	O
these	O
hemizygotes	B-UNK
,	O
adrenocortical	O
insufficiency	B-UNK
provoking	O
compensatory	B-UNK
high	B-UNK
acth	O
release	B-UNK
was	O
found	B-UNK
in	O
both	O
.	O

 	O
these	O
findings	B-UNK
should	O
be	O
taken	O
into	O
consideration	O
when	O
counseling	B-UNK
families	B-UNK
in	O
which	O
cases	B-UNK
with	O
clinically	B-UNK
expressed	B-UNK
ald	B-UNK
are	O
represented	B-UNK
in	O
several	O
generations	B-UNK
.	O
.	O

 	O
the	O
mapping	B-UNK
of	O
a	O
cdna	B-UNK
from	O
the	O
human	B-UNK
x	B-UNK
-	O
linked	B-UNK
duchenne	B-UNK
muscular	B-DISEASE
dystrophy	I-DISEASE
gene	B-UNK
to	O
the	O
mouse	B-UNK
x	B-DISEASE
chromosome	I-DISEASE
.	O

 	O
the	O
recent	B-UNK
discovery	B-UNK
of	O
sequences	B-UNK
at	B-DISEASE
the	O
site	B-UNK
of	O
the	O
duchenne	B-UNK
muscular	B-DISEASE
dystrophy	I-DISEASE
(	O
dmd	B-UNK
)	O
gene	B-UNK
in	O
humans	B-UNK
has	O
opened	O
up	O
the	O
possibility	O
of	O
a	O
detailed	B-UNK
molecular	B-UNK
analysis	B-UNK
of	O
the	O
genes	B-UNK
in	O
humans	B-UNK
and	O
in	O
related	B-UNK
mammalian	B-UNK
species	B-UNK
.	O

 	O
until	O
relatively	B-UNK
recently	B-UNK
,	O
there	O
was	O
no	O
obvious	B-UNK
mouse	B-UNK
model	I-UNK
of	O
this	O
genetic	B-UNK
disease	B-DISEASE
for	O
the	O
development	B-UNK
of	O
therapeutic	B-UNK
strategies	B-UNK
.	O

 	O
the	O
identification	B-UNK
of	O
a	O
mouse	B-UNK
x	B-UNK
-	O
linked	B-UNK
mutant	B-UNK
showing	B-UNK
muscular	B-DISEASE
dystrophy	I-DISEASE
,	O
mdx	B-UNK
,	O
has	O
provided	B-UNK
a	O
candidate	B-UNK
mouse	B-UNK
genetic	B-UNK
homologue	B-UNK
to	O
the	O
dmd	B-UNK
locus	B-UNK
;	O
the	O
relatively	B-UNK
mild	B-UNK
pathological	B-UNK
features	B-UNK
of	O
mdx	B-UNK
suggest	B-UNK
it	O
may	O
have	O
more	O
in	O
common	B-UNK
with	O
mutations	B-UNK
of	O
the	O
becker	O
muscular	B-DISEASE
dystrophy	I-DISEASE
type	B-UNK
at	B-DISEASE
the	O
same	O
human	B-UNK
locus	B-UNK
,	O
however	O
.	O

 	O
but	O
the	O
close	B-UNK
genetic	B-UNK
linkage	B-UNK
of	O
mdx	B-UNK
to	O
g6pd	B-UNK
and	O
hprt	B-UNK
on	O
the	O
mouse	B-UNK
x	B-DISEASE
chromosome	I-DISEASE
,	O
coupled	B-UNK
with	O
its	O
comparatively	O
mild	B-UNK
pathology	B-UNK
,	O
have	O
suggested	B-UNK
that	O
the	O
mdx	B-UNK
mutation	B-UNK
may	O
instead	B-UNK
correspond	O
to	O
emery	O
dreifuss	O
muscular	B-DISEASE
dystrophy	I-DISEASE
which	O
itself	O
is	O
closely	B-UNK
linked	I-UNK
to	O
dna	B-UNK
markers	I-UNK
at	B-DISEASE
xq28	B-UNK
-	O
qter	O
in	O
the	O
region	B-UNK
of	O
g6pd	B-UNK
on	O
the	O
human	B-UNK
x	B-DISEASE
chromosome	I-DISEASE
.	O

 	O
using	O
an	O
interspecific	B-UNK
mouse	B-UNK
domesticus	O
/	O
spretus	O
cross	B-UNK
,	O
segregating	B-UNK
for	O
a	O
variety	B-UNK
of	O
markers	B-UNK
on	O
the	O
mouse	B-UNK
x	B-DISEASE
chromosome	I-DISEASE
,	O
we	O
have	O
positioned	O
on	O
the	O
mouse	B-UNK
x	B-DISEASE
chromosome	I-DISEASE
sequences	B-UNK
homologous	B-UNK
to	O
a	O
dmd	B-UNK
cdna	B-UNK
clone	B-UNK
.	O

 	O
these	O
sequences	B-UNK
map	B-UNK
provocatively	O
close	B-UNK
to	O
the	O
mdx	B-UNK
mutation	B-UNK
and	O
unexpectedly	B-UNK
distant	O
from	O
sparse	O
fur	O
,	O
spf	O
,	O
the	O
mouse	B-UNK
homologue	B-UNK
of	O
otc	O
(	O
ornithine	O
transcarbamylase	O
)	O
which	O
is	O
closely	B-UNK
linked	I-UNK
to	O
dmd	B-UNK
on	O
the	O
human	B-UNK
x	B-DISEASE
chromosome	I-DISEASE
.	O
.	O

 	O
localization	B-UNK
of	O
the	O
region	B-UNK
homologous	B-UNK
to	O
the	O
duchenne	B-UNK
muscular	B-DISEASE
dystrophy	I-DISEASE
locus	B-UNK
on	O
the	O
mouse	B-UNK
x	B-DISEASE
chromosome	I-DISEASE
.	O

 	B-UNK
recent	I-UNK
progress	O
has	O
resulted	B-UNK
in	O
part	O
of	O
the	O
gene	B-UNK
mutated	B-UNK
in	O
duchenne	B-UNK
and	O
the	O
milder	B-UNK
becker	O
muscular	B-DISEASE
dystrophies	I-DISEASE
being	O
cloned	B-UNK
and	O
has	O
suggested	B-UNK
that	O
the	O
gene	B-UNK
itself	O
extends	O
over	O
1	O
,	O
000	O
to	O
2	O
,	O
000	O
kilobases	O
(	O
kb	B-UNK
)	O
.	O

 	O
to	O
study	B-UNK
how	O
mutations	B-UNK
in	O
this	O
gene	B-UNK
affect	B-UNK
muscle	B-UNK
development	B-UNK
and	O
integrity	O
,	O
it	O
would	O
be	O
of	O
interest	O
to	O
have	O
available	B-UNK
a	O
mouse	B-UNK
model	I-UNK
of	O
the	O
human	B-UNK
disease	B-DISEASE
.	O

 	O
the	O
mouse	B-UNK
mdx	B-UNK
mutation	B-UNK
affects	B-UNK
muscle	B-UNK
and	O
confers	O
a	O
mild	B-UNK
dystrophic	B-UNK
syndrome	B-DISEASE
,	O
but	O
it	O
is	O
not	O
clear	B-UNK
whether	O
this	O
mutation	B-UNK
is	O
equivalent	O
to	O
duchenne	B-UNK
/	O
becker	O
muscular	B-DISEASE
dystrophy	I-DISEASE
in	O
man	B-UNK
.	O

 	O
here	O
we	O
describe	B-UNK
the	O
use	B-UNK
of	O
two	O
sequences	B-UNK
from	O
the	O
human	B-UNK
duchenne	B-UNK
muscular	B-DISEASE
dystrophy	I-DISEASE
(	O
dmd	B-UNK
)	O
gene	B-UNK
that	O
cross	B-UNK
-	O
hybridize	O
to	O
mouse	B-UNK
x	B-UNK
-	O
linked	B-UNK
sequences	B-UNK
to	O
localize	B-UNK
the	O
gene	B-UNK
homologous	B-UNK
to	O
dmd	B-UNK
in	O
the	O
mouse	B-UNK
.	O

 	O
both	O
sequences	B-UNK
map	B-UNK
to	O
the	O
region	B-UNK
of	O
10	O
centimorgan	O
lying	O
between	O
the	O
tabby	O
(	O
ta	O
)	O
and	O
st14	O
-	O
1	O
(	O
dxpas8	O
)	O
loci	B-UNK
,	O
close	B-UNK
to	O
the	O
phosphorylase	O
b	B-UNK
kinase	B-UNK
locus	B-UNK
(	O
phk	O
)	O
.	O

 	O
by	O
analogy	O
with	O
the	O
human	B-UNK
x	B-UNK
-	O
chromosome	B-UNK
,	O
we	O
conclude	O
that	O
the	O
region	B-UNK
in	O
the	O
mouse	B-UNK
around	O
the	O
g6pd	B-UNK
and	O
st14	O
-	O
1	O
loci	B-UNK
may	O
contain	B-UNK
two	O
genes	B-UNK
corresponding	B-UNK
to	O
distinct	B-UNK
human	B-UNK
myopathies	B-DISEASE
emery	O
dreifuss	O
muscular	B-DISEASE
dystrophy	I-DISEASE
which	O
is	O
known	B-UNK
to	O
be	O
closely	B-UNK
linked	I-UNK
to	O
st14	O
-	O
1	O
in	O
man	B-UNK
and	O
the	O
dmd	B-UNK
homologue	B-UNK
described	B-UNK
here	O
.	O
.	O

 	O
gt	B-UNK
to	O
at	B-DISEASE
transition	B-UNK
at	B-DISEASE
a	O
splice	B-UNK
donor	I-UNK
site	I-UNK
causes	B-UNK
skipping	B-UNK
of	O
the	O
preceding	O
exon	B-UNK
in	O
phenylketonuria	B-DISEASE
.	O

 	O
classical	B-UNK
phenylketonuria	B-DISEASE
(	O
pku	B-DISEASE
)	O
is	O
an	O
autosomal	O
recessive	O
human	B-UNK
genetic	B-UNK
disorder	O
caused	B-UNK
by	O
a	O
deficiency	B-UNK
of	O
hepatic	B-UNK
phenylalanine	B-UNK
hydroxylase	I-UNK
(	O
pah	B-UNK
)	O
.	O

 	O
we	O
isolated	B-UNK
several	O
mutant	B-UNK
pah	I-UNK
cdna	B-UNK
clones	B-UNK
from	O
a	O
pku	B-DISEASE
carrier	B-UNK
individual	B-UNK
and	O
showed	B-UNK
that	O
they	O
contained	B-UNK
an	O
internal	B-UNK
116	O
base	B-UNK
pair	I-UNK
deletion	B-UNK
,	O
corresponding	B-UNK
precisely	O
to	O
exon	B-UNK
12	O
of	O
the	O
human	B-UNK
chromosomal	B-UNK
pah	B-UNK
gene	B-UNK
.	O

 	O
the	O
deletion	B-UNK
causes	B-UNK
the	O
synthesis	B-UNK
of	O
a	O
truncated	B-UNK
protein	B-UNK
lacking	B-UNK
the	O
c	B-UNK
-	O
terminal	B-UNK
52	O
amino	O
acids	O
.	O

 	O
gene	B-UNK
transfer	O
and	O
expression	B-UNK
studies	B-UNK
using	O
the	O
mutant	B-UNK
pah	I-UNK
cdna	B-UNK
indicated	B-UNK
that	O
the	O
deletion	B-UNK
abolishes	B-UNK
pah	B-UNK
activity	B-UNK
in	O
the	O
cell	B-UNK
as	O
a	O
result	B-UNK
of	O
protein	B-UNK
instability	B-UNK
.	O

 	O
to	O
determine	O
the	O
molecular	B-UNK
basis	I-UNK
of	O
the	O
deletion	B-UNK
,	O
the	O
mutant	B-UNK
chromosomal	B-UNK
pah	B-UNK
gene	B-UNK
was	O
isolated	B-UNK
from	O
this	O
individual	B-UNK
and	O
shown	B-UNK
to	O
contain	B-UNK
a	O
gt	B-UNK
-	O
-	O
greater	B-UNK
than	O
at	B-DISEASE
substitution	B-UNK
at	B-DISEASE
the	O
5	O
splice	B-UNK
donor	I-UNK
site	I-UNK
of	O
intron	B-UNK
12	O
.	O

 	O
thus	O
,	O
the	O
consequence	O
of	O
the	O
splice	B-UNK
donor	I-UNK
site	I-UNK
mutation	B-UNK
in	O
the	O
human	B-UNK
liver	B-DISEASE
is	O
the	O
skipping	B-UNK
of	O
the	O
preceding	O
exon	B-UNK
during	O
rna	B-UNK
splicing	I-UNK
.	O
.	O

 	O
conservation	B-UNK
of	O
the	O
duchenne	B-UNK
muscular	B-DISEASE
dystrophy	I-DISEASE
gene	B-UNK
in	O
mice	B-UNK
and	O
humans	B-UNK
.	O

 	O
a	O
portion	B-UNK
of	O
the	O
duchenne	B-UNK
muscular	B-DISEASE
dystrophy	I-DISEASE
(	O
dmd	B-UNK
)	O
gene	B-UNK
transcript	B-UNK
from	O
human	B-UNK
fetal	B-UNK
skeletal	B-UNK
muscle	I-UNK
and	O
mouse	B-UNK
adult	B-UNK
heart	B-UNK
was	O
sequenced	B-UNK
,	O
representing	B-UNK
approximately	B-UNK
25	O
percent	O
of	O
the	O
total	B-UNK
,	O
14	O
-	O
kb	B-UNK
dmd	B-UNK
transcript	B-UNK
.	O

 	O
the	O
nucleic	O
acid	O
and	O
predicted	B-UNK
amino	B-UNK
acid	I-UNK
sequences	B-UNK
from	O
the	O
two	O
species	B-UNK
are	O
nearly	O
90	O
percent	O
homologous	B-UNK
.	O

 	O
the	O
amino	B-UNK
acid	I-UNK
sequence	I-UNK
that	O
is	O
predicted	B-UNK
from	O
this	O
portion	B-UNK
of	O
the	O
dmd	B-UNK
gene	B-UNK
indicates	B-UNK
that	O
the	O
protein	B-UNK
product	B-UNK
might	O
serve	O
a	O
structural	B-UNK
role	B-UNK
in	O
muscle	B-UNK
,	O
but	O
the	O
abundance	O
and	O
tissue	B-UNK
distribution	B-UNK
of	O
the	O
messenger	B-UNK
rna	I-UNK
suggests	B-UNK
that	O
the	O
dmd	B-UNK
protein	B-UNK
is	O
not	O
nebulin	B-UNK
.	O
.	O

 	B-UNK
familial	I-UNK
prader	B-DISEASE
-	I-DISEASE
willi	I-DISEASE
syndrome	I-DISEASE
with	O
apparently	B-UNK
normal	I-UNK
chromosomes	B-UNK
.	O

 	O
we	O
report	B-UNK
on	O
4	O
sibs	B-UNK
(	O
2f	O
,	O
2	O
m	B-UNK
)	O
with	O
prader	B-DISEASE
-	I-DISEASE
willi	I-DISEASE
syndrome	I-DISEASE
(	O
pws	B-UNK
)	O
.	O

 	O
diagnosis	B-UNK
was	O
made	O
clinically	B-UNK
on	O
the	O
basis	B-UNK
of	O
history	B-UNK
,	O
behavior	O
,	O
and	O
physical	B-UNK
findings	B-UNK
in	O
3	O
of	O
the	O
sibs	B-UNK
.	O

 	O
the	O
other	O
child	B-UNK
had	O
died	O
at	B-DISEASE
age	B-UNK
10	O
months	O
with	O
a	O
history	B-UNK
and	O
clinical	B-UNK
findings	B-UNK
typical	B-UNK
of	O
first	O
phase	O
of	O
pws	B-UNK
.	O

 	B-UNK
results	I-UNK
of	O
chromosome	B-UNK
studies	B-UNK
on	O
the	O
parents	B-UNK
and	O
surviving	O
sibs	B-UNK
were	O
normal	B-UNK
.	O

 	O
the	O
implications	B-UNK
of	O
this	O
unusual	B-UNK
familial	B-UNK
occurrence	B-UNK
for	O
our	O
understanding	B-UNK
of	O
pws	B-UNK
are	O
discussed	O
.	O
.	O

 	O
nebulin	B-UNK
and	O
titin	O
expression	B-UNK
in	O
duchenne	B-UNK
muscular	B-DISEASE
dystrophy	I-DISEASE
appears	B-UNK
normal	B-UNK
.	O

 	O
monoclonal	B-UNK
antibodies	B-UNK
which	O
recognize	O
different	B-UNK
epitopes	O
on	O
either	O
titin	O
or	O
nebulin	B-UNK
show	O
normal	B-UNK
staining	B-UNK
patterns	B-UNK
on	O
frozen	O
sections	B-UNK
of	O
three	O
muscle	B-UNK
biopsies	B-UNK
of	O
duchenne	B-UNK
muscular	B-DISEASE
dystrophy	I-DISEASE
(	O
dmd	B-UNK
)	O
.	O

 	O
gel	B-UNK
electrophoresis	I-UNK
and	O
immunoblotting	O
performed	B-UNK
on	O
two	O
of	O
these	O
muscle	B-UNK
biopsies	B-UNK
show	O
the	O
normal	B-UNK
pattern	B-UNK
of	O
titin	O
and	O
nebulin	B-UNK
polypeptides	O
.	O

 	O
since	O
the	O
donor	O
of	O
one	O
of	O
these	O
biopsies	B-UNK
has	O
a	O
large	B-UNK
deletion	B-UNK
of	O
the	O
5	O
-	O
region	B-UNK
of	O
the	O
dmd	B-UNK
gene	B-UNK
,	O
our	O
results	B-UNK
argue	O
against	O
the	O
recent	B-UNK
proposal	O
that	O
nebulin	B-UNK
is	O
the	O
gene	B-UNK
mutated	B-UNK
in	O
dmd	B-UNK
.	O
.	O

 	B-UNK
heterozygous	I-UNK
c2	B-UNK
deficiency	I-UNK
associated	B-UNK
with	O
angioedema	B-DISEASE
,	O
myasthenia	B-DISEASE
gravis	I-DISEASE
,	O
and	O
systemic	B-DISEASE
lupus	I-DISEASE
erythematosus	I-DISEASE
.	O

 	O
we	O
describe	B-UNK
a	O
patient	B-UNK
with	O
myasthenia	B-DISEASE
gravis	I-DISEASE
,	O
systemic	B-DISEASE
lupus	I-DISEASE
erythematosus	I-DISEASE
,	O
and	O
angioedema	B-DISEASE
associated	B-UNK
with	O
heterozygous	B-UNK
complement	B-UNK
factor	B-UNK
2	O
(	O
c2	B-UNK
)	O
deficiency	B-UNK
.	O

 	O
the	O
significance	B-UNK
of	O
this	O
association	B-UNK
is	O
controversial	O
,	O
though	O
the	O
association	B-UNK
of	O
c2	B-UNK
deficiency	I-UNK
with	O
certain	B-UNK
histocompatibility	O
antigens	B-UNK
suggests	B-UNK
possible	B-UNK
linkage	B-UNK
to	O
immune	B-UNK
response	B-UNK
genes	B-UNK
.	O

 	O
to	O
our	O
knowledge	B-UNK
this	O
is	O
the	O
first	O
report	B-UNK
of	O
heterozygous	B-UNK
c2	I-UNK
deficiency	B-UNK
in	O
association	B-UNK
with	O
this	O
combination	O
of	O
autoimmune	B-UNK
disorders	B-UNK
,	O
and	O
we	O
discuss	O
the	O
aetiological	O
implications	B-UNK
.	O
.	O

 	B-UNK
genetic	I-UNK
analysis	B-UNK
of	O
an	O
inherited	B-UNK
deficiency	B-UNK
of	O
the	O
third	O
component	B-UNK
of	O
complement	B-UNK
in	O
brittany	B-UNK
spaniel	I-UNK
dogs	O
.	O

 	O
genetically	B-UNK
determined	I-UNK
c3	B-UNK
deficiency	I-UNK
in	O
brittany	B-UNK
spaniel	I-UNK
dogs	O
shares	B-UNK
a	O
number	B-UNK
of	O
biochemical	B-UNK
and	O
clinical	B-UNK
characteristics	B-UNK
with	O
the	O
human	B-UNK
disorder	O
.	O

 	O
in	O
humans	B-UNK
,	O
the	O
gene	B-UNK
for	O
c3	B-UNK
deficiency	I-UNK
is	O
a	O
null	B-UNK
gene	B-UNK
that	O
is	O
allelic	B-UNK
to	O
the	O
structural	B-UNK
gene	B-UNK
for	O
c3	B-UNK
and	O
is	O
not	O
linked	B-UNK
to	O
the	O
major	B-UNK
histocompatibility	I-UNK
locus	B-UNK
.	O

 	O
the	O
current	B-UNK
study	B-UNK
used	O
allotype	O
analysis	B-UNK
of	O
canine	B-UNK
c3	B-UNK
in	O
order	B-UNK
to	O
demonstrate	B-UNK
that	O
the	O
gene	B-UNK
for	O
c3	B-UNK
deficiency	I-UNK
in	O
these	O
dogs	O
is	O
also	O
a	O
null	B-UNK
gene	B-UNK
allelic	B-UNK
to	O
the	O
structural	B-UNK
gene	B-UNK
for	O
c3	B-UNK
.	O

 	O
in	O
addition	B-UNK
,	O
preliminary	O
pedigree	B-UNK
analysis	B-UNK
suggests	B-UNK
that	O
the	O
gene	B-UNK
for	O
canine	B-UNK
c3	B-UNK
deficiency	I-UNK
is	O
apparently	B-UNK
not	O
closely	B-UNK
linked	I-UNK
to	O
the	O
major	B-UNK
histocompatibility	I-UNK
complex	B-UNK
of	O
the	O
dog	O
.	O

 	O
thus	O
,	O
it	O
appears	B-UNK
that	O
c3	B-UNK
deficiency	I-UNK
in	O
brittany	B-UNK
spaniel	I-UNK
dogs	O
not	O
only	O
shares	B-UNK
biochemical	B-UNK
and	O
clinical	B-UNK
features	I-UNK
with	O
c3	B-UNK
deficiency	I-UNK
in	O
humans	B-UNK
,	O
but	O
also	O
shares	B-UNK
some	O
genetic	B-UNK
characteristics	B-UNK
with	O
the	O
human	B-UNK
disorder	O
.	O
.	O

 	O
gene	B-UNK
transfer	O
and	O
expression	B-UNK
of	O
human	B-UNK
phenylalanine	B-UNK
hydroxylase	I-UNK
.	O

 	O
phenylketonuria	B-DISEASE
(	O
pku	B-DISEASE
)	O
is	O
caused	B-UNK
by	O
a	O
genetic	B-UNK
deficiency	B-UNK
of	O
the	O
enzyme	B-UNK
phenylalanine	I-UNK
hydroxylase	I-UNK
(	O
pah	B-UNK
)	O
.	O

 	O
a	O
full	O
-	O
length	O
complementary	B-UNK
dna	I-UNK
clone	B-UNK
of	O
human	B-UNK
pah	I-UNK
was	O
inserted	O
into	O
a	O
eukaryotic	B-UNK
expression	B-UNK
vector	I-UNK
and	O
transferred	O
into	O
mouse	B-UNK
nih3t3	O
cells	B-UNK
which	O
do	O
not	O
normally	B-UNK
express	B-UNK
pah	B-UNK
.	O

 	O
the	O
transformed	B-UNK
mouse	B-UNK
cells	B-UNK
expressed	B-UNK
pah	B-UNK
messenger	B-UNK
rna	I-UNK
,	O
immunoreactive	B-UNK
protein	B-UNK
,	O
and	O
enzymatic	B-UNK
activity	I-UNK
that	O
are	O
characteristic	B-UNK
of	O
the	O
normal	B-UNK
human	I-UNK
liver	B-DISEASE
products	B-UNK
,	O
demonstrating	B-UNK
that	O
a	O
single	B-UNK
gene	B-UNK
contains	B-UNK
all	O
of	O
the	O
necessary	O
genetic	B-UNK
information	B-UNK
to	O
code	O
for	O
functional	B-UNK
pah	B-UNK
.	O

 	O
these	O
results	B-UNK
support	B-UNK
the	O
use	B-UNK
of	O
the	O
human	B-UNK
pah	I-UNK
probe	B-UNK
in	O
prenatal	B-UNK
diagnosis	I-UNK
and	O
detection	B-UNK
of	O
carriers	B-UNK
,	O
to	O
provide	B-UNK
new	B-UNK
opportunities	O
for	O
the	O
biochemical	B-UNK
characterization	I-UNK
of	O
normal	B-UNK
and	O
mutant	B-UNK
enzymes	B-UNK
,	O
and	O
in	O
the	O
investigation	O
of	O
alternative	B-UNK
genetic	B-UNK
therapies	O
for	O
pku	B-DISEASE
.	O
.	O

 	B-UNK
regional	I-UNK
mapping	B-UNK
of	O
the	O
phenylalanine	B-UNK
hydroxylase	I-UNK
gene	B-UNK
and	O
the	O
phenylketonuria	B-DISEASE
locus	B-UNK
in	O
the	O
human	B-UNK
genome	B-UNK
.	O

 	O
phenylketonuria	B-DISEASE
(	O
pku	B-DISEASE
)	O
is	O
an	O
autosomal	O
recessive	O
disorder	O
of	O
amino	B-DISEASE
acid	I-DISEASE
metabolism	I-DISEASE
caused	B-UNK
by	O
a	O
deficiency	B-UNK
of	O
the	O
hepatic	B-UNK
enzyme	I-UNK
phenylalanine	I-UNK
hydroxylase	O
(	O
pah	B-UNK
;	O
phenylalanine	O
4	O
-	O
monooxygenase	O
,	O
ec	O
1	O
.	O
14	O
.	O
16	O
.	O
1	O
)	O
.	O

 	O
a	O
cdna	B-UNK
clone	B-UNK
for	O
human	B-UNK
pah	I-UNK
has	O
previously	B-UNK
been	O
used	O
to	O
assign	O
the	O
corresponding	B-UNK
gene	B-UNK
to	O
human	B-UNK
chromosome	I-UNK
12	O
.	O

 	O
to	O
define	B-UNK
the	O
regional	B-UNK
map	B-UNK
position	I-UNK
of	O
the	O
disease	B-DISEASE
locus	B-UNK
and	O
the	O
pah	B-UNK
gene	B-UNK
on	O
human	B-UNK
chromosome	I-UNK
12	O
,	O
dna	B-UNK
was	O
isolated	B-UNK
from	O
human	B-UNK
-	O
hamster	B-UNK
somatic	B-UNK
cell	I-UNK
hybrids	I-UNK
with	O
various	O
deletions	B-UNK
of	O
human	B-UNK
chromosome	I-UNK
12	O
and	O
was	O
analyzed	B-UNK
by	O
southern	B-UNK
blot	I-UNK
analysis	I-UNK
using	O
the	O
human	B-UNK
cdna	B-UNK
pah	B-UNK
clone	B-UNK
as	O
a	O
hybridization	B-UNK
probe	B-UNK
.	O

 	O
from	O
these	O
results	B-UNK
,	O
together	O
with	O
detailed	B-UNK
biochemical	B-UNK
and	O
cytogenetic	B-UNK
characterization	B-UNK
of	O
the	O
hybrid	O
cells	B-UNK
,	O
the	O
region	B-UNK
on	O
chromosome	B-DISEASE
12	I-DISEASE
containing	B-UNK
the	O
human	B-UNK
pah	I-UNK
gene	B-UNK
has	O
been	O
defined	B-UNK
as	O
12q14	O
.	O

 	O
3	O
-	O
-	O
-	O
-	O
qter	O
3	O
-	O
-	O
-	O
-	O
qter	O
.	O

 	O
the	O
pah	B-UNK
map	B-UNK
position	I-UNK
on	O
chromosome	B-DISEASE
12	I-DISEASE
was	O
further	O
localized	B-UNK
by	O
in	O
situ	B-UNK
hybridization	I-UNK
of	O
125i	O
-	O
labeled	B-UNK
human	B-UNK
pah	I-UNK
cdna	I-UNK
to	O
chromosomes	B-UNK
prepared	O
from	O
a	O
human	B-UNK
lymphoblastoid	B-UNK
cell	B-UNK
line	B-UNK
.	O

 	B-UNK
results	I-UNK
of	O
these	O
experiments	B-UNK
demonstrated	B-UNK
that	O
the	O
region	B-UNK
on	O
chromosome	B-DISEASE
12	I-DISEASE
containing	B-UNK
the	O
pah	B-UNK
gene	B-UNK
and	O
the	O
pku	B-DISEASE
locus	B-UNK
in	O
man	B-UNK
is	O
12q22	O
-	O
-	O
-	O
-	O
12q24	O
.	O

 	O
1	O
.	O

 	O
these	O
results	B-UNK
not	O
only	O
provide	B-UNK
a	O
regionalized	O
map	B-UNK
position	I-UNK
for	O
a	O
major	B-UNK
human	B-UNK
disease	B-DISEASE
locus	B-UNK
but	O
also	O
can	O
serve	O
as	O
a	O
reference	B-UNK
point	B-UNK
for	O
linkage	B-UNK
analysis	I-UNK
with	O
other	O
dna	B-UNK
markers	I-UNK
on	O
human	B-UNK
chromosome	I-UNK
12	O

 	O
heterogeneity	B-UNK
of	O
type	B-UNK
i	O
von	B-DISEASE
willebrand	I-DISEASE
disease	I-DISEASE
:	O
evidence	B-UNK
for	O
a	O
subgroup	O
with	O
an	O
abnormal	B-UNK
von	B-DISEASE
willebrand	I-DISEASE
factor	I-DISEASE
.	O

 	O
type	B-UNK
i	O
von	B-DISEASE
willebrand	I-DISEASE
disease	I-DISEASE
(	O
vwd	O
)	O
is	O
characterized	B-UNK
by	O
equally	B-UNK
low	B-UNK
plasma	B-UNK
concentrations	B-UNK
of	O
von	B-DISEASE
willebrand	I-DISEASE
factor	I-DISEASE
antigen	B-UNK
(	O
vwf	B-UNK
ag	I-UNK
)	O
and	O
ristocetin	B-UNK
cofactor	O
(	O
ricof	O
)	O
and	O
by	O
the	O
presence	B-UNK
of	O
all	O
vwf	B-UNK
multimers	B-UNK
in	O
sodium	B-UNK
dodecyl	O
sulfate	B-UNK
(	O
sds	O
)	O
-	O
agarose	O
gel	B-UNK
electrophoresis	I-UNK
.	O

 	O
for	O
17	O
patients	B-UNK
(	O
13	O
kindreds	B-UNK
)	O
diagnosed	B-UNK
with	O
these	O
criteria	B-UNK
,	O
we	O
have	O
studied	B-UNK
the	O
platelet	B-UNK
contents	O
of	O
vwf	B-UNK
ag	I-UNK
and	O
ricof	O
and	O
the	O
changes	B-UNK
of	O
these	O
in	O
plasma	B-UNK
after	O
ddavp	B-UNK
infusion	B-UNK
.	O

 	O
platelet	B-UNK
vwf	B-UNK
ag	I-UNK
and	O
ricof	O
were	O
normal	B-UNK
in	O
four	O
kindreds	B-UNK
(	O
called	B-UNK
"	O
platelet	B-UNK
normal	B-UNK
"	O
subgroup	O
)	O
;	O
following	B-UNK
1	O
-	O
deamino	O
-	O
8	O
-	O
d	B-UNK
-	O
arginine	B-UNK
vasopressin	B-UNK
;	O
plasma	B-UNK
vwf	B-UNK
ag	I-UNK
,	O
ricof	O
and	O
the	O
bleeding	B-DISEASE
time	B-UNK
(	O
bt	O
)	O
became	O
normal	B-UNK
.	O

 	O
in	O
six	O
kindreds	B-UNK
,	O
platelet	B-UNK
vwf	B-UNK
ag	I-UNK
and	O
ricof	O
were	O
equally	B-UNK
low	B-UNK
(	O
platelet	B-UNK
low	B-UNK
)	O
;	O
after	O
ddavp	B-UNK
,	O
plasma	B-UNK
vwf	B-UNK
ag	I-UNK
and	O
ricof	O
remained	B-UNK
low	B-UNK
,	O
and	O
the	O
bt	O
was	O
prolonged	B-UNK
.	O

 	O
in	O
three	O
additional	B-UNK
kindreds	B-UNK
,	O
platelets	B-UNK
contained	B-UNK
normal	B-UNK
concentrations	B-UNK
of	O
vwf	B-UNK
ag	I-UNK
,	O
but	O
ricof	O
was	O
very	O
low	B-UNK
(	O
platelet	B-UNK
discordant	B-UNK
)	O
;	O
even	O
though	O
a	O
complete	B-UNK
set	B-UNK
of	O
multimers	B-UNK
was	O
found	B-UNK
in	O
plasma	B-UNK
and	O
platelets	B-UNK
,	O
there	O
was	O
a	O
relatively	B-UNK
small	B-UNK
amount	O
of	O
large	B-UNK
multimers	B-UNK
.	O

 	O
after	O
ddavp	B-UNK
,	O
plasma	B-UNK
vwf	B-UNK
ag	I-UNK
became	O
normal	B-UNK
,	O
but	O
ricof	O
remained	B-UNK
low	B-UNK
and	O
the	O
bt	O
was	O
very	O
prolonged	B-UNK
.	O

 	O
these	O
findings	B-UNK
demonstrated	B-UNK
that	O
there	O
can	O
be	O
an	O
abnormal	B-UNK
vwf	B-UNK
(	O
ricof	O
less	O
than	O
vwf	B-UNK
ag	I-UNK
)	O
even	O
in	O
type	B-UNK
i	O
vwd	O
,	O
coexisting	O
with	O
a	O
complete	B-UNK
set	B-UNK
of	O
vwf	B-UNK
multimers	B-UNK
(	O
platelet	B-UNK
discordant	B-UNK
)	O
;	O
that	O
the	O
abnormal	B-UNK
vwf	B-UNK
can	O
be	O
shown	B-UNK
more	O
clearly	B-UNK
in	O
platelets	B-UNK
than	O
in	O
plasma	B-UNK
or	O
else	O
in	O
plasma	B-UNK
after	O
ddavp	B-UNK
infusion	B-UNK
;	O
and	O
that	O
ddavp	B-UNK
normalizes	O
the	O
bt	O
only	O
in	O
those	O
patients	B-UNK
with	O
normal	B-UNK
platelet	B-UNK
levels	B-UNK
of	O
both	O
vwf	B-UNK
ag	I-UNK
and	O
ricof	O
(	O
platelet	B-UNK
normal	B-UNK
)	O
.	O
.	O

 	B-UNK
genetic	I-UNK
analysis	B-UNK
in	O
families	B-UNK
with	O
van	B-DISEASE
der	I-DISEASE
woude	I-DISEASE
syndrome	I-DISEASE
.	O

 	O
we	O
have	O
brought	O
together	O
information	B-UNK
on	O
864	O
affected	B-UNK
individuals	I-UNK
in	O
164	O
families	B-UNK
(	O
including	B-UNK
three	O
new	B-UNK
pedigrees	B-UNK
)	O
reported	B-UNK
in	O
the	O
137	O
year	B-UNK
period	B-UNK
since	O
1845	O
when	O
demarquay	O
first	O
described	B-UNK
a	O
family	B-UNK
with	O
what	O
was	O
later	B-UNK
called	B-UNK
van	B-DISEASE
der	I-DISEASE
woude	I-DISEASE
syndrome	I-DISEASE
(	O
vws	B-UNK
)	O
.	O

 	O
both	O
types	B-UNK
of	O
oral	B-UNK
cleft	O
,	O
cleft	B-DISEASE
palate	I-DISEASE
(	O
cp	O
)	O
and	O
cleft	B-DISEASE
lip	I-DISEASE
with	O
or	O
without	O
cp	O
(	O
clp	O
)	O
,	O
segregate	O
in	O
these	O
families	B-UNK
together	O
with	O
lower	B-UNK
lip	B-DISEASE
pits	O
or	O
fistulae	O
in	O
an	O
autosomal	O
dominant	B-UNK
mode	B-UNK
with	O
high	B-UNK
penetrance	B-UNK
estimated	B-UNK
to	O
be	O
k	B-UNK
=	O
.	O

 	O
89	O
and	O
.	O

 	O
99	O
by	O
different	B-UNK
methods	B-UNK
.	O

 	O
cleft	O
types	B-UNK
(	O
clp	O
and	O
cp	O
)	O
occur	B-UNK
in	O
vws	B-UNK
in	O
the	O
same	O
proportions	O
as	O
in	O
the	O
general	B-UNK
non	B-UNK
-	O
vws	B-UNK
population	B-UNK
,	O
ie	O
,	O
about	O
twice	O
as	O
many	O
cleft	O
-	O
bearing	B-UNK
individuals	B-UNK
have	O
clp	O
as	O
have	O
cp	O
.	O

 	O
on	O
the	O
other	O
hand	B-DISEASE
,	O
we	O
do	O
not	O
find	O
the	O
usually	B-UNK
observed	B-UNK
excess	B-UNK
of	O
females	B-UNK
with	O
cp	O
and	O
excess	B-UNK
of	O
males	B-UNK
with	O
clp	O
;	O
in	O
vws	B-UNK
the	O
sex	B-UNK
ratios	O
are	O
more	O
nearly	O
equal	B-UNK
.	O

 	O
lip	B-DISEASE
pits	O
also	O
are	O
equally	B-UNK
distributed	B-UNK
between	O
the	O
sexes	O
.	O

 	B-UNK
affected	I-UNK
males	B-UNK
and	O
females	B-UNK
are	O
equally	B-UNK
likely	B-UNK
to	O
transmit	O
vws	B-UNK
.	O

 	O
however	O
,	O
there	O
is	O
an	O
excess	B-UNK
of	O
less	O
severely	B-UNK
affected	I-UNK
individuals	B-UNK
among	O
transmitters	O
and	O
a	O
deficiency	B-UNK
of	O
more	O
severely	B-UNK
affected	I-UNK
,	O
brought	O
about	O
by	O
a	O
proband	B-UNK
bias	B-UNK
and	O
differential	B-UNK
fecundity	O
.	O

 	O
the	O
expression	B-UNK
of	O
vws	B-UNK
is	O
significantly	B-UNK
modified	B-UNK
by	O
the	O
genetic	B-UNK
background	B-UNK
more	O
extreme	B-UNK
phenotypes	B-UNK
in	O
parents	B-UNK
tend	O
to	O
produce	B-UNK
more	O
extreme	B-UNK
expression	B-UNK
in	O
their	O
children	B-UNK
.	O

 	O
for	O
a	O
vws	B-UNK
gene	B-UNK
carrier	B-UNK
the	O
relative	B-UNK
risk	B-UNK
of	O
transmitting	B-UNK
a	O
cleft	O
is	O
26	O
.	O

 	O
45	O
%	O
;	O
that	O
of	O
transmitting	B-UNK
lower	B-UNK
lip	B-DISEASE
pits	O
is	O
23	O
.	O

 	O
55	O
%	O
.	O

 	O
three	O
pedigrees	B-UNK
of	O
lip	B-DISEASE
pits	O
in	O
the	O
literature	O
show	O
no	O
clefts	O
among	O
a	O
significant	B-UNK
number	B-UNK
of	O
affected	B-UNK
individuals	I-UNK
.	O

 	O
control	B-UNK
of	O
gene	B-UNK
expression	B-UNK
in	O
vws	B-UNK
in	O
the	O
three	O
target	B-UNK
tissues	B-UNK
appears	B-UNK
to	O
be	O
independent	B-UNK
and	O
separately	B-UNK
designated	B-UNK
.	O

 	O
mutation	B-UNK
rate	B-UNK
of	O
the	O
vws	B-UNK
gene	B-UNK
is	O
calculated	O
to	O
be	O
1	O
.	O

 	O
8	O
x	B-UNK
10	O
(	O
-	O
5	O
)	O

 	B-UNK
hereditary	I-UNK
c7	B-UNK
deficiency	I-UNK
.	O

 	O
diagnosis	B-UNK
and	O
hla	B-UNK
studies	B-UNK
in	O
a	O
french	B-UNK
-	O
canadian	B-UNK
family	B-UNK
.	O

 	O
the	O
serum	B-UNK
of	O
a	O
44	O
-	O
yr	O
-	O
old	B-UNK
woman	B-UNK
of	O
french	B-UNK
-	O
canadian	B-UNK
descent	B-UNK
having	B-UNK
a	O
b	B-UNK
-	O
27	O
positive	B-UNK
ankylosing	B-DISEASE
spondylitis	I-DISEASE
was	O
deficient	B-UNK
in	O
the	O
seventh	B-UNK
component	B-UNK
of	O
complement	B-UNK
(	O
c7	B-UNK
)	O
as	O
determined	B-UNK
by	O
hemolytic	B-UNK
and	O
immunochemical	B-UNK
methods	B-UNK
.	O

 	O
no	O
inhibitor	B-UNK
against	O
c7	B-UNK
was	O
detected	B-UNK
,	O
and	O
the	O
levels	B-UNK
of	O
all	O
other	O
complement	B-UNK
components	B-UNK
were	O
normal	B-UNK
.	O

 	O
no	O
deficiency	B-UNK
in	O
the	O
opsonic	B-UNK
activity	B-UNK
of	O
the	O
serum	B-UNK
was	O
found	B-UNK
,	O
and	O
the	O
results	B-UNK
of	O
basic	O
coagulation	O
studies	B-UNK
of	O
the	O
plasma	B-UNK
were	O
normal	B-UNK
.	O

 	O
on	O
investigation	O
of	O
the	O
patients	B-UNK
family	B-UNK
,	O
two	O
sisters	O
were	O
found	B-UNK
to	O
have	O
the	O
same	O
deficiency	B-UNK
but	O
were	O
otherwise	O
in	O
good	B-UNK
health	B-UNK
.	O

 	O
the	O
seven	B-UNK
other	O
siblings	B-UNK
were	O
heterozygous	B-UNK
for	O
c7	B-UNK
deficiency	I-UNK
,	O
while	O
the	O
paternal	B-UNK
aunt	B-UNK
had	O
a	O
normal	B-UNK
c7	B-UNK
level	B-UNK
.	O

 	O
in	O
the	O
third	O
generation	B-UNK
,	O
six	O
children	B-UNK
of	O
the	O
three	O
homozygous	B-UNK
sisters	O
and	O
five	O
children	B-UNK
of	O
heterozygotes	B-UNK
were	O
available	B-UNK
for	O
testing	B-UNK
.	O

 	O
studies	B-UNK
of	O
the	O
hla	B-UNK
antigens	B-UNK
in	O
all	O
the	O
22	O
subjects	B-UNK
and	O
in	O
three	O
spouses	O
indicated	B-UNK
no	O
close	B-UNK
linkage	I-UNK
between	O
the	O
cm	B-DISEASE
deficienty	O
and	O
the	O
hla	B-UNK
system	B-UNK
.	O

 	O
in	O
addition	B-UNK
,	O
the	O
simultaneous	O
occurrence	B-UNK
of	O
two	O
hereditary	B-UNK
complement	B-UNK
deficiencies	B-UNK
(	O
c2	B-UNK
and	O
c7	B-UNK
)	O
was	O
discovered	O
in	O
one	O
family	B-UNK
of	O
this	O
remarkable	O
kindred	B-UNK
.	O
.	O

 	B-UNK
genetic	I-UNK
defect	B-UNK
in	O
secretion	B-UNK
of	O
complement	B-UNK
c5	B-UNK
in	O
mice	B-UNK
.	O

 	O
a	O
genetic	B-UNK
deficiency	B-UNK
of	O
the	O
fifth	B-UNK
(	O
c5	B-UNK
)	O
component	B-UNK
of	O
complement1	O
-	O
3	O
,	O
a	O
serum	B-UNK
glycoprotein	B-UNK
of	O
molecular	B-UNK
weight	I-UNK
(	O
mw	O
)	O
220	O
,	O
000	O
(	O
ref	O
.	O
4	O
)	O
,	O
has	O
been	O
found	B-UNK
in	O
39	O
%	O
of	O
inbred	O
strains	B-UNK
of	O
mice3	O
.	O

 	O
sera	O
of	O
deficient	B-UNK
mice	B-UNK
lack	B-UNK
detectable	B-UNK
c5	B-UNK
activity	B-UNK
and	O
protein2	O
,	O
3	O
.	O

 	O
in	O
addition	B-UNK
deficient	B-UNK
mice	B-UNK
produce	B-UNK
antibody	B-UNK
to	O
mouse	B-UNK
c5	B-UNK
when	O
injected	O
with	O
sera	O
from	O
c5	B-UNK
sufficient	B-UNK
(	O
normal	B-UNK
)	O
strains	B-UNK
.	O

 	O
levy	O
et	O
al	O
.	O

 	O
5	O
showed	B-UNK
that	O
somatic	B-UNK
cell	I-UNK
hybrids	I-UNK
between	O
c5	B-UNK
deficient	B-UNK
(	O
b10	O
.	O
d2	B-UNK
/	O
old	B-UNK
line	B-UNK
)	O
macrophages	O
and	O
either	O
c5	B-UNK
sufficient	B-UNK
(	O
b10	O
.	O
d2	B-UNK
/	O
new	B-UNK
line	B-UNK
)	O
mouse	B-UNK
kidney	B-UNK
or	O
chicken	O
erythroblasts	O
secreted	B-UNK
haemolytically	O
active	B-UNK
mouse	B-UNK
c5	B-UNK
in	O
vitro	B-UNK
.	O

 	O
several	O
possible	B-UNK
molecular	B-UNK
mechanisms	I-UNK
to	O
account	B-UNK
for	O
the	O
findings	B-UNK
were	O
considered	B-UNK
,	O
but	O
insufficient	O
direct	B-UNK
data	B-UNK
were	O
available	B-UNK
to	O
choose	O
among	O
them	O
.	O

 	O
we	O
recently	B-UNK
reported	B-UNK
that	O
mouse	B-UNK
(	O
cd	O
.	O
1	O
strain	O
)	O
peritoneal	B-UNK
cells	B-UNK
in	O
culture	B-UNK
synthesise	O
and	O
secrete	O
a	O
single	B-UNK
chain	O
precursor	B-UNK
,	O
pro	O
-	O
c5	B-UNK
(	O
mw	O
approximately	B-UNK
210	O
,	O
000	O
)	O
,	O
of	O
the	O
two	O
-	O
chain	O
(	O
alpha	B-UNK
chain	O
,	O
125	O
,	O
000	O
and	O
beta	B-UNK
chain	O
83	O
,	O
000	O
mw	O
)	O
c5	B-UNK
protein6	O
.	O

 	O
radiolabelled	O
precursor	B-UNK
c5	B-UNK
was	O
contained	B-UNK
within	O
the	O
cells	B-UNK
and	O
was	O
secreted	B-UNK
into	O
the	O
tissue	B-UNK
culture	B-UNK
media	O
.	O

 	O
using	O
similar	B-UNK
methods	B-UNK
,	O
we	O
now	O
find	O
that	O
c5	B-UNK
deficiency	B-UNK
in	O
each	O
of	O
five	O
different	B-UNK
mouse	B-UNK
strains	B-UNK
(	O
akr	O
,	O
swr	O
,	O
dba	O
/	O
2j8	O
a	O
/	O
hej	O
and	O
b10	O
.	O
d2	B-UNK
/	O
old	B-UNK
line	B-UNK
)	O
is	O
due	O
to	O
a	O
failure	O
in	O
secretion	B-UNK
of	O
c5	B-UNK
protein	B-UNK
and	O
not	O
to	O
a	O
failure	O
in	O
biosynthesis	O
of	O
pro	O
-	O
c5	B-UNK

 	B-UNK
recurrent	I-UNK
meningococcal	B-UNK
meningitis	B-DISEASE
with	O
absence	B-UNK
of	O
the	O
sixth	B-UNK
component	B-UNK
of	O
complement	B-UNK
:	O
an	O
evaluation	B-UNK
of	O
underlying	B-UNK
immunologic	B-UNK
mechanisms	B-UNK
.	O

 	O
a	O
51	O
/	O
2	O
-	O
year	B-UNK
-	O
old	B-UNK
black	B-UNK
girl	B-UNK
with	O
recurrent	B-UNK
meningococcal	B-UNK
meningitis	B-DISEASE
and	O
absence	B-UNK
of	O
the	O
sixth	B-UNK
component	B-UNK
of	O
complement	B-UNK
(	O
c6	B-UNK
)	O
is	O
reported	B-UNK
.	O

 	O
to	O
explore	O
the	O
pathogenesis	O
of	O
recurrent	B-UNK
neisserial	B-UNK
infections	B-DISEASE
in	O
c6	B-DISEASE
deficiency	I-DISEASE
,	O
a	O
detailed	B-UNK
analysis	B-UNK
of	O
her	O
immune	B-UNK
competence	O
was	O
conducted	O
.	O

 	O
her	O
serum	B-UNK
had	O
normal	B-UNK
chemotactic	B-UNK
,	O
opsonic	B-UNK
,	O
alternative	B-UNK
complement	B-UNK
pathway	B-UNK
,	O
and	O
specific	B-UNK
antibody	B-UNK
activity	B-UNK
,	O
but	O
lacked	B-UNK
complement	B-UNK
-	O
mediated	B-UNK
bacteriolytic	O
activity	B-UNK
.	O

 	O
in	O
addition	B-UNK
,	O
her	O
c6	B-UNK
-	O
deficient	B-UNK
serum	B-UNK
was	O
indistinguishable	O
from	O
normal	B-UNK
serum	I-UNK
in	O
a	O
complement	B-UNK
-	O
dependent	B-UNK
assay	B-UNK
of	O
phagocyte	O
bactericidal	B-UNK
activity	I-UNK
.	O

 	O
absent	B-UNK
bacteriolysis	O
remains	B-UNK
the	O
only	O
consistent	B-UNK
defect	B-UNK
associated	B-UNK
with	O
recurrent	B-UNK
neisserial	B-UNK
infections	B-DISEASE
and	O
absence	B-UNK
of	O
one	O
of	O
the	O
late	B-UNK
-	O
acting	O
complement	B-UNK
components	B-UNK
.	O
.	O

 	O
deficiency	B-UNK
of	O
the	O
fifth	B-UNK
component	B-UNK
of	O
complement	B-UNK
in	O
human	B-UNK
subjects	B-UNK
.	O

 	B-UNK
clinical	I-UNK
,	O
genetic	B-UNK
and	O
immunologic	B-UNK
studies	B-UNK
in	O
a	O
large	B-UNK
kindred	B-UNK
.	O

 	O
the	O
discovery	B-UNK
of	O
a	O
large	B-UNK
kindred	B-UNK
with	O
a	O
heritable	O
deficiency	B-UNK
of	O
the	O
fifth	B-UNK
component	B-UNK
of	O
complement	B-UNK
(	O
c5	B-UNK
)	O
has	O
permitted	O
the	O
accumulation	B-UNK
of	O
new	B-UNK
clinical	B-UNK
,	O
genetic	B-UNK
and	O
immunologic	B-UNK
data	B-UNK
concerning	B-UNK
the	O
role	B-UNK
of	O
c5	B-UNK
in	O
human	B-UNK
subjects	B-UNK
.	O

 	O
the	O
proband	B-UNK
,	O
who	O
has	O
had	O
nine	O
episodes	O
of	O
disseminated	B-UNK
gonococcal	B-UNK
infection	B-DISEASE
,	O
has	O
a	O
hemolytic	B-UNK
c5	B-UNK
level	B-UNK
of	O
approximately	B-UNK
0	O
.	O

 	O
5	O
per	O
cent	O
of	O
normal	B-UNK
.	O

 	O
no	O
c5	B-UNK
protein	B-UNK
was	O
detectable	B-UNK
,	O
but	O
low	B-UNK
levels	B-UNK
of	O
functional	B-UNK
c5	B-UNK
activity	B-UNK
could	O
be	O
found	B-UNK
using	O
a	O
sensitive	B-UNK
bactericidal	B-UNK
assay	B-UNK
.	O

 	O
the	O
probands	B-UNK
twin	B-UNK
as	O
well	O
as	O
another	O
sister	O
also	O
had	O
extremely	B-UNK
low	B-UNK
levels	B-UNK
of	O
hemolytic	B-UNK
c5	B-UNK
(	O
approximately	B-UNK
0	O
.	O
5	O
per	O
cent	O
normal	B-UNK
)	O
,	O
but	O
both	O
these	O
subjects	B-UNK
have	O
been	O
healthy	B-UNK
.	O

 	O
hemolytic	B-UNK
complement	I-UNK
and	O
bacteriolytic	O
activity	B-UNK
could	O
be	O
restored	B-UNK
by	O
the	O
addition	B-UNK
of	O
purified	B-UNK
c5	B-UNK
.	O

 	O
no	O
chemotactic	B-UNK
activity	B-UNK
for	O
polymorphonuclear	B-UNK
leukocytes	B-UNK
could	O
be	O
generated	B-UNK
in	O
the	O
c5	B-UNK
-	O
deficient	B-UNK
serums	O
upon	O
activation	B-UNK
of	O
either	O
the	O
classic	B-UNK
or	O
alternative	B-UNK
pathways	B-UNK
,	O
again	O
demonstrating	B-UNK
the	O
importance	O
of	O
c5	B-UNK
in	O
human	B-UNK
subjects	B-UNK
for	O
the	O
production	B-UNK
of	O
chemotactic	B-UNK
factors	B-UNK
.	O

 	O
the	O
chemotactic	B-UNK
responsiveness	O
of	O
the	O
patients	B-UNK
polymorphonuclear	B-UNK
leukocytes	B-UNK
and	O
monocytes	O
to	O
preformed	O
chemotactic	B-UNK
factors	B-UNK
was	O
not	O
depressed	B-DISEASE
.	O

 	O
twenty	O
-	O
two	O
of	O
32	O
other	O
family	B-UNK
members	I-UNK
from	O
three	O
generations	B-UNK
had	O
depressed	B-DISEASE
whole	O
hemolytic	B-UNK
complement	I-UNK
levels	B-UNK
.	O

 	O
in	O
19	O
of	O
30	O
family	B-UNK
members	I-UNK
,	O
levels	B-UNK
of	O
hemolytic	B-UNK
c5	B-UNK
ranged	O
from	O
13	O
to	O
64	O
per	O
cent	O
of	O
normal	B-UNK
.	O

 	O
no	O
linkage	B-UNK
for	O
c5	B-UNK
deficiency	B-UNK
and	O
the	O
a	O
or	O
b	B-UNK
loci	B-UNK
of	O
the	O
major	B-UNK
histocompatibility	I-UNK
complex	B-UNK
could	O
be	O
found	B-UNK
.	O

 	O
these	O
data	B-UNK
suggest	B-UNK
an	O
autosomal	O
codominant	B-UNK
mode	B-UNK
of	O
inheritance	B-UNK
of	O
c5	B-UNK
deficiency	B-UNK
.	O

 	O
deficiency	B-UNK
of	O
c5	B-UNK
is	O
compatible	O
with	O
good	B-UNK
health	B-UNK
,	O
but	O
it	O
can	O
be	O
associated	B-UNK
with	O
repeated	B-UNK
disseminated	B-UNK
gonococcal	B-UNK
infection	B-DISEASE

 	O
incidence	O
and	O
characteristics	B-UNK
of	O
glucose	B-UNK
-	O
6	O
-	O
phosphate	B-UNK
dehydrogenase	I-UNK
variants	B-UNK
in	O
japan	O
.	O

 	O
a	O
total	B-UNK
of	O
3000	O
men	B-UNK
living	B-UNK
in	O
yamaguchi	O
were	O
screened	O
for	O
glucose	B-UNK
-	O
6	O
-	O
phosphate	B-UNK
dehydrogenase	I-UNK
(	O
g6pd	B-UNK
)	O
deficiency	B-UNK
using	O
beutlers	O
spot	B-UNK
test	B-UNK
and	O
three	O
types	B-UNK
of	O
starch	O
gel	B-UNK
electrophoresis	I-UNK
.	O

 	O
these	O
electrophoresis	B-UNK
used	O
a	O
phosphate	B-UNK
buffer	O
system	B-UNK
at	B-DISEASE
ph	B-UNK
7	O
.	O

 	O
0	O
,	O
a	O
tris	O
-	O
edta	O
-	O
borate	O
buffer	O
system	B-UNK
at	B-DISEASE
ph	B-UNK
8	O
.	O

 	O
6	O
,	O
and	O
a	O
tris	O
-	O
hydrochloride	O
buffer	O
system	B-UNK
at	B-DISEASE
ph	B-UNK
8	O
.	O
.	O

 	O
fifteen	O
g6pd	B-UNK
-	O
deficient	B-UNK
variants	B-UNK
were	O
found	B-UNK
at	B-DISEASE
the	O
rate	B-UNK
of	O
0	O
.	O

 	O
5	O
%	O
and	O
classified	O
into	O
four	O
groups	B-UNK
.	O

 	O
as	O
new	B-UNK
variants	B-UNK
,	O
g6pd	B-UNK
konan	O
,	O
kamiube	O
,	O
and	O
kiwa	O
were	O
identified	B-UNK
.	O

 	O
these	O
three	O
variants	B-UNK
had	O
a	O
mild	B-UNK
to	O
moderate	B-UNK
g6pd	B-UNK
deficiency	I-UNK
and	O
were	O
not	O
associated	B-UNK
with	O
any	O
clinical	B-UNK
signs	B-UNK
.	O

 	B-UNK
g6pd	I-UNK
konan	O
had	O
fast	B-UNK
electrophoretic	B-UNK
mobility	I-UNK
as	O
compared	B-UNK
with	O
normal	B-UNK
levels	B-UNK
,	O
g6pd	B-UNK
kiwa	O
had	O
slightly	B-UNK
elevated	B-UNK
electrophoretic	B-UNK
mobility	I-UNK
,	O
and	O
g6pd	B-UNK
kamiube	O
had	O
normal	B-UNK
electrophoretic	I-UNK
mobility	B-UNK
.	O

 	O
these	O
three	O
variants	B-UNK
had	O
normal	B-UNK
levels	B-UNK
of	O
km	B-UNK
g6p	O
,	O
km	B-UNK
nadp	B-UNK
,	O
and	O
ki	O
nadph	B-UNK
,	O
normal	B-UNK
utilizations	O
of	O
both	O
2	O
-	O
deoxy	O
-	O
g6p	O
and	O
deamino	O
-	O
napd	O
,	O
normal	B-UNK
heat	B-UNK
stability	B-UNK
,	O
and	O
a	O
normal	B-UNK
ph	B-UNK
curve	I-UNK
.	O

 	O
the	O
other	O
variant	B-UNK
was	O
g6pd	B-UNK
ube	O
,	O
which	O
we	O
had	O
previously	B-UNK
found	B-UNK
in	O
yamaguchi	O
(	O
nakashima	O
et	O
al	O
.	O
,	O
1977	O
)	O
.	O

 	O
one	O
boy	B-UNK
with	O
g6pd	B-UNK
ube	O
was	O
korean	O

 	O
utilization	B-UNK
of	O
purines	O
by	O
an	O
hprt	B-UNK
variant	B-UNK
in	O
an	O
intelligent	O
,	O
nonmutilative	O
patient	B-UNK
with	O
features	B-UNK
of	O
the	O
lesch	B-DISEASE
-	I-DISEASE
nyhan	I-DISEASE
syndrome	I-DISEASE
.	O

 	O
the	O
patient	B-UNK
,	O
h	O
.	O

 	O
chr	O
.	O

 	O
b	B-UNK
.	O
,	O
was	O
among	O
the	O
first	O
reported	B-UNK
with	O
hyperuricemia	B-DISEASE
and	O
central	B-UNK
nervous	I-UNK
system	I-UNK
symptoms	B-UNK
.	O

 	O
he	O
has	O
been	O
found	B-UNK
to	O
have	O
a	O
variant	B-UNK
of	O
hypoxanthine	B-UNK
guanine	B-UNK
phosphoribosyl	O
transferase	O
(	O
hprt	B-UNK
;	O
e	B-UNK
.	O
c	B-UNK
.	O
2	O
.	O
4	O
.	O
2	O
.	O
8	O
)	O
distinct	B-UNK
from	O
the	O
enzyme	B-UNK
present	B-UNK
in	O
patients	B-UNK
with	O
the	O
lesch	B-DISEASE
-	I-DISEASE
nyhan	I-DISEASE
syndrome	I-DISEASE
.	O

 	O
the	O
patient	B-UNK
had	O
chroeoathetosis	O
,	O
spasticity	O
,	O
dysarthric	O
speech	O
,	O
and	O
hyperuricemia	B-DISEASE
.	O

 	O
however	O
,	O
his	O
intelligence	B-UNK
was	O
normal	B-UNK
and	O
he	O
had	O
no	O
evidence	B-UNK
of	O
self	O
-	O
mutilation	O
.	O

 	O
there	O
was	O
no	O
activity	B-UNK
of	O
hprt	B-UNK
in	O
the	O
lysates	O
of	O
erythrocytes	O
and	O
cultured	B-UNK
fibroblasts	B-UNK
when	O
analyzed	B-UNK
in	O
the	O
usual	O
manner	B-UNK
.	O

 	O
using	O
a	O
newly	B-UNK
developed	B-UNK
method	B-UNK
for	O
the	O
study	B-UNK
of	O
purine	O
metabolism	B-DISEASE
in	O
intact	B-UNK
cultured	B-UNK
cells	B-UNK
,	O
this	O
patient	B-UNK
was	O
found	B-UNK
to	O
metabolize	O
some	O
9	O
%	O
of	O
8	O
-	O
14c	O
-	O
hypoxanthine	B-UNK
,	O
and	O
90	O
%	O
of	O
the	O
isotope	O
utilized	O
was	O
converted	O
to	O
adenine	O
and	O
guanine	B-UNK
nucleotides	B-UNK
.	O

 	O
in	O
contrast	B-UNK
,	O
cells	B-UNK
from	O
patients	B-UNK
with	O
the	O
lesch	B-DISEASE
-	I-DISEASE
nyhan	I-DISEASE
syndrome	I-DISEASE
were	O
virtually	B-UNK
completely	B-UNK
unable	O
to	O
convert	O
hypoxanthine	B-UNK
to	O
nucleotides	B-UNK
.	O

 	O
the	O
patients	B-UNK
fibroblasts	B-UNK
were	O
even	O
more	O
efficient	O
in	O
the	O
metabolism	B-DISEASE
of	O
8	O
-	O
14c	O
-	O
guanine	B-UNK
,	O
which	O
was	O
utilized	O
to	O
the	O
extent	B-UNK
of	O
27	O
%	O
,	O
over	O
80	O
%	O
of	O
which	O
was	O
converted	O
to	O
guanine	B-UNK
and	O
adenine	O
nucleotides	B-UNK
.	O

 	O
the	O
growth	B-UNK
of	O
the	O
cultured	B-UNK
fibroblasts	B-UNK
of	O
this	O
patient	B-UNK
was	O
intermediate	B-UNK
in	O
media	O
containing	B-UNK
hypoxanthine	B-UNK
aminopterin	O
thymidine	B-UNK
(	O
hat	O
)	O
,	O
whereas	O
the	O
growth	B-UNK
of	O
lesch	O
-	O
nyhan	B-UNK
cells	B-UNK
was	O
inhibited	B-UNK
and	O
normal	B-UNK
cells	B-UNK
grew	O
normally	B-UNK
.	O

 	O
similarly	B-UNK
in	O
8	O
-	O
azaguanine	O
,	O
6	O
-	O
thioguanine	O
,	O
and	O
8	O
-	O
azahypoxanthine	O
,	O
the	O
growth	B-UNK
of	O
the	O
patients	B-UNK
cells	B-UNK
was	O
intermediate	B-UNK
between	O
normal	B-UNK
and	O
lesch	O
-	O
nyhan	B-UNK
cells	B-UNK
.	O

 	O
these	O
observations	B-UNK
provide	B-UNK
further	O
evidence	B-UNK
for	O
genetic	B-UNK
heterogeneity	B-UNK
among	O
patients	B-UNK
with	O
disorders	B-UNK
in	O
purine	O
metabolism	B-DISEASE
involving	B-UNK
the	O
hprt	B-UNK
gene	B-UNK
.	O

 	O
they	O
document	O
that	O
this	O
famous	O
patient	B-UNK
did	O
not	O
have	O
the	O
lesch	B-DISEASE
-	I-DISEASE
nyhan	I-DISEASE
syndrome	I-DISEASE

 	O
localisation	B-UNK
of	O
the	O
becker	O
muscular	B-DISEASE
dystrophy	I-DISEASE
gene	B-UNK
on	O
the	O
short	B-UNK
arm	B-UNK
of	O
the	O
x	B-DISEASE
chromosome	I-DISEASE
by	O
linkage	B-UNK
to	O
cloned	B-UNK
dna	B-UNK
sequences	I-UNK
.	O

 	O
a	O
linkage	B-UNK
study	I-UNK
in	O
30	O
becker	O
muscular	B-DISEASE
dystrophy	I-DISEASE
(	O
bmd	B-UNK
)	O
kindreds	B-UNK
using	O
three	O
cloned	B-UNK
dna	B-UNK
sequences	I-UNK
from	O
the	O
x	B-DISEASE
chromosome	I-DISEASE
which	O
demonstrate	B-UNK
restriction	B-UNK
fragment	I-UNK
length	I-UNK
polymorphisms	I-UNK
(	O
rflps	B-UNK
)	O
,	O
suggests	B-UNK
that	O
the	O
bmd	B-UNK
gene	B-UNK
is	O
located	B-UNK
on	O
the	O
short	B-UNK
arm	B-UNK
of	O
the	O
x	B-DISEASE
chromosome	I-DISEASE
,	O
in	O
the	O
p21	O
region	B-UNK
.	O

 	O
the	O
genes	B-UNK
for	O
becker	O
and	O
duchenne	B-UNK
dystrophies	O
must	O
therefore	O
be	O
closely	B-UNK
linked	I-UNK
,	O
if	O
not	O
allelic	B-UNK
,	O
and	O
any	O
future	B-UNK
dna	B-UNK
probes	I-UNK
found	B-UNK
to	O
be	O
of	O
practical	B-UNK
use	B-UNK
in	O
one	O
disorder	O
should	O
be	O
equally	B-UNK
applicable	O
to	O
the	O
other	O
.	O

 	O
the	O
linkage	B-UNK
analysis	I-UNK
also	O
provides	B-UNK
data	B-UNK
on	O
the	O
frequency	B-UNK
of	O
recombination	B-UNK
along	O
the	O
short	B-UNK
arm	B-UNK
of	O
the	O
x	B-DISEASE
chromosome	I-DISEASE
,	O
and	O
across	O
the	O
centromeric	B-UNK
region	B-UNK
.	O
.	O

 	B-UNK
molecular	I-UNK
evidence	B-UNK
for	O
new	B-UNK
mutation	B-UNK
at	B-DISEASE
the	O
hprt	B-UNK
locus	I-UNK
in	O
lesch	O
-	O
nyhan	B-UNK
patients	B-UNK
.	O

 	O
hypoxanthine	B-UNK
-	O
guanine	B-UNK
phosphoribosyltransferase	I-UNK
(	O
hprt	B-UNK
;	O
ec2	O
.	O
4	O
.	O
2	O
.	O
8	O
)	O
,	O
which	O
functions	B-UNK
in	O
the	O
metabolic	B-UNK
salvage	B-UNK
of	O
purines	O
,	O
is	O
encoded	B-UNK
by	O
an	O
x	B-UNK
-	O
linked	B-UNK
gene	B-UNK
in	O
man	B-UNK
.	O

 	B-UNK
partial	I-UNK
hprt	B-UNK
deficiencies	B-UNK
are	O
associated	B-UNK
with	O
gouty	O
arthritis	B-DISEASE
,	O
while	O
absence	B-UNK
of	O
activity	B-UNK
results	B-UNK
in	O
lesch	B-DISEASE
-	I-DISEASE
nyhan	I-DISEASE
syndrome	I-DISEASE
(	O
l	B-UNK
-	O
n	B-UNK
)	O
.	O

 	O
l	B-UNK
-	O
n	B-UNK
patients	B-UNK
fail	O
to	O
reproduce	O
and	O
the	O
heterozygous	B-UNK
state	B-UNK
appears	B-UNK
to	O
confer	B-UNK
no	O
selective	B-UNK
advantage	B-UNK
.	O

 	O
thus	O
,	O
haldanes	O
principle	O
predicts	B-UNK
that	O
new	B-UNK
mutations	B-UNK
at	B-DISEASE
the	O
hprt	B-UNK
locus	I-UNK
must	O
occur	B-UNK
frequently	B-UNK
in	O
order	B-UNK
for	O
l	B-UNK
-	O
n	B-DISEASE
syndrome	I-DISEASE
to	O
be	O
maintained	O
in	O
the	O
population	B-UNK
.	O

 	O
this	O
constant	B-UNK
introduction	O
of	O
new	B-UNK
mutations	B-UNK
would	O
be	O
expected	B-UNK
to	O
result	B-UNK
in	O
a	O
heterogeneous	B-UNK
collection	O
of	O
genetic	B-UNK
lesions	B-UNK
,	O
some	O
of	O
which	O
may	O
be	O
novel	B-UNK
.	O

 	O
as	O
we	O
report	B-UNK
here	O
,	O
the	O
mutations	B-UNK
in	O
the	O
hprt	B-UNK
gene	B-UNK
of	O
seven	B-UNK
l	B-UNK
-	O
n	B-UNK
patients	B-UNK
,	O
selected	B-UNK
from	O
an	O
initial	B-UNK
survey	B-UNK
of	O
28	O
patients	B-UNK
,	O
have	O
been	O
characterized	B-UNK
and	O
all	O
were	O
found	B-UNK
to	O
be	O
distinctly	O
different	B-UNK
,	O
as	O
predicted	B-UNK
.	O

 	O
the	O
origin	B-UNK
of	O
one	O
unusual	B-UNK
mutation	B-UNK
has	O
been	O
identified	B-UNK
by	O
analysis	B-UNK
of	O
dna	B-UNK
from	O
four	O
generations	B-UNK
of	O
family	B-UNK
members	I-UNK
.	O

 	O
further	O
molecular	B-UNK
analysis	B-UNK
of	O
the	O
origin	B-UNK
of	O
new	B-UNK
mutations	B-UNK
at	B-DISEASE
the	O
hprt	B-UNK
locus	I-UNK
should	O
aid	O
in	O
resolving	O
the	O
issue	O
of	O
an	O
apparent	B-UNK
difference	B-UNK
in	O
the	O
frequency	B-UNK
of	O
hprt	B-UNK
mutations	B-UNK
in	O
males	B-UNK
and	O
females	B-UNK

 	O
allelic	B-UNK
exclusion	B-UNK
of	O
glucose	B-UNK
-	O
6	O
-	O
phosphate	B-UNK
dehydrogenase	I-UNK
in	O
platelets	B-UNK
and	O
t	B-UNK
lymphocytes	I-UNK
from	O
a	O
wiskott	B-DISEASE
-	I-DISEASE
aldrich	I-DISEASE
syndrome	I-DISEASE
carrier	B-UNK
.	O

 	O
an	O
obligate	B-UNK
carrier	B-UNK
of	O
the	O
wiskott	B-DISEASE
-	I-DISEASE
aldrich	I-DISEASE
syndrome	I-DISEASE
(	O
was	O
)	O
who	O
was	O
also	O
heterozygous	B-UNK
for	O
the	O
a	O
and	O
b	B-UNK
types	B-UNK
of	O
x	B-UNK
-	O
linked	B-UNK
glucose	B-UNK
-	O
6	O
-	O
phosphate	B-UNK
dehydrogenase	I-UNK
was	O
found	B-UNK
.	O

 	O
with	O
her	O
it	O
became	O
possible	B-UNK
to	O
determine	O
whether	O
allelic	B-UNK
exclusion	B-UNK
occurs	B-UNK
in	O
particular	B-UNK
cell	B-UNK
-	O
types	B-UNK
of	O
the	O
was	O
carrier	B-UNK
.	O

 	O
if	O
so	O
,	O
the	O
remaining	B-UNK
cells	B-UNK
of	O
a	O
particular	B-UNK
cell	B-UNK
-	O
type	B-UNK
would	O
express	B-UNK
only	O
the	O
normal	B-UNK
x	B-DISEASE
chromosome	I-DISEASE
and	O
only	O
one	O
glucose	B-UNK
-	O
6	O
-	O
phosphate	B-UNK
dehydrogenase	I-UNK
isoenzyme	B-UNK
would	O
be	O
demonstrable	O
.	O

 	O
this	O
carrier	B-UNK
had	O
only	O
the	O
b	B-UNK
isoenzyme	B-UNK
of	O
glucose	B-UNK
-	O
6	O
-	O
phosphate	B-UNK
dehydrogenase	I-UNK
in	O
platelets	B-UNK
and	O
thymus	O
-	O
derived	B-UNK
t	B-UNK
lymphocytes	I-UNK
,	O
although	O
both	O
isoenzymes	O
a	O
and	O
b	B-UNK
were	O
present	B-UNK
in	O
erythrocytes	O
and	O
neutrophils	B-UNK
.	O

 	O
these	O
findings	B-UNK
suggest	B-UNK
that	O
selection	B-UNK
against	O
the	O
was	O
gene	B-UNK
occurs	B-UNK
in	O
platelets	B-UNK
and	O
thymus	O
-	O
derived	B-UNK
t	B-UNK
lymphocytes	I-UNK
and	O
that	O
the	O
defects	B-UNK
associated	B-UNK
with	O
was	O
expressed	B-UNK
in	O
these	O
cell	B-UNK
-	O
types	B-UNK
may	O
be	O
implicated	O
in	O
the	O
genesis	O
of	O
the	O
wiskott	B-DISEASE
-	I-DISEASE
aldrich	I-DISEASE
syndrome	I-DISEASE
.	O
.	O

 	B-UNK
complement	I-UNK
deficiency	B-UNK
and	O
nephritis	B-DISEASE
.	O

 	O
a	O
report	B-UNK
of	O
a	O
family	B-UNK
.	O

 	O
a	O
family	B-UNK
is	O
described	B-UNK
in	O
which	O
three	O
children	B-UNK
had	O
homozygous	B-UNK
deficiency	B-UNK
of	O
c3	B-UNK
and	O
in	O
which	O
both	O
parents	B-UNK
and	O
two	O
other	O
children	B-UNK
were	O
heterozygous	B-UNK
for	O
the	O
c3	B-UNK
null	B-UNK
gene	B-UNK
.	O

 	O
one	O
child	B-UNK
with	O
heterozygous	B-UNK
c3	B-UNK
deficiency	I-UNK
was	O
found	B-UNK
to	O
have	O
membranoproliferative	B-DISEASE
glomerulonephritis	I-DISEASE
;	O
proteinuria	B-DISEASE
and	O
/	O
or	O
microscopical	O
haematuria	O
was	O
present	B-UNK
in	O
all	O
three	O
homozygous	B-UNK
c3	B-UNK
-	O
deficient	B-UNK
children	B-UNK
.	O

 	O
all	O
children	B-UNK
with	O
homozygous	B-UNK
or	O
heterozygous	B-UNK
c3	B-UNK
deficiency	I-UNK
were	O
,	O
to	O
a	O
varying	B-UNK
degree	B-UNK
,	O
susceptible	B-UNK
to	O
infection	B-DISEASE
.	O

 	O
the	O
only	O
child	B-UNK
of	O
the	O
family	B-UNK
with	O
normal	B-UNK
complement	B-UNK
had	O
no	O
increased	B-UNK
risk	B-UNK
of	O
infection	B-DISEASE
and	O
no	O
renal	B-DISEASE
disease	B-DISEASE
.	O

 	O
this	O
family	B-UNK
study	I-UNK
provides	B-UNK
further	O
support	B-UNK
for	O
the	O
proposal	O
that	O
c3	B-UNK
deficiency	I-UNK
predisposes	O
to	O
nephritis	B-DISEASE
.	O
.	O

 	O
heterogeneity	B-UNK
of	O
glucose	B-UNK
-	O
6	O
-	O
phosphate	B-UNK
dehydrogenase	I-UNK
deficiency	B-UNK
in	O
algeria	B-UNK
.	O

 	O
study	B-UNK
in	O
northern	B-UNK
algeria	B-UNK
with	O
description	O
of	O
five	O
new	B-UNK
variants	B-UNK
.	O

 	O
glucose	B-UNK
-	O
6	O
-	O
phosphate	B-UNK
dehydrogenase	I-UNK
(	O
g6pd	B-UNK
)	O
deficiency	B-UNK
was	O
found	B-UNK
in	O
3	O
.	O

 	O
2	O
%	O
of	O
the	O
male	B-UNK
population	B-UNK
living	B-UNK
in	O
the	O
urban	B-UNK
area	B-UNK
of	O
algiers	O
.	O

 	O
the	O
deficient	B-UNK
subjects	B-UNK
originated	B-UNK
from	O
multiple	B-UNK
geographic	B-UNK
regions	B-UNK
of	O
northern	B-UNK
algeria	B-UNK
,	O
with	O
prevalence	B-UNK
of	O
individuals	B-UNK
of	O
berber	O
-	O
kabyle	B-UNK
origin	B-UNK
.	O

 	O
red	B-UNK
blood	I-UNK
cell	B-UNK
g6pd	B-UNK
was	O
partially	B-UNK
purified	B-UNK
and	O
characterized	B-UNK
in	O
deficient	B-UNK
males	B-UNK
from	O
17	O
families	B-UNK
,	O
and	O
six	O
different	B-UNK
variants	B-UNK
were	O
found	B-UNK
.	O

 	O
among	O
them	O
,	O
only	O
one	O
,	O
the	O
gd	B-UNK
(	O
-	O
)	O
kabyle	B-UNK
variant	B-UNK
,	O
had	O
been	O
previously	B-UNK
described	I-UNK
.	O

 	O
it	O
was	O
detected	B-UNK
in	O
nine	O
families	B-UNK
.	O

 	O
the	O
other	O
five	O
variants	B-UNK
were	O
new	B-UNK
gd	B-UNK
(	O
-	O
)	O
laghouat	O
(	O
four	O
cases	B-UNK
)	O
,	O
gd	B-UNK
(	O
-	O
)	O
blida	O
(	O
one	O
case	B-UNK
)	O
,	O
gd	B-UNK
(	O
-	O
)	O
thenia	O
(	O
one	O
case	B-UNK
)	O
,	O
gd	B-UNK
(	O
-	O
)	O
titteri	O
(	O
one	O
case	B-UNK
)	O
,	O
and	O
gd	B-UNK
(	O
-	O
)	O
alger	O
(	O
two	O
brothers	B-UNK
)	O
.	O

 	O
strikingly	B-UNK
,	O
the	O
common	B-UNK
mediterranean	B-UNK
variant	B-UNK
was	O
not	O
found	B-UNK
.	O

 	B-UNK
g6pd	I-UNK
deficiency	B-UNK
is	O
heterogeneous	B-UNK
in	O
northern	B-UNK
algeria	B-UNK
where	O
autochtonous	O
variants	B-UNK
seem	O
to	O
prevail	O
.	O

 	O
the	O
kabyle	B-UNK
variant	B-UNK
may	O
be	O
common	B-UNK
in	O
this	O
country	O
.	O

 	O
glucose	B-UNK
-	O
6	O
-	O
phosphate	B-UNK
dehydrogenase	I-UNK
deficiency	B-UNK
inhibits	B-UNK
in	O
vitro	B-UNK
growth	B-UNK
of	O
plasmodium	O
falciparum	O
.	O

 	O
glucose	B-UNK
-	O
6	O
-	O
phosphate	B-UNK
dehydrogenase	I-UNK
(	O
g6pd	B-UNK
;	O
ec	O
1	O
.	O
1	O
.	O
1	O
.	O
49	O
)	O
-	O
deficient	B-UNK
red	B-UNK
blood	I-UNK
cells	B-UNK
from	O
male	B-UNK
hemizygotes	B-UNK
and	O
female	B-UNK
heterozygotes	B-UNK
from	O
the	O
island	B-UNK
of	O
sardinia	O
were	O
studied	B-UNK
for	O
their	O
ability	B-UNK
to	O
support	B-UNK
growth	B-UNK
in	O
vitro	B-UNK
of	O
the	O
malaria	B-DISEASE
-	O
causing	B-UNK
organism	O
plasmodium	O
falciparum	O
.	O

 	O
parasite	O
growth	B-UNK
was	O
approximately	B-UNK
one	O
-	O
third	O
of	O
normal	B-UNK
in	O
both	O
hemi	O
-	O
and	O
heterozygotes	B-UNK
for	O
g6pd	B-UNK
deficiency	I-UNK
.	O

 	O
in	O
sardinians	O
with	O
the	O
beta	B-UNK
0	O
-	O
thalassemia	B-DISEASE
trait	B-UNK
,	O
parasite	O
growth	B-UNK
was	O
normal	B-UNK
except	O
when	O
g6pd	B-UNK
deficiency	I-UNK
occurred	B-UNK
together	O
with	O
the	O
thalassemia	B-DISEASE
trait	B-UNK
.	O

 	O
the	O
data	B-UNK
support	B-UNK
the	O
hypothesis	O
that	O
g6pd	B-UNK
deficiency	I-UNK
may	O
confer	B-UNK
a	O
selective	B-UNK
advantage	B-UNK
in	O
a	O
malarious	O
area	B-UNK
;	O
the	O
female	B-UNK
heterozygote	B-UNK
may	O
be	O
at	B-DISEASE
a	O
particular	B-UNK
advantage	B-UNK
because	O
resistance	O
to	O
malaria	B-DISEASE
equals	O
that	O
of	O
male	B-UNK
hemizygotes	B-UNK
,	O
but	O
the	O
risk	B-UNK
of	O
fatal	B-UNK
hemolysis	B-DISEASE
may	O
be	O
less	O
.	O

 	O
however	O
,	O
more	O
female	B-UNK
heterozygotes	B-UNK
must	O
be	O
studied	B-UNK
to	O
confirm	B-UNK
this	O
hypothesis	O
.	O

 	O
no	O
protective	O
effect	B-UNK
of	O
beta	B-UNK
0	O
-	O
thalassemia	B-DISEASE
trait	B-UNK
could	O
be	O
demonstrated	B-UNK
in	O
vitro	B-UNK
.	O

 	O
bone	B-UNK
marrow	I-UNK
transplant	I-UNK
in	O
adrenoleukodystrophy	B-DISEASE
.	O

 	O
an	O
allogeneic	O
bone	B-UNK
marrow	I-UNK
transplant	I-UNK
(	O
bmt	O
)	O
from	O
a	O
normal	B-UNK
hla	B-UNK
identical	B-UNK
sibling	B-UNK
donor	O
was	O
performed	B-UNK
in	O
a	O
13	O
-	O
year	B-UNK
-	O
old	B-UNK
boy	B-UNK
with	O
rapidly	B-UNK
progressive	B-UNK
adrenoleukodystrophy	B-DISEASE
(	O
ald	B-UNK
)	O
.	O

 	O
engraftment	O
and	O
complete	B-UNK
hematologic	O
recovery	O
occurred	B-UNK
within	O
4	O
weeks	O
,	O
but	O
neurologic	B-DISEASE
deterioration	B-UNK
continued	O
.	O

 	O
the	O
patient	B-UNK
died	O
of	O
an	O
adenovirus	O
infection	B-DISEASE
141	O
days	O
after	O
bmt	O
.	O

 	O
ald	B-UNK
is	O
characterized	B-UNK
by	O
abnormally	B-UNK
high	B-UNK
plasma	B-UNK
levels	B-UNK
of	O
very	O
long	B-UNK
chain	I-UNK
fatty	I-UNK
acids	O
(	O
vlcfa	B-UNK
)	O
as	O
a	O
result	B-UNK
of	O
impaired	B-UNK
capacity	B-UNK
to	O
degrade	O
them	O
.	O

 	O
ten	B-DISEASE
days	O
after	O
bmt	O
,	O
the	O
white	B-UNK
blood	B-UNK
cell	B-UNK
vlcfa	B-UNK
levels	B-UNK
and	O
enzyme	B-UNK
activity	I-UNK
became	O
normal	B-UNK
;	O
after	O
3	O
months	O
,	O
there	O
was	O
progressive	B-UNK
reduction	B-UNK
of	O
plasma	B-UNK
vlcfa	B-UNK
to	O
levels	B-UNK
only	O
slightly	B-UNK
above	O
normal	B-UNK
.	O
.	O

 	O
[	O
gd	B-UNK
-	O
allele	B-UNK
distribution	B-UNK
patterns	B-UNK
in	O
azerbaijan	O
.	O
iii	B-UNK
.	O
the	O
identification	B-UNK
of	O
mutant	B-UNK
forms	B-UNK
of	O
glucose	B-UNK
-	O
6	O
-	O
phosphate	B-UNK
dehydrogenase	I-UNK
]	O

 	O
in	O
28	O
families	B-UNK
with	O
g6pd	B-UNK
deficiency	I-UNK
living	B-UNK
in	O
3	O
settlements	O
of	O
shekii	B-UNK
district	B-UNK
of	O
azerbaijan	O
11	O
g6pd	B-UNK
variants	I-UNK
of	O
ii	B-UNK
and	O
iii	B-UNK
classes	O
differing	O
by	O
kinetic	B-UNK
properties	B-UNK
were	O
identified	B-UNK
according	B-UNK
who	O
program	B-UNK
.	O

 	O
9	O
of	O
them	O
are	O
characterized	B-UNK
with	O
the	O
same	O
electrophoretic	B-UNK
mobility	I-UNK
.	O

 	O
comparison	B-UNK
of	O
g6pd	B-UNK
spectra	O
in	O
two	O
subpopulations	O
and	O
in	O
a	O
mixed	B-UNK
group	B-UNK
permits	O
to	O
make	O
a	O
conclusion	B-UNK
about	O
existence	O
of	O
common	B-UNK
and	O
rare	B-UNK
g6pd	B-UNK
alleles	B-UNK
in	O
examined	B-UNK
population	B-UNK
.	O

 	O
they	O
distribute	O
by	O
gene	B-UNK
drift	O
supported	B-UNK
by	O
natural	B-UNK
selection	B-UNK
.	O

 	O
among	O
7	O
samples	B-UNK
of	O
g6pd	B-UNK
with	O
normal	B-UNK
and	O
increased	B-UNK
activity	B-UNK
two	O
new	B-UNK
variants	B-UNK
of	O
iv	B-UNK
class	B-UNK
-	O
-	O
nukha	O
and	O
bash	O
-	O
kungut	O
-	O
-	O
were	O
found	B-UNK
.	O
.	O

 	O
adrenoleukodystrophy	B-DISEASE
:	O
survey	B-UNK
of	O
303	O
cases	B-UNK
:	O
biochemistry	O
,	O
diagnosis	B-UNK
,	O
and	O
therapy	B-UNK
.	O

 	O
adrenoleukodystrophy	B-DISEASE
(	O
ald	B-UNK
)	O
is	O
a	O
genetically	B-UNK
determined	I-UNK
disorder	O
associated	B-UNK
with	O
progressive	B-UNK
central	B-UNK
demyelination	B-UNK
and	O
adrenal	B-UNK
cortical	O
insufficiency	B-UNK
.	O

 	O
all	O
affected	B-UNK
persons	B-UNK
show	O
increased	B-UNK
levels	I-UNK
of	O
saturated	O
unbranched	O
very	O
-	O
long	B-UNK
-	O
chain	B-UNK
fatty	I-UNK
acids	I-UNK
,	O
particularly	B-UNK
hexacosanoate	O
(	O
c26	B-UNK
0	O
)	O
,	O
because	O
of	O
impaired	B-UNK
capacity	B-UNK
to	O
degrade	O
these	O
acids	O
.	O

 	O
this	O
degradation	B-UNK
normally	B-UNK
takes	O
place	B-UNK
in	O
a	O
subcellular	B-UNK
organelle	O
called	B-UNK
the	O
peroxisome	B-UNK
,	O
and	O
ald	B-UNK
,	O
together	O
with	O
zellwegers	O
cerebrohepatorenal	B-DISEASE
syndrome	I-DISEASE
,	O
is	O
now	O
considered	B-UNK
to	O
belong	O
to	O
the	O
newly	B-UNK
formed	B-UNK
category	O
of	O
peroxisomal	B-DISEASE
disorders	I-DISEASE
.	O

 	B-UNK
biochemical	I-UNK
assays	B-UNK
permit	B-UNK
prenatal	B-UNK
diagnosis	I-UNK
,	O
as	O
well	O
as	O
identification	B-UNK
of	O
most	O
heterozygotes	B-UNK
.	O

 	O
we	O
have	O
identified	B-UNK
303	O
patients	B-UNK
with	O
ald	B-UNK
in	O
217	O
kindreds	B-UNK
.	O

 	O
these	O
patients	B-UNK
show	O
a	O
wide	B-UNK
phenotypic	B-UNK
variation	B-UNK
.	O

 	O
sixty	O
percent	O
of	O
patients	B-UNK
had	O
childhood	B-UNK
ald	I-UNK
and	O
17	O
%	O
adrenomyeloneuropathy	B-UNK
,	O
both	O
of	O
which	O
are	O
x	B-UNK
-	O
linked	B-UNK
,	O
with	O
the	O
gene	B-UNK
mapped	B-UNK
to	O
xq28	B-UNK
.	O

 	O
neonatal	B-UNK
ald	B-UNK
,	O
a	O
distinct	B-UNK
entity	B-UNK
with	O
autosomal	O
recessive	O
inheritance	B-UNK
and	O
points	O
of	O
resemblance	O
to	O
zellwegers	O
syndrome	B-DISEASE
,	O
accounted	B-UNK
for	O
7	O
%	O
of	O
the	O
cases	B-UNK
.	O

 	O
although	O
excess	B-UNK
c26	B-UNK
0	O
in	O
the	O
brain	B-UNK
of	O
patients	B-UNK
with	O
ald	B-UNK
is	O
partially	B-UNK
of	O
dietary	B-UNK
origin	B-UNK
,	O
dietary	B-UNK
c26	B-UNK
0	O
restriction	O
did	O
not	O
produce	B-UNK
clear	B-UNK
benefit	O
.	O

 	O
bone	B-UNK
marrow	I-UNK
transplant	I-UNK
lowered	O
the	O
plasma	B-UNK
c26	B-UNK
0	O
level	B-UNK
but	O
failed	B-UNK
to	O
arrest	O
neurological	B-UNK
progression	O
.	O
.	O

 	B-UNK
genetic	I-UNK
polymorphism	O
of	O
g6pd	B-UNK
in	O
a	O
bulgarian	B-UNK
population	B-UNK
.	O

 	O
considerable	B-UNK
genetic	B-UNK
heterogeneity	B-UNK
in	O
g6pd	B-UNK
was	O
found	B-UNK
in	O
the	O
bulgarian	B-UNK
population	B-UNK
-	O
14	O
g6pd	B-UNK
variants	I-UNK
isolated	B-UNK
from	O
117	O
hemizygous	B-UNK
carriers	B-UNK
of	O
g6pd	B-UNK
deficiency	I-UNK
.	O

 	O
of	O
these	O
,	O
g6pd	B-UNK
mediterranean	I-UNK
type	B-UNK
was	O
a	O
polymorphic	B-UNK
variant	B-UNK
and	O
g6pd	B-UNK
corinth	B-UNK
occurred	B-UNK
with	O
high	B-UNK
frequency	B-UNK
.	O

 	O
two	O
new	B-UNK
variants	B-UNK
were	O
identified	B-UNK
-	O
g6pd	B-UNK
rudosem	O
and	O
g6pd	B-UNK
nedelino	O
.	O

 	O
in	O
a	O
selected	B-UNK
group	B-UNK
of	O
78	O
subjects	B-UNK
with	O
clinical	B-UNK
manifestations	B-UNK
,	O
four	O
variants	B-UNK
were	O
established	B-UNK
g6pd	B-UNK
mediterranian	O
,	O
g6pd	B-UNK
corinth	B-UNK
,	O
g6pd	B-UNK
seattle	O
and	O
g6pd	B-UNK
ohut	O
ii	B-UNK
.	O
.	O

 	B-UNK
clinical	I-UNK
use	B-UNK
of	O
dna	B-UNK
markers	I-UNK
linked	B-UNK
to	O
the	O
gene	B-UNK
for	O
duchenne	B-UNK
muscular	B-DISEASE
dystrophy	I-DISEASE
.	O

 	O
seventy	O
families	B-UNK
with	O
duchenne	B-UNK
muscular	B-DISEASE
dystrophy	I-DISEASE
(	O
dmd	B-UNK
)	O
known	B-UNK
to	O
the	O
institute	O
of	O
child	B-UNK
health	B-UNK
fall	O
into	O
three	O
categories	O
with	O
respect	O
to	O
potential	B-UNK
linkage	B-UNK
analysis	I-UNK
with	O
the	O
x	B-DISEASE
chromosome	I-DISEASE
dna	B-UNK
markers	I-UNK
rc8	O
and	O
l1	O
.	O

 	O
28	O
that	O
bridge	O
the	O
dmd	B-UNK
gene	B-UNK
.	O

 	O
families	B-UNK
in	O
which	O
there	O
is	O
at	B-DISEASE
least	O
one	O
obligatory	O
female	B-UNK
heterozygote	B-UNK
(	O
n	B-UNK
=	O
13	O
)	O
.	O

 	O
here	O
prediction	O
and	O
exclusion	B-UNK
of	O
dmd	B-UNK
gene	B-UNK
transmission	B-UNK
may	O
be	O
possible	B-UNK
,	O
the	O
accuracy	O
being	O
dependent	B-UNK
on	O
the	O
closeness	O
of	O
the	O
linkage	B-UNK
of	O
the	O
dna	B-UNK
marker	B-UNK
(	O
s	O
)	O
to	O
the	O
dmd	B-UNK
gene	B-UNK
;	O
an	O
illustrative	O
case	B-UNK
is	O
reported	B-UNK
.	O

 	O
families	B-UNK
in	O
which	O
there	O
is	O
a	O
single	B-UNK
affected	B-UNK
boy	B-UNK
,	O
who	O
also	O
has	O
one	O
or	O
more	O
healthy	B-UNK
brothers	B-UNK
(	O
n	B-UNK
=	O
26	O
)	O
.	O

 	O
given	B-UNK
an	O
informative	B-UNK
restriction	B-UNK
fragment	I-UNK
length	I-UNK
polymorphism	I-UNK
(	O
rflp	B-UNK
)	O
,	O
the	O
probability	O
that	O
the	O
boy	B-UNK
represents	B-UNK
a	O
new	B-UNK
mutation	B-UNK
can	O
be	O
reassessed	O
;	O
it	O
is	O
also	O
possible	B-UNK
to	O
exclude	O
the	O
dmd	B-UNK
gene	B-UNK
in	O
a	O
sister	O
.	O

 	O
families	B-UNK
with	O
a	O
single	B-UNK
affected	B-UNK
boy	B-UNK
with	O
no	O
brother	B-UNK
(	O
n	B-UNK
=	O
30	O
)	O
.	O

 	O
here	O
exclusion	B-UNK
of	O
the	O
dmd	B-UNK
gene	B-UNK
in	O
a	O
sister	O
may	O
be	O
possible	B-UNK
.	O

 	O
only	O
in	O
one	O
family	B-UNK
was	O
there	O
no	O
possibility	O
of	O
useful	B-UNK
linkage	B-UNK
analysis	I-UNK
.	O

 	O
the	O
linkage	B-UNK
analysis	I-UNK
required	B-UNK
is	O
described	B-UNK
,	O
and	O
the	O
need	O
to	O
check	O
dmd	B-UNK
families	B-UNK
for	O
informative	B-UNK
rflps	B-UNK
is	O
stressed	O
.	O

 	B-UNK
family	I-UNK
studies	B-UNK
in	O
bechterew	O
'	O
s	O
syndrome	B-DISEASE
(	O
ankylosing	B-DISEASE
spondylitis	I-DISEASE
)	O
iii	B-UNK
.	O

 	O
genetics	B-UNK
.	O

 	O
the	O
results	B-UNK
of	O
segregation	B-UNK
analyses	B-UNK
in	O
75	O
families	B-UNK
where	O
the	O
proband	B-UNK
had	O
ankylosing	B-DISEASE
spondylitis	I-DISEASE
,	O
are	O
presented	B-UNK
.	O

 	O
of	O
the	O
278	O
adult	B-UNK
,	O
living	B-UNK
first	O
degree	B-UNK
relatives	B-UNK
,	O
approximately	B-UNK
85	O
%	O
cooperated	O
in	O
the	O
study	B-UNK
.	O

 	B-UNK
clinical	I-UNK
and	O
radiographical	O
examinations	O
were	O
performed	B-UNK
and	O
hla	B-UNK
typing	B-UNK
was	O
conducted	O
.	O

 	O
the	O
results	B-UNK
were	O
in	O
agreement	O
with	O
our	O
hypothesis	O
that	O
ankylosing	B-DISEASE
spondylitis	I-DISEASE
is	O
part	O
of	O
a	O
syndrome	B-DISEASE
where	O
different	B-UNK
genetic	B-UNK
factors	B-UNK
interact	B-UNK
.	O

 	O
such	O
known	B-UNK
factors	B-UNK
are	O
hla	B-UNK
b27	I-UNK
associated	B-UNK
disease	B-DISEASE
susceptibility	I-DISEASE
,	O
susceptibility	B-UNK
to	O
psoriatic	O
arthropathy	B-DISEASE
and	O
susceptibility	B-UNK
to	O
entero	O
-	O
arthropathy	B-DISEASE
.	O

 	O
radiographical	O
sacro	O
-	O
iliitis	O
was	O
restricted	O
to	O
hla	B-UNK
b27	I-UNK
positive	B-UNK
relatives	B-UNK
,	O
and	O
was	O
more	O
frequently	B-UNK
found	B-UNK
in	O
relatives	B-UNK
to	O
probands	B-UNK
with	O
psoriasis	B-DISEASE
than	O
in	O
relatives	B-UNK
to	O
probands	B-UNK
without	O
psoriasis	B-DISEASE
.	O

 	O
environmental	B-UNK
factors	B-UNK
(	O
intestinal	B-UNK
bacteria	O
)	O
are	O
known	B-UNK
to	O
trigger	O
the	O
disease	B-DISEASE
at	B-DISEASE
least	O
in	O
some	O
persons	B-UNK
,	O
and	O
we	O
have	O
postulated	O
that	O
all	O
or	O
most	O
of	O
them	O
have	O
the	O
predisposition	B-UNK
to	O
develop	B-UNK
disease	B-DISEASE
.	O

 	O
thus	O
,	O
the	O
syndrome	B-DISEASE
has	O
a	O
multifactorial	O
etiology	B-UNK
.	O

 	O
the	O
phenotypic	B-UNK
expressions	B-UNK
of	O
the	O
different	B-UNK
genetic	B-UNK
predispositions	O
involved	B-UNK
,	O
include	B-UNK
sacro	O
-	O
iliitis	O
,	O
psoriasis	B-DISEASE
,	O
acute	B-UNK
anterior	O
uveitis	B-DISEASE
,	O
peripheral	B-UNK
arthropathy	B-DISEASE
and	O
inflammatory	B-DISEASE
bowel	I-DISEASE
disease	I-DISEASE
.	O

 	O
we	O
suggest	B-UNK
the	O
descriptive	O
name	O
hereditary	B-UNK
multifocal	O
relapsing	O
inflammation	B-DISEASE
(	O
hemri	O
)	O
for	O
this	O
syndrome	B-DISEASE
.	O

 	O
ankylosing	B-DISEASE
spondylitis	I-DISEASE
,	O
psoriatic	O
arthropathy	B-DISEASE
and	O
entero	O
-	O
arthropathy	B-DISEASE
may	O
be	O
regarded	O
as	O
clinical	B-UNK
sub	O
-	O
types	B-UNK
of	O
the	O
syndrome	B-DISEASE
.	O
.	O

 	O
prader	B-DISEASE
-	I-DISEASE
willi	I-DISEASE
syndrome	I-DISEASE
and	O
chromosome	B-DISEASE
15	I-DISEASE
.	O

 	O
a	O
clinical	B-UNK
discussion	O
of	O
20	O
cases	B-UNK
.	O

 	O
a	O
chromosome	B-DISEASE
15	I-DISEASE
anomaly	B-UNK
was	O
observed	B-UNK
in	O
12	O
of	O
20	O
patients	B-UNK
,	O
17	O
of	O
whom	O
were	O
clinically	B-UNK
suspected	B-UNK
of	O
having	B-UNK
prader	B-DISEASE
-	I-DISEASE
willi	I-DISEASE
syndrome	I-DISEASE
(	O
pws	B-UNK
)	O
.	O

 	O
the	O
clinical	B-UNK
features	I-UNK
of	O
eight	O
cases	B-UNK
with	O
15q11	B-UNK
-	O
12	O
deletion	B-UNK
were	O
very	O
similar	B-UNK
to	O
those	O
originally	B-UNK
described	B-UNK
in	O
pws	B-UNK
.	O

 	O
on	O
the	O
other	O
hand	B-DISEASE
,	O
the	O
group	B-UNK
of	O
normal	B-UNK
karyotype	B-UNK
patients	B-UNK
is	O
heterogeneous	B-UNK
,	O
and	O
their	O
features	B-UNK
do	O
not	O
strictly	O
correspond	O
to	O
the	O
clinical	B-UNK
definition	O
of	O
pws	B-UNK
.	O

 	O
however	O
,	O
the	O
hypothesis	O
that	O
pws	B-UNK
is	O
associated	B-UNK
with	O
deletion	B-UNK
of	O
15q11	B-UNK
-	O
12	O
can	O
neither	O
explain	O
the	O
apparently	B-UNK
balanced	B-UNK
translocations	B-UNK
of	O
chromosome	B-DISEASE
15	I-DISEASE
nor	O
account	B-UNK
for	O
the	O
small	B-UNK
supernumerary	O
metacentric	O
chromosomes	B-UNK
corresponding	B-UNK
to	O
an	O
isochromosome	O
15	O
for	O
band	B-UNK
15q11	B-UNK
observed	B-UNK
in	O
some	O
cases	B-UNK
.	O
.	O

 	O
the	O
tay	B-DISEASE
-	I-DISEASE
sachs	I-DISEASE
disease	I-DISEASE
gene	B-UNK
in	O
north	B-UNK
american	I-UNK
jewish	B-UNK
populations	B-UNK
:	O
geographic	B-UNK
variations	O
and	O
origin	B-UNK
.	O

 	O
from	O
data	B-UNK
collected	B-UNK
in	O
a	O
north	B-UNK
american	I-UNK
tay	B-DISEASE
-	I-DISEASE
sachs	I-DISEASE
disease	I-DISEASE
(	O
tsd	B-UNK
)	O
heterozygote	B-UNK
screening	B-UNK
program	B-UNK
,	O
the	O
tsd	B-UNK
carrier	I-UNK
frequency	B-UNK
among	O
46	O
,	O
304	O
jewish	B-UNK
individuals	B-UNK
was	O
found	B-UNK
to	O
be	O
.	O

 	O
0324	O
(	O
1	O
in	O
31	O
individuals	B-UNK
)	O
.	O

 	O
this	O
frequency	B-UNK
is	O
consistent	B-UNK
with	O
earlier	B-UNK
estimates	B-UNK
based	B-UNK
on	O
tsd	B-UNK
incidence	O
data	B-UNK
.	O

 	O
tsd	B-UNK
carrier	I-UNK
frequencies	B-UNK
were	O
then	O
examined	B-UNK
by	O
single	B-UNK
country	O
and	O
single	B-UNK
region	B-UNK
of	O
origin	B-UNK
in	O
28	O
,	O
029	O
jews	B-UNK
within	O
this	O
sample	B-UNK
for	O
whom	O
such	O
data	B-UNK
were	O
available	B-UNK
for	O
analysis	B-UNK
.	O

 	O
jews	B-UNK
with	O
polish	B-UNK
and	O
/	O
or	O
russian	O
ancestry	B-UNK
constituted	O
88	O
%	O
of	O
this	O
sample	B-UNK
and	O
had	O
a	O
tsd	B-UNK
carrier	I-UNK
frequency	B-UNK
of	O
.	O

 	O
0327	O
.	O

 	O
no	O
tsd	B-UNK
carriers	B-UNK
were	O
observed	B-UNK
among	O
the	O
166	O
jews	B-UNK
of	O
near	B-UNK
eastern	B-UNK
origins	B-UNK
.	O

 	O
relative	B-UNK
to	O
jews	B-UNK
of	O
polish	B-UNK
and	O
russian	O
origins	B-UNK
,	O
there	O
was	O
at	B-DISEASE
least	O
a	O
twofold	O
increase	B-UNK
in	O
the	O
tsd	B-UNK
carrier	I-UNK
frequency	B-UNK
in	O
jews	B-UNK
of	O
austrian	O
,	O
hungarian	O
,	O
and	O
czechoslovakian	O
origins	B-UNK
(	O
p	B-UNK
less	O
than	O
.	O
005	O
)	O
.	O

 	O
these	O
findings	B-UNK
suggest	B-UNK
that	O
the	O
tsd	B-UNK
gene	B-UNK
proliferated	O
among	O
the	O
antecedents	O
of	O
modern	O
ashkenazi	B-UNK
jewry	O
after	O
the	O
second	B-UNK
diaspora	O
(	O
70	O
a	O
.	O
d	B-UNK
.	O
)	O
and	O
before	O
their	O
major	B-UNK
migrations	O
to	O
regions	B-UNK
of	O
poland	O
and	O
russia	O
(	O
before	O
1100	O
a	O
.	O
d	B-UNK
.	O
)	O
.	O

 	B-UNK
human	I-UNK
deficiency	B-UNK
of	O
the	O
sixth	B-UNK
component	B-UNK
of	O
complement	B-UNK
in	O
a	O
patient	B-UNK
with	O
meningococcal	B-UNK
meningitis	B-DISEASE
and	O
no	O
haemostasis	O
abnormality	B-UNK
.	O

 	O
a	O
case	B-UNK
of	O
human	B-UNK
complete	B-UNK
c6	B-DISEASE
deficiency	I-DISEASE
is	O
reported	B-UNK
.	O

 	O
the	O
patient	B-UNK
,	O
a	O
31	O
year	B-UNK
old	I-UNK
white	B-UNK
male	B-UNK
,	O
was	O
seen	B-UNK
on	O
the	O
occasion	O
of	O
an	O
isolated	B-UNK
episode	O
of	O
meningococcal	B-UNK
meningitis	B-DISEASE
.	O

 	B-UNK
serum	I-UNK
complement	B-UNK
hemolytic	B-UNK
and	O
bactericidal	B-UNK
activities	B-UNK
were	O
lacking	B-UNK
and	O
could	O
be	O
restored	B-UNK
to	O
normal	B-UNK
by	O
addition	B-UNK
of	O
appropriate	B-UNK
amounts	B-UNK
of	O
purified	B-UNK
c6	B-UNK
.	O

 	O
no	O
hemostatic	O
abnormalities	B-DISEASE
were	O
observed	B-UNK
.	O
.	O

 	O
absence	B-UNK
of	O
the	O
seventh	B-UNK
component	B-UNK
of	O
complement	B-UNK
in	O
a	O
patient	B-UNK
with	O
chronic	B-UNK
meningococcemia	O
presenting	B-UNK
as	O
vasculitis	B-DISEASE
.	O

 	O
a	O
previously	B-UNK
healthy	B-UNK
40	O
-	O
year	B-UNK
-	O
old	B-UNK
man	B-UNK
presenting	B-UNK
with	O
fever	B-DISEASE
,	O
arthritis	B-DISEASE
,	O
and	O
cutaneous	O
vasculitis	B-DISEASE
was	O
found	B-UNK
to	O
have	O
chronic	B-UNK
meningococcemia	O
.	O

 	O
evaluation	B-UNK
of	O
his	O
complement	B-UNK
system	B-UNK
showed	B-UNK
an	O
absence	B-UNK
of	O
functional	B-UNK
and	O
antigenic	O
c7	B-UNK
,	O
compatible	O
with	O
a	O
complete	B-UNK
deficiency	B-UNK
of	O
the	O
seventh	B-UNK
component	B-UNK
of	O
complement	B-UNK
.	O

 	O
study	B-UNK
of	O
the	O
patients	B-UNK
family	B-UNK
spanning	B-UNK
four	O
generations	B-UNK
showed	B-UNK
heterozygous	B-UNK
deficiency	B-UNK
of	O
c7	B-UNK
in	O
five	O
members	B-UNK
.	O

 	O
chronic	B-UNK
neisserial	B-UNK
infection	B-DISEASE
can	O
be	O
associated	B-UNK
with	O
c7	B-UNK
deficiency	I-UNK
and	O
must	O
be	O
distinguished	O
from	O
other	O
causes	B-UNK
of	O
cutaneous	O
vasculitis	B-DISEASE
.	O
.	O

 	B-UNK
familial	I-UNK
discoid	O
lupus	B-DISEASE
erythematosus	I-DISEASE
associated	B-UNK
with	O
heterozygote	B-UNK
c2	B-UNK
deficiency	I-UNK
.	O

 	O
two	O
siblings	B-UNK
with	O
chronic	B-UNK
discoid	O
lupus	B-DISEASE
erythematosus	I-DISEASE
and	O
several	O
family	B-UNK
members	I-UNK
were	O
found	B-UNK
with	O
heterozygous	B-UNK
c2	I-UNK
deficiency	B-UNK
.	O

 	O
an	O
association	B-UNK
with	O
histocompatibility	O
markers	B-UNK
hla	B-UNK
-	O
b18	O
and	O
hla	B-UNK
-	O
dw2	O
was	O
demonstrated	B-UNK
,	O
and	O
the	O
slow	B-UNK
allotype	O
of	O
factor	B-UNK
b	B-UNK
was	O
present	B-UNK
.	O

 	B-UNK
linkage	I-UNK
studies	B-UNK
in	O
this	O
family	B-UNK
suggested	B-UNK
a	O
close	B-UNK
linkage	I-UNK
between	O
the	O
c2	B-UNK
deficiency	I-UNK
gene	B-UNK
and	O
genes	B-UNK
coding	B-UNK
for	O
b18	O
,	O
dw2	O
,	O
and	O
bfs	O
antigens	B-UNK
.	O

 	O
one	O
hla	B-UNK
-	O
acb	O
/	O
dbf	O
recombinant	B-UNK
was	O
observed	B-UNK
showing	B-UNK
closer	O
linkage	B-UNK
between	O
hla	B-UNK
-	O
d	B-UNK
and	O
bf	O
than	O
between	O
hla	B-UNK
-	O
b	B-UNK
and	O
bf	O
.	O
.	O

 	O
severe	B-UNK
-	O
glucose	B-UNK
-	O
6	O
-	O
phosphate	B-UNK
dehydrogenase	I-UNK
(	O
g6pd	B-UNK
)	O
deficiency	B-UNK
associated	I-UNK
with	O
chronic	B-UNK
hemolytic	B-DISEASE
anemia	I-DISEASE
,	O
granulocyte	O
dysfunction	B-UNK
,	O
and	O
increased	B-UNK
susceptibility	B-UNK
to	O
infections	B-DISEASE
:	O
description	O
of	O
a	O
new	B-UNK
molecular	B-UNK
variant	B-UNK
(	O
g6pd	B-UNK
barcelona	O
)	O
.	O

 	B-UNK
molecular	I-UNK
,	O
kinetic	B-UNK
,	O
and	O
functional	B-UNK
studies	B-UNK
were	O
carried	B-UNK
out	O
on	O
erythrocytes	O
and	O
leukocytes	B-UNK
in	O
a	O
spanish	B-UNK
male	B-UNK
with	O
g6pd	B-UNK
deficiency	I-UNK
,	O
congenital	B-DISEASE
nonspherocytic	B-UNK
hemolytic	B-DISEASE
anemia	I-DISEASE
(	O
cnsha	O
)	O
,	O
and	O
increased	B-UNK
susceptibility	B-UNK
to	O
infections	B-DISEASE
.	O

 	B-UNK
g6pd	I-UNK
activity	B-UNK
was	O
absent	B-UNK
in	O
patients	B-UNK
red	B-UNK
cells	B-UNK
and	O
was	O
about	O
2	O
%	O
of	O
normal	B-UNK
in	O
leukocytes	B-UNK
.	O

 	B-UNK
molecular	I-UNK
studies	B-UNK
using	O
standard	B-UNK
methods	B-UNK
(	O
who	O
,	O
1967	O
)	O
showed	B-UNK
g6pd	B-UNK
in	O
the	O
patient	B-UNK
to	O
have	O
a	O
slightly	B-UNK
fast	B-UNK
electrophoretic	B-UNK
mobility	I-UNK
at	B-DISEASE
ph	B-UNK
8	O
.	O

 	O
0	O
with	O
otherwise	O
normal	B-UNK
properties	B-UNK
(	O
heat	B-UNK
stability	B-UNK
at	B-DISEASE
46	O
degrees	B-UNK
c	B-UNK
,	O
apparent	B-UNK
affinity	B-UNK
for	O
substrates	B-UNK
,	O
optimum	O
ph	B-UNK
,	O
and	O
utilization	B-UNK
of	O
substrate	B-UNK
analogues	B-UNK
)	O
.	O

 	O
other	O
tests	B-UNK
showed	B-UNK
the	O
patients	B-UNK
granulocytes	B-UNK
to	O
engulf	O
latex	O
particles	B-UNK
normally	B-UNK
,	O
but	O
to	O
have	O
impaired	B-UNK
reduction	B-UNK
of	O
nitroblue	O
tetrazolium	O
and	O
ferricytochrome	O
-	O
c	B-UNK
as	O
well	O
as	O
reduced	B-UNK
iodination	O
.	O

 	O
chemotaxis	B-UNK
and	O
random	B-UNK
migration	B-UNK
of	O
the	O
patients	B-UNK
granulocytes	B-UNK
were	O
normal	B-UNK
as	O
were	O
myeloperoxidase	O
,	O
leukocyte	B-UNK
alkaline	O
phosphatase	B-UNK
(	O
lap	O
)	O
,	O
and	O
ultrastructural	B-UNK
features	B-UNK
.	O

 	O
the	O
molecular	B-UNK
characteristics	B-UNK
of	O
g6pd	B-UNK
in	O
the	O
patient	B-UNK
differed	B-UNK
from	O
those	O
of	O
all	O
previously	B-UNK
reported	I-UNK
variants	B-UNK
associated	B-UNK
with	O
cnsha	O
,	O
so	O
the	O
present	B-UNK
variant	B-UNK
was	O
provisionally	B-UNK
called	B-UNK
g6pd	B-UNK
barcelona	O
to	O
distinguish	O
it	O
from	O
other	O
g6pd	B-UNK
variants	I-UNK
previously	B-UNK
described	I-UNK
.	O

 	O
possible	B-UNK
mechanisms	B-UNK
for	O
the	O
severe	B-UNK
deficiency	B-UNK
of	O
g6pd	B-UNK
in	O
erythrocytes	O
and	O
granulocytes	B-UNK
was	O
investigated	B-UNK
by	O
studies	B-UNK
on	O
the	O
immunologic	B-UNK
specific	B-UNK
activity	B-UNK
of	O
the	O
mutant	B-UNK
enzyme	B-UNK
.	O

 	O
glucose	B-UNK
-	O
6	O
-	O
phosphate	B-UNK
dehydrogenase	I-UNK
deficiency	B-UNK
in	O
papua	B-UNK
new	I-UNK
guinea	O
.	O

 	O
the	O
description	O
of	O
13	O
new	B-UNK
variants	B-UNK
.	O

 	O
a	O
total	B-UNK
of	O
362	O
males	B-UNK
from	O
various	O
regions	B-UNK
of	O
papua	B-UNK
new	I-UNK
guinea	O
were	O
screened	O
for	O
red	B-UNK
cell	B-UNK
glucose	B-UNK
-	O
6	O
-	O
phosphate	B-UNK
dehydrogenase	I-UNK
(	O
g6pd	B-UNK
)	O
activity	B-UNK
.	O

 	O
twenty	O
-	O
six	O
g6pd	B-UNK
deficient	B-UNK
individuals	B-UNK
were	O
identified	B-UNK
.	O

 	B-UNK
biochemical	I-UNK
characterization	B-UNK
of	O
g6pd	B-UNK
purified	B-UNK
from	O
these	O
subjects	B-UNK
has	O
revealed	B-UNK
13	O
new	B-UNK
variants	B-UNK
and	O
several	O
copies	B-UNK
of	O
previously	B-UNK
described	I-UNK
forms	B-UNK
of	O
g6pd	B-UNK
.	O

 	O
this	O
study	B-UNK
illustrates	B-UNK
the	O
extreme	B-UNK
heterogeneity	B-UNK
of	O
g6pd	B-UNK
deficiency	I-UNK
among	O
the	O
people	B-UNK
of	O
papua	B-UNK
new	I-UNK
guinea	O
.	O
.	O

 	O
heterogeneity	B-UNK
of	O
"	O
mediterranean	B-UNK
type	B-UNK
"	O
glucose	B-UNK
-	O
6	O
-	O
phosphate	B-UNK
dehydrogenase	I-UNK
(	O
g6pd	B-UNK
)	O
deficiency	B-UNK
in	O
spain	O
and	O
description	O
of	O
two	O
new	B-UNK
variants	B-UNK
associated	B-UNK
with	O
favism	B-DISEASE
.	O

 	O
glucose	B-UNK
-	O
6	O
-	O
phosphate	B-UNK
dehydrogenase	I-UNK
(	O
g6pd	B-UNK
)	O
;	O
ec	O
1	O
.	O

 	O
1	O
.	O

 	O
1	O
.	O

 	O
49	O
from	O
thirty	B-UNK
-	O
six	O
unrelated	B-UNK
spanish	B-UNK
males	B-UNK
was	O
partially	B-UNK
purified	B-UNK
from	O
blood	B-UNK
,	O
and	O
the	O
variants	B-UNK
were	O
characterized	B-UNK
biochemically	B-UNK
and	O
electrophoretically	O
according	B-UNK
to	O
the	O
methods	B-UNK
recommended	O
by	O
the	O
world	O
health	B-UNK
organization	B-UNK
.	O

 	O
subjects	B-UNK
were	O
from	O
multiple	B-UNK
geographic	B-UNK
regions	B-UNK
within	O
spain	O
,	O
and	O
all	O
suffered	O
from	O
hemolytic	B-DISEASE
anemia	I-DISEASE
,	O
either	O
acute	B-UNK
(	O
34	O
cases	B-UNK
)	O
or	O
chronic	B-UNK
nonspherocytic	B-UNK
(	O
2	O
cases	B-UNK
)	O
.	O

 	O
almost	O
all	O
the	O
variants	B-UNK
studied	B-UNK
presented	B-UNK
residual	B-UNK
erythrocyte	B-UNK
g6pd	B-UNK
activity	I-UNK
ranging	O
from	O
0	O
to	O
10	O
%	O
of	O
normal	B-UNK
,	O
and	O
five	O
different	B-UNK
mutants	B-UNK
were	O
responsible	B-UNK
for	O
the	O
deficient	B-UNK
phenotype	B-UNK
.	O

 	O
three	O
variants	B-UNK
were	O
similar	B-UNK
to	O
others	O
previously	B-UNK
described	I-UNK
g6pd	B-UNK
mediterranean	I-UNK
(	O
11	O
cases	B-UNK
)	O
,	O
g6pd	B-UNK
athens	O
-	O
like	B-UNK
(	O
3	O
cases	B-UNK
)	O
,	O
and	O
g6pd	B-UNK
union	O
(	O
2	O
cases	B-UNK
)	O
.	O

 	O
the	O
remaining	B-UNK
variants	B-UNK
were	O
different	B-UNK
from	O
the	O
numerous	B-UNK
variants	B-UNK
already	O
reported	B-UNK
and	O
have	O
been	O
considered	B-UNK
as	O
new	B-UNK
mutants	B-UNK
.	O

 	O
provisionally	B-UNK
they	O
are	O
called	B-UNK
g6pd	B-UNK
betica	B-UNK
(	O
19	O
cases	B-UNK
)	O
and	O
g6pd	B-UNK
menorca	O
(	O
1	O
case	B-UNK
)	O
.	O

 	O
the	O
present	B-UNK
study	I-UNK
constitutes	O
the	O
first	O
attempt	O
to	O
characterize	O
the	O
deficient	B-UNK
g6pd	B-UNK
variants	I-UNK
found	B-UNK
in	O
spain	O
and	O
supplies	O
new	B-UNK
data	B-UNK
on	O
the	O
relationship	B-UNK
between	O
molecular	B-UNK
characteristics	B-UNK
of	O
deficient	B-UNK
variants	B-UNK
and	O
their	O
clinical	B-UNK
manifestations	B-UNK
.	O

 	O
the	O
most	O
important	B-UNK
findings	B-UNK
can	O
be	O
summarized	O
as	O
follows	O
(	O
1	O
)	O
the	O
spanish	B-UNK
population	B-UNK
is	O
characterized	B-UNK
by	O
an	O
important	B-UNK
heterogeneity	B-UNK
in	O
g6pd	B-UNK
deficiency	I-UNK
.	O

 	O
(	O
2	O
)	O
although	O
g6pd	B-UNK
mediterranean	I-UNK
is	O
very	O
frequent	B-UNK
,	O
it	O
presents	O
a	O
relatively	B-UNK
high	B-UNK
degree	B-UNK
of	O
polymorphism	O
.	O

 	O
(	O
3	O
)	O
favism	B-DISEASE
has	O
been	O
observed	B-UNK
associated	B-UNK
with	O
all	O
kinds	O
of	O
variants	B-UNK
described	B-UNK
here	O
.	O

 	O
(	O
4	O
)	O
g6pd	B-UNK
betica	B-UNK
,	O
which	O
is	O
the	O
most	O
frequent	B-UNK
variant	B-UNK
found	B-UNK
in	O
subjects	B-UNK
of	O
southern	O
spanish	B-UNK
origin	B-UNK
,	O
has	O
been	O
observed	B-UNK
associated	B-UNK
with	O
favism	B-DISEASE
in	O
all	O
cases	B-UNK
except	O
one	O
.	O

 	O
a	O
new	B-UNK
glucose	B-UNK
-	O
6	O
-	O
phosphate	B-UNK
dehydrogenase	I-UNK
variant	B-UNK
(	O
g6pd	B-UNK
nagano	O
)	O
associated	B-UNK
with	O
congenital	B-DISEASE
hemolytic	B-DISEASE
anemia	I-DISEASE
.	O

 	O
a	O
new	B-UNK
glucose	B-UNK
-	O
6	O
-	O
phosphate	B-UNK
dehydrogenase	I-UNK
(	O
g6pd	B-UNK
)	O
variant	B-UNK
associated	B-UNK
with	O
chronic	B-UNK
nonspherocytic	B-UNK
hemolytic	B-DISEASE
anemia	I-DISEASE
was	O
reported	B-UNK
.	O

 	O
the	O
patient	B-UNK
,	O
a	O
6	O
-	O
year	B-UNK
-	O
old	B-UNK
japanese	B-UNK
male	B-UNK
,	O
was	O
noticed	O
to	O
have	O
hemolytic	B-DISEASE
anemia	I-DISEASE
soon	O
after	O
birth	O
,	O
and	O
a	O
diagnosis	B-UNK
of	O
g6pd	B-UNK
deficiency	I-UNK
was	O
made	O
at	B-DISEASE
the	O
age	B-UNK
of	O
2	O
.	O

 	O
he	O
had	O
episodes	O
of	O
hemolytic	B-UNK
crisis	O
several	O
times	B-UNK
after	O
upper	O
respiratory	B-UNK
infection	B-DISEASE
.	O

 	B-UNK
g6pd	I-UNK
activity	B-UNK
of	O
the	O
patient	B-UNK
was	O
5	O
.	O

 	O
5	O
%	O
of	O
normal	B-UNK
.	O

 	O
the	O
enzymatic	B-UNK
characteristics	B-UNK
were	O
examined	B-UNK
when	O
he	O
was	O
5	O
years	B-UNK
old	B-UNK
,	O
and	O
his	O
g6pd	B-UNK
showed	B-UNK
faster	O
-	O
than	O
-	O
normal	B-UNK
electrophoretic	I-UNK
mobility	B-UNK
,	O
low	B-UNK
km	B-UNK
g6p	O
,	O
high	B-UNK
km	B-UNK
nadp	B-UNK
,	O
low	B-UNK
ki	O
nadph	B-UNK
,	O
normal	B-UNK
utilization	B-UNK
of	O
substrate	B-UNK
analogues	B-UNK
,	O
heat	B-UNK
instability	B-UNK
,	O
and	O
a	O
normal	B-UNK
ph	B-UNK
optimum	I-UNK
curve	O
.	O

 	O
from	O
these	O
results	B-UNK
,	O
this	O
was	O
considered	B-UNK
to	O
be	O
a	O
new	B-UNK
variant	B-UNK
and	O
was	O
designated	B-UNK
g6pd	I-UNK
nagano	O
.	O

 	O
infection	B-DISEASE
-	O
induced	B-UNK
hemolysis	B-DISEASE
and	O
chronic	B-UNK
hemolytic	B-DISEASE
anemia	I-DISEASE
seem	O
to	O
be	O
due	O
to	O
markedly	B-UNK
impaired	B-UNK
enzyme	B-UNK
activity	I-UNK
and	O
thermal	B-UNK
instability	B-UNK
.	O

 	B-UNK
heterozygous	I-UNK
c2	B-UNK
-	O
deficiency	B-UNK
and	O
myasthenia	B-DISEASE
gravis	I-DISEASE
.	O

 	B-UNK
complement	I-UNK
deficiency	B-UNK
states	B-UNK
in	O
myasthenia	B-DISEASE
gravis	I-DISEASE
(	O
mg	O
)	O
have	O
not	O
been	O
reported	B-UNK
previously	B-UNK
.	O

 	O
we	O
describe	B-UNK
a	O
19	O
-	O
year	B-UNK
-	O
old	B-UNK
woman	B-UNK
with	O
typical	B-UNK
mg	O
and	O
heterozygous	B-UNK
c2	I-UNK
deficiency	B-UNK
,	O
along	O
with	O
hla	B-UNK
typing	B-UNK
of	O
the	O
patient	B-UNK
and	O
her	O
immediate	B-UNK
family	B-UNK
.	O
.	O

 	O
adrenoleukodystrophy	B-DISEASE
:	O
increased	B-UNK
plasma	B-UNK
content	B-UNK
of	O
saturated	O
very	O
long	B-UNK
chain	I-UNK
fatty	I-UNK
acids	O
.	O

 	O
with	O
a	O
new	B-UNK
method	B-UNK
we	O
measured	B-UNK
the	O
saturated	O
very	O
long	B-UNK
chain	I-UNK
fatty	I-UNK
acids	O
in	O
the	O
plasma	B-UNK
of	O
adrenoleukodystrophy	B-DISEASE
(	O
ald	B-UNK
)	O
hemizygotes	B-UNK
,	O
ald	B-UNK
heterozygotes	B-UNK
,	O
and	O
controls	B-UNK
.	O

 	O
ald	B-UNK
hemizygotes	B-UNK
showed	B-UNK
increased	B-UNK
levels	I-UNK
of	O
hexacosanoate	O
(	O
c26	B-UNK
fatty	O
acid	O
)	O
which	O
represented	B-UNK
0	O
.	O

 	O
081	O
+	O
/	O
-	O
0	O
.	O

 	O
0066	O
%	O
(	O
sem	O
)	O
of	O
total	B-UNK
fatty	O
acids	O
,	O
compared	B-UNK
to	O
0	O
.	O

 	O
015	O
+	O
/	O
-	O
0	O
.	O

 	O
0032	O
%	O
in	O
the	O
controls	B-UNK
.	O

 	O
c25	O
,	O
c24	O
,	O
and	O
c23	O
fatty	O
acids	O
were	O
also	O
increased	B-UNK
,	O
but	O
the	O
c22	O
and	O
c20	O
fatty	O
acids	O
were	O
normal	B-UNK
.	O

 	O
c26	B-UNK
levels	B-UNK
were	O
also	O
increased	B-UNK
in	O
most	O
ald	B-UNK
heterozygotes	B-UNK
,	O
with	O
a	O
mean	B-UNK
level	B-UNK
0	O
.	O

 	O
057	O
+	O
/	O
-	O
0	O
.	O

 	O
0063	O
%	O
of	O
total	B-UNK
fatty	O
acids	O
.	O

 	O
the	O
technique	B-UNK
can	O
be	O
used	O
for	O
diagnosis	B-UNK
and	O
carrier	B-UNK
identification	B-UNK
,	O
and	O
in	O
the	O
evaluation	B-UNK
of	O
therapy	B-UNK
.	O

 	B-UNK
abnormal	I-UNK
high	B-UNK
density	I-UNK
lipoproteins	I-UNK
in	O
cerebrotendinous	O
xanthomatosis	B-DISEASE
.	O

 	O
the	O
plasma	B-UNK
lipoprotein	B-UNK
profiles	O
and	O
high	B-UNK
density	I-UNK
lipoproteins	I-UNK
(	O
hdl	B-UNK
)	O
were	O
characterized	B-UNK
in	O
patients	B-UNK
with	O
the	O
genetic	B-UNK
disease	B-DISEASE
cerebrotendinous	O
xanthomatosis	B-DISEASE
(	O
ctx	B-UNK
)	O
.	O

 	O
abnormalities	B-DISEASE
in	O
the	O
hdl	B-UNK
may	O
contribute	B-UNK
to	O
their	O
increased	B-UNK
atherogenesis	O
and	O
excessive	B-UNK
deposits	O
of	O
tissue	B-UNK
sterols	O
in	O
the	O
presence	B-UNK
of	O
low	B-UNK
or	O
low	B-UNK
-	O
normal	B-UNK
concentrations	B-UNK
of	O
plasma	B-UNK
cholesterol	B-UNK
(	O
165	O
+	O
/	O
-	O
25	O
mg	O
/	O
dl	O
)	O
and	O
low	B-UNK
density	B-UNK
lipoproteins	I-UNK
(	O
ldl	O
)	O
.	O

 	O
the	O
mean	B-UNK
hdl	B-UNK
-	O
cholesterol	B-UNK
concentration	B-UNK
in	O
the	O
ctx	B-UNK
plasmas	O
was	O
14	O
.	O

 	O
5	O
+	O
/	O
-	O
3	O
.	O

 	O
2	O
mg	O
/	O
dl	O
,	O
about	O
one	O
-	O
third	O
the	O
normal	B-UNK
value	B-UNK
.	O

 	O
the	O
low	B-UNK
hdl	B-UNK
-	O
cholesterol	B-UNK
reflects	O
a	O
low	B-UNK
concentration	B-UNK
and	O
an	O
abnormal	B-UNK
lipid	B-UNK
composition	B-UNK
of	O
the	O
plasma	B-UNK
hdl	B-UNK
.	O

 	O
relative	B-UNK
to	O
normal	B-UNK
hdl	B-UNK
,	O
the	O
cholesteryl	O
esters	O
are	O
low	B-UNK
,	O
free	B-UNK
cholesterol	B-UNK
and	O
phospholipids	O
essentially	O
normal	B-UNK
,	O
and	O
triglycerides	O
increased	B-UNK
.	O

 	O
the	O
ratio	B-UNK
of	O
apoprotein	O
(	O
apo	O
)	O
to	O
total	B-UNK
cholesterol	B-UNK
in	O
the	O
hdl	B-UNK
of	O
ctx	B-UNK
was	O
two	O
to	O
three	O
times	B-UNK
greater	B-UNK
than	O
normal	B-UNK
.	O

 	O
in	O
the	O
ctx	B-UNK
hdl	B-UNK
,	O
the	O
ratio	B-UNK
of	O
apoai	O
to	O
apoaii	O
was	O
high	B-UNK
,	O
the	O
proportion	B-UNK
of	O
apoc	O
low	B-UNK
,	O
and	O
a	O
normally	B-UNK
minor	O
form	B-UNK
of	O
apoai	O
increased	B-UNK
relative	B-UNK
to	O
other	O
forms	B-UNK
.	O

 	O
the	O
hdl	B-UNK
in	O
electron	B-UNK
micrographs	O
appeared	B-UNK
normal	B-UNK
morphologically	B-UNK
and	O
in	O
particle	O
size	B-UNK
.	O

 	O
the	O
abnormalities	B-DISEASE
in	O
lipoprotein	B-UNK
distribution	B-UNK
profile	B-UNK
and	O
composition	B-UNK
of	O
the	O
plasma	B-UNK
hdl	B-UNK
result	B-UNK
from	O
metabolic	B-UNK
defects	B-UNK
that	O
are	O
not	O
understood	O
but	O
may	O
be	O
linked	B-UNK
to	O
the	O
genetic	B-UNK
defect	B-UNK
in	O
bile	O
acid	O
synthesis	B-UNK
in	O
ctx	B-UNK
.	O

 	O
as	O
a	O
consequence	O
,	O
it	O
is	O
probable	B-UNK
that	O
the	O
normal	B-UNK
functions	B-UNK
of	O
the	O
hdl	B-UNK
,	O
possibly	B-UNK
including	B-UNK
modulation	O
of	O
ldl	O
-	O
cholesterol	B-UNK
uptake	B-UNK
and	O
the	O
removal	O
of	O
excess	B-UNK
cholesterol	B-UNK
from	O
peripheral	B-UNK
tissues	B-UNK
,	O
are	O
perturbed	O
significantly	B-UNK
in	O
this	O
disease	B-DISEASE
.	O

 	O
genetics	B-UNK
of	O
cerebrotendinous	O
xanthomatosis	B-DISEASE
(	O
ctx	B-UNK
)	O
:	O
an	O
autosomal	O
recessive	O
trait	B-UNK
with	O
high	B-UNK
gene	B-UNK
frequency	B-UNK
in	O
sephardim	O
of	O
moroccan	B-UNK
origin	B-UNK
.	O

 	O
we	O
described	B-UNK
6	O
patients	B-UNK
(	O
from	O
3	O
families	B-UNK
)	O
affected	B-UNK
with	O
cerebrotendinous	O
xanthomatosis	B-DISEASE
(	O
ctx	B-UNK
)	O
.	O

 	O
all	O
are	O
sephardic	O
jews	B-UNK
of	O
moroccan	B-UNK
extraction	B-UNK
.	O

 	O
in	O
view	O
of	O
the	O
small	B-UNK
number	B-UNK
of	O
ctx	B-UNK
patients	B-UNK
diagnosed	B-UNK
in	O
the	O
world	O
(	O
a	O
total	B-UNK
of	O
50	O
including	B-UNK
our	O
6	O
patients	B-UNK
)	O
,	O
we	O
are	O
probably	B-UNK
dealing	O
with	O
an	O
ethnic	B-UNK
subgroup	O
with	O
a	O
high	B-UNK
ctx	B-UNK
gene	B-UNK
frequency	B-UNK
,	O
which	O
we	O
have	O
estimated	B-UNK
to	O
be	O
1	O
/	O
108	O
.	O

 	O
since	O
there	O
are	O
differences	B-UNK
in	O
expression	B-UNK
in	O
this	O
disease	B-DISEASE
,	O
we	O
recommend	O
cholestanol	B-UNK
study	B-UNK
in	O
cases	B-UNK
of	O
undiagnosed	O
cataract	B-DISEASE
or	O
tendinous	O
xanthomas	O
in	O
childhood	B-UNK
or	O
early	B-UNK
adolescence	O
.	O

 	O
the	O
diagnosis	B-UNK
in	O
ctx	B-UNK
is	O
important	B-UNK
not	O
only	O
for	O
genetic	B-UNK
counseling	B-UNK
,	O
but	O
also	O
in	O
veiw	O
of	O
possible	B-UNK
treatment	B-UNK
.	O
.	O

 	B-UNK
new	I-UNK
genetic	B-UNK
variants	B-UNK
of	O
glucose	B-UNK
6	O
-	O
phosphate	B-UNK
dehydrogenase	I-UNK
(	O
g6pd	B-UNK
)	O
in	O
italy	B-UNK
.	O

 	O
six	O
new	B-UNK
variants	B-UNK
of	O
human	B-UNK
erythrocyte	B-UNK
g6pd	B-UNK
have	O
been	O
characterized	B-UNK
.	O

 	O
all	O
of	O
them	O
were	O
found	B-UNK
in	O
italian	B-UNK
males	B-UNK
and	O
all	O
were	O
associated	B-UNK
with	O
enzyme	B-UNK
deficiency	B-UNK
,	O
but	O
only	O
two	O
with	O
signs	B-UNK
of	O
haemolysis	B-UNK
.	O

 	O
these	O
and	O
other	O
variants	B-UNK
reported	B-UNK
in	O
the	O
literature	O
,	O
which	O
must	O
thus	O
far	B-UNK
be	O
regarded	O
as	O
sporadic	B-UNK
,	O
are	O
found	B-UNK
to	O
map	B-UNK
in	O
parts	B-UNK
of	O
italy	B-UNK
where	O
common	B-UNK
types	B-UNK
of	O
g6pd	B-UNK
deficiency	I-UNK
are	O
also	O
prevalent	B-UNK
.	O
.	O

 	O
variants	B-UNK
of	O
erythrocyte	B-UNK
glucose	B-UNK
-	O
6	O
-	O
phosphate	B-UNK
dehydrogenase	I-UNK
(	O
g6pd	B-UNK
)	O
in	O
bulgarian	B-UNK
populations	B-UNK
.	O

 	O
ten	B-DISEASE
variants	B-UNK
of	O
erythrocyte	B-UNK
glucose	B-UNK
-	O
6	O
-	O
phosphate	B-UNK
dehydrogenase	I-UNK
were	O
identified	B-UNK
in	O
22	O
patients	B-UNK
with	O
g6pd	B-UNK
deficiency	I-UNK
from	O
three	O
districts	O
of	O
bulgaria	O
.	O

 	O
corinth	B-UNK
-	O
like	B-UNK
and	O
fayoum	O
-	O
like	B-UNK
variants	B-UNK
were	O
the	O
most	O
frequent	B-UNK
;	O
mediterranean	B-UNK
,	O
ohut	O
ii	B-UNK
,	O
kilgore	O
,	O
boston	O
,	O
poznan	O
,	O
and	O
panay	O
variants	B-UNK
and	O
two	O
new	B-UNK
variants	B-UNK
,	O
petrich	O
and	O
gotze	O
delchev	O
,	O
were	O
each	O
found	B-UNK
in	O
one	O
or	O
two	O
carriers	B-UNK
.	O

 	O
no	O
correlation	B-UNK
was	O
revealed	B-UNK
between	O
clinical	B-UNK
and	O
biochemical	B-UNK
polymorphism	O
.	O
.	O

 	O
nephropathy	B-DISEASE
in	O
the	O
wiskott	B-DISEASE
-	I-DISEASE
aldrich	I-DISEASE
syndrome	I-DISEASE
.	O

 	O
nephropathy	B-DISEASE
was	O
detected	B-UNK
in	O
five	O
of	O
32	O
patients	B-UNK
with	O
the	O
wiskott	B-DISEASE
-	I-DISEASE
aldrich	I-DISEASE
syndrome	I-DISEASE
who	O
were	O
participating	O
in	O
a	O
study	B-UNK
of	O
transfer	O
factor	B-UNK
(	O
tf	B-UNK
)	O
therapy	B-UNK
.	O

 	O
in	O
two	O
patients	B-UNK
,	O
nephropathy	B-DISEASE
was	O
present	B-UNK
before	O
tf	B-UNK
and	O
did	O
not	O
appear	B-UNK
changed	O
by	O
tf	B-UNK
therapy	B-UNK
.	O

 	O
one	O
of	O
these	O
patients	B-UNK
subsequently	B-UNK
developed	B-UNK
progressive	B-UNK
renal	B-DISEASE
failure	I-DISEASE
requiring	O
dialysis	O
beginning	O
5	O
1	O
/	O
2	O
years	B-UNK
after	O
tf	B-UNK
therapy	B-UNK
.	O

 	O
in	O
two	O
patients	B-UNK
,	O
decreased	B-UNK
renal	B-DISEASE
function	B-UNK
appeared	B-UNK
very	O
soon	O
after	O
the	O
administration	O
of	O
tf	B-UNK
.	O

 	O
one	O
patient	B-UNK
showed	B-UNK
gradually	O
decreasing	O
renal	B-DISEASE
function	B-UNK
beginning	O
after	O
two	O
years	B-UNK
of	O
tf	B-UNK
therapy	B-UNK
.	O

 	O
an	O
additional	B-UNK
patient	B-UNK
was	O
identified	B-UNK
who	O
died	O
with	O
renal	B-DISEASE
failure	I-DISEASE
without	O
having	B-UNK
received	O
tf	B-UNK
.	O

 	O
the	O
results	B-UNK
suggest	B-UNK
that	O
renal	B-DISEASE
failure	I-DISEASE
occurs	B-UNK
in	O
the	O
wiskott	B-DISEASE
-	I-DISEASE
aldrich	I-DISEASE
syndrome	I-DISEASE
more	O
frequently	B-UNK
than	O
generally	B-UNK
recognized	B-UNK
and	O
that	O
administration	O
of	O
tf	B-UNK
may	O
precipitate	O
or	O
accelerate	O
the	O
renal	B-DISEASE
disease	B-DISEASE
in	O
patients	B-UNK
with	O
this	O
syndrome	B-DISEASE
.	O
.	O

 	O
wiskott	B-DISEASE
-	I-DISEASE
aldrich	I-DISEASE
syndrome	I-DISEASE
:	O
cellular	B-UNK
impairments	O
and	O
their	O
implication	O
for	O
carrier	B-UNK
detection	I-UNK
.	O

 	O
a	O
family	B-UNK
in	O
which	O
two	O
male	B-UNK
siblings	B-UNK
were	O
affected	B-UNK
with	O
wiskott	B-DISEASE
-	I-DISEASE
aldrich	I-DISEASE
syndrome	I-DISEASE
(	O
was	O
)	O
was	O
studied	B-UNK
using	O
g	B-UNK
-	O
6	O
-	O
pd	B-DISEASE
isoenzymes	O
as	O
an	O
x	B-UNK
-	O
linked	B-UNK
marker	B-UNK
in	O
order	B-UNK
to	O
investigate	O
the	O
nature	B-UNK
of	O
cellular	B-UNK
abnormalities	B-DISEASE
.	O

 	O
isolated	B-UNK
peripheral	B-UNK
blood	I-UNK
cell	B-UNK
types	B-UNK
from	O
the	O
doubly	O
heterozygous	B-UNK
mother	B-UNK
of	O
the	O
affected	B-UNK
males	B-UNK
seemingly	O
failed	B-UNK
to	O
express	B-UNK
the	O
g	B-UNK
-	O
6	O
-	O
pd	B-DISEASE
allele	B-UNK
in	O
cis	B-UNK
position	B-UNK
with	O
the	O
was	O
allele	B-UNK
while	O
her	O
cultured	B-UNK
skin	B-DISEASE
fibroblasts	B-UNK
expressed	B-UNK
both	O
g	B-UNK
-	O
6	O
-	O
pd	B-DISEASE
alleles	B-UNK
.	O

 	O
additionally	B-UNK
,	O
a	O
histogram	O
analysis	B-UNK
of	O
platelet	B-UNK
size	B-UNK
revealed	B-UNK
a	O
single	B-UNK
population	B-UNK
of	O
abnormally	B-UNK
small	B-UNK
platelets	B-UNK
in	O
the	O
affected	B-UNK
propositus	O
,	O
whereas	O
the	O
heterozygous	B-UNK
mother	B-UNK
had	O
no	O
appreciable	O
small	B-UNK
platelet	B-UNK
subpopulation	O
.	O

 	O
in	O
vitro	B-UNK
culture	B-UNK
of	O
hemopoietic	B-UNK
progenitor	B-UNK
cells	B-UNK
of	O
the	O
heterozygous	B-UNK
mother	B-UNK
showed	B-UNK
that	O
the	O
majority	B-UNK
of	O
progenitor	B-UNK
cells	B-UNK
did	O
not	O
express	B-UNK
the	O
was	O
allele	B-UNK
.	O

 	O
however	O
,	O
a	O
small	B-UNK
number	B-UNK
of	O
cells	B-UNK
expressing	B-UNK
the	O
g	B-UNK
-	O
6	O
-	O
pd	B-DISEASE
type	B-UNK
linked	B-UNK
with	O
the	O
was	O
allele	B-UNK
were	O
detected	B-UNK
.	O

 	O
the	O
proportion	B-UNK
of	O
the	O
latter	O
progenitors	O
was	O
significantly	B-UNK
higher	B-UNK
among	O
more	O
primitive	B-UNK
progenitors	O
(	O
those	O
giving	O
rise	B-UNK
to	O
later	B-UNK
appearing	O
colonies	O
)	O
.	O

 	O
this	O
observation	B-UNK
suggests	B-UNK
that	O
selection	B-UNK
against	O
cells	B-UNK
expressing	B-UNK
the	O
wiskott	O
-	O
aldrich	O
defect	B-UNK
takes	O
place	B-UNK
in	O
the	O
hemopoietic	B-UNK
system	B-UNK
of	O
the	O
heterozygous	B-UNK
female	B-UNK
and	O
offers	O
a	O
possible	B-UNK
means	O
of	O
carrier	B-UNK
detection	I-UNK
in	O
some	O
women	B-UNK
.	O

 	B-UNK
linkage	I-UNK
studies	B-UNK
in	O
this	O
family	B-UNK
revealed	B-UNK
one	O
example	O
of	O
probable	B-UNK
recombination	B-UNK
between	O
the	O
loci	B-UNK
for	O
was	O
and	O
g	B-UNK
-	O
6	O
-	O
pd	B-DISEASE
among	O
three	O
informative	B-UNK
subjects	B-UNK
,	O
suggesting	B-UNK
that	O
these	O
two	O
loci	B-UNK
may	O
not	O
be	O
closely	B-UNK
linked	I-UNK
on	O
the	O
x	B-UNK
-	O
chromosome	B-UNK
.	O
.	O

 	O
a	O
new	B-UNK
ct	B-UNK
pattern	B-UNK
in	O
adrenoleukodystrophy	B-DISEASE
.	O

 	O
a	O
new	B-UNK
ct	B-UNK
pattern	B-UNK
was	O
observed	B-UNK
in	O
2	O
patients	B-UNK
with	O
adrenoleukodystrophy	B-DISEASE
(	O
ald	B-UNK
)	O
.	O

 	O
this	O
pattern	B-UNK
,	O
which	O
the	O
authors	B-UNK
call	O
type	B-UNK
ii	I-UNK
,	O
is	O
characterized	B-UNK
by	O
the	O
absence	B-UNK
of	O
posterior	O
periventricular	O
areas	B-UNK
of	O
decreased	B-UNK
attenuation	O
around	O
the	O
trigone	O
on	O
non	B-UNK
-	O
contrast	B-UNK
scans	O
after	O
contrast	B-UNK
infusion	B-UNK
,	O
however	O
,	O
there	O
is	O
striking	B-UNK
enhancement	O
of	O
various	O
white	B-UNK
-	O
matter	O
structures	B-UNK
(	O
tracts	O
or	O
fiber	O
systems	B-UNK
)	O
such	O
as	O
the	O
internal	B-UNK
capsules	O
,	O
corpus	B-DISEASE
callosum	I-DISEASE
,	O
corona	O
radiata	O
,	O
forceps	O
major	B-UNK
,	O
and	O
cerebral	O
peduncles	O
.	O

 	O
this	O
is	O
different	B-UNK
from	O
numerous	B-UNK
previous	B-UNK
descriptions	O
of	O
the	O
ct	B-UNK
pattern	B-UNK
in	O
ald	B-UNK
.	O

 	O
type	B-UNK
ii	I-UNK
ald	B-UNK
does	O
not	O
appear	B-UNK
to	O
have	O
been	O
seen	B-UNK
in	O
any	O
other	O
leukoencephalopathy	B-DISEASE
and	O
is	O
probably	B-UNK
specific	B-UNK
for	O
a	O
phenotypic	B-UNK
variant	B-UNK
or	O
an	O
evolving	O
stage	B-UNK
of	O
ald	B-UNK
.	O
.	O

 	O
further	O
evidence	B-UNK
for	O
heterogeneity	B-UNK
of	O
glucose	B-UNK
-	O
6	O
-	O
phosphate	B-UNK
dehydrogenase	I-UNK
deficiency	B-UNK
in	O
papua	B-UNK
new	I-UNK
guinea	O
.	O

 	O
four	O
new	B-UNK
g6pd	B-UNK
variants	I-UNK
have	O
been	O
characterized	B-UNK
in	O
individuals	B-UNK
from	O
papua	B-UNK
new	I-UNK
guinea	O
.	O

 	O
this	O
study	B-UNK
demonstrates	B-UNK
that	O
the	O
previously	B-UNK
reported	I-UNK
markham	O
variant	B-UNK
and	O
the	O
newly	B-UNK
characterized	B-UNK
salata	O
variant	B-UNK
may	O
be	O
widely	B-UNK
distributed	B-UNK
in	O
papua	B-UNK
new	I-UNK
guinea	O
.	O

 	O
th	O
data	B-UNK
presented	B-UNK
here	O
together	O
with	O
those	O
of	O
previously	B-UNK
published	I-UNK
studies	B-UNK
demonstrate	B-UNK
a	O
degree	B-UNK
of	O
heterogeneity	B-UNK
of	O
g6pd	B-UNK
deficiency	I-UNK
that	O
is	O
much	O
higher	B-UNK
than	O
that	O
in	O
other	O
regions	B-UNK
of	O
the	O
world	O
where	O
g6pd	B-UNK
deficiency	I-UNK
is	O
common	B-UNK
.	O
.	O

 	B-UNK
increased	I-UNK
incidence	O
of	O
cataracts	B-DISEASE
in	O
male	B-UNK
subjects	B-UNK
deficient	B-UNK
in	O
glucose	B-UNK
-	O
6	O
-	O
phosphate	B-UNK
dehydrogenase	I-UNK
.	O

 	O
glucose	B-UNK
-	O
6	O
-	O
phosphate	B-UNK
dehydrogenase	I-UNK
(	O
g6pd	B-UNK
)	O
deficiency	B-UNK
in	O
rbcs	O
was	O
found	B-UNK
significantly	B-UNK
more	O
frequently	B-UNK
in	O
210	O
male	B-UNK
cataractous	O
patients	B-UNK
than	O
in	O
672	O
control	B-UNK
subjects	B-UNK
of	O
sardinian	B-UNK
origin	B-UNK
.	O

 	O
the	O
frequency	B-UNK
of	O
the	O
deficiency	B-UNK
was	O
increasingly	O
higher	B-UNK
in	O
presenile	O
cataracts	B-DISEASE
.	O

 	O
in	O
the	O
g6pd	B-UNK
-	O
deficient	B-UNK
group	B-UNK
,	O
the	O
incidence	O
of	O
cortical	O
and	O
total	B-UNK
cataracts	B-DISEASE
was	O
also	O
increased	B-UNK
.	O

 	O
it	O
is	O
suggested	B-UNK
that	O
decrease	B-UNK
of	O
the	O
g6pd	B-UNK
activity	I-UNK
in	O
the	O
lens	O
,	O
which	O
accompanies	O
its	O
deficiency	B-UNK
in	O
the	O
erythrocyte	B-UNK
,	O
might	O
play	O
a	O
role	B-UNK
in	O
the	O
cataracto	O
-	O
genesis	O
of	O
these	O
patients	B-UNK
.	O

 	O
moreover	O
,	O
g6pd	B-UNK
deficiency	I-UNK
should	O
be	O
added	O
to	O
other	O
conditions	B-UNK
,	O
such	O
as	O
the	O
galactosemic	O
states	B-UNK
and	O
riboflavin	B-DISEASE
deficiency	I-DISEASE
,	O
where	O
cataracts	B-DISEASE
represent	B-UNK
a	O
sensitive	B-UNK
indicator	O
of	O
metabolic	B-UNK
abnormalities	B-DISEASE
of	O
the	O
rbc	O
.	O
.	O

 	B-UNK
molecular	I-UNK
basis	B-UNK
of	O
human	B-UNK
mitochondrial	B-UNK
very	O
-	O
long	B-DISEASE
-	I-DISEASE
chain	I-DISEASE
acyl	I-DISEASE
-	I-DISEASE
coa	I-DISEASE
dehydrogenase	I-DISEASE
deficiency	I-DISEASE
causing	B-UNK
cardiomyopathy	B-DISEASE
and	O
sudden	O
death	B-DISEASE
in	O
childhood	B-UNK
.	O

 	O
beta	B-UNK
-	O
oxidation	B-UNK
of	O
long	B-UNK
-	O
chain	B-UNK
fatty	I-UNK
acids	I-UNK
provides	B-UNK
the	O
major	B-UNK
source	O
of	O
energy	O
in	O
the	O
heart	B-UNK
.	O

 	O
defects	B-UNK
in	O
enzymes	B-UNK
of	O
the	O
beta	B-UNK
-	O
oxidation	B-UNK
pathway	B-UNK
cause	B-UNK
sudden	O
,	O
unexplained	O
death	B-DISEASE
in	O
childhood	B-UNK
,	O
acute	B-UNK
hepatic	B-DISEASE
encephalopathy	I-DISEASE
or	O
liver	B-DISEASE
failure	I-DISEASE
,	O
skeletal	B-UNK
myopathy	B-DISEASE
,	O
and	O
cardiomyopathy	B-DISEASE
.	O

 	O
very	O
-	O
long	B-UNK
-	O
chain	O
acyl	B-UNK
-	O
coa	B-UNK
dehydrogenase	I-UNK
[	O
vlcad	B-UNK
;	O
very	O
-	O
long	B-UNK
-	O
chain	O
-	O
acyl	B-UNK
-	O
coa	B-UNK
(	O
acceptor	B-UNK
)	O
2	O
,	O
3	O
-	O
oxidoreductase	B-UNK
,	O
ec	O
1	O
.	O
3	O
3	O
.	O
99	O
99	O
.	O
13	O
]	O
catalyzes	O
the	O
first	O
step	O
in	O
beta	B-UNK
-	O
oxidation	B-UNK
.	O

 	O
we	O
have	O
isolated	B-UNK
the	O
human	B-UNK
vlcad	B-UNK
cdna	B-UNK
and	O
gene	B-UNK
and	O
determined	B-UNK
the	O
complete	B-UNK
nucleotide	B-UNK
sequences	B-UNK
.	O

 	B-UNK
polymerase	I-UNK
chain	I-UNK
reaction	O
amplification	B-UNK
of	O
vlcad	B-UNK
mrna	B-UNK
and	O
genomic	B-UNK
exons	B-UNK
defined	B-UNK
the	O
molecular	B-UNK
defects	B-UNK
in	O
two	O
patients	B-UNK
with	O
vlcad	B-DISEASE
deficiency	I-DISEASE
who	O
presented	B-UNK
with	O
unexplained	O
cardiac	B-DISEASE
arrest	I-DISEASE
and	O
cardiomyopathy	B-DISEASE
.	O

 	O
in	O
one	O
,	O
a	O
homozygous	B-UNK
mutation	B-UNK
in	O
the	O
consensus	B-UNK
dinucleotide	B-UNK
of	O
the	O
donor	B-UNK
splice	I-UNK
site	I-UNK
(	O
g	B-UNK
+	O
1	O
-	O
-	O
>	O
a	O
)	O
was	O
associated	B-UNK
with	O
universal	O
skipping	B-UNK
of	O
the	O
prior	B-UNK
exon	B-UNK
(	O
exon	B-UNK
11	O
)	O
.	O

 	O
the	O
second	B-UNK
patient	B-UNK
was	O
a	O
compound	B-UNK
heterozygote	B-UNK
,	O
with	O
a	O
missense	B-UNK
mutation	I-UNK
,	O
c1837	O
-	O
-	O
>	O
t	B-UNK
,	O
changing	O
the	O
arginine	B-UNK
at	B-DISEASE
residue	B-UNK
613	O
to	O
tryptophan	O
on	O
one	O
allele	B-UNK
and	O
a	O
single	B-UNK
base	B-UNK
deletion	B-UNK
at	B-DISEASE
the	O
intron	B-UNK
-	O
exon	B-UNK
6	O
boundary	B-UNK
as	O
the	O
second	B-UNK
mutation	B-UNK
.	O

 	O
this	O
initial	B-UNK
delineation	O
of	O
human	B-UNK
mutations	B-UNK
in	O
vlcad	B-UNK
suggests	B-UNK
that	O
vlcad	B-DISEASE
deficiency	I-DISEASE
reduces	B-UNK
myocardial	O
fatty	B-UNK
acid	I-UNK
beta	I-UNK
-	O
oxidation	B-UNK
and	O
energy	O
production	B-UNK
and	O
is	O
associated	B-UNK
with	O
cardiomyopathy	B-DISEASE
and	O
sudden	O
death	B-DISEASE
in	O
childhood	B-UNK
.	O

 	B-UNK
aberrant	I-UNK
subcellular	B-UNK
localization	B-UNK
of	O
brca1	B-UNK
in	O
breast	B-DISEASE
cancer	I-DISEASE
.	O

 	O
the	O
brca1	B-UNK
gene	B-UNK
product	B-UNK
was	O
identified	B-UNK
as	O
a	O
220	O
-	O
kilodalton	O
nuclear	B-UNK
phosphoprotein	O
in	O
normal	B-UNK
cells	B-UNK
,	O
including	B-UNK
breast	B-UNK
ductal	O
epithelial	B-UNK
cells	I-UNK
,	O
and	O
in	O
18	O
of	O
20	O
tumor	B-DISEASE
cell	B-UNK
lines	B-UNK
derived	B-UNK
from	O
tissues	B-UNK
other	O
than	O
breast	B-UNK
and	O
ovary	O
.	O

 	O
in	O
16	O
of	O
17	O
breast	B-UNK
and	O
ovarian	B-DISEASE
cancer	I-DISEASE
lines	B-UNK
and	O
17	O
of	O
17	O
samples	B-UNK
of	O
cells	B-UNK
obtained	B-UNK
from	O
malignant	B-UNK
effusions	O
,	O
however	O
,	O
brca1	B-UNK
localized	B-UNK
mainly	B-UNK
in	O
cytoplasm	O
.	O

 	O
absence	B-UNK
of	O
brca1	B-UNK
or	O
aberrant	B-UNK
subcellular	B-UNK
location	B-UNK
was	O
also	O
observed	B-UNK
to	O
a	O
variable	B-UNK
extent	B-UNK
in	O
histological	O
sections	B-UNK
of	O
many	O
breast	B-DISEASE
cancer	I-DISEASE
biopsies	B-UNK
.	O

 	O
these	O
findings	B-UNK
suggest	B-UNK
that	O
brca1	B-UNK
abnormalities	B-DISEASE
may	O
be	O
involved	B-UNK
in	O
the	O
pathogenesis	O
of	O
many	O
breast	B-UNK
cancers	B-DISEASE
,	O
sporadic	B-UNK
as	O
well	O
as	O
familial	B-UNK
.	O
.	O

 	O
mapping	B-UNK
of	O
the	O
mouse	B-UNK
homologue	B-UNK
of	O
the	O
wilson	B-UNK
disease	B-DISEASE
gene	B-UNK
to	O
mouse	B-UNK
chromosome	I-UNK
8	O
.	O

 	O
atp7b	B-UNK
,	O
the	O
gene	B-UNK
altered	B-UNK
in	O
wilson	B-UNK
disease	B-DISEASE
(	O
wd	O
)	O
patients	B-UNK
,	O
lies	B-UNK
in	O
a	O
block	B-UNK
of	O
homology	B-UNK
shared	B-UNK
between	O
human	B-UNK
chromosome	I-UNK
13q14	B-UNK
and	O
the	O
central	B-UNK
region	B-UNK
of	O
mouse	B-UNK
chromosome	I-UNK
14	O
.	O

 	O
however	O
,	O
we	O
have	O
mapped	B-UNK
the	O
murine	B-UNK
homologue	B-UNK
of	O
atp7b	B-UNK
(	O
atp7b	B-UNK
)	O
to	O
mouse	B-UNK
chromosome	I-UNK
8	O
by	O
somatic	B-UNK
cell	I-UNK
hybrid	I-UNK
analysis	B-UNK
.	O

 	O
analysis	B-UNK
of	O
80	O
interspecific	B-UNK
backcross	B-UNK
offspring	B-UNK
was	O
used	O
to	O
position	B-UNK
atp7b	B-UNK
close	B-UNK
to	O
d8mit3	O
and	O
another	O
atpase	B-UNK
locus	B-UNK
,	O
atp4b	O
,	O
on	O
mouse	B-UNK
chromosome	I-UNK
8	O
.	O

 	O
atp4b	O
lies	B-UNK
in	O
13q34	O
and	O
is	O
separated	O
from	O
atp7b	B-UNK
by	O
several	O
loci	B-UNK
whose	O
mouse	B-UNK
homologues	B-UNK
map	B-UNK
to	O
mouse	B-UNK
chromosome	I-UNK
14	O
.	O

 	O
the	O
assignment	B-UNK
of	O
atp7b	B-UNK
to	O
mouse	B-UNK
chromosome	I-UNK
8	O
identifies	O
a	O
previously	B-UNK
unrecognized	O
region	B-UNK
of	O
homology	B-UNK
between	O
this	O
chromosome	B-UNK
and	O
human	B-UNK
chromosome	I-UNK
13	O
.	O

 	O
this	O
assignment	B-UNK
suggests	B-UNK
a	O
possible	B-UNK
location	B-UNK
for	O
the	O
toxic	B-UNK
milk	O
mutation	B-UNK
in	O
the	O
mouse	B-UNK
,	O
which	O
has	O
been	O
proposed	B-UNK
as	O
a	O
homologue	B-UNK
of	O
wd	O
.	O
.	O

 	B-UNK
germline	I-UNK
mutations	B-UNK
of	O
the	O
brca1	B-UNK
gene	B-UNK
in	O
breast	B-UNK
and	O
ovarian	B-DISEASE
cancer	I-DISEASE
families	B-UNK
provide	B-UNK
evidence	I-UNK
for	O
a	O
genotype	B-UNK
-	O
phenotype	B-UNK
correlation	B-UNK
.	O

 	O
mutations	B-UNK
in	O
the	O
brca1	B-UNK
gene	B-UNK
,	O
discovered	O
in	O
1994	O
,	O
are	O
associated	B-UNK
with	O
an	O
80	O
-	O
90	O
%	O
lifetime	O
risk	B-UNK
of	O
breast	B-DISEASE
cancer	I-DISEASE
.	O

 	O
we	O
have	O
analysed	B-UNK
60	O
families	B-UNK
with	O
a	O
history	B-UNK
of	O
breast	B-UNK
and	O
/	O
or	O
ovarian	B-DISEASE
cancer	I-DISEASE
for	O
germline	B-UNK
mutations	I-UNK
in	O
brca1	B-UNK
.	O

 	O
twenty	O
-	O
two	O
different	B-UNK
mutations	B-UNK
were	O
detected	B-UNK
in	O
32	O
families	B-UNK
(	O
53	O
%	O
)	O
,	O
of	O
which	O
14	O
are	O
previously	B-UNK
unreported	O
.	O

 	O
we	O
observed	B-UNK
a	O
significant	B-UNK
correlation	B-UNK
between	O
the	O
location	B-UNK
of	O
the	O
mutation	B-UNK
in	O
the	O
gene	B-UNK
and	O
the	O
ratio	B-UNK
of	O
breast	B-UNK
to	O
ovarian	B-DISEASE
cancer	I-DISEASE
incidence	O
within	O
each	O
family	B-UNK
.	O

 	O
our	O
data	B-UNK
suggest	B-UNK
a	O
transition	B-UNK
in	O
risk	B-UNK
such	O
that	O
mutations	B-UNK
in	O
the	O
3	O
third	O
of	O
the	O
gene	B-UNK
are	O
associated	B-UNK
with	O
a	O
lower	B-UNK
proportion	B-UNK
of	O
ovarian	B-DISEASE
cancer	I-DISEASE
.	O

 	B-UNK
haplotype	I-UNK
analysis	B-UNK
supports	B-UNK
previous	B-UNK
data	B-UNK
which	O
suggest	B-UNK
some	O
brca1	B-UNK
mutation	B-UNK
carriers	B-UNK
have	O
common	B-UNK
ancestors	O
;	O
however	O
,	O
we	O
have	O
found	B-UNK
at	B-DISEASE
least	O
two	O
examples	O
where	O
recurrent	B-UNK
mutations	B-UNK
appear	B-UNK
to	O
have	O
arisen	O
independently	B-UNK
.	O
.	O

 	B-UNK
hereditary	I-UNK
deficiency	B-UNK
of	O
the	O
seventh	B-UNK
component	B-UNK
of	O
complement	B-UNK
and	O
recurrent	B-UNK
meningococcal	B-UNK
infection	B-DISEASE
:	O
investigations	O
of	O
an	O
irish	B-UNK
family	B-UNK
using	O
a	O
novel	B-UNK
haemolytic	B-UNK
screening	B-UNK
assay	B-UNK
for	O
complement	B-UNK
activity	I-UNK
and	O
c7	B-UNK
m	B-UNK
/	O
n	B-UNK
allotyping	O
.	O

 	O
terminal	B-UNK
complement	B-UNK
component	I-UNK
deficiency	B-UNK
predisposes	O
to	O
meningococcal	B-UNK
infection	B-DISEASE
and	O
is	O
inherited	B-UNK
in	O
an	O
autosomal	O
co	B-UNK
-	O
dominant	B-UNK
manner	B-UNK
.	O

 	O
an	O
irish	B-UNK
family	B-UNK
is	O
described	B-UNK
,	O
in	O
which	O
2	O
of	O
3	O
brothers	B-UNK
had	O
recurrent	B-UNK
meningococcal	B-UNK
infection	B-DISEASE
.	O

 	O
a	O
novel	B-UNK
screening	B-UNK
assay	B-UNK
was	O
used	O
to	O
investigate	O
for	O
terminal	B-UNK
complement	B-UNK
deficiency	I-UNK
and	O
the	O
2	O
affected	B-UNK
brothers	B-UNK
were	O
found	B-UNK
to	O
be	O
completely	B-UNK
deficient	B-UNK
in	O
the	O
seventh	B-UNK
component	B-UNK
of	O
complement	B-UNK
(	O
c7	B-UNK
)	O
.	O

 	O
enzyme	B-UNK
-	O
linked	B-UNK
immunosorbent	O
assay	B-UNK
for	O
c7	B-UNK
revealed	B-UNK
lower	B-UNK
than	O
normal	B-UNK
levels	B-UNK
in	O
the	O
remaining	B-UNK
brother	B-UNK
and	O
parents	B-UNK
.	O

 	O
c7	B-UNK
m	B-UNK
/	O
n	B-UNK
protein	B-UNK
polymorphism	O
allotyping	O
,	O
used	O
to	O
investigate	O
the	O
segregation	B-UNK
of	O
the	O
c7	B-UNK
deficiency	I-UNK
genes	B-UNK
,	O
showed	B-UNK
that	O
the	O
apparently	B-UNK
complement	B-UNK
sufficient	B-UNK
brother	B-UNK
was	O
heterozygous	B-UNK
c7	B-UNK
deficient	B-UNK
and	O
a	O
carrier	B-UNK
of	O
one	O
of	O
the	O
deficiency	B-UNK
genes	B-UNK
.	O

 	B-UNK
complement	I-UNK
screening	B-UNK
should	O
be	O
carried	B-UNK
out	O
in	O
any	O
individual	B-UNK
suffering	B-UNK
recurrent	B-UNK
meningococcal	B-UNK
infection	B-DISEASE
or	O
infection	B-DISEASE
with	O
an	O
uncommon	B-UNK
meningococcal	B-UNK
serogroup	O
.	O

 	O
identification	B-UNK
of	O
complement	B-UNK
deficient	B-UNK
patients	I-UNK
allows	B-UNK
the	O
implementation	O
of	O
strategies	B-UNK
to	O
prevent	O
recurrent	B-UNK
infection	B-DISEASE
.	O
.	O

 	B-UNK
molecular	I-UNK
basis	B-UNK
of	O
subtotal	B-UNK
complement	B-UNK
c6	B-DISEASE
deficiency	I-DISEASE
.	O

 	O
a	O
carboxy	O
-	O
terminally	B-UNK
truncated	B-UNK
but	O
functionally	B-UNK
active	B-UNK
c6	B-UNK
.	O

 	O
individuals	B-UNK
with	O
subtotal	B-UNK
complement	B-UNK
c6	B-DISEASE
deficiency	I-DISEASE
possess	O
a	O
c6	B-UNK
molecule	B-UNK
that	O
is	O
14	O
%	O
shorter	B-UNK
than	O
normal	B-UNK
c6	B-UNK
and	O
present	B-UNK
in	O
low	B-UNK
but	O
detectable	B-UNK
concentrations	B-UNK
(	O
1	O
-	O
2	O
%	O
of	O
the	O
normal	B-UNK
mean	B-UNK
)	O
.	O

 	O
we	O
now	O
show	O
that	O
this	O
dysmorphic	B-UNK
c6	B-UNK
is	O
bactericidally	O
active	B-UNK
and	O
lacks	O
an	O
epitope	O
that	O
was	O
mapped	B-UNK
to	O
the	O
most	O
carboxy	O
-	O
terminal	B-UNK
part	O
of	O
c6	B-UNK
using	O
c6	B-UNK
cdna	B-UNK
fragments	B-UNK
expressed	B-UNK
as	O
fusion	B-UNK
proteins	B-UNK
in	O
the	O
puex	O
expression	B-UNK
system	B-UNK
.	O

 	O
we	O
thus	O
predicted	B-UNK
that	O
the	O
abnormal	B-UNK
c6	B-UNK
molecule	B-UNK
might	O
be	O
carboxy	O
-	O
terminally	B-UNK
truncated	B-UNK
and	O
sought	O
a	O
mutation	B-UNK
in	O
an	O
area	B-UNK
approximately	B-UNK
14	O
%	O
from	O
the	O
carboxy	O
-	O
terminal	B-UNK
end	B-UNK
of	O
the	O
coding	B-UNK
sequence	B-UNK
.	O

 	O
by	O
sequencing	B-UNK
pcr	B-UNK
-	O
amplified	B-UNK
products	B-UNK
from	O
this	O
region	B-UNK
,	O
we	O
found	B-UNK
,	O
in	O
three	O
individuals	B-UNK
from	O
two	O
families	B-UNK
,	O
a	O
mutation	B-UNK
that	O
might	O
plausibly	O
be	O
responsible	B-UNK
for	O
the	O
defect	B-UNK
.	O

 	O
all	O
three	O
have	O
an	O
abnormal	B-UNK
5	O
splice	B-UNK
donor	I-UNK
site	I-UNK
of	O
intron	B-UNK
15	O
,	O
which	O
would	O
probably	B-UNK
prevent	O
splicing	B-UNK
.	O

 	O
an	O
in	O
-	O
frame	B-UNK
stop	B-UNK
codon	B-UNK
is	O
found	B-UNK
17	O
codons	B-UNK
downstream	B-UNK
from	O
the	O
intron	B-UNK
boundary	B-UNK
,	O
which	O
would	O
lead	B-UNK
to	O
a	O
truncated	B-UNK
polypeptide	B-UNK
13	O
.	O

 	O
5	O
%	O
smaller	B-UNK
than	O
normal	B-UNK
c6	B-UNK
.	O

 	O
this	O
result	B-UNK
was	O
unexpected	B-UNK
,	O
as	O
earlier	B-UNK
studies	B-UNK
mapped	B-UNK
the	O
c5b	O
binding	B-UNK
site	B-UNK
,	O
or	O
a	O
putative	B-UNK
enzymatic	B-UNK
region	B-UNK
,	O
to	O
this	O
part	O
of	O
c6	B-UNK
.	O

 	O
interestingly	B-UNK
,	O
all	O
three	O
subjects	B-UNK
were	O
probably	B-UNK
heterozygous	B-UNK
for	O
both	O
subtotal	B-UNK
c6	B-UNK
and	O
complete	B-UNK
c6	B-DISEASE
deficiency	I-DISEASE
.	O

 	O
myotonic	B-DISEASE
dystrophy	I-DISEASE
:	O
evidence	B-UNK
for	O
a	O
possible	B-UNK
dominant	B-UNK
-	O
negative	B-UNK
rna	B-UNK
mutation	B-UNK
.	O

 	O
the	O
trinucleotide	B-UNK
expansion	B-UNK
mutation	B-UNK
causing	B-UNK
myotonic	B-DISEASE
dystrophy	I-DISEASE
is	O
in	O
the	O
3	O
untranslated	B-UNK
region	B-UNK
of	O
a	O
protein	B-UNK
kinase	B-UNK
gene	B-UNK
.	O

 	O
the	O
molecular	B-UNK
mechanisms	I-UNK
by	O
which	O
the	O
expanded	B-UNK
repeat	B-UNK
causes	B-UNK
the	O
clinically	B-UNK
variable	B-UNK
and	O
multisystemic	O
disease	B-DISEASE
,	O
myotonic	B-DISEASE
dystrophy	I-DISEASE
,	O
are	O
not	O
understood	O
.	O

 	O
it	O
has	O
been	O
particularly	B-UNK
difficult	O
to	O
rationalize	O
the	O
dominant	B-UNK
inheritance	B-UNK
with	O
the	O
fact	O
that	O
the	O
expansion	B-UNK
mutation	B-UNK
lies	B-UNK
outside	O
of	O
the	O
protein	B-UNK
-	O
encoding	B-UNK
gene	B-UNK
elements	B-UNK
,	O
and	O
should	O
not	O
be	O
translated	B-UNK
into	O
protein	B-UNK
.	O

 	O
here	O
we	O
use	B-UNK
muscle	B-UNK
biopsies	B-UNK
from	O
classical	B-UNK
adult	B-UNK
-	O
onset	B-UNK
myotonic	B-DISEASE
dystrophy	I-DISEASE
patients	B-UNK
to	O
study	B-UNK
the	O
accumulation	B-UNK
of	O
transcripts	B-UNK
from	O
both	O
the	O
normal	B-UNK
and	O
expanded	B-UNK
dm	B-DISEASE
kinase	B-UNK
genes	B-UNK
in	O
patient	B-UNK
muscle	B-UNK
,	O
and	O
compare	O
the	O
results	B-UNK
to	O
normal	B-UNK
and	O
myopathic	O
controls	B-UNK
.	O

 	O
we	O
found	B-UNK
relatively	B-UNK
small	B-UNK
decreases	B-UNK
of	O
dm	B-DISEASE
kinase	B-UNK
rna	B-UNK
in	O
the	O
total	B-UNK
rna	B-UNK
pool	O
from	O
muscle	B-UNK
;	O
however	O
,	O
these	O
reductions	O
were	O
not	O
disease	B-DISEASE
specific	B-UNK
.	O

 	O
analysis	B-UNK
of	O
poly	O
(	O
a	O
)	O
+	O
rna	B-UNK
showed	B-UNK
dramatic	B-UNK
decreases	B-UNK
of	O
both	O
the	O
mutant	B-UNK
and	O
normal	B-UNK
dm	B-DISEASE
kinase	B-UNK
rnas	B-UNK
,	O
and	O
these	O
changes	B-UNK
were	O
disease	B-DISEASE
-	O
specific	B-UNK
.	O

 	O
our	O
findings	B-UNK
are	O
consistent	B-UNK
with	O
a	O
novel	B-UNK
molecular	B-UNK
pathogenetic	B-UNK
mechanism	B-UNK
for	O
myotonic	B-DISEASE
dystrophy	I-DISEASE
both	O
the	O
normal	B-UNK
and	O
expanded	B-UNK
dm	B-DISEASE
kinase	B-UNK
genes	B-UNK
are	O
transcribed	B-UNK
in	O
patient	B-UNK
muscle	B-UNK
,	O
but	O
the	O
abnormal	B-UNK
expansion	B-UNK
-	O
containing	B-UNK
rna	B-UNK
has	O
a	O
dominant	B-UNK
effect	B-UNK
on	O
rna	B-UNK
metabolism	B-DISEASE
by	O
preventing	O
the	O
accumulation	B-UNK
of	O
poly	O
(	O
a	O
)	O
+	O
rna	B-UNK
.	O

 	O
the	O
ability	B-UNK
of	O
the	O
expansion	B-UNK
mutation	B-UNK
to	O
alter	B-UNK
accumulation	B-UNK
of	O
poly	O
(	O
a	O
)	O
+	O
rna	B-UNK
in	O
trans	B-UNK
suggests	B-UNK
that	O
myotonic	B-DISEASE
dystrophy	I-DISEASE
may	O
be	O
the	O
first	O
example	O
of	O
a	O
dominant	B-UNK
-	O
negative	B-UNK
mutation	B-UNK
manifested	O
at	B-DISEASE
the	O
rna	B-UNK
level	B-UNK
.	O
.	O

 	O
a	O
strong	B-UNK
candidate	B-UNK
for	O
the	O
breast	B-UNK
and	O
ovarian	B-DISEASE
cancer	I-DISEASE
susceptibility	B-UNK
gene	B-UNK
brca1	B-UNK
.	O

 	O
a	O
strong	B-UNK
candidate	B-UNK
for	O
the	O
17q	B-UNK
-	O
linked	B-UNK
brca1	B-UNK
gene	B-UNK
,	O
which	O
influences	B-UNK
susceptibility	B-UNK
to	O
breast	B-UNK
and	O
ovarian	B-DISEASE
cancer	I-DISEASE
,	O
has	O
been	O
identified	B-UNK
by	O
positional	B-UNK
cloning	I-UNK
methods	B-UNK
.	O

 	O
probable	B-UNK
predisposing	B-UNK
mutations	B-UNK
have	O
been	O
detected	B-UNK
in	O
five	O
of	O
eight	O
kindreds	B-UNK
presumed	B-UNK
to	O
segregate	O
brca1	B-UNK
susceptibility	B-UNK
alleles	B-UNK
.	O

 	O
the	O
mutations	B-UNK
include	B-UNK
an	O
11	O
-	O
base	B-UNK
pair	I-UNK
deletion	B-UNK
,	O
a	O
1	O
-	O
base	B-UNK
pair	I-UNK
insertion	B-UNK
,	O
a	O
stop	B-UNK
codon	B-UNK
,	O
a	O
missense	B-UNK
substitution	B-UNK
,	O
and	O
an	O
inferred	O
regulatory	B-UNK
mutation	B-UNK
.	O

 	O
the	O
brca1	B-UNK
gene	B-UNK
is	O
expressed	B-UNK
in	O
numerous	B-UNK
tissues	B-UNK
,	O
including	B-UNK
breast	B-UNK
and	O
ovary	O
,	O
and	O
encodes	B-UNK
a	O
predicted	B-UNK
protein	B-UNK
of	O
1863	O
amino	O
acids	O
.	O

 	O
this	O
protein	B-UNK
contains	B-UNK
a	O
zinc	B-DISEASE
finger	B-UNK
domain	B-UNK
in	O
its	O
amino	O
-	O
terminal	B-UNK
region	B-UNK
,	O
but	O
is	O
otherwise	O
unrelated	B-UNK
to	O
previously	B-UNK
described	I-UNK
proteins	B-UNK
.	O

 	O
identification	B-UNK
of	O
brca1	B-UNK
should	O
facilitate	B-UNK
early	B-UNK
diagnosis	B-UNK
of	O
breast	B-UNK
and	O
ovarian	B-DISEASE
cancer	I-DISEASE
susceptibility	B-UNK
in	O
some	O
individuals	B-UNK
as	O
well	O
as	O
a	O
better	B-UNK
understanding	B-UNK
of	O
breast	B-DISEASE
cancer	I-DISEASE
biology	O
.	O
.	O

 	B-UNK
molecular	I-UNK
characterization	B-UNK
of	O
galactosemia	B-UNK
(	O
type	B-UNK
1	O
)	O
mutations	B-UNK
in	O
japanese	B-UNK
.	O

 	O
we	O
characterized	B-UNK
two	O
novel	B-UNK
mutations	B-UNK
of	O
the	O
galactose	B-UNK
-	O
1	O
-	O
phosphate	B-UNK
uridyltransferase	B-UNK
(	O
galt	B-UNK
)	O
gene	B-UNK
in	O
two	O
japanese	B-UNK
patients	I-UNK
with	O
galt	B-UNK
deficiency	B-UNK
and	O
identified	B-UNK
n314d	B-UNK
and	O
r333w	O
mutations	B-UNK
,	O
previously	B-UNK
found	B-UNK
in	O
caucasians	B-UNK
.	O

 	O
one	O
novel	B-UNK
missense	I-UNK
mutation	B-UNK
was	O
an	O
g	B-UNK
-	O
to	O
-	O
a	O
transition	B-UNK
in	O
exon	B-UNK
8	O
,	O
resulting	B-UNK
in	O
the	O
substitution	B-UNK
of	O
arginine	B-UNK
by	O
histidine	B-UNK
at	B-DISEASE
the	O
codon	B-UNK
231	O
(	O
r231h	O
)	O
.	O

 	O
galt	B-UNK
activity	I-UNK
of	O
the	O
r231h	O
mutant	B-UNK
construct	B-UNK
was	O
reduced	B-UNK
to	O
15	O
%	O
of	O
normal	B-UNK
controls	B-UNK
in	O
a	O
cos	B-UNK
cell	B-UNK
expression	B-UNK
system	B-UNK
.	O

 	O
the	O
other	O
was	O
a	O
splicing	B-UNK
mutation	B-UNK
,	O
an	O
a	O
-	O
to	O
-	O
g	B-UNK
transition	B-UNK
at	B-DISEASE
the	O
38th	O
nucleotide	B-UNK
in	O
exon	B-UNK
3	O
(	O
318a	O
-	O
-	O
>	O
g	B-UNK
)	O
,	O
resulting	B-UNK
in	O
a	O
38	O
-	O
bp	B-UNK
deletion	I-UNK
in	O
the	O
galt	B-UNK
cdna	B-UNK
by	O
activating	B-UNK
a	O
cryptic	O
splice	O
acceptor	B-UNK
site	B-UNK
.	O

 	O
in	O
seven	B-UNK
japanese	B-UNK
families	B-UNK
(	O
14	O
alleles	B-UNK
for	O
classic	B-UNK
form	B-UNK
and	O
one	O
allele	B-UNK
for	O
duarte	B-UNK
variant	B-UNK
)	O
with	O
galt	B-UNK
deficiency	B-UNK
,	O
the	O
r231h	O
and	O
318a	O
-	O
-	O
>	O
g	B-UNK
mutations	B-UNK
were	O
found	B-UNK
only	O
on	O
both	O
alleles	B-UNK
of	O
the	O
proband	B-UNK
.	O

 	O
the	O
n314d	B-UNK
and	O
r333w	O
mutations	B-UNK
were	O
found	B-UNK
on	O
one	O
allele	B-UNK
each	O
.	O

 	O
the	O
q188r	O
was	O
prevalent	B-UNK
in	O
the	O
united	B-UNK
states	B-UNK
but	O
not	O
in	O
japanese	B-UNK
patients	I-UNK
.	O

 	O
the	O
n314d	B-UNK
mutation	B-UNK
was	O
associated	B-UNK
with	O
the	O
duarte	B-UNK
variant	B-UNK
in	O
japanese	B-UNK
persons	B-UNK
,	O
as	O
well	O
as	O
in	O
the	O
united	B-UNK
states	B-UNK
.	O

 	O
we	O
speculate	O
that	O
classic	B-UNK
galactosemia	B-UNK
mutations	B-UNK
appear	B-UNK
to	O
differ	B-UNK
between	O
japanese	B-UNK
and	O
caucasian	B-UNK
patients	B-UNK
.	O

 	O
our	O
limited	B-UNK
data	B-UNK
set	B-UNK
on	O
galactosemia	B-UNK
mutations	B-UNK
in	O
japanese	B-UNK
suggests	B-UNK
that	O
the	O
n314d	B-UNK
galt	B-UNK
mutation	B-UNK
encoding	B-UNK
the	O
duarte	B-UNK
variant	B-UNK
arose	B-UNK
before	O
asian	O
and	O
caucasian	B-UNK
people	B-UNK
diverged	O
and	O
that	O
classic	B-UNK
galactosemia	B-UNK
mutations	B-UNK
arose	B-UNK
and	O
/	O
or	O
accumulated	O
after	O
the	O
divergence	O
of	O
asian	O
and	O
caucasian	B-UNK
populations	B-UNK
.	O
.	O

 	O
three	O
novel	B-UNK
aniridia	B-DISEASE
mutations	B-UNK
in	O
the	O
human	B-UNK
pax6	B-UNK
gene	B-UNK
.	O

 	O
aniridia	B-DISEASE
(	O
iris	B-UNK
hypoplasia	B-UNK
)	O
is	O
an	O
autosomal	O
dominant	B-UNK
congenital	B-DISEASE
disorder	O
of	O
the	O
eye	B-UNK
.	O

 	O
mutations	B-UNK
in	O
the	O
human	B-UNK
aniridia	B-DISEASE
(	O
pax6	B-UNK
)	O
gene	B-UNK
have	O
now	O
been	O
identified	B-UNK
in	O
many	O
patients	B-UNK
from	O
various	O
ethnic	B-UNK
groups	B-UNK
.	O

 	O
in	O
the	O
study	B-UNK
reported	B-UNK
here	O
we	O
describe	B-UNK
pax6	B-UNK
mutations	B-UNK
in	O
one	O
sporadic	B-UNK
and	O
five	O
familial	B-UNK
cases	B-UNK
with	O
aniridia	B-DISEASE
.	O

 	O
of	O
the	O
four	O
different	B-UNK
mutations	B-UNK
identified	B-UNK
,	O
one	O
was	O
identical	B-UNK
to	O
a	O
previously	B-UNK
reported	I-UNK
mutation	B-UNK
(	O
c	B-UNK
-	O
-	O
>	O
t	B-UNK
transition	I-UNK
at	B-DISEASE
codon	B-UNK
240	O
)	O
,	O
and	O
three	O
were	O
novel	B-UNK
two	O
in	O
the	O
glycine	B-UNK
-	O
rich	B-UNK
region	B-UNK
and	O
one	O
in	O
the	O
proline	O
/	O
serine	B-UNK
/	O
threonine	B-UNK
-	O
rich	B-UNK
(	O
pst	B-UNK
)	O
region	B-UNK
.	O

 	O
one	O
pax6	B-UNK
mutation	B-UNK
found	B-UNK
in	O
the	O
pst	B-UNK
region	B-UNK
was	O
associated	B-UNK
with	O
cataracts	B-DISEASE
in	O
an	O
aniridia	B-DISEASE
family	B-UNK
.	O

 	O
another	O
splice	O
mutation	B-UNK
in	O
the	O
pst	B-UNK
domain	B-UNK
occurred	B-UNK
in	O
an	O
aniridia	B-DISEASE
patient	B-UNK
with	O
anosmia	B-DISEASE
(	O
inability	O
to	O
smell	O
)	O
.	O

 	O
the	O
six	O
new	B-UNK
aniridia	B-DISEASE
cases	B-UNK
reported	B-UNK
here	O
have	O
mutations	B-UNK
predicted	B-UNK
to	O
generate	B-UNK
incomplete	B-UNK
pax6	B-UNK
proteins	B-UNK
.	O

 	O
these	O
results	B-UNK
support	B-UNK
the	O
theory	O
that	O
human	B-UNK
aniridia	B-DISEASE
is	O
caused	B-UNK
by	O
haploinsufficiency	O
of	O
pax6	B-UNK
.	O
.	O

 	O
the	O
carrier	B-UNK
frequency	I-UNK
of	O
the	O
brca1	B-UNK
185delag	B-UNK
mutation	B-UNK
is	O
approximately	B-UNK
1	O
percent	O
in	O
ashkenazi	B-UNK
jewish	I-UNK
individuals	B-UNK
.	O

 	O
since	O
brca1	B-UNK
,	O
the	O
first	O
major	B-UNK
gene	B-UNK
responsible	B-UNK
for	O
inherited	B-UNK
breast	B-DISEASE
cancer	I-DISEASE
,	O
was	O
cloned	B-UNK
,	O
more	O
than	O
50	O
unique	B-UNK
mutations	B-UNK
have	O
been	O
detected	B-UNK
in	O
the	O
germline	B-UNK
of	O
individuals	B-UNK
with	O
breast	B-UNK
and	O
ovarian	B-DISEASE
cancer	I-DISEASE
.	O

 	O
in	O
high	B-UNK
-	O
risk	B-UNK
pedigrees	B-UNK
,	O
female	B-UNK
carriers	B-UNK
of	O
brca1	B-UNK
mutations	I-UNK
have	O
an	O
80	O
-	O
90	O
%	O
lifetime	O
risk	B-UNK
of	O
breast	B-DISEASE
cancer	I-DISEASE
,	O
and	O
a	O
40	O
-	O
50	O
%	O
risk	B-UNK
of	O
ovarian	B-DISEASE
cancer	I-DISEASE
.	O

 	O
however	O
,	O
the	O
mutation	B-UNK
stats	O
of	O
individuals	B-UNK
unselected	B-UNK
for	O
breast	B-UNK
or	O
ovarian	B-DISEASE
cancer	I-DISEASE
has	O
not	O
been	O
determined	B-UNK
,	O
and	O
it	O
is	O
not	O
known	B-UNK
whether	O
mutations	B-UNK
in	O
such	O
individuals	B-UNK
confer	B-UNK
the	O
same	O
risk	B-UNK
of	O
cancer	B-DISEASE
as	O
in	O
individuals	B-UNK
from	O
the	O
high	B-UNK
-	O
risk	B-UNK
families	B-UNK
studied	B-UNK
so	O
far	B-UNK
.	O

 	O
following	B-UNK
the	O
finding	B-UNK
of	O
a	O
185delag	B-UNK
frameshift	B-UNK
mutation	B-UNK
in	O
several	O
ashkenazi	B-UNK
jewish	I-UNK
breast	B-UNK
/	O
ovarian	B-UNK
families	B-UNK
,	O
we	O
have	O
determined	B-UNK
the	O
frequency	B-UNK
of	O
this	O
mutation	B-UNK
in	O
858	O
ashkenazim	O
seeking	O
genetic	B-UNK
testing	B-UNK
for	O
conditions	B-UNK
unrelated	B-UNK
to	O
cancer	B-DISEASE
,	O
and	O
in	O
815	O
reference	B-UNK
individuals	B-UNK
not	O
selected	B-UNK
for	O
ethnic	B-UNK
origin	B-UNK
.	O

 	O
we	O
observed	B-UNK
the	O
185delag	B-UNK
mutation	B-UNK
in	O
0	O
.	O

 	O
9	O
%	O
of	O
ashkenazim	O
(	O
95	O
%	O
confidence	B-UNK
limit	B-UNK
,	O
0	O
.	O
4	O
-	O
1	O
.	O
8	O
%	O
)	O
and	O
in	O
none	O
of	O
the	O
reference	B-UNK
samples	B-UNK
.	O

 	O
our	O
results	B-UNK
suggest	B-UNK
that	O
one	O
in	O
a	O
hundred	O
women	B-UNK
of	O
ashkenazi	B-UNK
descent	B-UNK
may	O
be	O
at	B-DISEASE
especially	B-UNK
high	B-UNK
risk	B-UNK
of	O
developing	B-UNK
breast	B-UNK
and	O
/	O
or	O
ovarian	B-DISEASE
cancer	I-DISEASE
.	O

 	O
identification	B-UNK
and	O
localization	B-UNK
of	O
huntingtin	B-UNK
in	O
brain	B-UNK
and	O
human	B-UNK
lymphoblastoid	B-UNK
cell	B-UNK
lines	B-UNK
with	O
anti	O
-	O
fusion	B-UNK
protein	B-UNK
antibodies	B-UNK
.	O

 	O
the	O
huntington	B-DISEASE
disease	I-DISEASE
(	O
hd	B-UNK
)	O
phenotype	B-UNK
is	O
associated	B-UNK
with	O
expansion	B-UNK
of	O
a	O
trinucleotide	B-UNK
repeat	I-UNK
in	O
the	O
it15	O
gene	B-UNK
,	O
which	O
is	O
predicted	B-UNK
to	O
encode	O
a	O
348	O
-	O
kda	B-UNK
protein	B-UNK
named	O
huntington	O
.	O

 	O
we	O
used	O
polyclonal	O
and	O
monoclonal	B-UNK
anti	O
-	O
fusion	B-UNK
protein	B-UNK
antibodies	B-UNK
to	O
identify	B-UNK
native	B-UNK
huntingtin	B-UNK
in	O
rat	B-UNK
,	O
monkey	O
,	O
and	O
human	B-UNK
.	O

 	O
western	B-UNK
blots	B-UNK
revealed	B-UNK
a	O
protein	B-UNK
with	O
the	O
expected	B-UNK
molecular	B-UNK
weight	I-UNK
which	O
is	O
present	B-UNK
in	O
the	O
soluble	B-UNK
fraction	B-UNK
of	O
rat	B-UNK
and	O
monkey	O
brain	B-UNK
tissues	B-UNK
and	O
lymphoblastoid	B-UNK
cells	B-UNK
from	O
control	B-UNK
cases	B-UNK
.	O

 	O
in	O
lymphoblastoid	B-UNK
cell	B-UNK
lines	B-UNK
from	O
juvenile	B-UNK
-	O
onset	B-UNK
heterozygote	B-UNK
hd	B-UNK
cases	B-UNK
,	O
both	O
normal	B-UNK
and	O
mutant	B-UNK
huntingtin	I-UNK
are	O
expressed	B-UNK
,	O
and	O
increasing	B-UNK
repeat	B-UNK
expansion	I-UNK
leads	B-UNK
to	O
lower	B-UNK
levels	B-UNK
of	O
the	O
mutant	B-UNK
protein	B-UNK
.	O

 	O
immunocytochemistry	O
indicates	B-UNK
that	O
huntingtin	B-UNK
is	O
located	B-UNK
in	O
neurons	B-UNK
throughout	O
the	O
brain	B-UNK
,	O
with	O
the	O
highest	B-UNK
levels	B-UNK
evident	O
in	O
larger	O
neurons	B-UNK
.	O

 	O
in	O
the	O
human	B-UNK
striatum	O
,	O
huntingtin	B-UNK
is	O
enriched	O
in	O
a	O
patch	O
-	O
like	B-UNK
distribution	B-UNK
,	O
potentially	B-UNK
corresponding	B-UNK
to	O
the	O
first	O
areas	B-UNK
affected	B-UNK
in	O
hd	B-UNK
.	O

 	O
subcellular	B-UNK
localization	B-UNK
of	O
huntingtin	B-UNK
is	O
consistent	B-UNK
with	O
a	O
cytosolic	O
protein	B-UNK
primarily	B-UNK
found	B-UNK
in	O
somatodendritic	O
regions	B-UNK
.	O

 	O
huntingtin	B-UNK
appears	B-UNK
to	O
particularly	B-UNK
associate	O
with	O
microtubules	O
,	O
although	O
some	O
is	O
also	O
associated	B-UNK
with	O
synaptic	B-UNK
vesicles	B-UNK
.	O

 	O
on	O
the	O
basis	B-UNK
of	O
the	O
localization	B-UNK
of	O
huntingtin	B-UNK
in	O
association	B-UNK
with	O
microtubules	O
,	O
we	O
speculate	O
that	O
the	O
mutation	B-UNK
impairs	O
the	O
cytoskeletal	B-UNK
anchoring	O
or	O
transport	B-UNK
of	O
mitochondria	O
,	O
vesicles	B-UNK
,	O
or	O
other	O
organelles	O
or	O
molecules	O
.	O
.	O

 	O
marked	B-UNK
phenotypic	B-UNK
heterogeneity	B-UNK
associated	B-UNK
with	O
expansion	B-UNK
of	O
a	O
cag	B-UNK
repeat	I-UNK
sequence	B-UNK
at	B-DISEASE
the	O
spinocerebellar	B-DISEASE
ataxia	I-DISEASE
3	O
/	O
machado	B-DISEASE
-	I-DISEASE
joseph	I-DISEASE
disease	I-DISEASE
locus	B-UNK
.	O

 	O
the	O
spinocerebellar	B-DISEASE
ataxia	I-DISEASE
3	O
locus	B-UNK
(	O
sca3	B-UNK
)	O
for	O
type	B-UNK
i	O
autosomal	O
dominant	B-UNK
cerebellar	B-DISEASE
ataxia	I-DISEASE
(	O
adca	B-UNK
type	B-UNK
i	O
)	O
,	O
a	O
clinically	B-UNK
and	O
genetically	B-UNK
heterogeneous	B-UNK
group	I-UNK
of	O
neurodegenerative	B-DISEASE
disorders	I-DISEASE
,	O
has	O
been	O
mapped	B-UNK
to	O
chromosome	B-UNK
14q32	B-UNK
.	O

 	O
1	O
1	O
.	O

 	O
adca	B-UNK
type	B-UNK
i	O
patients	B-UNK
from	O
families	B-UNK
segregating	B-UNK
sca3	B-UNK
share	B-UNK
clinical	B-UNK
features	I-UNK
in	O
common	B-UNK
with	O
those	O
with	O
machado	B-DISEASE
-	I-DISEASE
joseph	I-DISEASE
disease	I-DISEASE
(	O
mjd	B-UNK
)	O
,	O
the	O
gene	B-UNK
of	O
which	O
maps	B-UNK
to	O
the	O
same	O
region	B-UNK
.	O

 	O
we	O
show	O
here	O
that	O
the	O
disease	B-DISEASE
gene	B-UNK
segregating	B-UNK
in	O
each	O
of	O
three	O
french	B-UNK
adca	B-UNK
type	B-UNK
i	O
kindreds	B-UNK
and	O
in	O
a	O
french	B-UNK
family	B-UNK
with	O
neuropathological	O
findings	B-UNK
suggesting	B-UNK
the	O
ataxochoreic	O
form	B-UNK
of	O
dentatorubropallidoluysian	O
atrophy	B-DISEASE
carries	O
an	O
expanded	B-UNK
cag	I-UNK
repeat	B-UNK
sequence	B-UNK
located	B-UNK
at	B-DISEASE
the	O
same	O
locus	B-UNK
as	O
that	O
for	O
mjd	B-UNK
.	O

 	O
analysis	B-UNK
of	O
the	O
mutation	B-UNK
in	O
these	O
families	B-UNK
shows	B-UNK
a	O
strong	B-UNK
negative	B-UNK
correlation	B-UNK
between	O
size	B-UNK
of	O
the	O
expanded	B-UNK
cag	I-UNK
repeat	B-UNK
and	O
age	B-UNK
at	B-DISEASE
onset	B-UNK
of	O
clinical	B-UNK
disease	B-DISEASE
.	O

 	O
instability	B-UNK
of	O
the	O
expanded	B-UNK
triplet	B-UNK
repeat	I-UNK
was	O
not	O
found	B-UNK
to	O
be	O
affected	B-UNK
by	O
sex	B-UNK
of	O
the	O
parent	B-UNK
transmitting	B-UNK
the	O
mutation	B-UNK
.	O

 	O
evidence	B-UNK
was	O
found	B-UNK
for	O
somatic	B-UNK
and	O
gonadal	B-UNK
mosaicism	B-UNK
for	O
alleles	B-UNK
carrying	B-UNK
expanded	B-UNK
trinucleotide	B-UNK
repeats	B-UNK
.	O

 	O
overexpression	B-UNK
of	O
dm20	B-UNK
messenger	I-UNK
rna	B-UNK
in	O
two	O
brothers	B-UNK
with	O
pelizaeus	B-DISEASE
-	I-DISEASE
merzbacher	I-DISEASE
disease	I-DISEASE
.	O

 	O
pelizaeus	B-DISEASE
-	I-DISEASE
merzbacher	I-DISEASE
disease	I-DISEASE
is	O
a	O
rare	B-UNK
,	O
sex	B-UNK
-	O
linked	B-UNK
recessive	O
,	O
dysmyelinating	B-UNK
disease	B-DISEASE
of	O
the	O
central	B-UNK
nervous	I-UNK
system	I-UNK
that	O
has	O
been	O
associated	B-UNK
with	O
mutations	B-UNK
in	O
the	O
myelin	B-UNK
proteolipid	B-UNK
protein	B-UNK
(	O
plp	B-UNK
)	O
gene	B-UNK
.	O

 	O
only	O
25	O
%	O
of	O
patients	B-UNK
studied	B-UNK
with	O
pelizaeus	B-DISEASE
-	I-DISEASE
merzbacher	I-DISEASE
disease	I-DISEASE
have	O
exonic	B-UNK
mutations	B-UNK
in	O
this	O
gene	B-UNK
,	O
the	O
underlying	B-UNK
cause	B-UNK
of	O
the	O
disease	B-DISEASE
in	O
the	O
remaining	B-UNK
patients	B-UNK
is	O
unknown	B-UNK
.	O

 	O
the	O
plp	B-UNK
gene	B-UNK
encodes	B-UNK
two	O
major	B-UNK
alternatively	B-UNK
spliced	I-UNK
transcripts	B-UNK
called	B-UNK
plp	B-UNK
and	O
dm20	O
.	O

 	O
plp	B-UNK
messenger	B-UNK
rna	I-UNK
is	O
specifically	B-UNK
expressed	B-UNK
in	O
central	B-UNK
nervous	I-UNK
system	I-UNK
tissue	B-UNK
,	O
whereas	O
dm20	B-UNK
messenger	I-UNK
rna	B-UNK
is	O
found	B-UNK
in	O
central	B-UNK
nervous	I-UNK
system	I-UNK
,	O
cardiac	B-UNK
,	O
and	O
other	O
tissues	B-UNK
.	O

 	O
we	O
studied	B-UNK
cultured	B-UNK
skin	B-DISEASE
fibroblasts	B-UNK
from	O
2	O
brothers	B-UNK
with	O
pelizaeus	B-DISEASE
-	I-DISEASE
merzbacher	I-DISEASE
disease	I-DISEASE
who	O
exhibited	B-UNK
no	O
detectable	B-UNK
exonic	B-UNK
mutation	B-UNK
of	O
the	O
plp	B-UNK
gene	B-UNK
.	O

 	O
examination	B-UNK
of	O
rna	B-UNK
from	O
these	O
cells	B-UNK
showed	B-UNK
that	O
the	O
level	B-UNK
of	O
dm20	B-UNK
messenger	I-UNK
rna	B-UNK
is	O
elevated	B-UNK
sixfold	O
relative	B-UNK
to	O
male	B-UNK
control	B-UNK
skin	B-DISEASE
fibroblasts	B-UNK
.	O

 	O
an	O
unrelated	B-UNK
female	B-UNK
carrier	B-UNK
,	O
also	O
with	O
no	O
detectable	B-UNK
exonic	B-UNK
mutation	B-UNK
,	O
showed	B-UNK
a	O
threefold	O
increase	B-UNK
in	O
dm20	B-UNK
messenger	I-UNK
rna	B-UNK
in	O
cultured	B-UNK
skin	B-DISEASE
fibroblasts	B-UNK
.	O

 	O
our	O
findings	B-UNK
suggest	B-UNK
that	O
in	O
some	O
patients	B-UNK
,	O
pelizaeus	B-DISEASE
-	I-DISEASE
merzbacher	I-DISEASE
disease	I-DISEASE
is	O
caused	B-UNK
by	O
overexpression	B-UNK
of	O
plp	B-UNK
gene	B-UNK
transcripts	B-UNK
,	O
and	O
that	O
in	O
these	O
families	B-UNK
a	O
50	O
%	O
increase	B-UNK
of	O
dm20	B-UNK
messenger	I-UNK
rna	B-UNK
in	O
females	B-UNK
,	O
relative	B-UNK
to	O
the	O
increase	B-UNK
in	O
affected	B-UNK
males	B-UNK
,	O
can	O
identify	B-UNK
a	O
female	B-UNK
carrier	B-UNK
.	O
.	O

 	O
the	O
wiskott	B-DISEASE
-	I-DISEASE
aldrich	I-DISEASE
syndrome	I-DISEASE
and	O
x	B-UNK
-	O
linked	B-UNK
congenital	B-DISEASE
thrombocytopenia	B-DISEASE
are	O
caused	B-UNK
by	O
mutations	B-UNK
of	O
the	O
same	O
gene	B-UNK
.	O

 	O
the	O
wiskott	B-DISEASE
-	I-DISEASE
aldrich	I-DISEASE
syndrome	I-DISEASE
(	O
was	O
)	O
is	O
an	O
x	B-UNK
-	O
linked	B-UNK
recessive	O
disorder	O
characterized	B-UNK
by	O
thrombocytopenia	B-DISEASE
,	O
small	B-UNK
platelets	B-UNK
,	O
eczema	B-DISEASE
,	O
recurrent	B-UNK
infections	B-DISEASE
,	O
and	O
immunodeficiency	B-DISEASE
.	O

 	O
besides	O
the	O
classic	B-UNK
was	O
phenotype	B-UNK
,	O
there	O
is	O
a	O
group	B-UNK
of	O
patients	B-UNK
with	O
congenital	B-DISEASE
x	B-UNK
-	O
linked	B-UNK
thrombocytopenia	B-DISEASE
(	O
xlt	O
)	O
who	O
have	O
small	B-UNK
platelets	B-UNK
but	O
only	O
transient	O
eczema	B-DISEASE
,	O
if	O
any	O
,	O
and	O
minimal	B-UNK
immune	B-DISEASE
deficiency	I-DISEASE
.	O

 	O
because	O
the	O
gene	B-UNK
responsible	B-UNK
for	O
was	O
has	O
been	O
sequenced	B-UNK
,	O
it	O
was	O
possible	B-UNK
to	O
correlate	B-UNK
the	O
was	O
phenotypes	B-UNK
with	O
was	O
gene	B-UNK
mutations	B-UNK
.	O

 	O
using	O
a	O
fingerprinting	B-UNK
screening	B-UNK
technique	B-UNK
,	O
we	O
determined	B-UNK
the	O
approximate	O
location	B-UNK
of	O
the	O
mutation	B-UNK
in	O
13	O
unrelated	B-UNK
was	O
patients	B-UNK
with	O
mild	B-UNK
to	O
severe	B-UNK
clinical	I-UNK
symptoms	B-UNK
.	O

 	B-UNK
direct	I-UNK
sequence	B-UNK
analysis	B-UNK
of	O
cdna	B-UNK
and	O
genomic	B-UNK
dna	I-UNK
obtained	B-UNK
from	O
patient	B-UNK
-	O
derived	B-UNK
cell	B-UNK
lines	B-UNK
showed	B-UNK
12	O
unique	B-UNK
mutations	B-UNK
distributed	B-UNK
throughout	O
the	O
was	O
gene	B-UNK
,	O
including	B-UNK
insertions	B-UNK
,	O
deletions	B-UNK
,	O
and	O
point	B-UNK
mutations	I-UNK
resulting	B-UNK
in	O
amino	B-UNK
acid	I-UNK
substitutions	B-UNK
,	O
termination	B-UNK
,	O
exon	B-UNK
skipping	B-UNK
,	O
or	O
splicing	B-UNK
defects	B-UNK
.	O

 	O
of	O
4	O
unrelated	B-UNK
patients	B-UNK
with	O
the	O
xlt	O
phenotype	B-UNK
,	O
3	O
had	O
missense	B-UNK
mutations	I-UNK
affecting	B-UNK
exon	B-UNK
2	O
and	O
1	O
had	O
a	O
splice	O
-	O
site	B-UNK
mutation	B-UNK
affecting	B-UNK
exon	B-UNK
9	O
.	O

 	B-UNK
patients	I-UNK
with	O
classic	B-UNK
was	O
had	O
more	O
complex	B-UNK
mutations	B-UNK
,	O
resulting	B-UNK
in	O
termination	B-UNK
codons	B-UNK
,	O
frameshift	B-UNK
,	O
and	O
early	B-UNK
termination	B-UNK
.	O

 	O
these	O
findings	B-UNK
provide	I-UNK
direct	B-UNK
evidence	I-UNK
that	O
xlt	O
and	O
was	O
are	O
caused	B-UNK
by	O
mutations	B-UNK
of	O
the	O
same	O
gene	B-UNK
and	O
suggest	B-UNK
that	O
severe	B-UNK
clinical	I-UNK
phenotypes	B-UNK
are	O
associated	B-UNK
with	O
complex	B-UNK
mutations	B-UNK
.	O
.	O

 	O
myotonia	B-DISEASE
levior	O
is	O
a	O
chloride	B-UNK
channel	B-UNK
disorder	O
.	O

 	O
the	O
group	B-UNK
of	O
dominant	B-UNK
non	B-UNK
-	O
dystrophic	B-UNK
myotonias	O
,	O
comprising	B-UNK
disorders	B-UNK
characterized	B-UNK
by	O
clinically	B-UNK
similar	B-UNK
forms	B-UNK
of	O
myogenic	B-UNK
muscle	B-UNK
stiffness	O
,	O
is	O
genetically	B-UNK
inhomogeneous	O
.	O

 	O
dominant	B-UNK
myotonia	B-DISEASE
congenita	I-DISEASE
(	O
thomsens	O
disease	B-DISEASE
)	O
is	O
linked	B-UNK
to	O
clcn1	O
,	O
the	O
gene	B-UNK
encoding	B-UNK
the	O
major	B-UNK
muscle	B-UNK
chloride	B-UNK
channel	B-UNK
,	O
localized	B-UNK
on	O
chromosome	B-UNK
7q35	O
.	O

 	O
in	O
contrast	B-UNK
,	O
dominant	B-UNK
myotonias	O
sensitive	B-UNK
to	O
potassium	O
are	O
caused	B-UNK
by	O
point	B-UNK
mutations	I-UNK
in	O
scn4a	O
on	O
chromosome	B-UNK
17q	B-UNK
,	O
the	O
gene	B-UNK
for	O
the	O
alpha	B-UNK
subunit	B-UNK
of	O
the	O
adult	B-UNK
skeletal	B-UNK
muscle	I-UNK
sodium	B-UNK
channel	I-UNK
.	O

 	O
no	O
linkage	B-UNK
or	O
molecular	B-UNK
genetic	I-UNK
data	B-UNK
are	O
as	O
yet	O
available	B-UNK
on	O
myotonia	B-DISEASE
levior	O
characterized	B-UNK
by	O
milder	B-UNK
symptoms	B-UNK
and	O
later	B-UNK
onset	B-UNK
of	O
myotonia	B-DISEASE
than	O
in	O
thomsens	O
disease	B-DISEASE
,	O
and	O
absence	B-UNK
of	O
muscle	B-DISEASE
hypertrophy	I-DISEASE
.	O

 	O
we	O
report	B-UNK
a	O
clcn1	O
gln	B-UNK
-	O
552	O
-	O
arg	B-UNK
substitution	B-UNK
for	O
a	O
family	B-UNK
with	O
dominant	B-UNK
inheritance	B-UNK
previously	B-UNK
diagnosed	B-UNK
to	O
have	O
myotonia	B-DISEASE
levior	O
.	O

 	O
thus	O
,	O
this	O
disorder	O
appears	B-UNK
as	O
a	O
variant	B-UNK
of	O
thomsens	O
disease	B-DISEASE
due	O
to	O
mutations	B-UNK
leading	B-UNK
to	O
low	B-UNK
clinical	B-UNK
expressivity	B-UNK
.	O

 	O
in	O
addition	B-UNK
,	O
we	O
report	B-UNK
a	O
novel	B-UNK
ile	B-UNK
-	O
290	O
-	O
met	O
clcn1	O
mutation	B-UNK
for	O
a	O
typical	B-UNK
thomsen	O
pedigree	B-UNK
.	O

 	O
in	O
another	O
family	B-UNK
previously	I-UNK
diagnosed	B-UNK
as	O
having	B-UNK
thomsens	O
disease	B-DISEASE
,	O
we	O
unexpectedly	B-UNK
found	B-UNK
a	O
clcn1	O
14	O
bp	B-UNK
deletion	I-UNK
known	B-UNK
to	O
cause	B-UNK
recessive	O
myotonia	B-DISEASE
,	O
and	O
a	O
rare	B-UNK
trp	O
-	O
118	O
-	O
gly	B-UNK
polymorphism	O
.	O
.	O

 	O
southern	O
analysis	B-UNK
reveals	B-UNK
a	O
large	B-UNK
deletion	B-UNK
at	B-DISEASE
the	O
hypoxanthine	B-UNK
phosphoribosyltransferase	B-UNK
locus	B-UNK
in	O
a	O
patient	B-UNK
with	O
lesch	B-DISEASE
-	I-DISEASE
nyhan	I-DISEASE
syndrome	I-DISEASE
.	O

 	O
whole	O
genomic	B-UNK
hprt	B-UNK
clones	B-UNK
were	O
used	O
in	O
southern	O
analysis	B-UNK
to	O
screen	B-UNK
the	O
integrity	O
of	O
the	O
hprt	B-UNK
gene	B-UNK
in	O
a	O
family	B-UNK
that	O
includes	B-UNK
a	O
patient	B-UNK
with	O
hprt	B-UNK
enzyme	B-UNK
deficiency	B-UNK
causal	B-UNK
to	O
lesch	B-DISEASE
-	I-DISEASE
nyhan	I-DISEASE
syndrome	I-DISEASE
.	O

 	O
a	O
5	O
kb	B-UNK
dna	B-UNK
sequence	I-UNK
deletion	B-UNK
was	O
found	B-UNK
to	O
have	O
its	O
endpoints	B-UNK
in	O
the	O
first	O
and	O
third	O
introns	B-UNK
.	O

 	O
the	O
probes	B-UNK
identified	B-UNK
the	O
carrier	B-UNK
status	B-UNK
of	O
female	B-UNK
family	B-UNK
members	I-UNK
,	O
aided	O
by	O
an	O
rflp	B-UNK
carried	B-UNK
by	O
the	O
mothers	B-UNK
normal	B-UNK
x	B-UNK
-	O
chromosome	B-UNK
.	O
.	O

 	O
characterisation	O
of	O
molecular	B-UNK
defects	B-UNK
in	O
x	B-UNK
-	O
linked	B-UNK
amelogenesis	B-DISEASE
imperfecta	I-DISEASE
(	O
aih1	B-UNK
)	O
.	O

 	O
amelogenins	O
are	O
an	O
heterogenous	B-UNK
family	B-UNK
of	O
proteins	B-UNK
produced	B-UNK
by	O
ameloblasts	O
of	O
the	O
enamel	B-UNK
organ	O
during	O
tooth	B-DISEASE
development	B-UNK
.	O

 	O
disturbances	O
of	O
enamel	B-UNK
formation	B-UNK
occur	B-UNK
in	O
amelogenesis	B-DISEASE
imperfecta	I-DISEASE
,	O
a	O
clinically	B-UNK
heterogenous	B-UNK
group	B-UNK
of	O
inherited	B-UNK
disorders	B-UNK
characterised	B-UNK
by	O
defective	B-UNK
enamel	B-UNK
biomineralisation	O
.	O

 	O
an	O
amelogenin	O
gene	B-UNK
,	O
amgx	O
,	O
has	O
been	O
mapped	B-UNK
to	O
the	O
short	B-UNK
of	O
the	O
x	B-DISEASE
chromosome	I-DISEASE
(	O
xp22	O
.	O
1	O
-	O
p22	O
.	O
3	O
)	O
and	O
has	O
been	O
implicated	O
in	O
the	O
molecular	B-UNK
pathology	B-UNK
of	O
x	B-UNK
-	O
linked	B-UNK
amelogenesis	B-DISEASE
imperfecta	I-DISEASE
(	O
aih1	B-UNK
)	O
.	O

 	O
we	O
have	O
identified	B-UNK
three	O
families	B-UNK
exhibiting	B-UNK
aih1	B-UNK
and	O
screened	O
the	O
amgx	O
gene	B-UNK
for	O
mutations	B-UNK
using	O
single	B-UNK
-	O
strand	O
conformational	B-UNK
polymorphism	I-UNK
analysis	I-UNK
and	O
dna	B-UNK
sequencing	I-UNK
.	O

 	O
three	O
novel	B-UNK
mutations	B-UNK
were	O
identified	B-UNK
a	O
c	B-UNK
-	O
t	B-UNK
substitution	B-UNK
in	O
exon	B-UNK
5	O
,	O
and	O
a	O
g	B-UNK
-	O
t	B-UNK
substitution	B-UNK
and	O
single	B-UNK
cytosine	O
deletion	B-UNK
in	O
exon	B-UNK
6	O
,	O
confirming	O
the	O
existence	O
of	O
extensive	B-UNK
allelic	B-UNK
heterogeneity	I-UNK
in	O
this	O
condition	B-UNK
.	O

 	O
the	O
identification	B-UNK
of	O
family	B-UNK
-	O
specific	B-UNK
mutations	B-UNK
will	O
enable	O
early	B-UNK
identification	B-UNK
of	O
affected	B-UNK
individuals	I-UNK
and	O
correlation	B-UNK
of	O
clinical	B-UNK
phenotype	I-UNK
with	O
genotype	B-UNK
will	O
facilitate	B-UNK
an	O
objective	B-UNK
system	B-UNK
of	O
disease	B-DISEASE
classification	B-UNK
.	O

 	O
frequency	B-UNK
of	O
exon	B-UNK
15	O
missense	B-UNK
mutation	I-UNK
(	O
442d	B-UNK
:	O
g	B-UNK
)	O
in	O
cholesteryl	B-UNK
ester	I-UNK
transfer	I-UNK
protein	I-UNK
gene	B-UNK
in	O
hyperalphalipoproteinemic	B-UNK
japanese	B-UNK
subjects	B-UNK
.	O

 	O
cholesteryl	B-UNK
ester	I-UNK
transfer	I-UNK
protein	I-UNK
(	O
cetp	B-UNK
)	O
transfers	O
cholesteryl	O
ester	O
from	O
high	B-UNK
density	I-UNK
lipoprotein	B-UNK
(	O
hdl	B-UNK
)	O
to	O
apo	O
b	B-UNK
-	O
containing	B-UNK
lipoproteins	O
.	O

 	O
the	O
hyperalphalipoproteinemia	O
caused	B-UNK
by	O
cetp	B-UNK
deficiency	I-UNK
is	O
fairly	O
common	B-UNK
in	O
japan	O
and	O
one	O
of	O
the	O
most	O
common	B-UNK
mutations	B-UNK
in	O
the	O
cetp	B-UNK
gene	B-UNK
is	O
the	O
splicing	B-UNK
defect	B-UNK
of	O
the	O
intron	B-UNK
14	O
,	O
the	O
allelic	B-UNK
frequency	B-UNK
of	O
which	O
has	O
been	O
shown	B-UNK
to	O
be	O
0	O
.	O

 	O
0049	O
in	O
the	O
japanese	B-UNK
general	B-UNK
population	B-UNK
.	O

 	O
recently	B-UNK
,	O
we	O
have	O
reported	B-UNK
a	O
missense	B-UNK
mutation	I-UNK
in	O
exon	B-UNK
15	O
of	O
the	O
cetp	B-UNK
gene	B-UNK
(	O
442d	B-UNK
g	B-UNK
)	O
,	O
showing	B-UNK
a	O
dominant	B-UNK
effect	B-UNK
on	O
the	O
cetp	B-UNK
activity	I-UNK
and	O
hdl	B-UNK
-	O
cholesterol	B-UNK
level	B-UNK
.	O

 	O
in	O
the	O
current	B-UNK
study	B-UNK
,	O
we	O
determined	B-UNK
the	O
frequency	B-UNK
of	O
this	O
new	B-UNK
mutation	B-UNK
in	O
japanese	B-UNK
hyperalphalipoproteinemic	B-UNK
(	O
hdl	B-UNK
-	O
cholesterol	B-UNK
>	O
or	O
=	O
100	O
mg	O
/	O
dl	O
)	O
subjects	B-UNK
.	O

 	O
a	O
rapid	B-UNK
and	O
easy	O
screening	B-UNK
method	I-UNK
for	O
this	O
new	B-UNK
mutation	B-UNK
was	O
developed	B-UNK
using	O
a	O
polymerase	B-UNK
chain	I-UNK
reaction	I-UNK
(	O
pcr	B-UNK
)	O
-	O
mediated	B-UNK
site	B-UNK
-	O
directed	O
mutagenesis	B-UNK
.	O

 	O
among	O
117	O
japanese	B-UNK
hyperalphalipoproteinemic	B-UNK
subjects	B-UNK
(	O
hdl	B-UNK
-	O
cholesterol	B-UNK
;	O
116	O
.	O
7	O
+	O
/	O
-	O
16	O
.	O
5	O
mg	O
/	O
dl	O
,	O
mean	B-UNK
+	O
/	O
-	O
s	O
.	O
d	B-UNK
.	O
)	O
without	O
the	O
intron	B-UNK
14	O
splice	O
defect	B-UNK
,	O
three	O
homozygotes	B-UNK
(	O
2	O
.	O
5	O
%	O
)	O
and	O
34	O
heterozygotes	B-UNK
(	O
29	O
.	O
1	O
%	O
)	O
were	O
found	B-UNK
to	O
have	O
the	O
442d	B-UNK
g	B-UNK
mutation	B-UNK
.	O

 	O
the	O
relative	B-UNK
allelic	B-UNK
frequency	B-UNK
of	O
this	O
mutation	B-UNK
was	O
calculated	O
to	O
be	O
0	O
.	O

 	O
17	O
.	O

 	O
one	O
of	O
the	O
homozygotes	B-UNK
for	O
the	O
442d	B-UNK
g	B-UNK
mutation	B-UNK
was	O
the	O
patient	B-UNK
previously	B-UNK
described	I-UNK
by	O
us	O
as	O
having	B-UNK
hyperalphalipoproteinemia	O
with	O
corneal	B-DISEASE
opacity	I-DISEASE
and	O
coronary	B-DISEASE
heart	I-DISEASE
disease	I-DISEASE
.	O

 	O
this	O
was	O
the	O
first	O
reported	B-UNK
subject	B-UNK
homozygous	B-UNK
for	O
the	O
cetp	B-UNK
deficiency	I-UNK
who	O
also	O
demonstrated	B-UNK
atherosclerotic	B-DISEASE
symptoms	B-UNK
.	O

 	O
in	O
homozygous	B-UNK
subjects	B-UNK
,	O
cetp	B-UNK
activity	I-UNK
ranged	O
from	O
37	O
%	O
to	O
62	O
%	O
of	O
the	O
normal	B-UNK
value	B-UNK
,	O
which	O
was	O
consistent	B-UNK
with	O
the	O
results	B-UNK
obtained	B-UNK
from	O
the	O
transient	B-UNK
expression	I-UNK
experiment	O
previously	B-UNK
reported	I-UNK
;	O
however	O
,	O
the	O
specific	B-UNK
activity	B-UNK
of	O
cetp	B-UNK
was	O
not	O
as	O
low	B-UNK
as	O
expected	B-UNK
.	O

 	O
(	O
abstract	B-UNK
truncated	B-UNK
at	B-DISEASE
250	O
words	O
)	O

 	B-UNK
mucopolysaccharidosis	I-UNK
type	B-UNK
iva	B-UNK
:	O
common	B-UNK
double	B-UNK
deletion	B-UNK
in	O
the	O
n	B-UNK
-	O
acetylgalactosamine	O
-	O
6	O
-	O
sulfatase	B-UNK
gene	B-UNK
(	O
galns	B-UNK
)	O
.	O

 	B-UNK
mucopolysaccharidosis	I-UNK
iva	B-UNK
(	O
mps	B-UNK
iva	B-UNK
)	O
is	O
an	O
autosomal	O
recessive	O
disorder	O
caused	B-UNK
by	O
a	O
deficiency	B-UNK
in	O
n	B-UNK
-	O
acetylgalactosamine	O
-	O
6	O
-	O
sulfatase	B-UNK
(	O
galns	B-UNK
)	O
.	O

 	O
we	O
found	B-UNK
two	O
separate	B-UNK
deletions	B-UNK
of	O
nearly	O
8	O
.	O

 	O
0	O
and	O
6	O
.	O

 	O
0	O
kb	B-UNK
in	O
the	O
galns	B-UNK
gene	B-UNK
,	O
including	B-UNK
some	O
exons	B-UNK
.	O

 	O
there	O
are	O
alu	B-UNK
repetitive	O
elements	B-UNK
near	B-UNK
the	O
breakpoints	B-UNK
of	O
the	O
8	O
.	O

 	O
0	O
-	O
kb	B-UNK
deletion	B-UNK
,	O
and	O
this	O
deletion	B-UNK
resulted	B-UNK
from	O
an	O
alu	B-UNK
-	O
alu	B-UNK
recombination	B-UNK
.	O

 	O
the	O
other	O
6	O
.	O

 	O
0	O
-	O
kb	B-UNK
deletion	B-UNK
involved	B-UNK
illegitimate	B-UNK
recombinational	O
events	B-UNK
between	O
incomplete	B-UNK
short	B-UNK
direct	B-UNK
repeats	I-UNK
of	O
8	O
bp	B-UNK
at	B-DISEASE
deletion	B-UNK
breakpoints	B-UNK
.	O

 	O
the	O
same	O
rearrangement	B-UNK
has	O
been	O
observed	B-UNK
in	O
a	O
heteroallelic	O
state	B-UNK
in	O
four	O
unrelated	B-UNK
patients	B-UNK
.	O

 	O
this	O
is	O
the	O
first	O
documentation	O
of	O
a	O
common	B-UNK
double	B-UNK
deletion	B-UNK
a	O
gene	B-UNK
that	O
is	O
not	O
a	O
member	B-UNK
of	O
a	O
gene	B-UNK
cluster	O
.	O

 	O
detection	B-UNK
of	O
eight	O
brca1	B-UNK
mutations	I-UNK
in	O
10	O
breast	B-UNK
/	O
ovarian	B-DISEASE
cancer	I-DISEASE
families	B-UNK
,	O
including	B-UNK
1	O
family	B-UNK
with	O
male	B-DISEASE
breast	I-DISEASE
cancer	I-DISEASE
.	O

 	B-UNK
genetic	I-UNK
epidemiological	O
evidence	B-UNK
suggests	B-UNK
that	O
mutations	B-UNK
in	O
brca1	B-UNK
may	O
be	O
responsible	B-UNK
for	O
approximately	B-UNK
one	O
half	B-UNK
of	O
early	B-UNK
onset	I-UNK
familial	B-UNK
breast	B-DISEASE
cancer	I-DISEASE
and	O
the	O
majority	B-UNK
of	O
familial	B-UNK
breast	B-UNK
/	O
ovarian	B-DISEASE
cancer	I-DISEASE
.	O

 	O
the	O
recent	B-UNK
cloning	B-UNK
of	O
brca1	B-UNK
allows	B-UNK
for	O
the	O
direct	B-UNK
detection	B-UNK
of	O
mutations	B-UNK
,	O
but	O
the	O
feasibility	O
of	O
presymptomatic	B-UNK
screening	B-UNK
for	O
cancer	B-DISEASE
susceptibility	B-UNK
is	O
unknown	B-UNK
.	O

 	O
we	O
analyzed	B-UNK
genomic	B-UNK
dna	I-UNK
from	O
one	O
affected	B-UNK
individual	B-UNK
from	O
each	O
of	O
24	O
families	B-UNK
with	O
at	B-DISEASE
least	O
three	O
cases	B-UNK
of	O
ovarian	B-UNK
or	O
breast	B-DISEASE
cancer	I-DISEASE
,	O
using	O
sscp	B-UNK
assays	B-UNK
.	O

 	O
variant	B-UNK
sscp	B-UNK
bands	B-UNK
were	O
subcloned	O
and	O
sequenced	B-UNK
.	O

 	O
allele	B-UNK
-	O
specific	B-UNK
oligonucleotide	I-UNK
hybridization	B-UNK
was	O
used	O
to	O
verify	O
sequence	B-UNK
changes	B-UNK
and	O
to	O
screen	B-UNK
dna	B-UNK
from	O
control	B-UNK
individuals	I-UNK
.	O

 	O
six	O
frameshift	B-UNK
and	O
two	O
missense	B-UNK
mutations	I-UNK
were	O
detected	B-UNK
in	O
10	O
different	B-UNK
families	B-UNK
.	O

 	O
a	O
frameshift	B-UNK
mutation	B-UNK
was	O
detected	B-UNK
in	O
a	O
male	B-UNK
proband	B-UNK
affected	B-UNK
with	O
both	O
breast	B-UNK
and	O
prostate	B-DISEASE
cancer	I-DISEASE
.	O

 	O
a	O
40	O
-	O
bp	B-UNK
deletion	I-UNK
was	O
detected	B-UNK
in	O
a	O
patient	B-UNK
who	O
developed	B-UNK
intra	O
-	O
abdominal	O
carcinomatosis	O
1	O
year	B-UNK
after	O
prophylactic	O
oophorectomy	O
.	O

 	O
mutations	B-UNK
were	O
detected	B-UNK
throughout	O
the	O
gene	B-UNK
,	O
and	O
only	O
one	O
was	O
detected	B-UNK
in	O
more	O
than	O
a	O
single	B-UNK
family	B-UNK
.	O

 	O
these	O
results	B-UNK
provide	I-UNK
further	O
evidence	B-UNK
that	O
inherited	B-UNK
breast	B-UNK
and	O
ovarian	B-DISEASE
cancer	I-DISEASE
can	O
occur	B-UNK
as	O
a	O
consequence	O
of	O
a	O
wide	B-UNK
array	B-UNK
of	O
brca1	B-UNK
mutations	I-UNK
.	O

 	O
these	O
results	B-UNK
suggests	B-UNK
that	O
development	B-UNK
of	O
a	O
screening	B-UNK
test	B-UNK
for	O
brca1	B-UNK
mutations	I-UNK
will	O
be	O
technically	O
challenging	O
.	O

 	O
the	O
finding	B-UNK
of	O
a	O
mutation	B-UNK
in	O
a	O
family	B-UNK
with	O
male	B-DISEASE
breast	I-DISEASE
cancer	I-DISEASE
,	O
not	O
previously	B-UNK
thought	O
to	O
be	O
related	B-UNK
to	O
brca1	B-UNK
,	O
also	O
illustrates	B-UNK
the	O
potential	B-UNK
difficulties	O
of	O
genetic	B-UNK
counseling	B-UNK
for	O
individuals	B-UNK
known	B-UNK
to	O
carry	B-UNK
mutations	B-UNK
.	O
.	O

 	O
natural	B-UNK
selection	B-UNK
of	O
hemi	O
-	O
and	O
heterozygotes	B-UNK
for	O
g6pd	B-UNK
deficiency	I-UNK
in	O
africa	O
by	O
resistance	O
to	O
severe	B-UNK
malaria	B-DISEASE
.	O

 	O
glucose	B-UNK
-	O
6	O
-	O
phosphate	B-UNK
dehydrogenase	I-UNK
(	O
g6pd	B-UNK
)	O
deficiency	B-UNK
,	O
the	O
most	O
common	B-UNK
enzymopathy	B-UNK
of	O
humans	B-UNK
,	O
affects	B-UNK
over	O
400	O
million	B-UNK
people	B-UNK
.	O

 	O
the	O
geographical	O
correlation	B-UNK
of	O
its	O
distribution	B-UNK
with	O
the	O
historical	O
endemicity	O
of	O
malaria	B-DISEASE
suggests	B-UNK
that	O
this	O
disorder	O
has	O
risen	O
in	O
frequency	B-UNK
through	O
natural	B-UNK
selection	B-UNK
by	O
malaria	B-DISEASE
.	O

 	O
however	O
,	O
attempts	O
to	O
confirm	B-UNK
that	O
g6pd	B-UNK
deficiency	I-UNK
is	O
protective	O
in	O
case	B-UNK
-	O
control	B-UNK
studies	B-UNK
of	O
malaria	B-DISEASE
have	O
yielded	B-UNK
conflicting	B-UNK
results	I-UNK
.	O

 	O
hence	O
,	O
for	O
this	O
x	B-UNK
-	O
linked	B-UNK
disorder	O
,	O
it	O
is	O
unclear	O
whether	O
both	O
male	B-UNK
hemizygotes	B-UNK
and	O
female	B-UNK
heterozygotes	B-UNK
are	O
protected	O
or	O
,	O
as	O
frequently	B-UNK
suggested	B-UNK
,	O
only	O
females	B-UNK
.	O

 	O
furthermore	B-UNK
,	O
how	O
much	O
protection	O
may	O
be	O
afforded	O
is	O
unknown	B-UNK
.	O

 	O
here	O
we	O
report	B-UNK
that	O
,	O
in	O
two	O
large	B-UNK
case	B-UNK
-	O
control	B-UNK
studies	B-UNK
of	O
over	O
2	O
,	O
000	O
african	B-UNK
children	B-UNK
,	O
the	O
common	B-UNK
african	B-UNK
form	B-UNK
of	O
g6pd	B-UNK
deficiency	I-UNK
(	O
g6pd	B-UNK
a	O
-	O
)	O
is	O
associated	B-UNK
with	O
a	O
46	O
-	O
58	O
%	O
reduction	B-UNK
in	O
risk	B-UNK
of	O
severe	B-UNK
malaria	B-DISEASE
for	O
both	O
female	B-UNK
heterozygotes	B-UNK
and	O
male	B-UNK
hemizygotes	B-UNK
.	O

 	O
a	O
mathematical	O
model	B-UNK
incorporating	O
the	O
measured	B-UNK
selective	B-UNK
advantage	B-UNK
against	O
malaria	B-DISEASE
suggests	B-UNK
that	O
a	O
counterbalancing	O
selective	B-UNK
disadvantage	O
,	O
associated	B-UNK
with	O
this	O
enzyme	B-UNK
deficiency	B-UNK
,	O
has	O
retarded	O
its	O
rise	B-UNK
in	O
frequency	B-UNK
in	O
malaria	B-DISEASE
-	O
endemic	O
regions	B-UNK
.	O

 	O
although	O
g6pd	B-UNK
deficiency	I-UNK
is	O
now	O
regarded	O
as	O
a	O
generally	B-UNK
benign	B-UNK
disorder	O
,	O
in	O
earlier	B-UNK
environmental	B-UNK
conditions	B-UNK
it	O
could	O
have	O
been	O
significantly	B-UNK
disadvantageous	O
.	O
.	O

 	O
the	O
alveolar	O
rhabdomyosarcoma	B-DISEASE
pax3	B-UNK
/	O
fkhr	B-UNK
fusion	I-UNK
protein	B-UNK
is	O
a	O
transcriptional	B-UNK
activator	B-UNK
.	O

 	O
chimeric	B-UNK
transcription	B-UNK
factors	I-UNK
,	O
created	B-UNK
by	O
gene	B-UNK
fusions	O
as	O
the	O
result	B-UNK
of	O
chromosomal	B-UNK
translocations	B-UNK
,	O
have	O
been	O
implicated	O
in	O
the	O
pathogenesis	O
of	O
several	O
pathologically	O
disparate	O
solid	B-UNK
tumors	B-DISEASE
.	O

 	O
the	O
pax3	B-UNK
/	O
fkhr	B-UNK
fusion	I-UNK
gene	B-UNK
,	O
formed	B-UNK
by	O
a	O
t	B-UNK
(	O
2	O
;	O
13	O
)	O
(	O
q35	O
;	O
q14	O
)	O
in	O
alveolar	O
rhabdomyosarcoma	B-DISEASE
,	O
encodes	B-UNK
a	O
hybrid	O
protein	B-UNK
that	O
contains	B-UNK
both	O
pax3	B-UNK
dna	B-UNK
binding	I-UNK
domains	B-UNK
,	O
the	O
paired	B-UNK
box	B-UNK
and	O
homeodomain	O
,	O
linked	B-UNK
to	O
the	O
bisected	O
dna	B-UNK
binding	I-UNK
domain	B-UNK
of	O
fkhr	B-UNK
,	O
a	O
member	B-UNK
of	O
the	O
forkhead	B-UNK
family	B-UNK
of	O
transcription	B-UNK
factors	I-UNK
.	O

 	O
here	O
we	O
report	B-UNK
that	O
pax3	B-UNK
and	O
pax3	B-UNK
/	O
fkhr	B-UNK
display	B-UNK
similar	B-UNK
,	O
but	O
not	O
identical	B-UNK
transactivation	O
activities	B-UNK
when	O
tested	B-UNK
with	O
model	B-UNK
pax	B-UNK
recognition	B-UNK
sequences	B-UNK
.	O

 	O
no	O
functional	B-UNK
role	B-UNK
could	O
be	O
ascribed	O
solely	O
to	O
the	O
residual	B-UNK
fkhr	B-UNK
binding	B-UNK
domain	I-UNK
present	B-UNK
in	O
the	O
fusion	B-UNK
protein	B-UNK
,	O
but	O
fkhr	B-UNK
was	O
found	B-UNK
to	O
contribute	B-UNK
a	O
strong	B-UNK
carboxyl	B-UNK
terminal	B-UNK
activation	B-UNK
domain	B-UNK
replacing	O
the	O
one	O
located	B-UNK
in	O
the	O
unrearranged	O
pax3	B-UNK
gene	B-UNK
.	O

 	O
we	O
show	O
that	O
the	O
native	B-UNK
pax3	B-UNK
/	O
fkhr	B-UNK
protein	B-UNK
present	B-UNK
in	O
tumor	B-DISEASE
cells	B-UNK
with	O
this	O
translocation	B-DISEASE
has	O
transcriptional	B-UNK
characteristics	B-UNK
similar	B-UNK
to	O
the	O
in	O
vitro	B-UNK
expressed	B-UNK
protein	B-UNK
.	O

 	O
the	O
ability	B-UNK
of	O
the	O
pax3	B-UNK
/	O
fkhr	B-UNK
hybrid	O
protein	B-UNK
to	O
bind	B-UNK
dna	B-UNK
in	O
a	O
sequence	B-UNK
specific	B-UNK
manner	B-UNK
and	O
to	O
transactivate	O
the	O
expression	B-UNK
of	O
artificial	O
reporter	B-UNK
genes	B-UNK
suggests	B-UNK
that	O
its	O
aberrant	B-UNK
expression	B-UNK
could	O
subvert	O
the	O
transcriptional	B-UNK
programs	B-UNK
that	O
normally	B-UNK
control	B-UNK
the	O
growth	B-UNK
,	O
differentiation	B-UNK
,	O
and	O
survival	B-UNK
of	O
primitive	B-UNK
myogenic	B-UNK
precursors	O
in	O
vivo	B-UNK
.	O
.	O

 	O
a	O
p16ink4a	B-UNK
-	O
insensitive	O
cdk4	B-UNK
mutant	B-UNK
targeted	B-UNK
by	O
cytolytic	B-UNK
t	B-UNK
lymphocytes	I-UNK
in	O
a	O
human	B-UNK
melanoma	B-DISEASE
.	O

 	O
a	O
mutated	B-UNK
cyclin	O
-	O
dependent	B-UNK
kinase	B-UNK
4	O
(	O
cdk4	B-UNK
)	O
was	O
identified	B-UNK
as	O
a	O
tumor	B-DISEASE
-	O
specific	B-UNK
antigen	B-UNK
recognized	B-UNK
by	O
hla	B-UNK
-	O
a2	O
.	O

 	O
1	O
-	O
restricted	O
autologous	B-UNK
cytolytic	B-UNK
t	B-UNK
lymphocytes	I-UNK
(	O
ctls	O
)	O
in	O
a	O
human	B-UNK
melanoma	B-DISEASE
.	O

 	O
the	O
mutated	B-UNK
cdk4	B-UNK
allele	B-UNK
was	O
present	B-UNK
in	O
autologous	B-UNK
cultured	B-UNK
melanoma	B-DISEASE
cells	B-UNK
and	O
metastasis	O
tissue	B-UNK
,	O
but	O
not	O
in	O
the	O
patients	B-UNK
lymphocytes	B-UNK
.	O

 	O
the	O
mutation	B-UNK
,	O
an	O
arginine	B-UNK
-	O
to	O
-	O
cysteine	O
exchange	B-UNK
at	B-DISEASE
residue	B-UNK
24	O
,	O
was	O
part	O
of	O
the	O
cdk4	B-UNK
peptide	B-UNK
recognized	B-UNK
by	O
ctls	O
and	O
prevented	O
binding	B-UNK
of	O
the	O
cdk4	B-UNK
inhibitor	B-UNK
p16ink4a	B-UNK
,	O
but	O
not	O
of	O
p21	O
or	O
of	O
p27kip1	O
.	O

 	O
the	O
same	O
mutation	B-UNK
was	O
found	B-UNK
in	O
one	O
additional	B-UNK
melanoma	B-DISEASE
among	O
28	O
melanomas	O
analyzed	B-UNK
.	O

 	O
these	O
results	B-UNK
suggest	B-UNK
that	O
mutation	B-UNK
of	O
cdk4	B-UNK
can	O
create	O
a	O
tumor	B-DISEASE
-	O
specific	B-UNK
antigen	B-UNK
and	O
can	O
disrupt	O
the	O
cell	B-UNK
-	O
cycle	B-UNK
regulation	B-UNK
exerted	O
by	O
the	O
tumor	B-DISEASE
suppressor	B-UNK
p16ink4a	B-UNK
.	O
.	O

 	O
rapid	B-UNK
detection	B-UNK
of	O
brca1	B-UNK
mutations	I-UNK
by	O
the	O
protein	B-UNK
truncation	B-UNK
test	I-UNK
.	O

 	O
more	O
than	O
75	O
%	O
of	O
the	O
reported	B-UNK
mutations	B-UNK
in	O
the	O
hereditary	B-UNK
breast	B-UNK
and	O
ovarian	B-DISEASE
cancer	I-DISEASE
gene	B-UNK
,	O
brca1	B-UNK
,	O
result	B-UNK
in	O
truncated	B-UNK
proteins	B-UNK
.	O

 	O
we	O
have	O
used	O
the	O
protein	B-UNK
truncation	B-UNK
test	I-UNK
(	O
ptt	O
)	O
to	O
screen	B-UNK
for	O
mutations	B-UNK
in	O
exon	B-UNK
11	O
,	O
which	O
encodes	B-UNK
61	O
%	O
of	O
brca1	B-UNK
.	O

 	O
in	O
45	O
patients	B-UNK
from	O
breast	B-UNK
and	O
/	O
or	O
ovarian	B-DISEASE
cancer	I-DISEASE
families	B-UNK
we	O
found	B-UNK
six	O
novel	B-UNK
mutations	B-UNK
two	O
single	B-UNK
nucleotide	B-UNK
insertions	B-UNK
,	O
three	O
small	B-UNK
deletions	B-UNK
(	O
1	O
-	O
5	O
bp	B-UNK
)	O
and	O
a	O
nonsense	B-UNK
mutation	B-UNK
identified	B-UNK
two	O
unrelated	B-UNK
families	I-UNK
.	O

 	O
furthermore	B-UNK
,	O
we	O
were	O
able	O
to	O
amplify	O
the	O
remaining	B-UNK
coding	B-UNK
region	I-UNK
by	O
rt	O
-	O
pcr	B-UNK
using	O
lymphocyte	B-UNK
rna	B-UNK
.	O

 	B-UNK
combined	I-UNK
with	O
ptt	O
,	O
we	O
detected	B-UNK
aberrantly	B-UNK
spliced	O
products	B-UNK
affecting	B-UNK
exons	B-UNK
5	O
and	O
6	O
in	O
one	O
of	O
two	O
brca1	B-UNK
-	O
linked	B-UNK
families	B-UNK
examined	B-UNK
.	O

 	O
the	O
protein	B-UNK
truncation	B-UNK
test	I-UNK
promises	O
to	O
become	O
a	O
valuable	B-UNK
technique	B-UNK
in	O
detecting	B-UNK
brca1	B-UNK
mutations	I-UNK
.	O
.	O

 	O
cloning	B-UNK
of	O
human	B-UNK
very	O
-	O
long	B-UNK
-	O
chain	O
acyl	B-UNK
-	O
coenzyme	O
a	O
dehydrogenase	B-UNK
and	O
molecular	B-UNK
characterization	I-UNK
of	O
its	O
deficiency	B-UNK
in	O
two	O
patients	B-UNK
.	O

 	O
two	O
overlapping	B-UNK
cdna	B-UNK
clones	B-UNK
(	O
1	O
,	O
991	O
bp	B-UNK
and	O
736	O
bp	B-UNK
,	O
respectively	B-UNK
)	O
encoding	B-UNK
the	O
precursor	B-UNK
of	O
human	B-UNK
mitochondrial	B-UNK
very	O
-	O
long	B-UNK
-	O
chain	O
acyl	B-UNK
-	O
coenzyme	O
a	O
dehydrogenase	B-UNK
(	O
vlcad	B-UNK
)	O
were	O
cloned	B-UNK
and	O
sequenced	B-UNK
.	O

 	O
the	O
cdna	B-UNK
inserts	B-UNK
of	O
these	O
clones	B-UNK
together	O
encompass	O
a	O
region	B-UNK
of	O
2	O
,	O
177	O
bases	B-UNK
,	O
encoding	B-UNK
the	O
entire	B-UNK
protein	B-UNK
of	O
655	O
amino	O
acids	O
,	O
including	B-UNK
a	O
40	O
-	O
amino	B-UNK
acid	I-UNK
leader	B-UNK
peptide	B-UNK
and	O
a	O
615	O
-	O
amino	B-UNK
acid	I-UNK
mature	B-UNK
polypeptide	B-UNK
.	O

 	O
pcr	B-UNK
-	O
amplified	B-UNK
vlcad	B-UNK
cdnas	B-UNK
were	O
sequenced	B-UNK
in	O
cultured	B-UNK
fibroblasts	B-UNK
from	O
two	O
vlcad	B-UNK
-	O
deficient	B-UNK
patients	I-UNK
.	O

 	O
in	O
both	O
patients	B-UNK
,	O
a	O
105	O
-	O
bp	B-UNK
deletion	I-UNK
encompassing	O
bases	B-UNK
1078	O
-	O
1182	O
in	O
vlcad	B-UNK
cdna	B-UNK
was	O
identified	B-UNK
.	O

 	O
the	O
deletion	B-UNK
seems	O
to	O
occur	B-UNK
due	O
to	O
exon	B-UNK
skipping	B-UNK
during	O
processing	B-UNK
of	O
vlcad	B-UNK
pre	O
-	O
mrna	B-UNK
.	O

 	O
this	O
is	O
the	O
first	O
demonstration	O
of	O
a	O
mutation	B-UNK
causing	B-UNK
vlcad	B-DISEASE
deficiency	I-DISEASE
.	O

 	O
quantitative	B-UNK
cdna	B-UNK
expression	B-UNK
of	O
normal	B-UNK
human	I-UNK
vlcad	B-UNK
was	O
performed	B-UNK
in	O
the	O
patients	B-UNK
fibroblasts	B-UNK
,	O
using	O
vaccinia	B-DISEASE
viral	O
system	B-UNK
,	O
which	O
demonstrated	B-UNK
that	O
the	O
deficiency	B-UNK
of	O
the	O
normal	B-UNK
vlcad	B-UNK
protein	B-UNK
causes	B-UNK
impaired	B-UNK
long	B-UNK
-	O
chain	O
fatty	B-UNK
acid	I-UNK
beta	I-UNK
-	O
oxidation	B-UNK
activity	B-UNK
in	O
the	O
patients	B-UNK
fibroblasts	B-UNK
.	O

 	O
in	O
patient	B-UNK
fibroblasts	B-UNK
,	O
raising	O
vlcad	B-UNK
activity	B-UNK
to	O
approximately	B-UNK
20	O
%	O
of	O
normal	B-UNK
control	B-UNK
fibroblast	B-UNK
activity	B-UNK
raised	B-UNK
palmitic	O
acid	O
beta	B-UNK
-	O
oxidation	B-UNK
flux	O
to	O
the	O
level	B-UNK
found	B-UNK
in	O
control	B-UNK
fibroblasts	B-UNK
,	O
which	O
may	O
offer	O
important	B-UNK
information	B-UNK
for	O
the	O
rational	B-UNK
design	B-UNK
of	O
future	B-UNK
somatic	B-UNK
gene	B-UNK
therapy	B-UNK
for	O
vlcad	B-DISEASE
deficiency	I-DISEASE
.	O
.	O

 	O
brain	B-UNK
disease	B-DISEASE
and	O
molecular	B-UNK
analysis	B-UNK
in	O
myotonic	B-DISEASE
dystrophy	I-DISEASE
.	O

 	B-UNK
abnormal	I-UNK
amplification	B-UNK
of	O
a	O
ctg	B-UNK
repeat	I-UNK
on	O
chromosome	B-DISEASE
19	I-DISEASE
is	O
the	O
molecular	B-UNK
basis	I-UNK
of	O
myotonic	B-DISEASE
dystrophy	I-DISEASE
(	O
dm	B-DISEASE
)	O
.	O

 	O
expansion	B-UNK
of	O
the	O
repeat	B-UNK
has	O
been	O
correlated	B-UNK
with	O
severity	B-UNK
of	O
several	O
clinical	B-UNK
features	I-UNK
of	O
the	O
disease	B-DISEASE
.	O

 	O
we	O
performed	B-UNK
extensive	B-UNK
cognitive	B-UNK
testing	B-UNK
,	O
cerebral	O
magnetic	B-UNK
resonance	I-UNK
imaging	O
(	O
mri	B-UNK
)	O
and	O
a	O
molecular	B-UNK
analysis	B-UNK
in	O
28	O
cases	B-UNK
of	O
dm	B-DISEASE
to	O
determine	O
the	O
relationship	B-UNK
between	O
the	O
molecular	B-UNK
defect	B-UNK
and	O
brain	B-UNK
disease	B-DISEASE
.	O

 	O
performance	B-UNK
in	O
two	O
or	O
more	O
cognitive	B-UNK
tests	B-UNK
was	O
pathological	B-UNK
in	O
10	O
cases	B-UNK
.	O

 	O
fourteen	O
patients	B-UNK
had	O
subcortical	O
white	B-UNK
matter	I-UNK
lesions	B-UNK
on	O
mri	B-UNK
,	O
14	O
had	O
cerebral	O
atrophy	B-DISEASE
.	O

 	O
amplification	B-UNK
of	O
the	O
ctg	B-UNK
repeat	I-UNK
showed	B-UNK
a	O
strong	B-UNK
correlation	B-UNK
with	O
cognitive	B-UNK
test	B-UNK
deficits	B-UNK
when	O
exceeding	O
a	O
length	O
of	O
over	O
1000	O
trinucleotides	O
.	O

 	O
mri	B-UNK
lesions	B-UNK
were	O
associated	B-UNK
with	O
impaired	B-UNK
psychometric	O
performance	B-UNK
,	O
but	O
mri	B-UNK
and	O
molecular	B-UNK
findings	B-UNK
were	O
only	O
weakly	O
related	B-UNK
.	O

 	O
disease	B-DISEASE
duration	O
influenced	O
the	O
appearance	O
and	O
amount	O
of	O
white	B-UNK
matter	I-UNK
lesions	B-UNK
on	O
mri	B-UNK
.	O

 	O
quantification	O
of	O
ctg	B-UNK
repeat	I-UNK
size	B-UNK
may	O
allow	B-UNK
an	O
early	B-UNK
estimate	B-UNK
on	O
the	O
probability	O
of	O
brain	B-UNK
involvement	B-UNK
in	O
dm	B-DISEASE
;	O
cognitive	B-DISEASE
dysfunction	I-DISEASE
is	O
associated	B-UNK
with	O
white	B-UNK
matter	I-UNK
lesions	B-UNK
and	O
cerebral	O
atrophy	B-DISEASE
later	B-UNK
on	O
in	O
the	O
course	B-UNK
.	O
.	O

 	O
mutations	B-UNK
in	O
the	O
gene	B-UNK
for	O
x	B-UNK
-	O
linked	B-UNK
adrenoleukodystrophy	B-DISEASE
in	O
patients	B-UNK
with	O
different	B-UNK
clinical	I-UNK
phenotypes	B-UNK
.	O

 	O
recently	B-UNK
,	O
the	O
gene	B-UNK
for	O
the	O
most	O
common	B-UNK
peroxisomal	B-UNK
disorder	O
,	O
x	B-UNK
-	O
linked	B-UNK
adrenoleukodystrophy	B-DISEASE
(	O
x	B-UNK
-	O
ald	B-UNK
)	O
,	O
has	O
been	O
described	B-UNK
encoding	B-UNK
a	O
peroxisomal	B-UNK
membrane	I-UNK
transporter	B-UNK
protein	B-UNK
.	O

 	O
we	O
analyzed	B-UNK
the	O
entire	B-UNK
protein	B-UNK
-	O
coding	B-UNK
sequence	B-UNK
of	O
this	O
gene	B-UNK
by	O
reverse	B-UNK
-	O
transcription	B-UNK
pcr	B-UNK
,	O
sscp	B-UNK
,	O
and	O
dna	B-UNK
sequencing	I-UNK
in	O
five	O
patients	B-UNK
with	O
different	B-UNK
clinical	I-UNK
expression	B-UNK
of	O
x	B-UNK
-	O
ald	B-UNK
and	O
in	O
their	O
female	B-UNK
relatives	B-UNK
;	O
these	O
clinical	B-UNK
expressions	B-UNK
were	O
cerebral	O
childhood	B-UNK
ald	I-UNK
,	O
adrenomyeloneuropathy	B-UNK
(	O
amn	B-UNK
)	O
,	O
and	O
"	O
addison	B-DISEASE
disease	I-DISEASE
only	O
"	O
(	O
ado	O
)	O
phenotype	B-UNK
.	O

 	O
in	O
the	O
three	O
patients	B-UNK
exhibiting	B-UNK
the	O
classical	B-UNK
picture	B-UNK
of	O
severe	B-UNK
childhood	I-UNK
ald	B-UNK
we	O
identified	B-UNK
in	O
the	O
5	O
portion	B-UNK
of	O
the	O
x	B-UNK
-	O
ald	B-UNK
gene	B-UNK
a	O
38	O
-	O
bp	B-UNK
deletion	I-UNK
that	O
causes	B-UNK
a	O
frameshift	B-UNK
mutation	B-UNK
,	O
a	O
3	O
-	O
bp	B-UNK
deletion	I-UNK
leading	B-UNK
to	O
a	O
deletion	B-UNK
of	O
an	O
amino	B-UNK
acid	I-UNK
in	O
the	O
atp	B-UNK
-	O
binding	B-UNK
domain	I-UNK
of	O
the	O
ald	B-UNK
protein	B-UNK
,	O
and	O
a	O
missense	B-UNK
mutation	I-UNK
.	O

 	O
in	O
the	O
patient	B-UNK
with	O
the	O
clinical	B-UNK
phenotype	I-UNK
of	O
amn	B-UNK
,	O
a	O
nonsense	B-UNK
mutation	B-UNK
in	O
codon	B-UNK
212	O
,	O
along	O
with	O
a	O
second	B-UNK
site	B-UNK
mutation	B-UNK
at	B-DISEASE
codon	B-UNK
178	O
,	O
was	O
observed	B-UNK
.	O

 	O
analysis	B-UNK
of	O
the	O
patient	B-UNK
with	O
the	O
ado	O
phenotype	B-UNK
revealed	B-UNK
a	O
further	O
missense	B-UNK
mutation	I-UNK
at	B-DISEASE
a	O
highly	B-UNK
conserved	I-UNK
position	B-UNK
in	O
the	O
aldp	O
/	O
pmp70	B-UNK
comparison	B-UNK
.	O

 	O
the	O
disruptive	B-DISEASE
nature	B-UNK
of	O
two	O
mutations	B-UNK
(	O
i	O
.	O
e	B-UNK
.	O
,	O
the	O
frameshift	B-UNK
and	O
the	O
nonsense	B-UNK
mutation	B-UNK
)	O
in	O
patients	B-UNK
with	O
biochemically	B-UNK
proved	O
childhood	B-UNK
ald	I-UNK
and	O
amn	B-UNK
further	O
strongly	B-UNK
supports	B-UNK
the	O
hypothesis	O
that	O
alterations	B-UNK
in	O
this	O
gene	B-UNK
play	O
a	O
crucial	B-UNK
role	B-UNK
in	O
the	O
pathogenesis	O
of	O
x	B-UNK
-	O
ald	B-UNK
.	O

 	O
since	O
the	O
current	B-UNK
biochemical	B-UNK
techniques	B-UNK
for	O
x	B-UNK
-	O
ald	B-UNK
carrier	B-UNK
detection	I-UNK
in	O
affected	B-UNK
families	B-UNK
lack	B-UNK
sufficient	B-UNK
reliability	O
,	O
our	O
procedure	B-UNK
described	B-UNK
for	O
systematic	O
mutation	B-UNK
scanning	B-UNK
is	O
also	O
capable	O
of	O
improving	O
genetic	B-UNK
counseling	B-UNK
and	O
prenatal	B-UNK
diagnosis	I-UNK

 	O
duchenne	B-UNK
muscular	B-DISEASE
dystrophy	I-DISEASE
and	O
myotonic	B-DISEASE
dystrophy	I-DISEASE
in	O
the	O
same	O
patient	B-UNK
.	O

 	O
we	O
report	B-UNK
on	O
the	O
first	O
patient	B-UNK
identified	B-UNK
with	O
myotonic	B-DISEASE
dystrophy	I-DISEASE
and	O
duchenne	B-UNK
muscular	B-DISEASE
dystrophy	I-DISEASE
(	O
dmd	B-UNK
)	O
.	O

 	O
the	O
family	B-UNK
of	O
the	O
propositus	O
had	O
a	O
strong	B-UNK
history	B-UNK
of	O
myotonic	B-DISEASE
dystrophy	I-DISEASE
,	O
and	O
there	O
was	O
an	O
intrafamilial	B-UNK
pathological	B-UNK
expansion	B-UNK
of	O
the	O
responsible	B-UNK
ctg	B-UNK
repeat	I-UNK
between	O
the	O
mildly	B-UNK
affected	I-UNK
mother	B-UNK
(	O
160	O
repeats	B-UNK
;	O
normal	B-UNK
27	O
repeats	B-UNK
)	O
and	O
her	O
more	O
severely	B-UNK
affected	I-UNK
son	O
(	O
650	O
repeats	B-UNK
)	O
,	O
and	O
his	O
sister	O
(	O
650	O
repeats	B-UNK
)	O
.	O

 	O
the	O
propositus	O
was	O
an	O
isolated	B-UNK
case	B-UNK
of	O
duchenne	B-UNK
muscular	B-DISEASE
dystrophy	I-DISEASE
with	O
marked	B-UNK
dystrophin	B-UNK
deficiency	B-UNK
in	O
muscle	B-UNK
biopsy	B-UNK
.	O

 	O
the	O
patient	B-UNK
was	O
still	O
ambulatory	O
post	O
age	B-UNK
16	O
.	O

 	O
myotonic	B-DISEASE
dystrophy	I-DISEASE
could	O
interfere	O
to	O
some	O
extent	B-UNK
with	O
the	O
progression	O
of	O
duchenne	B-UNK
dystrophy	B-UNK
.	O

 	O
however	O
,	O
other	O
interpretations	O
are	O
possible	B-UNK
.	O

 	O
twelve	O
percent	O
of	O
dystrophin	B-UNK
revertant	O
fibers	B-UNK
as	O
observed	B-UNK
by	O
immunohistochemistry	O
could	O
be	O
sufficient	B-UNK
to	O
ameliorate	O
typical	B-UNK
dmd	B-UNK
clinical	B-UNK
severity	B-UNK
,	O
or	O
the	O
patient	B-UNK
may	O
present	B-UNK
a	O
somatic	B-UNK
mosaic	B-UNK
.	O

 	O
the	O
pathophysiological	O
interactions	B-UNK
of	O
these	O
two	O
unlinked	B-UNK
disorders	B-UNK
are	O
discussed	O
at	B-DISEASE
the	O
clinical	B-UNK
and	O
histopathological	O
levels	B-UNK
.	O
.	O

 	O
age	B-UNK
at	B-DISEASE
diagnosis	B-UNK
as	O
an	O
indicator	O
of	O
eligibility	O
for	O
brca1	B-UNK
dna	B-UNK
testing	B-UNK
in	O
familial	B-UNK
breast	B-DISEASE
cancer	I-DISEASE
.	O

 	O
we	O
searched	O
for	O
criteria	B-UNK
that	O
could	O
indicate	B-UNK
breast	B-DISEASE
cancer	I-DISEASE
families	B-UNK
with	O
a	O
high	B-UNK
prior	B-UNK
probability	O
of	O
being	O
caused	B-UNK
by	O
the	O
breast	B-UNK
/	O
ovarian	B-DISEASE
cancer	I-DISEASE
susceptibility	B-UNK
locus	B-UNK
brca1	B-UNK
on	O
chromosome	B-DISEASE
17	I-DISEASE
.	O

 	O
to	O
this	O
end	B-UNK
,	O
we	O
performed	B-UNK
a	O
linkage	B-UNK
study	I-UNK
with	O
59	O
consecutively	O
collected	B-UNK
dutch	B-UNK
breast	B-DISEASE
cancer	I-DISEASE
families	B-UNK
,	O
including	B-UNK
16	O
with	O
at	B-DISEASE
least	O
one	O
case	B-UNK
of	O
ovarian	B-DISEASE
cancer	I-DISEASE
.	O

 	O
we	O
used	O
an	O
intake	O
cut	O
-	O
off	O
of	O
at	B-DISEASE
least	O
three	O
first	O
-	O
degree	B-UNK
relatives	B-UNK
with	O
breast	B-UNK
and	O
/	O
or	O
ovarian	B-DISEASE
cancer	I-DISEASE
at	B-DISEASE
any	O
age	B-UNK
.	O

 	B-UNK
significant	I-UNK
evidence	B-UNK
for	O
linkage	B-UNK
was	O
found	B-UNK
only	O
among	O
the	O
13	O
breast	B-DISEASE
cancer	I-DISEASE
families	B-UNK
with	O
a	O
mean	B-UNK
age	B-UNK
at	B-DISEASE
diagnosis	B-UNK
of	O
less	O
than	O
45	O
years	B-UNK
.	O

 	O
an	O
unexpectedly	B-UNK
low	B-UNK
proportion	B-UNK
of	O
the	O
breast	B-DISEASE
-	I-DISEASE
ovarian	I-DISEASE
cancer	I-DISEASE
families	B-UNK
were	O
estimated	B-UNK
to	O
be	O
linked	B-UNK
to	O
brca1	B-UNK
,	O
which	O
could	O
be	O
due	O
to	O
a	O
founder	B-UNK
effect	B-UNK
in	O
the	O
dutch	B-UNK
population	B-UNK
.	O

 	O
given	B-UNK
the	O
expected	B-UNK
logistical	O
problems	B-UNK
in	O
clinical	B-UNK
management	O
now	O
that	O
brca1	B-UNK
has	O
been	O
identified	B-UNK
,	O
we	O
propose	O
an	O
interim	O
period	B-UNK
in	O
which	O
only	O
families	B-UNK
with	O
a	O
strong	B-UNK
positive	B-UNK
family	B-UNK
history	B-UNK
for	O
early	B-UNK
onset	I-UNK
breast	B-UNK
and	O
/	O
or	O
ovarian	B-DISEASE
cancer	I-DISEASE
will	O
be	O
offered	O
brca1	B-UNK
mutation	B-UNK
testing	B-UNK
.	O
.	O

 	B-UNK
linkage	I-UNK
analysis	B-UNK
of	O
26	O
canadian	B-UNK
breast	B-UNK
and	O
breast	B-DISEASE
-	I-DISEASE
ovarian	I-DISEASE
cancer	I-DISEASE
families	B-UNK
.	O

 	O
we	O
have	O
examined	B-UNK
26	O
canadian	B-UNK
families	B-UNK
with	O
hereditary	B-UNK
breast	B-UNK
or	O
ovarian	B-DISEASE
cancer	I-DISEASE
for	O
linkage	B-UNK
to	O
markers	B-UNK
flanking	B-UNK
the	O
brca1	B-UNK
gene	B-UNK
on	O
chromosome	B-UNK
17q12	B-UNK
-	O
q21	O
.	O

 	O
of	O
the	O
15	O
families	B-UNK
that	O
contain	B-UNK
cases	B-UNK
of	O
ovarian	B-DISEASE
cancer	I-DISEASE
,	O
94	O
%	O
were	O
estimated	B-UNK
to	O
be	O
linked	B-UNK
to	O
brca1	B-UNK
.	O

 	O
in	O
contrast	B-UNK
,	O
there	O
was	O
no	O
overall	B-UNK
evidence	B-UNK
of	O
linkage	B-UNK
in	O
the	O
group	B-UNK
of	O
10	O
families	B-UNK
with	O
breast	B-DISEASE
cancer	I-DISEASE
without	O
ovarian	B-DISEASE
cancer	I-DISEASE
.	O

 	O
a	O
genetic	B-UNK
recombinant	B-UNK
in	O
a	O
breast	B-DISEASE
-	I-DISEASE
ovarian	I-DISEASE
cancer	I-DISEASE
family	B-UNK
indicates	B-UNK
a	O
placement	O
of	O
brca1	B-UNK
telomeric	B-UNK
to	O
d17s776	O
,	O
and	O
helps	O
to	O
define	B-UNK
the	O
region	B-UNK
of	O
assignment	B-UNK
of	O
the	O
cancer	B-DISEASE
susceptibility	B-UNK
gene	B-UNK
.	O

 	O
other	O
cancers	B-DISEASE
of	O
interest	O
that	O
appeared	B-UNK
in	O
the	O
brca1	B-UNK
-	O
linked	B-UNK
families	B-UNK
included	B-UNK
primary	B-UNK
peritoneal	B-UNK
cancer	B-DISEASE
,	O
cancer	B-DISEASE
of	O
the	O
fallopian	O
tube	O
,	O
and	O
malignant	B-UNK
melanoma	B-DISEASE
.	O
.	O

 	O
structural	B-UNK
analysis	B-UNK
of	O
the	O
5	O
'	O
region	B-UNK
of	O
mouse	B-UNK
and	O
human	B-UNK
huntington	B-DISEASE
disease	I-DISEASE
genes	B-UNK
reveals	B-UNK
conservation	B-UNK
of	O
putative	B-UNK
promoter	B-UNK
region	I-UNK
and	O
di	O
-	O
and	O
trinucleotide	B-UNK
polymorphisms	B-UNK
.	O

 	O
we	O
have	O
previously	B-UNK
cloned	B-UNK
and	O
characterized	B-UNK
the	O
murine	B-UNK
homologue	B-UNK
of	O
the	O
huntington	B-DISEASE
disease	I-DISEASE
(	O
hd	B-UNK
)	O
gene	B-UNK
and	O
shown	B-UNK
that	O
it	O
maps	B-UNK
to	O
mouse	B-UNK
chromosome	I-UNK
5	O
within	O
a	O
region	B-UNK
of	O
conserved	B-UNK
synteny	B-UNK
with	O
human	B-UNK
chromosome	I-UNK
4p16	B-UNK
.	O

 	O
3	O
3	O
.	O

 	O
here	O
we	O
present	B-UNK
a	O
detailed	B-UNK
comparison	B-UNK
of	O
the	O
sequence	B-UNK
of	O
the	O
putative	B-UNK
promoter	B-UNK
and	O
the	O
organization	B-UNK
of	O
the	O
5	O
genomic	B-UNK
region	B-UNK
of	O
the	O
murine	B-UNK
(	O
hdh	O
)	O
and	O
human	B-UNK
hd	B-UNK
genes	B-UNK
encompassing	O
the	O
first	O
five	O
exons	B-UNK
.	O

 	O
we	O
show	O
that	O
in	O
this	O
region	B-UNK
these	O
two	O
genes	B-UNK
share	B-UNK
identical	B-UNK
exon	B-UNK
boundaries	B-UNK
,	O
but	O
have	O
different	B-UNK
-	O
size	B-UNK
introns	B-UNK
.	O

 	O
two	O
dinucleotide	B-UNK
(	O
ct	B-UNK
)	O
and	O
one	O
trinucleotide	B-UNK
intronic	B-UNK
polymorphism	O
in	O
hdh	O
and	O
an	O
intronic	B-UNK
ca	O
polymorphism	O
in	O
the	O
hd	B-UNK
gene	B-UNK
were	O
identified	B-UNK
.	O

 	O
comparison	B-UNK
of	O
940	O
-	O
bp	B-UNK
sequence	B-UNK
5	O
to	O
the	O
putative	B-UNK
translation	B-UNK
start	O
site	B-UNK
reveals	B-UNK
a	O
highly	B-UNK
conserved	I-UNK
region	B-UNK
(	O
78	O
.	O
8	O
%	O
nucleotide	B-UNK
identity	O
)	O
between	O
hdh	O
and	O
the	O
hd	B-UNK
gene	B-UNK
from	O
nucleotide	B-UNK
-	O
56	O
to	O
-	O
206	O
(	O
of	O
hdh	O
)	O
.	O

 	O
neither	O
hdh	O
nor	O
the	O
hd	B-UNK
gene	B-UNK
have	O
typical	B-UNK
tata	O
or	O
ccaat	O
elements	B-UNK
,	O
but	O
both	O
show	O
one	O
putative	B-UNK
ap2	O
binding	B-UNK
site	B-UNK
and	O
numerous	B-UNK
potential	B-UNK
sp1	O
binding	B-UNK
sites	B-UNK
.	O

 	O
the	O
high	B-UNK
sequence	B-UNK
identity	O
between	O
hdh	O
and	O
the	O
hd	B-UNK
gene	B-UNK
for	O
approximately	B-UNK
200	O
bp	B-UNK
5	O
to	O
the	O
putative	B-UNK
translation	B-UNK
start	O
site	B-UNK
indicates	B-UNK
that	O
these	O
sequences	B-UNK
may	O
play	O
a	O
role	B-UNK
in	O
regulating	O
expression	B-UNK
of	O
the	O
huntington	B-DISEASE
disease	I-DISEASE
gene	B-UNK

 	O
the	O
protein	B-UNK
deficient	B-UNK
in	O
lowe	O
syndrome	B-DISEASE
is	O
a	O
phosphatidylinositol	B-UNK
-	O
4	O
,	O
5	O
-	O
bisphosphate	O
5	O
-	O
phosphatase	B-UNK
.	O

 	O
lowe	O
syndrome	B-DISEASE
,	O
also	O
known	B-UNK
as	O
oculocerebrorenal	B-DISEASE
syndrome	I-DISEASE
,	O
is	O
caused	B-UNK
by	O
mutations	B-UNK
in	O
the	O
x	B-DISEASE
chromosome	I-DISEASE
-	O
encoded	B-UNK
ocrl	B-UNK
gene	B-UNK
.	O

 	O
the	O
ocrl	B-UNK
protein	B-UNK
is	O
51	O
%	O
identical	B-UNK
to	O
inositol	B-UNK
polyphosphate	O
5	O
-	O
phosphatase	B-UNK
ii	B-UNK
(	O
5	O
-	O
phosphatase	B-UNK
ii	B-UNK
)	O
from	O
human	B-UNK
platelets	B-UNK
over	O
a	O
span	B-UNK
of	O
744	O
aa	B-UNK
,	O
suggesting	B-UNK
that	O
ocrl	B-UNK
may	O
be	O
a	O
similar	B-UNK
enzyme	B-UNK
.	O

 	O
we	O
engineered	O
a	O
construct	B-UNK
of	O
the	O
ocrl	B-UNK
cdna	B-UNK
that	O
encodes	B-UNK
amino	O
acids	O
homologous	B-UNK
to	O
the	O
platelet	B-UNK
5	O
-	O
phosphatase	B-UNK
for	O
expression	B-UNK
in	O
baculovirus	O
-	O
infected	B-UNK
sf9	B-UNK
insect	O
cells	B-UNK
.	O

 	O
this	O
cdna	B-UNK
encodes	B-UNK
aa	B-UNK
264	O
-	O
968	O
of	O
the	O
ocrl	B-UNK
protein	B-UNK
.	O

 	O
the	O
recombinant	B-UNK
protein	B-UNK
was	O
found	B-UNK
to	O
catalyze	O
the	O
reactions	B-UNK
also	O
carried	B-UNK
out	O
by	O
platelet	B-UNK
5	O
-	O
phosphatase	B-UNK
ii	B-UNK
.	O

 	O
thus	O
ocrl	B-UNK
converts	B-UNK
inositol	B-UNK
1	O
,	O
4	O
,	O
5	O
-	O
trisphosphate	O
to	O
inositol	B-UNK
1	O
,	O
4	O
-	O
bisphosphate	O
,	O
and	O
it	O
converts	B-UNK
inositol	B-UNK
1	O
,	O
3	O
,	O
4	O
,	O
5	O
-	O
tetrakisphosphate	O
to	O
inositol	B-UNK
1	O
,	O
3	O
,	O
4	O
-	O
trisphosphate	O
.	O

 	O
most	O
important	B-UNK
,	O
the	O
enzyme	B-UNK
converts	B-UNK
phosphatidylinositol	B-UNK
4	O
,	O
5	O
-	O
bisphosphate	O
to	O
phosphatidylinositol	B-UNK
4	O
-	O
phosphate	B-UNK
.	O

 	O
the	O
relative	B-UNK
ability	B-UNK
of	O
ocrl	B-UNK
to	O
catalyze	O
the	O
three	O
reactions	B-UNK
is	O
different	B-UNK
from	O
that	O
of	O
5	O
-	O
phosphatase	B-UNK
ii	B-UNK
and	O
from	O
that	O
of	O
another	O
5	O
-	O
phosphatase	B-UNK
isoenzyme	B-UNK
from	O
platelets	B-UNK
,	O
5	O
-	O
phosphatase	B-UNK
i	O
.	O

 	O
the	O
recombinant	B-UNK
ocrl	B-UNK
protein	B-UNK
hydrolyzes	O
the	O
phospholipid	O
substrate	B-UNK
10	O
-	O
to	O
30	O
-	O
fold	B-UNK
better	B-UNK
than	O
5	O
-	O
phosphatase	B-UNK
ii	B-UNK
,	O
and	O
5	O
-	O
phosphatase	B-UNK
i	O
does	O
not	O
cleave	O
the	O
lipid	B-UNK
at	B-DISEASE
all	O
.	O

 	O
we	O
also	O
show	O
that	O
ocrl	B-UNK
functions	B-UNK
as	O
a	O
phosphatidylinositol	B-UNK
4	O
,	O
5	O
-	O
bisphosphate	O
5	O
-	O
phosphatase	B-UNK
in	O
ocrl	B-UNK
-	O
expressing	B-UNK
sf9	B-UNK
cells	B-UNK
.	O

 	O
these	O
results	B-UNK
suggest	B-UNK
that	O
ocrl	B-UNK
is	O
mainly	B-UNK
a	O
lipid	B-UNK
phosphatase	B-UNK
that	O
may	O
control	B-UNK
cellular	B-UNK
levels	B-UNK
of	O
a	O
critical	B-UNK
metabolite	O
,	O
phosphatidylinositol	B-UNK
4	O
,	O
5	O
-	O
bisphosphate	O
.	O

 	O
deficiency	B-UNK
of	O
this	O
enzyme	B-UNK
apparently	B-UNK
causes	B-UNK
the	O
protean	O
manifestations	B-UNK
of	O
lowe	O
syndrome	B-DISEASE
.	O
.	O

 	B-UNK
new	I-UNK
founder	B-UNK
haplotypes	B-UNK
at	B-DISEASE
the	O
myotonic	B-DISEASE
dystrophy	I-DISEASE
locus	B-UNK
in	O
southern	O
africa	O
.	O

 	O
the	O
association	B-UNK
between	O
normal	B-UNK
alleles	B-UNK
at	B-DISEASE
the	O
ctg	B-UNK
repeat	I-UNK
and	O
two	O
nearby	B-UNK
polymorphisms	B-UNK
in	O
the	O
myotonin	O
protein	B-UNK
kinase	B-UNK
gene	B-UNK
,	O
the	O
alu	B-UNK
insertion	B-UNK
/	O
deletion	B-UNK
polymorphism	O
and	O
the	O
myotonic	B-DISEASE
dystrophy	I-DISEASE
kinase	B-UNK
(	O
dmk	O
)	O
(	O
g	B-UNK
/	O
t	B-UNK
)	O
intron	B-UNK
9	O
/	O
hinfi	O
polymorphism	O
,	O
has	O
been	O
analyzed	B-UNK
in	O
south	B-UNK
african	I-UNK
negroids	O
,	O
a	O
population	B-UNK
in	O
which	O
myotonic	B-DISEASE
dystrophy	I-DISEASE
(	O
dm	B-DISEASE
)	O
has	O
not	O
been	O
described	B-UNK
.	O

 	O
south	B-UNK
african	I-UNK
negroids	O
have	O
a	O
ctg	B-UNK
allelic	B-UNK
distribution	B-UNK
that	O
is	O
significantly	B-UNK
different	B-UNK
from	O
that	O
in	O
caucasoids	O
and	O
japanese	B-UNK
the	O
ctg	B-UNK
repeat	I-UNK
lengths	O
of	O
>	O
or	O
=	O
19	O
are	O
very	O
rare	B-UNK
.	O

 	O
the	O
striking	B-UNK
linkage	B-UNK
disequilibrium	I-UNK
between	O
specific	B-UNK
alleles	B-UNK
at	B-DISEASE
the	O
alu	B-UNK
polymorphism	O
(	O
alu	B-UNK
(	O
ins	O
)	O
and	O
alu	B-UNK
(	O
del	O
)	O
)	O
,	O
the	O
hinfi	O
polymorphism	O
(	O
hinfi	O
-	O
1	O
and	O
hinfi	O
-	O
2	O
)	O
,	O
and	O
the	O
ctg	B-UNK
repeat	I-UNK
polymorphism	O
seen	B-UNK
in	O
caucasoid	O
(	O
europeans	O
and	O
canadians	O
)	O
populations	B-UNK
was	O
also	O
found	B-UNK
in	O
the	O
south	B-UNK
african	I-UNK
negroid	O
population	B-UNK
.	O

 	O
numerous	B-UNK
haplotypes	B-UNK
,	O
not	O
previously	B-UNK
described	I-UNK
in	O
europeans	O
,	O
were	O
,	O
however	O
,	O
found	B-UNK
.	O

 	O
it	O
thus	O
seems	O
likely	B-UNK
that	O
only	O
a	O
small	B-UNK
number	B-UNK
of	O
these	O
"	O
african	B-UNK
"	O
chromosomes	B-UNK
were	O
present	B-UNK
in	O
the	O
progenitors	O
of	O
all	O
non	B-UNK
-	O
african	B-UNK
peoples	O
.	O

 	O
these	O
data	B-UNK
provide	I-UNK
support	B-UNK
for	O
the	O
"	O
out	O
of	O
africa	O
"	O
model	B-UNK
for	O
the	O
origin	B-UNK
of	O
modern	O
humans	B-UNK
and	O
suggest	B-UNK
that	O
the	O
rare	B-UNK
ancestral	B-UNK
dm	B-DISEASE
mutation	B-UNK
event	B-UNK
may	O
have	O
occurred	B-UNK
after	O
the	O
migration	B-UNK
from	O
africa	O
,	O
hence	O
the	O
absence	B-UNK
of	O
dm	B-DISEASE
in	O
sub	O
-	O
saharan	O
negroid	O
peoples	O
.	O
.	O

 	O
discordant	B-UNK
clinical	B-UNK
outcome	I-UNK
in	O
myotonic	B-DISEASE
dystrophy	I-DISEASE
relatives	B-UNK
showing	B-UNK
(	O
ctg	B-UNK
)	O
n	B-UNK
>	O
700	O
repeats	B-UNK
.	O

 	O
a	O
myotonic	B-DISEASE
dystrophy	I-DISEASE
(	O
dm	B-DISEASE
)	O
family	B-UNK
is	O
described	B-UNK
in	O
which	O
discordant	B-UNK
dm	B-DISEASE
phenotypes	B-UNK
were	O
found	B-UNK
in	O
the	O
children	B-UNK
of	O
two	O
affected	B-UNK
sisters	O
with	O
similar	B-UNK
ctg	B-UNK
expansion	I-UNK
and	O
clinical	B-UNK
manifestations	B-UNK
.	O

 	O
in	O
this	O
family	B-UNK
,	O
congenital	B-DISEASE
as	O
well	O
as	O
early	B-UNK
severe	B-UNK
childhood	I-UNK
and	O
later	B-UNK
childhood	B-UNK
onset	B-UNK
dm	B-DISEASE
coexist	O
.	O

 	O
this	O
observation	B-UNK
strengthens	O
the	O
limited	B-UNK
ability	B-UNK
of	O
lymphocytes	B-UNK
ctg	B-UNK
repeat	I-UNK
number	B-UNK
analysis	B-UNK
in	O
predicting	B-UNK
genotype	B-UNK
-	O
phenotype	B-UNK
correlations	B-UNK
in	O
dm	B-DISEASE
patients	B-UNK
.	O
.	O

 	O
purification	O
of	O
human	B-UNK
very	O
-	O
long	B-UNK
-	O
chain	O
acyl	B-UNK
-	O
coenzyme	O
a	O
dehydrogenase	B-UNK
and	O
characterization	B-UNK
of	O
its	O
deficiency	B-UNK
in	O
seven	B-UNK
patients	B-UNK
.	O

 	O
mitochondrial	B-UNK
very	O
-	O
long	B-UNK
-	O
chain	O
acyl	B-UNK
-	O
coenzyme	O
a	O
dehydrogenase	B-UNK
(	O
vlcad	B-UNK
)	O
was	O
purified	B-UNK
from	O
human	B-UNK
liver	B-DISEASE
.	O

 	O
the	O
molecular	B-UNK
masses	O
of	O
the	O
native	B-UNK
enzyme	B-UNK
and	O
the	O
subunit	B-UNK
were	O
estimated	B-UNK
to	O
be	O
154	O
and	O
70	O
kd	O
,	O
respectively	B-UNK
.	O

 	O
the	O
enzyme	B-UNK
was	O
found	B-UNK
to	O
catalyze	O
the	O
major	B-UNK
part	O
of	O
mitochondrial	B-UNK
palmitoylcoenzyme	O
a	O
dehydrogenation	O
in	O
liver	B-DISEASE
,	O
heart	B-UNK
,	O
skeletal	B-UNK
muscle	I-UNK
,	O
and	O
skin	B-DISEASE
fibroblasts	B-UNK
(	O
89	O
-	O
97	O
,	O
86	O
-	O
99	O
,	O
96	O
-	O
99	O
,	O
and	O
78	O
-	O
87	O
%	O
,	O
respectively	B-UNK
)	O
.	O

 	O
skin	B-DISEASE
fibroblasts	B-UNK
from	O
26	O
patients	B-UNK
suspected	B-UNK
of	O
having	B-UNK
a	O
disorder	O
of	O
mitochondrial	B-UNK
beta	B-UNK
-	O
oxidation	B-UNK
were	O
analyzed	B-UNK
for	O
vlcad	B-UNK
protein	B-UNK
using	O
immunoblotting	O
,	O
and	O
7	O
of	O
them	O
contained	B-UNK
undetectable	B-UNK
or	O
trace	B-UNK
levels	B-UNK
of	O
the	O
enzyme	B-UNK
.	O

 	O
the	O
seven	B-UNK
deficient	B-UNK
fibroblast	B-UNK
lines	B-UNK
were	O
characterized	B-UNK
by	O
measuring	O
acyl	B-UNK
-	O
coenzyme	O
a	O
dehydrogenation	O
activities	B-UNK
,	O
overall	B-UNK
palmitic	O
acid	O
oxidation	B-UNK
,	O
and	O
vlcad	B-UNK
protein	B-UNK
synthesis	B-UNK
using	O
pulse	O
-	O
chase	O
,	O
further	O
confirming	O
the	O
diagnosis	B-UNK
of	O
vlcad	B-DISEASE
deficiency	I-DISEASE
.	O

 	O
these	O
results	B-UNK
suggested	B-UNK
the	O
heterogenous	B-UNK
nature	B-UNK
of	O
the	O
mutations	B-UNK
causing	B-UNK
the	O
deficiency	B-UNK
in	O
the	O
seven	B-UNK
patients	B-UNK
.	O

 	O
clinically	B-UNK
,	O
all	O
patients	B-UNK
with	O
vlcad	B-DISEASE
deficiency	I-DISEASE
exhibited	B-UNK
cardiac	B-DISEASE
disease	I-DISEASE
.	O

 	O
at	B-DISEASE
least	O
four	O
of	O
them	O
presented	B-UNK
with	O
hypertrophic	B-DISEASE
cardiomyopathy	I-DISEASE
.	O

 	O
this	O
frequency	B-UNK
(	O
>	O
57	O
%	O
)	O
was	O
much	O
higher	B-UNK
than	O
that	O
observed	B-UNK
in	O
patients	B-UNK
with	O
other	O
disorders	B-UNK
of	O
mitochondrial	B-UNK
long	B-UNK
-	O
chain	O
fatty	O
acid	O
oxidation	B-UNK
that	O
may	O
be	O
accompanied	O
by	O
cardiac	B-DISEASE
disease	I-DISEASE
in	O
infants	O
.	O
.	O

 	B-UNK
hereditary	I-UNK
deficiency	B-UNK
of	O
the	O
fifth	B-UNK
component	B-UNK
of	O
complement	B-UNK
in	O
man	B-UNK
.	O

 	O
ii	B-UNK
.	O

 	O
biological	B-UNK
properties	B-UNK
of	O
c5	B-UNK
-	O
deficient	B-UNK
human	B-UNK
serum	B-UNK
.	O

 	O
the	O
first	O
known	B-UNK
human	B-UNK
kindred	B-UNK
with	O
hereditary	B-UNK
deficiency	I-UNK
of	O
the	O
fifth	B-UNK
component	B-UNK
of	O
complement	B-UNK
(	O
c5	B-UNK
)	O
was	O
documented	B-UNK
in	O
the	O
accompanying	B-UNK
report	B-UNK
.	O

 	O
this	O
study	B-UNK
examines	O
several	O
biological	B-UNK
properties	B-UNK
of	O
c5	B-UNK
-	O
deficient	B-UNK
(	O
c5d	B-UNK
)	O
human	B-UNK
serum	B-UNK
,	O
particularly	B-UNK
sera	O
obtained	B-UNK
from	O
two	O
c5d	B-UNK
homozygotes	B-UNK
.	O

 	O
the	O
proband	B-UNK
,	O
who	O
has	O
inactive	B-UNK
systemic	B-DISEASE
lupus	I-DISEASE
erythematosus	I-DISEASE
is	O
completely	B-UNK
lacking	B-UNK
c5	B-UNK
,	O
while	O
her	O
healthy	B-UNK
half	B-UNK
-	O
sister	O
has	O
1	O
-	O
2	O
%	O
of	O
normal	B-UNK
levels	B-UNK
.	O

 	O
both	O
sera	O
were	O
severely	B-UNK
impaired	B-UNK
in	O
their	O
ability	B-UNK
to	O
generate	B-UNK
chemotactic	B-UNK
activity	B-UNK
for	O
normal	B-UNK
human	I-UNK
neutrophils	B-UNK
upon	O
incubation	O
with	O
aggregated	O
human	B-UNK
gamma	B-UNK
-	O
globulin	O
or	O
escherichia	B-UNK
coli	B-UNK
endotoxin	O
.	O

 	O
this	O
function	B-UNK
was	O
fully	B-UNK
restored	B-UNK
in	O
the	O
siblings	B-UNK
serum	B-UNK
,	O
and	O
substantially	B-UNK
improved	B-UNK
in	O
the	O
probands	B-UNK
serum	B-UNK
,	O
by	O
addition	B-UNK
of	O
highly	B-UNK
purified	B-UNK
human	B-UNK
c5	B-UNK
to	O
normal	B-UNK
serum	I-UNK
concentrations	B-UNK
.	O

 	O
sera	O
from	O
eight	O
family	B-UNK
members	I-UNK
who	O
were	O
apparently	B-UNK
heterozygous	B-UNK
for	O
c5	B-UNK
deficiency	B-UNK
gave	B-UNK
normal	B-UNK
chemotactic	B-UNK
scores	B-UNK
.	O

 	O
the	O
ability	B-UNK
of	O
c5d	B-UNK
serum	B-UNK
to	O
opsonize	O
saccharomyces	O
cerevisiae	O
(	O
bakers	O
yeast	B-UNK
)	O
or	O
candida	O
albicans	O
for	O
ingestion	O
by	O
normal	B-UNK
neutrophils	B-UNK
was	O
completely	B-UNK
normal	B-UNK
.	O

 	O
in	O
addition	B-UNK
,	O
c5d	B-UNK
serum	B-UNK
was	O
capable	O
of	O
promoting	O
normal	B-UNK
phagocytosis	B-DISEASE
and	O
intracellular	B-UNK
killing	O
of	O
staphylococcus	O
aureus	O
.	O

 	O
the	O
probands	B-UNK
serum	B-UNK
was	O
incapable	O
of	O
mediating	O
lysis	O
of	O
erythrocytes	O
from	O
a	O
patient	B-UNK
with	O
paroxysmal	B-UNK
nocturnal	B-UNK
hemoglobinuria	B-DISEASE
in	O
both	O
the	O
sucrose	O
hemolysia	O
and	O
acid	O
hemolysis	B-DISEASE
tests	B-UNK
,	O
and	O
also	O
lacked	B-UNK
bactericidal	B-UNK
activity	I-UNK
against	O
sensitized	O
or	O
unsensitized	O
salmonella	O
typhi	O
.	O

 	O
the	O
siblings	B-UNK
serum	B-UNK
,	O
containing	B-UNK
only	O
1	O
-	O
2	O
%	O
of	O
normal	B-UNK
c5	B-UNK
,	O
effectively	O
lysed	O
s	O
.	O
typhi	O
,	O
but	O
only	O
at	B-DISEASE
eightfold	O
lower	B-UNK
serum	B-UNK
dilutions	O
as	O
compared	B-UNK
to	O
normals	O
.	O

 	O
these	O
findings	B-UNK
underscore	O
the	O
critical	B-UNK
role	B-UNK
of	O
c5	B-UNK
in	O
the	O
generation	B-UNK
of	O
chemotactic	B-UNK
activity	B-UNK
and	O
in	O
cytolytic	B-UNK
reactions	B-UNK
,	O
as	O
opposed	O
to	O
a	O
nonobligatory	O
or	O
minimal	B-UNK
role	B-UNK
in	O
opsonization	O
,	O
at	B-DISEASE
least	O
for	O
the	O
organisms	O
under	O
study	B-UNK
.	O
.	O

 	B-UNK
human	I-UNK
peroxisomal	B-UNK
targeting	B-UNK
signal	B-UNK
-	O
1	O
receptor	B-UNK
restores	O
peroxisomal	B-UNK
protein	B-UNK
import	B-UNK
in	O
cells	B-UNK
from	O
patients	B-UNK
with	O
fatal	B-UNK
peroxisomal	B-DISEASE
disorders	I-DISEASE
.	O

 	O
two	O
peroxisomal	B-UNK
targeting	B-UNK
signals	B-UNK
,	O
pts1	O
and	O
pts2	O
,	O
are	O
involved	B-UNK
in	O
the	O
import	B-UNK
of	O
proteins	B-UNK
into	O
the	O
peroxisome	B-UNK
matrix	B-UNK
.	O

 	B-UNK
human	I-UNK
patients	B-UNK
with	O
fatal	B-UNK
generalized	O
peroxisomal	B-UNK
deficiency	B-UNK
disorders	B-UNK
fall	O
into	O
at	B-DISEASE
least	O
nine	O
genetic	B-UNK
complementation	B-UNK
groups	B-UNK
.	O

 	O
cells	B-UNK
from	O
many	O
of	O
these	O
patients	B-UNK
are	O
deficient	B-UNK
in	O
the	O
import	B-UNK
of	O
pts1	O
-	O
containing	B-UNK
proteins	B-UNK
,	O
but	O
the	O
causes	B-UNK
of	O
the	O
protein	B-UNK
-	O
import	B-UNK
defect	B-UNK
in	O
these	O
patients	B-UNK
are	O
unknown	B-UNK
.	O

 	O
we	O
have	O
cloned	B-UNK
and	O
sequenced	B-UNK
the	O
human	B-UNK
cdna	B-UNK
homologue	B-UNK
(	O
pts1r	B-UNK
)	O
of	O
the	O
pichia	O
pastoris	O
pas8	O
gene	B-UNK
,	O
the	O
pts1	O
receptor	B-UNK
(	O
mccollum	O
,	O
d	B-UNK
.	O
,	O
e	B-UNK
.	O
monosov	O
,	O
and	O
s	O
.	O
subramani	O
.	O
1993	O
.	O
j	B-UNK
.	O
cell	B-UNK
biol	O
.	O
121	O
761	O
-	O
774	O
)	O
.	O

 	O
the	O
pts1r	B-UNK
mrna	B-UNK
is	O
expressed	B-UNK
in	O
all	O
human	B-UNK
tissues	B-UNK
examined	B-UNK
.	O

 	O
antibodies	B-UNK
to	O
the	O
human	B-UNK
pts1r	B-UNK
recognize	O
this	O
protein	B-UNK
in	O
human	B-UNK
,	O
monkey	O
,	O
rat	B-UNK
,	O
and	O
hamster	B-UNK
cells	B-UNK
.	O

 	O
the	O
protein	B-UNK
is	O
localized	B-UNK
mainly	B-UNK
in	O
the	O
cytosol	O
but	O
is	O
also	O
found	B-UNK
to	O
be	O
associated	B-UNK
with	O
peroxisomes	O
.	O

 	O
part	O
of	O
the	O
peroxisomal	B-UNK
pts1r	B-UNK
protein	B-UNK
is	O
tightly	B-UNK
bound	O
to	O
the	O
peroxisomal	B-UNK
membrane	I-UNK
.	O

 	O
antibodies	B-UNK
to	O
pts1r	B-UNK
inhibit	O
peroxisomal	B-UNK
protein	B-UNK
-	O
import	B-UNK
of	O
pts1	O
-	O
containing	B-UNK
proteins	B-UNK
in	O
a	O
permeabilized	O
cho	O
cell	B-UNK
system	B-UNK
.	O

 	O
in	O
vitro	B-UNK
-	O
translated	B-UNK
pts1r	B-UNK
protein	B-UNK
specifically	B-UNK
binds	O
a	O
serine	B-UNK
-	O
lysine	O
-	O
leucine	O
-	O
peptide	B-UNK
.	O

 	O
a	O
pas8	O
-	O
pts1r	B-UNK
fusion	B-UNK
protein	B-UNK
complements	O
the	O
p	B-UNK
.	O
pastoris	O
pas8	O
mutant	B-UNK
.	O

 	O
the	O
pts1r	B-UNK
cdna	B-UNK
also	O
complements	O
the	O
pts1	O
protein	B-UNK
-	O
import	B-UNK
defect	B-UNK
in	O
skin	B-DISEASE
fibroblasts	B-UNK
from	O
patients	B-UNK
-	O
-	O
belonging	O
to	O
complementation	B-UNK
group	B-UNK
two	O
-	O
-	O
diagnosed	B-UNK
as	O
having	B-UNK
neonatal	B-UNK
adrenoleukodystrophy	B-DISEASE
or	O
zellweger	B-DISEASE
syndrome	I-DISEASE
.	O

 	O
the	O
pts1r	B-UNK
gene	B-UNK
has	O
been	O
localized	B-UNK
to	O
a	O
chromosomal	B-UNK
location	B-UNK
where	O
no	O
other	O
peroxisomal	B-UNK
disorder	O
genes	B-UNK
are	O
known	B-UNK
to	O
map	B-UNK
.	O

 	O
our	O
findings	B-UNK
represent	B-UNK
the	O
only	O
case	B-UNK
in	O
which	O
the	O
molecular	B-UNK
basis	I-UNK
of	O
the	O
protein	B-UNK
-	O
import	B-UNK
deficiency	B-UNK
in	O
human	B-UNK
peroxisomal	B-DISEASE
disorders	I-DISEASE
is	O
understood	O
.	O

 	O
spectrum	B-UNK
of	O
germline	B-UNK
mutations	I-UNK
in	O
the	O
rb1	B-UNK
gene	B-UNK
:	O
a	O
study	B-UNK
of	O
232	O
patients	B-UNK
with	O
hereditary	B-UNK
and	O
non	B-UNK
hereditary	B-UNK
retinoblastoma	B-DISEASE
.	O

 	B-UNK
germline	I-UNK
mutations	B-UNK
in	O
the	O
rb1	B-UNK
gene	B-UNK
confer	B-UNK
hereditary	B-UNK
predisposition	B-UNK
to	O
retinoblastoma	B-DISEASE
.	O

 	O
we	O
have	O
performed	B-UNK
a	O
mutation	B-UNK
survey	B-UNK
of	O
the	O
rb1	B-UNK
gene	B-UNK
in	O
232	O
patients	B-UNK
with	O
hereditary	B-UNK
or	O
non	B-UNK
hereditary	B-UNK
retinoblastoma	B-DISEASE
.	O

 	O
we	O
systematically	O
explored	O
all	O
27	O
exons	B-UNK
and	O
flanking	B-UNK
sequences	B-UNK
as	O
well	O
as	O
the	O
promotor	O
.	O

 	O
all	O
types	B-UNK
of	O
point	B-UNK
mutations	I-UNK
are	O
represented	B-UNK
and	O
are	O
found	B-UNK
unequally	O
distributed	B-UNK
along	O
the	O
rb1	B-UNK
gene	B-UNK
sequence	B-UNK
.	O

 	O
in	O
the	O
population	B-UNK
we	O
studied	B-UNK
,	O
exons	B-UNK
3	O
,	O
8	O
,	O
18	O
and	O
19	O
are	O
preferentially	B-UNK
altered	B-UNK
.	O

 	O
the	O
range	B-UNK
of	O
frequency	B-UNK
of	O
detection	B-UNK
of	O
germline	B-UNK
mutations	I-UNK
is	O
about	O
20	O
%	O
,	O
indicating	B-UNK
that	O
other	O
mechanisms	B-UNK
of	O
inactivation	B-UNK
of	O
rb1	B-UNK
should	O
be	O
involved	B-UNK
.	O

 	O
the	O
spectrum	B-UNK
of	O
mutations	B-UNK
presented	B-UNK
here	O
should	O
help	O
to	O
improve	O
the	O
clinical	B-UNK
management	O
of	O
retinoblastoma	B-DISEASE
and	O
to	O
understand	O
the	O
molecular	B-UNK
mechanisms	I-UNK
leading	B-UNK
to	O
tumorigenesis	B-UNK
.	O
.	O

 	O
aniridia	B-DISEASE
-	O
associated	B-UNK
cytogenetic	B-UNK
rearrangements	B-UNK
suggest	B-UNK
that	O
a	O
position	B-UNK
effect	B-UNK
may	O
cause	B-UNK
the	O
mutant	B-UNK
phenotype	B-UNK
.	O

 	O
current	B-UNK
evidence	B-UNK
suggests	B-UNK
that	O
aniridia	B-DISEASE
(	O
absence	B-UNK
of	O
iris	B-UNK
)	O
is	O
caused	B-UNK
by	O
loss	B-UNK
of	O
function	B-UNK
of	O
one	O
copy	B-UNK
of	O
the	O
pax6	B-UNK
gene	B-UNK
,	O
which	O
maps	B-UNK
to	O
11p13	B-UNK
.	O

 	O
we	O
present	B-UNK
the	O
further	O
characterisation	O
of	O
two	O
aniridia	B-DISEASE
pedigrees	B-UNK
in	O
which	O
the	O
disease	B-DISEASE
segregates	B-UNK
with	O
chromosomal	B-UNK
rearrangements	I-UNK
which	O
involve	B-UNK
11p13	B-UNK
but	O
do	O
not	O
disrupt	O
the	O
pax6	B-UNK
gene	B-UNK
.	O

 	O
we	O
have	O
isolated	B-UNK
three	O
human	B-UNK
yac	B-UNK
clones	I-UNK
which	O
encompass	O
the	O
pax6	B-UNK
locus	B-UNK
and	O
we	O
have	O
used	O
these	O
to	O
show	O
that	O
in	O
both	O
cases	B-UNK
the	O
chromosomal	B-UNK
breakpoint	B-UNK
is	O
at	B-DISEASE
least	O
85	O
kb	B-UNK
distal	B-UNK
of	O
the	O
3	O
end	B-UNK
of	O
pax6	B-UNK
.	O

 	O
in	O
addition	B-UNK
,	O
the	O
open	B-UNK
reading	I-UNK
frame	B-UNK
of	O
pax6	B-UNK
is	O
apparently	B-UNK
free	B-UNK
of	O
mutations	B-UNK
.	O

 	O
we	O
propose	O
that	O
the	O
pax6	B-UNK
gene	B-UNK
on	O
the	O
rearranged	B-UNK
chromosome	B-DISEASE
11	I-DISEASE
is	O
in	O
an	O
inappropriate	O
chromatin	B-UNK
environment	B-UNK
for	O
normal	B-UNK
expression	B-UNK
and	O
therefore	O
that	O
a	O
position	B-UNK
effect	B-UNK
is	O
the	O
underlying	B-UNK
mechanism	B-UNK
of	O
disease	B-DISEASE
in	O
these	O
families	B-UNK
.	O
.	O

 	O
somatic	B-UNK
mutations	B-UNK
in	O
the	O
brca1	B-UNK
gene	B-UNK
in	O
sporadic	B-UNK
ovarian	B-UNK
tumours	B-UNK
.	O

 	O
the	O
brca1	B-UNK
gene	B-UNK
on	O
chromosome	B-UNK
17q21	B-UNK
is	O
responsible	B-UNK
for	O
an	O
autosomal	O
dominant	B-UNK
syndrome	B-DISEASE
of	O
increased	B-UNK
susceptibility	B-UNK
to	O
breast	B-UNK
and	O
ovarian	B-DISEASE
cancer	I-DISEASE
but	O
no	O
somatic	B-UNK
mutations	B-UNK
in	O
tumours	B-UNK
have	O
yet	O
been	O
described	B-UNK
.	O

 	O
to	O
study	B-UNK
the	O
potential	B-UNK
role	B-UNK
of	O
brca1	B-UNK
in	O
sporadic	B-UNK
carcinogenesis	B-DISEASE
,	O
we	O
analysed	B-UNK
the	O
genomic	B-UNK
dna	I-UNK
of	O
tumour	B-UNK
and	O
normal	B-UNK
fractions	O
of	O
47	O
ovarian	B-UNK
cancers	B-DISEASE
for	O
mutations	B-UNK
in	O
brca1	B-UNK
using	O
the	O
single	B-UNK
-	O
strand	B-UNK
conformation	I-UNK
polymorphism	I-UNK
technique	B-UNK
.	O

 	O
we	O
now	O
describe	B-UNK
somatic	B-UNK
mutations	B-UNK
in	O
the	O
dna	B-UNK
of	O
four	O
tumours	B-UNK
which	O
also	O
had	O
loss	B-UNK
of	O
heterozygosity	B-UNK
(	O
loh	O
)	O
at	B-DISEASE
a	O
brca1	B-UNK
intragenic	B-UNK
marker	B-UNK
.	O

 	O
our	O
data	B-UNK
support	B-UNK
a	O
tumour	B-UNK
suppressor	I-UNK
mechanism	B-UNK
for	O
brca1	B-UNK
;	O
somatic	B-UNK
mutations	B-UNK
and	O
loh	O
may	O
result	B-UNK
in	O
inactivation	B-UNK
of	O
brca1	B-UNK
in	O
at	B-DISEASE
least	O
a	O
small	B-UNK
number	B-UNK
of	O
ovarian	B-UNK
cancers	B-DISEASE
.	O
.	O

 	O
decreased	B-UNK
expression	B-UNK
of	O
brca1	B-UNK
accelerates	O
growth	B-UNK
and	O
is	O
often	O
present	B-UNK
during	O
sporadic	B-UNK
breast	B-DISEASE
cancer	I-DISEASE
progression	O
.	O

 	O
we	O
have	O
characterized	B-UNK
expression	B-UNK
of	O
the	O
familial	B-UNK
breast	B-UNK
and	O
ovarian	B-DISEASE
cancer	I-DISEASE
gene	B-UNK
,	O
brca1	B-UNK
,	O
in	O
cases	B-UNK
of	O
non	B-UNK
-	O
hereditary	B-UNK
(	O
sporadic	B-UNK
)	O
breast	B-DISEASE
cancer	I-DISEASE
and	O
analyzed	B-UNK
the	O
effect	B-UNK
of	O
antisense	B-UNK
inhibition	B-UNK
of	O
brca1	B-UNK
on	O
the	O
proliferative	B-UNK
rate	B-UNK
of	O
mammary	B-UNK
epithelial	I-UNK
cells	B-UNK
.	O

 	B-UNK
brca1	I-UNK
mrna	B-UNK
levels	I-UNK
are	O
markedly	B-UNK
decreased	B-UNK
during	O
the	O
transition	B-UNK
from	O
carcinoma	B-DISEASE
in	I-DISEASE
situ	I-DISEASE
to	O
invasive	O
cancer	B-DISEASE
.	O

 	O
experimental	B-UNK
inhibition	B-UNK
of	O
brca1	B-UNK
expression	B-UNK
with	O
antisense	B-UNK
oligonucleotides	B-UNK
produced	B-UNK
accelerated	B-UNK
growth	B-UNK
of	O
normal	B-UNK
and	O
malignant	B-UNK
mammary	O
cells	B-UNK
,	O
but	O
had	O
no	O
effect	B-UNK
on	O
non	B-UNK
-	O
mammary	B-UNK
epithelial	I-UNK
cells	B-UNK
.	O

 	O
these	O
studies	B-UNK
suggest	I-UNK
that	O
brca1	B-UNK
may	O
normally	B-UNK
serve	O
as	O
a	O
negative	B-UNK
regulator	B-UNK
of	O
mammary	B-UNK
epithelial	I-UNK
cell	B-UNK
growth	B-UNK
whose	O
function	B-UNK
is	O
compromised	O
in	O
breast	B-DISEASE
cancer	I-DISEASE
either	O
by	O
direct	B-UNK
mutation	B-UNK
or	O
alterations	B-UNK
in	O
gene	B-UNK
expression	B-UNK
.	O
.	O

 	B-UNK
additional	I-UNK
case	B-UNK
of	O
female	B-UNK
monozygotic	B-UNK
twins	B-DISEASE
discordant	B-UNK
for	O
the	O
clinical	B-UNK
manifestations	B-UNK
of	O
duchenne	B-UNK
muscular	B-DISEASE
dystrophy	I-DISEASE
due	O
to	O
opposite	O
x	B-UNK
-	O
chromosome	B-UNK
inactivation	B-UNK
.	O

 	O
a	O
pair	O
of	O
female	B-UNK
monozygotic	B-UNK
(	O
mz	B-UNK
)	O
twins	B-DISEASE
,	O
heterozygous	B-UNK
carriers	B-UNK
for	O
a	O
deletion	B-UNK
in	O
the	O
dmd	B-UNK
gene	B-UNK
and	O
discordant	B-UNK
for	O
the	O
clinical	B-UNK
manifestations	B-UNK
of	O
duchenne	B-UNK
muscular	B-DISEASE
dystrophy	I-DISEASE
,	O
were	O
analyzed	B-UNK
by	O
molecular	B-UNK
studies	I-UNK
,	O
in	O
situ	B-UNK
hybridization	I-UNK
,	O
and	O
methylation	B-UNK
pattern	B-UNK
of	O
x	B-UNK
chromosomes	I-UNK
to	O
search	O
for	O
opposite	O
x	B-DISEASE
inactivation	I-DISEASE
as	O
an	O
explanation	B-UNK
of	O
their	O
clinical	B-UNK
discordance	O
.	O

 	B-UNK
results	I-UNK
in	O
lymphocytes	B-UNK
and	O
skin	B-DISEASE
fibroblast	B-UNK
cell	B-UNK
lines	B-UNK
suggest	B-UNK
a	O
partial	B-UNK
mirror	O
inactivation	B-UNK
with	O
the	O
normal	B-UNK
x	B-DISEASE
chromosome	I-DISEASE
preferentially	B-UNK
active	B-UNK
in	O
the	O
unaffected	B-UNK
twin	B-UNK
,	O
and	O
the	O
maternal	B-UNK
deleted	B-UNK
x	B-DISEASE
chromosome	I-DISEASE
preferentially	B-UNK
active	B-UNK
in	O
the	O
affected	B-UNK
twin	B-UNK
.	O

 	O
a	O
review	O
shows	B-UNK
that	O
mz	B-UNK
female	B-UNK
twins	B-DISEASE
discordant	B-UNK
for	O
x	B-UNK
-	O
linked	B-UNK
diseases	B-DISEASE
are	O
not	O
uncommon	B-UNK
.	O

 	O
twinning	O
and	O
x	B-DISEASE
inactivation	I-DISEASE
may	O
be	O
interrelated	O
and	O
could	O
explain	O
the	O
female	B-UNK
twins	B-DISEASE
discordant	B-UNK
for	O
x	B-UNK
-	O
linked	B-UNK
traits	O
.	O
.	O

 	O
x	B-UNK
-	O
linked	B-UNK
adrenoleukodystrophy	B-DISEASE
(	O
ald	B-UNK
)	O
:	O
a	O
novel	B-UNK
mutation	B-UNK
of	O
the	O
ald	B-UNK
gene	B-UNK
in	O
6	O
members	B-UNK
of	O
a	O
family	B-UNK
presenting	B-UNK
with	O
5	O
different	B-UNK
phenotypes	B-UNK
.	O

 	O
fragments	B-UNK
of	O
the	O
adrenoleukodystrophy	B-DISEASE
(	O
ald	B-UNK
)	O
cdna	B-UNK
from	O
a	O
patient	B-UNK
with	O
adolescent	O
ald	B-UNK
were	O
amplified	B-UNK
by	O
polymerase	B-UNK
chain	I-UNK
reaction	I-UNK
and	O
subcloned	O
.	O

 	O
bidirectional	O
sequencing	B-UNK
of	O
the	O
entire	B-UNK
coding	I-UNK
ald	B-UNK
gene	B-UNK
disclosed	B-UNK
a	O
cytosine	O
to	O
guanine	B-UNK
transversion	B-UNK
at	B-DISEASE
nucleotide	B-UNK
1451	O
in	O
exon	B-UNK
five	O
,	O
resulting	B-UNK
in	O
substitution	B-UNK
of	O
proline	O
484	O
by	O
arginine	B-UNK
.	O

 	O
five	O
of	O
nine	O
siblings	B-UNK
of	O
the	O
patient	B-UNK
,	O
comprising	B-UNK
two	O
cerebral	B-UNK
ald	I-UNK
,	O
one	O
adrenomyeloneuropathy	B-UNK
,	O
one	O
addison	O
only	O
as	O
well	O
as	O
the	O
symptomatic	B-UNK
mother	B-UNK
(	O
all	O
accumulating	O
very	O
long	B-UNK
chain	I-UNK
fatty	I-UNK
acids	O
)	O
carried	B-UNK
this	O
mutation	B-UNK
,	O
which	O
was	O
not	O
found	B-UNK
in	O
the	O
unaffected	B-UNK
persons	B-UNK
,	O
in	O
five	O
unrelated	B-UNK
ald	B-UNK
patients	I-UNK
,	O
and	O
in	O
twenty	O
controls	B-UNK
.	O

 	O
we	O
propose	O
that	O
this	O
missense	B-UNK
mutation	I-UNK
generated	B-UNK
the	O
disease	B-DISEASE
per	O
se	B-DISEASE
as	O
well	O
as	O
the	O
metabolic	B-UNK
defect	B-UNK
;	O
the	O
different	B-UNK
phenotypes	B-UNK
,	O
however	O
,	O
must	O
have	O
originated	B-UNK
by	O
means	O
of	O
additional	B-UNK
pathogenetic	B-UNK
factors	B-UNK
.	O
.	O

 	B-UNK
novel	I-UNK
mutation	B-UNK
at	B-DISEASE
the	O
initiation	B-UNK
codon	B-UNK
in	O
the	O
norrie	B-DISEASE
disease	I-DISEASE
gene	B-UNK
in	O
two	O
japanese	B-UNK
families	B-UNK
.	O

 	O
we	O
have	O
identified	B-UNK
a	O
new	B-UNK
mutation	B-UNK
of	O
norrie	B-DISEASE
disease	I-DISEASE
(	O
nd	B-UNK
)	O
gene	B-UNK
in	O
two	O
japanese	B-UNK
males	B-UNK
from	O
unrelated	B-UNK
families	I-UNK
;	O
they	O
showed	B-UNK
typical	B-UNK
ocular	O
features	B-UNK
of	O
nd	B-UNK
but	O
no	O
mental	B-DISEASE
retardation	I-DISEASE
or	O
hearing	B-DISEASE
impairment	I-DISEASE
.	O

 	O
a	O
mutation	B-UNK
was	O
found	B-UNK
in	O
both	O
patients	B-UNK
at	B-DISEASE
the	O
initiation	B-UNK
codon	B-UNK
of	O
exon	B-UNK
2	O
of	O
the	O
nd	B-UNK
gene	B-UNK
(	O
atg	O
to	O
gtg	O
)	O
,	O
with	O
otherwise	O
normal	B-UNK
nucleotide	B-UNK
sequences	B-UNK
.	O

 	O
their	O
mothers	B-UNK
had	O
the	O
normal	B-UNK
and	O
mutant	B-UNK
types	B-UNK
of	O
the	O
gene	B-UNK
,	O
which	O
was	O
expected	B-UNK
for	O
heterozygotes	B-UNK
of	O
the	O
disease	B-DISEASE
.	O

 	O
the	O
mutation	B-UNK
of	O
the	O
initiation	B-UNK
codon	B-UNK
would	O
cause	B-UNK
the	O
failure	O
of	O
nd	B-UNK
gene	B-UNK
expression	B-UNK
or	O
a	O
defect	B-UNK
in	O
translation	B-UNK
thereby	O
truncating	B-UNK
the	O
amino	O
terminus	B-UNK
of	O
nd	B-UNK
protein	B-UNK
.	O

 	O
in	O
view	O
of	O
the	O
rarity	O
and	O
marked	B-UNK
heterogeneity	B-UNK
of	O
mutations	B-UNK
in	O
the	O
nd	B-UNK
gene	B-UNK
,	O
the	O
present	B-UNK
apparently	B-UNK
unrelated	B-UNK
japanese	I-UNK
families	B-UNK
who	O
have	O
lived	O
in	O
the	O
same	O
area	B-UNK
for	O
over	O
two	O
centuries	O
presumably	O
share	B-UNK
the	O
origin	B-UNK
of	O
the	O
mutation	B-UNK
.	O
.	O

 	O
anticipation	B-DISEASE
resulting	B-UNK
in	O
elimination	O
of	O
the	O
myotonic	B-DISEASE
dystrophy	I-DISEASE
gene	B-UNK
:	O
a	O
follow	B-UNK
up	O
study	B-UNK
of	O
one	O
extended	B-UNK
family	B-UNK
.	O

 	O
we	O
have	O
re	O
-	O
examined	B-UNK
an	O
extended	B-UNK
myotonic	B-DISEASE
dystrophy	I-DISEASE
(	O
dm	B-DISEASE
)	O
family	B-UNK
,	O
previously	B-UNK
described	I-UNK
in	O
1955	O
,	O
in	O
order	B-UNK
to	O
study	B-UNK
the	O
long	B-UNK
term	B-UNK
effects	B-UNK
of	O
anticipation	B-DISEASE
in	O
dm	B-DISEASE
and	O
in	O
particular	B-UNK
the	O
implications	B-UNK
for	O
families	B-UNK
affected	B-UNK
by	O
this	O
disease	B-DISEASE
.	O

 	O
this	O
follow	B-UNK
up	O
study	B-UNK
provides	B-UNK
data	B-UNK
on	O
35	O
gene	B-UNK
carriers	B-UNK
and	O
46	O
asymptomatic	B-UNK
at	B-DISEASE
risk	B-UNK
family	B-UNK
members	I-UNK
in	O
five	O
generations	B-UNK
.	O

 	B-UNK
clinical	I-UNK
anticipation	B-DISEASE
,	O
defined	B-UNK
as	O
the	O
cascade	O
of	O
mild	B-UNK
,	O
adult	B-UNK
,	O
childhood	B-UNK
,	O
or	O
congenital	B-DISEASE
disease	B-DISEASE
in	O
subsequent	B-UNK
generations	B-UNK
,	O
appeared	B-UNK
to	O
be	O
a	O
relentless	O
process	B-UNK
,	O
occurring	B-UNK
in	O
all	O
affected	B-UNK
branches	B-UNK
of	O
the	O
family	B-UNK
.	O

 	O
the	O
cascade	O
was	O
found	B-UNK
to	O
proceed	O
asynchronously	O
in	O
the	O
different	B-UNK
branches	B-UNK
,	O
mainly	B-UNK
because	O
of	O
an	O
unequal	B-UNK
number	B-UNK
of	O
generations	B-UNK
with	O
mild	B-UNK
disease	B-DISEASE
.	O

 	O
the	O
transition	B-UNK
from	O
the	O
mild	B-UNK
to	O
the	O
adult	B-UNK
type	B-UNK
was	O
associated	B-UNK
with	O
transmission	B-UNK
through	O
a	O
male	B-UNK
parent	B-UNK
.	O

 	O
stable	B-UNK
transmission	B-UNK
of	O
the	O
asymptomatic	B-UNK
/	O
mild	B-UNK
phenotype	B-UNK
showed	B-UNK
a	O
female	B-UNK
transmission	B-UNK
bias	B-UNK
.	O

 	O
we	O
further	O
examined	B-UNK
the	O
extent	B-UNK
and	O
causes	B-UNK
of	O
gene	B-UNK
loss	B-UNK
in	O
this	O
pedigree	B-UNK
.	O

 	O
gene	B-UNK
loss	B-UNK
in	O
the	O
patient	B-UNK
group	B-UNK
was	O
complete	B-UNK
,	O
owing	O
to	O
infertility	B-DISEASE
of	O
the	O
male	B-UNK
patients	I-UNK
with	O
adult	B-UNK
onset	I-UNK
disease	B-DISEASE
and	O
the	O
fact	O
that	O
mentally	B-UNK
retarded	I-UNK
patients	B-UNK
did	O
not	O
procreate	O
.	O

 	O
out	O
of	O
the	O
46	O
at	B-DISEASE
risk	B-UNK
subjects	B-UNK
in	O
the	O
two	O
youngest	O
generations	B-UNK
,	O
only	O
one	O
was	O
found	B-UNK
to	O
have	O
a	O
full	O
mutation	B-UNK
.	O

 	O
this	O
is	O
the	O
only	O
subject	B-UNK
who	O
may	O
transmit	O
the	O
gene	B-UNK
to	O
the	O
sixth	B-UNK
generation	B-UNK
.	O

 	O
no	O
protomutation	O
carriers	B-UNK
were	O
found	B-UNK
in	O
the	O
fourth	B-UNK
and	O
fifth	B-UNK
generations	B-UNK
.	O

 	O
therefore	O
it	O
is	O
highly	B-UNK
probable	B-UNK
that	O
the	O
dm	B-DISEASE
gene	B-UNK
will	O
be	O
eliminated	O
from	O
this	O
pedigree	B-UNK
within	O
one	O
generation	B-UNK
.	O

 	O
the	O
high	B-UNK
population	B-UNK
frequency	B-UNK
of	O
dm	B-DISEASE
can	O
at	B-DISEASE
present	B-UNK
not	O
be	O
explained	O
by	O
the	O
contribution	O
of	O
asymptomatic	B-UNK
cases	B-UNK
in	O
the	O
younger	B-UNK
generations	B-UNK
of	O
known	B-UNK
families	B-UNK
,	O
but	O
is	O
probably	B-UNK
caused	B-UNK
by	O
the	O
events	B-UNK
in	O
the	O
ancestral	B-UNK
generations	B-UNK
.	O
.	O

 	O
the	O
gene	B-UNK
for	O
spinal	B-UNK
cerebellar	B-DISEASE
ataxia	I-DISEASE
3	O
(	O
sca3	B-UNK
)	O
is	O
located	B-UNK
in	O
a	O
region	B-UNK
of	O
approximately	B-UNK
3	O
cm	B-DISEASE
on	O
chromosome	B-UNK
14q24	O
.	O
3	O
-	O
q32	O
.	O
2	O
.	O

 	O
sca3	B-UNK
,	O
the	O
gene	B-UNK
for	O
spinal	B-UNK
cerebellar	B-DISEASE
ataxia	I-DISEASE
3	O
,	O
was	O
recently	B-UNK
mapped	B-UNK
to	O
a	O
15	O
-	O
cm	B-DISEASE
interval	B-UNK
between	O
d14s67	O
and	O
d14s81	O
on	O
chromosome	B-DISEASE
14q	I-DISEASE
,	O
by	O
linkage	B-UNK
analysis	I-UNK
in	O
two	O
families	B-UNK
of	O
french	B-UNK
ancestry	B-UNK
.	O

 	O
the	O
sca3	B-UNK
candidate	B-UNK
region	B-UNK
has	O
now	O
been	O
refined	O
by	O
linkage	B-UNK
analysis	I-UNK
with	O
four	O
new	B-UNK
microsatellite	I-UNK
markers	B-UNK
(	O
d14s256	O
,	O
d14s291	O
,	O
d14s280	O
,	O
and	O
afm343vf1	O
)	O
in	O
the	O
same	O
two	O
families	B-UNK
,	O
in	O
which	O
19	O
additional	B-UNK
individuals	B-UNK
were	O
genotyped	O
,	O
and	O
in	O
a	O
third	O
french	B-UNK
family	B-UNK
.	O

 	B-UNK
combined	I-UNK
two	O
-	O
point	B-UNK
linkage	I-UNK
analyses	B-UNK
show	O
that	O
the	O
new	B-UNK
markers	B-UNK
,	O
d14s280	O
and	O
afm343vf1	O
,	O
are	O
tightly	B-UNK
linked	I-UNK
to	O
the	O
sca3	B-UNK
locus	B-UNK
,	O
with	O
maximal	B-UNK
lod	I-UNK
scores	B-UNK
,	O
at	B-DISEASE
recombination	B-UNK
fraction	B-UNK
,	O
(	O
theta	B-UNK
)	O
=	O
.	O

 	O
00	O
,	O
of	O
7	O
.	O

 	O
05	O
and	O
13	O
.	O

 	O
70	O
,	O
respectively	B-UNK
.	O

 	B-UNK
combined	I-UNK
multipoint	B-UNK
and	O
recombinant	B-UNK
haplotype	B-UNK
analyses	B-UNK
localize	B-UNK
the	O
sca3	B-UNK
locus	B-UNK
to	O
a	O
3	O
-	O
cm	B-DISEASE
interval	B-UNK
flanked	O
by	O
d14s291	O
and	O
d14s81	O
.	O

 	O
the	O
same	O
allele	B-UNK
for	O
d14s280	O
segregates	B-UNK
with	O
the	O
disease	B-DISEASE
locus	B-UNK
in	O
the	O
three	O
kindreds	B-UNK
.	O

 	O
this	O
allele	B-UNK
is	O
frequent	B-UNK
in	O
the	O
french	B-UNK
population	B-UNK
,	O
however	O
,	O
and	O
linkage	B-UNK
disequilibrium	I-UNK
is	O
not	O
clearly	B-UNK
established	B-UNK
.	O

 	O
the	O
sca3	B-UNK
locus	B-UNK
remains	B-UNK
within	O
the	O
29	O
-	O
cm	B-DISEASE
region	B-UNK
on	O
14q24	O
.	O

 	O
3	O
-	O
q32	O
.	O

 	O
2	O
containing	B-UNK
the	O
gene	B-UNK
for	O
the	O
machado	B-DISEASE
-	I-DISEASE
joseph	I-DISEASE
disease	I-DISEASE
,	O
which	O
is	O
clinically	B-UNK
related	B-UNK
to	O
the	O
phenotype	B-UNK
determined	B-UNK
by	O
sca3	B-UNK
,	O
but	O
it	O
can	O
not	O
yet	O
be	O
concluded	O
that	O
both	O
diseases	B-DISEASE
result	B-UNK
from	O
alterations	B-UNK
of	O
the	O
same	O
gene	B-UNK

 	O
an	O
evaluation	B-UNK
of	O
genetic	B-UNK
heterogeneity	B-UNK
in	O
145	O
breast	B-DISEASE
-	I-DISEASE
ovarian	I-DISEASE
cancer	I-DISEASE
families	B-UNK
.	O

 	O
breast	B-DISEASE
cancer	I-DISEASE
linkage	B-UNK
consortium	B-UNK
.	O

 	O
the	O
breast	B-UNK
-	O
ovary	O
cancer	B-DISEASE
-	O
family	B-UNK
syndrome	B-DISEASE
is	O
a	O
dominant	B-UNK
predisposition	B-UNK
to	O
cancer	B-DISEASE
of	O
the	O
breast	B-UNK
and	O
ovaries	O
which	O
has	O
been	O
mapped	B-UNK
to	O
chromosome	B-UNK
region	I-UNK
17q12	B-UNK
-	O
q21	O
.	O

 	O
the	O
majority	B-UNK
,	O
but	O
not	O
all	O
,	O
of	O
breast	B-UNK
-	O
ovary	O
cancer	B-DISEASE
families	B-UNK
show	O
linkage	B-UNK
to	O
this	O
susceptibility	B-UNK
locus	B-UNK
,	O
designated	B-UNK
brca1	B-UNK
.	O

 	O
we	O
report	B-UNK
here	O
the	O
results	B-UNK
of	O
a	O
linkage	B-UNK
analysis	I-UNK
of	O
145	O
families	B-UNK
with	O
both	O
breast	B-UNK
and	O
ovarian	B-DISEASE
cancer	I-DISEASE
.	O

 	O
these	O
families	B-UNK
contain	B-UNK
either	O
a	O
total	B-UNK
of	O
three	O
or	O
more	O
cases	B-UNK
of	O
early	B-UNK
-	O
onset	B-UNK
(	O
before	O
age	B-UNK
60	O
years	B-UNK
)	O
breast	B-DISEASE
cancer	I-DISEASE
or	O
ovarian	B-DISEASE
cancer	I-DISEASE
.	O

 	O
all	O
families	B-UNK
contained	B-UNK
at	B-DISEASE
least	O
one	O
case	B-UNK
of	O
ovarian	B-DISEASE
cancer	I-DISEASE
.	O

 	O
overall	B-UNK
,	O
an	O
estimated	B-UNK
76	O
%	O
of	O
the	O
145	O
families	B-UNK
are	O
linked	B-UNK
to	O
the	O
brca1	B-UNK
locus	B-UNK
.	O

 	O
none	O
of	O
the	O
13	O
families	B-UNK
with	O
cases	B-UNK
of	O
male	B-DISEASE
breast	I-DISEASE
cancer	I-DISEASE
appear	B-UNK
to	O
be	O
linked	B-UNK
,	O
but	O
it	O
is	O
estimated	B-UNK
that	O
92	O
%	O
(	O
95	O
%	O
confidence	B-UNK
interval	B-UNK
76	O
%	O
-	O
100	O
%	O
)	O
of	O
families	B-UNK
with	O
no	O
male	B-DISEASE
breast	I-DISEASE
cancer	I-DISEASE
and	O
with	O
two	O
or	O
more	O
ovarian	B-UNK
cancers	B-DISEASE
are	O
linked	B-UNK
to	O
brca1	B-UNK
.	O

 	O
these	O
data	B-UNK
suggest	B-UNK
that	O
the	O
breast	B-DISEASE
-	I-DISEASE
ovarian	I-DISEASE
cancer	I-DISEASE
-	O
family	B-UNK
syndrome	B-DISEASE
is	O
genetically	B-UNK
heterogeneous	B-UNK
.	O

 	O
however	O
,	O
the	O
large	B-UNK
majority	B-UNK
of	O
families	B-UNK
with	O
early	B-UNK
-	O
onset	B-UNK
breast	B-DISEASE
cancer	I-DISEASE
and	O
with	O
two	O
or	O
more	O
cases	B-UNK
of	O
ovarian	B-DISEASE
cancer	I-DISEASE
are	O
likely	B-UNK
to	O
be	O
due	O
to	O
brca1	B-UNK
mutations	I-UNK
.	O
.	O

 	B-UNK
molecular	I-UNK
basis	B-UNK
of	O
essential	B-UNK
fructosuria	B-DISEASE
:	O
molecular	B-UNK
cloning	B-UNK
and	O
mutational	B-UNK
analysis	B-UNK
of	O
human	B-UNK
ketohexokinase	O
(	O
fructokinase	O
)	O
.	O

 	O
essential	B-UNK
fructosuria	B-DISEASE
is	O
one	O
of	O
the	O
oldest	O
known	B-UNK
inborn	B-UNK
errors	B-UNK
of	O
metabolism	B-DISEASE
.	O

 	O
it	O
is	O
a	O
benign	B-UNK
condition	B-UNK
which	O
is	O
believed	O
to	O
result	B-UNK
from	O
deficiency	B-UNK
of	O
hepatic	B-UNK
fructokinase	O
(	O
ketohexokinase	O
,	O
khk	B-UNK
,	O
e	B-UNK
.	O
c	B-UNK
.	O
2	O
.	O
7	O
.	O
1	O
.	O
3	O
)	O
.	O

 	O
this	O
enzyme	B-UNK
catalyses	O
the	O
first	O
step	O
of	O
metabolism	B-DISEASE
of	O
dietary	B-UNK
fructose	O
,	O
conversion	O
of	O
fructose	O
to	O
fructose	B-DISEASE
-	I-DISEASE
1	I-DISEASE
-	O
phosphate	B-UNK
.	O

 	O
despite	B-UNK
the	O
early	B-UNK
recognition	B-UNK
of	O
this	O
disorder	O
,	O
the	O
primary	B-UNK
structure	B-UNK
of	O
human	B-UNK
khk	B-UNK
and	O
the	O
molecular	B-UNK
basis	I-UNK
of	O
essential	B-UNK
fructosuria	B-DISEASE
have	O
not	O
been	O
previously	B-UNK
defined	B-UNK
.	O

 	O
in	O
this	O
report	B-UNK
,	O
the	O
isolation	B-UNK
and	O
sequencing	B-UNK
of	O
full	O
-	O
length	O
cdna	B-UNK
clones	B-UNK
encoding	B-UNK
human	B-UNK
ketohexokinase	O
are	O
described	B-UNK
.	O

 	O
alternative	B-UNK
mrna	B-UNK
species	B-UNK
and	O
alternative	B-UNK
khk	B-UNK
isozymes	O
are	O
produced	B-UNK
by	O
alternative	B-UNK
polyadenylation	O
and	O
splicing	B-UNK
of	O
the	O
khk	B-UNK
gene	B-UNK
.	O

 	O
the	O
khk	B-UNK
proteins	B-UNK
show	O
a	O
high	B-UNK
level	B-UNK
of	O
sequence	B-UNK
conservation	B-UNK
relative	B-UNK
to	O
rat	B-UNK
khk	B-UNK
.	O

 	B-UNK
direct	I-UNK
evidence	B-UNK
that	O
mutation	B-UNK
of	O
the	O
khk	B-UNK
structural	B-UNK
gene	B-UNK
is	O
the	O
cause	B-UNK
of	O
essential	B-UNK
fructosuria	B-DISEASE
was	O
also	O
obtained	B-UNK
.	O

 	O
in	O
a	O
well	O
-	O
characterized	B-UNK
family	B-UNK
,	O
in	O
which	O
three	O
of	O
eight	O
siblings	B-UNK
have	O
fructosuria	B-DISEASE
,	O
all	O
affected	B-UNK
individuals	I-UNK
are	O
compound	B-UNK
heterozygotes	B-UNK
for	O
two	O
mutations	B-UNK
gly40arg	O
and	O
ala43thr	O
.	O

 	O
both	O
mutations	B-UNK
result	B-UNK
from	O
g	B-UNK
-	O
-	O
>	O
a	O
transitions	B-UNK
,	O
and	O
each	O
alters	O
the	O
same	O
conserved	B-UNK
region	B-UNK
of	O
the	O
khk	B-UNK
protein	B-UNK
.	O

 	O
neither	O
mutation	B-UNK
was	O
seen	B-UNK
in	O
a	O
sample	B-UNK
of	O
52	O
unrelated	B-UNK
control	B-UNK
individuals	I-UNK
.	O

 	O
an	O
additional	B-UNK
conservative	O
amino	B-UNK
acid	I-UNK
change	B-UNK
(	O
val49iie	O
)	O
was	O
present	B-UNK
on	O
the	O
khk	B-UNK
allele	B-UNK
bearing	B-UNK
ala43thr	O

 	B-UNK
homozygous	I-UNK
presence	B-UNK
of	O
the	O
crossover	B-UNK
(	O
fusion	B-UNK
gene	B-UNK
)	O
mutation	B-UNK
identified	B-UNK
in	O
a	O
type	B-UNK
ii	I-UNK
gaucher	B-DISEASE
disease	I-DISEASE
fetus	B-UNK
:	O
is	O
this	O
analogous	O
to	O
the	O
gaucher	O
knock	O
-	O
out	O
mouse	B-UNK
model	I-UNK
?	O

 	O
gaucher	B-DISEASE
disease	I-DISEASE
(	O
gd	B-UNK
)	O
is	O
an	O
inherited	B-UNK
deficiency	B-UNK
of	O
beta	B-UNK
-	O
glucocerebrosidase	O
(	O
ec	O
3	O
.	O
1	O
.	O
2	O
.	O
45	O
,	O
gene	B-UNK
symbol	O
gba	B-UNK
)	O
.	O

 	O
in	O
type	B-UNK
i	O
gd	B-UNK
,	O
the	O
cns	B-UNK
is	O
not	O
involved	B-UNK
(	O
nonneuronopathic	O
)	O
,	O
whereas	O
in	O
type	B-UNK
ii	I-UNK
gd	B-UNK
(	O
acute	B-UNK
neuronopathic	B-UNK
)	O
cns	B-UNK
involvement	B-UNK
is	O
early	B-UNK
and	O
rapidly	B-UNK
progressive	B-UNK
,	O
while	O
in	O
type	B-UNK
iii	B-UNK
gd	B-UNK
(	O
subacute	O
neuronopathic	B-UNK
)	O
cns	B-UNK
involvement	B-UNK
occurs	B-UNK
later	B-UNK
and	O
is	O
slowly	B-UNK
progressive	B-UNK
.	O

 	O
the	O
t6433c	O
(	O
l444p	O
)	O
substitution	B-UNK
is	O
prevalent	B-UNK
in	O
type	B-UNK
gd	B-UNK
ii	B-UNK
.	O

 	O
it	O
may	O
occur	B-UNK
alone	O
as	O
a	O
single	B-UNK
base	B-UNK
-	O
pair	O
mutation	B-UNK
but	O
often	O
is	O
found	B-UNK
as	O
part	O
of	O
a	O
complex	B-UNK
allele	B-UNK
containing	B-UNK
additional	B-UNK
gba	B-UNK
nucleotide	B-UNK
substitutions	B-UNK
,	O
g6468c	O
(	O
a456p	O
)	O
and	O
g6482c	O
(	O
v460v	O
)	O
,	O
without	O
(	O
recncii	O
)	O
or	O
with	O
(	O
rectl	O
)	O
g5957c	O
(	O
d409h	O
)	O
.	O

 	O
this	O
complex	B-UNK
allele	B-UNK
is	O
presumed	B-UNK
to	O
have	O
formed	B-UNK
by	O
recombination	B-UNK
(	O
crossover	B-UNK
,	O
fusion	B-UNK
)	O
of	O
the	O
structural	B-UNK
gene	B-UNK
with	O
the	O
pseudogene	B-UNK
,	O
which	O
contains	B-UNK
the	O
mutated	B-UNK
sequences	B-UNK
.	O

 	O
two	O
complex	B-UNK
alleles	B-UNK
have	O
never	O
been	O
demonstrated	B-UNK
to	O
coexist	O
in	O
any	O
individual	B-UNK
.	O

 	O
we	O
devised	O
a	O
selective	B-UNK
pcr	B-UNK
method	B-UNK
for	O
the	O
specific	B-UNK
amplification	B-UNK
of	O
the	O
normal	B-UNK
and	O
/	O
or	O
fusion	B-UNK
gene	B-UNK
.	O

 	O
using	O
this	O
procedure	B-UNK
we	O
demonstrated	B-UNK
the	O
fusion	B-UNK
gene	B-UNK
in	O
homozygous	B-UNK
form	B-UNK
for	O
the	O
first	O
time	B-UNK
,	O
in	O
a	O
macedonian	O
/	O
ashkenazi	B-UNK
jewish	I-UNK
gd	B-UNK
type	B-UNK
ii	I-UNK
fetus	B-UNK
.	O

 	O
both	O
parents	B-UNK
were	O
carriers	B-UNK
of	O
the	O
recombination	B-UNK
.	O

 	O
this	O
was	O
confirmed	B-UNK
by	O
direct	B-UNK
sequence	B-UNK
analysis	B-UNK
.	O

 	O
a	O
previous	B-UNK
conceptus	O
in	O
this	O
family	B-UNK
was	O
stillborn	O
at	B-DISEASE
36	O
weeks	O
,	O
with	O
features	B-UNK
of	O
severe	B-UNK
type	B-UNK
ii	I-UNK
gd	B-UNK
.	O

 	O
neonates	O
showing	B-UNK
a	O
severe	B-UNK
clinical	I-UNK
phenotype	B-UNK
,	O
analogous	O
to	O
the	O
early	B-UNK
neonatal	B-UNK
lethal	B-UNK
disease	B-DISEASE
occurring	B-UNK
in	O
mice	B-UNK
homozygous	B-UNK
for	O
a	O
null	B-UNK
allele	B-UNK
produced	B-UNK
by	O
targeted	B-UNK
disruption	B-UNK
of	O
gba	B-UNK
,	O
have	O
been	O
described	B-UNK
elsewhere	O
,	O
but	O
the	O
specific	B-UNK
mutations	B-UNK
in	O
these	O
cases	B-UNK
have	O
not	O
yet	O
been	O
characterized	B-UNK
.	O

 	O
(	O
abstract	B-UNK
truncated	B-UNK
at	B-DISEASE
250	O
words	O
)	O

 	O
late	B-UNK
infantile	I-UNK
metachromatic	B-DISEASE
leukodystrophy	I-DISEASE
in	O
israel	O
.	O

 	O
metachromatic	B-DISEASE
leukodystrophy	I-DISEASE
(	O
mld	B-UNK
)	O
is	O
a	O
neurodegenerative	B-DISEASE
disease	I-DISEASE
in	O
which	O
the	O
lysosomal	B-UNK
enzyme	B-UNK
,	O
aryl	O
sulfatase	B-UNK
a	O
(	O
arsa	B-UNK
)	O
is	O
deficient	B-UNK
.	O

 	O
the	O
disease	B-DISEASE
is	O
inherited	B-UNK
as	O
an	O
autosomal	O
recessive	O
trait	B-UNK
and	O
its	O
frequency	B-UNK
is	O
estimated	B-UNK
to	O
be	O
1	O
/	O
40	O
,	O
000	O
live	B-UNK
births	B-UNK
.	O

 	O
the	O
gene	B-UNK
of	O
arsa	B-UNK
has	O
been	O
cloned	B-UNK
and	O
up	O
to	O
now	O
eight	O
mutations	B-UNK
causing	B-UNK
mld	B-UNK
have	O
been	O
reported	B-UNK
.	O

 	O
another	O
mutation	B-UNK
,	O
pd	B-DISEASE
,	O
leads	B-UNK
to	O
the	O
deficiency	B-UNK
of	O
the	O
enzyme	B-UNK
in	O
vitro	B-UNK
(	O
pseudodeficiency	O
)	O
without	O
any	O
known	B-UNK
clinical	B-UNK
effect	B-UNK
.	O

 	O
the	O
pd	B-DISEASE
mutation	B-UNK
is	O
frequent	B-UNK
in	O
all	O
populations	B-UNK
.	O

 	O
in	O
israel	O
,	O
late	B-UNK
infantile	I-UNK
mld	B-UNK
was	O
found	B-UNK
to	O
be	O
very	O
frequent	B-UNK
in	O
a	O
small	B-UNK
jewish	B-UNK
isolate	B-UNK
,	O
the	O
habbanite	O
jews	B-UNK
(	O
1	O
/	O
75	O
live	B-UNK
births	B-UNK
)	O
.	O

 	O
the	O
molecular	B-UNK
analysis	B-UNK
demonstrated	B-UNK
that	O
in	O
the	O
habbanite	O
population	B-UNK
,	O
the	O
mutation	B-UNK
occurred	B-UNK
on	O
an	O
allele	B-UNK
with	O
the	O
pd	B-DISEASE
mutation	B-UNK
.	O

 	O
the	O
loss	B-UNK
of	O
arsa	B-UNK
activity	I-UNK
is	O
due	O
to	O
a	O
point	B-UNK
mutation	I-UNK
c	B-UNK
>	O
t	B-UNK
leading	B-UNK
to	O
a	O
change	B-UNK
of	O
proline	O
to	O
leucine	O
.	O

 	O
mld	B-UNK
is	O
also	O
frequent	B-UNK
among	O
moslem	O
arabs	O
in	O
jerusalem	O
.	O

 	O
the	O
mutation	B-UNK
is	O
a	O
transition	B-UNK
g	B-UNK
>	I-UNK
a	O
destroying	O
the	O
splice	B-UNK
donor	I-UNK
site	I-UNK
of	O
exon	B-UNK
2	O
.	O

 	O
this	O
mutation	B-UNK
has	O
been	O
reported	B-UNK
in	O
patients	B-UNK
with	O
the	O
late	B-UNK
infantile	I-UNK
mld	B-UNK
from	O
different	B-UNK
ethnic	B-UNK
groups	B-UNK
.	O

 	O
the	O
christian	O
arabs	O
in	O
israel	O
also	O
have	O
a	O
high	B-UNK
incidence	O
of	O
the	O
disease	B-DISEASE
(	O
1	O
/	O
10	O
,	O
000	O
live	B-UNK
births	B-UNK
)	O
;	O
the	O
mutation	B-UNK
in	O
this	O
population	B-UNK
is	O
still	O
unknown	B-UNK
.	O

 	O
knowledge	B-UNK
of	O
the	O
different	B-UNK
mutations	B-UNK
causing	B-UNK
mld	B-UNK
in	O
these	O
defined	B-UNK
populations	B-UNK
will	O
allow	B-UNK
a	O
carrier	B-UNK
screening	B-UNK
program	B-UNK
to	O
be	O
carried	B-UNK
out	O
and	O
prevent	O
the	O
birth	O
of	O
additional	B-UNK
affected	B-UNK
children	B-UNK
.	O
.	O

 	O
a	O
single	B-UNK
amino	I-UNK
acid	I-UNK
substitution	B-UNK
(	O
g103d	O
)	O
in	O
the	O
type	B-UNK
ii	I-UNK
collagen	I-UNK
triple	B-UNK
helix	B-UNK
produces	B-UNK
kniest	B-DISEASE
dysplasia	I-DISEASE
.	O

 	O
kniest	B-DISEASE
dysplasia	I-DISEASE
is	O
a	O
moderately	B-UNK
severe	B-UNK
chondrodysplasia	B-DISEASE
phenotype	B-UNK
that	O
results	B-UNK
from	O
mutations	B-UNK
in	O
the	O
gene	B-UNK
for	O
type	B-UNK
ii	I-UNK
collagen	I-UNK
,	O
col2a1	B-UNK
.	O

 	O
characteristics	B-UNK
of	O
the	O
disorder	O
include	B-UNK
a	O
short	B-UNK
trunk	O
and	O
extremities	O
,	O
mid	O
-	O
face	O
hypoplasia	B-UNK
,	O
cleft	B-DISEASE
palate	I-DISEASE
,	O
myopia	B-DISEASE
,	O
retinal	B-DISEASE
detachment	I-DISEASE
,	O
and	O
hearing	B-DISEASE
loss	I-DISEASE
.	O

 	O
recently	B-UNK
,	O
deletions	B-UNK
of	O
all	O
or	O
part	O
of	O
exon	B-UNK
12	O
have	O
been	O
identified	B-UNK
in	O
individuals	B-UNK
with	O
kniest	B-DISEASE
dysplasia	I-DISEASE
,	O
suggesting	B-UNK
that	O
mutations	B-UNK
within	O
this	O
region	B-UNK
of	O
the	O
protein	B-UNK
may	O
primarily	B-UNK
result	B-UNK
in	O
the	O
kniest	B-DISEASE
dysplasia	I-DISEASE
phenotype	B-UNK
.	O

 	O
we	O
used	O
sscp	B-UNK
to	O
analyze	O
an	O
amplified	B-UNK
genomic	I-UNK
dna	B-UNK
fragment	O
containing	B-UNK
exon	B-UNK
12	O
from	O
seven	B-UNK
individuals	B-UNK
with	O
kniest	B-DISEASE
dysplasia	I-DISEASE
.	O

 	O
an	O
abnormality	B-UNK
was	O
identified	B-UNK
in	O
one	O
patient	B-UNK
.	O

 	B-UNK
dna	I-UNK
sequence	B-UNK
analysis	B-UNK
demonstrated	B-UNK
that	O
the	O
patient	B-UNK
was	O
heterozygous	B-UNK
for	O
a	O
g	B-UNK
to	O
a	O
transition	B-UNK
that	O
implied	O
substitution	B-UNK
of	O
glycine103	O
of	O
the	O
triple	B-UNK
helical	O
domain	B-UNK
by	O
aspartate	O
.	O

 	O
the	O
mutation	B-UNK
was	O
not	O
observed	B-UNK
in	O
dna	B-UNK
from	O
either	O
of	O
the	O
clinically	B-UNK
unaffected	B-UNK
parents	B-UNK
of	O
the	O
proband	B-UNK
.	O

 	O
protein	B-UNK
microsequencing	O
demonstrated	B-UNK
expression	B-UNK
of	O
the	O
abnormal	B-UNK
allele	B-UNK
in	O
cartilage	O
.	O

 	O
these	O
data	B-UNK
demonstrate	B-UNK
that	O
point	B-UNK
mutations	I-UNK
which	O
result	B-UNK
in	O
single	B-UNK
amino	I-UNK
acid	I-UNK
substitutions	B-UNK
can	O
produce	B-UNK
kniest	B-DISEASE
dysplasia	I-DISEASE
and	O
further	O
support	B-UNK
the	O
hypothesis	O
that	O
alteration	B-UNK
of	O
a	O
domain	B-UNK
,	O
which	O
includes	B-UNK
the	O
region	B-UNK
encoded	B-UNK
by	O
exon	B-UNK
12	O
,	O
in	O
the	O
type	B-UNK
ii	I-UNK
collagen	I-UNK
protein	B-UNK
leads	B-UNK
to	O
this	O
disorder	O
.	O
.	O

 	O
cag	B-UNK
expansions	B-UNK
in	O
a	O
novel	B-UNK
gene	B-UNK
for	O
machado	B-DISEASE
-	I-DISEASE
joseph	I-DISEASE
disease	I-DISEASE
at	B-DISEASE
chromosome	B-UNK
14q32	B-UNK
.	O
1	O
.	O

 	O
we	O
have	O
identified	B-UNK
a	O
novel	B-UNK
gene	B-UNK
containing	B-UNK
cag	B-UNK
repeats	B-UNK
and	O
mapped	B-UNK
it	O
to	O
chromosome	B-UNK
14q32	B-UNK
.	O

 	O
1	O
,	O
the	O
genetic	B-UNK
locus	B-UNK
for	O
machado	B-DISEASE
-	I-DISEASE
joseph	I-DISEASE
disease	I-DISEASE
(	O
mjd	B-UNK
)	O
.	O

 	O
in	O
normal	B-UNK
individuals	B-UNK
the	O
gene	B-UNK
contains	B-UNK
between	O
13	O
and	O
36	O
cag	B-UNK
repeats	B-UNK
,	O
whereas	O
most	O
of	O
the	O
clinically	B-UNK
diagnosed	B-UNK
patients	B-UNK
and	O
all	O
of	O
the	O
affected	B-UNK
members	B-UNK
of	O
a	O
family	B-UNK
with	O
the	O
clinical	B-UNK
and	O
pathological	B-UNK
diagnosis	B-UNK
of	O
mjd	B-UNK
show	O
expansion	B-UNK
of	O
the	O
repeat	B-UNK
-	O
number	B-UNK
(	O
from	O
68	O
-	O
79	O
)	O
.	O

 	B-UNK
southern	I-UNK
blot	I-UNK
analyses	B-UNK
and	O
genomic	B-UNK
cloning	B-UNK
demonstrates	B-UNK
the	O
existence	O
of	O
related	B-UNK
genes	B-UNK
.	O

 	O
these	O
results	B-UNK
raise	O
the	O
possibility	O
that	O
similar	B-UNK
abnormalities	B-DISEASE
in	O
related	B-UNK
genes	B-UNK
may	O
give	O
rise	B-UNK
to	O
diseases	B-DISEASE
similar	B-UNK
to	O
mjd	B-UNK
.	O

 	O
mutations	B-UNK
in	O
the	O
brca1	B-UNK
gene	B-UNK
in	O
families	B-UNK
with	O
early	B-UNK
-	O
onset	B-UNK
breast	B-UNK
and	O
ovarian	B-DISEASE
cancer	I-DISEASE
.	O

 	O
we	O
analysed	B-UNK
50	O
probands	B-UNK
with	O
a	O
family	B-UNK
history	B-UNK
of	O
breast	B-UNK
and	O
/	O
or	O
ovarian	B-DISEASE
cancer	I-DISEASE
for	O
germline	B-UNK
mutations	I-UNK
in	O
the	O
coding	B-UNK
region	I-UNK
of	O
the	O
brca1	B-UNK
candidate	B-UNK
gene	B-UNK
,	O
using	O
single	B-UNK
-	O
strand	B-UNK
conformation	I-UNK
polymorphism	I-UNK
(	O
sscp	B-UNK
)	O
analysis	B-UNK
on	O
pcr	B-UNK
-	O
amplified	B-UNK
genomic	I-UNK
dna	B-UNK
.	O

 	O
a	O
total	B-UNK
of	O
eight	O
putative	B-UNK
disease	B-DISEASE
-	O
causing	B-UNK
alterations	B-UNK
were	O
identified	B-UNK
four	O
of	O
these	O
are	O
frameshifts	O
and	O
two	O
are	O
nonsense	B-UNK
mutations	B-UNK
.	O

 	O
in	O
addition	B-UNK
,	O
we	O
found	B-UNK
two	O
missense	B-UNK
mutations	I-UNK
,	O
one	O
of	O
which	O
changes	B-UNK
the	O
final	O
cysteine	O
of	O
the	O
brca1	B-UNK
zinc	B-DISEASE
finger	B-UNK
motif	B-UNK
to	O
glycine	B-UNK
.	O

 	O
these	O
data	B-UNK
are	O
consistent	B-UNK
with	O
a	O
tumour	B-UNK
suppressor	I-UNK
model	B-UNK
,	O
and	O
support	B-UNK
the	O
notion	O
that	O
this	O
candidate	B-UNK
gene	B-UNK
is	O
in	O
fact	O
brca1	B-UNK
.	O

 	O
the	O
heterogeneity	B-UNK
of	O
mutations	B-UNK
,	O
coupled	B-UNK
with	O
the	O
large	B-UNK
size	B-UNK
of	O
the	O
gene	B-UNK
,	O
indicates	B-UNK
that	O
clinical	B-UNK
application	O
of	O
brca1	B-UNK
mutation	B-UNK
testing	B-UNK
will	O
be	O
technically	O
challenging	O
.	O
.	O

 	O
confirmation	O
of	O
brca1	B-UNK
by	O
analysis	B-UNK
of	O
germline	B-UNK
mutations	I-UNK
linked	B-UNK
to	O
breast	B-UNK
and	O
ovarian	B-DISEASE
cancer	I-DISEASE
in	O
ten	B-DISEASE
families	B-UNK
.	O

 	O
we	O
provide	B-UNK
genetic	B-UNK
evidence	B-UNK
supporting	B-UNK
the	O
identity	O
of	O
the	O
candidate	B-UNK
gene	B-UNK
for	O
brca1	B-UNK
through	O
the	O
characterization	B-UNK
of	O
germline	B-UNK
mutations	I-UNK
in	O
63	O
breast	B-DISEASE
cancer	I-DISEASE
patients	B-UNK
and	O
10	O
ovarian	B-DISEASE
cancer	I-DISEASE
patients	B-UNK
in	O
ten	B-DISEASE
families	B-UNK
with	O
cancer	B-DISEASE
linked	B-UNK
to	O
chromosome	B-UNK
17q21	B-UNK
.	O

 	O
nine	O
different	B-UNK
mutations	B-UNK
were	O
detected	B-UNK
by	O
screening	B-UNK
brca1	B-UNK
dna	B-UNK
and	O
rna	B-UNK
by	O
single	B-UNK
-	O
strand	B-UNK
conformation	I-UNK
polymorphism	I-UNK
analysis	B-UNK
and	O
direct	B-UNK
sequencing	I-UNK
.	O

 	B-UNK
seven	I-UNK
mutations	B-UNK
lead	B-UNK
to	O
protein	B-UNK
truncations	O
at	B-DISEASE
sites	B-UNK
throughout	O
the	O
gene	B-UNK
.	O

 	O
one	O
missense	B-UNK
mutation	I-UNK
(	O
which	O
occurred	B-UNK
independently	B-UNK
in	O
two	O
families	B-UNK
)	O
leads	B-UNK
to	O
loss	B-UNK
of	O
a	O
cysteine	O
in	O
the	O
zinc	B-DISEASE
binding	B-UNK
domain	I-UNK
.	O

 	O
an	O
intronic	B-UNK
single	B-UNK
basepair	O
substitution	B-UNK
destroys	O
an	O
acceptor	B-UNK
site	B-UNK
and	O
activates	O
a	O
cryptic	O
splice	B-UNK
site	I-UNK
,	O
leading	B-UNK
to	O
a	O
59	O
basepair	O
insertion	B-UNK
and	O
chain	O
termination	B-UNK
.	O

 	O
the	O
four	O
families	B-UNK
with	O
both	O
breast	B-UNK
and	O
ovarian	B-DISEASE
cancer	I-DISEASE
had	O
chain	O
termination	B-UNK
mutations	B-UNK
in	O
the	O
n	B-UNK
-	O
terminal	B-UNK
half	B-UNK
of	O
the	O
protein	B-UNK
.	O
.	O

 	O
high	B-UNK
resolution	B-UNK
genetic	B-UNK
analysis	B-UNK
suggests	B-UNK
one	O
ancestral	B-UNK
predisposing	B-UNK
haplotype	B-UNK
for	O
the	O
origin	B-UNK
of	O
the	O
myotonic	B-DISEASE
dystrophy	I-DISEASE
mutation	B-UNK
.	O

 	O
the	O
mutation	B-UNK
causing	B-UNK
myotonic	B-DISEASE
dystrophy	I-DISEASE
(	O
dm	B-DISEASE
)	O
has	O
been	O
identified	B-UNK
as	O
an	O
amplification	B-UNK
of	O
an	O
unstable	B-UNK
trinucleotide	B-UNK
(	O
ctg	B-UNK
)	O
n	B-UNK
repeat	I-UNK
in	O
over	O
99	O
%	O
of	O
the	O
global	O
dm	B-DISEASE
population	B-UNK
.	O

 	O
it	O
is	O
in	O
complete	B-UNK
linkage	B-UNK
disequilibrium	I-UNK
with	O
an	O
alu	B-UNK
element	B-UNK
polymorphism	O
within	O
the	O
dm	B-DISEASE
kinase	B-UNK
gene	B-UNK
,	O
suggesting	B-UNK
that	O
dm	B-DISEASE
is	O
a	O
consequence	O
of	O
one	O
or	O
few	O
ancestral	B-UNK
mutations	B-UNK
.	O

 	O
a	O
recent	B-UNK
analysis	B-UNK
utilizing	B-UNK
this	O
polymorphism	O
as	O
well	O
as	O
a	O
flanking	B-UNK
dinucleotide	B-UNK
marker	B-UNK
,	O
suggested	B-UNK
that	O
similar	B-UNK
to	O
fragile	B-DISEASE
x	I-DISEASE
syndrome	I-DISEASE
,	O
dm	B-DISEASE
exhibited	B-UNK
a	O
founder	B-UNK
effect	B-UNK
(	O
imbert	O
et	O
al	O
.	O
,	O
1993	O
nature	B-UNK
genet	B-UNK
.	O
4	O
,	O
72	O
-	O
76	O
)	O
.	O

 	O
in	O
contrast	B-UNK
,	O
the	O
low	B-UNK
reproductive	B-UNK
fitness	O
of	O
individuals	B-UNK
with	O
congenital	B-DISEASE
dm	B-DISEASE
(	O
the	O
endpoint	O
of	O
genetic	B-UNK
anticipation	B-DISEASE
in	O
myotonic	B-DISEASE
dystrophy	I-DISEASE
)	O
suggests	B-UNK
a	O
higher	B-UNK
rate	B-UNK
of	O
new	B-UNK
mutations	B-UNK
.	O

 	O
we	O
present	B-UNK
a	O
high	B-UNK
resolution	B-UNK
genetic	B-UNK
analysis	B-UNK
of	O
the	O
dm	B-DISEASE
locus	B-UNK
using	O
pcr	B-UNK
based	B-UNK
assays	B-UNK
of	O
nine	O
polymorphisms	B-UNK
,	O
spanning	B-UNK
a	O
physical	B-UNK
distance	B-UNK
of	O
30	O
kb	B-UNK
,	O
within	O
and	O
immediately	B-UNK
flanking	B-UNK
the	O
dm	B-DISEASE
kinase	B-UNK
gene	B-UNK
.	O

 	O
the	O
persistent	O
complete	B-UNK
allelic	B-UNK
association	B-UNK
of	O
the	O
dm	B-DISEASE
mutation	B-UNK
with	O
all	O
these	O
polymorphisms	B-UNK
provides	B-UNK
further	O
support	B-UNK
to	O
previous	B-UNK
observations	B-UNK
and	O
suggests	B-UNK
more	O
strongly	B-UNK
that	O
the	O
dm	B-DISEASE
mutation	B-UNK
occurred	B-UNK
on	O
the	O
background	B-UNK
of	O
a	O
particular	B-UNK
haplotype	B-UNK
in	O
which	O
the	O
(	O
ctg	B-UNK
)	O
n	B-UNK
repeat	I-UNK
became	O
inherently	O
unstable	B-UNK
and	O
therefore	O
predisposed	O
to	O
amplification	B-UNK
.	O

 	B-UNK
genetic	I-UNK
instability	B-UNK
in	O
human	B-UNK
ovarian	B-DISEASE
cancer	I-DISEASE
cell	B-UNK
lines	B-UNK
.	O

 	O
we	O
have	O
analyzed	B-UNK
the	O
stability	B-UNK
of	O
microsatellites	O
in	O
cell	B-UNK
lines	B-UNK
derived	B-UNK
from	O
human	B-UNK
ovarian	B-UNK
cancers	B-DISEASE
and	O
found	B-UNK
that	O
5	O
out	O
of	O
10	O
of	O
the	O
ovarian	B-UNK
tumor	B-DISEASE
cell	B-UNK
lines	B-UNK
are	O
genetically	B-UNK
unstable	B-UNK
at	B-DISEASE
the	O
majority	B-UNK
of	O
the	O
loci	B-UNK
analyzed	B-UNK
.	O

 	O
in	O
clones	B-UNK
and	O
subclones	O
derived	B-UNK
serially	O
from	O
one	O
of	O
these	O
cell	B-UNK
lines	B-UNK
(	O
2774	O
;	O
serous	O
cystadenocarcinoma	B-DISEASE
)	O
,	O
a	O
very	O
high	B-UNK
proportion	B-UNK
of	O
microsatellites	O
distributed	B-UNK
in	O
many	O
different	B-UNK
regions	B-UNK
of	O
the	O
genome	B-UNK
change	B-UNK
their	O
size	B-UNK
in	O
a	O
mercurial	O
fashion	O
.	O

 	O
we	O
conclude	O
that	O
genomic	B-DISEASE
instability	I-DISEASE
in	O
ovarian	B-UNK
tumors	B-DISEASE
is	O
a	O
dynamic	O
and	O
ongoing	O
process	B-UNK
whose	O
high	B-UNK
frequency	B-UNK
may	O
have	O
been	O
previously	B-UNK
underestimated	O
by	O
pcr	B-UNK
-	O
based	B-UNK
allelotyping	O
of	O
bulk	O
tumor	B-DISEASE
tissue	B-UNK
.	O

 	O
we	O
have	O
identified	B-UNK
the	O
source	O
of	O
the	O
genetic	B-UNK
instability	B-UNK
in	O
one	O
ovarian	B-UNK
tumor	B-DISEASE
as	O
a	O
point	B-UNK
mutation	I-UNK
(	O
r524p	O
)	O
in	O
the	O
human	B-UNK
mismatch	O
-	O
repair	B-UNK
gene	B-UNK
msh2	B-UNK
(	O
salmonella	O
muts	O
homologue	B-UNK
)	O
,	O
which	O
has	O
recently	B-UNK
been	O
shown	B-UNK
to	O
be	O
involved	B-UNK
in	O
hereditary	B-UNK
nonpolyposis	O
colorectal	B-DISEASE
cancer	I-DISEASE
.	O

 	O
patient	B-UNK
2774	O
was	O
a	O
38	O
-	O
year	B-UNK
-	O
old	B-UNK
heterozygote	B-UNK
,	O
and	O
her	O
normal	B-UNK
tissue	B-UNK
carried	B-UNK
both	O
mutant	B-UNK
and	O
wild	B-UNK
-	O
type	B-UNK
alleles	B-UNK
of	O
the	O
human	B-UNK
msh2	B-UNK
gene	B-UNK
.	O

 	O
however	O
the	O
wild	B-UNK
-	O
type	B-UNK
allele	B-UNK
was	O
lost	O
at	B-DISEASE
some	O
point	B-UNK
early	B-UNK
during	O
tumorigenesis	B-UNK
so	O
that	O
dna	B-UNK
isolated	B-UNK
either	O
from	O
the	O
patients	B-UNK
ovarian	B-UNK
tumor	B-DISEASE
or	O
from	O
the	O
2774	O
cell	B-UNK
line	B-UNK
carries	O
only	O
the	O
mutant	B-UNK
allele	I-UNK
of	O
the	O
human	B-UNK
msh2	B-UNK
gene	B-UNK
.	O

 	O
the	O
genetic	B-UNK
instability	B-UNK
observed	B-UNK
in	O
the	O
tumor	B-DISEASE
and	O
cell	B-UNK
line	B-UNK
dna	B-UNK
,	O
together	O
with	O
the	O
germ	O
-	O
line	B-UNK
mutation	B-UNK
in	O
a	O
mismatch	O
-	O
repair	B-UNK
gene	B-UNK
,	O
suggest	B-UNK
that	O
the	O
msh2	B-UNK
gene	B-UNK
is	O
involved	B-UNK
in	O
the	O
onset	B-UNK
and	O
/	O
or	O
progression	O
in	O
a	O
subset	O
of	O
ovarian	B-DISEASE
cancer	I-DISEASE
.	O
.	O

 	B-UNK
brca1	I-UNK
mutations	B-UNK
in	O
primary	B-UNK
breast	B-UNK
and	O
ovarian	B-UNK
carcinomas	B-UNK
.	O

 	O
loss	B-UNK
of	O
heterozygosity	B-UNK
data	B-UNK
from	O
familial	B-UNK
tumors	B-DISEASE
suggest	B-UNK
that	O
brca1	B-UNK
,	O
a	O
gene	B-UNK
that	O
confers	O
susceptibility	B-UNK
to	O
ovarian	B-UNK
and	O
early	B-UNK
-	O
onset	B-UNK
breast	B-DISEASE
cancer	I-DISEASE
,	O
encodes	B-UNK
a	O
tumor	B-DISEASE
suppressor	B-UNK
.	O

 	O
the	O
brca1	B-UNK
region	B-UNK
is	O
also	O
subject	B-UNK
to	O
allelic	B-UNK
loss	B-UNK
in	O
sporadic	B-UNK
breast	B-UNK
and	O
ovarian	B-UNK
cancers	B-DISEASE
,	O
an	O
indication	O
that	O
brca1	B-UNK
mutations	I-UNK
may	O
occur	B-UNK
somatically	O
in	O
these	O
tumors	B-DISEASE
.	O

 	O
the	O
brca1	B-UNK
coding	B-UNK
region	I-UNK
was	O
examined	B-UNK
for	O
mutations	B-UNK
in	O
primary	B-UNK
breast	B-UNK
and	O
ovarian	B-UNK
tumors	B-DISEASE
that	O
show	O
allele	B-UNK
loss	B-UNK
at	B-DISEASE
the	O
brca1	B-UNK
locus	B-UNK
.	O

 	O
mutations	B-UNK
were	O
detected	B-UNK
in	O
3	O
of	O
32	O
breast	B-UNK
and	O
1	O
of	O
12	O
ovarian	B-UNK
carcinomas	B-UNK
;	O
all	O
four	O
mutations	B-UNK
were	O
germline	B-UNK
alterations	B-UNK
and	O
occurred	B-UNK
in	O
early	B-UNK
-	O
onset	B-UNK
cancers	B-DISEASE
.	O

 	O
these	O
results	B-UNK
suggest	B-UNK
that	O
mutation	B-UNK
of	O
brca1	B-UNK
may	O
not	O
be	O
critical	B-UNK
in	O
the	O
development	B-UNK
of	O
the	O
majority	B-UNK
of	O
breast	B-UNK
and	O
ovarian	B-UNK
cancers	B-DISEASE
that	O
arise	O
in	O
the	O
absence	B-UNK
of	O
a	O
mutant	B-UNK
germline	B-UNK
allele	B-UNK
.	O
.	O

 	O
pax6	B-UNK
gene	B-UNK
dosage	O
effect	B-UNK
in	O
a	O
family	B-UNK
with	O
congenital	B-DISEASE
cataracts	I-DISEASE
,	O
aniridia	B-DISEASE
,	O
anophthalmia	O
and	O
central	B-UNK
nervous	I-UNK
system	I-UNK
defects	B-UNK
.	O

 	O
the	O
human	B-UNK
eye	B-UNK
malformation	O
aniridia	B-DISEASE
results	B-UNK
from	O
haploinsufficiency	O
of	O
pax6	B-UNK
,	O
a	O
paired	B-UNK
box	B-UNK
dna	B-UNK
-	O
binding	B-UNK
protein	B-UNK
.	O

 	O
to	O
study	B-UNK
this	O
dosage	O
effect	B-UNK
,	O
we	O
characterized	B-UNK
two	O
pax6	B-UNK
mutations	B-UNK
in	O
a	O
family	B-UNK
segregating	B-UNK
aniridia	B-DISEASE
and	O
a	O
milder	B-UNK
syndrome	B-DISEASE
consisting	O
of	O
congenital	B-DISEASE
cataracts	I-DISEASE
and	O
late	B-UNK
onset	B-UNK
corneal	B-DISEASE
dystrophy	I-DISEASE
.	O

 	O
the	O
nonsense	B-UNK
mutations	B-UNK
,	O
at	B-DISEASE
codons	B-UNK
103	O
and	O
353	O
,	O
truncate	O
pax6	B-UNK
within	O
the	O
n	B-UNK
-	O
terminal	B-UNK
paired	B-UNK
and	O
c	B-UNK
-	O
terminal	B-UNK
pst	B-UNK
domains	B-UNK
,	O
respectively	B-UNK
.	O

 	O
the	O
wild	B-UNK
-	O
type	B-UNK
pst	B-UNK
domain	B-UNK
activates	O
transcription	B-UNK
autonomously	O
and	O
the	O
mutant	B-UNK
form	B-UNK
has	O
partial	B-UNK
activity	B-UNK
.	O

 	O
a	O
compound	B-UNK
heterozygote	B-UNK
had	O
severe	B-UNK
craniofacial	O
and	O
central	B-UNK
nervous	I-UNK
system	I-UNK
defects	B-UNK
and	O
no	O
eyes	O
.	O

 	O
the	O
pattern	B-UNK
of	O
malformations	O
is	O
similar	B-UNK
to	O
that	O
in	O
homozygous	B-UNK
sey	O
mice	B-UNK
and	O
suggests	B-UNK
a	O
critical	B-UNK
role	B-UNK
for	O
pax6	B-UNK
in	O
controlling	O
the	O
migration	B-UNK
and	O
differentiation	B-UNK
of	O
specific	B-UNK
neuronal	B-UNK
progenitor	B-UNK
cells	B-UNK
in	O
the	O
brain	B-UNK
.	O
.	O

 	O
a	O
physical	B-UNK
map	B-UNK
and	O
candidate	B-UNK
genes	I-UNK
in	O
the	O
brca1	B-UNK
region	B-UNK
on	O
chromosome	B-UNK
17q12	B-UNK
-	O
21	O
.	O

 	O
we	O
have	O
constructed	B-UNK
a	O
physical	B-UNK
map	B-UNK
of	O
a	O
4	O
cm	B-DISEASE
region	B-UNK
on	O
chromosome	B-UNK
17q12	B-UNK
-	O
21	O
that	O
contains	B-UNK
the	O
hereditary	B-UNK
breast	B-UNK
and	O
ovarian	B-DISEASE
cancer	I-DISEASE
gene	B-UNK
brca1	B-UNK
.	O

 	O
the	O
map	B-UNK
comprises	O
a	O
contig	B-UNK
of	O
137	O
overlapping	B-UNK
yeast	B-UNK
artificial	I-UNK
chromosomes	B-UNK
and	O
p1	B-UNK
clones	B-UNK
,	O
onto	O
which	O
we	O
have	O
placed	O
112	O
pcr	B-UNK
markers	B-UNK
.	O

 	O
we	O
have	O
localized	B-UNK
more	O
than	O
20	O
genes	B-UNK
on	O
this	O
map	B-UNK
,	O
ten	B-DISEASE
of	O
which	O
had	O
not	O
been	O
mapped	B-UNK
to	O
the	O
region	B-UNK
previously	B-UNK
,	O
and	O
have	O
isolated	B-UNK
30	O
cdna	B-UNK
clones	B-UNK
representing	B-UNK
partial	B-UNK
sequences	B-UNK
of	O
as	O
yet	O
unidentified	B-UNK
genes	B-UNK
.	O

 	O
two	O
genes	B-UNK
that	O
lie	O
within	O
a	O
narrow	B-UNK
region	B-UNK
defined	B-UNK
by	O
meiotic	B-UNK
breakpoints	B-UNK
in	O
brca1	B-UNK
patients	B-UNK
have	O
been	O
sequenced	B-UNK
in	O
breast	B-DISEASE
cancer	I-DISEASE
patients	B-UNK
without	O
revealing	O
any	O
deleterious	O
mutations	B-UNK
.	O

 	O
these	O
new	B-UNK
reagents	B-UNK
should	O
facilitate	B-UNK
the	O
identification	B-UNK
of	O
brca1	B-UNK
.	O
.	O

 	O
the	O
lec	B-UNK
rat	B-UNK
has	O
a	O
deletion	B-UNK
in	O
the	O
copper	B-UNK
transporting	O
atpase	B-UNK
gene	B-UNK
homologous	B-UNK
to	O
the	O
wilson	B-UNK
disease	B-DISEASE
gene	B-UNK
.	O

 	O
the	O
long	B-UNK
-	O
evans	O
cinnamon	O
(	O
lec	B-UNK
)	O
rat	B-UNK
shows	B-UNK
similarity	B-UNK
to	O
wilson	B-UNK
disease	B-DISEASE
in	O
many	O
clinical	B-UNK
and	O
biochemical	B-UNK
features	B-UNK
.	O

 	O
we	O
have	O
cloned	B-UNK
cdnas	B-UNK
for	O
the	O
rat	B-UNK
gene	B-UNK
(	O
atp7b	B-UNK
)	O
homologous	B-UNK
to	O
the	O
human	B-UNK
wilson	B-UNK
disease	B-DISEASE
gene	B-UNK
(	O
atp7b	B-UNK
)	O
and	O
have	O
used	O
them	O
to	O
identify	B-UNK
a	O
partial	B-UNK
deletion	B-UNK
in	O
the	O
atp7b	B-UNK
gene	B-UNK
in	O
the	O
lec	B-UNK
rat	B-UNK
.	O

 	O
the	O
deletion	B-UNK
removes	O
at	B-DISEASE
least	O
900	O
bp	B-UNK
of	O
the	O
coding	B-UNK
region	I-UNK
at	B-DISEASE
the	O
3	O
end	B-UNK
,	O
includes	B-UNK
the	O
crucial	B-UNK
atp	B-UNK
binding	B-UNK
domain	I-UNK
and	O
extends	O
downstream	B-UNK
of	O
the	O
gene	B-UNK
.	O

 	O
our	O
results	B-UNK
provide	I-UNK
convincing	O
evidence	B-UNK
for	O
defining	O
the	O
lec	B-UNK
rat	B-UNK
as	O
an	O
animal	B-UNK
model	B-UNK
for	O
wilson	B-UNK
disease	B-DISEASE
.	O

 	O
this	O
model	B-UNK
will	O
be	O
important	B-UNK
for	O
studying	O
liver	B-DISEASE
pathophysiology	O
,	O
for	O
developing	B-UNK
therapy	B-UNK
for	O
wilson	B-UNK
disease	B-DISEASE
and	O
for	O
studying	O
the	O
pathway	B-UNK
of	O
copper	B-UNK
transport	B-UNK
and	O
its	O
possible	B-UNK
interaction	B-UNK
with	O
other	O
heavy	O
metals	O
.	O
.	O

 	B-UNK
genomic	I-UNK
organization	B-UNK
of	O
the	O
adrenoleukodystrophy	B-DISEASE
gene	B-UNK
.	O

 	O
adrenoleukodystrophy	B-DISEASE
(	O
ald	B-UNK
)	O
,	O
the	O
most	O
frequent	B-UNK
peroxisomal	B-UNK
disorder	O
,	O
is	O
a	O
severe	B-UNK
neurodegenerative	B-DISEASE
disease	I-DISEASE
associated	B-UNK
with	O
an	O
impairment	O
of	O
very	O
long	B-UNK
chain	I-UNK
fatty	I-UNK
acids	O
beta	B-UNK
-	O
oxidation	B-UNK
.	O

 	O
we	O
have	O
recently	B-UNK
identified	B-UNK
by	O
positional	B-UNK
cloning	I-UNK
the	O
gene	B-UNK
responsible	B-UNK
for	O
ald	B-UNK
,	O
located	B-UNK
in	O
xq28	B-UNK
.	O

 	O
it	O
encodes	B-UNK
a	O
new	B-UNK
member	B-UNK
of	O
the	O
"	O
abc	O
"	O
superfamily	O
of	O
membrane	B-UNK
-	O
associated	B-UNK
transporters	B-UNK
that	O
shows	B-UNK
,	O
in	O
particular	B-UNK
,	O
significant	B-UNK
homology	B-UNK
to	O
the	O
70	O
-	O
kda	B-UNK
peroxisomal	B-UNK
membrane	I-UNK
protein	B-UNK
(	O
pmp70	B-UNK
)	O
.	O

 	O
we	O
report	B-UNK
here	O
a	O
detailed	B-UNK
characterization	B-UNK
of	O
the	O
ald	B-UNK
gene	B-UNK
structure	B-UNK
.	O

 	O
it	O
extends	O
over	O
21	O
kb	B-UNK
and	O
consists	B-UNK
of	O
10	O
exons	B-UNK
.	O

 	O
to	O
facilitate	B-UNK
the	O
detection	B-UNK
of	O
mutations	B-UNK
in	O
ald	B-UNK
patients	I-UNK
,	O
we	O
have	O
determined	B-UNK
the	O
intronic	B-UNK
sequences	B-UNK
flanking	B-UNK
the	O
exons	B-UNK
as	O
well	O
as	O
the	O
sequence	B-UNK
of	O
the	O
3	O
untranslated	B-UNK
region	B-UNK
and	O
of	O
the	O
immediate	B-UNK
5	O
promoter	B-UNK
region	I-UNK
.	O

 	O
sequences	B-UNK
present	B-UNK
in	O
distal	B-UNK
exons	B-UNK
cross	B-UNK
-	O
hybridize	O
strongly	B-UNK
to	O
additional	B-UNK
sequences	B-UNK
in	O
the	O
human	B-UNK
genome	B-UNK
.	O

 	O
the	O
ald	B-UNK
gene	B-UNK
has	O
been	O
positioned	O
on	O
a	O
pulsed	O
-	O
field	B-UNK
map	B-UNK
between	O
dxs15	O
and	O
the	O
l1cam	O
gene	B-UNK
,	O
about	O
650	O
kb	B-UNK
upstream	B-UNK
from	O
the	O
color	B-UNK
pigment	I-UNK
genes	B-UNK
.	O

 	O
the	O
frequent	B-UNK
occurrence	B-UNK
of	O
color	B-UNK
vision	B-DISEASE
anomalies	B-UNK
observed	B-UNK
in	O
patients	B-UNK
with	O
adrenomyeloneuropathy	B-UNK
(	O
the	O
adult	B-UNK
onset	I-UNK
form	B-UNK
of	O
ald	B-UNK
)	O
thus	O
does	O
not	O
represent	B-UNK
a	O
contiguous	B-UNK
gene	B-UNK
syndrome	B-DISEASE
but	O
a	O
secondary	B-UNK
manifestation	B-UNK
of	O
ald	B-UNK
.	O
.	O

 	O
the	O
murine	B-UNK
homologues	B-UNK
of	O
the	O
huntington	B-DISEASE
disease	I-DISEASE
gene	B-UNK
(	O
hdh	O
)	O
and	O
the	O
alpha	B-UNK
-	O
adducin	O
gene	B-UNK
(	O
add1	O
)	O
map	B-UNK
to	O
mouse	B-UNK
chromosome	I-UNK
5	O
within	O
a	O
region	B-UNK
of	O
conserved	B-UNK
synteny	B-UNK
with	O
human	B-UNK
chromosome	I-UNK
4p16	B-UNK
.	O
3	O
.	O

 	O
huntington	B-DISEASE
disease	I-DISEASE
(	O
hd	B-UNK
)	O
is	O
a	O
severe	B-UNK
autosomal	O
dominant	B-UNK
neurodegenerative	B-DISEASE
disorder	I-DISEASE
associated	B-UNK
with	O
a	O
novel	B-UNK
gene	B-UNK
(	O
it15	O
)	O
.	O

 	O
recently	B-UNK
,	O
we	O
reported	B-UNK
the	O
cloning	B-UNK
of	O
hdh	O
,	O
the	O
murine	B-UNK
homologue	B-UNK
of	O
it15	O
.	O

 	O
here	O
,	O
using	O
an	O
interspecific	B-UNK
backcross	B-UNK
,	O
we	O
have	O
mapped	B-UNK
both	O
hdh	O
and	O
the	O
mouse	B-UNK
homologue	B-UNK
of	O
human	B-UNK
alpha	B-UNK
-	O
adducin	O
(	O
add1	O
)	O
,	O
a	O
membrane	B-UNK
-	O
associated	B-UNK
cytoskeletal	B-UNK
protein	B-UNK
gene	B-UNK
.	O

 	O
both	O
of	O
these	O
genes	B-UNK
map	B-UNK
in	O
the	O
same	O
position	B-UNK
on	O
mouse	B-UNK
chromosome	I-UNK
5	O
in	O
a	O
region	B-UNK
associated	B-UNK
with	O
ancestral	B-UNK
chromosomal	B-UNK
rearrangements	I-UNK
and	O
show	O
no	O
recombination	B-UNK
with	O
d5h4s43	O
,	O
d5h4s115	O
,	O
and	O
d5h4s62	O
,	O
the	O
murine	B-UNK
homologues	B-UNK
of	O
d4s43	O
,	O
d4s115	O
,	O
and	O
d4s62	O
,	O
respectively	B-UNK
.	O

 	O
further	O
mapping	B-UNK
studies	B-UNK
of	O
humans	B-UNK
,	O
mice	B-UNK
,	O
and	O
other	O
mammalian	B-UNK
species	B-UNK
should	O
reveal	B-UNK
the	O
nature	B-UNK
of	O
the	O
rearrangements	B-UNK
affecting	B-UNK
this	O
chromosomal	B-UNK
segment	B-UNK
during	O
mammalian	B-UNK
evolution	O
.	O
.	O

 	B-UNK
genetic	I-UNK
cholesteryl	B-DISEASE
ester	I-DISEASE
transfer	I-DISEASE
protein	I-DISEASE
deficiency	I-DISEASE
caused	B-UNK
by	O
two	O
prevalent	B-UNK
mutations	B-UNK
as	O
a	O
major	B-UNK
determinant	B-UNK
of	O
increased	B-UNK
levels	I-UNK
of	O
high	B-UNK
density	I-UNK
lipoprotein	B-UNK
cholesterol	I-UNK
.	O

 	B-UNK
genetic	I-UNK
determinants	O
of	O
hdl	B-UNK
cholesterol	B-UNK
(	O
hdl	B-UNK
-	O
c	B-UNK
)	O
levels	B-UNK
in	O
the	O
general	B-UNK
population	B-UNK
are	O
poorly	B-UNK
understood	O
.	O

 	O
we	O
previously	B-UNK
described	I-UNK
plasma	B-UNK
cholesteryl	B-UNK
ester	I-UNK
transfer	I-UNK
protein	I-UNK
(	O
cetp	B-UNK
)	O
deficiency	B-UNK
due	O
to	O
an	O
intron	B-UNK
14	O
g	B-UNK
(	O
+	O
1	O
)	O
-	O
to	O
-	O
a	O
mutation	B-UNK
(	O
int14	B-UNK
a	O
)	O
in	O
several	O
families	B-UNK
with	O
very	O
high	B-UNK
hdl	B-UNK
-	O
c	B-UNK
levels	B-UNK
in	O
japan	O
.	O

 	O
subjects	B-UNK
with	O
hdl	B-UNK
-	O
c	B-UNK
>	O
or	O
=	O
100	O
mg	O
/	O
dl	O
(	O
n	B-UNK
=	O
130	O
)	O
were	O
screened	O
by	O
pcr	B-UNK
single	B-UNK
strand	I-UNK
conformational	I-UNK
polymorphism	O
analysis	B-UNK
of	O
the	O
cetp	B-UNK
gene	B-UNK
.	O

 	O
two	O
other	O
mutations	B-UNK
were	O
identified	B-UNK
by	O
dna	B-UNK
sequencing	I-UNK
or	O
primer	B-UNK
-	O
mediated	B-UNK
restriction	O
map	B-UNK
modification	B-UNK
of	O
pcr	B-UNK
products	B-UNK
a	O
novel	B-UNK
intron	B-UNK
14	O
splice	B-UNK
donor	I-UNK
site	I-UNK
mutation	B-UNK
caused	B-UNK
by	O
a	O
t	B-UNK
insertion	B-UNK
at	B-DISEASE
position	B-UNK
+	O
3	O
from	O
the	O
exon14	O
/	O
intron14	O
boundary	B-UNK
(	O
int14	B-UNK
t	B-UNK
)	O
and	O
a	O
missense	B-UNK
mutation	I-UNK
(	O
asp442	O
to	O
gly	B-UNK
)	O
within	O
exon	B-UNK
15	O
(	O
d442	B-UNK
g	I-UNK
)	O
.	O

 	O
the	O
int14	B-UNK
t	B-UNK
mutation	B-UNK
was	O
only	O
found	B-UNK
in	O
one	O
family	B-UNK
.	O

 	O
however	O
,	O
the	O
d442	B-UNK
g	I-UNK
and	O
int14	B-UNK
a	O
mutations	B-UNK
were	O
highly	B-UNK
prevalent	B-UNK
in	O
subjects	B-UNK
with	O
hdl	B-UNK
-	O
c	B-UNK
>	O
or	O
=	O
60	O
mg	O
/	O
dl	O
,	O
with	O
combined	B-UNK
allele	B-UNK
frequencies	I-UNK
of	O
9	O
%	O
,	O
12	O
%	O
,	O
21	O
%	O
and	O
43	O
%	O
for	O
hdl	B-UNK
-	O
c	B-UNK
60	O
-	O
79	O
,	O
80	O
-	O
99	O
,	O
100	O
-	O
119	O
,	O
and	O
>	O
or	O
=	O
120	O
mg	O
/	O
dl	O
,	O
respectively	B-UNK
.	O

 	O
furthermore	B-UNK
,	O
prevalences	O
of	O
the	O
d442	B-UNK
g	I-UNK
and	O
int14	B-UNK
a	O
mutations	B-UNK
were	O
extremely	B-UNK
high	B-UNK
in	O
a	O
general	B-UNK
sample	B-UNK
of	O
japanese	B-UNK
men	B-UNK
(	O
n	B-UNK
=	O
236	O
)	O
,	O
with	O
heterozygote	B-UNK
frequencies	B-UNK
of	O
7	O
%	O
and	O
2	O
%	O
,	O
respectively	B-UNK
.	O

 	O
these	O
two	O
mutations	B-UNK
accounted	B-UNK
for	O
about	O
10	O
%	O
of	O
the	O
total	B-UNK
variance	O
of	O
hdl	B-UNK
-	O
c	B-UNK
in	O
this	O
population	B-UNK
.	O

 	O
the	O
phenotype	B-UNK
in	O
a	O
genetic	B-UNK
compound	B-UNK
heterozygote	B-UNK
(	O
int14	B-UNK
t	B-UNK
and	O
int14	B-UNK
a	O
)	O
was	O
similar	B-UNK
to	O
that	O
of	O
int14	B-UNK
a	O
homozygotes	B-UNK
(	O
no	O
detectable	B-UNK
cetp	B-UNK
and	O
markedly	B-UNK
increased	B-UNK
hdl	I-UNK
-	O
c	B-UNK
)	O
,	O
indicating	B-UNK
that	O
the	O
int14	B-UNK
t	B-UNK
produces	B-UNK
a	O
null	B-UNK
allele	B-UNK
.	O

 	O
in	O
four	O
d442	B-UNK
g	I-UNK
homozygotes	B-UNK
,	O
mean	B-UNK
hdl	B-UNK
-	O
c	B-UNK
levels	B-UNK
(	O
86	O
+	O
/	O
-	O
26	O
mg	O
/	O
dl	O
)	O
were	O
lower	B-UNK
than	O
in	O
int14	B-UNK
a	O
homozygotes	B-UNK
(	O
158	O
+	O
/	O
-	O
35	O
mg	O
/	O
dl	O
)	O
,	O
reflecting	O
residual	B-UNK
cetp	B-UNK
activity	I-UNK
in	O
plasma	B-UNK
.	O

 	O
in	O
47	O
d442	B-UNK
g	I-UNK
heterozygotes	B-UNK
,	O
mean	B-UNK
hdl	B-UNK
-	O
c	B-UNK
levels	B-UNK
were	O
91	O
+	O
/	O
-	O
23	O
mg	O
/	O
dl	O
,	O
similar	B-UNK
to	O
the	O
level	B-UNK
in	O
d442	B-UNK
g	I-UNK
homozygotes	B-UNK
,	O
and	O
significantly	B-UNK
greater	B-UNK
than	O
mean	B-UNK
hdl	B-UNK
-	O
c	B-UNK
levels	B-UNK
in	O
int14	B-UNK
a	O
heterozygotes	B-UNK
(	O
69	O
+	O
/	O
-	O
15	O
mg	O
/	O
dl	O
)	O
.	O

 	O
thus	O
,	O
the	O
d442	B-UNK
g	I-UNK
mutation	B-UNK
acts	B-UNK
differently	B-UNK
to	O
the	O
null	B-UNK
mutations	B-UNK
with	O
weaker	O
effects	B-UNK
on	O
hdl	B-UNK
in	O
the	O
homozygous	B-UNK
state	B-UNK
and	O
stronger	O
effects	B-UNK
in	O
the	O
heterozygotes	B-UNK
,	O
suggesting	B-UNK
dominant	B-UNK
expression	B-UNK
of	O
a	O
partially	B-UNK
defective	B-UNK
allele	B-UNK
.	O

 	B-UNK
cetp	I-UNK
deficiency	B-UNK
,	O
reflecting	O
two	O
prevalent	B-UNK
mutations	B-UNK
(	O
d442	B-UNK
g	I-UNK
and	O
int14	B-UNK
a	O
)	O
,	O
is	O
the	O
first	O
example	O
of	O
a	O
genetic	B-UNK
deficiency	B-UNK
state	B-UNK
which	O
is	O
sufficiently	O
common	B-UNK
to	O
explain	O
a	O
significant	B-UNK
fraction	B-UNK
of	O
the	O
variation	B-UNK
in	O
hdl	B-UNK
-	O
c	B-UNK
in	O
the	O
general	B-UNK
population	B-UNK
.	O
.	O

 	O
treatment	B-UNK
of	O
cerebrotendinous	O
xanthomatosis	B-DISEASE
:	O
effects	B-UNK
of	O
chenodeoxycholic	O
acid	O
,	O
pravastatin	O
,	O
and	O
combined	B-UNK
use	B-UNK
.	O

 	O
treatments	B-UNK
by	O
oral	B-UNK
administration	O
of	O
chenodeoxycholic	O
acid	O
(	O
cdca	O
)	O
alone	O
,	O
3	O
-	O
hydroxy	O
-	O
3	O
-	O
methylglutaryl	O
(	O
hmg	O
)	O
coa	B-UNK
reductase	O
inhibitor	B-UNK
(	O
pravastatin	O
)	O
alone	O
,	O
and	O
combination	O
of	O
the	O
two	O
drugs	B-UNK
were	O
attempted	O
for	O
7	O
patients	B-UNK
with	O
cerebrotendinous	O
xanthomatosis	B-DISEASE
(	O
ctx	B-UNK
)	O
.	O

 	O
cdca	O
treatment	B-UNK
at	B-DISEASE
a	O
dose	O
of	O
300	O
mg	O
/	O
day	B-UNK
reduced	B-UNK
serum	B-UNK
cholestanol	B-UNK
(	O
67	O
.	O
3	O
%	O
reduction	B-UNK
)	O
,	O
lathosterol	O
(	O
50	O
.	O
8	O
%	O
)	O
,	O
campesterol	O
(	O
61	O
.	O
7	O
%	O
)	O
and	O
sitosterol	O
(	O
12	O
.	O
7	O
%	O
)	O
.	O

 	O
however	O
,	O
the	O
sera	O
of	O
the	O
patients	B-UNK
changed	O
to	O
be	O
"	O
atherogenic	O
"	O
;	O
total	B-UNK
cholesterol	B-UNK
,	O
triglyceride	O
and	O
low	B-UNK
-	O
density	B-UNK
lipoprotein	I-UNK
(	O
ldl	O
)	O
-	O
cholesterol	B-UNK
were	O
increased	B-UNK
,	O
while	O
high	B-UNK
-	O
density	B-UNK
lipoprotein	I-UNK
(	O
hdl	B-UNK
)	O
-	O
cholesterol	B-UNK
was	O
decreased	B-UNK
.	O

 	O
contrarily	O
,	O
pravastatin	O
at	B-DISEASE
a	O
dose	O
of	O
10	O
mg	O
/	O
day	B-UNK
improved	B-UNK
the	O
sera	O
of	O
the	O
patients	B-UNK
to	O
be	O
markedly	B-UNK
"	O
anti	O
-	O
atherogenic	O
"	O
,	O
but	O
the	O
reductions	O
of	O
cholestanol	B-UNK
(	O
30	O
.	O
4	O
%	O
)	O
,	O
lathosterol	O
(	O
44	O
.	O
0	O
%	O
)	O
,	O
campesterol	O
(	O
22	O
.	O
9	O
%	O
)	O
and	O
sitosterol	O
(	O
9	O
.	O
6	O
%	O
)	O
were	O
inadequate	O
.	O

 	B-UNK
combined	I-UNK
treatment	B-UNK
with	O
cdca	O
and	O
pravastatin	O
showed	B-UNK
good	B-UNK
overlapping	B-UNK
of	O
the	O
effects	B-UNK
of	O
each	O
drug	O
alone	O
.	O

 	O
the	O
sera	O
of	O
the	O
patients	B-UNK
were	O
apparently	B-UNK
more	O
"	O
anti	O
-	O
atherogenic	O
"	O
than	O
those	O
after	O
cdca	O
treatment	B-UNK
.	O

 	B-UNK
serum	I-UNK
cholestanol	B-UNK
concentration	B-UNK
was	O
still	O
2	O
.	O

 	O
7	O
times	B-UNK
higher	B-UNK
than	O
in	O
controls	B-UNK
,	O
but	O
the	O
serum	B-UNK
lathosterol	O
level	B-UNK
was	O
within	O
the	O
normal	B-UNK
range	B-UNK
,	O
indicating	B-UNK
that	O
the	O
enhancement	O
of	O
overall	B-UNK
cholesterol	B-UNK
synthesis	B-UNK
in	O
the	O
patients	B-UNK
was	O
sufficiently	O
suppressed	O
.	O

 	O
plant	O
sterol	O
levels	B-UNK
were	O
also	O
within	O
the	O
normal	B-UNK
range	B-UNK
.	O

 	O
the	O
combination	O
of	O
cdca	O
and	O
pravastatin	O
was	O
a	O
good	B-UNK
treatment	B-UNK
for	O
ctx	B-UNK
,	O
based	B-UNK
on	O
the	O
improvement	O
of	O
serum	B-UNK
lipoprotein	B-UNK
metabolism	B-DISEASE
,	O
the	O
suppression	O
of	O
cholesterol	B-UNK
synthesis	B-UNK
,	O
and	O
reductions	O
of	O
cholestanol	B-UNK
and	O
plant	O
sterol	O
levels	B-UNK
.	O

 	O
in	O
all	O
of	O
7	O
patients	B-UNK
,	O
the	O
progression	O
of	O
disease	B-DISEASE
was	O
arrested	O
,	O
but	O
dramatic	B-UNK
effects	B-UNK
on	O
clinical	B-UNK
manifestations	B-UNK
,	O
xanthoma	O
,	O
and	O
electrophysiological	B-UNK
findings	B-UNK
could	O
not	O
be	O
found	B-UNK
after	O
the	O
treatment	B-UNK
of	O
these	O
drugs	B-UNK

 	O
mutation	B-UNK
spectrum	B-UNK
in	O
the	O
chm	B-UNK
gene	B-UNK
of	O
danish	O
and	O
swedish	B-UNK
choroideremia	B-DISEASE
patients	B-UNK
.	O

 	O
the	O
recent	B-UNK
isolation	B-UNK
of	O
the	O
complete	B-UNK
open	B-UNK
reading	I-UNK
frame	B-UNK
of	O
the	O
choroideremia	B-DISEASE
(	O
chm	B-UNK
)	O
gene	B-UNK
and	O
the	O
characterization	B-UNK
of	O
the	O
exon	B-UNK
-	O
intron	B-UNK
boundaries	B-UNK
has	O
paved	O
the	O
way	O
to	O
mutation	B-UNK
detection	B-UNK
in	O
patients	B-UNK
with	O
classical	B-UNK
choroideremia	B-DISEASE
.	O

 	O
we	O
have	O
performed	B-UNK
mutation	B-UNK
screening	B-UNK
in	O
patients	B-UNK
from	O
15	O
danish	O
and	O
swedish	B-UNK
families	B-UNK
by	O
using	O
southern	B-UNK
blot	I-UNK
hybridization	B-UNK
and	O
the	O
polymerase	B-UNK
chain	I-UNK
reaction	I-UNK
single	B-UNK
-	O
strand	B-UNK
conformation	I-UNK
polymorphism	I-UNK
(	O
pcr	B-UNK
-	O
sscp	B-UNK
)	O
technique	B-UNK
.	O

 	O
causative	B-UNK
mutations	B-UNK
in	O
the	O
chm	B-UNK
gene	B-UNK
were	O
detected	B-UNK
in	O
at	B-DISEASE
least	O
12	O
families	B-UNK
,	O
indicating	B-UNK
that	O
a	O
substantial	B-UNK
part	O
of	O
the	O
mutations	B-UNK
can	O
be	O
identified	B-UNK
by	O
this	O
approach	B-UNK
.	O

 	O
in	O
four	O
of	O
these	O
families	B-UNK
deletions	B-UNK
of	O
different	B-UNK
sizes	B-UNK
were	O
found	B-UNK
.	O

 	O
thus	O
,	O
in	O
one	O
patient	B-UNK
,	O
the	O
deletion	B-UNK
resulted	B-UNK
in	O
the	O
absence	B-UNK
of	O
only	O
one	O
exon	B-UNK
,	O
while	O
in	O
another	O
the	O
deletion	B-UNK
comprised	O
the	O
entire	B-UNK
chm	B-UNK
gene	B-UNK
.	O

 	O
mapping	B-UNK
of	O
the	O
deletion	B-UNK
endpoints	B-UNK
in	O
these	O
four	O
patients	B-UNK
and	O
in	O
another	O
11	O
male	B-UNK
patients	I-UNK
with	O
sizeable	O
deletions	B-UNK
enabled	B-UNK
us	O
to	O
construct	B-UNK
a	O
very	O
detailed	B-UNK
map	B-UNK
of	O
intervals	O
2	O
and	O
3	O
of	O
xq21	O
.	O

 	O
in	O
the	O
remaining	B-UNK
11	O
danish	O
and	O
swedish	B-UNK
families	B-UNK
at	B-DISEASE
least	O
8	O
causative	B-UNK
mutations	B-UNK
were	O
found	B-UNK
by	O
pcr	B-UNK
-	O
sscp	B-UNK
analysis	B-UNK
and	O
direct	B-UNK
sequencing	I-UNK
.	O

 	O
interestingly	B-UNK
,	O
all	O
chm	B-UNK
gene	B-UNK
mutations	B-UNK
detected	B-UNK
thus	O
far	B-UNK
in	O
choroideremia	B-DISEASE
patients	B-UNK
give	O
rise	B-UNK
to	O
the	O
introduction	O
of	O
a	O
premature	B-UNK
stop	B-UNK
codon	B-UNK
.	O
.	O

 	O
predominance	O
of	O
the	O
adrenomyeloneuropathy	B-UNK
phenotype	B-UNK
of	O
x	B-UNK
-	O
linked	B-UNK
adrenoleukodystrophy	B-DISEASE
in	O
the	O
netherlands	O
:	O
a	O
survey	B-UNK
of	O
30	O
kindreds	B-UNK
.	O

 	O
x	B-UNK
-	O
linked	B-UNK
adrenoleukodystrophy	B-DISEASE
(	O
x	B-UNK
-	O
ald	B-UNK
)	O
is	O
an	O
inherited	B-UNK
disorder	O
of	O
peroxisomal	B-UNK
beta	B-UNK
-	O
oxidation	B-UNK
associated	B-UNK
with	O
accumulation	B-UNK
of	O
saturated	O
very	O
long	B-UNK
-	O
chain	B-UNK
fatty	I-UNK
acids	I-UNK
,	O
which	O
results	B-UNK
in	O
central	B-UNK
and	O
peripheral	B-UNK
demyelination	B-UNK
and	O
in	O
impaired	B-UNK
function	B-UNK
of	O
adrenal	B-UNK
cortex	O
and	O
testes	O
.	O

 	O
the	O
phenotypic	B-UNK
expression	B-UNK
is	O
highly	B-UNK
variable	B-UNK
,	O
childhood	B-UNK
cerebral	I-UNK
ald	B-UNK
(	O
ccald	O
)	O
and	O
adrenomyeloneuropathy	B-UNK
(	O
amn	B-UNK
)	O
being	O
the	O
main	B-UNK
variants	B-UNK
.	O

 	O
we	O
explored	O
the	O
30	O
dutch	B-UNK
kindreds	B-UNK
well	O
known	B-UNK
to	O
the	O
dutch	B-UNK
x	B-UNK
-	O
ald	B-UNK
/	O
amn	B-UNK
study	B-UNK
group	B-UNK
and	O
phenotyped	O
77	O
male	B-UNK
patients	I-UNK
35	O
(	O
46	O
%	O
)	O
had	O
amn	B-UNK
and	O
24	O
(	O
31	O
%	O
)	O
ccald	O
or	O
adolescent	O
cerebral	B-UNK
ald	I-UNK
(	O
adolcald	O
)	O
.	O

 	O
these	O
percentages	O
differ	B-UNK
significantly	B-UNK
from	O
previous	B-UNK
reports	B-UNK
,	O
in	O
which	O
25	O
to	O
28	O
%	O
of	O
the	O
patients	B-UNK
developed	B-UNK
amn	B-UNK
and	O
53	O
to	O
57	O
%	O
ccald	O
or	O
adolcald	O
.	O

 	O
our	O
findings	B-UNK
indicate	B-UNK
that	O
-	O
-	O
at	B-DISEASE
least	O
in	O
the	O
netherlands	O
-	O
-	O
amn	B-UNK
may	O
be	O
the	O
most	O
frequent	B-UNK
phenotype	B-UNK
of	O
x	B-UNK
-	O
ald	B-UNK
.	O
.	O

 	O
adrenoleukodystrophy	B-DISEASE
gene	B-UNK
encodes	B-UNK
an	O
80	O
kda	B-UNK
membrane	B-UNK
protein	B-UNK
.	O

 	O
an	O
antibody	B-UNK
against	O
the	O
synthetic	B-UNK
c	B-UNK
-	O
terminal	B-UNK
peptides	O
deduced	O
from	O
the	O
cdna	B-UNK
of	O
the	O
gene	B-UNK
responsible	B-UNK
for	O
x	B-UNK
-	O
linked	B-UNK
adrenoleukodystrophy	B-DISEASE
(	O
ald	B-UNK
)	O
was	O
produced	B-UNK
to	O
characterize	O
the	O
product	B-UNK
of	O
the	O
ald	B-UNK
gene	B-UNK
.	O

 	O
the	O
antibody	B-UNK
reacted	O
with	O
the	O
80	O
kda	B-UNK
band	B-UNK
protein	B-UNK
in	O
control	B-UNK
fibroblasts	B-UNK
,	O
while	O
no	O
bands	B-UNK
were	O
detected	B-UNK
in	O
the	O
fibroblasts	B-UNK
from	O
a	O
patient	B-UNK
with	O
ald	B-UNK
(	O
#	O
163	O
)	O
,	O
in	O
which	O
mrna	B-UNK
of	O
the	O
ald	B-UNK
gene	B-UNK
was	O
undetectable	B-UNK
based	B-UNK
on	O
northern	B-UNK
blot	O
analysis	B-UNK
.	O

 	O
the	O
293	O
t	B-UNK
cells	I-UNK
transfected	B-UNK
with	O
the	O
full	O
-	O
coding	B-UNK
cdna	B-UNK
inserted	O
in	O
the	O
expression	B-UNK
vector	I-UNK
produced	B-UNK
a	O
new	B-UNK
80	O
kda	B-UNK
protein	B-UNK
,	O
as	O
detected	B-UNK
by	O
western	B-UNK
blot	O
.	O

 	O
in	O
an	O
immunocytological	O
study	B-UNK
,	O
the	O
staining	B-UNK
was	O
in	O
a	O
punctate	B-UNK
pattern	B-UNK
,	O
in	O
the	O
normal	B-UNK
fibroblasts	B-UNK
.	O

 	O
however	O
,	O
there	O
was	O
no	O
punctate	B-UNK
staining	B-UNK
in	O
the	O
#	O
163	O
cells	B-UNK
.	O

 	O
these	O
data	B-UNK
thus	O
indicate	B-UNK
that	O
the	O
ald	B-UNK
gene	B-UNK
encodes	B-UNK
an	O
80	O
kda	B-UNK
membrane	B-UNK
protein	B-UNK
.	O
.	O

 	O
isolation	B-UNK
of	O
the	O
gene	B-UNK
for	O
mcleod	B-UNK
syndrome	B-DISEASE
that	O
encodes	B-UNK
a	O
novel	B-UNK
membrane	B-UNK
transport	B-UNK
protein	B-UNK
.	O

 	O
mcleod	B-UNK
syndrome	B-DISEASE
is	O
an	O
x	B-UNK
-	O
linked	B-UNK
multisystem	O
disorder	O
characterized	B-UNK
by	O
abnormalities	B-DISEASE
in	O
the	O
neuromuscular	B-UNK
and	O
hematopoietic	B-UNK
systems	B-UNK
.	O

 	O
we	O
have	O
assembled	O
a	O
cosmid	B-UNK
contig	B-UNK
of	O
360	O
kb	B-UNK
that	O
encompasses	O
the	O
mcleod	B-UNK
gene	B-UNK
locus	B-UNK
.	O

 	O
a	O
50	O
kb	B-UNK
deletion	B-UNK
was	O
detected	B-UNK
by	O
screening	B-UNK
dna	B-UNK
from	O
patients	B-UNK
with	O
radiolabeled	O
whole	O
cosmids	O
,	O
and	O
two	O
transcription	B-UNK
units	B-UNK
were	O
identified	B-UNK
within	O
this	O
deletion	B-UNK
.	O

 	O
the	O
mrna	B-UNK
expression	B-UNK
pattern	B-UNK
of	O
one	O
of	O
them	O
,	O
designated	B-UNK
as	O
xk	O
,	O
correlates	B-UNK
closely	B-UNK
to	O
the	O
mcleod	B-UNK
phenotype	B-UNK
.	O

 	O
xk	O
encodes	B-UNK
a	O
novel	B-UNK
protein	B-UNK
with	O
structural	B-UNK
characteristics	B-UNK
of	O
prokaryotic	O
and	O
eukaryotic	B-UNK
membrane	B-UNK
transport	B-UNK
proteins	B-UNK
.	O

 	O
nucleotide	B-UNK
sequence	I-UNK
analysis	I-UNK
of	O
xk	O
from	O
two	O
unrelated	B-UNK
mcleod	B-UNK
patients	B-UNK
has	O
identified	B-UNK
point	B-UNK
mutations	I-UNK
at	B-DISEASE
conserved	B-UNK
splice	B-UNK
donor	I-UNK
and	O
acceptor	B-UNK
sites	B-UNK
.	O

 	O
these	O
findings	B-UNK
provide	I-UNK
direct	B-UNK
evidence	I-UNK
that	O
xk	O
is	O
responsible	B-UNK
for	O
mcleod	B-UNK
syndrome	B-DISEASE
.	O
.	O

 	O
x	B-UNK
-	O
linked	B-UNK
spastic	B-DISEASE
paraplegia	I-DISEASE
and	O
pelizaeus	B-DISEASE
-	I-DISEASE
merzbacher	I-DISEASE
disease	I-DISEASE
are	O
allelic	B-UNK
disorders	B-UNK
at	B-DISEASE
the	O
proteolipid	B-UNK
protein	B-UNK
locus	B-UNK
.	O

 	O
three	O
forms	B-UNK
of	O
x	B-UNK
-	O
linked	B-UNK
spastic	B-DISEASE
paraplegia	I-DISEASE
(	O
spg	O
)	O
have	O
been	O
defined	B-UNK
.	O

 	O
one	O
locus	B-UNK
(	O
spg	O
1	O
)	O
maps	B-UNK
to	O
xq28	B-UNK
while	O
two	O
clinically	B-UNK
distinct	I-UNK
forms	B-UNK
map	B-UNK
to	O
xq22	O
(	O
spg2	O
)	O
.	O

 	O
a	O
rare	B-UNK
x	B-UNK
-	O
linked	B-UNK
dysmyelinating	B-UNK
disorder	O
of	O
the	O
central	B-UNK
nervous	I-UNK
system	I-UNK
,	O
pelizaeus	B-DISEASE
-	I-DISEASE
merzbacher	I-DISEASE
disease	I-DISEASE
(	O
pmd	O
)	O
,	O
has	O
also	O
been	O
mapped	B-UNK
to	O
xq21	O
-	O
q22	O
,	O
and	O
is	O
caused	B-UNK
by	O
mutations	B-UNK
in	O
the	O
proteolipid	B-UNK
protein	B-UNK
gene	B-UNK
(	O
plp	B-UNK
)	O
which	O
encodes	B-UNK
two	O
myelin	B-UNK
proteins	B-UNK
,	O
plp	B-UNK
and	O
dm20	O
.	O

 	O
while	O
narrowing	O
the	O
genetic	B-UNK
interval	B-UNK
containing	B-UNK
spg2	O
in	O
a	O
large	B-UNK
pedigree	B-UNK
,	O
we	O
found	B-UNK
that	O
plp	B-UNK
was	O
the	O
closest	O
marker	B-UNK
to	O
the	O
disease	B-DISEASE
locus	B-UNK
,	O
implicating	O
plp	B-UNK
as	O
a	O
possible	B-UNK
candidate	B-UNK
gene	B-UNK
.	O

 	O
we	O
have	O
found	B-UNK
that	O
a	O
point	B-UNK
mutation	I-UNK
(	O
his139tyr	O
)	O
in	O
exon	B-UNK
3b	O
of	O
an	O
affected	B-UNK
male	B-UNK
produces	B-UNK
a	O
mutant	B-UNK
plp	B-UNK
but	O
a	O
normal	B-UNK
dm20	O
,	O
and	O
segregates	B-UNK
with	O
the	O
disease	B-DISEASE
(	O
zmax	B-UNK
=	O
6	O
.	O
63	O
,	O
theta	B-UNK
=	I-UNK
0	O
.	O
00	O
)	O
.	O

 	O
it	O
appears	B-UNK
,	O
therefore	O
,	O
that	O
spg2	O
and	O
pmd	O
are	O
allelic	B-UNK
disorders	B-UNK

 	O
canavan	B-DISEASE
disease	I-DISEASE
:	O
mutations	B-UNK
among	O
jewish	B-UNK
and	O
non	B-UNK
-	O
jewish	B-UNK
patients	B-UNK
.	O

 	O
canavan	B-DISEASE
disease	I-DISEASE
is	O
an	O
autosomal	O
recessive	O
leukodystrophy	B-DISEASE
caused	B-UNK
by	O
the	O
deficiency	B-UNK
of	O
aspartoacylase	O
(	O
aspa	B-UNK
)	O
.	O

 	O
sixty	O
-	O
four	O
probands	B-UNK
were	O
analyzed	B-UNK
for	O
mutations	B-UNK
in	O
the	O
aspa	B-UNK
gene	B-UNK
.	O

 	O
three	O
point	B-UNK
mutations	I-UNK
-	O
-	O
693c	O
-	O
-	O
>	O
a	O
,	O
854a	O
-	O
-	O
>	O
c	B-UNK
,	O
and	O
914c	O
-	O
-	O
>	O
a	O
-	O
-	O
were	O
identified	B-UNK
in	O
the	O
coding	B-UNK
sequence	B-UNK
.	O

 	O
the	O
693c	O
-	O
-	O
>	O
a	O
and	O
914c	O
-	O
-	O
>	O
a	O
base	B-UNK
changes	B-UNK
,	O
resulting	B-UNK
in	O
nonsense	B-UNK
tyr231	O
-	O
-	O
>	O
ter	B-UNK
and	O
missense	B-UNK
ala305	O
-	O
-	O
>	O
glu	B-UNK
mutations	B-UNK
,	O
respectively	B-UNK
,	O
lead	B-UNK
to	O
complete	B-UNK
loss	B-UNK
of	O
aspa	B-UNK
activity	B-UNK
in	O
in	O
vitro	B-UNK
expression	I-UNK
studies	B-UNK
.	O

 	O
the	O
854a	O
-	O
-	O
>	O
c	B-UNK
transversion	B-UNK
converted	O
glu	B-UNK
to	O
ala	B-UNK
in	O
codon	B-UNK
285	O
.	O

 	O
the	O
glu285	O
-	O
-	O
>	O
ala	B-UNK
mutant	B-UNK
aspa	B-UNK
has	O
2	O
.	O

 	O
5	O
%	O
of	O
the	O
activity	B-UNK
expressed	B-UNK
by	O
the	O
wild	B-UNK
-	O
type	B-UNK
enzyme	B-UNK
.	O

 	O
a	O
fourth	B-UNK
mutation	B-UNK
,	O
433	O
-	O
-	O
2	O
(	O
a	O
-	O
-	O
>	O
g	B-UNK
)	O
transition	B-UNK
,	O
was	O
identified	B-UNK
at	B-DISEASE
the	O
splice	O
-	O
acceptor	B-UNK
site	B-UNK
in	O
intron	B-UNK
2	O
.	O

 	O
the	O
splice	O
-	O
site	B-UNK
mutation	B-UNK
would	O
lead	B-UNK
to	O
skipping	B-UNK
of	O
exon	B-UNK
3	O
,	O
accompanied	O
by	O
a	O
frameshift	B-UNK
,	O
and	O
thus	O
would	O
produce	B-UNK
aberrant	B-UNK
aspa	B-UNK
.	O

 	O
of	O
the	O
128	O
unrelated	B-UNK
canavan	O
chromosomes	B-UNK
analyzed	B-UNK
,	O
88	O
were	O
from	O
probands	B-UNK
of	O
ashkenazi	B-UNK
jewish	I-UNK
descent	B-UNK
.	O

 	O
the	O
glu285	O
-	O
-	O
>	O
ala	B-UNK
mutation	B-UNK
was	O
predominant	B-UNK
(	O
82	O
.	O
9	O
%	O
)	O
in	O
this	O
population	B-UNK
,	O
followed	B-UNK
by	O
the	O
tyr231	O
-	O
-	O
>	O
ter	B-UNK
(	O
14	O
.	O
8	O
%	O
)	O
and	O
433	O
-	O
-	O
2	O
(	O
a	O
-	O
-	O
>	O
g	B-UNK
)	O
(	O
1	O
.	O
1	O
%	O
)	O
mutations	B-UNK
.	O

 	O
the	O
three	O
mutations	B-UNK
account	B-UNK
for	O
98	O
.	O

 	O
8	O
%	O
of	O
the	O
canavan	O
chromosomes	B-UNK
of	O
ashkenazi	B-UNK
jewish	I-UNK
origin	B-UNK
.	O

 	O
the	O
ala305	O
-	O
-	O
>	O
glu	B-UNK
mutation	B-UNK
was	O
found	B-UNK
exclusively	B-UNK
in	O
non	B-UNK
-	O
jewish	B-UNK
probands	B-UNK
of	O
european	B-UNK
descent	B-UNK
and	O
constituted	O
60	O
%	O
of	O
the	O
40	O
mutant	B-UNK
chromosomes	B-UNK
.	O

 	O
predominant	B-UNK
occurrence	B-UNK
of	O
certain	B-UNK
mutations	B-UNK
among	O
ashkenazi	B-UNK
jewish	I-UNK
and	O
non	B-UNK
-	O
jewish	B-UNK
patients	B-UNK
with	O
canavan	B-DISEASE
disease	I-DISEASE
would	O
suggest	B-UNK
a	O
founding	B-UNK
-	O
father	B-UNK
effect	B-UNK
in	O
propagation	O
of	O
these	O
mutant	B-UNK
chromosomes	B-UNK

 	O
intelligence	B-UNK
quotient	O
profile	B-UNK
in	O
myotonic	B-DISEASE
dystrophy	I-DISEASE
,	O
intergenerational	B-UNK
deficit	O
,	O
and	O
correlation	B-UNK
with	O
ctg	B-UNK
amplification	B-UNK
.	O

 	O
an	O
abbreviated	O
wechsler	O
adult	B-UNK
intelligence	B-UNK
scale	O
revised	O
(	O
wais	O
-	O
r	B-UNK
)	O
was	O
used	O
to	O
assess	B-UNK
verbal	O
and	O
arithmetical	O
cognitive	B-UNK
performance	I-UNK
in	O
55	O
subjects	B-UNK
with	O
myotonic	B-DISEASE
dystrophy	I-DISEASE
(	O
dm	B-DISEASE
)	O
,	O
covering	B-UNK
all	O
grades	O
of	O
disease	B-DISEASE
severity	B-UNK
,	O
and	O
31	O
controls	B-UNK
at	B-DISEASE
50	O
%	O
risk	B-UNK
of	O
inheriting	O
dm	B-DISEASE
.	O

 	O
scaled	O
scores	B-UNK
from	O
the	O
assessment	B-UNK
were	O
converted	O
into	O
an	O
intelligence	B-UNK
quotient	O
(	O
iq	B-UNK
)	O
estimation	B-UNK
on	O
each	O
person	O
.	O

 	B-UNK
significant	I-UNK
iq	B-UNK
differences	B-UNK
were	O
found	B-UNK
between	O
(	O
1	O
)	O
all	O
55	O
dm	B-DISEASE
subjects	B-UNK
(	O
mean	B-UNK
90	O
.	O
2	O
,	O
sd	O
16	O
.	O
1	O
)	O
and	O
31	O
controls	B-UNK
(	O
102	O
.	O
6	O
,	O
sd	O
9	O
.	O
4	O
)	O
,	O
with	O
no	O
sex	B-UNK
differences	B-UNK
in	O
either	O
group	B-UNK
;	O
(	O
2	O
)	O
15	O
affected	B-UNK
parents	B-UNK
(	O
99	O
.	O
3	O
,	O
sd	O
12	O
.	O
2	O
)	O
and	O
their	O
affected	B-UNK
children	B-UNK
(	O
88	O
.	O
1	O
,	O
sd	O
17	O
.	O
2	O
)	O
,	O
where	O
significance	B-UNK
was	O
dependent	B-UNK
on	O
parental	B-UNK
sex	B-UNK
being	O
female	B-UNK
;	O
and	O
(	O
3	O
)	O
15	O
pairs	B-UNK
of	O
affected	B-UNK
sibs	B-UNK
(	O
89	O
.	O
6	O
,	O
sd	O
13	O
.	O
2	O
)	O
and	O
their	O
normal	B-UNK
sibs	B-UNK
(	O
100	O
.	O
2	O
,	O
sd	O
7	O
.	O
6	O
)	O
.	O

 	O
iq	B-UNK
steadily	O
declined	O
as	O
(	O
1	O
)	O
the	O
age	B-UNK
of	O
onset	B-UNK
of	O
signs	B-DISEASE
and	I-DISEASE
symptoms	I-DISEASE
decreased	B-UNK
,	O
and	O
(	O
2	O
)	O
the	O
ctg	B-UNK
expansion	I-UNK
size	B-UNK
increased	B-UNK
.	O

 	O
the	O
correlation	B-UNK
appeared	B-UNK
to	O
be	O
more	O
linear	O
with	O
age	B-UNK
of	O
onset	B-UNK
.	O

 	O
the	O
correlation	B-UNK
of	O
iq	B-UNK
difference	B-UNK
and	O
ctg	B-UNK
expansion	I-UNK
difference	B-UNK
in	O
both	O
the	O
dm	B-DISEASE
parent	B-UNK
-	O
child	B-UNK
pairs	B-UNK
and	O
normal	B-UNK
sib	B-UNK
-	O
affected	B-UNK
sib	B-UNK
pairs	B-UNK
was	O
poor	B-UNK
,	O
indicating	B-UNK
that	O
ctg	B-UNK
expansion	I-UNK
is	O
not	O
a	O
reliable	B-UNK
predictor	O
of	O
iq	B-UNK
either	O
in	O
individual	B-UNK
persons	B-UNK
or	O
families	B-UNK
.	O

 	O
further	O
analysis	B-UNK
of	O
cognitive	B-UNK
function	B-UNK
in	O
dm	B-DISEASE
is	O
required	B-UNK
to	O
clarify	O
specific	B-UNK
deficits	B-UNK
characteristic	B-UNK
of	O
this	O
patient	B-UNK
group	B-UNK

 	O
adenomatous	B-DISEASE
polyposis	I-DISEASE
coli	I-DISEASE
and	O
a	O
cytogenetic	B-UNK
deletion	B-UNK
of	O
chromosome	B-DISEASE
5	I-DISEASE
resulting	B-UNK
from	O
a	O
maternal	B-UNK
intrachromosomal	O
insertion	B-UNK
.	O

 	O
we	O
present	B-UNK
the	O
clinical	B-UNK
and	O
laboratory	B-UNK
findings	B-UNK
in	O
an	O
institutionalised	O
adult	B-UNK
patient	B-UNK
originally	B-UNK
referred	O
for	O
autism	B-DISEASE
.	O

 	O
a	O
high	B-UNK
risk	B-UNK
of	O
colorectal	B-DISEASE
cancer	I-DISEASE
was	O
predicted	B-UNK
when	O
an	O
interstitial	B-UNK
deletion	B-UNK
of	O
the	O
long	B-UNK
arm	B-UNK
of	O
chromosome	B-DISEASE
5	I-DISEASE
,	O
del	O
(	O
5	O
)	O
(	O
q15q22	O
.	O
3	O
)	O
,	O
was	O
detected	B-UNK
in	O
her	O
lymphocytes	B-UNK
and	O
deletion	B-UNK
of	O
the	O
mcc	O
and	O
apc	B-UNK
genes	B-UNK
confirmed	B-UNK
by	O
molecular	B-UNK
analysis	B-UNK
.	O

 	O
adenomatous	B-DISEASE
polyposis	I-DISEASE
coli	I-DISEASE
and	O
carcinoma	B-DISEASE
of	O
the	O
rectum	O
were	O
subsequently	B-UNK
diagnosed	B-UNK
in	O
the	O
patient	B-UNK
.	O

 	O
she	O
was	O
profoundly	O
mentally	B-UNK
retarded	I-UNK
,	O
autistic	O
,	O
and	O
had	O
minor	O
dysmorphic	B-UNK
features	B-UNK
consistent	B-UNK
with	O
those	O
of	O
previous	B-UNK
patients	B-UNK
with	O
similar	B-UNK
deletions	B-UNK
.	O

 	O
the	O
deletion	B-UNK
arose	B-UNK
as	O
a	O
result	B-UNK
of	O
recombination	B-UNK
within	O
the	O
small	B-UNK
insertion	B-UNK
loop	B-UNK
formed	B-UNK
at	B-DISEASE
meiosis	O
by	O
the	O
direct	B-UNK
insertion	B-UNK
(	O
dir	O
ins	O
(	O
5	O
)	O
(	O
q22	O
.	O
3q14	O
.	O
2q15	O
)	O
)	O
found	B-UNK
in	O
the	O
patients	B-UNK
mother	B-UNK
.	O

 	O
this	O
family	B-UNK
further	O
confirms	B-UNK
the	O
cytogenetic	B-UNK
mapping	B-UNK
of	O
both	O
mcc	O
and	O
apc	B-UNK
genes	B-UNK
to	O
5q22	B-UNK
and	O
comparison	B-UNK
with	O
other	O
recent	B-UNK
cases	B-UNK
suggests	B-UNK
that	O
both	O
genes	B-UNK
and	O
their	O
closely	B-UNK
linked	I-UNK
markers	B-UNK
lie	O
within	O
the	O
5q22	B-UNK
.	O

 	O
1	O
subband	O

 	B-UNK
familial	I-UNK
male	B-DISEASE
breast	I-DISEASE
cancer	I-DISEASE
is	O
not	O
linked	B-UNK
to	O
the	O
brca1	B-UNK
locus	B-UNK
on	O
chromosome	B-UNK
17q	B-UNK
.	O

 	O
breast	B-DISEASE
cancer	I-DISEASE
in	O
men	B-UNK
is	O
about	O
a	O
hundredfold	O
less	O
common	B-UNK
than	O
in	O
women	B-UNK
and	O
this	O
has	O
hindered	O
research	B-UNK
into	O
its	O
genetic	B-UNK
basis	B-UNK
.	O

 	O
we	O
have	O
examined	B-UNK
22	O
families	B-UNK
with	O
at	B-DISEASE
least	O
one	O
case	B-UNK
of	O
male	B-DISEASE
breast	I-DISEASE
cancer	I-DISEASE
for	O
linkage	B-UNK
to	O
the	O
hereditary	B-UNK
breast	B-UNK
and	O
ovarian	B-DISEASE
cancer	I-DISEASE
locus	B-UNK
,	O
brca1	B-UNK
,	O
on	O
chromosome	B-UNK
17q	B-UNK
.	O

 	O
we	O
found	B-UNK
strong	B-UNK
evidence	B-UNK
against	O
linkage	B-UNK
to	O
brca1	B-UNK
(	O
lod	B-UNK
score	I-UNK
-	O
16	O
.	O
63	O
)	O
and	O
the	O
best	O
estimate	B-UNK
of	O
the	O
proportion	B-UNK
of	O
linked	B-UNK
families	B-UNK
was	O
0	O
%	O
(	O
95	O
%	O
ci	O
0	O
-	O
18	O
%	O
)	O
.	O

 	O
our	O
results	B-UNK
indicate	B-UNK
that	O
there	O
is	O
a	O
gene	B-UNK
(	O
s	O
)	O
other	O
than	O
brca1	B-UNK
which	O
predisposes	O
to	O
early	B-UNK
-	O
onset	B-UNK
breast	B-DISEASE
cancer	I-DISEASE
in	O
women	B-UNK
and	O
which	O
confers	O
a	O
higher	B-UNK
risk	B-UNK
of	O
male	B-DISEASE
breast	I-DISEASE
cancer	I-DISEASE
.	O

 	O
identification	B-UNK
of	O
additional	B-UNK
pedigrees	B-UNK
that	O
include	B-UNK
cases	B-UNK
of	O
male	B-DISEASE
breast	I-DISEASE
cancer	I-DISEASE
may	O
therefore	O
facilitate	B-UNK
the	O
mapping	B-UNK
and	O
isolation	B-UNK
of	O
this	O
gene	B-UNK
.	O

 	O
the	O
ews	B-UNK
gene	B-UNK
,	O
involved	B-UNK
in	O
ewing	O
family	B-UNK
of	O
tumors	B-DISEASE
,	O
malignant	B-UNK
melanoma	B-DISEASE
of	O
soft	B-UNK
parts	B-UNK
and	O
desmoplastic	B-DISEASE
small	I-DISEASE
round	I-DISEASE
cell	I-DISEASE
tumors	I-DISEASE
,	O
codes	O
for	O
an	O
rna	B-UNK
binding	I-UNK
protein	B-UNK
with	O
novel	B-UNK
regulatory	B-UNK
domains	B-UNK
.	O

 	O
the	O
ews	B-UNK
gene	B-UNK
,	O
which	O
maps	B-UNK
to	O
band	B-UNK
q12	O
of	O
human	B-UNK
chromosome	I-UNK
22	O
,	O
is	O
involved	B-UNK
in	O
a	O
wide	B-UNK
variety	B-UNK
of	O
human	B-UNK
solid	B-UNK
tumors	B-DISEASE
including	B-UNK
ewing	B-DISEASE
sarcoma	I-DISEASE
,	O
related	B-UNK
primitive	B-UNK
neuroectodermal	B-DISEASE
tumors	I-DISEASE
,	O
malignant	B-UNK
melanoma	B-DISEASE
of	O
soft	B-UNK
parts	B-UNK
and	O
desmoplastic	B-DISEASE
small	I-DISEASE
round	I-DISEASE
cell	I-DISEASE
tumors	I-DISEASE
.	O

 	O
in	O
these	O
tumors	B-DISEASE
,	O
the	O
ews	B-UNK
is	O
fused	O
to	O
genes	B-UNK
encoding	B-UNK
transcriptional	B-UNK
activators	O
/	O
repressors	O
,	O
like	B-UNK
fli	O
-	O
1	O
or	O
erg	B-UNK
or	O
atf	O
1	O
or	O
wt1	B-UNK
.	O

 	O
to	O
better	B-UNK
understand	O
the	O
function	B-UNK
of	O
the	O
ews	B-UNK
protein	B-UNK
,	O
we	O
cloned	B-UNK
the	O
ews	B-UNK
cdna	B-UNK
.	O

 	O
sequence	B-UNK
analysis	B-UNK
of	O
this	O
cdna	B-UNK
revealed	B-UNK
differential	B-UNK
splicing	B-UNK
involving	B-UNK
two	O
exons	B-UNK
encoding	B-UNK
72	O
amino	O
acids	O
.	O

 	O
both	O
alternatively	B-UNK
spliced	I-UNK
transcripts	B-UNK
,	O
ews	B-UNK
and	O
ews	B-UNK
-	O
b	B-UNK
,	O
are	O
expressed	B-UNK
in	O
a	O
variety	B-UNK
of	O
cells	B-UNK
.	O

 	O
because	O
ews	B-UNK
proteins	B-UNK
contain	B-UNK
putative	B-UNK
conserved	B-UNK
rna	B-UNK
binding	I-UNK
motifs	B-UNK
,	O
we	O
studied	B-UNK
the	O
rna	B-UNK
binding	I-UNK
properties	B-UNK
of	O
the	O
ews	B-UNK
protein	B-UNK
.	O

 	O
the	O
ews	B-UNK
-	O
b	B-UNK
protein	B-UNK
binds	O
to	O
rna	B-UNK
in	O
vitro	B-UNK
and	O
,	O
specifically	B-UNK
,	O
to	O
poly	O
g	B-UNK
and	O
poly	O
u	B-UNK
.	O

 	O
the	O
rna	B-UNK
binding	I-UNK
activity	B-UNK
was	O
localized	B-UNK
to	O
the	O
carboxy	O
terminal	B-UNK
86	O
amino	O
acids	O
,	O
which	O
constitute	B-UNK
rgg	O
box	B-UNK
.	O

 	O
thus	O
the	O
amino	O
terminal	B-UNK
domain	B-UNK
of	O
ews	B-UNK
(	O
ntd	O
-	O
ews	B-UNK
)	O
,	O
which	O
is	O
involved	B-UNK
in	O
chromosome	B-UNK
translocation	B-DISEASE
may	O
regulate	B-UNK
the	O
specificity	B-UNK
of	O
rna	B-UNK
binding	I-UNK
activity	B-UNK
of	O
ews	B-UNK
.	O

 	O
an	O
ews	B-UNK
-	O
erg	B-UNK
chimeric	I-UNK
protein	B-UNK
,	O
which	O
is	O
found	B-UNK
in	O
ewings	O
sarcoma	B-DISEASE
cells	B-UNK
,	O
functions	B-UNK
as	O
a	O
transcriptional	B-UNK
activator	B-UNK
.	O

 	B-UNK
mutational	I-UNK
analysis	B-UNK
of	O
ews	B-UNK
-	O
erg	B-UNK
chimeric	I-UNK
protein	B-UNK
revealed	B-UNK
that	O
ntd	O
-	O
ews	B-UNK
functions	B-UNK
as	O
a	O
regulatory	B-UNK
domain	B-UNK
for	O
the	O
transcriptional	B-UNK
activation	I-UNK
properties	B-UNK
of	O
ews	B-UNK
-	O
erg	B-UNK
chimeric	I-UNK
protein	B-UNK
.	O
.	O

 	O
canavan	B-DISEASE
disease	I-DISEASE
:	O
genomic	B-UNK
organization	B-UNK
and	O
localization	B-UNK
of	O
human	B-UNK
aspa	B-UNK
to	O
17p13	O
-	O
ter	B-UNK
and	O
conservation	B-UNK
of	O
the	O
aspa	B-UNK
gene	B-UNK
during	O
evolution	O
.	O

 	O
canavan	B-DISEASE
disease	I-DISEASE
,	O
or	O
spongy	O
degeneration	B-UNK
of	O
the	O
brain	B-UNK
,	O
is	O
a	O
severe	B-UNK
leukodystrophy	B-DISEASE
caused	B-UNK
by	O
the	O
deficiency	B-UNK
of	O
aspartoacylase	O
(	O
aspa	B-UNK
)	O
.	O

 	O
recently	B-UNK
,	O
a	O
missense	B-UNK
mutation	I-UNK
was	O
identified	B-UNK
in	O
human	B-UNK
aspa	B-UNK
coding	B-UNK
sequence	B-UNK
from	O
patients	B-UNK
with	O
canavan	B-DISEASE
disease	I-DISEASE
.	O

 	O
the	O
human	B-UNK
aspa	B-UNK
gene	B-UNK
has	O
been	O
cloned	B-UNK
and	O
found	B-UNK
to	O
span	B-UNK
29	O
kb	B-UNK
of	O
the	O
genome	B-UNK
.	O

 	B-UNK
human	I-UNK
aspartoacylase	O
is	O
coded	O
by	O
six	O
exons	B-UNK
intervened	O
by	O
five	O
introns	B-UNK
.	O

 	O
the	O
exons	B-UNK
vary	O
from	O
94	O
(	O
exon	B-UNK
iii	B-UNK
)	O
to	O
514	O
(	O
exon	B-UNK
vi	O
)	O
bases	B-UNK
.	O

 	O
the	O
exon	B-UNK
/	O
intron	B-UNK
splice	O
junction	B-UNK
sites	B-UNK
follow	B-UNK
the	O
gt	B-UNK
/	O
ag	B-UNK
consensus	B-UNK
sequence	B-UNK
rule	O
.	O

 	B-UNK
southern	I-UNK
blot	I-UNK
analysis	B-UNK
of	O
genomic	B-UNK
dna	I-UNK
from	O
human	B-UNK
/	O
mouse	B-UNK
somatic	B-UNK
cell	I-UNK
hybrid	I-UNK
cell	B-UNK
lines	B-UNK
localized	B-UNK
aspa	B-UNK
to	O
human	B-UNK
chromosome	I-UNK
17	O
.	O

 	O
the	O
human	B-UNK
aspa	B-UNK
locus	B-UNK
was	O
further	O
mapped	B-UNK
in	O
the	O
17p13	O
-	O
ter	B-UNK
region	B-UNK
by	O
fluorescence	B-UNK
in	O
situ	B-UNK
hybridization	I-UNK
.	O

 	O
the	O
bovine	O
aspa	B-UNK
gene	B-UNK
has	O
also	O
been	O
cloned	B-UNK
,	O
and	O
its	O
exon	B-UNK
/	O
intron	B-UNK
organization	B-UNK
is	O
identical	B-UNK
to	O
that	O
of	O
the	O
human	B-UNK
gene	B-UNK
.	O

 	O
the	O
500	O
-	O
base	B-UNK
sequence	B-UNK
upstream	B-UNK
of	O
the	O
initiator	O
atg	O
codon	B-UNK
in	O
the	O
human	B-UNK
gene	B-UNK
and	O
that	O
in	O
the	O
bovine	O
gene	B-UNK
are	O
77	O
%	O
identical	B-UNK
.	O

 	B-UNK
human	I-UNK
aspa	B-UNK
coding	B-UNK
sequences	I-UNK
cross	B-UNK
-	O
hybridize	O
with	O
genomic	B-UNK
dna	I-UNK
from	O
yeast	B-UNK
,	O
chicken	O
,	O
rabbit	O
,	O
cow	O
,	O
dog	O
,	O
mouse	B-UNK
,	O
rat	B-UNK
,	O
and	O
monkey	O
.	O

 	O
the	O
specificity	B-UNK
of	O
cross	B-UNK
-	O
species	B-UNK
hybridization	B-UNK
of	O
coding	B-UNK
sequences	I-UNK
suggests	B-UNK
that	O
aspartoacylase	O
has	O
been	O
conserved	B-UNK
during	O
evolution	O
.	O

 	O
it	O
should	O
now	O
be	O
possible	B-UNK
to	O
identify	B-UNK
mutations	B-UNK
in	O
the	O
noncoding	O
genomic	B-UNK
sequences	I-UNK
that	O
lead	B-UNK
to	O
canavan	B-DISEASE
disease	I-DISEASE
and	O
to	O
study	B-UNK
the	O
regulation	B-UNK
of	O
aspa	B-UNK
.	O
.	O

 	O
myotonic	B-DISEASE
dystrophy	I-DISEASE
:	O
size	B-UNK
-	O
and	O
sex	B-UNK
-	O
dependent	B-UNK
dynamics	O
of	O
ctg	B-UNK
meiotic	B-UNK
instability	I-UNK
,	O
and	O
somatic	B-UNK
mosaicism	B-UNK
.	O

 	O
myotonic	B-DISEASE
dystrophy	I-DISEASE
(	O
dm	B-DISEASE
)	O
is	O
a	O
progressive	B-UNK
neuromuscular	B-UNK
disorder	O
which	O
results	B-UNK
from	O
elongations	O
of	O
an	O
unstable	B-UNK
(	O
ctg	B-UNK
)	O
n	B-UNK
repeat	I-UNK
,	O
located	B-UNK
in	O
the	O
3	O
untranslated	B-UNK
region	B-UNK
of	O
the	O
dm	B-DISEASE
gene	B-UNK
.	O

 	O
a	O
correlation	B-UNK
has	O
been	O
demonstrated	B-UNK
between	O
the	O
increase	B-UNK
in	O
the	O
repeat	B-UNK
number	B-UNK
of	O
this	O
sequence	B-UNK
and	O
the	O
severity	B-UNK
of	O
the	O
disease	B-DISEASE
.	O

 	O
however	O
,	O
the	O
clinical	B-UNK
status	B-UNK
of	O
patients	B-UNK
can	O
not	O
be	O
unambiguously	B-UNK
ascertained	B-UNK
solely	O
on	O
the	O
basis	B-UNK
of	O
the	O
number	B-UNK
of	O
ctg	B-UNK
repeats	B-UNK
.	O

 	O
moreover	O
,	O
the	O
exclusive	B-UNK
maternal	B-UNK
inheritance	B-UNK
of	O
the	O
congenital	B-DISEASE
form	B-UNK
remains	B-UNK
unexplained	O
.	O

 	O
our	O
observation	B-UNK
of	O
differently	B-UNK
sized	B-UNK
repeats	B-UNK
in	O
various	O
dm	B-DISEASE
tissues	B-UNK
from	O
the	O
same	O
individual	B-UNK
may	O
explain	O
why	O
the	O
size	B-UNK
of	O
the	O
mutation	B-UNK
observed	B-UNK
in	O
lymphocytes	B-UNK
does	O
not	O
necessarily	O
correlate	B-UNK
with	O
the	O
severity	B-UNK
and	O
nature	B-UNK
of	O
symptoms	B-UNK
.	O

 	O
through	O
a	O
molecular	B-UNK
and	O
genetic	B-UNK
study	B-UNK
of	O
142	O
families	B-UNK
including	B-UNK
418	O
dm	B-DISEASE
patients	B-UNK
,	O
we	O
have	O
investigated	B-UNK
the	O
dynamics	O
of	O
the	O
ctg	B-UNK
repeat	I-UNK
meiotic	B-UNK
instability	I-UNK
.	O

 	O
a	O
positive	B-UNK
correlation	B-UNK
between	O
the	O
size	B-UNK
of	O
the	O
repeat	B-UNK
and	O
the	O
intergenerational	B-UNK
enlargement	O
was	O
observed	B-UNK
similarly	B-UNK
through	O
male	B-UNK
and	O
female	B-UNK
meioses	B-UNK
for	O
<	O
or	O
=	O
0	O
.	O

 	O
5	O
-	O
kb	B-UNK
ctg	B-UNK
sequences	B-UNK
.	O

 	O
beyond	O
0	O
.	O

 	O
5	O
kb	B-UNK
,	O
the	O
intergenerational	B-UNK
variation	B-UNK
was	O
more	O
important	B-UNK
through	O
female	B-UNK
meioses	B-UNK
,	O
whereas	O
a	O
tendency	O
to	O
compression	O
was	O
observed	B-UNK
almost	O
exclusively	B-UNK
in	O
male	B-UNK
meioses	B-UNK
,	O
for	O
>	O
or	O
=	O
1	O
.	O

 	O
5	O
-	O
kb	B-UNK
fragments	B-UNK
.	O

 	O
this	O
implies	O
a	O
size	B-UNK
-	O
and	O
sex	B-UNK
-	O
dependent	B-UNK
meiotic	B-UNK
instability	I-UNK
.	O

 	O
moreover	O
,	O
segregation	B-UNK
analysis	B-UNK
supports	B-UNK
the	O
hypothesis	O
of	O
a	O
maternal	B-UNK
as	O
well	O
as	O
a	O
familial	B-UNK
predisposition	B-UNK
for	O
the	O
occurrence	B-UNK
of	O
the	O
congenital	B-DISEASE
form	B-UNK
.	O

 	O
finally	B-UNK
,	O
this	O
analysis	B-UNK
reveals	B-UNK
a	O
significant	B-UNK
excess	B-UNK
of	O
transmitting	B-UNK
grandfathers	O
partially	B-UNK
accounted	B-UNK
for	O
by	O
increased	B-UNK
fertility	O
in	O
affected	B-UNK
males	B-UNK

 	O
illegitimate	B-UNK
transcription	B-UNK
of	O
the	O
phenylalanine	B-UNK
hydroxylase	I-UNK
gene	B-UNK
in	O
lymphocytes	B-UNK
for	O
identification	B-UNK
of	O
mutations	B-UNK
in	O
phenylketonuria	B-DISEASE
.	O

 	O
taking	O
advantage	B-UNK
of	O
the	O
illegitimate	B-UNK
transcription	B-UNK
of	O
the	O
phenylalanine	B-UNK
hydroxylase	I-UNK
(	O
pah	B-UNK
)	O
gene	B-UNK
,	O
we	O
have	O
been	O
able	O
to	O
analyse	O
the	O
pah	B-UNK
cdna	I-UNK
sequence	B-UNK
of	O
hyperphenylalaninemic	O
children	B-UNK
in	O
circulating	B-UNK
lymphocytes	B-UNK
.	O

 	O
using	O
this	O
approach	B-UNK
,	O
we	O
have	O
also	O
identified	B-UNK
3	O
novel	B-UNK
mutations	B-UNK
in	O
cdna	B-UNK
from	O
liver	B-DISEASE
and	O
lymphocytes	B-UNK
of	O
two	O
patients	B-UNK
.	O

 	O
one	O
mutation	B-UNK
,	O
detected	B-UNK
by	O
the	O
abnormal	B-UNK
pattern	B-UNK
of	O
migration	B-UNK
of	O
an	O
amplified	B-UNK
fragment	O
,	O
is	O
a	O
c	B-UNK
to	O
t	B-UNK
transition	I-UNK
in	O
the	O
splice	O
acceptor	B-UNK
site	B-UNK
of	O
intron	B-UNK
10	O
,	O
which	O
resulted	B-UNK
in	O
the	O
skipping	B-UNK
of	O
exon	B-UNK
11	O
with	O
the	O
premature	B-UNK
termination	I-UNK
of	O
rna	B-UNK
translation	B-UNK
downstream	B-UNK
from	O
exon	B-UNK
12	O
(	O
-	O
3	O
ivs10	O
)	O
.	O

 	O
the	O
other	O
two	O
mutations	B-UNK
are	O
missense	B-UNK
mutations	I-UNK
in	O
exons	B-UNK
10	O
and	O
11	O
(	O
respectively	B-UNK
,	O
l333f	O
and	O
e390	O
g	B-UNK
)	O
.	O

 	O
the	O
present	B-UNK
study	I-UNK
supports	B-UNK
the	O
view	O
that	O
circulating	B-UNK
lymphocytes	B-UNK
give	O
easy	O
access	O
to	O
pah	B-UNK
gene	B-UNK
transcripts	B-UNK
whose	O
nucleotide	B-UNK
sequence	B-UNK
is	O
identical	B-UNK
to	O
that	O
reported	B-UNK
in	O
liver	B-DISEASE
and	O
therefore	O
represent	B-UNK
a	O
useful	B-UNK
tool	B-UNK
for	O
molecular	B-UNK
genetic	I-UNK
studies	B-UNK
in	O
phenylketonuria	B-DISEASE
.	O
.	O

 	O
high	B-UNK
residual	B-UNK
arylsulfatase	B-UNK
a	O
(	O
arsa	B-UNK
)	O
activity	B-UNK
in	O
a	O
patient	B-UNK
with	O
late	B-UNK
-	O
infantile	B-UNK
metachromatic	B-DISEASE
leukodystrophy	I-DISEASE
.	O

 	O
we	O
identified	B-UNK
a	O
patient	B-UNK
suffering	B-UNK
from	O
late	B-UNK
-	O
infantile	B-UNK
metachromatic	B-DISEASE
leukodystrophy	I-DISEASE
(	O
mld	B-UNK
)	O
who	O
has	O
a	O
residual	B-UNK
arylsulfatase	B-UNK
a	O
(	O
arsa	B-UNK
)	O
activity	B-UNK
of	O
about	O
10	O
%	O
.	O

 	O
fibroblasts	B-UNK
of	O
the	O
patient	B-UNK
show	O
significant	B-UNK
sulfatide	O
degradation	B-UNK
activity	B-UNK
exceeding	O
that	O
of	O
adult	B-UNK
mld	B-UNK
patients	I-UNK
.	O

 	O
analysis	B-UNK
of	O
the	O
arsa	B-UNK
gene	B-UNK
in	O
this	O
patient	B-UNK
revealed	B-UNK
heterozygosity	B-UNK
for	O
two	O
new	B-UNK
mutant	B-UNK
alleles	I-UNK
in	O
one	O
allele	B-UNK
,	O
deletion	B-UNK
of	O
c	B-UNK
447	O
in	O
exon	B-UNK
2	O
leads	B-UNK
to	O
a	O
frameshift	B-UNK
and	O
to	O
a	O
premature	B-UNK
stop	B-UNK
codon	B-UNK
at	B-DISEASE
amino	B-UNK
acid	I-UNK
position	B-UNK
105	O
;	O
in	O
the	O
second	B-UNK
allele	B-UNK
,	O
a	O
g	B-UNK
-	O
-	O
>	O
a	O
transition	B-UNK
in	O
exon	B-UNK
5	O
causes	B-UNK
a	O
gly309	O
-	O
-	O
>	O
ser	B-UNK
substitution	B-UNK
.	O

 	O
transient	B-UNK
expression	I-UNK
of	O
the	O
mutant	B-UNK
ser309	O
-	O
arsa	B-UNK
resulted	B-UNK
in	O
only	O
13	O
%	O
enzyme	B-UNK
activity	I-UNK
of	O
that	O
observed	B-UNK
in	O
cells	B-UNK
expressing	B-UNK
normal	B-UNK
arsa	B-UNK
.	O

 	O
the	O
mutant	B-UNK
arsa	B-UNK
is	O
correctly	O
targeted	B-UNK
to	O
the	O
lysosomes	O
but	O
is	O
unstable	B-UNK
.	O

 	O
these	O
findings	B-UNK
are	O
in	O
contrast	B-UNK
to	O
previous	B-UNK
results	B-UNK
showing	B-UNK
that	O
the	O
late	B-UNK
-	O
infantile	B-UNK
type	B-UNK
of	O
mld	B-UNK
is	O
always	O
associated	B-UNK
with	O
the	O
complete	B-UNK
absence	B-UNK
of	O
arsa	B-UNK
activity	I-UNK
.	O

 	O
the	O
expression	B-UNK
of	O
the	O
mutant	B-UNK
arsa	B-UNK
protein	B-UNK
may	O
be	O
influenced	O
by	O
particular	B-UNK
features	B-UNK
of	O
oligodendrocytes	O
,	O
such	O
that	O
the	O
level	B-UNK
of	O
mutant	B-UNK
enzyme	B-UNK
is	O
lower	B-UNK
in	O
these	O
cells	B-UNK
than	O
in	O
others	O
.	O
.	O

 	O
an	O
arylsulfatase	B-UNK
a	O
(	O
arsa	B-UNK
)	O
missense	B-UNK
mutation	I-UNK
(	O
t274	B-UNK
m	B-UNK
)	O
causing	B-UNK
late	B-UNK
-	O
infantile	B-UNK
metachromatic	B-DISEASE
leukodystrophy	I-DISEASE
.	O

 	O
metachromatic	B-DISEASE
leukodystrophy	I-DISEASE
(	O
mld	B-UNK
)	O
is	O
an	O
autosomal	O
recessive	O
lysosomal	B-UNK
storage	B-UNK
disorder	I-UNK
caused	I-UNK
by	O
a	O
deficiency	B-UNK
of	O
arylsulfatase	B-UNK
a	O
(	O
arsa	B-UNK
;	O
ec	O
3	O
.	O
1	O
.	O
6	O
.	O
8	O
)	O
.	O

 	O
the	O
8	O
arsa	B-UNK
exons	B-UNK
and	O
adjacent	B-UNK
intron	B-UNK
boundaries	B-UNK
from	O
a	O
patient	B-UNK
with	O
late	B-UNK
-	O
infantile	B-UNK
metachromatic	B-DISEASE
leukodystrophy	I-DISEASE
were	O
polymerase	B-UNK
chain	I-UNK
reaction	I-UNK
(	O
pcr	B-UNK
)	O
amplified	B-UNK
in	O
seven	B-UNK
discrete	B-UNK
reactions	B-UNK
.	O

 	O
amplified	B-UNK
arsa	B-UNK
exons	B-UNK
were	O
analysed	B-UNK
for	O
the	O
presence	B-UNK
of	O
sequence	B-UNK
alterations	B-UNK
by	O
single	B-UNK
-	O
strand	B-UNK
conformation	I-UNK
polymorphism	I-UNK
analysis	B-UNK
,	O
followed	B-UNK
by	O
direct	B-UNK
sequencing	I-UNK
of	O
pcr	B-UNK
products	B-UNK
.	O

 	O
the	O
patient	B-UNK
was	O
found	B-UNK
to	O
be	O
homozygous	B-UNK
for	O
a	O
c	B-UNK
-	O
-	O
>	O
t	B-UNK
transition	I-UNK
in	O
exon	B-UNK
iv	B-UNK
that	O
results	B-UNK
in	O
the	O
substitution	B-UNK
of	O
a	O
highly	B-UNK
conserved	I-UNK
threonine	B-UNK
residue	B-UNK
at	B-DISEASE
amino	B-UNK
acid	I-UNK
274	O
with	O
a	O
methionine	O
(	O
t274	B-UNK
m	B-UNK
)	O
.	O

 	O
analysis	B-UNK
of	O
a	O
further	O
29	O
mld	B-UNK
patients	I-UNK
revealed	B-UNK
the	O
presence	B-UNK
of	O
five	O
additional	B-UNK
homozygotes	B-UNK
for	O
t274	B-UNK
m	B-UNK
.	O

 	O
all	O
6	O
t274	B-UNK
m	B-UNK
homozygotes	B-UNK
(	O
representing	B-UNK
four	O
families	B-UNK
)	O
were	O
of	O
lebanese	O
descent	B-UNK
,	O
and	O
all	O
were	O
known	B-UNK
to	O
be	O
the	O
result	B-UNK
of	O
consanguineous	B-UNK
marriages	O
.	O

 	O
the	O
altered	B-UNK
amino	B-UNK
acid	I-UNK
is	O
rigidly	O
conserved	B-UNK
among	O
10	O
sulfatases	O
from	O
escherichia	B-UNK
coli	B-UNK
to	O
humans	B-UNK
;	O
therefore	O
,	O
it	O
is	O
most	O
likely	B-UNK
that	O
the	O
resultant	B-UNK
mutant	B-UNK
protein	B-UNK
will	O
have	O
little	B-UNK
or	O
no	O
enzyme	B-UNK
activity	I-UNK
.	O

 	O
this	O
is	O
consistent	B-UNK
with	O
the	O
very	O
low	B-UNK
arsa	B-UNK
activity	I-UNK
measured	B-UNK
in	O
these	O
patients	B-UNK
and	O
their	O
uniformly	O
severe	B-UNK
clinical	I-UNK
presentation	O

 	O
mutations	B-UNK
in	O
the	O
pax6	B-UNK
gene	B-UNK
in	O
patients	B-UNK
with	O
hereditary	B-UNK
aniridia	B-DISEASE
.	O

 	O
the	O
14	O
exons	B-UNK
of	O
the	O
pax6	B-UNK
gene	B-UNK
have	O
been	O
analysed	B-UNK
exon	B-UNK
-	O
by	O
-	O
exon	B-UNK
using	O
sscp	B-UNK
in	O
6	O
aniridia	B-DISEASE
families	B-UNK
.	O

 	O
in	O
each	O
family	B-UNK
band	B-UNK
shifts	O
were	O
observed	B-UNK
on	O
the	O
sscp	B-UNK
gels	B-UNK
for	O
only	O
one	O
exon	B-UNK
and	O
direct	B-UNK
pcr	B-UNK
-	O
sequencing	B-UNK
revealed	I-UNK
mutations	B-UNK
in	O
each	O
case	B-UNK
.	O

 	O
two	O
mutations	B-UNK
involved	B-UNK
c	B-UNK
-	O
-	O
>	O
t	B-UNK
transitions	B-UNK
in	O
cgaarg	O
codons	B-UNK
in	O
exons	B-UNK
9	O
and	O
11	O
.	O

 	O
another	O
c	B-UNK
-	O
-	O
>	O
t	B-UNK
transition	I-UNK
converted	O
a	O
cag	B-UNK
-	O
glutamine	B-UNK
to	O
a	O
tag	O
-	O
stop	B-UNK
in	O
exon	B-UNK
7	O
.	O

 	B-UNK
small	I-UNK
insertions	B-UNK
created	B-UNK
frameshifts	O
which	O
produced	B-UNK
downstream	B-UNK
stop	B-UNK
codons	B-UNK
in	O
another	O
two	O
patients	B-UNK
and	O
an	O
a	O
-	O
-	O
>	O
t	B-UNK
mutation	B-UNK
disrupted	B-UNK
the	O
splice	B-UNK
donor	I-UNK
site	I-UNK
of	O
exon	B-UNK
5	O
in	O
the	O
remaining	B-UNK
family	B-UNK
.	O

 	O
thus	O
,	O
complete	B-UNK
inactivation	B-UNK
of	O
the	O
pax6	B-UNK
gene	B-UNK
is	O
predicted	B-UNK
in	O
all	O
cases	B-UNK
.	O

 	O
analysis	B-UNK
of	O
other	O
affected	B-UNK
members	B-UNK
of	O
the	O
families	B-UNK
showed	B-UNK
that	O
,	O
in	O
each	O
case	B-UNK
,	O
all	O
affected	B-UNK
individuals	I-UNK
carried	B-UNK
the	O
same	O
family	B-UNK
-	O
specific	B-UNK
mutation	B-UNK
.	O

 	O
one	O
polymorphism	O
was	O
found	B-UNK
in	O
exon	B-UNK
7	O
.	O

 	O
this	O
data	B-UNK
strongly	B-UNK
supports	B-UNK
the	O
candidature	O
of	O
pax6	B-UNK
as	O
the	O
gene	B-UNK
responsible	B-UNK
for	O
hereditary	B-UNK
aniridia	B-DISEASE
.	O
.	O

 	O
three	O
novel	B-UNK
mutations	B-UNK
in	O
five	O
unrelated	B-UNK
subjects	B-UNK
with	O
hereditary	B-UNK
protein	B-DISEASE
s	I-DISEASE
deficiency	I-DISEASE
type	B-UNK
i	O
.	O

 	O
a	O
panel	O
of	O
eight	O
unrelated	B-UNK
subjects	B-UNK
with	O
inherited	B-UNK
type	B-UNK
i	O
protein	B-DISEASE
s	I-DISEASE
deficiency	I-DISEASE
was	O
screened	O
for	O
mutations	B-UNK
in	O
the	O
pros1	B-UNK
gene	B-UNK
.	O

 	O
in	O
five	O
subjects	B-UNK
an	O
abnormality	B-UNK
was	O
found	B-UNK
but	O
mutations	B-UNK
were	O
not	O
detected	B-UNK
in	O
the	O
remaining	B-UNK
three	O
subjects	B-UNK
.	O

 	O
two	O
subjects	B-UNK
shared	B-UNK
a	O
g	B-UNK
-	O
-	O
>	O
a	O
transition	B-UNK
at	B-DISEASE
position	B-UNK
+	O
5	O
of	O
the	O
donor	B-UNK
splice	I-UNK
site	I-UNK
consensus	B-UNK
sequence	B-UNK
of	O
intron	B-UNK
10	O
.	O

 	O
also	O
in	O
two	O
subjects	B-UNK
an	O
a	O
-	O
-	O
>	O
t	B-UNK
transversion	B-UNK
was	O
detected	B-UNK
in	O
the	O
stopcodon	O
of	O
the	O
pros1	B-UNK
gene	B-UNK
;	O
this	O
transversion	B-UNK
predicts	B-UNK
a	O
protein	B-UNK
s	O
molecule	B-UNK
that	O
is	O
extended	B-UNK
by	O
14	O
amino	O
acids	O
.	O

 	O
the	O
fifth	B-UNK
subject	B-UNK
was	O
found	B-UNK
to	O
possess	O
two	O
sequence	B-UNK
abnormalities	B-DISEASE
.	O

 	O
one	O
allele	B-UNK
carried	B-UNK
a	O
g	B-UNK
-	O
-	O
>	O
a	O
transition	B-UNK
near	B-UNK
the	O
donor	O
splice	O
junction	B-UNK
of	O
intron	B-UNK
2	O
,	O
but	O
this	O
abnormality	B-UNK
is	O
probably	B-UNK
neutral	O
,	O
since	O
it	O
was	O
inherited	B-UNK
from	O
the	O
parent	B-UNK
with	O
normal	B-UNK
protein	B-UNK
s	O
antigen	B-UNK
levels	B-UNK
.	O

 	O
in	O
the	O
other	O
allele	B-UNK
a	O
single	B-UNK
t	B-UNK
insertion	B-UNK
in	O
codon	B-UNK
-	O
25	O
was	O
found	B-UNK
.	O

 	O
analysis	B-UNK
of	O
platelet	B-UNK
rna	B-UNK
showed	B-UNK
that	O
only	O
the	O
mrna	B-UNK
with	O
the	O
a	O
-	O
-	O
>	O
t	B-UNK
mutation	B-UNK
in	O
the	O
stopcodon	O
is	O
present	B-UNK
in	O
amounts	B-UNK
comparable	B-UNK
to	O
wildtype	O
rna	B-UNK
.	O

 	O
mrna	B-UNK
from	O
the	O
alleles	B-UNK
with	O
the	O
other	O
two	O
mutations	B-UNK
was	O
either	O
undetectable	B-UNK
or	O
present	B-UNK
in	O
greatly	B-UNK
reduced	B-UNK
amounts	B-UNK
.	O

 	O
the	O
latter	O
indicates	B-UNK
that	O
a	O
mrna	B-UNK
based	B-UNK
approach	B-UNK
is	O
not	O
feasible	O
for	O
the	O
genetic	B-UNK
analysis	B-UNK
of	O
protein	B-DISEASE
s	I-DISEASE
deficiency	I-DISEASE
type	B-UNK
i	O
.	O
.	O

 	O
characteristics	B-UNK
of	O
intergenerational	B-UNK
contractions	B-UNK
of	O
the	O
ctg	B-UNK
repeat	I-UNK
in	O
myotonic	B-DISEASE
dystrophy	I-DISEASE
.	O

 	O
in	O
myotonic	B-DISEASE
dystrophy	I-DISEASE
(	O
dm	B-DISEASE
)	O
,	O
the	O
size	B-UNK
of	O
a	O
ctg	B-UNK
repeat	I-UNK
in	O
the	O
dm	B-DISEASE
kinase	B-UNK
gene	B-UNK
generally	B-UNK
increases	B-UNK
in	O
successive	O
generations	B-UNK
with	O
clinical	B-UNK
evidence	B-UNK
of	O
anticipation	B-DISEASE
.	O

 	O
however	O
,	O
there	O
have	O
also	O
been	O
cases	B-UNK
with	O
an	O
intergenerational	B-UNK
contraction	B-UNK
of	O
the	O
repeat	B-UNK
.	O

 	O
we	O
examined	B-UNK
1	O
,	O
489	O
dm	B-DISEASE
parent	B-UNK
-	O
offspring	B-UNK
pairs	B-UNK
,	O
of	O
which	O
95	O
(	O
6	O
.	O
4	O
%	O
)	O
showed	B-UNK
such	O
contractions	B-UNK
in	O
peripheral	B-UNK
blood	I-UNK
leukocytes	B-UNK
(	O
pbl	O
)	O
.	O

 	O
in	O
56	O
of	O
the	O
95	O
pairs	B-UNK
,	O
clinical	B-UNK
data	B-UNK
allowed	B-UNK
an	O
analysis	B-UNK
of	O
their	O
anticipation	B-DISEASE
status	B-UNK
.	O

 	O
it	O
is	O
surprising	O
that	O
anticipation	B-DISEASE
occurred	B-UNK
in	O
27	O
(	O
48	O
%	O
)	O
of	O
these	O
56	O
pairs	B-UNK
,	O
while	O
none	O
clearly	B-UNK
showed	B-UNK
a	O
later	B-UNK
onset	B-UNK
of	O
dm	B-DISEASE
in	O
the	O
symptomatic	B-UNK
offspring	B-UNK
.	O

 	O
the	O
contraction	B-UNK
occurred	B-UNK
in	O
76	O
(	O
10	O
%	O
)	O
of	O
753	O
paternal	B-UNK
transmissions	O
and	O
in	O
19	O
(	O
3	O
%	O
)	O
of	O
736	O
maternal	B-UNK
transmissions	O
.	O

 	O
anticipation	B-DISEASE
was	O
observed	B-UNK
more	O
frequently	B-UNK
in	O
maternal	B-UNK
(	O
85	O
%	O
)	O
than	O
in	O
paternal	B-UNK
(	O
37	O
%	O
)	O
transmissions	O
(	O
p	B-UNK
<	O
.	O
001	O
)	O
.	O

 	O
the	O
parental	B-UNK
repeat	B-UNK
size	B-UNK
correlated	B-UNK
with	O
the	O
size	B-UNK
of	O
intergenerational	B-UNK
contraction	B-UNK
(	O
r2	O
=	O
.	O
50	O
,	O
p	B-UNK
<	O
<	O
.	O
001	O
)	O
,	O
and	O
the	O
slope	O
of	O
linear	O
regression	O
was	O
steeper	O
in	O
paternal	B-UNK
(	O
-	O
.	O
62	O
)	O
than	O
in	O
maternal	B-UNK
(	O
-	O
.	O
30	O
)	O
transmissions	O
(	O
p	B-UNK
<	O
<	O
.	O
001	O
)	O
.	O

 	O
sixteen	O
dm	B-DISEASE
parents	B-UNK
had	O
multiple	B-UNK
dm	B-DISEASE
offspring	B-UNK
with	O
the	O
ctg	B-UNK
repeat	I-UNK
contractions	B-UNK
.	O

 	O
this	O
frequency	B-UNK
was	O
higher	B-UNK
than	O
the	O
frequency	B-UNK
expected	B-UNK
from	O
the	O
probability	O
of	O
the	O
repeat	B-UNK
contractions	B-UNK
(	O
6	O
.	O
4	O
%	O
)	O
and	O
the	O
size	B-UNK
of	O
dm	B-DISEASE
sib	B-UNK
population	B-UNK
(	O
1	O
.	O
54	O
dm	B-DISEASE
offspring	B-UNK
per	O
dm	B-DISEASE
parent	B-UNK
,	O
in	O
968	O
dm	B-DISEASE
parents	B-UNK
)	O
.	O

 	O
we	O
conclude	O
that	O
(	O
1	O
)	O
intergenerational	B-UNK
contractions	B-UNK
of	O
the	O
ctg	B-UNK
repeat	I-UNK
in	O
leukocyte	B-UNK
dna	B-UNK
frequently	B-UNK
accompanies	O
apparent	B-UNK
anticipation	B-DISEASE
,	O
especially	B-UNK
when	O
dm	B-DISEASE
is	O
maternally	B-UNK
transmitted	B-UNK
,	O
and	O
(	O
2	O
)	O
the	O
paternal	B-UNK
origin	B-UNK
of	O
the	O
repeat	B-UNK
and	O
the	O
presence	B-UNK
of	O
the	O
repeat	B-UNK
contraction	B-UNK
in	O
a	O
sibling	B-UNK
increase	B-UNK
the	O
probability	O
of	O
the	O
ctg	B-UNK
repeat	I-UNK
contraction	B-UNK

 	O
gonosomal	O
mosaicism	B-UNK
in	O
myotonic	B-DISEASE
dystrophy	I-DISEASE
patients	B-UNK
:	O
involvement	B-UNK
of	O
mitotic	B-UNK
events	B-UNK
in	O
(	O
ctg	B-UNK
)	O
n	B-UNK
repeat	I-UNK
variation	B-UNK
and	O
selection	B-UNK
against	O
extreme	B-UNK
expansion	B-UNK
in	O
sperm	B-UNK
.	O

 	O
myotonic	B-DISEASE
dystrophy	I-DISEASE
(	O
dm	B-DISEASE
)	O
is	O
caused	B-UNK
by	O
abnormal	B-UNK
expansion	B-UNK
of	O
a	O
polymorphic	B-UNK
(	O
ctg	B-UNK
)	O
n	B-UNK
repeat	I-UNK
,	O
located	B-UNK
in	O
the	O
dm	B-DISEASE
protein	B-UNK
kinase	B-UNK
gene	B-UNK
.	O

 	O
we	O
determined	B-UNK
the	O
(	O
ctg	B-UNK
)	O
n	B-UNK
repeat	I-UNK
lengths	O
in	O
a	O
broad	B-UNK
range	B-UNK
of	O
tissue	B-UNK
dnas	B-UNK
from	O
patients	B-UNK
with	O
mild	B-UNK
,	O
classical	B-UNK
,	O
or	O
congenital	B-DISEASE
manifestation	B-UNK
of	O
dm	B-DISEASE
.	O

 	O
differences	B-UNK
in	O
the	O
repeat	B-UNK
length	O
were	O
seen	B-UNK
in	O
somatic	B-UNK
tissues	B-UNK
from	O
single	B-UNK
dm	B-DISEASE
individuals	B-UNK
and	O
twins	B-DISEASE
.	O

 	O
repeats	B-UNK
appeared	B-UNK
to	O
expand	O
to	O
a	O
similar	B-UNK
extent	B-UNK
in	O
tissues	B-UNK
originating	O
from	O
the	O
same	O
embryonal	O
origin	B-UNK
.	O

 	O
in	O
most	O
male	B-UNK
patients	I-UNK
carrying	B-UNK
intermediate	B-UNK
-	O
or	O
small	B-UNK
-	O
sized	B-UNK
expansions	B-UNK
in	O
blood	B-UNK
,	O
the	O
repeat	B-UNK
lengths	I-UNK
covered	O
a	O
markedly	B-UNK
wider	O
range	B-UNK
in	O
sperm	B-UNK
.	O

 	O
in	O
contrast	B-UNK
,	O
male	B-UNK
patients	I-UNK
with	O
large	B-UNK
allele	B-UNK
expansions	B-UNK
in	O
blood	B-UNK
(	O
>	O
700	O
ctgs	O
)	O
had	O
similar	B-UNK
or	O
smaller	B-UNK
repeats	B-UNK
in	O
sperm	B-UNK
,	O
when	O
detectable	B-UNK
.	O

 	O
sperm	B-UNK
alleles	B-UNK
with	O
>	O
1	O
,	O
000	O
ctgs	O
were	O
not	O
seen	B-UNK
.	O

 	O
we	O
conclude	O
that	O
dm	B-DISEASE
patients	B-UNK
can	O
be	O
considered	B-UNK
gonosomal	O
mosaics	O
,	O
i	O
.	O

 	O
e	B-UNK
e	B-UNK
.	O
,	O
combined	B-UNK
somatic	B-UNK
and	O
germ	O
-	O
line	B-UNK
tissue	B-UNK
mosaics	O
.	O

 	O
most	O
remarkably	O
,	O
we	O
observed	B-UNK
multiple	B-UNK
cases	B-UNK
where	O
the	O
length	O
distributions	O
of	O
intermediate	B-UNK
-	O
or	O
small	B-UNK
-	O
sized	B-UNK
alleles	B-UNK
in	O
fathers	B-UNK
sperm	B-UNK
were	O
significantly	B-UNK
different	B-UNK
from	O
that	O
in	O
their	O
offsprings	O
blood	B-UNK
.	O

 	O
our	O
combined	B-UNK
findings	B-UNK
indicate	B-UNK
that	O
intergenerational	B-UNK
length	O
changes	B-UNK
in	O
the	O
unstable	B-UNK
ctg	B-UNK
repeat	I-UNK
are	O
most	O
likely	B-UNK
to	O
occur	B-UNK
during	O
early	B-UNK
embryonic	I-UNK
mitotic	B-UNK
divisions	O
in	O
both	O
somatic	B-UNK
and	O
germ	O
-	O
line	B-UNK
tissue	B-UNK
formation	B-UNK
.	O

 	O
both	O
the	O
initial	B-UNK
ctg	B-UNK
length	O
,	O
the	O
overall	B-UNK
number	B-UNK
of	O
cell	B-UNK
divisions	O
involved	B-UNK
in	O
tissue	B-UNK
formation	B-UNK
,	O
and	O
perhaps	O
a	O
specific	B-UNK
selection	B-UNK
process	B-UNK
in	O
spermatogenesis	O
may	O
influence	O
the	O
dynamics	O
of	O
this	O
process	B-UNK
.	O

 	O
a	O
model	B-UNK
explaining	O
mitotic	B-UNK
instability	B-UNK
and	O
sex	B-UNK
-	O
dependent	B-UNK
segregation	B-UNK
phenomena	O
in	O
dm	B-DISEASE
manifestation	B-UNK
is	O
discussed	O

 	O
regionally	O
clustered	O
apc	B-UNK
mutations	B-UNK
are	O
associated	B-UNK
with	O
a	O
severe	B-UNK
phenotype	B-UNK
and	O
occur	B-UNK
at	B-DISEASE
a	O
high	B-UNK
frequency	B-UNK
in	O
new	B-UNK
mutation	B-UNK
cases	B-UNK
of	O
adenomatous	B-DISEASE
polyposis	I-DISEASE
coli	I-DISEASE
.	O

 	B-UNK
germline	I-UNK
mutation	B-UNK
in	O
apc	B-UNK
at	B-DISEASE
5q21	O
-	O
22	O
results	B-UNK
in	O
the	O
dominantly	B-UNK
inherited	I-UNK
syndrome	B-DISEASE
adenomatous	B-DISEASE
polyposis	I-DISEASE
coli	I-DISEASE
(	O
apc	B-UNK
)	O
.	O

 	O
somatic	B-UNK
mutation	B-UNK
in	O
this	O
gene	B-UNK
is	O
an	O
early	B-UNK
event	B-UNK
in	O
colorectal	B-UNK
tumourigenesis	O
.	O

 	O
both	O
types	B-UNK
of	O
mutation	B-UNK
are	O
concentrated	O
in	O
the	O
5	O
half	B-UNK
of	O
exon	B-UNK
15	O
.	O

 	O
we	O
have	O
used	O
single	B-UNK
strand	I-UNK
conformational	I-UNK
polymorphism	O
(	O
sscp	B-UNK
)	O
and	O
heteroduplex	B-UNK
analysis	B-UNK
to	O
screen	B-UNK
for	O
variants	B-UNK
in	O
this	O
region	B-UNK
of	O
the	O
gene	B-UNK
in	O
a	O
total	B-UNK
of	O
45	O
affected	B-UNK
but	O
unrelated	B-UNK
individuals	B-UNK
.	O

 	O
eighteen	O
patients	B-UNK
had	O
no	O
family	B-UNK
history	B-UNK
of	O
the	O
disease	B-DISEASE
;	O
of	O
these	O
11	O
were	O
classified	O
as	O
having	B-UNK
a	O
severe	B-UNK
phenotype	B-UNK
,	O
based	B-UNK
on	O
an	O
early	B-UNK
age	B-UNK
at	B-DISEASE
presentation	O
or	O
cancer	B-DISEASE
development	B-UNK
.	O

 	O
this	O
compared	B-UNK
with	O
6	O
of	O
27	O
familial	B-UNK
cases	B-UNK
.	O

 	O
a	O
5	O
bp	B-UNK
deletion	I-UNK
at	B-DISEASE
codon	B-UNK
1309	O
reported	B-UNK
to	O
occur	B-UNK
in	O
10	O
-	O
15	O
%	O
of	O
unselected	B-UNK
apc	B-UNK
patients	B-UNK
worldwide	B-UNK
,	O
was	O
found	B-UNK
in	O
5	O
of	O
the	O
18	O
new	B-UNK
mutation	B-UNK
cases	B-UNK
and	O
4	O
of	O
the	O
27	O
familial	B-UNK
cases	B-UNK
all	O
nine	O
were	O
classed	O
as	O
severe	B-UNK
.	O

 	O
a	O
further	O
3	O
new	B-UNK
mutations	B-UNK
and	O
1	O
familial	B-UNK
mutation	B-UNK
were	O
located	B-UNK
downstream	B-UNK
from	O
codon	B-UNK
1309	O
,	O
these	O
individuals	B-UNK
similarly	B-UNK
being	O
classed	O
as	O
phenotypically	O
severe	B-UNK
.	O

 	O
in	O
contrast	B-UNK
all	O
of	O
the	O
apc	B-UNK
mutations	B-UNK
detected	B-UNK
in	O
affected	B-UNK
individuals	I-UNK
with	O
an	O
average	B-UNK
phenotype	B-UNK
were	O
located	B-UNK
prior	B-UNK
to	O
codon	B-UNK
1309	O
.	O

 	O
the	O
frequent	B-UNK
association	B-UNK
of	O
a	O
severe	B-UNK
phenotype	B-UNK
with	O
fresh	B-UNK
mutation	B-UNK
may	O
explain	O
the	O
apparent	B-UNK
conflict	O
of	O
a	O
high	B-UNK
mutation	B-UNK
rate	B-UNK
(	O
20	O
-	O
30	O
%	O
)	O
in	O
a	O
condition	B-UNK
,	O
which	O
on	O
average	B-UNK
,	O
is	O
lethal	B-UNK
at	B-DISEASE
a	O
post	O
-	O
reproductive	B-UNK
age	B-UNK
.	O
.	O

 	O
mutations	B-UNK
at	B-DISEASE
the	O
pax6	B-UNK
locus	B-UNK
are	O
found	B-UNK
in	O
heterogeneous	B-UNK
anterior	B-UNK
segment	I-UNK
malformations	I-UNK
including	B-UNK
peters	O
'	O
anomaly	B-UNK
.	O

 	O
mutation	B-UNK
or	O
deletion	B-UNK
of	O
the	O
pax6	B-UNK
gene	B-UNK
underlies	O
many	O
cases	B-UNK
of	O
aniridia	B-DISEASE
.	O

 	O
three	O
lines	B-UNK
of	O
evidence	B-UNK
now	O
converge	O
to	O
implicate	B-UNK
pax6	B-UNK
more	O
widely	B-UNK
in	O
anterior	B-UNK
segment	I-UNK
malformations	I-UNK
including	B-UNK
peters	B-DISEASE
anomaly	I-DISEASE
.	O

 	O
first	O
,	O
a	O
child	B-UNK
with	O
peters	B-DISEASE
anomaly	I-DISEASE
is	O
deleted	B-UNK
for	O
one	O
copy	B-UNK
of	O
pax6	B-UNK
.	O

 	O
second	B-UNK
,	O
affected	B-UNK
members	B-UNK
of	O
a	O
family	B-UNK
with	O
dominantly	B-UNK
inherited	I-UNK
anterior	B-UNK
segment	I-UNK
malformations	I-UNK
,	O
including	B-UNK
peters	B-DISEASE
anomaly	I-DISEASE
are	O
heterozygous	B-UNK
for	O
an	O
r26	O
g	B-UNK
mutation	B-UNK
in	O
the	O
pax6	B-UNK
paired	B-UNK
box	B-UNK
.	O

 	O
third	O
,	O
a	O
proportion	B-UNK
of	O
sey	O
/	O
+	O
smalleye	O
mice	B-UNK
,	O
heterozygous	B-UNK
for	O
a	O
nonsense	B-UNK
mutation	B-UNK
in	O
murine	B-UNK
pax	B-UNK
-	O
6	O
,	O
have	O
an	O
ocular	O
phenotype	B-UNK
resembling	B-UNK
peters	B-DISEASE
anomaly	I-DISEASE
.	O

 	O
we	O
therefore	O
propose	O
that	O
a	O
variety	B-UNK
of	O
anterior	B-UNK
segment	I-UNK
anomalies	B-UNK
may	O
be	O
associated	B-UNK
with	O
pax6	B-UNK
mutations	B-UNK
.	O
.	O

 	O
huntington	B-DISEASE
disease	I-DISEASE
without	O
cag	B-UNK
expansion	B-UNK
:	O
phenocopies	O
or	O
errors	B-UNK
in	O
assignment	B-UNK
?	O

 	O
huntington	B-DISEASE
disease	I-DISEASE
(	O
hd	B-UNK
)	O
has	O
been	O
shown	B-UNK
to	O
be	O
associated	B-UNK
with	O
an	O
expanded	B-UNK
cag	I-UNK
repeat	B-UNK
within	O
a	O
novel	B-UNK
gene	B-UNK
on	O
4p16	B-UNK
.	O

 	O
3	O
(	O
it15	O
)	O
.	O

 	O
a	O
total	B-UNK
of	O
30	O
of	O
1	O
,	O
022	O
affected	B-UNK
persons	B-UNK
(	O
2	O
.	O
9	O
%	O
of	O
our	O
cohort	B-UNK
)	O
did	O
not	O
have	O
an	O
expanded	B-UNK
cag	I-UNK
in	O
the	O
disease	B-DISEASE
range	B-UNK
.	O

 	O
the	O
reasons	O
for	O
not	O
observing	O
expansion	B-UNK
in	O
affected	B-UNK
individuals	I-UNK
are	O
important	B-UNK
for	O
determining	O
the	O
sensitivity	B-UNK
of	O
using	O
repeat	B-UNK
length	O
both	O
for	O
diagnosis	B-UNK
of	O
affected	B-UNK
patients	I-UNK
and	O
for	O
predictive	B-UNK
testing	B-UNK
programs	B-UNK
and	O
may	O
have	O
biological	B-UNK
relevance	B-UNK
for	O
the	O
understanding	B-UNK
of	O
the	O
molecular	B-UNK
mechanism	B-UNK
underlying	B-UNK
hd	B-UNK
.	O

 	O
here	O
we	O
show	O
that	O
the	O
majority	B-UNK
(	O
18	O
)	O
of	O
the	O
individuals	B-UNK
with	O
normal	B-UNK
sized	I-UNK
alleles	B-UNK
represent	B-UNK
misdiagnosis	O
,	O
sample	B-UNK
mix	O
-	O
up	O
,	O
or	O
clerical	O
error	B-UNK
.	O

 	O
the	O
remaining	B-UNK
12	O
patients	B-UNK
represent	B-UNK
possible	B-UNK
phenocopies	O
for	O
hd	B-UNK
.	O

 	O
in	O
at	B-DISEASE
least	O
four	O
cases	B-UNK
,	O
family	B-UNK
studies	I-UNK
of	O
these	O
phenocopies	O
excluded	B-UNK
4p16	B-UNK
.	O

 	O
3	O
as	O
the	O
region	B-UNK
responsible	B-UNK
for	O
the	O
phenotype	B-UNK
.	O

 	O
mutations	B-UNK
in	O
the	O
hd	B-UNK
gene	B-UNK
that	O
are	O
other	O
than	O
cag	B-UNK
expansion	B-UNK
have	O
not	O
been	O
excluded	B-UNK
for	O
the	O
remaining	B-UNK
eight	O
cases	B-UNK
;	O
however	O
,	O
in	O
as	O
many	O
as	O
seven	B-UNK
of	O
these	O
persons	B-UNK
,	O
retrospective	B-UNK
review	O
of	O
these	O
patients	B-UNK
clinical	B-UNK
features	I-UNK
identified	B-UNK
characteristics	B-UNK
not	O
typical	B-UNK
for	O
hd	B-UNK
.	O

 	O
this	O
study	B-UNK
shows	B-UNK
that	O
on	O
rare	B-UNK
occasions	O
mutations	B-UNK
in	O
other	O
,	O
as	O
-	O
yet	O
-	O
undefined	O
genes	B-UNK
can	O
present	B-UNK
with	O
a	O
clinical	B-UNK
phenotype	I-UNK
very	O
similar	B-UNK
to	O
that	O
of	O
hd	B-UNK

 	O
frequent	B-UNK
detection	B-UNK
of	O
codon	B-UNK
877	O
mutation	B-UNK
in	O
the	O
androgen	O
receptor	B-UNK
gene	B-UNK
in	O
advanced	B-UNK
prostate	O
cancers	B-DISEASE
.	O

 	O
prostatic	O
tissue	B-UNK
specimens	B-UNK
derived	B-UNK
from	O
transurethral	O
resections	O
of	O
patients	B-UNK
with	O
metastatic	O
prostate	B-DISEASE
cancer	I-DISEASE
were	O
analyzed	B-UNK
for	O
genetic	B-UNK
alterations	B-UNK
in	O
the	O
hormone	B-UNK
-	O
binding	B-UNK
domain	I-UNK
of	O
the	O
androgen	O
receptor	B-UNK
(	O
ar	B-UNK
)	O
gene	B-UNK
.	O

 	B-UNK
direct	I-UNK
sequencing	B-UNK
of	O
the	O
polymerase	B-UNK
chain	I-UNK
reaction	I-UNK
-	O
derived	B-UNK
dnas	B-UNK
of	O
6	O
of	O
24	O
specimens	B-UNK
revealed	B-UNK
a	O
codon	B-UNK
877	O
mutation	B-UNK
(	O
act	B-UNK
-	O
-	O
>	O
gct	O
,	O
thr	O
-	O
-	O
>	O
ala	B-UNK
)	O
in	O
the	O
hormone	B-UNK
-	O
binding	B-UNK
domain	I-UNK
of	O
the	O
ar	B-UNK
gene	B-UNK
.	O

 	O
this	O
same	O
ar	B-UNK
mutation	B-UNK
has	O
been	O
reported	B-UNK
previously	B-UNK
in	O
a	O
metastatic	O
prostate	B-DISEASE
cancer	I-DISEASE
cell	B-UNK
line	B-UNK
,	O
lncap	O
,	O
where	O
this	O
mutation	B-UNK
confers	O
upon	O
the	O
ar	B-UNK
an	O
altered	B-UNK
ligand	B-UNK
-	O
binding	B-UNK
specificity	B-UNK
which	O
is	O
stimulated	B-UNK
by	O
estrogens	O
,	O
progestagens	O
,	O
and	O
antiandrogens	O
.	O

 	O
it	O
is	O
possible	B-UNK
that	O
analogous	O
to	O
an	O
activated	B-UNK
/	O
altered	B-UNK
growth	B-UNK
factor	I-UNK
receptor	I-UNK
oncogene	B-UNK
,	O
codon	B-UNK
877	O
mutant	B-UNK
ar	B-UNK
with	O
altered	B-UNK
ligand	B-UNK
binding	B-UNK
may	O
provide	B-UNK
a	O
selective	B-UNK
growth	B-UNK
advantage	B-UNK
in	O
the	O
genesis	O
of	O
a	O
subset	O
of	O
advanced	B-UNK
prostate	B-DISEASE
cancer	I-DISEASE
.	O

 	O
although	O
estrogens	O
are	O
used	O
infrequently	O
,	O
antiandrogens	O
are	O
used	O
increasingly	O
in	O
hormonal	O
therapy	B-UNK
for	O
patients	B-UNK
with	O
advanced	B-UNK
prostate	B-DISEASE
cancer	I-DISEASE
.	O

 	O
the	O
stimulatory	O
effect	B-UNK
of	O
these	O
therapeutic	B-UNK
agents	B-UNK
on	O
the	O
codon	B-UNK
877	O
mutant	B-UNK
ar	B-UNK
further	O
suggests	B-UNK
that	O
this	O
frequently	B-UNK
observed	B-UNK
ar	B-UNK
mutation	B-UNK
may	O
contribute	B-UNK
to	O
the	O
treatment	B-UNK
refractory	O
disease	B-DISEASE
.	O
.	O

 	O
the	O
human	B-UNK
gene	B-UNK
for	O
alkaptonuria	B-DISEASE
(	O
aku	B-UNK
)	O
maps	B-UNK
to	O
chromosome	B-UNK
3q	O
.	O

 	O
alkaptonuria	B-DISEASE
(	O
aku	B-UNK
;	O
mckusick	O
no	O
.	O
203500	O
)	O
is	O
a	O
rare	B-UNK
autosomal	I-UNK
recessive	I-UNK
disorder	I-UNK
caused	B-UNK
by	O
the	O
lack	B-UNK
of	O
homogentisic	O
acid	O
oxidase	B-UNK
activity	B-UNK
.	O

 	B-UNK
patients	I-UNK
excrete	O
large	B-UNK
amounts	B-UNK
of	O
homogentisic	O
acid	O
in	O
their	O
urine	B-DISEASE
and	O
a	O
black	B-UNK
ochronotic	O
pigment	O
is	O
deposited	O
in	O
their	O
cartilage	O
and	O
collagenous	O
tissues	B-UNK
.	O

 	O
ochronosis	B-DISEASE
is	O
the	O
predominant	B-UNK
clinical	B-UNK
complication	O
of	O
the	O
disease	B-DISEASE
leading	B-UNK
to	O
ochronotic	O
arthropathy	B-DISEASE
,	O
dark	O
urine	B-DISEASE
,	O
pigment	O
changes	B-UNK
of	O
the	O
skin	B-DISEASE
,	O
and	O
other	O
clinical	B-UNK
features	I-UNK
.	O

 	O
a	O
mutation	B-UNK
causing	B-UNK
alkaptonuria	B-DISEASE
in	O
the	O
mouse	B-UNK
has	O
mapped	B-UNK
to	O
chromosome	B-DISEASE
16	I-DISEASE
.	O

 	O
considering	O
conserved	B-UNK
synteny	B-UNK
,	O
we	O
were	O
able	O
to	O
map	B-UNK
the	O
human	B-UNK
gene	B-UNK
to	O
chromosome	B-UNK
3q	O
in	O
six	O
alkaptonuria	B-DISEASE
pedigrees	B-UNK
of	O
slovak	O
origin	B-UNK
.	O
.	O

 	O
structure	B-UNK
of	O
the	O
human	B-UNK
na	B-UNK
+	O
/	O
glucose	B-UNK
cotransporter	B-UNK
gene	I-UNK
sglt1	I-UNK
.	O

 	O
intestinal	B-UNK
uptake	B-UNK
of	O
dietary	B-UNK
glucose	B-UNK
and	O
galactose	B-UNK
is	O
mediated	B-UNK
by	O
the	O
sglt1	B-UNK
na	B-UNK
+	O
/	O
glucose	B-UNK
cotransporter	O
of	O
the	O
brush	B-UNK
border	B-UNK
.	O

 	O
an	O
sglt1	B-UNK
missense	B-UNK
mutation	I-UNK
underlies	O
hereditary	B-UNK
glucose	B-UNK
/	O
galactose	B-UNK
malabsorption	B-UNK
,	O
characterized	B-UNK
by	O
potentially	B-UNK
fatal	B-UNK
diarrhea	B-DISEASE
;	O
conversely	O
,	O
oral	B-UNK
rehydration	O
therapy	B-UNK
exploits	O
normal	B-UNK
transport	B-UNK
to	O
alleviate	O
life	B-UNK
-	O
threatening	O
diarrhea	B-DISEASE
of	O
infectious	B-UNK
origin	B-UNK
.	O

 	O
we	O
have	O
mapped	B-UNK
the	O
entire	B-UNK
human	B-UNK
sglt1	B-UNK
na	B-UNK
+	O
/	O
glucose	B-UNK
cotransporter	O
gene	B-UNK
from	O
cosmid	B-UNK
and	O
lambda	B-UNK
phage	B-UNK
clones	B-UNK
representing	B-UNK
a	O
genomic	B-UNK
region	B-UNK
of	O
112	O
kilobases	O
.	O

 	O
transcription	B-UNK
initiation	B-UNK
occurred	B-UNK
from	O
a	O
site	B-UNK
27	O
base	B-UNK
pairs	I-UNK
3	O
of	O
a	O
tataa	O
sequence	B-UNK
.	O

 	O
all	O
exon	B-UNK
-	O
flanking	B-UNK
regions	B-UNK
were	O
sequenced	B-UNK
,	O
and	O
the	O
entire	B-UNK
112	O
-	O
kilobase	O
region	B-UNK
mapped	B-UNK
with	O
four	O
restriction	O
enzymes	B-UNK
.	O

 	O
sglt1	B-UNK
is	O
comprised	O
of	O
15	O
exons	B-UNK
(	O
spanning	B-UNK
72	O
kilobases	O
)	O
;	O
a	O
possible	B-UNK
evolutionary	B-UNK
origin	B-UNK
from	O
a	O
six	O
-	O
membrane	B-UNK
-	O
span	B-UNK
ancestral	B-UNK
precursor	B-UNK
via	O
a	O
gene	B-UNK
duplication	B-UNK
event	B-UNK
is	O
suggested	B-UNK
from	O
comparison	B-UNK
of	O
exons	B-UNK
against	O
protein	B-UNK
secondary	B-UNK
structure	B-UNK
and	O
from	O
sequence	B-UNK
considerations	O
.	O

 	O
a	O
new	B-UNK
missense	B-UNK
mutation	I-UNK
in	O
exon	B-UNK
1	O
causing	B-UNK
glucose	B-UNK
/	O
galactose	B-UNK
malabsorption	B-UNK
is	O
also	O
described	B-UNK
.	O

 	O
this	O
is	O
the	O
first	O
na	B-UNK
(	O
+	O
)	O
-	O
dependent	B-UNK
cotransporter	O
gene	B-UNK
structure	B-UNK
reported	B-UNK
.	O

 	O
these	O
data	B-UNK
facilitate	B-UNK
the	O
search	O
for	O
new	B-UNK
glucose	B-UNK
/	O
galactose	B-UNK
malabsorption	B-UNK
-	O
related	B-UNK
mutations	B-UNK
in	O
this	O
important	B-UNK
gene	B-UNK
and	O
provide	B-UNK
a	O
basis	B-UNK
for	O
future	B-UNK
evolutionary	B-UNK
comparisons	O
with	O
other	O
na	B-UNK
(	O
+	O
)	O
-	O
dependent	B-UNK
cotransporters	O
.	O
.	O

 	O
four	O
novel	B-UNK
pepd	B-UNK
alleles	B-UNK
causing	B-UNK
prolidase	B-DISEASE
deficiency	I-DISEASE
.	O

 	O
mutations	B-UNK
at	B-DISEASE
the	O
pepd	B-UNK
locus	B-UNK
cause	B-UNK
prolidase	B-DISEASE
deficiency	I-DISEASE
(	O
mckusick	O
170100	O
)	O
,	O
a	O
rare	B-UNK
autosomal	I-UNK
recessive	I-UNK
disorder	I-UNK
characterized	B-UNK
by	O
iminodipeptiduria	O
,	O
skin	B-DISEASE
ulcers	O
,	O
mental	B-DISEASE
retardation	I-DISEASE
,	O
and	O
recurrent	B-UNK
infections	B-DISEASE
.	O

 	O
four	O
pepd	B-UNK
mutations	B-UNK
from	O
five	O
severely	B-UNK
affected	I-UNK
individuals	B-UNK
were	O
characterized	B-UNK
by	O
analysis	B-UNK
of	O
reverse	B-UNK
-	O
transcribed	B-UNK
,	O
pcr	B-UNK
-	O
amplified	B-UNK
(	O
rt	O
-	O
pcr	B-UNK
)	O
cdna	B-UNK
.	O

 	O
we	O
used	O
sscp	B-UNK
analysis	B-UNK
on	O
four	O
overlapping	B-UNK
cdna	B-UNK
fragments	B-UNK
covering	B-UNK
the	O
entire	B-UNK
coding	I-UNK
region	B-UNK
of	O
the	O
pepd	B-UNK
gene	B-UNK
and	O
detected	B-UNK
abnormal	B-UNK
sscp	B-UNK
bands	B-UNK
for	O
the	O
fragment	O
spanning	B-UNK
all	O
or	O
part	O
of	O
exons	B-UNK
13	O
-	O
15	O
in	O
three	O
of	O
the	O
probands	B-UNK
.	O

 	B-UNK
direct	I-UNK
sequencing	B-UNK
of	O
the	O
mutant	B-UNK
cdnas	I-UNK
showed	B-UNK
a	O
g	B-UNK
-	O
-	O
>	O
a	O
,	O
1342	O
substitution	B-UNK
(	O
g448r	O
)	O
in	O
two	O
patients	B-UNK
and	O
a	O
3	O
-	O
bp	B-UNK
deletion	I-UNK
(	O
delta	B-UNK
e452	O
or	O
delta	B-UNK
e453	O
)	O
in	O
another	O
.	O

 	O
in	O
the	O
other	O
two	O
probands	B-UNK
the	O
amplified	B-UNK
products	B-UNK
were	O
of	O
reduced	B-UNK
size	B-UNK
.	O

 	B-UNK
direct	I-UNK
sequencing	B-UNK
of	O
these	O
mutant	B-UNK
cdnas	I-UNK
revealed	B-UNK
a	O
deletion	B-UNK
of	O
exon	B-UNK
5	O
in	O
one	O
patient	B-UNK
and	O
of	O
exon	B-UNK
7	O
in	O
the	O
other	O
.	O

 	O
intronic	B-UNK
sequences	B-UNK
flanking	B-UNK
exons	B-UNK
5	O
and	O
7	O
were	O
identified	B-UNK
using	O
inverse	O
pcr	B-UNK
followed	B-UNK
by	O
direct	B-UNK
sequencing	I-UNK
.	O

 	O
conventional	B-UNK
pcr	B-UNK
and	O
direct	B-UNK
sequencing	I-UNK
then	O
established	B-UNK
the	O
intron	B-UNK
-	O
exon	B-UNK
borders	O
of	O
the	O
mutant	B-UNK
genomic	B-UNK
dna	I-UNK
revealing	O
two	O
splice	O
acceptor	B-UNK
mutations	B-UNK
a	O
g	B-UNK
-	O
-	O
>	O
c	B-UNK
substitution	B-UNK
at	B-DISEASE
position	B-UNK
-	O
1	O
of	O
intron	B-UNK
4	O
and	O
an	O
a	O
-	O
-	O
>	O
g	B-UNK
substitution	B-UNK
at	B-DISEASE
position	B-UNK
-	O
2	O
of	O
intron	B-UNK
6	O
.	O

 	O
our	O
results	B-UNK
indicate	B-UNK
that	O
the	O
severe	B-UNK
form	B-UNK
of	O
prolidase	B-DISEASE
deficiency	I-DISEASE
is	O
caused	B-UNK
by	O
multiple	B-UNK
pepd	B-UNK
alleles	B-UNK
.	O

 	O
in	O
this	O
report	B-UNK
we	O
attempt	O
to	O
begin	O
the	O
process	B-UNK
of	O
describing	O
these	O
alleles	B-UNK
and	O
cataloging	O
their	O
phenotypic	B-UNK
expression	B-UNK
.	O
.	O

 	O
recombinations	B-UNK
in	O
individuals	B-UNK
homozygous	B-UNK
by	O
descent	B-UNK
localize	B-UNK
the	O
friedreich	B-DISEASE
ataxia	I-DISEASE
locus	B-UNK
in	O
a	O
cloned	B-UNK
450	O
-	O
kb	B-UNK
interval	B-UNK
.	O

 	O
the	O
locus	B-UNK
for	O
friedreich	B-DISEASE
ataxia	I-DISEASE
(	O
frda	B-UNK
)	O
,	O
a	O
severe	B-UNK
neurodegenerative	B-DISEASE
disease	I-DISEASE
,	O
is	O
tightly	B-UNK
linked	I-UNK
to	O
markers	B-UNK
d9s5	O
and	O
d9s15	O
,	O
and	O
analysis	B-UNK
of	O
rare	B-UNK
recombination	B-UNK
events	I-UNK
has	O
suggested	B-UNK
the	O
order	B-UNK
cen	B-UNK
-	O
frda	B-UNK
-	O
d9s5	O
-	O
d9s15	O
-	O
qter	O
.	O

 	O
we	O
report	B-UNK
here	O
the	O
construction	O
of	O
a	O
yac	B-UNK
contig	B-UNK
extending	B-UNK
800	O
kb	B-UNK
centromeric	B-UNK
to	O
d9s5	O
and	O
the	O
isolation	B-UNK
of	O
five	O
new	B-UNK
microsatellite	I-UNK
markers	B-UNK
from	O
this	O
region	B-UNK
.	O

 	O
in	O
order	B-UNK
to	O
map	B-UNK
these	O
markers	B-UNK
with	O
respect	O
to	O
the	O
frda	B-UNK
locus	B-UNK
,	O
all	O
within	O
a	O
1	O
-	O
cm	B-DISEASE
confidence	B-UNK
interval	B-UNK
,	O
we	O
sought	O
to	O
increase	B-UNK
the	O
genetic	B-UNK
information	B-UNK
of	O
available	B-UNK
frda	B-UNK
families	B-UNK
by	O
considering	O
homozygosity	B-UNK
by	O
descent	B-UNK
and	O
association	B-UNK
with	O
founder	B-UNK
haplotypes	B-UNK
in	O
isolated	B-UNK
populations	B-UNK
.	O

 	O
this	O
approach	B-UNK
allowed	B-UNK
us	O
to	O
identify	B-UNK
one	O
phase	O
-	O
known	B-UNK
recombination	B-UNK
and	O
one	O
probable	B-UNK
historic	O
recombination	B-UNK
on	O
haplotypes	B-UNK
from	O
reunion	O
island	B-UNK
patients	B-UNK
,	O
both	O
of	O
which	O
place	B-UNK
three	O
of	O
the	O
five	O
markers	B-UNK
proximal	B-UNK
to	O
frda	B-UNK
.	O

 	O
this	O
represents	B-UNK
the	O
first	O
identification	B-UNK
of	O
close	B-UNK
frda	B-UNK
flanking	B-UNK
markers	B-UNK
on	O
the	O
centromeric	B-UNK
side	O
.	O

 	O
the	O
two	O
other	O
markers	B-UNK
allowed	B-UNK
us	O
to	O
narrow	B-UNK
the	O
breakpoint	B-UNK
of	O
a	O
previously	B-UNK
identified	I-UNK
distal	B-UNK
recombination	B-UNK
that	O
is	O
>	O
180	O
kb	B-UNK
from	O
d9s5	O
(	O
26p	O
)	O
.	O

 	O
taken	O
together	O
,	O
the	O
results	B-UNK
place	B-UNK
the	O
frda	B-UNK
locus	B-UNK
in	O
a	O
450	O
-	O
kb	B-UNK
interval	B-UNK
,	O
which	O
is	O
small	B-UNK
enough	O
for	O
direct	B-UNK
search	O
of	O
candidate	B-UNK
genes	I-UNK
.	O

 	O
a	O
detailed	B-UNK
rare	B-UNK
cutter	O
restriction	O
map	B-UNK
and	O
a	O
cosmid	B-UNK
contig	B-UNK
covering	B-UNK
this	O
interval	B-UNK
were	O
constructed	B-UNK
and	O
should	O
facilitate	B-UNK
the	O
search	O
of	O
genes	B-UNK
in	O
this	O
region	B-UNK
.	O
.	O

 	O
investigation	O
of	O
thermoregulatory	O
characteristics	B-UNK
in	O
patients	B-UNK
with	O
prader	B-DISEASE
-	I-DISEASE
willi	I-DISEASE
syndrome	I-DISEASE
.	O

 	O
a	O
survey	B-UNK
instrument	O
is	O
used	O
to	O
assess	B-UNK
temperature	O
regulation	B-UNK
characteristics	B-UNK
in	O
children	B-UNK
with	O
prader	B-DISEASE
-	I-DISEASE
willi	I-DISEASE
syndrome	I-DISEASE
(	O
pws	B-UNK
)	O
compared	B-UNK
to	O
3	O
control	B-UNK
groups	B-UNK
sibs	B-UNK
of	O
pws	B-UNK
patients	B-UNK
(	O
sib	B-UNK
)	O
,	O
neurodevelopmentally	O
handicapped	O
children	B-UNK
(	O
nd	B-UNK
)	O
,	O
and	O
age	B-UNK
and	O
gender	O
matched	B-UNK
well	O
children	B-UNK
(	O
wc	O
)	O
.	O

 	B-UNK
significant	I-UNK
differences	B-UNK
were	O
found	B-UNK
between	O
pws	B-UNK
patients	B-UNK
,	O
sib	B-UNK
controls	B-UNK
,	O
and	O
wc	O
controls	B-UNK
in	O
the	O
prevalence	B-UNK
of	O
febrile	B-DISEASE
convulsions	I-DISEASE
,	O
fever	B-DISEASE
-	O
associated	B-UNK
symptoms	B-UNK
,	O
and	O
temperature	O
less	O
than	O
94	O
degrees	B-UNK
f	B-UNK
.	O

 	O
no	O
differences	B-UNK
were	O
noted	O
in	O
any	O
variable	B-UNK
between	O
the	O
pws	B-UNK
patients	B-UNK
and	O
the	O
nd	B-UNK
controls	B-UNK
,	O
suggesting	B-UNK
that	O
these	O
abnormalities	B-DISEASE
are	O
not	O
unique	B-UNK
to	O
pws	B-UNK
,	O
but	O
can	O
occur	B-UNK
in	O
any	O
neurodevelopmentally	O
handicapped	O
individual	B-UNK
,	O
further	O
suggesting	B-UNK
these	O
do	O
not	O
necessarily	O
reflect	B-UNK
syndrome	B-DISEASE
-	O
specific	B-UNK
hypothalamic	O
abnormalities	B-DISEASE
.	O
.	O

 	O
phenotypic	B-UNK
variation	B-UNK
including	B-UNK
retinitis	B-DISEASE
pigmentosa	I-DISEASE
,	O
pattern	B-UNK
dystrophy	B-UNK
,	O
and	O
fundus	O
flavimaculatus	O
in	O
a	O
single	B-UNK
family	B-UNK
with	O
a	O
deletion	B-UNK
of	O
codon	B-UNK
153	O
or	O
154	O
of	O
the	O
peripherin	O
/	O
rds	B-UNK
gene	B-UNK
.	O

 	B-UNK
background	I-UNK
and	O
objectives	B-UNK
mutations	B-UNK
of	O
the	O
peripherin	O
/	O
rds	B-UNK
gene	B-UNK
have	O
been	O
reported	B-UNK
in	O
autosomal	O
dominant	B-UNK
retinitis	B-DISEASE
pigmentosa	I-DISEASE
,	O
pattern	B-UNK
macular	B-DISEASE
dystrophy	I-DISEASE
,	O
and	O
retinitis	B-DISEASE
punctata	O
albescens	O
.	O

 	O
we	O
report	B-UNK
herein	O
the	O
occurrence	B-UNK
of	O
three	O
separate	B-UNK
phenotypes	B-UNK
within	O
a	O
single	B-UNK
family	B-UNK
with	O
a	O
novel	B-UNK
3	O
-	O
base	B-UNK
pair	I-UNK
deletion	B-UNK
of	O
codon	B-UNK
153	O
or	O
154	O
of	O
the	O
peripherin	O
/	O
rds	B-UNK
gene	B-UNK
.	O

 	O
design	B-UNK
case	B-UNK
reports	B-UNK
with	O
clinical	B-UNK
features	I-UNK
,	O
fluorescein	O
angiography	O
,	O
kinetic	B-UNK
perimetry	O
,	O
electrophysiological	B-UNK
studies	B-UNK
,	O
and	O
molecular	B-UNK
genetics	B-UNK
.	O

 	O
setting	B-UNK
university	O
medical	O
centers	O
.	O

 	B-UNK
patients	I-UNK
a	O
75	O
-	O
year	B-UNK
-	O
old	B-UNK
woman	B-UNK
,	O
her	O
two	O
daughters	O
(	O
aged	O
44	O
and	O
50	O
years	B-UNK
)	O
,	O
and	O
her	O
49	O
-	O
year	B-UNK
-	O
old	B-UNK
son	O
were	O
screened	O
for	O
peripherin	O
/	O
rds	B-UNK
mutations	B-UNK
because	O
of	O
the	O
presence	B-UNK
of	O
multiple	B-UNK
phenotypes	B-UNK
within	O
the	O
same	O
family	B-UNK
.	O

 	B-UNK
results	I-UNK
the	O
mother	B-UNK
presented	B-UNK
at	B-DISEASE
age	B-UNK
63	O
years	B-UNK
with	O
a	O
profoundly	O
abnormal	B-UNK
electroretinogram	B-UNK
(	O
erg	B-UNK
)	O
and	O
adult	B-UNK
-	O
onset	B-UNK
retinitis	B-DISEASE
pigmentosa	I-DISEASE
that	O
progressed	O
dramatically	B-UNK
over	O
12	O
years	B-UNK
,	O
with	O
marked	B-UNK
loss	B-UNK
of	O
peripheral	B-UNK
visual	B-UNK
field	I-UNK
.	O

 	O
one	O
daughter	O
developed	B-UNK
pattern	B-UNK
macular	B-DISEASE
dystrophy	I-DISEASE
at	B-DISEASE
age	B-UNK
31	O
years	B-UNK
.	O

 	O
at	B-DISEASE
age	B-UNK
44	O
years	B-UNK
,	O
her	O
erg	B-UNK
was	O
moderately	B-UNK
abnormal	B-UNK
but	O
her	O
clinical	B-UNK
disease	B-DISEASE
was	O
limited	B-UNK
to	O
the	O
macula	O
.	O

 	O
another	O
daughter	O
presented	B-UNK
at	B-DISEASE
age	B-UNK
42	O
years	B-UNK
with	O
macular	B-DISEASE
degeneration	I-DISEASE
and	O
over	O
10	O
years	B-UNK
developed	B-UNK
the	O
clinical	B-UNK
picture	B-UNK
of	O
fundus	O
flavimaculatus	O
.	O

 	O
her	O
peripheral	B-UNK
visual	B-UNK
field	I-UNK
was	O
preserved	O
but	O
her	O
erg	B-UNK
was	O
moderately	B-UNK
abnormal	B-UNK
.	O

 	O
the	O
son	O
had	O
onset	B-UNK
of	O
macular	B-DISEASE
degeneration	I-DISEASE
at	B-DISEASE
age	B-UNK
44	O
years	B-UNK
.	O

 	O
pericentral	O
scotomas	O
were	O
present	B-UNK
and	O
the	O
erg	B-UNK
was	O
markedly	B-UNK
abnormal	B-UNK
.	O

 	O
fluorescein	O
angiography	O
revealed	B-UNK
punctate	B-UNK
pigment	O
epithelial	O
transmission	B-UNK
defects	B-UNK
.	O

 	O
conclusions	B-UNK
a	O
3	O
-	O
base	B-UNK
pair	I-UNK
deletion	B-UNK
of	O
codon	B-UNK
153	O
or	O
154	O
of	O
the	O
peripherin	O
/	O
rds	B-UNK
gene	B-UNK
can	O
produce	B-UNK
clinically	B-UNK
disparate	O
phenotypes	B-UNK
even	O
within	O
the	O
same	O
family	B-UNK
.	O
.	O

 	O
assignment	B-UNK
of	O
the	O
human	B-UNK
na	B-UNK
+	O
/	O
glucose	B-UNK
cotransporter	B-UNK
gene	I-UNK
sglt1	I-UNK
to	O
chromosome	B-UNK
22q13	O
.	O
1	O
.	O

 	O
the	O
na	B-UNK
+	O
/	O
glucose	B-UNK
cotransporter	B-UNK
gene	I-UNK
sglt1	I-UNK
encodes	B-UNK
the	O
primary	B-UNK
carrier	B-UNK
protein	B-UNK
responsible	B-UNK
for	O
the	O
uptake	B-UNK
of	O
the	O
dietary	B-UNK
sugars	O
glucose	B-UNK
and	O
galactose	B-UNK
from	O
the	O
intestinal	B-UNK
lumen	O
.	O

 	O
sglt1	B-UNK
transport	B-UNK
activity	B-UNK
is	O
currently	B-UNK
exploited	O
in	O
oral	B-UNK
rehydration	O
therapy	B-UNK
.	O

 	O
the	O
75	O
-	O
kda	B-UNK
glycoprotein	B-UNK
is	O
localized	B-UNK
in	O
the	O
brush	B-UNK
border	B-UNK
of	O
the	O
intestinal	B-UNK
epithelium	O
and	O
is	O
predicted	B-UNK
to	O
comprise	O
12	O
membrane	B-UNK
spans	B-UNK
.	O

 	O
in	O
two	O
patients	B-UNK
with	O
the	O
autosomal	O
recessive	O
disease	B-DISEASE
glucose	B-UNK
/	O
galactose	B-UNK
malabsorption	B-UNK
,	O
the	O
underlying	B-UNK
cause	B-UNK
was	O
found	B-UNK
to	O
be	O
a	O
missense	B-UNK
mutation	I-UNK
in	O
sglt1	B-UNK
,	O
and	O
the	O
asp28	O
-	O
-	O
>	O
asn	O
change	B-UNK
was	O
demonstrated	B-UNK
in	O
vitro	B-UNK
to	O
eliminate	O
sglt1	B-UNK
transport	B-UNK
activity	B-UNK
.	O

 	O
the	O
sglt1	B-UNK
gene	B-UNK
was	O
previously	B-UNK
shown	B-UNK
to	O
reside	O
on	O
the	O
distal	B-UNK
q	B-UNK
arm	B-UNK
of	O
chromosome	B-DISEASE
22	I-DISEASE
(	O
11	O
.	O
2	O
-	O
-	O
>	O
qter	O
)	O
.	O

 	O
we	O
have	O
used	O
a	O
cosmid	B-UNK
probe	B-UNK
for	O
fluorescence	B-UNK
in	O
situ	B-UNK
hybridization	I-UNK
,	O
which	O
refines	O
the	O
localization	B-UNK
to	O
22q13	O
.	O

 	O
1	O
,	O
and	O
provide	B-UNK
an	O
example	O
of	O
the	O
utility	O
of	O
the	O
sglt1	B-UNK
probe	B-UNK
as	O
a	O
diagnostic	B-UNK
for	O
genetic	B-DISEASE
diseases	I-DISEASE
associated	B-UNK
with	O
translocations	B-UNK
of	O
chromosome	B-DISEASE
22	I-DISEASE
.	O

 	O
restriction	O
of	O
ocular	B-UNK
fundus	I-UNK
lesions	I-UNK
to	O
a	O
specific	B-UNK
subgroup	O
of	O
apc	B-UNK
mutations	B-UNK
in	O
adenomatous	B-DISEASE
polyposis	I-DISEASE
coli	I-DISEASE
patients	B-UNK
.	O

 	O
in	O
humans	B-UNK
,	O
alteration	B-UNK
of	O
the	O
tumor	B-DISEASE
suppressor	B-UNK
gene	B-UNK
,	O
apc	B-UNK
,	O
causes	B-UNK
adenomatous	B-DISEASE
polyposis	I-DISEASE
coli	I-DISEASE
,	O
a	O
condition	B-UNK
causing	B-UNK
predisposition	B-UNK
to	O
colorectal	B-DISEASE
cancer	I-DISEASE
.	O

 	O
the	O
syndrome	B-DISEASE
inconsistently	O
associates	O
characteristic	B-UNK
patches	O
of	O
congenital	B-DISEASE
hypertrophy	B-DISEASE
of	O
the	O
retinal	B-UNK
pigment	I-UNK
epithelium	O
(	O
chrpe	O
)	O
.	O

 	O
ocular	O
examination	B-UNK
revealed	B-UNK
that	O
patients	B-UNK
expressing	B-UNK
chrpe	O
tend	O
to	O
cluster	O
within	O
specific	B-UNK
families	B-UNK
.	O

 	O
the	O
exact	O
apc	B-UNK
mutation	B-UNK
was	O
identified	B-UNK
in	O
42	O
unrelated	B-UNK
patients	B-UNK
.	O

 	O
in	O
all	O
cases	B-UNK
these	O
mutations	B-UNK
were	O
predicted	B-UNK
to	O
lead	B-UNK
to	O
the	O
synthesis	B-UNK
of	O
a	O
truncated	B-UNK
protein	B-UNK
.	O

 	O
the	O
extent	B-UNK
of	O
chrpe	O
was	O
found	B-UNK
to	O
be	O
dependent	B-UNK
on	O
the	O
position	B-UNK
of	O
the	O
mutation	B-UNK
along	O
the	O
coding	B-UNK
sequence	B-UNK
.	O

 	O
chrpe	O
lesions	B-UNK
are	O
almost	O
always	O
absent	B-UNK
if	O
the	O
mutation	B-UNK
occurs	B-UNK
before	O
exon	B-UNK
9	O
,	O
but	O
are	O
systematically	O
present	B-UNK
if	O
it	O
occurs	B-UNK
after	O
this	O
exon	B-UNK
.	O

 	O
thus	O
,	O
the	O
range	B-UNK
of	O
phenotypic	B-UNK
expression	B-UNK
observed	B-UNK
among	O
affected	B-UNK
patients	I-UNK
may	O
result	B-UNK
in	O
part	O
from	O
different	B-UNK
allelic	B-UNK
manifestations	B-UNK
of	O
apc	B-UNK
mutations	B-UNK
.	O
.	O

 	O
the	O
effects	B-UNK
of	O
dystrophin	B-UNK
gene	B-UNK
mutations	B-UNK
on	O
the	O
erg	B-UNK
in	O
mice	B-UNK
and	O
humans	B-UNK
.	O

 	O
purpose	O
.	O

 	O
the	O
authors	B-UNK
earlier	B-UNK
findings	B-UNK
of	O
a	O
negative	B-UNK
electroretinogram	B-UNK
(	O
erg	B-UNK
)	O
in	O
a	O
boy	B-UNK
with	O
duchenne	B-UNK
muscular	B-DISEASE
dystrophy	I-DISEASE
(	O
dmd	B-UNK
)	O
led	B-UNK
them	O
to	O
investigate	O
dystrophin	B-UNK
gene	B-UNK
deletions	B-UNK
and	O
ergs	B-UNK
in	O
five	O
boys	B-UNK
with	O
dmd	B-UNK
.	O

 	O
the	O
authors	B-UNK
wanted	O
to	O
determined	B-UNK
whether	O
there	O
were	O
similar	B-UNK
erg	B-UNK
findings	B-UNK
in	O
an	O
animal	B-UNK
model	B-UNK
for	O
dmd	B-UNK
,	O
the	O
mdx	B-UNK
mouse	B-UNK
.	O

 	O
methods	B-UNK
.	O

 	O
ganzfeld	O
ergs	B-UNK
were	O
recorded	O
in	O
five	O
boys	B-UNK
with	O
dmd	B-UNK
after	O
a	O
complete	B-UNK
ophthalmic	B-UNK
examination	B-UNK
.	O

 	O
the	O
dystrophin	B-UNK
gene	B-UNK
was	O
analyzed	B-UNK
by	O
southern	B-UNK
blot	I-UNK
hybridization	B-UNK
.	O

 	O
ergs	B-UNK
were	O
recorded	O
in	O
anesthetized	O
mdx	B-UNK
and	O
control	B-UNK
mice	B-UNK
with	O
a	O
modified	B-UNK
grass	O
photostimulator	O
(	O
grass	O
instrument	O
company	O
,	O
quincy	O
,	O
ma	O
)	O
.	O

 	B-UNK
results	I-UNK
.	O

 	O
ophthalmic	B-UNK
examinations	O
in	O
all	O
five	O
boys	B-UNK
had	O
normal	B-UNK
findings	B-UNK
,	O
yet	O
an	O
abnormal	B-UNK
negative	B-UNK
erg	B-UNK
was	O
recorded	O
for	O
each	O
subject	B-UNK
.	O

 	O
the	O
subjects	B-UNK
gene	B-UNK
deletions	B-UNK
were	O
variable	B-UNK
,	O
ranging	O
from	O
large	B-UNK
deletions	B-UNK
to	O
no	O
detectable	B-UNK
deletions	B-UNK
.	O

 	O
the	O
ergs	B-UNK
of	O
the	O
mdx	B-UNK
mice	B-UNK
were	O
normal	B-UNK
and	O
did	O
not	O
differ	B-UNK
significantly	B-UNK
from	O
those	O
of	O
the	O
control	B-UNK
mice	B-UNK
.	O

 	O
conclusions	B-UNK
.	O

 	O
the	O
authors	B-UNK
believe	O
the	O
unique	B-UNK
erg	B-UNK
recorded	O
for	O
the	O
human	B-UNK
subjects	B-UNK
is	O
a	O
manifestation	B-UNK
of	O
dmd	B-UNK
associated	B-UNK
with	O
defects	B-UNK
at	B-DISEASE
the	O
dystrophin	B-UNK
gene	B-UNK
locus	B-UNK
and	O
represents	B-UNK
a	O
new	B-UNK
clinical	B-UNK
entity	B-UNK
.	O

 	O
the	O
erg	B-UNK
of	O
the	O
mdx	B-UNK
mouse	B-UNK
may	O
be	O
spared	O
for	O
several	O
reasons	O
,	O
including	B-UNK
milder	B-UNK
effects	B-UNK
of	O
the	O
mouse	B-UNK
gene	B-UNK
defect	B-UNK
,	O
differences	B-UNK
in	O
muscle	B-UNK
and	O
retinal	B-UNK
gene	B-UNK
product	B-UNK
,	O
or	O
species	B-UNK
differences	B-UNK
in	O
the	O
biochemical	B-UNK
role	B-UNK
of	O
dystrophin	B-UNK
.	O

 	O
the	O
erg	B-UNK
shows	B-UNK
promise	O
of	O
becoming	O
a	O
noninvasive	O
diagnostic	B-UNK
tool	B-UNK
for	O
dmd	B-UNK
and	O
its	O
milder	B-UNK
allelic	B-UNK
forms	B-UNK
.	O
.	O

 	O
association	B-UNK
of	O
the	O
apc	B-UNK
tumor	B-DISEASE
suppressor	B-UNK
protein	B-UNK
with	O
catenins	O
.	O

 	O
mutations	B-UNK
of	O
apc	B-UNK
appear	B-UNK
to	O
initiate	O
sporadic	B-UNK
and	O
inherited	B-UNK
forms	B-UNK
of	O
human	B-UNK
colorectal	B-DISEASE
cancer	I-DISEASE
.	O

 	O
although	O
these	O
mutations	B-UNK
have	O
been	O
well	O
characterized	B-UNK
,	O
little	B-UNK
is	O
known	B-UNK
about	O
the	O
function	B-UNK
of	O
the	O
apc	B-UNK
gene	B-UNK
product	B-UNK
.	O

 	O
two	O
cellular	B-UNK
proteins	B-UNK
that	O
associate	O
with	O
apc	B-UNK
were	O
identified	B-UNK
by	O
nucleotide	B-UNK
sequence	I-UNK
analysis	I-UNK
and	O
peptide	B-UNK
mapping	B-UNK
as	O
the	O
e	B-UNK
-	O
cadherin	B-UNK
-	O
associated	B-UNK
proteins	B-UNK
alpha	B-UNK
-	O
and	O
beta	B-UNK
-	O
catenin	B-UNK
.	O

 	O
a	O
27	O
-	O
residue	B-UNK
fragment	O
of	O
apc	B-UNK
containing	B-UNK
a	O
15	O
-	O
amino	B-UNK
acid	I-UNK
repeat	B-UNK
was	O
sufficient	B-UNK
for	O
the	O
interaction	B-UNK
with	O
the	O
catenins	O
.	O

 	O
these	O
results	B-UNK
suggest	B-UNK
an	O
important	B-UNK
link	B-UNK
between	O
tumor	B-DISEASE
initiation	B-UNK
and	O
cell	B-UNK
adhesion	O
.	O
.	O

 	O
difference	B-UNK
in	O
methylation	B-UNK
patterns	B-UNK
within	O
the	O
d15s9	O
region	B-UNK
of	O
chromosome	B-UNK
15q11	I-UNK
-	O
13	O
in	O
first	O
cousins	O
with	O
angelman	B-DISEASE
syndrome	I-DISEASE
and	O
prader	B-DISEASE
-	I-DISEASE
willi	I-DISEASE
syndrome	I-DISEASE
.	O

 	O
abnormalities	B-DISEASE
of	O
chromosome	B-UNK
region	I-UNK
15q11	B-UNK
-	O
13	O
are	O
associated	B-UNK
with	O
angelman	B-DISEASE
syndrome	I-DISEASE
(	O
as	O
)	O
and	O
prader	B-DISEASE
-	I-DISEASE
willi	I-DISEASE
syndrome	I-DISEASE
(	O
pws	B-UNK
)	O
.	O

 	O
differences	B-UNK
between	O
the	O
methylation	B-UNK
patterns	B-UNK
of	O
the	O
region	B-UNK
of	O
chromosome	B-UNK
15q11	I-UNK
-	O
13	O
which	O
hybridizes	O
to	O
the	O
highly	B-UNK
conserved	I-UNK
dna	B-UNK
,	O
dn34	O
,	O
in	O
normal	B-UNK
individuals	B-UNK
and	O
in	O
patients	B-UNK
with	O
as	O
and	O
pws	B-UNK
have	O
been	O
described	B-UNK
.	O

 	O
we	O
report	B-UNK
on	O
a	O
family	B-UNK
in	O
which	O
first	O
cousins	O
are	O
affected	B-UNK
by	O
as	O
and	O
pws	B-UNK
as	O
a	O
result	B-UNK
of	O
a	O
familial	B-UNK
paracentric	O
inversion	B-UNK
of	O
15q11	B-UNK
-	O
q13	O
.	O

 	O
the	O
results	B-UNK
of	O
the	O
studies	B-UNK
on	O
this	O
family	B-UNK
demonstrate	B-UNK
the	O
differences	B-UNK
in	O
the	O
methylation	B-UNK
patterns	B-UNK
in	O
the	O
2	O
conditions	B-UNK
and	O
the	O
phenomenon	O
of	O
genomic	B-UNK
imprinting	B-UNK
,	O
whereby	O
genetic	B-UNK
information	B-UNK
is	O
expressed	B-UNK
differently	B-UNK
dependent	B-UNK
on	O
the	O
parent	B-UNK
of	O
origin	B-UNK
.	O
.	O

 	B-UNK
haplotype	I-UNK
studies	B-UNK
in	O
wilson	B-UNK
disease	B-DISEASE
.	O

 	O
in	O
51	O
families	B-UNK
with	O
wilson	B-UNK
disease	B-DISEASE
,	O
we	O
have	O
studied	B-UNK
dna	B-UNK
haplotypes	I-UNK
of	O
dinucleotide	B-UNK
repeat	B-UNK
polymorphisms	B-UNK
(	O
ca	O
repeats	B-UNK
)	O
in	O
the	O
13q14	B-UNK
.	O

 	O
3	O
region	B-UNK
,	O
to	O
examine	O
these	O
markers	B-UNK
for	O
association	B-UNK
with	O
the	O
wilson	B-UNK
disease	B-DISEASE
gene	B-UNK
(	O
wnd	O
)	O
.	O

 	O
in	O
addition	B-UNK
to	O
a	O
marker	B-UNK
(	O
d13s133	O
)	O
described	B-UNK
elsewhere	O
,	O
we	O
have	O
developed	B-UNK
three	O
new	B-UNK
highly	B-UNK
polymorphic	I-UNK
markers	B-UNK
(	O
d13s314	O
,	O
d13s315	O
,	O
and	O
d13s316	O
)	O
close	B-UNK
to	O
the	O
wnd	O
locus	B-UNK
.	O

 	O
we	O
have	O
examined	B-UNK
the	O
distribution	B-UNK
of	O
marker	B-UNK
alleles	B-UNK
at	B-DISEASE
the	O
loci	B-UNK
studied	B-UNK
and	O
have	O
found	B-UNK
that	O
d13s314	O
,	O
d13s133	O
,	O
and	O
d13s316	O
each	O
show	O
nonrandom	B-UNK
distribution	B-UNK
on	O
chromosomes	B-UNK
carrying	B-UNK
the	O
wnd	O
mutation	B-UNK
.	O

 	O
we	O
have	O
studied	B-UNK
haplotypes	B-UNK
of	O
these	O
three	O
markers	B-UNK
and	O
have	O
found	B-UNK
that	O
there	O
are	O
highly	B-UNK
significant	B-UNK
differences	I-UNK
between	O
wnd	O
and	O
normal	B-UNK
haplotypes	B-UNK
in	O
northern	B-UNK
european	I-UNK
families	B-UNK
.	O

 	O
these	O
findings	B-UNK
have	O
important	B-UNK
implications	B-UNK
for	O
mutation	B-UNK
detection	B-UNK
and	O
molecular	B-UNK
diagnosis	B-UNK
in	O
families	B-UNK
with	O
wilson	B-UNK
disease	B-DISEASE
.	O

 	B-UNK
genetic	I-UNK
analysis	B-UNK
of	O
the	O
brca1	B-UNK
region	B-UNK
in	O
a	O
large	B-UNK
breast	B-UNK
/	O
ovarian	B-UNK
family	B-UNK
:	O
refinement	O
of	O
the	O
minimal	B-UNK
region	B-UNK
containing	I-UNK
brca1	B-UNK
.	O

 	O
we	O
have	O
analyzed	B-UNK
a	O
single	B-UNK
multi	O
-	O
affected	B-UNK
breast	B-UNK
/	O
ovarian	B-DISEASE
cancer	I-DISEASE
pedigree	B-UNK
(	O
bov3	O
)	O
and	O
have	O
shown	B-UNK
consistent	B-UNK
inheritance	B-UNK
of	O
markers	B-UNK
on	O
chromosome	B-UNK
17q	B-UNK
with	O
the	O
disease	B-DISEASE
confirming	O
that	O
this	O
family	B-UNK
is	O
due	O
to	O
the	O
brca1	B-UNK
gene	B-UNK
.	O

 	O
analysis	B-UNK
of	O
17q	B-UNK
haplotypes	B-UNK
shows	B-UNK
a	O
recombination	B-UNK
event	B-UNK
in	O
a	O
bilateral	B-UNK
breast	B-DISEASE
cancer	I-DISEASE
case	B-UNK
which	O
suggests	B-UNK
that	O
the	O
brca1	B-UNK
gene	B-UNK
lies	B-UNK
distal	B-UNK
to	O
d17s857	O
;	O
d17s857	O
is	O
thus	O
the	O
new	B-UNK
proximal	B-UNK
boundary	B-UNK
for	O
the	O
region	B-UNK
containing	I-UNK
brca1	B-UNK
.	O

 	O
combining	B-UNK
this	O
information	B-UNK
with	O
previously	B-UNK
published	I-UNK
mapping	B-UNK
information	B-UNK
suggests	B-UNK
that	O
brca1	B-UNK
is	O
contained	B-UNK
in	O
a	O
region	B-UNK
estimated	B-UNK
at	B-DISEASE
1	O
-	O
1	O
.	O

 	O
5	O
mb	B-UNK
in	O
length	O
.	O

 	O
all	O
seven	B-UNK
breast	B-UNK
tumour	B-UNK
/	O
blood	B-UNK
pairs	B-UNK
examined	B-UNK
from	O
this	O
family	B-UNK
show	O
loss	B-UNK
of	O
heterozygosity	B-UNK
in	O
the	O
tumours	B-UNK
.	O

 	O
the	O
allel	O
retained	B-UNK
in	O
each	O
tumour	B-UNK
was	O
from	O
the	O
disease	B-DISEASE
-	O
bearing	B-UNK
chromosome	B-UNK
implicating	O
brca1	B-UNK
as	O
a	O
tumour	B-UNK
suppressor	I-UNK
gene	B-UNK
.	O

 	O
we	O
have	O
sequenced	B-UNK
the	O
17	O
beta	B-UNK
-	O
oestradiol	O
dehydrogenase	B-UNK
genes	B-UNK
(	O
edh17b1	O
and	O
edh17b2	B-UNK
)	O
which	O
have	O
been	O
suggested	B-UNK
as	O
candidate	B-UNK
genes	I-UNK
for	O
brca1	B-UNK
in	O
four	O
members	B-UNK
of	O
this	O
family	B-UNK
.	O

 	O
no	O
germline	B-UNK
mutations	I-UNK
were	O
detected	B-UNK
.	O

 	O
myotonic	B-DISEASE
dystrophy	I-DISEASE
kinase	B-UNK
is	O
a	O
component	B-UNK
of	O
neuromuscular	B-UNK
junctions	B-UNK
.	O

 	O
the	O
clinical	B-UNK
manifestation	B-UNK
of	O
myotonic	B-DISEASE
dystrophy	I-DISEASE
(	O
dm	B-DISEASE
)	O
is	O
correlated	B-UNK
to	O
the	O
extent	B-UNK
of	O
expansion	B-UNK
of	O
an	O
unstable	B-UNK
[	O
ctg	B-UNK
]	O
n	B-UNK
dna	B-UNK
motif	B-UNK
.	O

 	B-UNK
recent	I-UNK
studies	B-UNK
have	O
demonstrated	B-UNK
that	O
this	O
trinucleotide	B-UNK
motif	B-UNK
forms	B-UNK
part	O
of	O
the	O
last	O
,	O
3	O
untranslated	B-UNK
exon	B-UNK
of	O
a	O
gene	B-UNK
which	O
potentially	B-UNK
encodes	B-UNK
multiple	B-UNK
protein	B-UNK
isoforms	B-UNK
of	O
a	O
serine	B-UNK
/	O
threonine	B-UNK
protein	B-UNK
kinase	B-UNK
(	O
myotonic	B-DISEASE
dystrophy	I-DISEASE
protein	B-UNK
kinase	B-UNK
,	O
dm	B-DISEASE
-	O
pk	O
)	O
.	O

 	O
we	O
report	B-UNK
here	O
on	O
the	O
development	B-UNK
of	O
antisera	O
against	O
synthetic	B-UNK
dm	B-DISEASE
-	O
pk	O
peptide	B-UNK
antigens	B-UNK
and	O
their	O
use	B-UNK
in	O
biochemical	B-UNK
and	O
histochemical	O
studies	B-UNK
.	O

 	O
immunoreactive	B-UNK
dm	B-DISEASE
-	O
kinase	B-UNK
protein	B-UNK
of	O
53	O
kd	O
is	O
present	B-UNK
at	B-DISEASE
low	B-UNK
levels	B-UNK
in	O
skeletal	B-UNK
and	O
cardiac	B-UNK
muscle	B-UNK
extracts	B-UNK
of	O
dm	B-DISEASE
patients	B-UNK
and	O
normal	B-UNK
controls	B-UNK
.	O

 	B-UNK
immunohistochemical	I-UNK
staining	B-UNK
revealed	B-UNK
that	O
dm	B-DISEASE
-	O
pk	O
is	O
localised	B-UNK
prominently	O
at	B-DISEASE
sites	B-UNK
of	O
neuromuscular	B-UNK
and	O
myotendinous	O
junctions	B-UNK
(	O
nmjs	O
and	O
mtjs	O
)	O
of	O
human	B-UNK
and	O
rodent	O
skeletal	B-UNK
muscles	B-UNK
.	O

 	O
furthermore	B-UNK
,	O
very	O
low	B-UNK
levels	B-UNK
of	O
immunoreactive	B-UNK
dm	B-DISEASE
-	O
pk	O
protein	B-UNK
are	O
present	B-UNK
in	O
the	O
sarcoplasm	O
of	O
predominantly	B-UNK
type	B-UNK
i	O
fibres	O
in	O
various	O
muscles	B-UNK
.	O

 	O
strikingly	B-UNK
,	O
presence	B-UNK
of	O
the	O
protein	B-UNK
can	O
also	O
be	O
demonstrated	B-UNK
for	O
nmjs	O
of	O
muscular	O
tissues	B-UNK
of	O
adult	B-UNK
and	O
congenital	B-DISEASE
cases	B-UNK
of	O
dm	B-DISEASE
,	O
with	O
no	O
gross	O
changes	B-UNK
in	O
structural	B-UNK
organisation	O
.	O

 	O
our	O
findings	B-UNK
provide	I-UNK
a	O
basis	B-UNK
for	O
further	O
characterisation	O
of	O
the	O
role	B-UNK
of	O
the	O
kinase	B-UNK
in	O
protein	B-UNK
assembly	B-UNK
processes	B-UNK
or	O
signal	B-UNK
mediation	O
at	B-DISEASE
synaptic	B-UNK
sites	B-UNK
and	O
ultimately	O
for	O
the	O
understanding	B-UNK
of	O
the	O
complex	B-UNK
pathophysiology	O
of	O
dm	B-DISEASE
.	O
.	O

 	O
markedly	B-UNK
accelerated	B-UNK
catabolism	O
of	O
apolipoprotein	B-UNK
a	O
-	O
ii	B-UNK
(	O
apoa	O
-	O
ii	B-UNK
)	O
and	O
high	B-UNK
density	I-UNK
lipoproteins	I-UNK
containing	B-UNK
apoa	O
-	O
ii	B-UNK
in	O
classic	B-UNK
lecithin	O
:	O
cholesterol	B-UNK
acyltransferase	O
deficiency	B-UNK
and	O
fish	B-UNK
-	O
eye	B-UNK
disease	B-DISEASE
.	O

 	O
classic	B-UNK
(	O
complete	B-UNK
)	O
lecithin	O
cholesterol	B-UNK
acyltransferase	O
(	O
lcat	O
)	O
deficiency	B-UNK
and	O
fish	B-UNK
-	O
eye	B-UNK
disease	B-DISEASE
(	O
partial	B-UNK
lcat	B-UNK
deficiency	I-UNK
)	O
are	O
genetic	B-UNK
syndromes	B-UNK
associated	B-UNK
with	O
markedly	B-UNK
decreased	I-UNK
plasma	I-UNK
levels	B-UNK
of	O
high	B-UNK
density	I-UNK
lipoprotein	B-UNK
(	O
hdl	B-UNK
)	O
cholesterol	B-UNK
but	O
not	O
with	O
an	O
increased	B-UNK
risk	B-UNK
of	O
atherosclerotic	B-DISEASE
cardiovascular	B-DISEASE
disease	I-DISEASE
.	O

 	O
we	O
investigated	B-UNK
the	O
metabolism	B-DISEASE
of	O
the	O
hdl	B-UNK
apolipoproteins	O
(	O
apo	O
)	O
apoa	O
-	O
i	O
and	O
apoa	O
-	O
ii	B-UNK
in	O
a	O
total	B-UNK
of	O
five	O
patients	B-UNK
with	O
lcat	B-UNK
deficiency	I-UNK
,	O
one	O
with	O
classic	B-UNK
lcat	B-UNK
deficiency	I-UNK
and	O
four	O
with	O
fish	B-UNK
-	O
eye	B-UNK
disease	B-DISEASE
.	O

 	O
plasma	B-UNK
levels	B-UNK
of	O
apoa	O
-	O
ii	B-UNK
were	O
decreased	B-UNK
to	O
a	O
proportionately	O
greater	B-UNK
extent	B-UNK
(	O
23	O
%	O
of	O
normal	B-UNK
)	O
than	O
apoa	O
-	O
i	O
(	O
30	O
%	O
of	O
normal	B-UNK
)	O
.	O

 	O
in	O
addition	B-UNK
,	O
plasma	B-UNK
concentrations	B-UNK
of	O
hdl	B-UNK
particles	B-UNK
containing	B-UNK
both	O
apoa	O
-	O
i	O
and	O
apoa	O
-	O
ii	B-UNK
(	O
lpa	O
-	O
i	O
a	O
-	O
ii	B-UNK
)	O
were	O
much	O
lower	B-UNK
(	O
18	O
%	O
of	O
normal	B-UNK
)	O
than	O
those	O
of	O
particles	B-UNK
containing	B-UNK
only	O
apoa	O
-	O
i	O
(	O
lpa	O
-	O
i	O
)	O
(	O
51	O
%	O
of	O
normal	B-UNK
)	O
.	O

 	O
the	O
metabolic	B-UNK
basis	B-UNK
for	O
the	O
low	B-UNK
levels	B-UNK
of	O
apoa	O
-	O
ii	B-UNK
and	O
lpa	O
-	O
i	O
a	O
-	O
ii	B-UNK
was	O
investigated	B-UNK
in	O
all	O
five	O
patients	B-UNK
using	O
both	O
exogenous	B-UNK
radiotracer	O
and	O
endogenous	B-UNK
stable	B-UNK
isotope	O
labeling	O
techniques	B-UNK
.	O

 	O
the	O
mean	B-UNK
plasma	B-UNK
residence	O
time	B-UNK
of	O
apoa	O
-	O
i	O
was	O
decreased	B-UNK
at	B-DISEASE
2	O
.	O

 	O
08	O
+	O
/	O
-	O
0	O
.	O

 	O
27	O
d	B-UNK
(	O
controls	B-UNK
4	O
.	O
74	O
+	O
/	O
-	O
0	O
.	O
65	O
days	O
)	O
;	O
however	O
,	O
the	O
residence	O
time	B-UNK
of	O
apoa	O
-	O
ii	B-UNK
was	O
even	O
shorter	B-UNK
at	B-DISEASE
1	O
.	O

 	O
66	O
+	O
/	O
-	O
0	O
.	O

 	O
24	O
d	B-UNK
(	O
controls	B-UNK
5	O
.	O
25	O
+	O
/	O
-	O
0	O
.	O
61	O
d	B-UNK
)	O
.	O

 	O
in	O
addition	B-UNK
,	O
the	O
catabolism	O
of	O
apoa	O
-	O
i	O
in	O
lpa	O
-	O
i	O
a	O
-	O
ii	B-UNK
was	O
substantially	B-UNK
faster	O
than	O
that	O
of	O
apoa	O
-	O
i	O
in	O
lpa	O
-	O
i	O
.	O

 	O
in	O
summary	O
,	O
genetic	B-UNK
syndromes	B-UNK
of	O
either	O
complete	B-UNK
or	O
partial	B-UNK
lcat	B-UNK
deficiency	I-UNK
result	B-UNK
in	O
low	B-UNK
levels	B-UNK
of	O
hdl	B-UNK
through	O
preferential	B-UNK
hypercatabolism	O
of	O
apoa	O
-	O
ii	B-UNK
and	O
hdl	B-UNK
particles	B-UNK
containing	B-UNK
apoa	O
-	O
ii	B-UNK
.	O

 	O
because	O
lpa	O
-	O
i	O
has	O
been	O
proposed	B-UNK
to	O
be	O
more	O
protective	O
than	O
lpa	O
-	O
i	O
a	O
-	O
ii	B-UNK
against	O
atherosclerosis	B-DISEASE
,	O
this	O
selective	B-UNK
effect	B-UNK
on	O
the	O
metabolism	B-DISEASE
of	O
lpa	O
-	O
i	O
a	O
-	O
ii	B-UNK
may	O
provide	B-UNK
a	O
potential	B-UNK
explanation	B-UNK
why	O
patients	B-UNK
with	O
classic	B-UNK
lcat	B-UNK
deficiency	I-UNK
and	O
fish	B-UNK
-	O
eye	B-UNK
disease	B-DISEASE
are	O
not	O
at	B-DISEASE
increased	B-UNK
risk	B-UNK
for	O
premature	B-UNK
atherosclerosis	B-DISEASE
despite	B-UNK
markedly	B-UNK
decreased	B-UNK
levels	B-UNK
of	O
hdl	B-UNK
cholesterol	B-UNK
and	O
apoa	O
-	O
i	O

 	O
x	B-UNK
linked	I-UNK
recessive	O
thrombocytopenia	B-DISEASE
.	O

 	O
a	O
saudi	O
arab	O
boy	B-UNK
presented	B-UNK
in	O
early	B-UNK
childhood	B-UNK
with	O
thrombocytopenia	B-DISEASE
,	O
morphologically	B-UNK
large	B-UNK
and	O
normal	B-UNK
sized	I-UNK
platelets	B-UNK
,	O
increased	B-UNK
mean	B-UNK
platelet	B-UNK
volume	O
,	O
and	O
a	O
hypermegakaryocytic	O
bone	B-UNK
marrow	I-UNK
.	O

 	O
there	O
was	O
no	O
clinical	B-UNK
and	O
laboratory	B-UNK
evidence	B-UNK
of	O
any	O
significant	B-UNK
immunological	B-UNK
abnormalities	B-DISEASE
.	O

 	O
similar	B-UNK
findings	B-UNK
in	O
two	O
other	O
brothers	B-UNK
suggested	B-UNK
strongly	B-UNK
that	O
they	O
were	O
all	O
suffering	B-UNK
from	O
an	O
x	B-UNK
linked	I-UNK
recessive	O
thrombocytopenic	B-UNK
disorder	O
.	O

 	B-UNK
results	I-UNK
of	O
dna	B-UNK
analysis	B-UNK
with	O
the	O
probe	B-UNK
m27	O
beta	B-UNK
are	O
consistent	B-UNK
with	O
x	B-UNK
linkage	B-UNK
and	O
indicate	B-UNK
also	O
that	O
the	O
locus	B-UNK
of	O
the	O
relevant	B-UNK
gene	B-UNK
lies	B-UNK
close	B-UNK
to	O
or	O
is	O
identical	B-UNK
to	O
the	O
locus	B-UNK
of	O
the	O
gene	B-UNK
for	O
the	O
wiskott	B-DISEASE
-	I-DISEASE
aldrich	I-DISEASE
syndrome	I-DISEASE
(	O
was	O
)	O
.	O

 	O
because	O
of	O
various	O
features	B-UNK
which	O
include	B-UNK
the	O
presence	B-UNK
of	O
large	B-UNK
and	O
normal	B-UNK
sized	I-UNK
platelets	B-UNK
(	O
rather	O
than	O
small	B-UNK
platelets	B-UNK
)	O
and	O
freedom	O
from	O
significant	B-UNK
immune	B-UNK
deficiencies	B-UNK
,	O
it	O
is	O
likely	B-UNK
that	O
the	O
x	B-UNK
linked	I-UNK
recessive	O
thrombocytopenia	B-DISEASE
in	O
this	O
family	B-UNK
is	O
an	O
isolated	B-UNK
entity	B-UNK
quite	O
distinct	B-UNK
from	O
the	O
classical	B-UNK
was	O
phenotype	B-UNK
.	O

 	O
however	O
,	O
a	O
modified	B-UNK
expression	B-UNK
of	O
the	O
was	O
gene	B-UNK
producing	B-UNK
a	O
mild	B-UNK
phenotypic	B-UNK
variant	B-UNK
can	O
not	O
be	O
excluded	B-UNK
entirely	B-UNK
.	O
.	O

 	O
macular	B-DISEASE
dystrophy	I-DISEASE
associated	B-UNK
with	O
mutations	B-UNK
at	B-DISEASE
codon	B-UNK
172	O
in	O
the	O
human	B-UNK
retinal	B-DISEASE
degeneration	I-DISEASE
slow	B-UNK
gene	B-UNK
.	O

 	B-UNK
background	I-UNK
recently	B-UNK
,	O
mutations	B-UNK
in	O
the	O
retinal	B-DISEASE
degeneration	I-DISEASE
slow	B-UNK
(	O
rds	B-UNK
)	O
gene	B-UNK
which	O
codes	O
for	O
peripherin	O
-	O
rds	B-UNK
have	O
been	O
implicated	O
as	O
a	O
cause	B-UNK
of	O
autosomal	O
dominant	B-UNK
retinitis	B-DISEASE
pigmentosa	I-DISEASE
.	O

 	O
because	O
this	O
gene	B-UNK
is	O
expressed	B-UNK
in	O
both	O
rods	O
and	O
cones	O
,	O
mutations	B-UNK
in	O
the	O
rds	B-UNK
gene	B-UNK
might	O
be	O
expected	B-UNK
to	O
cause	B-UNK
degeneration	B-UNK
affecting	B-UNK
either	O
the	O
scotopic	O
or	O
photopic	O
systems	B-UNK
.	O

 	O
mutations	B-UNK
at	B-DISEASE
codon	B-UNK
172	O
of	O
the	O
rds	B-UNK
gene	B-UNK
have	O
been	O
identified	B-UNK
in	O
three	O
families	B-UNK
with	O
autosomal	O
dominantly	B-UNK
inherited	I-UNK
,	O
progressive	B-UNK
macular	B-DISEASE
dystrophy	I-DISEASE
.	O

 	O
methods	B-UNK
affected	B-UNK
individuals	I-UNK
underwent	B-UNK
ophthalmic	B-UNK
examination	B-UNK
,	O
scotopic	O
perimetry	O
,	O
dark	O
adaptometry	O
,	O
measurement	O
of	O
color	B-UNK
-	O
contrast	B-UNK
sensitivity	B-UNK
,	O
and	O
electroretinography	O
to	O
characterize	O
the	O
photoreceptor	B-UNK
dysfunction	B-UNK
.	O

 	B-UNK
results	I-UNK
in	O
all	O
but	O
one	O
affected	B-UNK
member	B-UNK
,	O
symptoms	B-UNK
of	O
progressive	B-UNK
central	B-UNK
visual	B-DISEASE
loss	I-DISEASE
developed	B-UNK
in	O
the	O
third	O
or	O
fourth	B-UNK
decade	O
of	O
life	B-UNK
accompanied	O
by	O
central	B-UNK
scotoma	B-DISEASE
and	O
well	O
-	O
demarcated	O
atrophy	B-DISEASE
of	O
the	O
retinal	B-UNK
pigment	I-UNK
epithelium	O
and	O
choriocapillaris	O
of	O
the	O
macula	O
.	O

 	O
in	O
general	B-UNK
,	O
cone	B-UNK
and	O
rod	B-UNK
thresholds	O
were	O
elevated	B-UNK
,	O
and	O
color	B-UNK
-	O
contrast	B-UNK
sensitivity	B-UNK
was	O
absent	B-UNK
in	O
the	O
central	B-UNK
visual	B-UNK
field	I-UNK
.	O

 	O
peripherally	O
,	O
the	O
scotopic	O
sensitivities	O
were	O
normal	B-UNK
,	O
as	O
was	O
the	O
recovery	O
from	O
bleach	O
.	O

 	O
cone	B-UNK
electroretinograms	B-UNK
were	O
diminished	B-UNK
in	O
amplitude	B-UNK
,	O
and	O
delayed	O
in	O
all	O
affected	B-UNK
adults	B-UNK
except	O
one	O
.	O

 	O
rod	B-UNK
electroretinograms	B-UNK
were	O
normal	B-UNK
or	O
near	B-UNK
normal	B-UNK
in	O
amplitude	B-UNK
,	O
and	O
had	O
normal	B-UNK
implicit	O
times	B-UNK
.	O

 	B-UNK
affected	I-UNK
asymptomatic	B-UNK
children	B-UNK
had	O
macular	O
changes	B-UNK
,	O
abnormal	B-UNK
color	B-UNK
-	O
contrast	B-UNK
sensitivity	B-UNK
,	O
and	O
reduced	B-UNK
pattern	B-UNK
and	O
cone	B-UNK
electroretinograms	B-UNK
.	O

 	O
conclusion	B-UNK
these	O
results	B-UNK
indicate	B-UNK
that	O
mutations	B-UNK
in	O
the	O
rds	B-UNK
gene	B-UNK
can	O
be	O
expressed	B-UNK
as	O
a	O
macular	B-DISEASE
dystrophy	I-DISEASE
,	O
with	O
evidence	B-UNK
of	O
primary	B-UNK
cone	B-UNK
dysfunction	B-UNK
and	O
preservation	O
of	O
peripheral	B-UNK
rod	B-UNK
function	B-UNK
.	O
.	O

 	O
anonymous	B-UNK
marker	B-UNK
loci	B-UNK
within	O
400	O
kb	B-UNK
of	O
hla	B-UNK
-	O
a	O
generate	B-UNK
haplotypes	B-UNK
in	O
linkage	B-UNK
disequilibrium	I-UNK
with	O
the	O
hemochromatosis	B-DISEASE
gene	B-UNK
(	O
hfe	B-UNK
)	O

 	O
the	O
hemochromatosis	B-DISEASE
gene	B-UNK
(	O
hfe	B-UNK
)	O
maps	B-UNK
to	O
6p21	O
.	O

 	O
3	O
and	O
is	O
less	O
than	O
1	O
cm	B-DISEASE
from	O
the	O
hla	B-UNK
class	B-UNK
i	O
genes	B-UNK
;	O
however	O
,	O
the	O
precise	B-UNK
physical	B-UNK
location	B-UNK
of	O
the	O
gene	B-UNK
has	O
remained	B-UNK
elusive	O
and	O
controversial	O
.	O

 	O
the	O
unambiguous	O
identification	B-UNK
of	O
a	O
crossover	B-UNK
event	B-UNK
within	O
hemochromatosis	B-DISEASE
families	B-UNK
is	O
very	O
difficult	O
;	O
it	O
is	O
particularly	B-UNK
hampered	O
by	O
the	O
variability	B-UNK
of	O
the	O
phenotypic	B-UNK
expression	B-UNK
as	O
well	O
as	O
by	O
the	O
sex	B-UNK
-	O
and	O
age	B-UNK
-	O
related	B-UNK
penetrance	B-UNK
of	O
the	O
disease	B-DISEASE
.	O

 	O
for	O
these	O
practical	B-UNK
considerations	O
,	O
traditional	O
linkage	B-UNK
analysis	I-UNK
could	O
prove	O
of	O
limited	B-UNK
value	B-UNK
in	O
further	O
refining	O
the	O
extrapolated	O
physical	B-UNK
position	B-UNK
of	O
hfe	B-UNK
.	O

 	O
we	O
therefore	O
embarked	O
upon	O
a	O
linkage	B-UNK
-	O
disequilibrium	B-UNK
analysis	B-UNK
of	O
hfe	B-UNK
and	O
normal	B-UNK
chromosomes	I-UNK
from	O
the	O
brittany	O
population	B-UNK
.	O

 	O
in	O
the	O
present	B-UNK
report	B-UNK
,	O
66	O
hemochromatosis	B-DISEASE
families	B-UNK
yielding	O
151	O
hemochromatosis	B-DISEASE
chromosomes	B-UNK
and	O
182	O
normal	B-UNK
chromosomes	I-UNK
were	O
rflp	B-UNK
-	O
typed	O
with	O
a	O
battery	O
of	O
probes	B-UNK
,	O
including	B-UNK
two	O
newly	B-UNK
derived	B-UNK
polymorphic	B-UNK
markers	I-UNK
from	O
the	O
6	O
.	O

 	O
7	O
and	O
hla	B-UNK
-	O
f	B-UNK
loci	B-UNK
located	B-UNK
150	O
and	O
250	O
kb	B-UNK
telomeric	B-UNK
to	O
hla	B-UNK
-	O
a	O
,	O
respectively	B-UNK
.	O

 	O
the	O
results	B-UNK
suggest	B-UNK
a	O
strong	B-UNK
peak	B-UNK
of	O
existing	O
linkage	B-UNK
disequilibrium	I-UNK
focused	O
within	O
the	O
i82	O
-	O
to	O
-	O
6	O
.	O

 	O
7	O
interval	B-UNK
(	O
approximately	B-UNK
250	O
kb	B-UNK
)	O
.	O

 	O
the	O
zone	O
of	O
linkage	B-UNK
disequilibrium	I-UNK
is	O
flanked	O
by	O
the	O
i97	O
locus	B-UNK
,	O
positioned	O
30	O
kb	B-UNK
proximal	B-UNK
to	O
i82	O
,	O
and	O
the	O
hla	B-UNK
-	O
f	B-UNK
gene	B-UNK
,	O
found	B-UNK
250	O
kb	B-UNK
distal	B-UNK
to	O
hla	B-UNK
-	O
a	O
,	O
markers	B-UNK
of	O
which	O
display	B-UNK
no	O
significant	B-UNK
association	B-UNK
with	O
hfe	B-UNK
.	O

 	O
these	O
data	B-UNK
support	B-UNK
the	O
possibility	O
that	O
hfe	B-UNK
resides	O
within	O
the	O
400	O
-	O
kb	B-UNK
expanse	O
of	O
dna	B-UNK
between	O
i97	O
and	O
hla	B-UNK
-	O
f	B-UNK
.	O

 	O
alternatively	O
,	O
the	O
very	O
tight	B-UNK
association	B-UNK
of	O
hla	B-UNK
-	O
a3	O
and	O
allele	B-UNK
1	O
of	O
the	O
6	O
.	O

 	O
7	O
locus	B-UNK
,	O
both	O
of	O
which	O
are	O
comprised	O
by	O
the	O
major	B-UNK
ancestral	B-UNK
or	O
founder	B-UNK
hfe	B-UNK
haplotype	B-UNK
in	O
brittany	O
,	O
supports	B-UNK
the	O
possibility	O
that	O
the	O
disease	B-DISEASE
gene	B-UNK
may	O
reside	O
immediately	B-UNK
telomeric	B-UNK
to	O
the	O
6	O
.	O

 	O
7	O
locus	B-UNK
within	O
the	O
linkage	B-UNK
-	O
disequilibrium	B-UNK
zone	O
.	O

 	O
additionally	B-UNK
,	O
hemochromatosis	B-DISEASE
haplotypes	B-UNK
possessing	O
hla	B-UNK
-	O
a11	O
and	O
the	O
low	B-UNK
-	O
frequency	B-UNK
hla	B-UNK
-	O
f	B-UNK
polymorphism	O
(	O
allele	B-UNK
2	O
)	O
are	O
supportive	O
of	O
a	O
separate	B-UNK
founder	B-UNK
chromosome	B-UNK
containing	B-UNK
a	O
second	B-UNK
,	O
independently	B-UNK
arising	O
mutant	B-UNK
allele	I-UNK
.	O

 	O
overall	B-UNK
,	O
the	O
establishment	O
of	O
a	O
likely	B-UNK
"	O
hemochromatosis	B-DISEASE
critical	B-UNK
region	I-UNK
"	O
centromeric	B-UNK
boundary	B-UNK
and	O
the	O
identification	B-UNK
of	O
a	O
linkage	B-UNK
-	O
disequilibrium	B-UNK
zone	O
both	O
significantly	B-UNK
contribute	B-UNK
to	O
a	O
reduction	B-UNK
in	O
the	O
amount	O
of	O
dna	B-UNK
required	B-UNK
to	O
be	O
searched	O
for	O
novel	B-UNK
coding	B-UNK
sequences	I-UNK
constituting	O
the	O
hfe	B-UNK
defect	B-UNK

 	B-UNK
genomic	I-UNK
structure	B-UNK
of	O
the	O
ews	B-UNK
gene	B-UNK
and	O
its	O
relationship	B-UNK
to	O
ewsr1	O
,	O
a	O
site	B-UNK
of	O
tumor	B-DISEASE
-	O
associated	B-UNK
chromosome	B-UNK
translocation	B-DISEASE
.	O

 	O
the	O
ews	B-UNK
gene	B-UNK
has	O
been	O
identified	B-UNK
based	B-UNK
on	O
its	O
location	B-UNK
at	B-DISEASE
the	O
chromosome	B-DISEASE
22	I-DISEASE
breakpoint	B-UNK
of	O
the	O
t	B-UNK
(	O
11	O
;	O
22	O
)	O
(	O
q24	O
;	O
q12	O
)	O
translocation	B-DISEASE
that	O
characterizes	O
ewing	B-DISEASE
sarcoma	I-DISEASE
and	O
related	B-UNK
neuroectodermal	B-DISEASE
tumors	I-DISEASE
.	O

 	O
the	O
ews	B-UNK
gene	B-UNK
spans	B-UNK
about	O
40	O
kb	B-UNK
of	O
dna	B-UNK
and	O
is	O
encoded	B-UNK
by	O
17	O
exons	B-UNK
.	O

 	O
the	O
nucleotide	B-UNK
sequence	B-UNK
of	O
the	O
exons	B-UNK
is	O
identical	B-UNK
to	O
that	O
of	O
the	O
previously	B-UNK
described	I-UNK
cdna	B-UNK
.	O

 	O
the	O
first	O
7	O
exons	B-UNK
encode	O
the	O
n	B-UNK
-	O
terminal	B-UNK
domain	B-UNK
of	O
ews	B-UNK
,	O
which	O
consists	B-UNK
of	O
a	O
repeated	B-UNK
degenerated	O
polypeptide	B-UNK
of	O
7	O
to	O
12	O
residues	B-UNK
rich	B-UNK
in	O
tyrosine	O
,	O
serine	B-UNK
,	O
threonine	B-UNK
,	O
glycine	B-UNK
,	O
and	O
glutamine	B-UNK
.	O

 	O
exons	B-UNK
11	O
,	O
12	O
,	O
and	O
13	O
encode	O
the	O
putative	B-UNK
rna	B-UNK
binding	I-UNK
domain	B-UNK
.	O

 	O
the	O
three	O
glycine	B-UNK
-	O
and	O
arginine	B-UNK
-	O
rich	B-UNK
motifs	B-UNK
of	O
the	O
gene	B-UNK
are	O
mainly	B-UNK
encoded	B-UNK
by	O
exons	B-UNK
8	O
-	O
9	O
,	O
14	O
,	O
and	O
16	O
.	O

 	O
the	O
dna	B-UNK
sequence	I-UNK
in	O
the	O
5	O
region	B-UNK
of	O
the	O
gene	B-UNK
has	O
features	B-UNK
of	O
a	O
cpg	B-UNK
-	O
rich	B-UNK
island	B-UNK
and	O
lacks	O
canonical	B-UNK
promoter	B-UNK
elements	B-UNK
,	O
such	O
as	O
tata	O
and	O
ccaat	O
consensus	B-UNK
sequences	B-UNK
.	O

 	O
positions	O
of	O
the	O
chromosome	B-DISEASE
22	I-DISEASE
breakpoints	B-UNK
were	O
determined	B-UNK
for	O
19	O
ewing	O
tumors	B-DISEASE
.	O

 	O
they	O
were	O
localized	B-UNK
in	O
introns	B-UNK
7	O
or	O
8	O
in	O
18	O
cases	B-UNK
and	O
in	O
intron	B-UNK
10	O
in	O
1	O
case	B-UNK
.	O
.	O

 	O
norrie	B-DISEASE
disease	I-DISEASE
gene	B-UNK
:	O
characterization	B-UNK
of	O
deletions	B-UNK
and	O
possible	B-UNK
function	B-UNK
.	O

 	O
positional	B-UNK
cloning	I-UNK
experiments	B-UNK
have	O
resulted	B-UNK
recently	B-UNK
in	O
the	O
isolation	B-UNK
of	O
a	O
candidate	B-UNK
gene	B-UNK
for	O
norrie	B-DISEASE
disease	I-DISEASE
(	O
pseudoglioma	O
;	O
ndp	B-UNK
)	O
,	O
a	O
severe	B-UNK
x	B-UNK
-	O
linked	B-UNK
neurodevelopmental	O
disorder	O
.	O

 	O
here	O
we	O
report	B-UNK
the	O
isolation	B-UNK
and	O
analysis	B-UNK
of	O
human	B-UNK
genomic	B-UNK
dna	I-UNK
clones	B-UNK
encompassing	O
the	O
ndp	B-UNK
gene	B-UNK
.	O

 	O
the	O
gene	B-UNK
spans	B-UNK
28	O
kb	B-UNK
and	O
consists	B-UNK
of	O
3	O
exons	B-UNK
,	O
the	O
first	O
of	O
which	O
is	O
entirely	B-UNK
contained	B-UNK
within	O
the	O
5	O
untranslated	B-UNK
region	B-UNK
.	O

 	O
detailed	B-UNK
analysis	B-UNK
of	O
genomic	B-UNK
deletions	B-UNK
in	O
norrie	O
patients	B-UNK
shows	B-UNK
that	O
they	O
are	O
heterogeneous	B-UNK
,	O
both	O
in	O
size	B-UNK
and	O
in	O
position	B-UNK
.	O

 	O
by	O
pcr	B-UNK
analysis	B-UNK
,	O
we	O
found	B-UNK
that	O
expression	B-UNK
of	O
the	O
ndp	B-UNK
gene	B-UNK
was	O
not	O
confined	O
to	O
the	O
eye	B-UNK
or	O
to	O
the	O
brain	B-UNK
.	O

 	O
an	O
extensive	B-UNK
dna	B-UNK
and	O
protein	B-UNK
sequence	B-UNK
comparison	B-UNK
between	O
the	O
human	B-UNK
ndp	B-UNK
gene	B-UNK
and	O
related	B-UNK
genes	B-UNK
from	O
the	O
database	B-UNK
revealed	B-UNK
homology	B-UNK
with	O
cysteine	O
-	O
rich	B-UNK
protein	B-UNK
-	O
binding	B-UNK
domains	B-UNK
of	O
immediate	B-UNK
-	O
-	O
early	B-UNK
genes	B-UNK
implicated	O
in	O
the	O
regulation	B-UNK
of	O
cell	B-UNK
proliferation	B-UNK
.	O

 	O
we	O
propose	O
that	O
ndp	B-UNK
is	O
a	O
molecule	B-UNK
related	B-UNK
in	O
function	B-UNK
to	O
these	O
genes	B-UNK
and	O
may	O
be	O
involved	B-UNK
in	O
a	O
pathway	B-UNK
that	O
regulates	B-UNK
neural	B-UNK
cell	B-UNK
differentiation	B-UNK
and	O
proliferation	B-UNK
.	O
.	O

 	O
the	O
normal	B-UNK
huntington	B-DISEASE
disease	I-DISEASE
(	O
hd	B-UNK
)	O
allele	B-UNK
,	O
or	O
a	O
closely	B-UNK
linked	I-UNK
gene	B-UNK
,	O
influences	B-UNK
age	B-UNK
at	B-DISEASE
onset	B-UNK
of	O
hd	B-UNK
.	O

 	O
we	O
evaluated	O
the	O
hypothesis	O
that	O
huntington	B-DISEASE
disease	I-DISEASE
(	O
hd	B-UNK
)	O
is	O
influenced	O
by	O
the	O
normal	B-UNK
hd	B-UNK
allele	B-UNK
by	O
comparing	B-UNK
transmission	B-UNK
patterns	B-UNK
of	O
genetically	B-UNK
linked	B-UNK
markers	I-UNK
at	B-DISEASE
the	O
d4s10	B-UNK
locus	B-UNK
in	O
the	O
normal	B-UNK
parent	B-UNK
against	O
age	B-UNK
at	B-DISEASE
onset	B-UNK
in	O
the	O
affected	B-UNK
offspring	B-UNK
.	O

 	O
analysis	B-UNK
of	O
information	B-UNK
from	O
21	O
sibships	O
in	O
14	O
kindreds	B-UNK
showed	B-UNK
a	O
significant	B-UNK
tendency	O
for	O
sibs	B-UNK
who	O
have	O
similar	B-UNK
onset	B-UNK
ages	O
to	O
share	B-UNK
the	O
same	O
d4s10	B-UNK
allele	B-UNK
from	O
the	O
normal	B-UNK
parent	B-UNK
.	O

 	B-UNK
affected	I-UNK
sibs	B-UNK
who	O
inherited	B-UNK
different	B-UNK
d4s10	B-UNK
alleles	B-UNK
from	O
the	O
normal	B-UNK
parent	B-UNK
tended	O
to	O
have	O
more	O
variable	B-UNK
ages	O
at	B-DISEASE
onset	B-UNK
.	O

 	O
these	O
findings	B-UNK
suggest	B-UNK
that	O
the	O
expression	B-UNK
of	O
hd	B-UNK
is	O
modulated	O
by	O
the	O
normal	B-UNK
hd	B-UNK
allele	B-UNK
or	O
by	O
a	O
closely	B-UNK
linked	I-UNK
locus	B-UNK
.	O
.	O

 	O
further	O
investigation	O
of	O
the	O
hexa	B-UNK
gene	B-UNK
intron	B-UNK
9	O
donor	B-UNK
splice	I-UNK
site	I-UNK
mutation	B-UNK
frequently	B-UNK
found	B-UNK
in	O
non	B-UNK
-	O
jewish	B-UNK
tay	B-DISEASE
-	I-DISEASE
sachs	I-DISEASE
disease	I-DISEASE
patients	B-UNK
from	O
the	O
british	B-UNK
isles	B-UNK
.	O

 	O
in	O
a	O
previous	B-UNK
study	B-UNK
we	O
found	B-UNK
that	O
a	O
tay	B-DISEASE
-	I-DISEASE
sachs	I-DISEASE
disease	I-DISEASE
(	O
tsd	B-UNK
)	O
causing	B-UNK
mutation	B-UNK
in	O
the	O
intron	B-UNK
9	O
donor	B-UNK
splice	I-UNK
site	I-UNK
of	O
the	O
hexa	B-UNK
gene	B-UNK
occurs	B-UNK
at	B-DISEASE
high	B-UNK
frequency	B-UNK
in	O
non	B-UNK
-	O
jewish	B-UNK
patients	B-UNK
and	O
carriers	B-UNK
from	O
the	O
british	B-UNK
isles	B-UNK
.	O

 	O
it	O
was	O
found	B-UNK
more	O
frequently	B-UNK
in	O
subjects	B-UNK
of	O
irish	B-UNK
,	O
scottish	O
,	O
and	O
welsh	O
origin	B-UNK
compared	B-UNK
with	O
english	O
origin	B-UNK
(	O
63	O
%	O
and	O
31	O
%	O
respectively	B-UNK
)	O
.	O

 	O
we	O
have	O
now	O
tested	B-UNK
,	O
in	O
a	O
blind	B-UNK
study	B-UNK
,	O
26	O
american	B-UNK
tsd	B-UNK
carriers	B-UNK
and	O
28	O
non	B-UNK
-	O
carriers	B-UNK
who	O
have	O
british	B-UNK
ancestry	B-UNK
for	O
the	O
intron	B-UNK
9	O
splice	B-UNK
site	I-UNK
mutation	I-UNK
.	O

 	O
six	O
of	O
the	O
carriers	B-UNK
and	O
none	O
of	O
the	O
controls	B-UNK
were	O
positive	B-UNK
for	O
the	O
mutation	B-UNK
.	O

 	O
all	O
six	O
had	O
irish	B-UNK
ancestry	B-UNK
,	O
compared	B-UNK
with	O
nine	O
of	O
the	O
20	O
other	O
(	O
intron	B-UNK
9	O
mutation	B-UNK
negative	B-UNK
)	O
tsd	B-UNK
carriers	B-UNK
(	O
p	B-UNK
<	O
0	O
.	O
05	O
)	O
.	O

 	O
these	O
results	B-UNK
confirm	B-UNK
the	O
previously	B-UNK
found	B-UNK
high	B-UNK
frequency	B-UNK
of	O
the	O
intron	B-UNK
9	O
mutation	B-UNK
in	O
non	B-UNK
-	O
jewish	B-UNK
tsd	I-UNK
families	B-UNK
of	O
british	B-UNK
isles	B-UNK
,	O
particularly	B-UNK
irish	B-UNK
,	O
origin	B-UNK
,	O
and	O
reinforce	O
the	O
need	O
to	O
screen	B-UNK
such	O
families	B-UNK
for	O
this	O
mutation	B-UNK
.	O

 	B-UNK
molecular	I-UNK
mechanisms	B-UNK
of	O
oncogenic	B-UNK
mutations	B-UNK
in	O
tumors	B-DISEASE
from	O
patients	B-UNK
with	O
bilateral	B-UNK
and	O
unilateral	B-UNK
retinoblastoma	B-DISEASE
.	O

 	O
the	O
rb1	B-UNK
gene	B-UNK
from	O
12	O
human	B-UNK
retinoblastoma	B-DISEASE
tumors	B-DISEASE
has	O
been	O
analyzed	B-UNK
exon	B-UNK
-	O
by	O
-	O
exon	B-UNK
with	O
the	O
single	B-UNK
-	O
strand	B-UNK
conformation	I-UNK
polymorphism	I-UNK
technique	B-UNK
.	O

 	O
mutations	B-UNK
were	O
found	B-UNK
in	O
all	O
tumors	B-DISEASE
,	O
and	O
one	O
-	O
third	O
of	O
the	O
tumors	B-DISEASE
had	O
independent	B-UNK
mutations	B-UNK
in	O
both	O
alleles	B-UNK
neither	O
of	O
which	O
were	O
found	B-UNK
in	O
the	O
germ	B-UNK
line	I-UNK
,	O
confirming	O
their	O
true	B-UNK
sporadic	B-UNK
nature	B-UNK
.	O

 	O
in	O
the	O
remaining	B-UNK
two	O
-	O
thirds	O
of	O
the	O
tumors	B-DISEASE
only	O
one	O
mutation	B-UNK
was	O
found	B-UNK
,	O
consistent	B-UNK
with	O
the	O
loss	B-UNK
-	O
of	O
-	O
heterozygosity	B-UNK
theory	O
of	O
tumorigenesis	B-UNK
.	O

 	B-UNK
point	I-UNK
mutations	B-UNK
,	O
the	O
majority	B-UNK
of	O
which	O
were	O
c	B-UNK
-	O
-	O
>	O
t	B-UNK
transitions	B-UNK
,	O
were	O
the	O
most	O
common	B-UNK
abnormality	B-UNK
and	O
usually	B-UNK
resulted	B-UNK
in	O
the	O
conversion	O
of	O
an	O
arginine	B-UNK
codon	B-UNK
to	O
a	O
stop	B-UNK
codon	B-UNK
.	O

 	B-UNK
small	I-UNK
deletions	B-UNK
were	O
the	O
second	B-UNK
most	O
common	B-UNK
abnormality	B-UNK
and	O
most	O
often	O
created	B-UNK
a	O
downstream	B-UNK
stop	B-UNK
codon	B-UNK
as	O
the	O
result	B-UNK
of	O
a	O
reading	O
frameshift	B-UNK
.	O

 	O
deletions	B-UNK
and	O
point	B-UNK
mutations	I-UNK
also	O
affected	B-UNK
splice	O
junctions	B-UNK
.	O

 	B-UNK
direct	I-UNK
repeats	B-UNK
were	O
present	B-UNK
at	B-DISEASE
the	O
breakpoint	B-UNK
junctions	B-UNK
in	O
the	O
majority	B-UNK
of	O
deletions	B-UNK
,	O
supporting	B-UNK
a	O
slipped	O
-	O
mispairing	O
mechanism	B-UNK
.	O

 	B-UNK
point	I-UNK
mutations	B-UNK
generally	B-UNK
produced	B-UNK
dna	B-UNK
sequences	I-UNK
which	O
resulted	B-UNK
in	O
perfect	O
homology	B-UNK
with	O
endogenous	B-UNK
sequences	B-UNK
which	O
lay	O
within	O
14	O
bp	B-UNK
.	O
.	O

 	O
pax6	B-UNK
mutations	B-UNK
in	O
aniridia	B-DISEASE
.	O

 	O
aniridia	B-DISEASE
is	O
a	O
congenital	B-DISEASE
malformation	O
of	O
the	O
eye	B-UNK
,	O
chiefly	O
characterised	B-UNK
by	O
iris	B-UNK
hypoplasia	B-UNK
,	O
which	O
can	O
cause	B-UNK
blindness	B-DISEASE
.	O

 	O
the	O
pax6	B-UNK
gene	B-UNK
was	O
isolated	B-UNK
as	O
a	O
candidate	B-UNK
aniridia	B-DISEASE
gene	B-UNK
by	O
positional	B-UNK
cloning	I-UNK
from	O
the	O
smallest	B-UNK
region	B-UNK
of	O
overlap	O
of	O
aniridia	B-DISEASE
-	O
associated	B-UNK
deletions	B-UNK
.	O

 	O
subsequently	B-UNK
pax6	B-UNK
intragenic	B-UNK
mutations	B-UNK
were	O
demonstrated	B-UNK
in	O
smalleye	O
,	O
a	O
mouse	B-UNK
mutant	B-UNK
which	O
is	O
an	O
animal	B-UNK
model	B-UNK
for	O
aniridia	B-DISEASE
,	O
and	O
six	O
human	B-UNK
aniridia	B-DISEASE
patients	B-UNK
.	O

 	O
in	O
this	O
paper	B-UNK
we	O
describe	B-UNK
four	O
additional	B-UNK
pax6	B-UNK
point	B-UNK
mutations	I-UNK
in	O
aniridia	B-DISEASE
patients	B-UNK
,	O
both	O
sporadic	B-UNK
and	O
familial	B-UNK
.	O

 	O
these	O
mutations	B-UNK
highlight	O
regions	B-UNK
of	O
the	O
gene	B-UNK
which	O
are	O
essential	B-UNK
for	O
normal	B-UNK
pax6	B-UNK
function	B-UNK
.	O

 	O
in	O
addition	B-UNK
,	O
the	O
frequency	B-UNK
at	B-DISEASE
which	O
we	O
have	O
found	B-UNK
pax6	B-UNK
mutations	B-UNK
suggests	B-UNK
that	O
lesions	B-UNK
in	O
pax6	B-UNK
will	O
account	B-UNK
for	O
most	O
cases	B-UNK
of	O
aniridia	B-DISEASE
.	O
.	O

 	O
detection	B-UNK
of	O
a	O
novel	B-UNK
arginine	B-UNK
vasopressin	B-UNK
defect	B-UNK
by	O
dideoxy	O
fingerprinting	B-UNK
.	O

 	O
autosomal	O
dominant	B-UNK
neurohypophyseal	B-UNK
diabetes	B-DISEASE
insipidus	I-DISEASE
is	O
a	O
familial	B-UNK
form	B-UNK
of	O
diabetes	B-DISEASE
insipidus	I-DISEASE
.	O

 	O
this	O
disorder	O
is	O
associated	B-UNK
with	O
variable	B-UNK
levels	B-UNK
of	O
arginine	B-UNK
vasopressin	B-UNK
(	O
avp	B-UNK
)	O
and	O
diabetes	B-DISEASE
insipidus	I-DISEASE
of	O
varying	B-UNK
severity	B-UNK
,	O
which	O
responds	O
to	O
exogenous	B-UNK
avp	B-UNK
.	O

 	O
to	O
determine	O
the	O
molecular	B-UNK
basis	I-UNK
of	O
autosomal	O
dominant	B-UNK
neurohypophyseal	B-UNK
diabetes	B-DISEASE
insipidus	I-DISEASE
,	O
the	O
avp	B-UNK
genes	B-UNK
of	O
members	B-UNK
of	O
a	O
large	B-UNK
kindred	B-UNK
were	O
analyzed	B-UNK
.	O

 	O
a	O
new	B-UNK
method	B-UNK
,	O
called	B-UNK
dideoxy	O
fingerprinting	B-UNK
,	O
was	O
used	O
to	O
detect	B-UNK
an	O
avp	B-UNK
mutation	B-UNK
that	O
was	O
characterized	B-UNK
by	O
dna	B-UNK
sequencing	I-UNK
.	O

 	O
the	O
novel	B-UNK
defect	B-UNK
found	B-UNK
changes	B-UNK
the	O
last	O
codon	B-UNK
of	O
the	O
avp	B-UNK
signal	B-UNK
peptide	I-UNK
from	O
alanine	O
to	O
threonine	B-UNK
,	O
which	O
should	O
perturb	O
cleavage	B-UNK
of	O
mature	B-UNK
avp	B-UNK
from	O
its	O
precursor	B-UNK
protein	B-UNK
and	O
inhibit	O
its	O
secretion	B-UNK
or	O
action	O
.	O
.	O

 	O
germinal	B-UNK
mosaicism	I-UNK
in	O
a	O
duchenne	B-UNK
muscular	B-DISEASE
dystrophy	I-DISEASE
family	B-UNK
:	O
implications	B-UNK
for	O
genetic	B-UNK
counselling	B-UNK
.	O

 	O
in	O
this	O
study	B-UNK
we	O
describe	B-UNK
a	O
three	O
-	O
generation	B-UNK
family	B-UNK
in	O
which	O
two	O
siblings	B-UNK
were	O
affected	B-UNK
by	O
duchenne	B-UNK
muscular	B-DISEASE
dystrophy	I-DISEASE
(	O
dmd	B-UNK
)	O
.	O

 	B-UNK
immunohistochemical	I-UNK
analysis	B-UNK
of	O
muscle	B-UNK
dystrophin	B-UNK
and	O
haplotype	B-UNK
analysis	B-UNK
of	O
the	O
dmd	B-UNK
locus	B-UNK
revealed	B-UNK
that	O
the	O
x	B-DISEASE
chromosome	I-DISEASE
carrying	B-UNK
the	O
dmd	B-UNK
gene	B-UNK
was	O
transmitted	B-UNK
from	O
the	O
healthy	B-UNK
maternal	B-UNK
grandfather	O
to	O
his	O
three	O
daughters	O
,	O
including	B-UNK
the	O
probands	B-UNK
mother	B-UNK
.	O

 	O
these	O
findings	B-UNK
indicate	B-UNK
that	O
the	O
grandfather	O
was	O
a	O
germinal	O
mosaic	B-UNK
for	O
the	O
dmd	B-UNK
gene	B-UNK
.	O

 	O
the	O
definition	O
of	O
the	O
carrier	B-UNK
status	B-UNK
in	O
two	O
possible	B-UNK
carriers	B-UNK
led	B-UNK
us	O
to	O
give	O
accurate	B-UNK
genetic	B-UNK
counselling	B-UNK
and	O
to	O
prevent	O
the	O
birth	O
of	O
an	O
affected	B-UNK
boy	B-UNK
.	O

 	O
the	O
results	B-UNK
of	O
this	O
study	B-UNK
demonstrate	B-UNK
the	O
usefulness	O
of	O
haplotype	B-UNK
analysis	B-UNK
and	O
immunohistochemical	O
muscle	B-UNK
dystrophin	B-UNK
studies	B-UNK
to	O
detect	B-UNK
hidden	O
germinal	B-UNK
mosaicism	I-UNK
and	O
to	O
improve	O
genetic	B-UNK
counselling	B-UNK
.	O
.	O

 	B-UNK
genetic	I-UNK
mapping	B-UNK
of	O
the	O
breast	B-DISEASE
-	I-DISEASE
ovarian	I-DISEASE
cancer	I-DISEASE
syndrome	B-DISEASE
to	O
a	O
small	B-UNK
interval	B-UNK
on	O
chromosome	B-UNK
17q12	B-UNK
-	O
21	O
:	O
exclusion	B-UNK
of	O
candidate	B-UNK
genes	I-UNK
edh17b2	B-UNK
and	O
rara	O
.	O

 	O
a	O
susceptibility	B-UNK
gene	B-UNK
for	O
hereditary	B-UNK
breast	B-DISEASE
-	I-DISEASE
ovarian	I-DISEASE
cancer	I-DISEASE
,	O
brca1	B-UNK
,	O
has	O
been	O
assigned	B-UNK
by	O
linkage	B-UNK
analysis	I-UNK
to	O
chromosome	B-UNK
17q21	B-UNK
.	O

 	O
candidate	B-UNK
genes	I-UNK
in	O
this	O
region	B-UNK
include	B-UNK
edh17b2	B-UNK
,	O
which	O
encodes	B-UNK
estradiol	O
17	O
beta	B-UNK
-	O
hydroxysteroid	O
dehydrogenase	B-UNK
ii	B-UNK
(	O
17	O
beta	B-UNK
-	O
hsd	O
ii	B-UNK
)	O
,	O
and	O
rara	O
,	O
the	O
gene	B-UNK
for	O
retinoic	O
acid	O
receptor	B-UNK
alpha	B-UNK
.	O

 	O
we	O
have	O
typed	O
22	O
breast	B-UNK
and	O
breast	B-DISEASE
-	I-DISEASE
ovarian	I-DISEASE
cancer	I-DISEASE
families	B-UNK
with	O
eight	O
polymorphisms	B-UNK
from	O
the	O
chromosome	B-UNK
17q12	B-UNK
-	O
21	O
region	B-UNK
,	O
including	B-UNK
two	O
in	O
the	O
edh17b2	B-UNK
gene	B-UNK
.	O

 	B-UNK
genetic	I-UNK
recombination	B-UNK
with	O
the	O
breast	B-DISEASE
cancer	I-DISEASE
trait	B-UNK
excludes	O
rara	O
from	O
further	O
consideration	O
as	O
a	O
candidate	B-UNK
gene	B-UNK
for	O
brca1	B-UNK
.	O

 	O
both	O
brca1	B-UNK
and	O
edh17b2	B-UNK
map	B-UNK
to	O
a	O
6	O
cm	B-DISEASE
interval	B-UNK
(	O
between	O
thra1	O
and	O
d17s579	O
)	O
and	O
no	O
recombination	B-UNK
was	O
observed	B-UNK
between	O
the	O
two	O
genes	B-UNK
.	O

 	O
however	O
,	O
direct	B-UNK
sequencing	I-UNK
of	O
overlapping	B-UNK
pcr	B-UNK
products	B-UNK
containing	B-UNK
the	O
entire	B-UNK
edh17b2	B-UNK
gene	B-UNK
in	O
four	O
unrelated	B-UNK
affected	B-UNK
women	B-UNK
did	O
not	O
uncover	O
any	O
sequence	B-UNK
variation	B-UNK
,	O
other	O
than	O
previously	B-UNK
described	I-UNK
polymorphisms	B-UNK
.	O

 	O
mutations	B-UNK
in	O
the	O
edh17b2	B-UNK
gene	B-UNK
,	O
therefore	O
do	O
not	O
appear	B-UNK
to	O
be	O
responsible	B-UNK
for	O
the	O
hereditary	B-UNK
breast	B-DISEASE
-	I-DISEASE
ovarian	I-DISEASE
cancer	I-DISEASE
syndrome	B-DISEASE
.	O

 	O
single	B-UNK
meiotic	B-UNK
crossovers	O
in	O
affected	B-UNK
women	B-UNK
suggest	B-UNK
that	O
brca1	B-UNK
is	O
flanked	O
by	O
the	O
loci	B-UNK
rara	O
and	O
d17s78	O
.	O
.	O

 	O
a	O
missense	B-UNK
mutation	I-UNK
in	O
the	O
cholesteryl	B-UNK
ester	I-UNK
transfer	I-UNK
protein	I-UNK
gene	B-UNK
with	O
possible	B-UNK
dominant	B-UNK
effects	B-UNK
on	O
plasma	B-UNK
high	B-UNK
density	I-UNK
lipoproteins	I-UNK
.	O

 	O
plasma	B-UNK
hdl	B-UNK
are	O
a	O
negative	B-UNK
risk	B-UNK
factor	B-UNK
for	O
atherosclerosis	B-DISEASE
.	O

 	O
cholesteryl	B-UNK
ester	I-UNK
transfer	I-UNK
protein	I-UNK
(	O
cetp	B-UNK
;	O
476	O
amino	O
acids	O
)	O
transfers	O
cholesteryl	O
ester	O
from	O
hdl	B-UNK
to	O
other	O
lipoproteins	O
.	O

 	O
subjects	B-UNK
with	O
homozygous	B-UNK
cetp	B-UNK
deficiency	I-UNK
caused	B-UNK
by	O
a	O
gene	B-UNK
splicing	B-UNK
defect	B-UNK
have	O
markedly	B-UNK
elevated	B-UNK
hdl	B-UNK
;	O
however	O
,	O
heterozygotes	B-UNK
have	O
only	O
mild	B-UNK
increases	B-UNK
in	O
hdl	B-UNK
.	O

 	O
we	O
describe	B-UNK
two	O
probands	B-UNK
with	O
a	O
cetp	B-UNK
missense	B-UNK
mutation	I-UNK
(	O
442	O
d	B-UNK
g	B-UNK
)	O
.	O

 	O
although	O
heterozygous	B-UNK
,	O
they	O
have	O
threefold	O
increases	B-UNK
in	O
hdl	B-UNK
concentration	B-UNK
and	O
markedly	B-UNK
decreased	I-UNK
plasma	I-UNK
cetp	B-UNK
mass	B-UNK
and	O
activity	B-UNK
,	O
suggesting	B-UNK
that	O
the	O
mutation	B-UNK
has	O
dominant	B-UNK
effects	B-UNK
on	O
cetp	B-UNK
and	O
hdl	B-UNK
in	O
vivo	B-UNK
.	O

 	O
cellular	B-UNK
expression	B-UNK
of	O
mutant	B-UNK
cdna	B-UNK
results	B-UNK
in	O
secretion	B-UNK
of	O
only	O
30	O
%	O
of	O
wild	B-UNK
type	B-UNK
cetp	B-UNK
activity	I-UNK
.	O

 	O
moreover	O
,	O
coexpression	O
of	O
wild	B-UNK
type	B-UNK
and	O
mutant	B-UNK
cdnas	I-UNK
leads	B-UNK
to	O
inhibition	B-UNK
of	O
wild	B-UNK
type	B-UNK
secretion	B-UNK
and	O
activity	B-UNK
.	O

 	O
the	O
dominant	B-UNK
effects	B-UNK
of	O
the	O
cetp	B-UNK
missense	B-UNK
mutation	I-UNK
during	O
cellular	B-UNK
expression	B-UNK
probably	B-UNK
explains	O
why	O
the	O
probands	B-UNK
have	O
markedly	B-UNK
increased	B-UNK
hdl	I-UNK
in	O
the	O
heterozygous	B-UNK
state	B-UNK
,	O
and	O
suggests	B-UNK
that	O
the	O
active	B-UNK
molecular	B-UNK
species	B-UNK
of	O
cetp	B-UNK
may	O
be	O
multimeric	O
.	O
.	O

 	O
familial	B-DISEASE
mediterranean	I-DISEASE
fever	I-DISEASE
in	O
the	O
colchicine	B-UNK
era	O
:	O
the	O
fate	O
of	O
one	O
family	B-UNK
.	O

 	O
in	O
order	B-UNK
to	O
demonstrate	B-UNK
the	O
effect	B-UNK
of	O
prophylactic	O
colchicine	B-UNK
treatment	B-UNK
on	O
the	O
natural	B-UNK
history	B-UNK
of	O
familial	B-DISEASE
mediterranean	I-DISEASE
fever	I-DISEASE
(	O
fmf	B-UNK
)	O
,	O
a	O
family	B-UNK
is	O
presented	B-UNK
with	O
6	O
out	O
of	O
9	O
siblings	B-UNK
affected	B-UNK
by	O
fmf	B-UNK
.	O

 	O
each	O
patient	B-UNK
represents	B-UNK
a	O
different	B-UNK
stage	B-UNK
of	O
the	O
amyloidotic	O
kidney	B-DISEASE
disease	I-DISEASE
of	O
fmf	B-UNK
and	O
the	O
effect	B-UNK
of	O
continuous	B-UNK
colchicine	B-UNK
treatment	B-UNK
on	O
its	O
course	B-UNK
.	O

 	O
considered	B-UNK
together	O
,	O
the	O
members	B-UNK
of	O
this	O
family	B-UNK
present	B-UNK
an	O
almost	O
complete	B-UNK
clinical	B-UNK
,	O
genetic	B-UNK
,	O
and	O
behavioral	B-UNK
picture	B-UNK
of	O
the	O
disease	B-DISEASE
.	O
.	O

 	O
detection	B-UNK
of	O
a	O
new	B-UNK
submicroscopic	B-UNK
norrie	B-DISEASE
disease	I-DISEASE
deletion	B-UNK
interval	B-UNK
with	O
a	O
novel	B-UNK
dna	B-UNK
probe	I-UNK
isolated	B-UNK
by	O
differential	B-UNK
alu	B-UNK
pcr	B-UNK
fingerprint	B-UNK
cloning	B-UNK
.	O

 	O
differential	B-UNK
alu	B-UNK
pcr	B-UNK
fingerprint	B-UNK
cloning	B-UNK
was	O
used	O
to	O
isolate	B-UNK
a	O
dna	B-UNK
probe	I-UNK
from	O
the	O
xp11	B-UNK
.	O

 	O
4	O
-	O
-	O
>	O
p11	O
.	O

 	O
21	O
region	B-UNK
of	O
the	O
human	B-UNK
x	B-DISEASE
chromosome	I-DISEASE
.	O

 	O
this	O
novel	B-UNK
sequence	B-UNK
,	O
cpxr318	O
(	O
dxs742	O
)	O
,	O
detects	O
a	O
new	B-UNK
submicroscopic	B-UNK
deletion	I-UNK
interval	B-UNK
at	B-DISEASE
the	O
norrie	B-DISEASE
disease	I-DISEASE
locus	B-UNK
(	O
ndp	B-UNK
)	O
.	O

 	O
combining	B-UNK
our	O
data	B-UNK
with	O
the	O
consensus	B-UNK
genetic	B-UNK
map	B-UNK
of	O
the	O
proximal	B-UNK
short	B-UNK
arm	B-UNK
of	O
the	O
x	B-DISEASE
chromosome	I-DISEASE
,	O
we	O
propose	O
the	O
physical	B-UNK
order	B-UNK
xcen	O
-	O
dxs14	O
-	O
dxs255	O
-	O
(	O
dxs426	O
,	O
timp	O
)	O
-	O
(	O
dxs742	O
-	O
(	O
[	O
maob	B-UNK
-	O
maoa	O
-	O
dxs7	B-UNK
]	O
,	O
ndp	B-UNK
)	O
-	O
dxs77	O
-	O
dxs228	O
)	O
-	O
dxs209	O
-	O
dxs148	O
-	O
dxs196	O
-	O
+	O
+	O
+	O
xpter	O
.	O

 	O
the	O
cpxr318	O
probe	B-UNK
and	O
a	O
subclone	O
from	O
a	O
cosmid	B-UNK
corresponding	B-UNK
to	O
the	O
dxs7	B-UNK
locus	B-UNK
were	O
converted	O
into	O
sequence	B-UNK
-	O
tagged	B-UNK
sites	B-UNK
.	O

 	O
finally	B-UNK
,	O
dxs742	O
,	O
dsx7	O
,	O
dxs77	O
,	O
and	O
maoa	O
were	O
integrated	O
into	O
a	O
physical	B-UNK
map	B-UNK
spanning	B-UNK
the	O
norrie	B-DISEASE
disease	I-DISEASE
locus	B-UNK

 	O
putative	B-UNK
x	B-UNK
-	O
linked	B-UNK
adrenoleukodystrophy	B-DISEASE
gene	B-UNK
shares	B-UNK
unexpected	B-UNK
homology	B-UNK
with	O
abc	O
transporters	B-UNK
.	O

 	O
adrenoleukodystrophy	B-DISEASE
(	O
ald	B-UNK
)	O
is	O
an	O
x	B-UNK
-	O
linked	B-UNK
disease	B-DISEASE
affecting	B-UNK
1	O
/	O
20	O
,	O
000	O
males	B-UNK
either	O
as	O
cerebral	B-UNK
ald	I-UNK
in	O
childhood	B-UNK
or	O
as	O
adrenomyeloneuropathy	B-UNK
(	O
amn	B-UNK
)	O
in	O
adults	B-UNK
.	O

 	O
childhood	B-UNK
ald	I-UNK
is	O
the	O
more	O
severe	B-UNK
form	B-UNK
,	O
with	O
onset	B-UNK
of	O
neurological	B-UNK
symptoms	B-UNK
between	O
5	O
-	O
12	O
years	B-UNK
of	O
age	B-UNK
.	O

 	O
central	B-UNK
nervous	I-UNK
system	I-UNK
demyelination	B-UNK
progresses	O
rapidly	B-UNK
and	O
death	B-DISEASE
occurs	B-UNK
within	O
a	O
few	O
years	B-UNK
.	O

 	O
amn	B-UNK
is	O
a	O
milder	B-UNK
form	B-UNK
of	O
the	O
disease	B-DISEASE
with	O
onset	B-UNK
at	B-DISEASE
15	O
-	O
30	O
years	B-UNK
of	O
age	B-UNK
and	O
a	O
more	O
progressive	B-UNK
course	B-UNK
.	O

 	O
adrenal	B-DISEASE
insufficiency	I-DISEASE
(	O
addisons	O
disease	B-DISEASE
)	O
may	O
remain	O
the	O
only	O
clinical	B-UNK
manifestation	B-UNK
of	O
ald	B-UNK
.	O

 	O
the	O
principal	B-UNK
biochemical	B-UNK
abnormality	B-UNK
of	O
ald	B-UNK
is	O
the	O
accumulation	B-UNK
of	O
very	O
-	O
long	B-UNK
-	O
chain	B-UNK
fatty	I-UNK
acids	I-UNK
(	O
vlcfa	B-UNK
)	O
because	O
of	O
impaired	B-UNK
beta	B-UNK
-	O
oxidation	B-UNK
in	O
peroxisomes	O
.	O

 	O
the	O
normal	B-UNK
oxidation	B-UNK
of	O
vlcfa	B-UNK
-	O
coa	B-UNK
in	O
patients	B-UNK
fibroblasts	B-UNK
suggested	B-UNK
that	O
the	O
gene	B-UNK
coding	B-UNK
for	O
the	O
vlcfa	B-UNK
-	O
coa	B-UNK
synthetase	O
could	O
be	O
a	O
candidate	B-UNK
gene	B-UNK
for	O
ald	B-UNK
.	O

 	O
here	O
we	O
use	B-UNK
positional	B-UNK
cloning	I-UNK
to	O
identify	B-UNK
a	O
gene	B-UNK
partially	B-UNK
deleted	B-UNK
in	O
6	O
of	O
85	O
independent	B-UNK
patients	B-UNK
with	O
ald	B-UNK
.	O

 	O
in	O
familial	B-UNK
cases	B-UNK
,	O
the	O
deletions	B-UNK
segregated	B-UNK
with	O
the	O
disease	B-DISEASE
.	O

 	O
an	O
identical	B-UNK
deletion	B-UNK
was	O
detected	B-UNK
in	O
two	O
brothers	B-UNK
presenting	B-UNK
with	O
different	B-UNK
clinical	I-UNK
ald	B-UNK
phenotypes	B-UNK
.	O

 	O
candidate	B-UNK
exons	B-UNK
were	O
identified	B-UNK
by	O
computer	O
analysis	B-UNK
of	O
genomic	B-UNK
sequences	I-UNK
and	O
used	O
to	O
isolate	B-UNK
complementary	O
dnas	B-UNK
by	O
exon	B-UNK
connection	O
and	O
screening	B-UNK
of	O
cdna	B-UNK
libraries	B-UNK
.	O

 	O
the	O
deduced	O
protein	B-UNK
sequence	B-UNK
shows	B-UNK
significant	B-UNK
sequence	B-UNK
identity	O
to	O
a	O
peroxisomal	B-UNK
membrane	I-UNK
protein	B-UNK
of	O
m	B-UNK
(	O
r	B-UNK
)	O
70k	O
that	O
is	O
involved	B-UNK
in	O
peroxisome	B-UNK
biogenesis	O
and	O
belongs	O
to	O
the	O
atp	B-UNK
-	O
binding	B-UNK
cassette	O
superfamily	O
of	O
transporters	B-UNK
.	O
.	O

 	B-UNK
targeted	I-UNK
modification	B-UNK
of	O
the	O
apolipoprotein	B-UNK
b	B-UNK
gene	B-UNK
results	B-UNK
in	O
hypobetalipoproteinemia	B-DISEASE
and	O
developmental	B-UNK
abnormalities	B-DISEASE
in	O
mice	B-UNK
.	O

 	B-UNK
familial	I-UNK
hypobetalipoproteinemia	B-DISEASE
is	O
an	O
autosomal	O
codominant	B-UNK
disorder	O
resulting	B-UNK
in	O
a	O
dramatic	B-UNK
reduction	B-UNK
in	O
plasma	B-UNK
concentrations	B-UNK
of	O
apolipoprotein	B-UNK
(	O
apo	O
)	O
b	B-UNK
,	O
cholesterol	B-UNK
,	O
and	O
beta	B-UNK
-	O
migrating	O
lipoproteins	O
.	O

 	O
a	O
benefit	O
of	O
hypobetalipoproteinemia	B-DISEASE
is	O
that	O
mildly	B-UNK
affected	I-UNK
individuals	B-UNK
may	O
be	O
protected	O
from	O
coronary	O
vascular	O
disease	B-DISEASE
.	O

 	O
we	O
have	O
used	O
gene	B-UNK
targeting	B-UNK
to	O
generate	B-UNK
mice	B-UNK
with	O
a	O
modified	B-UNK
apob	B-UNK
allele	B-UNK
.	O

 	B-UNK
mice	I-UNK
containing	B-UNK
this	O
allele	B-UNK
display	B-UNK
all	O
of	O
the	O
hallmarks	O
of	O
human	B-UNK
hypobetalipoproteinemia	B-DISEASE
they	O
produce	B-UNK
a	O
truncated	B-UNK
apob	B-UNK
protein	B-UNK
,	O
apob70	O
,	O
and	O
have	O
markedly	B-UNK
decreased	I-UNK
plasma	I-UNK
concentrations	B-UNK
of	O
apob	B-UNK
,	O
beta	B-UNK
-	O
lipoproteins	O
,	O
and	O
total	B-UNK
cholesterol	B-UNK
.	O

 	O
in	O
addition	B-UNK
,	O
the	O
mice	B-UNK
manifest	O
several	O
characteristics	B-UNK
that	O
are	O
occasionally	B-UNK
observed	B-UNK
in	O
human	B-UNK
hypobetalipoproteinemia	B-DISEASE
,	O
including	B-UNK
reduced	B-UNK
plasma	B-UNK
triglyceride	O
concentrations	B-UNK
,	O
fasting	O
chylomicronemia	B-DISEASE
,	O
and	O
reduced	B-UNK
high	B-UNK
density	I-UNK
lipoprotein	B-UNK
cholesterol	I-UNK
.	O

 	O
an	O
unexpected	B-UNK
finding	B-UNK
is	O
that	O
the	O
modified	B-UNK
apob	B-UNK
allele	B-UNK
is	O
strongly	B-UNK
associated	B-UNK
with	O
exencephalus	O
and	O
hydrocephalus	B-DISEASE
.	O

 	O
these	O
mice	B-UNK
should	O
help	O
increase	B-UNK
our	O
understanding	B-UNK
of	O
hypobetalipoproteinemia	B-DISEASE
,	O
atherogenesis	O
,	O
and	O
the	O
etiology	B-UNK
of	O
exencephalus	O
and	O
hydrocephalus	B-DISEASE
.	O
.	O

 	O
a	O
novel	B-UNK
disease	B-DISEASE
with	O
deficiency	B-UNK
of	O
mitochondrial	B-UNK
very	O
-	O
long	B-UNK
-	O
chain	O
acyl	B-UNK
-	O
coa	B-UNK
dehydrogenase	I-UNK
.	O

 	O
palmitoyl	B-UNK
-	O
coa	B-UNK
dehydrogenase	I-UNK
activity	B-UNK
in	O
skin	B-DISEASE
fibroblasts	B-UNK
from	O
seven	B-UNK
patients	B-UNK
with	O
unidentified	B-UNK
defects	B-UNK
of	O
fatty	O
acid	O
oxidation	B-UNK
was	O
measured	B-UNK
in	O
the	O
presence	B-UNK
and	O
absence	B-UNK
of	O
antibodies	B-UNK
against	O
medium	O
-	O
chain	O
,	O
long	B-UNK
-	O
chain	O
,	O
and	O
very	O
-	O
long	B-UNK
-	O
chain	O
acyl	B-UNK
-	O
coa	B-UNK
dehydrogenases	O
(	O
vlcad	B-UNK
)	O
.	O

 	O
two	O
of	O
the	O
patients	B-UNK
,	O
4	O
-	O
5	O
month	O
old	B-UNK
boys	B-UNK
,	O
were	O
found	B-UNK
to	O
have	O
a	O
novel	B-UNK
disease	B-DISEASE
,	O
vlcad	B-DISEASE
deficiency	I-DISEASE
,	O
as	O
judged	O
from	O
the	O
results	B-UNK
of	O
very	O
low	B-UNK
palmitoyl	B-UNK
-	O
coa	B-UNK
dehydrogenase	I-UNK
activity	B-UNK
and	O
the	O
lack	B-UNK
of	O
immunoreactivity	O
toward	O
antibody	B-UNK
raised	B-UNK
to	O
purified	B-UNK
vlcad	B-UNK
.	O
.	O

 	B-UNK
molecular	I-UNK
characterization	B-UNK
of	O
glucose	B-UNK
-	O
6	O
-	O
phosphate	B-UNK
dehydrogenase	I-UNK
(	O
g6pd	B-UNK
)	O
deficiency	B-UNK
in	O
patients	B-UNK
of	O
chinese	B-UNK
descent	B-UNK
and	O
identification	B-UNK
of	O
new	B-UNK
base	B-UNK
substitutions	B-UNK
in	O
the	O
human	B-UNK
g6pd	B-UNK
gene	B-UNK
.	O

 	O
the	O
underlying	B-UNK
dna	B-UNK
changes	B-UNK
associated	B-UNK
with	O
glucose	B-UNK
-	O
6	O
-	O
phosphate	B-UNK
dehydrogenase	I-UNK
(	O
g6pd	B-UNK
)	O
-	O
deficient	B-UNK
asians	O
have	O
not	O
been	O
extensively	O
investigated	B-UNK
.	O

 	O
to	O
fill	O
this	O
gap	O
,	O
we	O
sequenced	B-UNK
the	O
g6pd	B-UNK
gene	B-UNK
of	O
43	O
g6pd	B-UNK
-	O
deficient	B-UNK
chinese	B-UNK
whose	O
g6pd	B-UNK
was	O
well	O
characterized	B-UNK
biochemically	B-UNK
.	O

 	B-UNK
dna	I-UNK
samples	B-UNK
were	O
obtained	B-UNK
from	O
peripheral	B-UNK
blood	I-UNK
of	O
these	O
individuals	B-UNK
for	O
sequencing	B-UNK
using	O
a	O
direct	B-UNK
polymerase	B-UNK
chain	I-UNK
reaction	I-UNK
(	O
pcr	B-UNK
)	O
sequencing	B-UNK
procedure	B-UNK
.	O

 	O
from	O
these	O
43	O
samples	B-UNK
,	O
we	O
have	O
identified	B-UNK
five	O
different	B-UNK
types	B-UNK
of	O
nucleotide	B-UNK
substitutions	B-UNK
in	O
the	O
g6pd	B-UNK
gene	B-UNK
at	B-DISEASE
cdna	B-UNK
1388	O
from	O
g	B-UNK
to	O
a	O
(	O
arg	B-UNK
to	O
his	O
)	O
;	O
at	B-DISEASE
cdna	B-UNK
1376	O
from	O
g	B-UNK
to	O
t	B-UNK
(	O
arg	B-UNK
to	O
leu	B-UNK
)	O
;	O
at	B-DISEASE
cdna	B-UNK
1024	O
from	O
c	B-UNK
to	O
t	B-UNK
(	O
leu	B-UNK
to	O
phe	O
)	O
;	O
at	B-DISEASE
cdna	B-UNK
392	O
from	O
g	B-UNK
to	O
t	B-UNK
(	O
gly	B-UNK
to	O
val	O
)	O
;	O
at	B-DISEASE
cdna	B-UNK
95	O
from	O
a	O
to	O
g	B-UNK
(	O
his	O
to	O
arg	B-UNK
)	O
.	O

 	O
these	O
five	O
nucleotide	B-UNK
substitutions	B-UNK
account	B-UNK
for	O
over	O
83	O
%	O
of	O
our	O
43	O
g6pd	B-UNK
-	O
deficient	B-UNK
samples	B-UNK
and	O
these	O
substitutions	B-UNK
have	O
not	O
been	O
reported	B-UNK
in	O
non	B-UNK
-	O
asians	O
.	O

 	O
the	O
substitutions	B-UNK
found	B-UNK
at	B-DISEASE
cdna	B-UNK
392	O
and	O
cdna	B-UNK
1024	O
are	O
new	B-UNK
findings	B-UNK
.	O

 	O
the	O
substitutions	B-UNK
at	B-DISEASE
cdna	B-UNK
1376	O
and	O
1388	O
account	B-UNK
for	O
over	O
50	O
%	O
of	O
the	O
43	O
samples	B-UNK
examined	B-UNK
indicating	B-UNK
a	O
high	B-UNK
prevalence	B-UNK
of	O
these	O
two	O
alleles	B-UNK
among	O
g6pd	B-UNK
-	O
deficient	B-UNK
chinese	B-UNK
.	O

 	O
our	O
findings	B-UNK
add	O
support	B-UNK
to	O
the	O
notion	O
that	O
diverse	B-UNK
point	B-UNK
mutations	I-UNK
may	O
account	B-UNK
largely	B-UNK
for	O
much	O
of	O
the	O
phenotypic	B-UNK
heterogeneity	B-UNK
of	O
g6pd	B-UNK
deficiency	I-UNK
.	O
.	O

 	O
identification	B-UNK
of	O
mutations	B-UNK
in	O
danish	O
choroideremia	B-DISEASE
families	B-UNK
.	O

 	O
we	O
have	O
searched	O
for	O
mutations	B-UNK
in	O
the	O
choroideremia	B-DISEASE
gene	B-UNK
(	O
chm	B-UNK
)	O
in	O
patients	B-UNK
from	O
12	O
danish	O
families	B-UNK
in	O
which	O
chm	B-UNK
is	O
segregating	B-UNK
.	O

 	O
employing	B-UNK
polymerase	B-UNK
chain	I-UNK
reaction	I-UNK
(	O
pcr	B-UNK
)	O
,	O
single	B-UNK
strand	I-UNK
conformation	I-UNK
polymorphism	O
(	O
sscp	B-UNK
)	O
analysis	B-UNK
,	O
and	O
direct	B-UNK
dna	B-UNK
sequencing	I-UNK
,	O
different	B-UNK
mutations	B-UNK
have	O
been	O
identified	B-UNK
in	O
6	O
patients	B-UNK
.	O

 	O
all	O
the	O
mutations	B-UNK
will	O
interfere	O
with	O
the	O
correct	B-UNK
translation	B-UNK
of	O
the	O
mrna	B-UNK
predicting	B-UNK
a	O
truncated	B-UNK
protein	B-UNK
or	O
no	O
gene	B-UNK
product	B-UNK
at	B-DISEASE
all	O
.	O
.	O

 	O
structure	B-UNK
and	O
genomic	B-UNK
sequence	B-UNK
of	O
the	O
myotonic	B-DISEASE
dystrophy	I-DISEASE
(	O
dm	B-DISEASE
kinase	B-UNK
)	O
gene	B-UNK
.	O

 	O
the	O
mutation	B-UNK
causing	B-UNK
myotonic	B-DISEASE
dystrophy	I-DISEASE
(	O
dm	B-DISEASE
)	O
has	O
recently	B-UNK
been	O
identified	B-UNK
as	O
an	O
unstable	B-UNK
ctg	B-UNK
trinucleotide	B-UNK
repeat	I-UNK
located	B-UNK
in	O
the	O
3	O
untranslated	B-UNK
region	B-UNK
of	O
a	O
gene	B-UNK
encoding	B-UNK
for	O
a	O
protein	B-UNK
with	O
putative	B-UNK
serine	B-UNK
-	O
threonine	B-UNK
protein	B-UNK
kinase	B-UNK
activity	B-UNK
.	O

 	O
in	O
this	O
report	B-UNK
we	O
present	B-UNK
the	O
genomic	B-UNK
sequences	I-UNK
of	O
the	O
human	B-UNK
and	O
murine	B-UNK
dm	B-DISEASE
kinase	B-UNK
gene	B-UNK
.	O

 	O
a	O
comparison	B-UNK
of	O
these	O
sequences	B-UNK
with	O
each	O
other	O
and	O
with	O
known	B-UNK
cdna	B-UNK
sequences	B-UNK
from	O
both	O
species	B-UNK
,	O
led	B-UNK
us	O
to	O
predict	O
a	O
translation	B-UNK
initiation	I-UNK
codon	B-UNK
,	O
as	O
well	O
as	O
determine	O
the	O
organization	B-UNK
of	O
the	O
dm	B-DISEASE
kinase	B-UNK
gene	B-UNK
.	O

 	O
several	O
polymorphisms	B-UNK
within	O
the	O
human	B-UNK
dm	B-DISEASE
kinase	B-UNK
gene	B-UNK
have	O
been	O
identified	B-UNK
,	O
and	O
pcr	B-UNK
assays	B-UNK
to	O
detect	B-UNK
two	O
of	O
these	O
are	O
described	B-UNK
.	O

 	O
the	O
complete	B-UNK
sequence	B-UNK
and	O
characterization	B-UNK
of	O
the	O
structure	B-UNK
of	O
the	O
dm	B-DISEASE
kinase	B-UNK
gene	B-UNK
,	O
as	O
well	O
as	O
the	O
identification	B-UNK
of	O
novel	B-UNK
polymorphisms	B-UNK
within	O
the	O
gene	B-UNK
,	O
represent	B-UNK
an	O
important	B-UNK
step	O
in	O
a	O
further	O
understanding	B-UNK
of	O
the	O
genetics	B-UNK
of	O
myotonic	B-DISEASE
dystrophy	I-DISEASE
and	O
the	O
molecular	B-UNK
biology	O
of	O
the	O
gene	B-UNK
.	O
.	O

 	O
autosomal	O
recessive	O
transmission	B-UNK
of	O
hemophilia	B-DISEASE
a	I-DISEASE
due	O
to	O
a	O
von	B-DISEASE
willebrand	I-DISEASE
factor	I-DISEASE
mutation	B-UNK
.	O

 	O
the	O
differential	B-UNK
diagnosis	B-UNK
of	O
the	O
genetic	B-UNK
bleeding	B-DISEASE
disorders	B-UNK
,	O
hemophilia	B-DISEASE
a	I-DISEASE
and	O
von	B-DISEASE
willebrand	I-DISEASE
disease	I-DISEASE
,	O
is	O
occasionally	B-UNK
confounded	O
by	O
the	O
close	B-UNK
molecular	B-UNK
relationship	B-UNK
of	O
coagulation	O
factor	B-UNK
viii	O
and	O
von	B-DISEASE
willebrand	I-DISEASE
factor	I-DISEASE
(	O
vwf	B-UNK
)	O
.	O

 	O
this	O
report	B-UNK
describes	B-UNK
the	O
autosomal	O
inheritance	B-UNK
of	O
a	O
hemophilia	B-DISEASE
a	I-DISEASE
phenotype	B-UNK
due	O
to	O
a	O
mutation	B-UNK
of	O
vwf	B-UNK
that	O
results	B-UNK
in	O
defective	B-UNK
factor	B-UNK
viii	O
binding	B-UNK
.	O

 	O
the	O
proband	B-UNK
was	O
a	O
female	B-UNK
patient	B-UNK
with	O
low	B-UNK
levels	B-UNK
of	O
factor	B-UNK
viii	O
activity	B-UNK
.	O

 	B-UNK
polymerase	I-UNK
chain	I-UNK
reaction	O
(	O
pcr	B-UNK
)	O
amplification	B-UNK
and	O
dna	B-UNK
sequencing	I-UNK
were	O
employed	O
to	O
examine	O
exons	B-UNK
encoding	B-UNK
the	O
putative	B-UNK
factor	B-UNK
viii	O
binding	B-UNK
domain	I-UNK
of	O
vwf	B-UNK
.	O

 	O
the	O
patient	B-UNK
was	O
found	B-UNK
to	O
be	O
homozygous	B-UNK
for	O
a	O
single	B-UNK
point	B-UNK
mutation	I-UNK
causing	B-UNK
a	O
thr	O
-	O
-	O
>	O
met	O
substitution	B-UNK
at	B-DISEASE
amino	B-UNK
acid	I-UNK
position	B-UNK
28	O
in	O
the	O
mature	B-UNK
vwf	B-UNK
subunit	B-UNK
.	O

 	O
the	O
phenotypic	B-UNK
expression	B-UNK
of	O
the	O
mutation	B-UNK
was	O
determined	B-UNK
to	O
be	O
recessive	O
because	O
heterozygous	B-UNK
family	I-UNK
members	B-UNK
were	O
clinically	B-UNK
unaffected	B-UNK
.	O

 	O
recombinant	B-UNK
vwf	B-UNK
containing	B-UNK
the	O
observed	B-UNK
amino	B-UNK
acid	I-UNK
substitution	I-UNK
was	O
expressed	B-UNK
in	O
cos	B-UNK
-	O
1	O
cells	B-UNK
.	O

 	O
the	O
mutant	B-UNK
vwf	B-UNK
was	O
processed	B-UNK
and	O
secreted	B-UNK
normally	B-UNK
,	O
and	O
was	O
functionally	B-UNK
equivalent	O
to	O
wild	B-UNK
-	O
type	B-UNK
vwf	B-UNK
in	O
its	O
ability	B-UNK
to	O
bind	B-UNK
to	O
platelets	B-UNK
.	O

 	O
however	O
,	O
the	O
mutant	B-UNK
failed	B-UNK
to	O
bind	B-UNK
factor	B-UNK
viii	O
,	O
demonstrating	B-UNK
that	O
the	O
mutation	B-UNK
was	O
functionally	B-UNK
related	B-UNK
to	O
the	O
observed	B-UNK
hemophilia	B-DISEASE
phenotype	B-UNK
.	O

 	O
the	O
family	B-UNK
we	O
describe	B-UNK
demonstrates	B-UNK
the	O
recessive	O
inheritance	B-UNK
of	O
a	O
recently	B-UNK
recognized	B-UNK
class	B-UNK
of	O
genetic	B-UNK
bleeding	B-DISEASE
disorders	B-UNK
,	O
we	O
call	O
"	O
autosomal	O
hemophilia	B-DISEASE
.	O

 	O
"	O
we	O
conclude	O
that	O
vwf	B-UNK
mutation	B-UNK
may	O
be	O
an	O
under	O
recognized	B-UNK
cause	B-UNK
of	O
hemophilia	B-DISEASE
,	O
especially	B-UNK
in	O
cases	B-UNK
where	O
the	O
inheritance	B-UNK
pattern	B-UNK
is	O
not	O
consistent	B-UNK
with	O
x	B-UNK
-	O
linked	B-UNK
transmission	B-UNK
.	O

 	O
somatic	B-UNK
von	B-UNK
hippel	I-UNK
-	O
lindau	O
mutation	B-UNK
in	O
clear	B-UNK
cell	B-UNK
papillary	O
cystadenoma	B-DISEASE
of	O
the	O
epididymis	O
.	O

 	O
papillary	O
cystadenoma	B-DISEASE
of	O
the	O
epididymis	O
is	O
an	O
uncommon	B-UNK
benign	B-UNK
lesion	B-UNK
that	O
may	O
occur	B-UNK
sporadically	O
or	O
as	O
a	O
manifestation	B-UNK
of	O
von	B-UNK
hippel	I-UNK
-	O
lindau	O
(	O
vhl	B-UNK
)	O
disease	B-DISEASE
.	O

 	O
neither	O
immunohistochemical	O
studies	B-UNK
nor	O
molecular	B-UNK
genetic	I-UNK
analyses	B-UNK
of	O
the	O
vhl	B-UNK
gene	B-UNK
have	O
been	O
reported	B-UNK
previously	B-UNK
for	O
this	O
lesion	B-UNK
.	O

 	O
the	O
authors	B-UNK
describe	B-UNK
two	O
cases	B-UNK
of	O
clear	B-UNK
cell	B-UNK
papillary	O
cystadenoma	B-DISEASE
of	O
the	O
epididymis	O
,	O
both	O
of	O
which	O
were	O
initially	B-UNK
confused	O
with	O
metastatic	O
renal	B-DISEASE
cell	B-UNK
carcinoma	B-DISEASE
.	O

 	O
both	O
lesions	B-UNK
showed	B-UNK
positive	B-UNK
immunohistochemical	B-UNK
staining	I-UNK
for	O
low	B-UNK
and	O
intermediate	B-UNK
molecular	B-UNK
weight	I-UNK
keratins	O
(	O
cam	O
5	O
.	O
2	O
and	O
ae1	O
/	O
ae3	O
)	O
,	O
ema	O
,	O
vimentin	O
,	O
alpha	B-UNK
1	O
-	O
antitrypsin	O
,	O
and	O
alpha	B-UNK
1	O
-	O
antichymotrypsin	O
.	O

 	O
each	O
was	O
negative	B-UNK
for	O
cea	O
.	O

 	O
because	O
clear	B-UNK
cell	B-UNK
papillary	O
cystadenoma	B-DISEASE
is	O
similar	B-UNK
to	O
renal	B-DISEASE
cell	B-UNK
carcinoma	B-DISEASE
histologically	O
,	O
and	O
because	O
both	O
occur	B-UNK
as	O
components	B-UNK
of	O
the	O
von	B-DISEASE
hippel	I-DISEASE
-	I-DISEASE
lindau	I-DISEASE
disease	I-DISEASE
complex	B-UNK
,	O
the	O
authors	B-UNK
analyzed	B-UNK
both	O
cases	B-UNK
for	O
the	O
presence	B-UNK
of	O
mutations	B-UNK
in	O
the	O
vhl	B-UNK
gene	B-UNK
.	O

 	O
a	O
somatic	B-UNK
vhl	B-UNK
gene	B-UNK
mutation	B-UNK
was	O
detected	B-UNK
in	O
one	O
of	O
the	O
two	O
tumors	B-DISEASE
by	O
polymerase	B-UNK
chain	I-UNK
reaction	I-UNK
followed	B-UNK
by	O
single	B-UNK
-	O
strand	B-UNK
conformation	I-UNK
polymorphism	I-UNK
analysis	B-UNK
.	O

 	B-UNK
direct	I-UNK
sequencing	B-UNK
revealed	I-UNK
a	O
cytosine	O
to	O
thymine	O
transition	B-UNK
at	B-DISEASE
nucleotide	B-UNK
694	O
,	O
resulting	B-UNK
in	O
the	O
replacement	O
of	O
an	O
arginine	B-UNK
with	O
a	O
stop	B-UNK
codon	B-UNK
after	O
the	O
sixth	B-UNK
amino	B-UNK
acid	I-UNK
of	O
exon	B-UNK
3	O
.	O

 	O
as	O
the	O
vhl	B-UNK
gene	B-UNK
is	O
believed	O
to	O
function	B-UNK
as	O
a	O
tumor	B-DISEASE
suppressor	B-UNK
gene	B-UNK
,	O
vhl	B-UNK
gene	B-UNK
mutations	B-UNK
may	O
play	O
a	O
role	B-UNK
in	O
the	O
initiation	B-UNK
of	O
tumorigenesis	B-UNK
in	O
sporadic	B-UNK
cystadenomas	O
of	O
the	O
epididymis	O
.	O

 	O
identification	B-UNK
of	O
wasp	B-UNK
mutations	B-UNK
in	O
patients	B-UNK
with	O
wiskott	B-DISEASE
-	I-DISEASE
aldrich	I-DISEASE
syndrome	I-DISEASE
and	O
isolated	B-UNK
thrombocytopenia	B-DISEASE
reveals	B-UNK
allelic	B-UNK
heterogeneity	I-UNK
at	B-DISEASE
the	O
was	O
locus	B-UNK
.	O

 	O
mutation	B-UNK
in	O
the	O
gene	B-UNK
encoding	B-UNK
the	O
recently	B-UNK
isolated	B-UNK
wasp	B-UNK
protein	B-UNK
has	O
now	O
been	O
identified	B-UNK
as	O
the	O
genetic	B-UNK
defect	B-UNK
responsible	B-UNK
for	O
the	O
x	B-UNK
-	O
linked	B-UNK
wiskott	B-DISEASE
-	I-DISEASE
aldrich	I-DISEASE
syndrome	I-DISEASE
(	O
was	O
)	O
,	O
a	O
primary	B-DISEASE
immunodeficiency	I-DISEASE
disease	B-DISEASE
associated	B-UNK
with	O
extensive	B-UNK
phenotypic	B-UNK
variability	I-UNK
.	O

 	O
to	O
elucidate	O
the	O
range	B-UNK
of	O
wasp	B-UNK
mutations	B-UNK
responsible	B-UNK
for	O
was	O
,	O
we	O
used	O
pcr	B-UNK
-	O
sscp	B-UNK
analysis	B-UNK
to	O
screen	B-UNK
for	O
wasp	B-UNK
gene	B-UNK
mutation	B-UNK
in	O
19	O
unrelated	B-UNK
boys	B-UNK
with	O
the	O
diagnosis	B-UNK
of	O
classical	B-UNK
or	O
attenuated	O
was	O
or	O
isolated	B-UNK
thrombocytopenia	B-DISEASE
.	O

 	O
all	O
19	O
patients	B-UNK
had	O
wasp	B-UNK
mutations	B-UNK
,	O
each	O
of	O
which	O
localized	B-UNK
to	O
the	O
initial	B-UNK
three	O
or	O
terminal	B-UNK
three	O
exons	B-UNK
of	O
the	O
gene	B-UNK
,	O
and	O
the	O
majority	B-UNK
of	O
which	O
were	O
unique	B-UNK
in	O
each	O
case	B-UNK
.	O

 	O
however	O
,	O
a	O
missense	B-UNK
mutation	I-UNK
which	O
results	B-UNK
in	O
substitution	B-UNK
of	O
the	O
arginine	B-UNK
at	B-DISEASE
was	O
codon	B-UNK
86	O
was	O
identified	B-UNK
in	O
three	O
boys	B-UNK
with	O
severe	B-UNK
was	O
as	O
well	O
as	O
in	O
one	O
boy	B-UNK
presenting	B-UNK
with	O
thrombocytopenia	B-DISEASE
alone	O
.	O

 	O
while	O
the	O
three	O
mutations	B-UNK
found	B-UNK
in	O
the	O
isolated	B-UNK
thrombocytopenia	B-DISEASE
patients	B-UNK
leave	O
the	O
reading	B-UNK
frame	I-UNK
intact	B-UNK
,	O
about	O
one	O
-	O
half	B-UNK
of	O
the	O
gene	B-UNK
alterations	B-UNK
detected	B-UNK
in	O
both	O
severe	B-UNK
and	O
attenuated	O
was	O
patients	B-UNK
result	B-UNK
in	O
frameshifted	O
transcript	B-UNK
and	O
premature	B-UNK
translation	B-UNK
termination	B-UNK
.	O

 	O
these	O
findings	B-UNK
therefore	O
confirm	B-UNK
the	O
association	B-UNK
of	O
was	O
with	O
wasp	B-UNK
mutation	B-UNK
and	O
identify	B-UNK
wasp	B-UNK
mutation	B-UNK
as	O
a	O
cause	B-UNK
for	O
isolated	B-UNK
congenital	B-DISEASE
thrombocytopenia	B-DISEASE
in	O
males	B-UNK
.	O

 	O
while	O
the	O
wasp	B-UNK
gene	B-UNK
defects	B-UNK
responsible	B-UNK
for	O
isolated	B-UNK
thrombocytopenia	B-DISEASE
and	O
other	O
mild	B-UNK
presentations	B-UNK
of	O
was	O
do	O
not	O
appear	B-UNK
distinct	B-UNK
from	O
those	O
resulting	B-UNK
in	O
severe	B-UNK
was	O
,	O
these	O
data	B-UNK
indicate	B-UNK
that	O
analysis	B-UNK
of	O
wasp	B-UNK
gene	B-UNK
mutation	B-UNK
provides	B-UNK
a	O
valuable	B-UNK
tool	B-UNK
for	O
distinguishing	O
the	O
spectrum	B-UNK
of	O
was	O
patients	B-UNK
and	O
the	O
subset	O
of	O
males	B-UNK
with	O
isolated	B-UNK
thrombocytopenia	B-DISEASE
who	O
represent	B-UNK
mild	B-UNK
cases	B-UNK
of	O
was	O
.	O
.	O

 	O
wasp	B-UNK
gene	B-UNK
mutations	B-UNK
in	O
wiskott	B-DISEASE
-	I-DISEASE
aldrich	I-DISEASE
syndrome	I-DISEASE
and	O
x	B-UNK
-	O
linked	B-UNK
thrombocytopenia	B-DISEASE
.	O

 	O
the	O
wasp	B-UNK
gene	B-UNK
has	O
been	O
recently	B-UNK
cloned	B-UNK
from	O
xp11	B-UNK
.	O

 	O
23	O
and	O
shown	B-UNK
to	O
be	O
mutated	B-UNK
in	O
three	O
patients	B-UNK
with	O
the	O
wiskott	B-DISEASE
-	I-DISEASE
aldrich	I-DISEASE
syndrome	I-DISEASE
(	O
was	O
)	O
.	O

 	O
we	O
have	O
developed	B-UNK
a	O
screening	B-UNK
protocol	O
for	O
identifying	B-UNK
wasp	B-UNK
gene	B-UNK
alterations	B-UNK
in	O
genomic	B-UNK
dna	I-UNK
and	O
have	O
identified	B-UNK
a	O
spectrum	B-UNK
of	O
novel	B-UNK
mutations	B-UNK
in	O
12	O
additional	B-UNK
unrelated	B-UNK
families	I-UNK
.	O

 	O
these	O
missense	B-UNK
,	O
nonsense	B-UNK
and	O
frameshift	B-UNK
mutations	B-UNK
involve	B-UNK
eight	O
of	O
the	O
12	O
exons	B-UNK
of	O
the	O
gene	B-UNK
.	O

 	O
two	O
mutations	B-UNK
creating	B-UNK
premature	B-UNK
termination	I-UNK
codons	B-UNK
were	O
associated	B-UNK
with	O
lack	B-UNK
of	O
detectable	B-UNK
mrna	B-UNK
on	O
northern	B-UNK
blots	B-UNK
.	O

 	O
four	O
amino	B-UNK
acid	I-UNK
substitutions	B-UNK
,	O
leu27phe	O
,	O
thr48ile	O
,	O
val75met	O
and	O
arg477lys	O
,	O
were	O
found	B-UNK
in	O
patients	B-UNK
with	O
congenital	B-DISEASE
thrombocytopenia	B-DISEASE
and	O
no	O
clinically	B-UNK
evident	O
immune	B-UNK
defect	B-UNK
indicating	B-UNK
that	O
the	O
wasp	B-UNK
gene	B-UNK
is	O
the	O
site	B-UNK
for	O
mutations	B-UNK
in	O
x	B-UNK
-	O
linked	B-UNK
thrombocytopenia	B-DISEASE
as	O
well	O
as	O
in	O
was	O
.	O

 	O
a	O
t	B-UNK
-	O
cell	B-UNK
line	B-UNK
from	O
a	O
was	O
patient	B-UNK
contained	B-UNK
two	O
independent	B-UNK
dna	B-UNK
alterations	B-UNK
,	O
a	O
constitutional	B-UNK
frameshift	B-UNK
mutation	B-UNK
,	O
also	O
present	B-UNK
in	O
peripheral	B-UNK
blood	I-UNK
leukocytes	B-UNK
from	O
the	O
patient	B-UNK
,	O
and	O
compensatory	B-UNK
splice	B-UNK
site	I-UNK
mutation	I-UNK
unique	B-UNK
to	O
the	O
cell	B-UNK
line	B-UNK
.	O

 	O
the	O
distribution	B-UNK
of	O
eight	O
missense	B-UNK
mutations	I-UNK
provides	B-UNK
valuable	B-UNK
information	B-UNK
on	O
amino	O
acids	O
which	O
are	O
essential	B-UNK
for	O
normal	B-UNK
protein	B-UNK
function	B-UNK
,	O
and	O
suggests	B-UNK
that	O
sites	B-UNK
in	O
the	O
first	O
two	O
exons	B-UNK
are	O
hot	O
-	O
spots	O
for	O
mutation	B-UNK
.	O

 	O
evidence	B-UNK
for	O
inter	B-UNK
-	O
generational	B-UNK
instability	B-UNK
in	O
the	O
cag	B-UNK
repeat	I-UNK
in	O
the	O
mjd1	B-UNK
gene	B-UNK
and	O
for	O
conserved	B-UNK
haplotypes	B-UNK
at	B-DISEASE
flanking	B-UNK
markers	B-UNK
amongst	O
japanese	B-UNK
and	O
caucasian	B-UNK
subjects	I-UNK
with	O
machado	B-DISEASE
-	I-DISEASE
joseph	I-DISEASE
disease	I-DISEASE
.	O

 	O
the	O
size	B-UNK
of	O
the	O
(	O
cag	B-UNK
)	O
n	B-UNK
repeat	I-UNK
array	B-UNK
in	O
the	O
3	O
'	O
end	B-UNK
of	O
the	O
mjd1	B-UNK
gene	B-UNK
and	O
the	O
haplotype	B-UNK
at	B-DISEASE
a	O
series	B-UNK
of	O
microsatellite	B-UNK
markers	I-UNK
surrounding	B-UNK
the	O
mjd1	B-UNK
gene	B-UNK
were	O
examined	B-UNK
in	O
a	O
large	B-UNK
cohort	B-UNK
of	O
japanese	B-UNK
and	O
caucasian	B-UNK
subjects	I-UNK
affected	B-UNK
with	O
machado	B-DISEASE
-	I-DISEASE
joseph	I-DISEASE
disease	I-DISEASE
(	O
mjd	B-UNK
)	O
.	O

 	O
our	O
data	B-UNK
provide	I-UNK
five	O
novel	B-UNK
observations	B-UNK
.	O

 	O
first	O
,	O
mjd	B-UNK
is	O
associated	B-UNK
with	O
expansion	B-UNK
fo	O
the	O
array	B-UNK
from	O
the	O
normal	B-UNK
range	B-UNK
of	O
14	O
-	O
37	O
repeats	B-UNK
to	O
68	O
-	O
84	O
repeats	B-UNK
in	O
most	O
japanese	B-UNK
and	O
caucasian	B-UNK
subjects	I-UNK
,	O
but	O
no	O
subjects	B-UNK
were	O
observed	B-UNK
with	O
expansions	B-UNK
intermediate	B-UNK
in	O
size	B-UNK
between	O
those	O
of	O
the	O
normal	B-UNK
and	O
mjd	B-UNK
affected	B-UNK
groups	B-UNK
.	O

 	O
second	B-UNK
,	O
the	O
expanded	B-UNK
allele	B-UNK
associated	B-UNK
with	O
mjd	B-UNK
displays	B-UNK
inter	B-UNK
-	O
generational	B-UNK
instability	B-UNK
,	O
particularly	B-UNK
in	O
male	B-UNK
meioses	B-UNK
,	O
and	O
this	O
instability	B-UNK
was	O
associated	B-UNK
with	O
the	O
clinical	B-UNK
phenomenon	O
of	O
anticipation	B-DISEASE
.	O

 	O
third	O
,	O
the	O
size	B-UNK
of	O
the	O
expanded	B-UNK
allele	B-UNK
is	O
not	O
only	O
inversely	B-UNK
correlated	B-UNK
with	O
the	O
age	B-UNK
-	O
of	O
-	O
onset	B-UNK
of	O
mjd	B-UNK
(	O
r	B-UNK
=	O
-	O
0	O
.	O
738	O
,	O
p	B-UNK
<	O
0	O
.	O
001	O
)	O
,	O
but	O
is	O
also	O
correlated	B-UNK
with	O
the	O
frequency	B-UNK
of	O
other	O
clinical	B-UNK
features	I-UNK
[	O
e	B-UNK
.	O
g	B-UNK
.	O
pseudoexophthalmos	O
and	O
pyramidal	O
signs	B-UNK
were	O
more	O
frequent	B-UNK
in	O
subjects	B-UNK
with	O
large	B-UNK
repeats	B-UNK
(	O
p	B-UNK
<	O
0	O
.	O
001	O
and	O
p	B-UNK
<	O
0	O
.	O
05	O
respectively	B-UNK
)	O
]	O
.	O

 	O
fourth	B-UNK
,	O
the	O
disease	B-DISEASE
phenotype	B-UNK
is	O
significantly	B-UNK
more	O
severe	B-UNK
and	O
had	O
an	O
early	B-UNK
age	B-UNK
of	O
onset	B-UNK
(	O
16	O
years	B-UNK
)	O
in	O
a	O
subject	B-UNK
homozygous	B-UNK
for	O
the	O
expanded	B-UNK
allele	B-UNK
,	O
which	O
contrasts	O
with	O
huntington	B-DISEASE
disease	I-DISEASE
and	O
suggests	B-UNK
that	O
the	O
expanded	B-UNK
allele	B-UNK
in	O
the	O
mjd1	B-UNK
gene	B-UNK
could	O
exert	O
its	O
effect	B-UNK
either	O
by	O
a	O
dominant	B-UNK
negative	I-UNK
effect	B-UNK
(	O
putatively	B-UNK
excluded	B-UNK
in	O
hd	B-UNK
)	O
or	O
by	O
a	O
gain	O
of	O
function	B-UNK
effect	B-UNK
as	O
proposed	B-UNK
for	O
hd	B-UNK
.	O

 	O
finally	B-UNK
,	O
japanese	B-UNK
and	O
caucasian	B-UNK
subjects	I-UNK
affected	B-UNK
with	O
mjd	B-UNK
share	B-UNK
haplotypes	B-UNK
at	B-DISEASE
several	O
markers	B-UNK
surrounding	I-UNK
the	O
mjd1	B-UNK
gene	B-UNK
,	O
which	O
are	O
uncommon	B-UNK
in	O
the	O
normal	B-UNK
japanese	B-UNK
and	O
caucasian	B-UNK
population	B-UNK
,	O
and	O
which	O
suggests	B-UNK
the	O
existence	O
either	O
of	O
common	B-UNK
founders	O
in	O
these	O
populations	B-UNK
or	O
of	O
chromosomes	B-UNK
susceptible	B-UNK
to	O
pathologic	B-UNK
expansion	B-UNK
of	O
the	O
cag	B-UNK
repeat	I-UNK
in	O
the	O
mjd1	B-UNK
gene	B-UNK
.	O

 	O
evidence	B-UNK
for	O
inter	B-UNK
-	O
generational	B-UNK
instability	B-UNK
in	O
the	O
cag	B-UNK
repeat	I-UNK
in	O
the	O
mjd1	B-UNK
gene	B-UNK
and	O
for	O
conserved	B-UNK
haplotypes	B-UNK
at	B-DISEASE
flanking	B-UNK
markers	B-UNK
amongst	O
japanese	B-UNK
and	O
caucasian	B-UNK
subjects	I-UNK
with	O
machado	B-DISEASE
-	I-DISEASE
joseph	I-DISEASE
disease	I-DISEASE
.	O

 	O
the	O
size	B-UNK
of	O
the	O
(	O
cag	B-UNK
)	O
n	B-UNK
repeat	I-UNK
array	B-UNK
in	O
the	O
3	O
'	O
end	B-UNK
of	O
the	O
mjd1	B-UNK
gene	B-UNK
and	O
the	O
haplotype	B-UNK
at	B-DISEASE
a	O
series	B-UNK
of	O
microsatellite	B-UNK
markers	I-UNK
surrounding	B-UNK
the	O
mjd1	B-UNK
gene	B-UNK
were	O
examined	B-UNK
in	O
a	O
large	B-UNK
cohort	B-UNK
of	O
japanese	B-UNK
and	O
caucasian	B-UNK
subjects	I-UNK
affected	B-UNK
with	O
machado	B-DISEASE
-	I-DISEASE
joseph	I-DISEASE
disease	I-DISEASE
(	O
mjd	B-UNK
)	O
.	O

 	O
our	O
data	B-UNK
provide	I-UNK
five	O
novel	B-UNK
observations	B-UNK
.	O

 	O
first	O
,	O
mjd	B-UNK
is	O
associated	B-UNK
with	O
expansion	B-UNK
fo	O
the	O
array	B-UNK
from	O
the	O
normal	B-UNK
range	B-UNK
of	O
14	O
-	O
37	O
repeats	B-UNK
to	O
68	O
-	O
84	O
repeats	B-UNK
in	O
most	O
japanese	B-UNK
and	O
caucasian	B-UNK
subjects	I-UNK
,	O
but	O
no	O
subjects	B-UNK
were	O
observed	B-UNK
with	O
expansions	B-UNK
intermediate	B-UNK
in	O
size	B-UNK
between	O
those	O
of	O
the	O
normal	B-UNK
and	O
mjd	B-UNK
affected	B-UNK
groups	B-UNK
.	O

 	O
second	B-UNK
,	O
the	O
expanded	B-UNK
allele	B-UNK
associated	B-UNK
with	O
mjd	B-UNK
displays	B-UNK
inter	B-UNK
-	O
generational	B-UNK
instability	B-UNK
,	O
particularly	B-UNK
in	O
male	B-UNK
meioses	B-UNK
,	O
and	O
this	O
instability	B-UNK
was	O
associated	B-UNK
with	O
the	O
clinical	B-UNK
phenomenon	O
of	O
anticipation	B-DISEASE
.	O

 	O
third	O
,	O
the	O
size	B-UNK
of	O
the	O
expanded	B-UNK
allele	B-UNK
is	O
not	O
only	O
inversely	B-UNK
correlated	B-UNK
with	O
the	O
age	B-UNK
-	O
of	O
-	O
onset	B-UNK
of	O
mjd	B-UNK
(	O
r	B-UNK
=	O
-	O
0	O
.	O
738	O
,	O
p	B-UNK
<	O
0	O
.	O
001	O
)	O
,	O
but	O
is	O
also	O
correlated	B-UNK
with	O
the	O
frequency	B-UNK
of	O
other	O
clinical	B-UNK
features	I-UNK
[	O
e	B-UNK
.	O
g	B-UNK
.	O
pseudoexophthalmos	O
and	O
pyramidal	O
signs	B-UNK
were	O
more	O
frequent	B-UNK
in	O
subjects	B-UNK
with	O
large	B-UNK
repeats	B-UNK
(	O
p	B-UNK
<	O
0	O
.	O
001	O
and	O
p	B-UNK
<	O
0	O
.	O
05	O
respectively	B-UNK
)	O
]	O
.	O

 	O
fourth	B-UNK
,	O
the	O
disease	B-DISEASE
phenotype	B-UNK
is	O
significantly	B-UNK
more	O
severe	B-UNK
and	O
had	O
an	O
early	B-UNK
age	B-UNK
of	O
onset	B-UNK
(	O
16	O
years	B-UNK
)	O
in	O
a	O
subject	B-UNK
homozygous	B-UNK
for	O
the	O
expanded	B-UNK
allele	B-UNK
,	O
which	O
contrasts	O
with	O
huntington	B-DISEASE
disease	I-DISEASE
and	O
suggests	B-UNK
that	O
the	O
expanded	B-UNK
allele	B-UNK
in	O
the	O
mjd1	B-UNK
gene	B-UNK
could	O
exert	O
its	O
effect	B-UNK
either	O
by	O
a	O
dominant	B-UNK
negative	I-UNK
effect	B-UNK
(	O
putatively	B-UNK
excluded	B-UNK
in	O
hd	B-UNK
)	O
or	O
by	O
a	O
gain	O
of	O
function	B-UNK
effect	B-UNK
as	O
proposed	B-UNK
for	O
hd	B-UNK
.	O

 	O
finally	B-UNK
,	O
japanese	B-UNK
and	O
caucasian	B-UNK
subjects	I-UNK
affected	B-UNK
with	O
mjd	B-UNK
share	B-UNK
haplotypes	B-UNK
at	B-DISEASE
several	O
markers	B-UNK
surrounding	I-UNK
the	O
mjd1	B-UNK
gene	B-UNK
,	O
which	O
are	O
uncommon	B-UNK
in	O
the	O
normal	B-UNK
japanese	B-UNK
and	O
caucasian	B-UNK
population	B-UNK
,	O
and	O
which	O
suggests	B-UNK
the	O
existence	O
either	O
of	O
common	B-UNK
founders	O
in	O
these	O
populations	B-UNK
or	O
of	O
chromosomes	B-UNK
susceptible	B-UNK
to	O
pathologic	B-UNK
expansion	B-UNK
of	O
the	O
cag	B-UNK
repeat	I-UNK
in	O
the	O
mjd1	B-UNK
gene	B-UNK
.	O

 	O
a	O
4	O
-	O
megabase	O
yac	B-UNK
contig	B-UNK
that	O
spans	B-UNK
the	O
langer	B-DISEASE
-	I-DISEASE
giedion	I-DISEASE
syndrome	I-DISEASE
region	B-UNK
on	O
human	B-UNK
chromosome	I-UNK
8q24	B-UNK
.	O
1	O
:	O
use	B-UNK
in	O
refining	O
the	O
location	B-UNK
of	O
the	O
trichorhinophalangeal	B-DISEASE
syndrome	I-DISEASE
and	O
multiple	B-UNK
exostoses	B-DISEASE
genes	B-UNK
(	O
trps1	O
and	O
ext1	O
)	O
.	O

 	O
we	O
have	O
constructed	B-UNK
a	O
physical	B-UNK
map	B-UNK
covering	B-UNK
over	O
4	O
mb	B-UNK
of	O
human	B-UNK
chromosome	I-UNK
8q24	B-UNK
.	O

 	O
1	O
and	O
used	O
this	O
map	B-UNK
to	O
refine	O
the	O
locations	B-UNK
of	O
the	O
genes	B-UNK
responsible	B-UNK
for	O
langer	B-DISEASE
-	I-DISEASE
giedion	I-DISEASE
syndrome	I-DISEASE
.	O

 	O
the	O
map	B-UNK
is	O
composed	O
of	O
overlapping	B-UNK
yac	B-UNK
clones	I-UNK
that	O
were	O
identified	B-UNK
and	O
ordered	O
in	O
relation	O
to	O
sequence	B-UNK
tagged	B-UNK
sites	B-UNK
mapped	B-UNK
to	O
the	O
langer	O
-	O
giedion	O
chromosomal	B-UNK
region	B-UNK
on	O
somatic	B-UNK
cell	I-UNK
hybrids	I-UNK
.	O

 	O
the	O
minimal	B-UNK
region	B-UNK
of	O
overlap	O
of	O
langer	B-DISEASE
-	I-DISEASE
giedion	I-DISEASE
syndrome	I-DISEASE
deletions	B-UNK
,	O
previously	B-UNK
identified	I-UNK
by	O
analysis	B-UNK
of	O
15	O
patients	B-UNK
,	O
was	O
placed	O
on	O
the	O
map	B-UNK
by	O
analysis	B-UNK
of	O
2	O
patients	B-UNK
whose	O
deletions	B-UNK
define	B-UNK
the	O
endpoints	B-UNK
.	O

 	O
the	O
chromosome	B-DISEASE
8	I-DISEASE
breakpoint	B-UNK
of	O
a	O
balanced	B-UNK
t	B-UNK
(	O
8	O
;	O
9	O
)	O
(	O
q24	O
.	O
11	O
;	O
q33	O
.	O
3	O
)	O
translocation	B-DISEASE
from	O
a	O
patient	B-UNK
with	O
trichorhinophalangeal	B-DISEASE
syndrome	I-DISEASE
(	O
trps	O
i	O
)	O
was	O
found	B-UNK
to	O
be	O
located	B-UNK
just	O
within	O
the	O
proximal	B-UNK
end	B-UNK
of	O
the	O
minimal	B-UNK
deletion	B-UNK
region	I-UNK
.	O

 	O
a	O
deletion	B-UNK
of	O
8q24	B-UNK
.	O

 	O
11	O
-	O
q24	O
.	O

 	O
3	O
in	O
a	O
patient	B-UNK
with	O
multiple	B-UNK
exostoses	B-DISEASE
was	O
found	B-UNK
to	O
overlap	O
the	O
distal	B-UNK
end	B-UNK
of	O
the	O
lgs	O
deletion	B-UNK
region	I-UNK
,	O
indicating	B-UNK
that	O
the	O
ext1	O
gene	B-UNK
is	O
distal	B-UNK
to	O
the	O
trps1	O
gene	B-UNK
and	O
supporting	B-UNK
the	O
hypothesis	O
that	O
langer	B-DISEASE
-	I-DISEASE
giedion	I-DISEASE
syndrome	I-DISEASE
is	O
due	O
to	O
loss	B-UNK
of	O
functional	B-UNK
copies	B-UNK
of	O
both	O
the	O
trps1	O
and	O
the	O
ext1	O
genes	B-UNK

 	B-UNK
brca1	I-UNK
mutations	B-UNK
in	O
a	O
population	B-UNK
-	O
based	B-UNK
sample	B-UNK
of	O
young	B-UNK
women	B-UNK
with	O
breast	B-DISEASE
cancer	I-DISEASE
.	O

 	B-UNK
background	I-UNK
.	O

 	B-UNK
inherited	I-UNK
mutations	B-UNK
in	O
the	O
brca1	B-UNK
gene	B-UNK
are	O
associated	B-UNK
with	O
a	O
high	B-UNK
risk	B-UNK
of	O
breast	B-UNK
and	O
ovarian	B-DISEASE
cancer	I-DISEASE
in	O
some	O
families	B-UNK
.	O

 	O
however	O
,	O
little	B-UNK
is	O
known	B-UNK
about	O
the	O
contribution	O
of	O
brca1	B-UNK
mutations	I-UNK
to	O
breast	B-DISEASE
cancer	I-DISEASE
in	O
the	O
general	B-UNK
population	B-UNK
.	O

 	O
we	O
analyzed	B-UNK
dna	B-UNK
samples	I-UNK
from	O
women	B-UNK
enrolled	O
in	O
a	O
population	B-UNK
-	O
based	B-UNK
study	B-UNK
of	O
early	B-UNK
-	O
onset	B-UNK
breast	B-DISEASE
cancer	I-DISEASE
to	O
assess	B-UNK
the	O
spectrum	B-UNK
and	O
frequency	B-UNK
of	O
germ	O
-	O
line	B-UNK
brca1	B-UNK
mutations	I-UNK
in	O
young	B-UNK
women	B-UNK
with	O
breast	B-DISEASE
cancer	I-DISEASE
.	O

 	O
methods	B-UNK
.	O

 	O
we	O
studied	B-UNK
80	O
women	B-UNK
in	O
whom	O
breast	B-DISEASE
cancer	I-DISEASE
was	O
diagnosed	B-UNK
before	O
the	O
age	B-UNK
of	O
35	O
,	O
and	O
who	O
were	O
not	O
selected	B-UNK
on	O
the	O
basis	B-UNK
of	O
family	B-UNK
history	B-UNK
.	O

 	B-UNK
genomic	I-UNK
dna	B-UNK
was	O
studied	B-UNK
for	O
brca1	B-UNK
mutations	I-UNK
by	O
analysis	B-UNK
involving	B-UNK
single	B-UNK
-	O
strand	O
conformation	O
polymorphisms	B-UNK
and	O
with	O
allele	B-UNK
-	O
specific	B-UNK
assays	B-UNK
.	O

 	O
alterations	B-UNK
were	O
defined	B-UNK
by	O
dna	B-UNK
sequencing	I-UNK
.	O

 	B-UNK
results	I-UNK
.	O

 	O
germ	O
-	O
line	B-UNK
brca1	B-UNK
mutations	I-UNK
were	O
identified	B-UNK
in	O
6	O
of	O
the	O
80	O
women	B-UNK
.	O

 	O
four	O
additional	B-UNK
rare	B-UNK
sequence	B-UNK
variants	B-UNK
of	O
unknown	B-UNK
functional	B-UNK
importance	O
were	O
also	O
identified	B-UNK
.	O

 	O
two	O
of	O
the	O
mutations	B-UNK
and	O
three	O
of	O
the	O
rare	B-UNK
sequence	B-UNK
variants	B-UNK
were	O
found	B-UNK
among	O
the	O
39	O
women	B-UNK
who	O
reported	B-UNK
no	O
family	B-UNK
history	B-UNK
of	O
breast	B-UNK
or	O
ovarian	B-DISEASE
cancer	I-DISEASE
.	O

 	O
none	O
of	O
the	O
mutations	B-UNK
and	O
only	O
one	O
of	O
the	O
rare	B-UNK
variants	B-UNK
was	O
identified	B-UNK
in	O
a	O
reference	B-UNK
population	B-UNK
of	O
73	O
unrelated	B-UNK
subjects	B-UNK
.	O

 	O
conclusions	B-UNK
.	O

 	O
alterations	B-UNK
in	O
brca1	B-UNK
were	O
identified	B-UNK
in	O
approximately	B-UNK
10	O
percent	O
of	O
this	O
cohort	B-UNK
of	O
young	B-UNK
women	B-UNK
with	O
breast	B-DISEASE
cancer	I-DISEASE
.	O

 	O
the	O
risk	B-UNK
of	O
harboring	O
a	O
mutation	B-UNK
was	O
not	O
limited	B-UNK
to	O
women	B-UNK
with	O
family	B-UNK
histories	O
of	O
breast	B-UNK
or	O
ovarian	B-DISEASE
cancer	I-DISEASE
.	O

 	O
these	O
results	B-UNK
represent	B-UNK
a	O
minimal	B-UNK
estimate	B-UNK
of	O
the	O
frequency	B-UNK
of	O
brca1	B-UNK
mutations	I-UNK
in	O
this	O
population	B-UNK
.	O

 	O
comprehensive	B-UNK
methods	B-UNK
of	O
identifying	B-UNK
brca1	B-UNK
mutations	I-UNK
and	O
understanding	B-UNK
their	O
importance	O
will	O
be	O
needed	O
before	O
testing	B-UNK
of	O
women	B-UNK
in	O
the	O
general	B-UNK
population	B-UNK
can	O
be	O
undertaken	O
.	O
.	O

 	B-UNK
novel	I-UNK
inherited	B-UNK
mutations	B-UNK
and	O
variable	B-UNK
expressivity	B-UNK
of	O
brca1	B-UNK
alleles	B-UNK
,	O
including	B-UNK
the	O
founder	B-UNK
mutation	B-UNK
185delag	B-UNK
in	O
ashkenazi	B-UNK
jewish	I-UNK
families	B-UNK
.	O

 	O
thirty	B-UNK
-	O
seven	B-UNK
families	B-UNK
with	O
four	O
or	O
more	O
cases	B-UNK
of	O
breast	B-DISEASE
cancer	I-DISEASE
or	O
breast	B-UNK
and	O
ovarian	B-DISEASE
cancer	I-DISEASE
were	O
analyzed	B-UNK
for	O
mutations	B-UNK
in	O
brca1	B-UNK
.	O

 	O
twelve	O
different	B-UNK
germ	O
-	O
line	B-UNK
mutations	B-UNK
,	O
four	O
novel	B-UNK
and	O
eight	O
previously	B-UNK
observed	B-UNK
,	O
were	O
detected	B-UNK
in	O
16	O
families	B-UNK
.	O

 	O
five	O
families	B-UNK
of	O
ashkenazi	B-UNK
jewish	I-UNK
descent	B-UNK
carried	B-UNK
the	O
185delag	B-UNK
mutation	B-UNK
and	O
shared	B-UNK
the	O
same	O
haplotype	B-UNK
at	B-DISEASE
eight	O
polymorphic	B-UNK
markers	I-UNK
spanning	B-UNK
approximately	B-UNK
850	O
kb	B-UNK
at	B-DISEASE
brca1	B-UNK
.	O

 	O
expressivity	B-UNK
of	O
185delag	B-UNK
in	O
these	O
families	B-UNK
varied	B-UNK
,	O
from	O
early	B-UNK
-	O
onset	B-UNK
breast	B-DISEASE
cancer	I-DISEASE
without	O
ovarian	B-DISEASE
cancer	I-DISEASE
.	O

 	O
mutation	B-UNK
4184deltcaa	O
occurred	B-UNK
independently	B-UNK
in	O
two	O
families	B-UNK
.	O

 	O
in	O
one	O
family	B-UNK
,	O
penetrance	B-UNK
was	O
complete	B-UNK
,	O
with	O
females	B-UNK
developing	B-UNK
early	B-UNK
-	O
onset	B-UNK
breast	B-DISEASE
cancer	I-DISEASE
or	O
ovarian	B-DISEASE
cancer	I-DISEASE
and	O
the	O
male	B-UNK
carrier	B-UNK
developing	B-UNK
prostatic	O
cancer	B-DISEASE
,	O
whereas	O
,	O
in	O
the	O
other	O
family	B-UNK
,	O
penetrance	B-UNK
was	O
incomplete	B-UNK
and	O
only	O
breast	B-DISEASE
cancer	I-DISEASE
occurred	B-UNK
,	O
diagnosed	B-UNK
at	B-DISEASE
ages	O
38	O
-	O
81	O
years	B-UNK
.	O

 	O
two	O
novel	B-UNK
nonsense	B-UNK
mutations	B-UNK
led	B-UNK
to	O
the	O
loss	B-UNK
of	O
mutant	B-UNK
brca1	B-UNK
transcript	B-UNK
in	O
families	B-UNK
with	O
10	O
and	O
6	O
cases	B-UNK
of	O
early	B-UNK
-	O
onset	B-UNK
breast	B-DISEASE
cancer	I-DISEASE
and	O
ovarian	B-DISEASE
cancer	I-DISEASE
.	O

 	O
a	O
665	O
-	O
nt	O
segment	B-UNK
of	O
the	O
brca1	B-UNK
3	O
-	O
utr	B-UNK
and	O
1	O
.	O

 	O
3	O
kb	B-UNK
of	O
genomic	B-UNK
sequence	B-UNK
including	B-UNK
the	O
putative	B-UNK
promoter	B-UNK
region	I-UNK
were	O
invariant	O
by	O
single	B-UNK
-	O
strand	O
conformation	O
analysis	B-UNK
in	O
13	O
families	B-UNK
without	O
coding	B-UNK
-	O
sequence	B-UNK
mutations	B-UNK
.	O

 	O
overall	B-UNK
in	O
our	O
series	B-UNK
,	O
brca1	B-UNK
mutations	I-UNK
have	O
been	O
detected	B-UNK
in	O
26	O
families	B-UNK
16	O
with	O
positive	B-UNK
brca1	B-UNK
lod	B-UNK
scores	I-UNK
,	O
7	O
with	O
negative	B-UNK
lod	B-UNK
scores	I-UNK
(	O
reflecting	O
multiple	B-UNK
sporadic	B-UNK
breast	B-UNK
cancers	B-DISEASE
)	O
,	O
and	O
3	O
not	O
tested	B-UNK
for	O
linkage	B-UNK
.	O

 	O
three	O
other	O
families	B-UNK
have	O
positive	B-UNK
lod	I-UNK
scores	I-UNK
for	O
linkage	B-UNK
to	O
brca2	B-UNK
,	O
but	O
13	O
families	B-UNK
without	O
detected	B-UNK
brca1	B-UNK
mutations	I-UNK
have	O
negative	B-UNK
lod	B-UNK
scores	I-UNK
for	O
both	O
brca1	B-UNK
and	O
brca2	B-UNK
.	O

 	O
a	O
new	B-UNK
glucose	B-UNK
-	O
6	O
-	O
phosphate	B-UNK
dehydrogenase	I-UNK
variant	B-UNK
,	O
g6pd	B-UNK
orissa	B-UNK
(	O
44	O
ala	B-UNK
-	O
-	O
>	O
gly	B-UNK
)	O
,	O
is	O
the	O
major	B-UNK
polymorphic	B-UNK
variant	B-UNK
in	O
tribal	B-UNK
populations	B-UNK
in	O
india	O
.	O

 	O
deficiency	B-UNK
of	O
glucose	B-UNK
-	O
6	O
-	O
phosphate	B-UNK
dehydrogenase	I-UNK
(	O
g6pd	B-UNK
)	O
is	O
usually	B-UNK
found	B-UNK
at	B-DISEASE
high	B-UNK
frequencies	B-UNK
in	O
areas	B-UNK
of	O
the	O
world	O
where	O
malaria	B-DISEASE
has	O
been	O
endemic	O
.	O

 	O
the	O
frequency	B-UNK
and	O
genetic	B-UNK
basis	B-UNK
of	O
g6pd	B-UNK
deficiency	I-UNK
have	O
been	O
studied	B-UNK
in	O
africa	O
,	O
around	O
the	O
mediterranean	B-UNK
,	O
and	O
in	O
the	O
far	B-UNK
east	O
,	O
but	O
little	B-UNK
such	O
information	B-UNK
is	O
available	B-UNK
about	O
the	O
situation	O
in	O
india	O
.	O

 	O
to	O
determine	O
the	O
extent	B-UNK
of	O
heterogeneity	B-UNK
of	O
g6pd	B-UNK
,	O
we	O
have	O
studied	B-UNK
several	O
different	B-UNK
indian	B-UNK
populations	B-UNK
by	O
screening	B-UNK
for	O
g6pd	B-UNK
deficiency	I-UNK
,	O
followed	B-UNK
by	O
molecular	B-UNK
analysis	B-UNK
of	O
deficient	B-UNK
alleles	B-UNK
.	O

 	O
the	O
frequency	B-UNK
of	O
g6pd	B-UNK
deficiency	I-UNK
varies	B-UNK
between	O
3	O
%	O
and	O
15	O
%	O
in	O
different	B-UNK
tribal	B-UNK
and	O
urban	B-UNK
groups	B-UNK
.	O

 	O
remarkably	O
,	O
a	O
previously	B-UNK
unreported	O
deficient	B-UNK
variant	B-UNK
,	O
g6pd	B-UNK
orissa	B-UNK
(	O
44	O
ala	B-UNK
-	O
-	O
>	O
gly	B-UNK
)	O
,	O
is	O
responsible	B-UNK
for	O
most	O
of	O
the	O
g6pd	B-UNK
deficiency	I-UNK
in	O
tribal	B-UNK
indian	B-UNK
populations	B-UNK
but	O
is	O
not	O
found	B-UNK
in	O
urban	B-UNK
populations	B-UNK
,	O
where	O
most	O
of	O
the	O
g6pd	B-UNK
deficiency	I-UNK
is	O
due	O
to	O
the	O
g6pd	B-UNK
mediterranean	I-UNK
(	O
188	O
ser	B-UNK
-	O
-	O
>	O
phe	O
)	O
variant	B-UNK
.	O

 	O
the	O
kmnadp	O
of	O
g6pd	B-UNK
orissa	B-UNK
is	O
fivefold	O
higher	B-UNK
than	O
that	O
of	O
the	O
normal	B-UNK
enzyme	B-UNK
.	O

 	O
this	O
may	O
be	O
due	O
to	O
the	O
fact	O
that	O
the	O
alanine	O
residue	B-UNK
that	O
is	O
replaced	O
by	O
glycine	B-UNK
is	O
part	O
of	O
a	O
putative	B-UNK
coenzyme	O
-	O
binding	B-UNK
site	B-UNK
.	O
.	O

 	O
evidence	B-UNK
for	O
linkage	B-UNK
of	O
bipolar	B-DISEASE
disorder	I-DISEASE
to	O
chromosome	B-DISEASE
18	I-DISEASE
with	O
a	O
parent	B-UNK
-	O
of	O
-	O
origin	B-UNK
effect	B-UNK
.	O

 	O
a	O
susceptibility	B-UNK
gene	B-UNK
on	O
chromosome	B-DISEASE
18	I-DISEASE
and	O
a	O
parent	B-UNK
-	O
of	O
-	O
origin	B-UNK
effect	B-UNK
have	O
been	O
suggested	B-UNK
for	O
bipolar	B-DISEASE
affective	B-DISEASE
disorder	I-DISEASE
(	O
bpad	O
)	O
.	O

 	O
we	O
have	O
studied	B-UNK
28	O
nuclear	B-UNK
families	B-UNK
selected	B-UNK
for	O
apparent	B-UNK
unilineal	O
transmission	B-UNK
of	O
the	O
bpad	O
phenotype	B-UNK
,	O
by	O
using	O
31	O
polymorphic	B-UNK
markers	I-UNK
spanning	B-UNK
chromosome	B-DISEASE
18	I-DISEASE
.	O

 	O
evidence	B-UNK
for	O
linkage	B-UNK
was	O
tested	B-UNK
with	O
affected	B-UNK
-	O
sib	B-UNK
-	O
pair	O
and	O
lod	B-UNK
score	I-UNK
methods	B-UNK
under	O
two	O
definitions	O
of	O
the	O
affected	B-UNK
phenotype	B-UNK
.	O

 	O
the	O
affected	B-UNK
-	O
sibpair	O
analyses	B-UNK
indicated	B-UNK
excess	B-UNK
allele	B-UNK
sharing	I-UNK
for	O
markers	B-UNK
on	O
18p	O
within	O
the	O
region	B-UNK
reported	B-UNK
previously	B-UNK
.	O

 	O
the	O
greatest	B-UNK
sharing	B-UNK
was	O
at	B-DISEASE
d18s37	O
64	O
%	O
in	O
bipolar	B-DISEASE
and	O
recurrent	B-UNK
unipolar	O
(	O
rup	O
)	O
sib	B-UNK
pairs	B-UNK
(	O
p	B-UNK
=	O
.	O
0006	O
)	O
.	O

 	O
in	O
addition	B-UNK
,	O
excess	B-UNK
sharing	B-UNK
of	O
the	O
paternally	B-UNK
,	O
but	O
not	O
maternally	B-UNK
,	O
transmitted	B-UNK
alleles	B-UNK
was	O
observed	B-UNK
at	B-DISEASE
three	O
markers	B-UNK
on	O
18q	O
at	B-DISEASE
d18s41	O
,	O
51	O
bipolar	B-DISEASE
and	O
rup	O
sib	B-UNK
pairs	B-UNK
were	O
concordant	O
for	O
paternally	B-UNK
transmitted	B-UNK
alleles	B-UNK
,	O
and	O
21	O
pairs	B-UNK
were	O
discordant	B-UNK
(	O
p	B-UNK
=	O
0004	O
)	O
.	O

 	O
the	O
evidence	B-UNK
for	O
linkage	B-UNK
to	O
loci	B-UNK
on	O
both	O
18p	O
and	O
18q	O
was	O
strongest	O
in	O
the	O
11	O
paternal	B-UNK
pedigrees	B-UNK
,	O
i	O
.	O

 	O
e	B-UNK
e	B-UNK
.	O
,	O
those	O
in	O
which	O
the	O
father	B-UNK
or	O
one	O
of	O
the	O
fathers	B-UNK
sibs	B-UNK
is	O
affected	B-UNK
.	O

 	O
in	O
these	O
pedigrees	B-UNK
,	O
the	O
greatest	B-UNK
allele	B-UNK
sharing	I-UNK
(	O
81	O
%	O
;	O
p	B-UNK
=	O
.	O
00002	O
)	O
and	O
the	O
highest	B-UNK
lod	B-UNK
score	I-UNK
(	O
3	O
.	O
51	O
;	O
phi	O
=	O
0	O
.	O
0	O
)	O
were	O
observed	B-UNK
at	B-DISEASE
d18s41	O
.	O

 	O
our	O
results	B-UNK
provide	I-UNK
further	O
support	B-UNK
for	O
linkage	B-UNK
of	O
bpad	O
to	O
chromosome	B-DISEASE
18	I-DISEASE
and	O
the	O
first	O
molecular	B-UNK
evidence	B-UNK
for	O
a	O
parent	B-UNK
-	O
of	O
-	O
origin	B-UNK
effect	B-UNK
operating	O
in	O
this	O
disorder	O
.	O

 	O
the	O
number	B-UNK
of	O
loci	B-UNK
involved	B-UNK
,	O
and	O
their	O
precise	B-UNK
location	B-UNK
,	O
require	O
further	O
study	B-UNK

 	O
a	O
prevalent	B-UNK
mutation	B-UNK
for	O
galactosemia	B-UNK
among	O
black	B-UNK
americans	B-UNK
.	O

 	O
objective	B-UNK
to	O
define	B-UNK
the	O
mutation	B-UNK
causing	B-UNK
galactosemia	B-UNK
in	O
patients	B-UNK
of	O
black	B-UNK
american	I-UNK
origin	B-UNK
who	O
have	O
no	O
galactose	B-UNK
-	O
1	O
-	O
phosphate	B-UNK
uridyltransferase	B-UNK
(	O
galt	B-UNK
)	O
activity	B-UNK
in	O
erythrocytes	O
but	O
good	B-UNK
clinical	B-UNK
outcome	I-UNK
.	O

 	O
methods	B-UNK
we	O
discovered	O
a	O
mutation	B-UNK
caused	B-UNK
by	O
a	O
c	B-UNK
-	O
-	O
>	O
t	B-UNK
transition	I-UNK
at	B-DISEASE
base	B-UNK
-	O
pair	O
1158	O
of	O
the	O
galt	B-UNK
gene	B-UNK
that	O
results	B-UNK
in	O
a	O
serine	B-UNK
-	O
to	O
-	O
leucine	O
substitution	B-UNK
at	B-DISEASE
codon	B-UNK
135	O
(	O
s135l	B-UNK
)	O
.	O

 	O
we	O
developed	B-UNK
a	O
method	B-UNK
with	O
which	O
to	O
screen	B-UNK
populations	B-UNK
for	O
its	O
prevalence	B-UNK
.	O

 	O
we	O
compared	B-UNK
galactose	B-UNK
-	O
1	O
-	O
phosphate	B-UNK
uridyltransferase	B-UNK
among	O
erythrocytes	O
,	O
leukocytes	B-UNK
,	O
and	O
transformed	B-UNK
lymphoblasts	O
,	O
as	O
well	O
as	O
total	B-UNK
body	B-UNK
oxidation	B-UNK
of	O
d	B-UNK
-	O
(	O
13c	O
)	O
-	O
galactose	B-UNK
to	O
13co2	O
among	O
three	O
genotypes	O
for	O
galt	B-UNK
(	O
s135l	B-UNK
/	O
s135l	B-UNK
,	O
q188r	O
/	O
q188r	O
,	O
and	O
normal	B-UNK
/	O
normal	B-UNK
)	O
.	O

 	B-UNK
results	I-UNK
we	O
found	B-UNK
a	O
48	O
%	O
prevalence	B-UNK
of	O
the	O
s135l	B-UNK
mutation	B-UNK
among	O
17	O
black	B-UNK
american	I-UNK
patients	B-UNK
with	O
classic	B-UNK
galactosemia	B-UNK
and	O
a	O
1	O
%	O
prevalence	B-UNK
in	O
a	O
population	B-UNK
of	O
50	O
black	B-UNK
americans	B-UNK
without	O
galactosemia	B-UNK
.	O

 	O
the	O
s135l	B-UNK
mutation	B-UNK
was	O
not	O
found	B-UNK
in	O
84	O
white	B-UNK
patients	B-UNK
with	O
g	B-UNK
/	O
g	B-UNK
galactosemia	B-UNK
nor	O
in	O
87	O
white	B-UNK
control	B-UNK
subjects	B-UNK
without	O
galactosemia	B-UNK
.	O

 	O
we	O
found	B-UNK
normal	B-UNK
whole	O
body	B-UNK
oxidation	B-UNK
of	O
d	B-UNK
-	O
(	O
13c	O
)	O
-	O
galactose	B-UNK
by	O
the	O
patient	B-UNK
homozygous	B-UNK
for	O
s135l	B-UNK
and	O
various	O
degrees	B-UNK
of	O
enzyme	B-UNK
impairment	O
among	O
different	B-UNK
tissues	B-UNK
.	O

 	O
conclusions	B-UNK
the	O
s135l	B-UNK
mutation	B-UNK
in	O
the	O
galt	B-UNK
gene	B-UNK
is	O
a	O
prevalent	B-UNK
cause	B-UNK
of	O
galactosemia	B-UNK
among	O
black	B-UNK
patients	B-UNK
.	O

 	O
because	O
galt	B-UNK
activity	I-UNK
varies	B-UNK
in	O
different	B-UNK
tissues	B-UNK
of	O
patients	B-UNK
homozygous	B-UNK
for	O
s135l	B-UNK
,	O
they	O
may	O
have	O
a	O
better	B-UNK
clinical	B-UNK
outcome	I-UNK
than	O
patients	B-UNK
who	O
are	O
homozygous	B-UNK
for	O
q188r	O
when	O
both	O
are	O
treated	B-UNK
from	O
infancy	O
.	O
.	O

 	O
a	O
high	B-UNK
incidence	O
of	O
brca1	B-UNK
mutations	I-UNK
in	O
20	O
breast	B-DISEASE
-	I-DISEASE
ovarian	I-DISEASE
cancer	I-DISEASE
families	B-UNK
.	O

 	O
we	O
have	O
analyzed	B-UNK
20	O
breast	B-DISEASE
-	I-DISEASE
ovarian	I-DISEASE
cancer	I-DISEASE
families	B-UNK
,	O
the	O
majority	B-UNK
of	O
which	O
show	O
positive	B-UNK
evidence	B-UNK
of	O
linkage	B-UNK
to	O
chromosome	B-UNK
17q12	B-UNK
for	O
germ	O
-	O
line	B-UNK
mutations	B-UNK
in	O
the	O
brca1	B-UNK
gene	B-UNK
.	O

 	B-UNK
brca1	I-UNK
mutations	B-UNK
cosegregating	O
with	O
breast	B-UNK
and	O
ovarian	B-DISEASE
cancer	I-DISEASE
susceptibility	B-UNK
were	O
identified	B-UNK
in	O
16	O
families	B-UNK
,	O
including	B-UNK
1	O
family	B-UNK
with	O
a	O
case	B-UNK
of	O
male	B-DISEASE
breast	I-DISEASE
cancer	I-DISEASE
.	O

 	O
nine	O
of	O
these	O
mutations	B-UNK
have	O
not	O
been	O
reported	B-UNK
previously	B-UNK
.	O

 	O
the	O
majority	B-UNK
of	O
mutations	B-UNK
were	O
found	B-UNK
to	O
generate	B-UNK
a	O
premature	B-UNK
stop	B-UNK
codon	B-UNK
leading	B-UNK
to	O
the	O
formation	B-UNK
of	O
a	O
truncated	B-UNK
brca1	B-UNK
protein	B-UNK
of	O
2	O
%	O
-	O
88	O
%	O
of	O
the	O
expected	B-UNK
normal	B-UNK
length	O
.	O

 	O
two	O
mutations	B-UNK
altered	B-UNK
the	O
ring	O
finger	B-UNK
domain	B-UNK
.	O

 	O
sequencing	B-UNK
of	O
genomic	B-UNK
dna	I-UNK
led	B-UNK
to	O
the	O
identification	B-UNK
of	O
a	O
mutation	B-UNK
in	O
the	O
coding	B-UNK
region	I-UNK
of	O
brca1	B-UNK
in	O
12	O
families	B-UNK
,	O
and	O
cdna	B-UNK
analysis	B-UNK
revealed	B-UNK
an	O
abnormal	B-UNK
or	O
missing	O
brca1	B-UNK
transcript	B-UNK
in	O
4	O
of	O
the	O
8	O
remaining	B-UNK
families	B-UNK
.	O

 	O
a	O
total	B-UNK
of	O
eight	O
mutations	B-UNK
were	O
associated	B-UNK
with	O
a	O
reduced	B-UNK
quantity	O
of	O
brca1	B-UNK
transcript	B-UNK
.	O

 	O
we	O
were	O
unable	O
to	O
detect	B-UNK
brca1	B-UNK
mutations	I-UNK
in	O
4	O
of	O
the	O
20	O
families	B-UNK
,	O
but	O
only	O
1	O
of	O
these	O
was	O
clearly	B-UNK
linked	B-UNK
to	O
brca1	B-UNK
.	O

 	O
it	O
is	O
expected	B-UNK
that	O
the	O
majority	B-UNK
of	O
clear	B-UNK
examples	O
of	O
the	O
breast	B-UNK
-	O
ovarian	B-UNK
syndrome	B-DISEASE
will	O
be	O
associated	B-UNK
with	O
germ	O
-	O
line	B-UNK
mutations	B-UNK
in	O
the	O
coding	B-UNK
region	I-UNK
of	O
brca1	B-UNK
.	O
.	O

 	B-UNK
brca1	I-UNK
deficiency	B-UNK
results	B-UNK
in	O
early	B-UNK
embryonic	I-UNK
lethality	O
characterized	B-UNK
by	O
neuroepithelial	O
abnormalities	B-DISEASE
.	O

 	O
the	O
breast	B-UNK
and	O
ovarian	B-DISEASE
cancer	I-DISEASE
susceptibility	B-UNK
gene	B-UNK
,	O
brca1	B-UNK
,	O
has	O
been	O
cloned	B-UNK
and	O
shown	B-UNK
to	O
encode	O
a	O
zinc	B-DISEASE
-	O
finger	B-UNK
protein	B-UNK
of	O
unknown	B-UNK
function	B-UNK
.	O

 	O
mutations	B-UNK
in	O
brca1	B-UNK
account	B-UNK
for	O
at	B-DISEASE
least	O
80	O
%	O
of	O
families	B-UNK
with	O
both	O
breast	B-UNK
and	O
ovarian	B-DISEASE
cancer	I-DISEASE
,	O
as	O
well	O
as	O
some	O
non	B-UNK
-	O
familial	B-UNK
sporadic	B-UNK
ovarian	B-UNK
cancers	B-DISEASE
.	O

 	O
the	O
loss	B-UNK
of	O
wild	B-UNK
-	O
type	B-UNK
brca1	B-UNK
in	O
tumours	B-UNK
of	O
individuals	B-UNK
carrying	B-UNK
one	O
nonfunctional	O
brca1	B-UNK
allele	B-UNK
suggests	B-UNK
that	O
brca1	B-UNK
encodes	B-UNK
a	O
tumour	B-UNK
suppressor	I-UNK
that	O
may	O
inhibit	O
the	O
proliferation	B-UNK
of	O
mammary	B-UNK
epithelial	I-UNK
cells	B-UNK
.	O

 	O
to	O
examine	O
the	O
role	B-UNK
of	O
brca1	B-UNK
in	O
normal	B-UNK
tissue	B-UNK
growth	B-UNK
and	O
differentiation	B-UNK
,	O
and	O
to	O
generate	B-UNK
a	O
potential	B-UNK
model	B-UNK
for	O
the	O
cancer	B-DISEASE
susceptibility	B-UNK
associated	B-UNK
with	O
loss	B-UNK
of	O
brca1	B-UNK
function	B-UNK
,	O
we	O
have	O
created	B-UNK
a	O
mouse	B-UNK
line	B-UNK
carrying	B-UNK
a	O
mutation	B-UNK
in	O
one	O
brca1	B-UNK
allele	B-UNK
.	O

 	O
analysis	B-UNK
of	O
mice	B-UNK
homozygous	B-UNK
for	O
the	O
mutant	B-UNK
allele	I-UNK
indicate	B-UNK
that	O
brca1	B-UNK
is	O
critical	B-UNK
for	O
normal	B-UNK
development	B-UNK
,	O
as	O
these	O
mice	B-UNK
died	O
in	O
utero	O
between	O
10	O
and	O
13	O
days	O
of	O
gestation	O
(	O
e10	O
-	O
e13	O
)	O
.	O

 	O
abnormalities	B-DISEASE
in	O
brca1	B-UNK
-	O
deficient	B-UNK
embryos	B-UNK
were	O
most	O
evident	O
in	O
the	O
neural	B-UNK
tube	O
,	O
with	O
40	O
%	O
of	O
the	O
embryos	B-UNK
presenting	B-UNK
with	O
varying	B-UNK
degrees	B-UNK
of	O
spina	B-DISEASE
bifida	I-DISEASE
and	O
anencephaly	B-DISEASE
.	O

 	O
in	O
addition	B-UNK
,	O
the	O
neuroepithelium	O
in	O
brca1	B-UNK
-	O
deficient	B-UNK
embryos	B-UNK
appeared	B-UNK
disorganized	O
,	O
with	O
signs	B-UNK
of	O
both	O
rapid	B-UNK
proliferation	B-UNK
and	O
excessive	B-UNK
cell	B-UNK
death	B-DISEASE
.	O
.	O

 	O
identification	B-UNK
of	O
mutations	B-UNK
in	O
the	O
ald	B-UNK
-	O
gene	B-UNK
of	O
20	O
families	B-UNK
with	O
adrenoleukodystrophy	B-DISEASE
/	O
adrenomyeloneuropathy	B-UNK
.	O

 	O
adrenoleukodystrophy	B-DISEASE
(	O
ald	B-UNK
)	O
,	O
an	O
x	B-UNK
-	O
linked	B-UNK
inherited	B-UNK
metabolic	B-UNK
disorder	O
,	O
is	O
the	O
most	O
frequent	B-UNK
inborn	B-UNK
peroxisomal	B-UNK
disease	B-DISEASE
.	O

 	O
it	O
leads	B-UNK
to	O
demyelination	B-UNK
in	O
the	O
central	B-UNK
and	O
peripheral	B-UNK
nervous	B-UNK
system	I-UNK
.	O

 	B-UNK
defective	I-UNK
beta	B-UNK
-	O
oxidation	B-UNK
of	O
saturated	O
very	O
long	B-UNK
chain	I-UNK
fatty	I-UNK
acids	O
(	O
vlcfas	O
;	O
c22	O
0	O
-	O
c26	B-UNK
0	O
)	O
in	O
peroxisomes	O
has	O
been	O
shown	B-UNK
to	O
lead	B-UNK
to	O
an	O
accumulation	B-UNK
of	O
vlcfas	O
in	O
leukoid	O
areas	B-UNK
of	O
the	O
central	B-UNK
nervous	I-UNK
system	I-UNK
,	O
peripheral	B-UNK
nerves	O
,	O
adrenal	B-UNK
gland	O
,	O
and	O
blood	B-UNK
.	O

 	O
the	O
ald	B-UNK
gene	B-UNK
has	O
been	O
recently	B-UNK
identified	B-UNK
and	O
encodes	B-UNK
a	O
745	O
-	O
amino	O
-	O
acid	O
protein	B-UNK
.	O

 	O
we	O
screened	O
patients	B-UNK
with	O
adrenoleukodystrophy	B-DISEASE
/	O
adrenomyeloneuropathy	B-UNK
(	O
ald	B-UNK
/	O
amn	B-UNK
)	O
from	O
20	O
kindreds	B-UNK
for	O
mutations	B-UNK
in	O
the	O
ald	B-UNK
gene	B-UNK
.	O

 	O
eleven	O
missense	B-UNK
and	O
two	O
nonsense	B-UNK
mutations	B-UNK
,	O
five	O
deletions	B-UNK
,	O
and	O
one	O
insertion	B-UNK
were	O
detected	B-UNK
by	O
direct	B-UNK
sequencing	I-UNK
of	O
eight	O
reverse	B-UNK
transcribed	B-UNK
fragments	B-UNK
of	O
the	O
ald	B-UNK
-	O
gene	B-UNK
mrna	B-UNK
.	O

 	O
four	O
mutations	B-UNK
could	O
be	O
shown	B-UNK
to	O
be	O
de	B-UNK
novo	I-UNK
.	O

 	O
all	O
mutations	B-UNK
could	O
be	O
confirmed	B-UNK
in	O
carriers	B-UNK
by	O
sequencing	B-UNK
genomic	B-UNK
dna	I-UNK
.	O

 	O
no	O
correlation	B-UNK
between	O
the	O
type	B-UNK
of	O
mutation	B-UNK
and	O
the	O
severity	B-UNK
of	O
the	O
phenotype	B-UNK
could	O
be	O
observed	B-UNK
.	O

 	O
the	O
mutations	B-UNK
were	O
not	O
detected	B-UNK
in	O
the	O
ald	B-UNK
gene	B-UNK
of	O
30	O
healthy	B-UNK
persons	B-UNK
.	O
.	O

 	O
the	O
murine	B-UNK
homolog	B-UNK
of	O
the	O
human	B-UNK
breast	B-UNK
and	O
ovarian	B-DISEASE
cancer	I-DISEASE
susceptibility	B-UNK
gene	B-UNK
brca1	B-UNK
maps	B-UNK
to	O
mouse	B-UNK
chromosome	I-UNK
11d	O
.	O

 	O
the	O
recently	B-UNK
cloned	B-UNK
human	B-UNK
breast	B-UNK
and	O
ovarian	B-DISEASE
cancer	I-DISEASE
susceptibility	B-UNK
gene	B-UNK
,	O
brca1	B-UNK
,	O
is	O
located	B-UNK
on	O
human	B-UNK
chromosome	I-UNK
17q21	B-UNK
.	O

 	O
we	O
have	O
isolated	B-UNK
murine	B-UNK
genomic	B-UNK
clones	B-UNK
containing	B-UNK
brca1	I-UNK
as	O
a	O
first	O
step	O
in	O
generating	O
a	O
mouse	B-UNK
model	I-UNK
for	O
the	O
loss	B-UNK
of	O
brca1	B-UNK
function	B-UNK
.	O

 	O
a	O
mouse	B-UNK
genomic	B-UNK
library	B-UNK
was	O
screened	O
using	O
probes	B-UNK
corresponding	B-UNK
to	O
exon	B-UNK
11	O
of	O
the	O
human	B-UNK
brca1	B-UNK
gene	B-UNK
.	O

 	O
two	O
overlapping	B-UNK
mouse	B-UNK
clones	B-UNK
were	O
identified	B-UNK
that	O
hybridized	O
to	O
human	B-UNK
brca1	B-UNK
exons	B-UNK
9	O
-	O
12	O
.	O

 	O
sequence	B-UNK
analysis	B-UNK
of	O
1	O
.	O

 	O
4	O
kb	B-UNK
of	O
the	O
region	B-UNK
of	O
these	O
clones	B-UNK
corresponding	B-UNK
to	O
part	O
of	O
human	B-UNK
exon	B-UNK
11	O
revealed	B-UNK
72	O
%	O
nucleic	O
acid	O
identity	O
but	O
only	O
50	O
%	O
amino	B-UNK
acid	I-UNK
identity	O
with	O
the	O
human	B-UNK
gene	B-UNK
.	O

 	O
the	O
longest	O
of	O
the	O
mouse	B-UNK
brca1	I-UNK
genomic	B-UNK
clones	B-UNK
maps	B-UNK
to	O
chromosome	B-UNK
11d	O
,	O
as	O
determined	B-UNK
by	O
two	O
-	O
color	B-UNK
fluorescence	B-UNK
in	O
situ	B-UNK
hybridization	I-UNK
.	O

 	O
the	O
synteny	B-UNK
to	O
human	B-UNK
chromosome	I-UNK
17	O
was	O
confirmed	B-UNK
by	O
cohybridization	O
with	O
the	O
mouse	B-UNK
probe	B-UNK
for	O
the	O
nf1	O
-	O
gene	B-UNK
.	O

 	O
this	O
comparative	O
study	B-UNK
confirms	B-UNK
that	O
the	O
relative	B-UNK
location	B-UNK
of	O
the	O
brca1	B-UNK
gene	B-UNK
has	O
been	O
conserved	B-UNK
between	O
mice	B-UNK
and	O
humans	B-UNK
.	O

 	O
atelosteogenesis	B-DISEASE
type	B-UNK
ii	I-UNK
is	O
caused	B-UNK
by	O
mutations	B-UNK
in	O
the	O
diastrophic	B-DISEASE
dysplasia	I-DISEASE
sulfate	B-UNK
-	O
transporter	B-UNK
gene	B-UNK
(	O
dtdst	B-UNK
)	O
:	O
evidence	B-UNK
for	O
a	O
phenotypic	B-UNK
series	B-UNK
involving	B-UNK
three	O
chondrodysplasias	O
.	O

 	O
atelosteogenesis	B-DISEASE
type	B-UNK
ii	I-UNK
(	O
ao	B-UNK
ii	B-UNK
)	O
is	O
a	O
neonatally	O
lethal	B-UNK
chondrodysplasia	B-DISEASE
whose	O
clinical	B-UNK
and	O
histological	O
characteristics	B-UNK
resemble	O
those	O
of	O
another	O
chondrodysplasia	B-DISEASE
,	O
the	O
much	O
less	O
severe	B-UNK
diastrophic	B-DISEASE
dysplasia	I-DISEASE
(	O
dtd	O
)	O
.	O

 	O
the	O
similarity	B-UNK
suggests	B-UNK
a	O
shared	B-UNK
pathogenesis	O
involving	B-UNK
lesions	B-UNK
in	O
the	O
same	O
biochemical	B-UNK
pathway	B-UNK
and	O
perhaps	O
the	O
same	O
gene	B-UNK
.	O

 	O
dtd	O
is	O
caused	B-UNK
by	O
mutations	B-UNK
in	O
the	O
recently	B-UNK
identified	B-UNK
diastrophic	B-DISEASE
dysplasia	I-DISEASE
sulfate	B-UNK
-	O
transporter	B-UNK
gene	B-UNK
(	O
dtdst	B-UNK
)	O
.	O

 	O
here	O
,	O
we	O
report	B-UNK
that	O
aoii	O
patients	B-UNK
also	O
have	O
dtdst	B-UNK
mutations	B-UNK
,	O
which	O
lead	B-UNK
to	O
defective	B-UNK
uptake	B-UNK
of	O
inorganic	O
sulfate	B-UNK
and	O
insufficient	O
sulfation	O
of	O
macromolecules	O
by	O
patient	B-UNK
mesenchymal	B-UNK
cells	B-UNK
in	O
vitro	B-UNK
.	O

 	O
together	O
with	O
our	O
recent	B-UNK
observation	B-UNK
that	O
a	O
third	O
even	O
more	O
severe	B-UNK
chondrodysplasia	B-DISEASE
,	O
achondrogenesis	B-DISEASE
type	B-UNK
ib	O
,	O
is	O
also	O
caused	B-UNK
by	O
mutations	B-UNK
in	O
dtdst	B-UNK
,	O
these	O
results	B-UNK
demonstrate	B-UNK
a	O
phenotypic	B-UNK
series	B-UNK
of	O
three	O
chondrodysplasias	O
of	O
increasing	B-UNK
severity	B-UNK
caused	B-UNK
by	O
lesions	B-UNK
in	O
a	O
single	B-UNK
sulfate	B-UNK
-	O
transporter	B-UNK
gene	B-UNK
.	O

 	O
the	O
severity	B-UNK
of	O
the	O
phenotype	B-UNK
appears	B-UNK
to	O
be	O
correlated	B-UNK
with	O
the	O
predicted	B-UNK
effect	B-UNK
of	O
the	O
mutations	B-UNK
on	O
the	O
residual	B-UNK
activity	B-UNK
of	O
the	O
dtdst	B-UNK
protein	B-UNK
.	O
.	O

 	B-UNK
haplotype	I-UNK
and	O
phenotype	B-UNK
analysis	B-UNK
of	O
six	O
recurrent	B-UNK
brca1	B-UNK
mutations	I-UNK
in	O
61	O
families	B-UNK
:	O
results	B-UNK
of	O
an	O
international	B-UNK
study	B-UNK
.	O

 	O
several	O
brca1	B-UNK
mutations	I-UNK
have	O
now	O
been	O
found	B-UNK
to	O
occur	B-UNK
in	O
geographically	O
diverse	B-UNK
breast	B-UNK
and	O
ovarian	B-DISEASE
cancer	I-DISEASE
families	B-UNK
.	O

 	O
to	O
investigate	O
mutation	B-UNK
origin	B-UNK
and	O
mutation	B-UNK
-	O
specific	B-UNK
phenotypes	B-UNK
due	O
to	O
brca1	B-UNK
,	O
we	O
constructed	B-UNK
a	O
haplotype	B-UNK
of	O
nine	O
polymorphic	B-UNK
markers	I-UNK
within	O
or	O
immediately	B-UNK
flanking	B-UNK
the	O
brca1	B-UNK
locus	B-UNK
in	O
a	O
set	B-UNK
of	O
61	O
breast	B-UNK
/	O
ovarian	B-DISEASE
cancer	I-DISEASE
families	B-UNK
selected	B-UNK
for	O
having	B-UNK
one	O
of	O
six	O
recurrent	B-UNK
brca1	B-UNK
mutations	I-UNK
.	O

 	O
tests	B-UNK
of	O
both	O
mutations	B-UNK
and	O
family	B-UNK
-	O
specific	B-UNK
differences	B-UNK
in	O
age	B-UNK
at	B-DISEASE
diagnosis	B-UNK
were	O
not	O
significant	B-UNK
.	O

 	O
a	O
comparison	B-UNK
of	O
the	O
six	O
mutations	B-UNK
in	O
the	O
relative	B-UNK
proportions	O
of	O
cases	B-UNK
of	O
breast	B-UNK
and	O
ovarian	B-DISEASE
cancer	I-DISEASE
was	O
suggestive	O
of	O
an	O
effect	B-UNK
(	O
p	B-UNK
=	O
.	O
069	O
)	O
,	O
with	O
57	O
%	O
of	O
women	B-UNK
presumed	B-UNK
affected	B-UNK
because	O
of	O
the	O
1294	O
del	O
40	O
brca1	B-UNK
mutation	B-UNK
having	B-UNK
ovarian	B-DISEASE
cancer	I-DISEASE
,	O
compared	B-UNK
with	O
14	O
%	O
of	O
affected	B-UNK
women	B-UNK
with	O
the	O
splice	O
-	O
site	B-UNK
mutation	B-UNK
in	O
intron	B-UNK
5	O
of	O
brca1	B-UNK
.	O

 	O
for	O
the	O
brca1	B-UNK
mutations	I-UNK
studied	B-UNK
here	O
,	O
the	O
individual	B-UNK
mutations	B-UNK
are	O
estimated	B-UNK
to	O
have	O
arisen	O
9	O
-	O
170	O
generations	B-UNK
ago	B-UNK
.	O

 	O
in	O
general	B-UNK
,	O
a	O
high	B-UNK
degree	B-UNK
of	O
haplotype	B-UNK
conservation	B-UNK
across	O
the	O
region	B-UNK
was	O
observed	B-UNK
,	O
with	O
haplotype	B-UNK
differences	B-UNK
most	O
often	O
due	O
to	O
mutations	B-UNK
in	O
the	O
short	B-UNK
-	O
tandem	O
-	O
repeat	B-UNK
markers	B-UNK
,	O
although	O
some	O
likely	B-UNK
instances	O
of	O
recombination	B-UNK
also	O
were	O
observed	B-UNK
.	O

 	O
for	O
several	O
of	O
the	O
instances	O
,	O
there	O
was	O
evidence	B-UNK
for	O
multiple	B-UNK
,	O
independent	B-UNK
,	O
brca1	B-UNK
mutational	B-UNK
events	I-UNK
.	O

 	O
isolation	B-UNK
of	O
the	O
mouse	B-UNK
homologue	B-UNK
of	O
brca1	B-UNK
and	O
genetic	B-UNK
mapping	B-UNK
to	O
mouse	B-UNK
chromosome	I-UNK
11	O
.	O

 	O
the	O
brca1	B-UNK
gene	B-UNK
is	O
in	O
large	B-UNK
part	O
responsible	B-UNK
for	O
hereditary	B-UNK
human	B-UNK
breast	B-UNK
and	O
ovarian	B-DISEASE
cancer	I-DISEASE
.	O

 	O
here	O
we	O
report	B-UNK
the	O
isolation	B-UNK
of	O
the	O
murine	B-UNK
brca1	B-UNK
homologue	I-UNK
cdna	B-UNK
clones	B-UNK
.	O

 	O
in	O
addition	B-UNK
,	O
we	O
identified	B-UNK
genomic	B-UNK
p1	B-UNK
clones	B-UNK
that	O
contain	B-UNK
most	O
,	O
if	O
not	O
all	O
,	O
of	O
the	O
mouse	B-UNK
brca1	I-UNK
locus	B-UNK
.	O

 	B-UNK
dna	I-UNK
sequence	B-UNK
analysis	B-UNK
revealed	B-UNK
that	O
the	O
mouse	B-UNK
and	O
human	B-UNK
coding	B-UNK
regions	B-UNK
are	O
75	O
%	O
identical	B-UNK
at	B-DISEASE
the	O
nucleotide	B-UNK
level	B-UNK
while	O
the	O
predicted	B-UNK
amino	B-UNK
acid	I-UNK
identity	O
is	O
only	O
58	O
%	O
.	O

 	O
a	O
dna	B-UNK
sequence	I-UNK
variant	B-UNK
in	O
the	O
brca1	B-UNK
locus	B-UNK
was	O
identified	B-UNK
and	O
used	O
to	O
map	B-UNK
this	O
gene	B-UNK
on	O
a	O
(	O
mus	O
m	B-UNK
.	O
musculus	O
czech	O
ii	B-UNK
x	B-UNK
c57bl	O
/	O
ksj	O
)	O
f1	O
x	B-UNK
c57bl	O
/	O
ksj	O
intersubspecific	O
backcross	B-UNK
to	O
distal	B-UNK
mouse	B-UNK
chromosome	I-UNK
11	O
.	O

 	O
the	O
mapping	B-UNK
of	O
this	O
gene	B-UNK
to	O
a	O
region	B-UNK
highly	B-UNK
syntenic	O
with	O
human	B-UNK
chromosome	I-UNK
17	O
,	O
coupled	B-UNK
with	O
southern	O
and	O
northern	B-UNK
analyses	B-UNK
,	O
confirms	B-UNK
that	O
we	O
isolated	B-UNK
the	O
murine	B-UNK
brca1	B-UNK
homologue	I-UNK
rather	O
than	O
a	O
related	B-UNK
ring	O
finger	B-UNK
gene	B-UNK
.	O

 	O
the	O
isolation	B-UNK
of	O
the	O
mouse	B-UNK
brca1	I-UNK
homologue	B-UNK
will	O
facilitate	B-UNK
the	O
creation	O
of	O
mouse	B-UNK
models	B-UNK
for	O
germline	B-UNK
brca1	B-UNK
defects	B-UNK
.	O
.	O

 	O
emerin	B-UNK
deficiency	B-UNK
at	B-DISEASE
the	O
nuclear	B-UNK
membrane	I-UNK
in	O
patients	B-UNK
with	O
emery	B-DISEASE
-	I-DISEASE
dreifuss	I-DISEASE
muscular	I-DISEASE
dystrophy	I-DISEASE
.	O

 	O
mutations	B-UNK
in	O
the	O
sta	O
gene	B-UNK
at	B-DISEASE
the	O
xq28	B-UNK
locus	B-UNK
have	O
been	O
found	B-UNK
in	O
patients	B-UNK
with	O
x	B-DISEASE
-	I-DISEASE
linked	I-DISEASE
emery	I-DISEASE
-	I-DISEASE
dreifuss	I-DISEASE
muscular	I-DISEASE
dystrophy	I-DISEASE
(	O
edmd	B-UNK
)	O
.	O

 	O
this	O
gene	B-UNK
encodes	B-UNK
a	O
hitherto	B-UNK
unknown	B-UNK
protein	B-UNK
named	O
emerin	B-UNK
.	O

 	O
to	O
elucidate	O
the	O
subcellular	B-UNK
localization	B-UNK
of	O
emerin	B-UNK
,	O
we	O
raised	B-UNK
two	O
antisera	O
against	O
synthetic	B-UNK
peptide	B-UNK
fragments	B-UNK
predicted	B-UNK
from	O
emerin	B-UNK
cdna	B-UNK
.	O

 	O
using	O
both	O
antisera	O
,	O
we	O
found	B-UNK
positive	B-UNK
nuclear	B-UNK
membrane	I-UNK
staining	B-UNK
in	O
skeletal	B-UNK
,	O
cardiac	B-UNK
and	O
smooth	B-UNK
muscles	B-UNK
in	O
the	O
normal	B-UNK
controls	B-UNK
and	O
in	O
patients	B-UNK
with	O
neuromuscular	B-DISEASE
diseases	I-DISEASE
other	O
than	O
edmd	B-UNK
.	O

 	O
in	O
contrast	B-UNK
,	O
a	O
deficiency	B-UNK
in	O
immunofluorescent	O
staining	B-UNK
of	O
skeletal	B-UNK
and	O
cardiac	B-UNK
muscle	B-UNK
from	O
edmd	B-UNK
patients	B-UNK
was	O
observed	B-UNK
.	O

 	O
a	O
34	O
kd	O
protein	B-UNK
is	O
immunoreactive	B-UNK
with	O
the	O
antisera	O
-	O
-	O
the	O
protein	B-UNK
is	O
equivalent	O
to	O
that	O
predicted	B-UNK
for	O
emerin	B-UNK
.	O

 	O
together	O
,	O
our	O
findings	B-UNK
suggest	B-UNK
the	O
specific	B-UNK
deficiency	B-UNK
of	O
emerin	B-UNK
in	O
the	O
nuclear	B-UNK
membrane	I-UNK
of	O
muscle	B-UNK
cells	B-UNK
in	O
patients	B-UNK
with	O
edmd	B-UNK
.	O
.	O

 	O
growth	B-DISEASE
retardation	I-DISEASE
and	O
tumour	B-UNK
inhibition	B-UNK
by	O
brca1	B-UNK
.	O

 	B-UNK
inherited	I-UNK
mutations	B-UNK
in	O
brca1	B-UNK
predispose	B-UNK
to	O
breast	B-UNK
and	O
ovarian	B-DISEASE
cancer	I-DISEASE
,	O
but	O
the	O
role	B-UNK
of	O
brca1	B-UNK
in	O
sporadic	B-UNK
breast	B-UNK
and	O
ovarian	B-DISEASE
cancer	I-DISEASE
has	O
previously	B-UNK
been	O
elusive	O
.	O

 	O
here	O
,	O
we	O
show	O
that	O
retroviral	B-UNK
transfer	O
of	O
the	O
wild	B-UNK
-	O
type	B-UNK
brca1	B-UNK
gene	B-UNK
inhibits	B-UNK
growth	B-UNK
in	O
vitro	B-UNK
of	O
all	O
breast	B-UNK
and	O
ovarian	B-DISEASE
cancer	I-DISEASE
cell	B-UNK
lines	B-UNK
tested	B-UNK
,	O
but	O
not	O
colon	O
or	O
lung	B-DISEASE
cancer	I-DISEASE
cells	B-UNK
or	O
fibroblasts	B-UNK
.	O

 	B-UNK
mutant	I-UNK
brca1	B-UNK
has	O
no	O
effect	B-UNK
on	O
growth	B-UNK
of	O
breast	B-DISEASE
cancer	I-DISEASE
cells	B-UNK
;	O
ovarian	B-DISEASE
cancer	I-DISEASE
cell	B-UNK
growth	B-UNK
is	O
not	O
affected	B-UNK
by	O
brca1	B-UNK
mutations	I-UNK
in	O
the	O
5	O
portion	B-UNK
of	O
the	O
gene	B-UNK
,	O
but	O
is	O
inhibited	B-UNK
by	O
3	O
brca1	B-UNK
mutations	I-UNK
.	O

 	O
development	B-UNK
of	O
mcf	O
-	O
7	O
tumours	B-UNK
in	O
nude	O
mice	B-UNK
is	O
inhibited	B-UNK
when	O
mcf	O
-	O
7	O
cells	B-UNK
are	O
transfected	B-UNK
with	O
wild	B-UNK
-	O
type	B-UNK
,	O
but	O
not	O
mutant	B-UNK
,	O
brca1	B-UNK
.	O

 	O
most	O
importantly	O
,	O
among	O
mice	B-UNK
with	O
established	B-UNK
mcf	O
-	O
7	O
tumours	B-UNK
,	O
peritoneal	B-UNK
treatment	B-UNK
with	O
a	O
retroviral	B-UNK
vector	O
expressing	B-UNK
wild	B-UNK
-	O
type	B-UNK
brca1	B-UNK
significantly	B-UNK
inhibits	B-UNK
tumour	B-UNK
growth	B-UNK
and	O
increased	B-UNK
survival	B-UNK
.	O
.	O

